data_6nhw_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6nhw _Structure_validation_residue.Date_analyzed 2019-02-22 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.073 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 27.4 t 57.26 55.1 6.13 Favored 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.021 0.928 . . . . 0.0 111.942 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.84 -26.87 68.52 Favored 'General case' 0 N--CA 1.525 3.283 0 C-N-CA 123.989 0.915 . . . . 0.0 110.547 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.4 m -61.71 -26.44 68.04 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 123.498 0.719 . . . . 0.0 110.237 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.9 -35.43 63.55 Favored Glycine 0 N--CA 1.502 3.035 0 C-N-CA 125.108 1.337 . . . . 0.0 115.354 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 16.9 pt -58.0 -33.73 47.03 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.34 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.3 pp -55.71 -36.41 42.69 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.002 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -174.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 5.2 tp -73.49 -38.43 52.69 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.696 0 CA-C-N 119.472 1.033 . . . . 0.0 109.039 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.31 -45.36 88.76 Favored Glycine 1 N--CA 1.522 4.389 0 N-CA-C 114.891 0.716 . . . . 0.0 114.891 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.93 -36.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.971 0 CA-C-N 117.503 0.651 . . . . 0.0 110.724 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.7 p -58.92 -40.61 85.08 Favored 'General case' 0 N--CA 1.535 3.785 0 CA-C-O 121.082 0.467 . . . . 0.0 111.799 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.74 -39.31 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 123.753 0.821 . . . . 0.0 111.877 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.08 79.6 Favored 'General case' 0 N--CA 1.529 3.477 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.38 -50.02 56.0 Favored 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 m -63.75 -38.58 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.87 -32.86 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 CA-C-N 118.848 0.749 . . . . 0.0 110.723 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 5.9 tt -65.08 -37.88 88.95 Favored 'General case' 0 N--CA 1.536 3.829 0 CA-C-N 117.878 0.308 . . . . 0.0 110.708 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.8 mt -61.98 -36.67 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.84 0 C-N-CA 123.079 0.552 . . . . 0.0 110.351 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.21 -40.35 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.68 0 C-N-CA 122.968 0.507 . . . . 0.0 110.07 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.8 -32.59 67.71 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.191 0.596 . . . . 0.0 111.528 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.9 t -68.19 -37.96 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 C-N-CA 123.141 0.577 . . . . 0.0 109.87 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -70.1 -34.78 73.57 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.403 0.681 . . . . 0.0 110.086 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.02 -38.13 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 C-N-CA 123.968 0.907 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 79.8 m -60.07 -38.53 83.13 Favored 'General case' 0 N--CA 1.527 3.379 0 CA-C-O 121.195 0.522 . . . . 0.0 109.748 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -74.39 -37.8 63.32 Favored 'General case' 0 N--CA 1.519 2.998 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.208 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.0 p -63.76 -46.31 85.84 Favored 'General case' 0 N--CA 1.531 3.615 0 CA-C-O 121.434 0.635 . . . . 0.0 109.595 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.49 -19.35 62.94 Favored 'General case' 0 N--CA 1.53 3.561 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.563 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.7 tp -87.09 -28.21 22.66 Favored 'General case' 1 N--CA 1.541 4.115 0 CA-C-N 119.17 0.895 . . . . 0.0 109.11 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.8 m0 -78.68 107.74 11.59 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -168.0 88.99 0.27 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 11.6 tptp 71.92 -164.21 0.13 Allowed 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 124.052 0.941 . . . . 0.0 109.135 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.531 3.61 0 C-N-CA 124.935 1.294 . . . . 0.0 107.69 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.523 3.213 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.09 -36.44 84.32 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 124.299 1.04 . . . . 0.0 109.741 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.6 t -57.38 -25.64 59.81 Favored 'General case' 0 N--CA 1.525 3.316 0 C-N-CA 123.612 0.765 . . . . 0.0 110.907 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.44 -34.48 59.79 Favored Glycine 0 N--CA 1.512 3.752 0 C-N-CA 124.948 1.261 . . . . 0.0 114.544 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 17.3 pt -59.39 -34.8 55.43 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -176.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.21 -47.37 80.96 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.333 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.6 tt -72.48 -32.95 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.55 -29.32 47.68 Favored Glycine 0 N--CA 1.515 3.906 0 C-N-CA 123.444 0.545 . . . . 0.0 113.181 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 m -60.0 -37.38 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 CA-C-N 117.551 0.676 . . . . 0.0 111.8 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 1.3 t -61.05 -39.06 88.41 Favored 'General case' 1 N--CA 1.54 4.063 0 CA-C-O 120.825 0.345 . . . . 0.0 111.539 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 47.4 t -60.99 -31.5 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 123.76 0.824 . . . . 0.0 110.517 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.19 77.83 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 123.06 0.544 . . . . 0.0 111.316 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.69 -50.2 58.84 Favored 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.22 -38.56 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.726 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 27.0 m -65.36 -32.01 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 CA-C-N 118.584 0.629 . . . . 0.0 111.394 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 54.1 mt -66.73 -34.57 78.13 Favored 'General case' 0 N--CA 1.533 3.701 0 O-C-N 122.026 -0.421 . . . . 0.0 111.091 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 59.7 mt -61.35 -49.65 83.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.049 0 CA-C-N 118.066 0.394 . . . . 0.0 111.595 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.65 -37.01 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.71 0 O-C-N 121.902 -0.499 . . . . 0.0 110.099 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.55 -47.15 86.66 Favored 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 123.667 0.787 . . . . 0.0 112.603 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.69 -34.38 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.615 0 O-C-N 121.842 -0.536 . . . . 0.0 110.527 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -63.34 -44.36 95.11 Favored 'General case' 0 N--CA 1.528 3.441 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.92 -37.76 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.3 m -67.02 -32.85 74.34 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 122.988 0.515 . . . . 0.0 110.478 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -66.96 -32.26 73.38 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 123.498 0.719 . . . . 0.0 111.054 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 50.6 m -63.82 -29.34 70.55 Favored 'General case' 0 N--CA 1.528 3.454 0 C-N-CA 123.299 0.639 . . . . 0.0 111.244 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.27 -27.35 68.98 Favored 'General case' 0 N--CA 1.528 3.448 0 C-N-CA 123.45 0.7 . . . . 0.0 110.952 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 N--CA 1.538 3.944 0 C-N-CA 123.79 0.836 . . . . 0.0 109.893 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.52 3.074 0 CA-C-O 121.54 0.686 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 pp -62.9 -26.43 68.79 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 123.882 0.873 . . . . 0.0 111.053 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 34.8 t -62.34 -25.88 68.14 Favored 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 123.476 0.71 . . . . 0.0 110.999 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.48 -38.09 86.27 Favored Glycine 0 N--CA 1.514 3.851 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.91 -35.35 59.38 Favored 'Isoleucine or valine' 1 N--CA 1.555 4.803 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.01 -32.67 33.95 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.41 -31.78 55.34 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.194 0 CA-C-N 119.134 0.879 . . . . 0.0 108.781 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.77 -42.65 79.24 Favored Glycine 0 N--CA 1.516 3.987 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.746 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.48 -37.16 77.38 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 CA-C-N 117.989 0.895 . . . . 0.0 110.384 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 26.4 m -62.51 -47.6 83.25 Favored 'General case' 0 N--CA 1.519 3.002 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.502 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 9.4 p -71.21 -31.47 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.359 0 C-N-CA 123.649 0.78 . . . . 0.0 111.171 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.83 60.63 Favored 'General case' 0 N--CA 1.529 3.505 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.99 -50.34 64.63 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.11 -41.5 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.54 -32.65 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.617 0 O-C-N 121.826 -0.546 . . . . 0.0 112.166 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -75.52 -39.95 57.72 Favored 'General case' 0 N--CA 1.528 3.429 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 19.3 pt -69.49 -38.84 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 CA-C-N 118.562 0.619 . . . . 0.0 111.762 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.67 -37.29 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 O-C-N 121.592 -0.692 . . . . 0.0 109.967 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.99 83.8 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 123.737 0.815 . . . . 0.0 113.045 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.53 -34.26 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 O-C-N 121.811 -0.556 . . . . 0.0 110.223 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -64.08 -44.26 92.92 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.96 -37.59 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 87.8 m -64.66 -27.83 69.19 Favored 'General case' 0 N--CA 1.525 3.325 0 C-N-CA 123.038 0.535 . . . . 0.0 110.878 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -70.93 -35.75 72.36 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 122.901 0.48 . . . . 0.0 110.295 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.4 t -63.92 -23.24 67.27 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.499 0.72 . . . . 0.0 112.18 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.69 -21.57 65.32 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 123.336 0.655 . . . . 0.0 110.749 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.68 0.74 55.27 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 123.66 0.784 . . . . 0.0 109.925 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.26 -76.49 0.07 Allowed 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.503 0.721 . . . . 0.0 110.13 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 55.8 -135.61 1.29 Allowed 'General case' 0 N--CA 1.522 3.162 0 C-N-CA 123.891 0.877 . . . . 0.0 111.0 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 57.21 78.56 0.22 Allowed 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 124.199 1.0 . . . . 0.0 111.753 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.527 3.402 0 C-N-CA 124.968 1.307 . . . . 0.0 107.918 179.28 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.522 3.153 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.04 -28.69 69.66 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 123.812 0.845 . . . . 0.0 109.579 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 39.9 t -68.7 -32.35 72.09 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 123.498 0.719 . . . . 0.0 110.493 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.57 -40.27 86.21 Favored Glycine 0 N--CA 1.515 3.944 0 CA-C-N 114.947 -1.024 . . . . 0.0 115.103 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.05 -46.07 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.677 1.238 . . . . 0.0 112.018 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -32.79 50.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.063 0 C-N-CA 124.353 1.061 . . . . 0.0 113.198 -177.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 37.6 pt -71.84 -33.18 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 119.247 0.931 . . . . 0.0 108.527 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.45 -29.88 76.33 Favored Glycine 1 N--CA 1.521 4.316 0 C-N-CA 123.539 0.59 . . . . 0.0 111.878 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.67 -37.95 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.72 0 C-N-CA 124.102 0.961 . . . . 0.0 109.947 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 30.3 p -62.14 -45.08 95.03 Favored 'General case' 0 N--CA 1.531 3.592 0 CA-C-O 121.598 0.713 . . . . 0.0 110.414 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.06 -34.87 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.051 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.102 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.21 -36.54 84.49 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 123.117 0.567 . . . . 0.0 112.46 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.09 -49.97 45.58 Favored 'General case' 0 N--CA 1.512 2.654 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 33.2 m -63.16 -38.8 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.06 -35.96 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.847 0 CA-C-N 118.633 0.651 . . . . 0.0 111.094 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.29 -34.89 78.67 Favored 'General case' 0 N--CA 1.537 3.921 0 C-N-CA 122.543 0.337 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 78.7 mt -64.0 -36.32 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.767 0 C-N-CA 123.113 0.565 . . . . 0.0 110.051 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.29 -38.07 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 122.959 0.504 . . . . 0.0 110.064 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.08 95.09 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.83 -34.31 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 O-C-N 121.762 -0.586 . . . . 0.0 109.61 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -62.29 -43.57 98.52 Favored 'General case' 0 N--CA 1.529 3.483 0 C-N-CA 123.3 0.64 . . . . 0.0 112.531 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.08 -37.3 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 81.7 m -59.36 -32.21 69.9 Favored 'General case' 0 N--CA 1.529 3.517 0 C-N-CA 122.819 0.448 . . . . 0.0 110.897 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.99 -41.4 61.97 Favored 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 66.8 m -63.92 -31.43 72.61 Favored 'General case' 0 N--CA 1.526 3.347 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -36.19 68.12 Favored 'General case' 0 N--CA 1.524 3.275 0 C-N-CA 124.246 1.018 . . . . 0.0 108.495 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 53.8 tp -87.22 -16.72 34.44 Favored 'General case' 0 N--CA 1.538 3.957 0 C-N-CA 123.286 0.634 . . . . 0.0 110.816 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -61.59 -7.15 2.99 Favored 'General case' 0 N--CA 1.532 3.651 0 C-N-CA 123.447 0.699 . . . . 0.0 111.853 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.43 -31.99 72.77 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.602 0.761 . . . . 0.0 110.629 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 64.1 tttt . . . . . 0 N--CA 1.531 3.593 0 C-N-CA 123.515 0.726 . . . . 0.0 109.977 179.397 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.523 3.188 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 55.9 tp -65.12 -26.93 68.41 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 123.92 0.888 . . . . 0.0 110.177 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.3 p -68.57 -30.76 69.6 Favored 'General case' 0 N--CA 1.52 3.059 0 C-N-CA 123.642 0.777 . . . . 0.0 110.071 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.63 -46.49 61.58 Favored Glycine 0 N--CA 1.515 3.948 0 C-N-CA 124.147 0.879 . . . . 0.0 114.826 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.5 tt -70.73 -41.09 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 122.015 -0.697 . . . . 0.0 112.868 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.0 tt -64.49 -42.21 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 C-N-CA 122.729 0.412 . . . . 0.0 111.577 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.86 -34.39 39.9 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.009 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.15 -45.29 95.55 Favored Glycine 0 N--CA 1.513 3.801 0 CA-C-N 114.762 -1.108 . . . . 0.0 114.754 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.72 -36.81 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 CA-C-N 117.95 0.875 . . . . 0.0 110.943 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -63.16 -47.8 81.14 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-N 118.339 0.518 . . . . 0.0 112.32 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.43 -35.33 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 123.785 0.834 . . . . 0.0 112.118 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.83 -47.37 70.99 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.2 77.84 Favored 'General case' 0 N--CA 1.517 2.896 0 C-N-CA 123.416 0.686 . . . . 0.0 111.754 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 t -66.68 -49.42 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 C-N-CA 123.224 0.61 . . . . 0.0 110.861 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.26 -32.79 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.498 0 C-N-CA 123.442 0.697 . . . . 0.0 110.917 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.3 tt -64.8 -39.51 93.72 Favored 'General case' 0 N--CA 1.535 3.812 0 C-N-CA 122.991 0.516 . . . . 0.0 110.425 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 88.7 mt -65.35 -36.67 78.26 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 O-C-N 121.508 -0.745 . . . . 0.0 110.283 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.8 -37.44 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 C-N-CA 123.332 0.653 . . . . 0.0 109.807 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.73 -32.09 67.08 Favored 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.398 0.679 . . . . 0.0 111.649 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 46.7 t -68.97 -44.54 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.215 0.606 . . . . 0.0 111.575 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -61.3 -43.12 99.4 Favored 'General case' 1 N--CA 1.54 4.042 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.81 -37.46 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 CA-C-N 118.312 0.505 . . . . 0.0 109.701 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 92.9 m -59.1 -30.48 68.13 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 122.282 -0.261 . . . . 0.0 110.899 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -74.09 -15.47 61.05 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 123.006 0.522 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 67.9 p -63.44 -30.56 71.67 Favored 'General case' 0 N--CA 1.533 3.696 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 57.5 tp . . . . . 0 N--CA 1.517 2.909 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.031 178.429 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.519 3.006 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 55.8 tp -53.64 -26.76 23.67 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 124.655 1.182 . . . . 0.0 111.44 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 52.9 m -60.88 -40.11 91.79 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.857 0.863 . . . . 0.0 111.462 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.97 -35.6 79.35 Favored Glycine 1 N--CA 1.52 4.239 0 C-N-CA 124.0 0.809 . . . . 0.0 112.823 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 38.6 mm -64.57 -42.7 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 17.2 tt -56.62 -44.38 80.91 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.385 0 CA-C-N 119.466 1.03 . . . . 0.0 112.28 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 16.6 tt -73.73 -33.93 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.73 -42.99 99.6 Favored Glycine 0 N--CA 1.512 3.743 0 CA-C-N 114.884 -1.053 . . . . 0.0 114.609 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.91 -37.13 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 CA-C-N 117.729 0.764 . . . . 0.0 111.038 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 59.3 p -66.01 -46.71 76.98 Favored 'General case' 0 N--CA 1.532 3.641 0 CA-C-N 118.379 0.536 . . . . 0.0 112.064 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 11.4 p -69.94 -31.64 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.51 0 C-N-CA 122.778 0.431 . . . . 0.0 111.099 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.16 -41.13 71.46 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.174 0.59 . . . . 0.0 112.396 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.99 93.1 Favored 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 123.238 0.615 . . . . 0.0 111.074 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.82 -50.0 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.323 0 C-N-CA 123.412 0.685 . . . . 0.0 110.384 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.4 -32.54 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 123.626 0.77 . . . . 0.0 110.35 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.5 -34.99 79.0 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 122.891 0.476 . . . . 0.0 110.78 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.53 -37.36 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.47 -37.86 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 C-N-CA 123.233 0.613 . . . . 0.0 109.637 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.85 78.61 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.631 0.772 . . . . 0.0 112.671 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.79 -34.42 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.616 0 O-C-N 121.901 -0.5 . . . . 0.0 110.336 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -65.67 -43.66 88.62 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.107 0.563 . . . . 0.0 112.446 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.4 -37.55 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 79.5 m -61.21 -27.99 68.83 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 122.962 0.505 . . . . 0.0 111.158 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -72.49 -28.71 63.06 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.378 0.671 . . . . 0.0 110.708 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 28.1 t -65.5 -27.81 68.74 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.138 0.575 . . . . 0.0 111.823 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.83 -14.07 60.73 Favored 'General case' 0 N--CA 1.531 3.609 0 C-N-CA 123.916 0.886 . . . . 0.0 111.009 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 20.3 mt -86.87 1.9 50.96 Favored 'General case' 0 N--CA 1.535 3.81 0 C-N-CA 122.775 0.43 . . . . 0.0 110.606 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -76.82 -50.13 14.17 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.552 0.741 . . . . 0.0 109.274 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 50.1 pttt . . . . . 0 N--CA 1.527 3.425 0 C-N-CA 123.76 0.824 . . . . 0.0 111.959 -178.645 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.083 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 49.9 m 57.02 48.92 14.75 Favored 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 124.239 1.016 . . . . 0.0 112.503 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.14 -30.7 71.65 Favored 'General case' 0 N--CA 1.534 3.758 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 97.1 p -68.6 -26.71 65.51 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 123.701 0.8 . . . . 0.0 109.789 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.99 -45.04 64.29 Favored Glycine 1 N--CA 1.517 4.075 0 C-N-CA 124.26 0.933 . . . . 0.0 114.979 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 44.2 pt -70.61 -35.86 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -41.38 87.53 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.319 0 CA-C-N 118.524 0.602 . . . . 0.0 110.834 -177.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -33.59 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.93 -42.6 96.8 Favored Glycine 1 N--CA 1.518 4.104 0 N-CA-C 114.79 0.676 . . . . 0.0 114.79 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.0 -41.67 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.633 1.216 . . . . 0.0 111.817 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.1 t -66.72 -40.85 88.57 Favored 'General case' 0 N--CA 1.536 3.848 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.16 -30.92 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.725 0 CA-C-N 118.508 0.595 . . . . 0.0 110.279 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.26 -34.7 78.97 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 122.983 0.513 . . . . 0.0 111.696 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.57 -50.41 51.99 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.1 -38.88 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.57 -32.26 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 CA-C-N 118.112 0.414 . . . . 0.0 110.567 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 tt -74.54 -46.45 38.95 Favored 'General case' 0 N--CA 1.531 3.581 0 C-N-CA 123.102 0.561 . . . . 0.0 110.161 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.5 -44.49 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 O-C-N 121.826 -0.546 . . . . 0.0 111.996 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.3 -36.87 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 CA-C-N 118.665 0.666 . . . . 0.0 110.195 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.78 75.58 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.17 0.588 . . . . 0.0 111.847 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.85 -41.41 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 C-N-CA 122.617 0.367 . . . . 0.0 110.283 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.13 -43.86 98.23 Favored 'General case' 0 N--CA 1.529 3.478 0 C-N-CA 123.503 0.721 . . . . 0.0 112.782 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.62 -37.71 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 99.4 m -63.6 -28.09 69.69 Favored 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 122.855 0.462 . . . . 0.0 111.247 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.86 -28.27 67.4 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 123.227 0.611 . . . . 0.0 110.945 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.7 t -64.05 -36.33 83.63 Favored 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 123.337 0.655 . . . . 0.0 111.874 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.97 -14.4 22.47 Favored 'General case' 0 N--CA 1.533 3.699 0 C-N-CA 123.936 0.894 . . . . 0.0 111.104 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 23.5 mt -87.31 -28.32 22.34 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.271 0.629 . . . . 0.0 109.927 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -78.39 -141.42 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 60.6 15.24 5.54 Favored 'General case' 0 N--CA 1.52 3.028 0 C-N-CA 124.32 1.048 . . . . 0.0 112.102 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -160.12 118.86 2.71 Favored 'General case' 0 N--CA 1.53 3.544 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 N--CA 1.531 3.588 0 C-N-CA 125.175 1.39 . . . . 0.0 107.709 -179.5 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.521 3.112 0 CA-C-O 120.752 0.311 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.93 -26.62 68.67 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 124.253 1.021 . . . . 0.0 110.613 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 60.9 m -67.95 -26.03 65.74 Favored 'General case' 0 N--CA 1.522 3.171 0 C-N-CA 123.425 0.69 . . . . 0.0 110.614 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.14 -46.24 66.42 Favored Glycine 0 N--CA 1.514 3.896 0 C-N-CA 123.699 0.666 . . . . 0.0 113.953 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tp -70.67 -35.53 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.955 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 12.1 pt -56.82 -43.61 80.29 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.766 0 CA-C-N 119.83 1.195 . . . . 0.0 112.22 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -73.56 -33.66 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.616 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.65 -45.94 93.32 Favored Glycine 0 N--CA 1.515 3.942 0 CA-C-N 115.494 -0.776 . . . . 0.0 114.069 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.94 -36.78 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.803 0 CA-C-N 117.873 0.836 . . . . 0.0 111.055 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 50.8 p -62.44 -46.22 89.51 Favored 'General case' 0 N--CA 1.534 3.744 0 CA-C-N 118.252 0.478 . . . . 0.0 111.115 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.97 -34.83 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.414 0 C-N-CA 123.87 0.868 . . . . 0.0 110.676 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.93 -36.32 59.56 Favored 'General case' 0 N--CA 1.527 3.381 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -46.1 64.53 Favored 'General case' 0 N--CA 1.517 2.908 0 C-N-CA 123.136 0.575 . . . . 0.0 111.44 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -58.53 -44.79 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.677 0 C-N-CA 123.768 0.827 . . . . 0.0 112.204 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -66.65 -31.5 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.658 0 CA-C-O 121.125 0.488 . . . . 0.0 110.12 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -42.12 97.41 Favored 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.576 0.75 . . . . 0.0 111.906 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.05 -44.61 97.78 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.005 0 C-N-CA 122.892 0.477 . . . . 0.0 111.809 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 18.2 m -66.48 -36.55 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.792 0 O-C-N 121.801 -0.562 . . . . 0.0 109.928 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.3 86.09 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.73 -34.27 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.964 0 O-C-N 121.606 -0.684 . . . . 0.0 109.963 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.73 -44.03 97.16 Favored 'General case' 0 N--CA 1.53 3.542 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.78 -39.06 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 CA-C-O 121.569 0.7 . . . . 0.0 109.415 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.9 m -65.25 -29.48 70.27 Favored 'General case' 0 N--CA 1.521 3.101 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.311 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.36 -37.77 63.4 Favored 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 123.121 0.568 . . . . 0.0 109.477 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 50.5 m -64.15 -29.78 70.88 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.527 0.731 . . . . 0.0 111.245 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.76 -14.56 22.1 Favored 'General case' 0 N--CA 1.534 3.737 0 C-N-CA 123.61 0.764 . . . . 0.0 111.488 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 1 N--CA 1.54 4.034 0 C-N-CA 123.227 0.611 . . . . 0.0 109.409 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.522 3.13 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.95 -27.17 68.66 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 123.944 0.898 . . . . 0.0 110.16 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 99.3 p -68.13 -30.09 69.15 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.655 0.782 . . . . 0.0 110.625 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.22 -47.07 54.95 Favored Glycine 0 N--CA 1.514 3.842 0 CA-C-N 115.956 -0.565 . . . . 0.0 114.444 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.21 -39.35 73.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.088 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -176.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.44 -32.29 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.781 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.17 -32.77 44.44 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.119 0 CA-C-N 119.129 0.877 . . . . 0.0 109.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.21 -29.17 72.19 Favored Glycine 0 N--CA 1.511 3.67 0 C-N-CA 123.776 0.703 . . . . 0.0 113.648 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 5.4 p -59.27 -48.21 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.946 0 CA-C-N 117.558 0.679 . . . . 0.0 112.817 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 8.9 t -66.7 -39.64 88.16 Favored 'General case' 0 N--CA 1.536 3.841 0 CA-C-N 118.056 0.389 . . . . 0.0 110.95 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.38 -33.28 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.269 0 C-N-CA 123.475 0.71 . . . . 0.0 110.26 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.45 -43.08 97.24 Favored 'General case' 0 N--CA 1.526 3.353 0 O-C-N 122.214 -0.304 . . . . 0.0 111.705 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.43 73.3 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.4 -38.31 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 CA-C-N 118.042 0.383 . . . . 0.0 111.374 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.98 -32.76 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 C-N-CA 122.715 0.406 . . . . 0.0 110.086 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -37.82 85.5 Favored 'General case' 1 N--CA 1.544 4.265 0 CA-C-O 120.999 0.428 . . . . 0.0 110.013 -178.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 71.8 mt -64.09 -40.72 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.096 0.558 . . . . 0.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.63 -37.29 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 123.789 0.835 . . . . 0.0 109.935 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.67 -32.47 67.35 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.314 0.646 . . . . 0.0 112.071 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.47 -44.14 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.663 0 C-N-CA 122.636 0.375 . . . . 0.0 112.001 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -61.54 -43.67 98.45 Favored 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.5 -37.87 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.698 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 86.4 m -67.36 -34.17 76.75 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 122.93 0.492 . . . . 0.0 110.126 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -69.54 -34.53 74.35 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 123.466 0.706 . . . . 0.0 110.388 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 39.3 t -67.18 -37.51 83.82 Favored 'General case' 0 N--CA 1.522 3.169 0 CA-C-O 121.447 0.642 . . . . 0.0 110.198 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.7 -21.77 62.53 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 124.294 1.037 . . . . 0.0 110.512 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 56.0 tp -87.67 -28.08 22.04 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.72 0.808 . . . . 0.0 109.551 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -71.42 -124.82 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.346 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 54.67 111.39 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 124.311 1.045 . . . . 0.0 112.01 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -164.79 152.79 11.88 Favored 'General case' 0 N--CA 1.522 3.168 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 N--CA 1.527 3.41 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.708 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.521 3.095 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.18 -26.75 68.29 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 124.242 1.017 . . . . 0.0 110.651 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 46.9 t -65.8 -26.7 67.81 Favored 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 122.959 0.503 . . . . 0.0 110.528 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.22 -46.34 92.94 Favored Glycine 0 N--CA 1.509 3.545 0 C-N-CA 123.439 0.542 . . . . 0.0 114.192 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.38 -35.39 62.13 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.065 0 CA-C-N 118.446 1.123 . . . . 0.0 109.46 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 83.1 mt -64.56 -35.54 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 11.6 mm -72.5 -33.74 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.825 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.52 -47.16 92.53 Favored Glycine 0 N--CA 1.515 3.917 0 C-N-CA 123.983 0.802 . . . . 0.0 113.49 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 14.6 m -68.92 -36.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 O-C-N 121.781 -0.835 . . . . 0.0 109.981 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 32.9 m -60.44 -45.69 92.76 Favored 'General case' 0 N--CA 1.525 3.281 0 C-N-CA 123.577 0.751 . . . . 0.0 112.539 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.63 -30.83 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 C-N-CA 122.94 0.496 . . . . 0.0 110.049 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.72 -45.19 91.07 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 122.685 0.394 . . . . 0.0 111.868 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.99 -25.56 61.21 Favored 'General case' 0 N--CA 1.535 3.801 0 C-N-CA 123.422 0.689 . . . . 0.0 112.286 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.05 -37.04 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 C-N-CA 123.76 0.824 . . . . 0.0 110.326 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 2.6 p -55.97 -34.84 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.784 0 C-N-CA 123.457 0.703 . . . . 0.0 111.63 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 59.9 tp -69.63 -45.27 68.86 Favored 'General case' 0 N--CA 1.521 3.125 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.867 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.53 -49.76 63.83 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.232 0 C-N-CA 122.858 0.463 . . . . 0.0 111.188 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 26.5 m -66.4 -36.86 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 C-N-CA 122.437 0.295 . . . . 0.0 110.465 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.93 -32.91 68.23 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 123.179 0.592 . . . . 0.0 112.389 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.72 -34.78 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.73 0 O-C-N 122.021 -0.424 . . . . 0.0 110.283 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -68.46 -43.7 76.44 Favored 'General case' 0 N--CA 1.527 3.402 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 11.5 m -68.49 -37.93 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 O-C-N 122.198 -0.314 . . . . 0.0 111.324 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 15.5 p -65.33 -27.74 68.81 Favored 'General case' 0 N--CA 1.529 3.503 0 C-N-CA 122.217 0.207 . . . . 0.0 111.165 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -63.11 -42.51 99.57 Favored 'General case' 0 N--CA 1.526 3.333 0 CA-C-O 121.276 0.56 . . . . 0.0 109.922 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 69.4 m -65.74 -36.89 84.87 Favored 'General case' 0 N--CA 1.521 3.104 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.873 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -71.87 -25.88 62.13 Favored 'General case' 0 N--CA 1.528 3.475 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.507 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 49.9 tp -87.4 -12.72 45.42 Favored 'General case' 0 N--CA 1.537 3.886 0 C-N-CA 123.85 0.86 . . . . 0.0 110.883 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -55.66 -15.11 2.64 Favored 'General case' 0 N--CA 1.534 3.74 0 C-N-CA 123.684 0.794 . . . . 0.0 112.103 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.65 -25.4 63.89 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.729 0.812 . . . . 0.0 111.224 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 60.4 mttp . . . . . 0 N--CA 1.525 3.303 0 C-N-CA 123.927 0.891 . . . . 0.0 110.169 -178.462 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.522 3.166 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 42.8 mt -64.26 -27.5 69.09 Favored 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 124.114 0.966 . . . . 0.0 110.842 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 66.8 m -61.17 -26.62 67.83 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.669 0.788 . . . . 0.0 110.973 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.54 -34.33 88.81 Favored Glycine 0 N--CA 1.513 3.802 0 C-N-CA 125.062 1.315 . . . . 0.0 114.005 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -34.1 49.55 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.249 0 C-N-CA 124.615 1.166 . . . . 0.0 113.876 -174.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 16.3 pt -54.97 -32.36 26.67 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.257 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -174.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 13.0 pt -64.65 -33.36 62.7 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-O 121.256 0.55 . . . . 0.0 109.734 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.7 -50.14 70.93 Favored Glycine 1 N--CA 1.518 4.166 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.726 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.62 -36.81 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 CA-C-N 117.571 0.685 . . . . 0.0 110.384 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 85.9 m -61.77 -46.05 91.23 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 123.479 0.712 . . . . 0.0 112.043 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 70.1 t -69.19 -31.32 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 C-N-CA 123.712 0.805 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.9 -34.91 57.11 Favored 'General case' 0 N--CA 1.536 3.827 0 CA-C-O 121.041 0.448 . . . . 0.0 112.205 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.78 -43.58 65.48 Favored 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 123.37 0.668 . . . . 0.0 110.949 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.56 -43.11 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.38 0 C-N-CA 124.428 1.091 . . . . 0.0 112.62 -176.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 24.7 m -60.7 -31.29 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 O-C-N 121.992 -0.443 . . . . 0.0 111.628 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 46.9 tp -67.69 -36.23 80.28 Favored 'General case' 0 N--CA 1.536 3.855 0 O-C-N 121.474 -0.766 . . . . 0.0 109.875 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 41.1 mm -55.01 -51.98 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 C-N-CA 122.873 0.469 . . . . 0.0 112.157 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 17.2 m -60.57 -36.71 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 C-N-CA 122.356 0.262 . . . . 0.0 110.856 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.55 -31.84 66.51 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.067 0.547 . . . . 0.0 111.153 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.81 -38.21 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 O-C-N 121.99 -0.444 . . . . 0.0 110.353 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -73.04 -32.21 64.93 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 123.203 0.601 . . . . 0.0 110.076 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.56 -37.59 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.246 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.0 m -58.7 -46.79 86.52 Favored 'General case' 0 N--CA 1.524 3.268 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -74.65 -41.57 60.1 Favored 'General case' 0 N--CA 1.532 3.63 0 CA-C-O 121.111 0.481 . . . . 0.0 111.102 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.3 m -64.52 -46.86 81.09 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 123.565 0.746 . . . . 0.0 112.303 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 1 N--CA 1.54 4.066 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.52 3.056 0 CA-C-O 121.677 0.751 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.43 -27.15 69.1 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 124.044 0.938 . . . . 0.0 110.749 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 99.8 p -68.58 -32.63 72.67 Favored 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 123.581 0.752 . . . . 0.0 110.406 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.76 -46.61 60.14 Favored Glycine 1 N--CA 1.516 4.004 0 CA-C-N 115.362 -0.835 . . . . 0.0 114.979 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -70.91 -42.03 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.907 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -60.05 -42.13 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 C-N-CA 122.999 0.52 . . . . 0.0 112.395 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.71 -33.29 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.858 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.26 58.33 Favored Glycine 0 N--CA 1.51 3.617 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.524 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.0 m -59.47 -37.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.913 0 CA-C-N 117.634 0.717 . . . . 0.0 110.928 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 80.5 p -56.39 -46.61 80.03 Favored 'General case' 0 N--CA 1.531 3.584 0 CA-C-O 121.038 0.447 . . . . 0.0 111.214 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.83 -41.96 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 124.456 1.102 . . . . 0.0 110.88 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.55 -47.12 66.98 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.41 0.684 . . . . 0.0 112.633 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.65 -37.05 72.71 Favored 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 123.385 0.674 . . . . 0.0 111.674 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 36.2 t -67.98 -48.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 CA-C-O 121.315 0.578 . . . . 0.0 110.071 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.53 -32.65 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.111 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.388 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 16.1 mt -73.55 -46.7 45.96 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 122.67 0.388 . . . . 0.0 110.95 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 92.1 mt -60.14 -44.77 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 O-C-N 121.531 -0.731 . . . . 0.0 111.437 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.03 -37.8 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.87 0 CA-C-N 118.843 0.747 . . . . 0.0 110.631 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.81 91.09 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.553 0.741 . . . . 0.0 111.828 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 88.5 t -71.57 -34.47 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.348 0 C-N-CA 123.139 0.576 . . . . 0.0 109.777 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.01 -44.21 89.97 Favored 'General case' 0 N--CA 1.53 3.525 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.68 -37.41 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.781 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 88.0 m -61.19 -33.7 73.88 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 122.913 0.485 . . . . 0.0 110.855 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -74.28 -28.47 61.22 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 122.633 0.373 . . . . 0.0 110.461 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 57.5 m -75.27 -17.74 60.23 Favored 'General case' 0 N--CA 1.524 3.227 0 C-N-CA 123.104 0.562 . . . . 0.0 110.855 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.76 -38.43 86.57 Favored 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 123.499 0.72 . . . . 0.0 112.319 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -110.46 10.16 23.27 Favored 'General case' 1 N--CA 1.556 4.844 0 C-N-CA 123.414 0.686 . . . . 0.0 112.342 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -75.65 5.47 6.07 Favored 'General case' 0 N--CA 1.527 3.396 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 58.2 pttt . . . . . 0 N--CA 1.516 2.85 0 C-N-CA 124.242 1.017 . . . . 0.0 108.958 -179.226 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.144 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 99.3 p -162.61 27.65 0.1 Allowed 'General case' 0 N--CA 1.522 3.125 0 C-N-CA 124.108 0.963 . . . . 0.0 109.2 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 47.5 mt -64.14 -26.55 68.58 Favored 'General case' 0 N--CA 1.522 3.141 0 C-N-CA 124.566 1.147 . . . . 0.0 110.81 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.1 t -57.57 -26.41 61.4 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.606 0.762 . . . . 0.0 111.883 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.65 -34.23 77.92 Favored Glycine 0 N--CA 1.513 3.801 0 C-N-CA 124.724 1.154 . . . . 0.0 114.12 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -46.47 90.79 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.378 0 CA-C-N 117.821 0.81 . . . . 0.0 112.458 -174.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.7 tt -64.84 -31.54 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 C-N-CA 123.116 0.566 . . . . 0.0 110.779 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 51.1 mm -68.22 -33.51 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.37 -50.15 67.48 Favored Glycine 1 N--CA 1.517 4.074 0 C-N-CA 123.119 0.39 . . . . 0.0 113.127 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.0 m -61.85 -35.75 69.75 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 CA-C-N 117.861 0.83 . . . . 0.0 110.655 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.5 m -55.18 -42.28 72.99 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.045 0.538 . . . . 0.0 111.0 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.42 -36.99 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.47 0 C-N-CA 123.483 0.713 . . . . 0.0 110.576 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.47 68.41 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.42 -50.43 65.46 Favored 'General case' 0 N--CA 1.515 2.795 0 C-N-CA 123.315 0.646 . . . . 0.0 112.673 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.02 -38.34 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.784 0 CA-C-N 118.303 0.501 . . . . 0.0 111.311 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.5 t -62.41 -34.65 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 CA-C-N 117.954 0.343 . . . . 0.0 110.391 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.98 -34.53 78.32 Favored 'General case' 0 N--CA 1.529 3.507 0 CA-C-N 117.808 0.276 . . . . 0.0 111.468 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.48 -36.8 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.865 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.74 -37.71 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.692 0 C-N-CA 123.34 0.656 . . . . 0.0 110.212 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.91 -32.52 71.99 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.387 0.675 . . . . 0.0 111.342 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.57 -37.46 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 123.052 0.541 . . . . 0.0 109.899 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.43 -43.78 96.46 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.377 0.671 . . . . 0.0 112.434 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.9 m -68.24 -37.38 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.725 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 93.0 m -62.93 -31.4 72.48 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.989 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -74.43 -38.83 62.91 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 55.9 m -67.37 -28.04 67.61 Favored 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 123.384 0.674 . . . . 0.0 110.576 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.54 -34.54 78.13 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.463 0.705 . . . . 0.0 111.896 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.32 8.1 37.71 Favored 'General case' 1 N--CA 1.544 4.248 0 C-N-CA 123.092 0.557 . . . . 0.0 111.691 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -71.24 2.53 4.58 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 123.479 0.711 . . . . 0.0 110.471 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -52.37 173.57 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 124.52 1.128 . . . . 0.0 112.25 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -63.17 146.36 53.52 Favored 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 124.056 0.942 . . . . 0.0 111.281 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.527 3.402 0 C-N-CA 125.081 1.352 . . . . 0.0 108.128 179.451 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.517 2.925 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.09 -31.96 73.42 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 123.945 0.898 . . . . 0.0 110.162 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.9 t -68.36 -27.95 66.7 Favored 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 123.592 0.757 . . . . 0.0 110.631 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.04 -46.58 58.39 Favored Glycine 0 N--CA 1.514 3.872 0 C-N-CA 124.078 0.847 . . . . 0.0 114.723 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.8 pt -70.71 -37.35 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -64.29 -41.39 92.23 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.054 0 CA-C-N 118.376 0.534 . . . . 0.0 111.609 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.88 -33.28 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.31 -50.11 64.35 Favored Glycine 0 N--CA 1.513 3.807 0 C-N-CA 124.331 0.967 . . . . 0.0 113.906 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.32 -37.13 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 O-C-N 122.22 -0.577 . . . . 0.0 109.887 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 82.0 m -65.31 -47.22 77.34 Favored 'General case' 0 N--CA 1.523 3.204 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.3 p -70.74 -31.54 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 CA-C-N 118.117 0.417 . . . . 0.0 111.611 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.7 67.59 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.44 -36.41 83.83 Favored 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 123.121 0.568 . . . . 0.0 111.506 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 48.0 t -68.13 -52.11 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 C-N-CA 123.525 0.73 . . . . 0.0 111.779 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.08 -35.18 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.457 0 O-C-N 121.413 -0.804 . . . . 0.0 111.944 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 tt -75.01 -43.71 52.2 Favored 'General case' 0 N--CA 1.528 3.444 0 C-N-CA 122.58 0.352 . . . . 0.0 111.204 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 14.8 tt -65.73 -39.75 85.79 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 O-C-N 121.211 -0.931 . . . . 0.0 111.197 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.26 -37.42 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 C-N-CA 123.099 0.56 . . . . 0.0 109.939 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.85 -32.77 67.96 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.25 -38.63 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.594 0 CA-C-N 118.049 0.386 . . . . 0.0 111.386 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -64.39 -44.25 91.9 Favored 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.95 -39.89 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.467 0 C-N-CA 122.841 0.457 . . . . 0.0 110.109 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 99.0 m -67.55 -28.25 67.63 Favored 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 123.242 0.617 . . . . 0.0 111.226 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.3 -45.97 44.13 Favored 'General case' 0 N--CA 1.528 3.436 0 CA-C-O 121.123 0.487 . . . . 0.0 110.499 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.7 t -63.78 -19.05 64.69 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 123.629 0.772 . . . . 0.0 112.203 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 49.7 tp -69.24 -15.64 63.42 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.616 0.766 . . . . 0.0 110.614 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 N--CA 1.534 3.76 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.777 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.523 3.214 0 CA-C-O 121.459 0.647 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.34 -26.97 68.71 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 123.906 0.883 . . . . 0.0 110.294 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.2 m -68.41 -29.82 68.58 Favored 'General case' 0 N--CA 1.52 3.03 0 C-N-CA 123.636 0.775 . . . . 0.0 110.297 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.03 -46.67 58.13 Favored Glycine 1 N--CA 1.516 4.024 0 C-N-CA 123.96 0.79 . . . . 0.0 114.935 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 8.1 tp -70.97 -41.56 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.07 -41.07 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 C-N-CA 123.082 0.553 . . . . 0.0 112.335 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.94 -33.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.18 -28.21 41.46 Favored Glycine 1 N--CA 1.516 4.022 0 C-N-CA 124.54 1.066 . . . . 0.0 113.754 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 5.3 m -58.58 -37.04 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.789 0 CA-C-N 117.482 0.641 . . . . 0.0 111.587 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 7.7 t -55.78 -44.3 77.61 Favored 'General case' 0 N--CA 1.538 3.968 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.27 -31.72 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 C-N-CA 123.355 0.662 . . . . 0.0 110.85 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.76 -46.68 77.83 Favored 'General case' 0 N--CA 1.535 3.785 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.04 74.26 Favored 'General case' 0 N--CA 1.514 2.763 0 C-N-CA 123.529 0.732 . . . . 0.0 111.526 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 38.0 t -64.49 -47.77 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.682 0 C-N-CA 123.49 0.716 . . . . 0.0 110.663 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.48 -32.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 123.586 0.755 . . . . 0.0 109.995 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 36.1 tp -76.81 -33.87 57.96 Favored 'General case' 0 N--CA 1.516 2.865 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 tp -54.84 -43.83 69.48 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 C-N-CA 123.455 0.702 . . . . 0.0 112.267 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 12.6 m -64.73 -37.47 80.23 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.152 0 O-C-N 121.957 -0.464 . . . . 0.0 110.542 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.04 -32.27 67.83 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 122.949 0.5 . . . . 0.0 111.127 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.2 -35.0 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.789 0 C-N-CA 122.739 0.416 . . . . 0.0 110.256 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -72.11 -38.91 69.22 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 123.281 0.632 . . . . 0.0 109.672 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.11 -37.37 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 C-N-CA 124.136 0.974 . . . . 0.0 109.634 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.68 -38.39 78.11 Favored 'General case' 0 N--CA 1.523 3.19 0 C-N-CA 122.781 0.432 . . . . 0.0 110.081 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -74.2 -37.33 63.93 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 122.978 0.511 . . . . 0.0 110.114 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 32.1 t -64.23 -41.48 96.99 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.9 tp -65.19 -16.26 63.33 Favored 'General case' 0 N--CA 1.522 3.129 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.767 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.29 -23.55 14.38 Favored 'General case' 1 N--CA 1.557 4.92 0 C-N-CA 124.262 1.025 . . . . 0.0 108.655 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -108.19 94.58 5.15 Favored 'General case' 0 N--CA 1.53 3.561 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 26.07 0.09 Allowed 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.599 0.76 . . . . 0.0 110.841 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -54.57 154.41 4.88 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 124.143 0.977 . . . . 0.0 112.302 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.527 3.382 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -179.714 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.522 3.145 0 CA-C-O 121.511 0.672 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.03 -26.69 68.68 Favored 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 123.982 0.913 . . . . 0.0 109.735 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 64.0 m -60.45 -26.66 66.91 Favored 'General case' 0 N--CA 1.522 3.157 0 C-N-CA 123.542 0.737 . . . . 0.0 110.924 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.53 -42.17 82.04 Favored Glycine 0 N--CA 1.513 3.775 0 C-N-CA 124.262 0.934 . . . . 0.0 115.385 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -46.38 69.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.239 0 CA-C-N 118.192 0.996 . . . . 0.0 111.546 -176.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 19.7 tt -61.05 -35.55 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.14 -33.15 45.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.063 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.25 -47.41 90.98 Favored Glycine 0 N--CA 1.513 3.791 0 C-N-CA 123.831 0.729 . . . . 0.0 113.29 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 15.1 m -68.83 -37.1 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 CA-C-N 118.119 0.96 . . . . 0.0 110.141 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 37.9 m -62.04 -46.29 89.83 Favored 'General case' 0 N--CA 1.516 2.875 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.469 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 11.8 p -69.67 -31.55 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.546 0 CA-C-N 117.973 0.351 . . . . 0.0 110.572 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.9 70.82 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 122.635 0.374 . . . . 0.0 111.45 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.22 -37.74 86.26 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 123.558 0.743 . . . . 0.0 110.911 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.66 -42.8 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.376 0 C-N-CA 123.597 0.759 . . . . 0.0 110.563 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.08 -44.49 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.285 0.634 . . . . 0.0 111.361 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.2 -35.22 63.91 Favored 'General case' 0 N--CA 1.523 3.203 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 17.9 tt -69.63 -40.3 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 CA-C-N 118.627 0.649 . . . . 0.0 111.162 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.59 -36.97 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 O-C-N 121.942 -0.473 . . . . 0.0 109.948 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.45 82.22 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.945 0.898 . . . . 0.0 112.798 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.68 -34.18 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 O-C-N 121.915 -0.49 . . . . 0.0 110.084 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -64.38 -43.85 93.18 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.015 0.526 . . . . 0.0 112.316 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.59 -37.38 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.832 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 98.5 m -60.05 -28.84 68.11 Favored 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 122.768 0.427 . . . . 0.0 110.945 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -72.83 -32.46 65.51 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.988 0.515 . . . . 0.0 110.564 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 32.1 t -63.75 -17.76 63.36 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 123.159 0.584 . . . . 0.0 112.33 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.62 -20.79 65.12 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 123.503 0.721 . . . . 0.0 112.72 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.44 -5.22 58.92 Favored 'General case' 1 N--CA 1.544 4.262 0 CA-C-N 118.723 0.692 . . . . 0.0 111.116 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -64.89 -16.16 62.88 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.5 0.72 . . . . 0.0 110.622 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.44 161.2 14.72 Favored 'General case' 0 N--CA 1.523 3.199 0 C-N-CA 123.937 0.895 . . . . 0.0 110.651 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 N--CA 1.521 3.081 0 C-N-CA 123.901 0.88 . . . . 0.0 110.057 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.522 3.16 0 CA-C-O 120.36 0.124 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.19 -26.8 68.31 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 124.33 1.052 . . . . 0.0 110.714 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 65.6 m -57.89 -38.47 75.86 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 123.735 0.814 . . . . 0.0 111.254 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.87 -35.72 80.17 Favored Glycine 1 N--CA 1.518 4.147 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.212 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.31 -46.61 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.323 0 C-N-CA 124.072 0.949 . . . . 0.0 112.773 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.3 tt -66.45 -35.22 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.82 -32.95 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.9 -36.49 60.33 Favored Glycine 0 N--CA 1.514 3.854 0 C-N-CA 123.738 0.685 . . . . 0.0 114.683 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.47 -37.56 79.88 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.159 0 CA-C-N 118.214 1.007 . . . . 0.0 110.94 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 26.5 p -63.86 -45.82 87.75 Favored 'General case' 0 N--CA 1.527 3.402 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.931 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 50.9 t -66.92 -31.56 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.163 0 C-N-CA 124.426 1.09 . . . . 0.0 111.328 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.91 -43.07 65.94 Favored 'General case' 0 N--CA 1.532 3.647 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.47 -45.58 65.44 Favored 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 123.188 0.595 . . . . 0.0 110.364 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.97 -47.55 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 124.307 1.043 . . . . 0.0 112.969 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.55 -32.21 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.922 0 CA-C-N 118.093 0.406 . . . . 0.0 110.954 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 83.9 mt -68.67 -33.95 74.86 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 122.579 0.352 . . . . 0.0 110.383 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 46.6 mm -55.01 -39.79 51.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.232 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.01 -41.61 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.127 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.1 94.52 Favored 'General case' 0 N--CA 1.528 3.461 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.96 -34.12 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 O-C-N 121.718 -0.614 . . . . 0.0 109.476 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -63.03 -43.67 98.05 Favored 'General case' 0 N--CA 1.53 3.548 0 C-N-CA 123.103 0.561 . . . . 0.0 112.327 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.4 -37.57 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.7 m -61.51 -31.08 71.07 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.002 0.521 . . . . 0.0 110.358 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -73.86 -41.29 62.43 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 66.7 m -64.69 -32.62 74.37 Favored 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 123.482 0.713 . . . . 0.0 109.843 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.524 3.27 0 C-N-CA 123.862 0.865 . . . . 0.0 109.287 179.033 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.525 3.28 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 40.6 mt -64.98 -26.93 68.5 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.727 0.811 . . . . 0.0 110.54 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 69.6 m -68.5 -30.82 69.74 Favored 'General case' 0 N--CA 1.518 2.968 0 C-N-CA 123.753 0.821 . . . . 0.0 110.396 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.57 -46.33 62.78 Favored Glycine 0 N--CA 1.515 3.955 0 C-N-CA 124.3 0.952 . . . . 0.0 114.912 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 19.3 tt -71.01 -40.48 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.22 -40.28 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 C-N-CA 122.9 0.48 . . . . 0.0 112.075 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.1 tt -72.79 -32.8 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.47 -28.4 44.33 Favored Glycine 0 N--CA 1.51 3.572 0 C-N-CA 124.689 1.138 . . . . 0.0 113.442 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.6 m -58.87 -37.21 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.801 0 CA-C-N 117.339 0.569 . . . . 0.0 111.128 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 65.1 p -61.19 -46.39 90.68 Favored 'General case' 0 N--CA 1.533 3.72 0 CA-C-O 121.258 0.551 . . . . 0.0 110.926 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.75 -31.82 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 C-N-CA 124.545 1.138 . . . . 0.0 110.873 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.92 -42.02 71.7 Favored 'General case' 0 N--CA 1.531 3.623 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.67 90.92 Favored 'General case' 0 N--CA 1.517 2.906 0 C-N-CA 123.56 0.744 . . . . 0.0 111.169 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 26.5 t -58.63 -51.7 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.559 0.744 . . . . 0.0 111.63 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -67.06 -31.97 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 C-N-CA 123.078 0.551 . . . . 0.0 110.567 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.12 -35.46 61.7 Favored 'General case' 0 N--CA 1.533 3.718 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.68 -48.21 72.24 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.578 0 O-C-N 121.593 -0.692 . . . . 0.0 110.976 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 12.4 m -65.77 -36.35 77.35 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.042 0 O-C-N 121.902 -0.499 . . . . 0.0 110.378 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.01 68.14 Favored 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 122.865 0.466 . . . . 0.0 111.434 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.3 -34.82 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 C-N-CA 122.882 0.473 . . . . 0.0 110.41 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -72.66 -43.26 63.4 Favored 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.183 0.593 . . . . 0.0 112.399 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.83 -37.21 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 O-C-N 122.165 -0.335 . . . . 0.0 111.383 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 28.1 p -66.98 -27.71 67.66 Favored 'General case' 0 N--CA 1.53 3.548 0 O-C-N 122.311 -0.243 . . . . 0.0 110.971 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -68.53 -30.51 69.32 Favored 'General case' 0 N--CA 1.531 3.604 0 C-N-CA 123.029 0.532 . . . . 0.0 110.055 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 39.6 t -67.53 -39.62 85.06 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-O 121.437 0.637 . . . . 0.0 110.166 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -13.69 13.4 Favored 'General case' 0 N--CA 1.535 3.805 0 C-N-CA 125.567 1.547 . . . . 0.0 111.339 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 54.3 tp -86.77 -16.85 35.05 Favored 'General case' 1 N--CA 1.544 4.262 0 C-N-CA 123.656 0.782 . . . . 0.0 110.178 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -143.1 78.93 1.63 Allowed 'General case' 0 N--CA 1.52 3.043 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? . . . . . 0 N--CA 1.527 3.406 0 C-N-CA 124.482 1.113 . . . . 0.0 110.183 -175.499 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.154 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 47.8 t -168.38 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 CA-C-N 117.692 0.746 . . . . 0.0 110.305 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 tt -54.67 -28.47 47.68 Favored 'General case' 0 N--CA 1.53 3.558 0 C-N-CA 123.647 0.779 . . . . 0.0 111.234 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 46.5 t -66.52 -42.22 87.63 Favored 'General case' 0 N--CA 1.52 3.026 0 C-N-CA 123.734 0.813 . . . . 0.0 110.522 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.38 69.18 Favored Glycine 1 N--CA 1.517 4.099 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.65 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.96 -46.29 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.306 0 C-N-CA 124.003 0.921 . . . . 0.0 111.556 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -32.79 58.5 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.016 0 CA-C-O 121.268 0.556 . . . . 0.0 109.704 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 6.3 mm -71.94 -37.0 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 C-N-CA 123.863 0.865 . . . . 0.0 109.314 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.7 -29.87 71.07 Favored Glycine 1 N--CA 1.517 4.08 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.685 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.1 m -62.56 -36.19 73.83 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.285 0 CA-C-N 117.881 0.841 . . . . 0.0 110.564 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.442 ' HG1' ' N ' ' A' ' 220' ' ' VAL . 43.3 p -55.02 -44.18 74.36 Favored 'General case' 0 N--CA 1.528 3.427 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.24 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.442 ' N ' ' HG1' ' A' ' 219' ' ' THR . 41.5 t -66.16 -36.1 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.414 0 C-N-CA 123.771 0.828 . . . . 0.0 111.061 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.84 -44.43 66.72 Favored 'General case' 0 N--CA 1.533 3.675 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.95 -37.04 78.59 Favored 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 123.08 0.552 . . . . 0.0 111.541 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.3 t -67.15 -47.17 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 C-N-CA 123.106 0.563 . . . . 0.0 111.974 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.37 -35.85 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 CA-C-N 118.058 0.39 . . . . 0.0 111.006 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.8 mt -60.98 -34.44 74.78 Favored 'General case' 0 N--CA 1.539 3.978 0 CA-C-N 117.91 0.323 . . . . 0.0 110.949 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.26 -36.28 77.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 O-C-N 121.829 -0.544 . . . . 0.0 109.779 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.66 -37.68 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.701 0 C-N-CA 122.955 0.502 . . . . 0.0 110.182 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.41 79.98 Favored 'General case' 0 N--CA 1.53 3.556 0 C-N-CA 123.621 0.768 . . . . 0.0 112.582 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 26.3 m -71.76 -34.1 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.601 0 O-C-N 121.938 -0.476 . . . . 0.0 110.176 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.25 -44.01 97.53 Favored 'General case' 0 N--CA 1.53 3.564 0 C-N-CA 123.057 0.543 . . . . 0.0 112.416 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.73 -37.62 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.739 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -63.41 -27.87 69.59 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 123.066 0.546 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -63.35 -23.59 67.48 Favored 'General case' 0 N--CA 1.533 3.705 0 C-N-CA 123.103 0.561 . . . . 0.0 110.829 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 41.5 m -66.68 -40.27 88.49 Favored 'General case' 0 N--CA 1.526 3.358 0 CA-C-O 121.402 0.62 . . . . 0.0 109.847 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 44.5 mt -63.15 -23.98 67.68 Favored 'General case' 0 N--CA 1.524 3.239 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.289 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 46.4 tp -87.86 9.12 23.04 Favored 'General case' 0 N--CA 1.536 3.846 0 C-N-CA 124.057 0.943 . . . . 0.0 109.455 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -139.66 69.16 1.36 Allowed 'General case' 0 N--CA 1.532 3.626 0 C-N-CA 124.5 1.12 . . . . 0.0 109.816 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -84.83 -63.48 1.33 Allowed 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -168.82 168.11 10.67 Favored 'General case' 0 N--CA 1.521 3.117 0 C-N-CA 124.154 0.982 . . . . 0.0 108.821 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.531 3.603 0 C-N-CA 124.573 1.149 . . . . 0.0 108.761 179.656 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.523 3.182 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.28 -26.64 68.51 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 124.322 1.049 . . . . 0.0 110.268 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 90.9 p -64.93 -27.95 69.19 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 123.432 0.693 . . . . 0.0 110.82 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.69 -47.41 49.0 Favored Glycine 0 N--CA 1.515 3.904 0 N-CA-C 114.822 0.689 . . . . 0.0 114.822 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 39.3 pt -71.42 -34.63 54.09 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.406 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.6 tt -55.06 -31.83 26.24 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.148 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -32.2 49.16 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.496 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.17 -29.38 44.78 Favored Glycine 0 N--CA 1.51 3.617 0 CA-C-N 115.067 -0.969 . . . . 0.0 114.088 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 6.0 m -59.55 -37.49 70.6 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.021 0 CA-C-N 118.429 1.115 . . . . 0.0 110.551 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 48.3 p -66.13 -45.92 79.33 Favored 'General case' 0 N--CA 1.528 3.433 0 CA-C-O 121.13 0.491 . . . . 0.0 110.497 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 49.5 t -69.42 -32.96 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.178 0 C-N-CA 124.322 1.049 . . . . 0.0 110.415 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.13 76.79 Favored 'General case' 0 N--CA 1.523 3.225 0 C-N-CA 123.363 0.665 . . . . 0.0 111.801 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.92 -30.6 68.05 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.086 0.554 . . . . 0.0 111.005 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 38.8 t -64.01 -50.76 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 C-N-CA 123.302 0.641 . . . . 0.0 111.167 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.35 -32.12 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 C-N-CA 122.738 0.415 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.61 -47.36 26.86 Favored 'General case' 0 N--CA 1.528 3.425 0 C-N-CA 123.515 0.726 . . . . 0.0 111.561 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.6 tt -64.24 -39.02 84.04 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.058 0 O-C-N 121.593 -0.692 . . . . 0.0 112.779 -176.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.8 -36.92 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.738 0 O-C-N 122.087 -0.383 . . . . 0.0 110.375 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.66 74.9 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.282 0.633 . . . . 0.0 112.165 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 48.0 t -71.88 -38.96 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 C-N-CA 122.99 0.516 . . . . 0.0 111.159 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -69.23 -43.46 73.97 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.39 -37.73 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 C-N-CA 122.57 0.348 . . . . 0.0 111.232 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 18.7 p -67.03 -28.78 68.51 Favored 'General case' 0 N--CA 1.529 3.51 0 CA-C-N 117.85 0.295 . . . . 0.0 111.203 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -63.52 -29.47 70.73 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 123.301 0.64 . . . . 0.0 111.139 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.4 t -65.28 -33.33 75.72 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.384 0.674 . . . . 0.0 111.215 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 51.0 mt -65.72 -18.39 65.3 Favored 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 123.724 0.81 . . . . 0.0 111.931 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 N--CA 1.539 3.995 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.793 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 N--CA 1.522 3.126 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.29 -26.28 68.0 Favored 'General case' 0 N--CA 1.522 3.158 0 C-N-CA 124.261 1.024 . . . . 0.0 109.896 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 57.7 m -58.39 -27.22 64.05 Favored 'General case' 0 N--CA 1.521 3.077 0 C-N-CA 123.403 0.681 . . . . 0.0 111.293 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.67 -48.15 44.64 Favored Glycine 0 N--CA 1.513 3.83 0 CA-C-N 116.137 -0.483 . . . . 0.0 114.218 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 38.5 pt -72.74 -36.9 54.07 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 N-CA-C 115.618 1.711 . . . . 0.0 115.618 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 8.4 tp -56.52 -31.56 34.29 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 14.8 tt -58.98 -32.14 46.98 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.317 0 CA-C-N 119.078 0.854 . . . . 0.0 110.204 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.99 -27.39 37.39 Favored Glycine 1 N--CA 1.518 4.145 0 C-N-CA 123.674 0.654 . . . . 0.0 112.497 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 8.6 p -58.4 -44.83 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.77 0 C-N-CA 123.505 0.722 . . . . 0.0 112.888 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 9.7 t -66.24 -40.73 90.42 Favored 'General case' 0 N--CA 1.536 3.871 0 CA-C-N 118.51 0.595 . . . . 0.0 110.752 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 41.8 t -69.68 -32.28 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 C-N-CA 123.883 0.873 . . . . 0.0 110.764 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.4 -41.7 73.05 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.26 -34.56 74.97 Favored 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 123.202 0.601 . . . . 0.0 111.049 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.29 -52.35 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.088 0.555 . . . . 0.0 111.462 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.58 -31.97 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 122.956 0.502 . . . . 0.0 110.683 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.61 -46.1 91.53 Favored 'General case' 0 N--CA 1.534 3.728 0 C-N-CA 123.407 0.683 . . . . 0.0 110.807 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.49 -36.4 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 O-C-N 121.769 -0.582 . . . . 0.0 110.389 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.86 -38.0 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 122.948 0.499 . . . . 0.0 110.168 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.57 81.17 Favored 'General case' 0 N--CA 1.531 3.615 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.34 -34.3 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.854 0 O-C-N 122.088 -0.383 . . . . 0.0 110.017 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.85 -39.4 93.5 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 123.172 0.589 . . . . 0.0 109.545 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 9.4 t -68.17 -40.08 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 124.298 1.039 . . . . 0.0 109.199 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.44 -34.2 77.24 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 122.92 0.488 . . . . 0.0 109.895 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -73.51 -41.65 62.79 Favored 'General case' 0 N--CA 1.522 3.162 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.156 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.2 t -68.47 -45.9 71.18 Favored 'General case' 0 N--CA 1.528 3.473 0 CA-C-O 122.164 0.983 . . . . 0.0 109.389 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 39.7 tp -61.2 -12.94 14.74 Favored 'General case' 0 N--CA 1.521 3.108 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.872 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 40.8 tp -85.15 8.09 19.42 Favored 'General case' 1 N--CA 1.546 4.329 0 CA-C-N 118.369 0.531 . . . . 0.0 110.755 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -158.26 132.59 8.1 Favored 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -152.59 -18.78 0.16 Allowed 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 125.109 1.364 . . . . 0.0 108.235 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -65.99 -167.8 0.04 OUTLIER 'General case' 0 N--CA 1.52 3.053 0 C-N-CA 124.629 1.172 . . . . 0.0 110.187 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 70.1 t . . . . . 0 N--CA 1.529 3.49 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.845 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.523 3.214 0 CA-C-O 121.51 0.672 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.16 -26.36 68.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.121 0.969 . . . . 0.0 109.553 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 41.3 t -57.42 -25.88 60.27 Favored 'General case' 0 N--CA 1.522 3.164 0 C-N-CA 123.976 0.911 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.68 -34.33 83.12 Favored Glycine 0 N--CA 1.515 3.929 0 C-N-CA 124.293 0.949 . . . . 0.0 114.145 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -46.42 90.81 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.3 0 CA-C-N 117.851 0.825 . . . . 0.0 112.183 -175.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -66.73 -31.87 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.732 0 C-N-CA 123.023 0.529 . . . . 0.0 110.542 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 47.9 mm -68.3 -33.81 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.851 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.59 -45.64 92.41 Favored Glycine 1 N--CA 1.519 4.184 0 C-N-CA 123.226 0.441 . . . . 0.0 113.479 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 11.8 m -69.2 -36.85 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 0 O-C-N 121.549 -0.971 . . . . 0.0 109.914 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 95.4 m -58.64 -46.43 87.15 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 30.4 m -67.6 -30.8 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 123.278 0.631 . . . . 0.0 111.203 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.62 74.01 Favored 'General case' 0 N--CA 1.532 3.669 0 O-C-N 121.683 -0.635 . . . . 0.0 111.572 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.38 -50.04 73.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.71 0.804 . . . . 0.0 112.943 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 15.6 m -58.36 -37.61 64.57 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 CA-C-N 119.155 0.888 . . . . 0.0 110.491 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.48 -32.08 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 122.611 0.365 . . . . 0.0 110.873 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.2 -41.13 70.68 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 40.3 mm -55.31 -51.01 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 C-N-CA 123.349 0.66 . . . . 0.0 112.069 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 31.5 m -61.79 -35.75 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.965 0 C-N-CA 122.988 0.515 . . . . 0.0 110.673 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.88 -31.6 65.0 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.1 0.56 . . . . 0.0 111.414 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.03 -34.63 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 C-N-CA 122.758 0.423 . . . . 0.0 111.374 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -66.34 -43.96 84.64 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 122.951 0.5 . . . . 0.0 111.954 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 6.3 p -68.76 -36.74 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 118.76 0.709 . . . . 0.0 109.149 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 80.3 m -58.45 -27.6 64.52 Favored 'General case' 0 N--CA 1.531 3.615 0 C-N-CA 122.708 0.403 . . . . 0.0 110.969 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -62.98 -19.02 63.92 Favored 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 123.173 0.589 . . . . 0.0 110.739 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 37.2 m -64.14 -37.94 89.28 Favored 'General case' 0 N--CA 1.527 3.394 0 C-N-CA 123.564 0.745 . . . . 0.0 110.568 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.91 -28.81 69.21 Favored 'General case' 0 N--CA 1.534 3.747 0 C-N-CA 123.913 0.885 . . . . 0.0 109.841 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.35 -5.93 58.69 Favored 'General case' 0 N--CA 1.537 3.905 0 C-N-CA 124.466 1.106 . . . . 0.0 110.932 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -53.15 -12.72 0.4 Allowed 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 123.964 0.906 . . . . 0.0 112.872 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.37 137.65 52.33 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.392 0.677 . . . . 0.0 110.981 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp . . . . . 0 N--CA 1.521 3.106 0 C-N-CA 123.975 0.91 . . . . 0.0 109.131 -179.268 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.519 3.007 0 CA-C-O 121.948 0.88 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.85 -26.54 68.37 Favored 'General case' 0 N--CA 1.525 3.286 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.589 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 69.8 m -64.71 -30.93 71.96 Favored 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 123.57 0.748 . . . . 0.0 110.933 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.77 -46.97 58.54 Favored Glycine 1 N--CA 1.517 4.047 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.47 -41.52 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 8.1 tp -62.23 -39.19 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.844 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.2 tt -72.03 -33.2 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.818 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.76 -29.8 55.32 Favored Glycine 0 N--CA 1.512 3.747 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.536 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 2.0 m -63.77 -37.56 80.02 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.062 0 CA-C-N 117.768 0.784 . . . . 0.0 110.425 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 31.2 p -60.97 -46.61 90.03 Favored 'General case' 0 N--CA 1.528 3.449 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.37 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.26 -40.17 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.202 0 C-N-CA 124.033 0.933 . . . . 0.0 110.831 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.01 66.83 Favored 'General case' 0 N--CA 1.524 3.255 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.44 -41.51 76.18 Favored 'General case' 0 N--CA 1.514 2.738 0 C-N-CA 122.921 0.488 . . . . 0.0 111.58 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.75 -46.91 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.504 0 O-C-N 122.089 -0.382 . . . . 0.0 111.834 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.42 -32.44 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.626 0 CA-C-N 117.9 0.318 . . . . 0.0 111.697 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 32.9 tp -74.72 -39.25 61.99 Favored 'General case' 0 N--CA 1.521 3.083 0 CA-C-O 119.209 -0.424 . . . . 0.0 112.014 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 81.8 mt -64.87 -43.8 96.3 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.244 0 CA-C-N 118.945 0.793 . . . . 0.0 111.026 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.3 -36.7 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 117.969 0.349 . . . . 0.0 110.318 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.29 65.79 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.362 0.665 . . . . 0.0 111.941 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.6 -40.76 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.905 0 CA-C-N 117.929 0.331 . . . . 0.0 110.219 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -69.44 -36.18 76.4 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.274 0.63 . . . . 0.0 110.436 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.5 -37.5 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.27 0 C-N-CA 123.744 0.818 . . . . 0.0 109.635 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 72.7 m -58.06 -32.04 67.64 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 122.511 0.325 . . . . 0.0 110.146 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.3 -41.63 60.84 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 60.2 p -68.24 -32.87 73.37 Favored 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 123.257 0.623 . . . . 0.0 110.206 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 N--CA 1.535 3.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.624 -179.042 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.522 3.158 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.01 -25.99 68.09 Favored 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 124.437 1.095 . . . . 0.0 111.628 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 39.7 t -67.36 -33.31 74.97 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 123.469 0.708 . . . . 0.0 111.145 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.73 -44.63 69.34 Favored Glycine 1 N--CA 1.519 4.225 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -44.63 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.997 0 O-C-N 121.759 -0.847 . . . . 0.0 111.776 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 18.8 tt -60.68 -36.42 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 45.3 pt -72.48 -33.44 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 CA-C-N 118.699 0.681 . . . . 0.0 109.32 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.23 -48.65 84.5 Favored Glycine 1 N--CA 1.519 4.195 0 C-N-CA 123.835 0.731 . . . . 0.0 113.855 -177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.35 -36.79 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 C-N-CA 122.973 0.509 . . . . 0.0 109.803 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 90.3 m -64.1 -47.16 81.12 Favored 'General case' 0 N--CA 1.519 3.02 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -70.64 -31.48 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 CA-C-N 118.1 0.409 . . . . 0.0 111.191 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.45 -34.91 50.99 Favored 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.79 -38.62 85.95 Favored 'General case' 0 N--CA 1.523 3.194 0 C-N-CA 123.318 0.647 . . . . 0.0 111.0 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.66 -38.53 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.32 0 C-N-CA 123.697 0.799 . . . . 0.0 110.314 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.8 -37.53 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 123.469 0.708 . . . . 0.0 111.312 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 57.6 mt -72.87 -35.13 67.11 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 122.33 0.252 . . . . 0.0 111.208 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.47 -46.52 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.69 0 C-N-CA 123.08 0.552 . . . . 0.0 110.717 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 33.2 m -67.48 -37.27 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 O-C-N 121.687 -0.633 . . . . 0.0 110.225 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.93 95.25 Favored 'General case' 0 N--CA 1.524 3.23 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 18.3 m -71.32 -34.08 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 O-C-N 121.574 -0.704 . . . . 0.0 110.069 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -63.42 -44.32 94.95 Favored 'General case' 0 N--CA 1.528 3.431 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 13.0 m -68.67 -37.97 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 CA-C-N 118.643 0.656 . . . . 0.0 109.919 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 92.9 m -62.88 -27.54 69.42 Favored 'General case' 0 N--CA 1.522 3.14 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.99 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.79 -38.33 88.71 Favored 'General case' 0 N--CA 1.528 3.469 0 CA-C-O 120.939 0.4 . . . . 0.0 110.297 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 47.1 t -66.38 -36.73 83.59 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.632 0.773 . . . . 0.0 110.678 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.82 -13.67 16.88 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.847 0.859 . . . . 0.0 111.675 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 20.2 mt -86.6 -2.67 58.69 Favored 'General case' 0 N--CA 1.537 3.898 0 C-N-CA 123.059 0.543 . . . . 0.0 110.659 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -165.89 120.3 1.2 Allowed 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 123.441 0.696 . . . . 0.0 109.264 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.524 3.243 0 C-N-CA 124.211 1.005 . . . . 0.0 109.141 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.52 4.26 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.4 p -68.98 161.4 28.99 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.786 0.834 . . . . 0.0 110.936 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.44 -26.19 67.85 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 124.73 1.212 . . . . 0.0 109.466 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 40.9 t -57.57 -39.17 76.14 Favored 'General case' 0 N--CA 1.518 2.928 0 C-N-CA 123.934 0.894 . . . . 0.0 112.273 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.36 -38.57 87.3 Favored Glycine 1 N--CA 1.522 4.419 0 C-N-CA 123.208 0.432 . . . . 0.0 112.115 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.18 -46.43 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 C-N-CA 124.107 0.963 . . . . 0.0 111.766 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.97 -31.85 53.76 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.066 0 C-N-CA 123.228 0.611 . . . . 0.0 109.872 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 30.9 mm -72.62 -33.38 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.9 -46.92 79.11 Favored Glycine 1 N--CA 1.518 4.119 0 N-CA-C 114.298 0.479 . . . . 0.0 114.298 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.12 -37.52 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.888 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.3 t -61.12 -38.04 84.94 Favored 'General case' 0 N--CA 1.539 3.989 0 CA-C-N 119.31 0.959 . . . . 0.0 111.464 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 59.6 t -56.67 -36.69 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 C-N-CA 123.067 0.547 . . . . 0.0 110.475 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.5 76.06 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.0 -49.72 71.34 Favored 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.73 -38.45 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.538 0 CA-C-O 119.003 -0.522 . . . . 0.0 112.26 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.25 -33.94 58.57 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.031 0 CA-C-N 119.323 0.965 . . . . 0.0 110.924 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.22 -47.14 71.74 Favored 'General case' 0 N--CA 1.538 3.934 0 CA-C-O 121.745 0.783 . . . . 0.0 109.566 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.2 mt -54.5 -36.77 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 123.305 0.642 . . . . 0.0 111.383 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.84 -39.21 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.919 0 C-N-CA 122.765 0.426 . . . . 0.0 109.886 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.87 97.98 Favored 'General case' 0 N--CA 1.529 3.5 0 C-N-CA 122.853 0.461 . . . . 0.0 111.146 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 50.8 t -71.82 -35.28 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.284 0 C-N-CA 123.221 0.608 . . . . 0.0 110.065 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -64.01 -44.45 92.58 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.96 -38.06 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 81.9 m -67.16 -32.6 73.8 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 123.344 0.658 . . . . 0.0 110.462 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -70.92 -39.72 72.53 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.319 0.648 . . . . 0.0 109.635 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 75.1 m -65.51 -34.91 79.38 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.773 0.829 . . . . 0.0 109.462 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.8 tp -68.99 -14.11 62.85 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 124.444 1.098 . . . . 0.0 109.904 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.3 -22.55 26.7 Favored 'General case' 0 N--CA 1.535 3.8 0 C-N-CA 124.23 1.012 . . . . 0.0 109.592 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -80.88 -8.84 59.83 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.515 0.726 . . . . 0.0 110.142 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -84.84 -65.44 1.01 Allowed 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 124.108 0.963 . . . . 0.0 110.563 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -70.36 65.31 0.28 Allowed 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.934 0.893 . . . . 0.0 111.178 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.537 3.904 0 C-N-CA 124.37 1.068 . . . . 0.0 108.607 178.585 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.517 2.88 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 47.8 mt -64.63 -28.21 69.46 Favored 'General case' 0 N--CA 1.521 3.098 0 C-N-CA 124.134 0.974 . . . . 0.0 111.286 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 46.5 t -59.02 -44.73 91.76 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.695 0.798 . . . . 0.0 112.371 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.52 -36.92 84.67 Favored Glycine 1 N--CA 1.521 4.353 0 C-N-CA 123.311 0.482 . . . . 0.0 112.248 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.92 -46.08 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 C-N-CA 123.514 0.726 . . . . 0.0 111.45 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.1 tp -68.58 -33.37 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 CA-C-N 118.55 0.614 . . . . 0.0 109.835 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 74.3 mt -68.85 -33.81 61.25 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.128 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.05 -29.71 76.07 Favored Glycine 0 N--CA 1.514 3.897 0 C-N-CA 123.626 0.631 . . . . 0.0 113.208 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -37.18 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 C-N-CA 123.144 0.578 . . . . 0.0 110.157 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 64.5 p -65.09 -47.78 76.04 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.09 -32.95 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 C-N-CA 123.145 0.578 . . . . 0.0 112.427 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.98 -47.1 81.59 Favored 'General case' 0 N--CA 1.526 3.372 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.13 86.54 Favored 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 123.152 0.581 . . . . 0.0 112.018 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -68.41 -53.13 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.291 0 C-N-CA 122.743 0.417 . . . . 0.0 111.939 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.96 -32.54 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -176.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 5.3 tt -69.7 -38.23 76.87 Favored 'General case' 0 N--CA 1.522 3.172 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 85.7 mt -66.38 -36.98 78.67 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.004 0 CA-C-N 118.856 0.753 . . . . 0.0 110.184 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -66.39 -37.8 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.8 86.13 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 123.48 0.712 . . . . 0.0 111.867 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 62.9 t -71.86 -35.09 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.058 0.543 . . . . 0.0 110.145 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -64.33 -44.14 92.44 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.9 -37.54 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.19 -27.14 68.76 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.33 0.652 . . . . 0.0 111.125 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -70.93 -25.97 62.99 Favored 'General case' 0 N--CA 1.529 3.52 0 C-N-CA 122.827 0.451 . . . . 0.0 111.165 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 48.0 m -65.96 -46.32 78.54 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 123.156 0.582 . . . . 0.0 112.152 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.7 pp -68.81 -12.97 62.1 Favored 'General case' 0 N--CA 1.53 3.553 0 C-N-CA 123.897 0.879 . . . . 0.0 112.045 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.8 tp . . . . . 0 N--CA 1.536 3.857 0 C-N-CA 123.227 0.611 . . . . 0.0 109.582 -178.349 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.521 3.099 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.85 -26.9 68.53 Favored 'General case' 0 N--CA 1.536 3.835 0 C-N-CA 124.267 1.027 . . . . 0.0 109.328 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 92.1 p -67.86 -25.86 65.75 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.552 0.741 . . . . 0.0 110.37 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.92 -46.22 68.25 Favored Glycine 0 N--CA 1.515 3.961 0 C-N-CA 123.729 0.68 . . . . 0.0 114.665 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.9 tt -70.59 -35.74 62.62 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.029 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.55 -44.29 80.39 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.409 0 CA-C-N 118.874 0.761 . . . . 0.0 112.873 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.3 tt -72.41 -32.77 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.88 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.62 -28.84 46.95 Favored Glycine 1 N--CA 1.517 4.082 0 C-N-CA 124.296 0.951 . . . . 0.0 113.158 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.5 m -59.42 -36.7 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.979 0 CA-C-O 121.08 0.467 . . . . 0.0 111.03 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 66.2 p -55.37 -44.6 76.2 Favored 'General case' 0 N--CA 1.527 3.421 0 C-N-CA 123.139 0.576 . . . . 0.0 111.86 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.28 -33.3 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 123.385 0.674 . . . . 0.0 110.529 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.39 83.91 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 122.658 0.383 . . . . 0.0 110.813 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.66 -50.44 73.86 Favored 'General case' 0 N--CA 1.518 2.964 0 C-N-CA 123.393 0.677 . . . . 0.0 112.826 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 34.5 m -68.04 -38.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 CA-C-N 118.288 0.495 . . . . 0.0 111.004 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.33 -38.91 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.798 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 39.3 tp -62.01 -34.9 77.05 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 122.804 0.441 . . . . 0.0 111.416 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.09 -46.21 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.869 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.39 -37.6 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 123.029 0.532 . . . . 0.0 109.943 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.4 -49.86 75.89 Favored 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 123.586 0.754 . . . . 0.0 112.507 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 11.9 p -71.89 -34.38 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 O-C-N 122.05 -0.406 . . . . 0.0 110.882 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -62.91 -44.34 96.36 Favored 'General case' 0 N--CA 1.529 3.488 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.28 -39.69 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.31 -28.38 67.95 Favored 'General case' 0 N--CA 1.522 3.166 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.08 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.64 -31.03 72.07 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 123.179 0.592 . . . . 0.0 111.092 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 39.2 t -63.96 -36.99 85.78 Favored 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 123.631 0.772 . . . . 0.0 111.639 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 50.3 tp -60.66 -24.34 65.51 Favored 'General case' 0 N--CA 1.528 3.436 0 C-N-CA 123.641 0.776 . . . . 0.0 111.848 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.97 8.26 27.19 Favored 'General case' 0 N--CA 1.538 3.95 0 C-N-CA 123.289 0.636 . . . . 0.0 110.036 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -164.43 71.21 0.2 Allowed 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 122.729 0.412 . . . . 0.0 110.171 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -75.42 163.43 27.43 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -74.43 137.13 42.44 Favored 'General case' 0 N--CA 1.522 3.166 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.53 3.575 0 C-N-CA 124.573 1.149 . . . . 0.0 109.189 -179.19 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.518 2.963 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.2 -26.51 68.17 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 124.311 1.044 . . . . 0.0 109.678 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 43.7 t -67.13 -33.08 74.67 Favored 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 123.767 0.827 . . . . 0.0 111.338 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.87 -46.93 58.22 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 114.251 0.461 . . . . 0.0 114.251 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 tt -69.58 -35.28 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.88 0 CA-C-N 117.544 0.672 . . . . 0.0 112.345 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -56.51 -32.22 36.04 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 C-N-CA 123.447 0.699 . . . . 0.0 111.403 -177.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.86 -32.99 60.61 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.319 0 C-N-CA 122.934 0.494 . . . . 0.0 109.702 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.54 -29.33 47.67 Favored Glycine 1 N--CA 1.518 4.118 0 C-N-CA 123.802 0.715 . . . . 0.0 113.227 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.41 -37.49 69.92 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.102 0 C-N-CA 123.134 0.573 . . . . 0.0 110.633 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -59.34 -38.99 81.74 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 123.357 0.663 . . . . 0.0 111.252 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.93 -36.89 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.153 0 C-N-CA 123.783 0.833 . . . . 0.0 111.384 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.15 80.67 Favored 'General case' 0 N--CA 1.527 3.376 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.6 -49.95 42.27 Favored 'General case' 0 N--CA 1.518 2.94 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.4 -38.73 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.836 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.29 -32.25 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -36.09 74.34 Favored 'General case' 0 N--CA 1.534 3.754 0 C-N-CA 123.644 0.778 . . . . 0.0 109.833 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 37.2 mm -61.29 -36.98 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.894 0 C-N-CA 123.35 0.66 . . . . 0.0 110.553 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 40.5 t -66.13 -37.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 123.5 0.72 . . . . 0.0 109.892 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.08 77.85 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.51 0.724 . . . . 0.0 112.446 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.71 -34.32 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 O-C-N 122.125 -0.36 . . . . 0.0 110.646 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.99 -44.25 93.24 Favored 'General case' 0 N--CA 1.528 3.435 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.7 -37.75 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.717 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.15 -27.96 69.43 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.006 0.522 . . . . 0.0 111.227 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.69 -33.41 73.91 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 123.112 0.565 . . . . 0.0 110.762 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 49.8 m -63.79 -31.37 72.52 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.49 0.716 . . . . 0.0 112.173 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.34 -14.89 39.52 Favored 'General case' 0 N--CA 1.536 3.837 0 C-N-CA 123.725 0.81 . . . . 0.0 109.898 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -87.58 -11.65 48.03 Favored 'General case' 0 N--CA 1.533 3.716 0 C-N-CA 123.762 0.825 . . . . 0.0 110.962 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -0.55 0.29 Allowed 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.33 167.49 1.35 Allowed 'General case' 0 N--CA 1.531 3.576 0 C-N-CA 123.423 0.689 . . . . 0.0 111.417 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm . . . . . 0 N--CA 1.521 3.115 0 C-N-CA 124.115 0.966 . . . . 0.0 110.025 -179.667 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 95.4 p . . . . . 0 N--CA 1.525 3.279 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.72 -30.05 71.05 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 124.137 0.975 . . . . 0.0 109.9 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 60.4 m -58.37 -26.29 63.0 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 123.207 0.603 . . . . 0.0 110.803 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.29 -34.63 63.32 Favored Glycine 1 N--CA 1.517 4.057 0 C-N-CA 124.121 0.867 . . . . 0.0 113.571 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 13.2 tt -59.59 -44.99 94.48 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.049 0 CA-C-N 117.795 0.797 . . . . 0.0 112.911 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.4 pt -65.68 -34.92 73.6 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.437 0 CA-C-O 121.564 0.697 . . . . 0.0 110.038 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 49.3 mm -71.4 -33.57 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 124.183 0.993 . . . . 0.0 108.758 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.62 -31.02 78.48 Favored Glycine 1 N--CA 1.518 4.109 0 C-N-CA 123.389 0.519 . . . . 0.0 113.6 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 1.3 m -67.06 -37.35 79.13 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.103 0 CA-C-N 117.697 0.748 . . . . 0.0 110.397 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 37.4 p -60.81 -45.28 95.03 Favored 'General case' 0 N--CA 1.526 3.365 0 C-N-CA 123.168 0.587 . . . . 0.0 111.315 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.1 -36.53 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.254 0 C-N-CA 124.038 0.935 . . . . 0.0 111.325 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.91 -47.06 78.16 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 122.835 0.454 . . . . 0.0 112.027 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.72 90.85 Favored 'General case' 0 N--CA 1.52 3.073 0 C-N-CA 123.687 0.795 . . . . 0.0 111.655 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.46 -49.37 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 122.83 0.452 . . . . 0.0 110.699 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.15 -32.61 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.075 0.55 . . . . 0.0 110.312 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.08 -47.2 83.92 Favored 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 123.028 0.531 . . . . 0.0 111.048 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 80.1 mt -62.97 -38.86 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 C-N-CA 122.662 0.385 . . . . 0.0 110.477 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.19 -37.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 C-N-CA 123.288 0.635 . . . . 0.0 109.852 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.42 97.33 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.039 0.536 . . . . 0.0 111.334 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 62.8 t -71.74 -34.62 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.199 0.6 . . . . 0.0 109.749 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -63.46 -44.42 94.52 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.92 -37.7 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 77.5 m -67.12 -35.48 79.83 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.123 0.569 . . . . 0.0 110.295 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.67 -38.75 90.16 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 123.476 0.71 . . . . 0.0 111.282 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 86.7 p -65.1 -21.33 66.79 Favored 'General case' 0 N--CA 1.529 3.5 0 C-N-CA 123.082 0.553 . . . . 0.0 110.971 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.533 3.683 0 C-N-CA 123.958 0.903 . . . . 0.0 110.037 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.522 3.129 0 CA-C-O 121.4 0.619 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.19 -26.56 68.2 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 124.166 0.986 . . . . 0.0 109.445 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 65.5 m -57.66 -25.38 60.14 Favored 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.183 0.993 . . . . 0.0 111.415 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.0 -35.31 83.86 Favored Glycine 0 N--CA 1.515 3.923 0 C-N-CA 124.167 0.889 . . . . 0.0 115.267 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 12.2 tt -59.08 -35.09 55.35 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.593 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 9.3 tp -55.84 -31.85 30.97 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.31 -32.53 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.944 0 CA-C-N 118.383 0.538 . . . . 0.0 110.023 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.79 -29.54 54.91 Favored Glycine 0 N--CA 1.514 3.87 0 CA-C-O 119.555 -0.58 . . . . 0.0 113.873 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.6 m -59.92 -48.26 88.45 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 CA-C-N 118.075 0.938 . . . . 0.0 112.468 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 11.3 t -66.43 -38.76 88.14 Favored 'General case' 0 N--CA 1.536 3.847 0 O-C-N 121.955 -0.466 . . . . 0.0 110.98 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.87 -39.05 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.297 0 C-N-CA 123.46 0.704 . . . . 0.0 109.333 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.18 98.63 Favored 'General case' 0 N--CA 1.522 3.146 0 C-N-CA 123.137 0.575 . . . . 0.0 110.907 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.73 79.29 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 123.264 0.625 . . . . 0.0 111.781 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.37 -51.01 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.545 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.69 -33.25 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 123.632 0.773 . . . . 0.0 111.109 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 38.6 tp -66.07 -35.49 80.67 Favored 'General case' 0 N--CA 1.531 3.593 0 C-N-CA 122.513 0.325 . . . . 0.0 111.218 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 92.2 mt -69.2 -41.15 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.89 -37.96 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 123.413 0.685 . . . . 0.0 109.594 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.22 81.38 Favored 'General case' 0 N--CA 1.526 3.347 0 C-N-CA 123.81 0.844 . . . . 0.0 112.666 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.46 -34.0 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 O-C-N 121.872 -0.517 . . . . 0.0 109.98 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.73 -44.27 94.06 Favored 'General case' 0 N--CA 1.529 3.493 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.95 -37.53 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 98.0 m -59.42 -27.43 66.03 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.336 0.654 . . . . 0.0 111.316 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.34 -40.89 85.91 Favored 'General case' 0 N--CA 1.529 3.501 0 CA-C-O 121.078 0.466 . . . . 0.0 110.426 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 47.6 t -64.77 -17.58 64.3 Favored 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 124.129 0.972 . . . . 0.0 112.45 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.6 -15.08 63.14 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 122.977 0.511 . . . . 0.0 110.627 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.37 -28.7 22.04 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.115 0.566 . . . . 0.0 109.58 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -158.83 144.45 16.47 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.705 0.802 . . . . 0.0 108.98 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 N--CA 1.529 3.524 0 C-N-CA 124.725 1.21 . . . . 0.0 108.149 178.477 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.162 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 43.1 m 60.24 47.63 9.0 Favored 'General case' 0 N--CA 1.519 3.024 0 C-N-CA 124.317 1.047 . . . . 0.0 111.847 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.6 mp -65.14 -26.63 68.27 Favored 'General case' 0 N--CA 1.534 3.735 0 C-N-CA 123.829 0.852 . . . . 0.0 109.251 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 98.0 p -68.41 -27.43 66.2 Favored 'General case' 0 N--CA 1.521 3.076 0 C-N-CA 123.263 0.625 . . . . 0.0 110.049 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.46 -46.9 53.81 Favored Glycine 0 N--CA 1.513 3.779 0 N-CA-C 116.688 1.435 . . . . 0.0 116.688 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.5 pt -59.69 -35.24 58.61 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.467 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 -174.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.2 tt -56.75 -32.06 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 15.5 tt -70.78 -33.79 53.91 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 CA-C-N 120.131 1.332 . . . . 0.0 111.064 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.81 -43.63 80.92 Favored Glycine 1 N--CA 1.52 4.246 0 C-N-CA 123.053 0.359 . . . . 0.0 113.802 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.06 -37.29 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.977 0 O-C-N 121.639 -0.918 . . . . 0.0 110.922 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 61.3 p -64.84 -45.65 85.24 Favored 'General case' 0 N--CA 1.538 3.928 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.49 -30.87 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 C-N-CA 123.093 0.557 . . . . 0.0 111.766 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.43 -47.0 88.01 Favored 'General case' 0 N--CA 1.534 3.732 0 O-C-N 121.496 -0.753 . . . . 0.0 112.614 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.63 -44.24 96.79 Favored 'General case' 0 N--CA 1.521 3.124 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.65 -39.73 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.752 0 CA-C-N 118.773 0.715 . . . . 0.0 112.068 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.32 -34.15 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.339 0.518 . . . . 0.0 110.134 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.7 -48.06 78.65 Favored 'General case' 0 N--CA 1.524 3.24 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.6 pt -70.01 -36.74 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 O-C-N 122.065 -0.397 . . . . 0.0 111.339 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.3 -37.46 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.03 -41.13 82.57 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 122.968 0.507 . . . . 0.0 111.806 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.77 -37.12 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.192 0.597 . . . . 0.0 110.15 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -63.08 -44.16 96.52 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 123.211 0.604 . . . . 0.0 112.377 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.88 -37.62 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 93.2 m -64.68 -28.43 69.59 Favored 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 122.846 0.458 . . . . 0.0 110.727 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -72.93 -23.37 60.68 Favored 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 123.23 0.612 . . . . 0.0 110.924 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.1 m -66.19 -31.36 72.14 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 122.949 0.499 . . . . 0.0 111.432 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.68 -37.53 87.89 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.644 0.777 . . . . 0.0 112.377 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 pp -95.19 -16.26 22.68 Favored 'General case' 1 N--CA 1.547 4.392 0 C-N-CA 123.223 0.609 . . . . 0.0 111.531 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -67.1 -10.39 49.55 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 123.505 0.722 . . . . 0.0 111.193 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.1 116.2 4.01 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 123.625 0.77 . . . . 0.0 111.508 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.62 -162.99 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.648 0 C-N-CA 126.126 1.77 . . . . 0.0 114.538 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.528 3.474 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -179.846 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 71.9 p . . . . . 0 N--CA 1.522 3.128 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 48.4 mt -57.28 -25.82 59.85 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 124.873 1.269 . . . . 0.0 111.613 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.3 t -57.01 -37.69 72.06 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.581 0.752 . . . . 0.0 112.065 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.28 -46.32 57.65 Favored Glycine 1 N--CA 1.518 4.164 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.475 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.89 -46.38 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 124.53 1.132 . . . . 0.0 112.79 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.07 -38.23 59.42 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 17.0 tt -72.83 -32.93 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.884 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.6 -29.14 47.69 Favored Glycine 0 N--CA 1.513 3.821 0 C-N-CA 124.19 0.9 . . . . 0.0 113.581 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.5 -37.74 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.875 0 CA-C-N 117.27 0.535 . . . . 0.0 111.157 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 69.0 p -63.87 -45.93 87.22 Favored 'General case' 0 N--CA 1.529 3.489 0 CA-C-O 121.224 0.535 . . . . 0.0 110.804 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.52 -34.69 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.059 0 C-N-CA 124.101 0.961 . . . . 0.0 110.962 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.61 -46.96 67.22 Favored 'General case' 0 N--CA 1.529 3.52 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.8 74.53 Favored 'General case' 0 N--CA 1.522 3.143 0 C-N-CA 123.285 0.634 . . . . 0.0 111.807 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -67.13 -41.38 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.438 0 C-N-CA 122.913 0.485 . . . . 0.0 110.451 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.94 -38.52 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 0 C-N-CA 122.899 0.48 . . . . 0.0 111.495 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 56.9 tp -66.77 -43.13 84.82 Favored 'General case' 0 N--CA 1.532 3.631 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.19 -39.15 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.809 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.77 -37.07 78.74 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 CA-C-N 118.717 0.69 . . . . 0.0 109.82 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.55 -32.08 66.75 Favored 'General case' 0 N--CA 1.525 3.305 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.24 -34.89 72.13 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.175 0 CA-C-N 119.286 0.948 . . . . 0.0 112.355 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.73 -43.98 91.67 Favored 'General case' 0 N--CA 1.536 3.871 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.92 -37.73 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.803 0 O-C-N 121.832 -0.543 . . . . 0.0 109.574 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.08 -27.92 67.77 Favored 'General case' 0 N--CA 1.527 3.391 0 C-N-CA 123.259 0.623 . . . . 0.0 111.148 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.16 -30.19 71.26 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.054 0.542 . . . . 0.0 110.507 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 34.9 t -63.82 -39.03 93.27 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.368 0.667 . . . . 0.0 110.774 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.12 -15.94 63.04 Favored 'General case' 0 N--CA 1.527 3.418 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.746 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 49.6 tp . . . . . 0 N--CA 1.537 3.901 0 C-N-CA 124.184 0.993 . . . . 0.0 109.523 179.871 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 100.0 p . . . . . 0 N--CA 1.522 3.134 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.66 -39.43 88.36 Favored 'General case' 0 N--CA 1.535 3.782 0 C-N-CA 124.129 0.972 . . . . 0.0 109.25 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 42.0 t -68.19 -32.24 72.33 Favored 'General case' 0 N--CA 1.517 2.92 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.487 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.41 -46.34 63.9 Favored Glycine 0 N--CA 1.514 3.896 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.443 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 41.8 pt -66.3 -38.49 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 CA-C-N 118.062 0.931 . . . . 0.0 112.344 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.98 -32.59 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.37 -32.8 43.66 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.23 -29.09 44.51 Favored Glycine 0 N--CA 1.513 3.819 0 C-N-CA 124.172 0.891 . . . . 0.0 113.529 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.46 -37.57 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 117.505 0.653 . . . . 0.0 110.739 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 61.4 p -63.08 -46.21 88.47 Favored 'General case' 0 N--CA 1.528 3.432 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.959 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.77 -38.08 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 124.226 1.011 . . . . 0.0 110.184 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.06 63.98 Favored 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 123.663 0.785 . . . . 0.0 112.659 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.67 75.0 Favored 'General case' 0 N--CA 1.519 3.009 0 C-N-CA 123.345 0.658 . . . . 0.0 111.664 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.8 -48.25 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.367 0 C-N-CA 123.165 0.586 . . . . 0.0 111.425 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.4 -32.45 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 C-N-CA 122.615 0.366 . . . . 0.0 110.537 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.44 -42.24 98.44 Favored 'General case' 0 N--CA 1.53 3.546 0 C-N-CA 123.361 0.664 . . . . 0.0 110.313 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 94.8 mt -65.72 -44.17 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 123.33 0.652 . . . . 0.0 109.753 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.45 -37.55 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.484 0 C-N-CA 123.32 0.648 . . . . 0.0 109.708 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.95 81.55 Favored 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.284 0.634 . . . . 0.0 112.322 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 17.6 m -71.9 -34.44 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 O-C-N 121.96 -0.463 . . . . 0.0 110.647 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.69 -44.44 93.69 Favored 'General case' 0 N--CA 1.53 3.536 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.89 -37.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.759 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 70.7 m -67.47 -39.15 85.27 Favored 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 122.966 0.507 . . . . 0.0 110.479 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.15 -32.77 63.27 Favored 'General case' 0 N--CA 1.524 3.271 0 C-N-CA 123.554 0.742 . . . . 0.0 111.008 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 86.3 p -63.76 -24.75 67.89 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.175 0.59 . . . . 0.0 111.505 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.59 -30.9 69.75 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.804 0.842 . . . . 0.0 110.355 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.24 1.9 56.0 Favored 'General case' 0 N--CA 1.535 3.82 0 C-N-CA 124.25 1.02 . . . . 0.0 110.128 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -59.65 -15.95 22.85 Favored 'General case' 0 N--CA 1.533 3.682 0 C-N-CA 123.239 0.616 . . . . 0.0 110.978 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -67.49 157.57 33.95 Favored 'General case' 0 N--CA 1.518 2.962 0 C-N-CA 124.176 0.99 . . . . 0.0 110.011 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -165.36 -22.09 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.429 0 C-N-CA 123.856 0.862 . . . . 0.0 109.624 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.529 3.505 0 C-N-CA 125.2 1.4 . . . . 0.0 108.406 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 89.9 p . . . . . 0 N--CA 1.522 3.136 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.13 -39.04 92.5 Favored 'General case' 0 N--CA 1.527 3.391 0 C-N-CA 124.055 0.942 . . . . 0.0 109.817 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 92.4 p -68.23 -27.71 66.6 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.082 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.65 -47.25 50.31 Favored Glycine 0 N--CA 1.504 3.21 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.543 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.48 -37.98 66.44 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.322 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -176.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 10.2 tp -56.87 -31.86 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.622 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 pt -59.74 -39.65 80.3 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.318 0 CA-C-N 119.325 0.966 . . . . 0.0 111.562 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.53 -28.87 46.32 Favored Glycine 0 N--CA 1.516 3.992 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.257 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 2.9 p -59.36 -46.66 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 C-N-CA 123.697 0.799 . . . . 0.0 112.753 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 3.2 t -66.08 -38.71 88.95 Favored 'General case' 0 N--CA 1.534 3.752 0 CA-C-O 121.217 0.532 . . . . 0.0 110.667 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.4 -34.81 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.033 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.484 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.78 79.07 Favored 'General case' 0 N--CA 1.527 3.377 0 C-N-CA 123.03 0.532 . . . . 0.0 111.533 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -49.93 44.9 Favored 'General case' 0 N--CA 1.511 2.58 0 C-N-CA 123.38 0.672 . . . . 0.0 112.588 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 21.8 m -61.04 -42.27 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.82 -32.09 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.68 0 C-N-CA 122.845 0.458 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.15 -40.24 53.12 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mp -54.98 -44.41 73.69 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 C-N-CA 124.128 0.971 . . . . 0.0 112.187 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 22.5 m -66.19 -36.88 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 O-C-N 121.762 -0.586 . . . . 0.0 111.129 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.49 85.97 Favored 'General case' 0 N--CA 1.529 3.481 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 11.3 m -71.68 -34.32 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 O-C-N 121.873 -0.517 . . . . 0.0 110.326 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -63.67 -43.96 95.13 Favored 'General case' 0 N--CA 1.531 3.615 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.5 -37.18 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.62 -28.64 65.83 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 122.704 0.402 . . . . 0.0 111.566 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -58.01 -16.56 13.05 Favored 'General case' 1 N--CA 1.54 4.073 0 CA-C-N 118.308 0.503 . . . . 0.0 111.56 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 45.8 t -68.14 -43.98 77.08 Favored 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.79 -27.48 68.31 Favored 'General case' 0 N--CA 1.528 3.435 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.396 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.19 10.45 16.86 Favored 'General case' 1 N--CA 1.542 4.127 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -159.89 98.98 1.37 Allowed 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 123.176 0.59 . . . . 0.0 109.839 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -137.72 144.12 41.56 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 125.087 1.355 . . . . 0.0 107.441 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.518 2.962 0 C-N-CA 123.786 0.834 . . . . 0.0 108.843 179.102 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.524 3.232 0 CA-C-O 119.947 -0.073 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 47.3 mt -63.55 -26.79 68.86 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.014 0.926 . . . . 0.0 110.54 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 94.3 p -62.07 -39.73 93.38 Favored 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 123.844 0.858 . . . . 0.0 110.741 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.06 -39.98 83.89 Favored Glycine 1 N--CA 1.517 4.061 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.656 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.65 -46.36 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.405 0 C-N-CA 124.026 0.93 . . . . 0.0 112.669 -176.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.4 tt -61.94 -37.53 78.49 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.024 0 O-C-N 121.915 -0.49 . . . . 0.0 112.294 -176.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.1 tp -73.18 -33.65 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.684 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.8 -46.86 91.83 Favored Glycine 1 N--CA 1.516 4.009 0 CA-C-N 115.781 -0.645 . . . . 0.0 114.487 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.94 -37.42 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.844 0 CA-C-N 117.806 0.803 . . . . 0.0 110.899 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 54.5 p -66.36 -45.75 79.08 Favored 'General case' 0 N--CA 1.531 3.592 0 CA-C-O 120.914 0.388 . . . . 0.0 111.113 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.67 -31.37 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.417 0 C-N-CA 123.918 0.887 . . . . 0.0 111.212 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.71 72.48 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.03 -49.26 53.06 Favored 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.54 -39.81 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 31.9 m -68.02 -35.41 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 CA-C-N 118.519 0.6 . . . . 0.0 112.017 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 26.3 tp -69.87 -42.72 73.12 Favored 'General case' 0 N--CA 1.524 3.261 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 33.2 pt -66.67 -35.83 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.838 0.745 . . . . 0.0 111.153 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 92.9 t -65.05 -37.67 80.81 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.036 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.46 -35.81 74.79 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 123.17 0.588 . . . . 0.0 111.665 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 71.0 t -71.9 -36.33 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.27 0 C-N-CA 123.45 0.7 . . . . 0.0 110.762 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.07 -43.96 81.33 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.52 -38.01 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.519 0 C-N-CA 122.555 0.342 . . . . 0.0 110.893 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 14.4 p -67.11 -27.8 67.63 Favored 'General case' 0 N--CA 1.534 3.765 0 CA-C-N 117.876 0.307 . . . . 0.0 111.297 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -60.43 -30.04 69.38 Favored 'General case' 0 N--CA 1.529 3.489 0 C-N-CA 123.153 0.581 . . . . 0.0 110.965 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 45.6 t -64.94 -41.77 95.23 Favored 'General case' 0 N--CA 1.525 3.322 0 CA-C-O 121.695 0.759 . . . . 0.0 110.572 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 45.6 mt . . . . . 0 N--CA 1.518 2.938 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.053 -179.284 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.521 3.123 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.13 -26.91 68.39 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.785 0.834 . . . . 0.0 110.451 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 67.1 m -68.61 -35.18 76.98 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 123.544 0.737 . . . . 0.0 110.308 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.68 -43.2 76.99 Favored Glycine 1 N--CA 1.517 4.044 0 CA-C-N 115.228 -0.896 . . . . 0.0 115.17 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -45.85 71.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 CA-C-N 118.026 0.913 . . . . 0.0 111.406 -176.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 19.8 tt -60.83 -34.35 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 44.9 pt -72.57 -32.81 42.85 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.195 0 CA-C-N 119.556 1.071 . . . . 0.0 108.929 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.88 -29.77 51.6 Favored Glycine 0 N--CA 1.514 3.872 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.979 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.0 -37.53 72.88 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.021 0 CA-C-N 117.588 0.694 . . . . 0.0 110.963 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 43.1 p -62.99 -46.21 88.73 Favored 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.048 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.95 -36.06 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.151 0 C-N-CA 124.212 1.005 . . . . 0.0 110.749 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.42 -43.13 64.64 Favored 'General case' 0 N--CA 1.525 3.313 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.73 -43.11 85.1 Favored 'General case' 0 N--CA 1.519 3.012 0 C-N-CA 123.261 0.624 . . . . 0.0 111.972 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 36.9 t -66.72 -45.56 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 C-N-CA 122.943 0.497 . . . . 0.0 111.022 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.16 -38.83 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 123.263 0.625 . . . . 0.0 111.153 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.81 -34.63 78.6 Favored 'General case' 0 N--CA 1.532 3.64 0 CA-C-N 117.828 0.285 . . . . 0.0 110.803 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.67 -44.26 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.886 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.04 -37.77 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.625 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.65 -48.22 81.77 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.731 0.813 . . . . 0.0 112.807 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.58 -34.22 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 O-C-N 121.948 -0.47 . . . . 0.0 110.084 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -64.01 -44.13 93.53 Favored 'General case' 0 N--CA 1.527 3.401 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.71 -37.74 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 98.9 m -61.66 -27.92 69.02 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.039 0.536 . . . . 0.0 111.212 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -67.62 -30.62 70.24 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 122.947 0.499 . . . . 0.0 111.49 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 49.4 m -64.04 -31.99 73.38 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 123.324 0.649 . . . . 0.0 112.407 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.78 -33.0 72.31 Favored 'General case' 0 N--CA 1.534 3.754 0 C-N-CA 123.793 0.837 . . . . 0.0 112.379 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.33 10.97 23.47 Favored 'General case' 1 N--CA 1.547 4.399 0 C-N-CA 124.019 0.928 . . . . 0.0 111.466 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 31.7 t90 -139.25 79.24 1.71 Allowed 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 124.374 1.07 . . . . 0.0 108.648 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.525 3.277 0 C-N-CA 124.159 0.984 . . . . 0.0 109.963 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.1 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.8 m -161.22 44.25 0.17 Allowed 'General case' 0 N--CA 1.52 3.067 0 C-N-CA 123.684 0.794 . . . . 0.0 109.185 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 48.2 mt -64.72 -41.18 96.16 Favored 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 123.972 0.909 . . . . 0.0 110.123 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 95.3 p -57.95 -26.96 62.95 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 123.271 0.629 . . . . 0.0 110.678 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.21 -41.52 86.08 Favored Glycine 1 N--CA 1.52 4.266 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 62.3 mt -65.62 -37.1 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 C-N-CA 124.348 1.059 . . . . 0.0 109.083 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 45.6 mm -67.48 -40.81 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 C-N-CA 124.151 0.981 . . . . 0.0 108.384 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 87.7 mt -72.33 -33.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.04 -29.72 75.24 Favored Glycine 1 N--CA 1.518 4.111 0 C-N-CA 123.336 0.493 . . . . 0.0 112.458 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -37.23 72.81 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.18 0 C-N-CA 123.394 0.678 . . . . 0.0 109.916 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -57.46 -45.24 84.98 Favored 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.342 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 51.2 t -56.57 -42.07 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 C-N-CA 124.323 1.049 . . . . 0.0 111.454 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.62 -40.74 63.04 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.96 -37.25 75.76 Favored 'General case' 0 N--CA 1.523 3.179 0 C-N-CA 123.114 0.566 . . . . 0.0 111.726 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.09 -48.52 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.502 0 C-N-CA 123.492 0.717 . . . . 0.0 111.359 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.14 -32.62 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 O-C-N 121.926 -0.484 . . . . 0.0 111.847 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.15 -40.65 37.29 Favored 'General case' 0 N--CA 1.534 3.748 0 C-N-CA 122.61 0.364 . . . . 0.0 111.705 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.42 -38.78 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.355 0.525 . . . . 0.0 111.711 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 35.4 m -67.89 -37.59 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.564 0 CA-C-O 121.047 0.451 . . . . 0.0 110.406 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.05 97.17 Favored 'General case' 0 N--CA 1.523 3.21 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.03 -33.95 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 O-C-N 121.726 -0.609 . . . . 0.0 110.149 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -60.03 -44.27 94.73 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.95 -42.08 82.12 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 CA-C-O 121.681 0.753 . . . . 0.0 109.468 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 83.0 m -61.57 -27.56 68.71 Favored 'General case' 0 N--CA 1.518 2.955 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.293 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.21 -30.9 71.84 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 122.635 0.374 . . . . 0.0 110.373 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 34.0 t -64.01 -35.17 79.82 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.243 0.617 . . . . 0.0 111.152 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.91 -18.42 56.54 Favored 'General case' 0 N--CA 1.532 3.636 0 C-N-CA 122.968 0.507 . . . . 0.0 111.592 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.54 -2.01 58.32 Favored 'General case' 1 N--CA 1.541 4.119 0 C-N-CA 123.054 0.542 . . . . 0.0 109.86 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -66.62 -68.47 0.37 Allowed 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.172 0.589 . . . . 0.0 110.005 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 56.96 176.98 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.227 0 C-N-CA 124.26 1.024 . . . . 0.0 112.024 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -69.97 -178.22 1.53 Allowed 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 124.0 0.92 . . . . 0.0 110.359 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.529 3.498 0 C-N-CA 125.203 1.401 . . . . 0.0 108.228 179.8 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.52 3.068 0 CA-C-O 121.387 0.613 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 53.9 mt -65.1 -26.83 68.38 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.6 0.76 . . . . 0.0 109.996 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -65.82 -29.23 69.67 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.34 0.656 . . . . 0.0 110.519 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.52 -35.68 81.9 Favored Glycine 1 N--CA 1.523 4.451 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.21 -45.97 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 C-N-CA 124.037 0.935 . . . . 0.0 111.555 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.7 pt -65.22 -33.21 62.12 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.492 0 CA-C-O 121.844 0.83 . . . . 0.0 110.019 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 40.0 mm -73.06 -33.67 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.285 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.45 -48.26 77.32 Favored Glycine 1 N--CA 1.52 4.249 0 C-N-CA 123.435 0.541 . . . . 0.0 114.29 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.96 -37.71 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.77 0 CA-C-N 117.434 0.617 . . . . 0.0 110.861 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 72.7 p -66.64 -45.92 77.46 Favored 'General case' 0 N--CA 1.533 3.722 0 CA-C-N 118.141 0.428 . . . . 0.0 111.354 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.48 -31.53 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.25 0 C-N-CA 123.797 0.839 . . . . 0.0 111.301 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.49 -37.23 75.12 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.21 -50.08 43.67 Favored 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.13 -38.46 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.32 -32.5 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 36.2 tp -77.84 -39.4 43.64 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.0 pt -69.51 -37.01 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 CA-C-N 119.053 0.842 . . . . 0.0 112.171 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.0 -37.09 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 121.838 -0.539 . . . . 0.0 110.15 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.19 79.87 Favored 'General case' 0 N--CA 1.525 3.3 0 C-N-CA 123.78 0.832 . . . . 0.0 112.888 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.64 -34.43 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 O-C-N 121.926 -0.484 . . . . 0.0 110.394 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -64.38 -44.08 92.45 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 123.091 0.556 . . . . 0.0 112.307 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.85 -37.57 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.704 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 83.4 m -64.35 -27.84 69.29 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.066 0.546 . . . . 0.0 111.018 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -69.3 -30.52 68.62 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.089 0.556 . . . . 0.0 111.05 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 82.4 p -64.73 -31.22 72.35 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.198 0.599 . . . . 0.0 111.706 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.3 -17.32 62.41 Favored 'General case' 0 N--CA 1.536 3.825 0 C-N-CA 123.462 0.705 . . . . 0.0 111.085 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.537 3.892 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.519 3.025 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 45.8 mt -61.07 -26.2 67.48 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.49 1.116 . . . . 0.0 111.279 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 63.5 m -57.75 -43.49 85.43 Favored 'General case' 0 N--CA 1.522 3.174 0 C-N-CA 123.677 0.791 . . . . 0.0 112.097 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.62 81.28 Favored Glycine 1 N--CA 1.523 4.443 0 C-N-CA 123.559 0.599 . . . . 0.0 112.707 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 41.6 mm -59.98 -46.54 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.627 0 C-N-CA 123.979 0.912 . . . . 0.0 112.898 -176.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.01 -35.77 70.63 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.5 mm -72.25 -33.36 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.04 -29.72 56.15 Favored Glycine 0 N--CA 1.513 3.798 0 C-N-CA 124.018 0.818 . . . . 0.0 113.415 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 m -59.98 -37.63 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 CA-C-N 117.349 0.574 . . . . 0.0 110.89 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 43.7 p -61.09 -46.72 89.5 Favored 'General case' 0 N--CA 1.526 3.34 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.213 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.96 -39.87 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.037 0 C-N-CA 124.277 1.031 . . . . 0.0 110.453 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.41 -38.42 58.99 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.11 -43.38 82.59 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 122.952 0.501 . . . . 0.0 110.562 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.08 -43.31 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.368 0 C-N-CA 123.773 0.829 . . . . 0.0 110.811 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.6 -32.31 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.56 0 C-N-CA 123.468 0.707 . . . . 0.0 109.969 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -45.71 91.04 Favored 'General case' 0 N--CA 1.537 3.925 0 CA-C-O 121.293 0.568 . . . . 0.0 109.939 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 80.9 mt -54.94 -35.89 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.821 0 C-N-CA 123.615 0.766 . . . . 0.0 111.028 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.42 -36.1 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 C-N-CA 123.117 0.567 . . . . 0.0 110.487 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.2 64.63 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 3.1 m -64.41 -34.87 72.17 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.426 0 CA-C-N 119.582 1.083 . . . . 0.0 110.619 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -72.94 -31.93 64.93 Favored 'General case' 0 N--CA 1.529 3.496 0 C-N-CA 123.093 0.557 . . . . 0.0 110.04 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.44 -37.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.579 0 C-N-CA 123.41 0.684 . . . . 0.0 109.29 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.58 -36.58 74.19 Favored 'General case' 0 N--CA 1.525 3.324 0 CA-C-O 121.073 0.463 . . . . 0.0 110.06 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.33 -38.2 63.35 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.201 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.8 m -63.91 -46.7 83.63 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 123.066 0.546 . . . . 0.0 110.846 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 85.1 mt -67.05 -18.01 65.16 Favored 'General case' 0 N--CA 1.53 3.53 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.706 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 41.7 tp -92.4 -11.66 34.31 Favored 'General case' 1 N--CA 1.539 4.008 0 C-N-CA 123.907 0.883 . . . . 0.0 110.141 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -51.41 -26.31 7.72 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.993 0.917 . . . . 0.0 112.308 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -65.43 143.15 57.89 Favored 'General case' 0 N--CA 1.526 3.375 0 C-N-CA 123.375 0.67 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.66 8.42 Favored 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 124.119 0.968 . . . . 0.0 108.81 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.529 3.515 0 C-N-CA 124.832 1.253 . . . . 0.0 108.523 179.944 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.523 3.187 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.09 -43.18 92.98 Favored 'General case' 0 N--CA 1.534 3.746 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 89.4 p -58.94 -26.3 64.27 Favored 'General case' 0 N--CA 1.526 3.374 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.823 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.47 -34.43 79.3 Favored Glycine 0 N--CA 1.506 3.363 0 C-N-CA 124.64 1.114 . . . . 0.0 113.68 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -35.26 52.63 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.297 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -174.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 16.8 tt -55.96 -32.42 33.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.81 -32.31 48.53 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.258 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.65 -40.59 96.66 Favored Glycine 1 N--CA 1.519 4.167 0 CA-C-O 119.653 -0.526 . . . . 0.0 113.653 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.45 -37.07 78.22 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 CA-C-N 118.458 1.129 . . . . 0.0 109.924 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 89.1 m -56.0 -45.1 79.16 Favored 'General case' 0 N--CA 1.522 3.163 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.54 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.53 -41.66 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 123.385 0.674 . . . . 0.0 110.7 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.82 -35.59 64.07 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.63 -50.36 37.82 Favored 'General case' 0 N--CA 1.521 3.094 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 12.9 p -68.02 -38.59 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.567 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.34 -31.99 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 CA-C-N 118.161 0.437 . . . . 0.0 110.237 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.97 -34.86 63.7 Favored 'General case' 1 N--CA 1.54 4.062 0 CA-C-O 121.485 0.66 . . . . 0.0 110.607 -178.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 67.4 mt -61.14 -36.04 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 124.002 0.921 . . . . 0.0 110.76 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.68 -37.64 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 123.272 0.629 . . . . 0.0 110.226 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -47.59 84.71 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.401 0.681 . . . . 0.0 112.571 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.56 -34.06 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.624 0 O-C-N 121.866 -0.521 . . . . 0.0 110.168 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.97 -44.2 97.24 Favored 'General case' 0 N--CA 1.529 3.503 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.86 -37.84 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 70.8 m -62.06 -27.57 68.99 Favored 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.081 0.552 . . . . 0.0 111.11 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -59.76 -18.66 44.88 Favored 'General case' 0 N--CA 1.533 3.706 0 C-N-CA 122.946 0.498 . . . . 0.0 111.244 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 97.3 p -73.81 -40.08 63.63 Favored 'General case' 0 N--CA 1.524 3.275 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.15 -14.88 63.32 Favored 'General case' 0 N--CA 1.537 3.895 0 C-N-CA 123.411 0.684 . . . . 0.0 110.481 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 57.2 tp -89.62 -28.9 19.21 Favored 'General case' 1 N--CA 1.54 4.045 0 C-N-CA 124.252 1.021 . . . . 0.0 109.826 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -79.88 -71.36 0.46 Allowed 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 43.6 tptt 44.62 17.31 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? . . . . . 0 N--CA 1.529 3.523 0 C-N-CA 123.921 0.888 . . . . 0.0 109.094 179.648 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.523 3.181 0 N-CA-C 111.203 0.075 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 mp -64.22 -26.93 68.73 Favored 'General case' 1 N--CA 1.54 4.041 0 C-N-CA 123.498 0.719 . . . . 0.0 109.116 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 39.2 t -63.68 -35.85 81.91 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 123.805 0.842 . . . . 0.0 111.21 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.27 -35.69 83.22 Favored Glycine 1 N--CA 1.519 4.2 0 C-N-CA 123.846 0.736 . . . . 0.0 112.549 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.17 -47.04 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 C-N-CA 123.857 0.863 . . . . 0.0 112.292 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.83 -32.51 52.19 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 CA-C-N 118.564 0.62 . . . . 0.0 109.684 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.66 -32.24 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.76 -29.49 41.63 Favored Glycine 0 N--CA 1.511 3.698 0 C-N-CA 123.843 0.735 . . . . 0.0 113.402 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 m -60.32 -37.59 74.56 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.108 0 CA-C-N 117.918 0.859 . . . . 0.0 110.381 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 37.8 p -60.02 -45.8 91.61 Favored 'General case' 0 N--CA 1.528 3.47 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.235 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 47.6 t -69.49 -37.83 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 C-N-CA 124.229 1.012 . . . . 0.0 111.091 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.61 -42.96 65.06 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.85 -31.85 72.73 Favored 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 123.067 0.547 . . . . 0.0 111.748 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.05 -39.51 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.529 0 C-N-CA 123.089 0.556 . . . . 0.0 110.384 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.89 -33.01 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 C-N-CA 123.389 0.676 . . . . 0.0 110.558 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.59 -45.93 84.89 Favored 'General case' 0 N--CA 1.532 3.631 0 C-N-CA 122.715 0.406 . . . . 0.0 109.923 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 73.2 mt -54.78 -36.53 37.27 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 C-N-CA 122.851 0.46 . . . . 0.0 110.891 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.62 -37.88 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 C-N-CA 123.029 0.532 . . . . 0.0 109.889 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.95 -32.36 69.54 Favored 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.43 0.692 . . . . 0.0 111.387 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.17 -34.72 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.23 0 C-N-CA 123.638 0.775 . . . . 0.0 111.16 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -69.13 -43.98 73.3 Favored 'General case' 0 N--CA 1.531 3.586 0 O-C-N 122.059 -0.401 . . . . 0.0 112.015 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.69 -37.62 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 122.688 0.395 . . . . 0.0 110.661 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 12.3 p -59.98 -27.54 66.93 Favored 'General case' 0 N--CA 1.535 3.8 0 CA-C-N 118.089 0.404 . . . . 0.0 111.078 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -59.99 -27.01 66.5 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 123.393 0.677 . . . . 0.0 111.134 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 48.7 m -63.96 -33.99 76.96 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.401 0.68 . . . . 0.0 110.889 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 N--CA 1.525 3.292 0 C-N-CA 124.483 1.113 . . . . 0.0 111.973 -179.538 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 N--CA 1.521 3.098 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.14 -27.01 68.43 Favored 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 124.246 1.018 . . . . 0.0 110.369 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 50.3 m -57.79 -26.19 61.58 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.1 0.56 . . . . 0.0 111.074 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.38 -34.58 63.61 Favored Glycine 1 N--CA 1.516 4.011 0 C-N-CA 124.362 0.982 . . . . 0.0 113.612 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 10.9 tp -59.32 -43.68 90.6 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 5.8 pt -66.73 -35.99 76.14 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.389 0 CA-C-O 121.906 0.86 . . . . 0.0 109.437 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 87.8 mt -72.68 -40.05 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.254 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.507 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.58 -48.76 84.46 Favored Glycine 1 N--CA 1.518 4.126 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.874 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.31 -36.55 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 123.036 0.535 . . . . 0.0 109.869 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 90.5 m -64.33 -47.5 79.17 Favored 'General case' 0 N--CA 1.523 3.202 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.69 -31.62 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.64 0 C-N-CA 122.76 0.424 . . . . 0.0 111.257 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.05 -47.18 68.63 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.223 0.609 . . . . 0.0 112.614 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.41 69.96 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.346 0.658 . . . . 0.0 112.548 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 45.3 t -68.09 -53.16 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.462 0 O-C-N 122.109 -0.37 . . . . 0.0 111.113 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.39 -32.14 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.361 0 C-N-CA 123.144 0.578 . . . . 0.0 112.411 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -39.03 55.97 Favored 'General case' 1 N--CA 1.541 4.085 0 C-N-CA 122.698 0.399 . . . . 0.0 111.467 -177.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 95.3 mt -69.1 -40.78 81.07 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 O-C-N 121.193 -0.942 . . . . 0.0 111.172 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.76 -36.51 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 O-C-N 121.476 -0.765 . . . . 0.0 109.894 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.21 -45.56 83.72 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.455 0.702 . . . . 0.0 112.621 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 16.8 m -71.86 -34.54 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 O-C-N 121.785 -0.572 . . . . 0.0 110.3 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.19 -44.2 92.74 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.67 -37.53 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 90.2 m -65.22 -29.76 70.59 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.063 0.545 . . . . 0.0 110.739 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -69.5 -39.49 77.55 Favored 'General case' 0 N--CA 1.529 3.499 0 C-N-CA 122.846 0.458 . . . . 0.0 109.927 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.8 t -64.06 -17.93 63.87 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 123.569 0.748 . . . . 0.0 111.386 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.57 -24.48 64.61 Favored 'General case' 0 N--CA 1.532 3.628 0 C-N-CA 124.096 0.958 . . . . 0.0 109.352 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -87.41 -26.56 23.24 Favored 'General case' 0 N--CA 1.539 3.982 0 C-N-CA 123.587 0.755 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -63.95 -69.79 0.26 Allowed 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.261 0.624 . . . . 0.0 110.74 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 61.5 pttt . . . . . 0 N--CA 1.526 3.371 0 C-N-CA 123.615 0.766 . . . . 0.0 110.81 -179.803 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.223 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.3 p -69.77 139.5 53.27 Favored 'General case' 0 N--CA 1.522 3.144 0 C-N-CA 123.647 0.779 . . . . 0.0 110.326 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.4 mp -65.35 -26.4 68.01 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 124.072 0.949 . . . . 0.0 109.536 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 38.8 t -67.72 -27.52 66.87 Favored 'General case' 0 N--CA 1.519 3.009 0 C-N-CA 123.4 0.68 . . . . 0.0 110.527 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.92 -47.16 56.59 Favored Glycine 0 N--CA 1.504 3.217 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -70.55 -41.69 78.02 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.223 0 CA-C-N 118.085 0.943 . . . . 0.0 113.499 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 tt -59.23 -31.03 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 C-N-CA 123.614 0.766 . . . . 0.0 111.734 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -33.4 50.23 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.352 0 O-C-N 121.8 -0.562 . . . . 0.0 109.664 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.02 -38.5 65.85 Favored Glycine 1 N--CA 1.518 4.137 0 N-CA-C 115.282 0.873 . . . . 0.0 115.282 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.49 -37.53 77.91 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.285 0 CA-C-N 118.355 1.078 . . . . 0.0 111.199 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.415 ' HG1' ' N ' ' A' ' 220' ' ' VAL . 30.7 p -63.46 -46.02 88.15 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.415 ' N ' ' HG1' ' A' ' 219' ' ' THR . 7.2 p -68.48 -31.42 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.553 0 C-N-CA 123.424 0.69 . . . . 0.0 110.981 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.3 -47.02 72.87 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.22 -34.94 74.35 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.484 0.714 . . . . 0.0 112.376 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.61 -40.44 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.292 0 C-N-CA 123.482 0.713 . . . . 0.0 111.178 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.18 -45.19 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 C-N-CA 122.722 0.409 . . . . 0.0 110.985 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.55 -34.79 78.58 Favored 'General case' 0 N--CA 1.535 3.793 0 C-N-CA 122.418 0.287 . . . . 0.0 110.424 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 74.7 mt -64.35 -44.94 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.705 0 C-N-CA 122.581 0.352 . . . . 0.0 110.531 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.11 -41.05 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.684 0 O-C-N 121.829 -0.544 . . . . 0.0 109.842 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.38 94.58 Favored 'General case' 0 N--CA 1.524 3.252 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.0 m -71.51 -34.05 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 O-C-N 121.603 -0.686 . . . . 0.0 110.194 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -61.13 -44.11 97.84 Favored 'General case' 0 N--CA 1.526 3.341 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 10.1 m -68.84 -41.39 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.83 0 CA-C-N 118.596 0.635 . . . . 0.0 109.576 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 74.5 m -60.52 -27.75 67.86 Favored 'General case' 0 N--CA 1.523 3.215 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.326 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -66.65 -35.06 79.27 Favored 'General case' 0 N--CA 1.523 3.186 0 C-N-CA 122.675 0.39 . . . . 0.0 110.362 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 31.8 t -64.28 -38.48 91.19 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.424 0.69 . . . . 0.0 111.234 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.75 -13.99 18.47 Favored 'General case' 0 N--CA 1.536 3.852 0 C-N-CA 123.265 0.626 . . . . 0.0 110.998 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.06 -17.95 31.71 Favored 'General case' 0 N--CA 1.534 3.735 0 C-N-CA 123.02 0.528 . . . . 0.0 110.281 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -88.9 3.09 52.55 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 124.146 0.978 . . . . 0.0 111.13 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -64.28 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 123.107 0.563 . . . . 0.0 110.171 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -71.2 148.36 47.37 Favored 'General case' 0 N--CA 1.522 3.142 0 C-N-CA 123.698 0.799 . . . . 0.0 110.03 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.531 3.599 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.396 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.521 3.09 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.21 -26.22 68.03 Favored 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 124.703 1.201 . . . . 0.0 110.517 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 43.7 t -57.05 -24.99 57.84 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.539 0.736 . . . . 0.0 111.092 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.91 -47.01 82.29 Favored Glycine 1 N--CA 1.518 4.136 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.455 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 29.3 pt -71.6 -35.7 57.08 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.163 0 CA-C-N 118.204 1.002 . . . . 0.0 111.095 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 45.3 mm -57.23 -44.44 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.84 0 C-N-CA 124.474 1.11 . . . . 0.0 111.972 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.1 tp -72.41 -33.09 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.82 -44.68 97.73 Favored Glycine 1 N--CA 1.517 4.071 0 C-N-CA 123.919 0.771 . . . . 0.0 114.158 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.7 -37.21 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.726 0 CA-C-N 117.727 0.763 . . . . 0.0 110.905 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 67.4 p -65.44 -46.14 81.08 Favored 'General case' 0 N--CA 1.534 3.729 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.56 -31.03 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 C-N-CA 122.621 0.368 . . . . 0.0 111.262 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.22 -42.69 63.76 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.8 88.53 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.092 0.557 . . . . 0.0 111.249 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 24.3 t -64.66 -40.27 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 123.779 0.832 . . . . 0.0 111.234 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.57 -32.45 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 C-N-CA 123.247 0.619 . . . . 0.0 110.943 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 tp -76.54 -42.96 41.2 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.5 -44.05 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 C-N-CA 122.976 0.511 . . . . 0.0 111.841 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.27 -37.04 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.892 0 CA-C-N 118.575 0.625 . . . . 0.0 110.365 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.33 79.46 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.098 0.559 . . . . 0.0 111.812 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 90.3 t -71.66 -35.01 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 122.748 0.419 . . . . 0.0 109.995 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.29 -44.54 96.29 Favored 'General case' 0 N--CA 1.532 3.655 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.04 -38.25 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 73.4 m -67.2 -30.46 70.41 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 122.987 0.515 . . . . 0.0 110.711 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -67.34 -25.3 65.93 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.453 0.701 . . . . 0.0 111.097 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -63.91 -40.28 96.13 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.206 0.602 . . . . 0.0 111.292 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.95 -23.1 65.05 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.636 0.774 . . . . 0.0 110.734 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 N--CA 1.537 3.912 0 C-N-CA 124.129 0.971 . . . . 0.0 109.524 -179.564 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 N--CA 1.52 3.075 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.46 -40.98 96.73 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 123.636 0.774 . . . . 0.0 110.626 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 40.4 t -69.6 -26.59 64.52 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 123.144 0.577 . . . . 0.0 110.719 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.58 -46.03 64.11 Favored Glycine 1 N--CA 1.517 4.061 0 N-CA-C 116.508 1.363 . . . . 0.0 116.508 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -35.01 60.59 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 CA-C-N 119.806 1.803 . . . . 0.0 112.274 -176.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 2.7 pt -58.92 -45.0 92.1 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.491 0 CA-C-N 118.694 0.679 . . . . 0.0 111.812 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.0 pt -68.99 -32.99 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 C-N-CA 122.986 0.514 . . . . 0.0 109.75 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.7 -29.94 68.1 Favored Glycine 0 N--CA 1.513 3.783 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.425 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 2.7 m -60.38 -37.65 75.06 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.006 0 CA-C-N 117.847 0.823 . . . . 0.0 111.142 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 219' ' ' THR . . . . . 0.473 ' HG1' ' H ' ' C' ' 220' ' ' VAL . 56.2 p -63.14 -46.67 86.15 Favored 'General case' 0 N--CA 1.526 3.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.444 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . 0.473 ' H ' ' HG1' ' C' ' 219' ' ' THR . 47.2 t -70.1 -33.57 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.086 0 C-N-CA 124.158 0.983 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.91 90.04 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.538 0.735 . . . . 0.0 112.523 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.97 -48.55 70.9 Favored 'General case' 0 N--CA 1.516 2.841 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.4 m -67.9 -39.96 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.55 -34.16 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 CA-C-N 119.354 0.979 . . . . 0.0 111.759 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 45.1 tp -67.83 -47.59 68.57 Favored 'General case' 0 N--CA 1.528 3.425 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 27.7 pt -68.95 -36.3 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-N 118.231 0.469 . . . . 0.0 111.002 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.48 -37.42 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.962 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.25 72.47 Favored 'General case' 0 N--CA 1.533 3.683 0 C-N-CA 122.931 0.492 . . . . 0.0 112.086 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.77 -37.05 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.066 0.546 . . . . 0.0 110.304 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -63.31 -44.08 96.01 Favored 'General case' 0 N--CA 1.532 3.64 0 C-N-CA 123.135 0.574 . . . . 0.0 112.443 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.62 -37.46 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.63 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 98.0 m -62.2 -29.72 70.58 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 122.879 0.472 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -69.58 -27.67 65.32 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.214 0.606 . . . . 0.0 111.07 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 30.3 t -64.07 -32.72 74.38 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 123.204 0.602 . . . . 0.0 112.094 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.39 -21.48 66.31 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.648 0.779 . . . . 0.0 110.885 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 7.9 mp -87.51 -28.28 22.12 Favored 'General case' 0 N--CA 1.532 3.672 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -83.39 86.82 7.01 Favored 'General case' 0 N--CA 1.52 3.048 0 C-N-CA 123.978 0.911 . . . . 0.0 108.734 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.19 -17.88 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.294 0 C-N-CA 123.675 0.79 . . . . 0.0 110.204 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 59.0 -171.41 0.12 Allowed 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.932 0.893 . . . . 0.0 110.673 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.532 3.642 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.522 3.14 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.07 -32.71 74.56 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 123.88 0.872 . . . . 0.0 109.243 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 52.2 m -68.46 -25.48 65.01 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 123.682 0.793 . . . . 0.0 109.155 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.74 -46.88 89.01 Favored Glycine 0 N--CA 1.508 3.487 0 C-N-CA 123.848 0.737 . . . . 0.0 114.512 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 tt -70.84 -35.55 60.58 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.412 0 CA-C-N 118.688 1.244 . . . . 0.0 111.324 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 49.9 mm -56.28 -32.46 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 124.807 1.243 . . . . 0.0 112.124 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 1.7 pp -68.32 -33.96 63.39 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.091 0 CA-C-N 119.493 1.042 . . . . 0.0 109.569 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.09 -34.46 89.81 Favored Glycine 1 N--CA 1.521 4.32 0 C-N-CA 123.483 0.564 . . . . 0.0 111.799 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.07 -39.83 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 124.213 1.005 . . . . 0.0 110.031 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 219' ' ' THR . . . . . 0.454 ' HG1' ' N ' ' D' ' 220' ' ' VAL . 30.1 p -61.01 -38.92 87.8 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 123.162 0.585 . . . . 0.0 110.938 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . 0.454 ' N ' ' HG1' ' D' ' 219' ' ' THR . 41.2 t -67.12 -41.46 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.081 0 C-N-CA 123.79 0.836 . . . . 0.0 110.36 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.88 -47.18 85.86 Favored 'General case' 0 N--CA 1.523 3.187 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.51 -47.95 68.5 Favored 'General case' 0 N--CA 1.513 2.701 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.57 -41.94 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.471 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.08 -33.4 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 O-C-N 122.228 -0.295 . . . . 0.0 111.282 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.22 -35.6 81.34 Favored 'General case' 0 N--CA 1.529 3.499 0 C-N-CA 122.736 0.414 . . . . 0.0 110.675 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.43 -36.86 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.702 0 C-N-CA 123.191 0.597 . . . . 0.0 110.119 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.66 -43.31 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 C-N-CA 122.973 0.509 . . . . 0.0 110.093 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.14 87.72 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 20.9 m -71.58 -33.89 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 O-C-N 121.806 -0.559 . . . . 0.0 110.071 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.41 -43.49 97.36 Favored 'General case' 0 N--CA 1.526 3.359 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 10.0 m -68.38 -40.16 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 CA-C-N 118.684 0.675 . . . . 0.0 110.884 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 14.5 p -66.35 -28.5 68.7 Favored 'General case' 0 N--CA 1.533 3.711 0 O-C-N 122.197 -0.315 . . . . 0.0 110.38 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -73.77 -32.55 63.85 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 123.446 0.698 . . . . 0.0 109.845 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 47.8 m -64.18 -31.17 72.26 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.182 0.593 . . . . 0.0 110.751 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 60.0 mt -60.79 -23.66 65.2 Favored 'General case' 0 N--CA 1.531 3.594 0 C-N-CA 122.586 0.354 . . . . 0.0 111.206 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.68 -7.36 52.83 Favored 'General case' 1 N--CA 1.539 4.017 0 C-N-CA 123.946 0.898 . . . . 0.0 110.33 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -69.19 3.51 2.13 Favored 'General case' 0 N--CA 1.534 3.764 0 C-N-CA 123.013 0.525 . . . . 0.0 111.31 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -53.2 149.32 7.19 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 123.937 0.895 . . . . 0.0 111.332 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.52 3.034 0 C-N-CA 123.935 0.894 . . . . 0.0 110.79 -178.846 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 99.6 p . . . . . 0 N--CA 1.525 3.295 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 41.9 mt -64.28 -34.3 77.8 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.695 0.798 . . . . 0.0 110.056 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 61.2 m -68.69 -26.57 65.36 Favored 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 123.575 0.75 . . . . 0.0 110.104 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.84 -46.18 61.35 Favored Glycine 0 N--CA 1.514 3.887 0 C-N-CA 124.071 0.844 . . . . 0.0 114.705 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 45.9 pt -70.76 -35.77 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -175.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . 0.253 0.1 OUTLIER -57.77 -41.3 79.31 Favored 'Isoleucine or valine' 1 N--CA 1.558 4.95 0 CA-C-N 119.984 1.265 . . . . 0.0 112.945 -175.033 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.0 tt -72.38 -32.16 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 C-N-CA 124.297 1.039 . . . . 0.0 108.863 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.01 -29.37 43.39 Favored Glycine 0 N--CA 1.512 3.704 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.395 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.16 -37.8 79.39 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 CA-C-N 118.089 0.944 . . . . 0.0 110.7 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 36.1 p -65.98 -40.51 91.29 Favored 'General case' 0 N--CA 1.529 3.477 0 C-N-CA 123.344 0.657 . . . . 0.0 110.366 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.59 -32.08 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.06 0 C-N-CA 124.046 0.939 . . . . 0.0 110.49 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.54 91.48 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-O 121.062 0.458 . . . . 0.0 110.761 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.28 -47.97 80.09 Favored 'General case' 0 N--CA 1.519 3.017 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.91 -38.57 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.48 -32.8 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 40.6 tp -78.18 -42.64 30.94 Favored 'General case' 0 N--CA 1.535 3.79 0 CA-C-N 118.755 0.707 . . . . 0.0 112.311 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.12 -35.56 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.476 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 28.6 m -65.51 -35.21 74.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.354 0 CA-C-N 119.241 0.928 . . . . 0.0 109.978 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.07 -31.24 63.02 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.467 0.707 . . . . 0.0 112.144 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 3.2 m -56.96 -34.17 43.91 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 O-C-N 121.635 -0.666 . . . . 0.0 110.848 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.96 -44.65 96.3 Favored 'General case' 0 N--CA 1.53 3.527 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.59 -37.3 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.974 0 CA-C-N 119.067 0.849 . . . . 0.0 108.875 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 63.4 m -58.54 -27.56 64.66 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 122.854 0.461 . . . . 0.0 110.901 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -60.78 -18.12 53.2 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 122.916 0.487 . . . . 0.0 110.695 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 33.5 t -66.2 -25.53 66.97 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.616 0.766 . . . . 0.0 111.244 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 N--CA 1.532 3.641 0 C-N-CA 123.848 0.859 . . . . 0.0 111.4 -179.382 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 N--CA 1.524 3.262 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.54 -26.52 68.45 Favored 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.451 1.101 . . . . 0.0 110.871 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 55.1 m -65.46 -26.25 67.86 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.246 0.619 . . . . 0.0 111.002 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.15 -46.57 64.35 Favored Glycine 0 N--CA 1.516 3.974 0 C-N-CA 123.406 0.527 . . . . 0.0 114.233 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -70.85 -35.55 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 11.6 pt -56.64 -45.11 82.43 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.587 0 CA-C-N 119.529 1.059 . . . . 0.0 112.607 -175.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.99 -33.76 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 C-N-CA 123.358 0.663 . . . . 0.0 109.823 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.91 -30.08 76.69 Favored Glycine 0 N--CA 1.509 3.525 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.684 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.04 -37.65 73.55 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 CA-C-N 118.106 0.953 . . . . 0.0 111.589 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 29.2 p -65.82 -47.31 75.46 Favored 'General case' 0 N--CA 1.529 3.518 0 CA-C-O 121.319 0.58 . . . . 0.0 110.518 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.66 -42.38 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 C-N-CA 124.264 1.026 . . . . 0.0 111.176 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.04 -43.0 73.38 Favored 'General case' 0 N--CA 1.528 3.468 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.13 -50.49 68.01 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 p -68.39 -38.66 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 CA-C-N 118.499 0.59 . . . . 0.0 111.883 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.34 -33.69 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.456 0.571 . . . . 0.0 110.79 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 25.0 tp -69.71 -34.47 73.94 Favored 'General case' 0 N--CA 1.531 3.618 0 CA-C-N 118.689 0.677 . . . . 0.0 111.016 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 79.2 mt -65.72 -41.46 90.44 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.134 0 O-C-N 121.728 -0.608 . . . . 0.0 109.436 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.11 -37.41 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 C-N-CA 123.54 0.736 . . . . 0.0 109.807 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.09 68.35 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.21 0.604 . . . . 0.0 111.863 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 69.6 t -71.68 -38.04 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 122.812 0.445 . . . . 0.0 110.391 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -62.12 -44.07 97.45 Favored 'General case' 0 N--CA 1.532 3.644 0 C-N-CA 123.186 0.594 . . . . 0.0 112.579 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.69 -37.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.685 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 93.3 m -64.77 -29.68 70.66 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 122.924 0.489 . . . . 0.0 110.463 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -74.32 -40.03 62.47 Favored 'General case' 0 N--CA 1.525 3.321 0 C-N-CA 123.059 0.543 . . . . 0.0 109.585 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.3 t -63.82 -18.91 64.6 Favored 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 123.946 0.899 . . . . 0.0 112.376 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 50.5 tp -70.56 -14.82 62.66 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.673 0.789 . . . . 0.0 110.95 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 mp -87.21 -0.91 57.44 Favored 'General case' 0 N--CA 1.534 3.754 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.619 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -163.23 82.48 0.48 Allowed 'General case' 0 N--CA 1.538 3.949 0 CA-C-N 119.042 0.837 . . . . 0.0 112.3 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt . . . . . 0 N--CA 1.538 3.927 0 C-N-CA 125.038 1.335 . . . . 0.0 108.595 177.843 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.981 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.9 p -168.49 -53.17 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.88 -26.38 68.3 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 123.726 0.81 . . . . 0.0 109.099 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 37.4 t -57.79 -41.32 81.85 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 123.815 0.846 . . . . 0.0 112.248 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -35.48 79.71 Favored Glycine 1 N--CA 1.521 4.348 0 C-N-CA 123.883 0.754 . . . . 0.0 112.978 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.25 -46.29 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 C-N-CA 123.97 0.908 . . . . 0.0 112.845 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.11 -32.18 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 121.986 -0.446 . . . . 0.0 110.786 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.8 -33.75 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 C-N-CA 123.437 0.695 . . . . 0.0 110.185 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.32 84.8 Favored Glycine 1 N--CA 1.521 4.301 0 CA-C-O 119.941 -0.366 . . . . 0.0 113.851 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.7 m -60.0 -36.75 69.1 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.343 0 CA-C-N 117.762 0.781 . . . . 0.0 110.784 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.437 ' HG1' ' H ' ' A' ' 220' ' ' VAL . 30.5 p -55.47 -45.28 76.97 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.502 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.437 ' H ' ' HG1' ' A' ' 219' ' ' THR . 42.6 t -65.73 -37.96 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 C-N-CA 124.151 0.98 . . . . 0.0 111.46 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.95 -42.44 65.48 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.34 83.4 Favored 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 123.126 0.57 . . . . 0.0 111.184 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.4 t -64.29 -42.93 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.442 0.697 . . . . 0.0 110.934 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.2 -40.93 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 C-N-CA 123.144 0.578 . . . . 0.0 110.291 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.39 -38.5 91.39 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.928 0.491 . . . . 0.0 110.466 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.4 mt -56.97 -36.41 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.772 0 C-N-CA 123.441 0.696 . . . . 0.0 110.692 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 50.4 t -61.91 -37.94 79.44 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 C-N-CA 122.737 0.415 . . . . 0.0 110.469 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -31.85 68.71 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.563 0.745 . . . . 0.0 111.754 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.63 -34.73 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 C-N-CA 122.948 0.499 . . . . 0.0 111.393 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -67.59 -44.1 78.94 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.8 -37.43 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.954 0 CA-C-N 118.713 0.688 . . . . 0.0 109.903 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 76.4 m -66.12 -33.1 75.02 Favored 'General case' 0 N--CA 1.522 3.154 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.085 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -70.01 -41.24 74.6 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 123.276 0.631 . . . . 0.0 110.219 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 95.9 p -66.34 -30.21 70.57 Favored 'General case' 0 N--CA 1.53 3.539 0 C-N-CA 123.284 0.633 . . . . 0.0 109.766 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -14.32 45.25 Favored 'General case' 0 N--CA 1.531 3.618 0 C-N-CA 124.543 1.137 . . . . 0.0 110.255 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 32.5 mt -86.66 5.05 37.9 Favored 'General case' 0 N--CA 1.537 3.877 0 C-N-CA 123.241 0.617 . . . . 0.0 110.826 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -168.33 122.31 0.9 Allowed 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.558 0.743 . . . . 0.0 109.085 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -139.24 -0.64 1.8 Allowed 'General case' 0 N--CA 1.531 3.613 0 C-N-CA 124.81 1.244 . . . . 0.0 109.546 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -167.02 155.29 9.74 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.531 3.595 0 C-N-CA 124.886 1.275 . . . . 0.0 108.963 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 98.7 p . . . . . 0 N--CA 1.521 3.125 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.7 -26.81 68.27 Favored 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 124.31 1.044 . . . . 0.0 111.038 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 68.5 m -60.39 -26.53 66.73 Favored 'General case' 0 N--CA 1.528 3.463 0 C-N-CA 123.427 0.691 . . . . 0.0 110.647 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.09 -34.96 81.83 Favored Glycine 0 N--CA 1.512 3.767 0 C-N-CA 124.944 1.259 . . . . 0.0 115.015 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 14.4 tt -59.75 -35.76 61.93 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -175.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 1.9 pp -56.81 -47.76 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.0 tt -73.26 -33.5 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.32 -46.55 93.67 Favored Glycine 0 N--CA 1.513 3.782 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.979 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.59 -37.39 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 CA-C-N 117.615 0.707 . . . . 0.0 110.847 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 28.3 p -66.11 -46.1 78.77 Favored 'General case' 0 N--CA 1.526 3.371 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -69.93 -31.68 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.94 68.96 Favored 'General case' 0 N--CA 1.528 3.46 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.0 -49.97 58.36 Favored 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 22.0 m -66.95 -38.26 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 CA-C-N 118.534 0.606 . . . . 0.0 111.902 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.07 -32.74 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 122.504 0.322 . . . . 0.0 110.136 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.28 -41.43 94.18 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 122.602 0.361 . . . . 0.0 110.589 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 73.7 mt -56.85 -36.41 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 C-N-CA 122.889 0.476 . . . . 0.0 110.579 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.95 -37.28 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 C-N-CA 122.985 0.514 . . . . 0.0 110.517 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -31.88 66.96 Favored 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.53 0.732 . . . . 0.0 112.224 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.9 -34.92 73.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 O-C-N 121.587 -0.696 . . . . 0.0 110.469 -178.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -64.24 -44.58 91.41 Favored 'General case' 0 N--CA 1.527 3.409 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 16.0 m -69.07 -37.6 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-O 121.29 0.567 . . . . 0.0 109.742 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -66.46 -30.42 70.76 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -74.32 -40.12 62.43 Favored 'General case' 0 N--CA 1.525 3.285 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 70.9 m -65.07 -35.55 81.51 Favored 'General case' 0 N--CA 1.523 3.196 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.204 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.21 -14.23 24.09 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 124.082 0.953 . . . . 0.0 111.194 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 N--CA 1.522 3.168 0 C-N-CA 123.263 0.625 . . . . 0.0 109.412 179.534 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.521 3.085 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 tp -64.98 -35.74 82.17 Favored 'General case' 0 N--CA 1.527 3.424 0 C-N-CA 123.881 0.872 . . . . 0.0 109.971 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.0 m -67.2 -30.39 70.31 Favored 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 123.778 0.831 . . . . 0.0 110.446 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -47.0 57.97 Favored Glycine 0 N--CA 1.513 3.829 0 CA-C-N 115.526 -0.761 . . . . 0.0 114.334 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 34.6 pt -71.35 -39.7 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.2 tt -62.79 -39.77 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.62 -33.08 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.9 -29.12 50.13 Favored Glycine 0 N--CA 1.515 3.96 0 C-N-CA 123.609 0.623 . . . . 0.0 113.363 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.3 m -59.53 -46.28 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 5.3 t -66.11 -38.79 89.06 Favored 'General case' 0 N--CA 1.536 3.832 0 CA-C-O 121.045 0.45 . . . . 0.0 111.067 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.1 -39.61 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.183 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.66 72.68 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 123.461 0.704 . . . . 0.0 111.05 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.82 87.67 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 123.499 0.719 . . . . 0.0 111.224 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.33 -48.42 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 C-N-CA 123.269 0.627 . . . . 0.0 110.089 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.73 -36.77 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.561 0 C-N-CA 123.766 0.826 . . . . 0.0 110.9 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 22.4 mt -65.04 -34.35 78.21 Favored 'General case' 0 N--CA 1.534 3.727 0 C-N-CA 122.898 0.479 . . . . 0.0 110.591 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.98 -39.64 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.74 -37.87 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.514 0 C-N-CA 123.262 0.625 . . . . 0.0 109.601 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.28 83.29 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.748 0.819 . . . . 0.0 112.623 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.83 -34.35 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.594 0 O-C-N 121.897 -0.502 . . . . 0.0 110.215 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -63.8 -43.92 94.86 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 123.141 0.577 . . . . 0.0 112.517 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.39 -37.25 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 77.4 m -60.03 -28.42 67.73 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 122.658 0.383 . . . . 0.0 111.367 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -74.09 -28.65 61.48 Favored 'General case' 0 N--CA 1.531 3.602 0 C-N-CA 122.653 0.381 . . . . 0.0 110.817 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 57.9 m -67.41 -17.69 64.82 Favored 'General case' 0 N--CA 1.53 3.569 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.78 -38.54 67.25 Favored 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 124.126 0.97 . . . . 0.0 110.459 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 pp -87.93 -4.14 58.85 Favored 'General case' 1 N--CA 1.553 4.687 0 CA-C-N 118.767 0.712 . . . . 0.0 111.923 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -69.68 -11.84 61.16 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.518 0.727 . . . . 0.0 110.717 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -64.91 -26.09 68.17 Favored 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 124.009 0.924 . . . . 0.0 111.39 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -74.83 72.03 2.03 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.59 0.756 . . . . 0.0 109.852 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.533 3.718 0 C-N-CA 124.591 1.157 . . . . 0.0 108.178 179.351 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.518 2.956 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.04 -35.07 79.99 Favored 'General case' 0 N--CA 1.527 3.4 0 C-N-CA 124.533 1.133 . . . . 0.0 109.741 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 70.7 m -57.14 -26.04 59.88 Favored 'General case' 0 N--CA 1.525 3.318 0 C-N-CA 123.725 0.81 . . . . 0.0 110.523 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.46 -34.45 59.82 Favored Glycine 0 N--CA 1.509 3.504 0 C-N-CA 124.929 1.252 . . . . 0.0 114.979 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 16.2 pt -59.15 -34.67 54.2 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.12 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -175.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 8.9 pt -56.15 -45.57 80.84 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.265 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 5.8 tp -72.37 -33.87 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.26 -48.27 84.48 Favored Glycine 1 N--CA 1.517 4.039 0 C-N-CA 123.89 0.757 . . . . 0.0 113.706 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.29 -37.32 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.771 0 O-C-N 121.763 -0.845 . . . . 0.0 109.628 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 25.3 m -66.26 -45.75 79.47 Favored 'General case' 0 N--CA 1.519 2.978 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 12.8 p -63.59 -31.12 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 CA-C-N 118.203 0.456 . . . . 0.0 110.436 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.1 -47.2 81.64 Favored 'General case' 0 N--CA 1.528 3.453 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.94 73.93 Favored 'General case' 0 N--CA 1.523 3.194 0 C-N-CA 123.556 0.742 . . . . 0.0 112.036 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.83 -38.61 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 C-N-CA 123.366 0.666 . . . . 0.0 110.602 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.32 -44.79 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 C-N-CA 123.154 0.582 . . . . 0.0 110.135 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.73 -34.54 73.07 Favored 'General case' 1 N--CA 1.54 4.028 0 C-N-CA 123.12 0.568 . . . . 0.0 110.752 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.85 -40.1 87.5 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.22 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.65 -41.94 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 122.989 0.516 . . . . 0.0 109.814 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -41.06 82.09 Favored 'General case' 0 N--CA 1.527 3.406 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 19.0 m -71.17 -33.74 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 O-C-N 121.709 -0.619 . . . . 0.0 110.062 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -66.26 -43.92 85.14 Favored 'General case' 0 N--CA 1.528 3.463 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.76 -37.89 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 CA-C-N 118.327 0.512 . . . . 0.0 111.082 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 10.1 p -58.68 -27.51 64.88 Favored 'General case' 0 N--CA 1.531 3.616 0 C-N-CA 122.367 0.267 . . . . 0.0 111.499 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -61.27 -31.16 70.98 Favored 'General case' 0 N--CA 1.521 3.113 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.05 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 71.2 p -66.0 -38.06 87.52 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.459 0.704 . . . . 0.0 110.607 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 61.0 mt -60.77 -13.34 14.55 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 123.638 0.775 . . . . 0.0 111.901 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 26.8 mt -86.04 -7.65 58.48 Favored 'General case' 0 N--CA 1.534 3.727 0 C-N-CA 123.054 0.542 . . . . 0.0 110.366 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -70.67 -106.65 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.235 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 53.18 23.08 2.9 Favored 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 123.845 0.858 . . . . 0.0 111.94 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 24.7 tptm . . . . . 0 N--CA 1.526 3.341 0 C-N-CA 124.731 1.213 . . . . 0.0 110.537 -179.303 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.521 3.081 0 CA-C-O 120.579 0.228 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.24 -26.25 68.03 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 124.495 1.118 . . . . 0.0 109.945 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.4 p -57.32 -25.96 60.17 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.404 0.682 . . . . 0.0 110.975 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.11 -35.24 68.83 Favored Glycine 0 N--CA 1.516 3.998 0 C-N-CA 123.837 0.732 . . . . 0.0 113.755 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 7.6 pt -60.28 -44.04 94.81 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.203 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.1 pt -67.68 -32.47 56.93 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.284 0 C-N-CA 122.934 0.493 . . . . 0.0 110.26 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 47.7 mm -72.08 -32.7 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.601 0 C-N-CA 124.674 1.189 . . . . 0.0 108.79 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.93 -29.13 64.47 Favored Glycine 1 N--CA 1.518 4.13 0 C-N-CA 123.529 0.585 . . . . 0.0 113.26 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.71 -47.55 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 9.0 t -66.36 -38.96 88.79 Favored 'General case' 0 N--CA 1.537 3.899 0 O-C-N 121.827 -0.546 . . . . 0.0 111.196 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.17 -31.82 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 C-N-CA 123.511 0.724 . . . . 0.0 110.431 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.89 76.88 Favored 'General case' 0 N--CA 1.529 3.504 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.68 74.74 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 122.86 0.464 . . . . 0.0 111.459 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.7 -45.52 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 123.291 0.636 . . . . 0.0 112.296 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.24 -32.55 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 C-N-CA 122.352 0.261 . . . . 0.0 111.652 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.5 -34.85 78.83 Favored 'General case' 1 N--CA 1.541 4.117 0 O-C-N 122.098 -0.376 . . . . 0.0 110.255 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.39 -37.94 80.86 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.08 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.06 -37.86 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.5 0 C-N-CA 123.248 0.619 . . . . 0.0 109.975 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.24 96.6 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 17.2 m -71.66 -33.96 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.741 0 O-C-N 121.613 -0.679 . . . . 0.0 109.703 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -63.47 -43.75 96.4 Favored 'General case' 0 N--CA 1.529 3.483 0 C-N-CA 123.062 0.545 . . . . 0.0 112.309 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.41 -37.41 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.351 0.523 . . . . 0.0 109.631 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 79.1 m -60.21 -27.93 67.57 Favored 'General case' 0 N--CA 1.525 3.283 0 C-N-CA 123.143 0.577 . . . . 0.0 111.018 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.71 -35.02 79.55 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 122.796 0.438 . . . . 0.0 110.243 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 68.0 m -73.72 -36.27 65.19 Favored 'General case' 0 N--CA 1.523 3.185 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.529 3.501 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.827 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 64.8 m . . . . . 0 N--CA 1.52 3.034 0 CA-C-O 120.662 0.268 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.17 -26.38 68.14 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.915 0.886 . . . . 0.0 110.245 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 57.0 m -61.65 -26.78 68.22 Favored 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 123.653 0.781 . . . . 0.0 111.062 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.9 -47.5 54.49 Favored Glycine 1 N--CA 1.518 4.128 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.902 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 45.3 pt -72.33 -40.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -44.92 95.35 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.276 0 C-N-CA 123.194 0.597 . . . . 0.0 111.876 -175.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 6.4 tp -63.21 -32.62 57.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 C-N-CA 123.278 0.631 . . . . 0.0 109.382 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.31 -29.99 63.9 Favored Glycine 0 N--CA 1.513 3.802 0 CA-C-O 119.346 -0.697 . . . . 0.0 113.855 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.0 m -62.2 -47.21 94.16 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 CA-C-N 118.528 1.164 . . . . 0.0 112.045 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -38.82 89.24 Favored 'General case' 0 N--CA 1.536 3.872 0 C-N-CA 122.202 0.201 . . . . 0.0 110.766 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.78 -39.94 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.55 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.6 83.01 Favored 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 123.198 0.599 . . . . 0.0 111.136 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.66 85.64 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.173 0.589 . . . . 0.0 112.175 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.85 -41.15 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 122.909 0.483 . . . . 0.0 110.962 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.05 -41.89 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 C-N-CA 123.143 0.577 . . . . 0.0 110.852 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.7 -37.33 86.07 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 122.606 0.362 . . . . 0.0 111.667 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.76 -44.01 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.3 -40.3 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.73 -45.11 93.16 Favored 'General case' 0 N--CA 1.525 3.31 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.53 -34.05 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.703 0 O-C-N 121.633 -0.667 . . . . 0.0 109.788 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -63.06 -44.32 96.15 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 21.3 m -69.05 -37.88 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 CA-C-O 121.159 0.505 . . . . 0.0 109.841 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 76.3 m -65.54 -33.82 76.81 Favored 'General case' 0 N--CA 1.521 3.08 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.083 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -74.15 -39.75 63.06 Favored 'General case' 0 N--CA 1.537 3.898 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 58.6 m -63.75 -30.11 71.24 Favored 'General case' 0 N--CA 1.52 3.054 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.063 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.77 -21.62 66.51 Favored 'General case' 0 N--CA 1.526 3.364 0 C-N-CA 123.013 0.525 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -98.49 -15.81 19.44 Favored 'General case' 1 N--CA 1.548 4.459 0 C-N-CA 124.017 0.927 . . . . 0.0 110.472 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -68.12 3.53 1.59 Allowed 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.356 0.662 . . . . 0.0 111.624 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt . . . . . 0 N--CA 1.528 3.435 0 C-N-CA 122.847 0.459 . . . . 0.0 110.941 -179.534 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.217 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.0 m -74.63 40.39 0.14 Allowed 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 123.911 0.884 . . . . 0.0 110.571 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.0 -37.48 87.8 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 124.474 1.11 . . . . 0.0 109.978 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 45.2 t -68.61 -26.5 65.39 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.333 0.653 . . . . 0.0 110.702 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.66 -46.59 60.85 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 117.579 1.792 . . . . 0.0 117.579 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.8 -35.66 61.25 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.694 0 CA-C-N 119.612 1.706 . . . . 0.0 113.57 -175.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.54 -38.11 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.543 0 C-N-CA 123.55 0.74 . . . . 0.0 111.997 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 15.2 tt -71.41 -32.86 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.78 -28.87 48.41 Favored Glycine 1 N--CA 1.516 4.003 0 C-N-CA 124.057 0.837 . . . . 0.0 113.243 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.8 m -68.0 -37.27 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 CA-C-N 117.721 0.76 . . . . 0.0 110.407 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.8 p -60.56 -46.08 91.53 Favored 'General case' 0 N--CA 1.527 3.42 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.723 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.24 -31.85 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 C-N-CA 122.73 0.412 . . . . 0.0 110.493 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.44 -34.12 77.05 Favored 'General case' 0 N--CA 1.525 3.297 0 C-N-CA 123.091 0.556 . . . . 0.0 111.456 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.84 -50.24 44.67 Favored 'General case' 0 N--CA 1.519 2.995 0 C-N-CA 122.96 0.504 . . . . 0.0 111.914 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.96 -44.28 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 C-N-CA 123.365 0.666 . . . . 0.0 112.562 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.53 -32.66 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.603 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.24 -42.14 76.03 Favored 'General case' 0 N--CA 1.533 3.689 0 CA-C-N 118.613 0.642 . . . . 0.0 110.34 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.3 mt -54.8 -35.95 35.32 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 O-C-N 122.055 -0.403 . . . . 0.0 110.455 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.46 -37.17 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 O-C-N 121.763 -0.586 . . . . 0.0 110.374 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.87 -33.0 68.24 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.49 -34.54 53.42 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.188 0 CA-C-N 119.145 0.884 . . . . 0.0 110.611 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.96 -44.16 97.34 Favored 'General case' 0 N--CA 1.53 3.551 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.0 -37.6 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.693 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 71.6 m -64.27 -27.85 69.32 Favored 'General case' 0 N--CA 1.527 3.4 0 C-N-CA 123.151 0.58 . . . . 0.0 111.149 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -62.74 -22.88 66.87 Favored 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 122.992 0.517 . . . . 0.0 110.903 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 45.5 t -66.67 -46.2 76.43 Favored 'General case' 0 N--CA 1.525 3.29 0 CA-C-O 121.582 0.706 . . . . 0.0 110.565 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.98 -12.93 13.01 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 125.375 1.47 . . . . 0.0 112.471 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 54.9 tp -85.93 -28.36 24.36 Favored 'General case' 1 N--CA 1.547 4.403 0 C-N-CA 123.25 0.62 . . . . 0.0 111.303 -175.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 -121.26 63.17 0.89 Allowed 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -138.09 21.04 2.81 Favored 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.245 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -158.75 -11.34 0.07 Allowed 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.974 0.909 . . . . 0.0 109.685 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 N--CA 1.53 3.557 0 C-N-CA 125.279 1.432 . . . . 0.0 107.297 179.152 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 97.7 p . . . . . 0 N--CA 1.524 3.249 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.88 -26.77 68.46 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.976 0.911 . . . . 0.0 109.581 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 90.5 p -68.55 -26.19 65.29 Favored 'General case' 0 N--CA 1.522 3.143 0 C-N-CA 123.44 0.696 . . . . 0.0 110.43 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.36 -44.05 76.02 Favored Glycine 0 N--CA 1.516 3.975 0 C-N-CA 123.737 0.684 . . . . 0.0 114.08 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.87 -36.0 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.791 0 O-C-N 121.67 -0.9 . . . . 0.0 112.14 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 13.9 pt -67.55 -37.17 78.31 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.398 0 CA-C-N 119.001 0.818 . . . . 0.0 111.84 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 46.3 pt -72.26 -33.07 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.11 -45.31 82.51 Favored Glycine 0 N--CA 1.513 3.775 0 C-N-CA 124.419 1.009 . . . . 0.0 114.992 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.58 -37.2 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.734 0 CA-C-N 117.76 0.78 . . . . 0.0 111.163 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.0 p -65.28 -46.11 81.74 Favored 'General case' 0 N--CA 1.533 3.679 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.81 -30.63 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.485 0 C-N-CA 123.158 0.583 . . . . 0.0 111.174 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.81 -35.44 63.9 Favored 'General case' 0 N--CA 1.525 3.3 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -50.32 39.63 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 24.9 m -66.11 -38.24 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.8 -31.98 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.462 0.573 . . . . 0.0 111.859 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.59 -34.74 72.5 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 118.236 0.471 . . . . 0.0 110.746 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.1 -49.37 84.34 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.067 0 CA-C-N 118.065 0.393 . . . . 0.0 111.668 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.6 -37.28 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 O-C-N 121.721 -0.612 . . . . 0.0 109.957 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.48 79.97 Favored 'General case' 0 N--CA 1.524 3.26 0 C-N-CA 123.593 0.757 . . . . 0.0 112.811 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.63 -34.37 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 O-C-N 121.86 -0.525 . . . . 0.0 110.291 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -64.41 -44.21 91.97 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 122.964 0.506 . . . . 0.0 112.332 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.8 -37.91 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.826 0 CA-C-N 118.201 0.455 . . . . 0.0 109.781 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 75.2 m -65.64 -27.69 68.56 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 123.341 0.656 . . . . 0.0 111.211 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -63.82 -29.96 71.1 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 123.134 0.574 . . . . 0.0 110.725 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 54.8 m -64.16 -40.01 95.22 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.252 0.621 . . . . 0.0 110.517 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.88 -21.46 64.25 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.691 0.796 . . . . 0.0 110.251 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.5 tp . . . . . 0 N--CA 1.534 3.727 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.599 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 97.0 p . . . . . 0 N--CA 1.524 3.232 0 CA-C-O 121.375 0.607 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -54.36 -26.56 30.74 Favored 'General case' 0 N--CA 1.532 3.646 0 C-N-CA 123.785 0.834 . . . . 0.0 112.224 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 98.3 p -63.6 -36.45 83.86 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.825 0.85 . . . . 0.0 110.312 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.0 -35.75 79.55 Favored Glycine 0 N--CA 1.515 3.965 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.074 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 39.2 mm -70.31 -46.44 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 C-N-CA 124.164 0.986 . . . . 0.0 112.77 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 tt -64.53 -37.5 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.965 0 CA-C-N 118.207 0.458 . . . . 0.0 111.857 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.76 -32.22 39.75 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.13 -28.75 42.67 Favored Glycine 0 N--CA 1.512 3.714 0 C-N-CA 124.41 1.005 . . . . 0.0 113.198 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.34 -37.12 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 CA-C-N 117.383 0.592 . . . . 0.0 110.576 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 46.0 p -62.15 -45.14 94.75 Favored 'General case' 0 N--CA 1.529 3.509 0 CA-C-O 121.743 0.783 . . . . 0.0 110.319 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.86 -31.44 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 124.971 1.308 . . . . 0.0 111.447 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.07 75.69 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.361 0.664 . . . . 0.0 111.869 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.7 -46.78 62.49 Favored 'General case' 0 N--CA 1.521 3.087 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.01 -38.18 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 18.3 m -56.54 -31.33 33.8 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 CA-C-N 118.711 0.687 . . . . 0.0 110.712 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 39.7 tp -52.86 -48.14 67.29 Favored 'General case' 1 N--CA 1.543 4.176 0 CA-C-O 122.138 0.971 . . . . 0.0 109.865 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.78 -38.03 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.49 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.79 -37.64 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.437 0 C-N-CA 123.492 0.717 . . . . 0.0 109.489 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -32.71 68.1 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.216 0.606 . . . . 0.0 111.947 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.34 -43.47 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.12 0.568 . . . . 0.0 111.235 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -62.31 -42.92 99.78 Favored 'General case' 1 N--CA 1.539 4.022 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.03 -37.42 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.724 -0.61 . . . . 0.0 109.929 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 96.7 m -64.89 -27.98 69.23 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 122.657 0.383 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -65.8 -25.93 67.46 Favored 'General case' 0 N--CA 1.532 3.625 0 C-N-CA 123.224 0.609 . . . . 0.0 110.999 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 51.2 m -69.43 -34.08 73.92 Favored 'General case' 0 N--CA 1.525 3.311 0 C-N-CA 123.114 0.566 . . . . 0.0 110.444 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.19 -16.93 60.97 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.584 0.754 . . . . 0.0 110.214 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 57.0 tp -87.62 -20.81 25.84 Favored 'General case' 0 N--CA 1.536 3.864 0 C-N-CA 123.719 0.807 . . . . 0.0 110.218 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.76 -79.7 0.04 OUTLIER 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.808 0.843 . . . . 0.0 110.74 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 58.03 7.66 0.65 Allowed 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 124.206 1.002 . . . . 0.0 112.555 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? 59.82 120.67 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 124.352 1.061 . . . . 0.0 111.335 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.531 3.579 0 C-N-CA 124.932 1.293 . . . . 0.0 108.116 179.192 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.52 3.041 0 N-CA-C 111.501 0.186 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 49.7 mt -54.85 -26.71 37.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.015 0.926 . . . . 0.0 111.306 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -59.16 -32.38 69.83 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 123.174 0.59 . . . . 0.0 110.745 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.88 -38.84 89.52 Favored Glycine 1 N--CA 1.516 4.033 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.811 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.71 -41.1 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.471 0 C-N-CA 124.275 1.03 . . . . 0.0 108.969 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.92 -41.43 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.739 0 C-N-CA 124.326 1.051 . . . . 0.0 111.775 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 6.3 tp -72.73 -32.73 41.88 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.191 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.76 -46.7 91.98 Favored Glycine 1 N--CA 1.518 4.129 0 C-N-CA 123.551 0.596 . . . . 0.0 113.968 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 11.4 m -60.09 -36.46 67.8 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.211 0 CA-C-N 118.325 1.062 . . . . 0.0 111.472 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 22.0 p -55.7 -38.73 70.08 Favored 'General case' 0 N--CA 1.532 3.643 0 C-N-CA 122.988 0.515 . . . . 0.0 111.674 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.73 -37.81 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 C-N-CA 123.247 0.619 . . . . 0.0 110.813 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.87 -36.08 58.59 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 123.561 0.745 . . . . 0.0 112.745 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.53 -50.17 40.47 Favored 'General case' 0 N--CA 1.515 2.804 0 C-N-CA 123.318 0.647 . . . . 0.0 111.07 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.4 -46.03 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.53 0 C-N-CA 123.522 0.729 . . . . 0.0 112.336 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.43 -32.01 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.523 0 C-N-CA 122.537 0.335 . . . . 0.0 111.273 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.09 -41.59 61.44 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 122.435 0.294 . . . . 0.0 110.931 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.34 -42.33 93.23 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.022 0 C-N-CA 122.806 0.442 . . . . 0.0 111.681 -177.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.0 -36.83 78.09 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 CA-C-N 118.336 0.517 . . . . 0.0 110.094 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.61 -34.15 72.39 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.858 0.463 . . . . 0.0 111.346 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.93 -39.45 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -62.4 -43.49 98.69 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.527 0.731 . . . . 0.0 112.54 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 14.4 m -68.24 -37.78 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 CA-C-N 118.407 0.549 . . . . 0.0 109.806 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 88.3 m -59.02 -27.73 65.73 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 122.886 0.474 . . . . 0.0 111.082 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -64.56 -30.92 71.95 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 122.836 0.455 . . . . 0.0 110.243 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 24.1 t -64.92 -44.59 89.03 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 123.041 0.536 . . . . 0.0 110.398 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.96 -20.49 65.91 Favored 'General case' 0 N--CA 1.532 3.647 0 C-N-CA 123.477 0.711 . . . . 0.0 110.98 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 36.6 tp -87.75 -3.01 58.98 Favored 'General case' 0 N--CA 1.537 3.889 0 C-N-CA 123.394 0.678 . . . . 0.0 110.944 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -152.37 105.09 2.99 Favored 'General case' 0 N--CA 1.533 3.706 0 C-N-CA 123.037 0.535 . . . . 0.0 111.036 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -151.15 -53.84 0.14 Allowed 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? . . . . . 0 N--CA 1.525 3.31 0 C-N-CA 124.053 0.941 . . . . 0.0 109.732 -179.673 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.521 3.11 0 CA-C-O 121.413 0.625 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 mt -62.46 -26.35 68.47 Favored 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 124.32 1.048 . . . . 0.0 110.848 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.0 p -64.62 -26.34 68.35 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.143 0.577 . . . . 0.0 110.144 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.81 -46.9 89.5 Favored Glycine 1 N--CA 1.52 4.272 0 CA-C-O 119.523 -0.598 . . . . 0.0 114.095 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 18.8 tt -70.61 -35.61 61.98 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.204 0 CA-C-N 118.549 1.175 . . . . 0.0 109.688 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 46.8 mm -64.63 -42.71 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.753 0 C-N-CA 123.876 0.87 . . . . 0.0 108.834 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 23.0 mm -72.84 -33.39 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.767 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.33 -29.83 57.36 Favored Glycine 0 N--CA 1.513 3.817 0 C-N-CA 124.115 0.864 . . . . 0.0 114.573 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.63 -37.42 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.971 0 CA-C-N 118.113 0.957 . . . . 0.0 111.216 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 67.4 p -61.88 -47.52 84.62 Favored 'General case' 0 N--CA 1.528 3.46 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 10.1 p -70.99 -31.77 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.351 0 C-N-CA 123.02 0.528 . . . . 0.0 111.524 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.36 78.26 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.07 -34.46 77.63 Favored 'General case' 0 N--CA 1.515 2.823 0 C-N-CA 123.276 0.63 . . . . 0.0 111.721 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.22 -53.43 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 122.916 0.486 . . . . 0.0 111.177 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.62 -33.6 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.413 0 O-C-N 121.785 -0.572 . . . . 0.0 111.455 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 40.0 tp -77.2 -38.39 51.6 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 122.908 0.483 . . . . 0.0 112.285 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 16.3 tt -69.35 -38.17 76.87 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.114 0 CA-C-N 118.906 0.775 . . . . 0.0 110.586 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.77 -38.0 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.87 -51.1 71.01 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.281 0.632 . . . . 0.0 112.644 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.85 -34.23 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 C-N-CA 122.533 0.333 . . . . 0.0 110.701 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -70.39 -38.62 74.71 Favored 'General case' 0 N--CA 1.527 3.386 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.1 -37.59 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.625 0 C-N-CA 124.174 0.99 . . . . 0.0 109.464 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -58.72 -34.79 71.73 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 122.655 0.382 . . . . 0.0 110.207 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -74.58 -48.43 26.77 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.863 0.465 . . . . 0.0 110.124 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.5 m -63.68 -25.96 68.45 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 123.419 0.688 . . . . 0.0 111.231 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 4.8 tt . . . . . 0 N--CA 1.524 3.257 0 C-N-CA 123.611 0.764 . . . . 0.0 111.193 179.84 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.524 3.229 0 CA-C-O 121.544 0.687 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.74 -26.8 68.81 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 124.087 0.955 . . . . 0.0 110.121 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 66.0 m -66.23 -32.29 73.62 Favored 'General case' 0 N--CA 1.519 2.985 0 C-N-CA 123.587 0.755 . . . . 0.0 111.061 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.11 -47.53 52.85 Favored Glycine 1 N--CA 1.517 4.056 0 CA-C-N 116.099 -0.5 . . . . 0.0 114.261 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 20.4 tt -71.6 -41.66 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.94 -44.25 82.1 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.272 0 C-N-CA 123.059 0.544 . . . . 0.0 111.737 -176.078 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.1 tt -72.29 -33.16 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.854 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.93 -29.47 51.24 Favored Glycine 0 N--CA 1.512 3.736 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.434 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.69 -37.71 72.27 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 117.495 0.648 . . . . 0.0 110.991 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 72.7 p -62.39 -45.49 92.88 Favored 'General case' 0 N--CA 1.53 3.563 0 CA-C-O 121.648 0.737 . . . . 0.0 110.474 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.21 -31.65 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.094 0 C-N-CA 124.702 1.201 . . . . 0.0 110.814 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.99 -34.72 75.22 Favored 'General case' 0 N--CA 1.531 3.588 0 O-C-N 121.824 -0.547 . . . . 0.0 111.596 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.32 -50.35 70.38 Favored 'General case' 0 N--CA 1.516 2.841 0 C-N-CA 123.51 0.724 . . . . 0.0 112.772 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.03 -38.27 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 CA-C-N 118.373 0.533 . . . . 0.0 111.629 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.22 -34.59 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.827 0 C-N-CA 122.646 0.378 . . . . 0.0 110.664 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 41.3 tp -68.51 -34.46 75.92 Favored 'General case' 0 N--CA 1.533 3.713 0 CA-C-N 118.156 0.434 . . . . 0.0 110.622 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.9 mt -61.82 -35.4 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 C-N-CA 123.683 0.793 . . . . 0.0 109.893 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.34 -35.41 49.0 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.194 0 C-N-CA 123.341 0.657 . . . . 0.0 110.472 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.1 -31.46 63.29 Favored 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 123.468 0.707 . . . . 0.0 112.763 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 4.4 m -57.28 -34.83 46.91 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.123 0 CA-C-N 118.992 0.815 . . . . 0.0 112.682 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -65.2 -43.94 89.97 Favored 'General case' 1 N--CA 1.541 4.094 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.81 -37.14 77.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.019 0 CA-C-N 119.007 0.821 . . . . 0.0 108.982 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 75.5 m -58.37 -27.59 64.36 Favored 'General case' 0 N--CA 1.528 3.429 0 C-N-CA 122.821 0.448 . . . . 0.0 110.909 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.54 -26.14 67.75 Favored 'General case' 0 N--CA 1.53 3.544 0 C-N-CA 122.973 0.509 . . . . 0.0 110.573 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 60.4 p -63.63 -16.89 62.16 Favored 'General case' 0 N--CA 1.534 3.765 0 C-N-CA 123.689 0.796 . . . . 0.0 111.546 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 46.6 tp -59.82 -14.57 15.53 Favored 'General case' 0 N--CA 1.527 3.377 0 C-N-CA 124.284 1.033 . . . . 0.0 112.775 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 pp -86.88 9.01 20.56 Favored 'General case' 1 N--CA 1.545 4.306 0 CA-C-N 118.843 0.747 . . . . 0.0 110.247 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 56.4 m95 58.96 134.64 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.1 0 C-N-CA 124.856 1.262 . . . . 0.0 113.029 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp . . . . . 0 N--CA 1.525 3.307 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.202 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.193 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.9 m -162.38 104.73 1.11 Allowed 'General case' 0 N--CA 1.521 3.108 0 C-N-CA 123.708 0.803 . . . . 0.0 108.986 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.27 -26.73 68.56 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.12 0.968 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.8 m -57.64 -26.19 61.26 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.667 0.787 . . . . 0.0 110.921 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.99 -35.62 91.67 Favored Glycine 0 N--CA 1.508 3.466 0 C-N-CA 124.232 0.92 . . . . 0.0 115.205 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.4 tt -68.47 -35.07 68.99 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.286 0 CA-C-N 118.247 1.023 . . . . 0.0 113.55 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.19 -40.61 66.12 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 17.7 tt -73.06 -36.12 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.798 0 O-C-N 121.399 -0.813 . . . . 0.0 109.439 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.94 -43.43 94.9 Favored Glycine 1 N--CA 1.519 4.191 0 C-N-CA 123.37 0.509 . . . . 0.0 114.363 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.83 -36.76 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 CA-C-N 117.907 0.853 . . . . 0.0 110.586 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.2 p -58.38 -44.58 88.97 Favored 'General case' 1 N--CA 1.539 4.008 0 CA-C-N 118.42 0.555 . . . . 0.0 111.118 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.75 -37.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 123.426 0.69 . . . . 0.0 111.405 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.25 -37.03 66.7 Favored 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.2 -50.56 71.33 Favored 'General case' 0 N--CA 1.513 2.682 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.9 m -61.93 -37.8 79.11 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.147 0 CA-C-N 118.529 0.604 . . . . 0.0 111.649 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 56.6 t -59.23 -32.68 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.976 0 O-C-N 121.482 -0.761 . . . . 0.0 110.189 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 73.0 mt -72.82 -34.43 66.83 Favored 'General case' 0 N--CA 1.532 3.639 0 C-N-CA 122.385 0.274 . . . . 0.0 110.294 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.2 -47.8 91.42 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.287 0 C-N-CA 123.039 0.535 . . . . 0.0 111.415 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.51 -36.92 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 O-C-N 121.885 -0.509 . . . . 0.0 110.102 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.99 -49.0 78.33 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.245 0.618 . . . . 0.0 112.304 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.11 -34.28 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.542 0 O-C-N 122.022 -0.424 . . . . 0.0 110.94 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -70.21 -43.1 71.36 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.078 0.551 . . . . 0.0 112.16 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.95 -37.64 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.71 0 O-C-N 122.067 -0.396 . . . . 0.0 111.305 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 20.1 p -67.34 -28.02 67.62 Favored 'General case' 0 N--CA 1.532 3.67 0 CA-C-N 117.886 0.312 . . . . 0.0 110.939 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -67.57 -30.55 70.2 Favored 'General case' 0 N--CA 1.529 3.478 0 C-N-CA 123.217 0.607 . . . . 0.0 110.53 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.7 m -67.4 -27.56 67.18 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 123.356 0.662 . . . . 0.0 110.498 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.4 -14.52 57.02 Favored 'General case' 0 N--CA 1.533 3.702 0 C-N-CA 124.474 1.11 . . . . 0.0 109.908 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 30.2 mt -87.24 2.0 51.41 Favored 'General case' 0 N--CA 1.533 3.714 0 C-N-CA 123.749 0.82 . . . . 0.0 110.578 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -66.48 -2.29 4.49 Favored 'General case' 0 N--CA 1.529 3.525 0 C-N-CA 123.854 0.862 . . . . 0.0 111.001 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -62.22 177.44 0.48 Allowed 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.868 0.867 . . . . 0.0 110.941 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -64.87 153.71 39.41 Favored 'General case' 0 N--CA 1.526 3.335 0 C-N-CA 124.149 0.98 . . . . 0.0 110.097 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.528 3.432 0 C-N-CA 124.927 1.291 . . . . 0.0 108.113 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.521 3.081 0 N-CA-C 110.788 -0.079 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.24 -26.98 68.34 Favored 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 124.084 0.954 . . . . 0.0 109.923 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 94.6 p -58.26 -26.37 62.85 Favored 'General case' 0 N--CA 1.529 3.486 0 C-N-CA 123.333 0.653 . . . . 0.0 110.769 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.75 -35.61 75.32 Favored Glycine 0 N--CA 1.508 3.479 0 C-N-CA 124.772 1.177 . . . . 0.0 115.475 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 pt -59.47 -34.65 55.27 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.475 0 CA-C-N 119.039 1.419 . . . . 0.0 113.647 -176.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 1.6 pp -55.78 -35.18 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.976 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 20.0 pt -65.64 -33.74 65.68 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.264 0 CA-C-N 118.849 0.749 . . . . 0.0 109.238 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.77 -38.84 96.11 Favored Glycine 1 N--CA 1.519 4.201 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.26 -47.31 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 123.796 0.838 . . . . 0.0 109.423 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 88.3 m -66.03 -47.66 73.7 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.665 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 71.7 t -70.56 -33.27 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.376 0 C-N-CA 124.054 0.942 . . . . 0.0 111.486 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.87 79.3 Favored 'General case' 0 N--CA 1.534 3.731 0 CA-C-N 118.376 0.534 . . . . 0.0 112.102 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.55 -50.22 59.57 Favored 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.5 m -63.1 -39.07 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.64 -32.72 58.09 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.035 0 CA-C-N 118.723 0.692 . . . . 0.0 110.322 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -44.64 92.14 Favored 'General case' 0 N--CA 1.532 3.639 0 C-N-CA 123.205 0.602 . . . . 0.0 111.056 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.26 -39.74 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.792 0.437 . . . . 0.0 110.456 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.38 -39.34 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.508 0 C-N-CA 122.96 0.504 . . . . 0.0 109.802 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.4 93.9 Favored 'General case' 0 N--CA 1.528 3.46 0 C-N-CA 123.251 0.62 . . . . 0.0 111.961 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 93.0 t -71.65 -34.63 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.602 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.86 -43.87 94.8 Favored 'General case' 0 N--CA 1.526 3.355 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 11.3 m -68.65 -37.81 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 CA-C-N 118.693 0.679 . . . . 0.0 109.718 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.8 m -60.93 -37.18 81.43 Favored 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.844 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -27.25 66.71 Favored 'General case' 0 N--CA 1.537 3.919 0 C-N-CA 122.576 0.35 . . . . 0.0 110.594 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 23.1 t -63.52 -40.84 98.1 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.005 0.522 . . . . 0.0 110.991 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.41 -22.25 66.77 Favored 'General case' 0 N--CA 1.535 3.806 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 1 N--CA 1.543 4.222 0 C-N-CA 124.415 1.086 . . . . 0.0 109.378 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.522 3.155 0 CA-C-O 121.894 0.854 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -58.97 -25.82 63.91 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.601 1.16 . . . . 0.0 112.33 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 87.6 p -57.09 -25.73 59.24 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.436 0.694 . . . . 0.0 110.748 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.74 -35.34 62.53 Favored Glycine 0 N--CA 1.515 3.913 0 C-N-CA 124.52 1.057 . . . . 0.0 115.052 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.73 -34.01 62.55 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.427 0 CA-C-N 118.521 1.161 . . . . 0.0 113.872 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 1.5 pp -55.28 -32.84 29.51 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.115 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -172.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.7 tt -72.64 -32.4 40.97 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.368 0 CA-C-N 119.041 0.837 . . . . 0.0 109.348 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.08 -29.01 43.12 Favored Glycine 0 N--CA 1.515 3.946 0 C-N-CA 124.215 0.912 . . . . 0.0 113.939 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.91 -38.02 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 CA-C-N 117.435 0.618 . . . . 0.0 111.117 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 219' ' ' THR . . . . . 0.434 ' HG1' ' N ' ' C' ' 220' ' ' VAL . 64.6 p -64.78 -46.09 83.58 Favored 'General case' 0 N--CA 1.529 3.475 0 CA-C-O 121.155 0.502 . . . . 0.0 110.524 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . 0.434 ' N ' ' HG1' ' C' ' 219' ' ' THR . 47.9 t -70.08 -37.2 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.049 0 C-N-CA 124.078 0.951 . . . . 0.0 110.625 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.71 -39.93 62.49 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.91 65.76 Favored 'General case' 0 N--CA 1.515 2.783 0 C-N-CA 123.127 0.571 . . . . 0.0 111.434 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 44.6 t -61.8 -47.74 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.328 0 C-N-CA 123.225 0.61 . . . . 0.0 112.171 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.6 -32.59 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 C-N-CA 122.404 0.282 . . . . 0.0 111.377 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 38.5 tp -71.52 -34.74 70.33 Favored 'General case' 0 N--CA 1.522 3.173 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 87.1 mt -68.48 -44.85 82.85 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.372 0 CA-C-N 119.645 1.111 . . . . 0.0 110.16 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.11 -35.97 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.945 0.498 . . . . 0.0 109.973 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.12 -38.55 73.62 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.431 0.693 . . . . 0.0 111.904 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.07 -41.13 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 CA-C-O 120.742 0.305 . . . . 0.0 110.282 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -61.5 -43.93 97.99 Favored 'General case' 0 N--CA 1.529 3.498 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.23 -37.42 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.632 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 95.5 m -64.37 -33.52 76.03 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -74.04 -38.0 64.14 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.177 0.591 . . . . 0.0 110.321 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 82.2 p -63.92 -17.04 62.83 Favored 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 123.383 0.673 . . . . 0.0 111.321 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.98 -37.74 88.36 Favored 'General case' 0 N--CA 1.531 3.587 0 C-N-CA 123.963 0.905 . . . . 0.0 111.29 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.19 -2.29 57.53 Favored 'General case' 1 N--CA 1.544 4.231 0 C-N-CA 123.323 0.649 . . . . 0.0 112.2 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -70.98 92.3 0.92 Allowed 'General case' 0 N--CA 1.529 3.516 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.95 142.56 1.88 Allowed 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 124.045 0.938 . . . . 0.0 108.547 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -168.9 103.1 0.39 Allowed 'General case' 0 N--CA 1.52 3.046 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.531 3.577 0 C-N-CA 124.884 1.274 . . . . 0.0 107.676 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.522 3.153 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 49.3 mt -57.62 -26.77 62.05 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 123.949 0.899 . . . . 0.0 110.866 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 55.4 m -64.14 -35.34 80.45 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.818 0.847 . . . . 0.0 110.787 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.04 -35.02 77.5 Favored Glycine 0 N--CA 1.514 3.863 0 C-N-CA 124.354 0.978 . . . . 0.0 113.056 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 37.0 mm -68.1 -43.61 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.445 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.07 -36.31 50.73 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.213 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 15.8 tt -72.39 -33.16 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.864 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.89 -42.26 99.71 Favored Glycine 1 N--CA 1.518 4.142 0 C-N-CA 123.076 0.37 . . . . 0.0 113.838 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 18.7 m -68.72 -37.17 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.866 0 CA-C-N 118.184 0.992 . . . . 0.0 111.342 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 47.4 p -63.89 -45.78 87.85 Favored 'General case' 0 N--CA 1.53 3.54 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.36 -31.93 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 CA-C-N 118.882 0.765 . . . . 0.0 111.075 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.0 -46.76 82.06 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 122.629 0.371 . . . . 0.0 111.687 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.08 -42.23 85.15 Favored 'General case' 0 N--CA 1.519 2.998 0 C-N-CA 123.485 0.714 . . . . 0.0 111.92 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.58 -44.95 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.462 0 C-N-CA 123.102 0.561 . . . . 0.0 111.209 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.48 -40.38 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 C-N-CA 122.38 0.272 . . . . 0.0 110.626 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.66 -46.55 78.71 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 122.846 0.458 . . . . 0.0 111.603 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 85.7 mt -62.26 -36.99 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 O-C-N 122.029 -0.42 . . . . 0.0 110.585 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.12 -37.55 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.887 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.76 98.57 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.852 0.461 . . . . 0.0 111.202 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.75 -34.66 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.426 0 C-N-CA 123.165 0.586 . . . . 0.0 109.702 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -63.08 -44.1 96.71 Favored 'General case' 0 N--CA 1.53 3.571 0 C-N-CA 123.099 0.56 . . . . 0.0 112.366 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.12 -37.64 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.724 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 85.8 m -61.03 -27.31 68.24 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 123.151 0.58 . . . . 0.0 111.251 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -57.8 -27.19 62.89 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 122.811 0.444 . . . . 0.0 111.251 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 66.1 m -65.97 -41.18 91.51 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 123.78 0.832 . . . . 0.0 111.355 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -60.84 -13.42 15.39 Favored 'General case' 0 N--CA 1.532 3.653 0 C-N-CA 124.338 1.055 . . . . 0.0 111.28 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.45 -23.42 26.03 Favored 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.83 109.82 15.75 Favored 'General case' 0 N--CA 1.527 3.408 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -168.63 166.95 11.68 Favored 'General case' 0 N--CA 1.521 3.102 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 22.7 pttp . . . . . 0 N--CA 1.522 3.142 0 C-N-CA 124.05 0.94 . . . . 0.0 110.866 -179.388 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.525 3.299 0 CA-C-O 120.61 0.243 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -61.82 -27.03 68.48 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 123.3 0.64 . . . . 0.0 111.143 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 55.7 m -69.13 -26.1 64.72 Favored 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.984 0.914 . . . . 0.0 109.976 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.34 -46.01 88.32 Favored Glycine 0 N--CA 1.513 3.78 0 CA-C-N 115.394 -0.821 . . . . 0.0 114.256 -177.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 46.6 pt -70.47 -35.63 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 8.6 pt -61.8 -44.45 98.81 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.55 0 CA-C-N 119.249 0.931 . . . . 0.0 111.582 -176.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.33 -32.22 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.871 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.96 -29.4 43.1 Favored Glycine 0 N--CA 1.506 3.302 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.584 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.45 -37.25 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 CA-C-N 117.708 0.754 . . . . 0.0 111.179 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 35.9 p -64.66 -47.61 77.82 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 10.5 p -70.84 -31.24 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.327 0.651 . . . . 0.0 110.987 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.22 65.07 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.07 0.548 . . . . 0.0 112.324 -177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.77 -34.76 69.92 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 123.129 0.571 . . . . 0.0 111.83 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.95 -40.47 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 123.03 0.532 . . . . 0.0 110.307 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.15 -42.08 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.508 0.723 . . . . 0.0 110.746 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 66.6 mt -64.2 -34.58 78.42 Favored 'General case' 0 N--CA 1.528 3.449 0 C-N-CA 122.684 0.394 . . . . 0.0 110.749 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.64 -43.95 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 C-N-CA 122.852 0.461 . . . . 0.0 109.952 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 80.7 t -66.86 -39.2 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.59 -48.03 82.31 Favored 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 123.681 0.792 . . . . 0.0 112.953 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 35.2 m -71.58 -34.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 O-C-N 121.955 -0.465 . . . . 0.0 110.803 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.24 -44.25 92.42 Favored 'General case' 0 N--CA 1.528 3.471 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.96 -37.81 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 83.7 m -66.19 -32.63 74.18 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 122.875 0.47 . . . . 0.0 110.554 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -67.53 -32.2 72.84 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.422 0.689 . . . . 0.0 111.047 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -63.89 -26.8 68.76 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.312 0.645 . . . . 0.0 111.301 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 53.5 mt . . . . . 0 N--CA 1.525 3.282 0 C-N-CA 123.379 0.671 . . . . 0.0 110.274 179.82 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.521 3.103 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.23 -26.22 68.41 Favored 'General case' 0 N--CA 1.525 3.3 0 C-N-CA 124.014 0.926 . . . . 0.0 111.748 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 40.1 t -66.04 -33.09 75.01 Favored 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 123.609 0.764 . . . . 0.0 111.302 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.74 -45.98 62.99 Favored Glycine 1 N--CA 1.519 4.18 0 N-CA-C 115.047 0.779 . . . . 0.0 115.047 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 8.4 tp -70.85 -40.49 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.888 0 O-C-N 121.653 -0.91 . . . . 0.0 112.319 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -36.73 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 C-N-CA 123.207 0.603 . . . . 0.0 111.946 -177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.92 -31.73 46.34 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.421 0 CA-C-N 119.424 1.011 . . . . 0.0 109.232 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.49 -29.46 47.6 Favored Glycine 0 N--CA 1.516 3.987 0 C-N-CA 123.845 0.736 . . . . 0.0 113.801 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.74 -39.78 80.68 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.055 0 CA-C-N 117.525 0.663 . . . . 0.0 111.509 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 82.5 p -66.18 -45.91 79.19 Favored 'General case' 0 N--CA 1.53 3.564 0 CA-C-O 121.247 0.546 . . . . 0.0 110.794 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.23 -32.54 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.038 0 C-N-CA 124.24 1.016 . . . . 0.0 110.864 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.65 -45.2 66.6 Favored 'General case' 0 N--CA 1.529 3.498 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.53 -33.46 75.97 Favored 'General case' 0 N--CA 1.523 3.191 0 C-N-CA 123.449 0.7 . . . . 0.0 111.626 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 25.9 t -65.42 -38.62 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.652 0.781 . . . . 0.0 110.934 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.17 -32.52 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 C-N-CA 123.123 0.569 . . . . 0.0 111.185 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 43.2 tp -68.22 -39.26 82.4 Favored 'General case' 0 N--CA 1.526 3.356 0 CA-C-O 120.764 0.316 . . . . 0.0 110.191 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 41.5 mm -54.7 -50.15 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.865 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.742 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 18.7 m -67.04 -37.28 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.896 -0.502 . . . . 0.0 110.214 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.25 93.13 Favored 'General case' 0 N--CA 1.525 3.277 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 15.9 m -71.27 -33.99 52.55 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 CA-C-N 119.223 0.92 . . . . 0.0 110.102 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -64.12 -43.94 93.76 Favored 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 14.3 m -68.74 -37.65 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 CA-C-O 121.007 0.432 . . . . 0.0 109.901 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 91.0 m -58.67 -27.43 64.79 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 123.447 0.699 . . . . 0.0 111.104 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.05 -34.36 78.23 Favored 'General case' 0 N--CA 1.525 3.324 0 C-N-CA 122.335 0.254 . . . . 0.0 110.672 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 79.5 p -68.34 -36.41 79.21 Favored 'General case' 0 N--CA 1.532 3.647 0 C-N-CA 123.181 0.592 . . . . 0.0 110.685 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.85 -13.49 15.89 Favored 'General case' 0 N--CA 1.537 3.902 0 C-N-CA 123.555 0.742 . . . . 0.0 110.964 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 18.2 mt -86.68 0.38 54.72 Favored 'General case' 0 N--CA 1.535 3.811 0 C-N-CA 122.929 0.492 . . . . 0.0 111.383 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -163.92 108.53 1.01 Allowed 'General case' 0 N--CA 1.53 3.552 0 CA-C-N 118.073 0.397 . . . . 0.0 111.248 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 54.9 mttp . . . . . 0 N--CA 1.526 3.362 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.269 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.223 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.9 p -166.05 -20.09 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 124.153 0.981 . . . . 0.0 109.387 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.11 -26.41 68.19 Favored 'General case' 0 N--CA 1.528 3.474 0 C-N-CA 124.2 1.0 . . . . 0.0 109.164 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 95.1 p -65.95 -26.96 67.82 Favored 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.547 0.739 . . . . 0.0 110.49 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.12 -46.61 57.67 Favored Glycine 1 N--CA 1.52 4.254 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 8.4 tp -71.17 -41.1 75.41 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.174 0 CA-C-N 118.186 0.993 . . . . 0.0 112.967 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.3 tt -60.87 -35.25 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 123.672 0.789 . . . . 0.0 112.873 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 5.7 tp -73.16 -33.28 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.991 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.43 96.14 Favored Glycine 1 N--CA 1.521 4.311 0 C-N-CA 123.401 0.525 . . . . 0.0 114.219 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.6 p -59.71 -36.84 68.11 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 117.972 0.886 . . . . 0.0 110.787 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.9 p -55.95 -42.15 75.77 Favored 'General case' 0 N--CA 1.535 3.821 0 CA-C-O 120.919 0.39 . . . . 0.0 111.432 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.5 -40.4 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 123.85 0.86 . . . . 0.0 111.601 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.38 -39.91 61.42 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -176.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.54 -46.35 63.74 Favored 'General case' 0 N--CA 1.52 3.054 0 C-N-CA 122.997 0.519 . . . . 0.0 111.185 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.78 -46.62 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 C-N-CA 123.321 0.648 . . . . 0.0 112.385 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.8 p -66.18 -32.28 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.665 0 C-N-CA 122.512 0.325 . . . . 0.0 111.122 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.61 -41.32 96.28 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.584 0.354 . . . . 0.0 110.859 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 88.0 mt -58.62 -36.66 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.916 0 C-N-CA 122.658 0.383 . . . . 0.0 110.287 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.34 -37.69 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 C-N-CA 123.02 0.528 . . . . 0.0 110.324 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.62 -33.25 75.49 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.038 0.535 . . . . 0.0 110.877 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.07 -36.9 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 C-N-CA 123.308 0.643 . . . . 0.0 109.762 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -64.36 -43.45 94.5 Favored 'General case' 0 N--CA 1.528 3.466 0 C-N-CA 123.633 0.773 . . . . 0.0 112.544 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 19.2 m -67.7 -37.23 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 76.8 m -60.24 -38.35 83.19 Favored 'General case' 0 N--CA 1.527 3.392 0 C-N-CA 122.96 0.504 . . . . 0.0 111.26 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -74.27 -40.63 62.2 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 122.64 0.376 . . . . 0.0 110.074 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 83.5 p -63.91 -32.73 74.35 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.15 -23.18 57.77 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.063 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.4 tp -87.11 -22.67 25.24 Favored 'General case' 0 N--CA 1.537 3.919 0 C-N-CA 122.942 0.497 . . . . 0.0 110.16 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -71.45 65.61 0.45 Allowed 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.648 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -143.44 157.9 44.08 Favored 'General case' 0 N--CA 1.526 3.369 0 C-N-CA 124.822 1.249 . . . . 0.0 107.843 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.69 155.93 37.2 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 123.731 0.812 . . . . 0.0 109.216 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.529 3.488 0 C-N-CA 124.706 1.203 . . . . 0.0 108.329 179.579 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.522 3.168 0 CA-C-O 120.167 0.032 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.2 -28.72 69.58 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 124.061 0.944 . . . . 0.0 110.137 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 56.0 m -65.05 -26.88 68.44 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.04 0.536 . . . . 0.0 110.302 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.28 -35.79 91.98 Favored Glycine 1 N--CA 1.524 4.524 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 36.1 mm -68.71 -40.48 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.302 0 C-N-CA 124.583 1.153 . . . . 0.0 109.149 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 48.2 mm -66.46 -40.13 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 C-N-CA 124.538 1.135 . . . . 0.0 108.905 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 14.6 mm -71.38 -31.96 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.97 -29.17 42.58 Favored Glycine 0 N--CA 1.516 3.976 0 C-N-CA 123.708 0.67 . . . . 0.0 113.176 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.59 -37.59 71.31 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.095 0 CA-C-N 117.84 0.82 . . . . 0.0 110.769 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 46.9 p -57.48 -44.79 85.17 Favored 'General case' 0 N--CA 1.528 3.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.824 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.6 t -67.02 -31.79 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 C-N-CA 124.095 0.958 . . . . 0.0 110.875 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.87 79.35 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 122.482 0.313 . . . . 0.0 110.967 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.98 -50.11 74.51 Favored 'General case' 0 N--CA 1.521 3.117 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.37 -38.35 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 CA-C-N 118.224 0.465 . . . . 0.0 111.625 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.2 -38.38 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 118.23 0.468 . . . . 0.0 110.651 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.99 -38.72 92.11 Favored 'General case' 1 N--CA 1.539 4.021 0 C-N-CA 122.55 0.34 . . . . 0.0 110.543 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.78 -42.8 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.818 0 O-C-N 122.005 -0.434 . . . . 0.0 110.221 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 64.6 t -65.52 -37.71 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 C-N-CA 122.964 0.506 . . . . 0.0 110.082 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.56 80.3 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.432 0.693 . . . . 0.0 111.277 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 84.1 t -71.94 -34.88 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.26 0 C-N-CA 122.909 0.484 . . . . 0.0 110.443 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -62.66 -44.46 96.21 Favored 'General case' 0 N--CA 1.534 3.739 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.02 -39.34 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.721 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 73.6 m -67.18 -30.39 70.33 Favored 'General case' 0 N--CA 1.524 3.26 0 C-N-CA 123.115 0.566 . . . . 0.0 110.727 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -73.32 -35.33 66.04 Favored 'General case' 0 N--CA 1.526 3.339 0 C-N-CA 123.249 0.62 . . . . 0.0 110.343 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 62.8 m -63.67 -23.87 67.55 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.554 0.742 . . . . 0.0 111.689 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.95 -24.98 66.13 Favored 'General case' 0 N--CA 1.53 3.557 0 C-N-CA 123.688 0.795 . . . . 0.0 110.285 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.535 3.782 0 C-N-CA 123.632 0.773 . . . . 0.0 109.453 179.909 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.521 3.093 0 CA-C-O 121.819 0.819 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 7.8 mp -65.23 -26.92 68.33 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.932 0.893 . . . . 0.0 109.537 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 41.4 t -58.2 -25.94 62.2 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.579 0.751 . . . . 0.0 110.931 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.65 -34.4 60.51 Favored Glycine 0 N--CA 1.513 3.77 0 C-N-CA 125.123 1.344 . . . . 0.0 114.981 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.0 pt -57.95 -34.11 47.84 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.271 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -175.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 9.8 pt -55.74 -32.43 31.63 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.133 0 C-N-CA 123.128 0.571 . . . . 0.0 111.972 -176.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.96 -33.44 52.84 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.112 0 C-N-CA 123.613 0.765 . . . . 0.0 110.017 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.74 -29.9 50.72 Favored Glycine 0 N--CA 1.513 3.814 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.039 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.1 m -62.26 -37.82 79.55 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 117.937 0.868 . . . . 0.0 111.329 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 68.2 p -62.15 -45.77 91.96 Favored 'General case' 0 N--CA 1.532 3.633 0 CA-C-O 121.364 0.602 . . . . 0.0 110.669 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.18 -32.49 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 C-N-CA 124.197 0.999 . . . . 0.0 110.207 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.3 -34.61 78.74 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.534 0.733 . . . . 0.0 111.776 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.03 -49.87 46.98 Favored 'General case' 0 N--CA 1.516 2.844 0 C-N-CA 123.14 0.576 . . . . 0.0 112.503 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 29.3 m -63.92 -40.11 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.815 0 CA-C-N 118.523 0.602 . . . . 0.0 112.577 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 13.7 p -67.44 -32.01 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 CA-C-N 118.182 0.446 . . . . 0.0 110.558 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.49 -43.96 79.68 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 122.911 0.485 . . . . 0.0 110.333 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.52 -36.54 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 C-N-CA 123.48 0.712 . . . . 0.0 112.028 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.71 -36.68 67.14 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.683 0 CA-C-N 119.447 1.022 . . . . 0.0 110.517 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.28 -32.51 66.7 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.386 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.72 -41.25 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.394 0 C-N-CA 123.261 0.624 . . . . 0.0 110.086 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -61.42 -43.52 98.73 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.607 0.763 . . . . 0.0 112.915 -177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.26 -37.54 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 82.6 m -61.6 -27.82 68.91 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 122.619 0.368 . . . . 0.0 111.07 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -68.21 -27.38 66.33 Favored 'General case' 0 N--CA 1.531 3.576 0 C-N-CA 123.057 0.543 . . . . 0.0 110.738 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.9 m -69.07 -26.77 65.11 Favored 'General case' 0 N--CA 1.531 3.595 0 CA-C-O 121.225 0.536 . . . . 0.0 110.103 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -14.52 47.21 Favored 'General case' 0 N--CA 1.533 3.682 0 C-N-CA 124.807 1.243 . . . . 0.0 110.499 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 32.2 mt -86.59 -27.27 23.98 Favored 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 123.373 0.669 . . . . 0.0 110.387 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -71.56 84.98 0.86 Allowed 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.532 0.733 . . . . 0.0 109.234 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.64 117.09 15.71 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 124.988 1.315 . . . . 0.0 107.766 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? -164.53 134.02 3.78 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.531 3.578 0 C-N-CA 125.145 1.378 . . . . 0.0 108.685 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 N--CA 1.522 3.134 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -25.79 68.09 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.887 0.875 . . . . 0.0 111.659 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 99.6 p -68.17 -26.92 65.99 Favored 'General case' 0 N--CA 1.527 3.395 0 C-N-CA 123.331 0.652 . . . . 0.0 110.054 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.06 -34.02 71.35 Favored Glycine 0 N--CA 1.505 3.255 0 C-N-CA 125.589 1.566 . . . . 0.0 115.597 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 13.7 pt -58.24 -33.79 48.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.06 -43.39 69.58 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.388 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 18.4 tt -73.19 -34.47 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.984 0 CA-C-N 118.252 0.478 . . . . 0.0 110.375 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.11 -44.6 93.89 Favored Glycine 1 N--CA 1.519 4.184 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -60.11 -37.07 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.987 0 CA-C-N 117.629 0.714 . . . . 0.0 111.067 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 61.6 p -59.26 -39.0 81.48 Favored 'General case' 0 N--CA 1.532 3.637 0 CA-C-N 117.963 0.347 . . . . 0.0 111.41 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.48 -38.34 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 C-N-CA 123.41 0.684 . . . . 0.0 111.52 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.16 68.19 Favored 'General case' 0 N--CA 1.531 3.623 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.12 90.06 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 123.5 0.72 . . . . 0.0 111.71 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.23 -42.91 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.289 0.636 . . . . 0.0 112.129 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.81 -32.56 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.58 -47.33 22.82 Favored 'General case' 0 N--CA 1.539 3.997 0 CA-C-N 118.248 0.476 . . . . 0.0 111.352 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 20.2 pt -62.05 -36.31 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.721 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.07 -36.01 76.43 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.199 0 CA-C-N 119.425 1.011 . . . . 0.0 110.321 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.42 -32.16 66.59 Favored 'General case' 0 N--CA 1.523 3.187 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.77 -34.91 67.21 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.296 0 CA-C-N 119.709 1.14 . . . . 0.0 112.269 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -63.21 -43.53 97.86 Favored 'General case' 1 N--CA 1.539 4.019 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.37 -37.32 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 76.4 m -58.7 -31.3 68.12 Favored 'General case' 0 N--CA 1.531 3.619 0 C-N-CA 122.529 0.331 . . . . 0.0 111.257 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.11 -15.32 63.54 Favored 'General case' 0 N--CA 1.534 3.726 0 C-N-CA 123.103 0.561 . . . . 0.0 110.858 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 78.4 p -63.41 -28.78 70.22 Favored 'General case' 0 N--CA 1.529 3.51 0 CA-C-O 121.146 0.498 . . . . 0.0 109.87 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 57.6 mt -91.35 -18.65 23.95 Favored 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 124.507 1.123 . . . . 0.0 112.301 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 53.9 mt -87.53 3.0 49.14 Favored 'General case' 1 N--CA 1.544 4.264 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -70.2 -7.82 45.03 Favored 'General case' 1 N--CA 1.543 4.216 0 CA-C-N 119.65 1.114 . . . . 0.0 109.504 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -67.71 131.78 46.23 Favored 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 124.027 0.931 . . . . 0.0 109.844 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 N--CA 1.526 3.349 0 C-N-CA 123.708 0.803 . . . . 0.0 110.497 179.585 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p . . . . . 0 N--CA 1.519 3.018 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.16 -27.21 68.55 Favored 'General case' 0 N--CA 1.536 3.865 0 C-N-CA 123.641 0.777 . . . . 0.0 109.091 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -66.7 -28.26 68.29 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.421 0.689 . . . . 0.0 110.421 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.77 -35.56 80.3 Favored Glycine 1 N--CA 1.516 4.009 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 38.5 mm -69.81 -43.56 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.153 0 C-N-CA 124.528 1.131 . . . . 0.0 112.841 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 9.4 pt -59.49 -40.87 82.97 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.526 0 CA-C-N 118.852 0.751 . . . . 0.0 112.153 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.0 -32.94 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.98 -50.14 70.86 Favored Glycine 1 N--CA 1.52 4.276 0 C-N-CA 123.603 0.62 . . . . 0.0 113.364 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -61.76 -36.78 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-N 117.458 0.629 . . . . 0.0 109.747 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 86.1 m -63.6 -47.05 83.0 Favored 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 122.693 0.397 . . . . 0.0 111.604 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.7 -34.39 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 C-N-CA 123.491 0.716 . . . . 0.0 110.512 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.7 -46.57 67.39 Favored 'General case' 0 N--CA 1.527 3.382 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.43 91.09 Favored 'General case' 0 N--CA 1.519 2.99 0 C-N-CA 123.033 0.533 . . . . 0.0 111.687 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 43.2 t -68.16 -51.6 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.101 0 C-N-CA 123.134 0.574 . . . . 0.0 111.96 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 31.7 m -67.41 -32.72 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 O-C-N 121.892 -0.505 . . . . 0.0 111.813 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.03 -44.51 72.55 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 122.539 0.335 . . . . 0.0 111.33 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 24.7 pt -69.23 -36.48 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 CA-C-N 118.747 0.703 . . . . 0.0 111.149 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.07 -37.64 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.871 0 O-C-N 121.848 -0.533 . . . . 0.0 109.739 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.78 83.66 Favored 'General case' 0 N--CA 1.532 3.637 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.65 -34.16 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.554 0 O-C-N 122.079 -0.388 . . . . 0.0 110.937 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -68.75 -43.71 75.28 Favored 'General case' 0 N--CA 1.526 3.357 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 13.2 p -68.38 -37.83 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 CA-C-N 118.019 0.372 . . . . 0.0 111.175 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 16.3 p -66.31 -27.88 68.26 Favored 'General case' 0 N--CA 1.533 3.679 0 CA-C-N 117.855 0.298 . . . . 0.0 111.172 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -65.61 -30.98 71.78 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 123.214 0.606 . . . . 0.0 111.109 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 53.0 m -64.47 -32.37 73.96 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.391 0.676 . . . . 0.0 111.277 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 53.8 mt . . . . . 0 N--CA 1.527 3.379 0 C-N-CA 123.594 0.758 . . . . 0.0 111.928 -178.932 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.521 3.102 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.08 -35.61 81.69 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 124.312 1.045 . . . . 0.0 110.285 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 42.2 t -57.77 -26.95 62.6 Favored 'General case' 0 N--CA 1.528 3.451 0 C-N-CA 122.886 0.475 . . . . 0.0 111.593 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.38 -35.85 83.01 Favored Glycine 1 N--CA 1.527 4.741 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.29 -40.7 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 C-N-CA 124.428 1.091 . . . . 0.0 108.959 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.23 -42.67 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 C-N-CA 124.524 1.13 . . . . 0.0 108.771 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 30.8 mm -72.38 -33.06 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.627 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.42 -29.71 60.83 Favored Glycine 0 N--CA 1.514 3.88 0 C-N-CA 123.766 0.698 . . . . 0.0 113.362 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 2.5 m -60.43 -37.38 74.39 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 CA-C-N 117.825 0.812 . . . . 0.0 110.653 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 44.5 p -55.92 -46.1 78.55 Favored 'General case' 0 N--CA 1.529 3.517 0 CA-C-O 121.375 0.607 . . . . 0.0 111.403 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.62 -31.92 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.034 0 C-N-CA 124.387 1.075 . . . . 0.0 111.238 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.86 78.99 Favored 'General case' 0 N--CA 1.531 3.588 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.19 -50.28 70.94 Favored 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 28.1 m -63.09 -37.94 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.404 0.547 . . . . 0.0 111.883 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 93.9 t -60.5 -32.71 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 121.77 -0.581 . . . . 0.0 110.232 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.5 -38.08 77.47 Favored 'General case' 0 N--CA 1.532 3.669 0 CA-C-N 118.455 0.571 . . . . 0.0 109.958 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 11.6 mm -54.36 -36.85 35.21 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.026 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.44 -38.09 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 C-N-CA 123.468 0.707 . . . . 0.0 109.829 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.47 -32.21 72.21 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.431 0.692 . . . . 0.0 111.309 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.02 -34.51 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 C-N-CA 122.813 0.445 . . . . 0.0 109.855 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.02 -43.37 83.0 Favored 'General case' 0 N--CA 1.53 3.553 0 C-N-CA 123.07 0.548 . . . . 0.0 112.152 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 4.9 m -67.47 -36.1 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 CA-C-N 118.195 0.452 . . . . 0.0 109.937 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 96.6 m -57.61 -27.13 62.48 Favored 'General case' 0 N--CA 1.526 3.348 0 C-N-CA 123.004 0.521 . . . . 0.0 110.547 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -58.51 -15.71 12.3 Favored 'General case' 0 N--CA 1.531 3.6 0 C-N-CA 122.367 0.267 . . . . 0.0 110.867 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 50.8 m -75.04 -42.07 57.91 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.99 -14.22 21.51 Favored 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.474 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 43.2 tp -87.06 2.3 50.12 Favored 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 46.9 m95 66.92 164.29 0.2 Allowed 'General case' 0 N--CA 1.515 2.799 0 C-N-CA 125.148 1.379 . . . . 0.0 111.214 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.522 3.134 0 C-N-CA 125.358 1.463 . . . . 0.0 107.07 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.521 4.301 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 82.8 p 52.34 46.36 26.8 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 124.055 0.942 . . . . 0.0 112.199 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 43.4 mt -61.91 -26.85 68.41 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.774 0.83 . . . . 0.0 110.607 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 45.2 t -68.43 -26.36 65.48 Favored 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.675 0.79 . . . . 0.0 110.596 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.35 -43.79 77.2 Favored Glycine 0 N--CA 1.512 3.714 0 C-N-CA 123.599 0.619 . . . . 0.0 114.103 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.7 pt -70.68 -35.82 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 10.1 pt -58.56 -41.69 82.63 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.66 0 CA-C-N 119.433 1.015 . . . . 0.0 112.542 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.7 -33.18 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.06 -41.0 96.27 Favored Glycine 1 N--CA 1.516 4.002 0 CA-C-O 119.502 -0.61 . . . . 0.0 114.088 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.9 m -63.73 -36.62 77.17 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.349 0 CA-C-N 118.624 1.212 . . . . 0.0 111.134 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.8 p -55.74 -42.56 75.57 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.828 0.451 . . . . 0.0 111.092 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.93 -34.13 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 C-N-CA 124.059 0.944 . . . . 0.0 111.896 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.93 -42.42 65.4 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.75 -34.08 71.47 Favored 'General case' 0 N--CA 1.519 2.992 0 C-N-CA 123.232 0.613 . . . . 0.0 111.314 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.85 -49.23 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 123.647 0.779 . . . . 0.0 111.345 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.68 -32.71 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 C-N-CA 122.633 0.373 . . . . 0.0 110.674 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.28 -36.86 74.67 Favored 'General case' 0 N--CA 1.539 3.985 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.18 -37.11 34.66 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.352 0 C-N-CA 123.168 0.587 . . . . 0.0 109.975 178.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.1 t -66.93 -38.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 C-N-CA 123.187 0.595 . . . . 0.0 110.143 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -45.53 86.54 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.387 0.675 . . . . 0.0 112.681 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.7 -34.17 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.613 0 O-C-N 121.898 -0.501 . . . . 0.0 110.228 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.15 -44.1 93.15 Favored 'General case' 0 N--CA 1.532 3.629 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.53 -37.29 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 99.5 m -59.14 -27.95 66.11 Favored 'General case' 0 N--CA 1.531 3.6 0 C-N-CA 122.74 0.416 . . . . 0.0 110.859 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -73.29 -35.05 66.07 Favored 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 63.0 m -72.66 -30.86 64.62 Favored 'General case' 0 N--CA 1.525 3.321 0 C-N-CA 123.108 0.563 . . . . 0.0 109.852 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.78 -14.65 62.5 Favored 'General case' 0 N--CA 1.526 3.339 0 C-N-CA 124.513 1.125 . . . . 0.0 110.926 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 38.3 tp -87.33 10.21 18.0 Favored 'General case' 0 N--CA 1.537 3.917 0 C-N-CA 123.763 0.825 . . . . 0.0 110.663 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -66.05 9.31 0.15 Allowed 'General case' 1 N--CA 1.54 4.065 0 C-N-CA 123.217 0.607 . . . . 0.0 112.444 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -50.6 -47.34 58.16 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 124.099 0.96 . . . . 0.0 111.785 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt 61.18 153.72 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 124.384 1.074 . . . . 0.0 111.348 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.529 3.508 0 C-N-CA 125.216 1.406 . . . . 0.0 108.513 -179.898 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.524 3.247 0 N-CA-C 111.234 0.087 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -61.89 -26.5 68.2 Favored 'General case' 0 N--CA 1.529 3.48 0 C-N-CA 124.147 0.979 . . . . 0.0 110.162 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 95.7 p -68.15 -32.15 72.21 Favored 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.556 0.742 . . . . 0.0 110.391 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.86 -46.89 58.41 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.924 0.773 . . . . 0.0 115.0 -178.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.9 -41.16 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 tp -60.67 -40.42 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 C-N-CA 122.905 0.482 . . . . 0.0 112.276 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 7.0 tp -73.27 -33.79 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.711 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.13 -47.84 87.07 Favored Glycine 0 N--CA 1.515 3.914 0 C-N-CA 123.799 0.714 . . . . 0.0 114.167 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.16 -37.17 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 CA-C-N 117.566 0.683 . . . . 0.0 111.137 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 61.2 p -66.06 -46.3 78.26 Favored 'General case' 0 N--CA 1.534 3.727 0 CA-C-N 118.136 0.425 . . . . 0.0 110.721 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 84.7 t -70.03 -31.96 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 C-N-CA 123.741 0.817 . . . . 0.0 111.057 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.87 -43.79 66.35 Favored 'General case' 0 N--CA 1.533 3.707 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.06 73.2 Favored 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 123.185 0.594 . . . . 0.0 111.179 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.71 -46.79 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 123.395 0.678 . . . . 0.0 112.292 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.29 -31.58 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 C-N-CA 122.533 0.333 . . . . 0.0 111.39 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.72 -39.64 64.16 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 122.411 -0.181 . . . . 0.0 111.046 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 93.8 mt -59.96 -44.19 94.01 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.097 0 CA-C-N 118.357 0.526 . . . . 0.0 111.653 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 30.0 m -64.07 -36.7 77.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 CA-C-N 118.619 0.645 . . . . 0.0 110.429 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.9 -32.5 71.96 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.238 0.615 . . . . 0.0 111.871 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 86.2 t -71.31 -34.56 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.698 0.399 . . . . 0.0 109.939 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -61.34 -44.02 97.9 Favored 'General case' 0 N--CA 1.53 3.542 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.94 -40.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.858 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 80.7 m -58.67 -27.65 65.0 Favored 'General case' 0 N--CA 1.522 3.17 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.117 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -71.62 -15.85 62.26 Favored 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 122.528 0.331 . . . . 0.0 111.15 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 26.8 t -78.39 -46.55 19.62 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.88 -13.01 54.63 Favored 'General case' 1 N--CA 1.554 4.733 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -175.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 1 N--CA 1.566 5.33 0 CA-C-N 121.915 2.143 . . . . 0.0 112.438 -176.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 59.9 p . . . . . 0 N--CA 1.525 3.279 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.65 -26.66 68.75 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 123.955 0.902 . . . . 0.0 109.646 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 38.7 t -67.95 -26.85 66.15 Favored 'General case' 0 N--CA 1.519 2.993 0 C-N-CA 123.645 0.778 . . . . 0.0 110.611 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.14 -46.78 56.87 Favored Glycine 0 N--CA 1.512 3.704 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.321 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 43.2 pt -70.98 -37.97 70.15 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.121 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 7.5 tp -59.05 -31.8 46.49 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.092 0 C-N-CA 123.288 0.635 . . . . 0.0 112.659 -177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.4 pp -71.3 -32.17 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.7 -43.68 79.75 Favored Glycine 0 N--CA 1.512 3.743 0 C-N-CA 124.463 1.03 . . . . 0.0 114.949 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 11.3 p -68.2 -37.13 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 CA-C-N 118.133 0.967 . . . . 0.0 111.011 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.6 p -65.59 -46.49 79.18 Favored 'General case' 0 N--CA 1.531 3.582 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 10.8 p -69.71 -30.68 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.467 0 C-N-CA 123.451 0.7 . . . . 0.0 111.226 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.07 -43.19 63.71 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.59 -37.36 73.89 Favored 'General case' 0 N--CA 1.521 3.099 0 C-N-CA 123.335 0.654 . . . . 0.0 110.863 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.99 -52.13 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.313 0 C-N-CA 123.668 0.787 . . . . 0.0 111.27 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.4 -31.93 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.925 0 CA-C-O 120.91 0.386 . . . . 0.0 110.235 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -46.24 89.61 Favored 'General case' 0 N--CA 1.531 3.59 0 CA-C-O 121.57 0.7 . . . . 0.0 109.583 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.14 -39.51 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 C-N-CA 123.221 0.608 . . . . 0.0 109.814 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.91 -37.78 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.704 0 C-N-CA 123.144 0.578 . . . . 0.0 109.914 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.66 -46.52 88.78 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.386 0.674 . . . . 0.0 112.602 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.71 -34.26 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 O-C-N 121.825 -0.547 . . . . 0.0 109.871 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.68 -43.91 97.59 Favored 'General case' 0 N--CA 1.529 3.515 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.0 -37.69 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.12 -28.59 69.88 Favored 'General case' 0 N--CA 1.525 3.324 0 C-N-CA 123.23 0.612 . . . . 0.0 111.586 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -62.35 -37.27 85.02 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 122.924 0.49 . . . . 0.0 110.664 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 52.7 m -63.78 -26.84 68.82 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.614 0.766 . . . . 0.0 111.102 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 55.6 mt -90.12 -13.44 35.74 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 124.953 1.301 . . . . 0.0 111.281 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 41.7 tp -86.58 -11.3 51.91 Favored 'General case' 1 N--CA 1.54 4.054 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -175.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -60.55 -67.34 0.41 Allowed 'General case' 1 N--CA 1.541 4.114 0 CA-C-N 119.142 0.883 . . . . 0.0 110.007 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 56.55 -144.66 0.65 Allowed 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.77 0.828 . . . . 0.0 110.751 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp 62.14 170.69 0.13 Allowed 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 124.29 1.036 . . . . 0.0 111.304 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.526 3.351 0 C-N-CA 125.249 1.419 . . . . 0.0 107.978 -179.832 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.522 3.142 0 CA-C-O 121.061 0.458 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.2 -26.73 68.27 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 124.167 0.987 . . . . 0.0 109.82 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 45.1 t -68.65 -26.45 65.34 Favored 'General case' 0 N--CA 1.52 3.072 0 C-N-CA 123.358 0.663 . . . . 0.0 110.835 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.05 71.48 Favored Glycine 0 N--CA 1.511 3.642 0 C-N-CA 123.693 0.663 . . . . 0.0 114.08 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 6.4 tp -68.9 -35.97 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.911 0 CA-C-N 117.921 0.861 . . . . 0.0 111.908 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 8.3 pt -65.5 -32.37 57.93 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.461 0 CA-C-N 118.961 0.801 . . . . 0.0 110.16 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.62 -33.69 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 124.301 1.04 . . . . 0.0 108.861 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.24 -29.73 60.33 Favored Glycine 1 N--CA 1.518 4.118 0 C-N-CA 123.523 0.582 . . . . 0.0 113.159 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 m -60.07 -37.35 72.46 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 CA-C-N 117.349 0.574 . . . . 0.0 111.042 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 56.8 p -55.6 -39.74 71.16 Favored 'General case' 0 N--CA 1.524 3.235 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.325 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.7 t -61.88 -46.11 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.277 0 C-N-CA 123.703 0.801 . . . . 0.0 110.668 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.51 -35.09 60.27 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.262 0.625 . . . . 0.0 112.538 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.95 -37.32 81.45 Favored 'General case' 0 N--CA 1.519 2.991 0 C-N-CA 123.482 0.713 . . . . 0.0 111.083 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 28.3 t -56.37 -38.89 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 C-N-CA 123.288 0.635 . . . . 0.0 110.573 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.02 -32.11 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.387 0 C-N-CA 123.554 0.741 . . . . 0.0 110.028 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -44.07 70.45 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.433 0.693 . . . . 0.0 109.555 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.15 -49.19 63.72 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 C-N-CA 123.246 0.618 . . . . 0.0 111.772 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 22.2 m -66.19 -36.28 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 C-N-CA 122.594 0.358 . . . . 0.0 110.327 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.28 66.74 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 123.279 0.632 . . . . 0.0 112.338 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.4 -43.91 94.63 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.005 0 CA-C-N 118.237 0.471 . . . . 0.0 112.09 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -61.16 -43.62 98.6 Favored 'General case' 0 N--CA 1.538 3.951 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.56 -37.55 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 O-C-N 121.771 -0.581 . . . . 0.0 109.609 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 85.3 m -64.25 -27.63 69.18 Favored 'General case' 0 N--CA 1.527 3.385 0 C-N-CA 122.973 0.509 . . . . 0.0 111.105 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -64.36 -27.96 69.37 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.039 0.536 . . . . 0.0 111.423 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 50.5 m -63.73 -37.68 88.28 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 123.629 0.771 . . . . 0.0 111.767 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -60.84 -13.79 17.76 Favored 'General case' 0 N--CA 1.531 3.589 0 C-N-CA 124.625 1.17 . . . . 0.0 112.293 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -86.93 -28.15 22.93 Favored 'General case' 1 N--CA 1.542 4.175 0 CA-C-N 118.423 0.556 . . . . 0.0 110.539 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -73.42 68.25 1.09 Allowed 'General case' 0 N--CA 1.533 3.684 0 CA-C-O 121.387 0.613 . . . . 0.0 109.739 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -109.83 -37.61 5.59 Favored 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 125.096 1.358 . . . . 0.0 108.627 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 60.1 tttp . . . . . 0 N--CA 1.524 3.248 0 C-N-CA 124.651 1.181 . . . . 0.0 111.214 -179.657 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.524 3.241 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.5 -26.86 68.76 Favored 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 123.665 0.786 . . . . 0.0 111.473 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 66.0 m -68.28 -25.86 65.36 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.631 0.772 . . . . 0.0 109.563 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.38 -34.65 59.72 Favored Glycine 0 N--CA 1.512 3.747 0 C-N-CA 124.603 1.097 . . . . 0.0 113.952 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 11.1 tp -59.33 -43.16 89.46 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 CA-C-N 117.67 0.735 . . . . 0.0 112.827 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 5.5 pt -68.85 -34.16 63.07 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.411 0 CA-C-O 121.827 0.822 . . . . 0.0 109.399 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 81.9 mt -73.08 -38.98 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.185 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.56 -46.63 91.83 Favored Glycine 1 N--CA 1.516 4.016 0 CA-C-N 115.606 -0.725 . . . . 0.0 114.374 -177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.13 -37.55 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 CA-C-N 117.506 0.653 . . . . 0.0 110.854 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 70.1 p -66.22 -45.55 80.32 Favored 'General case' 0 N--CA 1.535 3.782 0 CA-C-N 118.354 0.525 . . . . 0.0 110.575 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.24 -31.24 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 C-N-CA 123.964 0.905 . . . . 0.0 110.891 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.32 -47.24 75.93 Favored 'General case' 0 N--CA 1.532 3.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.19 -25.64 67.81 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.571 0.748 . . . . 0.0 112.224 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.53 -37.09 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 C-N-CA 123.526 0.73 . . . . 0.0 109.464 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 46.1 t -55.78 -32.31 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.137 0.575 . . . . 0.0 110.306 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.96 -40.89 91.68 Favored 'General case' 0 N--CA 1.532 3.661 0 C-N-CA 123.017 0.527 . . . . 0.0 109.823 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 34.3 mm -60.62 -44.56 97.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.711 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.84 -39.72 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.258 0 C-N-CA 123.636 0.775 . . . . 0.0 109.855 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.84 87.81 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.676 0.79 . . . . 0.0 112.409 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.82 -34.36 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 O-C-N 121.846 -0.534 . . . . 0.0 110.334 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -63.63 -44.35 94.14 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.15 -37.99 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.9 m -67.26 -30.38 70.25 Favored 'General case' 0 N--CA 1.525 3.286 0 C-N-CA 123.115 0.566 . . . . 0.0 110.911 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -66.67 -35.21 79.61 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.347 0.659 . . . . 0.0 111.237 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 91.8 p -64.83 -33.63 76.46 Favored 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 123.121 0.568 . . . . 0.0 110.94 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 50.7 mt . . . . . 0 N--CA 1.523 3.176 0 C-N-CA 124.022 0.929 . . . . 0.0 111.166 -178.911 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 74.4 p . . . . . 0 N--CA 1.523 3.198 0 CA-C-O 122.042 0.925 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 42.2 mt -60.91 -26.61 67.58 Favored 'General case' 0 N--CA 1.524 3.235 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.952 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 61.9 m -62.99 -26.38 68.82 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.049 0.539 . . . . 0.0 110.069 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.96 -46.51 93.57 Favored Glycine 1 N--CA 1.519 4.23 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.565 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 48.7 pt -70.5 -35.33 61.29 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.141 0 CA-C-N 118.468 1.134 . . . . 0.0 109.85 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.38 -44.68 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 29.8 mm -72.88 -33.31 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.89 -29.08 49.93 Favored Glycine 0 N--CA 1.512 3.733 0 C-N-CA 124.666 1.126 . . . . 0.0 113.175 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.28 -39.25 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 C-N-CA 122.781 0.433 . . . . 0.0 111.199 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 72.9 p -65.91 -45.2 82.84 Favored 'General case' 0 N--CA 1.53 3.547 0 CA-C-O 121.657 0.741 . . . . 0.0 109.987 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 43.3 t -68.56 -31.69 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.976 0 C-N-CA 124.588 1.155 . . . . 0.0 111.676 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.65 77.83 Favored 'General case' 0 N--CA 1.533 3.713 0 O-C-N 121.706 -0.621 . . . . 0.0 112.608 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.39 -50.22 74.48 Favored 'General case' 0 N--CA 1.523 3.189 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.36 -38.11 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 CA-C-N 118.321 0.51 . . . . 0.0 111.402 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 84.2 t -56.75 -35.96 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 O-C-N 122.03 -0.419 . . . . 0.0 111.102 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 52.0 tp -66.32 -44.57 83.01 Favored 'General case' 1 N--CA 1.539 4.01 0 CA-C-N 118.809 0.732 . . . . 0.0 109.685 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.47 -42.45 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.465 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.201 -178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.31 -37.98 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 C-N-CA 123.036 0.534 . . . . 0.0 109.58 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.2 88.65 Favored 'General case' 0 N--CA 1.53 3.574 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 17.4 m -71.42 -34.35 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 O-C-N 121.843 -0.536 . . . . 0.0 110.811 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -64.51 -44.17 91.77 Favored 'General case' 0 N--CA 1.531 3.599 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.74 -37.64 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.1 -27.25 68.79 Favored 'General case' 0 N--CA 1.526 3.363 0 C-N-CA 123.437 0.695 . . . . 0.0 111.182 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -63.17 -34.39 77.52 Favored 'General case' 0 N--CA 1.53 3.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.774 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.8 t -66.1 -36.06 82.17 Favored 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.529 0.732 . . . . 0.0 111.432 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 4.4 tt -61.25 -13.97 22.63 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 124.231 1.012 . . . . 0.0 111.613 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 25.6 mt -86.03 -27.99 24.43 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.166 0.586 . . . . 0.0 109.594 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -102.6 98.1 8.2 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 124.543 1.137 . . . . 0.0 108.193 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? . . . . . 0 N--CA 1.527 3.398 0 C-N-CA 124.911 1.285 . . . . 0.0 108.659 -179.505 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.211 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.1 p -165.99 62.57 0.11 Allowed 'General case' 0 N--CA 1.523 3.18 0 CA-C-O 121.826 0.822 . . . . 0.0 108.923 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.02 -26.97 68.81 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 123.907 0.883 . . . . 0.0 110.19 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 69.2 m -68.37 -26.74 65.73 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 123.408 0.683 . . . . 0.0 109.993 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.7 -46.96 92.6 Favored Glycine 1 N--CA 1.519 4.228 0 C-N-CA 123.719 0.676 . . . . 0.0 113.562 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.7 tp -70.9 -35.1 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 CA-C-N 117.795 0.797 . . . . 0.0 109.869 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.83 -43.91 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 123.67 0.788 . . . . 0.0 111.512 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 18.6 tt -73.17 -33.48 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 119.263 0.938 . . . . 0.0 109.838 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.55 97.76 Favored Glycine 1 N--CA 1.521 4.352 0 C-N-CA 123.354 0.502 . . . . 0.0 114.091 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 p -59.93 -36.67 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.913 0 CA-C-N 117.677 0.739 . . . . 0.0 110.258 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.9 p -55.98 -44.86 78.94 Favored 'General case' 0 N--CA 1.536 3.843 0 CA-C-O 121.318 0.58 . . . . 0.0 111.388 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.88 -39.99 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 C-N-CA 124.073 0.949 . . . . 0.0 111.748 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.77 -46.78 74.42 Favored 'General case' 0 N--CA 1.528 3.434 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.36 -50.46 71.5 Favored 'General case' 0 N--CA 1.517 2.894 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.54 -38.48 81.53 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.094 0 CA-C-N 119.079 0.854 . . . . 0.0 112.614 -177.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.14 -32.12 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 CA-C-N 118.354 0.525 . . . . 0.0 110.227 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.38 -44.49 36.07 Favored 'General case' 0 N--CA 1.526 3.326 0 C-N-CA 122.653 0.381 . . . . 0.0 110.471 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.34 -44.8 89.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.034 0 C-N-CA 122.945 0.498 . . . . 0.0 111.869 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 30.6 m -61.29 -36.43 72.82 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.22 0 CA-C-N 118.94 0.791 . . . . 0.0 110.834 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.57 -31.87 66.58 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.234 0.614 . . . . 0.0 111.443 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.29 -41.87 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 123.027 0.531 . . . . 0.0 111.507 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -60.7 -43.95 97.15 Favored 'General case' 1 N--CA 1.541 4.091 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.68 -37.73 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 80.1 m -67.27 -32.65 73.81 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 122.733 0.413 . . . . 0.0 110.004 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -72.18 -29.44 64.0 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 123.715 0.806 . . . . 0.0 110.562 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -66.4 -21.35 66.22 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 123.145 0.578 . . . . 0.0 111.061 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 58.6 mt -91.55 -14.26 30.62 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 124.509 1.124 . . . . 0.0 111.189 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.1 tp -87.35 -28.3 22.3 Favored 'General case' 1 N--CA 1.541 4.111 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -174.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 48.8 p-90 -66.32 -64.21 0.91 Allowed 'General case' 1 N--CA 1.544 4.271 0 CA-C-N 120.272 1.396 . . . . 0.0 111.157 -177.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 54.72 176.41 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.852 0.861 . . . . 0.0 112.316 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -97.19 169.73 9.6 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 124.541 1.136 . . . . 0.0 108.918 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 50.3 t . . . . . 0 N--CA 1.531 3.604 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.811 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 N--CA 1.529 3.479 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.8 -26.79 68.32 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 124.232 1.013 . . . . 0.0 111.064 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 91.4 p -68.19 -30.81 70.0 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.535 0.734 . . . . 0.0 110.609 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.0 -46.9 57.58 Favored Glycine 0 N--CA 1.516 3.988 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.737 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 8.2 tp -71.29 -41.74 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.4 tt -60.57 -38.71 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.882 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.78 -32.78 41.86 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.101 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.55 -29.41 47.96 Favored Glycine 0 N--CA 1.512 3.717 0 C-N-CA 124.183 0.897 . . . . 0.0 113.923 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 8.6 p -59.76 -38.55 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 CA-C-N 117.661 0.73 . . . . 0.0 110.998 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 67.1 p -65.17 -45.53 84.52 Favored 'General case' 0 N--CA 1.528 3.441 0 CA-C-O 121.456 0.646 . . . . 0.0 110.389 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.38 -32.0 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 C-N-CA 124.307 1.043 . . . . 0.0 110.602 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.21 -45.9 82.89 Favored 'General case' 0 N--CA 1.524 3.273 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.95 -41.81 97.49 Favored 'General case' 0 N--CA 1.519 3.0 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.27 -44.14 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.99 -32.75 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 O-C-N 121.293 -0.88 . . . . 0.0 111.457 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 5.4 tt -67.34 -47.54 70.17 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 122.959 0.503 . . . . 0.0 111.446 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 22.8 pt -69.14 -36.29 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 O-C-N 121.671 -0.643 . . . . 0.0 110.884 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.69 -37.36 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.49 -47.47 81.82 Favored 'General case' 0 N--CA 1.532 3.626 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 30.9 m -71.81 -34.53 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 O-C-N 121.939 -0.476 . . . . 0.0 110.605 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -65.61 -43.71 88.78 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.05 -37.0 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.744 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.73 -33.93 70.79 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.308 0.243 . . . . 0.0 110.986 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -74.29 -15.7 60.96 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 122.894 0.478 . . . . 0.0 111.291 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 20.7 t -63.68 -29.13 70.4 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-O 121.467 0.651 . . . . 0.0 109.743 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 57.2 tp -72.18 -31.48 65.96 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.945 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.538 3.935 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.029 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 98.3 p . . . . . 0 N--CA 1.525 3.288 0 CA-C-O 119.65 -0.214 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.29 -26.9 68.28 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.926 0.89 . . . . 0.0 109.719 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 46.7 t -68.42 -26.17 65.4 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 123.524 0.73 . . . . 0.0 110.808 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.1 -46.34 66.07 Favored Glycine 0 N--CA 1.514 3.852 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.875 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.4 tt -70.72 -38.17 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.867 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 15.4 pt -57.04 -43.15 80.61 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.685 0 CA-C-N 119.584 1.084 . . . . 0.0 111.946 -176.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 6.1 tp -73.01 -32.97 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.17 -45.57 95.06 Favored Glycine 1 N--CA 1.518 4.121 0 C-N-CA 123.869 0.747 . . . . 0.0 113.292 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.65 -36.68 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 O-C-N 121.954 -0.733 . . . . 0.0 109.776 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 37.6 m -60.54 -47.08 87.75 Favored 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.74 -31.39 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 123.621 0.769 . . . . 0.0 111.23 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.13 -34.3 56.14 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.483 0.713 . . . . 0.0 112.801 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.8 -50.79 39.51 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.17 -38.44 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.665 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.48 -32.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 CA-C-N 118.255 0.479 . . . . 0.0 110.99 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.96 -42.47 99.16 Favored 'General case' 0 N--CA 1.532 3.641 0 O-C-N 122.198 -0.314 . . . . 0.0 110.428 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -57.22 -36.63 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.629 0 C-N-CA 123.317 0.647 . . . . 0.0 110.636 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.52 -37.81 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 123.444 0.697 . . . . 0.0 109.847 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.97 76.76 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.107 0.563 . . . . 0.0 111.219 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.61 -34.76 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.35 0.66 . . . . 0.0 110.15 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -63.81 -43.8 95.18 Favored 'General case' 0 N--CA 1.531 3.596 0 C-N-CA 123.132 0.573 . . . . 0.0 112.243 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 6.8 p -68.87 -37.46 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.675 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 82.2 m -58.84 -27.77 65.43 Favored 'General case' 0 N--CA 1.531 3.575 0 C-N-CA 122.624 0.37 . . . . 0.0 110.833 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -70.87 -22.05 62.34 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.102 0.561 . . . . 0.0 110.942 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 68.6 p -63.81 -26.49 68.65 Favored 'General case' 0 N--CA 1.534 3.742 0 C-N-CA 123.283 0.633 . . . . 0.0 111.552 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.78 -14.46 21.68 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 124.12 0.968 . . . . 0.0 111.43 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.29 8.04 26.0 Favored 'General case' 0 N--CA 1.538 3.971 0 C-N-CA 123.456 0.702 . . . . 0.0 109.243 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -83.57 26.25 0.69 Allowed 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 124.158 0.983 . . . . 0.0 109.493 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -62.41 -46.26 89.41 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 123.838 0.855 . . . . 0.0 110.863 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -69.13 145.62 53.2 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 123.572 0.749 . . . . 0.0 110.325 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.528 3.448 0 C-N-CA 124.929 1.292 . . . . 0.0 108.205 179.888 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.519 2.98 0 N-CA-C 111.587 0.218 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -24.91 67.61 Favored 'General case' 0 N--CA 1.527 3.385 0 C-N-CA 124.765 1.226 . . . . 0.0 110.968 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 90.3 p -57.19 -25.53 59.15 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 124.133 0.973 . . . . 0.0 111.96 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.63 83.15 Favored Glycine 0 N--CA 1.514 3.858 0 N-CA-C 115.381 0.912 . . . . 0.0 115.381 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 13.0 tt -59.38 -35.07 56.45 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.512 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 16.8 tt -55.69 -31.19 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.874 0 C-N-CA 123.862 0.865 . . . . 0.0 112.918 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.08 -33.57 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.13 -45.22 96.5 Favored Glycine 1 N--CA 1.522 4.419 0 C-N-CA 123.661 0.648 . . . . 0.0 114.298 -177.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -59.72 -36.08 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.962 0 CA-C-N 117.636 0.718 . . . . 0.0 110.231 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 24.5 p -55.9 -45.05 78.76 Favored 'General case' 0 N--CA 1.536 3.847 0 CA-C-O 120.988 0.423 . . . . 0.0 111.408 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.9 t -58.11 -40.64 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 124.15 0.98 . . . . 0.0 112.289 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.51 -45.93 66.46 Favored 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.57 -42.12 71.49 Favored 'General case' 0 N--CA 1.52 3.026 0 C-N-CA 122.691 0.396 . . . . 0.0 111.489 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.01 -43.6 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.156 0 C-N-CA 123.221 0.609 . . . . 0.0 112.42 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.76 -32.85 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.786 0 CA-C-N 118.51 0.596 . . . . 0.0 111.845 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 51.6 tp -66.0 -41.88 90.46 Favored 'General case' 0 N--CA 1.53 3.546 0 CA-C-N 118.034 0.379 . . . . 0.0 110.609 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 93.1 mt -57.48 -37.43 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 C-N-CA 122.782 0.433 . . . . 0.0 110.527 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.92 -44.12 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 122.847 0.459 . . . . 0.0 110.056 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -45.03 87.33 Favored 'General case' 0 N--CA 1.527 3.417 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.72 -33.89 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.685 0 O-C-N 121.583 -0.698 . . . . 0.0 109.684 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -63.81 -43.39 96.4 Favored 'General case' 0 N--CA 1.529 3.502 0 C-N-CA 123.255 0.622 . . . . 0.0 112.489 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.56 -36.82 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 CA-C-N 118.704 0.684 . . . . 0.0 109.645 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 73.6 m -57.9 -27.33 63.22 Favored 'General case' 0 N--CA 1.528 3.451 0 C-N-CA 122.8 0.44 . . . . 0.0 111.017 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -63.76 -27.67 69.35 Favored 'General case' 0 N--CA 1.532 3.657 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 53.2 p -64.19 -34.43 78.07 Favored 'General case' 0 N--CA 1.527 3.405 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -27.55 67.72 Favored 'General case' 0 N--CA 1.526 3.353 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.591 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 38.9 mt -86.82 -28.11 23.12 Favored 'General case' 0 N--CA 1.533 3.724 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -77.9 101.74 6.96 Favored 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.4 159.85 10.79 Favored 'General case' 0 N--CA 1.519 3.006 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 63.4 tttp . . . . . 0 N--CA 1.522 3.147 0 C-N-CA 123.949 0.9 . . . . 0.0 110.085 -179.459 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.52 3.044 0 N-CA-C 111.332 0.123 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.1 -26.61 68.29 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 124.318 1.047 . . . . 0.0 110.403 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 93.1 p -63.08 -25.73 68.5 Favored 'General case' 0 N--CA 1.522 3.155 0 C-N-CA 123.668 0.787 . . . . 0.0 111.134 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.53 -46.72 67.16 Favored Glycine 0 N--CA 1.516 3.973 0 CA-C-N 116.061 -0.518 . . . . 0.0 114.28 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.46 -40.2 72.04 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.07 0 CA-C-N 118.179 0.989 . . . . 0.0 113.659 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 18.0 pt -58.94 -40.53 80.62 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.453 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -175.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.2 tt -72.08 -32.33 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.811 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.2 -28.87 43.61 Favored Glycine 0 N--CA 1.515 3.954 0 C-N-CA 123.94 0.781 . . . . 0.0 113.206 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.34 -37.13 67.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.043 0 CA-C-N 117.501 0.651 . . . . 0.0 110.83 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 62.0 p -59.28 -45.19 91.92 Favored 'General case' 0 N--CA 1.527 3.421 0 C-N-CA 123.338 0.655 . . . . 0.0 111.801 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.69 -35.22 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.341 0 C-N-CA 123.607 0.763 . . . . 0.0 109.915 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.3 -34.23 77.66 Favored 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 123.497 0.719 . . . . 0.0 110.883 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.53 91.26 Favored 'General case' 0 N--CA 1.519 3.021 0 C-N-CA 123.135 0.574 . . . . 0.0 111.614 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.72 -52.8 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.612 0 C-N-CA 123.087 0.555 . . . . 0.0 111.851 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.96 -32.09 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 C-N-CA 122.717 0.407 . . . . 0.0 111.026 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.71 -35.28 79.24 Favored 'General case' 1 N--CA 1.541 4.101 0 C-N-CA 122.815 0.446 . . . . 0.0 110.617 -179.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 81.3 mt -69.28 -35.68 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.16 -36.21 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 C-N-CA 123.257 0.623 . . . . 0.0 109.692 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.35 -42.38 81.88 Favored 'General case' 0 N--CA 1.526 3.367 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 6.3 m -71.73 -34.49 52.09 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.047 0 CA-C-N 119.063 0.847 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -62.53 -43.76 98.03 Favored 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 123.334 0.654 . . . . 0.0 112.383 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 6.9 p -68.72 -37.43 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.58 -27.75 69.17 Favored 'General case' 0 N--CA 1.528 3.475 0 C-N-CA 123.02 0.528 . . . . 0.0 110.627 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -74.26 -18.4 60.73 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.467 0.707 . . . . 0.0 110.593 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 26.7 t -63.5 -46.37 86.43 Favored 'General case' 0 N--CA 1.529 3.494 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.53 3.568 0 C-N-CA 123.506 0.722 . . . . 0.0 112.584 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.52 3.049 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.1 -28.69 69.62 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.894 0.878 . . . . 0.0 109.617 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 96.2 p -68.39 -35.52 77.8 Favored 'General case' 0 N--CA 1.521 3.12 0 C-N-CA 123.415 0.686 . . . . 0.0 109.988 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.27 -47.05 54.61 Favored Glycine 0 N--CA 1.512 3.736 0 CA-C-N 115.03 -0.986 . . . . 0.0 114.646 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.0 -41.85 68.28 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.201 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 20.2 tt -56.87 -32.45 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -31.86 43.96 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.666 0 CA-C-N 120.291 1.405 . . . . 0.0 109.038 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.94 -36.18 60.03 Favored Glycine 0 N--CA 1.51 3.617 0 C-N-CA 124.172 0.892 . . . . 0.0 114.646 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.92 -38.24 75.6 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.17 0 CA-C-N 118.508 1.154 . . . . 0.0 111.015 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 29.9 p -66.41 -45.99 78.07 Favored 'General case' 0 N--CA 1.528 3.468 0 CA-C-O 121.617 0.722 . . . . 0.0 110.334 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 58.0 t -69.48 -33.9 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.006 0 C-N-CA 124.714 1.205 . . . . 0.0 110.535 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.16 68.97 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.51 91.92 Favored 'General case' 0 N--CA 1.518 2.928 0 C-N-CA 123.3 0.64 . . . . 0.0 111.275 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 43.4 t -66.75 -48.91 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.314 0 C-N-CA 123.599 0.76 . . . . 0.0 110.556 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.51 -33.83 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.552 0 C-N-CA 123.278 0.631 . . . . 0.0 110.094 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 33.7 tp -67.21 -34.16 76.9 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.247 0.619 . . . . 0.0 110.339 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 39.4 mt -64.66 -41.1 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.893 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.56 -37.89 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 C-N-CA 122.975 0.51 . . . . 0.0 109.825 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.43 71.01 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.695 0.798 . . . . 0.0 112.278 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.38 -33.97 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 C-N-CA 122.814 0.446 . . . . 0.0 110.244 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -65.98 -44.21 85.58 Favored 'General case' 0 N--CA 1.531 3.588 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.87 -37.73 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 O-C-N 122.232 -0.292 . . . . 0.0 110.55 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 8.3 p -58.74 -27.38 64.88 Favored 'General case' 0 N--CA 1.536 3.845 0 O-C-N 122.218 -0.301 . . . . 0.0 111.248 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -59.88 -18.68 46.36 Favored 'General case' 0 N--CA 1.531 3.62 0 C-N-CA 123.279 0.632 . . . . 0.0 111.203 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 51.5 m -70.34 -30.57 67.57 Favored 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.544 0.738 . . . . 0.0 110.362 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 64.4 mt -60.49 -13.12 11.93 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.398 1.079 . . . . 0.0 111.752 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.57 10.5 13.0 Favored 'General case' 0 N--CA 1.532 3.635 0 C-N-CA 123.196 0.598 . . . . 0.0 110.067 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 59.64 116.24 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 124.601 1.161 . . . . 0.0 112.257 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 mttp . . . . . 0 N--CA 1.526 3.334 0 C-N-CA 125.099 1.36 . . . . 0.0 107.868 179.156 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.181 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.3 p -97.83 41.92 1.11 Allowed 'General case' 0 N--CA 1.526 3.354 0 C-N-CA 124.685 1.194 . . . . 0.0 109.38 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 54.2 tp -59.98 -26.41 66.02 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 124.264 1.026 . . . . 0.0 110.978 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 71.2 m -57.43 -26.15 60.73 Favored 'General case' 0 N--CA 1.526 3.327 0 C-N-CA 123.735 0.814 . . . . 0.0 111.62 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.35 92.66 Favored Glycine 0 N--CA 1.509 3.566 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.91 -46.22 94.2 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.483 0 CA-C-N 118.772 1.286 . . . . 0.0 112.967 -175.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -67.66 -32.13 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.384 0.674 . . . . 0.0 110.323 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 90.4 mt -66.06 -34.06 67.72 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.013 0 C-N-CA 123.054 0.542 . . . . 0.0 109.848 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.69 -29.81 64.79 Favored Glycine 1 N--CA 1.517 4.055 0 CA-C-O 119.831 -0.427 . . . . 0.0 113.675 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.5 m -61.77 -37.11 77.3 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.29 0 CA-C-N 117.764 0.782 . . . . 0.0 110.907 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.6 p -55.51 -43.39 75.62 Favored 'General case' 0 N--CA 1.524 3.234 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.159 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.96 -45.99 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.073 0 C-N-CA 123.824 0.85 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.46 -45.13 65.95 Favored 'General case' 0 N--CA 1.527 3.403 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.32 90.22 Favored 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 122.953 0.501 . . . . 0.0 111.769 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.2 t -66.66 -39.78 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 122.91 0.484 . . . . 0.0 110.693 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.92 -39.78 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.585 0 C-N-CA 122.863 0.465 . . . . 0.0 110.837 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.26 -37.22 84.63 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 117.897 0.317 . . . . 0.0 111.519 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 99.3 mt -64.27 -42.59 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 C-N-CA 123.308 0.643 . . . . 0.0 110.028 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.76 -41.74 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.25 -45.5 87.68 Favored 'General case' 0 N--CA 1.525 3.309 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.73 -34.31 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 O-C-N 121.723 -0.611 . . . . 0.0 110.08 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.42 -44.24 95.96 Favored 'General case' 0 N--CA 1.529 3.516 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.7 m -68.65 -37.42 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 CA-C-O 121.212 0.53 . . . . 0.0 109.683 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 70.9 m -63.39 -46.08 88.1 Favored 'General case' 0 N--CA 1.523 3.178 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.26 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.67 -19.02 35.74 Favored 'General case' 0 N--CA 1.536 3.857 0 C-N-CA 122.744 0.418 . . . . 0.0 112.007 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 52.0 m -74.59 -40.17 61.76 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 51.0 mt -68.71 -29.16 67.54 Favored 'General case' 0 N--CA 1.524 3.264 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.511 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.04 10.58 16.1 Favored 'General case' 1 N--CA 1.545 4.324 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 54.6 t90 -139.81 70.78 1.37 Allowed 'General case' 0 N--CA 1.53 3.557 0 C-N-CA 124.176 0.99 . . . . 0.0 108.875 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -133.74 -18.56 2.13 Favored 'General case' 0 N--CA 1.534 3.765 0 C-N-CA 125.108 1.363 . . . . 0.0 109.139 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -163.68 86.81 0.51 Allowed 'General case' 0 N--CA 1.525 3.283 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.528 3.459 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.57 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.524 3.228 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 50.2 mt -65.15 -26.64 68.26 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 124.262 1.025 . . . . 0.0 110.098 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.1 m -59.43 -37.1 77.21 Favored 'General case' 0 N--CA 1.525 3.325 0 C-N-CA 123.14 0.576 . . . . 0.0 110.662 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.33 -36.22 92.76 Favored Glycine 1 N--CA 1.522 4.422 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.07 -40.96 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 C-N-CA 124.27 1.028 . . . . 0.0 109.088 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 91.2 mt -67.71 -39.44 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 C-N-CA 124.674 1.189 . . . . 0.0 109.046 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 87.8 mt -71.15 -32.07 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.77 -29.27 41.13 Favored Glycine 0 N--CA 1.515 3.946 0 C-N-CA 123.74 0.686 . . . . 0.0 113.218 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 4.0 m -59.85 -37.36 71.4 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 117.79 0.795 . . . . 0.0 110.475 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.9 p -62.27 -45.57 92.68 Favored 'General case' 0 N--CA 1.528 3.428 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.382 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.13 -35.48 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.194 0 C-N-CA 124.149 0.98 . . . . 0.0 110.485 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.01 -34.55 68.29 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.358 0.663 . . . . 0.0 111.851 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.2 -42.08 72.82 Favored 'General case' 0 N--CA 1.516 2.864 0 C-N-CA 123.205 0.602 . . . . 0.0 111.403 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.2 t -58.99 -47.0 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 C-N-CA 123.565 0.746 . . . . 0.0 112.19 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.9 m -67.1 -32.28 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.468 0 C-N-CA 122.959 0.504 . . . . 0.0 111.635 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.82 -45.08 45.76 Favored 'General case' 0 N--CA 1.524 3.257 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.7 pt -68.86 -36.75 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.904 0 CA-C-N 118.432 0.56 . . . . 0.0 112.468 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.21 -36.96 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 O-C-N 121.532 -0.73 . . . . 0.0 110.151 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.62 -44.98 85.93 Favored 'General case' 0 N--CA 1.526 3.366 0 C-N-CA 123.56 0.744 . . . . 0.0 112.977 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 13.7 m -71.19 -34.19 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 O-C-N 121.737 -0.602 . . . . 0.0 110.543 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -63.07 -44.49 95.65 Favored 'General case' 0 N--CA 1.531 3.612 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.06 -37.54 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.615 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.94 -29.22 66.96 Favored 'General case' 0 N--CA 1.527 3.411 0 C-N-CA 122.714 0.406 . . . . 0.0 111.424 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -64.19 -15.93 60.91 Favored 'General case' 1 N--CA 1.539 4.009 0 CA-C-N 118.048 0.386 . . . . 0.0 111.075 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 41.5 m -64.64 -34.34 78.06 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 51.1 tp -70.08 -28.19 65.22 Favored 'General case' 0 N--CA 1.526 3.335 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.139 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.538 3.934 0 C-N-CA 123.884 0.874 . . . . 0.0 109.582 -179.314 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 N--CA 1.521 3.111 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -64.58 -26.82 68.57 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 124.078 0.951 . . . . 0.0 109.77 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 42.7 t -61.29 -38.66 87.59 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.931 0.892 . . . . 0.0 110.951 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.33 -41.96 76.48 Favored Glycine 0 N--CA 1.513 3.806 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.428 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 61.7 mt -70.62 -45.81 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 C-N-CA 124.498 1.119 . . . . 0.0 113.255 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -56.63 -31.96 36.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.161 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.5 pp -66.98 -31.9 55.57 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.196 0 CA-C-N 119.336 0.971 . . . . 0.0 109.497 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.84 -36.15 59.5 Favored Glycine 0 N--CA 1.51 3.615 0 CA-C-N 115.614 -0.721 . . . . 0.0 114.788 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.46 -45.45 92.83 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 CA-C-N 118.279 1.04 . . . . 0.0 113.104 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 1.3 t -65.03 -45.25 86.25 Favored 'General case' 0 N--CA 1.538 3.945 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.7 -31.14 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.295 0 C-N-CA 122.987 0.515 . . . . 0.0 111.262 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.64 93.43 Favored 'General case' 0 N--CA 1.528 3.471 0 O-C-N 121.803 -0.56 . . . . 0.0 111.987 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.95 -48.03 81.14 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.81 -38.4 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.744 0 CA-C-N 118.196 0.453 . . . . 0.0 111.103 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.26 -40.94 86.01 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.009 0 CA-C-N 118.403 0.547 . . . . 0.0 110.356 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -34.34 77.69 Favored 'General case' 1 N--CA 1.54 4.055 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 tp -54.8 -36.94 38.89 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.401 0 C-N-CA 123.401 0.681 . . . . 0.0 110.483 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.65 -40.96 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 C-N-CA 123.416 0.687 . . . . 0.0 110.545 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.83 -35.61 71.13 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.42 0.688 . . . . 0.0 111.576 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -71.77 -36.61 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.298 0 C-N-CA 123.492 0.717 . . . . 0.0 111.728 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.93 -43.86 64.57 Favored 'General case' 0 N--CA 1.531 3.613 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.42 -37.57 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.087 0.555 . . . . 0.0 110.983 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 15.0 p -62.21 -27.63 69.12 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 122.353 0.261 . . . . 0.0 111.394 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.72 -40.38 84.25 Favored 'General case' 0 N--CA 1.53 3.528 0 CA-C-O 121.007 0.432 . . . . 0.0 110.436 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.7 t -64.03 -22.45 66.94 Favored 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 123.791 0.836 . . . . 0.0 112.467 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.4 tp -67.41 -17.44 64.72 Favored 'General case' 0 N--CA 1.529 3.508 0 C-N-CA 123.345 0.658 . . . . 0.0 110.819 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.35 -28.49 22.18 Favored 'General case' 0 N--CA 1.531 3.584 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -95.72 96.13 8.79 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 124.447 1.099 . . . . 0.0 108.993 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -169.82 9.77 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.382 0 C-N-CA 123.606 0.763 . . . . 0.0 110.511 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.18 137.57 54.95 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.382 0.673 . . . . 0.0 110.093 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.53 3.565 0 C-N-CA 125.176 1.39 . . . . 0.0 108.96 -179.359 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 98.9 p . . . . . 0 N--CA 1.523 3.222 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.18 -26.83 68.32 Favored 'General case' 0 N--CA 1.528 3.475 0 C-N-CA 123.962 0.905 . . . . 0.0 109.099 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 69.4 m -57.73 -26.15 61.39 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 124.105 0.962 . . . . 0.0 110.907 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.41 -35.28 84.51 Favored Glycine 1 N--CA 1.517 4.072 0 C-N-CA 123.657 0.646 . . . . 0.0 113.102 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -46.98 94.94 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 CA-C-N 117.084 0.442 . . . . 0.0 111.89 -177.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.8 -31.76 55.15 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.556 0 C-N-CA 124.038 0.935 . . . . 0.0 109.811 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.29 -33.55 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.29 -33.02 85.6 Favored Glycine 1 N--CA 1.52 4.289 0 C-N-CA 123.69 0.662 . . . . 0.0 112.159 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.23 -43.52 93.5 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.052 0 C-N-CA 124.194 0.997 . . . . 0.0 109.657 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 27.3 p -56.85 -45.31 82.52 Favored 'General case' 0 N--CA 1.525 3.313 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.373 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 49.9 t -67.75 -41.27 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.211 0 C-N-CA 124.251 1.021 . . . . 0.0 111.312 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.3 -44.74 65.2 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.58 81.13 Favored 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 123.254 0.621 . . . . 0.0 111.616 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 t -53.72 -39.49 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.927 0 C-N-CA 123.25 0.62 . . . . 0.0 111.857 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.45 -38.48 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 C-N-CA 122.768 0.427 . . . . 0.0 110.121 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 73.2 mt -70.94 -34.57 71.62 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 122.958 0.503 . . . . 0.0 110.223 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 20.0 mm -60.41 -50.52 80.01 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 C-N-CA 123.532 0.733 . . . . 0.0 110.951 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 31.6 m -66.62 -36.99 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 O-C-N 121.816 -0.553 . . . . 0.0 110.239 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.38 85.92 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.636 0.775 . . . . 0.0 112.594 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 34.4 m -71.98 -34.53 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.696 0 O-C-N 121.823 -0.548 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.58 -43.85 95.77 Favored 'General case' 0 N--CA 1.53 3.525 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.37 -37.22 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 74.3 m -58.76 -27.07 64.61 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.076 0.551 . . . . 0.0 111.845 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.54 -33.21 73.44 Favored 'General case' 0 N--CA 1.537 3.887 0 CA-C-N 118.343 0.519 . . . . 0.0 110.79 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 35.5 t -67.07 -27.86 67.72 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.155 0.582 . . . . 0.0 110.217 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 51.4 tp -89.77 -13.9 35.72 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 124.947 1.299 . . . . 0.0 110.378 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 39.7 tp -85.67 -1.69 57.42 Favored 'General case' 1 N--CA 1.545 4.287 0 CA-C-O 121.046 0.45 . . . . 0.0 109.999 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -139.8 -159.56 0.97 Allowed 'General case' 0 N--CA 1.522 3.125 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 64.27 161.83 0.12 Allowed 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 123.762 0.825 . . . . 0.0 110.283 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? . . . . . 0 N--CA 1.528 3.427 0 C-N-CA 124.218 1.007 . . . . 0.0 110.915 -179.87 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.519 2.978 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 58.3 tp -64.24 -27.04 68.78 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 124.152 0.981 . . . . 0.0 110.216 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 53.8 m -62.02 -25.91 67.93 Favored 'General case' 0 N--CA 1.518 2.955 0 C-N-CA 124.413 1.085 . . . . 0.0 110.681 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.85 -46.72 71.74 Favored Glycine 0 N--CA 1.51 3.62 0 CA-C-N 115.22 -0.9 . . . . 0.0 114.684 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 29.6 pt -71.04 -38.81 73.36 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 CA-C-N 118.826 1.313 . . . . 0.0 113.961 -177.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.7 tp -62.88 -32.52 56.22 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 C-N-CA 123.239 0.616 . . . . 0.0 112.497 -176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.8 -34.03 45.64 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.18 -45.15 83.48 Favored Glycine 0 N--CA 1.515 3.921 0 C-N-CA 124.8 1.191 . . . . 0.0 115.155 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.34 -37.41 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 CA-C-N 117.381 0.591 . . . . 0.0 110.779 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 35.6 p -66.35 -47.27 73.96 Favored 'General case' 0 N--CA 1.532 3.644 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.63 -31.88 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 C-N-CA 123.301 0.64 . . . . 0.0 112.269 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.77 -47.26 70.89 Favored 'General case' 0 N--CA 1.532 3.633 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.59 97.47 Favored 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 123.475 0.71 . . . . 0.0 111.679 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.47 -49.03 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.651 0.78 . . . . 0.0 111.989 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.84 -32.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 C-N-CA 123.321 0.648 . . . . 0.0 110.539 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.33 -39.93 94.88 Favored 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 123.124 0.57 . . . . 0.0 110.143 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.34 -37.7 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 C-N-CA 122.927 0.491 . . . . 0.0 110.426 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.15 -37.85 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 C-N-CA 123.09 0.556 . . . . 0.0 110.28 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.41 -32.27 68.49 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.339 0.655 . . . . 0.0 111.611 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.57 -43.75 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.458 0 C-N-CA 123.299 0.64 . . . . 0.0 111.659 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -62.19 -43.49 98.72 Favored 'General case' 1 N--CA 1.54 4.055 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.14 -38.38 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 95.4 m -67.68 -40.1 84.42 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 122.831 0.452 . . . . 0.0 110.449 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -72.72 -31.16 64.77 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 123.473 0.709 . . . . 0.0 110.454 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 46.2 t -64.44 -34.28 77.82 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.451 0.7 . . . . 0.0 110.765 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.522 3.151 0 C-N-CA 124.358 1.063 . . . . 0.0 109.747 -179.933 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.521 3.124 0 CA-C-O 120.546 0.212 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 44.7 mt -54.78 -25.79 30.31 Favored 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 124.885 1.274 . . . . 0.0 111.437 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 54.1 m -57.69 -36.42 71.94 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.583 0.753 . . . . 0.0 111.31 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.72 -39.52 86.03 Favored Glycine 1 N--CA 1.52 4.259 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.533 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.54 -46.27 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.895 0 C-N-CA 124.181 0.992 . . . . 0.0 110.993 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -32.17 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.983 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 85.1 mt -73.3 -40.36 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.93 95.51 Favored Glycine 0 N--CA 1.512 3.748 0 CA-C-N 115.227 -0.897 . . . . 0.0 114.8 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.5 -37.08 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 CA-C-N 117.923 0.862 . . . . 0.0 111.448 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 68.5 p -65.93 -46.5 77.99 Favored 'General case' 0 N--CA 1.533 3.695 0 CA-C-O 120.931 0.396 . . . . 0.0 110.715 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.76 -35.45 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.22 0 C-N-CA 124.051 0.94 . . . . 0.0 110.508 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.12 67.41 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.5 -34.53 69.18 Favored 'General case' 0 N--CA 1.521 3.077 0 C-N-CA 123.142 0.577 . . . . 0.0 112.017 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.42 -39.06 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.316 0 C-N-CA 123.048 0.539 . . . . 0.0 110.653 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.72 -41.32 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 123.427 0.691 . . . . 0.0 111.485 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.22 -35.69 77.9 Favored 'General case' 1 N--CA 1.54 4.026 0 C-N-CA 122.594 0.358 . . . . 0.0 110.743 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 68.7 mt -69.26 -40.9 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 98.4 t -66.74 -37.97 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.465 0 C-N-CA 123.335 0.654 . . . . 0.0 109.442 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.08 -47.66 82.53 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.727 0.811 . . . . 0.0 112.696 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 25.6 m -71.9 -34.51 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 O-C-N 121.993 -0.442 . . . . 0.0 110.195 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -63.86 -44.13 94.02 Favored 'General case' 0 N--CA 1.527 3.382 0 C-N-CA 123.053 0.541 . . . . 0.0 112.334 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.45 -37.7 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 86.4 m -62.77 -27.95 69.64 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 122.92 0.488 . . . . 0.0 110.129 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -69.57 -16.86 63.49 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.173 0.589 . . . . 0.0 110.62 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 19.5 m -68.8 -28.69 66.99 Favored 'General case' 0 N--CA 1.53 3.565 0 C-N-CA 123.062 0.545 . . . . 0.0 110.232 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.22 -23.51 66.44 Favored 'General case' 0 N--CA 1.525 3.289 0 C-N-CA 123.727 0.811 . . . . 0.0 110.715 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 8.2 mp -87.47 -26.16 23.37 Favored 'General case' 0 N--CA 1.534 3.732 0 C-N-CA 123.685 0.794 . . . . 0.0 109.215 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -73.64 92.52 1.97 Allowed 'General case' 0 N--CA 1.526 3.359 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 21.8 pttp . . . . . 0 N--CA 1.518 2.929 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.771 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 CA--C 1.574 1.888 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -78.65 145.66 20.68 Favored 'Trans proline' 0 N--CA 1.534 3.879 0 C-N-CA 122.359 2.04 . . . . 0.0 110.091 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 171.32 -39.93 0.18 Allowed Glycine 1 N--CA 1.517 4.073 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 27.4 t 57.26 55.1 6.13 Favored 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.021 0.928 . . . . 0.0 111.942 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.84 -26.87 68.52 Favored 'General case' 0 N--CA 1.525 3.283 0 C-N-CA 123.989 0.915 . . . . 0.0 110.547 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.4 m -61.71 -26.44 68.04 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 123.498 0.719 . . . . 0.0 110.237 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.9 -35.43 63.55 Favored Glycine 0 N--CA 1.502 3.035 0 C-N-CA 125.108 1.337 . . . . 0.0 115.354 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 16.9 pt -58.0 -33.73 47.03 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.34 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.3 pp -55.71 -36.41 42.69 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.002 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -174.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 5.2 tp -73.49 -38.43 52.69 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.696 0 CA-C-N 119.472 1.033 . . . . 0.0 109.039 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.31 -45.36 88.76 Favored Glycine 1 N--CA 1.522 4.389 0 N-CA-C 114.891 0.716 . . . . 0.0 114.891 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.93 -36.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.971 0 CA-C-N 117.503 0.651 . . . . 0.0 110.724 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.7 p -58.92 -40.61 85.08 Favored 'General case' 0 N--CA 1.535 3.785 0 CA-C-O 121.082 0.467 . . . . 0.0 111.799 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.74 -39.31 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 123.753 0.821 . . . . 0.0 111.877 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.08 79.6 Favored 'General case' 0 N--CA 1.529 3.477 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.38 -50.02 56.0 Favored 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 m -63.75 -38.58 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.87 -32.86 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 CA-C-N 118.848 0.749 . . . . 0.0 110.723 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 5.9 tt -65.08 -37.88 88.95 Favored 'General case' 0 N--CA 1.536 3.829 0 CA-C-N 117.878 0.308 . . . . 0.0 110.708 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.8 mt -61.98 -36.67 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.84 0 C-N-CA 123.079 0.552 . . . . 0.0 110.351 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.21 -40.35 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.68 0 C-N-CA 122.968 0.507 . . . . 0.0 110.07 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.8 -32.59 67.71 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.191 0.596 . . . . 0.0 111.528 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.9 t -68.19 -37.96 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 C-N-CA 123.141 0.577 . . . . 0.0 109.87 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -70.1 -34.78 73.57 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.403 0.681 . . . . 0.0 110.086 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.02 -38.13 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 C-N-CA 123.968 0.907 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 79.8 m -60.07 -38.53 83.13 Favored 'General case' 0 N--CA 1.527 3.379 0 CA-C-O 121.195 0.522 . . . . 0.0 109.748 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -74.39 -37.8 63.32 Favored 'General case' 0 N--CA 1.519 2.998 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.208 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.0 p -63.76 -46.31 85.84 Favored 'General case' 0 N--CA 1.531 3.615 0 CA-C-O 121.434 0.635 . . . . 0.0 109.595 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.49 -19.35 62.94 Favored 'General case' 0 N--CA 1.53 3.561 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.563 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.7 tp -87.09 -28.21 22.66 Favored 'General case' 1 N--CA 1.541 4.115 0 CA-C-N 119.17 0.895 . . . . 0.0 109.11 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.8 m0 -78.68 107.74 11.59 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -168.0 88.99 0.27 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 11.6 tptp 71.92 -164.21 0.13 Allowed 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 124.052 0.941 . . . . 0.0 109.135 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.51 138.03 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 C-N-CA 124.935 1.294 . . . . 0.0 107.69 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -100.29 102.0 16.75 Favored Pre-proline 0 N--CA 1.53 3.568 0 C-N-CA 125.017 1.327 . . . . 0.0 107.459 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo . . . . . 1 N--CA 1.536 4.014 0 C-N-CA 122.432 2.088 . . . . 0.0 110.788 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 CA--C 1.572 1.816 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.16 -17.1 15.28 Favored 'Trans proline' 1 N--CA 1.536 4.029 0 C-N-CA 122.434 2.089 . . . . 0.0 110.911 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 63.96 -169.54 21.52 Favored Glycine 1 N--CA 1.519 4.21 0 C-N-CA 123.701 0.667 . . . . 0.0 112.211 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 41.9 t -167.53 5.92 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.955 0.902 . . . . 0.0 110.45 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.09 -36.44 84.32 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 124.299 1.04 . . . . 0.0 109.741 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.6 t -57.38 -25.64 59.81 Favored 'General case' 0 N--CA 1.525 3.316 0 C-N-CA 123.612 0.765 . . . . 0.0 110.907 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.44 -34.48 59.79 Favored Glycine 0 N--CA 1.512 3.752 0 C-N-CA 124.948 1.261 . . . . 0.0 114.544 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 17.3 pt -59.39 -34.8 55.43 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -176.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.21 -47.37 80.96 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.333 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.6 tt -72.48 -32.95 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.55 -29.32 47.68 Favored Glycine 0 N--CA 1.515 3.906 0 C-N-CA 123.444 0.545 . . . . 0.0 113.181 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 m -60.0 -37.38 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 CA-C-N 117.551 0.676 . . . . 0.0 111.8 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 1.3 t -61.05 -39.06 88.41 Favored 'General case' 1 N--CA 1.54 4.063 0 CA-C-O 120.825 0.345 . . . . 0.0 111.539 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 47.4 t -60.99 -31.5 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 123.76 0.824 . . . . 0.0 110.517 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.19 77.83 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 123.06 0.544 . . . . 0.0 111.316 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.69 -50.2 58.84 Favored 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.22 -38.56 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.726 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 27.0 m -65.36 -32.01 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 CA-C-N 118.584 0.629 . . . . 0.0 111.394 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 54.1 mt -66.73 -34.57 78.13 Favored 'General case' 0 N--CA 1.533 3.701 0 O-C-N 122.026 -0.421 . . . . 0.0 111.091 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 59.7 mt -61.35 -49.65 83.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.049 0 CA-C-N 118.066 0.394 . . . . 0.0 111.595 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.65 -37.01 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.71 0 O-C-N 121.902 -0.499 . . . . 0.0 110.099 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.55 -47.15 86.66 Favored 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 123.667 0.787 . . . . 0.0 112.603 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.69 -34.38 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.615 0 O-C-N 121.842 -0.536 . . . . 0.0 110.527 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -63.34 -44.36 95.11 Favored 'General case' 0 N--CA 1.528 3.441 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.92 -37.76 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.3 m -67.02 -32.85 74.34 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 122.988 0.515 . . . . 0.0 110.478 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -66.96 -32.26 73.38 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 123.498 0.719 . . . . 0.0 111.054 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 50.6 m -63.82 -29.34 70.55 Favored 'General case' 0 N--CA 1.528 3.454 0 C-N-CA 123.299 0.639 . . . . 0.0 111.244 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.27 -27.35 68.98 Favored 'General case' 0 N--CA 1.528 3.448 0 C-N-CA 123.45 0.7 . . . . 0.0 110.952 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -87.81 -3.4 58.94 Favored 'General case' 0 N--CA 1.538 3.944 0 C-N-CA 123.79 0.836 . . . . 0.0 109.893 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -155.36 67.56 0.65 Allowed 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.858 0.863 . . . . 0.0 108.934 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.31 87.41 2.0 Allowed 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -70.66 67.66 0.37 Allowed 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 123.821 0.848 . . . . 0.0 111.276 -177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.08 133.05 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 8.5 mp -94.63 145.07 28.97 Favored Pre-proline 0 N--CA 1.532 3.641 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 1 N--CA 1.538 4.108 0 C-N-CA 122.028 1.819 . . . . 0.0 110.627 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 55.8 mtt . . . . . 0 CA--C 1.581 2.162 0 CA-C-O 117.776 -1.106 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.81 -23.32 20.3 Favored 'Trans proline' 1 N--CA 1.548 4.701 0 CA-C-N 122.26 1.843 . . . . 0.0 113.211 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 179.49 -78.31 0.06 OUTLIER Glycine 1 N--CA 1.52 4.297 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 49.8 m 56.22 48.48 17.22 Favored 'General case' 0 N--CA 1.52 3.074 0 C-N-CA 124.123 0.969 . . . . 0.0 111.854 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 pp -62.9 -26.43 68.79 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 123.882 0.873 . . . . 0.0 111.053 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 34.8 t -62.34 -25.88 68.14 Favored 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 123.476 0.71 . . . . 0.0 110.999 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.48 -38.09 86.27 Favored Glycine 0 N--CA 1.514 3.851 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.91 -35.35 59.38 Favored 'Isoleucine or valine' 1 N--CA 1.555 4.803 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.01 -32.67 33.95 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.41 -31.78 55.34 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.194 0 CA-C-N 119.134 0.879 . . . . 0.0 108.781 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.77 -42.65 79.24 Favored Glycine 0 N--CA 1.516 3.987 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.746 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.48 -37.16 77.38 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 CA-C-N 117.989 0.895 . . . . 0.0 110.384 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 26.4 m -62.51 -47.6 83.25 Favored 'General case' 0 N--CA 1.519 3.002 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.502 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 9.4 p -71.21 -31.47 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.359 0 C-N-CA 123.649 0.78 . . . . 0.0 111.171 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.83 60.63 Favored 'General case' 0 N--CA 1.529 3.505 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.99 -50.34 64.63 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.11 -41.5 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.54 -32.65 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.617 0 O-C-N 121.826 -0.546 . . . . 0.0 112.166 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -75.52 -39.95 57.72 Favored 'General case' 0 N--CA 1.528 3.429 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 19.3 pt -69.49 -38.84 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 CA-C-N 118.562 0.619 . . . . 0.0 111.762 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.67 -37.29 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 O-C-N 121.592 -0.692 . . . . 0.0 109.967 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.99 83.8 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 123.737 0.815 . . . . 0.0 113.045 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.53 -34.26 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 O-C-N 121.811 -0.556 . . . . 0.0 110.223 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -64.08 -44.26 92.92 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.96 -37.59 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 87.8 m -64.66 -27.83 69.19 Favored 'General case' 0 N--CA 1.525 3.325 0 C-N-CA 123.038 0.535 . . . . 0.0 110.878 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -70.93 -35.75 72.36 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 122.901 0.48 . . . . 0.0 110.295 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.4 t -63.92 -23.24 67.27 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.499 0.72 . . . . 0.0 112.18 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.69 -21.57 65.32 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 123.336 0.655 . . . . 0.0 110.749 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.68 0.74 55.27 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 123.66 0.784 . . . . 0.0 109.925 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.26 -76.49 0.07 Allowed 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.503 0.721 . . . . 0.0 110.13 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 55.8 -135.61 1.29 Allowed 'General case' 0 N--CA 1.522 3.162 0 C-N-CA 123.891 0.877 . . . . 0.0 111.0 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 57.21 78.56 0.22 Allowed 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 124.199 1.0 . . . . 0.0 111.753 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.2 135.15 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.402 0 C-N-CA 124.968 1.307 . . . . 0.0 107.918 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.56 146.71 31.95 Favored Pre-proline 0 N--CA 1.53 3.549 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 1 N--CA 1.54 4.251 0 C-N-CA 122.101 1.867 . . . . 0.0 110.652 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 CA--C 1.575 1.932 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.76 -57.49 2.23 Favored 'Trans proline' 1 N--CA 1.544 4.464 0 C-N-CA 122.416 2.077 . . . . 0.0 113.746 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 168.69 38.11 0.02 OUTLIER Glycine 1 N--CA 1.518 4.149 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 35.2 t -61.39 -12.51 14.53 Favored 'General case' 0 N--CA 1.522 3.153 0 C-N-CA 123.865 0.866 . . . . 0.0 112.216 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.04 -28.69 69.66 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 123.812 0.845 . . . . 0.0 109.579 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 39.9 t -68.7 -32.35 72.09 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 123.498 0.719 . . . . 0.0 110.493 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.57 -40.27 86.21 Favored Glycine 0 N--CA 1.515 3.944 0 CA-C-N 114.947 -1.024 . . . . 0.0 115.103 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.05 -46.07 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.677 1.238 . . . . 0.0 112.018 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -32.79 50.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.063 0 C-N-CA 124.353 1.061 . . . . 0.0 113.198 -177.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 37.6 pt -71.84 -33.18 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 119.247 0.931 . . . . 0.0 108.527 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.45 -29.88 76.33 Favored Glycine 1 N--CA 1.521 4.316 0 C-N-CA 123.539 0.59 . . . . 0.0 111.878 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.67 -37.95 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.72 0 C-N-CA 124.102 0.961 . . . . 0.0 109.947 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 30.3 p -62.14 -45.08 95.03 Favored 'General case' 0 N--CA 1.531 3.592 0 CA-C-O 121.598 0.713 . . . . 0.0 110.414 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.06 -34.87 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.051 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.102 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.21 -36.54 84.49 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 123.117 0.567 . . . . 0.0 112.46 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.09 -49.97 45.58 Favored 'General case' 0 N--CA 1.512 2.654 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 33.2 m -63.16 -38.8 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.06 -35.96 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.847 0 CA-C-N 118.633 0.651 . . . . 0.0 111.094 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.29 -34.89 78.67 Favored 'General case' 0 N--CA 1.537 3.921 0 C-N-CA 122.543 0.337 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 78.7 mt -64.0 -36.32 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.767 0 C-N-CA 123.113 0.565 . . . . 0.0 110.051 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.29 -38.07 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 122.959 0.504 . . . . 0.0 110.064 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.08 95.09 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.83 -34.31 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 O-C-N 121.762 -0.586 . . . . 0.0 109.61 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -62.29 -43.57 98.52 Favored 'General case' 0 N--CA 1.529 3.483 0 C-N-CA 123.3 0.64 . . . . 0.0 112.531 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.08 -37.3 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 81.7 m -59.36 -32.21 69.9 Favored 'General case' 0 N--CA 1.529 3.517 0 C-N-CA 122.819 0.448 . . . . 0.0 110.897 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.99 -41.4 61.97 Favored 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 66.8 m -63.92 -31.43 72.61 Favored 'General case' 0 N--CA 1.526 3.347 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -36.19 68.12 Favored 'General case' 0 N--CA 1.524 3.275 0 C-N-CA 124.246 1.018 . . . . 0.0 108.495 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 53.8 tp -87.22 -16.72 34.44 Favored 'General case' 0 N--CA 1.538 3.957 0 C-N-CA 123.286 0.634 . . . . 0.0 110.816 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -61.59 -7.15 2.99 Favored 'General case' 0 N--CA 1.532 3.651 0 C-N-CA 123.447 0.699 . . . . 0.0 111.853 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.43 -31.99 72.77 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.602 0.761 . . . . 0.0 110.629 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 64.1 tttt 64.1 177.25 0.17 Allowed 'General case' 0 N--CA 1.531 3.593 0 C-N-CA 123.515 0.726 . . . . 0.0 109.977 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.28 130.01 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 58.7 tp -98.3 103.05 16.05 Favored Pre-proline 0 N--CA 1.528 3.463 0 CA-C-O 117.328 -1.32 . . . . 0.0 108.66 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo . . . . . 1 N--CA 1.537 4.074 0 CA-C-N 122.674 1.991 . . . . 0.0 110.852 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 23.2 ptp . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.746 -1.121 . . . . 0.0 108.053 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.9 130.49 16.85 Favored 'Trans proline' 1 N--CA 1.54 4.225 0 C-N-CA 122.039 1.826 . . . . 0.0 110.286 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.68 -168.67 7.87 Favored Glycine 1 N--CA 1.517 4.083 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 69.8 m -161.18 17.26 0.11 Allowed 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 123.756 0.823 . . . . 0.0 110.044 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 55.9 tp -65.12 -26.93 68.41 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 123.92 0.888 . . . . 0.0 110.177 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.3 p -68.57 -30.76 69.6 Favored 'General case' 0 N--CA 1.52 3.059 0 C-N-CA 123.642 0.777 . . . . 0.0 110.071 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.63 -46.49 61.58 Favored Glycine 0 N--CA 1.515 3.948 0 C-N-CA 124.147 0.879 . . . . 0.0 114.826 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.5 tt -70.73 -41.09 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 122.015 -0.697 . . . . 0.0 112.868 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.0 tt -64.49 -42.21 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 C-N-CA 122.729 0.412 . . . . 0.0 111.577 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.86 -34.39 39.9 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.009 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.15 -45.29 95.55 Favored Glycine 0 N--CA 1.513 3.801 0 CA-C-N 114.762 -1.108 . . . . 0.0 114.754 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.72 -36.81 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 CA-C-N 117.95 0.875 . . . . 0.0 110.943 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -63.16 -47.8 81.14 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-N 118.339 0.518 . . . . 0.0 112.32 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.43 -35.33 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 123.785 0.834 . . . . 0.0 112.118 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.83 -47.37 70.99 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.2 77.84 Favored 'General case' 0 N--CA 1.517 2.896 0 C-N-CA 123.416 0.686 . . . . 0.0 111.754 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 t -66.68 -49.42 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 C-N-CA 123.224 0.61 . . . . 0.0 110.861 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.26 -32.79 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.498 0 C-N-CA 123.442 0.697 . . . . 0.0 110.917 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.3 tt -64.8 -39.51 93.72 Favored 'General case' 0 N--CA 1.535 3.812 0 C-N-CA 122.991 0.516 . . . . 0.0 110.425 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 88.7 mt -65.35 -36.67 78.26 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 O-C-N 121.508 -0.745 . . . . 0.0 110.283 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.8 -37.44 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 C-N-CA 123.332 0.653 . . . . 0.0 109.807 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.73 -32.09 67.08 Favored 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.398 0.679 . . . . 0.0 111.649 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 46.7 t -68.97 -44.54 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.215 0.606 . . . . 0.0 111.575 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -61.3 -43.12 99.4 Favored 'General case' 1 N--CA 1.54 4.042 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.81 -37.46 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 CA-C-N 118.312 0.505 . . . . 0.0 109.701 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 92.9 m -59.1 -30.48 68.13 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 122.282 -0.261 . . . . 0.0 110.899 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -74.09 -15.47 61.05 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 123.006 0.522 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 67.9 p -63.44 -30.56 71.67 Favored 'General case' 0 N--CA 1.533 3.696 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 57.5 tp -76.36 -30.97 57.79 Favored 'General case' 0 N--CA 1.517 2.909 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.031 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 32.3 mt -87.52 10.16 18.64 Favored 'General case' 0 N--CA 1.533 3.702 0 C-N-CA 123.349 0.659 . . . . 0.0 110.775 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -77.7 25.79 0.19 Allowed 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.855 0.862 . . . . 0.0 110.317 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -66.57 142.51 57.47 Favored 'General case' 0 N--CA 1.525 3.286 0 C-N-CA 123.843 0.857 . . . . 0.0 109.827 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.49 168.76 19.09 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.1 138.38 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 C-N-CA 124.908 1.283 . . . . 0.0 108.373 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.89 99.29 51.86 Favored Pre-proline 0 N--CA 1.526 3.353 0 C-N-CA 124.963 1.305 . . . . 0.0 108.574 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo . . . . . 1 N--CA 1.546 4.562 0 C-N-CA 122.314 2.009 . . . . 0.0 113.756 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.582 2.19 0 CA-C-O 117.474 -1.25 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -89.76 12.14 2.66 Favored 'Trans proline' 0 N--CA 1.535 3.968 0 C-N-CA 122.657 2.238 . . . . 0.0 111.589 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -179.19 -177.41 47.64 Favored Glycine 1 N--CA 1.519 4.185 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 45.8 t -167.91 88.66 0.26 Allowed 'General case' 0 N--CA 1.519 3.006 0 C-N-CA 123.913 0.885 . . . . 0.0 108.977 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 55.8 tp -53.64 -26.76 23.67 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 124.655 1.182 . . . . 0.0 111.44 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 52.9 m -60.88 -40.11 91.79 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.857 0.863 . . . . 0.0 111.462 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.97 -35.6 79.35 Favored Glycine 1 N--CA 1.52 4.239 0 C-N-CA 124.0 0.809 . . . . 0.0 112.823 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 38.6 mm -64.57 -42.7 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 17.2 tt -56.62 -44.38 80.91 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.385 0 CA-C-N 119.466 1.03 . . . . 0.0 112.28 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 16.6 tt -73.73 -33.93 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.73 -42.99 99.6 Favored Glycine 0 N--CA 1.512 3.743 0 CA-C-N 114.884 -1.053 . . . . 0.0 114.609 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.91 -37.13 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 CA-C-N 117.729 0.764 . . . . 0.0 111.038 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 59.3 p -66.01 -46.71 76.98 Favored 'General case' 0 N--CA 1.532 3.641 0 CA-C-N 118.379 0.536 . . . . 0.0 112.064 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 11.4 p -69.94 -31.64 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.51 0 C-N-CA 122.778 0.431 . . . . 0.0 111.099 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.16 -41.13 71.46 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.174 0.59 . . . . 0.0 112.396 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.99 93.1 Favored 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 123.238 0.615 . . . . 0.0 111.074 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.82 -50.0 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.323 0 C-N-CA 123.412 0.685 . . . . 0.0 110.384 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.4 -32.54 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 123.626 0.77 . . . . 0.0 110.35 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.5 -34.99 79.0 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 122.891 0.476 . . . . 0.0 110.78 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.53 -37.36 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.47 -37.86 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 C-N-CA 123.233 0.613 . . . . 0.0 109.637 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.85 78.61 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.631 0.772 . . . . 0.0 112.671 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.79 -34.42 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.616 0 O-C-N 121.901 -0.5 . . . . 0.0 110.336 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -65.67 -43.66 88.62 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.107 0.563 . . . . 0.0 112.446 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.4 -37.55 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 79.5 m -61.21 -27.99 68.83 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 122.962 0.505 . . . . 0.0 111.158 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -72.49 -28.71 63.06 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.378 0.671 . . . . 0.0 110.708 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 28.1 t -65.5 -27.81 68.74 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.138 0.575 . . . . 0.0 111.823 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.83 -14.07 60.73 Favored 'General case' 0 N--CA 1.531 3.609 0 C-N-CA 123.916 0.886 . . . . 0.0 111.009 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 20.3 mt -86.87 1.9 50.96 Favored 'General case' 0 N--CA 1.535 3.81 0 C-N-CA 122.775 0.43 . . . . 0.0 110.606 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -76.82 -50.13 14.17 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.552 0.741 . . . . 0.0 109.274 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -62.94 82.69 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.425 0 C-N-CA 123.76 0.824 . . . . 0.0 111.959 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -136.5 8.09 3.09 Favored 'General case' 0 N--CA 1.534 3.761 0 C-N-CA 124.831 1.252 . . . . 0.0 109.331 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.54 136.22 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 125.149 1.38 . . . . 0.0 107.9 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -94.63 146.33 31.25 Favored Pre-proline 0 N--CA 1.529 3.516 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 1 N--CA 1.539 4.151 0 C-N-CA 122.015 1.81 . . . . 0.0 110.641 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 CA--C 1.573 1.846 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.81 156.44 9.26 Favored 'Trans proline' 1 N--CA 1.544 4.461 0 C-N-CA 122.329 2.019 . . . . 0.0 113.126 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 175.13 -48.01 0.13 Allowed Glycine 1 N--CA 1.517 4.083 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 49.9 m 57.02 48.92 14.75 Favored 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 124.239 1.016 . . . . 0.0 112.503 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.14 -30.7 71.65 Favored 'General case' 0 N--CA 1.534 3.758 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 97.1 p -68.6 -26.71 65.51 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 123.701 0.8 . . . . 0.0 109.789 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.99 -45.04 64.29 Favored Glycine 1 N--CA 1.517 4.075 0 C-N-CA 124.26 0.933 . . . . 0.0 114.979 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 44.2 pt -70.61 -35.86 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -41.38 87.53 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.319 0 CA-C-N 118.524 0.602 . . . . 0.0 110.834 -177.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -33.59 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.93 -42.6 96.8 Favored Glycine 1 N--CA 1.518 4.104 0 N-CA-C 114.79 0.676 . . . . 0.0 114.79 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.0 -41.67 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.633 1.216 . . . . 0.0 111.817 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.1 t -66.72 -40.85 88.57 Favored 'General case' 0 N--CA 1.536 3.848 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.16 -30.92 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.725 0 CA-C-N 118.508 0.595 . . . . 0.0 110.279 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.26 -34.7 78.97 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 122.983 0.513 . . . . 0.0 111.696 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.57 -50.41 51.99 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.1 -38.88 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.57 -32.26 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 CA-C-N 118.112 0.414 . . . . 0.0 110.567 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 tt -74.54 -46.45 38.95 Favored 'General case' 0 N--CA 1.531 3.581 0 C-N-CA 123.102 0.561 . . . . 0.0 110.161 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.5 -44.49 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 O-C-N 121.826 -0.546 . . . . 0.0 111.996 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.3 -36.87 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 CA-C-N 118.665 0.666 . . . . 0.0 110.195 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.78 75.58 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.17 0.588 . . . . 0.0 111.847 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.85 -41.41 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 C-N-CA 122.617 0.367 . . . . 0.0 110.283 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.13 -43.86 98.23 Favored 'General case' 0 N--CA 1.529 3.478 0 C-N-CA 123.503 0.721 . . . . 0.0 112.782 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.62 -37.71 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 99.4 m -63.6 -28.09 69.69 Favored 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 122.855 0.462 . . . . 0.0 111.247 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.86 -28.27 67.4 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 123.227 0.611 . . . . 0.0 110.945 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.7 t -64.05 -36.33 83.63 Favored 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 123.337 0.655 . . . . 0.0 111.874 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.97 -14.4 22.47 Favored 'General case' 0 N--CA 1.533 3.699 0 C-N-CA 123.936 0.894 . . . . 0.0 111.104 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 23.5 mt -87.31 -28.32 22.34 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.271 0.629 . . . . 0.0 109.927 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -78.39 -141.42 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 60.6 15.24 5.54 Favored 'General case' 0 N--CA 1.52 3.028 0 C-N-CA 124.32 1.048 . . . . 0.0 112.102 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -160.12 118.86 2.71 Favored 'General case' 0 N--CA 1.53 3.544 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.3 t -112.77 138.41 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.588 0 C-N-CA 125.175 1.39 . . . . 0.0 107.709 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.25 146.74 32.12 Favored Pre-proline 0 N--CA 1.527 3.406 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 1 N--CA 1.541 4.287 0 C-N-CA 122.085 1.857 . . . . 0.0 110.664 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 CA--C 1.576 1.957 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -80.54 -110.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.534 3.864 0 C-N-CA 122.66 2.24 . . . . 0.0 110.099 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 61.27 12.19 30.33 Favored Glycine 1 N--CA 1.52 4.27 0 C-N-CA 123.689 0.661 . . . . 0.0 112.617 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 68.0 m -66.84 178.07 1.46 Allowed 'General case' 0 N--CA 1.521 3.112 0 C-N-CA 123.949 0.9 . . . . 0.0 110.95 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.93 -26.62 68.67 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 124.253 1.021 . . . . 0.0 110.613 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 60.9 m -67.95 -26.03 65.74 Favored 'General case' 0 N--CA 1.522 3.171 0 C-N-CA 123.425 0.69 . . . . 0.0 110.614 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.14 -46.24 66.42 Favored Glycine 0 N--CA 1.514 3.896 0 C-N-CA 123.699 0.666 . . . . 0.0 113.953 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tp -70.67 -35.53 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.955 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 12.1 pt -56.82 -43.61 80.29 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.766 0 CA-C-N 119.83 1.195 . . . . 0.0 112.22 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -73.56 -33.66 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.616 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.65 -45.94 93.32 Favored Glycine 0 N--CA 1.515 3.942 0 CA-C-N 115.494 -0.776 . . . . 0.0 114.069 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.94 -36.78 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.803 0 CA-C-N 117.873 0.836 . . . . 0.0 111.055 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 50.8 p -62.44 -46.22 89.51 Favored 'General case' 0 N--CA 1.534 3.744 0 CA-C-N 118.252 0.478 . . . . 0.0 111.115 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.97 -34.83 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.414 0 C-N-CA 123.87 0.868 . . . . 0.0 110.676 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.93 -36.32 59.56 Favored 'General case' 0 N--CA 1.527 3.381 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -46.1 64.53 Favored 'General case' 0 N--CA 1.517 2.908 0 C-N-CA 123.136 0.575 . . . . 0.0 111.44 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -58.53 -44.79 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.677 0 C-N-CA 123.768 0.827 . . . . 0.0 112.204 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -66.65 -31.5 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.658 0 CA-C-O 121.125 0.488 . . . . 0.0 110.12 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -42.12 97.41 Favored 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.576 0.75 . . . . 0.0 111.906 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.05 -44.61 97.78 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.005 0 C-N-CA 122.892 0.477 . . . . 0.0 111.809 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 18.2 m -66.48 -36.55 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.792 0 O-C-N 121.801 -0.562 . . . . 0.0 109.928 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.3 86.09 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.73 -34.27 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.964 0 O-C-N 121.606 -0.684 . . . . 0.0 109.963 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.73 -44.03 97.16 Favored 'General case' 0 N--CA 1.53 3.542 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.78 -39.06 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 CA-C-O 121.569 0.7 . . . . 0.0 109.415 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.9 m -65.25 -29.48 70.27 Favored 'General case' 0 N--CA 1.521 3.101 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.311 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.36 -37.77 63.4 Favored 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 123.121 0.568 . . . . 0.0 109.477 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 50.5 m -64.15 -29.78 70.88 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.527 0.731 . . . . 0.0 111.245 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.76 -14.56 22.1 Favored 'General case' 0 N--CA 1.534 3.737 0 C-N-CA 123.61 0.764 . . . . 0.0 111.488 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.95 10.34 16.6 Favored 'General case' 1 N--CA 1.54 4.034 0 C-N-CA 123.227 0.611 . . . . 0.0 109.409 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -157.42 -18.35 0.09 Allowed 'General case' 0 N--CA 1.53 3.529 0 C-N-CA 123.561 0.745 . . . . 0.0 109.508 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 90.4 mttt 66.62 -40.17 0.36 Allowed 'General case' 0 N--CA 1.519 2.997 0 C-N-CA 125.443 1.497 . . . . 0.0 113.35 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt 59.33 60.95 2.17 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 123.515 0.726 . . . . 0.0 111.085 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.13 136.72 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 49.8 mt -94.7 146.66 31.82 Favored Pre-proline 0 N--CA 1.527 3.388 0 CA-C-O 117.222 -1.37 . . . . 0.0 108.192 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo . . . . . 1 N--CA 1.54 4.25 0 C-N-CA 122.002 1.801 . . . . 0.0 110.688 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 52.3 tpp . . . . . 0 CA--C 1.572 1.817 0 CA-C-O 116.78 -1.581 . . . . 0.0 107.054 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -76.33 -32.24 4.09 Favored 'Trans proline' 1 N--CA 1.537 4.05 0 CA-C-N 122.9 2.072 . . . . 0.0 110.144 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.04 169.01 49.68 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 70.7 m -165.6 -57.1 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.13 0 C-N-CA 123.873 0.869 . . . . 0.0 108.722 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.95 -27.17 68.66 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 123.944 0.898 . . . . 0.0 110.16 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 99.3 p -68.13 -30.09 69.15 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.655 0.782 . . . . 0.0 110.625 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.22 -47.07 54.95 Favored Glycine 0 N--CA 1.514 3.842 0 CA-C-N 115.956 -0.565 . . . . 0.0 114.444 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.21 -39.35 73.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.088 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -176.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.44 -32.29 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.781 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.17 -32.77 44.44 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.119 0 CA-C-N 119.129 0.877 . . . . 0.0 109.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.21 -29.17 72.19 Favored Glycine 0 N--CA 1.511 3.67 0 C-N-CA 123.776 0.703 . . . . 0.0 113.648 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 5.4 p -59.27 -48.21 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.946 0 CA-C-N 117.558 0.679 . . . . 0.0 112.817 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 8.9 t -66.7 -39.64 88.16 Favored 'General case' 0 N--CA 1.536 3.841 0 CA-C-N 118.056 0.389 . . . . 0.0 110.95 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.38 -33.28 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.269 0 C-N-CA 123.475 0.71 . . . . 0.0 110.26 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.45 -43.08 97.24 Favored 'General case' 0 N--CA 1.526 3.353 0 O-C-N 122.214 -0.304 . . . . 0.0 111.705 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.43 73.3 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.4 -38.31 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 CA-C-N 118.042 0.383 . . . . 0.0 111.374 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.98 -32.76 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 C-N-CA 122.715 0.406 . . . . 0.0 110.086 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -37.82 85.5 Favored 'General case' 1 N--CA 1.544 4.265 0 CA-C-O 120.999 0.428 . . . . 0.0 110.013 -178.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 71.8 mt -64.09 -40.72 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.096 0.558 . . . . 0.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.63 -37.29 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 123.789 0.835 . . . . 0.0 109.935 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.67 -32.47 67.35 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.314 0.646 . . . . 0.0 112.071 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.47 -44.14 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.663 0 C-N-CA 122.636 0.375 . . . . 0.0 112.001 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -61.54 -43.67 98.45 Favored 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.5 -37.87 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.698 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 86.4 m -67.36 -34.17 76.75 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 122.93 0.492 . . . . 0.0 110.126 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -69.54 -34.53 74.35 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 123.466 0.706 . . . . 0.0 110.388 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 39.3 t -67.18 -37.51 83.82 Favored 'General case' 0 N--CA 1.522 3.169 0 CA-C-O 121.447 0.642 . . . . 0.0 110.198 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.7 -21.77 62.53 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 124.294 1.037 . . . . 0.0 110.512 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 56.0 tp -87.67 -28.08 22.04 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.72 0.808 . . . . 0.0 109.551 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -71.42 -124.82 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.346 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 54.67 111.39 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 124.311 1.045 . . . . 0.0 112.01 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -164.79 152.79 11.88 Favored 'General case' 0 N--CA 1.522 3.168 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 78.5 t -113.12 128.75 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.65 99.3 33.09 Favored Pre-proline 0 N--CA 1.53 3.546 0 C-N-CA 124.87 1.268 . . . . 0.0 108.237 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo . . . . . 1 N--CA 1.546 4.616 0 C-N-CA 122.254 1.969 . . . . 0.0 113.603 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.574 1.882 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.38 -33.69 10.72 Favored 'Trans proline' 1 N--CA 1.54 4.225 0 C-N-CA 122.234 1.956 . . . . 0.0 110.28 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 176.51 178.08 46.0 Favored Glycine 1 N--CA 1.518 4.133 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 45.3 t -69.38 143.34 53.72 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.633 0.773 . . . . 0.0 110.495 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.18 -26.75 68.29 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 124.242 1.017 . . . . 0.0 110.651 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 46.9 t -65.8 -26.7 67.81 Favored 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 122.959 0.503 . . . . 0.0 110.528 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.22 -46.34 92.94 Favored Glycine 0 N--CA 1.509 3.545 0 C-N-CA 123.439 0.542 . . . . 0.0 114.192 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.38 -35.39 62.13 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.065 0 CA-C-N 118.446 1.123 . . . . 0.0 109.46 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 83.1 mt -64.56 -35.54 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 11.6 mm -72.5 -33.74 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.825 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.52 -47.16 92.53 Favored Glycine 0 N--CA 1.515 3.917 0 C-N-CA 123.983 0.802 . . . . 0.0 113.49 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 14.6 m -68.92 -36.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 O-C-N 121.781 -0.835 . . . . 0.0 109.981 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 32.9 m -60.44 -45.69 92.76 Favored 'General case' 0 N--CA 1.525 3.281 0 C-N-CA 123.577 0.751 . . . . 0.0 112.539 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.63 -30.83 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 C-N-CA 122.94 0.496 . . . . 0.0 110.049 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.72 -45.19 91.07 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 122.685 0.394 . . . . 0.0 111.868 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.99 -25.56 61.21 Favored 'General case' 0 N--CA 1.535 3.801 0 C-N-CA 123.422 0.689 . . . . 0.0 112.286 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.05 -37.04 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 C-N-CA 123.76 0.824 . . . . 0.0 110.326 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 2.6 p -55.97 -34.84 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.784 0 C-N-CA 123.457 0.703 . . . . 0.0 111.63 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 59.9 tp -69.63 -45.27 68.86 Favored 'General case' 0 N--CA 1.521 3.125 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.867 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.53 -49.76 63.83 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.232 0 C-N-CA 122.858 0.463 . . . . 0.0 111.188 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 26.5 m -66.4 -36.86 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 C-N-CA 122.437 0.295 . . . . 0.0 110.465 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.93 -32.91 68.23 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 123.179 0.592 . . . . 0.0 112.389 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.72 -34.78 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.73 0 O-C-N 122.021 -0.424 . . . . 0.0 110.283 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -68.46 -43.7 76.44 Favored 'General case' 0 N--CA 1.527 3.402 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 11.5 m -68.49 -37.93 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 O-C-N 122.198 -0.314 . . . . 0.0 111.324 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 15.5 p -65.33 -27.74 68.81 Favored 'General case' 0 N--CA 1.529 3.503 0 C-N-CA 122.217 0.207 . . . . 0.0 111.165 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -63.11 -42.51 99.57 Favored 'General case' 0 N--CA 1.526 3.333 0 CA-C-O 121.276 0.56 . . . . 0.0 109.922 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 69.4 m -65.74 -36.89 84.87 Favored 'General case' 0 N--CA 1.521 3.104 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.873 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -71.87 -25.88 62.13 Favored 'General case' 0 N--CA 1.528 3.475 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.507 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 49.9 tp -87.4 -12.72 45.42 Favored 'General case' 0 N--CA 1.537 3.886 0 C-N-CA 123.85 0.86 . . . . 0.0 110.883 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -55.66 -15.11 2.64 Favored 'General case' 0 N--CA 1.534 3.74 0 C-N-CA 123.684 0.794 . . . . 0.0 112.103 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.65 -25.4 63.89 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.729 0.812 . . . . 0.0 111.224 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 59.71 -157.65 0.33 Allowed 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.927 0.891 . . . . 0.0 110.169 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.68 137.9 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -94.38 146.54 31.71 Favored Pre-proline 0 N--CA 1.532 3.661 0 C-N-CA 124.813 1.245 . . . . 0.0 109.808 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo . . . . . 1 N--CA 1.541 4.286 0 C-N-CA 121.964 1.776 . . . . 0.0 110.751 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 CA--C 1.576 1.967 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.58 -53.5 6.94 Favored 'Trans proline' 1 N--CA 1.549 4.756 0 C-N-CA 121.894 1.73 . . . . 0.0 113.95 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.06 159.01 53.46 Favored Glycine 1 N--CA 1.52 4.241 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 89.8 p -165.95 -111.04 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 123.698 0.799 . . . . 0.0 109.133 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 42.8 mt -64.26 -27.5 69.09 Favored 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 124.114 0.966 . . . . 0.0 110.842 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 66.8 m -61.17 -26.62 67.83 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.669 0.788 . . . . 0.0 110.973 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.54 -34.33 88.81 Favored Glycine 0 N--CA 1.513 3.802 0 C-N-CA 125.062 1.315 . . . . 0.0 114.005 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -34.1 49.55 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.249 0 C-N-CA 124.615 1.166 . . . . 0.0 113.876 -174.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 16.3 pt -54.97 -32.36 26.67 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.257 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -174.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 13.0 pt -64.65 -33.36 62.7 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-O 121.256 0.55 . . . . 0.0 109.734 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.7 -50.14 70.93 Favored Glycine 1 N--CA 1.518 4.166 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.726 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.62 -36.81 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 CA-C-N 117.571 0.685 . . . . 0.0 110.384 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 85.9 m -61.77 -46.05 91.23 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 123.479 0.712 . . . . 0.0 112.043 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 70.1 t -69.19 -31.32 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 C-N-CA 123.712 0.805 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.9 -34.91 57.11 Favored 'General case' 0 N--CA 1.536 3.827 0 CA-C-O 121.041 0.448 . . . . 0.0 112.205 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.78 -43.58 65.48 Favored 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 123.37 0.668 . . . . 0.0 110.949 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.56 -43.11 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.38 0 C-N-CA 124.428 1.091 . . . . 0.0 112.62 -176.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 24.7 m -60.7 -31.29 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 O-C-N 121.992 -0.443 . . . . 0.0 111.628 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 46.9 tp -67.69 -36.23 80.28 Favored 'General case' 0 N--CA 1.536 3.855 0 O-C-N 121.474 -0.766 . . . . 0.0 109.875 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 41.1 mm -55.01 -51.98 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 C-N-CA 122.873 0.469 . . . . 0.0 112.157 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 17.2 m -60.57 -36.71 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 C-N-CA 122.356 0.262 . . . . 0.0 110.856 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.55 -31.84 66.51 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.067 0.547 . . . . 0.0 111.153 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.81 -38.21 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 O-C-N 121.99 -0.444 . . . . 0.0 110.353 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -73.04 -32.21 64.93 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 123.203 0.601 . . . . 0.0 110.076 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.56 -37.59 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.246 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.0 m -58.7 -46.79 86.52 Favored 'General case' 0 N--CA 1.524 3.268 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -74.65 -41.57 60.1 Favored 'General case' 0 N--CA 1.532 3.63 0 CA-C-O 121.111 0.481 . . . . 0.0 111.102 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.3 m -64.52 -46.86 81.09 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 123.565 0.746 . . . . 0.0 112.303 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -22.48 63.89 Favored 'General case' 1 N--CA 1.54 4.066 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 43.6 tp -87.65 -9.59 53.78 Favored 'General case' 0 N--CA 1.539 3.984 0 C-N-CA 123.472 0.709 . . . . 0.0 110.613 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -53.87 -14.79 1.07 Allowed 'General case' 0 N--CA 1.531 3.616 0 C-N-CA 123.871 0.868 . . . . 0.0 112.369 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -59.14 154.75 15.31 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.746 0.818 . . . . 0.0 110.459 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -68.55 93.17 0.49 Allowed 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 123.806 0.842 . . . . 0.0 109.993 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.97 121.36 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 57.4 mt -94.58 146.96 32.4 Favored Pre-proline 0 N--CA 1.525 3.296 0 CA-C-O 117.453 -1.26 . . . . 0.0 108.254 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo . . . . . 1 N--CA 1.542 4.369 0 C-N-CA 122.115 1.877 . . . . 0.0 110.814 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 CA--C 1.576 1.958 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.91 -57.18 2.41 Favored 'Trans proline' 1 N--CA 1.544 4.453 0 C-N-CA 122.413 2.075 . . . . 0.0 113.543 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 169.23 -12.6 0.05 OUTLIER Glycine 1 N--CA 1.522 4.405 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 48.5 m 58.39 57.66 3.77 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 124.112 0.965 . . . . 0.0 111.286 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.43 -27.15 69.1 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 124.044 0.938 . . . . 0.0 110.749 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 99.8 p -68.58 -32.63 72.67 Favored 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 123.581 0.752 . . . . 0.0 110.406 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.76 -46.61 60.14 Favored Glycine 1 N--CA 1.516 4.004 0 CA-C-N 115.362 -0.835 . . . . 0.0 114.979 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -70.91 -42.03 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.907 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -60.05 -42.13 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 C-N-CA 122.999 0.52 . . . . 0.0 112.395 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.71 -33.29 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.858 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.26 58.33 Favored Glycine 0 N--CA 1.51 3.617 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.524 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.0 m -59.47 -37.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.913 0 CA-C-N 117.634 0.717 . . . . 0.0 110.928 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 80.5 p -56.39 -46.61 80.03 Favored 'General case' 0 N--CA 1.531 3.584 0 CA-C-O 121.038 0.447 . . . . 0.0 111.214 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.83 -41.96 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 124.456 1.102 . . . . 0.0 110.88 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.55 -47.12 66.98 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.41 0.684 . . . . 0.0 112.633 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.65 -37.05 72.71 Favored 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 123.385 0.674 . . . . 0.0 111.674 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 36.2 t -67.98 -48.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 CA-C-O 121.315 0.578 . . . . 0.0 110.071 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.53 -32.65 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.111 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.388 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 16.1 mt -73.55 -46.7 45.96 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 122.67 0.388 . . . . 0.0 110.95 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 92.1 mt -60.14 -44.77 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 O-C-N 121.531 -0.731 . . . . 0.0 111.437 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.03 -37.8 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.87 0 CA-C-N 118.843 0.747 . . . . 0.0 110.631 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.81 91.09 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.553 0.741 . . . . 0.0 111.828 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 88.5 t -71.57 -34.47 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.348 0 C-N-CA 123.139 0.576 . . . . 0.0 109.777 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.01 -44.21 89.97 Favored 'General case' 0 N--CA 1.53 3.525 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.68 -37.41 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.781 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 88.0 m -61.19 -33.7 73.88 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 122.913 0.485 . . . . 0.0 110.855 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -74.28 -28.47 61.22 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 122.633 0.373 . . . . 0.0 110.461 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 57.5 m -75.27 -17.74 60.23 Favored 'General case' 0 N--CA 1.524 3.227 0 C-N-CA 123.104 0.562 . . . . 0.0 110.855 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.76 -38.43 86.57 Favored 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 123.499 0.72 . . . . 0.0 112.319 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -110.46 10.16 23.27 Favored 'General case' 1 N--CA 1.556 4.844 0 C-N-CA 123.414 0.686 . . . . 0.0 112.342 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -75.65 5.47 6.07 Favored 'General case' 0 N--CA 1.527 3.396 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -163.84 172.53 13.93 Favored 'General case' 0 N--CA 1.516 2.85 0 C-N-CA 124.242 1.017 . . . . 0.0 108.958 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.11 -175.63 3.75 Favored 'General case' 0 N--CA 1.531 3.594 0 C-N-CA 124.565 1.146 . . . . 0.0 109.757 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.12 138.73 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 C-N-CA 125.09 1.356 . . . . 0.0 108.889 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.48 108.25 35.4 Favored Pre-proline 0 N--CA 1.526 3.336 0 CA-C-O 116.882 -1.533 . . . . 0.0 107.237 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo . . . . . 1 N--CA 1.549 4.736 0 C-N-CA 122.753 2.302 . . . . 0.0 114.727 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 85.4 mmm . . . . . 0 CA--C 1.576 1.96 0 CA-C-O 117.641 -1.171 . . . . 0.0 107.883 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.11 -36.62 55.75 Favored 'Trans proline' 1 N--CA 1.548 4.705 0 C-N-CA 121.95 1.766 . . . . 0.0 113.431 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.56 -154.88 0.49 Allowed Glycine 1 N--CA 1.518 4.144 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.761 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 99.3 p -162.61 27.65 0.1 Allowed 'General case' 0 N--CA 1.522 3.125 0 C-N-CA 124.108 0.963 . . . . 0.0 109.2 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 47.5 mt -64.14 -26.55 68.58 Favored 'General case' 0 N--CA 1.522 3.141 0 C-N-CA 124.566 1.147 . . . . 0.0 110.81 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.1 t -57.57 -26.41 61.4 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.606 0.762 . . . . 0.0 111.883 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.65 -34.23 77.92 Favored Glycine 0 N--CA 1.513 3.801 0 C-N-CA 124.724 1.154 . . . . 0.0 114.12 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -46.47 90.79 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.378 0 CA-C-N 117.821 0.81 . . . . 0.0 112.458 -174.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.7 tt -64.84 -31.54 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 C-N-CA 123.116 0.566 . . . . 0.0 110.779 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 51.1 mm -68.22 -33.51 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.37 -50.15 67.48 Favored Glycine 1 N--CA 1.517 4.074 0 C-N-CA 123.119 0.39 . . . . 0.0 113.127 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.0 m -61.85 -35.75 69.75 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 CA-C-N 117.861 0.83 . . . . 0.0 110.655 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.5 m -55.18 -42.28 72.99 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.045 0.538 . . . . 0.0 111.0 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.42 -36.99 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.47 0 C-N-CA 123.483 0.713 . . . . 0.0 110.576 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.47 68.41 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.42 -50.43 65.46 Favored 'General case' 0 N--CA 1.515 2.795 0 C-N-CA 123.315 0.646 . . . . 0.0 112.673 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.02 -38.34 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.784 0 CA-C-N 118.303 0.501 . . . . 0.0 111.311 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.5 t -62.41 -34.65 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 CA-C-N 117.954 0.343 . . . . 0.0 110.391 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.98 -34.53 78.32 Favored 'General case' 0 N--CA 1.529 3.507 0 CA-C-N 117.808 0.276 . . . . 0.0 111.468 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.48 -36.8 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.865 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.74 -37.71 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.692 0 C-N-CA 123.34 0.656 . . . . 0.0 110.212 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.91 -32.52 71.99 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.387 0.675 . . . . 0.0 111.342 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.57 -37.46 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 123.052 0.541 . . . . 0.0 109.899 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.43 -43.78 96.46 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.377 0.671 . . . . 0.0 112.434 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.9 m -68.24 -37.38 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.725 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 93.0 m -62.93 -31.4 72.48 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.989 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -74.43 -38.83 62.91 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 55.9 m -67.37 -28.04 67.61 Favored 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 123.384 0.674 . . . . 0.0 110.576 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.54 -34.54 78.13 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.463 0.705 . . . . 0.0 111.896 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.32 8.1 37.71 Favored 'General case' 1 N--CA 1.544 4.248 0 C-N-CA 123.092 0.557 . . . . 0.0 111.691 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -71.24 2.53 4.58 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 123.479 0.711 . . . . 0.0 110.471 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -52.37 173.57 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 124.52 1.128 . . . . 0.0 112.25 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -63.17 146.36 53.52 Favored 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 124.056 0.942 . . . . 0.0 111.281 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.51 138.29 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.402 0 C-N-CA 125.081 1.352 . . . . 0.0 108.128 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 66.4 mt -113.6 99.27 49.36 Favored Pre-proline 0 N--CA 1.525 3.319 0 C-N-CA 124.814 1.246 . . . . 0.0 108.629 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo . . . . . 1 N--CA 1.547 4.641 0 C-N-CA 122.345 2.03 . . . . 0.0 114.132 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.573 1.854 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.74 -40.06 4.11 Favored 'Trans proline' 1 N--CA 1.54 4.225 0 C-N-CA 122.02 1.813 . . . . 0.0 110.755 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 171.89 -163.42 35.86 Favored Glycine 1 N--CA 1.518 4.156 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 48.1 t -165.67 -57.59 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.925 0 C-N-CA 123.794 0.837 . . . . 0.0 109.11 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.09 -31.96 73.42 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 123.945 0.898 . . . . 0.0 110.162 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.9 t -68.36 -27.95 66.7 Favored 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 123.592 0.757 . . . . 0.0 110.631 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.04 -46.58 58.39 Favored Glycine 0 N--CA 1.514 3.872 0 C-N-CA 124.078 0.847 . . . . 0.0 114.723 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.8 pt -70.71 -37.35 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -64.29 -41.39 92.23 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.054 0 CA-C-N 118.376 0.534 . . . . 0.0 111.609 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.88 -33.28 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.31 -50.11 64.35 Favored Glycine 0 N--CA 1.513 3.807 0 C-N-CA 124.331 0.967 . . . . 0.0 113.906 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.32 -37.13 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 O-C-N 122.22 -0.577 . . . . 0.0 109.887 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 82.0 m -65.31 -47.22 77.34 Favored 'General case' 0 N--CA 1.523 3.204 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.3 p -70.74 -31.54 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 CA-C-N 118.117 0.417 . . . . 0.0 111.611 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.7 67.59 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.44 -36.41 83.83 Favored 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 123.121 0.568 . . . . 0.0 111.506 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 48.0 t -68.13 -52.11 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 C-N-CA 123.525 0.73 . . . . 0.0 111.779 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.08 -35.18 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.457 0 O-C-N 121.413 -0.804 . . . . 0.0 111.944 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 tt -75.01 -43.71 52.2 Favored 'General case' 0 N--CA 1.528 3.444 0 C-N-CA 122.58 0.352 . . . . 0.0 111.204 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 14.8 tt -65.73 -39.75 85.79 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 O-C-N 121.211 -0.931 . . . . 0.0 111.197 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.26 -37.42 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 C-N-CA 123.099 0.56 . . . . 0.0 109.939 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.85 -32.77 67.96 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.25 -38.63 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.594 0 CA-C-N 118.049 0.386 . . . . 0.0 111.386 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -64.39 -44.25 91.9 Favored 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.95 -39.89 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.467 0 C-N-CA 122.841 0.457 . . . . 0.0 110.109 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 99.0 m -67.55 -28.25 67.63 Favored 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 123.242 0.617 . . . . 0.0 111.226 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.3 -45.97 44.13 Favored 'General case' 0 N--CA 1.528 3.436 0 CA-C-O 121.123 0.487 . . . . 0.0 110.499 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.7 t -63.78 -19.05 64.69 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 123.629 0.772 . . . . 0.0 112.203 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 49.7 tp -69.24 -15.64 63.42 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.616 0.766 . . . . 0.0 110.614 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.52 -4.03 58.99 Favored 'General case' 0 N--CA 1.534 3.76 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 72.7 m95 61.5 160.8 0.06 Allowed 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 124.521 1.128 . . . . 0.0 110.668 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -129.49 -121.82 0.22 Allowed 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 124.615 1.166 . . . . 0.0 108.281 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -66.0 130.62 43.89 Favored 'General case' 0 N--CA 1.523 3.215 0 C-N-CA 123.501 0.72 . . . . 0.0 109.815 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 24.1 m -135.04 138.71 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 125.167 1.387 . . . . 0.0 108.338 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.25 146.64 31.94 Favored Pre-proline 0 N--CA 1.53 3.574 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 1 N--CA 1.54 4.25 0 C-N-CA 122.142 1.895 . . . . 0.0 110.843 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 66.4 mtp . . . . . 0 CA--C 1.584 2.262 0 CA-C-O 117.563 -1.208 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.82 172.4 15.92 Favored 'Trans proline' 1 N--CA 1.543 4.406 0 CA-C-N 122.914 2.076 . . . . 0.0 110.276 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.26 -43.11 93.64 Favored Glycine 1 N--CA 1.519 4.195 0 C-N-CA 123.683 0.659 . . . . 0.0 111.985 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 50.5 m 57.85 61.27 2.45 Favored 'General case' 0 N--CA 1.523 3.214 0 C-N-CA 124.032 0.933 . . . . 0.0 111.625 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.34 -26.97 68.71 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 123.906 0.883 . . . . 0.0 110.294 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.2 m -68.41 -29.82 68.58 Favored 'General case' 0 N--CA 1.52 3.03 0 C-N-CA 123.636 0.775 . . . . 0.0 110.297 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.03 -46.67 58.13 Favored Glycine 1 N--CA 1.516 4.024 0 C-N-CA 123.96 0.79 . . . . 0.0 114.935 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 8.1 tp -70.97 -41.56 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.07 -41.07 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 C-N-CA 123.082 0.553 . . . . 0.0 112.335 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.94 -33.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.18 -28.21 41.46 Favored Glycine 1 N--CA 1.516 4.022 0 C-N-CA 124.54 1.066 . . . . 0.0 113.754 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 5.3 m -58.58 -37.04 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.789 0 CA-C-N 117.482 0.641 . . . . 0.0 111.587 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 7.7 t -55.78 -44.3 77.61 Favored 'General case' 0 N--CA 1.538 3.968 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.27 -31.72 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 C-N-CA 123.355 0.662 . . . . 0.0 110.85 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.76 -46.68 77.83 Favored 'General case' 0 N--CA 1.535 3.785 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.04 74.26 Favored 'General case' 0 N--CA 1.514 2.763 0 C-N-CA 123.529 0.732 . . . . 0.0 111.526 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 38.0 t -64.49 -47.77 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.682 0 C-N-CA 123.49 0.716 . . . . 0.0 110.663 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.48 -32.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 123.586 0.755 . . . . 0.0 109.995 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 36.1 tp -76.81 -33.87 57.96 Favored 'General case' 0 N--CA 1.516 2.865 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 tp -54.84 -43.83 69.48 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 C-N-CA 123.455 0.702 . . . . 0.0 112.267 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 12.6 m -64.73 -37.47 80.23 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.152 0 O-C-N 121.957 -0.464 . . . . 0.0 110.542 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.04 -32.27 67.83 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 122.949 0.5 . . . . 0.0 111.127 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.2 -35.0 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.789 0 C-N-CA 122.739 0.416 . . . . 0.0 110.256 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -72.11 -38.91 69.22 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 123.281 0.632 . . . . 0.0 109.672 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.11 -37.37 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 C-N-CA 124.136 0.974 . . . . 0.0 109.634 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.68 -38.39 78.11 Favored 'General case' 0 N--CA 1.523 3.19 0 C-N-CA 122.781 0.432 . . . . 0.0 110.081 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -74.2 -37.33 63.93 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 122.978 0.511 . . . . 0.0 110.114 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 32.1 t -64.23 -41.48 96.99 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.9 tp -65.19 -16.26 63.33 Favored 'General case' 0 N--CA 1.522 3.129 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.767 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.29 -23.55 14.38 Favored 'General case' 1 N--CA 1.557 4.92 0 C-N-CA 124.262 1.025 . . . . 0.0 108.655 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -108.19 94.58 5.15 Favored 'General case' 0 N--CA 1.53 3.561 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 26.07 0.09 Allowed 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.599 0.76 . . . . 0.0 110.841 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -54.57 154.41 4.88 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 124.143 0.977 . . . . 0.0 112.302 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.47 138.49 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 49.3 mt -94.34 146.53 31.71 Favored Pre-proline 0 N--CA 1.529 3.488 0 CA-C-O 117.399 -1.286 . . . . 0.0 108.554 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 1 N--CA 1.54 4.246 0 C-N-CA 122.101 1.867 . . . . 0.0 110.734 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.14 173.29 13.18 Favored 'Trans proline' 1 N--CA 1.539 4.159 0 C-N-CA 122.074 1.85 . . . . 0.0 110.392 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -175.29 36.64 0.1 Allowed Glycine 1 N--CA 1.519 4.172 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 60.0 p 56.44 67.44 1.0 Allowed 'General case' 0 N--CA 1.522 3.145 0 C-N-CA 124.317 1.047 . . . . 0.0 111.711 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.03 -26.69 68.68 Favored 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 123.982 0.913 . . . . 0.0 109.735 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 64.0 m -60.45 -26.66 66.91 Favored 'General case' 0 N--CA 1.522 3.157 0 C-N-CA 123.542 0.737 . . . . 0.0 110.924 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.53 -42.17 82.04 Favored Glycine 0 N--CA 1.513 3.775 0 C-N-CA 124.262 0.934 . . . . 0.0 115.385 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -46.38 69.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.239 0 CA-C-N 118.192 0.996 . . . . 0.0 111.546 -176.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 19.7 tt -61.05 -35.55 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.14 -33.15 45.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.063 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.25 -47.41 90.98 Favored Glycine 0 N--CA 1.513 3.791 0 C-N-CA 123.831 0.729 . . . . 0.0 113.29 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 15.1 m -68.83 -37.1 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 CA-C-N 118.119 0.96 . . . . 0.0 110.141 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 37.9 m -62.04 -46.29 89.83 Favored 'General case' 0 N--CA 1.516 2.875 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.469 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 11.8 p -69.67 -31.55 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.546 0 CA-C-N 117.973 0.351 . . . . 0.0 110.572 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.9 70.82 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 122.635 0.374 . . . . 0.0 111.45 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.22 -37.74 86.26 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 123.558 0.743 . . . . 0.0 110.911 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.66 -42.8 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.376 0 C-N-CA 123.597 0.759 . . . . 0.0 110.563 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.08 -44.49 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.285 0.634 . . . . 0.0 111.361 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.2 -35.22 63.91 Favored 'General case' 0 N--CA 1.523 3.203 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 17.9 tt -69.63 -40.3 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 CA-C-N 118.627 0.649 . . . . 0.0 111.162 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.59 -36.97 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 O-C-N 121.942 -0.473 . . . . 0.0 109.948 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.45 82.22 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.945 0.898 . . . . 0.0 112.798 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.68 -34.18 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 O-C-N 121.915 -0.49 . . . . 0.0 110.084 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -64.38 -43.85 93.18 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.015 0.526 . . . . 0.0 112.316 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.59 -37.38 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.832 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 98.5 m -60.05 -28.84 68.11 Favored 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 122.768 0.427 . . . . 0.0 110.945 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -72.83 -32.46 65.51 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.988 0.515 . . . . 0.0 110.564 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 32.1 t -63.75 -17.76 63.36 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 123.159 0.584 . . . . 0.0 112.33 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.62 -20.79 65.12 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 123.503 0.721 . . . . 0.0 112.72 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.44 -5.22 58.92 Favored 'General case' 1 N--CA 1.544 4.262 0 CA-C-N 118.723 0.692 . . . . 0.0 111.116 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -64.89 -16.16 62.88 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.5 0.72 . . . . 0.0 110.622 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.44 161.2 14.72 Favored 'General case' 0 N--CA 1.523 3.199 0 C-N-CA 123.937 0.895 . . . . 0.0 110.651 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.9 168.28 15.58 Favored 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.901 0.88 . . . . 0.0 110.057 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.2 138.48 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.407 0 C-N-CA 124.859 1.264 . . . . 0.0 108.202 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.36 146.51 31.66 Favored Pre-proline 0 N--CA 1.529 3.513 0 CA-C-O 116.579 -1.677 . . . . 0.0 107.095 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 1 N--CA 1.549 4.773 0 C-N-CA 123.015 2.477 . . . . 0.0 114.905 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 CA--C 1.573 1.836 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.62 154.44 12.12 Favored 'Trans proline' 1 N--CA 1.542 4.38 0 C-N-CA 122.356 2.037 . . . . 0.0 113.086 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.7 67.52 2.05 Favored Glycine 1 N--CA 1.517 4.091 0 C-N-CA 123.678 0.656 . . . . 0.0 112.025 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 87.8 p -64.26 -78.2 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.757 0.823 . . . . 0.0 110.991 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.19 -26.8 68.31 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 124.33 1.052 . . . . 0.0 110.714 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 65.6 m -57.89 -38.47 75.86 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 123.735 0.814 . . . . 0.0 111.254 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.87 -35.72 80.17 Favored Glycine 1 N--CA 1.518 4.147 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.212 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.31 -46.61 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.323 0 C-N-CA 124.072 0.949 . . . . 0.0 112.773 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.3 tt -66.45 -35.22 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.82 -32.95 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.9 -36.49 60.33 Favored Glycine 0 N--CA 1.514 3.854 0 C-N-CA 123.738 0.685 . . . . 0.0 114.683 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.47 -37.56 79.88 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.159 0 CA-C-N 118.214 1.007 . . . . 0.0 110.94 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 26.5 p -63.86 -45.82 87.75 Favored 'General case' 0 N--CA 1.527 3.402 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.931 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 50.9 t -66.92 -31.56 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.163 0 C-N-CA 124.426 1.09 . . . . 0.0 111.328 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.91 -43.07 65.94 Favored 'General case' 0 N--CA 1.532 3.647 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.47 -45.58 65.44 Favored 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 123.188 0.595 . . . . 0.0 110.364 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.97 -47.55 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 124.307 1.043 . . . . 0.0 112.969 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.55 -32.21 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.922 0 CA-C-N 118.093 0.406 . . . . 0.0 110.954 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 83.9 mt -68.67 -33.95 74.86 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 122.579 0.352 . . . . 0.0 110.383 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 46.6 mm -55.01 -39.79 51.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.232 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.01 -41.61 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.127 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.1 94.52 Favored 'General case' 0 N--CA 1.528 3.461 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.96 -34.12 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 O-C-N 121.718 -0.614 . . . . 0.0 109.476 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -63.03 -43.67 98.05 Favored 'General case' 0 N--CA 1.53 3.548 0 C-N-CA 123.103 0.561 . . . . 0.0 112.327 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.4 -37.57 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.7 m -61.51 -31.08 71.07 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.002 0.521 . . . . 0.0 110.358 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -73.86 -41.29 62.43 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 66.7 m -64.69 -32.62 74.37 Favored 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 123.482 0.713 . . . . 0.0 109.843 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -72.29 -29.45 63.88 Favored 'General case' 0 N--CA 1.524 3.27 0 C-N-CA 123.862 0.865 . . . . 0.0 109.287 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 56.3 tp -87.11 -21.35 26.06 Favored 'General case' 0 N--CA 1.533 3.694 0 C-N-CA 123.848 0.859 . . . . 0.0 110.533 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -62.55 -13.08 26.93 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.48 0.712 . . . . 0.0 110.819 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -59.62 -101.61 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 124.165 0.986 . . . . 0.0 110.546 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -72.5 162.49 29.41 Favored 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 123.662 0.785 . . . . 0.0 109.575 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.19 138.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 C-N-CA 124.786 1.234 . . . . 0.0 108.169 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 58.5 tp -95.28 104.91 16.89 Favored Pre-proline 0 N--CA 1.529 3.514 0 CA-C-O 117.223 -1.37 . . . . 0.0 108.253 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo . . . . . 1 N--CA 1.537 4.059 0 CA-C-N 122.766 2.024 . . . . 0.0 111.063 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.37 -178.48 0.03 OUTLIER 'Trans proline' 1 N--CA 1.546 4.561 0 C-N-CA 122.462 2.108 . . . . 0.0 113.903 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 71.6 166.74 8.0 Favored Glycine 1 N--CA 1.516 4.024 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.067 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 72.4 m -163.63 -1.13 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 123.934 0.894 . . . . 0.0 110.244 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 40.6 mt -64.98 -26.93 68.5 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.727 0.811 . . . . 0.0 110.54 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 69.6 m -68.5 -30.82 69.74 Favored 'General case' 0 N--CA 1.518 2.968 0 C-N-CA 123.753 0.821 . . . . 0.0 110.396 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.57 -46.33 62.78 Favored Glycine 0 N--CA 1.515 3.955 0 C-N-CA 124.3 0.952 . . . . 0.0 114.912 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 19.3 tt -71.01 -40.48 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.22 -40.28 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 C-N-CA 122.9 0.48 . . . . 0.0 112.075 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.1 tt -72.79 -32.8 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.47 -28.4 44.33 Favored Glycine 0 N--CA 1.51 3.572 0 C-N-CA 124.689 1.138 . . . . 0.0 113.442 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.6 m -58.87 -37.21 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.801 0 CA-C-N 117.339 0.569 . . . . 0.0 111.128 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 65.1 p -61.19 -46.39 90.68 Favored 'General case' 0 N--CA 1.533 3.72 0 CA-C-O 121.258 0.551 . . . . 0.0 110.926 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.75 -31.82 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 C-N-CA 124.545 1.138 . . . . 0.0 110.873 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.92 -42.02 71.7 Favored 'General case' 0 N--CA 1.531 3.623 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.67 90.92 Favored 'General case' 0 N--CA 1.517 2.906 0 C-N-CA 123.56 0.744 . . . . 0.0 111.169 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 26.5 t -58.63 -51.7 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.559 0.744 . . . . 0.0 111.63 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -67.06 -31.97 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 C-N-CA 123.078 0.551 . . . . 0.0 110.567 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.12 -35.46 61.7 Favored 'General case' 0 N--CA 1.533 3.718 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.68 -48.21 72.24 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.578 0 O-C-N 121.593 -0.692 . . . . 0.0 110.976 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 12.4 m -65.77 -36.35 77.35 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.042 0 O-C-N 121.902 -0.499 . . . . 0.0 110.378 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.01 68.14 Favored 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 122.865 0.466 . . . . 0.0 111.434 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.3 -34.82 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 C-N-CA 122.882 0.473 . . . . 0.0 110.41 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -72.66 -43.26 63.4 Favored 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.183 0.593 . . . . 0.0 112.399 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.83 -37.21 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 O-C-N 122.165 -0.335 . . . . 0.0 111.383 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 28.1 p -66.98 -27.71 67.66 Favored 'General case' 0 N--CA 1.53 3.548 0 O-C-N 122.311 -0.243 . . . . 0.0 110.971 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -68.53 -30.51 69.32 Favored 'General case' 0 N--CA 1.531 3.604 0 C-N-CA 123.029 0.532 . . . . 0.0 110.055 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 39.6 t -67.53 -39.62 85.06 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-O 121.437 0.637 . . . . 0.0 110.166 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -13.69 13.4 Favored 'General case' 0 N--CA 1.535 3.805 0 C-N-CA 125.567 1.547 . . . . 0.0 111.339 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 54.3 tp -86.77 -16.85 35.05 Favored 'General case' 1 N--CA 1.544 4.262 0 C-N-CA 123.656 0.782 . . . . 0.0 110.178 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -143.1 78.93 1.63 Allowed 'General case' 0 N--CA 1.52 3.043 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -147.13 -21.66 0.4 Allowed 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 124.482 1.113 . . . . 0.0 110.183 -175.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -70.13 100.59 1.67 Allowed 'General case' 0 N--CA 1.524 3.259 0 C-N-CA 123.835 0.854 . . . . 0.0 109.284 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 8.1 p -135.49 138.2 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 124.704 1.201 . . . . 0.0 108.739 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 75.6 mt -102.25 99.93 14.06 Favored Pre-proline 0 N--CA 1.527 3.376 0 C-N-CA 124.849 1.259 . . . . 0.0 108.606 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 N--CA 1.535 3.942 0 C-N-CA 122.433 2.089 . . . . 0.0 110.869 -179.262 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.181 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.55 125.84 10.99 Favored 'Trans proline' 1 N--CA 1.538 4.14 0 C-N-CA 121.931 1.754 . . . . 0.0 110.47 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.38 141.63 15.98 Favored Glycine 1 N--CA 1.518 4.154 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 47.8 t -168.38 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 CA-C-N 117.692 0.746 . . . . 0.0 110.305 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 tt -54.67 -28.47 47.68 Favored 'General case' 0 N--CA 1.53 3.558 0 C-N-CA 123.647 0.779 . . . . 0.0 111.234 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 46.5 t -66.52 -42.22 87.63 Favored 'General case' 0 N--CA 1.52 3.026 0 C-N-CA 123.734 0.813 . . . . 0.0 110.522 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.38 69.18 Favored Glycine 1 N--CA 1.517 4.099 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.65 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.96 -46.29 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.306 0 C-N-CA 124.003 0.921 . . . . 0.0 111.556 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -32.79 58.5 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.016 0 CA-C-O 121.268 0.556 . . . . 0.0 109.704 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 6.3 mm -71.94 -37.0 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 C-N-CA 123.863 0.865 . . . . 0.0 109.314 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.7 -29.87 71.07 Favored Glycine 1 N--CA 1.517 4.08 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.685 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.1 m -62.56 -36.19 73.83 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.285 0 CA-C-N 117.881 0.841 . . . . 0.0 110.564 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.442 ' HG1' ' N ' ' A' ' 220' ' ' VAL . 43.3 p -55.02 -44.18 74.36 Favored 'General case' 0 N--CA 1.528 3.427 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.24 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.442 ' N ' ' HG1' ' A' ' 219' ' ' THR . 41.5 t -66.16 -36.1 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.414 0 C-N-CA 123.771 0.828 . . . . 0.0 111.061 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.84 -44.43 66.72 Favored 'General case' 0 N--CA 1.533 3.675 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.95 -37.04 78.59 Favored 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 123.08 0.552 . . . . 0.0 111.541 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.3 t -67.15 -47.17 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 C-N-CA 123.106 0.563 . . . . 0.0 111.974 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.37 -35.85 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 CA-C-N 118.058 0.39 . . . . 0.0 111.006 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.8 mt -60.98 -34.44 74.78 Favored 'General case' 0 N--CA 1.539 3.978 0 CA-C-N 117.91 0.323 . . . . 0.0 110.949 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.26 -36.28 77.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 O-C-N 121.829 -0.544 . . . . 0.0 109.779 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.66 -37.68 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.701 0 C-N-CA 122.955 0.502 . . . . 0.0 110.182 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.41 79.98 Favored 'General case' 0 N--CA 1.53 3.556 0 C-N-CA 123.621 0.768 . . . . 0.0 112.582 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 26.3 m -71.76 -34.1 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.601 0 O-C-N 121.938 -0.476 . . . . 0.0 110.176 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.25 -44.01 97.53 Favored 'General case' 0 N--CA 1.53 3.564 0 C-N-CA 123.057 0.543 . . . . 0.0 112.416 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.73 -37.62 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.739 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -63.41 -27.87 69.59 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 123.066 0.546 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -63.35 -23.59 67.48 Favored 'General case' 0 N--CA 1.533 3.705 0 C-N-CA 123.103 0.561 . . . . 0.0 110.829 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 41.5 m -66.68 -40.27 88.49 Favored 'General case' 0 N--CA 1.526 3.358 0 CA-C-O 121.402 0.62 . . . . 0.0 109.847 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 44.5 mt -63.15 -23.98 67.68 Favored 'General case' 0 N--CA 1.524 3.239 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.289 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 46.4 tp -87.86 9.12 23.04 Favored 'General case' 0 N--CA 1.536 3.846 0 C-N-CA 124.057 0.943 . . . . 0.0 109.455 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -139.66 69.16 1.36 Allowed 'General case' 0 N--CA 1.532 3.626 0 C-N-CA 124.5 1.12 . . . . 0.0 109.816 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -84.83 -63.48 1.33 Allowed 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -168.82 168.11 10.67 Favored 'General case' 0 N--CA 1.521 3.117 0 C-N-CA 124.154 0.982 . . . . 0.0 108.821 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.13 138.29 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.603 0 C-N-CA 124.573 1.149 . . . . 0.0 108.761 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -94.61 146.44 31.45 Favored Pre-proline 0 N--CA 1.533 3.701 0 C-N-CA 124.798 1.239 . . . . 0.0 109.498 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 1 N--CA 1.541 4.295 0 CA-C-N 122.223 1.829 . . . . 0.0 110.65 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 CA--C 1.574 1.872 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.96 112.33 3.38 Favored 'Trans proline' 1 N--CA 1.538 4.12 0 C-N-CA 122.173 1.915 . . . . 0.0 110.627 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.15 147.16 0.07 OUTLIER Glycine 1 N--CA 1.517 4.054 0 C-N-CA 123.882 0.753 . . . . 0.0 111.59 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 69.7 m -167.22 -25.54 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 C-N-CA 124.405 1.082 . . . . 0.0 108.982 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.28 -26.64 68.51 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 124.322 1.049 . . . . 0.0 110.268 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 90.9 p -64.93 -27.95 69.19 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 123.432 0.693 . . . . 0.0 110.82 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.69 -47.41 49.0 Favored Glycine 0 N--CA 1.515 3.904 0 N-CA-C 114.822 0.689 . . . . 0.0 114.822 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 39.3 pt -71.42 -34.63 54.09 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.406 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.6 tt -55.06 -31.83 26.24 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.148 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -32.2 49.16 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.496 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.17 -29.38 44.78 Favored Glycine 0 N--CA 1.51 3.617 0 CA-C-N 115.067 -0.969 . . . . 0.0 114.088 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 6.0 m -59.55 -37.49 70.6 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.021 0 CA-C-N 118.429 1.115 . . . . 0.0 110.551 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 48.3 p -66.13 -45.92 79.33 Favored 'General case' 0 N--CA 1.528 3.433 0 CA-C-O 121.13 0.491 . . . . 0.0 110.497 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 49.5 t -69.42 -32.96 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.178 0 C-N-CA 124.322 1.049 . . . . 0.0 110.415 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.13 76.79 Favored 'General case' 0 N--CA 1.523 3.225 0 C-N-CA 123.363 0.665 . . . . 0.0 111.801 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.92 -30.6 68.05 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.086 0.554 . . . . 0.0 111.005 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 38.8 t -64.01 -50.76 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 C-N-CA 123.302 0.641 . . . . 0.0 111.167 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.35 -32.12 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 C-N-CA 122.738 0.415 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.61 -47.36 26.86 Favored 'General case' 0 N--CA 1.528 3.425 0 C-N-CA 123.515 0.726 . . . . 0.0 111.561 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.6 tt -64.24 -39.02 84.04 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.058 0 O-C-N 121.593 -0.692 . . . . 0.0 112.779 -176.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.8 -36.92 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.738 0 O-C-N 122.087 -0.383 . . . . 0.0 110.375 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.66 74.9 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.282 0.633 . . . . 0.0 112.165 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 48.0 t -71.88 -38.96 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 C-N-CA 122.99 0.516 . . . . 0.0 111.159 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -69.23 -43.46 73.97 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.39 -37.73 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 C-N-CA 122.57 0.348 . . . . 0.0 111.232 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 18.7 p -67.03 -28.78 68.51 Favored 'General case' 0 N--CA 1.529 3.51 0 CA-C-N 117.85 0.295 . . . . 0.0 111.203 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -63.52 -29.47 70.73 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 123.301 0.64 . . . . 0.0 111.139 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.4 t -65.28 -33.33 75.72 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.384 0.674 . . . . 0.0 111.215 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 51.0 mt -65.72 -18.39 65.3 Favored 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 123.724 0.81 . . . . 0.0 111.931 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.2 mp -87.39 -28.35 22.23 Favored 'General case' 0 N--CA 1.539 3.995 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 51.7 t90 -87.17 58.8 5.23 Favored 'General case' 0 N--CA 1.526 3.349 0 C-N-CA 124.004 0.921 . . . . 0.0 108.88 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -67.21 -102.78 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 123.757 0.823 . . . . 0.0 110.318 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 58.28 108.37 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 124.437 1.095 . . . . 0.0 111.185 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.15 138.63 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 125.142 1.377 . . . . 0.0 108.393 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.25 147.41 64.96 Favored Pre-proline 0 N--CA 1.534 3.768 0 CA-C-O 116.81 -1.567 . . . . 0.0 109.161 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo . . . . . 1 N--CA 1.55 4.851 0 C-N-CA 123.13 2.553 . . . . 0.0 115.37 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 CA--C 1.575 1.91 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -82.34 16.29 1.82 Allowed 'Trans proline' 1 N--CA 1.537 4.05 0 C-N-CA 122.553 2.169 . . . . 0.0 111.089 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.79 39.39 1.11 Allowed Glycine 1 N--CA 1.518 4.103 0 C-N-CA 123.97 0.795 . . . . 0.0 111.994 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 74.8 m -163.56 170.13 17.68 Favored 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 123.841 0.857 . . . . 0.0 109.276 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.29 -26.28 68.0 Favored 'General case' 0 N--CA 1.522 3.158 0 C-N-CA 124.261 1.024 . . . . 0.0 109.896 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 57.7 m -58.39 -27.22 64.05 Favored 'General case' 0 N--CA 1.521 3.077 0 C-N-CA 123.403 0.681 . . . . 0.0 111.293 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.67 -48.15 44.64 Favored Glycine 0 N--CA 1.513 3.83 0 CA-C-N 116.137 -0.483 . . . . 0.0 114.218 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 38.5 pt -72.74 -36.9 54.07 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 N-CA-C 115.618 1.711 . . . . 0.0 115.618 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 8.4 tp -56.52 -31.56 34.29 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 14.8 tt -58.98 -32.14 46.98 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.317 0 CA-C-N 119.078 0.854 . . . . 0.0 110.204 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.99 -27.39 37.39 Favored Glycine 1 N--CA 1.518 4.145 0 C-N-CA 123.674 0.654 . . . . 0.0 112.497 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 8.6 p -58.4 -44.83 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.77 0 C-N-CA 123.505 0.722 . . . . 0.0 112.888 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 9.7 t -66.24 -40.73 90.42 Favored 'General case' 0 N--CA 1.536 3.871 0 CA-C-N 118.51 0.595 . . . . 0.0 110.752 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 41.8 t -69.68 -32.28 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 C-N-CA 123.883 0.873 . . . . 0.0 110.764 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.4 -41.7 73.05 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.26 -34.56 74.97 Favored 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 123.202 0.601 . . . . 0.0 111.049 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.29 -52.35 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.088 0.555 . . . . 0.0 111.462 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.58 -31.97 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 122.956 0.502 . . . . 0.0 110.683 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.61 -46.1 91.53 Favored 'General case' 0 N--CA 1.534 3.728 0 C-N-CA 123.407 0.683 . . . . 0.0 110.807 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.49 -36.4 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 O-C-N 121.769 -0.582 . . . . 0.0 110.389 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.86 -38.0 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 122.948 0.499 . . . . 0.0 110.168 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.57 81.17 Favored 'General case' 0 N--CA 1.531 3.615 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.34 -34.3 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.854 0 O-C-N 122.088 -0.383 . . . . 0.0 110.017 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.85 -39.4 93.5 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 123.172 0.589 . . . . 0.0 109.545 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 9.4 t -68.17 -40.08 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 124.298 1.039 . . . . 0.0 109.199 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.44 -34.2 77.24 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 122.92 0.488 . . . . 0.0 109.895 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -73.51 -41.65 62.79 Favored 'General case' 0 N--CA 1.522 3.162 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.156 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.2 t -68.47 -45.9 71.18 Favored 'General case' 0 N--CA 1.528 3.473 0 CA-C-O 122.164 0.983 . . . . 0.0 109.389 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 39.7 tp -61.2 -12.94 14.74 Favored 'General case' 0 N--CA 1.521 3.108 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.872 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 40.8 tp -85.15 8.09 19.42 Favored 'General case' 1 N--CA 1.546 4.329 0 CA-C-N 118.369 0.531 . . . . 0.0 110.755 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -158.26 132.59 8.1 Favored 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -152.59 -18.78 0.16 Allowed 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 125.109 1.364 . . . . 0.0 108.235 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -65.99 -167.8 0.04 OUTLIER 'General case' 0 N--CA 1.52 3.053 0 C-N-CA 124.629 1.172 . . . . 0.0 110.187 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 70.1 t -112.63 130.32 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 52.2 mt -94.64 146.66 31.84 Favored Pre-proline 0 N--CA 1.526 3.331 0 CA-C-O 117.434 -1.27 . . . . 0.0 108.501 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 1 N--CA 1.542 4.356 0 C-N-CA 122.015 1.81 . . . . 0.0 110.779 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 18.0 ptt? . . . . . 0 CA--C 1.578 2.038 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.12 168.94 0.11 Allowed 'Trans proline' 1 N--CA 1.546 4.596 0 C-N-CA 122.689 2.259 . . . . 0.0 113.84 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -173.35 45.43 0.16 Allowed Glycine 1 N--CA 1.52 4.278 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 77.2 p 55.16 66.99 1.08 Allowed 'General case' 0 N--CA 1.523 3.214 0 C-N-CA 124.357 1.063 . . . . 0.0 112.326 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.16 -26.36 68.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.121 0.969 . . . . 0.0 109.553 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 41.3 t -57.42 -25.88 60.27 Favored 'General case' 0 N--CA 1.522 3.164 0 C-N-CA 123.976 0.911 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.68 -34.33 83.12 Favored Glycine 0 N--CA 1.515 3.929 0 C-N-CA 124.293 0.949 . . . . 0.0 114.145 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -46.42 90.81 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.3 0 CA-C-N 117.851 0.825 . . . . 0.0 112.183 -175.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -66.73 -31.87 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.732 0 C-N-CA 123.023 0.529 . . . . 0.0 110.542 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 47.9 mm -68.3 -33.81 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.851 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.59 -45.64 92.41 Favored Glycine 1 N--CA 1.519 4.184 0 C-N-CA 123.226 0.441 . . . . 0.0 113.479 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 11.8 m -69.2 -36.85 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 0 O-C-N 121.549 -0.971 . . . . 0.0 109.914 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 95.4 m -58.64 -46.43 87.15 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 30.4 m -67.6 -30.8 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 123.278 0.631 . . . . 0.0 111.203 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.62 74.01 Favored 'General case' 0 N--CA 1.532 3.669 0 O-C-N 121.683 -0.635 . . . . 0.0 111.572 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.38 -50.04 73.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.71 0.804 . . . . 0.0 112.943 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 15.6 m -58.36 -37.61 64.57 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 CA-C-N 119.155 0.888 . . . . 0.0 110.491 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.48 -32.08 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 122.611 0.365 . . . . 0.0 110.873 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.2 -41.13 70.68 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 40.3 mm -55.31 -51.01 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 C-N-CA 123.349 0.66 . . . . 0.0 112.069 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 31.5 m -61.79 -35.75 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.965 0 C-N-CA 122.988 0.515 . . . . 0.0 110.673 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.88 -31.6 65.0 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.1 0.56 . . . . 0.0 111.414 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.03 -34.63 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 C-N-CA 122.758 0.423 . . . . 0.0 111.374 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -66.34 -43.96 84.64 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 122.951 0.5 . . . . 0.0 111.954 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 6.3 p -68.76 -36.74 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 118.76 0.709 . . . . 0.0 109.149 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 80.3 m -58.45 -27.6 64.52 Favored 'General case' 0 N--CA 1.531 3.615 0 C-N-CA 122.708 0.403 . . . . 0.0 110.969 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -62.98 -19.02 63.92 Favored 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 123.173 0.589 . . . . 0.0 110.739 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 37.2 m -64.14 -37.94 89.28 Favored 'General case' 0 N--CA 1.527 3.394 0 C-N-CA 123.564 0.745 . . . . 0.0 110.568 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.91 -28.81 69.21 Favored 'General case' 0 N--CA 1.534 3.747 0 C-N-CA 123.913 0.885 . . . . 0.0 109.841 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.35 -5.93 58.69 Favored 'General case' 0 N--CA 1.537 3.905 0 C-N-CA 124.466 1.106 . . . . 0.0 110.932 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -53.15 -12.72 0.4 Allowed 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 123.964 0.906 . . . . 0.0 112.872 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.37 137.65 52.33 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.392 0.677 . . . . 0.0 110.981 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -83.94 121.88 27.97 Favored 'General case' 0 N--CA 1.521 3.106 0 C-N-CA 123.975 0.91 . . . . 0.0 109.131 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.08 138.2 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 124.882 1.273 . . . . 0.0 108.141 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 65.8 mt -124.86 146.78 54.31 Favored Pre-proline 0 N--CA 1.532 3.651 0 C-N-CA 125.137 1.375 . . . . 0.0 107.961 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 1 N--CA 1.54 4.218 0 C-N-CA 122.038 1.826 . . . . 0.0 110.672 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.578 2.053 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -81.29 171.65 13.56 Favored 'Trans proline' 0 N--CA 1.535 3.97 0 C-N-CA 122.568 2.178 . . . . 0.0 110.647 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.5 -166.23 3.94 Favored Glycine 1 N--CA 1.519 4.197 0 C-N-CA 123.855 0.74 . . . . 0.0 111.502 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 47.2 t -163.26 54.6 0.18 Allowed 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 121.948 0.88 . . . . 0.0 109.582 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.85 -26.54 68.37 Favored 'General case' 0 N--CA 1.525 3.286 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.589 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 69.8 m -64.71 -30.93 71.96 Favored 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 123.57 0.748 . . . . 0.0 110.933 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.77 -46.97 58.54 Favored Glycine 1 N--CA 1.517 4.047 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.47 -41.52 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 8.1 tp -62.23 -39.19 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.844 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.2 tt -72.03 -33.2 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.818 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.76 -29.8 55.32 Favored Glycine 0 N--CA 1.512 3.747 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.536 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 2.0 m -63.77 -37.56 80.02 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.062 0 CA-C-N 117.768 0.784 . . . . 0.0 110.425 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 31.2 p -60.97 -46.61 90.03 Favored 'General case' 0 N--CA 1.528 3.449 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.37 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.26 -40.17 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.202 0 C-N-CA 124.033 0.933 . . . . 0.0 110.831 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.01 66.83 Favored 'General case' 0 N--CA 1.524 3.255 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.44 -41.51 76.18 Favored 'General case' 0 N--CA 1.514 2.738 0 C-N-CA 122.921 0.488 . . . . 0.0 111.58 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.75 -46.91 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.504 0 O-C-N 122.089 -0.382 . . . . 0.0 111.834 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.42 -32.44 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.626 0 CA-C-N 117.9 0.318 . . . . 0.0 111.697 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 32.9 tp -74.72 -39.25 61.99 Favored 'General case' 0 N--CA 1.521 3.083 0 CA-C-O 119.209 -0.424 . . . . 0.0 112.014 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 81.8 mt -64.87 -43.8 96.3 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.244 0 CA-C-N 118.945 0.793 . . . . 0.0 111.026 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.3 -36.7 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 117.969 0.349 . . . . 0.0 110.318 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.29 65.79 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.362 0.665 . . . . 0.0 111.941 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.6 -40.76 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.905 0 CA-C-N 117.929 0.331 . . . . 0.0 110.219 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -69.44 -36.18 76.4 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.274 0.63 . . . . 0.0 110.436 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.5 -37.5 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.27 0 C-N-CA 123.744 0.818 . . . . 0.0 109.635 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 72.7 m -58.06 -32.04 67.64 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 122.511 0.325 . . . . 0.0 110.146 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.3 -41.63 60.84 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 60.2 p -68.24 -32.87 73.37 Favored 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 123.257 0.623 . . . . 0.0 110.206 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.54 -37.54 81.57 Favored 'General case' 0 N--CA 1.535 3.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.624 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 3.2 pp -91.28 -28.13 17.97 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.686 0.794 . . . . 0.0 109.733 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 51.27 8.87 0.05 Allowed 'General case' 0 N--CA 1.529 3.497 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -65.31 164.31 13.77 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-N 118.798 0.726 . . . . 0.0 110.742 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -138.52 157.84 45.4 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 125.045 1.338 . . . . 0.0 107.488 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.33 138.13 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.56 0 C-N-CA 124.533 1.133 . . . . 0.0 109.216 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 46.1 tp -112.82 99.85 49.25 Favored Pre-proline 0 N--CA 1.531 3.587 0 C-N-CA 125.314 1.446 . . . . 0.0 107.433 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo . . . . . 0 N--CA 1.534 3.905 0 C-N-CA 122.274 1.983 . . . . 0.0 110.857 -179.106 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 CA--C 1.574 1.885 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.42 38.29 0.6 Allowed 'Trans proline' 1 N--CA 1.543 4.413 0 C-N-CA 122.27 1.98 . . . . 0.0 110.936 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 171.65 160.39 20.07 Favored Glycine 1 N--CA 1.519 4.193 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 89.8 p -168.59 161.24 11.38 Favored 'General case' 0 N--CA 1.522 3.158 0 C-N-CA 123.692 0.797 . . . . 0.0 109.237 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.01 -25.99 68.09 Favored 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 124.437 1.095 . . . . 0.0 111.628 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 39.7 t -67.36 -33.31 74.97 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 123.469 0.708 . . . . 0.0 111.145 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.73 -44.63 69.34 Favored Glycine 1 N--CA 1.519 4.225 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -44.63 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.997 0 O-C-N 121.759 -0.847 . . . . 0.0 111.776 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 18.8 tt -60.68 -36.42 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 45.3 pt -72.48 -33.44 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 CA-C-N 118.699 0.681 . . . . 0.0 109.32 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.23 -48.65 84.5 Favored Glycine 1 N--CA 1.519 4.195 0 C-N-CA 123.835 0.731 . . . . 0.0 113.855 -177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.35 -36.79 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 C-N-CA 122.973 0.509 . . . . 0.0 109.803 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 90.3 m -64.1 -47.16 81.12 Favored 'General case' 0 N--CA 1.519 3.02 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -70.64 -31.48 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 CA-C-N 118.1 0.409 . . . . 0.0 111.191 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.45 -34.91 50.99 Favored 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.79 -38.62 85.95 Favored 'General case' 0 N--CA 1.523 3.194 0 C-N-CA 123.318 0.647 . . . . 0.0 111.0 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.66 -38.53 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.32 0 C-N-CA 123.697 0.799 . . . . 0.0 110.314 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.8 -37.53 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 123.469 0.708 . . . . 0.0 111.312 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 57.6 mt -72.87 -35.13 67.11 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 122.33 0.252 . . . . 0.0 111.208 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.47 -46.52 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.69 0 C-N-CA 123.08 0.552 . . . . 0.0 110.717 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 33.2 m -67.48 -37.27 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 O-C-N 121.687 -0.633 . . . . 0.0 110.225 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.93 95.25 Favored 'General case' 0 N--CA 1.524 3.23 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 18.3 m -71.32 -34.08 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 O-C-N 121.574 -0.704 . . . . 0.0 110.069 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -63.42 -44.32 94.95 Favored 'General case' 0 N--CA 1.528 3.431 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 13.0 m -68.67 -37.97 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 CA-C-N 118.643 0.656 . . . . 0.0 109.919 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 92.9 m -62.88 -27.54 69.42 Favored 'General case' 0 N--CA 1.522 3.14 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.99 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.79 -38.33 88.71 Favored 'General case' 0 N--CA 1.528 3.469 0 CA-C-O 120.939 0.4 . . . . 0.0 110.297 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 47.1 t -66.38 -36.73 83.59 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.632 0.773 . . . . 0.0 110.678 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.82 -13.67 16.88 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.847 0.859 . . . . 0.0 111.675 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 20.2 mt -86.6 -2.67 58.69 Favored 'General case' 0 N--CA 1.537 3.898 0 C-N-CA 123.059 0.543 . . . . 0.0 110.659 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -165.89 120.3 1.2 Allowed 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 123.441 0.696 . . . . 0.0 109.264 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.34 23.59 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.211 1.005 . . . . 0.0 109.141 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -167.83 141.17 3.32 Favored 'General case' 0 N--CA 1.521 3.099 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.41 138.5 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 C-N-CA 124.876 1.27 . . . . 0.0 108.457 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 60.2 tp -105.68 99.7 23.13 Favored Pre-proline 0 N--CA 1.531 3.591 0 C-N-CA 125.082 1.353 . . . . 0.0 108.381 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo . . . . . 1 N--CA 1.549 4.741 0 C-N-CA 122.307 2.005 . . . . 0.0 114.01 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 CA--C 1.575 1.938 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.74 166.6 29.33 Favored 'Trans proline' 1 N--CA 1.539 4.161 0 C-N-CA 122.387 2.058 . . . . 0.0 110.475 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.44 24.35 65.71 Favored Glycine 1 N--CA 1.52 4.26 0 C-N-CA 123.686 0.66 . . . . 0.0 112.318 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.4 p -68.98 161.4 28.99 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.786 0.834 . . . . 0.0 110.936 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.44 -26.19 67.85 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 124.73 1.212 . . . . 0.0 109.466 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 40.9 t -57.57 -39.17 76.14 Favored 'General case' 0 N--CA 1.518 2.928 0 C-N-CA 123.934 0.894 . . . . 0.0 112.273 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.36 -38.57 87.3 Favored Glycine 1 N--CA 1.522 4.419 0 C-N-CA 123.208 0.432 . . . . 0.0 112.115 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.18 -46.43 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 C-N-CA 124.107 0.963 . . . . 0.0 111.766 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.97 -31.85 53.76 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.066 0 C-N-CA 123.228 0.611 . . . . 0.0 109.872 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 30.9 mm -72.62 -33.38 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.9 -46.92 79.11 Favored Glycine 1 N--CA 1.518 4.119 0 N-CA-C 114.298 0.479 . . . . 0.0 114.298 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.12 -37.52 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.888 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.3 t -61.12 -38.04 84.94 Favored 'General case' 0 N--CA 1.539 3.989 0 CA-C-N 119.31 0.959 . . . . 0.0 111.464 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 59.6 t -56.67 -36.69 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 C-N-CA 123.067 0.547 . . . . 0.0 110.475 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.5 76.06 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.0 -49.72 71.34 Favored 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.73 -38.45 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.538 0 CA-C-O 119.003 -0.522 . . . . 0.0 112.26 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.25 -33.94 58.57 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.031 0 CA-C-N 119.323 0.965 . . . . 0.0 110.924 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.22 -47.14 71.74 Favored 'General case' 0 N--CA 1.538 3.934 0 CA-C-O 121.745 0.783 . . . . 0.0 109.566 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.2 mt -54.5 -36.77 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 123.305 0.642 . . . . 0.0 111.383 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.84 -39.21 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.919 0 C-N-CA 122.765 0.426 . . . . 0.0 109.886 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.87 97.98 Favored 'General case' 0 N--CA 1.529 3.5 0 C-N-CA 122.853 0.461 . . . . 0.0 111.146 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 50.8 t -71.82 -35.28 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.284 0 C-N-CA 123.221 0.608 . . . . 0.0 110.065 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -64.01 -44.45 92.58 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.96 -38.06 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 81.9 m -67.16 -32.6 73.8 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 123.344 0.658 . . . . 0.0 110.462 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -70.92 -39.72 72.53 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.319 0.648 . . . . 0.0 109.635 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 75.1 m -65.51 -34.91 79.38 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.773 0.829 . . . . 0.0 109.462 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.8 tp -68.99 -14.11 62.85 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 124.444 1.098 . . . . 0.0 109.904 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.3 -22.55 26.7 Favored 'General case' 0 N--CA 1.535 3.8 0 C-N-CA 124.23 1.012 . . . . 0.0 109.592 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -80.88 -8.84 59.83 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.515 0.726 . . . . 0.0 110.142 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -84.84 -65.44 1.01 Allowed 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 124.108 0.963 . . . . 0.0 110.563 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -70.36 65.31 0.28 Allowed 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.934 0.893 . . . . 0.0 111.178 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 m -135.53 137.59 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.904 0 C-N-CA 124.37 1.068 . . . . 0.0 108.607 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 9.1 mp -97.34 106.35 31.6 Favored Pre-proline 0 N--CA 1.528 3.433 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo . . . . . 1 N--CA 1.549 4.76 0 C-N-CA 122.461 2.107 . . . . 0.0 114.455 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.583 2.225 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -85.68 78.54 2.34 Favored 'Trans proline' 0 N--CA 1.534 3.88 0 CA-C-N 122.688 1.996 . . . . 0.0 110.669 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.38 -43.66 98.75 Favored Glycine 1 N--CA 1.518 4.105 0 C-N-CA 123.752 0.692 . . . . 0.0 111.539 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 39.5 t 55.68 -97.05 0.07 Allowed 'General case' 0 N--CA 1.517 2.88 0 C-N-CA 124.102 0.961 . . . . 0.0 112.445 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 47.8 mt -64.63 -28.21 69.46 Favored 'General case' 0 N--CA 1.521 3.098 0 C-N-CA 124.134 0.974 . . . . 0.0 111.286 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 46.5 t -59.02 -44.73 91.76 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.695 0.798 . . . . 0.0 112.371 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.52 -36.92 84.67 Favored Glycine 1 N--CA 1.521 4.353 0 C-N-CA 123.311 0.482 . . . . 0.0 112.248 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.92 -46.08 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 C-N-CA 123.514 0.726 . . . . 0.0 111.45 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.1 tp -68.58 -33.37 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 CA-C-N 118.55 0.614 . . . . 0.0 109.835 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 74.3 mt -68.85 -33.81 61.25 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.128 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.05 -29.71 76.07 Favored Glycine 0 N--CA 1.514 3.897 0 C-N-CA 123.626 0.631 . . . . 0.0 113.208 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -37.18 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 C-N-CA 123.144 0.578 . . . . 0.0 110.157 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 64.5 p -65.09 -47.78 76.04 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.09 -32.95 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 C-N-CA 123.145 0.578 . . . . 0.0 112.427 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.98 -47.1 81.59 Favored 'General case' 0 N--CA 1.526 3.372 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.13 86.54 Favored 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 123.152 0.581 . . . . 0.0 112.018 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -68.41 -53.13 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.291 0 C-N-CA 122.743 0.417 . . . . 0.0 111.939 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.96 -32.54 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -176.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 5.3 tt -69.7 -38.23 76.87 Favored 'General case' 0 N--CA 1.522 3.172 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 85.7 mt -66.38 -36.98 78.67 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.004 0 CA-C-N 118.856 0.753 . . . . 0.0 110.184 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -66.39 -37.8 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.8 86.13 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 123.48 0.712 . . . . 0.0 111.867 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 62.9 t -71.86 -35.09 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.058 0.543 . . . . 0.0 110.145 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -64.33 -44.14 92.44 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.9 -37.54 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.19 -27.14 68.76 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.33 0.652 . . . . 0.0 111.125 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -70.93 -25.97 62.99 Favored 'General case' 0 N--CA 1.529 3.52 0 C-N-CA 122.827 0.451 . . . . 0.0 111.165 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 48.0 m -65.96 -46.32 78.54 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 123.156 0.582 . . . . 0.0 112.152 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.7 pp -68.81 -12.97 62.1 Favored 'General case' 0 N--CA 1.53 3.553 0 C-N-CA 123.897 0.879 . . . . 0.0 112.045 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.8 tp -86.2 -19.32 30.2 Favored 'General case' 0 N--CA 1.536 3.857 0 C-N-CA 123.227 0.611 . . . . 0.0 109.582 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -101.86 61.31 0.88 Allowed 'General case' 0 N--CA 1.528 3.475 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -63.26 72.56 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.264 1.026 . . . . 0.0 111.801 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -72.89 151.06 42.1 Favored 'General case' 0 N--CA 1.525 3.294 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.95 122.27 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.636 0 C-N-CA 124.65 1.18 . . . . 0.0 108.431 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -95.25 105.56 20.57 Favored Pre-proline 0 N--CA 1.529 3.495 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo . . . . . 1 N--CA 1.54 4.258 0 CA-C-N 122.851 2.054 . . . . 0.0 111.288 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.583 2.223 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.93 -162.99 0.02 OUTLIER 'Trans proline' 1 N--CA 1.549 4.772 0 C-N-CA 122.326 2.017 . . . . 0.0 112.817 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.01 -95.57 0.01 OUTLIER Glycine 1 N--CA 1.522 4.391 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 25.1 t 56.85 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.099 0 C-N-CA 124.408 1.083 . . . . 0.0 112.663 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.85 -26.9 68.53 Favored 'General case' 0 N--CA 1.536 3.835 0 C-N-CA 124.267 1.027 . . . . 0.0 109.328 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 92.1 p -67.86 -25.86 65.75 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.552 0.741 . . . . 0.0 110.37 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.92 -46.22 68.25 Favored Glycine 0 N--CA 1.515 3.961 0 C-N-CA 123.729 0.68 . . . . 0.0 114.665 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.9 tt -70.59 -35.74 62.62 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.029 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.55 -44.29 80.39 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.409 0 CA-C-N 118.874 0.761 . . . . 0.0 112.873 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.3 tt -72.41 -32.77 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.88 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.62 -28.84 46.95 Favored Glycine 1 N--CA 1.517 4.082 0 C-N-CA 124.296 0.951 . . . . 0.0 113.158 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.5 m -59.42 -36.7 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.979 0 CA-C-O 121.08 0.467 . . . . 0.0 111.03 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 66.2 p -55.37 -44.6 76.2 Favored 'General case' 0 N--CA 1.527 3.421 0 C-N-CA 123.139 0.576 . . . . 0.0 111.86 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.28 -33.3 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 123.385 0.674 . . . . 0.0 110.529 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.39 83.91 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 122.658 0.383 . . . . 0.0 110.813 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.66 -50.44 73.86 Favored 'General case' 0 N--CA 1.518 2.964 0 C-N-CA 123.393 0.677 . . . . 0.0 112.826 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 34.5 m -68.04 -38.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 CA-C-N 118.288 0.495 . . . . 0.0 111.004 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.33 -38.91 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.798 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 39.3 tp -62.01 -34.9 77.05 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 122.804 0.441 . . . . 0.0 111.416 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.09 -46.21 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.869 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.39 -37.6 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 123.029 0.532 . . . . 0.0 109.943 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.4 -49.86 75.89 Favored 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 123.586 0.754 . . . . 0.0 112.507 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 11.9 p -71.89 -34.38 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 O-C-N 122.05 -0.406 . . . . 0.0 110.882 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -62.91 -44.34 96.36 Favored 'General case' 0 N--CA 1.529 3.488 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.28 -39.69 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.31 -28.38 67.95 Favored 'General case' 0 N--CA 1.522 3.166 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.08 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.64 -31.03 72.07 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 123.179 0.592 . . . . 0.0 111.092 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 39.2 t -63.96 -36.99 85.78 Favored 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 123.631 0.772 . . . . 0.0 111.639 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 50.3 tp -60.66 -24.34 65.51 Favored 'General case' 0 N--CA 1.528 3.436 0 C-N-CA 123.641 0.776 . . . . 0.0 111.848 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.97 8.26 27.19 Favored 'General case' 0 N--CA 1.538 3.95 0 C-N-CA 123.289 0.636 . . . . 0.0 110.036 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -164.43 71.21 0.2 Allowed 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 122.729 0.412 . . . . 0.0 110.171 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -75.42 163.43 27.43 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -74.43 137.13 42.44 Favored 'General case' 0 N--CA 1.522 3.166 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.39 138.4 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.575 0 C-N-CA 124.573 1.149 . . . . 0.0 109.189 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.0 mp -94.37 146.61 31.85 Favored Pre-proline 0 N--CA 1.53 3.559 0 CA-C-O 116.668 -1.634 . . . . 0.0 106.707 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo . . . . . 1 N--CA 1.549 4.772 0 C-N-CA 122.782 2.322 . . . . 0.0 114.807 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.575 1.941 0 CA-C-O 117.725 -1.131 . . . . 0.0 108.117 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.16 -31.55 36.52 Favored 'Trans proline' 1 N--CA 1.547 4.669 0 C-N-CA 121.905 1.737 . . . . 0.0 113.661 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.58 -19.68 67.19 Favored Glycine 1 N--CA 1.523 4.474 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.753 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 40.6 m 60.84 136.07 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.963 0 C-N-CA 124.948 1.299 . . . . 0.0 112.002 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.2 -26.51 68.17 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 124.311 1.044 . . . . 0.0 109.678 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 43.7 t -67.13 -33.08 74.67 Favored 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 123.767 0.827 . . . . 0.0 111.338 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.87 -46.93 58.22 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 114.251 0.461 . . . . 0.0 114.251 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 tt -69.58 -35.28 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.88 0 CA-C-N 117.544 0.672 . . . . 0.0 112.345 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -56.51 -32.22 36.04 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 C-N-CA 123.447 0.699 . . . . 0.0 111.403 -177.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.86 -32.99 60.61 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.319 0 C-N-CA 122.934 0.494 . . . . 0.0 109.702 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.54 -29.33 47.67 Favored Glycine 1 N--CA 1.518 4.118 0 C-N-CA 123.802 0.715 . . . . 0.0 113.227 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.41 -37.49 69.92 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.102 0 C-N-CA 123.134 0.573 . . . . 0.0 110.633 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -59.34 -38.99 81.74 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 123.357 0.663 . . . . 0.0 111.252 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.93 -36.89 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.153 0 C-N-CA 123.783 0.833 . . . . 0.0 111.384 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.15 80.67 Favored 'General case' 0 N--CA 1.527 3.376 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.6 -49.95 42.27 Favored 'General case' 0 N--CA 1.518 2.94 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.4 -38.73 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.836 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.29 -32.25 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -36.09 74.34 Favored 'General case' 0 N--CA 1.534 3.754 0 C-N-CA 123.644 0.778 . . . . 0.0 109.833 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 37.2 mm -61.29 -36.98 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.894 0 C-N-CA 123.35 0.66 . . . . 0.0 110.553 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 40.5 t -66.13 -37.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 123.5 0.72 . . . . 0.0 109.892 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.08 77.85 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.51 0.724 . . . . 0.0 112.446 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.71 -34.32 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 O-C-N 122.125 -0.36 . . . . 0.0 110.646 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.99 -44.25 93.24 Favored 'General case' 0 N--CA 1.528 3.435 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.7 -37.75 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.717 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.15 -27.96 69.43 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.006 0.522 . . . . 0.0 111.227 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.69 -33.41 73.91 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 123.112 0.565 . . . . 0.0 110.762 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 49.8 m -63.79 -31.37 72.52 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.49 0.716 . . . . 0.0 112.173 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.34 -14.89 39.52 Favored 'General case' 0 N--CA 1.536 3.837 0 C-N-CA 123.725 0.81 . . . . 0.0 109.898 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -87.58 -11.65 48.03 Favored 'General case' 0 N--CA 1.533 3.716 0 C-N-CA 123.762 0.825 . . . . 0.0 110.962 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -0.55 0.29 Allowed 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.33 167.49 1.35 Allowed 'General case' 0 N--CA 1.531 3.576 0 C-N-CA 123.423 0.689 . . . . 0.0 111.417 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -69.82 166.68 18.87 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.115 0.966 . . . . 0.0 110.025 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.75 136.29 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 59.6 mt -94.85 146.72 31.88 Favored Pre-proline 0 N--CA 1.529 3.483 0 CA-C-O 117.486 -1.245 . . . . 0.0 108.434 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 1 N--CA 1.54 4.207 0 C-N-CA 122.001 1.801 . . . . 0.0 110.715 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 57.4 mtm . . . . . 0 CA--C 1.583 2.242 0 CA-C-O 117.5 -1.238 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -87.77 -18.0 2.54 Favored 'Trans proline' 1 N--CA 1.536 4.003 0 C-N-CA 122.533 2.155 . . . . 0.0 110.968 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -179.86 164.94 33.12 Favored Glycine 1 N--CA 1.516 4.013 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 95.4 p -168.76 -19.57 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 124.052 0.941 . . . . 0.0 109.56 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.72 -30.05 71.05 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 124.137 0.975 . . . . 0.0 109.9 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 60.4 m -58.37 -26.29 63.0 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 123.207 0.603 . . . . 0.0 110.803 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.29 -34.63 63.32 Favored Glycine 1 N--CA 1.517 4.057 0 C-N-CA 124.121 0.867 . . . . 0.0 113.571 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 13.2 tt -59.59 -44.99 94.48 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.049 0 CA-C-N 117.795 0.797 . . . . 0.0 112.911 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.4 pt -65.68 -34.92 73.6 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.437 0 CA-C-O 121.564 0.697 . . . . 0.0 110.038 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 49.3 mm -71.4 -33.57 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 124.183 0.993 . . . . 0.0 108.758 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.62 -31.02 78.48 Favored Glycine 1 N--CA 1.518 4.109 0 C-N-CA 123.389 0.519 . . . . 0.0 113.6 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 1.3 m -67.06 -37.35 79.13 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.103 0 CA-C-N 117.697 0.748 . . . . 0.0 110.397 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 37.4 p -60.81 -45.28 95.03 Favored 'General case' 0 N--CA 1.526 3.365 0 C-N-CA 123.168 0.587 . . . . 0.0 111.315 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.1 -36.53 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.254 0 C-N-CA 124.038 0.935 . . . . 0.0 111.325 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.91 -47.06 78.16 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 122.835 0.454 . . . . 0.0 112.027 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.72 90.85 Favored 'General case' 0 N--CA 1.52 3.073 0 C-N-CA 123.687 0.795 . . . . 0.0 111.655 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.46 -49.37 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 122.83 0.452 . . . . 0.0 110.699 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.15 -32.61 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.075 0.55 . . . . 0.0 110.312 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.08 -47.2 83.92 Favored 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 123.028 0.531 . . . . 0.0 111.048 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 80.1 mt -62.97 -38.86 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 C-N-CA 122.662 0.385 . . . . 0.0 110.477 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.19 -37.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 C-N-CA 123.288 0.635 . . . . 0.0 109.852 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.42 97.33 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.039 0.536 . . . . 0.0 111.334 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 62.8 t -71.74 -34.62 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.199 0.6 . . . . 0.0 109.749 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -63.46 -44.42 94.52 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.92 -37.7 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 77.5 m -67.12 -35.48 79.83 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.123 0.569 . . . . 0.0 110.295 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.67 -38.75 90.16 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 123.476 0.71 . . . . 0.0 111.282 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 86.7 p -65.1 -21.33 66.79 Favored 'General case' 0 N--CA 1.529 3.5 0 C-N-CA 123.082 0.553 . . . . 0.0 110.971 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.73 -21.58 64.37 Favored 'General case' 0 N--CA 1.533 3.683 0 C-N-CA 123.958 0.903 . . . . 0.0 110.037 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.6 -8.45 56.24 Favored 'General case' 1 N--CA 1.541 4.089 0 C-N-CA 123.592 0.757 . . . . 0.0 110.248 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 30.5 t90 -65.07 -106.43 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.541 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? 55.89 36.27 27.0 Favored 'General case' 0 N--CA 1.52 3.038 0 C-N-CA 123.952 0.901 . . . . 0.0 111.539 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 62.0 tttm 62.57 150.55 0.03 OUTLIER 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 124.463 1.105 . . . . 0.0 110.918 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 50.2 t -132.89 127.03 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 C-N-CA 124.743 1.217 . . . . 0.0 107.843 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.73 147.46 33.2 Favored Pre-proline 0 N--CA 1.533 3.685 0 CA-C-O 116.701 -1.619 . . . . 0.0 109.201 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo . . . . . 1 N--CA 1.551 4.865 0 C-N-CA 122.974 2.449 . . . . 0.0 115.098 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.99 -161.51 0.03 OUTLIER 'Trans proline' 1 N--CA 1.55 4.796 0 C-N-CA 121.896 1.73 . . . . 0.0 112.547 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -167.71 -98.81 0.13 Allowed Glycine 1 N--CA 1.519 4.204 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 48.1 t -166.58 76.34 0.19 Allowed 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.493 0.717 . . . . 0.0 109.802 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.19 -26.56 68.2 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 124.166 0.986 . . . . 0.0 109.445 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 65.5 m -57.66 -25.38 60.14 Favored 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.183 0.993 . . . . 0.0 111.415 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.0 -35.31 83.86 Favored Glycine 0 N--CA 1.515 3.923 0 C-N-CA 124.167 0.889 . . . . 0.0 115.267 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 12.2 tt -59.08 -35.09 55.35 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.593 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 9.3 tp -55.84 -31.85 30.97 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.31 -32.53 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.944 0 CA-C-N 118.383 0.538 . . . . 0.0 110.023 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.79 -29.54 54.91 Favored Glycine 0 N--CA 1.514 3.87 0 CA-C-O 119.555 -0.58 . . . . 0.0 113.873 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.6 m -59.92 -48.26 88.45 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 CA-C-N 118.075 0.938 . . . . 0.0 112.468 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 11.3 t -66.43 -38.76 88.14 Favored 'General case' 0 N--CA 1.536 3.847 0 O-C-N 121.955 -0.466 . . . . 0.0 110.98 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.87 -39.05 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.297 0 C-N-CA 123.46 0.704 . . . . 0.0 109.333 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.18 98.63 Favored 'General case' 0 N--CA 1.522 3.146 0 C-N-CA 123.137 0.575 . . . . 0.0 110.907 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.73 79.29 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 123.264 0.625 . . . . 0.0 111.781 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.37 -51.01 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.545 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.69 -33.25 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 123.632 0.773 . . . . 0.0 111.109 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 38.6 tp -66.07 -35.49 80.67 Favored 'General case' 0 N--CA 1.531 3.593 0 C-N-CA 122.513 0.325 . . . . 0.0 111.218 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 92.2 mt -69.2 -41.15 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.89 -37.96 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 123.413 0.685 . . . . 0.0 109.594 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.22 81.38 Favored 'General case' 0 N--CA 1.526 3.347 0 C-N-CA 123.81 0.844 . . . . 0.0 112.666 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.46 -34.0 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 O-C-N 121.872 -0.517 . . . . 0.0 109.98 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.73 -44.27 94.06 Favored 'General case' 0 N--CA 1.529 3.493 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.95 -37.53 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 98.0 m -59.42 -27.43 66.03 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.336 0.654 . . . . 0.0 111.316 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.34 -40.89 85.91 Favored 'General case' 0 N--CA 1.529 3.501 0 CA-C-O 121.078 0.466 . . . . 0.0 110.426 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 47.6 t -64.77 -17.58 64.3 Favored 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 124.129 0.972 . . . . 0.0 112.45 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.6 -15.08 63.14 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 122.977 0.511 . . . . 0.0 110.627 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.37 -28.7 22.04 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.115 0.566 . . . . 0.0 109.58 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -158.83 144.45 16.47 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.705 0.802 . . . . 0.0 108.98 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -140.19 160.4 40.03 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 124.725 1.21 . . . . 0.0 108.149 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -76.42 44.04 0.33 Allowed 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.152 0.981 . . . . 0.0 110.012 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.16 133.43 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.529 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.95 99.76 24.37 Favored Pre-proline 0 N--CA 1.532 3.657 0 C-N-CA 125.05 1.34 . . . . 0.0 107.502 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo . . . . . 1 N--CA 1.549 4.754 0 C-N-CA 122.476 2.118 . . . . 0.0 114.47 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 88.0 mmm . . . . . 0 CA--C 1.586 2.35 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.21 66.56 3.31 Favored 'Trans proline' 0 N--CA 1.535 3.926 0 C-N-CA 122.617 2.212 . . . . 0.0 110.627 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -178.42 -169.92 39.84 Favored Glycine 1 N--CA 1.518 4.162 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 43.1 m 60.24 47.63 9.0 Favored 'General case' 0 N--CA 1.519 3.024 0 C-N-CA 124.317 1.047 . . . . 0.0 111.847 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.6 mp -65.14 -26.63 68.27 Favored 'General case' 0 N--CA 1.534 3.735 0 C-N-CA 123.829 0.852 . . . . 0.0 109.251 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 98.0 p -68.41 -27.43 66.2 Favored 'General case' 0 N--CA 1.521 3.076 0 C-N-CA 123.263 0.625 . . . . 0.0 110.049 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.46 -46.9 53.81 Favored Glycine 0 N--CA 1.513 3.779 0 N-CA-C 116.688 1.435 . . . . 0.0 116.688 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.5 pt -59.69 -35.24 58.61 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.467 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 -174.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.2 tt -56.75 -32.06 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 15.5 tt -70.78 -33.79 53.91 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 CA-C-N 120.131 1.332 . . . . 0.0 111.064 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.81 -43.63 80.92 Favored Glycine 1 N--CA 1.52 4.246 0 C-N-CA 123.053 0.359 . . . . 0.0 113.802 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.06 -37.29 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.977 0 O-C-N 121.639 -0.918 . . . . 0.0 110.922 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 61.3 p -64.84 -45.65 85.24 Favored 'General case' 0 N--CA 1.538 3.928 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.49 -30.87 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 C-N-CA 123.093 0.557 . . . . 0.0 111.766 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.43 -47.0 88.01 Favored 'General case' 0 N--CA 1.534 3.732 0 O-C-N 121.496 -0.753 . . . . 0.0 112.614 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.63 -44.24 96.79 Favored 'General case' 0 N--CA 1.521 3.124 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.65 -39.73 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.752 0 CA-C-N 118.773 0.715 . . . . 0.0 112.068 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.32 -34.15 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.339 0.518 . . . . 0.0 110.134 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.7 -48.06 78.65 Favored 'General case' 0 N--CA 1.524 3.24 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.6 pt -70.01 -36.74 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 O-C-N 122.065 -0.397 . . . . 0.0 111.339 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.3 -37.46 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.03 -41.13 82.57 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 122.968 0.507 . . . . 0.0 111.806 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.77 -37.12 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.192 0.597 . . . . 0.0 110.15 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -63.08 -44.16 96.52 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 123.211 0.604 . . . . 0.0 112.377 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.88 -37.62 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 93.2 m -64.68 -28.43 69.59 Favored 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 122.846 0.458 . . . . 0.0 110.727 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -72.93 -23.37 60.68 Favored 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 123.23 0.612 . . . . 0.0 110.924 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.1 m -66.19 -31.36 72.14 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 122.949 0.499 . . . . 0.0 111.432 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.68 -37.53 87.89 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.644 0.777 . . . . 0.0 112.377 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 pp -95.19 -16.26 22.68 Favored 'General case' 1 N--CA 1.547 4.392 0 C-N-CA 123.223 0.609 . . . . 0.0 111.531 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -67.1 -10.39 49.55 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 123.505 0.722 . . . . 0.0 111.193 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.1 116.2 4.01 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 123.625 0.77 . . . . 0.0 111.508 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.62 -162.99 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.648 0 C-N-CA 126.126 1.77 . . . . 0.0 114.538 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.15 136.15 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 56.0 tp -133.42 99.57 14.39 Favored Pre-proline 0 N--CA 1.531 3.595 0 C-N-CA 124.86 1.264 . . . . 0.0 108.06 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 1 N--CA 1.536 4.007 0 C-N-CA 122.417 2.078 . . . . 0.0 111.097 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 49.1 tpp . . . . . 0 CA--C 1.58 2.101 0 CA-C-O 117.657 -1.164 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.03 141.96 55.47 Favored 'Trans proline' 1 N--CA 1.548 4.707 0 CA-C-N 122.41 1.897 . . . . 0.0 113.082 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 170.78 -137.7 4.56 Favored Glycine 1 N--CA 1.519 4.21 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 71.9 p 56.51 176.43 0.04 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 124.557 1.143 . . . . 0.0 112.519 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 48.4 mt -57.28 -25.82 59.85 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 124.873 1.269 . . . . 0.0 111.613 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.3 t -57.01 -37.69 72.06 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.581 0.752 . . . . 0.0 112.065 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.28 -46.32 57.65 Favored Glycine 1 N--CA 1.518 4.164 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.475 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.89 -46.38 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 124.53 1.132 . . . . 0.0 112.79 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.07 -38.23 59.42 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 17.0 tt -72.83 -32.93 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.884 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.6 -29.14 47.69 Favored Glycine 0 N--CA 1.513 3.821 0 C-N-CA 124.19 0.9 . . . . 0.0 113.581 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.5 -37.74 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.875 0 CA-C-N 117.27 0.535 . . . . 0.0 111.157 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 69.0 p -63.87 -45.93 87.22 Favored 'General case' 0 N--CA 1.529 3.489 0 CA-C-O 121.224 0.535 . . . . 0.0 110.804 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.52 -34.69 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.059 0 C-N-CA 124.101 0.961 . . . . 0.0 110.962 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.61 -46.96 67.22 Favored 'General case' 0 N--CA 1.529 3.52 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.8 74.53 Favored 'General case' 0 N--CA 1.522 3.143 0 C-N-CA 123.285 0.634 . . . . 0.0 111.807 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -67.13 -41.38 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.438 0 C-N-CA 122.913 0.485 . . . . 0.0 110.451 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.94 -38.52 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 0 C-N-CA 122.899 0.48 . . . . 0.0 111.495 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 56.9 tp -66.77 -43.13 84.82 Favored 'General case' 0 N--CA 1.532 3.631 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.19 -39.15 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.809 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.77 -37.07 78.74 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 CA-C-N 118.717 0.69 . . . . 0.0 109.82 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.55 -32.08 66.75 Favored 'General case' 0 N--CA 1.525 3.305 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.24 -34.89 72.13 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.175 0 CA-C-N 119.286 0.948 . . . . 0.0 112.355 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.73 -43.98 91.67 Favored 'General case' 0 N--CA 1.536 3.871 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.92 -37.73 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.803 0 O-C-N 121.832 -0.543 . . . . 0.0 109.574 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.08 -27.92 67.77 Favored 'General case' 0 N--CA 1.527 3.391 0 C-N-CA 123.259 0.623 . . . . 0.0 111.148 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.16 -30.19 71.26 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.054 0.542 . . . . 0.0 110.507 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 34.9 t -63.82 -39.03 93.27 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.368 0.667 . . . . 0.0 110.774 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.12 -15.94 63.04 Favored 'General case' 0 N--CA 1.527 3.418 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.746 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 49.6 tp -101.99 -17.37 16.13 Favored 'General case' 0 N--CA 1.537 3.901 0 C-N-CA 124.184 0.993 . . . . 0.0 109.523 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -74.99 15.77 0.37 Allowed 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 124.056 0.942 . . . . 0.0 111.155 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.46 -175.6 0.13 Allowed 'General case' 0 N--CA 1.532 3.656 0 C-N-CA 123.234 0.614 . . . . 0.0 110.116 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 66.39 156.82 0.1 Allowed 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 124.523 1.129 . . . . 0.0 110.094 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.04 137.97 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.645 0 C-N-CA 124.839 1.256 . . . . 0.0 107.776 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.86 105.93 21.88 Favored Pre-proline 0 N--CA 1.529 3.502 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo . . . . . 1 N--CA 1.537 4.07 0 CA-C-N 122.743 2.015 . . . . 0.0 110.792 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 CA--C 1.581 2.164 0 CA-C-O 117.53 -1.224 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -89.5 68.48 2.2 Favored 'Trans proline' 0 N--CA 1.533 3.852 0 C-N-CA 122.723 2.282 . . . . 0.0 110.97 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.48 -171.58 36.8 Favored Glycine 1 N--CA 1.519 4.211 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.56 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 100.0 p -163.97 -165.32 0.99 Allowed 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 123.739 0.816 . . . . 0.0 109.093 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.66 -39.43 88.36 Favored 'General case' 0 N--CA 1.535 3.782 0 C-N-CA 124.129 0.972 . . . . 0.0 109.25 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 42.0 t -68.19 -32.24 72.33 Favored 'General case' 0 N--CA 1.517 2.92 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.487 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.41 -46.34 63.9 Favored Glycine 0 N--CA 1.514 3.896 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.443 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 41.8 pt -66.3 -38.49 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 CA-C-N 118.062 0.931 . . . . 0.0 112.344 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.98 -32.59 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.37 -32.8 43.66 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.23 -29.09 44.51 Favored Glycine 0 N--CA 1.513 3.819 0 C-N-CA 124.172 0.891 . . . . 0.0 113.529 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.46 -37.57 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 117.505 0.653 . . . . 0.0 110.739 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 61.4 p -63.08 -46.21 88.47 Favored 'General case' 0 N--CA 1.528 3.432 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.959 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.77 -38.08 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 124.226 1.011 . . . . 0.0 110.184 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.06 63.98 Favored 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 123.663 0.785 . . . . 0.0 112.659 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.67 75.0 Favored 'General case' 0 N--CA 1.519 3.009 0 C-N-CA 123.345 0.658 . . . . 0.0 111.664 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.8 -48.25 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.367 0 C-N-CA 123.165 0.586 . . . . 0.0 111.425 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.4 -32.45 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 C-N-CA 122.615 0.366 . . . . 0.0 110.537 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.44 -42.24 98.44 Favored 'General case' 0 N--CA 1.53 3.546 0 C-N-CA 123.361 0.664 . . . . 0.0 110.313 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 94.8 mt -65.72 -44.17 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 123.33 0.652 . . . . 0.0 109.753 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.45 -37.55 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.484 0 C-N-CA 123.32 0.648 . . . . 0.0 109.708 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.95 81.55 Favored 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.284 0.634 . . . . 0.0 112.322 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 17.6 m -71.9 -34.44 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 O-C-N 121.96 -0.463 . . . . 0.0 110.647 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.69 -44.44 93.69 Favored 'General case' 0 N--CA 1.53 3.536 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.89 -37.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.759 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 70.7 m -67.47 -39.15 85.27 Favored 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 122.966 0.507 . . . . 0.0 110.479 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.15 -32.77 63.27 Favored 'General case' 0 N--CA 1.524 3.271 0 C-N-CA 123.554 0.742 . . . . 0.0 111.008 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 86.3 p -63.76 -24.75 67.89 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.175 0.59 . . . . 0.0 111.505 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.59 -30.9 69.75 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.804 0.842 . . . . 0.0 110.355 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.24 1.9 56.0 Favored 'General case' 0 N--CA 1.535 3.82 0 C-N-CA 124.25 1.02 . . . . 0.0 110.128 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -59.65 -15.95 22.85 Favored 'General case' 0 N--CA 1.533 3.682 0 C-N-CA 123.239 0.616 . . . . 0.0 110.978 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -67.49 157.57 33.95 Favored 'General case' 0 N--CA 1.518 2.962 0 C-N-CA 124.176 0.99 . . . . 0.0 110.011 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -165.36 -22.09 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.429 0 C-N-CA 123.856 0.862 . . . . 0.0 109.624 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.14 138.45 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 125.2 1.4 . . . . 0.0 108.406 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 53.0 tp -133.21 99.62 14.63 Favored Pre-proline 0 N--CA 1.53 3.57 0 C-N-CA 124.988 1.315 . . . . 0.0 107.765 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 N--CA 1.536 3.978 0 C-N-CA 122.528 2.152 . . . . 0.0 110.966 -179.509 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.576 1.957 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.01 -10.78 23.15 Favored 'Trans proline' 1 N--CA 1.538 4.121 0 C-N-CA 122.277 1.985 . . . . 0.0 111.076 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.59 -95.7 0.33 Allowed Glycine 1 N--CA 1.518 4.128 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 89.9 p -167.76 96.86 0.46 Allowed 'General case' 0 N--CA 1.522 3.136 0 C-N-CA 123.841 0.856 . . . . 0.0 108.81 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.13 -39.04 92.5 Favored 'General case' 0 N--CA 1.527 3.391 0 C-N-CA 124.055 0.942 . . . . 0.0 109.817 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 92.4 p -68.23 -27.71 66.6 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.082 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.65 -47.25 50.31 Favored Glycine 0 N--CA 1.504 3.21 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.543 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.48 -37.98 66.44 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.322 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -176.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 10.2 tp -56.87 -31.86 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.622 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 pt -59.74 -39.65 80.3 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.318 0 CA-C-N 119.325 0.966 . . . . 0.0 111.562 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.53 -28.87 46.32 Favored Glycine 0 N--CA 1.516 3.992 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.257 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 2.9 p -59.36 -46.66 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 C-N-CA 123.697 0.799 . . . . 0.0 112.753 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 3.2 t -66.08 -38.71 88.95 Favored 'General case' 0 N--CA 1.534 3.752 0 CA-C-O 121.217 0.532 . . . . 0.0 110.667 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.4 -34.81 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.033 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.484 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.78 79.07 Favored 'General case' 0 N--CA 1.527 3.377 0 C-N-CA 123.03 0.532 . . . . 0.0 111.533 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -49.93 44.9 Favored 'General case' 0 N--CA 1.511 2.58 0 C-N-CA 123.38 0.672 . . . . 0.0 112.588 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 21.8 m -61.04 -42.27 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.82 -32.09 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.68 0 C-N-CA 122.845 0.458 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.15 -40.24 53.12 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mp -54.98 -44.41 73.69 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 C-N-CA 124.128 0.971 . . . . 0.0 112.187 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 22.5 m -66.19 -36.88 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 O-C-N 121.762 -0.586 . . . . 0.0 111.129 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.49 85.97 Favored 'General case' 0 N--CA 1.529 3.481 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 11.3 m -71.68 -34.32 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 O-C-N 121.873 -0.517 . . . . 0.0 110.326 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -63.67 -43.96 95.13 Favored 'General case' 0 N--CA 1.531 3.615 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.5 -37.18 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.62 -28.64 65.83 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 122.704 0.402 . . . . 0.0 111.566 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -58.01 -16.56 13.05 Favored 'General case' 1 N--CA 1.54 4.073 0 CA-C-N 118.308 0.503 . . . . 0.0 111.56 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 45.8 t -68.14 -43.98 77.08 Favored 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.79 -27.48 68.31 Favored 'General case' 0 N--CA 1.528 3.435 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.396 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.19 10.45 16.86 Favored 'General case' 1 N--CA 1.542 4.127 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -159.89 98.98 1.37 Allowed 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 123.176 0.59 . . . . 0.0 109.839 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -137.72 144.12 41.56 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 125.087 1.355 . . . . 0.0 107.441 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -74.94 105.91 6.2 Favored 'General case' 0 N--CA 1.518 2.962 0 C-N-CA 123.786 0.834 . . . . 0.0 108.843 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 30.3 m -134.9 138.18 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 124.728 1.211 . . . . 0.0 108.568 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.48 98.88 14.77 Favored Pre-proline 0 N--CA 1.528 3.469 0 C-N-CA 124.823 1.249 . . . . 0.0 107.966 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo . . . . . 1 N--CA 1.548 4.716 0 C-N-CA 122.365 2.044 . . . . 0.0 114.155 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.575 1.94 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.35 160.66 3.28 Favored 'Trans proline' 1 N--CA 1.548 4.696 0 CA-C-N 121.962 1.737 . . . . 0.0 113.154 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.94 97.56 0.01 OUTLIER Glycine 1 N--CA 1.52 4.277 0 C-N-CA 123.622 0.629 . . . . 0.0 111.772 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t -166.87 5.06 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.675 0.79 . . . . 0.0 110.816 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 47.3 mt -63.55 -26.79 68.86 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.014 0.926 . . . . 0.0 110.54 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 94.3 p -62.07 -39.73 93.38 Favored 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 123.844 0.858 . . . . 0.0 110.741 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.06 -39.98 83.89 Favored Glycine 1 N--CA 1.517 4.061 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.656 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.65 -46.36 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.405 0 C-N-CA 124.026 0.93 . . . . 0.0 112.669 -176.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.4 tt -61.94 -37.53 78.49 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.024 0 O-C-N 121.915 -0.49 . . . . 0.0 112.294 -176.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.1 tp -73.18 -33.65 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.684 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.8 -46.86 91.83 Favored Glycine 1 N--CA 1.516 4.009 0 CA-C-N 115.781 -0.645 . . . . 0.0 114.487 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.94 -37.42 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.844 0 CA-C-N 117.806 0.803 . . . . 0.0 110.899 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 54.5 p -66.36 -45.75 79.08 Favored 'General case' 0 N--CA 1.531 3.592 0 CA-C-O 120.914 0.388 . . . . 0.0 111.113 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.67 -31.37 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.417 0 C-N-CA 123.918 0.887 . . . . 0.0 111.212 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.71 72.48 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.03 -49.26 53.06 Favored 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.54 -39.81 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 31.9 m -68.02 -35.41 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 CA-C-N 118.519 0.6 . . . . 0.0 112.017 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 26.3 tp -69.87 -42.72 73.12 Favored 'General case' 0 N--CA 1.524 3.261 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 33.2 pt -66.67 -35.83 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.838 0.745 . . . . 0.0 111.153 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 92.9 t -65.05 -37.67 80.81 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.036 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.46 -35.81 74.79 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 123.17 0.588 . . . . 0.0 111.665 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 71.0 t -71.9 -36.33 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.27 0 C-N-CA 123.45 0.7 . . . . 0.0 110.762 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.07 -43.96 81.33 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.52 -38.01 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.519 0 C-N-CA 122.555 0.342 . . . . 0.0 110.893 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 14.4 p -67.11 -27.8 67.63 Favored 'General case' 0 N--CA 1.534 3.765 0 CA-C-N 117.876 0.307 . . . . 0.0 111.297 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -60.43 -30.04 69.38 Favored 'General case' 0 N--CA 1.529 3.489 0 C-N-CA 123.153 0.581 . . . . 0.0 110.965 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 45.6 t -64.94 -41.77 95.23 Favored 'General case' 0 N--CA 1.525 3.322 0 CA-C-O 121.695 0.759 . . . . 0.0 110.572 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 45.6 mt -69.29 -13.73 62.55 Favored 'General case' 0 N--CA 1.518 2.938 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.053 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 55.6 tp -86.61 -28.5 23.21 Favored 'General case' 0 N--CA 1.538 3.972 0 C-N-CA 122.908 0.483 . . . . 0.0 110.124 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -82.51 -149.23 0.08 Allowed 'General case' 0 N--CA 1.527 3.4 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 55.3 mttm 62.02 53.82 2.91 Favored 'General case' 0 N--CA 1.519 3.024 0 C-N-CA 123.875 0.87 . . . . 0.0 111.119 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -164.3 -16.12 0.03 OUTLIER 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 123.808 0.843 . . . . 0.0 110.01 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 31.4 m -112.76 138.23 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.626 0 C-N-CA 125.18 1.392 . . . . 0.0 109.295 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -133.41 99.49 14.46 Favored Pre-proline 0 N--CA 1.53 3.537 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo . . . . . 1 N--CA 1.538 4.105 0 C-N-CA 122.438 2.092 . . . . 0.0 111.279 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 83.3 mmm . . . . . 0 CA--C 1.586 2.334 0 CA-C-O 117.491 -1.242 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -88.17 157.62 6.98 Favored 'Trans proline' 0 N--CA 1.535 3.939 0 C-N-CA 122.51 2.14 . . . . 0.0 110.569 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.43 135.7 24.02 Favored Glycine 1 N--CA 1.516 4.011 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 69.5 m -70.52 162.17 29.29 Favored 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 123.76 0.824 . . . . 0.0 109.917 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.13 -26.91 68.39 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.785 0.834 . . . . 0.0 110.451 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 67.1 m -68.61 -35.18 76.98 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 123.544 0.737 . . . . 0.0 110.308 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.68 -43.2 76.99 Favored Glycine 1 N--CA 1.517 4.044 0 CA-C-N 115.228 -0.896 . . . . 0.0 115.17 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -45.85 71.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 CA-C-N 118.026 0.913 . . . . 0.0 111.406 -176.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 19.8 tt -60.83 -34.35 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 44.9 pt -72.57 -32.81 42.85 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.195 0 CA-C-N 119.556 1.071 . . . . 0.0 108.929 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.88 -29.77 51.6 Favored Glycine 0 N--CA 1.514 3.872 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.979 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.0 -37.53 72.88 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.021 0 CA-C-N 117.588 0.694 . . . . 0.0 110.963 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 43.1 p -62.99 -46.21 88.73 Favored 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.048 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.95 -36.06 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.151 0 C-N-CA 124.212 1.005 . . . . 0.0 110.749 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.42 -43.13 64.64 Favored 'General case' 0 N--CA 1.525 3.313 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.73 -43.11 85.1 Favored 'General case' 0 N--CA 1.519 3.012 0 C-N-CA 123.261 0.624 . . . . 0.0 111.972 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 36.9 t -66.72 -45.56 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 C-N-CA 122.943 0.497 . . . . 0.0 111.022 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.16 -38.83 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 123.263 0.625 . . . . 0.0 111.153 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.81 -34.63 78.6 Favored 'General case' 0 N--CA 1.532 3.64 0 CA-C-N 117.828 0.285 . . . . 0.0 110.803 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.67 -44.26 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.886 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.04 -37.77 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.625 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.65 -48.22 81.77 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.731 0.813 . . . . 0.0 112.807 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.58 -34.22 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 O-C-N 121.948 -0.47 . . . . 0.0 110.084 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -64.01 -44.13 93.53 Favored 'General case' 0 N--CA 1.527 3.401 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.71 -37.74 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 98.9 m -61.66 -27.92 69.02 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.039 0.536 . . . . 0.0 111.212 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -67.62 -30.62 70.24 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 122.947 0.499 . . . . 0.0 111.49 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 49.4 m -64.04 -31.99 73.38 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 123.324 0.649 . . . . 0.0 112.407 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.78 -33.0 72.31 Favored 'General case' 0 N--CA 1.534 3.754 0 C-N-CA 123.793 0.837 . . . . 0.0 112.379 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.33 10.97 23.47 Favored 'General case' 1 N--CA 1.547 4.399 0 C-N-CA 124.019 0.928 . . . . 0.0 111.466 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 31.7 t90 -139.25 79.24 1.71 Allowed 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 124.374 1.07 . . . . 0.0 108.648 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.33 11.46 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 124.159 0.984 . . . . 0.0 109.963 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -67.38 108.55 2.82 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 123.83 0.852 . . . . 0.0 110.046 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.16 138.25 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.389 0 C-N-CA 124.976 1.31 . . . . 0.0 108.244 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.48 113.11 60.15 Favored Pre-proline 0 N--CA 1.526 3.363 0 CA-C-O 116.859 -1.543 . . . . 0.0 107.314 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo . . . . . 1 N--CA 1.536 4.013 0 CA-C-N 123.052 2.126 . . . . 0.0 110.698 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.576 1.946 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.85 -169.47 0.34 Allowed 'Trans proline' 1 N--CA 1.543 4.409 0 C-N-CA 122.36 2.04 . . . . 0.0 110.214 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -163.36 -153.07 7.11 Favored Glycine 1 N--CA 1.517 4.1 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.8 m -161.22 44.25 0.17 Allowed 'General case' 0 N--CA 1.52 3.067 0 C-N-CA 123.684 0.794 . . . . 0.0 109.185 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 48.2 mt -64.72 -41.18 96.16 Favored 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 123.972 0.909 . . . . 0.0 110.123 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 95.3 p -57.95 -26.96 62.95 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 123.271 0.629 . . . . 0.0 110.678 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.21 -41.52 86.08 Favored Glycine 1 N--CA 1.52 4.266 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 62.3 mt -65.62 -37.1 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 C-N-CA 124.348 1.059 . . . . 0.0 109.083 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 45.6 mm -67.48 -40.81 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 C-N-CA 124.151 0.981 . . . . 0.0 108.384 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 87.7 mt -72.33 -33.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.04 -29.72 75.24 Favored Glycine 1 N--CA 1.518 4.111 0 C-N-CA 123.336 0.493 . . . . 0.0 112.458 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -37.23 72.81 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.18 0 C-N-CA 123.394 0.678 . . . . 0.0 109.916 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -57.46 -45.24 84.98 Favored 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.342 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 51.2 t -56.57 -42.07 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 C-N-CA 124.323 1.049 . . . . 0.0 111.454 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.62 -40.74 63.04 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.96 -37.25 75.76 Favored 'General case' 0 N--CA 1.523 3.179 0 C-N-CA 123.114 0.566 . . . . 0.0 111.726 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.09 -48.52 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.502 0 C-N-CA 123.492 0.717 . . . . 0.0 111.359 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.14 -32.62 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 O-C-N 121.926 -0.484 . . . . 0.0 111.847 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.15 -40.65 37.29 Favored 'General case' 0 N--CA 1.534 3.748 0 C-N-CA 122.61 0.364 . . . . 0.0 111.705 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.42 -38.78 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.355 0.525 . . . . 0.0 111.711 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 35.4 m -67.89 -37.59 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.564 0 CA-C-O 121.047 0.451 . . . . 0.0 110.406 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.05 97.17 Favored 'General case' 0 N--CA 1.523 3.21 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.03 -33.95 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 O-C-N 121.726 -0.609 . . . . 0.0 110.149 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -60.03 -44.27 94.73 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.95 -42.08 82.12 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 CA-C-O 121.681 0.753 . . . . 0.0 109.468 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 83.0 m -61.57 -27.56 68.71 Favored 'General case' 0 N--CA 1.518 2.955 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.293 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.21 -30.9 71.84 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 122.635 0.374 . . . . 0.0 110.373 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 34.0 t -64.01 -35.17 79.82 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.243 0.617 . . . . 0.0 111.152 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.91 -18.42 56.54 Favored 'General case' 0 N--CA 1.532 3.636 0 C-N-CA 122.968 0.507 . . . . 0.0 111.592 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.54 -2.01 58.32 Favored 'General case' 1 N--CA 1.541 4.119 0 C-N-CA 123.054 0.542 . . . . 0.0 109.86 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -66.62 -68.47 0.37 Allowed 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.172 0.589 . . . . 0.0 110.005 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 56.96 176.98 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.227 0 C-N-CA 124.26 1.024 . . . . 0.0 112.024 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -69.97 -178.22 1.53 Allowed 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 124.0 0.92 . . . . 0.0 110.359 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.95 138.31 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.498 0 C-N-CA 125.203 1.401 . . . . 0.0 108.228 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -108.16 99.21 30.39 Favored Pre-proline 0 N--CA 1.532 3.665 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo . . . . . 1 N--CA 1.547 4.67 0 C-N-CA 122.451 2.101 . . . . 0.0 114.55 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 CA--C 1.574 1.885 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.76 -97.59 0.01 OUTLIER 'Trans proline' 1 N--CA 1.542 4.368 0 C-N-CA 122.214 1.943 . . . . 0.0 110.72 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -168.91 -175.95 38.68 Favored Glycine 1 N--CA 1.52 4.249 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 99.5 p -78.9 72.94 5.45 Favored 'General case' 0 N--CA 1.52 3.068 0 C-N-CA 123.798 0.839 . . . . 0.0 110.035 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 53.9 mt -65.1 -26.83 68.38 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.6 0.76 . . . . 0.0 109.996 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -65.82 -29.23 69.67 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.34 0.656 . . . . 0.0 110.519 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.52 -35.68 81.9 Favored Glycine 1 N--CA 1.523 4.451 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.21 -45.97 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 C-N-CA 124.037 0.935 . . . . 0.0 111.555 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.7 pt -65.22 -33.21 62.12 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.492 0 CA-C-O 121.844 0.83 . . . . 0.0 110.019 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 40.0 mm -73.06 -33.67 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.285 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.45 -48.26 77.32 Favored Glycine 1 N--CA 1.52 4.249 0 C-N-CA 123.435 0.541 . . . . 0.0 114.29 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.96 -37.71 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.77 0 CA-C-N 117.434 0.617 . . . . 0.0 110.861 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 72.7 p -66.64 -45.92 77.46 Favored 'General case' 0 N--CA 1.533 3.722 0 CA-C-N 118.141 0.428 . . . . 0.0 111.354 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.48 -31.53 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.25 0 C-N-CA 123.797 0.839 . . . . 0.0 111.301 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.49 -37.23 75.12 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.21 -50.08 43.67 Favored 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.13 -38.46 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.32 -32.5 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 36.2 tp -77.84 -39.4 43.64 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.0 pt -69.51 -37.01 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 CA-C-N 119.053 0.842 . . . . 0.0 112.171 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.0 -37.09 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 121.838 -0.539 . . . . 0.0 110.15 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.19 79.87 Favored 'General case' 0 N--CA 1.525 3.3 0 C-N-CA 123.78 0.832 . . . . 0.0 112.888 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.64 -34.43 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 O-C-N 121.926 -0.484 . . . . 0.0 110.394 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -64.38 -44.08 92.45 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 123.091 0.556 . . . . 0.0 112.307 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.85 -37.57 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.704 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 83.4 m -64.35 -27.84 69.29 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.066 0.546 . . . . 0.0 111.018 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -69.3 -30.52 68.62 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.089 0.556 . . . . 0.0 111.05 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 82.4 p -64.73 -31.22 72.35 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.198 0.599 . . . . 0.0 111.706 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.3 -17.32 62.41 Favored 'General case' 0 N--CA 1.536 3.825 0 C-N-CA 123.462 0.705 . . . . 0.0 111.085 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -87.57 -28.54 21.88 Favored 'General case' 0 N--CA 1.537 3.892 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -79.15 -150.44 0.05 Allowed 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm 60.88 109.7 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.251 0 C-N-CA 123.929 0.892 . . . . 0.0 110.997 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -165.8 151.06 8.77 Favored 'General case' 0 N--CA 1.522 3.172 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.3 138.43 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.458 0 C-N-CA 124.857 1.263 . . . . 0.0 108.405 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 54.7 mt -94.56 146.67 31.89 Favored Pre-proline 0 N--CA 1.526 3.351 0 CA-C-O 117.295 -1.336 . . . . 0.0 108.179 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo . . . . . 1 N--CA 1.54 4.256 0 C-N-CA 122.044 1.829 . . . . 0.0 110.737 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 16.8 ptm . . . . . 0 CA--C 1.574 1.896 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.67 -29.69 19.16 Favored 'Trans proline' 1 N--CA 1.542 4.346 0 C-N-CA 122.268 1.979 . . . . 0.0 110.468 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.2 92.47 0.21 Allowed Glycine 1 N--CA 1.519 4.205 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.633 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 75.3 m -164.43 -41.16 0.03 OUTLIER 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 124.122 0.969 . . . . 0.0 108.598 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 45.8 mt -61.07 -26.2 67.48 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.49 1.116 . . . . 0.0 111.279 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 63.5 m -57.75 -43.49 85.43 Favored 'General case' 0 N--CA 1.522 3.174 0 C-N-CA 123.677 0.791 . . . . 0.0 112.097 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.62 81.28 Favored Glycine 1 N--CA 1.523 4.443 0 C-N-CA 123.559 0.599 . . . . 0.0 112.707 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 41.6 mm -59.98 -46.54 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.627 0 C-N-CA 123.979 0.912 . . . . 0.0 112.898 -176.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.01 -35.77 70.63 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.5 mm -72.25 -33.36 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.04 -29.72 56.15 Favored Glycine 0 N--CA 1.513 3.798 0 C-N-CA 124.018 0.818 . . . . 0.0 113.415 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 m -59.98 -37.63 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 CA-C-N 117.349 0.574 . . . . 0.0 110.89 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 43.7 p -61.09 -46.72 89.5 Favored 'General case' 0 N--CA 1.526 3.34 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.213 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.96 -39.87 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.037 0 C-N-CA 124.277 1.031 . . . . 0.0 110.453 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.41 -38.42 58.99 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.11 -43.38 82.59 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 122.952 0.501 . . . . 0.0 110.562 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.08 -43.31 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.368 0 C-N-CA 123.773 0.829 . . . . 0.0 110.811 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.6 -32.31 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.56 0 C-N-CA 123.468 0.707 . . . . 0.0 109.969 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -45.71 91.04 Favored 'General case' 0 N--CA 1.537 3.925 0 CA-C-O 121.293 0.568 . . . . 0.0 109.939 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 80.9 mt -54.94 -35.89 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.821 0 C-N-CA 123.615 0.766 . . . . 0.0 111.028 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.42 -36.1 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 C-N-CA 123.117 0.567 . . . . 0.0 110.487 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.2 64.63 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 3.1 m -64.41 -34.87 72.17 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.426 0 CA-C-N 119.582 1.083 . . . . 0.0 110.619 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -72.94 -31.93 64.93 Favored 'General case' 0 N--CA 1.529 3.496 0 C-N-CA 123.093 0.557 . . . . 0.0 110.04 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.44 -37.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.579 0 C-N-CA 123.41 0.684 . . . . 0.0 109.29 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.58 -36.58 74.19 Favored 'General case' 0 N--CA 1.525 3.324 0 CA-C-O 121.073 0.463 . . . . 0.0 110.06 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.33 -38.2 63.35 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.201 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.8 m -63.91 -46.7 83.63 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 123.066 0.546 . . . . 0.0 110.846 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 85.1 mt -67.05 -18.01 65.16 Favored 'General case' 0 N--CA 1.53 3.53 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.706 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 41.7 tp -92.4 -11.66 34.31 Favored 'General case' 1 N--CA 1.539 4.008 0 C-N-CA 123.907 0.883 . . . . 0.0 110.141 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -51.41 -26.31 7.72 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.993 0.917 . . . . 0.0 112.308 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -65.43 143.15 57.89 Favored 'General case' 0 N--CA 1.526 3.375 0 C-N-CA 123.375 0.67 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.66 8.42 Favored 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 124.119 0.968 . . . . 0.0 108.81 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 m -135.33 138.53 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 C-N-CA 124.832 1.253 . . . . 0.0 108.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.47 147.28 64.12 Favored Pre-proline 0 N--CA 1.535 3.814 0 C-N-CA 125.183 1.393 . . . . 0.0 108.652 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo . . . . . 1 N--CA 1.541 4.307 0 C-N-CA 122.0 1.8 . . . . 0.0 110.7 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 CA--C 1.576 1.95 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.67 -175.95 1.82 Allowed 'Trans proline' 1 N--CA 1.539 4.197 0 C-N-CA 122.332 2.021 . . . . 0.0 110.572 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -175.68 -169.53 37.45 Favored Glycine 1 N--CA 1.519 4.169 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 68.2 m -160.26 27.17 0.17 Allowed 'General case' 0 N--CA 1.523 3.187 0 C-N-CA 123.63 0.772 . . . . 0.0 109.825 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.09 -43.18 92.98 Favored 'General case' 0 N--CA 1.534 3.746 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 89.4 p -58.94 -26.3 64.27 Favored 'General case' 0 N--CA 1.526 3.374 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.823 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.47 -34.43 79.3 Favored Glycine 0 N--CA 1.506 3.363 0 C-N-CA 124.64 1.114 . . . . 0.0 113.68 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -35.26 52.63 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.297 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -174.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 16.8 tt -55.96 -32.42 33.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.81 -32.31 48.53 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.258 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.65 -40.59 96.66 Favored Glycine 1 N--CA 1.519 4.167 0 CA-C-O 119.653 -0.526 . . . . 0.0 113.653 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.45 -37.07 78.22 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 CA-C-N 118.458 1.129 . . . . 0.0 109.924 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 89.1 m -56.0 -45.1 79.16 Favored 'General case' 0 N--CA 1.522 3.163 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.54 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.53 -41.66 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 123.385 0.674 . . . . 0.0 110.7 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.82 -35.59 64.07 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.63 -50.36 37.82 Favored 'General case' 0 N--CA 1.521 3.094 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 12.9 p -68.02 -38.59 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.567 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.34 -31.99 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 CA-C-N 118.161 0.437 . . . . 0.0 110.237 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.97 -34.86 63.7 Favored 'General case' 1 N--CA 1.54 4.062 0 CA-C-O 121.485 0.66 . . . . 0.0 110.607 -178.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 67.4 mt -61.14 -36.04 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 124.002 0.921 . . . . 0.0 110.76 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.68 -37.64 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 123.272 0.629 . . . . 0.0 110.226 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -47.59 84.71 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.401 0.681 . . . . 0.0 112.571 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.56 -34.06 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.624 0 O-C-N 121.866 -0.521 . . . . 0.0 110.168 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.97 -44.2 97.24 Favored 'General case' 0 N--CA 1.529 3.503 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.86 -37.84 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 70.8 m -62.06 -27.57 68.99 Favored 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.081 0.552 . . . . 0.0 111.11 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -59.76 -18.66 44.88 Favored 'General case' 0 N--CA 1.533 3.706 0 C-N-CA 122.946 0.498 . . . . 0.0 111.244 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 97.3 p -73.81 -40.08 63.63 Favored 'General case' 0 N--CA 1.524 3.275 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.15 -14.88 63.32 Favored 'General case' 0 N--CA 1.537 3.895 0 C-N-CA 123.411 0.684 . . . . 0.0 110.481 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 57.2 tp -89.62 -28.9 19.21 Favored 'General case' 1 N--CA 1.54 4.045 0 C-N-CA 124.252 1.021 . . . . 0.0 109.826 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -79.88 -71.36 0.46 Allowed 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 43.6 tptt 44.62 17.31 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? 64.83 115.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.523 0 C-N-CA 123.921 0.888 . . . . 0.0 109.094 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.71 138.12 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.632 0 C-N-CA 124.834 1.253 . . . . 0.0 109.146 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 58.3 mt -97.91 146.88 32.22 Favored Pre-proline 0 N--CA 1.526 3.373 0 CA-C-O 117.249 -1.358 . . . . 0.0 108.211 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 1 N--CA 1.541 4.286 0 C-N-CA 122.013 1.809 . . . . 0.0 110.625 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.578 2.025 0 CA-C-O 117.6 -1.19 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.83 -1.59 6.46 Favored 'Trans proline' 1 N--CA 1.537 4.058 0 C-N-CA 122.52 2.146 . . . . 0.0 111.688 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -179.78 -132.18 1.76 Allowed Glycine 1 N--CA 1.518 4.139 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 19.9 p 81.23 -29.19 0.12 Allowed 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 125.416 1.487 . . . . 0.0 111.203 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 mp -64.22 -26.93 68.73 Favored 'General case' 1 N--CA 1.54 4.041 0 C-N-CA 123.498 0.719 . . . . 0.0 109.116 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 39.2 t -63.68 -35.85 81.91 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 123.805 0.842 . . . . 0.0 111.21 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.27 -35.69 83.22 Favored Glycine 1 N--CA 1.519 4.2 0 C-N-CA 123.846 0.736 . . . . 0.0 112.549 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.17 -47.04 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 C-N-CA 123.857 0.863 . . . . 0.0 112.292 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.83 -32.51 52.19 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 CA-C-N 118.564 0.62 . . . . 0.0 109.684 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.66 -32.24 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.76 -29.49 41.63 Favored Glycine 0 N--CA 1.511 3.698 0 C-N-CA 123.843 0.735 . . . . 0.0 113.402 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 m -60.32 -37.59 74.56 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.108 0 CA-C-N 117.918 0.859 . . . . 0.0 110.381 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 37.8 p -60.02 -45.8 91.61 Favored 'General case' 0 N--CA 1.528 3.47 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.235 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 47.6 t -69.49 -37.83 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 C-N-CA 124.229 1.012 . . . . 0.0 111.091 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.61 -42.96 65.06 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.85 -31.85 72.73 Favored 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 123.067 0.547 . . . . 0.0 111.748 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.05 -39.51 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.529 0 C-N-CA 123.089 0.556 . . . . 0.0 110.384 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.89 -33.01 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 C-N-CA 123.389 0.676 . . . . 0.0 110.558 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.59 -45.93 84.89 Favored 'General case' 0 N--CA 1.532 3.631 0 C-N-CA 122.715 0.406 . . . . 0.0 109.923 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 73.2 mt -54.78 -36.53 37.27 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 C-N-CA 122.851 0.46 . . . . 0.0 110.891 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.62 -37.88 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 C-N-CA 123.029 0.532 . . . . 0.0 109.889 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.95 -32.36 69.54 Favored 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.43 0.692 . . . . 0.0 111.387 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.17 -34.72 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.23 0 C-N-CA 123.638 0.775 . . . . 0.0 111.16 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -69.13 -43.98 73.3 Favored 'General case' 0 N--CA 1.531 3.586 0 O-C-N 122.059 -0.401 . . . . 0.0 112.015 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.69 -37.62 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 122.688 0.395 . . . . 0.0 110.661 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 12.3 p -59.98 -27.54 66.93 Favored 'General case' 0 N--CA 1.535 3.8 0 CA-C-N 118.089 0.404 . . . . 0.0 111.078 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -59.99 -27.01 66.5 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 123.393 0.677 . . . . 0.0 111.134 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 48.7 m -63.96 -33.99 76.96 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.401 0.68 . . . . 0.0 110.889 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 46.3 mt -61.05 -13.85 19.61 Favored 'General case' 0 N--CA 1.525 3.292 0 C-N-CA 124.483 1.113 . . . . 0.0 111.973 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 31.7 mt -86.57 -21.45 26.85 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.352 0.661 . . . . 0.0 110.233 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -76.94 95.2 4.07 Favored 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -166.63 -173.04 2.32 Favored 'General case' 0 N--CA 1.52 3.042 0 C-N-CA 123.849 0.859 . . . . 0.0 109.131 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -60.45 141.46 56.39 Favored 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 123.991 0.916 . . . . 0.0 111.088 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.63 138.22 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 124.834 1.254 . . . . 0.0 108.226 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 51.2 tp -109.24 99.64 37.22 Favored Pre-proline 0 N--CA 1.531 3.591 0 C-N-CA 124.871 1.269 . . . . 0.0 108.017 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo . . . . . 0 N--CA 1.535 3.968 0 C-N-CA 122.449 2.099 . . . . 0.0 111.11 -179.674 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 73.7 mtp . . . . . 0 CA--C 1.576 1.947 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.17 82.79 1.53 Allowed 'Trans proline' 1 N--CA 1.538 4.113 0 C-N-CA 122.318 2.012 . . . . 0.0 110.148 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.24 -131.58 30.14 Favored Glycine 1 N--CA 1.519 4.228 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 98.5 p -163.91 158.42 19.78 Favored 'General case' 0 N--CA 1.521 3.098 0 C-N-CA 123.581 0.753 . . . . 0.0 109.081 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.14 -27.01 68.43 Favored 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 124.246 1.018 . . . . 0.0 110.369 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 50.3 m -57.79 -26.19 61.58 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.1 0.56 . . . . 0.0 111.074 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.38 -34.58 63.61 Favored Glycine 1 N--CA 1.516 4.011 0 C-N-CA 124.362 0.982 . . . . 0.0 113.612 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 10.9 tp -59.32 -43.68 90.6 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 5.8 pt -66.73 -35.99 76.14 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.389 0 CA-C-O 121.906 0.86 . . . . 0.0 109.437 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 87.8 mt -72.68 -40.05 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.254 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.507 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.58 -48.76 84.46 Favored Glycine 1 N--CA 1.518 4.126 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.874 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.31 -36.55 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 123.036 0.535 . . . . 0.0 109.869 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 90.5 m -64.33 -47.5 79.17 Favored 'General case' 0 N--CA 1.523 3.202 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.69 -31.62 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.64 0 C-N-CA 122.76 0.424 . . . . 0.0 111.257 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.05 -47.18 68.63 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.223 0.609 . . . . 0.0 112.614 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.41 69.96 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.346 0.658 . . . . 0.0 112.548 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 45.3 t -68.09 -53.16 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.462 0 O-C-N 122.109 -0.37 . . . . 0.0 111.113 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.39 -32.14 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.361 0 C-N-CA 123.144 0.578 . . . . 0.0 112.411 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -39.03 55.97 Favored 'General case' 1 N--CA 1.541 4.085 0 C-N-CA 122.698 0.399 . . . . 0.0 111.467 -177.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 95.3 mt -69.1 -40.78 81.07 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 O-C-N 121.193 -0.942 . . . . 0.0 111.172 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.76 -36.51 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 O-C-N 121.476 -0.765 . . . . 0.0 109.894 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.21 -45.56 83.72 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.455 0.702 . . . . 0.0 112.621 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 16.8 m -71.86 -34.54 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 O-C-N 121.785 -0.572 . . . . 0.0 110.3 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.19 -44.2 92.74 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.67 -37.53 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 90.2 m -65.22 -29.76 70.59 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.063 0.545 . . . . 0.0 110.739 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -69.5 -39.49 77.55 Favored 'General case' 0 N--CA 1.529 3.499 0 C-N-CA 122.846 0.458 . . . . 0.0 109.927 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.8 t -64.06 -17.93 63.87 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 123.569 0.748 . . . . 0.0 111.386 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.57 -24.48 64.61 Favored 'General case' 0 N--CA 1.532 3.628 0 C-N-CA 124.096 0.958 . . . . 0.0 109.352 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -87.41 -26.56 23.24 Favored 'General case' 0 N--CA 1.539 3.982 0 C-N-CA 123.587 0.755 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -63.95 -69.79 0.26 Allowed 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.261 0.624 . . . . 0.0 110.74 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -66.28 -179.46 0.79 Allowed 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 123.615 0.766 . . . . 0.0 110.81 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -167.81 173.3 8.42 Favored 'General case' 0 N--CA 1.521 3.121 0 C-N-CA 123.889 0.876 . . . . 0.0 109.305 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 26.1 m -135.13 138.24 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 C-N-CA 124.837 1.255 . . . . 0.0 108.245 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 53.1 tp -98.4 103.44 18.3 Favored Pre-proline 0 N--CA 1.529 3.498 0 CA-C-O 117.27 -1.348 . . . . 0.0 108.329 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo . . . . . 1 N--CA 1.536 4.003 0 C-N-CA 122.276 1.984 . . . . 0.0 110.974 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 CA--C 1.58 2.103 0 CA-C-O 117.714 -1.136 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.53 -31.99 51.42 Favored 'Trans proline' 1 N--CA 1.548 4.734 0 CA-C-N 122.302 1.858 . . . . 0.0 113.227 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 179.2 163.11 29.62 Favored Glycine 1 N--CA 1.519 4.223 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.3 p -69.77 139.5 53.27 Favored 'General case' 0 N--CA 1.522 3.144 0 C-N-CA 123.647 0.779 . . . . 0.0 110.326 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.4 mp -65.35 -26.4 68.01 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 124.072 0.949 . . . . 0.0 109.536 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 38.8 t -67.72 -27.52 66.87 Favored 'General case' 0 N--CA 1.519 3.009 0 C-N-CA 123.4 0.68 . . . . 0.0 110.527 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.92 -47.16 56.59 Favored Glycine 0 N--CA 1.504 3.217 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -70.55 -41.69 78.02 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.223 0 CA-C-N 118.085 0.943 . . . . 0.0 113.499 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 tt -59.23 -31.03 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 C-N-CA 123.614 0.766 . . . . 0.0 111.734 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -33.4 50.23 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.352 0 O-C-N 121.8 -0.562 . . . . 0.0 109.664 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.02 -38.5 65.85 Favored Glycine 1 N--CA 1.518 4.137 0 N-CA-C 115.282 0.873 . . . . 0.0 115.282 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.49 -37.53 77.91 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.285 0 CA-C-N 118.355 1.078 . . . . 0.0 111.199 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.415 ' HG1' ' N ' ' A' ' 220' ' ' VAL . 30.7 p -63.46 -46.02 88.15 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.415 ' N ' ' HG1' ' A' ' 219' ' ' THR . 7.2 p -68.48 -31.42 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.553 0 C-N-CA 123.424 0.69 . . . . 0.0 110.981 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.3 -47.02 72.87 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.22 -34.94 74.35 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.484 0.714 . . . . 0.0 112.376 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.61 -40.44 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.292 0 C-N-CA 123.482 0.713 . . . . 0.0 111.178 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.18 -45.19 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 C-N-CA 122.722 0.409 . . . . 0.0 110.985 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.55 -34.79 78.58 Favored 'General case' 0 N--CA 1.535 3.793 0 C-N-CA 122.418 0.287 . . . . 0.0 110.424 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 74.7 mt -64.35 -44.94 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.705 0 C-N-CA 122.581 0.352 . . . . 0.0 110.531 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.11 -41.05 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.684 0 O-C-N 121.829 -0.544 . . . . 0.0 109.842 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.38 94.58 Favored 'General case' 0 N--CA 1.524 3.252 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.0 m -71.51 -34.05 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 O-C-N 121.603 -0.686 . . . . 0.0 110.194 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -61.13 -44.11 97.84 Favored 'General case' 0 N--CA 1.526 3.341 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 10.1 m -68.84 -41.39 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.83 0 CA-C-N 118.596 0.635 . . . . 0.0 109.576 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 74.5 m -60.52 -27.75 67.86 Favored 'General case' 0 N--CA 1.523 3.215 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.326 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -66.65 -35.06 79.27 Favored 'General case' 0 N--CA 1.523 3.186 0 C-N-CA 122.675 0.39 . . . . 0.0 110.362 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 31.8 t -64.28 -38.48 91.19 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.424 0.69 . . . . 0.0 111.234 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.75 -13.99 18.47 Favored 'General case' 0 N--CA 1.536 3.852 0 C-N-CA 123.265 0.626 . . . . 0.0 110.998 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.06 -17.95 31.71 Favored 'General case' 0 N--CA 1.534 3.735 0 C-N-CA 123.02 0.528 . . . . 0.0 110.281 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -88.9 3.09 52.55 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 124.146 0.978 . . . . 0.0 111.13 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -64.28 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 123.107 0.563 . . . . 0.0 110.171 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -71.2 148.36 47.37 Favored 'General case' 0 N--CA 1.522 3.142 0 C-N-CA 123.698 0.799 . . . . 0.0 110.03 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.96 128.86 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -103.53 99.84 16.83 Favored Pre-proline 0 N--CA 1.532 3.651 0 C-N-CA 124.873 1.269 . . . . 0.0 107.652 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 1 N--CA 1.536 4.01 0 C-N-CA 122.434 2.089 . . . . 0.0 110.564 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 44.1 ttm . . . . . 0 CA--C 1.58 2.115 0 CA-C-O 117.73 -1.129 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.5 172.88 0.11 Allowed 'Trans proline' 1 N--CA 1.548 4.701 0 CA-C-N 122.241 1.836 . . . . 0.0 113.782 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -178.5 -129.89 1.35 Allowed Glycine 1 N--CA 1.517 4.062 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 41.2 t -167.23 156.45 10.34 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-N 117.686 0.743 . . . . 0.0 110.004 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.21 -26.22 68.03 Favored 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 124.703 1.201 . . . . 0.0 110.517 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 43.7 t -57.05 -24.99 57.84 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.539 0.736 . . . . 0.0 111.092 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.91 -47.01 82.29 Favored Glycine 1 N--CA 1.518 4.136 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.455 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 29.3 pt -71.6 -35.7 57.08 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.163 0 CA-C-N 118.204 1.002 . . . . 0.0 111.095 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 45.3 mm -57.23 -44.44 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.84 0 C-N-CA 124.474 1.11 . . . . 0.0 111.972 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.1 tp -72.41 -33.09 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.82 -44.68 97.73 Favored Glycine 1 N--CA 1.517 4.071 0 C-N-CA 123.919 0.771 . . . . 0.0 114.158 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.7 -37.21 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.726 0 CA-C-N 117.727 0.763 . . . . 0.0 110.905 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 67.4 p -65.44 -46.14 81.08 Favored 'General case' 0 N--CA 1.534 3.729 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.56 -31.03 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 C-N-CA 122.621 0.368 . . . . 0.0 111.262 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.22 -42.69 63.76 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.8 88.53 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.092 0.557 . . . . 0.0 111.249 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 24.3 t -64.66 -40.27 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 123.779 0.832 . . . . 0.0 111.234 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.57 -32.45 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 C-N-CA 123.247 0.619 . . . . 0.0 110.943 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 tp -76.54 -42.96 41.2 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.5 -44.05 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 C-N-CA 122.976 0.511 . . . . 0.0 111.841 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.27 -37.04 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.892 0 CA-C-N 118.575 0.625 . . . . 0.0 110.365 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.33 79.46 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.098 0.559 . . . . 0.0 111.812 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 90.3 t -71.66 -35.01 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 122.748 0.419 . . . . 0.0 109.995 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.29 -44.54 96.29 Favored 'General case' 0 N--CA 1.532 3.655 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.04 -38.25 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 73.4 m -67.2 -30.46 70.41 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 122.987 0.515 . . . . 0.0 110.711 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -67.34 -25.3 65.93 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.453 0.701 . . . . 0.0 111.097 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -63.91 -40.28 96.13 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.206 0.602 . . . . 0.0 111.292 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.95 -23.1 65.05 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.636 0.774 . . . . 0.0 110.734 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.7 mp -91.89 -19.82 22.09 Favored 'General case' 0 N--CA 1.537 3.912 0 C-N-CA 124.129 0.971 . . . . 0.0 109.524 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -146.69 57.18 1.16 Allowed 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.754 0.822 . . . . 0.0 109.187 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -79.05 -27.83 43.14 Favored 'General case' 0 N--CA 1.524 3.253 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.06 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 62.5 tttm 61.87 150.73 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 124.709 1.204 . . . . 0.0 111.367 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 66.1 t -113.06 135.35 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 125.031 1.332 . . . . 0.0 107.566 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.98 107.06 29.06 Favored Pre-proline 0 N--CA 1.526 3.348 0 CA-C-O 116.928 -1.511 . . . . 0.0 107.492 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo . . . . . 1 N--CA 1.548 4.721 0 CA-C-N 122.95 2.089 . . . . 0.0 114.27 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 CA--C 1.582 2.182 0 CA-C-O 117.892 -1.051 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -53.56 -10.24 1.43 Allowed 'Trans proline' 1 N--CA 1.548 4.733 0 C-N-CA 122.155 1.903 . . . . 0.0 114.132 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.68 87.79 0.28 Allowed Glycine 1 N--CA 1.518 4.153 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 96.2 p -58.33 -62.31 1.93 Allowed 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.929 0.891 . . . . 0.0 111.96 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.46 -40.98 96.73 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 123.636 0.774 . . . . 0.0 110.626 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 40.4 t -69.6 -26.59 64.52 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 123.144 0.577 . . . . 0.0 110.719 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.58 -46.03 64.11 Favored Glycine 1 N--CA 1.517 4.061 0 N-CA-C 116.508 1.363 . . . . 0.0 116.508 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -35.01 60.59 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 CA-C-N 119.806 1.803 . . . . 0.0 112.274 -176.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 2.7 pt -58.92 -45.0 92.1 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.491 0 CA-C-N 118.694 0.679 . . . . 0.0 111.812 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.0 pt -68.99 -32.99 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 C-N-CA 122.986 0.514 . . . . 0.0 109.75 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.7 -29.94 68.1 Favored Glycine 0 N--CA 1.513 3.783 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.425 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 2.7 m -60.38 -37.65 75.06 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.006 0 CA-C-N 117.847 0.823 . . . . 0.0 111.142 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 219' ' ' THR . . . . . 0.473 ' HG1' ' H ' ' C' ' 220' ' ' VAL . 56.2 p -63.14 -46.67 86.15 Favored 'General case' 0 N--CA 1.526 3.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.444 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . 0.473 ' H ' ' HG1' ' C' ' 219' ' ' THR . 47.2 t -70.1 -33.57 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.086 0 C-N-CA 124.158 0.983 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.91 90.04 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.538 0.735 . . . . 0.0 112.523 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.97 -48.55 70.9 Favored 'General case' 0 N--CA 1.516 2.841 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.4 m -67.9 -39.96 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.55 -34.16 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 CA-C-N 119.354 0.979 . . . . 0.0 111.759 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 45.1 tp -67.83 -47.59 68.57 Favored 'General case' 0 N--CA 1.528 3.425 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 27.7 pt -68.95 -36.3 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-N 118.231 0.469 . . . . 0.0 111.002 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.48 -37.42 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.962 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.25 72.47 Favored 'General case' 0 N--CA 1.533 3.683 0 C-N-CA 122.931 0.492 . . . . 0.0 112.086 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.77 -37.05 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.066 0.546 . . . . 0.0 110.304 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -63.31 -44.08 96.01 Favored 'General case' 0 N--CA 1.532 3.64 0 C-N-CA 123.135 0.574 . . . . 0.0 112.443 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.62 -37.46 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.63 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 98.0 m -62.2 -29.72 70.58 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 122.879 0.472 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -69.58 -27.67 65.32 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.214 0.606 . . . . 0.0 111.07 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 30.3 t -64.07 -32.72 74.38 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 123.204 0.602 . . . . 0.0 112.094 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.39 -21.48 66.31 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.648 0.779 . . . . 0.0 110.885 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 7.9 mp -87.51 -28.28 22.12 Favored 'General case' 0 N--CA 1.532 3.672 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -83.39 86.82 7.01 Favored 'General case' 0 N--CA 1.52 3.048 0 C-N-CA 123.978 0.911 . . . . 0.0 108.734 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.19 -17.88 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.294 0 C-N-CA 123.675 0.79 . . . . 0.0 110.204 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 59.0 -171.41 0.12 Allowed 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.932 0.893 . . . . 0.0 110.673 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.64 117.96 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.52 146.73 32.01 Favored Pre-proline 0 N--CA 1.528 3.431 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo . . . . . 1 N--CA 1.54 4.233 0 C-N-CA 122.089 1.859 . . . . 0.0 110.619 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 CA--C 1.575 1.928 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -50.83 143.36 30.19 Favored 'Trans proline' 1 N--CA 1.544 4.448 0 C-N-CA 122.441 2.094 . . . . 0.0 113.671 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.55 -169.03 9.98 Favored Glycine 0 N--CA 1.515 3.957 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 99.5 p -165.96 67.83 0.12 Allowed 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 123.735 0.814 . . . . 0.0 108.841 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.07 -32.71 74.56 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 123.88 0.872 . . . . 0.0 109.243 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 52.2 m -68.46 -25.48 65.01 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 123.682 0.793 . . . . 0.0 109.155 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.74 -46.88 89.01 Favored Glycine 0 N--CA 1.508 3.487 0 C-N-CA 123.848 0.737 . . . . 0.0 114.512 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 tt -70.84 -35.55 60.58 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.412 0 CA-C-N 118.688 1.244 . . . . 0.0 111.324 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 49.9 mm -56.28 -32.46 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 124.807 1.243 . . . . 0.0 112.124 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 1.7 pp -68.32 -33.96 63.39 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.091 0 CA-C-N 119.493 1.042 . . . . 0.0 109.569 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.09 -34.46 89.81 Favored Glycine 1 N--CA 1.521 4.32 0 C-N-CA 123.483 0.564 . . . . 0.0 111.799 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.07 -39.83 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 124.213 1.005 . . . . 0.0 110.031 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 219' ' ' THR . . . . . 0.454 ' HG1' ' N ' ' D' ' 220' ' ' VAL . 30.1 p -61.01 -38.92 87.8 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 123.162 0.585 . . . . 0.0 110.938 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . 0.454 ' N ' ' HG1' ' D' ' 219' ' ' THR . 41.2 t -67.12 -41.46 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.081 0 C-N-CA 123.79 0.836 . . . . 0.0 110.36 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.88 -47.18 85.86 Favored 'General case' 0 N--CA 1.523 3.187 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.51 -47.95 68.5 Favored 'General case' 0 N--CA 1.513 2.701 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.57 -41.94 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.471 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.08 -33.4 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 O-C-N 122.228 -0.295 . . . . 0.0 111.282 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.22 -35.6 81.34 Favored 'General case' 0 N--CA 1.529 3.499 0 C-N-CA 122.736 0.414 . . . . 0.0 110.675 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.43 -36.86 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.702 0 C-N-CA 123.191 0.597 . . . . 0.0 110.119 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.66 -43.31 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 C-N-CA 122.973 0.509 . . . . 0.0 110.093 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.14 87.72 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 20.9 m -71.58 -33.89 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 O-C-N 121.806 -0.559 . . . . 0.0 110.071 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.41 -43.49 97.36 Favored 'General case' 0 N--CA 1.526 3.359 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 10.0 m -68.38 -40.16 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 CA-C-N 118.684 0.675 . . . . 0.0 110.884 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 14.5 p -66.35 -28.5 68.7 Favored 'General case' 0 N--CA 1.533 3.711 0 O-C-N 122.197 -0.315 . . . . 0.0 110.38 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -73.77 -32.55 63.85 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 123.446 0.698 . . . . 0.0 109.845 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 47.8 m -64.18 -31.17 72.26 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.182 0.593 . . . . 0.0 110.751 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 60.0 mt -60.79 -23.66 65.2 Favored 'General case' 0 N--CA 1.531 3.594 0 C-N-CA 122.586 0.354 . . . . 0.0 111.206 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.68 -7.36 52.83 Favored 'General case' 1 N--CA 1.539 4.017 0 C-N-CA 123.946 0.898 . . . . 0.0 110.33 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -69.19 3.51 2.13 Favored 'General case' 0 N--CA 1.534 3.764 0 C-N-CA 123.013 0.525 . . . . 0.0 111.31 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -53.2 149.32 7.19 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 123.937 0.895 . . . . 0.0 111.332 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -67.29 126.16 28.38 Favored 'General case' 0 N--CA 1.52 3.034 0 C-N-CA 123.935 0.894 . . . . 0.0 110.79 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 22.2 m -135.3 138.26 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.457 0 C-N-CA 124.952 1.301 . . . . 0.0 108.059 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -94.53 146.38 31.37 Favored Pre-proline 0 N--CA 1.534 3.746 0 C-N-CA 124.634 1.174 . . . . 0.0 109.629 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 1 N--CA 1.54 4.26 0 CA-C-N 122.166 1.809 . . . . 0.0 110.796 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.573 1.844 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.09 -42.31 3.17 Favored 'Trans proline' 1 N--CA 1.54 4.249 0 C-N-CA 122.02 1.813 . . . . 0.0 110.485 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -75.31 138.02 22.77 Favored Glycine 1 N--CA 1.518 4.102 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 99.6 p -167.3 -21.84 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.612 0.765 . . . . 0.0 109.99 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 41.9 mt -64.28 -34.3 77.8 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.695 0.798 . . . . 0.0 110.056 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 61.2 m -68.69 -26.57 65.36 Favored 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 123.575 0.75 . . . . 0.0 110.104 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.84 -46.18 61.35 Favored Glycine 0 N--CA 1.514 3.887 0 C-N-CA 124.071 0.844 . . . . 0.0 114.705 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 45.9 pt -70.76 -35.77 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -175.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . 0.253 0.1 OUTLIER -57.77 -41.3 79.31 Favored 'Isoleucine or valine' 1 N--CA 1.558 4.95 0 CA-C-N 119.984 1.265 . . . . 0.0 112.945 -175.033 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.0 tt -72.38 -32.16 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 C-N-CA 124.297 1.039 . . . . 0.0 108.863 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.01 -29.37 43.39 Favored Glycine 0 N--CA 1.512 3.704 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.395 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.16 -37.8 79.39 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 CA-C-N 118.089 0.944 . . . . 0.0 110.7 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 36.1 p -65.98 -40.51 91.29 Favored 'General case' 0 N--CA 1.529 3.477 0 C-N-CA 123.344 0.657 . . . . 0.0 110.366 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.59 -32.08 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.06 0 C-N-CA 124.046 0.939 . . . . 0.0 110.49 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.54 91.48 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-O 121.062 0.458 . . . . 0.0 110.761 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.28 -47.97 80.09 Favored 'General case' 0 N--CA 1.519 3.017 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.91 -38.57 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.48 -32.8 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 40.6 tp -78.18 -42.64 30.94 Favored 'General case' 0 N--CA 1.535 3.79 0 CA-C-N 118.755 0.707 . . . . 0.0 112.311 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.12 -35.56 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.476 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 28.6 m -65.51 -35.21 74.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.354 0 CA-C-N 119.241 0.928 . . . . 0.0 109.978 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.07 -31.24 63.02 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.467 0.707 . . . . 0.0 112.144 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 3.2 m -56.96 -34.17 43.91 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 O-C-N 121.635 -0.666 . . . . 0.0 110.848 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.96 -44.65 96.3 Favored 'General case' 0 N--CA 1.53 3.527 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.59 -37.3 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.974 0 CA-C-N 119.067 0.849 . . . . 0.0 108.875 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 63.4 m -58.54 -27.56 64.66 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 122.854 0.461 . . . . 0.0 110.901 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -60.78 -18.12 53.2 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 122.916 0.487 . . . . 0.0 110.695 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 33.5 t -66.2 -25.53 66.97 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.616 0.766 . . . . 0.0 111.244 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 46.0 tp -60.38 -14.42 18.72 Favored 'General case' 0 N--CA 1.532 3.641 0 C-N-CA 123.848 0.859 . . . . 0.0 111.4 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.16 3.1 47.74 Favored 'General case' 0 N--CA 1.534 3.773 0 C-N-CA 123.682 0.793 . . . . 0.0 111.142 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -73.04 68.18 0.92 Allowed 'General case' 1 N--CA 1.542 4.166 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -92.25 -167.98 1.88 Allowed 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 124.907 1.283 . . . . 0.0 109.063 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -168.28 153.22 6.45 Favored 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 124.099 0.96 . . . . 0.0 108.458 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 23.8 m -135.21 138.23 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 124.851 1.26 . . . . 0.0 108.477 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . 0.402 ' H ' ' CD2' ' E' ' 241' ' ' LEU . 1.7 pt? -94.81 146.91 32.23 Favored Pre-proline 0 N--CA 1.534 3.734 0 CA-C-O 116.657 -1.64 . . . . 0.0 109.602 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo . . . . . 1 N--CA 1.55 4.838 0 C-N-CA 122.654 2.236 . . . . 0.0 114.818 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 CA--C 1.575 1.921 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -75.33 48.52 2.1 Favored 'Trans proline' 1 N--CA 1.54 4.236 0 C-N-CA 122.53 2.153 . . . . 0.0 110.446 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -176.05 142.4 6.02 Favored Glycine 1 N--CA 1.519 4.226 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 93.3 p -170.17 7.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 124.476 1.11 . . . . 0.0 109.524 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.54 -26.52 68.45 Favored 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.451 1.101 . . . . 0.0 110.871 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 55.1 m -65.46 -26.25 67.86 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.246 0.619 . . . . 0.0 111.002 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.15 -46.57 64.35 Favored Glycine 0 N--CA 1.516 3.974 0 C-N-CA 123.406 0.527 . . . . 0.0 114.233 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -70.85 -35.55 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 11.6 pt -56.64 -45.11 82.43 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.587 0 CA-C-N 119.529 1.059 . . . . 0.0 112.607 -175.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.99 -33.76 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 C-N-CA 123.358 0.663 . . . . 0.0 109.823 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.91 -30.08 76.69 Favored Glycine 0 N--CA 1.509 3.525 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.684 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.04 -37.65 73.55 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 CA-C-N 118.106 0.953 . . . . 0.0 111.589 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 29.2 p -65.82 -47.31 75.46 Favored 'General case' 0 N--CA 1.529 3.518 0 CA-C-O 121.319 0.58 . . . . 0.0 110.518 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.66 -42.38 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 C-N-CA 124.264 1.026 . . . . 0.0 111.176 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.04 -43.0 73.38 Favored 'General case' 0 N--CA 1.528 3.468 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.13 -50.49 68.01 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 p -68.39 -38.66 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 CA-C-N 118.499 0.59 . . . . 0.0 111.883 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.34 -33.69 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.456 0.571 . . . . 0.0 110.79 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 25.0 tp -69.71 -34.47 73.94 Favored 'General case' 0 N--CA 1.531 3.618 0 CA-C-N 118.689 0.677 . . . . 0.0 111.016 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 79.2 mt -65.72 -41.46 90.44 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.134 0 O-C-N 121.728 -0.608 . . . . 0.0 109.436 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.11 -37.41 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 C-N-CA 123.54 0.736 . . . . 0.0 109.807 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.09 68.35 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.21 0.604 . . . . 0.0 111.863 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 69.6 t -71.68 -38.04 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 122.812 0.445 . . . . 0.0 110.391 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -62.12 -44.07 97.45 Favored 'General case' 0 N--CA 1.532 3.644 0 C-N-CA 123.186 0.594 . . . . 0.0 112.579 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.69 -37.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.685 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 93.3 m -64.77 -29.68 70.66 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 122.924 0.489 . . . . 0.0 110.463 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -74.32 -40.03 62.47 Favored 'General case' 0 N--CA 1.525 3.321 0 C-N-CA 123.059 0.543 . . . . 0.0 109.585 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.3 t -63.82 -18.91 64.6 Favored 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 123.946 0.899 . . . . 0.0 112.376 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 50.5 tp -70.56 -14.82 62.66 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.673 0.789 . . . . 0.0 110.95 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 mp -87.21 -0.91 57.44 Favored 'General case' 0 N--CA 1.534 3.754 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.619 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -163.23 82.48 0.48 Allowed 'General case' 0 N--CA 1.538 3.949 0 CA-C-N 119.042 0.837 . . . . 0.0 112.3 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -145.61 -8.37 0.57 Allowed 'General case' 0 N--CA 1.538 3.927 0 C-N-CA 125.038 1.335 . . . . 0.0 108.595 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -70.43 149.96 46.72 Favored 'General case' 0 N--CA 1.527 3.402 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.32 138.38 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 124.82 1.248 . . . . 0.0 108.368 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.9 pp -94.67 146.51 31.56 Favored Pre-proline 0 N--CA 1.528 3.462 0 CA-C-O 117.316 -1.326 . . . . 0.0 108.444 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 1 N--CA 1.539 4.195 0 C-N-CA 122.011 1.807 . . . . 0.0 110.104 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 3.5 ppp? . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 117.746 -1.121 . . . . 0.0 108.172 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.22 153.82 56.65 Favored 'Trans proline' 1 N--CA 1.539 4.151 0 C-N-CA 122.026 1.817 . . . . 0.0 110.157 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -73.6 178.72 41.82 Favored Glycine 0 N--CA 1.516 3.981 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.9 p -168.49 -53.17 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.88 -26.38 68.3 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 123.726 0.81 . . . . 0.0 109.099 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 37.4 t -57.79 -41.32 81.85 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 123.815 0.846 . . . . 0.0 112.248 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -35.48 79.71 Favored Glycine 1 N--CA 1.521 4.348 0 C-N-CA 123.883 0.754 . . . . 0.0 112.978 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.25 -46.29 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 C-N-CA 123.97 0.908 . . . . 0.0 112.845 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.11 -32.18 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 121.986 -0.446 . . . . 0.0 110.786 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.8 -33.75 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 C-N-CA 123.437 0.695 . . . . 0.0 110.185 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.32 84.8 Favored Glycine 1 N--CA 1.521 4.301 0 CA-C-O 119.941 -0.366 . . . . 0.0 113.851 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.7 m -60.0 -36.75 69.1 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.343 0 CA-C-N 117.762 0.781 . . . . 0.0 110.784 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.437 ' HG1' ' H ' ' A' ' 220' ' ' VAL . 30.5 p -55.47 -45.28 76.97 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.502 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.437 ' H ' ' HG1' ' A' ' 219' ' ' THR . 42.6 t -65.73 -37.96 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 C-N-CA 124.151 0.98 . . . . 0.0 111.46 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.95 -42.44 65.48 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.34 83.4 Favored 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 123.126 0.57 . . . . 0.0 111.184 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.4 t -64.29 -42.93 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.442 0.697 . . . . 0.0 110.934 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.2 -40.93 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 C-N-CA 123.144 0.578 . . . . 0.0 110.291 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.39 -38.5 91.39 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.928 0.491 . . . . 0.0 110.466 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.4 mt -56.97 -36.41 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.772 0 C-N-CA 123.441 0.696 . . . . 0.0 110.692 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 50.4 t -61.91 -37.94 79.44 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 C-N-CA 122.737 0.415 . . . . 0.0 110.469 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -31.85 68.71 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.563 0.745 . . . . 0.0 111.754 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.63 -34.73 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 C-N-CA 122.948 0.499 . . . . 0.0 111.393 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -67.59 -44.1 78.94 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.8 -37.43 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.954 0 CA-C-N 118.713 0.688 . . . . 0.0 109.903 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 76.4 m -66.12 -33.1 75.02 Favored 'General case' 0 N--CA 1.522 3.154 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.085 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -70.01 -41.24 74.6 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 123.276 0.631 . . . . 0.0 110.219 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 95.9 p -66.34 -30.21 70.57 Favored 'General case' 0 N--CA 1.53 3.539 0 C-N-CA 123.284 0.633 . . . . 0.0 109.766 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -14.32 45.25 Favored 'General case' 0 N--CA 1.531 3.618 0 C-N-CA 124.543 1.137 . . . . 0.0 110.255 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 32.5 mt -86.66 5.05 37.9 Favored 'General case' 0 N--CA 1.537 3.877 0 C-N-CA 123.241 0.617 . . . . 0.0 110.826 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -168.33 122.31 0.9 Allowed 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.558 0.743 . . . . 0.0 109.085 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -139.24 -0.64 1.8 Allowed 'General case' 0 N--CA 1.531 3.613 0 C-N-CA 124.81 1.244 . . . . 0.0 109.546 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -167.02 155.29 9.74 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.61 138.27 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 C-N-CA 124.886 1.275 . . . . 0.0 108.963 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.85 147.28 33.22 Favored Pre-proline 0 N--CA 1.526 3.346 0 C-N-CA 125.312 1.445 . . . . 0.0 108.329 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 1 N--CA 1.541 4.307 0 C-N-CA 121.991 1.794 . . . . 0.0 110.758 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.574 1.883 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -69.63 165.19 31.65 Favored 'Trans proline' 1 N--CA 1.54 4.259 0 C-N-CA 122.281 1.987 . . . . 0.0 110.378 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.07 178.65 15.93 Favored Glycine 1 N--CA 1.517 4.038 0 C-N-CA 123.723 0.677 . . . . 0.0 112.036 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 98.7 p -167.19 39.15 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.125 0 C-N-CA 124.222 1.009 . . . . 0.0 108.395 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.7 -26.81 68.27 Favored 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 124.31 1.044 . . . . 0.0 111.038 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 68.5 m -60.39 -26.53 66.73 Favored 'General case' 0 N--CA 1.528 3.463 0 C-N-CA 123.427 0.691 . . . . 0.0 110.647 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.09 -34.96 81.83 Favored Glycine 0 N--CA 1.512 3.767 0 C-N-CA 124.944 1.259 . . . . 0.0 115.015 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 14.4 tt -59.75 -35.76 61.93 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -175.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 1.9 pp -56.81 -47.76 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.0 tt -73.26 -33.5 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.32 -46.55 93.67 Favored Glycine 0 N--CA 1.513 3.782 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.979 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.59 -37.39 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 CA-C-N 117.615 0.707 . . . . 0.0 110.847 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 28.3 p -66.11 -46.1 78.77 Favored 'General case' 0 N--CA 1.526 3.371 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -69.93 -31.68 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.94 68.96 Favored 'General case' 0 N--CA 1.528 3.46 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.0 -49.97 58.36 Favored 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 22.0 m -66.95 -38.26 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 CA-C-N 118.534 0.606 . . . . 0.0 111.902 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.07 -32.74 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 122.504 0.322 . . . . 0.0 110.136 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.28 -41.43 94.18 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 122.602 0.361 . . . . 0.0 110.589 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 73.7 mt -56.85 -36.41 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 C-N-CA 122.889 0.476 . . . . 0.0 110.579 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.95 -37.28 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 C-N-CA 122.985 0.514 . . . . 0.0 110.517 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -31.88 66.96 Favored 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.53 0.732 . . . . 0.0 112.224 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.9 -34.92 73.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 O-C-N 121.587 -0.696 . . . . 0.0 110.469 -178.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -64.24 -44.58 91.41 Favored 'General case' 0 N--CA 1.527 3.409 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 16.0 m -69.07 -37.6 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-O 121.29 0.567 . . . . 0.0 109.742 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -66.46 -30.42 70.76 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -74.32 -40.12 62.43 Favored 'General case' 0 N--CA 1.525 3.285 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 70.9 m -65.07 -35.55 81.51 Favored 'General case' 0 N--CA 1.523 3.196 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.204 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.21 -14.23 24.09 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 124.082 0.953 . . . . 0.0 111.194 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 21.9 mt -87.56 10.15 18.78 Favored 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 123.263 0.625 . . . . 0.0 109.412 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -25.33 134.91 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.068 0 C-N-CA 125.629 1.572 . . . . 0.0 113.427 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -132.43 166.84 21.09 Favored 'General case' 0 N--CA 1.526 3.36 0 C-N-CA 124.191 0.996 . . . . 0.0 109.698 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -67.63 -171.71 0.21 Allowed 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 124.14 0.976 . . . . 0.0 110.452 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.88 130.06 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 52.3 tp -133.43 99.83 14.22 Favored Pre-proline 0 N--CA 1.531 3.605 0 C-N-CA 124.981 1.312 . . . . 0.0 107.975 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 1 N--CA 1.536 4.022 0 C-N-CA 122.351 2.034 . . . . 0.0 110.926 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.577 1.982 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -85.25 28.07 0.58 Allowed 'Trans proline' 0 N--CA 1.535 3.949 0 C-N-CA 122.89 2.393 . . . . 0.0 110.769 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.13 14.1 65.58 Favored Glycine 1 N--CA 1.519 4.228 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.19 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 50.0 m 55.08 88.04 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 124.126 0.97 . . . . 0.0 111.829 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 tp -64.98 -35.74 82.17 Favored 'General case' 0 N--CA 1.527 3.424 0 C-N-CA 123.881 0.872 . . . . 0.0 109.971 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.0 m -67.2 -30.39 70.31 Favored 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 123.778 0.831 . . . . 0.0 110.446 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -47.0 57.97 Favored Glycine 0 N--CA 1.513 3.829 0 CA-C-N 115.526 -0.761 . . . . 0.0 114.334 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 34.6 pt -71.35 -39.7 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.2 tt -62.79 -39.77 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.62 -33.08 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.9 -29.12 50.13 Favored Glycine 0 N--CA 1.515 3.96 0 C-N-CA 123.609 0.623 . . . . 0.0 113.363 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.3 m -59.53 -46.28 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 5.3 t -66.11 -38.79 89.06 Favored 'General case' 0 N--CA 1.536 3.832 0 CA-C-O 121.045 0.45 . . . . 0.0 111.067 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.1 -39.61 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.183 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.66 72.68 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 123.461 0.704 . . . . 0.0 111.05 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.82 87.67 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 123.499 0.719 . . . . 0.0 111.224 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.33 -48.42 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 C-N-CA 123.269 0.627 . . . . 0.0 110.089 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.73 -36.77 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.561 0 C-N-CA 123.766 0.826 . . . . 0.0 110.9 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 22.4 mt -65.04 -34.35 78.21 Favored 'General case' 0 N--CA 1.534 3.727 0 C-N-CA 122.898 0.479 . . . . 0.0 110.591 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.98 -39.64 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.74 -37.87 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.514 0 C-N-CA 123.262 0.625 . . . . 0.0 109.601 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.28 83.29 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.748 0.819 . . . . 0.0 112.623 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.83 -34.35 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.594 0 O-C-N 121.897 -0.502 . . . . 0.0 110.215 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -63.8 -43.92 94.86 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 123.141 0.577 . . . . 0.0 112.517 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.39 -37.25 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 77.4 m -60.03 -28.42 67.73 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 122.658 0.383 . . . . 0.0 111.367 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -74.09 -28.65 61.48 Favored 'General case' 0 N--CA 1.531 3.602 0 C-N-CA 122.653 0.381 . . . . 0.0 110.817 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 57.9 m -67.41 -17.69 64.82 Favored 'General case' 0 N--CA 1.53 3.569 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.78 -38.54 67.25 Favored 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 124.126 0.97 . . . . 0.0 110.459 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 pp -87.93 -4.14 58.85 Favored 'General case' 1 N--CA 1.553 4.687 0 CA-C-N 118.767 0.712 . . . . 0.0 111.923 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -69.68 -11.84 61.16 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.518 0.727 . . . . 0.0 110.717 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -64.91 -26.09 68.17 Favored 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 124.009 0.924 . . . . 0.0 111.39 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -74.83 72.03 2.03 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.59 0.756 . . . . 0.0 109.852 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.48 135.82 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 124.591 1.157 . . . . 0.0 108.178 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.9 mp -94.88 116.48 66.42 Favored Pre-proline 0 N--CA 1.527 3.417 0 CA-C-O 116.568 -1.682 . . . . 0.0 106.917 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 1 N--CA 1.538 4.093 0 CA-C-N 123.325 2.223 . . . . 0.0 110.66 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 CA--C 1.579 2.084 0 CA-C-O 117.753 -1.117 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.77 -18.64 9.31 Favored 'Trans proline' 1 N--CA 1.548 4.684 0 CA-C-N 122.283 1.851 . . . . 0.0 113.331 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.48 -170.84 50.23 Favored Glycine 1 N--CA 1.518 4.12 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 70.2 m -159.7 40.61 0.2 Allowed 'General case' 0 N--CA 1.518 2.956 0 C-N-CA 124.084 0.954 . . . . 0.0 108.736 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.04 -35.07 79.99 Favored 'General case' 0 N--CA 1.527 3.4 0 C-N-CA 124.533 1.133 . . . . 0.0 109.741 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 70.7 m -57.14 -26.04 59.88 Favored 'General case' 0 N--CA 1.525 3.318 0 C-N-CA 123.725 0.81 . . . . 0.0 110.523 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.46 -34.45 59.82 Favored Glycine 0 N--CA 1.509 3.504 0 C-N-CA 124.929 1.252 . . . . 0.0 114.979 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 16.2 pt -59.15 -34.67 54.2 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.12 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -175.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 8.9 pt -56.15 -45.57 80.84 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.265 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 5.8 tp -72.37 -33.87 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.26 -48.27 84.48 Favored Glycine 1 N--CA 1.517 4.039 0 C-N-CA 123.89 0.757 . . . . 0.0 113.706 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.29 -37.32 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.771 0 O-C-N 121.763 -0.845 . . . . 0.0 109.628 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 25.3 m -66.26 -45.75 79.47 Favored 'General case' 0 N--CA 1.519 2.978 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 12.8 p -63.59 -31.12 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 CA-C-N 118.203 0.456 . . . . 0.0 110.436 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.1 -47.2 81.64 Favored 'General case' 0 N--CA 1.528 3.453 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.94 73.93 Favored 'General case' 0 N--CA 1.523 3.194 0 C-N-CA 123.556 0.742 . . . . 0.0 112.036 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.83 -38.61 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 C-N-CA 123.366 0.666 . . . . 0.0 110.602 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.32 -44.79 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 C-N-CA 123.154 0.582 . . . . 0.0 110.135 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.73 -34.54 73.07 Favored 'General case' 1 N--CA 1.54 4.028 0 C-N-CA 123.12 0.568 . . . . 0.0 110.752 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.85 -40.1 87.5 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.22 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.65 -41.94 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 122.989 0.516 . . . . 0.0 109.814 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -41.06 82.09 Favored 'General case' 0 N--CA 1.527 3.406 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 19.0 m -71.17 -33.74 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 O-C-N 121.709 -0.619 . . . . 0.0 110.062 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -66.26 -43.92 85.14 Favored 'General case' 0 N--CA 1.528 3.463 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.76 -37.89 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 CA-C-N 118.327 0.512 . . . . 0.0 111.082 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 10.1 p -58.68 -27.51 64.88 Favored 'General case' 0 N--CA 1.531 3.616 0 C-N-CA 122.367 0.267 . . . . 0.0 111.499 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -61.27 -31.16 70.98 Favored 'General case' 0 N--CA 1.521 3.113 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.05 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 71.2 p -66.0 -38.06 87.52 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.459 0.704 . . . . 0.0 110.607 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 61.0 mt -60.77 -13.34 14.55 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 123.638 0.775 . . . . 0.0 111.901 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 26.8 mt -86.04 -7.65 58.48 Favored 'General case' 0 N--CA 1.534 3.727 0 C-N-CA 123.054 0.542 . . . . 0.0 110.366 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -70.67 -106.65 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.235 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 53.18 23.08 2.9 Favored 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 123.845 0.858 . . . . 0.0 111.94 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 24.7 tptm 61.01 121.65 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.341 0 C-N-CA 124.731 1.213 . . . . 0.0 110.537 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.81 138.06 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.613 0 C-N-CA 124.928 1.291 . . . . 0.0 108.985 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -106.03 146.5 33.03 Favored Pre-proline 0 N--CA 1.535 3.793 0 C-N-CA 125.29 1.436 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo . . . . . 1 N--CA 1.542 4.327 0 CA-C-N 122.267 1.845 . . . . 0.0 110.597 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.573 1.83 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.83 -179.66 4.44 Favored 'Trans proline' 1 N--CA 1.539 4.192 0 C-N-CA 122.139 1.893 . . . . 0.0 110.46 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.65 88.99 0.14 Allowed Glycine 1 N--CA 1.519 4.189 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 66.5 m -63.55 165.14 8.4 Favored 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.918 0.887 . . . . 0.0 111.347 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.24 -26.25 68.03 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 124.495 1.118 . . . . 0.0 109.945 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.4 p -57.32 -25.96 60.17 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.404 0.682 . . . . 0.0 110.975 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.11 -35.24 68.83 Favored Glycine 0 N--CA 1.516 3.998 0 C-N-CA 123.837 0.732 . . . . 0.0 113.755 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 7.6 pt -60.28 -44.04 94.81 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.203 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.1 pt -67.68 -32.47 56.93 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.284 0 C-N-CA 122.934 0.493 . . . . 0.0 110.26 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 47.7 mm -72.08 -32.7 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.601 0 C-N-CA 124.674 1.189 . . . . 0.0 108.79 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.93 -29.13 64.47 Favored Glycine 1 N--CA 1.518 4.13 0 C-N-CA 123.529 0.585 . . . . 0.0 113.26 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.71 -47.55 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 9.0 t -66.36 -38.96 88.79 Favored 'General case' 0 N--CA 1.537 3.899 0 O-C-N 121.827 -0.546 . . . . 0.0 111.196 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.17 -31.82 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 C-N-CA 123.511 0.724 . . . . 0.0 110.431 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.89 76.88 Favored 'General case' 0 N--CA 1.529 3.504 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.68 74.74 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 122.86 0.464 . . . . 0.0 111.459 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.7 -45.52 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 123.291 0.636 . . . . 0.0 112.296 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.24 -32.55 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 C-N-CA 122.352 0.261 . . . . 0.0 111.652 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.5 -34.85 78.83 Favored 'General case' 1 N--CA 1.541 4.117 0 O-C-N 122.098 -0.376 . . . . 0.0 110.255 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.39 -37.94 80.86 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.08 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.06 -37.86 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.5 0 C-N-CA 123.248 0.619 . . . . 0.0 109.975 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.24 96.6 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 17.2 m -71.66 -33.96 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.741 0 O-C-N 121.613 -0.679 . . . . 0.0 109.703 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -63.47 -43.75 96.4 Favored 'General case' 0 N--CA 1.529 3.483 0 C-N-CA 123.062 0.545 . . . . 0.0 112.309 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.41 -37.41 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.351 0.523 . . . . 0.0 109.631 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 79.1 m -60.21 -27.93 67.57 Favored 'General case' 0 N--CA 1.525 3.283 0 C-N-CA 123.143 0.577 . . . . 0.0 111.018 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.71 -35.02 79.55 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 122.796 0.438 . . . . 0.0 110.243 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 68.0 m -73.72 -36.27 65.19 Favored 'General case' 0 N--CA 1.523 3.185 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -17.75 63.65 Favored 'General case' 0 N--CA 1.529 3.501 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.827 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.11 -26.67 23.54 Favored 'General case' 0 N--CA 1.536 3.842 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -78.89 66.36 4.34 Favored 'General case' 0 N--CA 1.52 3.059 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.1 170.17 3.85 Favored 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 123.913 0.885 . . . . 0.0 110.759 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.75 -14.84 62.11 Favored 'General case' 0 N--CA 1.526 3.36 0 C-N-CA 123.996 0.918 . . . . 0.0 111.156 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.57 138.28 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 C-N-CA 125.316 1.446 . . . . 0.0 108.874 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.44 146.56 31.73 Favored Pre-proline 0 N--CA 1.53 3.56 0 CA-C-O 116.579 -1.677 . . . . 0.0 106.989 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 1 N--CA 1.55 4.8 0 C-N-CA 123.05 2.5 . . . . 0.0 114.933 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 CA--C 1.569 1.704 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.68 168.13 25.3 Favored 'Trans proline' 1 N--CA 1.539 4.192 0 C-N-CA 122.063 1.842 . . . . 0.0 110.168 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 173.97 -12.74 0.04 OUTLIER Glycine 1 N--CA 1.522 4.408 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 64.8 m -68.56 89.79 0.37 Allowed 'General case' 0 N--CA 1.52 3.034 0 C-N-CA 123.762 0.825 . . . . 0.0 110.962 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.17 -26.38 68.14 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.915 0.886 . . . . 0.0 110.245 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 57.0 m -61.65 -26.78 68.22 Favored 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 123.653 0.781 . . . . 0.0 111.062 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.9 -47.5 54.49 Favored Glycine 1 N--CA 1.518 4.128 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.902 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 45.3 pt -72.33 -40.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -44.92 95.35 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.276 0 C-N-CA 123.194 0.597 . . . . 0.0 111.876 -175.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 6.4 tp -63.21 -32.62 57.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 C-N-CA 123.278 0.631 . . . . 0.0 109.382 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.31 -29.99 63.9 Favored Glycine 0 N--CA 1.513 3.802 0 CA-C-O 119.346 -0.697 . . . . 0.0 113.855 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.0 m -62.2 -47.21 94.16 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 CA-C-N 118.528 1.164 . . . . 0.0 112.045 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -38.82 89.24 Favored 'General case' 0 N--CA 1.536 3.872 0 C-N-CA 122.202 0.201 . . . . 0.0 110.766 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.78 -39.94 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.55 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.6 83.01 Favored 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 123.198 0.599 . . . . 0.0 111.136 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.66 85.64 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.173 0.589 . . . . 0.0 112.175 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.85 -41.15 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 122.909 0.483 . . . . 0.0 110.962 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.05 -41.89 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 C-N-CA 123.143 0.577 . . . . 0.0 110.852 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.7 -37.33 86.07 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 122.606 0.362 . . . . 0.0 111.667 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.76 -44.01 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.3 -40.3 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.73 -45.11 93.16 Favored 'General case' 0 N--CA 1.525 3.31 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.53 -34.05 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.703 0 O-C-N 121.633 -0.667 . . . . 0.0 109.788 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -63.06 -44.32 96.15 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 21.3 m -69.05 -37.88 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 CA-C-O 121.159 0.505 . . . . 0.0 109.841 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 76.3 m -65.54 -33.82 76.81 Favored 'General case' 0 N--CA 1.521 3.08 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.083 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -74.15 -39.75 63.06 Favored 'General case' 0 N--CA 1.537 3.898 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 58.6 m -63.75 -30.11 71.24 Favored 'General case' 0 N--CA 1.52 3.054 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.063 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.77 -21.62 66.51 Favored 'General case' 0 N--CA 1.526 3.364 0 C-N-CA 123.013 0.525 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -98.49 -15.81 19.44 Favored 'General case' 1 N--CA 1.548 4.459 0 C-N-CA 124.017 0.927 . . . . 0.0 110.472 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -68.12 3.53 1.59 Allowed 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.356 0.662 . . . . 0.0 111.624 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -166.02 -28.03 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 122.847 0.459 . . . . 0.0 110.941 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt 63.24 138.81 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 124.275 1.03 . . . . 0.0 110.531 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 56.1 t -134.92 136.96 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.553 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 3.8 tt -133.16 99.83 14.57 Favored Pre-proline 0 N--CA 1.534 3.751 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 1 N--CA 1.536 4.012 0 C-N-CA 122.529 2.153 . . . . 0.0 111.114 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 59.2 tpp . . . . . 0 CA--C 1.577 2.009 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -79.6 -33.35 1.3 Allowed 'Trans proline' 0 N--CA 1.536 3.995 0 C-N-CA 122.454 2.103 . . . . 0.0 110.497 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.37 43.0 95.71 Favored Glycine 1 N--CA 1.519 4.217 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.247 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.0 m -74.63 40.39 0.14 Allowed 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 123.911 0.884 . . . . 0.0 110.571 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.0 -37.48 87.8 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 124.474 1.11 . . . . 0.0 109.978 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 45.2 t -68.61 -26.5 65.39 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.333 0.653 . . . . 0.0 110.702 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.66 -46.59 60.85 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 117.579 1.792 . . . . 0.0 117.579 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.8 -35.66 61.25 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.694 0 CA-C-N 119.612 1.706 . . . . 0.0 113.57 -175.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.54 -38.11 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.543 0 C-N-CA 123.55 0.74 . . . . 0.0 111.997 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 15.2 tt -71.41 -32.86 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.78 -28.87 48.41 Favored Glycine 1 N--CA 1.516 4.003 0 C-N-CA 124.057 0.837 . . . . 0.0 113.243 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.8 m -68.0 -37.27 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 CA-C-N 117.721 0.76 . . . . 0.0 110.407 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.8 p -60.56 -46.08 91.53 Favored 'General case' 0 N--CA 1.527 3.42 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.723 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.24 -31.85 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 C-N-CA 122.73 0.412 . . . . 0.0 110.493 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.44 -34.12 77.05 Favored 'General case' 0 N--CA 1.525 3.297 0 C-N-CA 123.091 0.556 . . . . 0.0 111.456 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.84 -50.24 44.67 Favored 'General case' 0 N--CA 1.519 2.995 0 C-N-CA 122.96 0.504 . . . . 0.0 111.914 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.96 -44.28 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 C-N-CA 123.365 0.666 . . . . 0.0 112.562 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.53 -32.66 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.603 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.24 -42.14 76.03 Favored 'General case' 0 N--CA 1.533 3.689 0 CA-C-N 118.613 0.642 . . . . 0.0 110.34 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.3 mt -54.8 -35.95 35.32 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 O-C-N 122.055 -0.403 . . . . 0.0 110.455 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.46 -37.17 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 O-C-N 121.763 -0.586 . . . . 0.0 110.374 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.87 -33.0 68.24 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.49 -34.54 53.42 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.188 0 CA-C-N 119.145 0.884 . . . . 0.0 110.611 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.96 -44.16 97.34 Favored 'General case' 0 N--CA 1.53 3.551 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.0 -37.6 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.693 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 71.6 m -64.27 -27.85 69.32 Favored 'General case' 0 N--CA 1.527 3.4 0 C-N-CA 123.151 0.58 . . . . 0.0 111.149 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -62.74 -22.88 66.87 Favored 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 122.992 0.517 . . . . 0.0 110.903 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 45.5 t -66.67 -46.2 76.43 Favored 'General case' 0 N--CA 1.525 3.29 0 CA-C-O 121.582 0.706 . . . . 0.0 110.565 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.98 -12.93 13.01 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 125.375 1.47 . . . . 0.0 112.471 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 54.9 tp -85.93 -28.36 24.36 Favored 'General case' 1 N--CA 1.547 4.403 0 C-N-CA 123.25 0.62 . . . . 0.0 111.303 -175.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 -121.26 63.17 0.89 Allowed 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -138.09 21.04 2.81 Favored 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.245 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -158.75 -11.34 0.07 Allowed 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.974 0.909 . . . . 0.0 109.685 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.54 133.22 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.557 0 C-N-CA 125.279 1.432 . . . . 0.0 107.297 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 51.9 tp -107.69 99.33 28.86 Favored Pre-proline 0 N--CA 1.531 3.593 0 C-N-CA 125.023 1.329 . . . . 0.0 108.31 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo . . . . . 1 N--CA 1.548 4.692 0 C-N-CA 122.273 1.982 . . . . 0.0 114.169 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 48.7 ttm . . . . . 0 CA--C 1.574 1.896 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -80.08 -167.11 0.46 Allowed 'Trans proline' 0 N--CA 1.534 3.891 0 C-N-CA 122.556 2.17 . . . . 0.0 110.32 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.34 57.89 4.5 Favored Glycine 1 N--CA 1.516 4.006 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 97.7 p -167.22 -15.26 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.249 0 C-N-CA 124.036 0.934 . . . . 0.0 109.9 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.88 -26.77 68.46 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.976 0.911 . . . . 0.0 109.581 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 90.5 p -68.55 -26.19 65.29 Favored 'General case' 0 N--CA 1.522 3.143 0 C-N-CA 123.44 0.696 . . . . 0.0 110.43 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.36 -44.05 76.02 Favored Glycine 0 N--CA 1.516 3.975 0 C-N-CA 123.737 0.684 . . . . 0.0 114.08 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.87 -36.0 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.791 0 O-C-N 121.67 -0.9 . . . . 0.0 112.14 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 13.9 pt -67.55 -37.17 78.31 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.398 0 CA-C-N 119.001 0.818 . . . . 0.0 111.84 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 46.3 pt -72.26 -33.07 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.11 -45.31 82.51 Favored Glycine 0 N--CA 1.513 3.775 0 C-N-CA 124.419 1.009 . . . . 0.0 114.992 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.58 -37.2 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.734 0 CA-C-N 117.76 0.78 . . . . 0.0 111.163 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.0 p -65.28 -46.11 81.74 Favored 'General case' 0 N--CA 1.533 3.679 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.81 -30.63 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.485 0 C-N-CA 123.158 0.583 . . . . 0.0 111.174 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.81 -35.44 63.9 Favored 'General case' 0 N--CA 1.525 3.3 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -50.32 39.63 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 24.9 m -66.11 -38.24 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.8 -31.98 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.462 0.573 . . . . 0.0 111.859 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.59 -34.74 72.5 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 118.236 0.471 . . . . 0.0 110.746 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.1 -49.37 84.34 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.067 0 CA-C-N 118.065 0.393 . . . . 0.0 111.668 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.6 -37.28 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 O-C-N 121.721 -0.612 . . . . 0.0 109.957 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.48 79.97 Favored 'General case' 0 N--CA 1.524 3.26 0 C-N-CA 123.593 0.757 . . . . 0.0 112.811 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.63 -34.37 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 O-C-N 121.86 -0.525 . . . . 0.0 110.291 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -64.41 -44.21 91.97 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 122.964 0.506 . . . . 0.0 112.332 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.8 -37.91 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.826 0 CA-C-N 118.201 0.455 . . . . 0.0 109.781 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 75.2 m -65.64 -27.69 68.56 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 123.341 0.656 . . . . 0.0 111.211 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -63.82 -29.96 71.1 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 123.134 0.574 . . . . 0.0 110.725 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 54.8 m -64.16 -40.01 95.22 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.252 0.621 . . . . 0.0 110.517 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.88 -21.46 64.25 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.691 0.796 . . . . 0.0 110.251 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.5 tp -87.53 -28.32 22.06 Favored 'General case' 0 N--CA 1.534 3.727 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -77.79 52.7 1.05 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -64.66 -11.49 36.08 Favored 'General case' 0 N--CA 1.525 3.278 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.246 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -68.19 142.35 55.71 Favored 'General case' 0 N--CA 1.524 3.239 0 C-N-CA 123.797 0.839 . . . . 0.0 109.631 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 59.3 t -134.32 138.14 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.557 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 8.7 mp -94.69 106.87 26.85 Favored Pre-proline 0 N--CA 1.527 3.384 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo . . . . . 1 N--CA 1.536 4.012 0 CA-C-N 122.819 2.042 . . . . 0.0 110.858 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.577 1.991 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -77.14 78.93 3.28 Favored 'Trans proline' 1 N--CA 1.537 4.034 0 C-N-CA 122.444 2.096 . . . . 0.0 110.362 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.58 63.59 3.81 Favored Glycine 1 N--CA 1.518 4.153 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 97.0 p -86.02 47.71 1.5 Allowed 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 124.145 0.978 . . . . 0.0 109.605 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -54.36 -26.56 30.74 Favored 'General case' 0 N--CA 1.532 3.646 0 C-N-CA 123.785 0.834 . . . . 0.0 112.224 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 98.3 p -63.6 -36.45 83.86 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.825 0.85 . . . . 0.0 110.312 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.0 -35.75 79.55 Favored Glycine 0 N--CA 1.515 3.965 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.074 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 39.2 mm -70.31 -46.44 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 C-N-CA 124.164 0.986 . . . . 0.0 112.77 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 tt -64.53 -37.5 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.965 0 CA-C-N 118.207 0.458 . . . . 0.0 111.857 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.76 -32.22 39.75 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.13 -28.75 42.67 Favored Glycine 0 N--CA 1.512 3.714 0 C-N-CA 124.41 1.005 . . . . 0.0 113.198 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.34 -37.12 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 CA-C-N 117.383 0.592 . . . . 0.0 110.576 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 46.0 p -62.15 -45.14 94.75 Favored 'General case' 0 N--CA 1.529 3.509 0 CA-C-O 121.743 0.783 . . . . 0.0 110.319 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.86 -31.44 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 124.971 1.308 . . . . 0.0 111.447 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.07 75.69 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.361 0.664 . . . . 0.0 111.869 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.7 -46.78 62.49 Favored 'General case' 0 N--CA 1.521 3.087 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.01 -38.18 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 18.3 m -56.54 -31.33 33.8 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 CA-C-N 118.711 0.687 . . . . 0.0 110.712 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 39.7 tp -52.86 -48.14 67.29 Favored 'General case' 1 N--CA 1.543 4.176 0 CA-C-O 122.138 0.971 . . . . 0.0 109.865 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.78 -38.03 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.49 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.79 -37.64 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.437 0 C-N-CA 123.492 0.717 . . . . 0.0 109.489 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -32.71 68.1 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.216 0.606 . . . . 0.0 111.947 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.34 -43.47 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.12 0.568 . . . . 0.0 111.235 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -62.31 -42.92 99.78 Favored 'General case' 1 N--CA 1.539 4.022 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.03 -37.42 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.724 -0.61 . . . . 0.0 109.929 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 96.7 m -64.89 -27.98 69.23 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 122.657 0.383 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -65.8 -25.93 67.46 Favored 'General case' 0 N--CA 1.532 3.625 0 C-N-CA 123.224 0.609 . . . . 0.0 110.999 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 51.2 m -69.43 -34.08 73.92 Favored 'General case' 0 N--CA 1.525 3.311 0 C-N-CA 123.114 0.566 . . . . 0.0 110.444 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.19 -16.93 60.97 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.584 0.754 . . . . 0.0 110.214 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 57.0 tp -87.62 -20.81 25.84 Favored 'General case' 0 N--CA 1.536 3.864 0 C-N-CA 123.719 0.807 . . . . 0.0 110.218 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.76 -79.7 0.04 OUTLIER 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.808 0.843 . . . . 0.0 110.74 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 58.03 7.66 0.65 Allowed 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 124.206 1.002 . . . . 0.0 112.555 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? 59.82 120.67 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 124.352 1.061 . . . . 0.0 111.335 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.91 137.97 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.579 0 C-N-CA 124.932 1.293 . . . . 0.0 108.116 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.64 146.9 32.28 Favored Pre-proline 0 N--CA 1.53 3.549 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 1 N--CA 1.542 4.337 0 C-N-CA 122.068 1.845 . . . . 0.0 110.888 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.579 2.06 0 CA-C-O 117.541 -1.219 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -90.06 30.8 0.38 Allowed 'Trans proline' 0 N--CA 1.536 3.994 0 C-N-CA 122.703 2.269 . . . . 0.0 110.994 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 69.3 49.79 36.97 Favored Glycine 1 N--CA 1.519 4.224 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 40.5 t -76.34 22.32 0.17 Allowed 'General case' 0 N--CA 1.52 3.041 0 C-N-CA 124.129 0.972 . . . . 0.0 111.501 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 49.7 mt -54.85 -26.71 37.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.015 0.926 . . . . 0.0 111.306 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -59.16 -32.38 69.83 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 123.174 0.59 . . . . 0.0 110.745 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.88 -38.84 89.52 Favored Glycine 1 N--CA 1.516 4.033 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.811 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.71 -41.1 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.471 0 C-N-CA 124.275 1.03 . . . . 0.0 108.969 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.92 -41.43 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.739 0 C-N-CA 124.326 1.051 . . . . 0.0 111.775 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 6.3 tp -72.73 -32.73 41.88 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.191 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.76 -46.7 91.98 Favored Glycine 1 N--CA 1.518 4.129 0 C-N-CA 123.551 0.596 . . . . 0.0 113.968 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 11.4 m -60.09 -36.46 67.8 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.211 0 CA-C-N 118.325 1.062 . . . . 0.0 111.472 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 22.0 p -55.7 -38.73 70.08 Favored 'General case' 0 N--CA 1.532 3.643 0 C-N-CA 122.988 0.515 . . . . 0.0 111.674 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.73 -37.81 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 C-N-CA 123.247 0.619 . . . . 0.0 110.813 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.87 -36.08 58.59 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 123.561 0.745 . . . . 0.0 112.745 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.53 -50.17 40.47 Favored 'General case' 0 N--CA 1.515 2.804 0 C-N-CA 123.318 0.647 . . . . 0.0 111.07 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.4 -46.03 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.53 0 C-N-CA 123.522 0.729 . . . . 0.0 112.336 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.43 -32.01 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.523 0 C-N-CA 122.537 0.335 . . . . 0.0 111.273 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.09 -41.59 61.44 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 122.435 0.294 . . . . 0.0 110.931 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.34 -42.33 93.23 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.022 0 C-N-CA 122.806 0.442 . . . . 0.0 111.681 -177.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.0 -36.83 78.09 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 CA-C-N 118.336 0.517 . . . . 0.0 110.094 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.61 -34.15 72.39 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.858 0.463 . . . . 0.0 111.346 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.93 -39.45 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -62.4 -43.49 98.69 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.527 0.731 . . . . 0.0 112.54 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 14.4 m -68.24 -37.78 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 CA-C-N 118.407 0.549 . . . . 0.0 109.806 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 88.3 m -59.02 -27.73 65.73 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 122.886 0.474 . . . . 0.0 111.082 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -64.56 -30.92 71.95 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 122.836 0.455 . . . . 0.0 110.243 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 24.1 t -64.92 -44.59 89.03 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 123.041 0.536 . . . . 0.0 110.398 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.96 -20.49 65.91 Favored 'General case' 0 N--CA 1.532 3.647 0 C-N-CA 123.477 0.711 . . . . 0.0 110.98 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 36.6 tp -87.75 -3.01 58.98 Favored 'General case' 0 N--CA 1.537 3.889 0 C-N-CA 123.394 0.678 . . . . 0.0 110.944 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -152.37 105.09 2.99 Favored 'General case' 0 N--CA 1.533 3.706 0 C-N-CA 123.037 0.535 . . . . 0.0 111.036 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -151.15 -53.84 0.14 Allowed 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -66.37 150.82 48.3 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 124.053 0.941 . . . . 0.0 109.732 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.2 138.26 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 125.069 1.348 . . . . 0.0 108.149 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.4 98.82 14.93 Favored Pre-proline 0 N--CA 1.533 3.71 0 C-N-CA 124.799 1.24 . . . . 0.0 108.893 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 1 N--CA 1.547 4.658 0 C-N-CA 122.275 1.984 . . . . 0.0 113.866 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 44.3 ttm . . . . . 0 CA--C 1.582 2.191 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -87.16 21.17 1.09 Allowed 'Trans proline' 0 N--CA 1.536 3.971 0 C-N-CA 122.507 2.138 . . . . 0.0 111.294 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.89 -34.83 1.24 Allowed Glycine 1 N--CA 1.519 4.186 0 C-N-CA 123.922 0.772 . . . . 0.0 111.786 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 50.4 m 57.55 67.57 0.95 Allowed 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 124.082 0.953 . . . . 0.0 111.286 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 mt -62.46 -26.35 68.47 Favored 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 124.32 1.048 . . . . 0.0 110.848 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.0 p -64.62 -26.34 68.35 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.143 0.577 . . . . 0.0 110.144 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.81 -46.9 89.5 Favored Glycine 1 N--CA 1.52 4.272 0 CA-C-O 119.523 -0.598 . . . . 0.0 114.095 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 18.8 tt -70.61 -35.61 61.98 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.204 0 CA-C-N 118.549 1.175 . . . . 0.0 109.688 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 46.8 mm -64.63 -42.71 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.753 0 C-N-CA 123.876 0.87 . . . . 0.0 108.834 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 23.0 mm -72.84 -33.39 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.767 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.33 -29.83 57.36 Favored Glycine 0 N--CA 1.513 3.817 0 C-N-CA 124.115 0.864 . . . . 0.0 114.573 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.63 -37.42 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.971 0 CA-C-N 118.113 0.957 . . . . 0.0 111.216 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 67.4 p -61.88 -47.52 84.62 Favored 'General case' 0 N--CA 1.528 3.46 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 10.1 p -70.99 -31.77 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.351 0 C-N-CA 123.02 0.528 . . . . 0.0 111.524 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.36 78.26 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.07 -34.46 77.63 Favored 'General case' 0 N--CA 1.515 2.823 0 C-N-CA 123.276 0.63 . . . . 0.0 111.721 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.22 -53.43 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 122.916 0.486 . . . . 0.0 111.177 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.62 -33.6 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.413 0 O-C-N 121.785 -0.572 . . . . 0.0 111.455 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 40.0 tp -77.2 -38.39 51.6 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 122.908 0.483 . . . . 0.0 112.285 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 16.3 tt -69.35 -38.17 76.87 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.114 0 CA-C-N 118.906 0.775 . . . . 0.0 110.586 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.77 -38.0 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.87 -51.1 71.01 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.281 0.632 . . . . 0.0 112.644 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.85 -34.23 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 C-N-CA 122.533 0.333 . . . . 0.0 110.701 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -70.39 -38.62 74.71 Favored 'General case' 0 N--CA 1.527 3.386 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.1 -37.59 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.625 0 C-N-CA 124.174 0.99 . . . . 0.0 109.464 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -58.72 -34.79 71.73 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 122.655 0.382 . . . . 0.0 110.207 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -74.58 -48.43 26.77 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.863 0.465 . . . . 0.0 110.124 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.5 m -63.68 -25.96 68.45 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 123.419 0.688 . . . . 0.0 111.231 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.43 -14.73 20.73 Favored 'General case' 0 N--CA 1.524 3.257 0 C-N-CA 123.611 0.764 . . . . 0.0 111.193 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 8.6 mp -87.41 -28.38 22.18 Favored 'General case' 0 N--CA 1.538 3.969 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 89.4 m95 53.74 57.7 5.82 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.75 0.82 . . . . 0.0 111.43 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -63.99 107.12 1.17 Allowed 'General case' 0 N--CA 1.524 3.259 0 C-N-CA 123.729 0.812 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -163.63 77.36 0.4 Allowed 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 57.1 t -133.8 138.13 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 57.9 mt -94.51 146.69 31.94 Favored Pre-proline 0 N--CA 1.525 3.308 0 CA-C-O 117.373 -1.298 . . . . 0.0 108.255 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 1 N--CA 1.54 4.216 0 C-N-CA 121.997 1.798 . . . . 0.0 110.82 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 17.0 ptm . . . . . 0 CA--C 1.573 1.846 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -67.98 -43.88 4.52 Favored 'Trans proline' 1 N--CA 1.541 4.306 0 C-N-CA 122.106 1.871 . . . . 0.0 110.634 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.26 -38.38 13.02 Favored Glycine 1 N--CA 1.516 4.003 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 59.5 p 56.02 65.56 1.41 Allowed 'General case' 0 N--CA 1.524 3.229 0 C-N-CA 124.111 0.964 . . . . 0.0 111.261 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.74 -26.8 68.81 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 124.087 0.955 . . . . 0.0 110.121 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 66.0 m -66.23 -32.29 73.62 Favored 'General case' 0 N--CA 1.519 2.985 0 C-N-CA 123.587 0.755 . . . . 0.0 111.061 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.11 -47.53 52.85 Favored Glycine 1 N--CA 1.517 4.056 0 CA-C-N 116.099 -0.5 . . . . 0.0 114.261 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 20.4 tt -71.6 -41.66 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.94 -44.25 82.1 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.272 0 C-N-CA 123.059 0.544 . . . . 0.0 111.737 -176.078 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.1 tt -72.29 -33.16 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.854 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.93 -29.47 51.24 Favored Glycine 0 N--CA 1.512 3.736 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.434 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.69 -37.71 72.27 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 117.495 0.648 . . . . 0.0 110.991 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 72.7 p -62.39 -45.49 92.88 Favored 'General case' 0 N--CA 1.53 3.563 0 CA-C-O 121.648 0.737 . . . . 0.0 110.474 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.21 -31.65 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.094 0 C-N-CA 124.702 1.201 . . . . 0.0 110.814 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.99 -34.72 75.22 Favored 'General case' 0 N--CA 1.531 3.588 0 O-C-N 121.824 -0.547 . . . . 0.0 111.596 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.32 -50.35 70.38 Favored 'General case' 0 N--CA 1.516 2.841 0 C-N-CA 123.51 0.724 . . . . 0.0 112.772 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.03 -38.27 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 CA-C-N 118.373 0.533 . . . . 0.0 111.629 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.22 -34.59 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.827 0 C-N-CA 122.646 0.378 . . . . 0.0 110.664 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 41.3 tp -68.51 -34.46 75.92 Favored 'General case' 0 N--CA 1.533 3.713 0 CA-C-N 118.156 0.434 . . . . 0.0 110.622 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.9 mt -61.82 -35.4 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 C-N-CA 123.683 0.793 . . . . 0.0 109.893 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.34 -35.41 49.0 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.194 0 C-N-CA 123.341 0.657 . . . . 0.0 110.472 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.1 -31.46 63.29 Favored 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 123.468 0.707 . . . . 0.0 112.763 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 4.4 m -57.28 -34.83 46.91 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.123 0 CA-C-N 118.992 0.815 . . . . 0.0 112.682 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -65.2 -43.94 89.97 Favored 'General case' 1 N--CA 1.541 4.094 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.81 -37.14 77.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.019 0 CA-C-N 119.007 0.821 . . . . 0.0 108.982 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 75.5 m -58.37 -27.59 64.36 Favored 'General case' 0 N--CA 1.528 3.429 0 C-N-CA 122.821 0.448 . . . . 0.0 110.909 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.54 -26.14 67.75 Favored 'General case' 0 N--CA 1.53 3.544 0 C-N-CA 122.973 0.509 . . . . 0.0 110.573 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 60.4 p -63.63 -16.89 62.16 Favored 'General case' 0 N--CA 1.534 3.765 0 C-N-CA 123.689 0.796 . . . . 0.0 111.546 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 46.6 tp -59.82 -14.57 15.53 Favored 'General case' 0 N--CA 1.527 3.377 0 C-N-CA 124.284 1.033 . . . . 0.0 112.775 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 pp -86.88 9.01 20.56 Favored 'General case' 1 N--CA 1.545 4.306 0 CA-C-N 118.843 0.747 . . . . 0.0 110.247 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 56.4 m95 58.96 134.64 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.1 0 C-N-CA 124.856 1.262 . . . . 0.0 113.029 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -144.76 63.13 1.31 Allowed 'General case' 0 N--CA 1.525 3.307 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -63.36 -177.1 0.18 Allowed 'General case' 0 N--CA 1.523 3.179 0 C-N-CA 124.335 1.054 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.49 138.07 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.521 0 C-N-CA 124.662 1.185 . . . . 0.0 109.136 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 77.2 mt -102.64 146.92 33.25 Favored Pre-proline 0 N--CA 1.529 3.511 0 C-N-CA 125.097 1.359 . . . . 0.0 108.275 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 1 N--CA 1.541 4.283 0 C-N-CA 121.997 1.798 . . . . 0.0 110.774 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 67.2 mtp . . . . . 0 CA--C 1.574 1.904 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -67.45 -19.24 49.29 Favored 'Trans proline' 1 N--CA 1.543 4.405 0 C-N-CA 122.236 1.957 . . . . 0.0 111.053 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.96 -168.26 6.65 Favored Glycine 1 N--CA 1.519 4.193 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.9 m -162.38 104.73 1.11 Allowed 'General case' 0 N--CA 1.521 3.108 0 C-N-CA 123.708 0.803 . . . . 0.0 108.986 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.27 -26.73 68.56 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.12 0.968 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.8 m -57.64 -26.19 61.26 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.667 0.787 . . . . 0.0 110.921 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.99 -35.62 91.67 Favored Glycine 0 N--CA 1.508 3.466 0 C-N-CA 124.232 0.92 . . . . 0.0 115.205 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.4 tt -68.47 -35.07 68.99 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.286 0 CA-C-N 118.247 1.023 . . . . 0.0 113.55 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.19 -40.61 66.12 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 17.7 tt -73.06 -36.12 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.798 0 O-C-N 121.399 -0.813 . . . . 0.0 109.439 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.94 -43.43 94.9 Favored Glycine 1 N--CA 1.519 4.191 0 C-N-CA 123.37 0.509 . . . . 0.0 114.363 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.83 -36.76 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 CA-C-N 117.907 0.853 . . . . 0.0 110.586 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.2 p -58.38 -44.58 88.97 Favored 'General case' 1 N--CA 1.539 4.008 0 CA-C-N 118.42 0.555 . . . . 0.0 111.118 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.75 -37.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 123.426 0.69 . . . . 0.0 111.405 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.25 -37.03 66.7 Favored 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.2 -50.56 71.33 Favored 'General case' 0 N--CA 1.513 2.682 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.9 m -61.93 -37.8 79.11 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.147 0 CA-C-N 118.529 0.604 . . . . 0.0 111.649 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 56.6 t -59.23 -32.68 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.976 0 O-C-N 121.482 -0.761 . . . . 0.0 110.189 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 73.0 mt -72.82 -34.43 66.83 Favored 'General case' 0 N--CA 1.532 3.639 0 C-N-CA 122.385 0.274 . . . . 0.0 110.294 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.2 -47.8 91.42 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.287 0 C-N-CA 123.039 0.535 . . . . 0.0 111.415 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.51 -36.92 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 O-C-N 121.885 -0.509 . . . . 0.0 110.102 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.99 -49.0 78.33 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.245 0.618 . . . . 0.0 112.304 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.11 -34.28 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.542 0 O-C-N 122.022 -0.424 . . . . 0.0 110.94 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -70.21 -43.1 71.36 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.078 0.551 . . . . 0.0 112.16 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.95 -37.64 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.71 0 O-C-N 122.067 -0.396 . . . . 0.0 111.305 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 20.1 p -67.34 -28.02 67.62 Favored 'General case' 0 N--CA 1.532 3.67 0 CA-C-N 117.886 0.312 . . . . 0.0 110.939 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -67.57 -30.55 70.2 Favored 'General case' 0 N--CA 1.529 3.478 0 C-N-CA 123.217 0.607 . . . . 0.0 110.53 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.7 m -67.4 -27.56 67.18 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 123.356 0.662 . . . . 0.0 110.498 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.4 -14.52 57.02 Favored 'General case' 0 N--CA 1.533 3.702 0 C-N-CA 124.474 1.11 . . . . 0.0 109.908 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 30.2 mt -87.24 2.0 51.41 Favored 'General case' 0 N--CA 1.533 3.714 0 C-N-CA 123.749 0.82 . . . . 0.0 110.578 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -66.48 -2.29 4.49 Favored 'General case' 0 N--CA 1.529 3.525 0 C-N-CA 123.854 0.862 . . . . 0.0 111.001 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -62.22 177.44 0.48 Allowed 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.868 0.867 . . . . 0.0 110.941 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -64.87 153.71 39.41 Favored 'General case' 0 N--CA 1.526 3.335 0 C-N-CA 124.149 0.98 . . . . 0.0 110.097 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.36 138.13 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 C-N-CA 124.927 1.291 . . . . 0.0 108.113 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.66 99.49 38.07 Favored Pre-proline 0 N--CA 1.531 3.581 0 C-N-CA 125.073 1.349 . . . . 0.0 108.191 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo . . . . . 0 N--CA 1.535 3.923 0 C-N-CA 122.591 2.194 . . . . 0.0 110.946 -179.898 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.576 1.949 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.54 -176.22 0.02 OUTLIER 'Trans proline' 1 N--CA 1.547 4.623 0 C-N-CA 122.508 2.138 . . . . 0.0 113.935 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 103.24 67.35 0.75 Allowed Glycine 1 N--CA 1.525 4.629 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 46.5 t -67.06 159.68 28.23 Favored 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.833 0.853 . . . . 0.0 110.788 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.24 -26.98 68.34 Favored 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 124.084 0.954 . . . . 0.0 109.923 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 94.6 p -58.26 -26.37 62.85 Favored 'General case' 0 N--CA 1.529 3.486 0 C-N-CA 123.333 0.653 . . . . 0.0 110.769 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.75 -35.61 75.32 Favored Glycine 0 N--CA 1.508 3.479 0 C-N-CA 124.772 1.177 . . . . 0.0 115.475 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 pt -59.47 -34.65 55.27 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.475 0 CA-C-N 119.039 1.419 . . . . 0.0 113.647 -176.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 1.6 pp -55.78 -35.18 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.976 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 20.0 pt -65.64 -33.74 65.68 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.264 0 CA-C-N 118.849 0.749 . . . . 0.0 109.238 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.77 -38.84 96.11 Favored Glycine 1 N--CA 1.519 4.201 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.26 -47.31 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 123.796 0.838 . . . . 0.0 109.423 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 88.3 m -66.03 -47.66 73.7 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.665 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 71.7 t -70.56 -33.27 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.376 0 C-N-CA 124.054 0.942 . . . . 0.0 111.486 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.87 79.3 Favored 'General case' 0 N--CA 1.534 3.731 0 CA-C-N 118.376 0.534 . . . . 0.0 112.102 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.55 -50.22 59.57 Favored 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.5 m -63.1 -39.07 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.64 -32.72 58.09 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.035 0 CA-C-N 118.723 0.692 . . . . 0.0 110.322 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -44.64 92.14 Favored 'General case' 0 N--CA 1.532 3.639 0 C-N-CA 123.205 0.602 . . . . 0.0 111.056 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.26 -39.74 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.792 0.437 . . . . 0.0 110.456 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.38 -39.34 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.508 0 C-N-CA 122.96 0.504 . . . . 0.0 109.802 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.4 93.9 Favored 'General case' 0 N--CA 1.528 3.46 0 C-N-CA 123.251 0.62 . . . . 0.0 111.961 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 93.0 t -71.65 -34.63 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.602 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.86 -43.87 94.8 Favored 'General case' 0 N--CA 1.526 3.355 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 11.3 m -68.65 -37.81 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 CA-C-N 118.693 0.679 . . . . 0.0 109.718 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.8 m -60.93 -37.18 81.43 Favored 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.844 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -27.25 66.71 Favored 'General case' 0 N--CA 1.537 3.919 0 C-N-CA 122.576 0.35 . . . . 0.0 110.594 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 23.1 t -63.52 -40.84 98.1 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.005 0.522 . . . . 0.0 110.991 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.41 -22.25 66.77 Favored 'General case' 0 N--CA 1.535 3.806 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.17 -4.45 27.22 Favored 'General case' 1 N--CA 1.543 4.222 0 C-N-CA 124.415 1.086 . . . . 0.0 109.378 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -153.34 96.13 2.01 Favored 'General case' 0 N--CA 1.521 3.096 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -134.56 12.56 3.76 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 125.003 1.321 . . . . 0.0 109.575 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt 57.5 -166.26 0.15 Allowed 'General case' 0 N--CA 1.52 3.074 0 C-N-CA 124.187 0.995 . . . . 0.0 111.639 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.2 138.13 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 C-N-CA 125.039 1.336 . . . . 0.0 108.196 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 tt -102.75 100.22 15.81 Favored Pre-proline 0 N--CA 1.535 3.78 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 1 N--CA 1.536 4.029 0 C-N-CA 122.443 2.095 . . . . 0.0 110.993 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.576 1.976 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -68.57 -17.29 43.28 Favored 'Trans proline' 1 N--CA 1.544 4.46 0 C-N-CA 122.213 1.942 . . . . 0.0 111.283 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.87 -96.88 0.02 OUTLIER Glycine 1 N--CA 1.522 4.367 0 C-N-CA 123.53 0.586 . . . . 0.0 112.003 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 23.3 t 59.42 48.3 10.08 Favored 'General case' 0 N--CA 1.522 3.155 0 C-N-CA 124.059 0.944 . . . . 0.0 111.521 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -58.97 -25.82 63.91 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.601 1.16 . . . . 0.0 112.33 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 87.6 p -57.09 -25.73 59.24 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.436 0.694 . . . . 0.0 110.748 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.74 -35.34 62.53 Favored Glycine 0 N--CA 1.515 3.913 0 C-N-CA 124.52 1.057 . . . . 0.0 115.052 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.73 -34.01 62.55 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.427 0 CA-C-N 118.521 1.161 . . . . 0.0 113.872 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 1.5 pp -55.28 -32.84 29.51 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.115 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -172.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.7 tt -72.64 -32.4 40.97 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.368 0 CA-C-N 119.041 0.837 . . . . 0.0 109.348 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.08 -29.01 43.12 Favored Glycine 0 N--CA 1.515 3.946 0 C-N-CA 124.215 0.912 . . . . 0.0 113.939 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.91 -38.02 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 CA-C-N 117.435 0.618 . . . . 0.0 111.117 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 219' ' ' THR . . . . . 0.434 ' HG1' ' N ' ' C' ' 220' ' ' VAL . 64.6 p -64.78 -46.09 83.58 Favored 'General case' 0 N--CA 1.529 3.475 0 CA-C-O 121.155 0.502 . . . . 0.0 110.524 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . 0.434 ' N ' ' HG1' ' C' ' 219' ' ' THR . 47.9 t -70.08 -37.2 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.049 0 C-N-CA 124.078 0.951 . . . . 0.0 110.625 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.71 -39.93 62.49 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.91 65.76 Favored 'General case' 0 N--CA 1.515 2.783 0 C-N-CA 123.127 0.571 . . . . 0.0 111.434 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 44.6 t -61.8 -47.74 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.328 0 C-N-CA 123.225 0.61 . . . . 0.0 112.171 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.6 -32.59 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 C-N-CA 122.404 0.282 . . . . 0.0 111.377 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 38.5 tp -71.52 -34.74 70.33 Favored 'General case' 0 N--CA 1.522 3.173 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 87.1 mt -68.48 -44.85 82.85 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.372 0 CA-C-N 119.645 1.111 . . . . 0.0 110.16 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.11 -35.97 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.945 0.498 . . . . 0.0 109.973 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.12 -38.55 73.62 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.431 0.693 . . . . 0.0 111.904 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.07 -41.13 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 CA-C-O 120.742 0.305 . . . . 0.0 110.282 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -61.5 -43.93 97.99 Favored 'General case' 0 N--CA 1.529 3.498 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.23 -37.42 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.632 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 95.5 m -64.37 -33.52 76.03 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -74.04 -38.0 64.14 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.177 0.591 . . . . 0.0 110.321 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 82.2 p -63.92 -17.04 62.83 Favored 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 123.383 0.673 . . . . 0.0 111.321 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.98 -37.74 88.36 Favored 'General case' 0 N--CA 1.531 3.587 0 C-N-CA 123.963 0.905 . . . . 0.0 111.29 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.19 -2.29 57.53 Favored 'General case' 1 N--CA 1.544 4.231 0 C-N-CA 123.323 0.649 . . . . 0.0 112.2 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -70.98 92.3 0.92 Allowed 'General case' 0 N--CA 1.529 3.516 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.95 142.56 1.88 Allowed 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 124.045 0.938 . . . . 0.0 108.547 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -168.9 103.1 0.39 Allowed 'General case' 0 N--CA 1.52 3.046 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.92 124.5 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 124.884 1.274 . . . . 0.0 107.676 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 56.9 mt -94.54 146.81 32.15 Favored Pre-proline 0 N--CA 1.524 3.258 0 CA-C-O 117.409 -1.281 . . . . 0.0 108.269 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 1 N--CA 1.541 4.309 0 C-N-CA 122.008 1.805 . . . . 0.0 110.587 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 79.2 mtp . . . . . 0 CA--C 1.571 1.771 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.53 160.41 44.37 Favored 'Trans proline' 1 N--CA 1.538 4.106 0 C-N-CA 122.187 1.925 . . . . 0.0 110.259 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.12 -165.61 7.95 Favored Glycine 1 N--CA 1.517 4.072 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 46.7 t -165.35 -25.83 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.153 0 C-N-CA 123.486 0.715 . . . . 0.0 110.339 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 49.3 mt -57.62 -26.77 62.05 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 123.949 0.899 . . . . 0.0 110.866 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 55.4 m -64.14 -35.34 80.45 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.818 0.847 . . . . 0.0 110.787 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.04 -35.02 77.5 Favored Glycine 0 N--CA 1.514 3.863 0 C-N-CA 124.354 0.978 . . . . 0.0 113.056 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 37.0 mm -68.1 -43.61 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.445 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.07 -36.31 50.73 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.213 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 15.8 tt -72.39 -33.16 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.864 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.89 -42.26 99.71 Favored Glycine 1 N--CA 1.518 4.142 0 C-N-CA 123.076 0.37 . . . . 0.0 113.838 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 18.7 m -68.72 -37.17 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.866 0 CA-C-N 118.184 0.992 . . . . 0.0 111.342 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 47.4 p -63.89 -45.78 87.85 Favored 'General case' 0 N--CA 1.53 3.54 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.36 -31.93 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 CA-C-N 118.882 0.765 . . . . 0.0 111.075 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.0 -46.76 82.06 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 122.629 0.371 . . . . 0.0 111.687 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.08 -42.23 85.15 Favored 'General case' 0 N--CA 1.519 2.998 0 C-N-CA 123.485 0.714 . . . . 0.0 111.92 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.58 -44.95 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.462 0 C-N-CA 123.102 0.561 . . . . 0.0 111.209 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.48 -40.38 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 C-N-CA 122.38 0.272 . . . . 0.0 110.626 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.66 -46.55 78.71 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 122.846 0.458 . . . . 0.0 111.603 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 85.7 mt -62.26 -36.99 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 O-C-N 122.029 -0.42 . . . . 0.0 110.585 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.12 -37.55 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.887 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.76 98.57 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.852 0.461 . . . . 0.0 111.202 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.75 -34.66 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.426 0 C-N-CA 123.165 0.586 . . . . 0.0 109.702 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -63.08 -44.1 96.71 Favored 'General case' 0 N--CA 1.53 3.571 0 C-N-CA 123.099 0.56 . . . . 0.0 112.366 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.12 -37.64 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.724 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 85.8 m -61.03 -27.31 68.24 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 123.151 0.58 . . . . 0.0 111.251 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -57.8 -27.19 62.89 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 122.811 0.444 . . . . 0.0 111.251 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 66.1 m -65.97 -41.18 91.51 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 123.78 0.832 . . . . 0.0 111.355 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -60.84 -13.42 15.39 Favored 'General case' 0 N--CA 1.532 3.653 0 C-N-CA 124.338 1.055 . . . . 0.0 111.28 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.45 -23.42 26.03 Favored 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.83 109.82 15.75 Favored 'General case' 0 N--CA 1.527 3.408 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -168.63 166.95 11.68 Favored 'General case' 0 N--CA 1.521 3.102 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.59 172.42 6.26 Favored 'General case' 0 N--CA 1.522 3.142 0 C-N-CA 124.05 0.94 . . . . 0.0 110.866 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.48 138.65 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.284 0 C-N-CA 125.14 1.376 . . . . 0.0 107.728 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 47.9 mt -94.24 122.3 61.77 Favored Pre-proline 0 N--CA 1.524 3.245 0 CA-C-O 116.416 -1.754 . . . . 0.0 108.382 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 1 N--CA 1.549 4.768 0 C-N-CA 122.798 2.332 . . . . 0.0 114.904 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 CA--C 1.574 1.892 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.84 -38.14 67.34 Favored 'Trans proline' 1 N--CA 1.544 4.473 0 C-N-CA 122.382 2.055 . . . . 0.0 113.643 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.93 -176.57 25.34 Favored Glycine 1 N--CA 1.521 4.339 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 45.0 t -165.83 23.87 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 123.178 0.591 . . . . 0.0 110.713 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -61.82 -27.03 68.48 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 123.3 0.64 . . . . 0.0 111.143 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 55.7 m -69.13 -26.1 64.72 Favored 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.984 0.914 . . . . 0.0 109.976 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.34 -46.01 88.32 Favored Glycine 0 N--CA 1.513 3.78 0 CA-C-N 115.394 -0.821 . . . . 0.0 114.256 -177.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 46.6 pt -70.47 -35.63 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 8.6 pt -61.8 -44.45 98.81 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.55 0 CA-C-N 119.249 0.931 . . . . 0.0 111.582 -176.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.33 -32.22 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.871 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.96 -29.4 43.1 Favored Glycine 0 N--CA 1.506 3.302 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.584 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.45 -37.25 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 CA-C-N 117.708 0.754 . . . . 0.0 111.179 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 35.9 p -64.66 -47.61 77.82 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 10.5 p -70.84 -31.24 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.327 0.651 . . . . 0.0 110.987 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.22 65.07 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.07 0.548 . . . . 0.0 112.324 -177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.77 -34.76 69.92 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 123.129 0.571 . . . . 0.0 111.83 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.95 -40.47 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 123.03 0.532 . . . . 0.0 110.307 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.15 -42.08 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.508 0.723 . . . . 0.0 110.746 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 66.6 mt -64.2 -34.58 78.42 Favored 'General case' 0 N--CA 1.528 3.449 0 C-N-CA 122.684 0.394 . . . . 0.0 110.749 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.64 -43.95 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 C-N-CA 122.852 0.461 . . . . 0.0 109.952 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 80.7 t -66.86 -39.2 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.59 -48.03 82.31 Favored 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 123.681 0.792 . . . . 0.0 112.953 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 35.2 m -71.58 -34.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 O-C-N 121.955 -0.465 . . . . 0.0 110.803 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.24 -44.25 92.42 Favored 'General case' 0 N--CA 1.528 3.471 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.96 -37.81 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 83.7 m -66.19 -32.63 74.18 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 122.875 0.47 . . . . 0.0 110.554 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -67.53 -32.2 72.84 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.422 0.689 . . . . 0.0 111.047 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -63.89 -26.8 68.76 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.312 0.645 . . . . 0.0 111.301 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 53.5 mt -70.93 -30.89 67.33 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.379 0.671 . . . . 0.0 110.274 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 9.6 mp -87.96 5.6 39.89 Favored 'General case' 0 N--CA 1.535 3.798 0 C-N-CA 124.175 0.99 . . . . 0.0 110.396 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -73.39 57.68 0.53 Allowed 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.299 0.64 . . . . 0.0 109.452 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -74.8 -175.11 2.38 Favored 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.017 0.927 . . . . 0.0 109.6 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -68.01 149.03 50.22 Favored 'General case' 0 N--CA 1.524 3.239 0 C-N-CA 123.836 0.854 . . . . 0.0 109.499 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.03 138.25 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.568 0 C-N-CA 124.847 1.259 . . . . 0.0 108.361 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 pp -103.09 146.47 32.5 Favored Pre-proline 0 N--CA 1.53 3.567 0 C-N-CA 125.12 1.368 . . . . 0.0 108.623 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo . . . . . 1 N--CA 1.539 4.168 0 C-N-CA 122.053 1.835 . . . . 0.0 110.443 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 23.6 ptt? . . . . . 0 CA--C 1.574 1.869 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -67.13 166.95 21.38 Favored 'Trans proline' 1 N--CA 1.542 4.374 0 C-N-CA 122.182 1.921 . . . . 0.0 110.729 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.76 96.66 0.16 Allowed Glycine 1 N--CA 1.517 4.072 0 C-N-CA 123.703 0.668 . . . . 0.0 112.061 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 69.4 m -67.85 162.02 25.02 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.862 0.865 . . . . 0.0 110.309 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.23 -26.22 68.41 Favored 'General case' 0 N--CA 1.525 3.3 0 C-N-CA 124.014 0.926 . . . . 0.0 111.748 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 40.1 t -66.04 -33.09 75.01 Favored 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 123.609 0.764 . . . . 0.0 111.302 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.74 -45.98 62.99 Favored Glycine 1 N--CA 1.519 4.18 0 N-CA-C 115.047 0.779 . . . . 0.0 115.047 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 8.4 tp -70.85 -40.49 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.888 0 O-C-N 121.653 -0.91 . . . . 0.0 112.319 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -36.73 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 C-N-CA 123.207 0.603 . . . . 0.0 111.946 -177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.92 -31.73 46.34 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.421 0 CA-C-N 119.424 1.011 . . . . 0.0 109.232 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.49 -29.46 47.6 Favored Glycine 0 N--CA 1.516 3.987 0 C-N-CA 123.845 0.736 . . . . 0.0 113.801 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.74 -39.78 80.68 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.055 0 CA-C-N 117.525 0.663 . . . . 0.0 111.509 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 82.5 p -66.18 -45.91 79.19 Favored 'General case' 0 N--CA 1.53 3.564 0 CA-C-O 121.247 0.546 . . . . 0.0 110.794 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.23 -32.54 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.038 0 C-N-CA 124.24 1.016 . . . . 0.0 110.864 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.65 -45.2 66.6 Favored 'General case' 0 N--CA 1.529 3.498 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.53 -33.46 75.97 Favored 'General case' 0 N--CA 1.523 3.191 0 C-N-CA 123.449 0.7 . . . . 0.0 111.626 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 25.9 t -65.42 -38.62 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.652 0.781 . . . . 0.0 110.934 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.17 -32.52 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 C-N-CA 123.123 0.569 . . . . 0.0 111.185 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 43.2 tp -68.22 -39.26 82.4 Favored 'General case' 0 N--CA 1.526 3.356 0 CA-C-O 120.764 0.316 . . . . 0.0 110.191 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 41.5 mm -54.7 -50.15 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.865 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.742 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 18.7 m -67.04 -37.28 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.896 -0.502 . . . . 0.0 110.214 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.25 93.13 Favored 'General case' 0 N--CA 1.525 3.277 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 15.9 m -71.27 -33.99 52.55 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 CA-C-N 119.223 0.92 . . . . 0.0 110.102 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -64.12 -43.94 93.76 Favored 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 14.3 m -68.74 -37.65 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 CA-C-O 121.007 0.432 . . . . 0.0 109.901 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 91.0 m -58.67 -27.43 64.79 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 123.447 0.699 . . . . 0.0 111.104 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.05 -34.36 78.23 Favored 'General case' 0 N--CA 1.525 3.324 0 C-N-CA 122.335 0.254 . . . . 0.0 110.672 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 79.5 p -68.34 -36.41 79.21 Favored 'General case' 0 N--CA 1.532 3.647 0 C-N-CA 123.181 0.592 . . . . 0.0 110.685 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.85 -13.49 15.89 Favored 'General case' 0 N--CA 1.537 3.902 0 C-N-CA 123.555 0.742 . . . . 0.0 110.964 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 18.2 mt -86.68 0.38 54.72 Favored 'General case' 0 N--CA 1.535 3.811 0 C-N-CA 122.929 0.492 . . . . 0.0 111.383 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -163.92 108.53 1.01 Allowed 'General case' 0 N--CA 1.53 3.552 0 CA-C-N 118.073 0.397 . . . . 0.0 111.248 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -149.51 157.56 43.39 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -172.55 151.85 2.49 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.57 130.01 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.345 0 C-N-CA 124.938 1.295 . . . . 0.0 107.719 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.95 144.79 28.4 Favored Pre-proline 0 N--CA 1.53 3.556 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 1 N--CA 1.538 4.103 0 CA-C-N 122.181 1.815 . . . . 0.0 110.416 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 CA--C 1.575 1.911 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.46 -179.14 0.03 OUTLIER 'Trans proline' 1 N--CA 1.546 4.593 0 C-N-CA 122.426 2.084 . . . . 0.0 113.614 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -167.31 98.8 0.15 Allowed Glycine 1 N--CA 1.519 4.223 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.9 p -166.05 -20.09 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 124.153 0.981 . . . . 0.0 109.387 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.11 -26.41 68.19 Favored 'General case' 0 N--CA 1.528 3.474 0 C-N-CA 124.2 1.0 . . . . 0.0 109.164 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 95.1 p -65.95 -26.96 67.82 Favored 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.547 0.739 . . . . 0.0 110.49 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.12 -46.61 57.67 Favored Glycine 1 N--CA 1.52 4.254 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 8.4 tp -71.17 -41.1 75.41 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.174 0 CA-C-N 118.186 0.993 . . . . 0.0 112.967 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.3 tt -60.87 -35.25 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 123.672 0.789 . . . . 0.0 112.873 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 5.7 tp -73.16 -33.28 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.991 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.43 96.14 Favored Glycine 1 N--CA 1.521 4.311 0 C-N-CA 123.401 0.525 . . . . 0.0 114.219 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.6 p -59.71 -36.84 68.11 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 117.972 0.886 . . . . 0.0 110.787 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.9 p -55.95 -42.15 75.77 Favored 'General case' 0 N--CA 1.535 3.821 0 CA-C-O 120.919 0.39 . . . . 0.0 111.432 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.5 -40.4 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 123.85 0.86 . . . . 0.0 111.601 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.38 -39.91 61.42 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -176.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.54 -46.35 63.74 Favored 'General case' 0 N--CA 1.52 3.054 0 C-N-CA 122.997 0.519 . . . . 0.0 111.185 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.78 -46.62 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 C-N-CA 123.321 0.648 . . . . 0.0 112.385 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.8 p -66.18 -32.28 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.665 0 C-N-CA 122.512 0.325 . . . . 0.0 111.122 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.61 -41.32 96.28 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.584 0.354 . . . . 0.0 110.859 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 88.0 mt -58.62 -36.66 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.916 0 C-N-CA 122.658 0.383 . . . . 0.0 110.287 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.34 -37.69 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 C-N-CA 123.02 0.528 . . . . 0.0 110.324 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.62 -33.25 75.49 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.038 0.535 . . . . 0.0 110.877 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.07 -36.9 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 C-N-CA 123.308 0.643 . . . . 0.0 109.762 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -64.36 -43.45 94.5 Favored 'General case' 0 N--CA 1.528 3.466 0 C-N-CA 123.633 0.773 . . . . 0.0 112.544 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 19.2 m -67.7 -37.23 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 76.8 m -60.24 -38.35 83.19 Favored 'General case' 0 N--CA 1.527 3.392 0 C-N-CA 122.96 0.504 . . . . 0.0 111.26 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -74.27 -40.63 62.2 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 122.64 0.376 . . . . 0.0 110.074 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 83.5 p -63.91 -32.73 74.35 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.15 -23.18 57.77 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.063 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.4 tp -87.11 -22.67 25.24 Favored 'General case' 0 N--CA 1.537 3.919 0 C-N-CA 122.942 0.497 . . . . 0.0 110.16 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -71.45 65.61 0.45 Allowed 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.648 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -143.44 157.9 44.08 Favored 'General case' 0 N--CA 1.526 3.369 0 C-N-CA 124.822 1.249 . . . . 0.0 107.843 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.69 155.93 37.2 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 123.731 0.812 . . . . 0.0 109.216 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.58 137.19 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 124.706 1.203 . . . . 0.0 108.329 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.74 146.58 31.67 Favored Pre-proline 0 N--CA 1.528 3.458 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 1 N--CA 1.54 4.256 0 C-N-CA 121.935 1.756 . . . . 0.0 110.645 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 58.9 mtt . . . . . 0 CA--C 1.585 2.29 0 CA-C-O 117.623 -1.179 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -89.84 -4.38 5.4 Favored 'Trans proline' 1 N--CA 1.536 4.004 0 C-N-CA 122.736 2.291 . . . . 0.0 111.893 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 179.86 93.09 0.09 OUTLIER Glycine 1 N--CA 1.518 4.146 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 47.4 t -64.18 158.0 24.19 Favored 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 123.717 0.807 . . . . 0.0 111.052 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.2 -28.72 69.58 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 124.061 0.944 . . . . 0.0 110.137 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 56.0 m -65.05 -26.88 68.44 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.04 0.536 . . . . 0.0 110.302 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.28 -35.79 91.98 Favored Glycine 1 N--CA 1.524 4.524 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 36.1 mm -68.71 -40.48 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.302 0 C-N-CA 124.583 1.153 . . . . 0.0 109.149 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 48.2 mm -66.46 -40.13 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 C-N-CA 124.538 1.135 . . . . 0.0 108.905 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 14.6 mm -71.38 -31.96 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.97 -29.17 42.58 Favored Glycine 0 N--CA 1.516 3.976 0 C-N-CA 123.708 0.67 . . . . 0.0 113.176 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.59 -37.59 71.31 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.095 0 CA-C-N 117.84 0.82 . . . . 0.0 110.769 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 46.9 p -57.48 -44.79 85.17 Favored 'General case' 0 N--CA 1.528 3.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.824 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.6 t -67.02 -31.79 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 C-N-CA 124.095 0.958 . . . . 0.0 110.875 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.87 79.35 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 122.482 0.313 . . . . 0.0 110.967 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.98 -50.11 74.51 Favored 'General case' 0 N--CA 1.521 3.117 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.37 -38.35 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 CA-C-N 118.224 0.465 . . . . 0.0 111.625 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.2 -38.38 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 118.23 0.468 . . . . 0.0 110.651 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.99 -38.72 92.11 Favored 'General case' 1 N--CA 1.539 4.021 0 C-N-CA 122.55 0.34 . . . . 0.0 110.543 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.78 -42.8 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.818 0 O-C-N 122.005 -0.434 . . . . 0.0 110.221 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 64.6 t -65.52 -37.71 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 C-N-CA 122.964 0.506 . . . . 0.0 110.082 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.56 80.3 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.432 0.693 . . . . 0.0 111.277 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 84.1 t -71.94 -34.88 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.26 0 C-N-CA 122.909 0.484 . . . . 0.0 110.443 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -62.66 -44.46 96.21 Favored 'General case' 0 N--CA 1.534 3.739 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.02 -39.34 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.721 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 73.6 m -67.18 -30.39 70.33 Favored 'General case' 0 N--CA 1.524 3.26 0 C-N-CA 123.115 0.566 . . . . 0.0 110.727 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -73.32 -35.33 66.04 Favored 'General case' 0 N--CA 1.526 3.339 0 C-N-CA 123.249 0.62 . . . . 0.0 110.343 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 62.8 m -63.67 -23.87 67.55 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.554 0.742 . . . . 0.0 111.689 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.95 -24.98 66.13 Favored 'General case' 0 N--CA 1.53 3.557 0 C-N-CA 123.688 0.795 . . . . 0.0 110.285 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.24 -27.2 23.09 Favored 'General case' 0 N--CA 1.535 3.782 0 C-N-CA 123.632 0.773 . . . . 0.0 109.453 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -114.66 102.88 10.44 Favored 'General case' 0 N--CA 1.536 3.835 0 C-N-CA 124.489 1.116 . . . . 0.0 109.35 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -168.37 170.62 9.76 Favored 'General case' 0 N--CA 1.522 3.135 0 C-N-CA 124.003 0.921 . . . . 0.0 109.135 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -166.49 156.01 11.42 Favored 'General case' 0 N--CA 1.524 3.258 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.62 138.09 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.563 0 C-N-CA 125.011 1.324 . . . . 0.0 107.694 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.44 146.78 32.14 Favored Pre-proline 0 N--CA 1.528 3.441 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo . . . . . 1 N--CA 1.539 4.186 0 C-N-CA 122.132 1.888 . . . . 0.0 110.772 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 23.2 ptt? . . . . . 0 CA--C 1.575 1.909 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.77 125.52 12.23 Favored 'Trans proline' 1 N--CA 1.541 4.323 0 C-N-CA 122.155 1.903 . . . . 0.0 110.139 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 177.6 36.17 0.06 OUTLIER Glycine 1 N--CA 1.519 4.167 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 44.6 t -165.7 45.68 0.08 Allowed 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.771 0.828 . . . . 0.0 109.323 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 7.8 mp -65.23 -26.92 68.33 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.932 0.893 . . . . 0.0 109.537 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 41.4 t -58.2 -25.94 62.2 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.579 0.751 . . . . 0.0 110.931 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.65 -34.4 60.51 Favored Glycine 0 N--CA 1.513 3.77 0 C-N-CA 125.123 1.344 . . . . 0.0 114.981 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.0 pt -57.95 -34.11 47.84 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.271 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -175.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 9.8 pt -55.74 -32.43 31.63 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.133 0 C-N-CA 123.128 0.571 . . . . 0.0 111.972 -176.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.96 -33.44 52.84 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.112 0 C-N-CA 123.613 0.765 . . . . 0.0 110.017 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.74 -29.9 50.72 Favored Glycine 0 N--CA 1.513 3.814 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.039 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.1 m -62.26 -37.82 79.55 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 117.937 0.868 . . . . 0.0 111.329 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 68.2 p -62.15 -45.77 91.96 Favored 'General case' 0 N--CA 1.532 3.633 0 CA-C-O 121.364 0.602 . . . . 0.0 110.669 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.18 -32.49 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 C-N-CA 124.197 0.999 . . . . 0.0 110.207 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.3 -34.61 78.74 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.534 0.733 . . . . 0.0 111.776 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.03 -49.87 46.98 Favored 'General case' 0 N--CA 1.516 2.844 0 C-N-CA 123.14 0.576 . . . . 0.0 112.503 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 29.3 m -63.92 -40.11 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.815 0 CA-C-N 118.523 0.602 . . . . 0.0 112.577 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 13.7 p -67.44 -32.01 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 CA-C-N 118.182 0.446 . . . . 0.0 110.558 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.49 -43.96 79.68 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 122.911 0.485 . . . . 0.0 110.333 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.52 -36.54 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 C-N-CA 123.48 0.712 . . . . 0.0 112.028 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.71 -36.68 67.14 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.683 0 CA-C-N 119.447 1.022 . . . . 0.0 110.517 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.28 -32.51 66.7 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.386 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.72 -41.25 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.394 0 C-N-CA 123.261 0.624 . . . . 0.0 110.086 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -61.42 -43.52 98.73 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.607 0.763 . . . . 0.0 112.915 -177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.26 -37.54 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 82.6 m -61.6 -27.82 68.91 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 122.619 0.368 . . . . 0.0 111.07 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -68.21 -27.38 66.33 Favored 'General case' 0 N--CA 1.531 3.576 0 C-N-CA 123.057 0.543 . . . . 0.0 110.738 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.9 m -69.07 -26.77 65.11 Favored 'General case' 0 N--CA 1.531 3.595 0 CA-C-O 121.225 0.536 . . . . 0.0 110.103 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -14.52 47.21 Favored 'General case' 0 N--CA 1.533 3.682 0 C-N-CA 124.807 1.243 . . . . 0.0 110.499 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 32.2 mt -86.59 -27.27 23.98 Favored 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 123.373 0.669 . . . . 0.0 110.387 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -71.56 84.98 0.86 Allowed 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.532 0.733 . . . . 0.0 109.234 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.64 117.09 15.71 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 124.988 1.315 . . . . 0.0 107.766 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? -164.53 134.02 3.78 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 28.9 m -117.78 138.23 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 C-N-CA 125.145 1.378 . . . . 0.0 108.685 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -133.65 146.5 60.64 Favored Pre-proline 0 N--CA 1.533 3.696 0 C-N-CA 125.154 1.382 . . . . 0.0 109.069 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 1 N--CA 1.541 4.269 0 CA-C-N 122.295 1.855 . . . . 0.0 110.766 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -82.32 26.66 0.62 Allowed 'Trans proline' 0 N--CA 1.536 3.998 0 C-N-CA 122.626 2.217 . . . . 0.0 111.112 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.18 -177.51 9.58 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 123.684 0.659 . . . . 0.0 111.521 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 95.7 p -166.23 80.64 0.27 Allowed 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 123.824 0.85 . . . . 0.0 108.744 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -25.79 68.09 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.887 0.875 . . . . 0.0 111.659 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 99.6 p -68.17 -26.92 65.99 Favored 'General case' 0 N--CA 1.527 3.395 0 C-N-CA 123.331 0.652 . . . . 0.0 110.054 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.06 -34.02 71.35 Favored Glycine 0 N--CA 1.505 3.255 0 C-N-CA 125.589 1.566 . . . . 0.0 115.597 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 13.7 pt -58.24 -33.79 48.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.06 -43.39 69.58 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.388 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 18.4 tt -73.19 -34.47 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.984 0 CA-C-N 118.252 0.478 . . . . 0.0 110.375 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.11 -44.6 93.89 Favored Glycine 1 N--CA 1.519 4.184 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -60.11 -37.07 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.987 0 CA-C-N 117.629 0.714 . . . . 0.0 111.067 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 61.6 p -59.26 -39.0 81.48 Favored 'General case' 0 N--CA 1.532 3.637 0 CA-C-N 117.963 0.347 . . . . 0.0 111.41 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.48 -38.34 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 C-N-CA 123.41 0.684 . . . . 0.0 111.52 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.16 68.19 Favored 'General case' 0 N--CA 1.531 3.623 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.12 90.06 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 123.5 0.72 . . . . 0.0 111.71 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.23 -42.91 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.289 0.636 . . . . 0.0 112.129 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.81 -32.56 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.58 -47.33 22.82 Favored 'General case' 0 N--CA 1.539 3.997 0 CA-C-N 118.248 0.476 . . . . 0.0 111.352 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 20.2 pt -62.05 -36.31 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.721 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.07 -36.01 76.43 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.199 0 CA-C-N 119.425 1.011 . . . . 0.0 110.321 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.42 -32.16 66.59 Favored 'General case' 0 N--CA 1.523 3.187 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.77 -34.91 67.21 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.296 0 CA-C-N 119.709 1.14 . . . . 0.0 112.269 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -63.21 -43.53 97.86 Favored 'General case' 1 N--CA 1.539 4.019 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.37 -37.32 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 76.4 m -58.7 -31.3 68.12 Favored 'General case' 0 N--CA 1.531 3.619 0 C-N-CA 122.529 0.331 . . . . 0.0 111.257 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.11 -15.32 63.54 Favored 'General case' 0 N--CA 1.534 3.726 0 C-N-CA 123.103 0.561 . . . . 0.0 110.858 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 78.4 p -63.41 -28.78 70.22 Favored 'General case' 0 N--CA 1.529 3.51 0 CA-C-O 121.146 0.498 . . . . 0.0 109.87 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 57.6 mt -91.35 -18.65 23.95 Favored 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 124.507 1.123 . . . . 0.0 112.301 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 53.9 mt -87.53 3.0 49.14 Favored 'General case' 1 N--CA 1.544 4.264 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -70.2 -7.82 45.03 Favored 'General case' 1 N--CA 1.543 4.216 0 CA-C-N 119.65 1.114 . . . . 0.0 109.504 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -67.71 131.78 46.23 Favored 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 124.027 0.931 . . . . 0.0 109.844 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -168.7 3.52 0.02 OUTLIER 'General case' 0 N--CA 1.526 3.349 0 C-N-CA 123.708 0.803 . . . . 0.0 110.497 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 8.6 m -135.53 138.37 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.752 0 C-N-CA 125.229 1.412 . . . . 0.0 107.758 177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 70.1 mt -125.85 146.78 56.49 Favored Pre-proline 0 N--CA 1.531 3.599 0 C-N-CA 125.389 1.475 . . . . 0.0 107.629 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 1 N--CA 1.54 4.227 0 C-N-CA 121.999 1.799 . . . . 0.0 110.897 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 CA--C 1.576 1.964 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.52 -22.32 44.98 Favored 'Trans proline' 1 N--CA 1.543 4.429 0 C-N-CA 122.223 1.949 . . . . 0.0 111.264 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 177.91 -171.37 43.9 Favored Glycine 1 N--CA 1.521 4.328 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p -167.16 -65.17 0.03 OUTLIER 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.16 -27.21 68.55 Favored 'General case' 0 N--CA 1.536 3.865 0 C-N-CA 123.641 0.777 . . . . 0.0 109.091 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -66.7 -28.26 68.29 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.421 0.689 . . . . 0.0 110.421 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.77 -35.56 80.3 Favored Glycine 1 N--CA 1.516 4.009 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 38.5 mm -69.81 -43.56 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.153 0 C-N-CA 124.528 1.131 . . . . 0.0 112.841 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 9.4 pt -59.49 -40.87 82.97 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.526 0 CA-C-N 118.852 0.751 . . . . 0.0 112.153 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.0 -32.94 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.98 -50.14 70.86 Favored Glycine 1 N--CA 1.52 4.276 0 C-N-CA 123.603 0.62 . . . . 0.0 113.364 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -61.76 -36.78 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-N 117.458 0.629 . . . . 0.0 109.747 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 86.1 m -63.6 -47.05 83.0 Favored 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 122.693 0.397 . . . . 0.0 111.604 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.7 -34.39 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 C-N-CA 123.491 0.716 . . . . 0.0 110.512 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.7 -46.57 67.39 Favored 'General case' 0 N--CA 1.527 3.382 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.43 91.09 Favored 'General case' 0 N--CA 1.519 2.99 0 C-N-CA 123.033 0.533 . . . . 0.0 111.687 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 43.2 t -68.16 -51.6 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.101 0 C-N-CA 123.134 0.574 . . . . 0.0 111.96 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 31.7 m -67.41 -32.72 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 O-C-N 121.892 -0.505 . . . . 0.0 111.813 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.03 -44.51 72.55 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 122.539 0.335 . . . . 0.0 111.33 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 24.7 pt -69.23 -36.48 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 CA-C-N 118.747 0.703 . . . . 0.0 111.149 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.07 -37.64 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.871 0 O-C-N 121.848 -0.533 . . . . 0.0 109.739 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.78 83.66 Favored 'General case' 0 N--CA 1.532 3.637 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.65 -34.16 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.554 0 O-C-N 122.079 -0.388 . . . . 0.0 110.937 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -68.75 -43.71 75.28 Favored 'General case' 0 N--CA 1.526 3.357 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 13.2 p -68.38 -37.83 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 CA-C-N 118.019 0.372 . . . . 0.0 111.175 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 16.3 p -66.31 -27.88 68.26 Favored 'General case' 0 N--CA 1.533 3.679 0 CA-C-N 117.855 0.298 . . . . 0.0 111.172 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -65.61 -30.98 71.78 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 123.214 0.606 . . . . 0.0 111.109 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 53.0 m -64.47 -32.37 73.96 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.391 0.676 . . . . 0.0 111.277 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 53.8 mt -63.08 -16.41 59.84 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.594 0.758 . . . . 0.0 111.928 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.85 -0.54 57.09 Favored 'General case' 0 N--CA 1.538 3.969 0 C-N-CA 123.356 0.663 . . . . 0.0 109.701 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -70.16 -29.86 66.86 Favored 'General case' 0 N--CA 1.523 3.225 0 C-N-CA 123.743 0.817 . . . . 0.0 110.515 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -61.19 -45.19 95.62 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 123.605 0.762 . . . . 0.0 111.904 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -82.55 166.4 19.29 Favored 'General case' 0 N--CA 1.524 3.271 0 C-N-CA 123.678 0.791 . . . . 0.0 109.772 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.34 138.23 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 C-N-CA 124.894 1.278 . . . . 0.0 108.284 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 8.6 mp -94.55 107.5 30.5 Favored Pre-proline 0 N--CA 1.528 3.431 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo . . . . . 1 N--CA 1.538 4.089 0 CA-C-N 122.725 2.009 . . . . 0.0 110.836 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 CA--C 1.585 2.309 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -87.26 -24.55 1.23 Allowed 'Trans proline' 1 N--CA 1.536 4.028 0 C-N-CA 122.471 2.114 . . . . 0.0 111.104 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 178.36 -16.74 0.03 OUTLIER Glycine 1 N--CA 1.521 4.301 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 51.1 m 57.8 172.68 0.05 Allowed 'General case' 0 N--CA 1.521 3.102 0 C-N-CA 124.482 1.113 . . . . 0.0 112.267 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.08 -35.61 81.69 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 124.312 1.045 . . . . 0.0 110.285 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 42.2 t -57.77 -26.95 62.6 Favored 'General case' 0 N--CA 1.528 3.451 0 C-N-CA 122.886 0.475 . . . . 0.0 111.593 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.38 -35.85 83.01 Favored Glycine 1 N--CA 1.527 4.741 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.29 -40.7 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 C-N-CA 124.428 1.091 . . . . 0.0 108.959 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.23 -42.67 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 C-N-CA 124.524 1.13 . . . . 0.0 108.771 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 30.8 mm -72.38 -33.06 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.627 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.42 -29.71 60.83 Favored Glycine 0 N--CA 1.514 3.88 0 C-N-CA 123.766 0.698 . . . . 0.0 113.362 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 2.5 m -60.43 -37.38 74.39 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 CA-C-N 117.825 0.812 . . . . 0.0 110.653 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 44.5 p -55.92 -46.1 78.55 Favored 'General case' 0 N--CA 1.529 3.517 0 CA-C-O 121.375 0.607 . . . . 0.0 111.403 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.62 -31.92 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.034 0 C-N-CA 124.387 1.075 . . . . 0.0 111.238 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.86 78.99 Favored 'General case' 0 N--CA 1.531 3.588 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.19 -50.28 70.94 Favored 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 28.1 m -63.09 -37.94 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.404 0.547 . . . . 0.0 111.883 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 93.9 t -60.5 -32.71 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 121.77 -0.581 . . . . 0.0 110.232 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.5 -38.08 77.47 Favored 'General case' 0 N--CA 1.532 3.669 0 CA-C-N 118.455 0.571 . . . . 0.0 109.958 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 11.6 mm -54.36 -36.85 35.21 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.026 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.44 -38.09 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 C-N-CA 123.468 0.707 . . . . 0.0 109.829 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.47 -32.21 72.21 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.431 0.692 . . . . 0.0 111.309 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.02 -34.51 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 C-N-CA 122.813 0.445 . . . . 0.0 109.855 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.02 -43.37 83.0 Favored 'General case' 0 N--CA 1.53 3.553 0 C-N-CA 123.07 0.548 . . . . 0.0 112.152 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 4.9 m -67.47 -36.1 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 CA-C-N 118.195 0.452 . . . . 0.0 109.937 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 96.6 m -57.61 -27.13 62.48 Favored 'General case' 0 N--CA 1.526 3.348 0 C-N-CA 123.004 0.521 . . . . 0.0 110.547 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -58.51 -15.71 12.3 Favored 'General case' 0 N--CA 1.531 3.6 0 C-N-CA 122.367 0.267 . . . . 0.0 110.867 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 50.8 m -75.04 -42.07 57.91 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.99 -14.22 21.51 Favored 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.474 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 43.2 tp -87.06 2.3 50.12 Favored 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 46.9 m95 66.92 164.29 0.2 Allowed 'General case' 0 N--CA 1.515 2.799 0 C-N-CA 125.148 1.379 . . . . 0.0 111.214 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -133.86 -148.98 0.34 Allowed 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 125.358 1.463 . . . . 0.0 107.07 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -159.69 63.59 0.37 Allowed 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.53 138.19 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 C-N-CA 125.037 1.335 . . . . 0.0 107.959 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 57.8 tp -103.39 99.78 16.18 Favored Pre-proline 0 N--CA 1.531 3.605 0 C-N-CA 124.842 1.257 . . . . 0.0 108.438 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 N--CA 1.536 3.998 0 C-N-CA 122.426 2.084 . . . . 0.0 110.963 -179.607 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 43.9 ttm . . . . . 0 CA--C 1.583 2.229 0 CA-C-O 117.593 -1.194 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -88.84 -157.08 0.06 OUTLIER 'Trans proline' 1 N--CA 1.536 4.01 0 C-N-CA 122.705 2.27 . . . . 0.0 110.511 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -160.42 -33.41 0.02 OUTLIER Glycine 1 N--CA 1.521 4.301 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 82.8 p 52.34 46.36 26.8 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 124.055 0.942 . . . . 0.0 112.199 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 43.4 mt -61.91 -26.85 68.41 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.774 0.83 . . . . 0.0 110.607 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 45.2 t -68.43 -26.36 65.48 Favored 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.675 0.79 . . . . 0.0 110.596 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.35 -43.79 77.2 Favored Glycine 0 N--CA 1.512 3.714 0 C-N-CA 123.599 0.619 . . . . 0.0 114.103 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.7 pt -70.68 -35.82 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 10.1 pt -58.56 -41.69 82.63 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.66 0 CA-C-N 119.433 1.015 . . . . 0.0 112.542 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.7 -33.18 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.06 -41.0 96.27 Favored Glycine 1 N--CA 1.516 4.002 0 CA-C-O 119.502 -0.61 . . . . 0.0 114.088 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.9 m -63.73 -36.62 77.17 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.349 0 CA-C-N 118.624 1.212 . . . . 0.0 111.134 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.8 p -55.74 -42.56 75.57 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.828 0.451 . . . . 0.0 111.092 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.93 -34.13 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 C-N-CA 124.059 0.944 . . . . 0.0 111.896 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.93 -42.42 65.4 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.75 -34.08 71.47 Favored 'General case' 0 N--CA 1.519 2.992 0 C-N-CA 123.232 0.613 . . . . 0.0 111.314 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.85 -49.23 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 123.647 0.779 . . . . 0.0 111.345 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.68 -32.71 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 C-N-CA 122.633 0.373 . . . . 0.0 110.674 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.28 -36.86 74.67 Favored 'General case' 0 N--CA 1.539 3.985 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.18 -37.11 34.66 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.352 0 C-N-CA 123.168 0.587 . . . . 0.0 109.975 178.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.1 t -66.93 -38.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 C-N-CA 123.187 0.595 . . . . 0.0 110.143 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -45.53 86.54 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.387 0.675 . . . . 0.0 112.681 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.7 -34.17 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.613 0 O-C-N 121.898 -0.501 . . . . 0.0 110.228 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.15 -44.1 93.15 Favored 'General case' 0 N--CA 1.532 3.629 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.53 -37.29 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 99.5 m -59.14 -27.95 66.11 Favored 'General case' 0 N--CA 1.531 3.6 0 C-N-CA 122.74 0.416 . . . . 0.0 110.859 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -73.29 -35.05 66.07 Favored 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 63.0 m -72.66 -30.86 64.62 Favored 'General case' 0 N--CA 1.525 3.321 0 C-N-CA 123.108 0.563 . . . . 0.0 109.852 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.78 -14.65 62.5 Favored 'General case' 0 N--CA 1.526 3.339 0 C-N-CA 124.513 1.125 . . . . 0.0 110.926 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 38.3 tp -87.33 10.21 18.0 Favored 'General case' 0 N--CA 1.537 3.917 0 C-N-CA 123.763 0.825 . . . . 0.0 110.663 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -66.05 9.31 0.15 Allowed 'General case' 1 N--CA 1.54 4.065 0 C-N-CA 123.217 0.607 . . . . 0.0 112.444 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -50.6 -47.34 58.16 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 124.099 0.96 . . . . 0.0 111.785 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt 61.18 153.72 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 124.384 1.074 . . . . 0.0 111.348 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.1 m -112.52 138.32 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.508 0 C-N-CA 125.216 1.406 . . . . 0.0 108.513 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -95.76 106.59 28.48 Favored Pre-proline 0 N--CA 1.529 3.523 0 CA-C-O 117.075 -1.441 . . . . 0.0 107.892 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo . . . . . 1 N--CA 1.549 4.742 0 C-N-CA 122.682 2.255 . . . . 0.0 114.965 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 CA--C 1.574 1.892 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.95 -46.18 32.15 Favored 'Trans proline' 1 N--CA 1.543 4.419 0 C-N-CA 122.402 2.068 . . . . 0.0 113.623 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 175.64 155.69 13.34 Favored Glycine 1 N--CA 1.519 4.169 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 42.2 t -87.24 5.75 36.67 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 124.053 0.941 . . . . 0.0 111.234 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -61.89 -26.5 68.2 Favored 'General case' 0 N--CA 1.529 3.48 0 C-N-CA 124.147 0.979 . . . . 0.0 110.162 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 95.7 p -68.15 -32.15 72.21 Favored 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.556 0.742 . . . . 0.0 110.391 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.86 -46.89 58.41 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.924 0.773 . . . . 0.0 115.0 -178.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.9 -41.16 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 tp -60.67 -40.42 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 C-N-CA 122.905 0.482 . . . . 0.0 112.276 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 7.0 tp -73.27 -33.79 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.711 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.13 -47.84 87.07 Favored Glycine 0 N--CA 1.515 3.914 0 C-N-CA 123.799 0.714 . . . . 0.0 114.167 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.16 -37.17 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 CA-C-N 117.566 0.683 . . . . 0.0 111.137 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 61.2 p -66.06 -46.3 78.26 Favored 'General case' 0 N--CA 1.534 3.727 0 CA-C-N 118.136 0.425 . . . . 0.0 110.721 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 84.7 t -70.03 -31.96 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 C-N-CA 123.741 0.817 . . . . 0.0 111.057 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.87 -43.79 66.35 Favored 'General case' 0 N--CA 1.533 3.707 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.06 73.2 Favored 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 123.185 0.594 . . . . 0.0 111.179 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.71 -46.79 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 123.395 0.678 . . . . 0.0 112.292 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.29 -31.58 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 C-N-CA 122.533 0.333 . . . . 0.0 111.39 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.72 -39.64 64.16 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 122.411 -0.181 . . . . 0.0 111.046 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 93.8 mt -59.96 -44.19 94.01 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.097 0 CA-C-N 118.357 0.526 . . . . 0.0 111.653 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 30.0 m -64.07 -36.7 77.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 CA-C-N 118.619 0.645 . . . . 0.0 110.429 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.9 -32.5 71.96 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.238 0.615 . . . . 0.0 111.871 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 86.2 t -71.31 -34.56 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.698 0.399 . . . . 0.0 109.939 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -61.34 -44.02 97.9 Favored 'General case' 0 N--CA 1.53 3.542 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.94 -40.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.858 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 80.7 m -58.67 -27.65 65.0 Favored 'General case' 0 N--CA 1.522 3.17 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.117 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -71.62 -15.85 62.26 Favored 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 122.528 0.331 . . . . 0.0 111.15 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 26.8 t -78.39 -46.55 19.62 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.88 -13.01 54.63 Favored 'General case' 1 N--CA 1.554 4.733 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -175.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.69 3.69 43.7 Favored 'General case' 1 N--CA 1.566 5.33 0 CA-C-N 121.915 2.143 . . . . 0.0 112.438 -176.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -122.53 -36.61 2.9 Favored 'General case' 1 N--CA 1.543 4.207 0 C-N-CA 124.814 1.246 . . . . 0.0 107.644 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp 62.19 5.36 1.48 Allowed 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 124.598 1.159 . . . . 0.0 112.284 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -73.52 105.19 4.76 Favored 'General case' 0 N--CA 1.533 3.676 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.41 138.33 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.468 0 C-N-CA 124.847 1.259 . . . . 0.0 108.564 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.71 147.53 40.06 Favored Pre-proline 0 N--CA 1.538 3.93 0 C-N-CA 125.435 1.494 . . . . 0.0 108.668 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 1 N--CA 1.542 4.34 0 C-N-CA 121.933 1.755 . . . . 0.0 110.704 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 CA--C 1.575 1.94 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -82.63 179.76 5.13 Favored 'Trans proline' 0 N--CA 1.535 3.915 0 C-N-CA 122.632 2.221 . . . . 0.0 110.732 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.89 -37.98 93.82 Favored Glycine 1 N--CA 1.52 4.26 0 C-N-CA 123.672 0.653 . . . . 0.0 111.486 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 59.9 p 55.98 111.1 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 124.545 1.138 . . . . 0.0 112.225 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.65 -26.66 68.75 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 123.955 0.902 . . . . 0.0 109.646 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 38.7 t -67.95 -26.85 66.15 Favored 'General case' 0 N--CA 1.519 2.993 0 C-N-CA 123.645 0.778 . . . . 0.0 110.611 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.14 -46.78 56.87 Favored Glycine 0 N--CA 1.512 3.704 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.321 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 43.2 pt -70.98 -37.97 70.15 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.121 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 7.5 tp -59.05 -31.8 46.49 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.092 0 C-N-CA 123.288 0.635 . . . . 0.0 112.659 -177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.4 pp -71.3 -32.17 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.7 -43.68 79.75 Favored Glycine 0 N--CA 1.512 3.743 0 C-N-CA 124.463 1.03 . . . . 0.0 114.949 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 11.3 p -68.2 -37.13 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 CA-C-N 118.133 0.967 . . . . 0.0 111.011 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.6 p -65.59 -46.49 79.18 Favored 'General case' 0 N--CA 1.531 3.582 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 10.8 p -69.71 -30.68 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.467 0 C-N-CA 123.451 0.7 . . . . 0.0 111.226 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.07 -43.19 63.71 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.59 -37.36 73.89 Favored 'General case' 0 N--CA 1.521 3.099 0 C-N-CA 123.335 0.654 . . . . 0.0 110.863 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.99 -52.13 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.313 0 C-N-CA 123.668 0.787 . . . . 0.0 111.27 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.4 -31.93 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.925 0 CA-C-O 120.91 0.386 . . . . 0.0 110.235 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -46.24 89.61 Favored 'General case' 0 N--CA 1.531 3.59 0 CA-C-O 121.57 0.7 . . . . 0.0 109.583 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.14 -39.51 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 C-N-CA 123.221 0.608 . . . . 0.0 109.814 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.91 -37.78 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.704 0 C-N-CA 123.144 0.578 . . . . 0.0 109.914 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.66 -46.52 88.78 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.386 0.674 . . . . 0.0 112.602 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.71 -34.26 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 O-C-N 121.825 -0.547 . . . . 0.0 109.871 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.68 -43.91 97.59 Favored 'General case' 0 N--CA 1.529 3.515 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.0 -37.69 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.12 -28.59 69.88 Favored 'General case' 0 N--CA 1.525 3.324 0 C-N-CA 123.23 0.612 . . . . 0.0 111.586 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -62.35 -37.27 85.02 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 122.924 0.49 . . . . 0.0 110.664 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 52.7 m -63.78 -26.84 68.82 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.614 0.766 . . . . 0.0 111.102 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 55.6 mt -90.12 -13.44 35.74 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 124.953 1.301 . . . . 0.0 111.281 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 41.7 tp -86.58 -11.3 51.91 Favored 'General case' 1 N--CA 1.54 4.054 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -175.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -60.55 -67.34 0.41 Allowed 'General case' 1 N--CA 1.541 4.114 0 CA-C-N 119.142 0.883 . . . . 0.0 110.007 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 56.55 -144.66 0.65 Allowed 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.77 0.828 . . . . 0.0 110.751 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp 62.14 170.69 0.13 Allowed 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 124.29 1.036 . . . . 0.0 111.304 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.05 138.64 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.351 0 C-N-CA 125.249 1.419 . . . . 0.0 107.978 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 60.5 tp -94.7 105.33 17.96 Favored Pre-proline 0 N--CA 1.529 3.513 0 CA-C-O 117.311 -1.328 . . . . 0.0 108.352 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 1 N--CA 1.537 4.034 0 C-N-CA 122.359 2.039 . . . . 0.0 110.968 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 CA--C 1.577 1.995 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.77 -170.81 0.73 Allowed 'Trans proline' 1 N--CA 1.538 4.101 0 C-N-CA 122.254 1.969 . . . . 0.0 110.015 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.72 86.86 0.26 Allowed Glycine 1 N--CA 1.518 4.167 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t -165.62 23.29 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.142 0 C-N-CA 123.946 0.899 . . . . 0.0 109.895 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.2 -26.73 68.27 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 124.167 0.987 . . . . 0.0 109.82 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 45.1 t -68.65 -26.45 65.34 Favored 'General case' 0 N--CA 1.52 3.072 0 C-N-CA 123.358 0.663 . . . . 0.0 110.835 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.05 71.48 Favored Glycine 0 N--CA 1.511 3.642 0 C-N-CA 123.693 0.663 . . . . 0.0 114.08 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 6.4 tp -68.9 -35.97 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.911 0 CA-C-N 117.921 0.861 . . . . 0.0 111.908 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 8.3 pt -65.5 -32.37 57.93 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.461 0 CA-C-N 118.961 0.801 . . . . 0.0 110.16 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.62 -33.69 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 124.301 1.04 . . . . 0.0 108.861 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.24 -29.73 60.33 Favored Glycine 1 N--CA 1.518 4.118 0 C-N-CA 123.523 0.582 . . . . 0.0 113.159 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 m -60.07 -37.35 72.46 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 CA-C-N 117.349 0.574 . . . . 0.0 111.042 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 56.8 p -55.6 -39.74 71.16 Favored 'General case' 0 N--CA 1.524 3.235 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.325 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.7 t -61.88 -46.11 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.277 0 C-N-CA 123.703 0.801 . . . . 0.0 110.668 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.51 -35.09 60.27 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.262 0.625 . . . . 0.0 112.538 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.95 -37.32 81.45 Favored 'General case' 0 N--CA 1.519 2.991 0 C-N-CA 123.482 0.713 . . . . 0.0 111.083 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 28.3 t -56.37 -38.89 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 C-N-CA 123.288 0.635 . . . . 0.0 110.573 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.02 -32.11 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.387 0 C-N-CA 123.554 0.741 . . . . 0.0 110.028 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -44.07 70.45 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.433 0.693 . . . . 0.0 109.555 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.15 -49.19 63.72 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 C-N-CA 123.246 0.618 . . . . 0.0 111.772 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 22.2 m -66.19 -36.28 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 C-N-CA 122.594 0.358 . . . . 0.0 110.327 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.28 66.74 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 123.279 0.632 . . . . 0.0 112.338 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.4 -43.91 94.63 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.005 0 CA-C-N 118.237 0.471 . . . . 0.0 112.09 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -61.16 -43.62 98.6 Favored 'General case' 0 N--CA 1.538 3.951 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.56 -37.55 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 O-C-N 121.771 -0.581 . . . . 0.0 109.609 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 85.3 m -64.25 -27.63 69.18 Favored 'General case' 0 N--CA 1.527 3.385 0 C-N-CA 122.973 0.509 . . . . 0.0 111.105 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -64.36 -27.96 69.37 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.039 0.536 . . . . 0.0 111.423 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 50.5 m -63.73 -37.68 88.28 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 123.629 0.771 . . . . 0.0 111.767 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -60.84 -13.79 17.76 Favored 'General case' 0 N--CA 1.531 3.589 0 C-N-CA 124.625 1.17 . . . . 0.0 112.293 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -86.93 -28.15 22.93 Favored 'General case' 1 N--CA 1.542 4.175 0 CA-C-N 118.423 0.556 . . . . 0.0 110.539 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -73.42 68.25 1.09 Allowed 'General case' 0 N--CA 1.533 3.684 0 CA-C-O 121.387 0.613 . . . . 0.0 109.739 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -109.83 -37.61 5.59 Favored 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 125.096 1.358 . . . . 0.0 108.627 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 60.1 tttp 62.24 148.74 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 124.651 1.181 . . . . 0.0 111.214 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.46 138.29 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 C-N-CA 125.003 1.321 . . . . 0.0 108.601 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.58 146.6 31.76 Favored Pre-proline 0 N--CA 1.529 3.512 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 1 N--CA 1.541 4.305 0 C-N-CA 122.04 1.827 . . . . 0.0 110.718 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 CA--C 1.582 2.203 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.35 -10.3 1.28 Allowed 'Trans proline' 1 N--CA 1.55 4.84 0 C-N-CA 122.055 1.837 . . . . 0.0 114.075 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 76.53 -177.51 51.23 Favored Glycine 1 N--CA 1.518 4.165 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 67.1 m -161.27 15.23 0.1 Allowed 'General case' 0 N--CA 1.524 3.241 0 C-N-CA 123.601 0.761 . . . . 0.0 110.35 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.5 -26.86 68.76 Favored 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 123.665 0.786 . . . . 0.0 111.473 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 66.0 m -68.28 -25.86 65.36 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.631 0.772 . . . . 0.0 109.563 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.38 -34.65 59.72 Favored Glycine 0 N--CA 1.512 3.747 0 C-N-CA 124.603 1.097 . . . . 0.0 113.952 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 11.1 tp -59.33 -43.16 89.46 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 CA-C-N 117.67 0.735 . . . . 0.0 112.827 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 5.5 pt -68.85 -34.16 63.07 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.411 0 CA-C-O 121.827 0.822 . . . . 0.0 109.399 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 81.9 mt -73.08 -38.98 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.185 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.56 -46.63 91.83 Favored Glycine 1 N--CA 1.516 4.016 0 CA-C-N 115.606 -0.725 . . . . 0.0 114.374 -177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.13 -37.55 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 CA-C-N 117.506 0.653 . . . . 0.0 110.854 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 70.1 p -66.22 -45.55 80.32 Favored 'General case' 0 N--CA 1.535 3.782 0 CA-C-N 118.354 0.525 . . . . 0.0 110.575 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.24 -31.24 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 C-N-CA 123.964 0.905 . . . . 0.0 110.891 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.32 -47.24 75.93 Favored 'General case' 0 N--CA 1.532 3.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.19 -25.64 67.81 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.571 0.748 . . . . 0.0 112.224 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.53 -37.09 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 C-N-CA 123.526 0.73 . . . . 0.0 109.464 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 46.1 t -55.78 -32.31 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.137 0.575 . . . . 0.0 110.306 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.96 -40.89 91.68 Favored 'General case' 0 N--CA 1.532 3.661 0 C-N-CA 123.017 0.527 . . . . 0.0 109.823 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 34.3 mm -60.62 -44.56 97.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.711 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.84 -39.72 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.258 0 C-N-CA 123.636 0.775 . . . . 0.0 109.855 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.84 87.81 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.676 0.79 . . . . 0.0 112.409 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.82 -34.36 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 O-C-N 121.846 -0.534 . . . . 0.0 110.334 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -63.63 -44.35 94.14 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.15 -37.99 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.9 m -67.26 -30.38 70.25 Favored 'General case' 0 N--CA 1.525 3.286 0 C-N-CA 123.115 0.566 . . . . 0.0 110.911 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -66.67 -35.21 79.61 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.347 0.659 . . . . 0.0 111.237 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 91.8 p -64.83 -33.63 76.46 Favored 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 123.121 0.568 . . . . 0.0 110.94 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 50.7 mt -78.75 -14.86 59.05 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 124.022 0.929 . . . . 0.0 111.166 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 50.6 tp -87.46 -16.1 35.76 Favored 'General case' 0 N--CA 1.536 3.845 0 C-N-CA 123.516 0.727 . . . . 0.0 110.554 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -61.82 -8.26 4.66 Favored 'General case' 0 N--CA 1.53 3.563 0 C-N-CA 123.393 0.677 . . . . 0.0 111.583 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -64.94 144.68 57.12 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 123.782 0.833 . . . . 0.0 110.387 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -69.69 136.03 50.56 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.655 0.782 . . . . 0.0 109.622 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 30.7 m -135.27 138.28 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.413 0 C-N-CA 124.994 1.318 . . . . 0.0 108.192 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 58.2 mt -94.72 129.95 34.69 Favored Pre-proline 0 N--CA 1.527 3.404 0 CA-C-O 116.732 -1.604 . . . . 0.0 108.052 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 1 N--CA 1.538 4.122 0 CA-C-N 123.125 2.152 . . . . 0.0 110.679 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.582 2.199 0 CA-C-O 117.326 -1.321 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -87.91 -177.5 1.95 Allowed 'Trans proline' 0 N--CA 1.535 3.949 0 C-N-CA 122.473 2.115 . . . . 0.0 110.623 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -175.61 -105.75 0.19 Allowed Glycine 1 N--CA 1.518 4.13 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 74.4 p 54.19 44.51 29.02 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-O 122.042 0.925 . . . . 0.0 111.413 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 42.2 mt -60.91 -26.61 67.58 Favored 'General case' 0 N--CA 1.524 3.235 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.952 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 61.9 m -62.99 -26.38 68.82 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.049 0.539 . . . . 0.0 110.069 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.96 -46.51 93.57 Favored Glycine 1 N--CA 1.519 4.23 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.565 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 48.7 pt -70.5 -35.33 61.29 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.141 0 CA-C-N 118.468 1.134 . . . . 0.0 109.85 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.38 -44.68 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 29.8 mm -72.88 -33.31 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.89 -29.08 49.93 Favored Glycine 0 N--CA 1.512 3.733 0 C-N-CA 124.666 1.126 . . . . 0.0 113.175 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.28 -39.25 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 C-N-CA 122.781 0.433 . . . . 0.0 111.199 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 72.9 p -65.91 -45.2 82.84 Favored 'General case' 0 N--CA 1.53 3.547 0 CA-C-O 121.657 0.741 . . . . 0.0 109.987 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 43.3 t -68.56 -31.69 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.976 0 C-N-CA 124.588 1.155 . . . . 0.0 111.676 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.65 77.83 Favored 'General case' 0 N--CA 1.533 3.713 0 O-C-N 121.706 -0.621 . . . . 0.0 112.608 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.39 -50.22 74.48 Favored 'General case' 0 N--CA 1.523 3.189 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.36 -38.11 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 CA-C-N 118.321 0.51 . . . . 0.0 111.402 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 84.2 t -56.75 -35.96 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 O-C-N 122.03 -0.419 . . . . 0.0 111.102 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 52.0 tp -66.32 -44.57 83.01 Favored 'General case' 1 N--CA 1.539 4.01 0 CA-C-N 118.809 0.732 . . . . 0.0 109.685 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.47 -42.45 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.465 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.201 -178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.31 -37.98 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 C-N-CA 123.036 0.534 . . . . 0.0 109.58 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.2 88.65 Favored 'General case' 0 N--CA 1.53 3.574 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 17.4 m -71.42 -34.35 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 O-C-N 121.843 -0.536 . . . . 0.0 110.811 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -64.51 -44.17 91.77 Favored 'General case' 0 N--CA 1.531 3.599 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.74 -37.64 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.1 -27.25 68.79 Favored 'General case' 0 N--CA 1.526 3.363 0 C-N-CA 123.437 0.695 . . . . 0.0 111.182 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -63.17 -34.39 77.52 Favored 'General case' 0 N--CA 1.53 3.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.774 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.8 t -66.1 -36.06 82.17 Favored 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.529 0.732 . . . . 0.0 111.432 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 4.4 tt -61.25 -13.97 22.63 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 124.231 1.012 . . . . 0.0 111.613 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 25.6 mt -86.03 -27.99 24.43 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.166 0.586 . . . . 0.0 109.594 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -102.6 98.1 8.2 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 124.543 1.137 . . . . 0.0 108.193 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -126.38 71.22 1.27 Allowed 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 124.911 1.285 . . . . 0.0 108.659 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -166.1 82.55 0.29 Allowed 'General case' 0 N--CA 1.522 3.174 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.45 132.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.51 146.76 32.07 Favored Pre-proline 0 N--CA 1.528 3.433 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo . . . . . 1 N--CA 1.54 4.225 0 C-N-CA 122.022 1.814 . . . . 0.0 110.72 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 76.5 mtp . . . . . 0 CA--C 1.572 1.81 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.46 3.09 4.46 Favored 'Trans proline' 1 N--CA 1.54 4.248 0 C-N-CA 122.057 1.838 . . . . 0.0 111.184 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.6 -177.92 25.18 Favored Glycine 1 N--CA 1.519 4.211 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.1 p -165.99 62.57 0.11 Allowed 'General case' 0 N--CA 1.523 3.18 0 CA-C-O 121.826 0.822 . . . . 0.0 108.923 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.02 -26.97 68.81 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 123.907 0.883 . . . . 0.0 110.19 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 69.2 m -68.37 -26.74 65.73 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 123.408 0.683 . . . . 0.0 109.993 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.7 -46.96 92.6 Favored Glycine 1 N--CA 1.519 4.228 0 C-N-CA 123.719 0.676 . . . . 0.0 113.562 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.7 tp -70.9 -35.1 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 CA-C-N 117.795 0.797 . . . . 0.0 109.869 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.83 -43.91 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 123.67 0.788 . . . . 0.0 111.512 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 18.6 tt -73.17 -33.48 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 119.263 0.938 . . . . 0.0 109.838 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.55 97.76 Favored Glycine 1 N--CA 1.521 4.352 0 C-N-CA 123.354 0.502 . . . . 0.0 114.091 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 p -59.93 -36.67 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.913 0 CA-C-N 117.677 0.739 . . . . 0.0 110.258 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.9 p -55.98 -44.86 78.94 Favored 'General case' 0 N--CA 1.536 3.843 0 CA-C-O 121.318 0.58 . . . . 0.0 111.388 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.88 -39.99 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 C-N-CA 124.073 0.949 . . . . 0.0 111.748 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.77 -46.78 74.42 Favored 'General case' 0 N--CA 1.528 3.434 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.36 -50.46 71.5 Favored 'General case' 0 N--CA 1.517 2.894 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.54 -38.48 81.53 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.094 0 CA-C-N 119.079 0.854 . . . . 0.0 112.614 -177.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.14 -32.12 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 CA-C-N 118.354 0.525 . . . . 0.0 110.227 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.38 -44.49 36.07 Favored 'General case' 0 N--CA 1.526 3.326 0 C-N-CA 122.653 0.381 . . . . 0.0 110.471 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.34 -44.8 89.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.034 0 C-N-CA 122.945 0.498 . . . . 0.0 111.869 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 30.6 m -61.29 -36.43 72.82 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.22 0 CA-C-N 118.94 0.791 . . . . 0.0 110.834 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.57 -31.87 66.58 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.234 0.614 . . . . 0.0 111.443 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.29 -41.87 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 123.027 0.531 . . . . 0.0 111.507 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -60.7 -43.95 97.15 Favored 'General case' 1 N--CA 1.541 4.091 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.68 -37.73 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 80.1 m -67.27 -32.65 73.81 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 122.733 0.413 . . . . 0.0 110.004 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -72.18 -29.44 64.0 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 123.715 0.806 . . . . 0.0 110.562 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -66.4 -21.35 66.22 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 123.145 0.578 . . . . 0.0 111.061 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 58.6 mt -91.55 -14.26 30.62 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 124.509 1.124 . . . . 0.0 111.189 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.1 tp -87.35 -28.3 22.3 Favored 'General case' 1 N--CA 1.541 4.111 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -174.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 48.8 p-90 -66.32 -64.21 0.91 Allowed 'General case' 1 N--CA 1.544 4.271 0 CA-C-N 120.272 1.396 . . . . 0.0 111.157 -177.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 54.72 176.41 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.852 0.861 . . . . 0.0 112.316 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -97.19 169.73 9.6 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 124.541 1.136 . . . . 0.0 108.918 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 50.3 t -132.34 136.17 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.58 98.75 25.45 Favored Pre-proline 0 N--CA 1.536 3.834 0 C-N-CA 124.939 1.296 . . . . 0.0 109.352 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo . . . . . 1 N--CA 1.547 4.648 0 C-N-CA 122.349 2.033 . . . . 0.0 114.16 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 CA--C 1.572 1.793 0 CA-C-O 116.923 -1.513 . . . . 0.0 107.003 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.66 143.93 30.92 Favored 'Trans proline' 1 N--CA 1.539 4.197 0 CA-C-N 122.656 1.984 . . . . 0.0 109.974 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.03 175.1 48.42 Favored Glycine 1 N--CA 1.516 4.014 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 70.4 m -101.89 27.77 6.25 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 124.741 1.216 . . . . 0.0 109.437 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.8 -26.79 68.32 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 124.232 1.013 . . . . 0.0 111.064 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 91.4 p -68.19 -30.81 70.0 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.535 0.734 . . . . 0.0 110.609 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.0 -46.9 57.58 Favored Glycine 0 N--CA 1.516 3.988 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.737 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 8.2 tp -71.29 -41.74 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.4 tt -60.57 -38.71 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.882 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.78 -32.78 41.86 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.101 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.55 -29.41 47.96 Favored Glycine 0 N--CA 1.512 3.717 0 C-N-CA 124.183 0.897 . . . . 0.0 113.923 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 8.6 p -59.76 -38.55 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 CA-C-N 117.661 0.73 . . . . 0.0 110.998 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 67.1 p -65.17 -45.53 84.52 Favored 'General case' 0 N--CA 1.528 3.441 0 CA-C-O 121.456 0.646 . . . . 0.0 110.389 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.38 -32.0 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 C-N-CA 124.307 1.043 . . . . 0.0 110.602 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.21 -45.9 82.89 Favored 'General case' 0 N--CA 1.524 3.273 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.95 -41.81 97.49 Favored 'General case' 0 N--CA 1.519 3.0 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.27 -44.14 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.99 -32.75 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 O-C-N 121.293 -0.88 . . . . 0.0 111.457 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 5.4 tt -67.34 -47.54 70.17 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 122.959 0.503 . . . . 0.0 111.446 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 22.8 pt -69.14 -36.29 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 O-C-N 121.671 -0.643 . . . . 0.0 110.884 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.69 -37.36 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.49 -47.47 81.82 Favored 'General case' 0 N--CA 1.532 3.626 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 30.9 m -71.81 -34.53 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 O-C-N 121.939 -0.476 . . . . 0.0 110.605 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -65.61 -43.71 88.78 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.05 -37.0 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.744 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.73 -33.93 70.79 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.308 0.243 . . . . 0.0 110.986 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -74.29 -15.7 60.96 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 122.894 0.478 . . . . 0.0 111.291 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 20.7 t -63.68 -29.13 70.4 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-O 121.467 0.651 . . . . 0.0 109.743 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 57.2 tp -72.18 -31.48 65.96 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.945 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.28 -24.41 24.35 Favored 'General case' 0 N--CA 1.538 3.935 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 61.0 t-105 -69.46 -3.04 12.83 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.639 0.776 . . . . 0.0 110.926 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 168.3 1.07 Allowed 'General case' 0 N--CA 1.527 3.425 0 C-N-CA 123.693 0.797 . . . . 0.0 112.1 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -175.57 171.38 2.79 Favored 'General case' 0 N--CA 1.528 3.445 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 8.0 p -135.39 137.22 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.537 0 C-N-CA 124.537 1.135 . . . . 0.0 108.724 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 60.7 mt -98.36 146.74 32.07 Favored Pre-proline 0 N--CA 1.528 3.427 0 CA-C-O 117.275 -1.345 . . . . 0.0 108.273 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 1 N--CA 1.54 4.25 0 CA-C-N 122.086 1.781 . . . . 0.0 110.679 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 CA--C 1.586 2.354 0 CA-C-O 117.456 -1.259 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -88.79 150.76 6.04 Favored 'Trans proline' 0 N--CA 1.535 3.95 0 C-N-CA 122.534 2.156 . . . . 0.0 111.018 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.81 73.11 1.49 Allowed Glycine 1 N--CA 1.517 4.083 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 98.3 p -66.63 124.17 22.11 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.711 0.804 . . . . 0.0 110.48 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.29 -26.9 68.28 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.926 0.89 . . . . 0.0 109.719 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 46.7 t -68.42 -26.17 65.4 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 123.524 0.73 . . . . 0.0 110.808 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.1 -46.34 66.07 Favored Glycine 0 N--CA 1.514 3.852 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.875 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.4 tt -70.72 -38.17 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.867 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 15.4 pt -57.04 -43.15 80.61 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.685 0 CA-C-N 119.584 1.084 . . . . 0.0 111.946 -176.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 6.1 tp -73.01 -32.97 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.17 -45.57 95.06 Favored Glycine 1 N--CA 1.518 4.121 0 C-N-CA 123.869 0.747 . . . . 0.0 113.292 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.65 -36.68 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 O-C-N 121.954 -0.733 . . . . 0.0 109.776 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 37.6 m -60.54 -47.08 87.75 Favored 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.74 -31.39 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 123.621 0.769 . . . . 0.0 111.23 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.13 -34.3 56.14 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.483 0.713 . . . . 0.0 112.801 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.8 -50.79 39.51 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.17 -38.44 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.665 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.48 -32.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 CA-C-N 118.255 0.479 . . . . 0.0 110.99 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.96 -42.47 99.16 Favored 'General case' 0 N--CA 1.532 3.641 0 O-C-N 122.198 -0.314 . . . . 0.0 110.428 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -57.22 -36.63 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.629 0 C-N-CA 123.317 0.647 . . . . 0.0 110.636 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.52 -37.81 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 123.444 0.697 . . . . 0.0 109.847 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.97 76.76 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.107 0.563 . . . . 0.0 111.219 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.61 -34.76 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.35 0.66 . . . . 0.0 110.15 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -63.81 -43.8 95.18 Favored 'General case' 0 N--CA 1.531 3.596 0 C-N-CA 123.132 0.573 . . . . 0.0 112.243 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 6.8 p -68.87 -37.46 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.675 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 82.2 m -58.84 -27.77 65.43 Favored 'General case' 0 N--CA 1.531 3.575 0 C-N-CA 122.624 0.37 . . . . 0.0 110.833 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -70.87 -22.05 62.34 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.102 0.561 . . . . 0.0 110.942 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 68.6 p -63.81 -26.49 68.65 Favored 'General case' 0 N--CA 1.534 3.742 0 C-N-CA 123.283 0.633 . . . . 0.0 111.552 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.78 -14.46 21.68 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 124.12 0.968 . . . . 0.0 111.43 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.29 8.04 26.0 Favored 'General case' 0 N--CA 1.538 3.971 0 C-N-CA 123.456 0.702 . . . . 0.0 109.243 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -83.57 26.25 0.69 Allowed 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 124.158 0.983 . . . . 0.0 109.493 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -62.41 -46.26 89.41 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 123.838 0.855 . . . . 0.0 110.863 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -69.13 145.62 53.2 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 123.572 0.749 . . . . 0.0 110.325 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 24.4 m -135.25 138.42 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 124.929 1.292 . . . . 0.0 108.205 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.66 146.53 31.6 Favored Pre-proline 0 N--CA 1.529 3.487 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo . . . . . 1 N--CA 1.54 4.264 0 C-N-CA 122.021 1.814 . . . . 0.0 110.686 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.578 2.026 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -77.68 -176.61 3.31 Favored 'Trans proline' 0 N--CA 1.534 3.91 0 C-N-CA 122.127 1.885 . . . . 0.0 110.387 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 69.55 71.11 1.04 Allowed Glycine 1 N--CA 1.517 4.091 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 43.0 t -63.9 149.74 46.48 Favored 'General case' 0 N--CA 1.519 2.98 0 C-N-CA 123.802 0.841 . . . . 0.0 111.587 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -24.91 67.61 Favored 'General case' 0 N--CA 1.527 3.385 0 C-N-CA 124.765 1.226 . . . . 0.0 110.968 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 90.3 p -57.19 -25.53 59.15 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 124.133 0.973 . . . . 0.0 111.96 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.63 83.15 Favored Glycine 0 N--CA 1.514 3.858 0 N-CA-C 115.381 0.912 . . . . 0.0 115.381 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 13.0 tt -59.38 -35.07 56.45 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.512 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 16.8 tt -55.69 -31.19 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.874 0 C-N-CA 123.862 0.865 . . . . 0.0 112.918 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.08 -33.57 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.13 -45.22 96.5 Favored Glycine 1 N--CA 1.522 4.419 0 C-N-CA 123.661 0.648 . . . . 0.0 114.298 -177.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -59.72 -36.08 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.962 0 CA-C-N 117.636 0.718 . . . . 0.0 110.231 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 24.5 p -55.9 -45.05 78.76 Favored 'General case' 0 N--CA 1.536 3.847 0 CA-C-O 120.988 0.423 . . . . 0.0 111.408 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.9 t -58.11 -40.64 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 124.15 0.98 . . . . 0.0 112.289 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.51 -45.93 66.46 Favored 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.57 -42.12 71.49 Favored 'General case' 0 N--CA 1.52 3.026 0 C-N-CA 122.691 0.396 . . . . 0.0 111.489 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.01 -43.6 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.156 0 C-N-CA 123.221 0.609 . . . . 0.0 112.42 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.76 -32.85 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.786 0 CA-C-N 118.51 0.596 . . . . 0.0 111.845 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 51.6 tp -66.0 -41.88 90.46 Favored 'General case' 0 N--CA 1.53 3.546 0 CA-C-N 118.034 0.379 . . . . 0.0 110.609 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 93.1 mt -57.48 -37.43 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 C-N-CA 122.782 0.433 . . . . 0.0 110.527 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.92 -44.12 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 122.847 0.459 . . . . 0.0 110.056 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -45.03 87.33 Favored 'General case' 0 N--CA 1.527 3.417 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.72 -33.89 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.685 0 O-C-N 121.583 -0.698 . . . . 0.0 109.684 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -63.81 -43.39 96.4 Favored 'General case' 0 N--CA 1.529 3.502 0 C-N-CA 123.255 0.622 . . . . 0.0 112.489 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.56 -36.82 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 CA-C-N 118.704 0.684 . . . . 0.0 109.645 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 73.6 m -57.9 -27.33 63.22 Favored 'General case' 0 N--CA 1.528 3.451 0 C-N-CA 122.8 0.44 . . . . 0.0 111.017 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -63.76 -27.67 69.35 Favored 'General case' 0 N--CA 1.532 3.657 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 53.2 p -64.19 -34.43 78.07 Favored 'General case' 0 N--CA 1.527 3.405 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -27.55 67.72 Favored 'General case' 0 N--CA 1.526 3.353 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.591 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 38.9 mt -86.82 -28.11 23.12 Favored 'General case' 0 N--CA 1.533 3.724 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -77.9 101.74 6.96 Favored 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.4 159.85 10.79 Favored 'General case' 0 N--CA 1.519 3.006 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -70.06 121.35 17.29 Favored 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 123.949 0.9 . . . . 0.0 110.085 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.3 138.21 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.403 0 C-N-CA 124.976 1.31 . . . . 0.0 107.767 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.58 146.61 31.77 Favored Pre-proline 0 N--CA 1.529 3.489 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo . . . . . 1 N--CA 1.54 4.261 0 C-N-CA 122.182 1.921 . . . . 0.0 110.657 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 CA--C 1.582 2.197 0 CA-C-O 117.542 -1.218 . . . . 0.0 111.636 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.39 -1.99 6.82 Favored 'Trans proline' 1 N--CA 1.538 4.136 0 C-N-CA 122.615 2.21 . . . . 0.0 111.803 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -79.44 31.16 2.15 Favored Glycine 1 N--CA 1.52 4.258 0 C-N-CA 123.825 0.726 . . . . 0.0 111.525 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 45.3 t -65.58 159.9 23.66 Favored 'General case' 0 N--CA 1.52 3.044 0 C-N-CA 123.651 0.78 . . . . 0.0 111.332 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.1 -26.61 68.29 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 124.318 1.047 . . . . 0.0 110.403 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 93.1 p -63.08 -25.73 68.5 Favored 'General case' 0 N--CA 1.522 3.155 0 C-N-CA 123.668 0.787 . . . . 0.0 111.134 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.53 -46.72 67.16 Favored Glycine 0 N--CA 1.516 3.973 0 CA-C-N 116.061 -0.518 . . . . 0.0 114.28 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.46 -40.2 72.04 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.07 0 CA-C-N 118.179 0.989 . . . . 0.0 113.659 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 18.0 pt -58.94 -40.53 80.62 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.453 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -175.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.2 tt -72.08 -32.33 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.811 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.2 -28.87 43.61 Favored Glycine 0 N--CA 1.515 3.954 0 C-N-CA 123.94 0.781 . . . . 0.0 113.206 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.34 -37.13 67.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.043 0 CA-C-N 117.501 0.651 . . . . 0.0 110.83 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 62.0 p -59.28 -45.19 91.92 Favored 'General case' 0 N--CA 1.527 3.421 0 C-N-CA 123.338 0.655 . . . . 0.0 111.801 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.69 -35.22 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.341 0 C-N-CA 123.607 0.763 . . . . 0.0 109.915 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.3 -34.23 77.66 Favored 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 123.497 0.719 . . . . 0.0 110.883 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.53 91.26 Favored 'General case' 0 N--CA 1.519 3.021 0 C-N-CA 123.135 0.574 . . . . 0.0 111.614 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.72 -52.8 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.612 0 C-N-CA 123.087 0.555 . . . . 0.0 111.851 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.96 -32.09 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 C-N-CA 122.717 0.407 . . . . 0.0 111.026 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.71 -35.28 79.24 Favored 'General case' 1 N--CA 1.541 4.101 0 C-N-CA 122.815 0.446 . . . . 0.0 110.617 -179.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 81.3 mt -69.28 -35.68 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.16 -36.21 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 C-N-CA 123.257 0.623 . . . . 0.0 109.692 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.35 -42.38 81.88 Favored 'General case' 0 N--CA 1.526 3.367 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 6.3 m -71.73 -34.49 52.09 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.047 0 CA-C-N 119.063 0.847 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -62.53 -43.76 98.03 Favored 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 123.334 0.654 . . . . 0.0 112.383 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 6.9 p -68.72 -37.43 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.58 -27.75 69.17 Favored 'General case' 0 N--CA 1.528 3.475 0 C-N-CA 123.02 0.528 . . . . 0.0 110.627 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -74.26 -18.4 60.73 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.467 0.707 . . . . 0.0 110.593 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 26.7 t -63.5 -46.37 86.43 Favored 'General case' 0 N--CA 1.529 3.494 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.22 -13.58 58.64 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 123.506 0.722 . . . . 0.0 112.584 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 53.0 tp -87.14 -8.77 56.62 Favored 'General case' 0 N--CA 1.538 3.925 0 C-N-CA 123.566 0.747 . . . . 0.0 110.287 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -58.79 -1.28 0.14 Allowed 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 123.966 0.906 . . . . 0.0 112.792 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -59.59 167.3 2.07 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.32 0.648 . . . . 0.0 110.081 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -165.8 113.85 0.95 Allowed 'General case' 0 N--CA 1.523 3.22 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.46 138.51 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 124.903 1.281 . . . . 0.0 108.436 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -94.14 147.12 32.85 Favored Pre-proline 0 N--CA 1.532 3.656 0 CA-C-O 116.88 -1.533 . . . . 0.0 109.87 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo . . . . . 1 N--CA 1.551 4.911 0 C-N-CA 122.882 2.388 . . . . 0.0 114.876 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 17.2 ptm . . . . . 0 CA--C 1.574 1.877 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -67.79 -171.57 0.34 Allowed 'Trans proline' 1 N--CA 1.543 4.401 0 C-N-CA 122.337 2.025 . . . . 0.0 110.836 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 76.02 162.07 12.02 Favored Glycine 0 N--CA 1.516 3.999 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 41.3 t -170.89 113.47 0.41 Allowed 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 124.001 0.92 . . . . 0.0 108.969 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.1 -28.69 69.62 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.894 0.878 . . . . 0.0 109.617 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 96.2 p -68.39 -35.52 77.8 Favored 'General case' 0 N--CA 1.521 3.12 0 C-N-CA 123.415 0.686 . . . . 0.0 109.988 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.27 -47.05 54.61 Favored Glycine 0 N--CA 1.512 3.736 0 CA-C-N 115.03 -0.986 . . . . 0.0 114.646 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.0 -41.85 68.28 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.201 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 20.2 tt -56.87 -32.45 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -31.86 43.96 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.666 0 CA-C-N 120.291 1.405 . . . . 0.0 109.038 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.94 -36.18 60.03 Favored Glycine 0 N--CA 1.51 3.617 0 C-N-CA 124.172 0.892 . . . . 0.0 114.646 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.92 -38.24 75.6 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.17 0 CA-C-N 118.508 1.154 . . . . 0.0 111.015 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 29.9 p -66.41 -45.99 78.07 Favored 'General case' 0 N--CA 1.528 3.468 0 CA-C-O 121.617 0.722 . . . . 0.0 110.334 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 58.0 t -69.48 -33.9 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.006 0 C-N-CA 124.714 1.205 . . . . 0.0 110.535 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.16 68.97 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.51 91.92 Favored 'General case' 0 N--CA 1.518 2.928 0 C-N-CA 123.3 0.64 . . . . 0.0 111.275 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 43.4 t -66.75 -48.91 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.314 0 C-N-CA 123.599 0.76 . . . . 0.0 110.556 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.51 -33.83 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.552 0 C-N-CA 123.278 0.631 . . . . 0.0 110.094 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 33.7 tp -67.21 -34.16 76.9 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.247 0.619 . . . . 0.0 110.339 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 39.4 mt -64.66 -41.1 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.893 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.56 -37.89 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 C-N-CA 122.975 0.51 . . . . 0.0 109.825 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.43 71.01 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.695 0.798 . . . . 0.0 112.278 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.38 -33.97 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 C-N-CA 122.814 0.446 . . . . 0.0 110.244 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -65.98 -44.21 85.58 Favored 'General case' 0 N--CA 1.531 3.588 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.87 -37.73 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 O-C-N 122.232 -0.292 . . . . 0.0 110.55 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 8.3 p -58.74 -27.38 64.88 Favored 'General case' 0 N--CA 1.536 3.845 0 O-C-N 122.218 -0.301 . . . . 0.0 111.248 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -59.88 -18.68 46.36 Favored 'General case' 0 N--CA 1.531 3.62 0 C-N-CA 123.279 0.632 . . . . 0.0 111.203 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 51.5 m -70.34 -30.57 67.57 Favored 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.544 0.738 . . . . 0.0 110.362 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 64.4 mt -60.49 -13.12 11.93 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.398 1.079 . . . . 0.0 111.752 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.57 10.5 13.0 Favored 'General case' 0 N--CA 1.532 3.635 0 C-N-CA 123.196 0.598 . . . . 0.0 110.067 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 59.64 116.24 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 124.601 1.161 . . . . 0.0 112.257 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -139.94 105.57 5.12 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 125.099 1.36 . . . . 0.0 107.868 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -132.33 -173.67 3.23 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 124.839 1.256 . . . . 0.0 108.463 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.26 138.11 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 C-N-CA 124.678 1.191 . . . . 0.0 108.566 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.55 146.53 32.19 Favored Pre-proline 0 N--CA 1.529 3.497 0 CA-C-O 117.247 -1.359 . . . . 0.0 108.421 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo . . . . . 1 N--CA 1.54 4.209 0 CA-C-N 122.23 1.832 . . . . 0.0 110.042 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 64.2 mtp . . . . . 0 CA--C 1.585 2.305 0 CA-C-O 117.509 -1.234 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -87.88 -169.99 0.51 Allowed 'Trans proline' 0 N--CA 1.536 3.995 0 C-N-CA 122.649 2.233 . . . . 0.0 110.819 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -169.94 153.29 21.24 Favored Glycine 1 N--CA 1.519 4.181 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.3 p -97.83 41.92 1.11 Allowed 'General case' 0 N--CA 1.526 3.354 0 C-N-CA 124.685 1.194 . . . . 0.0 109.38 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 54.2 tp -59.98 -26.41 66.02 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 124.264 1.026 . . . . 0.0 110.978 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 71.2 m -57.43 -26.15 60.73 Favored 'General case' 0 N--CA 1.526 3.327 0 C-N-CA 123.735 0.814 . . . . 0.0 111.62 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.35 92.66 Favored Glycine 0 N--CA 1.509 3.566 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.91 -46.22 94.2 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.483 0 CA-C-N 118.772 1.286 . . . . 0.0 112.967 -175.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -67.66 -32.13 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.384 0.674 . . . . 0.0 110.323 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 90.4 mt -66.06 -34.06 67.72 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.013 0 C-N-CA 123.054 0.542 . . . . 0.0 109.848 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.69 -29.81 64.79 Favored Glycine 1 N--CA 1.517 4.055 0 CA-C-O 119.831 -0.427 . . . . 0.0 113.675 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.5 m -61.77 -37.11 77.3 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.29 0 CA-C-N 117.764 0.782 . . . . 0.0 110.907 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.6 p -55.51 -43.39 75.62 Favored 'General case' 0 N--CA 1.524 3.234 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.159 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.96 -45.99 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.073 0 C-N-CA 123.824 0.85 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.46 -45.13 65.95 Favored 'General case' 0 N--CA 1.527 3.403 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.32 90.22 Favored 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 122.953 0.501 . . . . 0.0 111.769 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.2 t -66.66 -39.78 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 122.91 0.484 . . . . 0.0 110.693 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.92 -39.78 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.585 0 C-N-CA 122.863 0.465 . . . . 0.0 110.837 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.26 -37.22 84.63 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 117.897 0.317 . . . . 0.0 111.519 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 99.3 mt -64.27 -42.59 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 C-N-CA 123.308 0.643 . . . . 0.0 110.028 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.76 -41.74 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.25 -45.5 87.68 Favored 'General case' 0 N--CA 1.525 3.309 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.73 -34.31 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 O-C-N 121.723 -0.611 . . . . 0.0 110.08 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.42 -44.24 95.96 Favored 'General case' 0 N--CA 1.529 3.516 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.7 m -68.65 -37.42 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 CA-C-O 121.212 0.53 . . . . 0.0 109.683 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 70.9 m -63.39 -46.08 88.1 Favored 'General case' 0 N--CA 1.523 3.178 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.26 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.67 -19.02 35.74 Favored 'General case' 0 N--CA 1.536 3.857 0 C-N-CA 122.744 0.418 . . . . 0.0 112.007 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 52.0 m -74.59 -40.17 61.76 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 51.0 mt -68.71 -29.16 67.54 Favored 'General case' 0 N--CA 1.524 3.264 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.511 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.04 10.58 16.1 Favored 'General case' 1 N--CA 1.545 4.324 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 54.6 t90 -139.81 70.78 1.37 Allowed 'General case' 0 N--CA 1.53 3.557 0 C-N-CA 124.176 0.99 . . . . 0.0 108.875 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -133.74 -18.56 2.13 Favored 'General case' 0 N--CA 1.534 3.765 0 C-N-CA 125.108 1.363 . . . . 0.0 109.139 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -163.68 86.81 0.51 Allowed 'General case' 0 N--CA 1.525 3.283 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.56 130.51 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 60.7 tp -133.36 99.42 14.56 Favored Pre-proline 0 N--CA 1.531 3.581 0 C-N-CA 124.843 1.257 . . . . 0.0 108.478 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo . . . . . 1 N--CA 1.547 4.624 0 C-N-CA 122.331 2.021 . . . . 0.0 114.199 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 CA--C 1.577 2.005 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -47.46 -67.63 0.11 Allowed 'Trans proline' 1 N--CA 1.545 4.545 0 C-N-CA 122.694 2.263 . . . . 0.0 114.12 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 63.19 122.64 0.01 OUTLIER Glycine 1 N--CA 1.523 4.442 0 C-N-CA 123.912 0.768 . . . . 0.0 111.636 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 68.1 m -162.8 89.46 0.66 Allowed 'General case' 0 N--CA 1.524 3.228 0 CA-C-N 117.7 0.75 . . . . 0.0 109.646 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 50.2 mt -65.15 -26.64 68.26 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 124.262 1.025 . . . . 0.0 110.098 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.1 m -59.43 -37.1 77.21 Favored 'General case' 0 N--CA 1.525 3.325 0 C-N-CA 123.14 0.576 . . . . 0.0 110.662 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.33 -36.22 92.76 Favored Glycine 1 N--CA 1.522 4.422 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.07 -40.96 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 C-N-CA 124.27 1.028 . . . . 0.0 109.088 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 91.2 mt -67.71 -39.44 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 C-N-CA 124.674 1.189 . . . . 0.0 109.046 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 87.8 mt -71.15 -32.07 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.77 -29.27 41.13 Favored Glycine 0 N--CA 1.515 3.946 0 C-N-CA 123.74 0.686 . . . . 0.0 113.218 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 4.0 m -59.85 -37.36 71.4 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 117.79 0.795 . . . . 0.0 110.475 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.9 p -62.27 -45.57 92.68 Favored 'General case' 0 N--CA 1.528 3.428 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.382 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.13 -35.48 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.194 0 C-N-CA 124.149 0.98 . . . . 0.0 110.485 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.01 -34.55 68.29 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.358 0.663 . . . . 0.0 111.851 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.2 -42.08 72.82 Favored 'General case' 0 N--CA 1.516 2.864 0 C-N-CA 123.205 0.602 . . . . 0.0 111.403 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.2 t -58.99 -47.0 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 C-N-CA 123.565 0.746 . . . . 0.0 112.19 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.9 m -67.1 -32.28 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.468 0 C-N-CA 122.959 0.504 . . . . 0.0 111.635 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.82 -45.08 45.76 Favored 'General case' 0 N--CA 1.524 3.257 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.7 pt -68.86 -36.75 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.904 0 CA-C-N 118.432 0.56 . . . . 0.0 112.468 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.21 -36.96 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 O-C-N 121.532 -0.73 . . . . 0.0 110.151 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.62 -44.98 85.93 Favored 'General case' 0 N--CA 1.526 3.366 0 C-N-CA 123.56 0.744 . . . . 0.0 112.977 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 13.7 m -71.19 -34.19 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 O-C-N 121.737 -0.602 . . . . 0.0 110.543 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -63.07 -44.49 95.65 Favored 'General case' 0 N--CA 1.531 3.612 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.06 -37.54 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.615 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.94 -29.22 66.96 Favored 'General case' 0 N--CA 1.527 3.411 0 C-N-CA 122.714 0.406 . . . . 0.0 111.424 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -64.19 -15.93 60.91 Favored 'General case' 1 N--CA 1.539 4.009 0 CA-C-N 118.048 0.386 . . . . 0.0 111.075 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 41.5 m -64.64 -34.34 78.06 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 51.1 tp -70.08 -28.19 65.22 Favored 'General case' 0 N--CA 1.526 3.335 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.139 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.95 11.05 14.43 Favored 'General case' 0 N--CA 1.538 3.934 0 C-N-CA 123.884 0.874 . . . . 0.0 109.582 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -155.79 107.47 2.56 Favored 'General case' 0 N--CA 1.526 3.333 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -166.07 10.3 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 123.702 0.801 . . . . 0.0 110.266 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.97 141.29 57.65 Favored 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 124.07 0.948 . . . . 0.0 110.099 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 52.2 t -122.19 137.13 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 C-N-CA 125.036 1.335 . . . . 0.0 107.404 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 7.9 mp -94.2 146.77 32.18 Favored Pre-proline 0 N--CA 1.53 3.543 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 1 N--CA 1.54 4.223 0 C-N-CA 122.139 1.892 . . . . 0.0 110.545 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.573 1.85 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -76.97 48.89 2.62 Favored 'Trans proline' 1 N--CA 1.538 4.13 0 C-N-CA 122.138 1.892 . . . . 0.0 110.056 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.95 81.1 0.21 Allowed Glycine 1 N--CA 1.518 4.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.392 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 69.1 m -64.37 151.56 43.69 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 123.8 0.84 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -64.58 -26.82 68.57 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 124.078 0.951 . . . . 0.0 109.77 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 42.7 t -61.29 -38.66 87.59 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.931 0.892 . . . . 0.0 110.951 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.33 -41.96 76.48 Favored Glycine 0 N--CA 1.513 3.806 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.428 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 61.7 mt -70.62 -45.81 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 C-N-CA 124.498 1.119 . . . . 0.0 113.255 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -56.63 -31.96 36.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.161 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.5 pp -66.98 -31.9 55.57 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.196 0 CA-C-N 119.336 0.971 . . . . 0.0 109.497 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.84 -36.15 59.5 Favored Glycine 0 N--CA 1.51 3.615 0 CA-C-N 115.614 -0.721 . . . . 0.0 114.788 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.46 -45.45 92.83 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 CA-C-N 118.279 1.04 . . . . 0.0 113.104 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 1.3 t -65.03 -45.25 86.25 Favored 'General case' 0 N--CA 1.538 3.945 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.7 -31.14 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.295 0 C-N-CA 122.987 0.515 . . . . 0.0 111.262 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.64 93.43 Favored 'General case' 0 N--CA 1.528 3.471 0 O-C-N 121.803 -0.56 . . . . 0.0 111.987 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.95 -48.03 81.14 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.81 -38.4 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.744 0 CA-C-N 118.196 0.453 . . . . 0.0 111.103 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.26 -40.94 86.01 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.009 0 CA-C-N 118.403 0.547 . . . . 0.0 110.356 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -34.34 77.69 Favored 'General case' 1 N--CA 1.54 4.055 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 tp -54.8 -36.94 38.89 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.401 0 C-N-CA 123.401 0.681 . . . . 0.0 110.483 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.65 -40.96 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 C-N-CA 123.416 0.687 . . . . 0.0 110.545 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.83 -35.61 71.13 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.42 0.688 . . . . 0.0 111.576 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -71.77 -36.61 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.298 0 C-N-CA 123.492 0.717 . . . . 0.0 111.728 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.93 -43.86 64.57 Favored 'General case' 0 N--CA 1.531 3.613 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.42 -37.57 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.087 0.555 . . . . 0.0 110.983 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 15.0 p -62.21 -27.63 69.12 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 122.353 0.261 . . . . 0.0 111.394 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.72 -40.38 84.25 Favored 'General case' 0 N--CA 1.53 3.528 0 CA-C-O 121.007 0.432 . . . . 0.0 110.436 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.7 t -64.03 -22.45 66.94 Favored 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 123.791 0.836 . . . . 0.0 112.467 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.4 tp -67.41 -17.44 64.72 Favored 'General case' 0 N--CA 1.529 3.508 0 C-N-CA 123.345 0.658 . . . . 0.0 110.819 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.35 -28.49 22.18 Favored 'General case' 0 N--CA 1.531 3.584 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -95.72 96.13 8.79 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 124.447 1.099 . . . . 0.0 108.993 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -169.82 9.77 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.382 0 C-N-CA 123.606 0.763 . . . . 0.0 110.511 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.18 137.57 54.95 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.382 0.673 . . . . 0.0 110.093 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.9 p -118.89 138.27 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.565 0 C-N-CA 125.176 1.39 . . . . 0.0 108.96 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 48.6 tp -95.13 104.92 16.63 Favored Pre-proline 0 N--CA 1.528 3.447 0 CA-C-O 117.3 -1.334 . . . . 0.0 107.808 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo . . . . . 1 N--CA 1.537 4.052 0 CA-C-N 122.713 2.005 . . . . 0.0 111.089 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 68.2 mtp . . . . . 0 CA--C 1.574 1.883 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.5 -28.25 8.53 Favored 'Trans proline' 0 N--CA 1.535 3.959 0 C-N-CA 122.293 1.995 . . . . 0.0 110.593 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.7 90.84 0.04 OUTLIER Glycine 1 N--CA 1.519 4.208 0 C-N-CA 123.657 0.646 . . . . 0.0 111.496 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 98.9 p -163.36 7.62 0.05 OUTLIER 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 123.783 0.833 . . . . 0.0 110.422 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.18 -26.83 68.32 Favored 'General case' 0 N--CA 1.528 3.475 0 C-N-CA 123.962 0.905 . . . . 0.0 109.099 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 69.4 m -57.73 -26.15 61.39 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 124.105 0.962 . . . . 0.0 110.907 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.41 -35.28 84.51 Favored Glycine 1 N--CA 1.517 4.072 0 C-N-CA 123.657 0.646 . . . . 0.0 113.102 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -46.98 94.94 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 CA-C-N 117.084 0.442 . . . . 0.0 111.89 -177.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.8 -31.76 55.15 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.556 0 C-N-CA 124.038 0.935 . . . . 0.0 109.811 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.29 -33.55 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.29 -33.02 85.6 Favored Glycine 1 N--CA 1.52 4.289 0 C-N-CA 123.69 0.662 . . . . 0.0 112.159 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.23 -43.52 93.5 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.052 0 C-N-CA 124.194 0.997 . . . . 0.0 109.657 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 27.3 p -56.85 -45.31 82.52 Favored 'General case' 0 N--CA 1.525 3.313 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.373 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 49.9 t -67.75 -41.27 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.211 0 C-N-CA 124.251 1.021 . . . . 0.0 111.312 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.3 -44.74 65.2 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.58 81.13 Favored 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 123.254 0.621 . . . . 0.0 111.616 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 t -53.72 -39.49 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.927 0 C-N-CA 123.25 0.62 . . . . 0.0 111.857 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.45 -38.48 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 C-N-CA 122.768 0.427 . . . . 0.0 110.121 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 73.2 mt -70.94 -34.57 71.62 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 122.958 0.503 . . . . 0.0 110.223 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 20.0 mm -60.41 -50.52 80.01 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 C-N-CA 123.532 0.733 . . . . 0.0 110.951 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 31.6 m -66.62 -36.99 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 O-C-N 121.816 -0.553 . . . . 0.0 110.239 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.38 85.92 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.636 0.775 . . . . 0.0 112.594 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 34.4 m -71.98 -34.53 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.696 0 O-C-N 121.823 -0.548 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.58 -43.85 95.77 Favored 'General case' 0 N--CA 1.53 3.525 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.37 -37.22 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 74.3 m -58.76 -27.07 64.61 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.076 0.551 . . . . 0.0 111.845 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.54 -33.21 73.44 Favored 'General case' 0 N--CA 1.537 3.887 0 CA-C-N 118.343 0.519 . . . . 0.0 110.79 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 35.5 t -67.07 -27.86 67.72 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.155 0.582 . . . . 0.0 110.217 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 51.4 tp -89.77 -13.9 35.72 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 124.947 1.299 . . . . 0.0 110.378 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 39.7 tp -85.67 -1.69 57.42 Favored 'General case' 1 N--CA 1.545 4.287 0 CA-C-O 121.046 0.45 . . . . 0.0 109.999 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -139.8 -159.56 0.97 Allowed 'General case' 0 N--CA 1.522 3.125 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 64.27 161.83 0.12 Allowed 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 123.762 0.825 . . . . 0.0 110.283 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? 59.02 17.59 5.58 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 124.218 1.007 . . . . 0.0 110.915 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 16.3 m -117.27 138.29 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 C-N-CA 124.93 1.292 . . . . 0.0 108.152 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 75.5 mt -121.92 146.44 46.15 Favored Pre-proline 0 N--CA 1.53 3.566 0 CA-C-O 116.493 -1.718 . . . . 0.0 107.445 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo . . . . . 1 N--CA 1.548 4.733 0 CA-C-N 123.074 2.134 . . . . 0.0 114.526 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.574 1.867 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -48.02 103.23 0.05 OUTLIER 'Trans proline' 1 N--CA 1.543 4.428 0 C-N-CA 122.707 2.271 . . . . 0.0 114.142 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 63.16 167.82 0.9 Allowed Glycine 1 N--CA 1.519 4.209 0 C-N-CA 123.748 0.69 . . . . 0.0 112.331 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 41.2 t -172.5 -54.4 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.978 0 C-N-CA 124.26 1.024 . . . . 0.0 108.577 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 58.3 tp -64.24 -27.04 68.78 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 124.152 0.981 . . . . 0.0 110.216 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 53.8 m -62.02 -25.91 67.93 Favored 'General case' 0 N--CA 1.518 2.955 0 C-N-CA 124.413 1.085 . . . . 0.0 110.681 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.85 -46.72 71.74 Favored Glycine 0 N--CA 1.51 3.62 0 CA-C-N 115.22 -0.9 . . . . 0.0 114.684 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 29.6 pt -71.04 -38.81 73.36 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 CA-C-N 118.826 1.313 . . . . 0.0 113.961 -177.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.7 tp -62.88 -32.52 56.22 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 C-N-CA 123.239 0.616 . . . . 0.0 112.497 -176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.8 -34.03 45.64 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.18 -45.15 83.48 Favored Glycine 0 N--CA 1.515 3.921 0 C-N-CA 124.8 1.191 . . . . 0.0 115.155 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.34 -37.41 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 CA-C-N 117.381 0.591 . . . . 0.0 110.779 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 35.6 p -66.35 -47.27 73.96 Favored 'General case' 0 N--CA 1.532 3.644 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.63 -31.88 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 C-N-CA 123.301 0.64 . . . . 0.0 112.269 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.77 -47.26 70.89 Favored 'General case' 0 N--CA 1.532 3.633 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.59 97.47 Favored 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 123.475 0.71 . . . . 0.0 111.679 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.47 -49.03 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.651 0.78 . . . . 0.0 111.989 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.84 -32.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 C-N-CA 123.321 0.648 . . . . 0.0 110.539 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.33 -39.93 94.88 Favored 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 123.124 0.57 . . . . 0.0 110.143 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.34 -37.7 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 C-N-CA 122.927 0.491 . . . . 0.0 110.426 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.15 -37.85 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 C-N-CA 123.09 0.556 . . . . 0.0 110.28 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.41 -32.27 68.49 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.339 0.655 . . . . 0.0 111.611 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.57 -43.75 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.458 0 C-N-CA 123.299 0.64 . . . . 0.0 111.659 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -62.19 -43.49 98.72 Favored 'General case' 1 N--CA 1.54 4.055 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.14 -38.38 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 95.4 m -67.68 -40.1 84.42 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 122.831 0.452 . . . . 0.0 110.449 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -72.72 -31.16 64.77 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 123.473 0.709 . . . . 0.0 110.454 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 46.2 t -64.44 -34.28 77.82 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.451 0.7 . . . . 0.0 110.765 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.75 -34.54 67.09 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 124.358 1.063 . . . . 0.0 109.747 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 4.6 tt -87.24 -9.0 56.2 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 124.389 1.075 . . . . 0.0 111.633 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -52.27 -38.26 57.77 Favored 'General case' 0 N--CA 1.528 3.47 0 C-N-CA 123.789 0.835 . . . . 0.0 112.129 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -64.92 134.35 53.78 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 123.377 0.671 . . . . 0.0 110.545 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt 61.61 145.14 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 124.637 1.175 . . . . 0.0 111.196 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 47.8 t -135.12 129.27 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 C-N-CA 124.691 1.196 . . . . 0.0 107.834 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.64 146.66 31.85 Favored Pre-proline 0 N--CA 1.529 3.51 0 CA-C-O 116.558 -1.686 . . . . 0.0 107.039 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo . . . . . 1 N--CA 1.55 4.844 0 C-N-CA 122.928 2.419 . . . . 0.0 115.112 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 52.3 tpp . . . . . 0 CA--C 1.573 1.844 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -81.12 133.78 8.97 Favored 'Trans proline' 0 N--CA 1.533 3.805 0 C-N-CA 122.52 2.147 . . . . 0.0 109.945 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.53 -15.51 66.25 Favored Glycine 1 N--CA 1.519 4.189 0 C-N-CA 123.596 0.617 . . . . 0.0 112.206 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 50.7 m 58.77 90.04 0.05 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 124.301 1.04 . . . . 0.0 111.24 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 44.7 mt -54.78 -25.79 30.31 Favored 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 124.885 1.274 . . . . 0.0 111.437 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 54.1 m -57.69 -36.42 71.94 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.583 0.753 . . . . 0.0 111.31 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.72 -39.52 86.03 Favored Glycine 1 N--CA 1.52 4.259 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.533 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.54 -46.27 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.895 0 C-N-CA 124.181 0.992 . . . . 0.0 110.993 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -32.17 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.983 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 85.1 mt -73.3 -40.36 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.93 95.51 Favored Glycine 0 N--CA 1.512 3.748 0 CA-C-N 115.227 -0.897 . . . . 0.0 114.8 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.5 -37.08 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 CA-C-N 117.923 0.862 . . . . 0.0 111.448 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 68.5 p -65.93 -46.5 77.99 Favored 'General case' 0 N--CA 1.533 3.695 0 CA-C-O 120.931 0.396 . . . . 0.0 110.715 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.76 -35.45 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.22 0 C-N-CA 124.051 0.94 . . . . 0.0 110.508 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.12 67.41 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.5 -34.53 69.18 Favored 'General case' 0 N--CA 1.521 3.077 0 C-N-CA 123.142 0.577 . . . . 0.0 112.017 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.42 -39.06 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.316 0 C-N-CA 123.048 0.539 . . . . 0.0 110.653 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.72 -41.32 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 123.427 0.691 . . . . 0.0 111.485 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.22 -35.69 77.9 Favored 'General case' 1 N--CA 1.54 4.026 0 C-N-CA 122.594 0.358 . . . . 0.0 110.743 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 68.7 mt -69.26 -40.9 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 98.4 t -66.74 -37.97 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.465 0 C-N-CA 123.335 0.654 . . . . 0.0 109.442 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.08 -47.66 82.53 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.727 0.811 . . . . 0.0 112.696 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 25.6 m -71.9 -34.51 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 O-C-N 121.993 -0.442 . . . . 0.0 110.195 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -63.86 -44.13 94.02 Favored 'General case' 0 N--CA 1.527 3.382 0 C-N-CA 123.053 0.541 . . . . 0.0 112.334 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.45 -37.7 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 86.4 m -62.77 -27.95 69.64 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 122.92 0.488 . . . . 0.0 110.129 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -69.57 -16.86 63.49 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.173 0.589 . . . . 0.0 110.62 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 19.5 m -68.8 -28.69 66.99 Favored 'General case' 0 N--CA 1.53 3.565 0 C-N-CA 123.062 0.545 . . . . 0.0 110.232 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.22 -23.51 66.44 Favored 'General case' 0 N--CA 1.525 3.289 0 C-N-CA 123.727 0.811 . . . . 0.0 110.715 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 8.2 mp -87.47 -26.16 23.37 Favored 'General case' 0 N--CA 1.534 3.732 0 C-N-CA 123.685 0.794 . . . . 0.0 109.215 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -73.64 92.52 1.97 Allowed 'General case' 0 N--CA 1.526 3.359 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -168.57 148.33 4.47 Favored 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -163.96 -19.66 0.03 OUTLIER 'General case' 0 N--CA 1.532 3.662 0 C-N-CA 123.618 0.767 . . . . 0.0 109.738 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.46 138.2 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.518 0 C-N-CA 125.411 1.485 . . . . 0.0 108.966 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -110.89 146.52 34.62 Favored Pre-proline 0 N--CA 1.536 3.837 0 C-N-CA 125.39 1.476 . . . . 0.0 109.49 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 1 N--CA 1.541 4.303 0 CA-C-N 122.227 1.831 . . . . 0.0 110.392 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.073 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 27.4 t 57.26 55.1 6.13 Favored 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.021 0.928 . . . . 0.0 111.942 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.84 -26.87 68.52 Favored 'General case' 0 N--CA 1.525 3.283 0 C-N-CA 123.989 0.915 . . . . 0.0 110.547 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.4 m -61.71 -26.44 68.04 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 123.498 0.719 . . . . 0.0 110.237 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.9 -35.43 63.55 Favored Glycine 0 N--CA 1.502 3.035 0 C-N-CA 125.108 1.337 . . . . 0.0 115.354 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 16.9 pt -58.0 -33.73 47.03 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.34 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 216' ' ' ILE . 1.3 pp -55.71 -36.41 42.69 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.002 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -174.303 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 215' ' ' ILE . 5.2 tp -73.49 -38.43 52.69 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.696 0 CA-C-N 119.472 1.033 . . . . 0.0 109.039 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.31 -45.36 88.76 Favored Glycine 1 N--CA 1.522 4.389 0 N-CA-C 114.891 0.716 . . . . 0.0 114.891 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.93 -36.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.971 0 CA-C-N 117.503 0.651 . . . . 0.0 110.724 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.7 p -58.92 -40.61 85.08 Favored 'General case' 0 N--CA 1.535 3.785 0 CA-C-O 121.082 0.467 . . . . 0.0 111.799 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.74 -39.31 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 123.753 0.821 . . . . 0.0 111.877 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.08 79.6 Favored 'General case' 0 N--CA 1.529 3.477 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.38 -50.02 56.0 Favored 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 m -63.75 -38.58 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.87 -32.86 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 CA-C-N 118.848 0.749 . . . . 0.0 110.723 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 5.9 tt -65.08 -37.88 88.95 Favored 'General case' 0 N--CA 1.536 3.829 0 CA-C-N 117.878 0.308 . . . . 0.0 110.708 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.8 mt -61.98 -36.67 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.84 0 C-N-CA 123.079 0.552 . . . . 0.0 110.351 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.21 -40.35 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.68 0 C-N-CA 122.968 0.507 . . . . 0.0 110.07 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.8 -32.59 67.71 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.191 0.596 . . . . 0.0 111.528 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.9 t -68.19 -37.96 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 C-N-CA 123.141 0.577 . . . . 0.0 109.87 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -70.1 -34.78 73.57 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.403 0.681 . . . . 0.0 110.086 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.02 -38.13 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 C-N-CA 123.968 0.907 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 79.8 m -60.07 -38.53 83.13 Favored 'General case' 0 N--CA 1.527 3.379 0 CA-C-O 121.195 0.522 . . . . 0.0 109.748 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -74.39 -37.8 63.32 Favored 'General case' 0 N--CA 1.519 2.998 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.208 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.0 p -63.76 -46.31 85.84 Favored 'General case' 0 N--CA 1.531 3.615 0 CA-C-O 121.434 0.635 . . . . 0.0 109.595 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.49 -19.35 62.94 Favored 'General case' 0 N--CA 1.53 3.561 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.563 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.7 tp -87.09 -28.21 22.66 Favored 'General case' 1 N--CA 1.541 4.115 0 CA-C-N 119.17 0.895 . . . . 0.0 109.11 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.8 m0 -78.68 107.74 11.59 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -168.0 88.99 0.27 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 11.6 tptp 71.92 -164.21 0.13 Allowed 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 124.052 0.941 . . . . 0.0 109.135 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.531 3.61 0 C-N-CA 124.935 1.294 . . . . 0.0 107.69 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.523 3.213 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.09 -36.44 84.32 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 124.299 1.04 . . . . 0.0 109.741 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.6 t -57.38 -25.64 59.81 Favored 'General case' 0 N--CA 1.525 3.316 0 C-N-CA 123.612 0.765 . . . . 0.0 110.907 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.44 -34.48 59.79 Favored Glycine 0 N--CA 1.512 3.752 0 C-N-CA 124.948 1.261 . . . . 0.0 114.544 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 17.3 pt -59.39 -34.8 55.43 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -176.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.21 -47.37 80.96 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.333 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.6 tt -72.48 -32.95 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.55 -29.32 47.68 Favored Glycine 0 N--CA 1.515 3.906 0 C-N-CA 123.444 0.545 . . . . 0.0 113.181 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 m -60.0 -37.38 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 CA-C-N 117.551 0.676 . . . . 0.0 111.8 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 1.3 t -61.05 -39.06 88.41 Favored 'General case' 1 N--CA 1.54 4.063 0 CA-C-O 120.825 0.345 . . . . 0.0 111.539 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 47.4 t -60.99 -31.5 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 123.76 0.824 . . . . 0.0 110.517 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.19 77.83 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 123.06 0.544 . . . . 0.0 111.316 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.69 -50.2 58.84 Favored 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.22 -38.56 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.726 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 27.0 m -65.36 -32.01 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 CA-C-N 118.584 0.629 . . . . 0.0 111.394 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 54.1 mt -66.73 -34.57 78.13 Favored 'General case' 0 N--CA 1.533 3.701 0 O-C-N 122.026 -0.421 . . . . 0.0 111.091 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 59.7 mt -61.35 -49.65 83.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.049 0 CA-C-N 118.066 0.394 . . . . 0.0 111.595 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.65 -37.01 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.71 0 O-C-N 121.902 -0.499 . . . . 0.0 110.099 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.55 -47.15 86.66 Favored 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 123.667 0.787 . . . . 0.0 112.603 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.69 -34.38 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.615 0 O-C-N 121.842 -0.536 . . . . 0.0 110.527 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -63.34 -44.36 95.11 Favored 'General case' 0 N--CA 1.528 3.441 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.92 -37.76 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.3 m -67.02 -32.85 74.34 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 122.988 0.515 . . . . 0.0 110.478 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -66.96 -32.26 73.38 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 123.498 0.719 . . . . 0.0 111.054 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 50.6 m -63.82 -29.34 70.55 Favored 'General case' 0 N--CA 1.528 3.454 0 C-N-CA 123.299 0.639 . . . . 0.0 111.244 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.27 -27.35 68.98 Favored 'General case' 0 N--CA 1.528 3.448 0 C-N-CA 123.45 0.7 . . . . 0.0 110.952 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 N--CA 1.538 3.944 0 C-N-CA 123.79 0.836 . . . . 0.0 109.893 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.52 3.074 0 CA-C-O 121.54 0.686 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 pp -62.9 -26.43 68.79 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 123.882 0.873 . . . . 0.0 111.053 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 34.8 t -62.34 -25.88 68.14 Favored 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 123.476 0.71 . . . . 0.0 110.999 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.48 -38.09 86.27 Favored Glycine 0 N--CA 1.514 3.851 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.91 -35.35 59.38 Favored 'Isoleucine or valine' 1 N--CA 1.555 4.803 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.01 -32.67 33.95 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.41 -31.78 55.34 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.194 0 CA-C-N 119.134 0.879 . . . . 0.0 108.781 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.77 -42.65 79.24 Favored Glycine 0 N--CA 1.516 3.987 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.746 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.48 -37.16 77.38 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 CA-C-N 117.989 0.895 . . . . 0.0 110.384 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 26.4 m -62.51 -47.6 83.25 Favored 'General case' 0 N--CA 1.519 3.002 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.502 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 9.4 p -71.21 -31.47 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.359 0 C-N-CA 123.649 0.78 . . . . 0.0 111.171 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.83 60.63 Favored 'General case' 0 N--CA 1.529 3.505 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.99 -50.34 64.63 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.11 -41.5 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.54 -32.65 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.617 0 O-C-N 121.826 -0.546 . . . . 0.0 112.166 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -75.52 -39.95 57.72 Favored 'General case' 0 N--CA 1.528 3.429 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 19.3 pt -69.49 -38.84 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 CA-C-N 118.562 0.619 . . . . 0.0 111.762 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.67 -37.29 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 O-C-N 121.592 -0.692 . . . . 0.0 109.967 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.99 83.8 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 123.737 0.815 . . . . 0.0 113.045 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.53 -34.26 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 O-C-N 121.811 -0.556 . . . . 0.0 110.223 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -64.08 -44.26 92.92 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.96 -37.59 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 87.8 m -64.66 -27.83 69.19 Favored 'General case' 0 N--CA 1.525 3.325 0 C-N-CA 123.038 0.535 . . . . 0.0 110.878 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -70.93 -35.75 72.36 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 122.901 0.48 . . . . 0.0 110.295 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.4 t -63.92 -23.24 67.27 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.499 0.72 . . . . 0.0 112.18 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.69 -21.57 65.32 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 123.336 0.655 . . . . 0.0 110.749 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.68 0.74 55.27 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 123.66 0.784 . . . . 0.0 109.925 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.26 -76.49 0.07 Allowed 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.503 0.721 . . . . 0.0 110.13 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 55.8 -135.61 1.29 Allowed 'General case' 0 N--CA 1.522 3.162 0 C-N-CA 123.891 0.877 . . . . 0.0 111.0 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 57.21 78.56 0.22 Allowed 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 124.199 1.0 . . . . 0.0 111.753 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.527 3.402 0 C-N-CA 124.968 1.307 . . . . 0.0 107.918 179.28 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.522 3.153 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.04 -28.69 69.66 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 123.812 0.845 . . . . 0.0 109.579 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 39.9 t -68.7 -32.35 72.09 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 123.498 0.719 . . . . 0.0 110.493 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.57 -40.27 86.21 Favored Glycine 0 N--CA 1.515 3.944 0 CA-C-N 114.947 -1.024 . . . . 0.0 115.103 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.05 -46.07 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.677 1.238 . . . . 0.0 112.018 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -32.79 50.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.063 0 C-N-CA 124.353 1.061 . . . . 0.0 113.198 -177.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 37.6 pt -71.84 -33.18 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 119.247 0.931 . . . . 0.0 108.527 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.45 -29.88 76.33 Favored Glycine 1 N--CA 1.521 4.316 0 C-N-CA 123.539 0.59 . . . . 0.0 111.878 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.67 -37.95 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.72 0 C-N-CA 124.102 0.961 . . . . 0.0 109.947 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 30.3 p -62.14 -45.08 95.03 Favored 'General case' 0 N--CA 1.531 3.592 0 CA-C-O 121.598 0.713 . . . . 0.0 110.414 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.06 -34.87 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.051 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.102 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.21 -36.54 84.49 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 123.117 0.567 . . . . 0.0 112.46 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.09 -49.97 45.58 Favored 'General case' 0 N--CA 1.512 2.654 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 33.2 m -63.16 -38.8 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.06 -35.96 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.847 0 CA-C-N 118.633 0.651 . . . . 0.0 111.094 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.29 -34.89 78.67 Favored 'General case' 0 N--CA 1.537 3.921 0 C-N-CA 122.543 0.337 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 78.7 mt -64.0 -36.32 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.767 0 C-N-CA 123.113 0.565 . . . . 0.0 110.051 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.29 -38.07 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 122.959 0.504 . . . . 0.0 110.064 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.08 95.09 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.83 -34.31 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 O-C-N 121.762 -0.586 . . . . 0.0 109.61 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -62.29 -43.57 98.52 Favored 'General case' 0 N--CA 1.529 3.483 0 C-N-CA 123.3 0.64 . . . . 0.0 112.531 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.08 -37.3 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 81.7 m -59.36 -32.21 69.9 Favored 'General case' 0 N--CA 1.529 3.517 0 C-N-CA 122.819 0.448 . . . . 0.0 110.897 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.99 -41.4 61.97 Favored 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 66.8 m -63.92 -31.43 72.61 Favored 'General case' 0 N--CA 1.526 3.347 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -36.19 68.12 Favored 'General case' 0 N--CA 1.524 3.275 0 C-N-CA 124.246 1.018 . . . . 0.0 108.495 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 53.8 tp -87.22 -16.72 34.44 Favored 'General case' 0 N--CA 1.538 3.957 0 C-N-CA 123.286 0.634 . . . . 0.0 110.816 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -61.59 -7.15 2.99 Favored 'General case' 0 N--CA 1.532 3.651 0 C-N-CA 123.447 0.699 . . . . 0.0 111.853 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.43 -31.99 72.77 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.602 0.761 . . . . 0.0 110.629 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 64.1 tttt . . . . . 0 N--CA 1.531 3.593 0 C-N-CA 123.515 0.726 . . . . 0.0 109.977 179.397 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.523 3.188 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 55.9 tp -65.12 -26.93 68.41 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 123.92 0.888 . . . . 0.0 110.177 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.3 p -68.57 -30.76 69.6 Favored 'General case' 0 N--CA 1.52 3.059 0 C-N-CA 123.642 0.777 . . . . 0.0 110.071 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.63 -46.49 61.58 Favored Glycine 0 N--CA 1.515 3.948 0 C-N-CA 124.147 0.879 . . . . 0.0 114.826 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.5 tt -70.73 -41.09 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 122.015 -0.697 . . . . 0.0 112.868 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.0 tt -64.49 -42.21 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 C-N-CA 122.729 0.412 . . . . 0.0 111.577 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 216' ' ' ILE . . . . . 0.498 ' O ' HD13 ' E' ' 216' ' ' ILE . 0.1 OUTLIER -73.86 -34.39 39.9 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.009 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.553 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.15 -45.29 95.55 Favored Glycine 0 N--CA 1.513 3.801 0 CA-C-N 114.762 -1.108 . . . . 0.0 114.754 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.72 -36.81 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 CA-C-N 117.95 0.875 . . . . 0.0 110.943 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -63.16 -47.8 81.14 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-N 118.339 0.518 . . . . 0.0 112.32 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.43 -35.33 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 123.785 0.834 . . . . 0.0 112.118 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.83 -47.37 70.99 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.2 77.84 Favored 'General case' 0 N--CA 1.517 2.896 0 C-N-CA 123.416 0.686 . . . . 0.0 111.754 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 t -66.68 -49.42 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 C-N-CA 123.224 0.61 . . . . 0.0 110.861 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.26 -32.79 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.498 0 C-N-CA 123.442 0.697 . . . . 0.0 110.917 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.3 tt -64.8 -39.51 93.72 Favored 'General case' 0 N--CA 1.535 3.812 0 C-N-CA 122.991 0.516 . . . . 0.0 110.425 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 88.7 mt -65.35 -36.67 78.26 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 O-C-N 121.508 -0.745 . . . . 0.0 110.283 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.8 -37.44 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 C-N-CA 123.332 0.653 . . . . 0.0 109.807 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.73 -32.09 67.08 Favored 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.398 0.679 . . . . 0.0 111.649 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 46.7 t -68.97 -44.54 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.215 0.606 . . . . 0.0 111.575 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -61.3 -43.12 99.4 Favored 'General case' 1 N--CA 1.54 4.042 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.81 -37.46 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 CA-C-N 118.312 0.505 . . . . 0.0 109.701 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 92.9 m -59.1 -30.48 68.13 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 122.282 -0.261 . . . . 0.0 110.899 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -74.09 -15.47 61.05 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 123.006 0.522 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 67.9 p -63.44 -30.56 71.67 Favored 'General case' 0 N--CA 1.533 3.696 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 57.5 tp . . . . . 0 N--CA 1.517 2.909 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.031 178.429 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.519 3.006 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 55.8 tp -53.64 -26.76 23.67 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 124.655 1.182 . . . . 0.0 111.44 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 52.9 m -60.88 -40.11 91.79 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.857 0.863 . . . . 0.0 111.462 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.97 -35.6 79.35 Favored Glycine 1 N--CA 1.52 4.239 0 C-N-CA 124.0 0.809 . . . . 0.0 112.823 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 38.6 mm -64.57 -42.7 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 17.2 tt -56.62 -44.38 80.91 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.385 0 CA-C-N 119.466 1.03 . . . . 0.0 112.28 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 16.6 tt -73.73 -33.93 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.73 -42.99 99.6 Favored Glycine 0 N--CA 1.512 3.743 0 CA-C-N 114.884 -1.053 . . . . 0.0 114.609 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.91 -37.13 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 CA-C-N 117.729 0.764 . . . . 0.0 111.038 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 59.3 p -66.01 -46.71 76.98 Favored 'General case' 0 N--CA 1.532 3.641 0 CA-C-N 118.379 0.536 . . . . 0.0 112.064 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 11.4 p -69.94 -31.64 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.51 0 C-N-CA 122.778 0.431 . . . . 0.0 111.099 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.16 -41.13 71.46 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.174 0.59 . . . . 0.0 112.396 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.99 93.1 Favored 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 123.238 0.615 . . . . 0.0 111.074 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.82 -50.0 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.323 0 C-N-CA 123.412 0.685 . . . . 0.0 110.384 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.4 -32.54 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 123.626 0.77 . . . . 0.0 110.35 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.5 -34.99 79.0 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 122.891 0.476 . . . . 0.0 110.78 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.53 -37.36 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.47 -37.86 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 C-N-CA 123.233 0.613 . . . . 0.0 109.637 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.85 78.61 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.631 0.772 . . . . 0.0 112.671 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.79 -34.42 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.616 0 O-C-N 121.901 -0.5 . . . . 0.0 110.336 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -65.67 -43.66 88.62 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.107 0.563 . . . . 0.0 112.446 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.4 -37.55 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 79.5 m -61.21 -27.99 68.83 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 122.962 0.505 . . . . 0.0 111.158 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -72.49 -28.71 63.06 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.378 0.671 . . . . 0.0 110.708 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 28.1 t -65.5 -27.81 68.74 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.138 0.575 . . . . 0.0 111.823 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.83 -14.07 60.73 Favored 'General case' 0 N--CA 1.531 3.609 0 C-N-CA 123.916 0.886 . . . . 0.0 111.009 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 20.3 mt -86.87 1.9 50.96 Favored 'General case' 0 N--CA 1.535 3.81 0 C-N-CA 122.775 0.43 . . . . 0.0 110.606 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -76.82 -50.13 14.17 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.552 0.741 . . . . 0.0 109.274 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 50.1 pttt . . . . . 0 N--CA 1.527 3.425 0 C-N-CA 123.76 0.824 . . . . 0.0 111.959 -178.645 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.083 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 49.9 m 57.02 48.92 14.75 Favored 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 124.239 1.016 . . . . 0.0 112.503 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.14 -30.7 71.65 Favored 'General case' 0 N--CA 1.534 3.758 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 97.1 p -68.6 -26.71 65.51 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 123.701 0.8 . . . . 0.0 109.789 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.99 -45.04 64.29 Favored Glycine 1 N--CA 1.517 4.075 0 C-N-CA 124.26 0.933 . . . . 0.0 114.979 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 44.2 pt -70.61 -35.86 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.427 HD13 ' O ' ' A' ' 215' ' ' ILE . 0.1 OUTLIER -66.9 -41.38 87.53 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.319 0 CA-C-N 118.524 0.602 . . . . 0.0 110.834 -177.416 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.523 ' O ' HD13 ' A' ' 216' ' ' ILE . 0.0 OUTLIER -72.22 -33.59 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.93 -42.6 96.8 Favored Glycine 1 N--CA 1.518 4.104 0 N-CA-C 114.79 0.676 . . . . 0.0 114.79 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.0 -41.67 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.633 1.216 . . . . 0.0 111.817 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.1 t -66.72 -40.85 88.57 Favored 'General case' 0 N--CA 1.536 3.848 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.16 -30.92 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.725 0 CA-C-N 118.508 0.595 . . . . 0.0 110.279 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.26 -34.7 78.97 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 122.983 0.513 . . . . 0.0 111.696 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.57 -50.41 51.99 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.1 -38.88 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.57 -32.26 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 CA-C-N 118.112 0.414 . . . . 0.0 110.567 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 tt -74.54 -46.45 38.95 Favored 'General case' 0 N--CA 1.531 3.581 0 C-N-CA 123.102 0.561 . . . . 0.0 110.161 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.5 -44.49 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 O-C-N 121.826 -0.546 . . . . 0.0 111.996 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.3 -36.87 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 CA-C-N 118.665 0.666 . . . . 0.0 110.195 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.78 75.58 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.17 0.588 . . . . 0.0 111.847 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.85 -41.41 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 C-N-CA 122.617 0.367 . . . . 0.0 110.283 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.13 -43.86 98.23 Favored 'General case' 0 N--CA 1.529 3.478 0 C-N-CA 123.503 0.721 . . . . 0.0 112.782 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.62 -37.71 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 99.4 m -63.6 -28.09 69.69 Favored 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 122.855 0.462 . . . . 0.0 111.247 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.86 -28.27 67.4 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 123.227 0.611 . . . . 0.0 110.945 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.7 t -64.05 -36.33 83.63 Favored 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 123.337 0.655 . . . . 0.0 111.874 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.97 -14.4 22.47 Favored 'General case' 0 N--CA 1.533 3.699 0 C-N-CA 123.936 0.894 . . . . 0.0 111.104 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 23.5 mt -87.31 -28.32 22.34 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.271 0.629 . . . . 0.0 109.927 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -78.39 -141.42 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 60.6 15.24 5.54 Favored 'General case' 0 N--CA 1.52 3.028 0 C-N-CA 124.32 1.048 . . . . 0.0 112.102 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -160.12 118.86 2.71 Favored 'General case' 0 N--CA 1.53 3.544 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 N--CA 1.531 3.588 0 C-N-CA 125.175 1.39 . . . . 0.0 107.709 -179.5 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.521 3.112 0 CA-C-O 120.752 0.311 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.93 -26.62 68.67 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 124.253 1.021 . . . . 0.0 110.613 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 60.9 m -67.95 -26.03 65.74 Favored 'General case' 0 N--CA 1.522 3.171 0 C-N-CA 123.425 0.69 . . . . 0.0 110.614 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.14 -46.24 66.42 Favored Glycine 0 N--CA 1.514 3.896 0 C-N-CA 123.699 0.666 . . . . 0.0 113.953 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tp -70.67 -35.53 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.955 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 12.1 pt -56.82 -43.61 80.29 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.766 0 CA-C-N 119.83 1.195 . . . . 0.0 112.22 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -73.56 -33.66 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.616 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.65 -45.94 93.32 Favored Glycine 0 N--CA 1.515 3.942 0 CA-C-N 115.494 -0.776 . . . . 0.0 114.069 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.94 -36.78 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.803 0 CA-C-N 117.873 0.836 . . . . 0.0 111.055 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 50.8 p -62.44 -46.22 89.51 Favored 'General case' 0 N--CA 1.534 3.744 0 CA-C-N 118.252 0.478 . . . . 0.0 111.115 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.97 -34.83 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.414 0 C-N-CA 123.87 0.868 . . . . 0.0 110.676 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.93 -36.32 59.56 Favored 'General case' 0 N--CA 1.527 3.381 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -46.1 64.53 Favored 'General case' 0 N--CA 1.517 2.908 0 C-N-CA 123.136 0.575 . . . . 0.0 111.44 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -58.53 -44.79 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.677 0 C-N-CA 123.768 0.827 . . . . 0.0 112.204 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -66.65 -31.5 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.658 0 CA-C-O 121.125 0.488 . . . . 0.0 110.12 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -42.12 97.41 Favored 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.576 0.75 . . . . 0.0 111.906 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.05 -44.61 97.78 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.005 0 C-N-CA 122.892 0.477 . . . . 0.0 111.809 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 18.2 m -66.48 -36.55 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.792 0 O-C-N 121.801 -0.562 . . . . 0.0 109.928 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.3 86.09 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.73 -34.27 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.964 0 O-C-N 121.606 -0.684 . . . . 0.0 109.963 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.73 -44.03 97.16 Favored 'General case' 0 N--CA 1.53 3.542 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.78 -39.06 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 CA-C-O 121.569 0.7 . . . . 0.0 109.415 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.9 m -65.25 -29.48 70.27 Favored 'General case' 0 N--CA 1.521 3.101 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.311 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.36 -37.77 63.4 Favored 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 123.121 0.568 . . . . 0.0 109.477 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 50.5 m -64.15 -29.78 70.88 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.527 0.731 . . . . 0.0 111.245 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.76 -14.56 22.1 Favored 'General case' 0 N--CA 1.534 3.737 0 C-N-CA 123.61 0.764 . . . . 0.0 111.488 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 1 N--CA 1.54 4.034 0 C-N-CA 123.227 0.611 . . . . 0.0 109.409 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.522 3.13 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.95 -27.17 68.66 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 123.944 0.898 . . . . 0.0 110.16 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 99.3 p -68.13 -30.09 69.15 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.655 0.782 . . . . 0.0 110.625 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.22 -47.07 54.95 Favored Glycine 0 N--CA 1.514 3.842 0 CA-C-N 115.956 -0.565 . . . . 0.0 114.444 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.21 -39.35 73.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.088 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -176.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.44 -32.29 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.781 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.17 -32.77 44.44 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.119 0 CA-C-N 119.129 0.877 . . . . 0.0 109.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.21 -29.17 72.19 Favored Glycine 0 N--CA 1.511 3.67 0 C-N-CA 123.776 0.703 . . . . 0.0 113.648 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 5.4 p -59.27 -48.21 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.946 0 CA-C-N 117.558 0.679 . . . . 0.0 112.817 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 8.9 t -66.7 -39.64 88.16 Favored 'General case' 0 N--CA 1.536 3.841 0 CA-C-N 118.056 0.389 . . . . 0.0 110.95 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.38 -33.28 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.269 0 C-N-CA 123.475 0.71 . . . . 0.0 110.26 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.45 -43.08 97.24 Favored 'General case' 0 N--CA 1.526 3.353 0 O-C-N 122.214 -0.304 . . . . 0.0 111.705 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.43 73.3 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.4 -38.31 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 CA-C-N 118.042 0.383 . . . . 0.0 111.374 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.98 -32.76 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 C-N-CA 122.715 0.406 . . . . 0.0 110.086 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -37.82 85.5 Favored 'General case' 1 N--CA 1.544 4.265 0 CA-C-O 120.999 0.428 . . . . 0.0 110.013 -178.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 71.8 mt -64.09 -40.72 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.096 0.558 . . . . 0.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.63 -37.29 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 123.789 0.835 . . . . 0.0 109.935 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.67 -32.47 67.35 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.314 0.646 . . . . 0.0 112.071 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.47 -44.14 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.663 0 C-N-CA 122.636 0.375 . . . . 0.0 112.001 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -61.54 -43.67 98.45 Favored 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.5 -37.87 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.698 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 86.4 m -67.36 -34.17 76.75 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 122.93 0.492 . . . . 0.0 110.126 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -69.54 -34.53 74.35 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 123.466 0.706 . . . . 0.0 110.388 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 39.3 t -67.18 -37.51 83.82 Favored 'General case' 0 N--CA 1.522 3.169 0 CA-C-O 121.447 0.642 . . . . 0.0 110.198 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.7 -21.77 62.53 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 124.294 1.037 . . . . 0.0 110.512 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 56.0 tp -87.67 -28.08 22.04 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.72 0.808 . . . . 0.0 109.551 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -71.42 -124.82 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.346 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 54.67 111.39 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 124.311 1.045 . . . . 0.0 112.01 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -164.79 152.79 11.88 Favored 'General case' 0 N--CA 1.522 3.168 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 N--CA 1.527 3.41 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.708 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.521 3.095 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.18 -26.75 68.29 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 124.242 1.017 . . . . 0.0 110.651 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 46.9 t -65.8 -26.7 67.81 Favored 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 122.959 0.503 . . . . 0.0 110.528 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.22 -46.34 92.94 Favored Glycine 0 N--CA 1.509 3.545 0 C-N-CA 123.439 0.542 . . . . 0.0 114.192 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.38 -35.39 62.13 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.065 0 CA-C-N 118.446 1.123 . . . . 0.0 109.46 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 83.1 mt -64.56 -35.54 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 11.6 mm -72.5 -33.74 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.825 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.52 -47.16 92.53 Favored Glycine 0 N--CA 1.515 3.917 0 C-N-CA 123.983 0.802 . . . . 0.0 113.49 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 14.6 m -68.92 -36.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 O-C-N 121.781 -0.835 . . . . 0.0 109.981 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 32.9 m -60.44 -45.69 92.76 Favored 'General case' 0 N--CA 1.525 3.281 0 C-N-CA 123.577 0.751 . . . . 0.0 112.539 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.63 -30.83 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 C-N-CA 122.94 0.496 . . . . 0.0 110.049 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.72 -45.19 91.07 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 122.685 0.394 . . . . 0.0 111.868 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.99 -25.56 61.21 Favored 'General case' 0 N--CA 1.535 3.801 0 C-N-CA 123.422 0.689 . . . . 0.0 112.286 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.05 -37.04 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 C-N-CA 123.76 0.824 . . . . 0.0 110.326 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 2.6 p -55.97 -34.84 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.784 0 C-N-CA 123.457 0.703 . . . . 0.0 111.63 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 59.9 tp -69.63 -45.27 68.86 Favored 'General case' 0 N--CA 1.521 3.125 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.867 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.53 -49.76 63.83 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.232 0 C-N-CA 122.858 0.463 . . . . 0.0 111.188 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 26.5 m -66.4 -36.86 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 C-N-CA 122.437 0.295 . . . . 0.0 110.465 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.93 -32.91 68.23 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 123.179 0.592 . . . . 0.0 112.389 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.72 -34.78 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.73 0 O-C-N 122.021 -0.424 . . . . 0.0 110.283 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -68.46 -43.7 76.44 Favored 'General case' 0 N--CA 1.527 3.402 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 11.5 m -68.49 -37.93 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 O-C-N 122.198 -0.314 . . . . 0.0 111.324 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 15.5 p -65.33 -27.74 68.81 Favored 'General case' 0 N--CA 1.529 3.503 0 C-N-CA 122.217 0.207 . . . . 0.0 111.165 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -63.11 -42.51 99.57 Favored 'General case' 0 N--CA 1.526 3.333 0 CA-C-O 121.276 0.56 . . . . 0.0 109.922 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 69.4 m -65.74 -36.89 84.87 Favored 'General case' 0 N--CA 1.521 3.104 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.873 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 235' ' ' LEU . . . . . 0.552 ' O ' HD13 ' D' ' 235' ' ' LEU . 1.7 tm? -71.87 -25.88 62.13 Favored 'General case' 0 N--CA 1.528 3.475 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.507 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 49.9 tp -87.4 -12.72 45.42 Favored 'General case' 0 N--CA 1.537 3.886 0 C-N-CA 123.85 0.86 . . . . 0.0 110.883 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -55.66 -15.11 2.64 Favored 'General case' 0 N--CA 1.534 3.74 0 C-N-CA 123.684 0.794 . . . . 0.0 112.103 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.65 -25.4 63.89 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.729 0.812 . . . . 0.0 111.224 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 60.4 mttp . . . . . 0 N--CA 1.525 3.303 0 C-N-CA 123.927 0.891 . . . . 0.0 110.169 -178.462 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.522 3.166 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 42.8 mt -64.26 -27.5 69.09 Favored 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 124.114 0.966 . . . . 0.0 110.842 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 66.8 m -61.17 -26.62 67.83 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.669 0.788 . . . . 0.0 110.973 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.54 -34.33 88.81 Favored Glycine 0 N--CA 1.513 3.802 0 C-N-CA 125.062 1.315 . . . . 0.0 114.005 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -34.1 49.55 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.249 0 C-N-CA 124.615 1.166 . . . . 0.0 113.876 -174.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 16.3 pt -54.97 -32.36 26.67 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.257 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -174.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 13.0 pt -64.65 -33.36 62.7 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-O 121.256 0.55 . . . . 0.0 109.734 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.7 -50.14 70.93 Favored Glycine 1 N--CA 1.518 4.166 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.726 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.62 -36.81 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 CA-C-N 117.571 0.685 . . . . 0.0 110.384 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 85.9 m -61.77 -46.05 91.23 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 123.479 0.712 . . . . 0.0 112.043 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 70.1 t -69.19 -31.32 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 C-N-CA 123.712 0.805 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.9 -34.91 57.11 Favored 'General case' 0 N--CA 1.536 3.827 0 CA-C-O 121.041 0.448 . . . . 0.0 112.205 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.78 -43.58 65.48 Favored 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 123.37 0.668 . . . . 0.0 110.949 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.56 -43.11 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.38 0 C-N-CA 124.428 1.091 . . . . 0.0 112.62 -176.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 24.7 m -60.7 -31.29 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 O-C-N 121.992 -0.443 . . . . 0.0 111.628 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 46.9 tp -67.69 -36.23 80.28 Favored 'General case' 0 N--CA 1.536 3.855 0 O-C-N 121.474 -0.766 . . . . 0.0 109.875 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 41.1 mm -55.01 -51.98 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 C-N-CA 122.873 0.469 . . . . 0.0 112.157 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 17.2 m -60.57 -36.71 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 C-N-CA 122.356 0.262 . . . . 0.0 110.856 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.55 -31.84 66.51 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.067 0.547 . . . . 0.0 111.153 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.81 -38.21 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 O-C-N 121.99 -0.444 . . . . 0.0 110.353 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -73.04 -32.21 64.93 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 123.203 0.601 . . . . 0.0 110.076 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.56 -37.59 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.246 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.0 m -58.7 -46.79 86.52 Favored 'General case' 0 N--CA 1.524 3.268 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -74.65 -41.57 60.1 Favored 'General case' 0 N--CA 1.532 3.63 0 CA-C-O 121.111 0.481 . . . . 0.0 111.102 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.3 m -64.52 -46.86 81.09 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 123.565 0.746 . . . . 0.0 112.303 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 1 N--CA 1.54 4.066 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.52 3.056 0 CA-C-O 121.677 0.751 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.43 -27.15 69.1 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 124.044 0.938 . . . . 0.0 110.749 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 99.8 p -68.58 -32.63 72.67 Favored 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 123.581 0.752 . . . . 0.0 110.406 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.76 -46.61 60.14 Favored Glycine 1 N--CA 1.516 4.004 0 CA-C-N 115.362 -0.835 . . . . 0.0 114.979 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -70.91 -42.03 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.907 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -60.05 -42.13 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 C-N-CA 122.999 0.52 . . . . 0.0 112.395 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.71 -33.29 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.858 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.26 58.33 Favored Glycine 0 N--CA 1.51 3.617 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.524 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.0 m -59.47 -37.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.913 0 CA-C-N 117.634 0.717 . . . . 0.0 110.928 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 80.5 p -56.39 -46.61 80.03 Favored 'General case' 0 N--CA 1.531 3.584 0 CA-C-O 121.038 0.447 . . . . 0.0 111.214 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.83 -41.96 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 124.456 1.102 . . . . 0.0 110.88 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.55 -47.12 66.98 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.41 0.684 . . . . 0.0 112.633 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.65 -37.05 72.71 Favored 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 123.385 0.674 . . . . 0.0 111.674 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 36.2 t -67.98 -48.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 CA-C-O 121.315 0.578 . . . . 0.0 110.071 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.53 -32.65 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.111 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.388 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 16.1 mt -73.55 -46.7 45.96 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 122.67 0.388 . . . . 0.0 110.95 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 92.1 mt -60.14 -44.77 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 O-C-N 121.531 -0.731 . . . . 0.0 111.437 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.03 -37.8 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.87 0 CA-C-N 118.843 0.747 . . . . 0.0 110.631 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.81 91.09 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.553 0.741 . . . . 0.0 111.828 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 88.5 t -71.57 -34.47 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.348 0 C-N-CA 123.139 0.576 . . . . 0.0 109.777 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.01 -44.21 89.97 Favored 'General case' 0 N--CA 1.53 3.525 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.68 -37.41 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.781 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 88.0 m -61.19 -33.7 73.88 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 122.913 0.485 . . . . 0.0 110.855 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -74.28 -28.47 61.22 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 122.633 0.373 . . . . 0.0 110.461 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 57.5 m -75.27 -17.74 60.23 Favored 'General case' 0 N--CA 1.524 3.227 0 C-N-CA 123.104 0.562 . . . . 0.0 110.855 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.76 -38.43 86.57 Favored 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 123.499 0.72 . . . . 0.0 112.319 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -110.46 10.16 23.27 Favored 'General case' 1 N--CA 1.556 4.844 0 C-N-CA 123.414 0.686 . . . . 0.0 112.342 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -75.65 5.47 6.07 Favored 'General case' 0 N--CA 1.527 3.396 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 58.2 pttt . . . . . 0 N--CA 1.516 2.85 0 C-N-CA 124.242 1.017 . . . . 0.0 108.958 -179.226 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.144 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 99.3 p -162.61 27.65 0.1 Allowed 'General case' 0 N--CA 1.522 3.125 0 C-N-CA 124.108 0.963 . . . . 0.0 109.2 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 47.5 mt -64.14 -26.55 68.58 Favored 'General case' 0 N--CA 1.522 3.141 0 C-N-CA 124.566 1.147 . . . . 0.0 110.81 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.1 t -57.57 -26.41 61.4 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.606 0.762 . . . . 0.0 111.883 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.65 -34.23 77.92 Favored Glycine 0 N--CA 1.513 3.801 0 C-N-CA 124.724 1.154 . . . . 0.0 114.12 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -46.47 90.79 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.378 0 CA-C-N 117.821 0.81 . . . . 0.0 112.458 -174.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.7 tt -64.84 -31.54 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 C-N-CA 123.116 0.566 . . . . 0.0 110.779 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 51.1 mm -68.22 -33.51 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.37 -50.15 67.48 Favored Glycine 1 N--CA 1.517 4.074 0 C-N-CA 123.119 0.39 . . . . 0.0 113.127 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.0 m -61.85 -35.75 69.75 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 CA-C-N 117.861 0.83 . . . . 0.0 110.655 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.5 m -55.18 -42.28 72.99 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.045 0.538 . . . . 0.0 111.0 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.42 -36.99 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.47 0 C-N-CA 123.483 0.713 . . . . 0.0 110.576 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.47 68.41 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.42 -50.43 65.46 Favored 'General case' 0 N--CA 1.515 2.795 0 C-N-CA 123.315 0.646 . . . . 0.0 112.673 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.02 -38.34 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.784 0 CA-C-N 118.303 0.501 . . . . 0.0 111.311 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.5 t -62.41 -34.65 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 CA-C-N 117.954 0.343 . . . . 0.0 110.391 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.98 -34.53 78.32 Favored 'General case' 0 N--CA 1.529 3.507 0 CA-C-N 117.808 0.276 . . . . 0.0 111.468 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.48 -36.8 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.865 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.74 -37.71 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.692 0 C-N-CA 123.34 0.656 . . . . 0.0 110.212 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.91 -32.52 71.99 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.387 0.675 . . . . 0.0 111.342 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.57 -37.46 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 123.052 0.541 . . . . 0.0 109.899 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.43 -43.78 96.46 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.377 0.671 . . . . 0.0 112.434 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.9 m -68.24 -37.38 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.725 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 93.0 m -62.93 -31.4 72.48 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.989 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -74.43 -38.83 62.91 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 55.9 m -67.37 -28.04 67.61 Favored 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 123.384 0.674 . . . . 0.0 110.576 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.54 -34.54 78.13 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.463 0.705 . . . . 0.0 111.896 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.32 8.1 37.71 Favored 'General case' 1 N--CA 1.544 4.248 0 C-N-CA 123.092 0.557 . . . . 0.0 111.691 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -71.24 2.53 4.58 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 123.479 0.711 . . . . 0.0 110.471 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -52.37 173.57 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 124.52 1.128 . . . . 0.0 112.25 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -63.17 146.36 53.52 Favored 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 124.056 0.942 . . . . 0.0 111.281 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.527 3.402 0 C-N-CA 125.081 1.352 . . . . 0.0 108.128 179.451 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.517 2.925 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.09 -31.96 73.42 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 123.945 0.898 . . . . 0.0 110.162 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.9 t -68.36 -27.95 66.7 Favored 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 123.592 0.757 . . . . 0.0 110.631 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.04 -46.58 58.39 Favored Glycine 0 N--CA 1.514 3.872 0 C-N-CA 124.078 0.847 . . . . 0.0 114.723 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.8 pt -70.71 -37.35 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -64.29 -41.39 92.23 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.054 0 CA-C-N 118.376 0.534 . . . . 0.0 111.609 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.88 -33.28 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.31 -50.11 64.35 Favored Glycine 0 N--CA 1.513 3.807 0 C-N-CA 124.331 0.967 . . . . 0.0 113.906 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.32 -37.13 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 O-C-N 122.22 -0.577 . . . . 0.0 109.887 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 82.0 m -65.31 -47.22 77.34 Favored 'General case' 0 N--CA 1.523 3.204 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.3 p -70.74 -31.54 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 CA-C-N 118.117 0.417 . . . . 0.0 111.611 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.7 67.59 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.44 -36.41 83.83 Favored 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 123.121 0.568 . . . . 0.0 111.506 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 48.0 t -68.13 -52.11 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 C-N-CA 123.525 0.73 . . . . 0.0 111.779 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.08 -35.18 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.457 0 O-C-N 121.413 -0.804 . . . . 0.0 111.944 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 tt -75.01 -43.71 52.2 Favored 'General case' 0 N--CA 1.528 3.444 0 C-N-CA 122.58 0.352 . . . . 0.0 111.204 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 14.8 tt -65.73 -39.75 85.79 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 O-C-N 121.211 -0.931 . . . . 0.0 111.197 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.26 -37.42 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 C-N-CA 123.099 0.56 . . . . 0.0 109.939 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.85 -32.77 67.96 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.25 -38.63 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.594 0 CA-C-N 118.049 0.386 . . . . 0.0 111.386 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -64.39 -44.25 91.9 Favored 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.95 -39.89 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.467 0 C-N-CA 122.841 0.457 . . . . 0.0 110.109 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 99.0 m -67.55 -28.25 67.63 Favored 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 123.242 0.617 . . . . 0.0 111.226 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.3 -45.97 44.13 Favored 'General case' 0 N--CA 1.528 3.436 0 CA-C-O 121.123 0.487 . . . . 0.0 110.499 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.7 t -63.78 -19.05 64.69 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 123.629 0.772 . . . . 0.0 112.203 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 49.7 tp -69.24 -15.64 63.42 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.616 0.766 . . . . 0.0 110.614 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 N--CA 1.534 3.76 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.777 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.523 3.214 0 CA-C-O 121.459 0.647 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.34 -26.97 68.71 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 123.906 0.883 . . . . 0.0 110.294 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.2 m -68.41 -29.82 68.58 Favored 'General case' 0 N--CA 1.52 3.03 0 C-N-CA 123.636 0.775 . . . . 0.0 110.297 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.03 -46.67 58.13 Favored Glycine 1 N--CA 1.516 4.024 0 C-N-CA 123.96 0.79 . . . . 0.0 114.935 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 8.1 tp -70.97 -41.56 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.07 -41.07 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 C-N-CA 123.082 0.553 . . . . 0.0 112.335 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.94 -33.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.18 -28.21 41.46 Favored Glycine 1 N--CA 1.516 4.022 0 C-N-CA 124.54 1.066 . . . . 0.0 113.754 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 5.3 m -58.58 -37.04 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.789 0 CA-C-N 117.482 0.641 . . . . 0.0 111.587 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 7.7 t -55.78 -44.3 77.61 Favored 'General case' 0 N--CA 1.538 3.968 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.27 -31.72 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 C-N-CA 123.355 0.662 . . . . 0.0 110.85 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.76 -46.68 77.83 Favored 'General case' 0 N--CA 1.535 3.785 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.04 74.26 Favored 'General case' 0 N--CA 1.514 2.763 0 C-N-CA 123.529 0.732 . . . . 0.0 111.526 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 38.0 t -64.49 -47.77 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.682 0 C-N-CA 123.49 0.716 . . . . 0.0 110.663 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.48 -32.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 123.586 0.755 . . . . 0.0 109.995 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 36.1 tp -76.81 -33.87 57.96 Favored 'General case' 0 N--CA 1.516 2.865 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 tp -54.84 -43.83 69.48 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 C-N-CA 123.455 0.702 . . . . 0.0 112.267 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 12.6 m -64.73 -37.47 80.23 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.152 0 O-C-N 121.957 -0.464 . . . . 0.0 110.542 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.04 -32.27 67.83 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 122.949 0.5 . . . . 0.0 111.127 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.2 -35.0 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.789 0 C-N-CA 122.739 0.416 . . . . 0.0 110.256 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -72.11 -38.91 69.22 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 123.281 0.632 . . . . 0.0 109.672 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.11 -37.37 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 C-N-CA 124.136 0.974 . . . . 0.0 109.634 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.68 -38.39 78.11 Favored 'General case' 0 N--CA 1.523 3.19 0 C-N-CA 122.781 0.432 . . . . 0.0 110.081 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -74.2 -37.33 63.93 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 122.978 0.511 . . . . 0.0 110.114 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 32.1 t -64.23 -41.48 96.99 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.9 tp -65.19 -16.26 63.33 Favored 'General case' 0 N--CA 1.522 3.129 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.767 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.29 -23.55 14.38 Favored 'General case' 1 N--CA 1.557 4.92 0 C-N-CA 124.262 1.025 . . . . 0.0 108.655 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -108.19 94.58 5.15 Favored 'General case' 0 N--CA 1.53 3.561 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 26.07 0.09 Allowed 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.599 0.76 . . . . 0.0 110.841 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -54.57 154.41 4.88 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 124.143 0.977 . . . . 0.0 112.302 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.527 3.382 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -179.714 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.522 3.145 0 CA-C-O 121.511 0.672 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.03 -26.69 68.68 Favored 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 123.982 0.913 . . . . 0.0 109.735 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 64.0 m -60.45 -26.66 66.91 Favored 'General case' 0 N--CA 1.522 3.157 0 C-N-CA 123.542 0.737 . . . . 0.0 110.924 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.53 -42.17 82.04 Favored Glycine 0 N--CA 1.513 3.775 0 C-N-CA 124.262 0.934 . . . . 0.0 115.385 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -46.38 69.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.239 0 CA-C-N 118.192 0.996 . . . . 0.0 111.546 -176.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 19.7 tt -61.05 -35.55 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.14 -33.15 45.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.063 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.25 -47.41 90.98 Favored Glycine 0 N--CA 1.513 3.791 0 C-N-CA 123.831 0.729 . . . . 0.0 113.29 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 15.1 m -68.83 -37.1 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 CA-C-N 118.119 0.96 . . . . 0.0 110.141 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 37.9 m -62.04 -46.29 89.83 Favored 'General case' 0 N--CA 1.516 2.875 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.469 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 11.8 p -69.67 -31.55 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.546 0 CA-C-N 117.973 0.351 . . . . 0.0 110.572 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.9 70.82 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 122.635 0.374 . . . . 0.0 111.45 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.22 -37.74 86.26 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 123.558 0.743 . . . . 0.0 110.911 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.66 -42.8 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.376 0 C-N-CA 123.597 0.759 . . . . 0.0 110.563 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.08 -44.49 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.285 0.634 . . . . 0.0 111.361 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.2 -35.22 63.91 Favored 'General case' 0 N--CA 1.523 3.203 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 17.9 tt -69.63 -40.3 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 CA-C-N 118.627 0.649 . . . . 0.0 111.162 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.59 -36.97 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 O-C-N 121.942 -0.473 . . . . 0.0 109.948 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.45 82.22 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.945 0.898 . . . . 0.0 112.798 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.68 -34.18 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 O-C-N 121.915 -0.49 . . . . 0.0 110.084 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -64.38 -43.85 93.18 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.015 0.526 . . . . 0.0 112.316 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.59 -37.38 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.832 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 98.5 m -60.05 -28.84 68.11 Favored 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 122.768 0.427 . . . . 0.0 110.945 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -72.83 -32.46 65.51 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.988 0.515 . . . . 0.0 110.564 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 32.1 t -63.75 -17.76 63.36 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 123.159 0.584 . . . . 0.0 112.33 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.62 -20.79 65.12 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 123.503 0.721 . . . . 0.0 112.72 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.44 -5.22 58.92 Favored 'General case' 1 N--CA 1.544 4.262 0 CA-C-N 118.723 0.692 . . . . 0.0 111.116 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -64.89 -16.16 62.88 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.5 0.72 . . . . 0.0 110.622 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.44 161.2 14.72 Favored 'General case' 0 N--CA 1.523 3.199 0 C-N-CA 123.937 0.895 . . . . 0.0 110.651 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 N--CA 1.521 3.081 0 C-N-CA 123.901 0.88 . . . . 0.0 110.057 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.522 3.16 0 CA-C-O 120.36 0.124 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.19 -26.8 68.31 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 124.33 1.052 . . . . 0.0 110.714 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 65.6 m -57.89 -38.47 75.86 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 123.735 0.814 . . . . 0.0 111.254 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.87 -35.72 80.17 Favored Glycine 1 N--CA 1.518 4.147 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.212 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.31 -46.61 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.323 0 C-N-CA 124.072 0.949 . . . . 0.0 112.773 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.3 tt -66.45 -35.22 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.82 -32.95 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.9 -36.49 60.33 Favored Glycine 0 N--CA 1.514 3.854 0 C-N-CA 123.738 0.685 . . . . 0.0 114.683 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.47 -37.56 79.88 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.159 0 CA-C-N 118.214 1.007 . . . . 0.0 110.94 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 26.5 p -63.86 -45.82 87.75 Favored 'General case' 0 N--CA 1.527 3.402 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.931 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 50.9 t -66.92 -31.56 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.163 0 C-N-CA 124.426 1.09 . . . . 0.0 111.328 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.91 -43.07 65.94 Favored 'General case' 0 N--CA 1.532 3.647 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.47 -45.58 65.44 Favored 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 123.188 0.595 . . . . 0.0 110.364 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.97 -47.55 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 124.307 1.043 . . . . 0.0 112.969 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.55 -32.21 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.922 0 CA-C-N 118.093 0.406 . . . . 0.0 110.954 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 83.9 mt -68.67 -33.95 74.86 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 122.579 0.352 . . . . 0.0 110.383 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 46.6 mm -55.01 -39.79 51.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.232 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.01 -41.61 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.127 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.1 94.52 Favored 'General case' 0 N--CA 1.528 3.461 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.96 -34.12 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 O-C-N 121.718 -0.614 . . . . 0.0 109.476 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -63.03 -43.67 98.05 Favored 'General case' 0 N--CA 1.53 3.548 0 C-N-CA 123.103 0.561 . . . . 0.0 112.327 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.4 -37.57 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.7 m -61.51 -31.08 71.07 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.002 0.521 . . . . 0.0 110.358 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -73.86 -41.29 62.43 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 66.7 m -64.69 -32.62 74.37 Favored 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 123.482 0.713 . . . . 0.0 109.843 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.524 3.27 0 C-N-CA 123.862 0.865 . . . . 0.0 109.287 179.033 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.525 3.28 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 40.6 mt -64.98 -26.93 68.5 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.727 0.811 . . . . 0.0 110.54 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 69.6 m -68.5 -30.82 69.74 Favored 'General case' 0 N--CA 1.518 2.968 0 C-N-CA 123.753 0.821 . . . . 0.0 110.396 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.57 -46.33 62.78 Favored Glycine 0 N--CA 1.515 3.955 0 C-N-CA 124.3 0.952 . . . . 0.0 114.912 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 19.3 tt -71.01 -40.48 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.22 -40.28 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 C-N-CA 122.9 0.48 . . . . 0.0 112.075 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.1 tt -72.79 -32.8 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.47 -28.4 44.33 Favored Glycine 0 N--CA 1.51 3.572 0 C-N-CA 124.689 1.138 . . . . 0.0 113.442 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.6 m -58.87 -37.21 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.801 0 CA-C-N 117.339 0.569 . . . . 0.0 111.128 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 65.1 p -61.19 -46.39 90.68 Favored 'General case' 0 N--CA 1.533 3.72 0 CA-C-O 121.258 0.551 . . . . 0.0 110.926 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.75 -31.82 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 C-N-CA 124.545 1.138 . . . . 0.0 110.873 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.92 -42.02 71.7 Favored 'General case' 0 N--CA 1.531 3.623 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.67 90.92 Favored 'General case' 0 N--CA 1.517 2.906 0 C-N-CA 123.56 0.744 . . . . 0.0 111.169 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 26.5 t -58.63 -51.7 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.559 0.744 . . . . 0.0 111.63 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -67.06 -31.97 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 C-N-CA 123.078 0.551 . . . . 0.0 110.567 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.12 -35.46 61.7 Favored 'General case' 0 N--CA 1.533 3.718 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.68 -48.21 72.24 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.578 0 O-C-N 121.593 -0.692 . . . . 0.0 110.976 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 12.4 m -65.77 -36.35 77.35 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.042 0 O-C-N 121.902 -0.499 . . . . 0.0 110.378 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.01 68.14 Favored 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 122.865 0.466 . . . . 0.0 111.434 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.3 -34.82 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 C-N-CA 122.882 0.473 . . . . 0.0 110.41 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -72.66 -43.26 63.4 Favored 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.183 0.593 . . . . 0.0 112.399 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.83 -37.21 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 O-C-N 122.165 -0.335 . . . . 0.0 111.383 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 28.1 p -66.98 -27.71 67.66 Favored 'General case' 0 N--CA 1.53 3.548 0 O-C-N 122.311 -0.243 . . . . 0.0 110.971 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -68.53 -30.51 69.32 Favored 'General case' 0 N--CA 1.531 3.604 0 C-N-CA 123.029 0.532 . . . . 0.0 110.055 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 39.6 t -67.53 -39.62 85.06 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-O 121.437 0.637 . . . . 0.0 110.166 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -13.69 13.4 Favored 'General case' 0 N--CA 1.535 3.805 0 C-N-CA 125.567 1.547 . . . . 0.0 111.339 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 54.3 tp -86.77 -16.85 35.05 Favored 'General case' 1 N--CA 1.544 4.262 0 C-N-CA 123.656 0.782 . . . . 0.0 110.178 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -143.1 78.93 1.63 Allowed 'General case' 0 N--CA 1.52 3.043 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? . . . . . 0 N--CA 1.527 3.406 0 C-N-CA 124.482 1.113 . . . . 0.0 110.183 -175.499 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.154 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 47.8 t -168.38 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 CA-C-N 117.692 0.746 . . . . 0.0 110.305 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 tt -54.67 -28.47 47.68 Favored 'General case' 0 N--CA 1.53 3.558 0 C-N-CA 123.647 0.779 . . . . 0.0 111.234 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 46.5 t -66.52 -42.22 87.63 Favored 'General case' 0 N--CA 1.52 3.026 0 C-N-CA 123.734 0.813 . . . . 0.0 110.522 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.38 69.18 Favored Glycine 1 N--CA 1.517 4.099 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.65 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.96 -46.29 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.306 0 C-N-CA 124.003 0.921 . . . . 0.0 111.556 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 215' ' ' ILE . 0.2 OUTLIER -67.59 -32.79 58.5 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.016 0 CA-C-O 121.268 0.556 . . . . 0.0 109.704 -178.435 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 6.3 mm -71.94 -37.0 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 C-N-CA 123.863 0.865 . . . . 0.0 109.314 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.7 -29.87 71.07 Favored Glycine 1 N--CA 1.517 4.08 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.685 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.1 m -62.56 -36.19 73.83 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.285 0 CA-C-N 117.881 0.841 . . . . 0.0 110.564 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.3 p -55.02 -44.18 74.36 Favored 'General case' 0 N--CA 1.528 3.427 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.24 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.16 -36.1 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.414 0 C-N-CA 123.771 0.828 . . . . 0.0 111.061 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.84 -44.43 66.72 Favored 'General case' 0 N--CA 1.533 3.675 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.95 -37.04 78.59 Favored 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 123.08 0.552 . . . . 0.0 111.541 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.3 t -67.15 -47.17 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 C-N-CA 123.106 0.563 . . . . 0.0 111.974 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.37 -35.85 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 CA-C-N 118.058 0.39 . . . . 0.0 111.006 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.8 mt -60.98 -34.44 74.78 Favored 'General case' 0 N--CA 1.539 3.978 0 CA-C-N 117.91 0.323 . . . . 0.0 110.949 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.26 -36.28 77.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 O-C-N 121.829 -0.544 . . . . 0.0 109.779 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.66 -37.68 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.701 0 C-N-CA 122.955 0.502 . . . . 0.0 110.182 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.41 79.98 Favored 'General case' 0 N--CA 1.53 3.556 0 C-N-CA 123.621 0.768 . . . . 0.0 112.582 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 26.3 m -71.76 -34.1 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.601 0 O-C-N 121.938 -0.476 . . . . 0.0 110.176 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.25 -44.01 97.53 Favored 'General case' 0 N--CA 1.53 3.564 0 C-N-CA 123.057 0.543 . . . . 0.0 112.416 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.73 -37.62 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.739 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -63.41 -27.87 69.59 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 123.066 0.546 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -63.35 -23.59 67.48 Favored 'General case' 0 N--CA 1.533 3.705 0 C-N-CA 123.103 0.561 . . . . 0.0 110.829 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 41.5 m -66.68 -40.27 88.49 Favored 'General case' 0 N--CA 1.526 3.358 0 CA-C-O 121.402 0.62 . . . . 0.0 109.847 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 44.5 mt -63.15 -23.98 67.68 Favored 'General case' 0 N--CA 1.524 3.239 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.289 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 46.4 tp -87.86 9.12 23.04 Favored 'General case' 0 N--CA 1.536 3.846 0 C-N-CA 124.057 0.943 . . . . 0.0 109.455 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -139.66 69.16 1.36 Allowed 'General case' 0 N--CA 1.532 3.626 0 C-N-CA 124.5 1.12 . . . . 0.0 109.816 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -84.83 -63.48 1.33 Allowed 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -168.82 168.11 10.67 Favored 'General case' 0 N--CA 1.521 3.117 0 C-N-CA 124.154 0.982 . . . . 0.0 108.821 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.531 3.603 0 C-N-CA 124.573 1.149 . . . . 0.0 108.761 179.656 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.523 3.182 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.28 -26.64 68.51 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 124.322 1.049 . . . . 0.0 110.268 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 90.9 p -64.93 -27.95 69.19 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 123.432 0.693 . . . . 0.0 110.82 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' GLY . . . . . 0.53 ' O ' HD12 ' B' ' 216' ' ' ILE . . . -69.69 -47.41 49.0 Favored Glycine 0 N--CA 1.515 3.904 0 N-CA-C 114.822 0.689 . . . . 0.0 114.822 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 39.3 pt -71.42 -34.63 54.09 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.406 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.6 tt -55.06 -31.83 26.24 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.148 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.69 HD13 ' N ' ' B' ' 217' ' ' GLY . 0.0 OUTLIER -59.83 -32.2 49.16 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.496 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.949 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 217' ' ' GLY . . . . . 0.69 ' N ' HD13 ' B' ' 216' ' ' ILE . . . -54.17 -29.38 44.78 Favored Glycine 0 N--CA 1.51 3.617 0 CA-C-N 115.067 -0.969 . . . . 0.0 114.088 -178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 6.0 m -59.55 -37.49 70.6 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.021 0 CA-C-N 118.429 1.115 . . . . 0.0 110.551 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 48.3 p -66.13 -45.92 79.33 Favored 'General case' 0 N--CA 1.528 3.433 0 CA-C-O 121.13 0.491 . . . . 0.0 110.497 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 49.5 t -69.42 -32.96 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.178 0 C-N-CA 124.322 1.049 . . . . 0.0 110.415 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.13 76.79 Favored 'General case' 0 N--CA 1.523 3.225 0 C-N-CA 123.363 0.665 . . . . 0.0 111.801 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.92 -30.6 68.05 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.086 0.554 . . . . 0.0 111.005 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 38.8 t -64.01 -50.76 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 C-N-CA 123.302 0.641 . . . . 0.0 111.167 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.35 -32.12 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 C-N-CA 122.738 0.415 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.61 -47.36 26.86 Favored 'General case' 0 N--CA 1.528 3.425 0 C-N-CA 123.515 0.726 . . . . 0.0 111.561 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.6 tt -64.24 -39.02 84.04 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.058 0 O-C-N 121.593 -0.692 . . . . 0.0 112.779 -176.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.8 -36.92 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.738 0 O-C-N 122.087 -0.383 . . . . 0.0 110.375 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.66 74.9 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.282 0.633 . . . . 0.0 112.165 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 48.0 t -71.88 -38.96 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 C-N-CA 122.99 0.516 . . . . 0.0 111.159 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -69.23 -43.46 73.97 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.39 -37.73 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 C-N-CA 122.57 0.348 . . . . 0.0 111.232 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 18.7 p -67.03 -28.78 68.51 Favored 'General case' 0 N--CA 1.529 3.51 0 CA-C-N 117.85 0.295 . . . . 0.0 111.203 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -63.52 -29.47 70.73 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 123.301 0.64 . . . . 0.0 111.139 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.4 t -65.28 -33.33 75.72 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.384 0.674 . . . . 0.0 111.215 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 51.0 mt -65.72 -18.39 65.3 Favored 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 123.724 0.81 . . . . 0.0 111.931 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 N--CA 1.539 3.995 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.793 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 N--CA 1.522 3.126 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 211' ' ' LEU . . . . . 0.406 HD22 ' N ' ' C' ' 211' ' ' LEU . 2.0 mm? -65.29 -26.28 68.0 Favored 'General case' 0 N--CA 1.522 3.158 0 C-N-CA 124.261 1.024 . . . . 0.0 109.896 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 57.7 m -58.39 -27.22 64.05 Favored 'General case' 0 N--CA 1.521 3.077 0 C-N-CA 123.403 0.681 . . . . 0.0 111.293 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.67 -48.15 44.64 Favored Glycine 0 N--CA 1.513 3.83 0 CA-C-N 116.137 -0.483 . . . . 0.0 114.218 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 38.5 pt -72.74 -36.9 54.07 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 N-CA-C 115.618 1.711 . . . . 0.0 115.618 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 215' ' ' ILE . . . . . 0.471 ' O ' HG12 ' C' ' 218' ' ' VAL . 8.4 tp -56.52 -31.56 34.29 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 14.8 tt -58.98 -32.14 46.98 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.317 0 CA-C-N 119.078 0.854 . . . . 0.0 110.204 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.99 -27.39 37.39 Favored Glycine 1 N--CA 1.518 4.145 0 C-N-CA 123.674 0.654 . . . . 0.0 112.497 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 218' ' ' VAL . . . . . 0.471 HG12 ' O ' ' C' ' 215' ' ' ILE . 8.6 p -58.4 -44.83 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.77 0 C-N-CA 123.505 0.722 . . . . 0.0 112.888 -176.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 9.7 t -66.24 -40.73 90.42 Favored 'General case' 0 N--CA 1.536 3.871 0 CA-C-N 118.51 0.595 . . . . 0.0 110.752 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 41.8 t -69.68 -32.28 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 C-N-CA 123.883 0.873 . . . . 0.0 110.764 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.4 -41.7 73.05 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.26 -34.56 74.97 Favored 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 123.202 0.601 . . . . 0.0 111.049 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.29 -52.35 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.088 0.555 . . . . 0.0 111.462 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.58 -31.97 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 122.956 0.502 . . . . 0.0 110.683 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.61 -46.1 91.53 Favored 'General case' 0 N--CA 1.534 3.728 0 C-N-CA 123.407 0.683 . . . . 0.0 110.807 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.49 -36.4 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 O-C-N 121.769 -0.582 . . . . 0.0 110.389 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.86 -38.0 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 122.948 0.499 . . . . 0.0 110.168 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.57 81.17 Favored 'General case' 0 N--CA 1.531 3.615 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.34 -34.3 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.854 0 O-C-N 122.088 -0.383 . . . . 0.0 110.017 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.85 -39.4 93.5 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 123.172 0.589 . . . . 0.0 109.545 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 9.4 t -68.17 -40.08 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 124.298 1.039 . . . . 0.0 109.199 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.44 -34.2 77.24 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 122.92 0.488 . . . . 0.0 109.895 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -73.51 -41.65 62.79 Favored 'General case' 0 N--CA 1.522 3.162 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.156 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.2 t -68.47 -45.9 71.18 Favored 'General case' 0 N--CA 1.528 3.473 0 CA-C-O 122.164 0.983 . . . . 0.0 109.389 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 39.7 tp -61.2 -12.94 14.74 Favored 'General case' 0 N--CA 1.521 3.108 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.872 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 40.8 tp -85.15 8.09 19.42 Favored 'General case' 1 N--CA 1.546 4.329 0 CA-C-N 118.369 0.531 . . . . 0.0 110.755 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -158.26 132.59 8.1 Favored 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 238' ' ' LYS . . . . . 0.423 ' H ' ' H ' ' C' ' 239' ' ' LYS . 58.1 mtmt -152.59 -18.78 0.16 Allowed 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 125.109 1.364 . . . . 0.0 108.235 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 239' ' ' LYS . . . . . 0.423 ' H ' ' H ' ' C' ' 238' ' ' LYS . 52.8 mtmt -65.99 -167.8 0.04 OUTLIER 'General case' 0 N--CA 1.52 3.053 0 C-N-CA 124.629 1.172 . . . . 0.0 110.187 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 70.1 t . . . . . 0 N--CA 1.529 3.49 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.845 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.523 3.214 0 CA-C-O 121.51 0.672 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.16 -26.36 68.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.121 0.969 . . . . 0.0 109.553 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 41.3 t -57.42 -25.88 60.27 Favored 'General case' 0 N--CA 1.522 3.164 0 C-N-CA 123.976 0.911 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.68 -34.33 83.12 Favored Glycine 0 N--CA 1.515 3.929 0 C-N-CA 124.293 0.949 . . . . 0.0 114.145 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -46.42 90.81 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.3 0 CA-C-N 117.851 0.825 . . . . 0.0 112.183 -175.117 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -66.73 -31.87 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.732 0 C-N-CA 123.023 0.529 . . . . 0.0 110.542 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 47.9 mm -68.3 -33.81 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.851 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.59 -45.64 92.41 Favored Glycine 1 N--CA 1.519 4.184 0 C-N-CA 123.226 0.441 . . . . 0.0 113.479 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 11.8 m -69.2 -36.85 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 0 O-C-N 121.549 -0.971 . . . . 0.0 109.914 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 95.4 m -58.64 -46.43 87.15 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 30.4 m -67.6 -30.8 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 123.278 0.631 . . . . 0.0 111.203 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.62 74.01 Favored 'General case' 0 N--CA 1.532 3.669 0 O-C-N 121.683 -0.635 . . . . 0.0 111.572 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.38 -50.04 73.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.71 0.804 . . . . 0.0 112.943 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 15.6 m -58.36 -37.61 64.57 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 CA-C-N 119.155 0.888 . . . . 0.0 110.491 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.48 -32.08 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 122.611 0.365 . . . . 0.0 110.873 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.2 -41.13 70.68 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 40.3 mm -55.31 -51.01 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 C-N-CA 123.349 0.66 . . . . 0.0 112.069 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 31.5 m -61.79 -35.75 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.965 0 C-N-CA 122.988 0.515 . . . . 0.0 110.673 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.88 -31.6 65.0 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.1 0.56 . . . . 0.0 111.414 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.03 -34.63 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 C-N-CA 122.758 0.423 . . . . 0.0 111.374 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -66.34 -43.96 84.64 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 122.951 0.5 . . . . 0.0 111.954 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 6.3 p -68.76 -36.74 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 118.76 0.709 . . . . 0.0 109.149 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 80.3 m -58.45 -27.6 64.52 Favored 'General case' 0 N--CA 1.531 3.615 0 C-N-CA 122.708 0.403 . . . . 0.0 110.969 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -62.98 -19.02 63.92 Favored 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 123.173 0.589 . . . . 0.0 110.739 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 37.2 m -64.14 -37.94 89.28 Favored 'General case' 0 N--CA 1.527 3.394 0 C-N-CA 123.564 0.745 . . . . 0.0 110.568 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.91 -28.81 69.21 Favored 'General case' 0 N--CA 1.534 3.747 0 C-N-CA 123.913 0.885 . . . . 0.0 109.841 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.35 -5.93 58.69 Favored 'General case' 0 N--CA 1.537 3.905 0 C-N-CA 124.466 1.106 . . . . 0.0 110.932 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -53.15 -12.72 0.4 Allowed 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 123.964 0.906 . . . . 0.0 112.872 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.37 137.65 52.33 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.392 0.677 . . . . 0.0 110.981 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp . . . . . 0 N--CA 1.521 3.106 0 C-N-CA 123.975 0.91 . . . . 0.0 109.131 -179.268 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.519 3.007 0 CA-C-O 121.948 0.88 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.85 -26.54 68.37 Favored 'General case' 0 N--CA 1.525 3.286 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.589 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 69.8 m -64.71 -30.93 71.96 Favored 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 123.57 0.748 . . . . 0.0 110.933 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.77 -46.97 58.54 Favored Glycine 1 N--CA 1.517 4.047 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.47 -41.52 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 8.1 tp -62.23 -39.19 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.844 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.2 tt -72.03 -33.2 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.818 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.76 -29.8 55.32 Favored Glycine 0 N--CA 1.512 3.747 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.536 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 2.0 m -63.77 -37.56 80.02 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.062 0 CA-C-N 117.768 0.784 . . . . 0.0 110.425 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 31.2 p -60.97 -46.61 90.03 Favored 'General case' 0 N--CA 1.528 3.449 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.37 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.26 -40.17 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.202 0 C-N-CA 124.033 0.933 . . . . 0.0 110.831 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.01 66.83 Favored 'General case' 0 N--CA 1.524 3.255 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.44 -41.51 76.18 Favored 'General case' 0 N--CA 1.514 2.738 0 C-N-CA 122.921 0.488 . . . . 0.0 111.58 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.75 -46.91 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.504 0 O-C-N 122.089 -0.382 . . . . 0.0 111.834 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.42 -32.44 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.626 0 CA-C-N 117.9 0.318 . . . . 0.0 111.697 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 32.9 tp -74.72 -39.25 61.99 Favored 'General case' 0 N--CA 1.521 3.083 0 CA-C-O 119.209 -0.424 . . . . 0.0 112.014 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 81.8 mt -64.87 -43.8 96.3 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.244 0 CA-C-N 118.945 0.793 . . . . 0.0 111.026 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.3 -36.7 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 117.969 0.349 . . . . 0.0 110.318 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.29 65.79 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.362 0.665 . . . . 0.0 111.941 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.6 -40.76 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.905 0 CA-C-N 117.929 0.331 . . . . 0.0 110.219 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -69.44 -36.18 76.4 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.274 0.63 . . . . 0.0 110.436 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.5 -37.5 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.27 0 C-N-CA 123.744 0.818 . . . . 0.0 109.635 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 72.7 m -58.06 -32.04 67.64 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 122.511 0.325 . . . . 0.0 110.146 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.3 -41.63 60.84 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 60.2 p -68.24 -32.87 73.37 Favored 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 123.257 0.623 . . . . 0.0 110.206 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 N--CA 1.535 3.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.624 -179.042 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.522 3.158 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.01 -25.99 68.09 Favored 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 124.437 1.095 . . . . 0.0 111.628 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 39.7 t -67.36 -33.31 74.97 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 123.469 0.708 . . . . 0.0 111.145 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.73 -44.63 69.34 Favored Glycine 1 N--CA 1.519 4.225 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 214' ' ' ILE . . . . . 0.417 ' O ' HD13 ' F' ' 214' ' ' ILE . 0.0 OUTLIER -70.67 -44.63 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.997 0 O-C-N 121.759 -0.847 . . . . 0.0 111.776 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 18.8 tt -60.68 -36.42 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 45.3 pt -72.48 -33.44 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 CA-C-N 118.699 0.681 . . . . 0.0 109.32 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.23 -48.65 84.5 Favored Glycine 1 N--CA 1.519 4.195 0 C-N-CA 123.835 0.731 . . . . 0.0 113.855 -177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.35 -36.79 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 C-N-CA 122.973 0.509 . . . . 0.0 109.803 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 90.3 m -64.1 -47.16 81.12 Favored 'General case' 0 N--CA 1.519 3.02 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -70.64 -31.48 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 CA-C-N 118.1 0.409 . . . . 0.0 111.191 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.45 -34.91 50.99 Favored 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.79 -38.62 85.95 Favored 'General case' 0 N--CA 1.523 3.194 0 C-N-CA 123.318 0.647 . . . . 0.0 111.0 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.66 -38.53 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.32 0 C-N-CA 123.697 0.799 . . . . 0.0 110.314 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.8 -37.53 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 123.469 0.708 . . . . 0.0 111.312 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 57.6 mt -72.87 -35.13 67.11 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 122.33 0.252 . . . . 0.0 111.208 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.47 -46.52 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.69 0 C-N-CA 123.08 0.552 . . . . 0.0 110.717 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 33.2 m -67.48 -37.27 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 O-C-N 121.687 -0.633 . . . . 0.0 110.225 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.93 95.25 Favored 'General case' 0 N--CA 1.524 3.23 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 18.3 m -71.32 -34.08 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 O-C-N 121.574 -0.704 . . . . 0.0 110.069 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -63.42 -44.32 94.95 Favored 'General case' 0 N--CA 1.528 3.431 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 13.0 m -68.67 -37.97 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 CA-C-N 118.643 0.656 . . . . 0.0 109.919 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 92.9 m -62.88 -27.54 69.42 Favored 'General case' 0 N--CA 1.522 3.14 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.99 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.79 -38.33 88.71 Favored 'General case' 0 N--CA 1.528 3.469 0 CA-C-O 120.939 0.4 . . . . 0.0 110.297 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 47.1 t -66.38 -36.73 83.59 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.632 0.773 . . . . 0.0 110.678 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.82 -13.67 16.88 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.847 0.859 . . . . 0.0 111.675 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 20.2 mt -86.6 -2.67 58.69 Favored 'General case' 0 N--CA 1.537 3.898 0 C-N-CA 123.059 0.543 . . . . 0.0 110.659 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -165.89 120.3 1.2 Allowed 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 123.441 0.696 . . . . 0.0 109.264 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.524 3.243 0 C-N-CA 124.211 1.005 . . . . 0.0 109.141 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.52 4.26 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.4 p -68.98 161.4 28.99 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.786 0.834 . . . . 0.0 110.936 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 211' ' ' LEU . 2.0 mm? -65.44 -26.19 67.85 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 124.73 1.212 . . . . 0.0 109.466 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 40.9 t -57.57 -39.17 76.14 Favored 'General case' 0 N--CA 1.518 2.928 0 C-N-CA 123.934 0.894 . . . . 0.0 112.273 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.36 -38.57 87.3 Favored Glycine 1 N--CA 1.522 4.419 0 C-N-CA 123.208 0.432 . . . . 0.0 112.115 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.18 -46.43 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 C-N-CA 124.107 0.963 . . . . 0.0 111.766 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.97 -31.85 53.76 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.066 0 C-N-CA 123.228 0.611 . . . . 0.0 109.872 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 30.9 mm -72.62 -33.38 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.9 -46.92 79.11 Favored Glycine 1 N--CA 1.518 4.119 0 N-CA-C 114.298 0.479 . . . . 0.0 114.298 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.12 -37.52 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.888 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.3 t -61.12 -38.04 84.94 Favored 'General case' 0 N--CA 1.539 3.989 0 CA-C-N 119.31 0.959 . . . . 0.0 111.464 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 59.6 t -56.67 -36.69 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 C-N-CA 123.067 0.547 . . . . 0.0 110.475 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.5 76.06 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.0 -49.72 71.34 Favored 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.73 -38.45 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.538 0 CA-C-O 119.003 -0.522 . . . . 0.0 112.26 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.25 -33.94 58.57 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.031 0 CA-C-N 119.323 0.965 . . . . 0.0 110.924 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.22 -47.14 71.74 Favored 'General case' 0 N--CA 1.538 3.934 0 CA-C-O 121.745 0.783 . . . . 0.0 109.566 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.2 mt -54.5 -36.77 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 123.305 0.642 . . . . 0.0 111.383 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.84 -39.21 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.919 0 C-N-CA 122.765 0.426 . . . . 0.0 109.886 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.87 97.98 Favored 'General case' 0 N--CA 1.529 3.5 0 C-N-CA 122.853 0.461 . . . . 0.0 111.146 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 50.8 t -71.82 -35.28 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.284 0 C-N-CA 123.221 0.608 . . . . 0.0 110.065 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -64.01 -44.45 92.58 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.96 -38.06 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 81.9 m -67.16 -32.6 73.8 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 123.344 0.658 . . . . 0.0 110.462 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -70.92 -39.72 72.53 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.319 0.648 . . . . 0.0 109.635 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 75.1 m -65.51 -34.91 79.38 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.773 0.829 . . . . 0.0 109.462 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.8 tp -68.99 -14.11 62.85 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 124.444 1.098 . . . . 0.0 109.904 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.3 -22.55 26.7 Favored 'General case' 0 N--CA 1.535 3.8 0 C-N-CA 124.23 1.012 . . . . 0.0 109.592 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -80.88 -8.84 59.83 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.515 0.726 . . . . 0.0 110.142 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -84.84 -65.44 1.01 Allowed 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 124.108 0.963 . . . . 0.0 110.563 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -70.36 65.31 0.28 Allowed 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.934 0.893 . . . . 0.0 111.178 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.537 3.904 0 C-N-CA 124.37 1.068 . . . . 0.0 108.607 178.585 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.517 2.88 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 47.8 mt -64.63 -28.21 69.46 Favored 'General case' 0 N--CA 1.521 3.098 0 C-N-CA 124.134 0.974 . . . . 0.0 111.286 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 46.5 t -59.02 -44.73 91.76 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.695 0.798 . . . . 0.0 112.371 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.52 -36.92 84.67 Favored Glycine 1 N--CA 1.521 4.353 0 C-N-CA 123.311 0.482 . . . . 0.0 112.248 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.92 -46.08 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 C-N-CA 123.514 0.726 . . . . 0.0 111.45 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.1 tp -68.58 -33.37 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 CA-C-N 118.55 0.614 . . . . 0.0 109.835 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 74.3 mt -68.85 -33.81 61.25 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.128 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.05 -29.71 76.07 Favored Glycine 0 N--CA 1.514 3.897 0 C-N-CA 123.626 0.631 . . . . 0.0 113.208 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -37.18 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 C-N-CA 123.144 0.578 . . . . 0.0 110.157 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 64.5 p -65.09 -47.78 76.04 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.09 -32.95 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 C-N-CA 123.145 0.578 . . . . 0.0 112.427 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.98 -47.1 81.59 Favored 'General case' 0 N--CA 1.526 3.372 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.13 86.54 Favored 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 123.152 0.581 . . . . 0.0 112.018 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -68.41 -53.13 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.291 0 C-N-CA 122.743 0.417 . . . . 0.0 111.939 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.96 -32.54 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -176.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 5.3 tt -69.7 -38.23 76.87 Favored 'General case' 0 N--CA 1.522 3.172 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 85.7 mt -66.38 -36.98 78.67 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.004 0 CA-C-N 118.856 0.753 . . . . 0.0 110.184 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -66.39 -37.8 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.8 86.13 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 123.48 0.712 . . . . 0.0 111.867 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 62.9 t -71.86 -35.09 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.058 0.543 . . . . 0.0 110.145 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -64.33 -44.14 92.44 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.9 -37.54 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.19 -27.14 68.76 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.33 0.652 . . . . 0.0 111.125 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -70.93 -25.97 62.99 Favored 'General case' 0 N--CA 1.529 3.52 0 C-N-CA 122.827 0.451 . . . . 0.0 111.165 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 48.0 m -65.96 -46.32 78.54 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 123.156 0.582 . . . . 0.0 112.152 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.7 pp -68.81 -12.97 62.1 Favored 'General case' 0 N--CA 1.53 3.553 0 C-N-CA 123.897 0.879 . . . . 0.0 112.045 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.8 tp . . . . . 0 N--CA 1.536 3.857 0 C-N-CA 123.227 0.611 . . . . 0.0 109.582 -178.349 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.521 3.099 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.85 -26.9 68.53 Favored 'General case' 0 N--CA 1.536 3.835 0 C-N-CA 124.267 1.027 . . . . 0.0 109.328 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 92.1 p -67.86 -25.86 65.75 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.552 0.741 . . . . 0.0 110.37 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.92 -46.22 68.25 Favored Glycine 0 N--CA 1.515 3.961 0 C-N-CA 123.729 0.68 . . . . 0.0 114.665 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.9 tt -70.59 -35.74 62.62 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.029 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.55 -44.29 80.39 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.409 0 CA-C-N 118.874 0.761 . . . . 0.0 112.873 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.3 tt -72.41 -32.77 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.88 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.62 -28.84 46.95 Favored Glycine 1 N--CA 1.517 4.082 0 C-N-CA 124.296 0.951 . . . . 0.0 113.158 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.5 m -59.42 -36.7 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.979 0 CA-C-O 121.08 0.467 . . . . 0.0 111.03 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 66.2 p -55.37 -44.6 76.2 Favored 'General case' 0 N--CA 1.527 3.421 0 C-N-CA 123.139 0.576 . . . . 0.0 111.86 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.28 -33.3 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 123.385 0.674 . . . . 0.0 110.529 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.39 83.91 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 122.658 0.383 . . . . 0.0 110.813 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.66 -50.44 73.86 Favored 'General case' 0 N--CA 1.518 2.964 0 C-N-CA 123.393 0.677 . . . . 0.0 112.826 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 34.5 m -68.04 -38.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 CA-C-N 118.288 0.495 . . . . 0.0 111.004 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.33 -38.91 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.798 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 39.3 tp -62.01 -34.9 77.05 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 122.804 0.441 . . . . 0.0 111.416 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.09 -46.21 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.869 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.39 -37.6 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 123.029 0.532 . . . . 0.0 109.943 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.4 -49.86 75.89 Favored 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 123.586 0.754 . . . . 0.0 112.507 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 11.9 p -71.89 -34.38 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 O-C-N 122.05 -0.406 . . . . 0.0 110.882 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -62.91 -44.34 96.36 Favored 'General case' 0 N--CA 1.529 3.488 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.28 -39.69 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.31 -28.38 67.95 Favored 'General case' 0 N--CA 1.522 3.166 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.08 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.64 -31.03 72.07 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 123.179 0.592 . . . . 0.0 111.092 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 39.2 t -63.96 -36.99 85.78 Favored 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 123.631 0.772 . . . . 0.0 111.639 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 50.3 tp -60.66 -24.34 65.51 Favored 'General case' 0 N--CA 1.528 3.436 0 C-N-CA 123.641 0.776 . . . . 0.0 111.848 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.97 8.26 27.19 Favored 'General case' 0 N--CA 1.538 3.95 0 C-N-CA 123.289 0.636 . . . . 0.0 110.036 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -164.43 71.21 0.2 Allowed 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 122.729 0.412 . . . . 0.0 110.171 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -75.42 163.43 27.43 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -74.43 137.13 42.44 Favored 'General case' 0 N--CA 1.522 3.166 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.53 3.575 0 C-N-CA 124.573 1.149 . . . . 0.0 109.189 -179.19 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.518 2.963 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.2 -26.51 68.17 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 124.311 1.044 . . . . 0.0 109.678 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 43.7 t -67.13 -33.08 74.67 Favored 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 123.767 0.827 . . . . 0.0 111.338 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.87 -46.93 58.22 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 114.251 0.461 . . . . 0.0 114.251 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 tt -69.58 -35.28 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.88 0 CA-C-N 117.544 0.672 . . . . 0.0 112.345 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 215' ' ' ILE . . . . . 0.461 ' O ' HG12 ' D' ' 218' ' ' VAL . 0.4 OUTLIER -56.51 -32.22 36.04 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 C-N-CA 123.447 0.699 . . . . 0.0 111.403 -177.395 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.86 -32.99 60.61 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.319 0 C-N-CA 122.934 0.494 . . . . 0.0 109.702 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.54 -29.33 47.67 Favored Glycine 1 N--CA 1.518 4.118 0 C-N-CA 123.802 0.715 . . . . 0.0 113.227 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 218' ' ' VAL . . . . . 0.461 HG12 ' O ' ' D' ' 215' ' ' ILE . 9.5 p -59.41 -37.49 69.92 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.102 0 C-N-CA 123.134 0.573 . . . . 0.0 110.633 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -59.34 -38.99 81.74 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 123.357 0.663 . . . . 0.0 111.252 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.93 -36.89 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.153 0 C-N-CA 123.783 0.833 . . . . 0.0 111.384 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.15 80.67 Favored 'General case' 0 N--CA 1.527 3.376 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.6 -49.95 42.27 Favored 'General case' 0 N--CA 1.518 2.94 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.4 -38.73 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.836 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.29 -32.25 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -36.09 74.34 Favored 'General case' 0 N--CA 1.534 3.754 0 C-N-CA 123.644 0.778 . . . . 0.0 109.833 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 37.2 mm -61.29 -36.98 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.894 0 C-N-CA 123.35 0.66 . . . . 0.0 110.553 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 40.5 t -66.13 -37.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 123.5 0.72 . . . . 0.0 109.892 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.08 77.85 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.51 0.724 . . . . 0.0 112.446 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.71 -34.32 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 O-C-N 122.125 -0.36 . . . . 0.0 110.646 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.99 -44.25 93.24 Favored 'General case' 0 N--CA 1.528 3.435 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.7 -37.75 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.717 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.15 -27.96 69.43 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.006 0.522 . . . . 0.0 111.227 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.69 -33.41 73.91 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 123.112 0.565 . . . . 0.0 110.762 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 49.8 m -63.79 -31.37 72.52 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.49 0.716 . . . . 0.0 112.173 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.34 -14.89 39.52 Favored 'General case' 0 N--CA 1.536 3.837 0 C-N-CA 123.725 0.81 . . . . 0.0 109.898 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -87.58 -11.65 48.03 Favored 'General case' 0 N--CA 1.533 3.716 0 C-N-CA 123.762 0.825 . . . . 0.0 110.962 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -0.55 0.29 Allowed 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.33 167.49 1.35 Allowed 'General case' 0 N--CA 1.531 3.576 0 C-N-CA 123.423 0.689 . . . . 0.0 111.417 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm . . . . . 0 N--CA 1.521 3.115 0 C-N-CA 124.115 0.966 . . . . 0.0 110.025 -179.667 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 95.4 p . . . . . 0 N--CA 1.525 3.279 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.72 -30.05 71.05 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 124.137 0.975 . . . . 0.0 109.9 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 60.4 m -58.37 -26.29 63.0 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 123.207 0.603 . . . . 0.0 110.803 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.29 -34.63 63.32 Favored Glycine 1 N--CA 1.517 4.057 0 C-N-CA 124.121 0.867 . . . . 0.0 113.571 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 13.2 tt -59.59 -44.99 94.48 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.049 0 CA-C-N 117.795 0.797 . . . . 0.0 112.911 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.4 pt -65.68 -34.92 73.6 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.437 0 CA-C-O 121.564 0.697 . . . . 0.0 110.038 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 49.3 mm -71.4 -33.57 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 124.183 0.993 . . . . 0.0 108.758 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.62 -31.02 78.48 Favored Glycine 1 N--CA 1.518 4.109 0 C-N-CA 123.389 0.519 . . . . 0.0 113.6 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 1.3 m -67.06 -37.35 79.13 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.103 0 CA-C-N 117.697 0.748 . . . . 0.0 110.397 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 37.4 p -60.81 -45.28 95.03 Favored 'General case' 0 N--CA 1.526 3.365 0 C-N-CA 123.168 0.587 . . . . 0.0 111.315 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.1 -36.53 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.254 0 C-N-CA 124.038 0.935 . . . . 0.0 111.325 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.91 -47.06 78.16 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 122.835 0.454 . . . . 0.0 112.027 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.72 90.85 Favored 'General case' 0 N--CA 1.52 3.073 0 C-N-CA 123.687 0.795 . . . . 0.0 111.655 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.46 -49.37 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 122.83 0.452 . . . . 0.0 110.699 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.15 -32.61 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.075 0.55 . . . . 0.0 110.312 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.08 -47.2 83.92 Favored 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 123.028 0.531 . . . . 0.0 111.048 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 80.1 mt -62.97 -38.86 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 C-N-CA 122.662 0.385 . . . . 0.0 110.477 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.19 -37.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 C-N-CA 123.288 0.635 . . . . 0.0 109.852 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.42 97.33 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.039 0.536 . . . . 0.0 111.334 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 62.8 t -71.74 -34.62 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.199 0.6 . . . . 0.0 109.749 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -63.46 -44.42 94.52 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.92 -37.7 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 77.5 m -67.12 -35.48 79.83 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.123 0.569 . . . . 0.0 110.295 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.67 -38.75 90.16 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 123.476 0.71 . . . . 0.0 111.282 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 86.7 p -65.1 -21.33 66.79 Favored 'General case' 0 N--CA 1.529 3.5 0 C-N-CA 123.082 0.553 . . . . 0.0 110.971 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.533 3.683 0 C-N-CA 123.958 0.903 . . . . 0.0 110.037 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.522 3.129 0 CA-C-O 121.4 0.619 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.19 -26.56 68.2 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 124.166 0.986 . . . . 0.0 109.445 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 65.5 m -57.66 -25.38 60.14 Favored 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.183 0.993 . . . . 0.0 111.415 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.0 -35.31 83.86 Favored Glycine 0 N--CA 1.515 3.923 0 C-N-CA 124.167 0.889 . . . . 0.0 115.267 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 12.2 tt -59.08 -35.09 55.35 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.593 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 9.3 tp -55.84 -31.85 30.97 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.31 -32.53 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.944 0 CA-C-N 118.383 0.538 . . . . 0.0 110.023 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.79 -29.54 54.91 Favored Glycine 0 N--CA 1.514 3.87 0 CA-C-O 119.555 -0.58 . . . . 0.0 113.873 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.6 m -59.92 -48.26 88.45 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 CA-C-N 118.075 0.938 . . . . 0.0 112.468 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 11.3 t -66.43 -38.76 88.14 Favored 'General case' 0 N--CA 1.536 3.847 0 O-C-N 121.955 -0.466 . . . . 0.0 110.98 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.87 -39.05 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.297 0 C-N-CA 123.46 0.704 . . . . 0.0 109.333 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.18 98.63 Favored 'General case' 0 N--CA 1.522 3.146 0 C-N-CA 123.137 0.575 . . . . 0.0 110.907 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.73 79.29 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 123.264 0.625 . . . . 0.0 111.781 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.37 -51.01 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.545 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.69 -33.25 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 123.632 0.773 . . . . 0.0 111.109 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 38.6 tp -66.07 -35.49 80.67 Favored 'General case' 0 N--CA 1.531 3.593 0 C-N-CA 122.513 0.325 . . . . 0.0 111.218 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 92.2 mt -69.2 -41.15 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.89 -37.96 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 123.413 0.685 . . . . 0.0 109.594 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.22 81.38 Favored 'General case' 0 N--CA 1.526 3.347 0 C-N-CA 123.81 0.844 . . . . 0.0 112.666 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.46 -34.0 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 O-C-N 121.872 -0.517 . . . . 0.0 109.98 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.73 -44.27 94.06 Favored 'General case' 0 N--CA 1.529 3.493 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.95 -37.53 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 98.0 m -59.42 -27.43 66.03 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.336 0.654 . . . . 0.0 111.316 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.34 -40.89 85.91 Favored 'General case' 0 N--CA 1.529 3.501 0 CA-C-O 121.078 0.466 . . . . 0.0 110.426 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 47.6 t -64.77 -17.58 64.3 Favored 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 124.129 0.972 . . . . 0.0 112.45 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.6 -15.08 63.14 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 122.977 0.511 . . . . 0.0 110.627 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.37 -28.7 22.04 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.115 0.566 . . . . 0.0 109.58 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -158.83 144.45 16.47 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.705 0.802 . . . . 0.0 108.98 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 N--CA 1.529 3.524 0 C-N-CA 124.725 1.21 . . . . 0.0 108.149 178.477 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.162 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 43.1 m 60.24 47.63 9.0 Favored 'General case' 0 N--CA 1.519 3.024 0 C-N-CA 124.317 1.047 . . . . 0.0 111.847 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.6 mp -65.14 -26.63 68.27 Favored 'General case' 0 N--CA 1.534 3.735 0 C-N-CA 123.829 0.852 . . . . 0.0 109.251 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 98.0 p -68.41 -27.43 66.2 Favored 'General case' 0 N--CA 1.521 3.076 0 C-N-CA 123.263 0.625 . . . . 0.0 110.049 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.46 -46.9 53.81 Favored Glycine 0 N--CA 1.513 3.779 0 N-CA-C 116.688 1.435 . . . . 0.0 116.688 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.5 pt -59.69 -35.24 58.61 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.467 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 -174.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.2 tt -56.75 -32.06 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 15.5 tt -70.78 -33.79 53.91 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 CA-C-N 120.131 1.332 . . . . 0.0 111.064 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.81 -43.63 80.92 Favored Glycine 1 N--CA 1.52 4.246 0 C-N-CA 123.053 0.359 . . . . 0.0 113.802 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.06 -37.29 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.977 0 O-C-N 121.639 -0.918 . . . . 0.0 110.922 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 61.3 p -64.84 -45.65 85.24 Favored 'General case' 0 N--CA 1.538 3.928 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.49 -30.87 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 C-N-CA 123.093 0.557 . . . . 0.0 111.766 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.43 -47.0 88.01 Favored 'General case' 0 N--CA 1.534 3.732 0 O-C-N 121.496 -0.753 . . . . 0.0 112.614 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.63 -44.24 96.79 Favored 'General case' 0 N--CA 1.521 3.124 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.65 -39.73 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.752 0 CA-C-N 118.773 0.715 . . . . 0.0 112.068 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.32 -34.15 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.339 0.518 . . . . 0.0 110.134 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.7 -48.06 78.65 Favored 'General case' 0 N--CA 1.524 3.24 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.6 pt -70.01 -36.74 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 O-C-N 122.065 -0.397 . . . . 0.0 111.339 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.3 -37.46 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.03 -41.13 82.57 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 122.968 0.507 . . . . 0.0 111.806 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.77 -37.12 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.192 0.597 . . . . 0.0 110.15 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -63.08 -44.16 96.52 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 123.211 0.604 . . . . 0.0 112.377 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.88 -37.62 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 93.2 m -64.68 -28.43 69.59 Favored 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 122.846 0.458 . . . . 0.0 110.727 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -72.93 -23.37 60.68 Favored 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 123.23 0.612 . . . . 0.0 110.924 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.1 m -66.19 -31.36 72.14 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 122.949 0.499 . . . . 0.0 111.432 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.68 -37.53 87.89 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.644 0.777 . . . . 0.0 112.377 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 pp -95.19 -16.26 22.68 Favored 'General case' 1 N--CA 1.547 4.392 0 C-N-CA 123.223 0.609 . . . . 0.0 111.531 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -67.1 -10.39 49.55 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 123.505 0.722 . . . . 0.0 111.193 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.1 116.2 4.01 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 123.625 0.77 . . . . 0.0 111.508 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.62 -162.99 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.648 0 C-N-CA 126.126 1.77 . . . . 0.0 114.538 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.528 3.474 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -179.846 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 71.9 p . . . . . 0 N--CA 1.522 3.128 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 48.4 mt -57.28 -25.82 59.85 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 124.873 1.269 . . . . 0.0 111.613 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.3 t -57.01 -37.69 72.06 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.581 0.752 . . . . 0.0 112.065 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.28 -46.32 57.65 Favored Glycine 1 N--CA 1.518 4.164 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.475 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.403 ' N ' HD12 ' B' ' 214' ' ' ILE . 1.5 mp -70.89 -46.38 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 124.53 1.132 . . . . 0.0 112.79 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 215' ' ' ILE . . . . . 0.477 ' O ' HG12 ' B' ' 218' ' ' VAL . 18.6 tt -57.07 -38.23 59.42 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -175.262 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 17.0 tt -72.83 -32.93 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.884 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.6 -29.14 47.69 Favored Glycine 0 N--CA 1.513 3.821 0 C-N-CA 124.19 0.9 . . . . 0.0 113.581 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 218' ' ' VAL . . . . . 0.477 HG12 ' O ' ' B' ' 215' ' ' ILE . 8.3 p -59.5 -37.74 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.875 0 CA-C-N 117.27 0.535 . . . . 0.0 111.157 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 69.0 p -63.87 -45.93 87.22 Favored 'General case' 0 N--CA 1.529 3.489 0 CA-C-O 121.224 0.535 . . . . 0.0 110.804 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.52 -34.69 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.059 0 C-N-CA 124.101 0.961 . . . . 0.0 110.962 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.61 -46.96 67.22 Favored 'General case' 0 N--CA 1.529 3.52 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.8 74.53 Favored 'General case' 0 N--CA 1.522 3.143 0 C-N-CA 123.285 0.634 . . . . 0.0 111.807 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -67.13 -41.38 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.438 0 C-N-CA 122.913 0.485 . . . . 0.0 110.451 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.94 -38.52 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 0 C-N-CA 122.899 0.48 . . . . 0.0 111.495 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 56.9 tp -66.77 -43.13 84.82 Favored 'General case' 0 N--CA 1.532 3.631 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.19 -39.15 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.809 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.77 -37.07 78.74 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 CA-C-N 118.717 0.69 . . . . 0.0 109.82 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.55 -32.08 66.75 Favored 'General case' 0 N--CA 1.525 3.305 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.24 -34.89 72.13 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.175 0 CA-C-N 119.286 0.948 . . . . 0.0 112.355 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.73 -43.98 91.67 Favored 'General case' 0 N--CA 1.536 3.871 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.92 -37.73 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.803 0 O-C-N 121.832 -0.543 . . . . 0.0 109.574 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.08 -27.92 67.77 Favored 'General case' 0 N--CA 1.527 3.391 0 C-N-CA 123.259 0.623 . . . . 0.0 111.148 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.16 -30.19 71.26 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.054 0.542 . . . . 0.0 110.507 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 34.9 t -63.82 -39.03 93.27 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.368 0.667 . . . . 0.0 110.774 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.12 -15.94 63.04 Favored 'General case' 0 N--CA 1.527 3.418 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.746 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 49.6 tp . . . . . 0 N--CA 1.537 3.901 0 C-N-CA 124.184 0.993 . . . . 0.0 109.523 179.871 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 100.0 p . . . . . 0 N--CA 1.522 3.134 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.66 -39.43 88.36 Favored 'General case' 0 N--CA 1.535 3.782 0 C-N-CA 124.129 0.972 . . . . 0.0 109.25 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 42.0 t -68.19 -32.24 72.33 Favored 'General case' 0 N--CA 1.517 2.92 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.487 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.41 -46.34 63.9 Favored Glycine 0 N--CA 1.514 3.896 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.443 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 41.8 pt -66.3 -38.49 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 CA-C-N 118.062 0.931 . . . . 0.0 112.344 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.98 -32.59 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.37 -32.8 43.66 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.23 -29.09 44.51 Favored Glycine 0 N--CA 1.513 3.819 0 C-N-CA 124.172 0.891 . . . . 0.0 113.529 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.46 -37.57 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 117.505 0.653 . . . . 0.0 110.739 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 61.4 p -63.08 -46.21 88.47 Favored 'General case' 0 N--CA 1.528 3.432 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.959 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.77 -38.08 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 124.226 1.011 . . . . 0.0 110.184 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.06 63.98 Favored 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 123.663 0.785 . . . . 0.0 112.659 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.67 75.0 Favored 'General case' 0 N--CA 1.519 3.009 0 C-N-CA 123.345 0.658 . . . . 0.0 111.664 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.8 -48.25 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.367 0 C-N-CA 123.165 0.586 . . . . 0.0 111.425 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.4 -32.45 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 C-N-CA 122.615 0.366 . . . . 0.0 110.537 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.44 -42.24 98.44 Favored 'General case' 0 N--CA 1.53 3.546 0 C-N-CA 123.361 0.664 . . . . 0.0 110.313 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 94.8 mt -65.72 -44.17 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 123.33 0.652 . . . . 0.0 109.753 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.45 -37.55 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.484 0 C-N-CA 123.32 0.648 . . . . 0.0 109.708 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.95 81.55 Favored 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.284 0.634 . . . . 0.0 112.322 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 17.6 m -71.9 -34.44 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 O-C-N 121.96 -0.463 . . . . 0.0 110.647 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.69 -44.44 93.69 Favored 'General case' 0 N--CA 1.53 3.536 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.89 -37.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.759 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 70.7 m -67.47 -39.15 85.27 Favored 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 122.966 0.507 . . . . 0.0 110.479 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.15 -32.77 63.27 Favored 'General case' 0 N--CA 1.524 3.271 0 C-N-CA 123.554 0.742 . . . . 0.0 111.008 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 86.3 p -63.76 -24.75 67.89 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.175 0.59 . . . . 0.0 111.505 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.59 -30.9 69.75 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.804 0.842 . . . . 0.0 110.355 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.24 1.9 56.0 Favored 'General case' 0 N--CA 1.535 3.82 0 C-N-CA 124.25 1.02 . . . . 0.0 110.128 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -59.65 -15.95 22.85 Favored 'General case' 0 N--CA 1.533 3.682 0 C-N-CA 123.239 0.616 . . . . 0.0 110.978 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -67.49 157.57 33.95 Favored 'General case' 0 N--CA 1.518 2.962 0 C-N-CA 124.176 0.99 . . . . 0.0 110.011 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -165.36 -22.09 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.429 0 C-N-CA 123.856 0.862 . . . . 0.0 109.624 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.529 3.505 0 C-N-CA 125.2 1.4 . . . . 0.0 108.406 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 89.9 p . . . . . 0 N--CA 1.522 3.136 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.13 -39.04 92.5 Favored 'General case' 0 N--CA 1.527 3.391 0 C-N-CA 124.055 0.942 . . . . 0.0 109.817 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 92.4 p -68.23 -27.71 66.6 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.082 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.65 -47.25 50.31 Favored Glycine 0 N--CA 1.504 3.21 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.543 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.48 -37.98 66.44 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.322 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -176.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 10.2 tp -56.87 -31.86 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.622 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 pt -59.74 -39.65 80.3 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.318 0 CA-C-N 119.325 0.966 . . . . 0.0 111.562 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.53 -28.87 46.32 Favored Glycine 0 N--CA 1.516 3.992 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.257 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 2.9 p -59.36 -46.66 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 C-N-CA 123.697 0.799 . . . . 0.0 112.753 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 3.2 t -66.08 -38.71 88.95 Favored 'General case' 0 N--CA 1.534 3.752 0 CA-C-O 121.217 0.532 . . . . 0.0 110.667 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.4 -34.81 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.033 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.484 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.78 79.07 Favored 'General case' 0 N--CA 1.527 3.377 0 C-N-CA 123.03 0.532 . . . . 0.0 111.533 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -49.93 44.9 Favored 'General case' 0 N--CA 1.511 2.58 0 C-N-CA 123.38 0.672 . . . . 0.0 112.588 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 21.8 m -61.04 -42.27 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.82 -32.09 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.68 0 C-N-CA 122.845 0.458 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.15 -40.24 53.12 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mp -54.98 -44.41 73.69 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 C-N-CA 124.128 0.971 . . . . 0.0 112.187 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 22.5 m -66.19 -36.88 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 O-C-N 121.762 -0.586 . . . . 0.0 111.129 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.49 85.97 Favored 'General case' 0 N--CA 1.529 3.481 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 11.3 m -71.68 -34.32 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 O-C-N 121.873 -0.517 . . . . 0.0 110.326 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -63.67 -43.96 95.13 Favored 'General case' 0 N--CA 1.531 3.615 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.5 -37.18 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.62 -28.64 65.83 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 122.704 0.402 . . . . 0.0 111.566 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -58.01 -16.56 13.05 Favored 'General case' 1 N--CA 1.54 4.073 0 CA-C-N 118.308 0.503 . . . . 0.0 111.56 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 45.8 t -68.14 -43.98 77.08 Favored 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.79 -27.48 68.31 Favored 'General case' 0 N--CA 1.528 3.435 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.396 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.19 10.45 16.86 Favored 'General case' 1 N--CA 1.542 4.127 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -159.89 98.98 1.37 Allowed 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 123.176 0.59 . . . . 0.0 109.839 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -137.72 144.12 41.56 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 125.087 1.355 . . . . 0.0 107.441 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.518 2.962 0 C-N-CA 123.786 0.834 . . . . 0.0 108.843 179.102 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.524 3.232 0 CA-C-O 119.947 -0.073 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 47.3 mt -63.55 -26.79 68.86 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.014 0.926 . . . . 0.0 110.54 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 94.3 p -62.07 -39.73 93.38 Favored 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 123.844 0.858 . . . . 0.0 110.741 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.06 -39.98 83.89 Favored Glycine 1 N--CA 1.517 4.061 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.656 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.65 -46.36 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.405 0 C-N-CA 124.026 0.93 . . . . 0.0 112.669 -176.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.4 tt -61.94 -37.53 78.49 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.024 0 O-C-N 121.915 -0.49 . . . . 0.0 112.294 -176.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.1 tp -73.18 -33.65 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.684 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.8 -46.86 91.83 Favored Glycine 1 N--CA 1.516 4.009 0 CA-C-N 115.781 -0.645 . . . . 0.0 114.487 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.94 -37.42 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.844 0 CA-C-N 117.806 0.803 . . . . 0.0 110.899 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 54.5 p -66.36 -45.75 79.08 Favored 'General case' 0 N--CA 1.531 3.592 0 CA-C-O 120.914 0.388 . . . . 0.0 111.113 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.67 -31.37 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.417 0 C-N-CA 123.918 0.887 . . . . 0.0 111.212 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.71 72.48 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.03 -49.26 53.06 Favored 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.54 -39.81 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 31.9 m -68.02 -35.41 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 CA-C-N 118.519 0.6 . . . . 0.0 112.017 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 26.3 tp -69.87 -42.72 73.12 Favored 'General case' 0 N--CA 1.524 3.261 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 33.2 pt -66.67 -35.83 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.838 0.745 . . . . 0.0 111.153 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 92.9 t -65.05 -37.67 80.81 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.036 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.46 -35.81 74.79 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 123.17 0.588 . . . . 0.0 111.665 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 71.0 t -71.9 -36.33 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.27 0 C-N-CA 123.45 0.7 . . . . 0.0 110.762 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.07 -43.96 81.33 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.52 -38.01 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.519 0 C-N-CA 122.555 0.342 . . . . 0.0 110.893 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 14.4 p -67.11 -27.8 67.63 Favored 'General case' 0 N--CA 1.534 3.765 0 CA-C-N 117.876 0.307 . . . . 0.0 111.297 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -60.43 -30.04 69.38 Favored 'General case' 0 N--CA 1.529 3.489 0 C-N-CA 123.153 0.581 . . . . 0.0 110.965 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 45.6 t -64.94 -41.77 95.23 Favored 'General case' 0 N--CA 1.525 3.322 0 CA-C-O 121.695 0.759 . . . . 0.0 110.572 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 45.6 mt . . . . . 0 N--CA 1.518 2.938 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.053 -179.284 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.521 3.123 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.13 -26.91 68.39 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.785 0.834 . . . . 0.0 110.451 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 67.1 m -68.61 -35.18 76.98 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 123.544 0.737 . . . . 0.0 110.308 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.68 -43.2 76.99 Favored Glycine 1 N--CA 1.517 4.044 0 CA-C-N 115.228 -0.896 . . . . 0.0 115.17 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 214' ' ' ILE . . . . . 0.409 ' O ' HD13 ' F' ' 214' ' ' ILE . 0.0 OUTLIER -70.72 -45.85 71.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 CA-C-N 118.026 0.913 . . . . 0.0 111.406 -176.863 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 19.8 tt -60.83 -34.35 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 44.9 pt -72.57 -32.81 42.85 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.195 0 CA-C-N 119.556 1.071 . . . . 0.0 108.929 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.88 -29.77 51.6 Favored Glycine 0 N--CA 1.514 3.872 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.979 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.0 -37.53 72.88 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.021 0 CA-C-N 117.588 0.694 . . . . 0.0 110.963 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 43.1 p -62.99 -46.21 88.73 Favored 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.048 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.95 -36.06 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.151 0 C-N-CA 124.212 1.005 . . . . 0.0 110.749 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.42 -43.13 64.64 Favored 'General case' 0 N--CA 1.525 3.313 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.73 -43.11 85.1 Favored 'General case' 0 N--CA 1.519 3.012 0 C-N-CA 123.261 0.624 . . . . 0.0 111.972 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 36.9 t -66.72 -45.56 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 C-N-CA 122.943 0.497 . . . . 0.0 111.022 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.16 -38.83 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 123.263 0.625 . . . . 0.0 111.153 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.81 -34.63 78.6 Favored 'General case' 0 N--CA 1.532 3.64 0 CA-C-N 117.828 0.285 . . . . 0.0 110.803 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.67 -44.26 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.886 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.04 -37.77 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.625 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.65 -48.22 81.77 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.731 0.813 . . . . 0.0 112.807 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.58 -34.22 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 O-C-N 121.948 -0.47 . . . . 0.0 110.084 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -64.01 -44.13 93.53 Favored 'General case' 0 N--CA 1.527 3.401 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.71 -37.74 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 98.9 m -61.66 -27.92 69.02 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.039 0.536 . . . . 0.0 111.212 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -67.62 -30.62 70.24 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 122.947 0.499 . . . . 0.0 111.49 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 49.4 m -64.04 -31.99 73.38 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 123.324 0.649 . . . . 0.0 112.407 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.78 -33.0 72.31 Favored 'General case' 0 N--CA 1.534 3.754 0 C-N-CA 123.793 0.837 . . . . 0.0 112.379 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 236' ' ' LEU . . . . . 0.544 HD13 ' H ' ' F' ' 236' ' ' LEU . 0.0 OUTLIER -110.33 10.97 23.47 Favored 'General case' 1 N--CA 1.547 4.399 0 C-N-CA 124.019 0.928 . . . . 0.0 111.466 -179.773 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 31.7 t90 -139.25 79.24 1.71 Allowed 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 124.374 1.07 . . . . 0.0 108.648 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.525 3.277 0 C-N-CA 124.159 0.984 . . . . 0.0 109.963 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.1 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.8 m -161.22 44.25 0.17 Allowed 'General case' 0 N--CA 1.52 3.067 0 C-N-CA 123.684 0.794 . . . . 0.0 109.185 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 48.2 mt -64.72 -41.18 96.16 Favored 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 123.972 0.909 . . . . 0.0 110.123 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 95.3 p -57.95 -26.96 62.95 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 123.271 0.629 . . . . 0.0 110.678 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.21 -41.52 86.08 Favored Glycine 1 N--CA 1.52 4.266 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 62.3 mt -65.62 -37.1 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 C-N-CA 124.348 1.059 . . . . 0.0 109.083 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 45.6 mm -67.48 -40.81 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 C-N-CA 124.151 0.981 . . . . 0.0 108.384 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 87.7 mt -72.33 -33.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.04 -29.72 75.24 Favored Glycine 1 N--CA 1.518 4.111 0 C-N-CA 123.336 0.493 . . . . 0.0 112.458 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -37.23 72.81 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.18 0 C-N-CA 123.394 0.678 . . . . 0.0 109.916 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -57.46 -45.24 84.98 Favored 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.342 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 51.2 t -56.57 -42.07 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 C-N-CA 124.323 1.049 . . . . 0.0 111.454 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.62 -40.74 63.04 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.96 -37.25 75.76 Favored 'General case' 0 N--CA 1.523 3.179 0 C-N-CA 123.114 0.566 . . . . 0.0 111.726 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.09 -48.52 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.502 0 C-N-CA 123.492 0.717 . . . . 0.0 111.359 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.14 -32.62 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 O-C-N 121.926 -0.484 . . . . 0.0 111.847 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.15 -40.65 37.29 Favored 'General case' 0 N--CA 1.534 3.748 0 C-N-CA 122.61 0.364 . . . . 0.0 111.705 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.42 -38.78 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.355 0.525 . . . . 0.0 111.711 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 35.4 m -67.89 -37.59 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.564 0 CA-C-O 121.047 0.451 . . . . 0.0 110.406 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.05 97.17 Favored 'General case' 0 N--CA 1.523 3.21 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.03 -33.95 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 O-C-N 121.726 -0.609 . . . . 0.0 110.149 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -60.03 -44.27 94.73 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.95 -42.08 82.12 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 CA-C-O 121.681 0.753 . . . . 0.0 109.468 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 83.0 m -61.57 -27.56 68.71 Favored 'General case' 0 N--CA 1.518 2.955 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.293 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.21 -30.9 71.84 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 122.635 0.374 . . . . 0.0 110.373 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 34.0 t -64.01 -35.17 79.82 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.243 0.617 . . . . 0.0 111.152 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.91 -18.42 56.54 Favored 'General case' 0 N--CA 1.532 3.636 0 C-N-CA 122.968 0.507 . . . . 0.0 111.592 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.54 -2.01 58.32 Favored 'General case' 1 N--CA 1.541 4.119 0 C-N-CA 123.054 0.542 . . . . 0.0 109.86 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -66.62 -68.47 0.37 Allowed 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.172 0.589 . . . . 0.0 110.005 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 56.96 176.98 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.227 0 C-N-CA 124.26 1.024 . . . . 0.0 112.024 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -69.97 -178.22 1.53 Allowed 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 124.0 0.92 . . . . 0.0 110.359 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.529 3.498 0 C-N-CA 125.203 1.401 . . . . 0.0 108.228 179.8 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.52 3.068 0 CA-C-O 121.387 0.613 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 53.9 mt -65.1 -26.83 68.38 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.6 0.76 . . . . 0.0 109.996 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -65.82 -29.23 69.67 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.34 0.656 . . . . 0.0 110.519 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.52 -35.68 81.9 Favored Glycine 1 N--CA 1.523 4.451 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.21 -45.97 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 C-N-CA 124.037 0.935 . . . . 0.0 111.555 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.7 pt -65.22 -33.21 62.12 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.492 0 CA-C-O 121.844 0.83 . . . . 0.0 110.019 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 40.0 mm -73.06 -33.67 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.285 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.45 -48.26 77.32 Favored Glycine 1 N--CA 1.52 4.249 0 C-N-CA 123.435 0.541 . . . . 0.0 114.29 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.96 -37.71 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.77 0 CA-C-N 117.434 0.617 . . . . 0.0 110.861 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 72.7 p -66.64 -45.92 77.46 Favored 'General case' 0 N--CA 1.533 3.722 0 CA-C-N 118.141 0.428 . . . . 0.0 111.354 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.48 -31.53 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.25 0 C-N-CA 123.797 0.839 . . . . 0.0 111.301 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.49 -37.23 75.12 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.21 -50.08 43.67 Favored 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.13 -38.46 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.32 -32.5 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 36.2 tp -77.84 -39.4 43.64 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.0 pt -69.51 -37.01 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 CA-C-N 119.053 0.842 . . . . 0.0 112.171 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.0 -37.09 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 121.838 -0.539 . . . . 0.0 110.15 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.19 79.87 Favored 'General case' 0 N--CA 1.525 3.3 0 C-N-CA 123.78 0.832 . . . . 0.0 112.888 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.64 -34.43 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 O-C-N 121.926 -0.484 . . . . 0.0 110.394 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -64.38 -44.08 92.45 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 123.091 0.556 . . . . 0.0 112.307 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.85 -37.57 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.704 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 83.4 m -64.35 -27.84 69.29 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.066 0.546 . . . . 0.0 111.018 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -69.3 -30.52 68.62 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.089 0.556 . . . . 0.0 111.05 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 82.4 p -64.73 -31.22 72.35 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.198 0.599 . . . . 0.0 111.706 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.3 -17.32 62.41 Favored 'General case' 0 N--CA 1.536 3.825 0 C-N-CA 123.462 0.705 . . . . 0.0 111.085 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.537 3.892 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.519 3.025 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 45.8 mt -61.07 -26.2 67.48 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.49 1.116 . . . . 0.0 111.279 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 63.5 m -57.75 -43.49 85.43 Favored 'General case' 0 N--CA 1.522 3.174 0 C-N-CA 123.677 0.791 . . . . 0.0 112.097 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.62 81.28 Favored Glycine 1 N--CA 1.523 4.443 0 C-N-CA 123.559 0.599 . . . . 0.0 112.707 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 41.6 mm -59.98 -46.54 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.627 0 C-N-CA 123.979 0.912 . . . . 0.0 112.898 -176.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 215' ' ' ILE . . . . . 0.452 ' O ' HD13 ' C' ' 215' ' ' ILE . 0.1 OUTLIER -69.01 -35.77 70.63 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.683 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.5 mm -72.25 -33.36 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.04 -29.72 56.15 Favored Glycine 0 N--CA 1.513 3.798 0 C-N-CA 124.018 0.818 . . . . 0.0 113.415 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 m -59.98 -37.63 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 CA-C-N 117.349 0.574 . . . . 0.0 110.89 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 43.7 p -61.09 -46.72 89.5 Favored 'General case' 0 N--CA 1.526 3.34 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.213 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.96 -39.87 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.037 0 C-N-CA 124.277 1.031 . . . . 0.0 110.453 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.41 -38.42 58.99 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.11 -43.38 82.59 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 122.952 0.501 . . . . 0.0 110.562 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.08 -43.31 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.368 0 C-N-CA 123.773 0.829 . . . . 0.0 110.811 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.6 -32.31 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.56 0 C-N-CA 123.468 0.707 . . . . 0.0 109.969 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -45.71 91.04 Favored 'General case' 0 N--CA 1.537 3.925 0 CA-C-O 121.293 0.568 . . . . 0.0 109.939 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 80.9 mt -54.94 -35.89 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.821 0 C-N-CA 123.615 0.766 . . . . 0.0 111.028 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.42 -36.1 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 C-N-CA 123.117 0.567 . . . . 0.0 110.487 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.2 64.63 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 3.1 m -64.41 -34.87 72.17 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.426 0 CA-C-N 119.582 1.083 . . . . 0.0 110.619 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -72.94 -31.93 64.93 Favored 'General case' 0 N--CA 1.529 3.496 0 C-N-CA 123.093 0.557 . . . . 0.0 110.04 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.44 -37.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.579 0 C-N-CA 123.41 0.684 . . . . 0.0 109.29 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.58 -36.58 74.19 Favored 'General case' 0 N--CA 1.525 3.324 0 CA-C-O 121.073 0.463 . . . . 0.0 110.06 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.33 -38.2 63.35 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.201 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.8 m -63.91 -46.7 83.63 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 123.066 0.546 . . . . 0.0 110.846 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 85.1 mt -67.05 -18.01 65.16 Favored 'General case' 0 N--CA 1.53 3.53 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.706 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 41.7 tp -92.4 -11.66 34.31 Favored 'General case' 1 N--CA 1.539 4.008 0 C-N-CA 123.907 0.883 . . . . 0.0 110.141 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -51.41 -26.31 7.72 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.993 0.917 . . . . 0.0 112.308 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -65.43 143.15 57.89 Favored 'General case' 0 N--CA 1.526 3.375 0 C-N-CA 123.375 0.67 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.66 8.42 Favored 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 124.119 0.968 . . . . 0.0 108.81 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.529 3.515 0 C-N-CA 124.832 1.253 . . . . 0.0 108.523 179.944 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.523 3.187 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.09 -43.18 92.98 Favored 'General case' 0 N--CA 1.534 3.746 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 89.4 p -58.94 -26.3 64.27 Favored 'General case' 0 N--CA 1.526 3.374 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.823 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.47 -34.43 79.3 Favored Glycine 0 N--CA 1.506 3.363 0 C-N-CA 124.64 1.114 . . . . 0.0 113.68 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -35.26 52.63 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.297 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -174.057 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 16.8 tt -55.96 -32.42 33.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.81 -32.31 48.53 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.258 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.65 -40.59 96.66 Favored Glycine 1 N--CA 1.519 4.167 0 CA-C-O 119.653 -0.526 . . . . 0.0 113.653 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.45 -37.07 78.22 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 CA-C-N 118.458 1.129 . . . . 0.0 109.924 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 89.1 m -56.0 -45.1 79.16 Favored 'General case' 0 N--CA 1.522 3.163 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.54 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.53 -41.66 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 123.385 0.674 . . . . 0.0 110.7 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.82 -35.59 64.07 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.63 -50.36 37.82 Favored 'General case' 0 N--CA 1.521 3.094 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 12.9 p -68.02 -38.59 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.567 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.34 -31.99 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 CA-C-N 118.161 0.437 . . . . 0.0 110.237 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.97 -34.86 63.7 Favored 'General case' 1 N--CA 1.54 4.062 0 CA-C-O 121.485 0.66 . . . . 0.0 110.607 -178.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 67.4 mt -61.14 -36.04 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 124.002 0.921 . . . . 0.0 110.76 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.68 -37.64 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 123.272 0.629 . . . . 0.0 110.226 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -47.59 84.71 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.401 0.681 . . . . 0.0 112.571 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.56 -34.06 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.624 0 O-C-N 121.866 -0.521 . . . . 0.0 110.168 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.97 -44.2 97.24 Favored 'General case' 0 N--CA 1.529 3.503 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.86 -37.84 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 70.8 m -62.06 -27.57 68.99 Favored 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.081 0.552 . . . . 0.0 111.11 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -59.76 -18.66 44.88 Favored 'General case' 0 N--CA 1.533 3.706 0 C-N-CA 122.946 0.498 . . . . 0.0 111.244 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 97.3 p -73.81 -40.08 63.63 Favored 'General case' 0 N--CA 1.524 3.275 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.15 -14.88 63.32 Favored 'General case' 0 N--CA 1.537 3.895 0 C-N-CA 123.411 0.684 . . . . 0.0 110.481 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 57.2 tp -89.62 -28.9 19.21 Favored 'General case' 1 N--CA 1.54 4.045 0 C-N-CA 124.252 1.021 . . . . 0.0 109.826 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -79.88 -71.36 0.46 Allowed 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 43.6 tptt 44.62 17.31 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? . . . . . 0 N--CA 1.529 3.523 0 C-N-CA 123.921 0.888 . . . . 0.0 109.094 179.648 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.523 3.181 0 N-CA-C 111.203 0.075 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 mp -64.22 -26.93 68.73 Favored 'General case' 1 N--CA 1.54 4.041 0 C-N-CA 123.498 0.719 . . . . 0.0 109.116 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 39.2 t -63.68 -35.85 81.91 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 123.805 0.842 . . . . 0.0 111.21 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.27 -35.69 83.22 Favored Glycine 1 N--CA 1.519 4.2 0 C-N-CA 123.846 0.736 . . . . 0.0 112.549 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.17 -47.04 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 C-N-CA 123.857 0.863 . . . . 0.0 112.292 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.83 -32.51 52.19 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 CA-C-N 118.564 0.62 . . . . 0.0 109.684 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.66 -32.24 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.76 -29.49 41.63 Favored Glycine 0 N--CA 1.511 3.698 0 C-N-CA 123.843 0.735 . . . . 0.0 113.402 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 m -60.32 -37.59 74.56 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.108 0 CA-C-N 117.918 0.859 . . . . 0.0 110.381 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 37.8 p -60.02 -45.8 91.61 Favored 'General case' 0 N--CA 1.528 3.47 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.235 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 47.6 t -69.49 -37.83 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 C-N-CA 124.229 1.012 . . . . 0.0 111.091 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.61 -42.96 65.06 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.85 -31.85 72.73 Favored 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 123.067 0.547 . . . . 0.0 111.748 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.05 -39.51 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.529 0 C-N-CA 123.089 0.556 . . . . 0.0 110.384 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.89 -33.01 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 C-N-CA 123.389 0.676 . . . . 0.0 110.558 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.59 -45.93 84.89 Favored 'General case' 0 N--CA 1.532 3.631 0 C-N-CA 122.715 0.406 . . . . 0.0 109.923 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 73.2 mt -54.78 -36.53 37.27 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 C-N-CA 122.851 0.46 . . . . 0.0 110.891 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.62 -37.88 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 C-N-CA 123.029 0.532 . . . . 0.0 109.889 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.95 -32.36 69.54 Favored 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.43 0.692 . . . . 0.0 111.387 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.17 -34.72 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.23 0 C-N-CA 123.638 0.775 . . . . 0.0 111.16 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -69.13 -43.98 73.3 Favored 'General case' 0 N--CA 1.531 3.586 0 O-C-N 122.059 -0.401 . . . . 0.0 112.015 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.69 -37.62 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 122.688 0.395 . . . . 0.0 110.661 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 12.3 p -59.98 -27.54 66.93 Favored 'General case' 0 N--CA 1.535 3.8 0 CA-C-N 118.089 0.404 . . . . 0.0 111.078 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -59.99 -27.01 66.5 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 123.393 0.677 . . . . 0.0 111.134 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 48.7 m -63.96 -33.99 76.96 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.401 0.68 . . . . 0.0 110.889 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 N--CA 1.525 3.292 0 C-N-CA 124.483 1.113 . . . . 0.0 111.973 -179.538 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 N--CA 1.521 3.098 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.14 -27.01 68.43 Favored 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 124.246 1.018 . . . . 0.0 110.369 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 50.3 m -57.79 -26.19 61.58 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.1 0.56 . . . . 0.0 111.074 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.38 -34.58 63.61 Favored Glycine 1 N--CA 1.516 4.011 0 C-N-CA 124.362 0.982 . . . . 0.0 113.612 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 10.9 tp -59.32 -43.68 90.6 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 5.8 pt -66.73 -35.99 76.14 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.389 0 CA-C-O 121.906 0.86 . . . . 0.0 109.437 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 87.8 mt -72.68 -40.05 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.254 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.507 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.58 -48.76 84.46 Favored Glycine 1 N--CA 1.518 4.126 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.874 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.31 -36.55 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 123.036 0.535 . . . . 0.0 109.869 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 90.5 m -64.33 -47.5 79.17 Favored 'General case' 0 N--CA 1.523 3.202 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.69 -31.62 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.64 0 C-N-CA 122.76 0.424 . . . . 0.0 111.257 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.05 -47.18 68.63 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.223 0.609 . . . . 0.0 112.614 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.41 69.96 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.346 0.658 . . . . 0.0 112.548 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 45.3 t -68.09 -53.16 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.462 0 O-C-N 122.109 -0.37 . . . . 0.0 111.113 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.39 -32.14 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.361 0 C-N-CA 123.144 0.578 . . . . 0.0 112.411 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -39.03 55.97 Favored 'General case' 1 N--CA 1.541 4.085 0 C-N-CA 122.698 0.399 . . . . 0.0 111.467 -177.317 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 95.3 mt -69.1 -40.78 81.07 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 O-C-N 121.193 -0.942 . . . . 0.0 111.172 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.76 -36.51 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 O-C-N 121.476 -0.765 . . . . 0.0 109.894 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.21 -45.56 83.72 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.455 0.702 . . . . 0.0 112.621 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 16.8 m -71.86 -34.54 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 O-C-N 121.785 -0.572 . . . . 0.0 110.3 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.19 -44.2 92.74 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.67 -37.53 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 90.2 m -65.22 -29.76 70.59 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.063 0.545 . . . . 0.0 110.739 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -69.5 -39.49 77.55 Favored 'General case' 0 N--CA 1.529 3.499 0 C-N-CA 122.846 0.458 . . . . 0.0 109.927 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.8 t -64.06 -17.93 63.87 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 123.569 0.748 . . . . 0.0 111.386 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.57 -24.48 64.61 Favored 'General case' 0 N--CA 1.532 3.628 0 C-N-CA 124.096 0.958 . . . . 0.0 109.352 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -87.41 -26.56 23.24 Favored 'General case' 0 N--CA 1.539 3.982 0 C-N-CA 123.587 0.755 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -63.95 -69.79 0.26 Allowed 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.261 0.624 . . . . 0.0 110.74 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 61.5 pttt . . . . . 0 N--CA 1.526 3.371 0 C-N-CA 123.615 0.766 . . . . 0.0 110.81 -179.803 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.223 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.3 p -69.77 139.5 53.27 Favored 'General case' 0 N--CA 1.522 3.144 0 C-N-CA 123.647 0.779 . . . . 0.0 110.326 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.4 mp -65.35 -26.4 68.01 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 124.072 0.949 . . . . 0.0 109.536 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 38.8 t -67.72 -27.52 66.87 Favored 'General case' 0 N--CA 1.519 3.009 0 C-N-CA 123.4 0.68 . . . . 0.0 110.527 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.92 -47.16 56.59 Favored Glycine 0 N--CA 1.504 3.217 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -70.55 -41.69 78.02 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.223 0 CA-C-N 118.085 0.943 . . . . 0.0 113.499 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 tt -59.23 -31.03 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 C-N-CA 123.614 0.766 . . . . 0.0 111.734 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -33.4 50.23 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.352 0 O-C-N 121.8 -0.562 . . . . 0.0 109.664 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.02 -38.5 65.85 Favored Glycine 1 N--CA 1.518 4.137 0 N-CA-C 115.282 0.873 . . . . 0.0 115.282 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.49 -37.53 77.91 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.285 0 CA-C-N 118.355 1.078 . . . . 0.0 111.199 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.7 p -63.46 -46.02 88.15 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.48 -31.42 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.553 0 C-N-CA 123.424 0.69 . . . . 0.0 110.981 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.3 -47.02 72.87 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.22 -34.94 74.35 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.484 0.714 . . . . 0.0 112.376 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.61 -40.44 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.292 0 C-N-CA 123.482 0.713 . . . . 0.0 111.178 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.18 -45.19 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 C-N-CA 122.722 0.409 . . . . 0.0 110.985 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.55 -34.79 78.58 Favored 'General case' 0 N--CA 1.535 3.793 0 C-N-CA 122.418 0.287 . . . . 0.0 110.424 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 74.7 mt -64.35 -44.94 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.705 0 C-N-CA 122.581 0.352 . . . . 0.0 110.531 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.11 -41.05 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.684 0 O-C-N 121.829 -0.544 . . . . 0.0 109.842 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.38 94.58 Favored 'General case' 0 N--CA 1.524 3.252 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.0 m -71.51 -34.05 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 O-C-N 121.603 -0.686 . . . . 0.0 110.194 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -61.13 -44.11 97.84 Favored 'General case' 0 N--CA 1.526 3.341 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 10.1 m -68.84 -41.39 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.83 0 CA-C-N 118.596 0.635 . . . . 0.0 109.576 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 74.5 m -60.52 -27.75 67.86 Favored 'General case' 0 N--CA 1.523 3.215 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.326 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -66.65 -35.06 79.27 Favored 'General case' 0 N--CA 1.523 3.186 0 C-N-CA 122.675 0.39 . . . . 0.0 110.362 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 31.8 t -64.28 -38.48 91.19 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.424 0.69 . . . . 0.0 111.234 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.75 -13.99 18.47 Favored 'General case' 0 N--CA 1.536 3.852 0 C-N-CA 123.265 0.626 . . . . 0.0 110.998 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.06 -17.95 31.71 Favored 'General case' 0 N--CA 1.534 3.735 0 C-N-CA 123.02 0.528 . . . . 0.0 110.281 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -88.9 3.09 52.55 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 124.146 0.978 . . . . 0.0 111.13 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -64.28 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 123.107 0.563 . . . . 0.0 110.171 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -71.2 148.36 47.37 Favored 'General case' 0 N--CA 1.522 3.142 0 C-N-CA 123.698 0.799 . . . . 0.0 110.03 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.531 3.599 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.396 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.521 3.09 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.21 -26.22 68.03 Favored 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 124.703 1.201 . . . . 0.0 110.517 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 43.7 t -57.05 -24.99 57.84 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.539 0.736 . . . . 0.0 111.092 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.91 -47.01 82.29 Favored Glycine 1 N--CA 1.518 4.136 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.455 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 29.3 pt -71.6 -35.7 57.08 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.163 0 CA-C-N 118.204 1.002 . . . . 0.0 111.095 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 45.3 mm -57.23 -44.44 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.84 0 C-N-CA 124.474 1.11 . . . . 0.0 111.972 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.1 tp -72.41 -33.09 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.82 -44.68 97.73 Favored Glycine 1 N--CA 1.517 4.071 0 C-N-CA 123.919 0.771 . . . . 0.0 114.158 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.7 -37.21 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.726 0 CA-C-N 117.727 0.763 . . . . 0.0 110.905 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 67.4 p -65.44 -46.14 81.08 Favored 'General case' 0 N--CA 1.534 3.729 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.56 -31.03 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 C-N-CA 122.621 0.368 . . . . 0.0 111.262 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.22 -42.69 63.76 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.8 88.53 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.092 0.557 . . . . 0.0 111.249 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 24.3 t -64.66 -40.27 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 123.779 0.832 . . . . 0.0 111.234 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.57 -32.45 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 C-N-CA 123.247 0.619 . . . . 0.0 110.943 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 tp -76.54 -42.96 41.2 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.5 -44.05 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 C-N-CA 122.976 0.511 . . . . 0.0 111.841 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.27 -37.04 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.892 0 CA-C-N 118.575 0.625 . . . . 0.0 110.365 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.33 79.46 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.098 0.559 . . . . 0.0 111.812 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 90.3 t -71.66 -35.01 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 122.748 0.419 . . . . 0.0 109.995 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.29 -44.54 96.29 Favored 'General case' 0 N--CA 1.532 3.655 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.04 -38.25 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 73.4 m -67.2 -30.46 70.41 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 122.987 0.515 . . . . 0.0 110.711 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -67.34 -25.3 65.93 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.453 0.701 . . . . 0.0 111.097 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -63.91 -40.28 96.13 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.206 0.602 . . . . 0.0 111.292 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.95 -23.1 65.05 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.636 0.774 . . . . 0.0 110.734 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 N--CA 1.537 3.912 0 C-N-CA 124.129 0.971 . . . . 0.0 109.524 -179.564 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 N--CA 1.52 3.075 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.46 -40.98 96.73 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 123.636 0.774 . . . . 0.0 110.626 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 40.4 t -69.6 -26.59 64.52 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 123.144 0.577 . . . . 0.0 110.719 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.58 -46.03 64.11 Favored Glycine 1 N--CA 1.517 4.061 0 N-CA-C 116.508 1.363 . . . . 0.0 116.508 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -35.01 60.59 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 CA-C-N 119.806 1.803 . . . . 0.0 112.274 -176.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 2.7 pt -58.92 -45.0 92.1 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.491 0 CA-C-N 118.694 0.679 . . . . 0.0 111.812 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.0 pt -68.99 -32.99 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 C-N-CA 122.986 0.514 . . . . 0.0 109.75 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.7 -29.94 68.1 Favored Glycine 0 N--CA 1.513 3.783 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.425 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 2.7 m -60.38 -37.65 75.06 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.006 0 CA-C-N 117.847 0.823 . . . . 0.0 111.142 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 56.2 p -63.14 -46.67 86.15 Favored 'General case' 0 N--CA 1.526 3.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.444 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 47.2 t -70.1 -33.57 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.086 0 C-N-CA 124.158 0.983 . . . . 0.0 110.5 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.91 90.04 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.538 0.735 . . . . 0.0 112.523 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.97 -48.55 70.9 Favored 'General case' 0 N--CA 1.516 2.841 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.4 m -67.9 -39.96 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.55 -34.16 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 CA-C-N 119.354 0.979 . . . . 0.0 111.759 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 45.1 tp -67.83 -47.59 68.57 Favored 'General case' 0 N--CA 1.528 3.425 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 27.7 pt -68.95 -36.3 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-N 118.231 0.469 . . . . 0.0 111.002 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.48 -37.42 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.962 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.25 72.47 Favored 'General case' 0 N--CA 1.533 3.683 0 C-N-CA 122.931 0.492 . . . . 0.0 112.086 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.77 -37.05 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.066 0.546 . . . . 0.0 110.304 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -63.31 -44.08 96.01 Favored 'General case' 0 N--CA 1.532 3.64 0 C-N-CA 123.135 0.574 . . . . 0.0 112.443 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.62 -37.46 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.63 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 98.0 m -62.2 -29.72 70.58 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 122.879 0.472 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -69.58 -27.67 65.32 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.214 0.606 . . . . 0.0 111.07 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 30.3 t -64.07 -32.72 74.38 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 123.204 0.602 . . . . 0.0 112.094 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.39 -21.48 66.31 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.648 0.779 . . . . 0.0 110.885 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 7.9 mp -87.51 -28.28 22.12 Favored 'General case' 0 N--CA 1.532 3.672 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -83.39 86.82 7.01 Favored 'General case' 0 N--CA 1.52 3.048 0 C-N-CA 123.978 0.911 . . . . 0.0 108.734 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.19 -17.88 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.294 0 C-N-CA 123.675 0.79 . . . . 0.0 110.204 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 59.0 -171.41 0.12 Allowed 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.932 0.893 . . . . 0.0 110.673 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.532 3.642 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.522 3.14 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.07 -32.71 74.56 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 123.88 0.872 . . . . 0.0 109.243 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 52.2 m -68.46 -25.48 65.01 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 123.682 0.793 . . . . 0.0 109.155 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.74 -46.88 89.01 Favored Glycine 0 N--CA 1.508 3.487 0 C-N-CA 123.848 0.737 . . . . 0.0 114.512 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 tt -70.84 -35.55 60.58 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.412 0 CA-C-N 118.688 1.244 . . . . 0.0 111.324 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 49.9 mm -56.28 -32.46 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 124.807 1.243 . . . . 0.0 112.124 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 1.7 pp -68.32 -33.96 63.39 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.091 0 CA-C-N 119.493 1.042 . . . . 0.0 109.569 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.09 -34.46 89.81 Favored Glycine 1 N--CA 1.521 4.32 0 C-N-CA 123.483 0.564 . . . . 0.0 111.799 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.07 -39.83 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 124.213 1.005 . . . . 0.0 110.031 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 30.1 p -61.01 -38.92 87.8 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 123.162 0.585 . . . . 0.0 110.938 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 41.2 t -67.12 -41.46 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.081 0 C-N-CA 123.79 0.836 . . . . 0.0 110.36 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.88 -47.18 85.86 Favored 'General case' 0 N--CA 1.523 3.187 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.51 -47.95 68.5 Favored 'General case' 0 N--CA 1.513 2.701 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.57 -41.94 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.471 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.08 -33.4 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 O-C-N 122.228 -0.295 . . . . 0.0 111.282 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.22 -35.6 81.34 Favored 'General case' 0 N--CA 1.529 3.499 0 C-N-CA 122.736 0.414 . . . . 0.0 110.675 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.43 -36.86 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.702 0 C-N-CA 123.191 0.597 . . . . 0.0 110.119 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.66 -43.31 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 C-N-CA 122.973 0.509 . . . . 0.0 110.093 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.14 87.72 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 20.9 m -71.58 -33.89 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 O-C-N 121.806 -0.559 . . . . 0.0 110.071 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.41 -43.49 97.36 Favored 'General case' 0 N--CA 1.526 3.359 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 10.0 m -68.38 -40.16 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 CA-C-N 118.684 0.675 . . . . 0.0 110.884 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 14.5 p -66.35 -28.5 68.7 Favored 'General case' 0 N--CA 1.533 3.711 0 O-C-N 122.197 -0.315 . . . . 0.0 110.38 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -73.77 -32.55 63.85 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 123.446 0.698 . . . . 0.0 109.845 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 47.8 m -64.18 -31.17 72.26 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.182 0.593 . . . . 0.0 110.751 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 60.0 mt -60.79 -23.66 65.2 Favored 'General case' 0 N--CA 1.531 3.594 0 C-N-CA 122.586 0.354 . . . . 0.0 111.206 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.68 -7.36 52.83 Favored 'General case' 1 N--CA 1.539 4.017 0 C-N-CA 123.946 0.898 . . . . 0.0 110.33 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -69.19 3.51 2.13 Favored 'General case' 0 N--CA 1.534 3.764 0 C-N-CA 123.013 0.525 . . . . 0.0 111.31 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -53.2 149.32 7.19 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 123.937 0.895 . . . . 0.0 111.332 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.52 3.034 0 C-N-CA 123.935 0.894 . . . . 0.0 110.79 -178.846 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 99.6 p . . . . . 0 N--CA 1.525 3.295 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 41.9 mt -64.28 -34.3 77.8 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.695 0.798 . . . . 0.0 110.056 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 61.2 m -68.69 -26.57 65.36 Favored 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 123.575 0.75 . . . . 0.0 110.104 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.84 -46.18 61.35 Favored Glycine 0 N--CA 1.514 3.887 0 C-N-CA 124.071 0.844 . . . . 0.0 114.705 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 45.9 pt -70.76 -35.77 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -175.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 215' ' ' ILE . . . . . 0.411 HD13 ' H ' ' E' ' 216' ' ' ILE 0.253 0.1 OUTLIER -57.77 -41.3 79.31 Favored 'Isoleucine or valine' 1 N--CA 1.558 4.95 0 CA-C-N 119.984 1.265 . . . . 0.0 112.945 -175.033 . . . . . . . . 5 4 . 1 . 008 nuclear build core ' E' E ' 216' ' ' ILE . . . . . 0.411 ' H ' HD13 ' E' ' 215' ' ' ILE . 17.0 tt -72.38 -32.16 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 C-N-CA 124.297 1.039 . . . . 0.0 108.863 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.01 -29.37 43.39 Favored Glycine 0 N--CA 1.512 3.704 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.395 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.16 -37.8 79.39 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 CA-C-N 118.089 0.944 . . . . 0.0 110.7 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 36.1 p -65.98 -40.51 91.29 Favored 'General case' 0 N--CA 1.529 3.477 0 C-N-CA 123.344 0.657 . . . . 0.0 110.366 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.59 -32.08 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.06 0 C-N-CA 124.046 0.939 . . . . 0.0 110.49 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.54 91.48 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-O 121.062 0.458 . . . . 0.0 110.761 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.28 -47.97 80.09 Favored 'General case' 0 N--CA 1.519 3.017 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.91 -38.57 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.48 -32.8 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 40.6 tp -78.18 -42.64 30.94 Favored 'General case' 0 N--CA 1.535 3.79 0 CA-C-N 118.755 0.707 . . . . 0.0 112.311 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.12 -35.56 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.476 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 28.6 m -65.51 -35.21 74.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.354 0 CA-C-N 119.241 0.928 . . . . 0.0 109.978 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.07 -31.24 63.02 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.467 0.707 . . . . 0.0 112.144 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 3.2 m -56.96 -34.17 43.91 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 O-C-N 121.635 -0.666 . . . . 0.0 110.848 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.96 -44.65 96.3 Favored 'General case' 0 N--CA 1.53 3.527 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.59 -37.3 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.974 0 CA-C-N 119.067 0.849 . . . . 0.0 108.875 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 63.4 m -58.54 -27.56 64.66 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 122.854 0.461 . . . . 0.0 110.901 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -60.78 -18.12 53.2 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 122.916 0.487 . . . . 0.0 110.695 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 33.5 t -66.2 -25.53 66.97 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.616 0.766 . . . . 0.0 111.244 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 N--CA 1.532 3.641 0 C-N-CA 123.848 0.859 . . . . 0.0 111.4 -179.382 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 N--CA 1.524 3.262 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.54 -26.52 68.45 Favored 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.451 1.101 . . . . 0.0 110.871 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 55.1 m -65.46 -26.25 67.86 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.246 0.619 . . . . 0.0 111.002 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.15 -46.57 64.35 Favored Glycine 0 N--CA 1.516 3.974 0 C-N-CA 123.406 0.527 . . . . 0.0 114.233 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -70.85 -35.55 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 11.6 pt -56.64 -45.11 82.43 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.587 0 CA-C-N 119.529 1.059 . . . . 0.0 112.607 -175.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.99 -33.76 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 C-N-CA 123.358 0.663 . . . . 0.0 109.823 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.91 -30.08 76.69 Favored Glycine 0 N--CA 1.509 3.525 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.684 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.04 -37.65 73.55 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 CA-C-N 118.106 0.953 . . . . 0.0 111.589 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 29.2 p -65.82 -47.31 75.46 Favored 'General case' 0 N--CA 1.529 3.518 0 CA-C-O 121.319 0.58 . . . . 0.0 110.518 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.66 -42.38 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 C-N-CA 124.264 1.026 . . . . 0.0 111.176 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.04 -43.0 73.38 Favored 'General case' 0 N--CA 1.528 3.468 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.13 -50.49 68.01 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 p -68.39 -38.66 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 CA-C-N 118.499 0.59 . . . . 0.0 111.883 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.34 -33.69 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.456 0.571 . . . . 0.0 110.79 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 25.0 tp -69.71 -34.47 73.94 Favored 'General case' 0 N--CA 1.531 3.618 0 CA-C-N 118.689 0.677 . . . . 0.0 111.016 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 79.2 mt -65.72 -41.46 90.44 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.134 0 O-C-N 121.728 -0.608 . . . . 0.0 109.436 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.11 -37.41 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 C-N-CA 123.54 0.736 . . . . 0.0 109.807 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.09 68.35 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.21 0.604 . . . . 0.0 111.863 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 69.6 t -71.68 -38.04 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 122.812 0.445 . . . . 0.0 110.391 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -62.12 -44.07 97.45 Favored 'General case' 0 N--CA 1.532 3.644 0 C-N-CA 123.186 0.594 . . . . 0.0 112.579 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.69 -37.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.685 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 93.3 m -64.77 -29.68 70.66 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 122.924 0.489 . . . . 0.0 110.463 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -74.32 -40.03 62.47 Favored 'General case' 0 N--CA 1.525 3.321 0 C-N-CA 123.059 0.543 . . . . 0.0 109.585 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.3 t -63.82 -18.91 64.6 Favored 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 123.946 0.899 . . . . 0.0 112.376 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 50.5 tp -70.56 -14.82 62.66 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.673 0.789 . . . . 0.0 110.95 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 mp -87.21 -0.91 57.44 Favored 'General case' 0 N--CA 1.534 3.754 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.619 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -163.23 82.48 0.48 Allowed 'General case' 0 N--CA 1.538 3.949 0 CA-C-N 119.042 0.837 . . . . 0.0 112.3 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt . . . . . 0 N--CA 1.538 3.927 0 C-N-CA 125.038 1.335 . . . . 0.0 108.595 177.843 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.981 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.9 p -168.49 -53.17 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.88 -26.38 68.3 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 123.726 0.81 . . . . 0.0 109.099 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 37.4 t -57.79 -41.32 81.85 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 123.815 0.846 . . . . 0.0 112.248 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -35.48 79.71 Favored Glycine 1 N--CA 1.521 4.348 0 C-N-CA 123.883 0.754 . . . . 0.0 112.978 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.25 -46.29 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 C-N-CA 123.97 0.908 . . . . 0.0 112.845 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.11 -32.18 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 121.986 -0.446 . . . . 0.0 110.786 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.8 -33.75 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 C-N-CA 123.437 0.695 . . . . 0.0 110.185 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.32 84.8 Favored Glycine 1 N--CA 1.521 4.301 0 CA-C-O 119.941 -0.366 . . . . 0.0 113.851 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.7 m -60.0 -36.75 69.1 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.343 0 CA-C-N 117.762 0.781 . . . . 0.0 110.784 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -55.47 -45.28 76.97 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.502 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 42.6 t -65.73 -37.96 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 C-N-CA 124.151 0.98 . . . . 0.0 111.46 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.95 -42.44 65.48 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.34 83.4 Favored 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 123.126 0.57 . . . . 0.0 111.184 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.4 t -64.29 -42.93 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.442 0.697 . . . . 0.0 110.934 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.2 -40.93 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 C-N-CA 123.144 0.578 . . . . 0.0 110.291 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.39 -38.5 91.39 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.928 0.491 . . . . 0.0 110.466 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.4 mt -56.97 -36.41 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.772 0 C-N-CA 123.441 0.696 . . . . 0.0 110.692 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 50.4 t -61.91 -37.94 79.44 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 C-N-CA 122.737 0.415 . . . . 0.0 110.469 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -31.85 68.71 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.563 0.745 . . . . 0.0 111.754 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.63 -34.73 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 C-N-CA 122.948 0.499 . . . . 0.0 111.393 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -67.59 -44.1 78.94 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.8 -37.43 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.954 0 CA-C-N 118.713 0.688 . . . . 0.0 109.903 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 76.4 m -66.12 -33.1 75.02 Favored 'General case' 0 N--CA 1.522 3.154 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.085 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -70.01 -41.24 74.6 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 123.276 0.631 . . . . 0.0 110.219 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 95.9 p -66.34 -30.21 70.57 Favored 'General case' 0 N--CA 1.53 3.539 0 C-N-CA 123.284 0.633 . . . . 0.0 109.766 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -14.32 45.25 Favored 'General case' 0 N--CA 1.531 3.618 0 C-N-CA 124.543 1.137 . . . . 0.0 110.255 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 32.5 mt -86.66 5.05 37.9 Favored 'General case' 0 N--CA 1.537 3.877 0 C-N-CA 123.241 0.617 . . . . 0.0 110.826 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -168.33 122.31 0.9 Allowed 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.558 0.743 . . . . 0.0 109.085 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -139.24 -0.64 1.8 Allowed 'General case' 0 N--CA 1.531 3.613 0 C-N-CA 124.81 1.244 . . . . 0.0 109.546 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -167.02 155.29 9.74 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.531 3.595 0 C-N-CA 124.886 1.275 . . . . 0.0 108.963 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 98.7 p . . . . . 0 N--CA 1.521 3.125 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.7 -26.81 68.27 Favored 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 124.31 1.044 . . . . 0.0 111.038 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 68.5 m -60.39 -26.53 66.73 Favored 'General case' 0 N--CA 1.528 3.463 0 C-N-CA 123.427 0.691 . . . . 0.0 110.647 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.09 -34.96 81.83 Favored Glycine 0 N--CA 1.512 3.767 0 C-N-CA 124.944 1.259 . . . . 0.0 115.015 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 14.4 tt -59.75 -35.76 61.93 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -175.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 1.9 pp -56.81 -47.76 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.0 tt -73.26 -33.5 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.32 -46.55 93.67 Favored Glycine 0 N--CA 1.513 3.782 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.979 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.59 -37.39 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 CA-C-N 117.615 0.707 . . . . 0.0 110.847 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 28.3 p -66.11 -46.1 78.77 Favored 'General case' 0 N--CA 1.526 3.371 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -69.93 -31.68 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.94 68.96 Favored 'General case' 0 N--CA 1.528 3.46 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.0 -49.97 58.36 Favored 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 22.0 m -66.95 -38.26 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 CA-C-N 118.534 0.606 . . . . 0.0 111.902 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.07 -32.74 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 122.504 0.322 . . . . 0.0 110.136 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.28 -41.43 94.18 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 122.602 0.361 . . . . 0.0 110.589 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 73.7 mt -56.85 -36.41 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 C-N-CA 122.889 0.476 . . . . 0.0 110.579 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.95 -37.28 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 C-N-CA 122.985 0.514 . . . . 0.0 110.517 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -31.88 66.96 Favored 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.53 0.732 . . . . 0.0 112.224 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.9 -34.92 73.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 O-C-N 121.587 -0.696 . . . . 0.0 110.469 -178.547 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -64.24 -44.58 91.41 Favored 'General case' 0 N--CA 1.527 3.409 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 16.0 m -69.07 -37.6 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-O 121.29 0.567 . . . . 0.0 109.742 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -66.46 -30.42 70.76 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -74.32 -40.12 62.43 Favored 'General case' 0 N--CA 1.525 3.285 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 70.9 m -65.07 -35.55 81.51 Favored 'General case' 0 N--CA 1.523 3.196 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.204 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.21 -14.23 24.09 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 124.082 0.953 . . . . 0.0 111.194 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 N--CA 1.522 3.168 0 C-N-CA 123.263 0.625 . . . . 0.0 109.412 179.534 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.521 3.085 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 tp -64.98 -35.74 82.17 Favored 'General case' 0 N--CA 1.527 3.424 0 C-N-CA 123.881 0.872 . . . . 0.0 109.971 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.0 m -67.2 -30.39 70.31 Favored 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 123.778 0.831 . . . . 0.0 110.446 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -47.0 57.97 Favored Glycine 0 N--CA 1.513 3.829 0 CA-C-N 115.526 -0.761 . . . . 0.0 114.334 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 34.6 pt -71.35 -39.7 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -176.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.2 tt -62.79 -39.77 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.62 -33.08 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.9 -29.12 50.13 Favored Glycine 0 N--CA 1.515 3.96 0 C-N-CA 123.609 0.623 . . . . 0.0 113.363 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.3 m -59.53 -46.28 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 5.3 t -66.11 -38.79 89.06 Favored 'General case' 0 N--CA 1.536 3.832 0 CA-C-O 121.045 0.45 . . . . 0.0 111.067 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.1 -39.61 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.183 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.66 72.68 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 123.461 0.704 . . . . 0.0 111.05 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.82 87.67 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 123.499 0.719 . . . . 0.0 111.224 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.33 -48.42 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 C-N-CA 123.269 0.627 . . . . 0.0 110.089 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.73 -36.77 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.561 0 C-N-CA 123.766 0.826 . . . . 0.0 110.9 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 22.4 mt -65.04 -34.35 78.21 Favored 'General case' 0 N--CA 1.534 3.727 0 C-N-CA 122.898 0.479 . . . . 0.0 110.591 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.98 -39.64 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.74 -37.87 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.514 0 C-N-CA 123.262 0.625 . . . . 0.0 109.601 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.28 83.29 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.748 0.819 . . . . 0.0 112.623 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.83 -34.35 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.594 0 O-C-N 121.897 -0.502 . . . . 0.0 110.215 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -63.8 -43.92 94.86 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 123.141 0.577 . . . . 0.0 112.517 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.39 -37.25 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 77.4 m -60.03 -28.42 67.73 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 122.658 0.383 . . . . 0.0 111.367 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -74.09 -28.65 61.48 Favored 'General case' 0 N--CA 1.531 3.602 0 C-N-CA 122.653 0.381 . . . . 0.0 110.817 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 57.9 m -67.41 -17.69 64.82 Favored 'General case' 0 N--CA 1.53 3.569 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.78 -38.54 67.25 Favored 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 124.126 0.97 . . . . 0.0 110.459 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 pp -87.93 -4.14 58.85 Favored 'General case' 1 N--CA 1.553 4.687 0 CA-C-N 118.767 0.712 . . . . 0.0 111.923 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -69.68 -11.84 61.16 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.518 0.727 . . . . 0.0 110.717 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -64.91 -26.09 68.17 Favored 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 124.009 0.924 . . . . 0.0 111.39 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -74.83 72.03 2.03 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.59 0.756 . . . . 0.0 109.852 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.533 3.718 0 C-N-CA 124.591 1.157 . . . . 0.0 108.178 179.351 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.518 2.956 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.04 -35.07 79.99 Favored 'General case' 0 N--CA 1.527 3.4 0 C-N-CA 124.533 1.133 . . . . 0.0 109.741 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 70.7 m -57.14 -26.04 59.88 Favored 'General case' 0 N--CA 1.525 3.318 0 C-N-CA 123.725 0.81 . . . . 0.0 110.523 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.46 -34.45 59.82 Favored Glycine 0 N--CA 1.509 3.504 0 C-N-CA 124.929 1.252 . . . . 0.0 114.979 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 16.2 pt -59.15 -34.67 54.2 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.12 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -175.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 8.9 pt -56.15 -45.57 80.84 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.265 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 5.8 tp -72.37 -33.87 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.26 -48.27 84.48 Favored Glycine 1 N--CA 1.517 4.039 0 C-N-CA 123.89 0.757 . . . . 0.0 113.706 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.29 -37.32 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.771 0 O-C-N 121.763 -0.845 . . . . 0.0 109.628 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 25.3 m -66.26 -45.75 79.47 Favored 'General case' 0 N--CA 1.519 2.978 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 12.8 p -63.59 -31.12 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 CA-C-N 118.203 0.456 . . . . 0.0 110.436 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.1 -47.2 81.64 Favored 'General case' 0 N--CA 1.528 3.453 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.94 73.93 Favored 'General case' 0 N--CA 1.523 3.194 0 C-N-CA 123.556 0.742 . . . . 0.0 112.036 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.83 -38.61 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 C-N-CA 123.366 0.666 . . . . 0.0 110.602 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.32 -44.79 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 C-N-CA 123.154 0.582 . . . . 0.0 110.135 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.73 -34.54 73.07 Favored 'General case' 1 N--CA 1.54 4.028 0 C-N-CA 123.12 0.568 . . . . 0.0 110.752 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.85 -40.1 87.5 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.22 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.65 -41.94 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 122.989 0.516 . . . . 0.0 109.814 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -41.06 82.09 Favored 'General case' 0 N--CA 1.527 3.406 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 19.0 m -71.17 -33.74 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 O-C-N 121.709 -0.619 . . . . 0.0 110.062 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -66.26 -43.92 85.14 Favored 'General case' 0 N--CA 1.528 3.463 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.76 -37.89 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 CA-C-N 118.327 0.512 . . . . 0.0 111.082 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 10.1 p -58.68 -27.51 64.88 Favored 'General case' 0 N--CA 1.531 3.616 0 C-N-CA 122.367 0.267 . . . . 0.0 111.499 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -61.27 -31.16 70.98 Favored 'General case' 0 N--CA 1.521 3.113 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.05 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 71.2 p -66.0 -38.06 87.52 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.459 0.704 . . . . 0.0 110.607 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 61.0 mt -60.77 -13.34 14.55 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 123.638 0.775 . . . . 0.0 111.901 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 26.8 mt -86.04 -7.65 58.48 Favored 'General case' 0 N--CA 1.534 3.727 0 C-N-CA 123.054 0.542 . . . . 0.0 110.366 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -70.67 -106.65 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.235 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 53.18 23.08 2.9 Favored 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 123.845 0.858 . . . . 0.0 111.94 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 24.7 tptm . . . . . 0 N--CA 1.526 3.341 0 C-N-CA 124.731 1.213 . . . . 0.0 110.537 -179.303 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.521 3.081 0 CA-C-O 120.579 0.228 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.24 -26.25 68.03 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 124.495 1.118 . . . . 0.0 109.945 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.4 p -57.32 -25.96 60.17 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.404 0.682 . . . . 0.0 110.975 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.11 -35.24 68.83 Favored Glycine 0 N--CA 1.516 3.998 0 C-N-CA 123.837 0.732 . . . . 0.0 113.755 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 7.6 pt -60.28 -44.04 94.81 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.203 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 215' ' ' ILE . . . . . 0.514 ' O ' HG12 ' E' ' 218' ' ' VAL . 6.1 pt -67.68 -32.47 56.93 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.284 0 C-N-CA 122.934 0.493 . . . . 0.0 110.26 -178.207 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 47.7 mm -72.08 -32.7 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.601 0 C-N-CA 124.674 1.189 . . . . 0.0 108.79 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.93 -29.13 64.47 Favored Glycine 1 N--CA 1.518 4.13 0 C-N-CA 123.529 0.585 . . . . 0.0 113.26 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 218' ' ' VAL . . . . . 0.514 HG12 ' O ' ' E' ' 215' ' ' ILE . 9.8 p -59.71 -47.55 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 9.0 t -66.36 -38.96 88.79 Favored 'General case' 0 N--CA 1.537 3.899 0 O-C-N 121.827 -0.546 . . . . 0.0 111.196 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.17 -31.82 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 C-N-CA 123.511 0.724 . . . . 0.0 110.431 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.89 76.88 Favored 'General case' 0 N--CA 1.529 3.504 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.68 74.74 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 122.86 0.464 . . . . 0.0 111.459 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.7 -45.52 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 123.291 0.636 . . . . 0.0 112.296 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.24 -32.55 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 C-N-CA 122.352 0.261 . . . . 0.0 111.652 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.5 -34.85 78.83 Favored 'General case' 1 N--CA 1.541 4.117 0 O-C-N 122.098 -0.376 . . . . 0.0 110.255 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.39 -37.94 80.86 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.08 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.06 -37.86 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.5 0 C-N-CA 123.248 0.619 . . . . 0.0 109.975 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.24 96.6 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 17.2 m -71.66 -33.96 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.741 0 O-C-N 121.613 -0.679 . . . . 0.0 109.703 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -63.47 -43.75 96.4 Favored 'General case' 0 N--CA 1.529 3.483 0 C-N-CA 123.062 0.545 . . . . 0.0 112.309 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.41 -37.41 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.351 0.523 . . . . 0.0 109.631 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 79.1 m -60.21 -27.93 67.57 Favored 'General case' 0 N--CA 1.525 3.283 0 C-N-CA 123.143 0.577 . . . . 0.0 111.018 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.71 -35.02 79.55 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 122.796 0.438 . . . . 0.0 110.243 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 68.0 m -73.72 -36.27 65.19 Favored 'General case' 0 N--CA 1.523 3.185 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.529 3.501 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.827 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 64.8 m . . . . . 0 N--CA 1.52 3.034 0 CA-C-O 120.662 0.268 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.17 -26.38 68.14 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.915 0.886 . . . . 0.0 110.245 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 57.0 m -61.65 -26.78 68.22 Favored 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 123.653 0.781 . . . . 0.0 111.062 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.9 -47.5 54.49 Favored Glycine 1 N--CA 1.518 4.128 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.902 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 45.3 pt -72.33 -40.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -44.92 95.35 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.276 0 C-N-CA 123.194 0.597 . . . . 0.0 111.876 -175.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 6.4 tp -63.21 -32.62 57.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 C-N-CA 123.278 0.631 . . . . 0.0 109.382 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.31 -29.99 63.9 Favored Glycine 0 N--CA 1.513 3.802 0 CA-C-O 119.346 -0.697 . . . . 0.0 113.855 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.0 m -62.2 -47.21 94.16 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 CA-C-N 118.528 1.164 . . . . 0.0 112.045 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -38.82 89.24 Favored 'General case' 0 N--CA 1.536 3.872 0 C-N-CA 122.202 0.201 . . . . 0.0 110.766 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.78 -39.94 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.55 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.6 83.01 Favored 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 123.198 0.599 . . . . 0.0 111.136 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.66 85.64 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.173 0.589 . . . . 0.0 112.175 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.85 -41.15 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 122.909 0.483 . . . . 0.0 110.962 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.05 -41.89 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 C-N-CA 123.143 0.577 . . . . 0.0 110.852 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.7 -37.33 86.07 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 122.606 0.362 . . . . 0.0 111.667 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.76 -44.01 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.3 -40.3 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.73 -45.11 93.16 Favored 'General case' 0 N--CA 1.525 3.31 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.53 -34.05 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.703 0 O-C-N 121.633 -0.667 . . . . 0.0 109.788 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -63.06 -44.32 96.15 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 21.3 m -69.05 -37.88 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 CA-C-O 121.159 0.505 . . . . 0.0 109.841 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 76.3 m -65.54 -33.82 76.81 Favored 'General case' 0 N--CA 1.521 3.08 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.083 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -74.15 -39.75 63.06 Favored 'General case' 0 N--CA 1.537 3.898 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 58.6 m -63.75 -30.11 71.24 Favored 'General case' 0 N--CA 1.52 3.054 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.063 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.77 -21.62 66.51 Favored 'General case' 0 N--CA 1.526 3.364 0 C-N-CA 123.013 0.525 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -98.49 -15.81 19.44 Favored 'General case' 1 N--CA 1.548 4.459 0 C-N-CA 124.017 0.927 . . . . 0.0 110.472 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -68.12 3.53 1.59 Allowed 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.356 0.662 . . . . 0.0 111.624 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt . . . . . 0 N--CA 1.528 3.435 0 C-N-CA 122.847 0.459 . . . . 0.0 110.941 -179.534 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.217 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.0 m -74.63 40.39 0.14 Allowed 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 123.911 0.884 . . . . 0.0 110.571 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.0 -37.48 87.8 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 124.474 1.11 . . . . 0.0 109.978 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 45.2 t -68.61 -26.5 65.39 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.333 0.653 . . . . 0.0 110.702 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.66 -46.59 60.85 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 117.579 1.792 . . . . 0.0 117.579 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.8 -35.66 61.25 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.694 0 CA-C-N 119.612 1.706 . . . . 0.0 113.57 -175.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.54 -38.11 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.543 0 C-N-CA 123.55 0.74 . . . . 0.0 111.997 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 15.2 tt -71.41 -32.86 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.78 -28.87 48.41 Favored Glycine 1 N--CA 1.516 4.003 0 C-N-CA 124.057 0.837 . . . . 0.0 113.243 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.8 m -68.0 -37.27 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 CA-C-N 117.721 0.76 . . . . 0.0 110.407 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.8 p -60.56 -46.08 91.53 Favored 'General case' 0 N--CA 1.527 3.42 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.723 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.24 -31.85 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 C-N-CA 122.73 0.412 . . . . 0.0 110.493 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.44 -34.12 77.05 Favored 'General case' 0 N--CA 1.525 3.297 0 C-N-CA 123.091 0.556 . . . . 0.0 111.456 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.84 -50.24 44.67 Favored 'General case' 0 N--CA 1.519 2.995 0 C-N-CA 122.96 0.504 . . . . 0.0 111.914 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.96 -44.28 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 C-N-CA 123.365 0.666 . . . . 0.0 112.562 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.53 -32.66 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.603 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.24 -42.14 76.03 Favored 'General case' 0 N--CA 1.533 3.689 0 CA-C-N 118.613 0.642 . . . . 0.0 110.34 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.3 mt -54.8 -35.95 35.32 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 O-C-N 122.055 -0.403 . . . . 0.0 110.455 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.46 -37.17 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 O-C-N 121.763 -0.586 . . . . 0.0 110.374 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.87 -33.0 68.24 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.49 -34.54 53.42 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.188 0 CA-C-N 119.145 0.884 . . . . 0.0 110.611 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.96 -44.16 97.34 Favored 'General case' 0 N--CA 1.53 3.551 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.0 -37.6 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.693 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 71.6 m -64.27 -27.85 69.32 Favored 'General case' 0 N--CA 1.527 3.4 0 C-N-CA 123.151 0.58 . . . . 0.0 111.149 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -62.74 -22.88 66.87 Favored 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 122.992 0.517 . . . . 0.0 110.903 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 45.5 t -66.67 -46.2 76.43 Favored 'General case' 0 N--CA 1.525 3.29 0 CA-C-O 121.582 0.706 . . . . 0.0 110.565 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.98 -12.93 13.01 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 125.375 1.47 . . . . 0.0 112.471 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 54.9 tp -85.93 -28.36 24.36 Favored 'General case' 1 N--CA 1.547 4.403 0 C-N-CA 123.25 0.62 . . . . 0.0 111.303 -175.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 -121.26 63.17 0.89 Allowed 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -138.09 21.04 2.81 Favored 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.245 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -158.75 -11.34 0.07 Allowed 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.974 0.909 . . . . 0.0 109.685 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 N--CA 1.53 3.557 0 C-N-CA 125.279 1.432 . . . . 0.0 107.297 179.152 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 97.7 p . . . . . 0 N--CA 1.524 3.249 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.88 -26.77 68.46 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.976 0.911 . . . . 0.0 109.581 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 90.5 p -68.55 -26.19 65.29 Favored 'General case' 0 N--CA 1.522 3.143 0 C-N-CA 123.44 0.696 . . . . 0.0 110.43 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.36 -44.05 76.02 Favored Glycine 0 N--CA 1.516 3.975 0 C-N-CA 123.737 0.684 . . . . 0.0 114.08 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.87 -36.0 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.791 0 O-C-N 121.67 -0.9 . . . . 0.0 112.14 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 13.9 pt -67.55 -37.17 78.31 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.398 0 CA-C-N 119.001 0.818 . . . . 0.0 111.84 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 46.3 pt -72.26 -33.07 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.11 -45.31 82.51 Favored Glycine 0 N--CA 1.513 3.775 0 C-N-CA 124.419 1.009 . . . . 0.0 114.992 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.58 -37.2 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.734 0 CA-C-N 117.76 0.78 . . . . 0.0 111.163 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.0 p -65.28 -46.11 81.74 Favored 'General case' 0 N--CA 1.533 3.679 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.81 -30.63 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.485 0 C-N-CA 123.158 0.583 . . . . 0.0 111.174 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.81 -35.44 63.9 Favored 'General case' 0 N--CA 1.525 3.3 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -50.32 39.63 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 24.9 m -66.11 -38.24 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.8 -31.98 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.462 0.573 . . . . 0.0 111.859 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.59 -34.74 72.5 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 118.236 0.471 . . . . 0.0 110.746 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.1 -49.37 84.34 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.067 0 CA-C-N 118.065 0.393 . . . . 0.0 111.668 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.6 -37.28 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 O-C-N 121.721 -0.612 . . . . 0.0 109.957 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.48 79.97 Favored 'General case' 0 N--CA 1.524 3.26 0 C-N-CA 123.593 0.757 . . . . 0.0 112.811 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.63 -34.37 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 O-C-N 121.86 -0.525 . . . . 0.0 110.291 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -64.41 -44.21 91.97 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 122.964 0.506 . . . . 0.0 112.332 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.8 -37.91 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.826 0 CA-C-N 118.201 0.455 . . . . 0.0 109.781 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 75.2 m -65.64 -27.69 68.56 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 123.341 0.656 . . . . 0.0 111.211 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -63.82 -29.96 71.1 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 123.134 0.574 . . . . 0.0 110.725 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 54.8 m -64.16 -40.01 95.22 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.252 0.621 . . . . 0.0 110.517 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.88 -21.46 64.25 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.691 0.796 . . . . 0.0 110.251 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.5 tp . . . . . 0 N--CA 1.534 3.727 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.599 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 97.0 p . . . . . 0 N--CA 1.524 3.232 0 CA-C-O 121.375 0.607 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -54.36 -26.56 30.74 Favored 'General case' 0 N--CA 1.532 3.646 0 C-N-CA 123.785 0.834 . . . . 0.0 112.224 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 98.3 p -63.6 -36.45 83.86 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.825 0.85 . . . . 0.0 110.312 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.0 -35.75 79.55 Favored Glycine 0 N--CA 1.515 3.965 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.074 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 39.2 mm -70.31 -46.44 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 C-N-CA 124.164 0.986 . . . . 0.0 112.77 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 tt -64.53 -37.5 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.965 0 CA-C-N 118.207 0.458 . . . . 0.0 111.857 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.76 -32.22 39.75 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.13 -28.75 42.67 Favored Glycine 0 N--CA 1.512 3.714 0 C-N-CA 124.41 1.005 . . . . 0.0 113.198 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.34 -37.12 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 CA-C-N 117.383 0.592 . . . . 0.0 110.576 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 46.0 p -62.15 -45.14 94.75 Favored 'General case' 0 N--CA 1.529 3.509 0 CA-C-O 121.743 0.783 . . . . 0.0 110.319 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.86 -31.44 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 124.971 1.308 . . . . 0.0 111.447 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.07 75.69 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.361 0.664 . . . . 0.0 111.869 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.7 -46.78 62.49 Favored 'General case' 0 N--CA 1.521 3.087 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.01 -38.18 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 18.3 m -56.54 -31.33 33.8 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 CA-C-N 118.711 0.687 . . . . 0.0 110.712 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 39.7 tp -52.86 -48.14 67.29 Favored 'General case' 1 N--CA 1.543 4.176 0 CA-C-O 122.138 0.971 . . . . 0.0 109.865 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.78 -38.03 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.49 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.79 -37.64 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.437 0 C-N-CA 123.492 0.717 . . . . 0.0 109.489 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -32.71 68.1 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.216 0.606 . . . . 0.0 111.947 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.34 -43.47 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.12 0.568 . . . . 0.0 111.235 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -62.31 -42.92 99.78 Favored 'General case' 1 N--CA 1.539 4.022 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.03 -37.42 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.724 -0.61 . . . . 0.0 109.929 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 96.7 m -64.89 -27.98 69.23 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 122.657 0.383 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -65.8 -25.93 67.46 Favored 'General case' 0 N--CA 1.532 3.625 0 C-N-CA 123.224 0.609 . . . . 0.0 110.999 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 51.2 m -69.43 -34.08 73.92 Favored 'General case' 0 N--CA 1.525 3.311 0 C-N-CA 123.114 0.566 . . . . 0.0 110.444 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.19 -16.93 60.97 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.584 0.754 . . . . 0.0 110.214 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 57.0 tp -87.62 -20.81 25.84 Favored 'General case' 0 N--CA 1.536 3.864 0 C-N-CA 123.719 0.807 . . . . 0.0 110.218 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.76 -79.7 0.04 OUTLIER 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.808 0.843 . . . . 0.0 110.74 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 58.03 7.66 0.65 Allowed 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 124.206 1.002 . . . . 0.0 112.555 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? 59.82 120.67 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 124.352 1.061 . . . . 0.0 111.335 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.531 3.579 0 C-N-CA 124.932 1.293 . . . . 0.0 108.116 179.192 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.52 3.041 0 N-CA-C 111.501 0.186 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 49.7 mt -54.85 -26.71 37.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.015 0.926 . . . . 0.0 111.306 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -59.16 -32.38 69.83 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 123.174 0.59 . . . . 0.0 110.745 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.88 -38.84 89.52 Favored Glycine 1 N--CA 1.516 4.033 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.811 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 214' ' ' ILE . . . . . 0.412 ' N ' HD12 ' D' ' 214' ' ' ILE . 1.5 mp -70.71 -41.1 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.471 0 C-N-CA 124.275 1.03 . . . . 0.0 108.969 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.92 -41.43 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.739 0 C-N-CA 124.326 1.051 . . . . 0.0 111.775 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 6.3 tp -72.73 -32.73 41.88 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.191 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.76 -46.7 91.98 Favored Glycine 1 N--CA 1.518 4.129 0 C-N-CA 123.551 0.596 . . . . 0.0 113.968 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 11.4 m -60.09 -36.46 67.8 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.211 0 CA-C-N 118.325 1.062 . . . . 0.0 111.472 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 22.0 p -55.7 -38.73 70.08 Favored 'General case' 0 N--CA 1.532 3.643 0 C-N-CA 122.988 0.515 . . . . 0.0 111.674 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.73 -37.81 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 C-N-CA 123.247 0.619 . . . . 0.0 110.813 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.87 -36.08 58.59 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 123.561 0.745 . . . . 0.0 112.745 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.53 -50.17 40.47 Favored 'General case' 0 N--CA 1.515 2.804 0 C-N-CA 123.318 0.647 . . . . 0.0 111.07 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.4 -46.03 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.53 0 C-N-CA 123.522 0.729 . . . . 0.0 112.336 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.43 -32.01 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.523 0 C-N-CA 122.537 0.335 . . . . 0.0 111.273 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.09 -41.59 61.44 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 122.435 0.294 . . . . 0.0 110.931 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.34 -42.33 93.23 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.022 0 C-N-CA 122.806 0.442 . . . . 0.0 111.681 -177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.0 -36.83 78.09 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 CA-C-N 118.336 0.517 . . . . 0.0 110.094 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.61 -34.15 72.39 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.858 0.463 . . . . 0.0 111.346 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.93 -39.45 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -62.4 -43.49 98.69 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.527 0.731 . . . . 0.0 112.54 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 14.4 m -68.24 -37.78 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 CA-C-N 118.407 0.549 . . . . 0.0 109.806 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 88.3 m -59.02 -27.73 65.73 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 122.886 0.474 . . . . 0.0 111.082 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -64.56 -30.92 71.95 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 122.836 0.455 . . . . 0.0 110.243 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 24.1 t -64.92 -44.59 89.03 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 123.041 0.536 . . . . 0.0 110.398 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.96 -20.49 65.91 Favored 'General case' 0 N--CA 1.532 3.647 0 C-N-CA 123.477 0.711 . . . . 0.0 110.98 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 36.6 tp -87.75 -3.01 58.98 Favored 'General case' 0 N--CA 1.537 3.889 0 C-N-CA 123.394 0.678 . . . . 0.0 110.944 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -152.37 105.09 2.99 Favored 'General case' 0 N--CA 1.533 3.706 0 C-N-CA 123.037 0.535 . . . . 0.0 111.036 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -151.15 -53.84 0.14 Allowed 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? . . . . . 0 N--CA 1.525 3.31 0 C-N-CA 124.053 0.941 . . . . 0.0 109.732 -179.673 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.521 3.11 0 CA-C-O 121.413 0.625 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 mt -62.46 -26.35 68.47 Favored 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 124.32 1.048 . . . . 0.0 110.848 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.0 p -64.62 -26.34 68.35 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.143 0.577 . . . . 0.0 110.144 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.81 -46.9 89.5 Favored Glycine 1 N--CA 1.52 4.272 0 CA-C-O 119.523 -0.598 . . . . 0.0 114.095 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 18.8 tt -70.61 -35.61 61.98 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.204 0 CA-C-N 118.549 1.175 . . . . 0.0 109.688 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 46.8 mm -64.63 -42.71 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.753 0 C-N-CA 123.876 0.87 . . . . 0.0 108.834 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 23.0 mm -72.84 -33.39 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.767 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.33 -29.83 57.36 Favored Glycine 0 N--CA 1.513 3.817 0 C-N-CA 124.115 0.864 . . . . 0.0 114.573 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.63 -37.42 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.971 0 CA-C-N 118.113 0.957 . . . . 0.0 111.216 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 67.4 p -61.88 -47.52 84.62 Favored 'General case' 0 N--CA 1.528 3.46 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 10.1 p -70.99 -31.77 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.351 0 C-N-CA 123.02 0.528 . . . . 0.0 111.524 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.36 78.26 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.07 -34.46 77.63 Favored 'General case' 0 N--CA 1.515 2.823 0 C-N-CA 123.276 0.63 . . . . 0.0 111.721 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.22 -53.43 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 122.916 0.486 . . . . 0.0 111.177 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.62 -33.6 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.413 0 O-C-N 121.785 -0.572 . . . . 0.0 111.455 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 40.0 tp -77.2 -38.39 51.6 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 122.908 0.483 . . . . 0.0 112.285 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 16.3 tt -69.35 -38.17 76.87 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.114 0 CA-C-N 118.906 0.775 . . . . 0.0 110.586 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.77 -38.0 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.87 -51.1 71.01 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.281 0.632 . . . . 0.0 112.644 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.85 -34.23 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 C-N-CA 122.533 0.333 . . . . 0.0 110.701 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -70.39 -38.62 74.71 Favored 'General case' 0 N--CA 1.527 3.386 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.1 -37.59 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.625 0 C-N-CA 124.174 0.99 . . . . 0.0 109.464 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -58.72 -34.79 71.73 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 122.655 0.382 . . . . 0.0 110.207 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -74.58 -48.43 26.77 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.863 0.465 . . . . 0.0 110.124 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.5 m -63.68 -25.96 68.45 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 123.419 0.688 . . . . 0.0 111.231 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 4.8 tt . . . . . 0 N--CA 1.524 3.257 0 C-N-CA 123.611 0.764 . . . . 0.0 111.193 179.84 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.524 3.229 0 CA-C-O 121.544 0.687 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.74 -26.8 68.81 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 124.087 0.955 . . . . 0.0 110.121 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 66.0 m -66.23 -32.29 73.62 Favored 'General case' 0 N--CA 1.519 2.985 0 C-N-CA 123.587 0.755 . . . . 0.0 111.061 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.11 -47.53 52.85 Favored Glycine 1 N--CA 1.517 4.056 0 CA-C-N 116.099 -0.5 . . . . 0.0 114.261 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 20.4 tt -71.6 -41.66 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.94 -44.25 82.1 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.272 0 C-N-CA 123.059 0.544 . . . . 0.0 111.737 -176.078 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.1 tt -72.29 -33.16 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.854 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.93 -29.47 51.24 Favored Glycine 0 N--CA 1.512 3.736 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.434 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.69 -37.71 72.27 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 117.495 0.648 . . . . 0.0 110.991 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 72.7 p -62.39 -45.49 92.88 Favored 'General case' 0 N--CA 1.53 3.563 0 CA-C-O 121.648 0.737 . . . . 0.0 110.474 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.21 -31.65 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.094 0 C-N-CA 124.702 1.201 . . . . 0.0 110.814 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.99 -34.72 75.22 Favored 'General case' 0 N--CA 1.531 3.588 0 O-C-N 121.824 -0.547 . . . . 0.0 111.596 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.32 -50.35 70.38 Favored 'General case' 0 N--CA 1.516 2.841 0 C-N-CA 123.51 0.724 . . . . 0.0 112.772 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.03 -38.27 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 CA-C-N 118.373 0.533 . . . . 0.0 111.629 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.22 -34.59 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.827 0 C-N-CA 122.646 0.378 . . . . 0.0 110.664 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 41.3 tp -68.51 -34.46 75.92 Favored 'General case' 0 N--CA 1.533 3.713 0 CA-C-N 118.156 0.434 . . . . 0.0 110.622 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.9 mt -61.82 -35.4 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 C-N-CA 123.683 0.793 . . . . 0.0 109.893 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.34 -35.41 49.0 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.194 0 C-N-CA 123.341 0.657 . . . . 0.0 110.472 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.1 -31.46 63.29 Favored 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 123.468 0.707 . . . . 0.0 112.763 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 4.4 m -57.28 -34.83 46.91 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.123 0 CA-C-N 118.992 0.815 . . . . 0.0 112.682 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -65.2 -43.94 89.97 Favored 'General case' 1 N--CA 1.541 4.094 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.81 -37.14 77.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.019 0 CA-C-N 119.007 0.821 . . . . 0.0 108.982 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 75.5 m -58.37 -27.59 64.36 Favored 'General case' 0 N--CA 1.528 3.429 0 C-N-CA 122.821 0.448 . . . . 0.0 110.909 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.54 -26.14 67.75 Favored 'General case' 0 N--CA 1.53 3.544 0 C-N-CA 122.973 0.509 . . . . 0.0 110.573 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 60.4 p -63.63 -16.89 62.16 Favored 'General case' 0 N--CA 1.534 3.765 0 C-N-CA 123.689 0.796 . . . . 0.0 111.546 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 46.6 tp -59.82 -14.57 15.53 Favored 'General case' 0 N--CA 1.527 3.377 0 C-N-CA 124.284 1.033 . . . . 0.0 112.775 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 pp -86.88 9.01 20.56 Favored 'General case' 1 N--CA 1.545 4.306 0 CA-C-N 118.843 0.747 . . . . 0.0 110.247 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 56.4 m95 58.96 134.64 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.1 0 C-N-CA 124.856 1.262 . . . . 0.0 113.029 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp . . . . . 0 N--CA 1.525 3.307 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.202 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.193 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.9 m -162.38 104.73 1.11 Allowed 'General case' 0 N--CA 1.521 3.108 0 C-N-CA 123.708 0.803 . . . . 0.0 108.986 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.27 -26.73 68.56 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.12 0.968 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.8 m -57.64 -26.19 61.26 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.667 0.787 . . . . 0.0 110.921 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.99 -35.62 91.67 Favored Glycine 0 N--CA 1.508 3.466 0 C-N-CA 124.232 0.92 . . . . 0.0 115.205 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.4 tt -68.47 -35.07 68.99 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.286 0 CA-C-N 118.247 1.023 . . . . 0.0 113.55 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.19 -40.61 66.12 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 17.7 tt -73.06 -36.12 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.798 0 O-C-N 121.399 -0.813 . . . . 0.0 109.439 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.94 -43.43 94.9 Favored Glycine 1 N--CA 1.519 4.191 0 C-N-CA 123.37 0.509 . . . . 0.0 114.363 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.83 -36.76 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 CA-C-N 117.907 0.853 . . . . 0.0 110.586 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.2 p -58.38 -44.58 88.97 Favored 'General case' 1 N--CA 1.539 4.008 0 CA-C-N 118.42 0.555 . . . . 0.0 111.118 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.75 -37.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 123.426 0.69 . . . . 0.0 111.405 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.25 -37.03 66.7 Favored 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.2 -50.56 71.33 Favored 'General case' 0 N--CA 1.513 2.682 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.9 m -61.93 -37.8 79.11 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.147 0 CA-C-N 118.529 0.604 . . . . 0.0 111.649 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 56.6 t -59.23 -32.68 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.976 0 O-C-N 121.482 -0.761 . . . . 0.0 110.189 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 73.0 mt -72.82 -34.43 66.83 Favored 'General case' 0 N--CA 1.532 3.639 0 C-N-CA 122.385 0.274 . . . . 0.0 110.294 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.2 -47.8 91.42 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.287 0 C-N-CA 123.039 0.535 . . . . 0.0 111.415 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.51 -36.92 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 O-C-N 121.885 -0.509 . . . . 0.0 110.102 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.99 -49.0 78.33 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.245 0.618 . . . . 0.0 112.304 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.11 -34.28 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.542 0 O-C-N 122.022 -0.424 . . . . 0.0 110.94 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -70.21 -43.1 71.36 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.078 0.551 . . . . 0.0 112.16 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.95 -37.64 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.71 0 O-C-N 122.067 -0.396 . . . . 0.0 111.305 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 20.1 p -67.34 -28.02 67.62 Favored 'General case' 0 N--CA 1.532 3.67 0 CA-C-N 117.886 0.312 . . . . 0.0 110.939 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -67.57 -30.55 70.2 Favored 'General case' 0 N--CA 1.529 3.478 0 C-N-CA 123.217 0.607 . . . . 0.0 110.53 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.7 m -67.4 -27.56 67.18 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 123.356 0.662 . . . . 0.0 110.498 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 235' ' ' LEU . 0.8 OUTLIER -64.4 -14.52 57.02 Favored 'General case' 0 N--CA 1.533 3.702 0 C-N-CA 124.474 1.11 . . . . 0.0 109.908 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 30.2 mt -87.24 2.0 51.41 Favored 'General case' 0 N--CA 1.533 3.714 0 C-N-CA 123.749 0.82 . . . . 0.0 110.578 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -66.48 -2.29 4.49 Favored 'General case' 0 N--CA 1.529 3.525 0 C-N-CA 123.854 0.862 . . . . 0.0 111.001 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -62.22 177.44 0.48 Allowed 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.868 0.867 . . . . 0.0 110.941 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -64.87 153.71 39.41 Favored 'General case' 0 N--CA 1.526 3.335 0 C-N-CA 124.149 0.98 . . . . 0.0 110.097 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.528 3.432 0 C-N-CA 124.927 1.291 . . . . 0.0 108.113 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.521 3.081 0 N-CA-C 110.788 -0.079 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.24 -26.98 68.34 Favored 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 124.084 0.954 . . . . 0.0 109.923 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 94.6 p -58.26 -26.37 62.85 Favored 'General case' 0 N--CA 1.529 3.486 0 C-N-CA 123.333 0.653 . . . . 0.0 110.769 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.75 -35.61 75.32 Favored Glycine 0 N--CA 1.508 3.479 0 C-N-CA 124.772 1.177 . . . . 0.0 115.475 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 pt -59.47 -34.65 55.27 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.475 0 CA-C-N 119.039 1.419 . . . . 0.0 113.647 -176.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 1.6 pp -55.78 -35.18 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.976 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 20.0 pt -65.64 -33.74 65.68 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.264 0 CA-C-N 118.849 0.749 . . . . 0.0 109.238 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.77 -38.84 96.11 Favored Glycine 1 N--CA 1.519 4.201 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.26 -47.31 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 123.796 0.838 . . . . 0.0 109.423 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 88.3 m -66.03 -47.66 73.7 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.665 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 71.7 t -70.56 -33.27 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.376 0 C-N-CA 124.054 0.942 . . . . 0.0 111.486 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.87 79.3 Favored 'General case' 0 N--CA 1.534 3.731 0 CA-C-N 118.376 0.534 . . . . 0.0 112.102 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.55 -50.22 59.57 Favored 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.5 m -63.1 -39.07 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.64 -32.72 58.09 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.035 0 CA-C-N 118.723 0.692 . . . . 0.0 110.322 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -44.64 92.14 Favored 'General case' 0 N--CA 1.532 3.639 0 C-N-CA 123.205 0.602 . . . . 0.0 111.056 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.26 -39.74 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.792 0.437 . . . . 0.0 110.456 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.38 -39.34 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.508 0 C-N-CA 122.96 0.504 . . . . 0.0 109.802 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.4 93.9 Favored 'General case' 0 N--CA 1.528 3.46 0 C-N-CA 123.251 0.62 . . . . 0.0 111.961 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 93.0 t -71.65 -34.63 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.602 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.86 -43.87 94.8 Favored 'General case' 0 N--CA 1.526 3.355 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 11.3 m -68.65 -37.81 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 CA-C-N 118.693 0.679 . . . . 0.0 109.718 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.8 m -60.93 -37.18 81.43 Favored 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.844 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -27.25 66.71 Favored 'General case' 0 N--CA 1.537 3.919 0 C-N-CA 122.576 0.35 . . . . 0.0 110.594 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 23.1 t -63.52 -40.84 98.1 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.005 0.522 . . . . 0.0 110.991 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.41 -22.25 66.77 Favored 'General case' 0 N--CA 1.535 3.806 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 1 N--CA 1.543 4.222 0 C-N-CA 124.415 1.086 . . . . 0.0 109.378 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.522 3.155 0 CA-C-O 121.894 0.854 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -58.97 -25.82 63.91 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.601 1.16 . . . . 0.0 112.33 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 87.6 p -57.09 -25.73 59.24 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.436 0.694 . . . . 0.0 110.748 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.74 -35.34 62.53 Favored Glycine 0 N--CA 1.515 3.913 0 C-N-CA 124.52 1.057 . . . . 0.0 115.052 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.73 -34.01 62.55 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.427 0 CA-C-N 118.521 1.161 . . . . 0.0 113.872 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 215' ' ' ILE . . . . . 0.498 ' O ' HG12 ' C' ' 218' ' ' VAL . 1.5 pp -55.28 -32.84 29.51 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.115 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -172.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.7 tt -72.64 -32.4 40.97 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.368 0 CA-C-N 119.041 0.837 . . . . 0.0 109.348 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.08 -29.01 43.12 Favored Glycine 0 N--CA 1.515 3.946 0 C-N-CA 124.215 0.912 . . . . 0.0 113.939 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 218' ' ' VAL . . . . . 0.498 HG12 ' O ' ' C' ' 215' ' ' ILE . 15.0 p -58.91 -38.02 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 CA-C-N 117.435 0.618 . . . . 0.0 111.117 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 64.6 p -64.78 -46.09 83.58 Favored 'General case' 0 N--CA 1.529 3.475 0 CA-C-O 121.155 0.502 . . . . 0.0 110.524 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.08 -37.2 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.049 0 C-N-CA 124.078 0.951 . . . . 0.0 110.625 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.71 -39.93 62.49 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.91 65.76 Favored 'General case' 0 N--CA 1.515 2.783 0 C-N-CA 123.127 0.571 . . . . 0.0 111.434 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 44.6 t -61.8 -47.74 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.328 0 C-N-CA 123.225 0.61 . . . . 0.0 112.171 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.6 -32.59 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 C-N-CA 122.404 0.282 . . . . 0.0 111.377 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 38.5 tp -71.52 -34.74 70.33 Favored 'General case' 0 N--CA 1.522 3.173 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 87.1 mt -68.48 -44.85 82.85 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.372 0 CA-C-N 119.645 1.111 . . . . 0.0 110.16 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.11 -35.97 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.945 0.498 . . . . 0.0 109.973 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.12 -38.55 73.62 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.431 0.693 . . . . 0.0 111.904 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.07 -41.13 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 CA-C-O 120.742 0.305 . . . . 0.0 110.282 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -61.5 -43.93 97.99 Favored 'General case' 0 N--CA 1.529 3.498 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.23 -37.42 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.632 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 95.5 m -64.37 -33.52 76.03 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -74.04 -38.0 64.14 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.177 0.591 . . . . 0.0 110.321 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 82.2 p -63.92 -17.04 62.83 Favored 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 123.383 0.673 . . . . 0.0 111.321 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.98 -37.74 88.36 Favored 'General case' 0 N--CA 1.531 3.587 0 C-N-CA 123.963 0.905 . . . . 0.0 111.29 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.19 -2.29 57.53 Favored 'General case' 1 N--CA 1.544 4.231 0 C-N-CA 123.323 0.649 . . . . 0.0 112.2 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -70.98 92.3 0.92 Allowed 'General case' 0 N--CA 1.529 3.516 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.95 142.56 1.88 Allowed 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 124.045 0.938 . . . . 0.0 108.547 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -168.9 103.1 0.39 Allowed 'General case' 0 N--CA 1.52 3.046 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.531 3.577 0 C-N-CA 124.884 1.274 . . . . 0.0 107.676 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.522 3.153 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 49.3 mt -57.62 -26.77 62.05 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 123.949 0.899 . . . . 0.0 110.866 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 55.4 m -64.14 -35.34 80.45 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.818 0.847 . . . . 0.0 110.787 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.04 -35.02 77.5 Favored Glycine 0 N--CA 1.514 3.863 0 C-N-CA 124.354 0.978 . . . . 0.0 113.056 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 37.0 mm -68.1 -43.61 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.445 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.07 -36.31 50.73 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.213 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 15.8 tt -72.39 -33.16 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.864 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.89 -42.26 99.71 Favored Glycine 1 N--CA 1.518 4.142 0 C-N-CA 123.076 0.37 . . . . 0.0 113.838 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 18.7 m -68.72 -37.17 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.866 0 CA-C-N 118.184 0.992 . . . . 0.0 111.342 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 47.4 p -63.89 -45.78 87.85 Favored 'General case' 0 N--CA 1.53 3.54 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.36 -31.93 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 CA-C-N 118.882 0.765 . . . . 0.0 111.075 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.0 -46.76 82.06 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 122.629 0.371 . . . . 0.0 111.687 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.08 -42.23 85.15 Favored 'General case' 0 N--CA 1.519 2.998 0 C-N-CA 123.485 0.714 . . . . 0.0 111.92 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.58 -44.95 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.462 0 C-N-CA 123.102 0.561 . . . . 0.0 111.209 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.48 -40.38 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 C-N-CA 122.38 0.272 . . . . 0.0 110.626 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.66 -46.55 78.71 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 122.846 0.458 . . . . 0.0 111.603 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 85.7 mt -62.26 -36.99 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 O-C-N 122.029 -0.42 . . . . 0.0 110.585 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.12 -37.55 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.887 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.76 98.57 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.852 0.461 . . . . 0.0 111.202 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.75 -34.66 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.426 0 C-N-CA 123.165 0.586 . . . . 0.0 109.702 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -63.08 -44.1 96.71 Favored 'General case' 0 N--CA 1.53 3.571 0 C-N-CA 123.099 0.56 . . . . 0.0 112.366 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.12 -37.64 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.724 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 85.8 m -61.03 -27.31 68.24 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 123.151 0.58 . . . . 0.0 111.251 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -57.8 -27.19 62.89 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 122.811 0.444 . . . . 0.0 111.251 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 66.1 m -65.97 -41.18 91.51 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 123.78 0.832 . . . . 0.0 111.355 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -60.84 -13.42 15.39 Favored 'General case' 0 N--CA 1.532 3.653 0 C-N-CA 124.338 1.055 . . . . 0.0 111.28 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.45 -23.42 26.03 Favored 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.83 109.82 15.75 Favored 'General case' 0 N--CA 1.527 3.408 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -168.63 166.95 11.68 Favored 'General case' 0 N--CA 1.521 3.102 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 22.7 pttp . . . . . 0 N--CA 1.522 3.142 0 C-N-CA 124.05 0.94 . . . . 0.0 110.866 -179.388 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.525 3.299 0 CA-C-O 120.61 0.243 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -61.82 -27.03 68.48 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 123.3 0.64 . . . . 0.0 111.143 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 55.7 m -69.13 -26.1 64.72 Favored 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.984 0.914 . . . . 0.0 109.976 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.34 -46.01 88.32 Favored Glycine 0 N--CA 1.513 3.78 0 CA-C-N 115.394 -0.821 . . . . 0.0 114.256 -177.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 46.6 pt -70.47 -35.63 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 8.6 pt -61.8 -44.45 98.81 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.55 0 CA-C-N 119.249 0.931 . . . . 0.0 111.582 -176.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.33 -32.22 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.871 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.96 -29.4 43.1 Favored Glycine 0 N--CA 1.506 3.302 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.584 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.45 -37.25 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 CA-C-N 117.708 0.754 . . . . 0.0 111.179 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 35.9 p -64.66 -47.61 77.82 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 10.5 p -70.84 -31.24 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.327 0.651 . . . . 0.0 110.987 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.22 65.07 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.07 0.548 . . . . 0.0 112.324 -177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.77 -34.76 69.92 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 123.129 0.571 . . . . 0.0 111.83 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.95 -40.47 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 123.03 0.532 . . . . 0.0 110.307 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.15 -42.08 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.508 0.723 . . . . 0.0 110.746 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 66.6 mt -64.2 -34.58 78.42 Favored 'General case' 0 N--CA 1.528 3.449 0 C-N-CA 122.684 0.394 . . . . 0.0 110.749 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.64 -43.95 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 C-N-CA 122.852 0.461 . . . . 0.0 109.952 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 80.7 t -66.86 -39.2 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.59 -48.03 82.31 Favored 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 123.681 0.792 . . . . 0.0 112.953 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 35.2 m -71.58 -34.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 O-C-N 121.955 -0.465 . . . . 0.0 110.803 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.24 -44.25 92.42 Favored 'General case' 0 N--CA 1.528 3.471 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.96 -37.81 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 83.7 m -66.19 -32.63 74.18 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 122.875 0.47 . . . . 0.0 110.554 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -67.53 -32.2 72.84 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.422 0.689 . . . . 0.0 111.047 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -63.89 -26.8 68.76 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.312 0.645 . . . . 0.0 111.301 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 53.5 mt . . . . . 0 N--CA 1.525 3.282 0 C-N-CA 123.379 0.671 . . . . 0.0 110.274 179.82 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.521 3.103 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.23 -26.22 68.41 Favored 'General case' 0 N--CA 1.525 3.3 0 C-N-CA 124.014 0.926 . . . . 0.0 111.748 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 40.1 t -66.04 -33.09 75.01 Favored 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 123.609 0.764 . . . . 0.0 111.302 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.74 -45.98 62.99 Favored Glycine 1 N--CA 1.519 4.18 0 N-CA-C 115.047 0.779 . . . . 0.0 115.047 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 8.4 tp -70.85 -40.49 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.888 0 O-C-N 121.653 -0.91 . . . . 0.0 112.319 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 215' ' ' ILE . . . . . 0.479 HD13 ' O ' ' F' ' 215' ' ' ILE . 0.0 OUTLIER -66.01 -36.73 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 C-N-CA 123.207 0.603 . . . . 0.0 111.946 -177.084 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' F' F ' 216' ' ' ILE . . . . . 0.563 HD12 ' N ' ' F' ' 217' ' ' GLY . 1.9 pp -70.92 -31.73 46.34 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.421 0 CA-C-N 119.424 1.011 . . . . 0.0 109.232 177.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' F' F ' 217' ' ' GLY . . . . . 0.563 ' N ' HD12 ' F' ' 216' ' ' ILE . . . -54.49 -29.46 47.6 Favored Glycine 0 N--CA 1.516 3.987 0 C-N-CA 123.845 0.736 . . . . 0.0 113.801 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 218' ' ' VAL . . . . . 0.44 HG12 ' O ' ' F' ' 215' ' ' ILE . 8.2 p -59.74 -39.78 80.68 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.055 0 CA-C-N 117.525 0.663 . . . . 0.0 111.509 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 82.5 p -66.18 -45.91 79.19 Favored 'General case' 0 N--CA 1.53 3.564 0 CA-C-O 121.247 0.546 . . . . 0.0 110.794 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.23 -32.54 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.038 0 C-N-CA 124.24 1.016 . . . . 0.0 110.864 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.65 -45.2 66.6 Favored 'General case' 0 N--CA 1.529 3.498 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.53 -33.46 75.97 Favored 'General case' 0 N--CA 1.523 3.191 0 C-N-CA 123.449 0.7 . . . . 0.0 111.626 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 25.9 t -65.42 -38.62 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.652 0.781 . . . . 0.0 110.934 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.17 -32.52 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 C-N-CA 123.123 0.569 . . . . 0.0 111.185 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 43.2 tp -68.22 -39.26 82.4 Favored 'General case' 0 N--CA 1.526 3.356 0 CA-C-O 120.764 0.316 . . . . 0.0 110.191 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 41.5 mm -54.7 -50.15 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.865 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.742 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 18.7 m -67.04 -37.28 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.896 -0.502 . . . . 0.0 110.214 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.25 93.13 Favored 'General case' 0 N--CA 1.525 3.277 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 15.9 m -71.27 -33.99 52.55 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 CA-C-N 119.223 0.92 . . . . 0.0 110.102 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -64.12 -43.94 93.76 Favored 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 14.3 m -68.74 -37.65 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 CA-C-O 121.007 0.432 . . . . 0.0 109.901 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 91.0 m -58.67 -27.43 64.79 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 123.447 0.699 . . . . 0.0 111.104 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.05 -34.36 78.23 Favored 'General case' 0 N--CA 1.525 3.324 0 C-N-CA 122.335 0.254 . . . . 0.0 110.672 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 79.5 p -68.34 -36.41 79.21 Favored 'General case' 0 N--CA 1.532 3.647 0 C-N-CA 123.181 0.592 . . . . 0.0 110.685 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.85 -13.49 15.89 Favored 'General case' 0 N--CA 1.537 3.902 0 C-N-CA 123.555 0.742 . . . . 0.0 110.964 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 18.2 mt -86.68 0.38 54.72 Favored 'General case' 0 N--CA 1.535 3.811 0 C-N-CA 122.929 0.492 . . . . 0.0 111.383 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -163.92 108.53 1.01 Allowed 'General case' 0 N--CA 1.53 3.552 0 CA-C-N 118.073 0.397 . . . . 0.0 111.248 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 54.9 mttp . . . . . 0 N--CA 1.526 3.362 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.269 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.223 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.9 p -166.05 -20.09 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 124.153 0.981 . . . . 0.0 109.387 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.11 -26.41 68.19 Favored 'General case' 0 N--CA 1.528 3.474 0 C-N-CA 124.2 1.0 . . . . 0.0 109.164 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 95.1 p -65.95 -26.96 67.82 Favored 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.547 0.739 . . . . 0.0 110.49 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.12 -46.61 57.67 Favored Glycine 1 N--CA 1.52 4.254 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 8.4 tp -71.17 -41.1 75.41 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.174 0 CA-C-N 118.186 0.993 . . . . 0.0 112.967 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.3 tt -60.87 -35.25 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 123.672 0.789 . . . . 0.0 112.873 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 5.7 tp -73.16 -33.28 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.991 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.43 96.14 Favored Glycine 1 N--CA 1.521 4.311 0 C-N-CA 123.401 0.525 . . . . 0.0 114.219 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.6 p -59.71 -36.84 68.11 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 117.972 0.886 . . . . 0.0 110.787 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.9 p -55.95 -42.15 75.77 Favored 'General case' 0 N--CA 1.535 3.821 0 CA-C-O 120.919 0.39 . . . . 0.0 111.432 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.5 -40.4 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 123.85 0.86 . . . . 0.0 111.601 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.38 -39.91 61.42 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -176.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.54 -46.35 63.74 Favored 'General case' 0 N--CA 1.52 3.054 0 C-N-CA 122.997 0.519 . . . . 0.0 111.185 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.78 -46.62 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 C-N-CA 123.321 0.648 . . . . 0.0 112.385 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.8 p -66.18 -32.28 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.665 0 C-N-CA 122.512 0.325 . . . . 0.0 111.122 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.61 -41.32 96.28 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.584 0.354 . . . . 0.0 110.859 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 88.0 mt -58.62 -36.66 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.916 0 C-N-CA 122.658 0.383 . . . . 0.0 110.287 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.34 -37.69 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 C-N-CA 123.02 0.528 . . . . 0.0 110.324 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.62 -33.25 75.49 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.038 0.535 . . . . 0.0 110.877 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.07 -36.9 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 C-N-CA 123.308 0.643 . . . . 0.0 109.762 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -64.36 -43.45 94.5 Favored 'General case' 0 N--CA 1.528 3.466 0 C-N-CA 123.633 0.773 . . . . 0.0 112.544 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 19.2 m -67.7 -37.23 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 76.8 m -60.24 -38.35 83.19 Favored 'General case' 0 N--CA 1.527 3.392 0 C-N-CA 122.96 0.504 . . . . 0.0 111.26 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -74.27 -40.63 62.2 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 122.64 0.376 . . . . 0.0 110.074 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 83.5 p -63.91 -32.73 74.35 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.15 -23.18 57.77 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.063 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.4 tp -87.11 -22.67 25.24 Favored 'General case' 0 N--CA 1.537 3.919 0 C-N-CA 122.942 0.497 . . . . 0.0 110.16 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -71.45 65.61 0.45 Allowed 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.648 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -143.44 157.9 44.08 Favored 'General case' 0 N--CA 1.526 3.369 0 C-N-CA 124.822 1.249 . . . . 0.0 107.843 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.69 155.93 37.2 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 123.731 0.812 . . . . 0.0 109.216 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.529 3.488 0 C-N-CA 124.706 1.203 . . . . 0.0 108.329 179.579 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.522 3.168 0 CA-C-O 120.167 0.032 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.2 -28.72 69.58 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 124.061 0.944 . . . . 0.0 110.137 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 56.0 m -65.05 -26.88 68.44 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.04 0.536 . . . . 0.0 110.302 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.28 -35.79 91.98 Favored Glycine 1 N--CA 1.524 4.524 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 36.1 mm -68.71 -40.48 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.302 0 C-N-CA 124.583 1.153 . . . . 0.0 109.149 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 48.2 mm -66.46 -40.13 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 C-N-CA 124.538 1.135 . . . . 0.0 108.905 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 14.6 mm -71.38 -31.96 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.97 -29.17 42.58 Favored Glycine 0 N--CA 1.516 3.976 0 C-N-CA 123.708 0.67 . . . . 0.0 113.176 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.59 -37.59 71.31 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.095 0 CA-C-N 117.84 0.82 . . . . 0.0 110.769 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 46.9 p -57.48 -44.79 85.17 Favored 'General case' 0 N--CA 1.528 3.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.824 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.6 t -67.02 -31.79 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 C-N-CA 124.095 0.958 . . . . 0.0 110.875 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.87 79.35 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 122.482 0.313 . . . . 0.0 110.967 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.98 -50.11 74.51 Favored 'General case' 0 N--CA 1.521 3.117 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.37 -38.35 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 CA-C-N 118.224 0.465 . . . . 0.0 111.625 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.2 -38.38 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 118.23 0.468 . . . . 0.0 110.651 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.99 -38.72 92.11 Favored 'General case' 1 N--CA 1.539 4.021 0 C-N-CA 122.55 0.34 . . . . 0.0 110.543 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.78 -42.8 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.818 0 O-C-N 122.005 -0.434 . . . . 0.0 110.221 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 64.6 t -65.52 -37.71 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 C-N-CA 122.964 0.506 . . . . 0.0 110.082 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.56 80.3 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.432 0.693 . . . . 0.0 111.277 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 84.1 t -71.94 -34.88 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.26 0 C-N-CA 122.909 0.484 . . . . 0.0 110.443 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -62.66 -44.46 96.21 Favored 'General case' 0 N--CA 1.534 3.739 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.02 -39.34 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.721 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 73.6 m -67.18 -30.39 70.33 Favored 'General case' 0 N--CA 1.524 3.26 0 C-N-CA 123.115 0.566 . . . . 0.0 110.727 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -73.32 -35.33 66.04 Favored 'General case' 0 N--CA 1.526 3.339 0 C-N-CA 123.249 0.62 . . . . 0.0 110.343 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 62.8 m -63.67 -23.87 67.55 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.554 0.742 . . . . 0.0 111.689 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.95 -24.98 66.13 Favored 'General case' 0 N--CA 1.53 3.557 0 C-N-CA 123.688 0.795 . . . . 0.0 110.285 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.535 3.782 0 C-N-CA 123.632 0.773 . . . . 0.0 109.453 179.909 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.521 3.093 0 CA-C-O 121.819 0.819 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 7.8 mp -65.23 -26.92 68.33 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.932 0.893 . . . . 0.0 109.537 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 41.4 t -58.2 -25.94 62.2 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.579 0.751 . . . . 0.0 110.931 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.65 -34.4 60.51 Favored Glycine 0 N--CA 1.513 3.77 0 C-N-CA 125.123 1.344 . . . . 0.0 114.981 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.0 pt -57.95 -34.11 47.84 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.271 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -175.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 9.8 pt -55.74 -32.43 31.63 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.133 0 C-N-CA 123.128 0.571 . . . . 0.0 111.972 -176.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.96 -33.44 52.84 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.112 0 C-N-CA 123.613 0.765 . . . . 0.0 110.017 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.74 -29.9 50.72 Favored Glycine 0 N--CA 1.513 3.814 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.039 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.1 m -62.26 -37.82 79.55 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 117.937 0.868 . . . . 0.0 111.329 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 68.2 p -62.15 -45.77 91.96 Favored 'General case' 0 N--CA 1.532 3.633 0 CA-C-O 121.364 0.602 . . . . 0.0 110.669 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.18 -32.49 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 C-N-CA 124.197 0.999 . . . . 0.0 110.207 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.3 -34.61 78.74 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.534 0.733 . . . . 0.0 111.776 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.03 -49.87 46.98 Favored 'General case' 0 N--CA 1.516 2.844 0 C-N-CA 123.14 0.576 . . . . 0.0 112.503 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 29.3 m -63.92 -40.11 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.815 0 CA-C-N 118.523 0.602 . . . . 0.0 112.577 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 13.7 p -67.44 -32.01 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 CA-C-N 118.182 0.446 . . . . 0.0 110.558 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.49 -43.96 79.68 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 122.911 0.485 . . . . 0.0 110.333 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.52 -36.54 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 C-N-CA 123.48 0.712 . . . . 0.0 112.028 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.71 -36.68 67.14 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.683 0 CA-C-N 119.447 1.022 . . . . 0.0 110.517 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.28 -32.51 66.7 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.386 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.72 -41.25 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.394 0 C-N-CA 123.261 0.624 . . . . 0.0 110.086 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -61.42 -43.52 98.73 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.607 0.763 . . . . 0.0 112.915 -177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.26 -37.54 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 82.6 m -61.6 -27.82 68.91 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 122.619 0.368 . . . . 0.0 111.07 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -68.21 -27.38 66.33 Favored 'General case' 0 N--CA 1.531 3.576 0 C-N-CA 123.057 0.543 . . . . 0.0 110.738 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.9 m -69.07 -26.77 65.11 Favored 'General case' 0 N--CA 1.531 3.595 0 CA-C-O 121.225 0.536 . . . . 0.0 110.103 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -14.52 47.21 Favored 'General case' 0 N--CA 1.533 3.682 0 C-N-CA 124.807 1.243 . . . . 0.0 110.499 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 32.2 mt -86.59 -27.27 23.98 Favored 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 123.373 0.669 . . . . 0.0 110.387 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -71.56 84.98 0.86 Allowed 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.532 0.733 . . . . 0.0 109.234 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.64 117.09 15.71 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 124.988 1.315 . . . . 0.0 107.766 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? -164.53 134.02 3.78 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.531 3.578 0 C-N-CA 125.145 1.378 . . . . 0.0 108.685 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 N--CA 1.522 3.134 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -25.79 68.09 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.887 0.875 . . . . 0.0 111.659 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 212' ' ' SER . . . . . 0.435 ' O ' HD12 ' D' ' 215' ' ' ILE . 99.6 p -68.17 -26.92 65.99 Favored 'General case' 0 N--CA 1.527 3.395 0 C-N-CA 123.331 0.652 . . . . 0.0 110.054 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.06 -34.02 71.35 Favored Glycine 0 N--CA 1.505 3.255 0 C-N-CA 125.589 1.566 . . . . 0.0 115.597 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 13.7 pt -58.24 -33.79 48.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 215' ' ' ILE . . . . . 0.534 HD13 ' H ' ' D' ' 216' ' ' ILE . 0.1 OUTLIER -55.06 -43.39 69.58 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.388 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.302 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' D' D ' 216' ' ' ILE . . . . . 0.534 ' H ' HD13 ' D' ' 215' ' ' ILE . 18.4 tt -73.19 -34.47 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.984 0 CA-C-N 118.252 0.478 . . . . 0.0 110.375 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.11 -44.6 93.89 Favored Glycine 1 N--CA 1.519 4.184 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -60.11 -37.07 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.987 0 CA-C-N 117.629 0.714 . . . . 0.0 111.067 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 61.6 p -59.26 -39.0 81.48 Favored 'General case' 0 N--CA 1.532 3.637 0 CA-C-N 117.963 0.347 . . . . 0.0 111.41 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.48 -38.34 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 C-N-CA 123.41 0.684 . . . . 0.0 111.52 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.16 68.19 Favored 'General case' 0 N--CA 1.531 3.623 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.12 90.06 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 123.5 0.72 . . . . 0.0 111.71 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.23 -42.91 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.289 0.636 . . . . 0.0 112.129 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.81 -32.56 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.58 -47.33 22.82 Favored 'General case' 0 N--CA 1.539 3.997 0 CA-C-N 118.248 0.476 . . . . 0.0 111.352 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 20.2 pt -62.05 -36.31 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.721 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.07 -36.01 76.43 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.199 0 CA-C-N 119.425 1.011 . . . . 0.0 110.321 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.42 -32.16 66.59 Favored 'General case' 0 N--CA 1.523 3.187 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.77 -34.91 67.21 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.296 0 CA-C-N 119.709 1.14 . . . . 0.0 112.269 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -63.21 -43.53 97.86 Favored 'General case' 1 N--CA 1.539 4.019 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.37 -37.32 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 76.4 m -58.7 -31.3 68.12 Favored 'General case' 0 N--CA 1.531 3.619 0 C-N-CA 122.529 0.331 . . . . 0.0 111.257 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.11 -15.32 63.54 Favored 'General case' 0 N--CA 1.534 3.726 0 C-N-CA 123.103 0.561 . . . . 0.0 110.858 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 78.4 p -63.41 -28.78 70.22 Favored 'General case' 0 N--CA 1.529 3.51 0 CA-C-O 121.146 0.498 . . . . 0.0 109.87 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 57.6 mt -91.35 -18.65 23.95 Favored 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 124.507 1.123 . . . . 0.0 112.301 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 53.9 mt -87.53 3.0 49.14 Favored 'General case' 1 N--CA 1.544 4.264 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -70.2 -7.82 45.03 Favored 'General case' 1 N--CA 1.543 4.216 0 CA-C-N 119.65 1.114 . . . . 0.0 109.504 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -67.71 131.78 46.23 Favored 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 124.027 0.931 . . . . 0.0 109.844 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 N--CA 1.526 3.349 0 C-N-CA 123.708 0.803 . . . . 0.0 110.497 179.585 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p . . . . . 0 N--CA 1.519 3.018 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.16 -27.21 68.55 Favored 'General case' 0 N--CA 1.536 3.865 0 C-N-CA 123.641 0.777 . . . . 0.0 109.091 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -66.7 -28.26 68.29 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.421 0.689 . . . . 0.0 110.421 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.77 -35.56 80.3 Favored Glycine 1 N--CA 1.516 4.009 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 38.5 mm -69.81 -43.56 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.153 0 C-N-CA 124.528 1.131 . . . . 0.0 112.841 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 9.4 pt -59.49 -40.87 82.97 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.526 0 CA-C-N 118.852 0.751 . . . . 0.0 112.153 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.0 -32.94 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.98 -50.14 70.86 Favored Glycine 1 N--CA 1.52 4.276 0 C-N-CA 123.603 0.62 . . . . 0.0 113.364 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -61.76 -36.78 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-N 117.458 0.629 . . . . 0.0 109.747 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 86.1 m -63.6 -47.05 83.0 Favored 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 122.693 0.397 . . . . 0.0 111.604 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.7 -34.39 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 C-N-CA 123.491 0.716 . . . . 0.0 110.512 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.7 -46.57 67.39 Favored 'General case' 0 N--CA 1.527 3.382 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.43 91.09 Favored 'General case' 0 N--CA 1.519 2.99 0 C-N-CA 123.033 0.533 . . . . 0.0 111.687 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 43.2 t -68.16 -51.6 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.101 0 C-N-CA 123.134 0.574 . . . . 0.0 111.96 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 31.7 m -67.41 -32.72 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 O-C-N 121.892 -0.505 . . . . 0.0 111.813 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.03 -44.51 72.55 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 122.539 0.335 . . . . 0.0 111.33 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 24.7 pt -69.23 -36.48 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 CA-C-N 118.747 0.703 . . . . 0.0 111.149 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.07 -37.64 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.871 0 O-C-N 121.848 -0.533 . . . . 0.0 109.739 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.78 83.66 Favored 'General case' 0 N--CA 1.532 3.637 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.65 -34.16 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.554 0 O-C-N 122.079 -0.388 . . . . 0.0 110.937 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -68.75 -43.71 75.28 Favored 'General case' 0 N--CA 1.526 3.357 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 13.2 p -68.38 -37.83 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 CA-C-N 118.019 0.372 . . . . 0.0 111.175 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 16.3 p -66.31 -27.88 68.26 Favored 'General case' 0 N--CA 1.533 3.679 0 CA-C-N 117.855 0.298 . . . . 0.0 111.172 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -65.61 -30.98 71.78 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 123.214 0.606 . . . . 0.0 111.109 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 53.0 m -64.47 -32.37 73.96 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.391 0.676 . . . . 0.0 111.277 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 53.8 mt . . . . . 0 N--CA 1.527 3.379 0 C-N-CA 123.594 0.758 . . . . 0.0 111.928 -178.932 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.521 3.102 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.08 -35.61 81.69 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 124.312 1.045 . . . . 0.0 110.285 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 42.2 t -57.77 -26.95 62.6 Favored 'General case' 0 N--CA 1.528 3.451 0 C-N-CA 122.886 0.475 . . . . 0.0 111.593 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.38 -35.85 83.01 Favored Glycine 1 N--CA 1.527 4.741 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.29 -40.7 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 C-N-CA 124.428 1.091 . . . . 0.0 108.959 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.23 -42.67 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 C-N-CA 124.524 1.13 . . . . 0.0 108.771 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 30.8 mm -72.38 -33.06 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.627 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.42 -29.71 60.83 Favored Glycine 0 N--CA 1.514 3.88 0 C-N-CA 123.766 0.698 . . . . 0.0 113.362 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 2.5 m -60.43 -37.38 74.39 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 CA-C-N 117.825 0.812 . . . . 0.0 110.653 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 44.5 p -55.92 -46.1 78.55 Favored 'General case' 0 N--CA 1.529 3.517 0 CA-C-O 121.375 0.607 . . . . 0.0 111.403 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.62 -31.92 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.034 0 C-N-CA 124.387 1.075 . . . . 0.0 111.238 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.86 78.99 Favored 'General case' 0 N--CA 1.531 3.588 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.19 -50.28 70.94 Favored 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 28.1 m -63.09 -37.94 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.404 0.547 . . . . 0.0 111.883 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 93.9 t -60.5 -32.71 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 121.77 -0.581 . . . . 0.0 110.232 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.5 -38.08 77.47 Favored 'General case' 0 N--CA 1.532 3.669 0 CA-C-N 118.455 0.571 . . . . 0.0 109.958 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 11.6 mm -54.36 -36.85 35.21 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.026 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.44 -38.09 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 C-N-CA 123.468 0.707 . . . . 0.0 109.829 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.47 -32.21 72.21 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.431 0.692 . . . . 0.0 111.309 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.02 -34.51 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 C-N-CA 122.813 0.445 . . . . 0.0 109.855 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.02 -43.37 83.0 Favored 'General case' 0 N--CA 1.53 3.553 0 C-N-CA 123.07 0.548 . . . . 0.0 112.152 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 4.9 m -67.47 -36.1 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 CA-C-N 118.195 0.452 . . . . 0.0 109.937 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 96.6 m -57.61 -27.13 62.48 Favored 'General case' 0 N--CA 1.526 3.348 0 C-N-CA 123.004 0.521 . . . . 0.0 110.547 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -58.51 -15.71 12.3 Favored 'General case' 0 N--CA 1.531 3.6 0 C-N-CA 122.367 0.267 . . . . 0.0 110.867 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 50.8 m -75.04 -42.07 57.91 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.99 -14.22 21.51 Favored 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.474 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 43.2 tp -87.06 2.3 50.12 Favored 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 46.9 m95 66.92 164.29 0.2 Allowed 'General case' 0 N--CA 1.515 2.799 0 C-N-CA 125.148 1.379 . . . . 0.0 111.214 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.522 3.134 0 C-N-CA 125.358 1.463 . . . . 0.0 107.07 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.521 4.301 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 82.8 p 52.34 46.36 26.8 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 124.055 0.942 . . . . 0.0 112.199 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 43.4 mt -61.91 -26.85 68.41 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.774 0.83 . . . . 0.0 110.607 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 45.2 t -68.43 -26.36 65.48 Favored 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.675 0.79 . . . . 0.0 110.596 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.35 -43.79 77.2 Favored Glycine 0 N--CA 1.512 3.714 0 C-N-CA 123.599 0.619 . . . . 0.0 114.103 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.7 pt -70.68 -35.82 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 10.1 pt -58.56 -41.69 82.63 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.66 0 CA-C-N 119.433 1.015 . . . . 0.0 112.542 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.7 -33.18 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.06 -41.0 96.27 Favored Glycine 1 N--CA 1.516 4.002 0 CA-C-O 119.502 -0.61 . . . . 0.0 114.088 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.9 m -63.73 -36.62 77.17 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.349 0 CA-C-N 118.624 1.212 . . . . 0.0 111.134 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.8 p -55.74 -42.56 75.57 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.828 0.451 . . . . 0.0 111.092 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.93 -34.13 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 C-N-CA 124.059 0.944 . . . . 0.0 111.896 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.93 -42.42 65.4 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.75 -34.08 71.47 Favored 'General case' 0 N--CA 1.519 2.992 0 C-N-CA 123.232 0.613 . . . . 0.0 111.314 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.85 -49.23 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 123.647 0.779 . . . . 0.0 111.345 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.68 -32.71 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 C-N-CA 122.633 0.373 . . . . 0.0 110.674 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.28 -36.86 74.67 Favored 'General case' 0 N--CA 1.539 3.985 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.18 -37.11 34.66 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.352 0 C-N-CA 123.168 0.587 . . . . 0.0 109.975 178.587 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.1 t -66.93 -38.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 C-N-CA 123.187 0.595 . . . . 0.0 110.143 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -45.53 86.54 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.387 0.675 . . . . 0.0 112.681 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.7 -34.17 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.613 0 O-C-N 121.898 -0.501 . . . . 0.0 110.228 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.15 -44.1 93.15 Favored 'General case' 0 N--CA 1.532 3.629 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.53 -37.29 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 99.5 m -59.14 -27.95 66.11 Favored 'General case' 0 N--CA 1.531 3.6 0 C-N-CA 122.74 0.416 . . . . 0.0 110.859 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -73.29 -35.05 66.07 Favored 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 63.0 m -72.66 -30.86 64.62 Favored 'General case' 0 N--CA 1.525 3.321 0 C-N-CA 123.108 0.563 . . . . 0.0 109.852 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.78 -14.65 62.5 Favored 'General case' 0 N--CA 1.526 3.339 0 C-N-CA 124.513 1.125 . . . . 0.0 110.926 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 38.3 tp -87.33 10.21 18.0 Favored 'General case' 0 N--CA 1.537 3.917 0 C-N-CA 123.763 0.825 . . . . 0.0 110.663 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -66.05 9.31 0.15 Allowed 'General case' 1 N--CA 1.54 4.065 0 C-N-CA 123.217 0.607 . . . . 0.0 112.444 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -50.6 -47.34 58.16 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 124.099 0.96 . . . . 0.0 111.785 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt 61.18 153.72 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 124.384 1.074 . . . . 0.0 111.348 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.529 3.508 0 C-N-CA 125.216 1.406 . . . . 0.0 108.513 -179.898 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.524 3.247 0 N-CA-C 111.234 0.087 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -61.89 -26.5 68.2 Favored 'General case' 0 N--CA 1.529 3.48 0 C-N-CA 124.147 0.979 . . . . 0.0 110.162 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 95.7 p -68.15 -32.15 72.21 Favored 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.556 0.742 . . . . 0.0 110.391 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.86 -46.89 58.41 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.924 0.773 . . . . 0.0 115.0 -178.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.9 -41.16 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 tp -60.67 -40.42 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 C-N-CA 122.905 0.482 . . . . 0.0 112.276 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 7.0 tp -73.27 -33.79 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.711 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.13 -47.84 87.07 Favored Glycine 0 N--CA 1.515 3.914 0 C-N-CA 123.799 0.714 . . . . 0.0 114.167 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.16 -37.17 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 CA-C-N 117.566 0.683 . . . . 0.0 111.137 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 61.2 p -66.06 -46.3 78.26 Favored 'General case' 0 N--CA 1.534 3.727 0 CA-C-N 118.136 0.425 . . . . 0.0 110.721 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 84.7 t -70.03 -31.96 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 C-N-CA 123.741 0.817 . . . . 0.0 111.057 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.87 -43.79 66.35 Favored 'General case' 0 N--CA 1.533 3.707 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.06 73.2 Favored 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 123.185 0.594 . . . . 0.0 111.179 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.71 -46.79 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 123.395 0.678 . . . . 0.0 112.292 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.29 -31.58 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 C-N-CA 122.533 0.333 . . . . 0.0 111.39 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.72 -39.64 64.16 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 122.411 -0.181 . . . . 0.0 111.046 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 93.8 mt -59.96 -44.19 94.01 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.097 0 CA-C-N 118.357 0.526 . . . . 0.0 111.653 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 30.0 m -64.07 -36.7 77.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 CA-C-N 118.619 0.645 . . . . 0.0 110.429 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.9 -32.5 71.96 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.238 0.615 . . . . 0.0 111.871 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 86.2 t -71.31 -34.56 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.698 0.399 . . . . 0.0 109.939 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -61.34 -44.02 97.9 Favored 'General case' 0 N--CA 1.53 3.542 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.94 -40.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.858 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 80.7 m -58.67 -27.65 65.0 Favored 'General case' 0 N--CA 1.522 3.17 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.117 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -71.62 -15.85 62.26 Favored 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 122.528 0.331 . . . . 0.0 111.15 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 26.8 t -78.39 -46.55 19.62 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.551 ' H ' HD13 ' B' ' 235' ' ' LEU . 0.0 OUTLIER -83.88 -13.01 54.63 Favored 'General case' 1 N--CA 1.554 4.733 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -175.242 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 1 N--CA 1.566 5.33 0 CA-C-N 121.915 2.143 . . . . 0.0 112.438 -176.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 59.9 p . . . . . 0 N--CA 1.525 3.279 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.65 -26.66 68.75 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 123.955 0.902 . . . . 0.0 109.646 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 38.7 t -67.95 -26.85 66.15 Favored 'General case' 0 N--CA 1.519 2.993 0 C-N-CA 123.645 0.778 . . . . 0.0 110.611 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.14 -46.78 56.87 Favored Glycine 0 N--CA 1.512 3.704 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.321 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 43.2 pt -70.98 -37.97 70.15 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.121 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 7.5 tp -59.05 -31.8 46.49 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.092 0 C-N-CA 123.288 0.635 . . . . 0.0 112.659 -177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.4 pp -71.3 -32.17 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.7 -43.68 79.75 Favored Glycine 0 N--CA 1.512 3.743 0 C-N-CA 124.463 1.03 . . . . 0.0 114.949 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 11.3 p -68.2 -37.13 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 CA-C-N 118.133 0.967 . . . . 0.0 111.011 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.6 p -65.59 -46.49 79.18 Favored 'General case' 0 N--CA 1.531 3.582 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 10.8 p -69.71 -30.68 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.467 0 C-N-CA 123.451 0.7 . . . . 0.0 111.226 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.07 -43.19 63.71 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.59 -37.36 73.89 Favored 'General case' 0 N--CA 1.521 3.099 0 C-N-CA 123.335 0.654 . . . . 0.0 110.863 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.99 -52.13 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.313 0 C-N-CA 123.668 0.787 . . . . 0.0 111.27 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.4 -31.93 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.925 0 CA-C-O 120.91 0.386 . . . . 0.0 110.235 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -46.24 89.61 Favored 'General case' 0 N--CA 1.531 3.59 0 CA-C-O 121.57 0.7 . . . . 0.0 109.583 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.14 -39.51 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 C-N-CA 123.221 0.608 . . . . 0.0 109.814 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.91 -37.78 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.704 0 C-N-CA 123.144 0.578 . . . . 0.0 109.914 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.66 -46.52 88.78 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.386 0.674 . . . . 0.0 112.602 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.71 -34.26 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 O-C-N 121.825 -0.547 . . . . 0.0 109.871 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.68 -43.91 97.59 Favored 'General case' 0 N--CA 1.529 3.515 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.0 -37.69 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.12 -28.59 69.88 Favored 'General case' 0 N--CA 1.525 3.324 0 C-N-CA 123.23 0.612 . . . . 0.0 111.586 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -62.35 -37.27 85.02 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 122.924 0.49 . . . . 0.0 110.664 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 52.7 m -63.78 -26.84 68.82 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.614 0.766 . . . . 0.0 111.102 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 55.6 mt -90.12 -13.44 35.74 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 124.953 1.301 . . . . 0.0 111.281 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 41.7 tp -86.58 -11.3 51.91 Favored 'General case' 1 N--CA 1.54 4.054 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -175.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -60.55 -67.34 0.41 Allowed 'General case' 1 N--CA 1.541 4.114 0 CA-C-N 119.142 0.883 . . . . 0.0 110.007 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 56.55 -144.66 0.65 Allowed 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.77 0.828 . . . . 0.0 110.751 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp 62.14 170.69 0.13 Allowed 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 124.29 1.036 . . . . 0.0 111.304 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.526 3.351 0 C-N-CA 125.249 1.419 . . . . 0.0 107.978 -179.832 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.522 3.142 0 CA-C-O 121.061 0.458 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.2 -26.73 68.27 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 124.167 0.987 . . . . 0.0 109.82 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 45.1 t -68.65 -26.45 65.34 Favored 'General case' 0 N--CA 1.52 3.072 0 C-N-CA 123.358 0.663 . . . . 0.0 110.835 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.05 71.48 Favored Glycine 0 N--CA 1.511 3.642 0 C-N-CA 123.693 0.663 . . . . 0.0 114.08 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 6.4 tp -68.9 -35.97 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.911 0 CA-C-N 117.921 0.861 . . . . 0.0 111.908 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 8.3 pt -65.5 -32.37 57.93 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.461 0 CA-C-N 118.961 0.801 . . . . 0.0 110.16 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.62 -33.69 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 124.301 1.04 . . . . 0.0 108.861 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.24 -29.73 60.33 Favored Glycine 1 N--CA 1.518 4.118 0 C-N-CA 123.523 0.582 . . . . 0.0 113.159 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 m -60.07 -37.35 72.46 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 CA-C-N 117.349 0.574 . . . . 0.0 111.042 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 56.8 p -55.6 -39.74 71.16 Favored 'General case' 0 N--CA 1.524 3.235 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.325 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.7 t -61.88 -46.11 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.277 0 C-N-CA 123.703 0.801 . . . . 0.0 110.668 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.51 -35.09 60.27 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.262 0.625 . . . . 0.0 112.538 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.95 -37.32 81.45 Favored 'General case' 0 N--CA 1.519 2.991 0 C-N-CA 123.482 0.713 . . . . 0.0 111.083 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 28.3 t -56.37 -38.89 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 C-N-CA 123.288 0.635 . . . . 0.0 110.573 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.02 -32.11 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.387 0 C-N-CA 123.554 0.741 . . . . 0.0 110.028 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -44.07 70.45 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.433 0.693 . . . . 0.0 109.555 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.15 -49.19 63.72 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 C-N-CA 123.246 0.618 . . . . 0.0 111.772 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 22.2 m -66.19 -36.28 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 C-N-CA 122.594 0.358 . . . . 0.0 110.327 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.28 66.74 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 123.279 0.632 . . . . 0.0 112.338 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.4 -43.91 94.63 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.005 0 CA-C-N 118.237 0.471 . . . . 0.0 112.09 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -61.16 -43.62 98.6 Favored 'General case' 0 N--CA 1.538 3.951 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.56 -37.55 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 O-C-N 121.771 -0.581 . . . . 0.0 109.609 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 85.3 m -64.25 -27.63 69.18 Favored 'General case' 0 N--CA 1.527 3.385 0 C-N-CA 122.973 0.509 . . . . 0.0 111.105 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -64.36 -27.96 69.37 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.039 0.536 . . . . 0.0 111.423 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 50.5 m -63.73 -37.68 88.28 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 123.629 0.771 . . . . 0.0 111.767 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -60.84 -13.79 17.76 Favored 'General case' 0 N--CA 1.531 3.589 0 C-N-CA 124.625 1.17 . . . . 0.0 112.293 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -86.93 -28.15 22.93 Favored 'General case' 1 N--CA 1.542 4.175 0 CA-C-N 118.423 0.556 . . . . 0.0 110.539 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -73.42 68.25 1.09 Allowed 'General case' 0 N--CA 1.533 3.684 0 CA-C-O 121.387 0.613 . . . . 0.0 109.739 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -109.83 -37.61 5.59 Favored 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 125.096 1.358 . . . . 0.0 108.627 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 60.1 tttp . . . . . 0 N--CA 1.524 3.248 0 C-N-CA 124.651 1.181 . . . . 0.0 111.214 -179.657 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.524 3.241 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.5 -26.86 68.76 Favored 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 123.665 0.786 . . . . 0.0 111.473 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 66.0 m -68.28 -25.86 65.36 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.631 0.772 . . . . 0.0 109.563 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.38 -34.65 59.72 Favored Glycine 0 N--CA 1.512 3.747 0 C-N-CA 124.603 1.097 . . . . 0.0 113.952 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 11.1 tp -59.33 -43.16 89.46 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 CA-C-N 117.67 0.735 . . . . 0.0 112.827 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 5.5 pt -68.85 -34.16 63.07 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.411 0 CA-C-O 121.827 0.822 . . . . 0.0 109.399 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 81.9 mt -73.08 -38.98 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.185 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.56 -46.63 91.83 Favored Glycine 1 N--CA 1.516 4.016 0 CA-C-N 115.606 -0.725 . . . . 0.0 114.374 -177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.13 -37.55 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 CA-C-N 117.506 0.653 . . . . 0.0 110.854 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 70.1 p -66.22 -45.55 80.32 Favored 'General case' 0 N--CA 1.535 3.782 0 CA-C-N 118.354 0.525 . . . . 0.0 110.575 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.24 -31.24 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 C-N-CA 123.964 0.905 . . . . 0.0 110.891 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.32 -47.24 75.93 Favored 'General case' 0 N--CA 1.532 3.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.19 -25.64 67.81 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.571 0.748 . . . . 0.0 112.224 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.53 -37.09 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 C-N-CA 123.526 0.73 . . . . 0.0 109.464 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 46.1 t -55.78 -32.31 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.137 0.575 . . . . 0.0 110.306 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.96 -40.89 91.68 Favored 'General case' 0 N--CA 1.532 3.661 0 C-N-CA 123.017 0.527 . . . . 0.0 109.823 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 34.3 mm -60.62 -44.56 97.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.711 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.84 -39.72 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.258 0 C-N-CA 123.636 0.775 . . . . 0.0 109.855 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.84 87.81 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.676 0.79 . . . . 0.0 112.409 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.82 -34.36 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 O-C-N 121.846 -0.534 . . . . 0.0 110.334 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -63.63 -44.35 94.14 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.15 -37.99 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.9 m -67.26 -30.38 70.25 Favored 'General case' 0 N--CA 1.525 3.286 0 C-N-CA 123.115 0.566 . . . . 0.0 110.911 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -66.67 -35.21 79.61 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.347 0.659 . . . . 0.0 111.237 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 91.8 p -64.83 -33.63 76.46 Favored 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 123.121 0.568 . . . . 0.0 110.94 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 50.7 mt . . . . . 0 N--CA 1.523 3.176 0 C-N-CA 124.022 0.929 . . . . 0.0 111.166 -178.911 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 74.4 p . . . . . 0 N--CA 1.523 3.198 0 CA-C-O 122.042 0.925 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 42.2 mt -60.91 -26.61 67.58 Favored 'General case' 0 N--CA 1.524 3.235 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.952 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 61.9 m -62.99 -26.38 68.82 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.049 0.539 . . . . 0.0 110.069 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.96 -46.51 93.57 Favored Glycine 1 N--CA 1.519 4.23 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.565 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 48.7 pt -70.5 -35.33 61.29 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.141 0 CA-C-N 118.468 1.134 . . . . 0.0 109.85 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 215' ' ' ILE . . . . . 0.432 ' O ' HG12 ' F' ' 218' ' ' VAL . 49.4 mm -62.38 -44.68 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 29.8 mm -72.88 -33.31 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.89 -29.08 49.93 Favored Glycine 0 N--CA 1.512 3.733 0 C-N-CA 124.666 1.126 . . . . 0.0 113.175 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 218' ' ' VAL . . . . . 0.432 HG12 ' O ' ' F' ' 215' ' ' ILE . 9.8 p -59.28 -39.25 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 C-N-CA 122.781 0.433 . . . . 0.0 111.199 -177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 72.9 p -65.91 -45.2 82.84 Favored 'General case' 0 N--CA 1.53 3.547 0 CA-C-O 121.657 0.741 . . . . 0.0 109.987 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 43.3 t -68.56 -31.69 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.976 0 C-N-CA 124.588 1.155 . . . . 0.0 111.676 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.65 77.83 Favored 'General case' 0 N--CA 1.533 3.713 0 O-C-N 121.706 -0.621 . . . . 0.0 112.608 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.39 -50.22 74.48 Favored 'General case' 0 N--CA 1.523 3.189 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.36 -38.11 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 CA-C-N 118.321 0.51 . . . . 0.0 111.402 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 84.2 t -56.75 -35.96 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 O-C-N 122.03 -0.419 . . . . 0.0 111.102 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 52.0 tp -66.32 -44.57 83.01 Favored 'General case' 1 N--CA 1.539 4.01 0 CA-C-N 118.809 0.732 . . . . 0.0 109.685 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.47 -42.45 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.465 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.201 -178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.31 -37.98 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 C-N-CA 123.036 0.534 . . . . 0.0 109.58 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.2 88.65 Favored 'General case' 0 N--CA 1.53 3.574 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 17.4 m -71.42 -34.35 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 O-C-N 121.843 -0.536 . . . . 0.0 110.811 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -64.51 -44.17 91.77 Favored 'General case' 0 N--CA 1.531 3.599 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.74 -37.64 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.1 -27.25 68.79 Favored 'General case' 0 N--CA 1.526 3.363 0 C-N-CA 123.437 0.695 . . . . 0.0 111.182 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -63.17 -34.39 77.52 Favored 'General case' 0 N--CA 1.53 3.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.774 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.8 t -66.1 -36.06 82.17 Favored 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.529 0.732 . . . . 0.0 111.432 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 4.4 tt -61.25 -13.97 22.63 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 124.231 1.012 . . . . 0.0 111.613 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 25.6 mt -86.03 -27.99 24.43 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.166 0.586 . . . . 0.0 109.594 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -102.6 98.1 8.2 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 124.543 1.137 . . . . 0.0 108.193 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? . . . . . 0 N--CA 1.527 3.398 0 C-N-CA 124.911 1.285 . . . . 0.0 108.659 -179.505 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.211 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.1 p -165.99 62.57 0.11 Allowed 'General case' 0 N--CA 1.523 3.18 0 CA-C-O 121.826 0.822 . . . . 0.0 108.923 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.02 -26.97 68.81 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 123.907 0.883 . . . . 0.0 110.19 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 69.2 m -68.37 -26.74 65.73 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 123.408 0.683 . . . . 0.0 109.993 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.7 -46.96 92.6 Favored Glycine 1 N--CA 1.519 4.228 0 C-N-CA 123.719 0.676 . . . . 0.0 113.562 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.7 tp -70.9 -35.1 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 CA-C-N 117.795 0.797 . . . . 0.0 109.869 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.83 -43.91 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 123.67 0.788 . . . . 0.0 111.512 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 18.6 tt -73.17 -33.48 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 119.263 0.938 . . . . 0.0 109.838 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.55 97.76 Favored Glycine 1 N--CA 1.521 4.352 0 C-N-CA 123.354 0.502 . . . . 0.0 114.091 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 p -59.93 -36.67 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.913 0 CA-C-N 117.677 0.739 . . . . 0.0 110.258 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.9 p -55.98 -44.86 78.94 Favored 'General case' 0 N--CA 1.536 3.843 0 CA-C-O 121.318 0.58 . . . . 0.0 111.388 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.88 -39.99 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 C-N-CA 124.073 0.949 . . . . 0.0 111.748 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.77 -46.78 74.42 Favored 'General case' 0 N--CA 1.528 3.434 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.36 -50.46 71.5 Favored 'General case' 0 N--CA 1.517 2.894 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.54 -38.48 81.53 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.094 0 CA-C-N 119.079 0.854 . . . . 0.0 112.614 -177.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.14 -32.12 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 CA-C-N 118.354 0.525 . . . . 0.0 110.227 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.38 -44.49 36.07 Favored 'General case' 0 N--CA 1.526 3.326 0 C-N-CA 122.653 0.381 . . . . 0.0 110.471 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.34 -44.8 89.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.034 0 C-N-CA 122.945 0.498 . . . . 0.0 111.869 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 30.6 m -61.29 -36.43 72.82 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.22 0 CA-C-N 118.94 0.791 . . . . 0.0 110.834 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.57 -31.87 66.58 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.234 0.614 . . . . 0.0 111.443 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.29 -41.87 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 123.027 0.531 . . . . 0.0 111.507 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -60.7 -43.95 97.15 Favored 'General case' 1 N--CA 1.541 4.091 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.68 -37.73 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 80.1 m -67.27 -32.65 73.81 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 122.733 0.413 . . . . 0.0 110.004 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -72.18 -29.44 64.0 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 123.715 0.806 . . . . 0.0 110.562 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -66.4 -21.35 66.22 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 123.145 0.578 . . . . 0.0 111.061 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 58.6 mt -91.55 -14.26 30.62 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 124.509 1.124 . . . . 0.0 111.189 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.1 tp -87.35 -28.3 22.3 Favored 'General case' 1 N--CA 1.541 4.111 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -174.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 48.8 p-90 -66.32 -64.21 0.91 Allowed 'General case' 1 N--CA 1.544 4.271 0 CA-C-N 120.272 1.396 . . . . 0.0 111.157 -177.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 54.72 176.41 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.852 0.861 . . . . 0.0 112.316 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -97.19 169.73 9.6 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 124.541 1.136 . . . . 0.0 108.918 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 50.3 t . . . . . 0 N--CA 1.531 3.604 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.811 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 N--CA 1.529 3.479 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.8 -26.79 68.32 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 124.232 1.013 . . . . 0.0 111.064 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 91.4 p -68.19 -30.81 70.0 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.535 0.734 . . . . 0.0 110.609 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.0 -46.9 57.58 Favored Glycine 0 N--CA 1.516 3.988 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.737 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 8.2 tp -71.29 -41.74 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 215' ' ' ILE . . . . . 0.411 ' O ' HG12 ' B' ' 218' ' ' VAL . 19.4 tt -60.57 -38.71 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.882 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.78 -32.78 41.86 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.101 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.55 -29.41 47.96 Favored Glycine 0 N--CA 1.512 3.717 0 C-N-CA 124.183 0.897 . . . . 0.0 113.923 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 218' ' ' VAL . . . . . 0.411 HG12 ' O ' ' B' ' 215' ' ' ILE . 8.6 p -59.76 -38.55 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 CA-C-N 117.661 0.73 . . . . 0.0 110.998 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 67.1 p -65.17 -45.53 84.52 Favored 'General case' 0 N--CA 1.528 3.441 0 CA-C-O 121.456 0.646 . . . . 0.0 110.389 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.38 -32.0 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 C-N-CA 124.307 1.043 . . . . 0.0 110.602 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.21 -45.9 82.89 Favored 'General case' 0 N--CA 1.524 3.273 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.95 -41.81 97.49 Favored 'General case' 0 N--CA 1.519 3.0 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.27 -44.14 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.99 -32.75 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 O-C-N 121.293 -0.88 . . . . 0.0 111.457 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 5.4 tt -67.34 -47.54 70.17 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 122.959 0.503 . . . . 0.0 111.446 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 22.8 pt -69.14 -36.29 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 O-C-N 121.671 -0.643 . . . . 0.0 110.884 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.69 -37.36 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.49 -47.47 81.82 Favored 'General case' 0 N--CA 1.532 3.626 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 30.9 m -71.81 -34.53 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 O-C-N 121.939 -0.476 . . . . 0.0 110.605 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -65.61 -43.71 88.78 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.05 -37.0 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.744 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.73 -33.93 70.79 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.308 0.243 . . . . 0.0 110.986 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -74.29 -15.7 60.96 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 122.894 0.478 . . . . 0.0 111.291 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 20.7 t -63.68 -29.13 70.4 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-O 121.467 0.651 . . . . 0.0 109.743 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 57.2 tp -72.18 -31.48 65.96 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.945 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.538 3.935 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.029 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 98.3 p . . . . . 0 N--CA 1.525 3.288 0 CA-C-O 119.65 -0.214 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.29 -26.9 68.28 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.926 0.89 . . . . 0.0 109.719 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 46.7 t -68.42 -26.17 65.4 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 123.524 0.73 . . . . 0.0 110.808 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.1 -46.34 66.07 Favored Glycine 0 N--CA 1.514 3.852 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.875 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.4 tt -70.72 -38.17 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.867 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 15.4 pt -57.04 -43.15 80.61 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.685 0 CA-C-N 119.584 1.084 . . . . 0.0 111.946 -176.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 6.1 tp -73.01 -32.97 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.17 -45.57 95.06 Favored Glycine 1 N--CA 1.518 4.121 0 C-N-CA 123.869 0.747 . . . . 0.0 113.292 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.65 -36.68 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 O-C-N 121.954 -0.733 . . . . 0.0 109.776 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 37.6 m -60.54 -47.08 87.75 Favored 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.74 -31.39 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 123.621 0.769 . . . . 0.0 111.23 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.13 -34.3 56.14 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.483 0.713 . . . . 0.0 112.801 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.8 -50.79 39.51 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.17 -38.44 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.665 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.48 -32.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 CA-C-N 118.255 0.479 . . . . 0.0 110.99 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.96 -42.47 99.16 Favored 'General case' 0 N--CA 1.532 3.641 0 O-C-N 122.198 -0.314 . . . . 0.0 110.428 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -57.22 -36.63 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.629 0 C-N-CA 123.317 0.647 . . . . 0.0 110.636 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.52 -37.81 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 123.444 0.697 . . . . 0.0 109.847 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.97 76.76 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.107 0.563 . . . . 0.0 111.219 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.61 -34.76 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.35 0.66 . . . . 0.0 110.15 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -63.81 -43.8 95.18 Favored 'General case' 0 N--CA 1.531 3.596 0 C-N-CA 123.132 0.573 . . . . 0.0 112.243 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 6.8 p -68.87 -37.46 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.675 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 82.2 m -58.84 -27.77 65.43 Favored 'General case' 0 N--CA 1.531 3.575 0 C-N-CA 122.624 0.37 . . . . 0.0 110.833 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -70.87 -22.05 62.34 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.102 0.561 . . . . 0.0 110.942 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 68.6 p -63.81 -26.49 68.65 Favored 'General case' 0 N--CA 1.534 3.742 0 C-N-CA 123.283 0.633 . . . . 0.0 111.552 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.78 -14.46 21.68 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 124.12 0.968 . . . . 0.0 111.43 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.29 8.04 26.0 Favored 'General case' 0 N--CA 1.538 3.971 0 C-N-CA 123.456 0.702 . . . . 0.0 109.243 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -83.57 26.25 0.69 Allowed 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 124.158 0.983 . . . . 0.0 109.493 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -62.41 -46.26 89.41 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 123.838 0.855 . . . . 0.0 110.863 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -69.13 145.62 53.2 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 123.572 0.749 . . . . 0.0 110.325 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.528 3.448 0 C-N-CA 124.929 1.292 . . . . 0.0 108.205 179.888 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.519 2.98 0 N-CA-C 111.587 0.218 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -24.91 67.61 Favored 'General case' 0 N--CA 1.527 3.385 0 C-N-CA 124.765 1.226 . . . . 0.0 110.968 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 90.3 p -57.19 -25.53 59.15 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 124.133 0.973 . . . . 0.0 111.96 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.63 83.15 Favored Glycine 0 N--CA 1.514 3.858 0 N-CA-C 115.381 0.912 . . . . 0.0 115.381 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 13.0 tt -59.38 -35.07 56.45 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.512 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 16.8 tt -55.69 -31.19 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.874 0 C-N-CA 123.862 0.865 . . . . 0.0 112.918 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.08 -33.57 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.13 -45.22 96.5 Favored Glycine 1 N--CA 1.522 4.419 0 C-N-CA 123.661 0.648 . . . . 0.0 114.298 -177.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -59.72 -36.08 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.962 0 CA-C-N 117.636 0.718 . . . . 0.0 110.231 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 24.5 p -55.9 -45.05 78.76 Favored 'General case' 0 N--CA 1.536 3.847 0 CA-C-O 120.988 0.423 . . . . 0.0 111.408 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.9 t -58.11 -40.64 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 124.15 0.98 . . . . 0.0 112.289 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.51 -45.93 66.46 Favored 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.57 -42.12 71.49 Favored 'General case' 0 N--CA 1.52 3.026 0 C-N-CA 122.691 0.396 . . . . 0.0 111.489 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.01 -43.6 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.156 0 C-N-CA 123.221 0.609 . . . . 0.0 112.42 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.76 -32.85 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.786 0 CA-C-N 118.51 0.596 . . . . 0.0 111.845 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 51.6 tp -66.0 -41.88 90.46 Favored 'General case' 0 N--CA 1.53 3.546 0 CA-C-N 118.034 0.379 . . . . 0.0 110.609 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 93.1 mt -57.48 -37.43 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 C-N-CA 122.782 0.433 . . . . 0.0 110.527 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.92 -44.12 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 122.847 0.459 . . . . 0.0 110.056 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -45.03 87.33 Favored 'General case' 0 N--CA 1.527 3.417 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.72 -33.89 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.685 0 O-C-N 121.583 -0.698 . . . . 0.0 109.684 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -63.81 -43.39 96.4 Favored 'General case' 0 N--CA 1.529 3.502 0 C-N-CA 123.255 0.622 . . . . 0.0 112.489 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.56 -36.82 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 CA-C-N 118.704 0.684 . . . . 0.0 109.645 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 73.6 m -57.9 -27.33 63.22 Favored 'General case' 0 N--CA 1.528 3.451 0 C-N-CA 122.8 0.44 . . . . 0.0 111.017 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -63.76 -27.67 69.35 Favored 'General case' 0 N--CA 1.532 3.657 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 53.2 p -64.19 -34.43 78.07 Favored 'General case' 0 N--CA 1.527 3.405 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -27.55 67.72 Favored 'General case' 0 N--CA 1.526 3.353 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.591 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 38.9 mt -86.82 -28.11 23.12 Favored 'General case' 0 N--CA 1.533 3.724 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -77.9 101.74 6.96 Favored 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.4 159.85 10.79 Favored 'General case' 0 N--CA 1.519 3.006 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 63.4 tttp . . . . . 0 N--CA 1.522 3.147 0 C-N-CA 123.949 0.9 . . . . 0.0 110.085 -179.459 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.52 3.044 0 N-CA-C 111.332 0.123 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.1 -26.61 68.29 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 124.318 1.047 . . . . 0.0 110.403 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 93.1 p -63.08 -25.73 68.5 Favored 'General case' 0 N--CA 1.522 3.155 0 C-N-CA 123.668 0.787 . . . . 0.0 111.134 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.53 -46.72 67.16 Favored Glycine 0 N--CA 1.516 3.973 0 CA-C-N 116.061 -0.518 . . . . 0.0 114.28 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.46 -40.2 72.04 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.07 0 CA-C-N 118.179 0.989 . . . . 0.0 113.659 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 18.0 pt -58.94 -40.53 80.62 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.453 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -175.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.2 tt -72.08 -32.33 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.811 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.2 -28.87 43.61 Favored Glycine 0 N--CA 1.515 3.954 0 C-N-CA 123.94 0.781 . . . . 0.0 113.206 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.34 -37.13 67.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.043 0 CA-C-N 117.501 0.651 . . . . 0.0 110.83 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 62.0 p -59.28 -45.19 91.92 Favored 'General case' 0 N--CA 1.527 3.421 0 C-N-CA 123.338 0.655 . . . . 0.0 111.801 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.69 -35.22 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.341 0 C-N-CA 123.607 0.763 . . . . 0.0 109.915 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.3 -34.23 77.66 Favored 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 123.497 0.719 . . . . 0.0 110.883 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.53 91.26 Favored 'General case' 0 N--CA 1.519 3.021 0 C-N-CA 123.135 0.574 . . . . 0.0 111.614 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.72 -52.8 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.612 0 C-N-CA 123.087 0.555 . . . . 0.0 111.851 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.96 -32.09 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 C-N-CA 122.717 0.407 . . . . 0.0 111.026 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.71 -35.28 79.24 Favored 'General case' 1 N--CA 1.541 4.101 0 C-N-CA 122.815 0.446 . . . . 0.0 110.617 -179.278 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 81.3 mt -69.28 -35.68 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.16 -36.21 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 C-N-CA 123.257 0.623 . . . . 0.0 109.692 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.35 -42.38 81.88 Favored 'General case' 0 N--CA 1.526 3.367 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 6.3 m -71.73 -34.49 52.09 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.047 0 CA-C-N 119.063 0.847 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -62.53 -43.76 98.03 Favored 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 123.334 0.654 . . . . 0.0 112.383 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 6.9 p -68.72 -37.43 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.58 -27.75 69.17 Favored 'General case' 0 N--CA 1.528 3.475 0 C-N-CA 123.02 0.528 . . . . 0.0 110.627 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -74.26 -18.4 60.73 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.467 0.707 . . . . 0.0 110.593 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 26.7 t -63.5 -46.37 86.43 Favored 'General case' 0 N--CA 1.529 3.494 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.53 3.568 0 C-N-CA 123.506 0.722 . . . . 0.0 112.584 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.52 3.049 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.1 -28.69 69.62 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.894 0.878 . . . . 0.0 109.617 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 96.2 p -68.39 -35.52 77.8 Favored 'General case' 0 N--CA 1.521 3.12 0 C-N-CA 123.415 0.686 . . . . 0.0 109.988 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.27 -47.05 54.61 Favored Glycine 0 N--CA 1.512 3.736 0 CA-C-N 115.03 -0.986 . . . . 0.0 114.646 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.0 -41.85 68.28 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.201 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 20.2 tt -56.87 -32.45 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -31.86 43.96 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.666 0 CA-C-N 120.291 1.405 . . . . 0.0 109.038 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.94 -36.18 60.03 Favored Glycine 0 N--CA 1.51 3.617 0 C-N-CA 124.172 0.892 . . . . 0.0 114.646 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.92 -38.24 75.6 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.17 0 CA-C-N 118.508 1.154 . . . . 0.0 111.015 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 29.9 p -66.41 -45.99 78.07 Favored 'General case' 0 N--CA 1.528 3.468 0 CA-C-O 121.617 0.722 . . . . 0.0 110.334 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 58.0 t -69.48 -33.9 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.006 0 C-N-CA 124.714 1.205 . . . . 0.0 110.535 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.16 68.97 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.51 91.92 Favored 'General case' 0 N--CA 1.518 2.928 0 C-N-CA 123.3 0.64 . . . . 0.0 111.275 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 43.4 t -66.75 -48.91 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.314 0 C-N-CA 123.599 0.76 . . . . 0.0 110.556 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.51 -33.83 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.552 0 C-N-CA 123.278 0.631 . . . . 0.0 110.094 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 33.7 tp -67.21 -34.16 76.9 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.247 0.619 . . . . 0.0 110.339 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 39.4 mt -64.66 -41.1 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.893 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.56 -37.89 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 C-N-CA 122.975 0.51 . . . . 0.0 109.825 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.43 71.01 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.695 0.798 . . . . 0.0 112.278 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.38 -33.97 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 C-N-CA 122.814 0.446 . . . . 0.0 110.244 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -65.98 -44.21 85.58 Favored 'General case' 0 N--CA 1.531 3.588 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.87 -37.73 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 O-C-N 122.232 -0.292 . . . . 0.0 110.55 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 8.3 p -58.74 -27.38 64.88 Favored 'General case' 0 N--CA 1.536 3.845 0 O-C-N 122.218 -0.301 . . . . 0.0 111.248 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -59.88 -18.68 46.36 Favored 'General case' 0 N--CA 1.531 3.62 0 C-N-CA 123.279 0.632 . . . . 0.0 111.203 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 51.5 m -70.34 -30.57 67.57 Favored 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.544 0.738 . . . . 0.0 110.362 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 64.4 mt -60.49 -13.12 11.93 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.398 1.079 . . . . 0.0 111.752 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.57 10.5 13.0 Favored 'General case' 0 N--CA 1.532 3.635 0 C-N-CA 123.196 0.598 . . . . 0.0 110.067 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 59.64 116.24 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 124.601 1.161 . . . . 0.0 112.257 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 mttp . . . . . 0 N--CA 1.526 3.334 0 C-N-CA 125.099 1.36 . . . . 0.0 107.868 179.156 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.181 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.3 p -97.83 41.92 1.11 Allowed 'General case' 0 N--CA 1.526 3.354 0 C-N-CA 124.685 1.194 . . . . 0.0 109.38 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 54.2 tp -59.98 -26.41 66.02 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 124.264 1.026 . . . . 0.0 110.978 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 71.2 m -57.43 -26.15 60.73 Favored 'General case' 0 N--CA 1.526 3.327 0 C-N-CA 123.735 0.814 . . . . 0.0 111.62 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.35 92.66 Favored Glycine 0 N--CA 1.509 3.566 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.91 -46.22 94.2 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.483 0 CA-C-N 118.772 1.286 . . . . 0.0 112.967 -175.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -67.66 -32.13 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.384 0.674 . . . . 0.0 110.323 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 90.4 mt -66.06 -34.06 67.72 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.013 0 C-N-CA 123.054 0.542 . . . . 0.0 109.848 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.69 -29.81 64.79 Favored Glycine 1 N--CA 1.517 4.055 0 CA-C-O 119.831 -0.427 . . . . 0.0 113.675 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.5 m -61.77 -37.11 77.3 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.29 0 CA-C-N 117.764 0.782 . . . . 0.0 110.907 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.6 p -55.51 -43.39 75.62 Favored 'General case' 0 N--CA 1.524 3.234 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.159 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.96 -45.99 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.073 0 C-N-CA 123.824 0.85 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.46 -45.13 65.95 Favored 'General case' 0 N--CA 1.527 3.403 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.32 90.22 Favored 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 122.953 0.501 . . . . 0.0 111.769 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.2 t -66.66 -39.78 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 122.91 0.484 . . . . 0.0 110.693 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.92 -39.78 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.585 0 C-N-CA 122.863 0.465 . . . . 0.0 110.837 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.26 -37.22 84.63 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 117.897 0.317 . . . . 0.0 111.519 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 99.3 mt -64.27 -42.59 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 C-N-CA 123.308 0.643 . . . . 0.0 110.028 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.76 -41.74 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.25 -45.5 87.68 Favored 'General case' 0 N--CA 1.525 3.309 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.73 -34.31 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 O-C-N 121.723 -0.611 . . . . 0.0 110.08 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.42 -44.24 95.96 Favored 'General case' 0 N--CA 1.529 3.516 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.7 m -68.65 -37.42 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 CA-C-O 121.212 0.53 . . . . 0.0 109.683 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 70.9 m -63.39 -46.08 88.1 Favored 'General case' 0 N--CA 1.523 3.178 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.26 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.67 -19.02 35.74 Favored 'General case' 0 N--CA 1.536 3.857 0 C-N-CA 122.744 0.418 . . . . 0.0 112.007 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 52.0 m -74.59 -40.17 61.76 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 51.0 mt -68.71 -29.16 67.54 Favored 'General case' 0 N--CA 1.524 3.264 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.511 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.04 10.58 16.1 Favored 'General case' 1 N--CA 1.545 4.324 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 54.6 t90 -139.81 70.78 1.37 Allowed 'General case' 0 N--CA 1.53 3.557 0 C-N-CA 124.176 0.99 . . . . 0.0 108.875 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -133.74 -18.56 2.13 Favored 'General case' 0 N--CA 1.534 3.765 0 C-N-CA 125.108 1.363 . . . . 0.0 109.139 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -163.68 86.81 0.51 Allowed 'General case' 0 N--CA 1.525 3.283 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.528 3.459 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.57 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.524 3.228 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 50.2 mt -65.15 -26.64 68.26 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 124.262 1.025 . . . . 0.0 110.098 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.1 m -59.43 -37.1 77.21 Favored 'General case' 0 N--CA 1.525 3.325 0 C-N-CA 123.14 0.576 . . . . 0.0 110.662 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.33 -36.22 92.76 Favored Glycine 1 N--CA 1.522 4.422 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.07 -40.96 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 C-N-CA 124.27 1.028 . . . . 0.0 109.088 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 91.2 mt -67.71 -39.44 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 C-N-CA 124.674 1.189 . . . . 0.0 109.046 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 87.8 mt -71.15 -32.07 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.77 -29.27 41.13 Favored Glycine 0 N--CA 1.515 3.946 0 C-N-CA 123.74 0.686 . . . . 0.0 113.218 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 4.0 m -59.85 -37.36 71.4 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 117.79 0.795 . . . . 0.0 110.475 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.9 p -62.27 -45.57 92.68 Favored 'General case' 0 N--CA 1.528 3.428 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.382 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.13 -35.48 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.194 0 C-N-CA 124.149 0.98 . . . . 0.0 110.485 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.01 -34.55 68.29 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.358 0.663 . . . . 0.0 111.851 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.2 -42.08 72.82 Favored 'General case' 0 N--CA 1.516 2.864 0 C-N-CA 123.205 0.602 . . . . 0.0 111.403 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.2 t -58.99 -47.0 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 C-N-CA 123.565 0.746 . . . . 0.0 112.19 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.9 m -67.1 -32.28 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.468 0 C-N-CA 122.959 0.504 . . . . 0.0 111.635 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.82 -45.08 45.76 Favored 'General case' 0 N--CA 1.524 3.257 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.7 pt -68.86 -36.75 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.904 0 CA-C-N 118.432 0.56 . . . . 0.0 112.468 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.21 -36.96 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 O-C-N 121.532 -0.73 . . . . 0.0 110.151 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.62 -44.98 85.93 Favored 'General case' 0 N--CA 1.526 3.366 0 C-N-CA 123.56 0.744 . . . . 0.0 112.977 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 13.7 m -71.19 -34.19 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 O-C-N 121.737 -0.602 . . . . 0.0 110.543 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -63.07 -44.49 95.65 Favored 'General case' 0 N--CA 1.531 3.612 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.06 -37.54 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.615 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.94 -29.22 66.96 Favored 'General case' 0 N--CA 1.527 3.411 0 C-N-CA 122.714 0.406 . . . . 0.0 111.424 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -64.19 -15.93 60.91 Favored 'General case' 1 N--CA 1.539 4.009 0 CA-C-N 118.048 0.386 . . . . 0.0 111.075 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 41.5 m -64.64 -34.34 78.06 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 51.1 tp -70.08 -28.19 65.22 Favored 'General case' 0 N--CA 1.526 3.335 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.139 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.538 3.934 0 C-N-CA 123.884 0.874 . . . . 0.0 109.582 -179.314 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 N--CA 1.521 3.111 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -64.58 -26.82 68.57 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 124.078 0.951 . . . . 0.0 109.77 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 42.7 t -61.29 -38.66 87.59 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.931 0.892 . . . . 0.0 110.951 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.33 -41.96 76.48 Favored Glycine 0 N--CA 1.513 3.806 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.428 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 61.7 mt -70.62 -45.81 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 C-N-CA 124.498 1.119 . . . . 0.0 113.255 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -56.63 -31.96 36.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.161 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.5 pp -66.98 -31.9 55.57 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.196 0 CA-C-N 119.336 0.971 . . . . 0.0 109.497 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.84 -36.15 59.5 Favored Glycine 0 N--CA 1.51 3.615 0 CA-C-N 115.614 -0.721 . . . . 0.0 114.788 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.46 -45.45 92.83 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 CA-C-N 118.279 1.04 . . . . 0.0 113.104 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 1.3 t -65.03 -45.25 86.25 Favored 'General case' 0 N--CA 1.538 3.945 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.7 -31.14 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.295 0 C-N-CA 122.987 0.515 . . . . 0.0 111.262 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.64 93.43 Favored 'General case' 0 N--CA 1.528 3.471 0 O-C-N 121.803 -0.56 . . . . 0.0 111.987 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.95 -48.03 81.14 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.81 -38.4 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.744 0 CA-C-N 118.196 0.453 . . . . 0.0 111.103 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.26 -40.94 86.01 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.009 0 CA-C-N 118.403 0.547 . . . . 0.0 110.356 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -34.34 77.69 Favored 'General case' 1 N--CA 1.54 4.055 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 tp -54.8 -36.94 38.89 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.401 0 C-N-CA 123.401 0.681 . . . . 0.0 110.483 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.65 -40.96 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 C-N-CA 123.416 0.687 . . . . 0.0 110.545 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.83 -35.61 71.13 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.42 0.688 . . . . 0.0 111.576 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -71.77 -36.61 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.298 0 C-N-CA 123.492 0.717 . . . . 0.0 111.728 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.93 -43.86 64.57 Favored 'General case' 0 N--CA 1.531 3.613 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.42 -37.57 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.087 0.555 . . . . 0.0 110.983 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 15.0 p -62.21 -27.63 69.12 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 122.353 0.261 . . . . 0.0 111.394 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.72 -40.38 84.25 Favored 'General case' 0 N--CA 1.53 3.528 0 CA-C-O 121.007 0.432 . . . . 0.0 110.436 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.7 t -64.03 -22.45 66.94 Favored 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 123.791 0.836 . . . . 0.0 112.467 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.4 tp -67.41 -17.44 64.72 Favored 'General case' 0 N--CA 1.529 3.508 0 C-N-CA 123.345 0.658 . . . . 0.0 110.819 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.35 -28.49 22.18 Favored 'General case' 0 N--CA 1.531 3.584 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -95.72 96.13 8.79 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 124.447 1.099 . . . . 0.0 108.993 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -169.82 9.77 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.382 0 C-N-CA 123.606 0.763 . . . . 0.0 110.511 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.18 137.57 54.95 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.382 0.673 . . . . 0.0 110.093 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.53 3.565 0 C-N-CA 125.176 1.39 . . . . 0.0 108.96 -179.359 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 98.9 p . . . . . 0 N--CA 1.523 3.222 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.18 -26.83 68.32 Favored 'General case' 0 N--CA 1.528 3.475 0 C-N-CA 123.962 0.905 . . . . 0.0 109.099 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 69.4 m -57.73 -26.15 61.39 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 124.105 0.962 . . . . 0.0 110.907 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.41 -35.28 84.51 Favored Glycine 1 N--CA 1.517 4.072 0 C-N-CA 123.657 0.646 . . . . 0.0 113.102 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -46.98 94.94 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 CA-C-N 117.084 0.442 . . . . 0.0 111.89 -177.256 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.8 -31.76 55.15 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.556 0 C-N-CA 124.038 0.935 . . . . 0.0 109.811 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.29 -33.55 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.29 -33.02 85.6 Favored Glycine 1 N--CA 1.52 4.289 0 C-N-CA 123.69 0.662 . . . . 0.0 112.159 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.23 -43.52 93.5 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.052 0 C-N-CA 124.194 0.997 . . . . 0.0 109.657 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 27.3 p -56.85 -45.31 82.52 Favored 'General case' 0 N--CA 1.525 3.313 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.373 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 49.9 t -67.75 -41.27 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.211 0 C-N-CA 124.251 1.021 . . . . 0.0 111.312 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.3 -44.74 65.2 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.58 81.13 Favored 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 123.254 0.621 . . . . 0.0 111.616 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 t -53.72 -39.49 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.927 0 C-N-CA 123.25 0.62 . . . . 0.0 111.857 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.45 -38.48 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 C-N-CA 122.768 0.427 . . . . 0.0 110.121 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 73.2 mt -70.94 -34.57 71.62 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 122.958 0.503 . . . . 0.0 110.223 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 20.0 mm -60.41 -50.52 80.01 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 C-N-CA 123.532 0.733 . . . . 0.0 110.951 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 31.6 m -66.62 -36.99 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 O-C-N 121.816 -0.553 . . . . 0.0 110.239 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.38 85.92 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.636 0.775 . . . . 0.0 112.594 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 34.4 m -71.98 -34.53 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.696 0 O-C-N 121.823 -0.548 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.58 -43.85 95.77 Favored 'General case' 0 N--CA 1.53 3.525 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.37 -37.22 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 74.3 m -58.76 -27.07 64.61 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.076 0.551 . . . . 0.0 111.845 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.54 -33.21 73.44 Favored 'General case' 0 N--CA 1.537 3.887 0 CA-C-N 118.343 0.519 . . . . 0.0 110.79 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 35.5 t -67.07 -27.86 67.72 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.155 0.582 . . . . 0.0 110.217 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 51.4 tp -89.77 -13.9 35.72 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 124.947 1.299 . . . . 0.0 110.378 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 39.7 tp -85.67 -1.69 57.42 Favored 'General case' 1 N--CA 1.545 4.287 0 CA-C-O 121.046 0.45 . . . . 0.0 109.999 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -139.8 -159.56 0.97 Allowed 'General case' 0 N--CA 1.522 3.125 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 64.27 161.83 0.12 Allowed 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 123.762 0.825 . . . . 0.0 110.283 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? . . . . . 0 N--CA 1.528 3.427 0 C-N-CA 124.218 1.007 . . . . 0.0 110.915 -179.87 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.519 2.978 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 58.3 tp -64.24 -27.04 68.78 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 124.152 0.981 . . . . 0.0 110.216 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 53.8 m -62.02 -25.91 67.93 Favored 'General case' 0 N--CA 1.518 2.955 0 C-N-CA 124.413 1.085 . . . . 0.0 110.681 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.85 -46.72 71.74 Favored Glycine 0 N--CA 1.51 3.62 0 CA-C-N 115.22 -0.9 . . . . 0.0 114.684 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 29.6 pt -71.04 -38.81 73.36 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 CA-C-N 118.826 1.313 . . . . 0.0 113.961 -177.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.7 tp -62.88 -32.52 56.22 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 C-N-CA 123.239 0.616 . . . . 0.0 112.497 -176.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.8 -34.03 45.64 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.791 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.18 -45.15 83.48 Favored Glycine 0 N--CA 1.515 3.921 0 C-N-CA 124.8 1.191 . . . . 0.0 115.155 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.34 -37.41 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 CA-C-N 117.381 0.591 . . . . 0.0 110.779 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 35.6 p -66.35 -47.27 73.96 Favored 'General case' 0 N--CA 1.532 3.644 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.63 -31.88 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 C-N-CA 123.301 0.64 . . . . 0.0 112.269 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.77 -47.26 70.89 Favored 'General case' 0 N--CA 1.532 3.633 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.59 97.47 Favored 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 123.475 0.71 . . . . 0.0 111.679 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.47 -49.03 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.651 0.78 . . . . 0.0 111.989 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.84 -32.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 C-N-CA 123.321 0.648 . . . . 0.0 110.539 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.33 -39.93 94.88 Favored 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 123.124 0.57 . . . . 0.0 110.143 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.34 -37.7 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 C-N-CA 122.927 0.491 . . . . 0.0 110.426 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.15 -37.85 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 C-N-CA 123.09 0.556 . . . . 0.0 110.28 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.41 -32.27 68.49 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.339 0.655 . . . . 0.0 111.611 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.57 -43.75 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.458 0 C-N-CA 123.299 0.64 . . . . 0.0 111.659 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -62.19 -43.49 98.72 Favored 'General case' 1 N--CA 1.54 4.055 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.14 -38.38 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 95.4 m -67.68 -40.1 84.42 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 122.831 0.452 . . . . 0.0 110.449 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -72.72 -31.16 64.77 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 123.473 0.709 . . . . 0.0 110.454 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 46.2 t -64.44 -34.28 77.82 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.451 0.7 . . . . 0.0 110.765 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.522 3.151 0 C-N-CA 124.358 1.063 . . . . 0.0 109.747 -179.933 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.521 3.124 0 CA-C-O 120.546 0.212 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 44.7 mt -54.78 -25.79 30.31 Favored 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 124.885 1.274 . . . . 0.0 111.437 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 54.1 m -57.69 -36.42 71.94 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.583 0.753 . . . . 0.0 111.31 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.72 -39.52 86.03 Favored Glycine 1 N--CA 1.52 4.259 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.533 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.54 -46.27 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.895 0 C-N-CA 124.181 0.992 . . . . 0.0 110.993 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 215' ' ' ILE . . . . . 0.459 HD13 ' O ' ' F' ' 215' ' ' ILE . 0.0 OUTLIER -68.63 -32.17 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.983 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 85.1 mt -73.3 -40.36 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.93 95.51 Favored Glycine 0 N--CA 1.512 3.748 0 CA-C-N 115.227 -0.897 . . . . 0.0 114.8 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.5 -37.08 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 CA-C-N 117.923 0.862 . . . . 0.0 111.448 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 68.5 p -65.93 -46.5 77.99 Favored 'General case' 0 N--CA 1.533 3.695 0 CA-C-O 120.931 0.396 . . . . 0.0 110.715 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.76 -35.45 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.22 0 C-N-CA 124.051 0.94 . . . . 0.0 110.508 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.12 67.41 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.5 -34.53 69.18 Favored 'General case' 0 N--CA 1.521 3.077 0 C-N-CA 123.142 0.577 . . . . 0.0 112.017 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.42 -39.06 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.316 0 C-N-CA 123.048 0.539 . . . . 0.0 110.653 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.72 -41.32 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 123.427 0.691 . . . . 0.0 111.485 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.22 -35.69 77.9 Favored 'General case' 1 N--CA 1.54 4.026 0 C-N-CA 122.594 0.358 . . . . 0.0 110.743 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 68.7 mt -69.26 -40.9 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 98.4 t -66.74 -37.97 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.465 0 C-N-CA 123.335 0.654 . . . . 0.0 109.442 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.08 -47.66 82.53 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.727 0.811 . . . . 0.0 112.696 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 25.6 m -71.9 -34.51 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 O-C-N 121.993 -0.442 . . . . 0.0 110.195 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -63.86 -44.13 94.02 Favored 'General case' 0 N--CA 1.527 3.382 0 C-N-CA 123.053 0.541 . . . . 0.0 112.334 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.45 -37.7 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 86.4 m -62.77 -27.95 69.64 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 122.92 0.488 . . . . 0.0 110.129 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -69.57 -16.86 63.49 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.173 0.589 . . . . 0.0 110.62 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 19.5 m -68.8 -28.69 66.99 Favored 'General case' 0 N--CA 1.53 3.565 0 C-N-CA 123.062 0.545 . . . . 0.0 110.232 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.22 -23.51 66.44 Favored 'General case' 0 N--CA 1.525 3.289 0 C-N-CA 123.727 0.811 . . . . 0.0 110.715 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 8.2 mp -87.47 -26.16 23.37 Favored 'General case' 0 N--CA 1.534 3.732 0 C-N-CA 123.685 0.794 . . . . 0.0 109.215 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -73.64 92.52 1.97 Allowed 'General case' 0 N--CA 1.526 3.359 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 21.8 pttp . . . . . 0 N--CA 1.518 2.929 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.771 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 CA--C 1.574 1.888 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -78.65 145.66 20.68 Favored 'Trans proline' 0 N--CA 1.534 3.879 0 C-N-CA 122.359 2.04 . . . . 0.0 110.091 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 171.32 -39.93 0.18 Allowed Glycine 1 N--CA 1.517 4.073 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 27.4 t 57.26 55.1 6.13 Favored 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.021 0.928 . . . . 0.0 111.942 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.84 -26.87 68.52 Favored 'General case' 0 N--CA 1.525 3.283 0 C-N-CA 123.989 0.915 . . . . 0.0 110.547 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.4 m -61.71 -26.44 68.04 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 123.498 0.719 . . . . 0.0 110.237 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.9 -35.43 63.55 Favored Glycine 0 N--CA 1.502 3.035 0 C-N-CA 125.108 1.337 . . . . 0.0 115.354 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 16.9 pt -58.0 -33.73 47.03 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.34 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 216' ' ' ILE . 1.3 pp -55.71 -36.41 42.69 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.002 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -174.303 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 215' ' ' ILE . 5.2 tp -73.49 -38.43 52.69 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.696 0 CA-C-N 119.472 1.033 . . . . 0.0 109.039 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.31 -45.36 88.76 Favored Glycine 1 N--CA 1.522 4.389 0 N-CA-C 114.891 0.716 . . . . 0.0 114.891 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.93 -36.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.971 0 CA-C-N 117.503 0.651 . . . . 0.0 110.724 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.7 p -58.92 -40.61 85.08 Favored 'General case' 0 N--CA 1.535 3.785 0 CA-C-O 121.082 0.467 . . . . 0.0 111.799 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.74 -39.31 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 123.753 0.821 . . . . 0.0 111.877 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.08 79.6 Favored 'General case' 0 N--CA 1.529 3.477 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.38 -50.02 56.0 Favored 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 m -63.75 -38.58 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.87 -32.86 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 CA-C-N 118.848 0.749 . . . . 0.0 110.723 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 5.9 tt -65.08 -37.88 88.95 Favored 'General case' 0 N--CA 1.536 3.829 0 CA-C-N 117.878 0.308 . . . . 0.0 110.708 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.8 mt -61.98 -36.67 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.84 0 C-N-CA 123.079 0.552 . . . . 0.0 110.351 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.21 -40.35 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.68 0 C-N-CA 122.968 0.507 . . . . 0.0 110.07 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.8 -32.59 67.71 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.191 0.596 . . . . 0.0 111.528 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.9 t -68.19 -37.96 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 C-N-CA 123.141 0.577 . . . . 0.0 109.87 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -70.1 -34.78 73.57 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.403 0.681 . . . . 0.0 110.086 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.02 -38.13 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 C-N-CA 123.968 0.907 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 79.8 m -60.07 -38.53 83.13 Favored 'General case' 0 N--CA 1.527 3.379 0 CA-C-O 121.195 0.522 . . . . 0.0 109.748 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -74.39 -37.8 63.32 Favored 'General case' 0 N--CA 1.519 2.998 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.208 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.0 p -63.76 -46.31 85.84 Favored 'General case' 0 N--CA 1.531 3.615 0 CA-C-O 121.434 0.635 . . . . 0.0 109.595 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.49 -19.35 62.94 Favored 'General case' 0 N--CA 1.53 3.561 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.563 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.7 tp -87.09 -28.21 22.66 Favored 'General case' 1 N--CA 1.541 4.115 0 CA-C-N 119.17 0.895 . . . . 0.0 109.11 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.8 m0 -78.68 107.74 11.59 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -168.0 88.99 0.27 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 11.6 tptp 71.92 -164.21 0.13 Allowed 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 124.052 0.941 . . . . 0.0 109.135 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.51 138.03 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 C-N-CA 124.935 1.294 . . . . 0.0 107.69 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -100.29 102.0 16.75 Favored Pre-proline 0 N--CA 1.53 3.568 0 C-N-CA 125.017 1.327 . . . . 0.0 107.459 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo . . . . . 1 N--CA 1.536 4.014 0 C-N-CA 122.432 2.088 . . . . 0.0 110.788 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 CA--C 1.572 1.816 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.16 -17.1 15.28 Favored 'Trans proline' 1 N--CA 1.536 4.029 0 C-N-CA 122.434 2.089 . . . . 0.0 110.911 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 63.96 -169.54 21.52 Favored Glycine 1 N--CA 1.519 4.21 0 C-N-CA 123.701 0.667 . . . . 0.0 112.211 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 41.9 t -167.53 5.92 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.955 0.902 . . . . 0.0 110.45 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.09 -36.44 84.32 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 124.299 1.04 . . . . 0.0 109.741 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.6 t -57.38 -25.64 59.81 Favored 'General case' 0 N--CA 1.525 3.316 0 C-N-CA 123.612 0.765 . . . . 0.0 110.907 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.44 -34.48 59.79 Favored Glycine 0 N--CA 1.512 3.752 0 C-N-CA 124.948 1.261 . . . . 0.0 114.544 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 17.3 pt -59.39 -34.8 55.43 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -176.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.21 -47.37 80.96 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.333 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.6 tt -72.48 -32.95 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.55 -29.32 47.68 Favored Glycine 0 N--CA 1.515 3.906 0 C-N-CA 123.444 0.545 . . . . 0.0 113.181 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 m -60.0 -37.38 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 CA-C-N 117.551 0.676 . . . . 0.0 111.8 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 1.3 t -61.05 -39.06 88.41 Favored 'General case' 1 N--CA 1.54 4.063 0 CA-C-O 120.825 0.345 . . . . 0.0 111.539 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 47.4 t -60.99 -31.5 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 123.76 0.824 . . . . 0.0 110.517 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.19 77.83 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 123.06 0.544 . . . . 0.0 111.316 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.69 -50.2 58.84 Favored 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.22 -38.56 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.726 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 27.0 m -65.36 -32.01 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 CA-C-N 118.584 0.629 . . . . 0.0 111.394 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 54.1 mt -66.73 -34.57 78.13 Favored 'General case' 0 N--CA 1.533 3.701 0 O-C-N 122.026 -0.421 . . . . 0.0 111.091 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 59.7 mt -61.35 -49.65 83.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.049 0 CA-C-N 118.066 0.394 . . . . 0.0 111.595 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.65 -37.01 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.71 0 O-C-N 121.902 -0.499 . . . . 0.0 110.099 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.55 -47.15 86.66 Favored 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 123.667 0.787 . . . . 0.0 112.603 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.69 -34.38 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.615 0 O-C-N 121.842 -0.536 . . . . 0.0 110.527 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -63.34 -44.36 95.11 Favored 'General case' 0 N--CA 1.528 3.441 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.92 -37.76 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.3 m -67.02 -32.85 74.34 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 122.988 0.515 . . . . 0.0 110.478 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -66.96 -32.26 73.38 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 123.498 0.719 . . . . 0.0 111.054 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 50.6 m -63.82 -29.34 70.55 Favored 'General case' 0 N--CA 1.528 3.454 0 C-N-CA 123.299 0.639 . . . . 0.0 111.244 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.27 -27.35 68.98 Favored 'General case' 0 N--CA 1.528 3.448 0 C-N-CA 123.45 0.7 . . . . 0.0 110.952 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -87.81 -3.4 58.94 Favored 'General case' 0 N--CA 1.538 3.944 0 C-N-CA 123.79 0.836 . . . . 0.0 109.893 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -155.36 67.56 0.65 Allowed 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.858 0.863 . . . . 0.0 108.934 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.31 87.41 2.0 Allowed 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -70.66 67.66 0.37 Allowed 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 123.821 0.848 . . . . 0.0 111.276 -177.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.08 133.05 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 8.5 mp -94.63 145.07 28.97 Favored Pre-proline 0 N--CA 1.532 3.641 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 1 N--CA 1.538 4.108 0 C-N-CA 122.028 1.819 . . . . 0.0 110.627 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 55.8 mtt . . . . . 0 CA--C 1.581 2.162 0 CA-C-O 117.776 -1.106 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.81 -23.32 20.3 Favored 'Trans proline' 1 N--CA 1.548 4.701 0 CA-C-N 122.26 1.843 . . . . 0.0 113.211 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 179.49 -78.31 0.06 OUTLIER Glycine 1 N--CA 1.52 4.297 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 49.8 m 56.22 48.48 17.22 Favored 'General case' 0 N--CA 1.52 3.074 0 C-N-CA 124.123 0.969 . . . . 0.0 111.854 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 pp -62.9 -26.43 68.79 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 123.882 0.873 . . . . 0.0 111.053 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 34.8 t -62.34 -25.88 68.14 Favored 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 123.476 0.71 . . . . 0.0 110.999 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.48 -38.09 86.27 Favored Glycine 0 N--CA 1.514 3.851 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.91 -35.35 59.38 Favored 'Isoleucine or valine' 1 N--CA 1.555 4.803 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.01 -32.67 33.95 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.41 -31.78 55.34 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.194 0 CA-C-N 119.134 0.879 . . . . 0.0 108.781 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.77 -42.65 79.24 Favored Glycine 0 N--CA 1.516 3.987 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.746 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.48 -37.16 77.38 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 CA-C-N 117.989 0.895 . . . . 0.0 110.384 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 26.4 m -62.51 -47.6 83.25 Favored 'General case' 0 N--CA 1.519 3.002 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.502 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 9.4 p -71.21 -31.47 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.359 0 C-N-CA 123.649 0.78 . . . . 0.0 111.171 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.83 60.63 Favored 'General case' 0 N--CA 1.529 3.505 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.99 -50.34 64.63 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.11 -41.5 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.54 -32.65 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.617 0 O-C-N 121.826 -0.546 . . . . 0.0 112.166 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -75.52 -39.95 57.72 Favored 'General case' 0 N--CA 1.528 3.429 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 19.3 pt -69.49 -38.84 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 CA-C-N 118.562 0.619 . . . . 0.0 111.762 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.67 -37.29 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 O-C-N 121.592 -0.692 . . . . 0.0 109.967 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.99 83.8 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 123.737 0.815 . . . . 0.0 113.045 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.53 -34.26 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 O-C-N 121.811 -0.556 . . . . 0.0 110.223 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -64.08 -44.26 92.92 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.96 -37.59 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 87.8 m -64.66 -27.83 69.19 Favored 'General case' 0 N--CA 1.525 3.325 0 C-N-CA 123.038 0.535 . . . . 0.0 110.878 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -70.93 -35.75 72.36 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 122.901 0.48 . . . . 0.0 110.295 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.4 t -63.92 -23.24 67.27 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.499 0.72 . . . . 0.0 112.18 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.69 -21.57 65.32 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 123.336 0.655 . . . . 0.0 110.749 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.68 0.74 55.27 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 123.66 0.784 . . . . 0.0 109.925 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.26 -76.49 0.07 Allowed 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.503 0.721 . . . . 0.0 110.13 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 55.8 -135.61 1.29 Allowed 'General case' 0 N--CA 1.522 3.162 0 C-N-CA 123.891 0.877 . . . . 0.0 111.0 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 57.21 78.56 0.22 Allowed 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 124.199 1.0 . . . . 0.0 111.753 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.2 135.15 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.402 0 C-N-CA 124.968 1.307 . . . . 0.0 107.918 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.56 146.71 31.95 Favored Pre-proline 0 N--CA 1.53 3.549 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 1 N--CA 1.54 4.251 0 C-N-CA 122.101 1.867 . . . . 0.0 110.652 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 CA--C 1.575 1.932 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.76 -57.49 2.23 Favored 'Trans proline' 1 N--CA 1.544 4.464 0 C-N-CA 122.416 2.077 . . . . 0.0 113.746 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 168.69 38.11 0.02 OUTLIER Glycine 1 N--CA 1.518 4.149 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 35.2 t -61.39 -12.51 14.53 Favored 'General case' 0 N--CA 1.522 3.153 0 C-N-CA 123.865 0.866 . . . . 0.0 112.216 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.04 -28.69 69.66 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 123.812 0.845 . . . . 0.0 109.579 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 39.9 t -68.7 -32.35 72.09 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 123.498 0.719 . . . . 0.0 110.493 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.57 -40.27 86.21 Favored Glycine 0 N--CA 1.515 3.944 0 CA-C-N 114.947 -1.024 . . . . 0.0 115.103 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.05 -46.07 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.677 1.238 . . . . 0.0 112.018 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -32.79 50.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.063 0 C-N-CA 124.353 1.061 . . . . 0.0 113.198 -177.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 37.6 pt -71.84 -33.18 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 119.247 0.931 . . . . 0.0 108.527 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.45 -29.88 76.33 Favored Glycine 1 N--CA 1.521 4.316 0 C-N-CA 123.539 0.59 . . . . 0.0 111.878 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.67 -37.95 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.72 0 C-N-CA 124.102 0.961 . . . . 0.0 109.947 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 30.3 p -62.14 -45.08 95.03 Favored 'General case' 0 N--CA 1.531 3.592 0 CA-C-O 121.598 0.713 . . . . 0.0 110.414 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.06 -34.87 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.051 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.102 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.21 -36.54 84.49 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 123.117 0.567 . . . . 0.0 112.46 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.09 -49.97 45.58 Favored 'General case' 0 N--CA 1.512 2.654 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 33.2 m -63.16 -38.8 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.06 -35.96 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.847 0 CA-C-N 118.633 0.651 . . . . 0.0 111.094 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.29 -34.89 78.67 Favored 'General case' 0 N--CA 1.537 3.921 0 C-N-CA 122.543 0.337 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 78.7 mt -64.0 -36.32 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.767 0 C-N-CA 123.113 0.565 . . . . 0.0 110.051 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.29 -38.07 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 122.959 0.504 . . . . 0.0 110.064 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.08 95.09 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.83 -34.31 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 O-C-N 121.762 -0.586 . . . . 0.0 109.61 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -62.29 -43.57 98.52 Favored 'General case' 0 N--CA 1.529 3.483 0 C-N-CA 123.3 0.64 . . . . 0.0 112.531 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.08 -37.3 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 81.7 m -59.36 -32.21 69.9 Favored 'General case' 0 N--CA 1.529 3.517 0 C-N-CA 122.819 0.448 . . . . 0.0 110.897 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.99 -41.4 61.97 Favored 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 66.8 m -63.92 -31.43 72.61 Favored 'General case' 0 N--CA 1.526 3.347 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -36.19 68.12 Favored 'General case' 0 N--CA 1.524 3.275 0 C-N-CA 124.246 1.018 . . . . 0.0 108.495 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 53.8 tp -87.22 -16.72 34.44 Favored 'General case' 0 N--CA 1.538 3.957 0 C-N-CA 123.286 0.634 . . . . 0.0 110.816 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -61.59 -7.15 2.99 Favored 'General case' 0 N--CA 1.532 3.651 0 C-N-CA 123.447 0.699 . . . . 0.0 111.853 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.43 -31.99 72.77 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.602 0.761 . . . . 0.0 110.629 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 64.1 tttt 64.1 177.25 0.17 Allowed 'General case' 0 N--CA 1.531 3.593 0 C-N-CA 123.515 0.726 . . . . 0.0 109.977 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.28 130.01 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 58.7 tp -98.3 103.05 16.05 Favored Pre-proline 0 N--CA 1.528 3.463 0 CA-C-O 117.328 -1.32 . . . . 0.0 108.66 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo . . . . . 1 N--CA 1.537 4.074 0 CA-C-N 122.674 1.991 . . . . 0.0 110.852 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 23.2 ptp . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.746 -1.121 . . . . 0.0 108.053 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.9 130.49 16.85 Favored 'Trans proline' 1 N--CA 1.54 4.225 0 C-N-CA 122.039 1.826 . . . . 0.0 110.286 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.68 -168.67 7.87 Favored Glycine 1 N--CA 1.517 4.083 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 69.8 m -161.18 17.26 0.11 Allowed 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 123.756 0.823 . . . . 0.0 110.044 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 55.9 tp -65.12 -26.93 68.41 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 123.92 0.888 . . . . 0.0 110.177 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.3 p -68.57 -30.76 69.6 Favored 'General case' 0 N--CA 1.52 3.059 0 C-N-CA 123.642 0.777 . . . . 0.0 110.071 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.63 -46.49 61.58 Favored Glycine 0 N--CA 1.515 3.948 0 C-N-CA 124.147 0.879 . . . . 0.0 114.826 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.5 tt -70.73 -41.09 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 122.015 -0.697 . . . . 0.0 112.868 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.0 tt -64.49 -42.21 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 C-N-CA 122.729 0.412 . . . . 0.0 111.577 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 216' ' ' ILE . . . . . 0.498 ' O ' HD13 ' E' ' 216' ' ' ILE . 0.1 OUTLIER -73.86 -34.39 39.9 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.009 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.553 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.15 -45.29 95.55 Favored Glycine 0 N--CA 1.513 3.801 0 CA-C-N 114.762 -1.108 . . . . 0.0 114.754 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.72 -36.81 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 CA-C-N 117.95 0.875 . . . . 0.0 110.943 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -63.16 -47.8 81.14 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-N 118.339 0.518 . . . . 0.0 112.32 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.43 -35.33 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 123.785 0.834 . . . . 0.0 112.118 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.83 -47.37 70.99 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.2 77.84 Favored 'General case' 0 N--CA 1.517 2.896 0 C-N-CA 123.416 0.686 . . . . 0.0 111.754 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 t -66.68 -49.42 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 C-N-CA 123.224 0.61 . . . . 0.0 110.861 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.26 -32.79 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.498 0 C-N-CA 123.442 0.697 . . . . 0.0 110.917 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.3 tt -64.8 -39.51 93.72 Favored 'General case' 0 N--CA 1.535 3.812 0 C-N-CA 122.991 0.516 . . . . 0.0 110.425 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 88.7 mt -65.35 -36.67 78.26 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 O-C-N 121.508 -0.745 . . . . 0.0 110.283 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.8 -37.44 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 C-N-CA 123.332 0.653 . . . . 0.0 109.807 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.73 -32.09 67.08 Favored 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.398 0.679 . . . . 0.0 111.649 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 46.7 t -68.97 -44.54 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.215 0.606 . . . . 0.0 111.575 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -61.3 -43.12 99.4 Favored 'General case' 1 N--CA 1.54 4.042 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.81 -37.46 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 CA-C-N 118.312 0.505 . . . . 0.0 109.701 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 92.9 m -59.1 -30.48 68.13 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 122.282 -0.261 . . . . 0.0 110.899 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -74.09 -15.47 61.05 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 123.006 0.522 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 67.9 p -63.44 -30.56 71.67 Favored 'General case' 0 N--CA 1.533 3.696 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 57.5 tp -76.36 -30.97 57.79 Favored 'General case' 0 N--CA 1.517 2.909 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.031 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 32.3 mt -87.52 10.16 18.64 Favored 'General case' 0 N--CA 1.533 3.702 0 C-N-CA 123.349 0.659 . . . . 0.0 110.775 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -77.7 25.79 0.19 Allowed 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.855 0.862 . . . . 0.0 110.317 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -66.57 142.51 57.47 Favored 'General case' 0 N--CA 1.525 3.286 0 C-N-CA 123.843 0.857 . . . . 0.0 109.827 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.49 168.76 19.09 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.1 138.38 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 C-N-CA 124.908 1.283 . . . . 0.0 108.373 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.89 99.29 51.86 Favored Pre-proline 0 N--CA 1.526 3.353 0 C-N-CA 124.963 1.305 . . . . 0.0 108.574 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo . . . . . 1 N--CA 1.546 4.562 0 C-N-CA 122.314 2.009 . . . . 0.0 113.756 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.582 2.19 0 CA-C-O 117.474 -1.25 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -89.76 12.14 2.66 Favored 'Trans proline' 0 N--CA 1.535 3.968 0 C-N-CA 122.657 2.238 . . . . 0.0 111.589 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -179.19 -177.41 47.64 Favored Glycine 1 N--CA 1.519 4.185 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 45.8 t -167.91 88.66 0.26 Allowed 'General case' 0 N--CA 1.519 3.006 0 C-N-CA 123.913 0.885 . . . . 0.0 108.977 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 55.8 tp -53.64 -26.76 23.67 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 124.655 1.182 . . . . 0.0 111.44 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 52.9 m -60.88 -40.11 91.79 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.857 0.863 . . . . 0.0 111.462 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.97 -35.6 79.35 Favored Glycine 1 N--CA 1.52 4.239 0 C-N-CA 124.0 0.809 . . . . 0.0 112.823 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 38.6 mm -64.57 -42.7 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 17.2 tt -56.62 -44.38 80.91 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.385 0 CA-C-N 119.466 1.03 . . . . 0.0 112.28 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 16.6 tt -73.73 -33.93 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.73 -42.99 99.6 Favored Glycine 0 N--CA 1.512 3.743 0 CA-C-N 114.884 -1.053 . . . . 0.0 114.609 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.91 -37.13 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 CA-C-N 117.729 0.764 . . . . 0.0 111.038 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 59.3 p -66.01 -46.71 76.98 Favored 'General case' 0 N--CA 1.532 3.641 0 CA-C-N 118.379 0.536 . . . . 0.0 112.064 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 11.4 p -69.94 -31.64 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.51 0 C-N-CA 122.778 0.431 . . . . 0.0 111.099 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.16 -41.13 71.46 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.174 0.59 . . . . 0.0 112.396 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.99 93.1 Favored 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 123.238 0.615 . . . . 0.0 111.074 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.82 -50.0 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.323 0 C-N-CA 123.412 0.685 . . . . 0.0 110.384 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.4 -32.54 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 123.626 0.77 . . . . 0.0 110.35 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.5 -34.99 79.0 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 122.891 0.476 . . . . 0.0 110.78 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.53 -37.36 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.47 -37.86 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 C-N-CA 123.233 0.613 . . . . 0.0 109.637 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.85 78.61 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.631 0.772 . . . . 0.0 112.671 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.79 -34.42 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.616 0 O-C-N 121.901 -0.5 . . . . 0.0 110.336 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -65.67 -43.66 88.62 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.107 0.563 . . . . 0.0 112.446 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.4 -37.55 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 79.5 m -61.21 -27.99 68.83 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 122.962 0.505 . . . . 0.0 111.158 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -72.49 -28.71 63.06 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.378 0.671 . . . . 0.0 110.708 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 28.1 t -65.5 -27.81 68.74 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.138 0.575 . . . . 0.0 111.823 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.83 -14.07 60.73 Favored 'General case' 0 N--CA 1.531 3.609 0 C-N-CA 123.916 0.886 . . . . 0.0 111.009 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 20.3 mt -86.87 1.9 50.96 Favored 'General case' 0 N--CA 1.535 3.81 0 C-N-CA 122.775 0.43 . . . . 0.0 110.606 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -76.82 -50.13 14.17 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.552 0.741 . . . . 0.0 109.274 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -62.94 82.69 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.425 0 C-N-CA 123.76 0.824 . . . . 0.0 111.959 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -136.5 8.09 3.09 Favored 'General case' 0 N--CA 1.534 3.761 0 C-N-CA 124.831 1.252 . . . . 0.0 109.331 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.54 136.22 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 125.149 1.38 . . . . 0.0 107.9 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -94.63 146.33 31.25 Favored Pre-proline 0 N--CA 1.529 3.516 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 1 N--CA 1.539 4.151 0 C-N-CA 122.015 1.81 . . . . 0.0 110.641 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 CA--C 1.573 1.846 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.81 156.44 9.26 Favored 'Trans proline' 1 N--CA 1.544 4.461 0 C-N-CA 122.329 2.019 . . . . 0.0 113.126 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 175.13 -48.01 0.13 Allowed Glycine 1 N--CA 1.517 4.083 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 49.9 m 57.02 48.92 14.75 Favored 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 124.239 1.016 . . . . 0.0 112.503 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.14 -30.7 71.65 Favored 'General case' 0 N--CA 1.534 3.758 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 97.1 p -68.6 -26.71 65.51 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 123.701 0.8 . . . . 0.0 109.789 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.99 -45.04 64.29 Favored Glycine 1 N--CA 1.517 4.075 0 C-N-CA 124.26 0.933 . . . . 0.0 114.979 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 44.2 pt -70.61 -35.86 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.427 HD13 ' O ' ' A' ' 215' ' ' ILE . 0.1 OUTLIER -66.9 -41.38 87.53 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.319 0 CA-C-N 118.524 0.602 . . . . 0.0 110.834 -177.416 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.523 ' O ' HD13 ' A' ' 216' ' ' ILE . 0.0 OUTLIER -72.22 -33.59 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.93 -42.6 96.8 Favored Glycine 1 N--CA 1.518 4.104 0 N-CA-C 114.79 0.676 . . . . 0.0 114.79 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.0 -41.67 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.633 1.216 . . . . 0.0 111.817 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.1 t -66.72 -40.85 88.57 Favored 'General case' 0 N--CA 1.536 3.848 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.16 -30.92 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.725 0 CA-C-N 118.508 0.595 . . . . 0.0 110.279 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.26 -34.7 78.97 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 122.983 0.513 . . . . 0.0 111.696 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.57 -50.41 51.99 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.1 -38.88 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.57 -32.26 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 CA-C-N 118.112 0.414 . . . . 0.0 110.567 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 tt -74.54 -46.45 38.95 Favored 'General case' 0 N--CA 1.531 3.581 0 C-N-CA 123.102 0.561 . . . . 0.0 110.161 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.5 -44.49 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 O-C-N 121.826 -0.546 . . . . 0.0 111.996 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.3 -36.87 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 CA-C-N 118.665 0.666 . . . . 0.0 110.195 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.78 75.58 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.17 0.588 . . . . 0.0 111.847 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.85 -41.41 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 C-N-CA 122.617 0.367 . . . . 0.0 110.283 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.13 -43.86 98.23 Favored 'General case' 0 N--CA 1.529 3.478 0 C-N-CA 123.503 0.721 . . . . 0.0 112.782 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.62 -37.71 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 99.4 m -63.6 -28.09 69.69 Favored 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 122.855 0.462 . . . . 0.0 111.247 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.86 -28.27 67.4 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 123.227 0.611 . . . . 0.0 110.945 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.7 t -64.05 -36.33 83.63 Favored 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 123.337 0.655 . . . . 0.0 111.874 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.97 -14.4 22.47 Favored 'General case' 0 N--CA 1.533 3.699 0 C-N-CA 123.936 0.894 . . . . 0.0 111.104 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 23.5 mt -87.31 -28.32 22.34 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.271 0.629 . . . . 0.0 109.927 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -78.39 -141.42 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 60.6 15.24 5.54 Favored 'General case' 0 N--CA 1.52 3.028 0 C-N-CA 124.32 1.048 . . . . 0.0 112.102 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -160.12 118.86 2.71 Favored 'General case' 0 N--CA 1.53 3.544 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.3 t -112.77 138.41 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.588 0 C-N-CA 125.175 1.39 . . . . 0.0 107.709 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.25 146.74 32.12 Favored Pre-proline 0 N--CA 1.527 3.406 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 1 N--CA 1.541 4.287 0 C-N-CA 122.085 1.857 . . . . 0.0 110.664 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 CA--C 1.576 1.957 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -80.54 -110.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.534 3.864 0 C-N-CA 122.66 2.24 . . . . 0.0 110.099 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 61.27 12.19 30.33 Favored Glycine 1 N--CA 1.52 4.27 0 C-N-CA 123.689 0.661 . . . . 0.0 112.617 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 68.0 m -66.84 178.07 1.46 Allowed 'General case' 0 N--CA 1.521 3.112 0 C-N-CA 123.949 0.9 . . . . 0.0 110.95 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.93 -26.62 68.67 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 124.253 1.021 . . . . 0.0 110.613 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 60.9 m -67.95 -26.03 65.74 Favored 'General case' 0 N--CA 1.522 3.171 0 C-N-CA 123.425 0.69 . . . . 0.0 110.614 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.14 -46.24 66.42 Favored Glycine 0 N--CA 1.514 3.896 0 C-N-CA 123.699 0.666 . . . . 0.0 113.953 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tp -70.67 -35.53 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.955 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 12.1 pt -56.82 -43.61 80.29 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.766 0 CA-C-N 119.83 1.195 . . . . 0.0 112.22 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -73.56 -33.66 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.616 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.65 -45.94 93.32 Favored Glycine 0 N--CA 1.515 3.942 0 CA-C-N 115.494 -0.776 . . . . 0.0 114.069 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.94 -36.78 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.803 0 CA-C-N 117.873 0.836 . . . . 0.0 111.055 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 50.8 p -62.44 -46.22 89.51 Favored 'General case' 0 N--CA 1.534 3.744 0 CA-C-N 118.252 0.478 . . . . 0.0 111.115 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.97 -34.83 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.414 0 C-N-CA 123.87 0.868 . . . . 0.0 110.676 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.93 -36.32 59.56 Favored 'General case' 0 N--CA 1.527 3.381 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -46.1 64.53 Favored 'General case' 0 N--CA 1.517 2.908 0 C-N-CA 123.136 0.575 . . . . 0.0 111.44 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -58.53 -44.79 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.677 0 C-N-CA 123.768 0.827 . . . . 0.0 112.204 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -66.65 -31.5 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.658 0 CA-C-O 121.125 0.488 . . . . 0.0 110.12 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -42.12 97.41 Favored 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.576 0.75 . . . . 0.0 111.906 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.05 -44.61 97.78 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.005 0 C-N-CA 122.892 0.477 . . . . 0.0 111.809 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 18.2 m -66.48 -36.55 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.792 0 O-C-N 121.801 -0.562 . . . . 0.0 109.928 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.3 86.09 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.73 -34.27 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.964 0 O-C-N 121.606 -0.684 . . . . 0.0 109.963 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.73 -44.03 97.16 Favored 'General case' 0 N--CA 1.53 3.542 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.78 -39.06 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 CA-C-O 121.569 0.7 . . . . 0.0 109.415 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.9 m -65.25 -29.48 70.27 Favored 'General case' 0 N--CA 1.521 3.101 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.311 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.36 -37.77 63.4 Favored 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 123.121 0.568 . . . . 0.0 109.477 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 50.5 m -64.15 -29.78 70.88 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.527 0.731 . . . . 0.0 111.245 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.76 -14.56 22.1 Favored 'General case' 0 N--CA 1.534 3.737 0 C-N-CA 123.61 0.764 . . . . 0.0 111.488 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.95 10.34 16.6 Favored 'General case' 1 N--CA 1.54 4.034 0 C-N-CA 123.227 0.611 . . . . 0.0 109.409 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 237' ' ' TRP . . . . . 0.406 ' H ' ' H ' ' B' ' 238' ' ' LYS . 19.3 t-105 -157.42 -18.35 0.09 Allowed 'General case' 0 N--CA 1.53 3.529 0 C-N-CA 123.561 0.745 . . . . 0.0 109.508 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 238' ' ' LYS . . . . . 0.406 ' H ' ' H ' ' B' ' 237' ' ' TRP . 90.4 mttt 66.62 -40.17 0.36 Allowed 'General case' 0 N--CA 1.519 2.997 0 C-N-CA 125.443 1.497 . . . . 0.0 113.35 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt 59.33 60.95 2.17 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 123.515 0.726 . . . . 0.0 111.085 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.13 136.72 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 49.8 mt -94.7 146.66 31.82 Favored Pre-proline 0 N--CA 1.527 3.388 0 CA-C-O 117.222 -1.37 . . . . 0.0 108.192 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo . . . . . 1 N--CA 1.54 4.25 0 C-N-CA 122.002 1.801 . . . . 0.0 110.688 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 52.3 tpp . . . . . 0 CA--C 1.572 1.817 0 CA-C-O 116.78 -1.581 . . . . 0.0 107.054 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -76.33 -32.24 4.09 Favored 'Trans proline' 1 N--CA 1.537 4.05 0 CA-C-N 122.9 2.072 . . . . 0.0 110.144 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.04 169.01 49.68 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 70.7 m -165.6 -57.1 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.13 0 C-N-CA 123.873 0.869 . . . . 0.0 108.722 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.95 -27.17 68.66 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 123.944 0.898 . . . . 0.0 110.16 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 99.3 p -68.13 -30.09 69.15 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.655 0.782 . . . . 0.0 110.625 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.22 -47.07 54.95 Favored Glycine 0 N--CA 1.514 3.842 0 CA-C-N 115.956 -0.565 . . . . 0.0 114.444 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.21 -39.35 73.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.088 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -176.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.44 -32.29 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.781 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.17 -32.77 44.44 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.119 0 CA-C-N 119.129 0.877 . . . . 0.0 109.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.21 -29.17 72.19 Favored Glycine 0 N--CA 1.511 3.67 0 C-N-CA 123.776 0.703 . . . . 0.0 113.648 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 5.4 p -59.27 -48.21 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.946 0 CA-C-N 117.558 0.679 . . . . 0.0 112.817 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 8.9 t -66.7 -39.64 88.16 Favored 'General case' 0 N--CA 1.536 3.841 0 CA-C-N 118.056 0.389 . . . . 0.0 110.95 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.38 -33.28 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.269 0 C-N-CA 123.475 0.71 . . . . 0.0 110.26 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.45 -43.08 97.24 Favored 'General case' 0 N--CA 1.526 3.353 0 O-C-N 122.214 -0.304 . . . . 0.0 111.705 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.43 73.3 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.4 -38.31 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 CA-C-N 118.042 0.383 . . . . 0.0 111.374 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.98 -32.76 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 C-N-CA 122.715 0.406 . . . . 0.0 110.086 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -37.82 85.5 Favored 'General case' 1 N--CA 1.544 4.265 0 CA-C-O 120.999 0.428 . . . . 0.0 110.013 -178.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 71.8 mt -64.09 -40.72 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.096 0.558 . . . . 0.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.63 -37.29 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 123.789 0.835 . . . . 0.0 109.935 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.67 -32.47 67.35 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.314 0.646 . . . . 0.0 112.071 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.47 -44.14 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.663 0 C-N-CA 122.636 0.375 . . . . 0.0 112.001 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -61.54 -43.67 98.45 Favored 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.5 -37.87 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.698 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 86.4 m -67.36 -34.17 76.75 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 122.93 0.492 . . . . 0.0 110.126 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -69.54 -34.53 74.35 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 123.466 0.706 . . . . 0.0 110.388 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 39.3 t -67.18 -37.51 83.82 Favored 'General case' 0 N--CA 1.522 3.169 0 CA-C-O 121.447 0.642 . . . . 0.0 110.198 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.7 -21.77 62.53 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 124.294 1.037 . . . . 0.0 110.512 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 56.0 tp -87.67 -28.08 22.04 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.72 0.808 . . . . 0.0 109.551 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -71.42 -124.82 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.346 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 54.67 111.39 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 124.311 1.045 . . . . 0.0 112.01 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -164.79 152.79 11.88 Favored 'General case' 0 N--CA 1.522 3.168 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 78.5 t -113.12 128.75 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.65 99.3 33.09 Favored Pre-proline 0 N--CA 1.53 3.546 0 C-N-CA 124.87 1.268 . . . . 0.0 108.237 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo . . . . . 1 N--CA 1.546 4.616 0 C-N-CA 122.254 1.969 . . . . 0.0 113.603 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.574 1.882 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.38 -33.69 10.72 Favored 'Trans proline' 1 N--CA 1.54 4.225 0 C-N-CA 122.234 1.956 . . . . 0.0 110.28 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 176.51 178.08 46.0 Favored Glycine 1 N--CA 1.518 4.133 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 45.3 t -69.38 143.34 53.72 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.633 0.773 . . . . 0.0 110.495 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.18 -26.75 68.29 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 124.242 1.017 . . . . 0.0 110.651 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 46.9 t -65.8 -26.7 67.81 Favored 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 122.959 0.503 . . . . 0.0 110.528 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.22 -46.34 92.94 Favored Glycine 0 N--CA 1.509 3.545 0 C-N-CA 123.439 0.542 . . . . 0.0 114.192 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.38 -35.39 62.13 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.065 0 CA-C-N 118.446 1.123 . . . . 0.0 109.46 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 83.1 mt -64.56 -35.54 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 11.6 mm -72.5 -33.74 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.825 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.52 -47.16 92.53 Favored Glycine 0 N--CA 1.515 3.917 0 C-N-CA 123.983 0.802 . . . . 0.0 113.49 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 14.6 m -68.92 -36.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 O-C-N 121.781 -0.835 . . . . 0.0 109.981 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 32.9 m -60.44 -45.69 92.76 Favored 'General case' 0 N--CA 1.525 3.281 0 C-N-CA 123.577 0.751 . . . . 0.0 112.539 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.63 -30.83 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 C-N-CA 122.94 0.496 . . . . 0.0 110.049 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.72 -45.19 91.07 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 122.685 0.394 . . . . 0.0 111.868 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.99 -25.56 61.21 Favored 'General case' 0 N--CA 1.535 3.801 0 C-N-CA 123.422 0.689 . . . . 0.0 112.286 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.05 -37.04 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 C-N-CA 123.76 0.824 . . . . 0.0 110.326 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 2.6 p -55.97 -34.84 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.784 0 C-N-CA 123.457 0.703 . . . . 0.0 111.63 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 59.9 tp -69.63 -45.27 68.86 Favored 'General case' 0 N--CA 1.521 3.125 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.867 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.53 -49.76 63.83 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.232 0 C-N-CA 122.858 0.463 . . . . 0.0 111.188 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 26.5 m -66.4 -36.86 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 C-N-CA 122.437 0.295 . . . . 0.0 110.465 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.93 -32.91 68.23 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 123.179 0.592 . . . . 0.0 112.389 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.72 -34.78 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.73 0 O-C-N 122.021 -0.424 . . . . 0.0 110.283 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -68.46 -43.7 76.44 Favored 'General case' 0 N--CA 1.527 3.402 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 11.5 m -68.49 -37.93 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 O-C-N 122.198 -0.314 . . . . 0.0 111.324 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 15.5 p -65.33 -27.74 68.81 Favored 'General case' 0 N--CA 1.529 3.503 0 C-N-CA 122.217 0.207 . . . . 0.0 111.165 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -63.11 -42.51 99.57 Favored 'General case' 0 N--CA 1.526 3.333 0 CA-C-O 121.276 0.56 . . . . 0.0 109.922 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 69.4 m -65.74 -36.89 84.87 Favored 'General case' 0 N--CA 1.521 3.104 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.873 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 235' ' ' LEU . . . . . 0.552 ' O ' HD13 ' D' ' 235' ' ' LEU . 1.7 tm? -71.87 -25.88 62.13 Favored 'General case' 0 N--CA 1.528 3.475 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.507 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 49.9 tp -87.4 -12.72 45.42 Favored 'General case' 0 N--CA 1.537 3.886 0 C-N-CA 123.85 0.86 . . . . 0.0 110.883 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -55.66 -15.11 2.64 Favored 'General case' 0 N--CA 1.534 3.74 0 C-N-CA 123.684 0.794 . . . . 0.0 112.103 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.65 -25.4 63.89 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.729 0.812 . . . . 0.0 111.224 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 59.71 -157.65 0.33 Allowed 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.927 0.891 . . . . 0.0 110.169 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.68 137.9 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.578 HD23 ' H ' ' D' ' 241' ' ' LEU . 1.7 pt? -94.38 146.54 31.71 Favored Pre-proline 0 N--CA 1.532 3.661 0 C-N-CA 124.813 1.245 . . . . 0.0 109.808 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo . . . . . 1 N--CA 1.541 4.286 0 C-N-CA 121.964 1.776 . . . . 0.0 110.751 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 CA--C 1.576 1.967 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.58 -53.5 6.94 Favored 'Trans proline' 1 N--CA 1.549 4.756 0 C-N-CA 121.894 1.73 . . . . 0.0 113.95 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.06 159.01 53.46 Favored Glycine 1 N--CA 1.52 4.241 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 89.8 p -165.95 -111.04 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 123.698 0.799 . . . . 0.0 109.133 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 42.8 mt -64.26 -27.5 69.09 Favored 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 124.114 0.966 . . . . 0.0 110.842 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 66.8 m -61.17 -26.62 67.83 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.669 0.788 . . . . 0.0 110.973 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.54 -34.33 88.81 Favored Glycine 0 N--CA 1.513 3.802 0 C-N-CA 125.062 1.315 . . . . 0.0 114.005 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -34.1 49.55 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.249 0 C-N-CA 124.615 1.166 . . . . 0.0 113.876 -174.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 16.3 pt -54.97 -32.36 26.67 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.257 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -174.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 13.0 pt -64.65 -33.36 62.7 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-O 121.256 0.55 . . . . 0.0 109.734 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.7 -50.14 70.93 Favored Glycine 1 N--CA 1.518 4.166 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.726 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.62 -36.81 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 CA-C-N 117.571 0.685 . . . . 0.0 110.384 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 85.9 m -61.77 -46.05 91.23 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 123.479 0.712 . . . . 0.0 112.043 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 70.1 t -69.19 -31.32 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 C-N-CA 123.712 0.805 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.9 -34.91 57.11 Favored 'General case' 0 N--CA 1.536 3.827 0 CA-C-O 121.041 0.448 . . . . 0.0 112.205 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.78 -43.58 65.48 Favored 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 123.37 0.668 . . . . 0.0 110.949 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.56 -43.11 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.38 0 C-N-CA 124.428 1.091 . . . . 0.0 112.62 -176.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 24.7 m -60.7 -31.29 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 O-C-N 121.992 -0.443 . . . . 0.0 111.628 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 46.9 tp -67.69 -36.23 80.28 Favored 'General case' 0 N--CA 1.536 3.855 0 O-C-N 121.474 -0.766 . . . . 0.0 109.875 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 41.1 mm -55.01 -51.98 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 C-N-CA 122.873 0.469 . . . . 0.0 112.157 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 17.2 m -60.57 -36.71 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 C-N-CA 122.356 0.262 . . . . 0.0 110.856 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.55 -31.84 66.51 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.067 0.547 . . . . 0.0 111.153 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.81 -38.21 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 O-C-N 121.99 -0.444 . . . . 0.0 110.353 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -73.04 -32.21 64.93 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 123.203 0.601 . . . . 0.0 110.076 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.56 -37.59 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.246 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.0 m -58.7 -46.79 86.52 Favored 'General case' 0 N--CA 1.524 3.268 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -74.65 -41.57 60.1 Favored 'General case' 0 N--CA 1.532 3.63 0 CA-C-O 121.111 0.481 . . . . 0.0 111.102 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.3 m -64.52 -46.86 81.09 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 123.565 0.746 . . . . 0.0 112.303 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -22.48 63.89 Favored 'General case' 1 N--CA 1.54 4.066 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 43.6 tp -87.65 -9.59 53.78 Favored 'General case' 0 N--CA 1.539 3.984 0 C-N-CA 123.472 0.709 . . . . 0.0 110.613 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -53.87 -14.79 1.07 Allowed 'General case' 0 N--CA 1.531 3.616 0 C-N-CA 123.871 0.868 . . . . 0.0 112.369 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -59.14 154.75 15.31 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.746 0.818 . . . . 0.0 110.459 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -68.55 93.17 0.49 Allowed 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 123.806 0.842 . . . . 0.0 109.993 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.97 121.36 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 57.4 mt -94.58 146.96 32.4 Favored Pre-proline 0 N--CA 1.525 3.296 0 CA-C-O 117.453 -1.26 . . . . 0.0 108.254 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo . . . . . 1 N--CA 1.542 4.369 0 C-N-CA 122.115 1.877 . . . . 0.0 110.814 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 CA--C 1.576 1.958 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.91 -57.18 2.41 Favored 'Trans proline' 1 N--CA 1.544 4.453 0 C-N-CA 122.413 2.075 . . . . 0.0 113.543 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 169.23 -12.6 0.05 OUTLIER Glycine 1 N--CA 1.522 4.405 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 48.5 m 58.39 57.66 3.77 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 124.112 0.965 . . . . 0.0 111.286 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.43 -27.15 69.1 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 124.044 0.938 . . . . 0.0 110.749 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 99.8 p -68.58 -32.63 72.67 Favored 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 123.581 0.752 . . . . 0.0 110.406 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.76 -46.61 60.14 Favored Glycine 1 N--CA 1.516 4.004 0 CA-C-N 115.362 -0.835 . . . . 0.0 114.979 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -70.91 -42.03 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.907 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -60.05 -42.13 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 C-N-CA 122.999 0.52 . . . . 0.0 112.395 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.71 -33.29 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.858 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.26 58.33 Favored Glycine 0 N--CA 1.51 3.617 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.524 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.0 m -59.47 -37.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.913 0 CA-C-N 117.634 0.717 . . . . 0.0 110.928 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 80.5 p -56.39 -46.61 80.03 Favored 'General case' 0 N--CA 1.531 3.584 0 CA-C-O 121.038 0.447 . . . . 0.0 111.214 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.83 -41.96 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 124.456 1.102 . . . . 0.0 110.88 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.55 -47.12 66.98 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.41 0.684 . . . . 0.0 112.633 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.65 -37.05 72.71 Favored 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 123.385 0.674 . . . . 0.0 111.674 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 36.2 t -67.98 -48.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 CA-C-O 121.315 0.578 . . . . 0.0 110.071 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.53 -32.65 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.111 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.388 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 16.1 mt -73.55 -46.7 45.96 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 122.67 0.388 . . . . 0.0 110.95 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 92.1 mt -60.14 -44.77 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 O-C-N 121.531 -0.731 . . . . 0.0 111.437 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.03 -37.8 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.87 0 CA-C-N 118.843 0.747 . . . . 0.0 110.631 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.81 91.09 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.553 0.741 . . . . 0.0 111.828 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 88.5 t -71.57 -34.47 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.348 0 C-N-CA 123.139 0.576 . . . . 0.0 109.777 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.01 -44.21 89.97 Favored 'General case' 0 N--CA 1.53 3.525 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.68 -37.41 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.781 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 88.0 m -61.19 -33.7 73.88 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 122.913 0.485 . . . . 0.0 110.855 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -74.28 -28.47 61.22 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 122.633 0.373 . . . . 0.0 110.461 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 57.5 m -75.27 -17.74 60.23 Favored 'General case' 0 N--CA 1.524 3.227 0 C-N-CA 123.104 0.562 . . . . 0.0 110.855 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.76 -38.43 86.57 Favored 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 123.499 0.72 . . . . 0.0 112.319 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -110.46 10.16 23.27 Favored 'General case' 1 N--CA 1.556 4.844 0 C-N-CA 123.414 0.686 . . . . 0.0 112.342 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -75.65 5.47 6.07 Favored 'General case' 0 N--CA 1.527 3.396 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -163.84 172.53 13.93 Favored 'General case' 0 N--CA 1.516 2.85 0 C-N-CA 124.242 1.017 . . . . 0.0 108.958 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.11 -175.63 3.75 Favored 'General case' 0 N--CA 1.531 3.594 0 C-N-CA 124.565 1.146 . . . . 0.0 109.757 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.12 138.73 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 C-N-CA 125.09 1.356 . . . . 0.0 108.889 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.48 108.25 35.4 Favored Pre-proline 0 N--CA 1.526 3.336 0 CA-C-O 116.882 -1.533 . . . . 0.0 107.237 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo . . . . . 1 N--CA 1.549 4.736 0 C-N-CA 122.753 2.302 . . . . 0.0 114.727 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 85.4 mmm . . . . . 0 CA--C 1.576 1.96 0 CA-C-O 117.641 -1.171 . . . . 0.0 107.883 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.11 -36.62 55.75 Favored 'Trans proline' 1 N--CA 1.548 4.705 0 C-N-CA 121.95 1.766 . . . . 0.0 113.431 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.56 -154.88 0.49 Allowed Glycine 1 N--CA 1.518 4.144 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.761 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 99.3 p -162.61 27.65 0.1 Allowed 'General case' 0 N--CA 1.522 3.125 0 C-N-CA 124.108 0.963 . . . . 0.0 109.2 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 47.5 mt -64.14 -26.55 68.58 Favored 'General case' 0 N--CA 1.522 3.141 0 C-N-CA 124.566 1.147 . . . . 0.0 110.81 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.1 t -57.57 -26.41 61.4 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.606 0.762 . . . . 0.0 111.883 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.65 -34.23 77.92 Favored Glycine 0 N--CA 1.513 3.801 0 C-N-CA 124.724 1.154 . . . . 0.0 114.12 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -46.47 90.79 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.378 0 CA-C-N 117.821 0.81 . . . . 0.0 112.458 -174.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.7 tt -64.84 -31.54 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 C-N-CA 123.116 0.566 . . . . 0.0 110.779 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 51.1 mm -68.22 -33.51 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.37 -50.15 67.48 Favored Glycine 1 N--CA 1.517 4.074 0 C-N-CA 123.119 0.39 . . . . 0.0 113.127 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.0 m -61.85 -35.75 69.75 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 CA-C-N 117.861 0.83 . . . . 0.0 110.655 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.5 m -55.18 -42.28 72.99 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.045 0.538 . . . . 0.0 111.0 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.42 -36.99 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.47 0 C-N-CA 123.483 0.713 . . . . 0.0 110.576 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.47 68.41 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.42 -50.43 65.46 Favored 'General case' 0 N--CA 1.515 2.795 0 C-N-CA 123.315 0.646 . . . . 0.0 112.673 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.02 -38.34 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.784 0 CA-C-N 118.303 0.501 . . . . 0.0 111.311 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.5 t -62.41 -34.65 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 CA-C-N 117.954 0.343 . . . . 0.0 110.391 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.98 -34.53 78.32 Favored 'General case' 0 N--CA 1.529 3.507 0 CA-C-N 117.808 0.276 . . . . 0.0 111.468 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.48 -36.8 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.865 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.74 -37.71 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.692 0 C-N-CA 123.34 0.656 . . . . 0.0 110.212 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.91 -32.52 71.99 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.387 0.675 . . . . 0.0 111.342 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.57 -37.46 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 123.052 0.541 . . . . 0.0 109.899 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.43 -43.78 96.46 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.377 0.671 . . . . 0.0 112.434 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.9 m -68.24 -37.38 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.725 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 93.0 m -62.93 -31.4 72.48 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.989 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -74.43 -38.83 62.91 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 55.9 m -67.37 -28.04 67.61 Favored 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 123.384 0.674 . . . . 0.0 110.576 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.54 -34.54 78.13 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.463 0.705 . . . . 0.0 111.896 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.32 8.1 37.71 Favored 'General case' 1 N--CA 1.544 4.248 0 C-N-CA 123.092 0.557 . . . . 0.0 111.691 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -71.24 2.53 4.58 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 123.479 0.711 . . . . 0.0 110.471 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -52.37 173.57 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 124.52 1.128 . . . . 0.0 112.25 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -63.17 146.36 53.52 Favored 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 124.056 0.942 . . . . 0.0 111.281 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.51 138.29 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.402 0 C-N-CA 125.081 1.352 . . . . 0.0 108.128 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 66.4 mt -113.6 99.27 49.36 Favored Pre-proline 0 N--CA 1.525 3.319 0 C-N-CA 124.814 1.246 . . . . 0.0 108.629 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo . . . . . 1 N--CA 1.547 4.641 0 C-N-CA 122.345 2.03 . . . . 0.0 114.132 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.573 1.854 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.74 -40.06 4.11 Favored 'Trans proline' 1 N--CA 1.54 4.225 0 C-N-CA 122.02 1.813 . . . . 0.0 110.755 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 171.89 -163.42 35.86 Favored Glycine 1 N--CA 1.518 4.156 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 48.1 t -165.67 -57.59 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.925 0 C-N-CA 123.794 0.837 . . . . 0.0 109.11 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.09 -31.96 73.42 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 123.945 0.898 . . . . 0.0 110.162 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.9 t -68.36 -27.95 66.7 Favored 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 123.592 0.757 . . . . 0.0 110.631 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.04 -46.58 58.39 Favored Glycine 0 N--CA 1.514 3.872 0 C-N-CA 124.078 0.847 . . . . 0.0 114.723 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.8 pt -70.71 -37.35 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -64.29 -41.39 92.23 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.054 0 CA-C-N 118.376 0.534 . . . . 0.0 111.609 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.88 -33.28 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.31 -50.11 64.35 Favored Glycine 0 N--CA 1.513 3.807 0 C-N-CA 124.331 0.967 . . . . 0.0 113.906 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.32 -37.13 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 O-C-N 122.22 -0.577 . . . . 0.0 109.887 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 82.0 m -65.31 -47.22 77.34 Favored 'General case' 0 N--CA 1.523 3.204 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.3 p -70.74 -31.54 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 CA-C-N 118.117 0.417 . . . . 0.0 111.611 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.7 67.59 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.44 -36.41 83.83 Favored 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 123.121 0.568 . . . . 0.0 111.506 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 48.0 t -68.13 -52.11 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 C-N-CA 123.525 0.73 . . . . 0.0 111.779 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.08 -35.18 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.457 0 O-C-N 121.413 -0.804 . . . . 0.0 111.944 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 tt -75.01 -43.71 52.2 Favored 'General case' 0 N--CA 1.528 3.444 0 C-N-CA 122.58 0.352 . . . . 0.0 111.204 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 14.8 tt -65.73 -39.75 85.79 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 O-C-N 121.211 -0.931 . . . . 0.0 111.197 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.26 -37.42 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 C-N-CA 123.099 0.56 . . . . 0.0 109.939 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.85 -32.77 67.96 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.25 -38.63 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.594 0 CA-C-N 118.049 0.386 . . . . 0.0 111.386 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -64.39 -44.25 91.9 Favored 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.95 -39.89 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.467 0 C-N-CA 122.841 0.457 . . . . 0.0 110.109 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 99.0 m -67.55 -28.25 67.63 Favored 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 123.242 0.617 . . . . 0.0 111.226 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.3 -45.97 44.13 Favored 'General case' 0 N--CA 1.528 3.436 0 CA-C-O 121.123 0.487 . . . . 0.0 110.499 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.7 t -63.78 -19.05 64.69 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 123.629 0.772 . . . . 0.0 112.203 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 49.7 tp -69.24 -15.64 63.42 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.616 0.766 . . . . 0.0 110.614 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.52 -4.03 58.99 Favored 'General case' 0 N--CA 1.534 3.76 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 72.7 m95 61.5 160.8 0.06 Allowed 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 124.521 1.128 . . . . 0.0 110.668 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -129.49 -121.82 0.22 Allowed 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 124.615 1.166 . . . . 0.0 108.281 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -66.0 130.62 43.89 Favored 'General case' 0 N--CA 1.523 3.215 0 C-N-CA 123.501 0.72 . . . . 0.0 109.815 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 24.1 m -135.04 138.71 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 125.167 1.387 . . . . 0.0 108.338 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.25 146.64 31.94 Favored Pre-proline 0 N--CA 1.53 3.574 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 1 N--CA 1.54 4.25 0 C-N-CA 122.142 1.895 . . . . 0.0 110.843 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 66.4 mtp . . . . . 0 CA--C 1.584 2.262 0 CA-C-O 117.563 -1.208 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.82 172.4 15.92 Favored 'Trans proline' 1 N--CA 1.543 4.406 0 CA-C-N 122.914 2.076 . . . . 0.0 110.276 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.26 -43.11 93.64 Favored Glycine 1 N--CA 1.519 4.195 0 C-N-CA 123.683 0.659 . . . . 0.0 111.985 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 50.5 m 57.85 61.27 2.45 Favored 'General case' 0 N--CA 1.523 3.214 0 C-N-CA 124.032 0.933 . . . . 0.0 111.625 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.34 -26.97 68.71 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 123.906 0.883 . . . . 0.0 110.294 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.2 m -68.41 -29.82 68.58 Favored 'General case' 0 N--CA 1.52 3.03 0 C-N-CA 123.636 0.775 . . . . 0.0 110.297 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.03 -46.67 58.13 Favored Glycine 1 N--CA 1.516 4.024 0 C-N-CA 123.96 0.79 . . . . 0.0 114.935 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 8.1 tp -70.97 -41.56 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.07 -41.07 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 C-N-CA 123.082 0.553 . . . . 0.0 112.335 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.94 -33.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.18 -28.21 41.46 Favored Glycine 1 N--CA 1.516 4.022 0 C-N-CA 124.54 1.066 . . . . 0.0 113.754 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 5.3 m -58.58 -37.04 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.789 0 CA-C-N 117.482 0.641 . . . . 0.0 111.587 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 7.7 t -55.78 -44.3 77.61 Favored 'General case' 0 N--CA 1.538 3.968 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.27 -31.72 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 C-N-CA 123.355 0.662 . . . . 0.0 110.85 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.76 -46.68 77.83 Favored 'General case' 0 N--CA 1.535 3.785 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.04 74.26 Favored 'General case' 0 N--CA 1.514 2.763 0 C-N-CA 123.529 0.732 . . . . 0.0 111.526 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 38.0 t -64.49 -47.77 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.682 0 C-N-CA 123.49 0.716 . . . . 0.0 110.663 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.48 -32.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 123.586 0.755 . . . . 0.0 109.995 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 36.1 tp -76.81 -33.87 57.96 Favored 'General case' 0 N--CA 1.516 2.865 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 tp -54.84 -43.83 69.48 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 C-N-CA 123.455 0.702 . . . . 0.0 112.267 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 12.6 m -64.73 -37.47 80.23 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.152 0 O-C-N 121.957 -0.464 . . . . 0.0 110.542 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.04 -32.27 67.83 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 122.949 0.5 . . . . 0.0 111.127 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.2 -35.0 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.789 0 C-N-CA 122.739 0.416 . . . . 0.0 110.256 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -72.11 -38.91 69.22 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 123.281 0.632 . . . . 0.0 109.672 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.11 -37.37 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 C-N-CA 124.136 0.974 . . . . 0.0 109.634 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.68 -38.39 78.11 Favored 'General case' 0 N--CA 1.523 3.19 0 C-N-CA 122.781 0.432 . . . . 0.0 110.081 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -74.2 -37.33 63.93 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 122.978 0.511 . . . . 0.0 110.114 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 32.1 t -64.23 -41.48 96.99 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.9 tp -65.19 -16.26 63.33 Favored 'General case' 0 N--CA 1.522 3.129 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.767 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.29 -23.55 14.38 Favored 'General case' 1 N--CA 1.557 4.92 0 C-N-CA 124.262 1.025 . . . . 0.0 108.655 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -108.19 94.58 5.15 Favored 'General case' 0 N--CA 1.53 3.561 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 26.07 0.09 Allowed 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.599 0.76 . . . . 0.0 110.841 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -54.57 154.41 4.88 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 124.143 0.977 . . . . 0.0 112.302 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.47 138.49 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 49.3 mt -94.34 146.53 31.71 Favored Pre-proline 0 N--CA 1.529 3.488 0 CA-C-O 117.399 -1.286 . . . . 0.0 108.554 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 1 N--CA 1.54 4.246 0 C-N-CA 122.101 1.867 . . . . 0.0 110.734 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.14 173.29 13.18 Favored 'Trans proline' 1 N--CA 1.539 4.159 0 C-N-CA 122.074 1.85 . . . . 0.0 110.392 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -175.29 36.64 0.1 Allowed Glycine 1 N--CA 1.519 4.172 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 60.0 p 56.44 67.44 1.0 Allowed 'General case' 0 N--CA 1.522 3.145 0 C-N-CA 124.317 1.047 . . . . 0.0 111.711 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.03 -26.69 68.68 Favored 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 123.982 0.913 . . . . 0.0 109.735 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 64.0 m -60.45 -26.66 66.91 Favored 'General case' 0 N--CA 1.522 3.157 0 C-N-CA 123.542 0.737 . . . . 0.0 110.924 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.53 -42.17 82.04 Favored Glycine 0 N--CA 1.513 3.775 0 C-N-CA 124.262 0.934 . . . . 0.0 115.385 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -46.38 69.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.239 0 CA-C-N 118.192 0.996 . . . . 0.0 111.546 -176.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 19.7 tt -61.05 -35.55 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.14 -33.15 45.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.063 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.25 -47.41 90.98 Favored Glycine 0 N--CA 1.513 3.791 0 C-N-CA 123.831 0.729 . . . . 0.0 113.29 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 15.1 m -68.83 -37.1 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 CA-C-N 118.119 0.96 . . . . 0.0 110.141 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 37.9 m -62.04 -46.29 89.83 Favored 'General case' 0 N--CA 1.516 2.875 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.469 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 11.8 p -69.67 -31.55 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.546 0 CA-C-N 117.973 0.351 . . . . 0.0 110.572 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.9 70.82 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 122.635 0.374 . . . . 0.0 111.45 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.22 -37.74 86.26 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 123.558 0.743 . . . . 0.0 110.911 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.66 -42.8 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.376 0 C-N-CA 123.597 0.759 . . . . 0.0 110.563 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.08 -44.49 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.285 0.634 . . . . 0.0 111.361 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.2 -35.22 63.91 Favored 'General case' 0 N--CA 1.523 3.203 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 17.9 tt -69.63 -40.3 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 CA-C-N 118.627 0.649 . . . . 0.0 111.162 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.59 -36.97 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 O-C-N 121.942 -0.473 . . . . 0.0 109.948 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.45 82.22 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.945 0.898 . . . . 0.0 112.798 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.68 -34.18 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 O-C-N 121.915 -0.49 . . . . 0.0 110.084 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -64.38 -43.85 93.18 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.015 0.526 . . . . 0.0 112.316 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.59 -37.38 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.832 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 98.5 m -60.05 -28.84 68.11 Favored 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 122.768 0.427 . . . . 0.0 110.945 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -72.83 -32.46 65.51 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.988 0.515 . . . . 0.0 110.564 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 32.1 t -63.75 -17.76 63.36 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 123.159 0.584 . . . . 0.0 112.33 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.62 -20.79 65.12 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 123.503 0.721 . . . . 0.0 112.72 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.44 -5.22 58.92 Favored 'General case' 1 N--CA 1.544 4.262 0 CA-C-N 118.723 0.692 . . . . 0.0 111.116 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -64.89 -16.16 62.88 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.5 0.72 . . . . 0.0 110.622 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.44 161.2 14.72 Favored 'General case' 0 N--CA 1.523 3.199 0 C-N-CA 123.937 0.895 . . . . 0.0 110.651 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.9 168.28 15.58 Favored 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.901 0.88 . . . . 0.0 110.057 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.2 138.48 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.407 0 C-N-CA 124.859 1.264 . . . . 0.0 108.202 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.36 146.51 31.66 Favored Pre-proline 0 N--CA 1.529 3.513 0 CA-C-O 116.579 -1.677 . . . . 0.0 107.095 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 1 N--CA 1.549 4.773 0 C-N-CA 123.015 2.477 . . . . 0.0 114.905 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 CA--C 1.573 1.836 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.62 154.44 12.12 Favored 'Trans proline' 1 N--CA 1.542 4.38 0 C-N-CA 122.356 2.037 . . . . 0.0 113.086 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.7 67.52 2.05 Favored Glycine 1 N--CA 1.517 4.091 0 C-N-CA 123.678 0.656 . . . . 0.0 112.025 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 87.8 p -64.26 -78.2 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.757 0.823 . . . . 0.0 110.991 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.19 -26.8 68.31 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 124.33 1.052 . . . . 0.0 110.714 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 65.6 m -57.89 -38.47 75.86 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 123.735 0.814 . . . . 0.0 111.254 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.87 -35.72 80.17 Favored Glycine 1 N--CA 1.518 4.147 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.212 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.31 -46.61 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.323 0 C-N-CA 124.072 0.949 . . . . 0.0 112.773 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.3 tt -66.45 -35.22 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.82 -32.95 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.9 -36.49 60.33 Favored Glycine 0 N--CA 1.514 3.854 0 C-N-CA 123.738 0.685 . . . . 0.0 114.683 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.47 -37.56 79.88 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.159 0 CA-C-N 118.214 1.007 . . . . 0.0 110.94 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 26.5 p -63.86 -45.82 87.75 Favored 'General case' 0 N--CA 1.527 3.402 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.931 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 50.9 t -66.92 -31.56 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.163 0 C-N-CA 124.426 1.09 . . . . 0.0 111.328 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.91 -43.07 65.94 Favored 'General case' 0 N--CA 1.532 3.647 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.47 -45.58 65.44 Favored 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 123.188 0.595 . . . . 0.0 110.364 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.97 -47.55 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 124.307 1.043 . . . . 0.0 112.969 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.55 -32.21 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.922 0 CA-C-N 118.093 0.406 . . . . 0.0 110.954 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 83.9 mt -68.67 -33.95 74.86 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 122.579 0.352 . . . . 0.0 110.383 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 46.6 mm -55.01 -39.79 51.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.232 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.01 -41.61 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.127 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.1 94.52 Favored 'General case' 0 N--CA 1.528 3.461 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.96 -34.12 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 O-C-N 121.718 -0.614 . . . . 0.0 109.476 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -63.03 -43.67 98.05 Favored 'General case' 0 N--CA 1.53 3.548 0 C-N-CA 123.103 0.561 . . . . 0.0 112.327 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.4 -37.57 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.7 m -61.51 -31.08 71.07 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.002 0.521 . . . . 0.0 110.358 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -73.86 -41.29 62.43 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 66.7 m -64.69 -32.62 74.37 Favored 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 123.482 0.713 . . . . 0.0 109.843 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -72.29 -29.45 63.88 Favored 'General case' 0 N--CA 1.524 3.27 0 C-N-CA 123.862 0.865 . . . . 0.0 109.287 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 56.3 tp -87.11 -21.35 26.06 Favored 'General case' 0 N--CA 1.533 3.694 0 C-N-CA 123.848 0.859 . . . . 0.0 110.533 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -62.55 -13.08 26.93 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.48 0.712 . . . . 0.0 110.819 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -59.62 -101.61 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 124.165 0.986 . . . . 0.0 110.546 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -72.5 162.49 29.41 Favored 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 123.662 0.785 . . . . 0.0 109.575 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.19 138.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 C-N-CA 124.786 1.234 . . . . 0.0 108.169 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 58.5 tp -95.28 104.91 16.89 Favored Pre-proline 0 N--CA 1.529 3.514 0 CA-C-O 117.223 -1.37 . . . . 0.0 108.253 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo . . . . . 1 N--CA 1.537 4.059 0 CA-C-N 122.766 2.024 . . . . 0.0 111.063 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.37 -178.48 0.03 OUTLIER 'Trans proline' 1 N--CA 1.546 4.561 0 C-N-CA 122.462 2.108 . . . . 0.0 113.903 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 71.6 166.74 8.0 Favored Glycine 1 N--CA 1.516 4.024 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.067 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 72.4 m -163.63 -1.13 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 123.934 0.894 . . . . 0.0 110.244 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 40.6 mt -64.98 -26.93 68.5 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.727 0.811 . . . . 0.0 110.54 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 69.6 m -68.5 -30.82 69.74 Favored 'General case' 0 N--CA 1.518 2.968 0 C-N-CA 123.753 0.821 . . . . 0.0 110.396 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.57 -46.33 62.78 Favored Glycine 0 N--CA 1.515 3.955 0 C-N-CA 124.3 0.952 . . . . 0.0 114.912 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 19.3 tt -71.01 -40.48 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.22 -40.28 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 C-N-CA 122.9 0.48 . . . . 0.0 112.075 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.1 tt -72.79 -32.8 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.47 -28.4 44.33 Favored Glycine 0 N--CA 1.51 3.572 0 C-N-CA 124.689 1.138 . . . . 0.0 113.442 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.6 m -58.87 -37.21 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.801 0 CA-C-N 117.339 0.569 . . . . 0.0 111.128 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 65.1 p -61.19 -46.39 90.68 Favored 'General case' 0 N--CA 1.533 3.72 0 CA-C-O 121.258 0.551 . . . . 0.0 110.926 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.75 -31.82 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 C-N-CA 124.545 1.138 . . . . 0.0 110.873 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.92 -42.02 71.7 Favored 'General case' 0 N--CA 1.531 3.623 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.67 90.92 Favored 'General case' 0 N--CA 1.517 2.906 0 C-N-CA 123.56 0.744 . . . . 0.0 111.169 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 26.5 t -58.63 -51.7 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.559 0.744 . . . . 0.0 111.63 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -67.06 -31.97 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 C-N-CA 123.078 0.551 . . . . 0.0 110.567 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.12 -35.46 61.7 Favored 'General case' 0 N--CA 1.533 3.718 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.68 -48.21 72.24 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.578 0 O-C-N 121.593 -0.692 . . . . 0.0 110.976 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 12.4 m -65.77 -36.35 77.35 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.042 0 O-C-N 121.902 -0.499 . . . . 0.0 110.378 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.01 68.14 Favored 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 122.865 0.466 . . . . 0.0 111.434 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.3 -34.82 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 C-N-CA 122.882 0.473 . . . . 0.0 110.41 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -72.66 -43.26 63.4 Favored 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.183 0.593 . . . . 0.0 112.399 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.83 -37.21 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 O-C-N 122.165 -0.335 . . . . 0.0 111.383 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 28.1 p -66.98 -27.71 67.66 Favored 'General case' 0 N--CA 1.53 3.548 0 O-C-N 122.311 -0.243 . . . . 0.0 110.971 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -68.53 -30.51 69.32 Favored 'General case' 0 N--CA 1.531 3.604 0 C-N-CA 123.029 0.532 . . . . 0.0 110.055 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 39.6 t -67.53 -39.62 85.06 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-O 121.437 0.637 . . . . 0.0 110.166 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -13.69 13.4 Favored 'General case' 0 N--CA 1.535 3.805 0 C-N-CA 125.567 1.547 . . . . 0.0 111.339 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 54.3 tp -86.77 -16.85 35.05 Favored 'General case' 1 N--CA 1.544 4.262 0 C-N-CA 123.656 0.782 . . . . 0.0 110.178 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -143.1 78.93 1.63 Allowed 'General case' 0 N--CA 1.52 3.043 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -147.13 -21.66 0.4 Allowed 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 124.482 1.113 . . . . 0.0 110.183 -175.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -70.13 100.59 1.67 Allowed 'General case' 0 N--CA 1.524 3.259 0 C-N-CA 123.835 0.854 . . . . 0.0 109.284 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 8.1 p -135.49 138.2 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 124.704 1.201 . . . . 0.0 108.739 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 75.6 mt -102.25 99.93 14.06 Favored Pre-proline 0 N--CA 1.527 3.376 0 C-N-CA 124.849 1.259 . . . . 0.0 108.606 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 N--CA 1.535 3.942 0 C-N-CA 122.433 2.089 . . . . 0.0 110.869 -179.262 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.181 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.55 125.84 10.99 Favored 'Trans proline' 1 N--CA 1.538 4.14 0 C-N-CA 121.931 1.754 . . . . 0.0 110.47 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.38 141.63 15.98 Favored Glycine 1 N--CA 1.518 4.154 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 47.8 t -168.38 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 CA-C-N 117.692 0.746 . . . . 0.0 110.305 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 tt -54.67 -28.47 47.68 Favored 'General case' 0 N--CA 1.53 3.558 0 C-N-CA 123.647 0.779 . . . . 0.0 111.234 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 46.5 t -66.52 -42.22 87.63 Favored 'General case' 0 N--CA 1.52 3.026 0 C-N-CA 123.734 0.813 . . . . 0.0 110.522 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.38 69.18 Favored Glycine 1 N--CA 1.517 4.099 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.65 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.96 -46.29 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.306 0 C-N-CA 124.003 0.921 . . . . 0.0 111.556 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 215' ' ' ILE . 0.2 OUTLIER -67.59 -32.79 58.5 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.016 0 CA-C-O 121.268 0.556 . . . . 0.0 109.704 -178.435 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 6.3 mm -71.94 -37.0 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 C-N-CA 123.863 0.865 . . . . 0.0 109.314 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.7 -29.87 71.07 Favored Glycine 1 N--CA 1.517 4.08 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.685 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.1 m -62.56 -36.19 73.83 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.285 0 CA-C-N 117.881 0.841 . . . . 0.0 110.564 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.3 p -55.02 -44.18 74.36 Favored 'General case' 0 N--CA 1.528 3.427 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.24 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.16 -36.1 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.414 0 C-N-CA 123.771 0.828 . . . . 0.0 111.061 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.84 -44.43 66.72 Favored 'General case' 0 N--CA 1.533 3.675 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.95 -37.04 78.59 Favored 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 123.08 0.552 . . . . 0.0 111.541 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.3 t -67.15 -47.17 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 C-N-CA 123.106 0.563 . . . . 0.0 111.974 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.37 -35.85 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 CA-C-N 118.058 0.39 . . . . 0.0 111.006 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.8 mt -60.98 -34.44 74.78 Favored 'General case' 0 N--CA 1.539 3.978 0 CA-C-N 117.91 0.323 . . . . 0.0 110.949 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.26 -36.28 77.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 O-C-N 121.829 -0.544 . . . . 0.0 109.779 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.66 -37.68 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.701 0 C-N-CA 122.955 0.502 . . . . 0.0 110.182 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.41 79.98 Favored 'General case' 0 N--CA 1.53 3.556 0 C-N-CA 123.621 0.768 . . . . 0.0 112.582 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 26.3 m -71.76 -34.1 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.601 0 O-C-N 121.938 -0.476 . . . . 0.0 110.176 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.25 -44.01 97.53 Favored 'General case' 0 N--CA 1.53 3.564 0 C-N-CA 123.057 0.543 . . . . 0.0 112.416 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.73 -37.62 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.739 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -63.41 -27.87 69.59 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 123.066 0.546 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -63.35 -23.59 67.48 Favored 'General case' 0 N--CA 1.533 3.705 0 C-N-CA 123.103 0.561 . . . . 0.0 110.829 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 41.5 m -66.68 -40.27 88.49 Favored 'General case' 0 N--CA 1.526 3.358 0 CA-C-O 121.402 0.62 . . . . 0.0 109.847 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 44.5 mt -63.15 -23.98 67.68 Favored 'General case' 0 N--CA 1.524 3.239 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.289 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 46.4 tp -87.86 9.12 23.04 Favored 'General case' 0 N--CA 1.536 3.846 0 C-N-CA 124.057 0.943 . . . . 0.0 109.455 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -139.66 69.16 1.36 Allowed 'General case' 0 N--CA 1.532 3.626 0 C-N-CA 124.5 1.12 . . . . 0.0 109.816 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -84.83 -63.48 1.33 Allowed 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -168.82 168.11 10.67 Favored 'General case' 0 N--CA 1.521 3.117 0 C-N-CA 124.154 0.982 . . . . 0.0 108.821 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.13 138.29 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.603 0 C-N-CA 124.573 1.149 . . . . 0.0 108.761 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.579 HD23 ' H ' ' A' ' 241' ' ' LEU . 1.6 pt? -94.61 146.44 31.45 Favored Pre-proline 0 N--CA 1.533 3.701 0 C-N-CA 124.798 1.239 . . . . 0.0 109.498 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 1 N--CA 1.541 4.295 0 CA-C-N 122.223 1.829 . . . . 0.0 110.65 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 CA--C 1.574 1.872 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.96 112.33 3.38 Favored 'Trans proline' 1 N--CA 1.538 4.12 0 C-N-CA 122.173 1.915 . . . . 0.0 110.627 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.15 147.16 0.07 OUTLIER Glycine 1 N--CA 1.517 4.054 0 C-N-CA 123.882 0.753 . . . . 0.0 111.59 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 69.7 m -167.22 -25.54 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 C-N-CA 124.405 1.082 . . . . 0.0 108.982 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.28 -26.64 68.51 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 124.322 1.049 . . . . 0.0 110.268 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 90.9 p -64.93 -27.95 69.19 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 123.432 0.693 . . . . 0.0 110.82 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.53 ' O ' HD12 ' B' ' 216' ' ' ILE . . . -69.69 -47.41 49.0 Favored Glycine 0 N--CA 1.515 3.904 0 N-CA-C 114.822 0.689 . . . . 0.0 114.822 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 39.3 pt -71.42 -34.63 54.09 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.406 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.6 tt -55.06 -31.83 26.24 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.148 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.69 HD13 ' N ' ' B' ' 217' ' ' GLY . 0.0 OUTLIER -59.83 -32.2 49.16 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.496 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.949 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 217' ' ' GLY . . . . . 0.69 ' N ' HD13 ' B' ' 216' ' ' ILE . . . -54.17 -29.38 44.78 Favored Glycine 0 N--CA 1.51 3.617 0 CA-C-N 115.067 -0.969 . . . . 0.0 114.088 -178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 6.0 m -59.55 -37.49 70.6 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.021 0 CA-C-N 118.429 1.115 . . . . 0.0 110.551 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 48.3 p -66.13 -45.92 79.33 Favored 'General case' 0 N--CA 1.528 3.433 0 CA-C-O 121.13 0.491 . . . . 0.0 110.497 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 49.5 t -69.42 -32.96 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.178 0 C-N-CA 124.322 1.049 . . . . 0.0 110.415 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.13 76.79 Favored 'General case' 0 N--CA 1.523 3.225 0 C-N-CA 123.363 0.665 . . . . 0.0 111.801 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.92 -30.6 68.05 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.086 0.554 . . . . 0.0 111.005 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 38.8 t -64.01 -50.76 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 C-N-CA 123.302 0.641 . . . . 0.0 111.167 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.35 -32.12 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 C-N-CA 122.738 0.415 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.61 -47.36 26.86 Favored 'General case' 0 N--CA 1.528 3.425 0 C-N-CA 123.515 0.726 . . . . 0.0 111.561 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.6 tt -64.24 -39.02 84.04 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.058 0 O-C-N 121.593 -0.692 . . . . 0.0 112.779 -176.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.8 -36.92 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.738 0 O-C-N 122.087 -0.383 . . . . 0.0 110.375 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.66 74.9 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.282 0.633 . . . . 0.0 112.165 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 48.0 t -71.88 -38.96 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 C-N-CA 122.99 0.516 . . . . 0.0 111.159 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -69.23 -43.46 73.97 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.39 -37.73 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 C-N-CA 122.57 0.348 . . . . 0.0 111.232 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 18.7 p -67.03 -28.78 68.51 Favored 'General case' 0 N--CA 1.529 3.51 0 CA-C-N 117.85 0.295 . . . . 0.0 111.203 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -63.52 -29.47 70.73 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 123.301 0.64 . . . . 0.0 111.139 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.4 t -65.28 -33.33 75.72 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.384 0.674 . . . . 0.0 111.215 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 51.0 mt -65.72 -18.39 65.3 Favored 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 123.724 0.81 . . . . 0.0 111.931 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.2 mp -87.39 -28.35 22.23 Favored 'General case' 0 N--CA 1.539 3.995 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 51.7 t90 -87.17 58.8 5.23 Favored 'General case' 0 N--CA 1.526 3.349 0 C-N-CA 124.004 0.921 . . . . 0.0 108.88 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -67.21 -102.78 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 123.757 0.823 . . . . 0.0 110.318 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 58.28 108.37 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 124.437 1.095 . . . . 0.0 111.185 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.15 138.63 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 125.142 1.377 . . . . 0.0 108.393 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.525 ' H ' HD13 ' B' ' 241' ' ' LEU . 0.0 OUTLIER -133.25 147.41 64.96 Favored Pre-proline 0 N--CA 1.534 3.768 0 CA-C-O 116.81 -1.567 . . . . 0.0 109.161 -179.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo . . . . . 1 N--CA 1.55 4.851 0 C-N-CA 123.13 2.553 . . . . 0.0 115.37 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 CA--C 1.575 1.91 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -82.34 16.29 1.82 Allowed 'Trans proline' 1 N--CA 1.537 4.05 0 C-N-CA 122.553 2.169 . . . . 0.0 111.089 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.79 39.39 1.11 Allowed Glycine 1 N--CA 1.518 4.103 0 C-N-CA 123.97 0.795 . . . . 0.0 111.994 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 74.8 m -163.56 170.13 17.68 Favored 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 123.841 0.857 . . . . 0.0 109.276 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 211' ' ' LEU . . . . . 0.406 HD22 ' N ' ' C' ' 211' ' ' LEU . 2.0 mm? -65.29 -26.28 68.0 Favored 'General case' 0 N--CA 1.522 3.158 0 C-N-CA 124.261 1.024 . . . . 0.0 109.896 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 57.7 m -58.39 -27.22 64.05 Favored 'General case' 0 N--CA 1.521 3.077 0 C-N-CA 123.403 0.681 . . . . 0.0 111.293 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.67 -48.15 44.64 Favored Glycine 0 N--CA 1.513 3.83 0 CA-C-N 116.137 -0.483 . . . . 0.0 114.218 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 38.5 pt -72.74 -36.9 54.07 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 N-CA-C 115.618 1.711 . . . . 0.0 115.618 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 215' ' ' ILE . . . . . 0.471 ' O ' HG12 ' C' ' 218' ' ' VAL . 8.4 tp -56.52 -31.56 34.29 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 14.8 tt -58.98 -32.14 46.98 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.317 0 CA-C-N 119.078 0.854 . . . . 0.0 110.204 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.99 -27.39 37.39 Favored Glycine 1 N--CA 1.518 4.145 0 C-N-CA 123.674 0.654 . . . . 0.0 112.497 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 218' ' ' VAL . . . . . 0.471 HG12 ' O ' ' C' ' 215' ' ' ILE . 8.6 p -58.4 -44.83 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.77 0 C-N-CA 123.505 0.722 . . . . 0.0 112.888 -176.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 9.7 t -66.24 -40.73 90.42 Favored 'General case' 0 N--CA 1.536 3.871 0 CA-C-N 118.51 0.595 . . . . 0.0 110.752 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 41.8 t -69.68 -32.28 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 C-N-CA 123.883 0.873 . . . . 0.0 110.764 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.4 -41.7 73.05 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.26 -34.56 74.97 Favored 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 123.202 0.601 . . . . 0.0 111.049 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.29 -52.35 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.088 0.555 . . . . 0.0 111.462 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.58 -31.97 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 122.956 0.502 . . . . 0.0 110.683 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.61 -46.1 91.53 Favored 'General case' 0 N--CA 1.534 3.728 0 C-N-CA 123.407 0.683 . . . . 0.0 110.807 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.49 -36.4 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 O-C-N 121.769 -0.582 . . . . 0.0 110.389 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.86 -38.0 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 122.948 0.499 . . . . 0.0 110.168 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.57 81.17 Favored 'General case' 0 N--CA 1.531 3.615 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.34 -34.3 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.854 0 O-C-N 122.088 -0.383 . . . . 0.0 110.017 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.85 -39.4 93.5 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 123.172 0.589 . . . . 0.0 109.545 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 9.4 t -68.17 -40.08 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 124.298 1.039 . . . . 0.0 109.199 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.44 -34.2 77.24 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 122.92 0.488 . . . . 0.0 109.895 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -73.51 -41.65 62.79 Favored 'General case' 0 N--CA 1.522 3.162 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.156 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.2 t -68.47 -45.9 71.18 Favored 'General case' 0 N--CA 1.528 3.473 0 CA-C-O 122.164 0.983 . . . . 0.0 109.389 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 39.7 tp -61.2 -12.94 14.74 Favored 'General case' 0 N--CA 1.521 3.108 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.872 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 40.8 tp -85.15 8.09 19.42 Favored 'General case' 1 N--CA 1.546 4.329 0 CA-C-N 118.369 0.531 . . . . 0.0 110.755 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -158.26 132.59 8.1 Favored 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 238' ' ' LYS . . . . . 0.423 ' H ' ' H ' ' C' ' 239' ' ' LYS . 58.1 mtmt -152.59 -18.78 0.16 Allowed 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 125.109 1.364 . . . . 0.0 108.235 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 239' ' ' LYS . . . . . 0.423 ' H ' ' H ' ' C' ' 238' ' ' LYS . 52.8 mtmt -65.99 -167.8 0.04 OUTLIER 'General case' 0 N--CA 1.52 3.053 0 C-N-CA 124.629 1.172 . . . . 0.0 110.187 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 70.1 t -112.63 130.32 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 52.2 mt -94.64 146.66 31.84 Favored Pre-proline 0 N--CA 1.526 3.331 0 CA-C-O 117.434 -1.27 . . . . 0.0 108.501 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 1 N--CA 1.542 4.356 0 C-N-CA 122.015 1.81 . . . . 0.0 110.779 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 18.0 ptt? . . . . . 0 CA--C 1.578 2.038 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.12 168.94 0.11 Allowed 'Trans proline' 1 N--CA 1.546 4.596 0 C-N-CA 122.689 2.259 . . . . 0.0 113.84 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -173.35 45.43 0.16 Allowed Glycine 1 N--CA 1.52 4.278 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 77.2 p 55.16 66.99 1.08 Allowed 'General case' 0 N--CA 1.523 3.214 0 C-N-CA 124.357 1.063 . . . . 0.0 112.326 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.16 -26.36 68.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.121 0.969 . . . . 0.0 109.553 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 41.3 t -57.42 -25.88 60.27 Favored 'General case' 0 N--CA 1.522 3.164 0 C-N-CA 123.976 0.911 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.68 -34.33 83.12 Favored Glycine 0 N--CA 1.515 3.929 0 C-N-CA 124.293 0.949 . . . . 0.0 114.145 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -46.42 90.81 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.3 0 CA-C-N 117.851 0.825 . . . . 0.0 112.183 -175.117 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -66.73 -31.87 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.732 0 C-N-CA 123.023 0.529 . . . . 0.0 110.542 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 47.9 mm -68.3 -33.81 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.851 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.59 -45.64 92.41 Favored Glycine 1 N--CA 1.519 4.184 0 C-N-CA 123.226 0.441 . . . . 0.0 113.479 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 11.8 m -69.2 -36.85 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 0 O-C-N 121.549 -0.971 . . . . 0.0 109.914 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 95.4 m -58.64 -46.43 87.15 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 30.4 m -67.6 -30.8 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 123.278 0.631 . . . . 0.0 111.203 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.62 74.01 Favored 'General case' 0 N--CA 1.532 3.669 0 O-C-N 121.683 -0.635 . . . . 0.0 111.572 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.38 -50.04 73.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.71 0.804 . . . . 0.0 112.943 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 15.6 m -58.36 -37.61 64.57 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 CA-C-N 119.155 0.888 . . . . 0.0 110.491 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.48 -32.08 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 122.611 0.365 . . . . 0.0 110.873 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.2 -41.13 70.68 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 40.3 mm -55.31 -51.01 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 C-N-CA 123.349 0.66 . . . . 0.0 112.069 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 31.5 m -61.79 -35.75 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.965 0 C-N-CA 122.988 0.515 . . . . 0.0 110.673 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.88 -31.6 65.0 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.1 0.56 . . . . 0.0 111.414 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.03 -34.63 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 C-N-CA 122.758 0.423 . . . . 0.0 111.374 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -66.34 -43.96 84.64 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 122.951 0.5 . . . . 0.0 111.954 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 6.3 p -68.76 -36.74 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 118.76 0.709 . . . . 0.0 109.149 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 80.3 m -58.45 -27.6 64.52 Favored 'General case' 0 N--CA 1.531 3.615 0 C-N-CA 122.708 0.403 . . . . 0.0 110.969 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -62.98 -19.02 63.92 Favored 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 123.173 0.589 . . . . 0.0 110.739 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 37.2 m -64.14 -37.94 89.28 Favored 'General case' 0 N--CA 1.527 3.394 0 C-N-CA 123.564 0.745 . . . . 0.0 110.568 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.91 -28.81 69.21 Favored 'General case' 0 N--CA 1.534 3.747 0 C-N-CA 123.913 0.885 . . . . 0.0 109.841 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.35 -5.93 58.69 Favored 'General case' 0 N--CA 1.537 3.905 0 C-N-CA 124.466 1.106 . . . . 0.0 110.932 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -53.15 -12.72 0.4 Allowed 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 123.964 0.906 . . . . 0.0 112.872 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.37 137.65 52.33 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.392 0.677 . . . . 0.0 110.981 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -83.94 121.88 27.97 Favored 'General case' 0 N--CA 1.521 3.106 0 C-N-CA 123.975 0.91 . . . . 0.0 109.131 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.08 138.2 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 124.882 1.273 . . . . 0.0 108.141 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 65.8 mt -124.86 146.78 54.31 Favored Pre-proline 0 N--CA 1.532 3.651 0 C-N-CA 125.137 1.375 . . . . 0.0 107.961 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 1 N--CA 1.54 4.218 0 C-N-CA 122.038 1.826 . . . . 0.0 110.672 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.578 2.053 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -81.29 171.65 13.56 Favored 'Trans proline' 0 N--CA 1.535 3.97 0 C-N-CA 122.568 2.178 . . . . 0.0 110.647 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.5 -166.23 3.94 Favored Glycine 1 N--CA 1.519 4.197 0 C-N-CA 123.855 0.74 . . . . 0.0 111.502 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 47.2 t -163.26 54.6 0.18 Allowed 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 121.948 0.88 . . . . 0.0 109.582 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.85 -26.54 68.37 Favored 'General case' 0 N--CA 1.525 3.286 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.589 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 69.8 m -64.71 -30.93 71.96 Favored 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 123.57 0.748 . . . . 0.0 110.933 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.77 -46.97 58.54 Favored Glycine 1 N--CA 1.517 4.047 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.47 -41.52 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 8.1 tp -62.23 -39.19 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.844 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.2 tt -72.03 -33.2 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.818 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.76 -29.8 55.32 Favored Glycine 0 N--CA 1.512 3.747 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.536 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 2.0 m -63.77 -37.56 80.02 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.062 0 CA-C-N 117.768 0.784 . . . . 0.0 110.425 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 31.2 p -60.97 -46.61 90.03 Favored 'General case' 0 N--CA 1.528 3.449 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.37 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.26 -40.17 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.202 0 C-N-CA 124.033 0.933 . . . . 0.0 110.831 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.01 66.83 Favored 'General case' 0 N--CA 1.524 3.255 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.44 -41.51 76.18 Favored 'General case' 0 N--CA 1.514 2.738 0 C-N-CA 122.921 0.488 . . . . 0.0 111.58 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.75 -46.91 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.504 0 O-C-N 122.089 -0.382 . . . . 0.0 111.834 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.42 -32.44 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.626 0 CA-C-N 117.9 0.318 . . . . 0.0 111.697 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 32.9 tp -74.72 -39.25 61.99 Favored 'General case' 0 N--CA 1.521 3.083 0 CA-C-O 119.209 -0.424 . . . . 0.0 112.014 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 81.8 mt -64.87 -43.8 96.3 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.244 0 CA-C-N 118.945 0.793 . . . . 0.0 111.026 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.3 -36.7 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 117.969 0.349 . . . . 0.0 110.318 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.29 65.79 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.362 0.665 . . . . 0.0 111.941 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.6 -40.76 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.905 0 CA-C-N 117.929 0.331 . . . . 0.0 110.219 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -69.44 -36.18 76.4 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.274 0.63 . . . . 0.0 110.436 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.5 -37.5 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.27 0 C-N-CA 123.744 0.818 . . . . 0.0 109.635 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 72.7 m -58.06 -32.04 67.64 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 122.511 0.325 . . . . 0.0 110.146 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.3 -41.63 60.84 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 60.2 p -68.24 -32.87 73.37 Favored 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 123.257 0.623 . . . . 0.0 110.206 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.54 -37.54 81.57 Favored 'General case' 0 N--CA 1.535 3.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.624 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 3.2 pp -91.28 -28.13 17.97 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.686 0.794 . . . . 0.0 109.733 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 51.27 8.87 0.05 Allowed 'General case' 0 N--CA 1.529 3.497 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -65.31 164.31 13.77 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-N 118.798 0.726 . . . . 0.0 110.742 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -138.52 157.84 45.4 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 125.045 1.338 . . . . 0.0 107.488 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.33 138.13 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.56 0 C-N-CA 124.533 1.133 . . . . 0.0 109.216 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 46.1 tp -112.82 99.85 49.25 Favored Pre-proline 0 N--CA 1.531 3.587 0 C-N-CA 125.314 1.446 . . . . 0.0 107.433 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo . . . . . 0 N--CA 1.534 3.905 0 C-N-CA 122.274 1.983 . . . . 0.0 110.857 -179.106 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 CA--C 1.574 1.885 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.42 38.29 0.6 Allowed 'Trans proline' 1 N--CA 1.543 4.413 0 C-N-CA 122.27 1.98 . . . . 0.0 110.936 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 171.65 160.39 20.07 Favored Glycine 1 N--CA 1.519 4.193 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 89.8 p -168.59 161.24 11.38 Favored 'General case' 0 N--CA 1.522 3.158 0 C-N-CA 123.692 0.797 . . . . 0.0 109.237 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.01 -25.99 68.09 Favored 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 124.437 1.095 . . . . 0.0 111.628 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 39.7 t -67.36 -33.31 74.97 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 123.469 0.708 . . . . 0.0 111.145 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.73 -44.63 69.34 Favored Glycine 1 N--CA 1.519 4.225 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 214' ' ' ILE . . . . . 0.417 ' O ' HD13 ' F' ' 214' ' ' ILE . 0.0 OUTLIER -70.67 -44.63 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.997 0 O-C-N 121.759 -0.847 . . . . 0.0 111.776 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 18.8 tt -60.68 -36.42 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 45.3 pt -72.48 -33.44 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 CA-C-N 118.699 0.681 . . . . 0.0 109.32 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.23 -48.65 84.5 Favored Glycine 1 N--CA 1.519 4.195 0 C-N-CA 123.835 0.731 . . . . 0.0 113.855 -177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.35 -36.79 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 C-N-CA 122.973 0.509 . . . . 0.0 109.803 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 90.3 m -64.1 -47.16 81.12 Favored 'General case' 0 N--CA 1.519 3.02 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -70.64 -31.48 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 CA-C-N 118.1 0.409 . . . . 0.0 111.191 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.45 -34.91 50.99 Favored 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.79 -38.62 85.95 Favored 'General case' 0 N--CA 1.523 3.194 0 C-N-CA 123.318 0.647 . . . . 0.0 111.0 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.66 -38.53 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.32 0 C-N-CA 123.697 0.799 . . . . 0.0 110.314 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.8 -37.53 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 123.469 0.708 . . . . 0.0 111.312 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 57.6 mt -72.87 -35.13 67.11 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 122.33 0.252 . . . . 0.0 111.208 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.47 -46.52 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.69 0 C-N-CA 123.08 0.552 . . . . 0.0 110.717 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 33.2 m -67.48 -37.27 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 O-C-N 121.687 -0.633 . . . . 0.0 110.225 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.93 95.25 Favored 'General case' 0 N--CA 1.524 3.23 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 18.3 m -71.32 -34.08 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 O-C-N 121.574 -0.704 . . . . 0.0 110.069 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -63.42 -44.32 94.95 Favored 'General case' 0 N--CA 1.528 3.431 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 13.0 m -68.67 -37.97 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 CA-C-N 118.643 0.656 . . . . 0.0 109.919 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 92.9 m -62.88 -27.54 69.42 Favored 'General case' 0 N--CA 1.522 3.14 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.99 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.79 -38.33 88.71 Favored 'General case' 0 N--CA 1.528 3.469 0 CA-C-O 120.939 0.4 . . . . 0.0 110.297 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 47.1 t -66.38 -36.73 83.59 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.632 0.773 . . . . 0.0 110.678 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.82 -13.67 16.88 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.847 0.859 . . . . 0.0 111.675 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 20.2 mt -86.6 -2.67 58.69 Favored 'General case' 0 N--CA 1.537 3.898 0 C-N-CA 123.059 0.543 . . . . 0.0 110.659 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -165.89 120.3 1.2 Allowed 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 123.441 0.696 . . . . 0.0 109.264 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.34 23.59 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.211 1.005 . . . . 0.0 109.141 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -167.83 141.17 3.32 Favored 'General case' 0 N--CA 1.521 3.099 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.41 138.5 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 C-N-CA 124.876 1.27 . . . . 0.0 108.457 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 60.2 tp -105.68 99.7 23.13 Favored Pre-proline 0 N--CA 1.531 3.591 0 C-N-CA 125.082 1.353 . . . . 0.0 108.381 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo . . . . . 1 N--CA 1.549 4.741 0 C-N-CA 122.307 2.005 . . . . 0.0 114.01 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 CA--C 1.575 1.938 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.74 166.6 29.33 Favored 'Trans proline' 1 N--CA 1.539 4.161 0 C-N-CA 122.387 2.058 . . . . 0.0 110.475 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.44 24.35 65.71 Favored Glycine 1 N--CA 1.52 4.26 0 C-N-CA 123.686 0.66 . . . . 0.0 112.318 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.4 p -68.98 161.4 28.99 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.786 0.834 . . . . 0.0 110.936 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 211' ' ' LEU . 2.0 mm? -65.44 -26.19 67.85 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 124.73 1.212 . . . . 0.0 109.466 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 40.9 t -57.57 -39.17 76.14 Favored 'General case' 0 N--CA 1.518 2.928 0 C-N-CA 123.934 0.894 . . . . 0.0 112.273 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.36 -38.57 87.3 Favored Glycine 1 N--CA 1.522 4.419 0 C-N-CA 123.208 0.432 . . . . 0.0 112.115 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.18 -46.43 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 C-N-CA 124.107 0.963 . . . . 0.0 111.766 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.97 -31.85 53.76 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.066 0 C-N-CA 123.228 0.611 . . . . 0.0 109.872 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 30.9 mm -72.62 -33.38 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.9 -46.92 79.11 Favored Glycine 1 N--CA 1.518 4.119 0 N-CA-C 114.298 0.479 . . . . 0.0 114.298 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.12 -37.52 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.888 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.3 t -61.12 -38.04 84.94 Favored 'General case' 0 N--CA 1.539 3.989 0 CA-C-N 119.31 0.959 . . . . 0.0 111.464 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 59.6 t -56.67 -36.69 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 C-N-CA 123.067 0.547 . . . . 0.0 110.475 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.5 76.06 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.0 -49.72 71.34 Favored 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.73 -38.45 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.538 0 CA-C-O 119.003 -0.522 . . . . 0.0 112.26 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.25 -33.94 58.57 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.031 0 CA-C-N 119.323 0.965 . . . . 0.0 110.924 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.22 -47.14 71.74 Favored 'General case' 0 N--CA 1.538 3.934 0 CA-C-O 121.745 0.783 . . . . 0.0 109.566 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.2 mt -54.5 -36.77 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 123.305 0.642 . . . . 0.0 111.383 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.84 -39.21 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.919 0 C-N-CA 122.765 0.426 . . . . 0.0 109.886 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.87 97.98 Favored 'General case' 0 N--CA 1.529 3.5 0 C-N-CA 122.853 0.461 . . . . 0.0 111.146 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 50.8 t -71.82 -35.28 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.284 0 C-N-CA 123.221 0.608 . . . . 0.0 110.065 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -64.01 -44.45 92.58 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.96 -38.06 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 81.9 m -67.16 -32.6 73.8 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 123.344 0.658 . . . . 0.0 110.462 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -70.92 -39.72 72.53 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.319 0.648 . . . . 0.0 109.635 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 75.1 m -65.51 -34.91 79.38 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.773 0.829 . . . . 0.0 109.462 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.8 tp -68.99 -14.11 62.85 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 124.444 1.098 . . . . 0.0 109.904 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.3 -22.55 26.7 Favored 'General case' 0 N--CA 1.535 3.8 0 C-N-CA 124.23 1.012 . . . . 0.0 109.592 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -80.88 -8.84 59.83 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.515 0.726 . . . . 0.0 110.142 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -84.84 -65.44 1.01 Allowed 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 124.108 0.963 . . . . 0.0 110.563 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -70.36 65.31 0.28 Allowed 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.934 0.893 . . . . 0.0 111.178 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 m -135.53 137.59 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.904 0 C-N-CA 124.37 1.068 . . . . 0.0 108.607 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 9.1 mp -97.34 106.35 31.6 Favored Pre-proline 0 N--CA 1.528 3.433 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo . . . . . 1 N--CA 1.549 4.76 0 C-N-CA 122.461 2.107 . . . . 0.0 114.455 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.583 2.225 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -85.68 78.54 2.34 Favored 'Trans proline' 0 N--CA 1.534 3.88 0 CA-C-N 122.688 1.996 . . . . 0.0 110.669 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.38 -43.66 98.75 Favored Glycine 1 N--CA 1.518 4.105 0 C-N-CA 123.752 0.692 . . . . 0.0 111.539 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 39.5 t 55.68 -97.05 0.07 Allowed 'General case' 0 N--CA 1.517 2.88 0 C-N-CA 124.102 0.961 . . . . 0.0 112.445 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 47.8 mt -64.63 -28.21 69.46 Favored 'General case' 0 N--CA 1.521 3.098 0 C-N-CA 124.134 0.974 . . . . 0.0 111.286 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 46.5 t -59.02 -44.73 91.76 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.695 0.798 . . . . 0.0 112.371 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.52 -36.92 84.67 Favored Glycine 1 N--CA 1.521 4.353 0 C-N-CA 123.311 0.482 . . . . 0.0 112.248 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.92 -46.08 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 C-N-CA 123.514 0.726 . . . . 0.0 111.45 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.1 tp -68.58 -33.37 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 CA-C-N 118.55 0.614 . . . . 0.0 109.835 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 74.3 mt -68.85 -33.81 61.25 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.128 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.05 -29.71 76.07 Favored Glycine 0 N--CA 1.514 3.897 0 C-N-CA 123.626 0.631 . . . . 0.0 113.208 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -37.18 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 C-N-CA 123.144 0.578 . . . . 0.0 110.157 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 64.5 p -65.09 -47.78 76.04 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.09 -32.95 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 C-N-CA 123.145 0.578 . . . . 0.0 112.427 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.98 -47.1 81.59 Favored 'General case' 0 N--CA 1.526 3.372 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.13 86.54 Favored 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 123.152 0.581 . . . . 0.0 112.018 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -68.41 -53.13 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.291 0 C-N-CA 122.743 0.417 . . . . 0.0 111.939 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.96 -32.54 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -176.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 5.3 tt -69.7 -38.23 76.87 Favored 'General case' 0 N--CA 1.522 3.172 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 85.7 mt -66.38 -36.98 78.67 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.004 0 CA-C-N 118.856 0.753 . . . . 0.0 110.184 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -66.39 -37.8 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.8 86.13 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 123.48 0.712 . . . . 0.0 111.867 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 62.9 t -71.86 -35.09 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.058 0.543 . . . . 0.0 110.145 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -64.33 -44.14 92.44 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.9 -37.54 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.19 -27.14 68.76 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.33 0.652 . . . . 0.0 111.125 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -70.93 -25.97 62.99 Favored 'General case' 0 N--CA 1.529 3.52 0 C-N-CA 122.827 0.451 . . . . 0.0 111.165 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 48.0 m -65.96 -46.32 78.54 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 123.156 0.582 . . . . 0.0 112.152 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.7 pp -68.81 -12.97 62.1 Favored 'General case' 0 N--CA 1.53 3.553 0 C-N-CA 123.897 0.879 . . . . 0.0 112.045 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.8 tp -86.2 -19.32 30.2 Favored 'General case' 0 N--CA 1.536 3.857 0 C-N-CA 123.227 0.611 . . . . 0.0 109.582 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -101.86 61.31 0.88 Allowed 'General case' 0 N--CA 1.528 3.475 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -63.26 72.56 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.264 1.026 . . . . 0.0 111.801 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -72.89 151.06 42.1 Favored 'General case' 0 N--CA 1.525 3.294 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.95 122.27 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.636 0 C-N-CA 124.65 1.18 . . . . 0.0 108.431 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -95.25 105.56 20.57 Favored Pre-proline 0 N--CA 1.529 3.495 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo . . . . . 1 N--CA 1.54 4.258 0 CA-C-N 122.851 2.054 . . . . 0.0 111.288 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.583 2.223 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.93 -162.99 0.02 OUTLIER 'Trans proline' 1 N--CA 1.549 4.772 0 C-N-CA 122.326 2.017 . . . . 0.0 112.817 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.01 -95.57 0.01 OUTLIER Glycine 1 N--CA 1.522 4.391 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 25.1 t 56.85 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.099 0 C-N-CA 124.408 1.083 . . . . 0.0 112.663 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.85 -26.9 68.53 Favored 'General case' 0 N--CA 1.536 3.835 0 C-N-CA 124.267 1.027 . . . . 0.0 109.328 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 92.1 p -67.86 -25.86 65.75 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.552 0.741 . . . . 0.0 110.37 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.92 -46.22 68.25 Favored Glycine 0 N--CA 1.515 3.961 0 C-N-CA 123.729 0.68 . . . . 0.0 114.665 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.9 tt -70.59 -35.74 62.62 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.029 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.55 -44.29 80.39 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.409 0 CA-C-N 118.874 0.761 . . . . 0.0 112.873 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.3 tt -72.41 -32.77 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.88 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.62 -28.84 46.95 Favored Glycine 1 N--CA 1.517 4.082 0 C-N-CA 124.296 0.951 . . . . 0.0 113.158 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.5 m -59.42 -36.7 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.979 0 CA-C-O 121.08 0.467 . . . . 0.0 111.03 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 66.2 p -55.37 -44.6 76.2 Favored 'General case' 0 N--CA 1.527 3.421 0 C-N-CA 123.139 0.576 . . . . 0.0 111.86 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.28 -33.3 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 123.385 0.674 . . . . 0.0 110.529 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.39 83.91 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 122.658 0.383 . . . . 0.0 110.813 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.66 -50.44 73.86 Favored 'General case' 0 N--CA 1.518 2.964 0 C-N-CA 123.393 0.677 . . . . 0.0 112.826 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 34.5 m -68.04 -38.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 CA-C-N 118.288 0.495 . . . . 0.0 111.004 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.33 -38.91 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.798 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 39.3 tp -62.01 -34.9 77.05 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 122.804 0.441 . . . . 0.0 111.416 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.09 -46.21 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.869 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.39 -37.6 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 123.029 0.532 . . . . 0.0 109.943 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.4 -49.86 75.89 Favored 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 123.586 0.754 . . . . 0.0 112.507 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 11.9 p -71.89 -34.38 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 O-C-N 122.05 -0.406 . . . . 0.0 110.882 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -62.91 -44.34 96.36 Favored 'General case' 0 N--CA 1.529 3.488 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.28 -39.69 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.31 -28.38 67.95 Favored 'General case' 0 N--CA 1.522 3.166 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.08 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.64 -31.03 72.07 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 123.179 0.592 . . . . 0.0 111.092 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 39.2 t -63.96 -36.99 85.78 Favored 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 123.631 0.772 . . . . 0.0 111.639 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 50.3 tp -60.66 -24.34 65.51 Favored 'General case' 0 N--CA 1.528 3.436 0 C-N-CA 123.641 0.776 . . . . 0.0 111.848 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.97 8.26 27.19 Favored 'General case' 0 N--CA 1.538 3.95 0 C-N-CA 123.289 0.636 . . . . 0.0 110.036 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -164.43 71.21 0.2 Allowed 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 122.729 0.412 . . . . 0.0 110.171 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -75.42 163.43 27.43 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -74.43 137.13 42.44 Favored 'General case' 0 N--CA 1.522 3.166 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.39 138.4 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.575 0 C-N-CA 124.573 1.149 . . . . 0.0 109.189 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.0 mp -94.37 146.61 31.85 Favored Pre-proline 0 N--CA 1.53 3.559 0 CA-C-O 116.668 -1.634 . . . . 0.0 106.707 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo . . . . . 1 N--CA 1.549 4.772 0 C-N-CA 122.782 2.322 . . . . 0.0 114.807 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.575 1.941 0 CA-C-O 117.725 -1.131 . . . . 0.0 108.117 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.16 -31.55 36.52 Favored 'Trans proline' 1 N--CA 1.547 4.669 0 C-N-CA 121.905 1.737 . . . . 0.0 113.661 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.58 -19.68 67.19 Favored Glycine 1 N--CA 1.523 4.474 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.753 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 40.6 m 60.84 136.07 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.963 0 C-N-CA 124.948 1.299 . . . . 0.0 112.002 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.2 -26.51 68.17 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 124.311 1.044 . . . . 0.0 109.678 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 43.7 t -67.13 -33.08 74.67 Favored 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 123.767 0.827 . . . . 0.0 111.338 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.87 -46.93 58.22 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 114.251 0.461 . . . . 0.0 114.251 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 tt -69.58 -35.28 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.88 0 CA-C-N 117.544 0.672 . . . . 0.0 112.345 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 215' ' ' ILE . . . . . 0.461 ' O ' HG12 ' D' ' 218' ' ' VAL . 0.4 OUTLIER -56.51 -32.22 36.04 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 C-N-CA 123.447 0.699 . . . . 0.0 111.403 -177.395 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.86 -32.99 60.61 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.319 0 C-N-CA 122.934 0.494 . . . . 0.0 109.702 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.54 -29.33 47.67 Favored Glycine 1 N--CA 1.518 4.118 0 C-N-CA 123.802 0.715 . . . . 0.0 113.227 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 218' ' ' VAL . . . . . 0.461 HG12 ' O ' ' D' ' 215' ' ' ILE . 9.5 p -59.41 -37.49 69.92 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.102 0 C-N-CA 123.134 0.573 . . . . 0.0 110.633 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -59.34 -38.99 81.74 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 123.357 0.663 . . . . 0.0 111.252 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.93 -36.89 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.153 0 C-N-CA 123.783 0.833 . . . . 0.0 111.384 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.15 80.67 Favored 'General case' 0 N--CA 1.527 3.376 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.6 -49.95 42.27 Favored 'General case' 0 N--CA 1.518 2.94 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.4 -38.73 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.836 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.29 -32.25 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -36.09 74.34 Favored 'General case' 0 N--CA 1.534 3.754 0 C-N-CA 123.644 0.778 . . . . 0.0 109.833 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 37.2 mm -61.29 -36.98 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.894 0 C-N-CA 123.35 0.66 . . . . 0.0 110.553 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 40.5 t -66.13 -37.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 123.5 0.72 . . . . 0.0 109.892 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.08 77.85 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.51 0.724 . . . . 0.0 112.446 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.71 -34.32 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 O-C-N 122.125 -0.36 . . . . 0.0 110.646 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.99 -44.25 93.24 Favored 'General case' 0 N--CA 1.528 3.435 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.7 -37.75 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.717 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.15 -27.96 69.43 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.006 0.522 . . . . 0.0 111.227 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.69 -33.41 73.91 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 123.112 0.565 . . . . 0.0 110.762 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 49.8 m -63.79 -31.37 72.52 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.49 0.716 . . . . 0.0 112.173 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.34 -14.89 39.52 Favored 'General case' 0 N--CA 1.536 3.837 0 C-N-CA 123.725 0.81 . . . . 0.0 109.898 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -87.58 -11.65 48.03 Favored 'General case' 0 N--CA 1.533 3.716 0 C-N-CA 123.762 0.825 . . . . 0.0 110.962 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -0.55 0.29 Allowed 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.33 167.49 1.35 Allowed 'General case' 0 N--CA 1.531 3.576 0 C-N-CA 123.423 0.689 . . . . 0.0 111.417 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -69.82 166.68 18.87 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.115 0.966 . . . . 0.0 110.025 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.75 136.29 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 59.6 mt -94.85 146.72 31.88 Favored Pre-proline 0 N--CA 1.529 3.483 0 CA-C-O 117.486 -1.245 . . . . 0.0 108.434 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 1 N--CA 1.54 4.207 0 C-N-CA 122.001 1.801 . . . . 0.0 110.715 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 57.4 mtm . . . . . 0 CA--C 1.583 2.242 0 CA-C-O 117.5 -1.238 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -87.77 -18.0 2.54 Favored 'Trans proline' 1 N--CA 1.536 4.003 0 C-N-CA 122.533 2.155 . . . . 0.0 110.968 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -179.86 164.94 33.12 Favored Glycine 1 N--CA 1.516 4.013 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 210' ' ' SER . . . . . 0.419 ' H ' ' H ' ' E' ' 211' ' ' LEU . 95.4 p -168.76 -19.57 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 124.052 0.941 . . . . 0.0 109.56 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 211' ' ' LEU . . . . . 0.419 ' H ' ' H ' ' E' ' 210' ' ' SER . 8.7 mp -64.72 -30.05 71.05 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 124.137 0.975 . . . . 0.0 109.9 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 60.4 m -58.37 -26.29 63.0 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 123.207 0.603 . . . . 0.0 110.803 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.29 -34.63 63.32 Favored Glycine 1 N--CA 1.517 4.057 0 C-N-CA 124.121 0.867 . . . . 0.0 113.571 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 13.2 tt -59.59 -44.99 94.48 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.049 0 CA-C-N 117.795 0.797 . . . . 0.0 112.911 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.4 pt -65.68 -34.92 73.6 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.437 0 CA-C-O 121.564 0.697 . . . . 0.0 110.038 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 49.3 mm -71.4 -33.57 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 124.183 0.993 . . . . 0.0 108.758 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.62 -31.02 78.48 Favored Glycine 1 N--CA 1.518 4.109 0 C-N-CA 123.389 0.519 . . . . 0.0 113.6 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 1.3 m -67.06 -37.35 79.13 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.103 0 CA-C-N 117.697 0.748 . . . . 0.0 110.397 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 37.4 p -60.81 -45.28 95.03 Favored 'General case' 0 N--CA 1.526 3.365 0 C-N-CA 123.168 0.587 . . . . 0.0 111.315 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.1 -36.53 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.254 0 C-N-CA 124.038 0.935 . . . . 0.0 111.325 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.91 -47.06 78.16 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 122.835 0.454 . . . . 0.0 112.027 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.72 90.85 Favored 'General case' 0 N--CA 1.52 3.073 0 C-N-CA 123.687 0.795 . . . . 0.0 111.655 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.46 -49.37 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 122.83 0.452 . . . . 0.0 110.699 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.15 -32.61 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.075 0.55 . . . . 0.0 110.312 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.08 -47.2 83.92 Favored 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 123.028 0.531 . . . . 0.0 111.048 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 80.1 mt -62.97 -38.86 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 C-N-CA 122.662 0.385 . . . . 0.0 110.477 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.19 -37.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 C-N-CA 123.288 0.635 . . . . 0.0 109.852 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.42 97.33 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.039 0.536 . . . . 0.0 111.334 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 62.8 t -71.74 -34.62 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.199 0.6 . . . . 0.0 109.749 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -63.46 -44.42 94.52 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.92 -37.7 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 77.5 m -67.12 -35.48 79.83 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.123 0.569 . . . . 0.0 110.295 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.67 -38.75 90.16 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 123.476 0.71 . . . . 0.0 111.282 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 86.7 p -65.1 -21.33 66.79 Favored 'General case' 0 N--CA 1.529 3.5 0 C-N-CA 123.082 0.553 . . . . 0.0 110.971 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.73 -21.58 64.37 Favored 'General case' 0 N--CA 1.533 3.683 0 C-N-CA 123.958 0.903 . . . . 0.0 110.037 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.6 -8.45 56.24 Favored 'General case' 1 N--CA 1.541 4.089 0 C-N-CA 123.592 0.757 . . . . 0.0 110.248 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 30.5 t90 -65.07 -106.43 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.541 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? 55.89 36.27 27.0 Favored 'General case' 0 N--CA 1.52 3.038 0 C-N-CA 123.952 0.901 . . . . 0.0 111.539 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 62.0 tttm 62.57 150.55 0.03 OUTLIER 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 124.463 1.105 . . . . 0.0 110.918 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 50.2 t -132.89 127.03 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 C-N-CA 124.743 1.217 . . . . 0.0 107.843 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.544 HD13 ' H ' ' E' ' 241' ' ' LEU . 0.0 OUTLIER -94.73 147.46 33.2 Favored Pre-proline 0 N--CA 1.533 3.685 0 CA-C-O 116.701 -1.619 . . . . 0.0 109.201 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo . . . . . 1 N--CA 1.551 4.865 0 C-N-CA 122.974 2.449 . . . . 0.0 115.098 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.99 -161.51 0.03 OUTLIER 'Trans proline' 1 N--CA 1.55 4.796 0 C-N-CA 121.896 1.73 . . . . 0.0 112.547 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -167.71 -98.81 0.13 Allowed Glycine 1 N--CA 1.519 4.204 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 48.1 t -166.58 76.34 0.19 Allowed 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.493 0.717 . . . . 0.0 109.802 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.19 -26.56 68.2 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 124.166 0.986 . . . . 0.0 109.445 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 65.5 m -57.66 -25.38 60.14 Favored 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.183 0.993 . . . . 0.0 111.415 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.0 -35.31 83.86 Favored Glycine 0 N--CA 1.515 3.923 0 C-N-CA 124.167 0.889 . . . . 0.0 115.267 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 12.2 tt -59.08 -35.09 55.35 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.593 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 9.3 tp -55.84 -31.85 30.97 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.31 -32.53 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.944 0 CA-C-N 118.383 0.538 . . . . 0.0 110.023 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.79 -29.54 54.91 Favored Glycine 0 N--CA 1.514 3.87 0 CA-C-O 119.555 -0.58 . . . . 0.0 113.873 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.6 m -59.92 -48.26 88.45 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 CA-C-N 118.075 0.938 . . . . 0.0 112.468 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 11.3 t -66.43 -38.76 88.14 Favored 'General case' 0 N--CA 1.536 3.847 0 O-C-N 121.955 -0.466 . . . . 0.0 110.98 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.87 -39.05 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.297 0 C-N-CA 123.46 0.704 . . . . 0.0 109.333 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.18 98.63 Favored 'General case' 0 N--CA 1.522 3.146 0 C-N-CA 123.137 0.575 . . . . 0.0 110.907 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.73 79.29 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 123.264 0.625 . . . . 0.0 111.781 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.37 -51.01 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.545 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.69 -33.25 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 123.632 0.773 . . . . 0.0 111.109 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 38.6 tp -66.07 -35.49 80.67 Favored 'General case' 0 N--CA 1.531 3.593 0 C-N-CA 122.513 0.325 . . . . 0.0 111.218 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 92.2 mt -69.2 -41.15 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.89 -37.96 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 123.413 0.685 . . . . 0.0 109.594 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.22 81.38 Favored 'General case' 0 N--CA 1.526 3.347 0 C-N-CA 123.81 0.844 . . . . 0.0 112.666 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.46 -34.0 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 O-C-N 121.872 -0.517 . . . . 0.0 109.98 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.73 -44.27 94.06 Favored 'General case' 0 N--CA 1.529 3.493 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.95 -37.53 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 98.0 m -59.42 -27.43 66.03 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.336 0.654 . . . . 0.0 111.316 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.34 -40.89 85.91 Favored 'General case' 0 N--CA 1.529 3.501 0 CA-C-O 121.078 0.466 . . . . 0.0 110.426 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 47.6 t -64.77 -17.58 64.3 Favored 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 124.129 0.972 . . . . 0.0 112.45 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.6 -15.08 63.14 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 122.977 0.511 . . . . 0.0 110.627 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.37 -28.7 22.04 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.115 0.566 . . . . 0.0 109.58 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -158.83 144.45 16.47 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.705 0.802 . . . . 0.0 108.98 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -140.19 160.4 40.03 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 124.725 1.21 . . . . 0.0 108.149 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -76.42 44.04 0.33 Allowed 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.152 0.981 . . . . 0.0 110.012 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.16 133.43 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.529 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.95 99.76 24.37 Favored Pre-proline 0 N--CA 1.532 3.657 0 C-N-CA 125.05 1.34 . . . . 0.0 107.502 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo . . . . . 1 N--CA 1.549 4.754 0 C-N-CA 122.476 2.118 . . . . 0.0 114.47 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 88.0 mmm . . . . . 0 CA--C 1.586 2.35 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.21 66.56 3.31 Favored 'Trans proline' 0 N--CA 1.535 3.926 0 C-N-CA 122.617 2.212 . . . . 0.0 110.627 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -178.42 -169.92 39.84 Favored Glycine 1 N--CA 1.518 4.162 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 43.1 m 60.24 47.63 9.0 Favored 'General case' 0 N--CA 1.519 3.024 0 C-N-CA 124.317 1.047 . . . . 0.0 111.847 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.6 mp -65.14 -26.63 68.27 Favored 'General case' 0 N--CA 1.534 3.735 0 C-N-CA 123.829 0.852 . . . . 0.0 109.251 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 98.0 p -68.41 -27.43 66.2 Favored 'General case' 0 N--CA 1.521 3.076 0 C-N-CA 123.263 0.625 . . . . 0.0 110.049 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.46 -46.9 53.81 Favored Glycine 0 N--CA 1.513 3.779 0 N-CA-C 116.688 1.435 . . . . 0.0 116.688 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.5 pt -59.69 -35.24 58.61 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.467 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 -174.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.2 tt -56.75 -32.06 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 15.5 tt -70.78 -33.79 53.91 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 CA-C-N 120.131 1.332 . . . . 0.0 111.064 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.81 -43.63 80.92 Favored Glycine 1 N--CA 1.52 4.246 0 C-N-CA 123.053 0.359 . . . . 0.0 113.802 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.06 -37.29 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.977 0 O-C-N 121.639 -0.918 . . . . 0.0 110.922 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 61.3 p -64.84 -45.65 85.24 Favored 'General case' 0 N--CA 1.538 3.928 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.49 -30.87 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 C-N-CA 123.093 0.557 . . . . 0.0 111.766 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.43 -47.0 88.01 Favored 'General case' 0 N--CA 1.534 3.732 0 O-C-N 121.496 -0.753 . . . . 0.0 112.614 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.63 -44.24 96.79 Favored 'General case' 0 N--CA 1.521 3.124 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.65 -39.73 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.752 0 CA-C-N 118.773 0.715 . . . . 0.0 112.068 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.32 -34.15 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.339 0.518 . . . . 0.0 110.134 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.7 -48.06 78.65 Favored 'General case' 0 N--CA 1.524 3.24 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.6 pt -70.01 -36.74 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 O-C-N 122.065 -0.397 . . . . 0.0 111.339 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.3 -37.46 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.03 -41.13 82.57 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 122.968 0.507 . . . . 0.0 111.806 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.77 -37.12 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.192 0.597 . . . . 0.0 110.15 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -63.08 -44.16 96.52 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 123.211 0.604 . . . . 0.0 112.377 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.88 -37.62 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 93.2 m -64.68 -28.43 69.59 Favored 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 122.846 0.458 . . . . 0.0 110.727 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -72.93 -23.37 60.68 Favored 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 123.23 0.612 . . . . 0.0 110.924 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.1 m -66.19 -31.36 72.14 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 122.949 0.499 . . . . 0.0 111.432 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.68 -37.53 87.89 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.644 0.777 . . . . 0.0 112.377 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 pp -95.19 -16.26 22.68 Favored 'General case' 1 N--CA 1.547 4.392 0 C-N-CA 123.223 0.609 . . . . 0.0 111.531 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -67.1 -10.39 49.55 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 123.505 0.722 . . . . 0.0 111.193 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.1 116.2 4.01 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 123.625 0.77 . . . . 0.0 111.508 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.62 -162.99 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.648 0 C-N-CA 126.126 1.77 . . . . 0.0 114.538 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.15 136.15 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 56.0 tp -133.42 99.57 14.39 Favored Pre-proline 0 N--CA 1.531 3.595 0 C-N-CA 124.86 1.264 . . . . 0.0 108.06 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 1 N--CA 1.536 4.007 0 C-N-CA 122.417 2.078 . . . . 0.0 111.097 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 49.1 tpp . . . . . 0 CA--C 1.58 2.101 0 CA-C-O 117.657 -1.164 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.03 141.96 55.47 Favored 'Trans proline' 1 N--CA 1.548 4.707 0 CA-C-N 122.41 1.897 . . . . 0.0 113.082 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 170.78 -137.7 4.56 Favored Glycine 1 N--CA 1.519 4.21 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 71.9 p 56.51 176.43 0.04 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 124.557 1.143 . . . . 0.0 112.519 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 48.4 mt -57.28 -25.82 59.85 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 124.873 1.269 . . . . 0.0 111.613 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.3 t -57.01 -37.69 72.06 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.581 0.752 . . . . 0.0 112.065 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.28 -46.32 57.65 Favored Glycine 1 N--CA 1.518 4.164 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.475 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.403 ' N ' HD12 ' B' ' 214' ' ' ILE . 1.5 mp -70.89 -46.38 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 124.53 1.132 . . . . 0.0 112.79 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 215' ' ' ILE . . . . . 0.477 ' O ' HG12 ' B' ' 218' ' ' VAL . 18.6 tt -57.07 -38.23 59.42 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -175.262 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 17.0 tt -72.83 -32.93 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.884 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.6 -29.14 47.69 Favored Glycine 0 N--CA 1.513 3.821 0 C-N-CA 124.19 0.9 . . . . 0.0 113.581 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 218' ' ' VAL . . . . . 0.477 HG12 ' O ' ' B' ' 215' ' ' ILE . 8.3 p -59.5 -37.74 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.875 0 CA-C-N 117.27 0.535 . . . . 0.0 111.157 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 69.0 p -63.87 -45.93 87.22 Favored 'General case' 0 N--CA 1.529 3.489 0 CA-C-O 121.224 0.535 . . . . 0.0 110.804 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.52 -34.69 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.059 0 C-N-CA 124.101 0.961 . . . . 0.0 110.962 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.61 -46.96 67.22 Favored 'General case' 0 N--CA 1.529 3.52 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.8 74.53 Favored 'General case' 0 N--CA 1.522 3.143 0 C-N-CA 123.285 0.634 . . . . 0.0 111.807 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -67.13 -41.38 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.438 0 C-N-CA 122.913 0.485 . . . . 0.0 110.451 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.94 -38.52 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 0 C-N-CA 122.899 0.48 . . . . 0.0 111.495 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 56.9 tp -66.77 -43.13 84.82 Favored 'General case' 0 N--CA 1.532 3.631 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.19 -39.15 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.809 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.77 -37.07 78.74 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 CA-C-N 118.717 0.69 . . . . 0.0 109.82 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.55 -32.08 66.75 Favored 'General case' 0 N--CA 1.525 3.305 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.24 -34.89 72.13 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.175 0 CA-C-N 119.286 0.948 . . . . 0.0 112.355 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.73 -43.98 91.67 Favored 'General case' 0 N--CA 1.536 3.871 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.92 -37.73 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.803 0 O-C-N 121.832 -0.543 . . . . 0.0 109.574 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.08 -27.92 67.77 Favored 'General case' 0 N--CA 1.527 3.391 0 C-N-CA 123.259 0.623 . . . . 0.0 111.148 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.16 -30.19 71.26 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.054 0.542 . . . . 0.0 110.507 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 34.9 t -63.82 -39.03 93.27 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.368 0.667 . . . . 0.0 110.774 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.12 -15.94 63.04 Favored 'General case' 0 N--CA 1.527 3.418 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.746 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 49.6 tp -101.99 -17.37 16.13 Favored 'General case' 0 N--CA 1.537 3.901 0 C-N-CA 124.184 0.993 . . . . 0.0 109.523 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -74.99 15.77 0.37 Allowed 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 124.056 0.942 . . . . 0.0 111.155 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.46 -175.6 0.13 Allowed 'General case' 0 N--CA 1.532 3.656 0 C-N-CA 123.234 0.614 . . . . 0.0 110.116 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 66.39 156.82 0.1 Allowed 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 124.523 1.129 . . . . 0.0 110.094 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.04 137.97 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.645 0 C-N-CA 124.839 1.256 . . . . 0.0 107.776 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.86 105.93 21.88 Favored Pre-proline 0 N--CA 1.529 3.502 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo . . . . . 1 N--CA 1.537 4.07 0 CA-C-N 122.743 2.015 . . . . 0.0 110.792 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 CA--C 1.581 2.164 0 CA-C-O 117.53 -1.224 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -89.5 68.48 2.2 Favored 'Trans proline' 0 N--CA 1.533 3.852 0 C-N-CA 122.723 2.282 . . . . 0.0 110.97 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.48 -171.58 36.8 Favored Glycine 1 N--CA 1.519 4.211 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.56 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 100.0 p -163.97 -165.32 0.99 Allowed 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 123.739 0.816 . . . . 0.0 109.093 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.66 -39.43 88.36 Favored 'General case' 0 N--CA 1.535 3.782 0 C-N-CA 124.129 0.972 . . . . 0.0 109.25 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 42.0 t -68.19 -32.24 72.33 Favored 'General case' 0 N--CA 1.517 2.92 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.487 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.41 -46.34 63.9 Favored Glycine 0 N--CA 1.514 3.896 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.443 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 41.8 pt -66.3 -38.49 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 CA-C-N 118.062 0.931 . . . . 0.0 112.344 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.98 -32.59 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.37 -32.8 43.66 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.23 -29.09 44.51 Favored Glycine 0 N--CA 1.513 3.819 0 C-N-CA 124.172 0.891 . . . . 0.0 113.529 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.46 -37.57 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 117.505 0.653 . . . . 0.0 110.739 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 61.4 p -63.08 -46.21 88.47 Favored 'General case' 0 N--CA 1.528 3.432 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.959 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.77 -38.08 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 124.226 1.011 . . . . 0.0 110.184 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.06 63.98 Favored 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 123.663 0.785 . . . . 0.0 112.659 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.67 75.0 Favored 'General case' 0 N--CA 1.519 3.009 0 C-N-CA 123.345 0.658 . . . . 0.0 111.664 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.8 -48.25 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.367 0 C-N-CA 123.165 0.586 . . . . 0.0 111.425 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.4 -32.45 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 C-N-CA 122.615 0.366 . . . . 0.0 110.537 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.44 -42.24 98.44 Favored 'General case' 0 N--CA 1.53 3.546 0 C-N-CA 123.361 0.664 . . . . 0.0 110.313 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 94.8 mt -65.72 -44.17 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 123.33 0.652 . . . . 0.0 109.753 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.45 -37.55 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.484 0 C-N-CA 123.32 0.648 . . . . 0.0 109.708 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.95 81.55 Favored 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.284 0.634 . . . . 0.0 112.322 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 17.6 m -71.9 -34.44 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 O-C-N 121.96 -0.463 . . . . 0.0 110.647 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.69 -44.44 93.69 Favored 'General case' 0 N--CA 1.53 3.536 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.89 -37.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.759 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 70.7 m -67.47 -39.15 85.27 Favored 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 122.966 0.507 . . . . 0.0 110.479 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.15 -32.77 63.27 Favored 'General case' 0 N--CA 1.524 3.271 0 C-N-CA 123.554 0.742 . . . . 0.0 111.008 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 86.3 p -63.76 -24.75 67.89 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.175 0.59 . . . . 0.0 111.505 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.59 -30.9 69.75 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.804 0.842 . . . . 0.0 110.355 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.24 1.9 56.0 Favored 'General case' 0 N--CA 1.535 3.82 0 C-N-CA 124.25 1.02 . . . . 0.0 110.128 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -59.65 -15.95 22.85 Favored 'General case' 0 N--CA 1.533 3.682 0 C-N-CA 123.239 0.616 . . . . 0.0 110.978 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -67.49 157.57 33.95 Favored 'General case' 0 N--CA 1.518 2.962 0 C-N-CA 124.176 0.99 . . . . 0.0 110.011 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -165.36 -22.09 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.429 0 C-N-CA 123.856 0.862 . . . . 0.0 109.624 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.14 138.45 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 125.2 1.4 . . . . 0.0 108.406 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 53.0 tp -133.21 99.62 14.63 Favored Pre-proline 0 N--CA 1.53 3.57 0 C-N-CA 124.988 1.315 . . . . 0.0 107.765 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 N--CA 1.536 3.978 0 C-N-CA 122.528 2.152 . . . . 0.0 110.966 -179.509 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.576 1.957 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.01 -10.78 23.15 Favored 'Trans proline' 1 N--CA 1.538 4.121 0 C-N-CA 122.277 1.985 . . . . 0.0 111.076 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.59 -95.7 0.33 Allowed Glycine 1 N--CA 1.518 4.128 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 89.9 p -167.76 96.86 0.46 Allowed 'General case' 0 N--CA 1.522 3.136 0 C-N-CA 123.841 0.856 . . . . 0.0 108.81 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.13 -39.04 92.5 Favored 'General case' 0 N--CA 1.527 3.391 0 C-N-CA 124.055 0.942 . . . . 0.0 109.817 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 92.4 p -68.23 -27.71 66.6 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.082 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.65 -47.25 50.31 Favored Glycine 0 N--CA 1.504 3.21 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.543 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.48 -37.98 66.44 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.322 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -176.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 10.2 tp -56.87 -31.86 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.622 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 pt -59.74 -39.65 80.3 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.318 0 CA-C-N 119.325 0.966 . . . . 0.0 111.562 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.53 -28.87 46.32 Favored Glycine 0 N--CA 1.516 3.992 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.257 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 2.9 p -59.36 -46.66 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 C-N-CA 123.697 0.799 . . . . 0.0 112.753 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 3.2 t -66.08 -38.71 88.95 Favored 'General case' 0 N--CA 1.534 3.752 0 CA-C-O 121.217 0.532 . . . . 0.0 110.667 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.4 -34.81 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.033 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.484 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.78 79.07 Favored 'General case' 0 N--CA 1.527 3.377 0 C-N-CA 123.03 0.532 . . . . 0.0 111.533 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -49.93 44.9 Favored 'General case' 0 N--CA 1.511 2.58 0 C-N-CA 123.38 0.672 . . . . 0.0 112.588 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 21.8 m -61.04 -42.27 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.82 -32.09 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.68 0 C-N-CA 122.845 0.458 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.15 -40.24 53.12 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mp -54.98 -44.41 73.69 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 C-N-CA 124.128 0.971 . . . . 0.0 112.187 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 22.5 m -66.19 -36.88 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 O-C-N 121.762 -0.586 . . . . 0.0 111.129 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.49 85.97 Favored 'General case' 0 N--CA 1.529 3.481 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 11.3 m -71.68 -34.32 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 O-C-N 121.873 -0.517 . . . . 0.0 110.326 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -63.67 -43.96 95.13 Favored 'General case' 0 N--CA 1.531 3.615 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.5 -37.18 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.62 -28.64 65.83 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 122.704 0.402 . . . . 0.0 111.566 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -58.01 -16.56 13.05 Favored 'General case' 1 N--CA 1.54 4.073 0 CA-C-N 118.308 0.503 . . . . 0.0 111.56 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 45.8 t -68.14 -43.98 77.08 Favored 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.79 -27.48 68.31 Favored 'General case' 0 N--CA 1.528 3.435 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.396 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.19 10.45 16.86 Favored 'General case' 1 N--CA 1.542 4.127 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -159.89 98.98 1.37 Allowed 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 123.176 0.59 . . . . 0.0 109.839 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -137.72 144.12 41.56 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 125.087 1.355 . . . . 0.0 107.441 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -74.94 105.91 6.2 Favored 'General case' 0 N--CA 1.518 2.962 0 C-N-CA 123.786 0.834 . . . . 0.0 108.843 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 30.3 m -134.9 138.18 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 124.728 1.211 . . . . 0.0 108.568 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.492 ' N ' HD13 ' D' ' 241' ' ' LEU . 0.0 OUTLIER -133.48 98.88 14.77 Favored Pre-proline 0 N--CA 1.528 3.469 0 C-N-CA 124.823 1.249 . . . . 0.0 107.966 179.296 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo . . . . . 1 N--CA 1.548 4.716 0 C-N-CA 122.365 2.044 . . . . 0.0 114.155 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.575 1.94 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.35 160.66 3.28 Favored 'Trans proline' 1 N--CA 1.548 4.696 0 CA-C-N 121.962 1.737 . . . . 0.0 113.154 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.94 97.56 0.01 OUTLIER Glycine 1 N--CA 1.52 4.277 0 C-N-CA 123.622 0.629 . . . . 0.0 111.772 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t -166.87 5.06 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.675 0.79 . . . . 0.0 110.816 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 47.3 mt -63.55 -26.79 68.86 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.014 0.926 . . . . 0.0 110.54 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 94.3 p -62.07 -39.73 93.38 Favored 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 123.844 0.858 . . . . 0.0 110.741 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.06 -39.98 83.89 Favored Glycine 1 N--CA 1.517 4.061 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.656 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.65 -46.36 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.405 0 C-N-CA 124.026 0.93 . . . . 0.0 112.669 -176.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.4 tt -61.94 -37.53 78.49 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.024 0 O-C-N 121.915 -0.49 . . . . 0.0 112.294 -176.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.1 tp -73.18 -33.65 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.684 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.8 -46.86 91.83 Favored Glycine 1 N--CA 1.516 4.009 0 CA-C-N 115.781 -0.645 . . . . 0.0 114.487 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.94 -37.42 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.844 0 CA-C-N 117.806 0.803 . . . . 0.0 110.899 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 54.5 p -66.36 -45.75 79.08 Favored 'General case' 0 N--CA 1.531 3.592 0 CA-C-O 120.914 0.388 . . . . 0.0 111.113 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.67 -31.37 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.417 0 C-N-CA 123.918 0.887 . . . . 0.0 111.212 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.71 72.48 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.03 -49.26 53.06 Favored 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.54 -39.81 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 31.9 m -68.02 -35.41 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 CA-C-N 118.519 0.6 . . . . 0.0 112.017 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 26.3 tp -69.87 -42.72 73.12 Favored 'General case' 0 N--CA 1.524 3.261 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 33.2 pt -66.67 -35.83 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.838 0.745 . . . . 0.0 111.153 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 92.9 t -65.05 -37.67 80.81 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.036 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.46 -35.81 74.79 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 123.17 0.588 . . . . 0.0 111.665 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 71.0 t -71.9 -36.33 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.27 0 C-N-CA 123.45 0.7 . . . . 0.0 110.762 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.07 -43.96 81.33 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.52 -38.01 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.519 0 C-N-CA 122.555 0.342 . . . . 0.0 110.893 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 14.4 p -67.11 -27.8 67.63 Favored 'General case' 0 N--CA 1.534 3.765 0 CA-C-N 117.876 0.307 . . . . 0.0 111.297 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -60.43 -30.04 69.38 Favored 'General case' 0 N--CA 1.529 3.489 0 C-N-CA 123.153 0.581 . . . . 0.0 110.965 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 45.6 t -64.94 -41.77 95.23 Favored 'General case' 0 N--CA 1.525 3.322 0 CA-C-O 121.695 0.759 . . . . 0.0 110.572 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 45.6 mt -69.29 -13.73 62.55 Favored 'General case' 0 N--CA 1.518 2.938 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.053 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 55.6 tp -86.61 -28.5 23.21 Favored 'General case' 0 N--CA 1.538 3.972 0 C-N-CA 122.908 0.483 . . . . 0.0 110.124 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -82.51 -149.23 0.08 Allowed 'General case' 0 N--CA 1.527 3.4 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 55.3 mttm 62.02 53.82 2.91 Favored 'General case' 0 N--CA 1.519 3.024 0 C-N-CA 123.875 0.87 . . . . 0.0 111.119 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -164.3 -16.12 0.03 OUTLIER 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 123.808 0.843 . . . . 0.0 110.01 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 31.4 m -112.76 138.23 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.626 0 C-N-CA 125.18 1.392 . . . . 0.0 109.295 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -133.41 99.49 14.46 Favored Pre-proline 0 N--CA 1.53 3.537 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo . . . . . 1 N--CA 1.538 4.105 0 C-N-CA 122.438 2.092 . . . . 0.0 111.279 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 83.3 mmm . . . . . 0 CA--C 1.586 2.334 0 CA-C-O 117.491 -1.242 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -88.17 157.62 6.98 Favored 'Trans proline' 0 N--CA 1.535 3.939 0 C-N-CA 122.51 2.14 . . . . 0.0 110.569 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.43 135.7 24.02 Favored Glycine 1 N--CA 1.516 4.011 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 69.5 m -70.52 162.17 29.29 Favored 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 123.76 0.824 . . . . 0.0 109.917 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.13 -26.91 68.39 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.785 0.834 . . . . 0.0 110.451 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 67.1 m -68.61 -35.18 76.98 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 123.544 0.737 . . . . 0.0 110.308 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.68 -43.2 76.99 Favored Glycine 1 N--CA 1.517 4.044 0 CA-C-N 115.228 -0.896 . . . . 0.0 115.17 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 214' ' ' ILE . . . . . 0.409 ' O ' HD13 ' F' ' 214' ' ' ILE . 0.0 OUTLIER -70.72 -45.85 71.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 CA-C-N 118.026 0.913 . . . . 0.0 111.406 -176.863 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 19.8 tt -60.83 -34.35 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 44.9 pt -72.57 -32.81 42.85 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.195 0 CA-C-N 119.556 1.071 . . . . 0.0 108.929 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.88 -29.77 51.6 Favored Glycine 0 N--CA 1.514 3.872 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.979 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.0 -37.53 72.88 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.021 0 CA-C-N 117.588 0.694 . . . . 0.0 110.963 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 43.1 p -62.99 -46.21 88.73 Favored 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.048 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.95 -36.06 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.151 0 C-N-CA 124.212 1.005 . . . . 0.0 110.749 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.42 -43.13 64.64 Favored 'General case' 0 N--CA 1.525 3.313 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.73 -43.11 85.1 Favored 'General case' 0 N--CA 1.519 3.012 0 C-N-CA 123.261 0.624 . . . . 0.0 111.972 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 36.9 t -66.72 -45.56 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 C-N-CA 122.943 0.497 . . . . 0.0 111.022 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.16 -38.83 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 123.263 0.625 . . . . 0.0 111.153 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.81 -34.63 78.6 Favored 'General case' 0 N--CA 1.532 3.64 0 CA-C-N 117.828 0.285 . . . . 0.0 110.803 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.67 -44.26 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.886 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.04 -37.77 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.625 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.65 -48.22 81.77 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.731 0.813 . . . . 0.0 112.807 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.58 -34.22 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 O-C-N 121.948 -0.47 . . . . 0.0 110.084 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -64.01 -44.13 93.53 Favored 'General case' 0 N--CA 1.527 3.401 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.71 -37.74 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 98.9 m -61.66 -27.92 69.02 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.039 0.536 . . . . 0.0 111.212 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -67.62 -30.62 70.24 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 122.947 0.499 . . . . 0.0 111.49 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 49.4 m -64.04 -31.99 73.38 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 123.324 0.649 . . . . 0.0 112.407 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.78 -33.0 72.31 Favored 'General case' 0 N--CA 1.534 3.754 0 C-N-CA 123.793 0.837 . . . . 0.0 112.379 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 236' ' ' LEU . . . . . 0.544 HD13 ' H ' ' F' ' 236' ' ' LEU . 0.0 OUTLIER -110.33 10.97 23.47 Favored 'General case' 1 N--CA 1.547 4.399 0 C-N-CA 124.019 0.928 . . . . 0.0 111.466 -179.773 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 31.7 t90 -139.25 79.24 1.71 Allowed 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 124.374 1.07 . . . . 0.0 108.648 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.33 11.46 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 124.159 0.984 . . . . 0.0 109.963 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -67.38 108.55 2.82 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 123.83 0.852 . . . . 0.0 110.046 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.16 138.25 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.389 0 C-N-CA 124.976 1.31 . . . . 0.0 108.244 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.48 113.11 60.15 Favored Pre-proline 0 N--CA 1.526 3.363 0 CA-C-O 116.859 -1.543 . . . . 0.0 107.314 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo . . . . . 1 N--CA 1.536 4.013 0 CA-C-N 123.052 2.126 . . . . 0.0 110.698 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.576 1.946 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.85 -169.47 0.34 Allowed 'Trans proline' 1 N--CA 1.543 4.409 0 C-N-CA 122.36 2.04 . . . . 0.0 110.214 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -163.36 -153.07 7.11 Favored Glycine 1 N--CA 1.517 4.1 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.8 m -161.22 44.25 0.17 Allowed 'General case' 0 N--CA 1.52 3.067 0 C-N-CA 123.684 0.794 . . . . 0.0 109.185 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 48.2 mt -64.72 -41.18 96.16 Favored 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 123.972 0.909 . . . . 0.0 110.123 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 95.3 p -57.95 -26.96 62.95 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 123.271 0.629 . . . . 0.0 110.678 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.21 -41.52 86.08 Favored Glycine 1 N--CA 1.52 4.266 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 62.3 mt -65.62 -37.1 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 C-N-CA 124.348 1.059 . . . . 0.0 109.083 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 45.6 mm -67.48 -40.81 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 C-N-CA 124.151 0.981 . . . . 0.0 108.384 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 87.7 mt -72.33 -33.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.04 -29.72 75.24 Favored Glycine 1 N--CA 1.518 4.111 0 C-N-CA 123.336 0.493 . . . . 0.0 112.458 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -37.23 72.81 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.18 0 C-N-CA 123.394 0.678 . . . . 0.0 109.916 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -57.46 -45.24 84.98 Favored 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.342 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 51.2 t -56.57 -42.07 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 C-N-CA 124.323 1.049 . . . . 0.0 111.454 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.62 -40.74 63.04 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.96 -37.25 75.76 Favored 'General case' 0 N--CA 1.523 3.179 0 C-N-CA 123.114 0.566 . . . . 0.0 111.726 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.09 -48.52 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.502 0 C-N-CA 123.492 0.717 . . . . 0.0 111.359 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.14 -32.62 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 O-C-N 121.926 -0.484 . . . . 0.0 111.847 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.15 -40.65 37.29 Favored 'General case' 0 N--CA 1.534 3.748 0 C-N-CA 122.61 0.364 . . . . 0.0 111.705 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.42 -38.78 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.355 0.525 . . . . 0.0 111.711 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 35.4 m -67.89 -37.59 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.564 0 CA-C-O 121.047 0.451 . . . . 0.0 110.406 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.05 97.17 Favored 'General case' 0 N--CA 1.523 3.21 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.03 -33.95 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 O-C-N 121.726 -0.609 . . . . 0.0 110.149 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -60.03 -44.27 94.73 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.95 -42.08 82.12 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 CA-C-O 121.681 0.753 . . . . 0.0 109.468 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 83.0 m -61.57 -27.56 68.71 Favored 'General case' 0 N--CA 1.518 2.955 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.293 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.21 -30.9 71.84 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 122.635 0.374 . . . . 0.0 110.373 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 34.0 t -64.01 -35.17 79.82 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.243 0.617 . . . . 0.0 111.152 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.91 -18.42 56.54 Favored 'General case' 0 N--CA 1.532 3.636 0 C-N-CA 122.968 0.507 . . . . 0.0 111.592 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.54 -2.01 58.32 Favored 'General case' 1 N--CA 1.541 4.119 0 C-N-CA 123.054 0.542 . . . . 0.0 109.86 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -66.62 -68.47 0.37 Allowed 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.172 0.589 . . . . 0.0 110.005 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 56.96 176.98 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.227 0 C-N-CA 124.26 1.024 . . . . 0.0 112.024 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -69.97 -178.22 1.53 Allowed 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 124.0 0.92 . . . . 0.0 110.359 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.95 138.31 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.498 0 C-N-CA 125.203 1.401 . . . . 0.0 108.228 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -108.16 99.21 30.39 Favored Pre-proline 0 N--CA 1.532 3.665 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo . . . . . 1 N--CA 1.547 4.67 0 C-N-CA 122.451 2.101 . . . . 0.0 114.55 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 CA--C 1.574 1.885 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.76 -97.59 0.01 OUTLIER 'Trans proline' 1 N--CA 1.542 4.368 0 C-N-CA 122.214 1.943 . . . . 0.0 110.72 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -168.91 -175.95 38.68 Favored Glycine 1 N--CA 1.52 4.249 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 99.5 p -78.9 72.94 5.45 Favored 'General case' 0 N--CA 1.52 3.068 0 C-N-CA 123.798 0.839 . . . . 0.0 110.035 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 53.9 mt -65.1 -26.83 68.38 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.6 0.76 . . . . 0.0 109.996 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -65.82 -29.23 69.67 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.34 0.656 . . . . 0.0 110.519 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.52 -35.68 81.9 Favored Glycine 1 N--CA 1.523 4.451 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.21 -45.97 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 C-N-CA 124.037 0.935 . . . . 0.0 111.555 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.7 pt -65.22 -33.21 62.12 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.492 0 CA-C-O 121.844 0.83 . . . . 0.0 110.019 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 40.0 mm -73.06 -33.67 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.285 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.45 -48.26 77.32 Favored Glycine 1 N--CA 1.52 4.249 0 C-N-CA 123.435 0.541 . . . . 0.0 114.29 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.96 -37.71 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.77 0 CA-C-N 117.434 0.617 . . . . 0.0 110.861 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 72.7 p -66.64 -45.92 77.46 Favored 'General case' 0 N--CA 1.533 3.722 0 CA-C-N 118.141 0.428 . . . . 0.0 111.354 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.48 -31.53 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.25 0 C-N-CA 123.797 0.839 . . . . 0.0 111.301 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.49 -37.23 75.12 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.21 -50.08 43.67 Favored 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.13 -38.46 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.32 -32.5 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 36.2 tp -77.84 -39.4 43.64 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.0 pt -69.51 -37.01 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 CA-C-N 119.053 0.842 . . . . 0.0 112.171 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.0 -37.09 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 121.838 -0.539 . . . . 0.0 110.15 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.19 79.87 Favored 'General case' 0 N--CA 1.525 3.3 0 C-N-CA 123.78 0.832 . . . . 0.0 112.888 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.64 -34.43 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 O-C-N 121.926 -0.484 . . . . 0.0 110.394 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -64.38 -44.08 92.45 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 123.091 0.556 . . . . 0.0 112.307 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.85 -37.57 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.704 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 83.4 m -64.35 -27.84 69.29 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.066 0.546 . . . . 0.0 111.018 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -69.3 -30.52 68.62 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.089 0.556 . . . . 0.0 111.05 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 82.4 p -64.73 -31.22 72.35 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.198 0.599 . . . . 0.0 111.706 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.3 -17.32 62.41 Favored 'General case' 0 N--CA 1.536 3.825 0 C-N-CA 123.462 0.705 . . . . 0.0 111.085 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -87.57 -28.54 21.88 Favored 'General case' 0 N--CA 1.537 3.892 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -79.15 -150.44 0.05 Allowed 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm 60.88 109.7 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.251 0 C-N-CA 123.929 0.892 . . . . 0.0 110.997 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -165.8 151.06 8.77 Favored 'General case' 0 N--CA 1.522 3.172 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.3 138.43 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.458 0 C-N-CA 124.857 1.263 . . . . 0.0 108.405 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 54.7 mt -94.56 146.67 31.89 Favored Pre-proline 0 N--CA 1.526 3.351 0 CA-C-O 117.295 -1.336 . . . . 0.0 108.179 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo . . . . . 1 N--CA 1.54 4.256 0 C-N-CA 122.044 1.829 . . . . 0.0 110.737 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 16.8 ptm . . . . . 0 CA--C 1.574 1.896 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.67 -29.69 19.16 Favored 'Trans proline' 1 N--CA 1.542 4.346 0 C-N-CA 122.268 1.979 . . . . 0.0 110.468 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.2 92.47 0.21 Allowed Glycine 1 N--CA 1.519 4.205 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.633 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 75.3 m -164.43 -41.16 0.03 OUTLIER 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 124.122 0.969 . . . . 0.0 108.598 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 45.8 mt -61.07 -26.2 67.48 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.49 1.116 . . . . 0.0 111.279 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 63.5 m -57.75 -43.49 85.43 Favored 'General case' 0 N--CA 1.522 3.174 0 C-N-CA 123.677 0.791 . . . . 0.0 112.097 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.62 81.28 Favored Glycine 1 N--CA 1.523 4.443 0 C-N-CA 123.559 0.599 . . . . 0.0 112.707 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 41.6 mm -59.98 -46.54 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.627 0 C-N-CA 123.979 0.912 . . . . 0.0 112.898 -176.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 215' ' ' ILE . . . . . 0.452 ' O ' HD13 ' C' ' 215' ' ' ILE . 0.1 OUTLIER -69.01 -35.77 70.63 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.683 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.5 mm -72.25 -33.36 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.04 -29.72 56.15 Favored Glycine 0 N--CA 1.513 3.798 0 C-N-CA 124.018 0.818 . . . . 0.0 113.415 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 m -59.98 -37.63 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 CA-C-N 117.349 0.574 . . . . 0.0 110.89 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 43.7 p -61.09 -46.72 89.5 Favored 'General case' 0 N--CA 1.526 3.34 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.213 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.96 -39.87 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.037 0 C-N-CA 124.277 1.031 . . . . 0.0 110.453 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.41 -38.42 58.99 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.11 -43.38 82.59 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 122.952 0.501 . . . . 0.0 110.562 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.08 -43.31 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.368 0 C-N-CA 123.773 0.829 . . . . 0.0 110.811 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.6 -32.31 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.56 0 C-N-CA 123.468 0.707 . . . . 0.0 109.969 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -45.71 91.04 Favored 'General case' 0 N--CA 1.537 3.925 0 CA-C-O 121.293 0.568 . . . . 0.0 109.939 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 80.9 mt -54.94 -35.89 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.821 0 C-N-CA 123.615 0.766 . . . . 0.0 111.028 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.42 -36.1 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 C-N-CA 123.117 0.567 . . . . 0.0 110.487 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.2 64.63 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 3.1 m -64.41 -34.87 72.17 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.426 0 CA-C-N 119.582 1.083 . . . . 0.0 110.619 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -72.94 -31.93 64.93 Favored 'General case' 0 N--CA 1.529 3.496 0 C-N-CA 123.093 0.557 . . . . 0.0 110.04 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.44 -37.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.579 0 C-N-CA 123.41 0.684 . . . . 0.0 109.29 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.58 -36.58 74.19 Favored 'General case' 0 N--CA 1.525 3.324 0 CA-C-O 121.073 0.463 . . . . 0.0 110.06 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.33 -38.2 63.35 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.201 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.8 m -63.91 -46.7 83.63 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 123.066 0.546 . . . . 0.0 110.846 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 85.1 mt -67.05 -18.01 65.16 Favored 'General case' 0 N--CA 1.53 3.53 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.706 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 41.7 tp -92.4 -11.66 34.31 Favored 'General case' 1 N--CA 1.539 4.008 0 C-N-CA 123.907 0.883 . . . . 0.0 110.141 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -51.41 -26.31 7.72 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.993 0.917 . . . . 0.0 112.308 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -65.43 143.15 57.89 Favored 'General case' 0 N--CA 1.526 3.375 0 C-N-CA 123.375 0.67 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.66 8.42 Favored 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 124.119 0.968 . . . . 0.0 108.81 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 m -135.33 138.53 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 C-N-CA 124.832 1.253 . . . . 0.0 108.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.47 147.28 64.12 Favored Pre-proline 0 N--CA 1.535 3.814 0 C-N-CA 125.183 1.393 . . . . 0.0 108.652 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo . . . . . 1 N--CA 1.541 4.307 0 C-N-CA 122.0 1.8 . . . . 0.0 110.7 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 CA--C 1.576 1.95 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.67 -175.95 1.82 Allowed 'Trans proline' 1 N--CA 1.539 4.197 0 C-N-CA 122.332 2.021 . . . . 0.0 110.572 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -175.68 -169.53 37.45 Favored Glycine 1 N--CA 1.519 4.169 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 68.2 m -160.26 27.17 0.17 Allowed 'General case' 0 N--CA 1.523 3.187 0 C-N-CA 123.63 0.772 . . . . 0.0 109.825 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.09 -43.18 92.98 Favored 'General case' 0 N--CA 1.534 3.746 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 89.4 p -58.94 -26.3 64.27 Favored 'General case' 0 N--CA 1.526 3.374 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.823 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.47 -34.43 79.3 Favored Glycine 0 N--CA 1.506 3.363 0 C-N-CA 124.64 1.114 . . . . 0.0 113.68 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -35.26 52.63 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.297 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -174.057 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 16.8 tt -55.96 -32.42 33.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.81 -32.31 48.53 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.258 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.65 -40.59 96.66 Favored Glycine 1 N--CA 1.519 4.167 0 CA-C-O 119.653 -0.526 . . . . 0.0 113.653 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.45 -37.07 78.22 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 CA-C-N 118.458 1.129 . . . . 0.0 109.924 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 89.1 m -56.0 -45.1 79.16 Favored 'General case' 0 N--CA 1.522 3.163 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.54 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.53 -41.66 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 123.385 0.674 . . . . 0.0 110.7 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.82 -35.59 64.07 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.63 -50.36 37.82 Favored 'General case' 0 N--CA 1.521 3.094 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 12.9 p -68.02 -38.59 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.567 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.34 -31.99 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 CA-C-N 118.161 0.437 . . . . 0.0 110.237 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.97 -34.86 63.7 Favored 'General case' 1 N--CA 1.54 4.062 0 CA-C-O 121.485 0.66 . . . . 0.0 110.607 -178.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 67.4 mt -61.14 -36.04 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 124.002 0.921 . . . . 0.0 110.76 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.68 -37.64 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 123.272 0.629 . . . . 0.0 110.226 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -47.59 84.71 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.401 0.681 . . . . 0.0 112.571 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.56 -34.06 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.624 0 O-C-N 121.866 -0.521 . . . . 0.0 110.168 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.97 -44.2 97.24 Favored 'General case' 0 N--CA 1.529 3.503 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.86 -37.84 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 70.8 m -62.06 -27.57 68.99 Favored 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.081 0.552 . . . . 0.0 111.11 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -59.76 -18.66 44.88 Favored 'General case' 0 N--CA 1.533 3.706 0 C-N-CA 122.946 0.498 . . . . 0.0 111.244 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 97.3 p -73.81 -40.08 63.63 Favored 'General case' 0 N--CA 1.524 3.275 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.15 -14.88 63.32 Favored 'General case' 0 N--CA 1.537 3.895 0 C-N-CA 123.411 0.684 . . . . 0.0 110.481 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 57.2 tp -89.62 -28.9 19.21 Favored 'General case' 1 N--CA 1.54 4.045 0 C-N-CA 124.252 1.021 . . . . 0.0 109.826 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -79.88 -71.36 0.46 Allowed 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 43.6 tptt 44.62 17.31 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? 64.83 115.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.523 0 C-N-CA 123.921 0.888 . . . . 0.0 109.094 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.71 138.12 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.632 0 C-N-CA 124.834 1.253 . . . . 0.0 109.146 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 58.3 mt -97.91 146.88 32.22 Favored Pre-proline 0 N--CA 1.526 3.373 0 CA-C-O 117.249 -1.358 . . . . 0.0 108.211 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 1 N--CA 1.541 4.286 0 C-N-CA 122.013 1.809 . . . . 0.0 110.625 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.578 2.025 0 CA-C-O 117.6 -1.19 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.83 -1.59 6.46 Favored 'Trans proline' 1 N--CA 1.537 4.058 0 C-N-CA 122.52 2.146 . . . . 0.0 111.688 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -179.78 -132.18 1.76 Allowed Glycine 1 N--CA 1.518 4.139 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 19.9 p 81.23 -29.19 0.12 Allowed 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 125.416 1.487 . . . . 0.0 111.203 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 mp -64.22 -26.93 68.73 Favored 'General case' 1 N--CA 1.54 4.041 0 C-N-CA 123.498 0.719 . . . . 0.0 109.116 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 39.2 t -63.68 -35.85 81.91 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 123.805 0.842 . . . . 0.0 111.21 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.27 -35.69 83.22 Favored Glycine 1 N--CA 1.519 4.2 0 C-N-CA 123.846 0.736 . . . . 0.0 112.549 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.17 -47.04 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 C-N-CA 123.857 0.863 . . . . 0.0 112.292 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.83 -32.51 52.19 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 CA-C-N 118.564 0.62 . . . . 0.0 109.684 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.66 -32.24 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.76 -29.49 41.63 Favored Glycine 0 N--CA 1.511 3.698 0 C-N-CA 123.843 0.735 . . . . 0.0 113.402 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 m -60.32 -37.59 74.56 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.108 0 CA-C-N 117.918 0.859 . . . . 0.0 110.381 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 37.8 p -60.02 -45.8 91.61 Favored 'General case' 0 N--CA 1.528 3.47 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.235 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 47.6 t -69.49 -37.83 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 C-N-CA 124.229 1.012 . . . . 0.0 111.091 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.61 -42.96 65.06 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.85 -31.85 72.73 Favored 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 123.067 0.547 . . . . 0.0 111.748 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.05 -39.51 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.529 0 C-N-CA 123.089 0.556 . . . . 0.0 110.384 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.89 -33.01 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 C-N-CA 123.389 0.676 . . . . 0.0 110.558 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.59 -45.93 84.89 Favored 'General case' 0 N--CA 1.532 3.631 0 C-N-CA 122.715 0.406 . . . . 0.0 109.923 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 73.2 mt -54.78 -36.53 37.27 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 C-N-CA 122.851 0.46 . . . . 0.0 110.891 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.62 -37.88 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 C-N-CA 123.029 0.532 . . . . 0.0 109.889 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.95 -32.36 69.54 Favored 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.43 0.692 . . . . 0.0 111.387 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.17 -34.72 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.23 0 C-N-CA 123.638 0.775 . . . . 0.0 111.16 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -69.13 -43.98 73.3 Favored 'General case' 0 N--CA 1.531 3.586 0 O-C-N 122.059 -0.401 . . . . 0.0 112.015 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.69 -37.62 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 122.688 0.395 . . . . 0.0 110.661 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 12.3 p -59.98 -27.54 66.93 Favored 'General case' 0 N--CA 1.535 3.8 0 CA-C-N 118.089 0.404 . . . . 0.0 111.078 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -59.99 -27.01 66.5 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 123.393 0.677 . . . . 0.0 111.134 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 48.7 m -63.96 -33.99 76.96 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.401 0.68 . . . . 0.0 110.889 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 46.3 mt -61.05 -13.85 19.61 Favored 'General case' 0 N--CA 1.525 3.292 0 C-N-CA 124.483 1.113 . . . . 0.0 111.973 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 31.7 mt -86.57 -21.45 26.85 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.352 0.661 . . . . 0.0 110.233 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -76.94 95.2 4.07 Favored 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -166.63 -173.04 2.32 Favored 'General case' 0 N--CA 1.52 3.042 0 C-N-CA 123.849 0.859 . . . . 0.0 109.131 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -60.45 141.46 56.39 Favored 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 123.991 0.916 . . . . 0.0 111.088 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.63 138.22 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 124.834 1.254 . . . . 0.0 108.226 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 51.2 tp -109.24 99.64 37.22 Favored Pre-proline 0 N--CA 1.531 3.591 0 C-N-CA 124.871 1.269 . . . . 0.0 108.017 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo . . . . . 0 N--CA 1.535 3.968 0 C-N-CA 122.449 2.099 . . . . 0.0 111.11 -179.674 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 73.7 mtp . . . . . 0 CA--C 1.576 1.947 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.17 82.79 1.53 Allowed 'Trans proline' 1 N--CA 1.538 4.113 0 C-N-CA 122.318 2.012 . . . . 0.0 110.148 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.24 -131.58 30.14 Favored Glycine 1 N--CA 1.519 4.228 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 98.5 p -163.91 158.42 19.78 Favored 'General case' 0 N--CA 1.521 3.098 0 C-N-CA 123.581 0.753 . . . . 0.0 109.081 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.14 -27.01 68.43 Favored 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 124.246 1.018 . . . . 0.0 110.369 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 50.3 m -57.79 -26.19 61.58 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.1 0.56 . . . . 0.0 111.074 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.38 -34.58 63.61 Favored Glycine 1 N--CA 1.516 4.011 0 C-N-CA 124.362 0.982 . . . . 0.0 113.612 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 10.9 tp -59.32 -43.68 90.6 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 5.8 pt -66.73 -35.99 76.14 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.389 0 CA-C-O 121.906 0.86 . . . . 0.0 109.437 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 87.8 mt -72.68 -40.05 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.254 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.507 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.58 -48.76 84.46 Favored Glycine 1 N--CA 1.518 4.126 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.874 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.31 -36.55 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 123.036 0.535 . . . . 0.0 109.869 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 90.5 m -64.33 -47.5 79.17 Favored 'General case' 0 N--CA 1.523 3.202 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.69 -31.62 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.64 0 C-N-CA 122.76 0.424 . . . . 0.0 111.257 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.05 -47.18 68.63 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.223 0.609 . . . . 0.0 112.614 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.41 69.96 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.346 0.658 . . . . 0.0 112.548 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 45.3 t -68.09 -53.16 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.462 0 O-C-N 122.109 -0.37 . . . . 0.0 111.113 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.39 -32.14 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.361 0 C-N-CA 123.144 0.578 . . . . 0.0 112.411 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -39.03 55.97 Favored 'General case' 1 N--CA 1.541 4.085 0 C-N-CA 122.698 0.399 . . . . 0.0 111.467 -177.317 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 95.3 mt -69.1 -40.78 81.07 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 O-C-N 121.193 -0.942 . . . . 0.0 111.172 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.76 -36.51 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 O-C-N 121.476 -0.765 . . . . 0.0 109.894 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.21 -45.56 83.72 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.455 0.702 . . . . 0.0 112.621 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 16.8 m -71.86 -34.54 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 O-C-N 121.785 -0.572 . . . . 0.0 110.3 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.19 -44.2 92.74 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.67 -37.53 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 90.2 m -65.22 -29.76 70.59 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.063 0.545 . . . . 0.0 110.739 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -69.5 -39.49 77.55 Favored 'General case' 0 N--CA 1.529 3.499 0 C-N-CA 122.846 0.458 . . . . 0.0 109.927 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.8 t -64.06 -17.93 63.87 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 123.569 0.748 . . . . 0.0 111.386 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.57 -24.48 64.61 Favored 'General case' 0 N--CA 1.532 3.628 0 C-N-CA 124.096 0.958 . . . . 0.0 109.352 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -87.41 -26.56 23.24 Favored 'General case' 0 N--CA 1.539 3.982 0 C-N-CA 123.587 0.755 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -63.95 -69.79 0.26 Allowed 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.261 0.624 . . . . 0.0 110.74 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -66.28 -179.46 0.79 Allowed 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 123.615 0.766 . . . . 0.0 110.81 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -167.81 173.3 8.42 Favored 'General case' 0 N--CA 1.521 3.121 0 C-N-CA 123.889 0.876 . . . . 0.0 109.305 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 26.1 m -135.13 138.24 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 C-N-CA 124.837 1.255 . . . . 0.0 108.245 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 53.1 tp -98.4 103.44 18.3 Favored Pre-proline 0 N--CA 1.529 3.498 0 CA-C-O 117.27 -1.348 . . . . 0.0 108.329 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo . . . . . 1 N--CA 1.536 4.003 0 C-N-CA 122.276 1.984 . . . . 0.0 110.974 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 CA--C 1.58 2.103 0 CA-C-O 117.714 -1.136 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.53 -31.99 51.42 Favored 'Trans proline' 1 N--CA 1.548 4.734 0 CA-C-N 122.302 1.858 . . . . 0.0 113.227 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 179.2 163.11 29.62 Favored Glycine 1 N--CA 1.519 4.223 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.3 p -69.77 139.5 53.27 Favored 'General case' 0 N--CA 1.522 3.144 0 C-N-CA 123.647 0.779 . . . . 0.0 110.326 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.4 mp -65.35 -26.4 68.01 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 124.072 0.949 . . . . 0.0 109.536 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 38.8 t -67.72 -27.52 66.87 Favored 'General case' 0 N--CA 1.519 3.009 0 C-N-CA 123.4 0.68 . . . . 0.0 110.527 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.92 -47.16 56.59 Favored Glycine 0 N--CA 1.504 3.217 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -70.55 -41.69 78.02 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.223 0 CA-C-N 118.085 0.943 . . . . 0.0 113.499 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 tt -59.23 -31.03 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 C-N-CA 123.614 0.766 . . . . 0.0 111.734 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -33.4 50.23 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.352 0 O-C-N 121.8 -0.562 . . . . 0.0 109.664 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.02 -38.5 65.85 Favored Glycine 1 N--CA 1.518 4.137 0 N-CA-C 115.282 0.873 . . . . 0.0 115.282 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.49 -37.53 77.91 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.285 0 CA-C-N 118.355 1.078 . . . . 0.0 111.199 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.7 p -63.46 -46.02 88.15 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.48 -31.42 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.553 0 C-N-CA 123.424 0.69 . . . . 0.0 110.981 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.3 -47.02 72.87 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.22 -34.94 74.35 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.484 0.714 . . . . 0.0 112.376 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.61 -40.44 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.292 0 C-N-CA 123.482 0.713 . . . . 0.0 111.178 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.18 -45.19 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 C-N-CA 122.722 0.409 . . . . 0.0 110.985 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.55 -34.79 78.58 Favored 'General case' 0 N--CA 1.535 3.793 0 C-N-CA 122.418 0.287 . . . . 0.0 110.424 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 74.7 mt -64.35 -44.94 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.705 0 C-N-CA 122.581 0.352 . . . . 0.0 110.531 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.11 -41.05 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.684 0 O-C-N 121.829 -0.544 . . . . 0.0 109.842 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.38 94.58 Favored 'General case' 0 N--CA 1.524 3.252 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.0 m -71.51 -34.05 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 O-C-N 121.603 -0.686 . . . . 0.0 110.194 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -61.13 -44.11 97.84 Favored 'General case' 0 N--CA 1.526 3.341 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 10.1 m -68.84 -41.39 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.83 0 CA-C-N 118.596 0.635 . . . . 0.0 109.576 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 74.5 m -60.52 -27.75 67.86 Favored 'General case' 0 N--CA 1.523 3.215 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.326 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -66.65 -35.06 79.27 Favored 'General case' 0 N--CA 1.523 3.186 0 C-N-CA 122.675 0.39 . . . . 0.0 110.362 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 31.8 t -64.28 -38.48 91.19 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.424 0.69 . . . . 0.0 111.234 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.75 -13.99 18.47 Favored 'General case' 0 N--CA 1.536 3.852 0 C-N-CA 123.265 0.626 . . . . 0.0 110.998 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.06 -17.95 31.71 Favored 'General case' 0 N--CA 1.534 3.735 0 C-N-CA 123.02 0.528 . . . . 0.0 110.281 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -88.9 3.09 52.55 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 124.146 0.978 . . . . 0.0 111.13 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -64.28 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 123.107 0.563 . . . . 0.0 110.171 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -71.2 148.36 47.37 Favored 'General case' 0 N--CA 1.522 3.142 0 C-N-CA 123.698 0.799 . . . . 0.0 110.03 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.96 128.86 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -103.53 99.84 16.83 Favored Pre-proline 0 N--CA 1.532 3.651 0 C-N-CA 124.873 1.269 . . . . 0.0 107.652 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 1 N--CA 1.536 4.01 0 C-N-CA 122.434 2.089 . . . . 0.0 110.564 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 44.1 ttm . . . . . 0 CA--C 1.58 2.115 0 CA-C-O 117.73 -1.129 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.5 172.88 0.11 Allowed 'Trans proline' 1 N--CA 1.548 4.701 0 CA-C-N 122.241 1.836 . . . . 0.0 113.782 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -178.5 -129.89 1.35 Allowed Glycine 1 N--CA 1.517 4.062 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 41.2 t -167.23 156.45 10.34 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-N 117.686 0.743 . . . . 0.0 110.004 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.21 -26.22 68.03 Favored 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 124.703 1.201 . . . . 0.0 110.517 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 43.7 t -57.05 -24.99 57.84 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.539 0.736 . . . . 0.0 111.092 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.91 -47.01 82.29 Favored Glycine 1 N--CA 1.518 4.136 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.455 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 29.3 pt -71.6 -35.7 57.08 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.163 0 CA-C-N 118.204 1.002 . . . . 0.0 111.095 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 45.3 mm -57.23 -44.44 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.84 0 C-N-CA 124.474 1.11 . . . . 0.0 111.972 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.1 tp -72.41 -33.09 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.82 -44.68 97.73 Favored Glycine 1 N--CA 1.517 4.071 0 C-N-CA 123.919 0.771 . . . . 0.0 114.158 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.7 -37.21 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.726 0 CA-C-N 117.727 0.763 . . . . 0.0 110.905 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 67.4 p -65.44 -46.14 81.08 Favored 'General case' 0 N--CA 1.534 3.729 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.56 -31.03 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 C-N-CA 122.621 0.368 . . . . 0.0 111.262 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.22 -42.69 63.76 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.8 88.53 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.092 0.557 . . . . 0.0 111.249 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 24.3 t -64.66 -40.27 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 123.779 0.832 . . . . 0.0 111.234 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.57 -32.45 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 C-N-CA 123.247 0.619 . . . . 0.0 110.943 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 tp -76.54 -42.96 41.2 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.5 -44.05 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 C-N-CA 122.976 0.511 . . . . 0.0 111.841 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.27 -37.04 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.892 0 CA-C-N 118.575 0.625 . . . . 0.0 110.365 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.33 79.46 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.098 0.559 . . . . 0.0 111.812 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 90.3 t -71.66 -35.01 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 122.748 0.419 . . . . 0.0 109.995 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.29 -44.54 96.29 Favored 'General case' 0 N--CA 1.532 3.655 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.04 -38.25 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 73.4 m -67.2 -30.46 70.41 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 122.987 0.515 . . . . 0.0 110.711 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -67.34 -25.3 65.93 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.453 0.701 . . . . 0.0 111.097 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -63.91 -40.28 96.13 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.206 0.602 . . . . 0.0 111.292 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.95 -23.1 65.05 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.636 0.774 . . . . 0.0 110.734 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.7 mp -91.89 -19.82 22.09 Favored 'General case' 0 N--CA 1.537 3.912 0 C-N-CA 124.129 0.971 . . . . 0.0 109.524 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -146.69 57.18 1.16 Allowed 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.754 0.822 . . . . 0.0 109.187 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -79.05 -27.83 43.14 Favored 'General case' 0 N--CA 1.524 3.253 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.06 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 62.5 tttm 61.87 150.73 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 124.709 1.204 . . . . 0.0 111.367 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 66.1 t -113.06 135.35 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 125.031 1.332 . . . . 0.0 107.566 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.98 107.06 29.06 Favored Pre-proline 0 N--CA 1.526 3.348 0 CA-C-O 116.928 -1.511 . . . . 0.0 107.492 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo . . . . . 1 N--CA 1.548 4.721 0 CA-C-N 122.95 2.089 . . . . 0.0 114.27 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 CA--C 1.582 2.182 0 CA-C-O 117.892 -1.051 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -53.56 -10.24 1.43 Allowed 'Trans proline' 1 N--CA 1.548 4.733 0 C-N-CA 122.155 1.903 . . . . 0.0 114.132 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.68 87.79 0.28 Allowed Glycine 1 N--CA 1.518 4.153 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 96.2 p -58.33 -62.31 1.93 Allowed 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.929 0.891 . . . . 0.0 111.96 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.46 -40.98 96.73 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 123.636 0.774 . . . . 0.0 110.626 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 40.4 t -69.6 -26.59 64.52 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 123.144 0.577 . . . . 0.0 110.719 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.58 -46.03 64.11 Favored Glycine 1 N--CA 1.517 4.061 0 N-CA-C 116.508 1.363 . . . . 0.0 116.508 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -35.01 60.59 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 CA-C-N 119.806 1.803 . . . . 0.0 112.274 -176.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 2.7 pt -58.92 -45.0 92.1 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.491 0 CA-C-N 118.694 0.679 . . . . 0.0 111.812 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.0 pt -68.99 -32.99 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 C-N-CA 122.986 0.514 . . . . 0.0 109.75 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.7 -29.94 68.1 Favored Glycine 0 N--CA 1.513 3.783 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.425 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 2.7 m -60.38 -37.65 75.06 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.006 0 CA-C-N 117.847 0.823 . . . . 0.0 111.142 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 56.2 p -63.14 -46.67 86.15 Favored 'General case' 0 N--CA 1.526 3.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.444 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 47.2 t -70.1 -33.57 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.086 0 C-N-CA 124.158 0.983 . . . . 0.0 110.5 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.91 90.04 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.538 0.735 . . . . 0.0 112.523 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.97 -48.55 70.9 Favored 'General case' 0 N--CA 1.516 2.841 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.4 m -67.9 -39.96 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.55 -34.16 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 CA-C-N 119.354 0.979 . . . . 0.0 111.759 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 45.1 tp -67.83 -47.59 68.57 Favored 'General case' 0 N--CA 1.528 3.425 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 27.7 pt -68.95 -36.3 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-N 118.231 0.469 . . . . 0.0 111.002 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.48 -37.42 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.962 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.25 72.47 Favored 'General case' 0 N--CA 1.533 3.683 0 C-N-CA 122.931 0.492 . . . . 0.0 112.086 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.77 -37.05 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.066 0.546 . . . . 0.0 110.304 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -63.31 -44.08 96.01 Favored 'General case' 0 N--CA 1.532 3.64 0 C-N-CA 123.135 0.574 . . . . 0.0 112.443 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.62 -37.46 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.63 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 98.0 m -62.2 -29.72 70.58 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 122.879 0.472 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -69.58 -27.67 65.32 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.214 0.606 . . . . 0.0 111.07 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 30.3 t -64.07 -32.72 74.38 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 123.204 0.602 . . . . 0.0 112.094 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.39 -21.48 66.31 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.648 0.779 . . . . 0.0 110.885 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 7.9 mp -87.51 -28.28 22.12 Favored 'General case' 0 N--CA 1.532 3.672 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -83.39 86.82 7.01 Favored 'General case' 0 N--CA 1.52 3.048 0 C-N-CA 123.978 0.911 . . . . 0.0 108.734 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.19 -17.88 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.294 0 C-N-CA 123.675 0.79 . . . . 0.0 110.204 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 59.0 -171.41 0.12 Allowed 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.932 0.893 . . . . 0.0 110.673 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.64 117.96 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.52 146.73 32.01 Favored Pre-proline 0 N--CA 1.528 3.431 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo . . . . . 1 N--CA 1.54 4.233 0 C-N-CA 122.089 1.859 . . . . 0.0 110.619 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 CA--C 1.575 1.928 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -50.83 143.36 30.19 Favored 'Trans proline' 1 N--CA 1.544 4.448 0 C-N-CA 122.441 2.094 . . . . 0.0 113.671 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.55 -169.03 9.98 Favored Glycine 0 N--CA 1.515 3.957 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 99.5 p -165.96 67.83 0.12 Allowed 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 123.735 0.814 . . . . 0.0 108.841 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.07 -32.71 74.56 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 123.88 0.872 . . . . 0.0 109.243 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 52.2 m -68.46 -25.48 65.01 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 123.682 0.793 . . . . 0.0 109.155 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.74 -46.88 89.01 Favored Glycine 0 N--CA 1.508 3.487 0 C-N-CA 123.848 0.737 . . . . 0.0 114.512 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 tt -70.84 -35.55 60.58 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.412 0 CA-C-N 118.688 1.244 . . . . 0.0 111.324 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 49.9 mm -56.28 -32.46 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 124.807 1.243 . . . . 0.0 112.124 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 1.7 pp -68.32 -33.96 63.39 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.091 0 CA-C-N 119.493 1.042 . . . . 0.0 109.569 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.09 -34.46 89.81 Favored Glycine 1 N--CA 1.521 4.32 0 C-N-CA 123.483 0.564 . . . . 0.0 111.799 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.07 -39.83 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 124.213 1.005 . . . . 0.0 110.031 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 30.1 p -61.01 -38.92 87.8 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 123.162 0.585 . . . . 0.0 110.938 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 41.2 t -67.12 -41.46 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.081 0 C-N-CA 123.79 0.836 . . . . 0.0 110.36 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.88 -47.18 85.86 Favored 'General case' 0 N--CA 1.523 3.187 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.51 -47.95 68.5 Favored 'General case' 0 N--CA 1.513 2.701 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.57 -41.94 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.471 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.08 -33.4 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 O-C-N 122.228 -0.295 . . . . 0.0 111.282 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.22 -35.6 81.34 Favored 'General case' 0 N--CA 1.529 3.499 0 C-N-CA 122.736 0.414 . . . . 0.0 110.675 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.43 -36.86 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.702 0 C-N-CA 123.191 0.597 . . . . 0.0 110.119 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.66 -43.31 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 C-N-CA 122.973 0.509 . . . . 0.0 110.093 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.14 87.72 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 20.9 m -71.58 -33.89 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 O-C-N 121.806 -0.559 . . . . 0.0 110.071 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.41 -43.49 97.36 Favored 'General case' 0 N--CA 1.526 3.359 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 10.0 m -68.38 -40.16 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 CA-C-N 118.684 0.675 . . . . 0.0 110.884 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 14.5 p -66.35 -28.5 68.7 Favored 'General case' 0 N--CA 1.533 3.711 0 O-C-N 122.197 -0.315 . . . . 0.0 110.38 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -73.77 -32.55 63.85 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 123.446 0.698 . . . . 0.0 109.845 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 47.8 m -64.18 -31.17 72.26 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.182 0.593 . . . . 0.0 110.751 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 60.0 mt -60.79 -23.66 65.2 Favored 'General case' 0 N--CA 1.531 3.594 0 C-N-CA 122.586 0.354 . . . . 0.0 111.206 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.68 -7.36 52.83 Favored 'General case' 1 N--CA 1.539 4.017 0 C-N-CA 123.946 0.898 . . . . 0.0 110.33 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -69.19 3.51 2.13 Favored 'General case' 0 N--CA 1.534 3.764 0 C-N-CA 123.013 0.525 . . . . 0.0 111.31 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -53.2 149.32 7.19 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 123.937 0.895 . . . . 0.0 111.332 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -67.29 126.16 28.38 Favored 'General case' 0 N--CA 1.52 3.034 0 C-N-CA 123.935 0.894 . . . . 0.0 110.79 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 22.2 m -135.3 138.26 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.457 0 C-N-CA 124.952 1.301 . . . . 0.0 108.059 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.561 HD23 ' H ' ' D' ' 241' ' ' LEU . 1.7 pt? -94.53 146.38 31.37 Favored Pre-proline 0 N--CA 1.534 3.746 0 C-N-CA 124.634 1.174 . . . . 0.0 109.629 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 1 N--CA 1.54 4.26 0 CA-C-N 122.166 1.809 . . . . 0.0 110.796 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.573 1.844 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.09 -42.31 3.17 Favored 'Trans proline' 1 N--CA 1.54 4.249 0 C-N-CA 122.02 1.813 . . . . 0.0 110.485 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -75.31 138.02 22.77 Favored Glycine 1 N--CA 1.518 4.102 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 99.6 p -167.3 -21.84 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.612 0.765 . . . . 0.0 109.99 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 41.9 mt -64.28 -34.3 77.8 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.695 0.798 . . . . 0.0 110.056 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 61.2 m -68.69 -26.57 65.36 Favored 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 123.575 0.75 . . . . 0.0 110.104 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.84 -46.18 61.35 Favored Glycine 0 N--CA 1.514 3.887 0 C-N-CA 124.071 0.844 . . . . 0.0 114.705 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 45.9 pt -70.76 -35.77 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -175.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 215' ' ' ILE . . . . . 0.411 HD13 ' H ' ' E' ' 216' ' ' ILE 0.253 0.1 OUTLIER -57.77 -41.3 79.31 Favored 'Isoleucine or valine' 1 N--CA 1.558 4.95 0 CA-C-N 119.984 1.265 . . . . 0.0 112.945 -175.033 . . . . . . . . 5 4 . 1 . 008 nuclear build full ' E' E ' 216' ' ' ILE . . . . . 0.411 ' H ' HD13 ' E' ' 215' ' ' ILE . 17.0 tt -72.38 -32.16 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 C-N-CA 124.297 1.039 . . . . 0.0 108.863 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.01 -29.37 43.39 Favored Glycine 0 N--CA 1.512 3.704 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.395 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.16 -37.8 79.39 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 CA-C-N 118.089 0.944 . . . . 0.0 110.7 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 36.1 p -65.98 -40.51 91.29 Favored 'General case' 0 N--CA 1.529 3.477 0 C-N-CA 123.344 0.657 . . . . 0.0 110.366 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.59 -32.08 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.06 0 C-N-CA 124.046 0.939 . . . . 0.0 110.49 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.54 91.48 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-O 121.062 0.458 . . . . 0.0 110.761 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.28 -47.97 80.09 Favored 'General case' 0 N--CA 1.519 3.017 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.91 -38.57 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.48 -32.8 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 40.6 tp -78.18 -42.64 30.94 Favored 'General case' 0 N--CA 1.535 3.79 0 CA-C-N 118.755 0.707 . . . . 0.0 112.311 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.12 -35.56 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.476 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 28.6 m -65.51 -35.21 74.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.354 0 CA-C-N 119.241 0.928 . . . . 0.0 109.978 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.07 -31.24 63.02 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.467 0.707 . . . . 0.0 112.144 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 3.2 m -56.96 -34.17 43.91 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 O-C-N 121.635 -0.666 . . . . 0.0 110.848 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.96 -44.65 96.3 Favored 'General case' 0 N--CA 1.53 3.527 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.59 -37.3 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.974 0 CA-C-N 119.067 0.849 . . . . 0.0 108.875 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 63.4 m -58.54 -27.56 64.66 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 122.854 0.461 . . . . 0.0 110.901 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -60.78 -18.12 53.2 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 122.916 0.487 . . . . 0.0 110.695 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 33.5 t -66.2 -25.53 66.97 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.616 0.766 . . . . 0.0 111.244 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 46.0 tp -60.38 -14.42 18.72 Favored 'General case' 0 N--CA 1.532 3.641 0 C-N-CA 123.848 0.859 . . . . 0.0 111.4 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.16 3.1 47.74 Favored 'General case' 0 N--CA 1.534 3.773 0 C-N-CA 123.682 0.793 . . . . 0.0 111.142 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -73.04 68.18 0.92 Allowed 'General case' 1 N--CA 1.542 4.166 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -92.25 -167.98 1.88 Allowed 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 124.907 1.283 . . . . 0.0 109.063 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -168.28 153.22 6.45 Favored 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 124.099 0.96 . . . . 0.0 108.458 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 23.8 m -135.21 138.23 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 124.851 1.26 . . . . 0.0 108.477 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.596 ' H ' HD23 ' E' ' 241' ' ' LEU . 1.7 pt? -94.81 146.91 32.23 Favored Pre-proline 0 N--CA 1.534 3.734 0 CA-C-O 116.657 -1.64 . . . . 0.0 109.602 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo . . . . . 1 N--CA 1.55 4.838 0 C-N-CA 122.654 2.236 . . . . 0.0 114.818 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 CA--C 1.575 1.921 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -75.33 48.52 2.1 Favored 'Trans proline' 1 N--CA 1.54 4.236 0 C-N-CA 122.53 2.153 . . . . 0.0 110.446 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -176.05 142.4 6.02 Favored Glycine 1 N--CA 1.519 4.226 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 210' ' ' SER . . . . . 0.424 ' H ' ' H ' ' F' ' 211' ' ' LEU . 93.3 p -170.17 7.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 124.476 1.11 . . . . 0.0 109.524 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 211' ' ' LEU . . . . . 0.424 ' H ' ' H ' ' F' ' 210' ' ' SER . 56.9 tp -64.54 -26.52 68.45 Favored 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.451 1.101 . . . . 0.0 110.871 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 55.1 m -65.46 -26.25 67.86 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.246 0.619 . . . . 0.0 111.002 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.15 -46.57 64.35 Favored Glycine 0 N--CA 1.516 3.974 0 C-N-CA 123.406 0.527 . . . . 0.0 114.233 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -70.85 -35.55 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 11.6 pt -56.64 -45.11 82.43 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.587 0 CA-C-N 119.529 1.059 . . . . 0.0 112.607 -175.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.99 -33.76 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 C-N-CA 123.358 0.663 . . . . 0.0 109.823 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.91 -30.08 76.69 Favored Glycine 0 N--CA 1.509 3.525 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.684 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.04 -37.65 73.55 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 CA-C-N 118.106 0.953 . . . . 0.0 111.589 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 29.2 p -65.82 -47.31 75.46 Favored 'General case' 0 N--CA 1.529 3.518 0 CA-C-O 121.319 0.58 . . . . 0.0 110.518 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.66 -42.38 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 C-N-CA 124.264 1.026 . . . . 0.0 111.176 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.04 -43.0 73.38 Favored 'General case' 0 N--CA 1.528 3.468 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.13 -50.49 68.01 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 p -68.39 -38.66 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 CA-C-N 118.499 0.59 . . . . 0.0 111.883 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.34 -33.69 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.456 0.571 . . . . 0.0 110.79 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 25.0 tp -69.71 -34.47 73.94 Favored 'General case' 0 N--CA 1.531 3.618 0 CA-C-N 118.689 0.677 . . . . 0.0 111.016 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 79.2 mt -65.72 -41.46 90.44 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.134 0 O-C-N 121.728 -0.608 . . . . 0.0 109.436 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.11 -37.41 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 C-N-CA 123.54 0.736 . . . . 0.0 109.807 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.09 68.35 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.21 0.604 . . . . 0.0 111.863 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 69.6 t -71.68 -38.04 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 122.812 0.445 . . . . 0.0 110.391 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -62.12 -44.07 97.45 Favored 'General case' 0 N--CA 1.532 3.644 0 C-N-CA 123.186 0.594 . . . . 0.0 112.579 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.69 -37.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.685 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 93.3 m -64.77 -29.68 70.66 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 122.924 0.489 . . . . 0.0 110.463 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -74.32 -40.03 62.47 Favored 'General case' 0 N--CA 1.525 3.321 0 C-N-CA 123.059 0.543 . . . . 0.0 109.585 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.3 t -63.82 -18.91 64.6 Favored 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 123.946 0.899 . . . . 0.0 112.376 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 50.5 tp -70.56 -14.82 62.66 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.673 0.789 . . . . 0.0 110.95 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 mp -87.21 -0.91 57.44 Favored 'General case' 0 N--CA 1.534 3.754 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.619 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -163.23 82.48 0.48 Allowed 'General case' 0 N--CA 1.538 3.949 0 CA-C-N 119.042 0.837 . . . . 0.0 112.3 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -145.61 -8.37 0.57 Allowed 'General case' 0 N--CA 1.538 3.927 0 C-N-CA 125.038 1.335 . . . . 0.0 108.595 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -70.43 149.96 46.72 Favored 'General case' 0 N--CA 1.527 3.402 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.32 138.38 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 124.82 1.248 . . . . 0.0 108.368 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.9 pp -94.67 146.51 31.56 Favored Pre-proline 0 N--CA 1.528 3.462 0 CA-C-O 117.316 -1.326 . . . . 0.0 108.444 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 1 N--CA 1.539 4.195 0 C-N-CA 122.011 1.807 . . . . 0.0 110.104 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 3.5 ppp? . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 117.746 -1.121 . . . . 0.0 108.172 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.22 153.82 56.65 Favored 'Trans proline' 1 N--CA 1.539 4.151 0 C-N-CA 122.026 1.817 . . . . 0.0 110.157 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -73.6 178.72 41.82 Favored Glycine 0 N--CA 1.516 3.981 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.9 p -168.49 -53.17 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.88 -26.38 68.3 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 123.726 0.81 . . . . 0.0 109.099 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 37.4 t -57.79 -41.32 81.85 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 123.815 0.846 . . . . 0.0 112.248 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -35.48 79.71 Favored Glycine 1 N--CA 1.521 4.348 0 C-N-CA 123.883 0.754 . . . . 0.0 112.978 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.25 -46.29 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 C-N-CA 123.97 0.908 . . . . 0.0 112.845 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.11 -32.18 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 121.986 -0.446 . . . . 0.0 110.786 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.8 -33.75 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 C-N-CA 123.437 0.695 . . . . 0.0 110.185 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.32 84.8 Favored Glycine 1 N--CA 1.521 4.301 0 CA-C-O 119.941 -0.366 . . . . 0.0 113.851 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.7 m -60.0 -36.75 69.1 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.343 0 CA-C-N 117.762 0.781 . . . . 0.0 110.784 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -55.47 -45.28 76.97 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.502 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 42.6 t -65.73 -37.96 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 C-N-CA 124.151 0.98 . . . . 0.0 111.46 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.95 -42.44 65.48 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.34 83.4 Favored 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 123.126 0.57 . . . . 0.0 111.184 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.4 t -64.29 -42.93 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.442 0.697 . . . . 0.0 110.934 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.2 -40.93 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 C-N-CA 123.144 0.578 . . . . 0.0 110.291 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.39 -38.5 91.39 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.928 0.491 . . . . 0.0 110.466 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.4 mt -56.97 -36.41 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.772 0 C-N-CA 123.441 0.696 . . . . 0.0 110.692 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 50.4 t -61.91 -37.94 79.44 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 C-N-CA 122.737 0.415 . . . . 0.0 110.469 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -31.85 68.71 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.563 0.745 . . . . 0.0 111.754 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.63 -34.73 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 C-N-CA 122.948 0.499 . . . . 0.0 111.393 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -67.59 -44.1 78.94 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.8 -37.43 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.954 0 CA-C-N 118.713 0.688 . . . . 0.0 109.903 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 76.4 m -66.12 -33.1 75.02 Favored 'General case' 0 N--CA 1.522 3.154 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.085 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -70.01 -41.24 74.6 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 123.276 0.631 . . . . 0.0 110.219 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 95.9 p -66.34 -30.21 70.57 Favored 'General case' 0 N--CA 1.53 3.539 0 C-N-CA 123.284 0.633 . . . . 0.0 109.766 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -14.32 45.25 Favored 'General case' 0 N--CA 1.531 3.618 0 C-N-CA 124.543 1.137 . . . . 0.0 110.255 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 32.5 mt -86.66 5.05 37.9 Favored 'General case' 0 N--CA 1.537 3.877 0 C-N-CA 123.241 0.617 . . . . 0.0 110.826 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -168.33 122.31 0.9 Allowed 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.558 0.743 . . . . 0.0 109.085 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -139.24 -0.64 1.8 Allowed 'General case' 0 N--CA 1.531 3.613 0 C-N-CA 124.81 1.244 . . . . 0.0 109.546 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -167.02 155.29 9.74 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.61 138.27 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 C-N-CA 124.886 1.275 . . . . 0.0 108.963 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.85 147.28 33.22 Favored Pre-proline 0 N--CA 1.526 3.346 0 C-N-CA 125.312 1.445 . . . . 0.0 108.329 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 1 N--CA 1.541 4.307 0 C-N-CA 121.991 1.794 . . . . 0.0 110.758 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.574 1.883 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -69.63 165.19 31.65 Favored 'Trans proline' 1 N--CA 1.54 4.259 0 C-N-CA 122.281 1.987 . . . . 0.0 110.378 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.07 178.65 15.93 Favored Glycine 1 N--CA 1.517 4.038 0 C-N-CA 123.723 0.677 . . . . 0.0 112.036 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 98.7 p -167.19 39.15 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.125 0 C-N-CA 124.222 1.009 . . . . 0.0 108.395 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.7 -26.81 68.27 Favored 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 124.31 1.044 . . . . 0.0 111.038 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 68.5 m -60.39 -26.53 66.73 Favored 'General case' 0 N--CA 1.528 3.463 0 C-N-CA 123.427 0.691 . . . . 0.0 110.647 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.09 -34.96 81.83 Favored Glycine 0 N--CA 1.512 3.767 0 C-N-CA 124.944 1.259 . . . . 0.0 115.015 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 14.4 tt -59.75 -35.76 61.93 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -175.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 1.9 pp -56.81 -47.76 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.0 tt -73.26 -33.5 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.32 -46.55 93.67 Favored Glycine 0 N--CA 1.513 3.782 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.979 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.59 -37.39 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 CA-C-N 117.615 0.707 . . . . 0.0 110.847 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 28.3 p -66.11 -46.1 78.77 Favored 'General case' 0 N--CA 1.526 3.371 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -69.93 -31.68 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.94 68.96 Favored 'General case' 0 N--CA 1.528 3.46 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.0 -49.97 58.36 Favored 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 22.0 m -66.95 -38.26 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 CA-C-N 118.534 0.606 . . . . 0.0 111.902 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.07 -32.74 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 122.504 0.322 . . . . 0.0 110.136 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.28 -41.43 94.18 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 122.602 0.361 . . . . 0.0 110.589 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 73.7 mt -56.85 -36.41 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 C-N-CA 122.889 0.476 . . . . 0.0 110.579 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.95 -37.28 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 C-N-CA 122.985 0.514 . . . . 0.0 110.517 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -31.88 66.96 Favored 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.53 0.732 . . . . 0.0 112.224 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.9 -34.92 73.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 O-C-N 121.587 -0.696 . . . . 0.0 110.469 -178.547 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -64.24 -44.58 91.41 Favored 'General case' 0 N--CA 1.527 3.409 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 16.0 m -69.07 -37.6 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-O 121.29 0.567 . . . . 0.0 109.742 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -66.46 -30.42 70.76 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -74.32 -40.12 62.43 Favored 'General case' 0 N--CA 1.525 3.285 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 70.9 m -65.07 -35.55 81.51 Favored 'General case' 0 N--CA 1.523 3.196 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.204 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.21 -14.23 24.09 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 124.082 0.953 . . . . 0.0 111.194 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 21.9 mt -87.56 10.15 18.78 Favored 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 123.263 0.625 . . . . 0.0 109.412 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -25.33 134.91 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.068 0 C-N-CA 125.629 1.572 . . . . 0.0 113.427 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -132.43 166.84 21.09 Favored 'General case' 0 N--CA 1.526 3.36 0 C-N-CA 124.191 0.996 . . . . 0.0 109.698 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -67.63 -171.71 0.21 Allowed 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 124.14 0.976 . . . . 0.0 110.452 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.88 130.06 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 52.3 tp -133.43 99.83 14.22 Favored Pre-proline 0 N--CA 1.531 3.605 0 C-N-CA 124.981 1.312 . . . . 0.0 107.975 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 1 N--CA 1.536 4.022 0 C-N-CA 122.351 2.034 . . . . 0.0 110.926 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.577 1.982 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -85.25 28.07 0.58 Allowed 'Trans proline' 0 N--CA 1.535 3.949 0 C-N-CA 122.89 2.393 . . . . 0.0 110.769 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.13 14.1 65.58 Favored Glycine 1 N--CA 1.519 4.228 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.19 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 50.0 m 55.08 88.04 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 124.126 0.97 . . . . 0.0 111.829 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 tp -64.98 -35.74 82.17 Favored 'General case' 0 N--CA 1.527 3.424 0 C-N-CA 123.881 0.872 . . . . 0.0 109.971 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.0 m -67.2 -30.39 70.31 Favored 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 123.778 0.831 . . . . 0.0 110.446 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -47.0 57.97 Favored Glycine 0 N--CA 1.513 3.829 0 CA-C-N 115.526 -0.761 . . . . 0.0 114.334 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 34.6 pt -71.35 -39.7 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -176.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.2 tt -62.79 -39.77 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.62 -33.08 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.9 -29.12 50.13 Favored Glycine 0 N--CA 1.515 3.96 0 C-N-CA 123.609 0.623 . . . . 0.0 113.363 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.3 m -59.53 -46.28 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 5.3 t -66.11 -38.79 89.06 Favored 'General case' 0 N--CA 1.536 3.832 0 CA-C-O 121.045 0.45 . . . . 0.0 111.067 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.1 -39.61 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.183 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.66 72.68 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 123.461 0.704 . . . . 0.0 111.05 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.82 87.67 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 123.499 0.719 . . . . 0.0 111.224 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.33 -48.42 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 C-N-CA 123.269 0.627 . . . . 0.0 110.089 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.73 -36.77 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.561 0 C-N-CA 123.766 0.826 . . . . 0.0 110.9 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 22.4 mt -65.04 -34.35 78.21 Favored 'General case' 0 N--CA 1.534 3.727 0 C-N-CA 122.898 0.479 . . . . 0.0 110.591 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.98 -39.64 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.74 -37.87 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.514 0 C-N-CA 123.262 0.625 . . . . 0.0 109.601 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.28 83.29 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.748 0.819 . . . . 0.0 112.623 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.83 -34.35 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.594 0 O-C-N 121.897 -0.502 . . . . 0.0 110.215 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -63.8 -43.92 94.86 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 123.141 0.577 . . . . 0.0 112.517 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.39 -37.25 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 77.4 m -60.03 -28.42 67.73 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 122.658 0.383 . . . . 0.0 111.367 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -74.09 -28.65 61.48 Favored 'General case' 0 N--CA 1.531 3.602 0 C-N-CA 122.653 0.381 . . . . 0.0 110.817 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 57.9 m -67.41 -17.69 64.82 Favored 'General case' 0 N--CA 1.53 3.569 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.78 -38.54 67.25 Favored 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 124.126 0.97 . . . . 0.0 110.459 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 pp -87.93 -4.14 58.85 Favored 'General case' 1 N--CA 1.553 4.687 0 CA-C-N 118.767 0.712 . . . . 0.0 111.923 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -69.68 -11.84 61.16 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.518 0.727 . . . . 0.0 110.717 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -64.91 -26.09 68.17 Favored 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 124.009 0.924 . . . . 0.0 111.39 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -74.83 72.03 2.03 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.59 0.756 . . . . 0.0 109.852 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.48 135.82 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 124.591 1.157 . . . . 0.0 108.178 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.9 mp -94.88 116.48 66.42 Favored Pre-proline 0 N--CA 1.527 3.417 0 CA-C-O 116.568 -1.682 . . . . 0.0 106.917 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 1 N--CA 1.538 4.093 0 CA-C-N 123.325 2.223 . . . . 0.0 110.66 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 CA--C 1.579 2.084 0 CA-C-O 117.753 -1.117 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.77 -18.64 9.31 Favored 'Trans proline' 1 N--CA 1.548 4.684 0 CA-C-N 122.283 1.851 . . . . 0.0 113.331 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.48 -170.84 50.23 Favored Glycine 1 N--CA 1.518 4.12 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 70.2 m -159.7 40.61 0.2 Allowed 'General case' 0 N--CA 1.518 2.956 0 C-N-CA 124.084 0.954 . . . . 0.0 108.736 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.04 -35.07 79.99 Favored 'General case' 0 N--CA 1.527 3.4 0 C-N-CA 124.533 1.133 . . . . 0.0 109.741 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 70.7 m -57.14 -26.04 59.88 Favored 'General case' 0 N--CA 1.525 3.318 0 C-N-CA 123.725 0.81 . . . . 0.0 110.523 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.46 -34.45 59.82 Favored Glycine 0 N--CA 1.509 3.504 0 C-N-CA 124.929 1.252 . . . . 0.0 114.979 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 16.2 pt -59.15 -34.67 54.2 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.12 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -175.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 8.9 pt -56.15 -45.57 80.84 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.265 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 5.8 tp -72.37 -33.87 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.26 -48.27 84.48 Favored Glycine 1 N--CA 1.517 4.039 0 C-N-CA 123.89 0.757 . . . . 0.0 113.706 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.29 -37.32 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.771 0 O-C-N 121.763 -0.845 . . . . 0.0 109.628 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 25.3 m -66.26 -45.75 79.47 Favored 'General case' 0 N--CA 1.519 2.978 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 12.8 p -63.59 -31.12 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 CA-C-N 118.203 0.456 . . . . 0.0 110.436 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.1 -47.2 81.64 Favored 'General case' 0 N--CA 1.528 3.453 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.94 73.93 Favored 'General case' 0 N--CA 1.523 3.194 0 C-N-CA 123.556 0.742 . . . . 0.0 112.036 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.83 -38.61 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 C-N-CA 123.366 0.666 . . . . 0.0 110.602 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.32 -44.79 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 C-N-CA 123.154 0.582 . . . . 0.0 110.135 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.73 -34.54 73.07 Favored 'General case' 1 N--CA 1.54 4.028 0 C-N-CA 123.12 0.568 . . . . 0.0 110.752 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.85 -40.1 87.5 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.22 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.65 -41.94 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 122.989 0.516 . . . . 0.0 109.814 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -41.06 82.09 Favored 'General case' 0 N--CA 1.527 3.406 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 19.0 m -71.17 -33.74 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 O-C-N 121.709 -0.619 . . . . 0.0 110.062 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -66.26 -43.92 85.14 Favored 'General case' 0 N--CA 1.528 3.463 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.76 -37.89 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 CA-C-N 118.327 0.512 . . . . 0.0 111.082 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 10.1 p -58.68 -27.51 64.88 Favored 'General case' 0 N--CA 1.531 3.616 0 C-N-CA 122.367 0.267 . . . . 0.0 111.499 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -61.27 -31.16 70.98 Favored 'General case' 0 N--CA 1.521 3.113 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.05 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 71.2 p -66.0 -38.06 87.52 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.459 0.704 . . . . 0.0 110.607 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 61.0 mt -60.77 -13.34 14.55 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 123.638 0.775 . . . . 0.0 111.901 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 26.8 mt -86.04 -7.65 58.48 Favored 'General case' 0 N--CA 1.534 3.727 0 C-N-CA 123.054 0.542 . . . . 0.0 110.366 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -70.67 -106.65 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.235 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 53.18 23.08 2.9 Favored 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 123.845 0.858 . . . . 0.0 111.94 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 24.7 tptm 61.01 121.65 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.341 0 C-N-CA 124.731 1.213 . . . . 0.0 110.537 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.81 138.06 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.613 0 C-N-CA 124.928 1.291 . . . . 0.0 108.985 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.669 HD23 ' H ' ' D' ' 241' ' ' LEU . 1.6 pt? -106.03 146.5 33.03 Favored Pre-proline 0 N--CA 1.535 3.793 0 C-N-CA 125.29 1.436 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo . . . . . 1 N--CA 1.542 4.327 0 CA-C-N 122.267 1.845 . . . . 0.0 110.597 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.573 1.83 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.83 -179.66 4.44 Favored 'Trans proline' 1 N--CA 1.539 4.192 0 C-N-CA 122.139 1.893 . . . . 0.0 110.46 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.65 88.99 0.14 Allowed Glycine 1 N--CA 1.519 4.189 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 66.5 m -63.55 165.14 8.4 Favored 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.918 0.887 . . . . 0.0 111.347 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.24 -26.25 68.03 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 124.495 1.118 . . . . 0.0 109.945 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.4 p -57.32 -25.96 60.17 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.404 0.682 . . . . 0.0 110.975 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.11 -35.24 68.83 Favored Glycine 0 N--CA 1.516 3.998 0 C-N-CA 123.837 0.732 . . . . 0.0 113.755 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 7.6 pt -60.28 -44.04 94.81 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.203 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 215' ' ' ILE . . . . . 0.514 ' O ' HG12 ' E' ' 218' ' ' VAL . 6.1 pt -67.68 -32.47 56.93 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.284 0 C-N-CA 122.934 0.493 . . . . 0.0 110.26 -178.207 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 47.7 mm -72.08 -32.7 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.601 0 C-N-CA 124.674 1.189 . . . . 0.0 108.79 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.93 -29.13 64.47 Favored Glycine 1 N--CA 1.518 4.13 0 C-N-CA 123.529 0.585 . . . . 0.0 113.26 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 218' ' ' VAL . . . . . 0.514 HG12 ' O ' ' E' ' 215' ' ' ILE . 9.8 p -59.71 -47.55 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 9.0 t -66.36 -38.96 88.79 Favored 'General case' 0 N--CA 1.537 3.899 0 O-C-N 121.827 -0.546 . . . . 0.0 111.196 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.17 -31.82 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 C-N-CA 123.511 0.724 . . . . 0.0 110.431 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.89 76.88 Favored 'General case' 0 N--CA 1.529 3.504 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.68 74.74 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 122.86 0.464 . . . . 0.0 111.459 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.7 -45.52 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 123.291 0.636 . . . . 0.0 112.296 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.24 -32.55 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 C-N-CA 122.352 0.261 . . . . 0.0 111.652 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.5 -34.85 78.83 Favored 'General case' 1 N--CA 1.541 4.117 0 O-C-N 122.098 -0.376 . . . . 0.0 110.255 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.39 -37.94 80.86 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.08 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.06 -37.86 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.5 0 C-N-CA 123.248 0.619 . . . . 0.0 109.975 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.24 96.6 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 17.2 m -71.66 -33.96 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.741 0 O-C-N 121.613 -0.679 . . . . 0.0 109.703 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -63.47 -43.75 96.4 Favored 'General case' 0 N--CA 1.529 3.483 0 C-N-CA 123.062 0.545 . . . . 0.0 112.309 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.41 -37.41 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.351 0.523 . . . . 0.0 109.631 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 79.1 m -60.21 -27.93 67.57 Favored 'General case' 0 N--CA 1.525 3.283 0 C-N-CA 123.143 0.577 . . . . 0.0 111.018 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.71 -35.02 79.55 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 122.796 0.438 . . . . 0.0 110.243 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 68.0 m -73.72 -36.27 65.19 Favored 'General case' 0 N--CA 1.523 3.185 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -17.75 63.65 Favored 'General case' 0 N--CA 1.529 3.501 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.827 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.11 -26.67 23.54 Favored 'General case' 0 N--CA 1.536 3.842 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -78.89 66.36 4.34 Favored 'General case' 0 N--CA 1.52 3.059 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.1 170.17 3.85 Favored 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 123.913 0.885 . . . . 0.0 110.759 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.75 -14.84 62.11 Favored 'General case' 0 N--CA 1.526 3.36 0 C-N-CA 123.996 0.918 . . . . 0.0 111.156 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.57 138.28 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 C-N-CA 125.316 1.446 . . . . 0.0 108.874 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.44 146.56 31.73 Favored Pre-proline 0 N--CA 1.53 3.56 0 CA-C-O 116.579 -1.677 . . . . 0.0 106.989 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 1 N--CA 1.55 4.8 0 C-N-CA 123.05 2.5 . . . . 0.0 114.933 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 CA--C 1.569 1.704 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.68 168.13 25.3 Favored 'Trans proline' 1 N--CA 1.539 4.192 0 C-N-CA 122.063 1.842 . . . . 0.0 110.168 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 173.97 -12.74 0.04 OUTLIER Glycine 1 N--CA 1.522 4.408 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 64.8 m -68.56 89.79 0.37 Allowed 'General case' 0 N--CA 1.52 3.034 0 C-N-CA 123.762 0.825 . . . . 0.0 110.962 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.17 -26.38 68.14 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.915 0.886 . . . . 0.0 110.245 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 57.0 m -61.65 -26.78 68.22 Favored 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 123.653 0.781 . . . . 0.0 111.062 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.9 -47.5 54.49 Favored Glycine 1 N--CA 1.518 4.128 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.902 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 45.3 pt -72.33 -40.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -44.92 95.35 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.276 0 C-N-CA 123.194 0.597 . . . . 0.0 111.876 -175.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 6.4 tp -63.21 -32.62 57.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 C-N-CA 123.278 0.631 . . . . 0.0 109.382 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.31 -29.99 63.9 Favored Glycine 0 N--CA 1.513 3.802 0 CA-C-O 119.346 -0.697 . . . . 0.0 113.855 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.0 m -62.2 -47.21 94.16 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 CA-C-N 118.528 1.164 . . . . 0.0 112.045 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -38.82 89.24 Favored 'General case' 0 N--CA 1.536 3.872 0 C-N-CA 122.202 0.201 . . . . 0.0 110.766 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.78 -39.94 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.55 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.6 83.01 Favored 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 123.198 0.599 . . . . 0.0 111.136 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.66 85.64 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.173 0.589 . . . . 0.0 112.175 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.85 -41.15 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 122.909 0.483 . . . . 0.0 110.962 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.05 -41.89 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 C-N-CA 123.143 0.577 . . . . 0.0 110.852 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.7 -37.33 86.07 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 122.606 0.362 . . . . 0.0 111.667 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.76 -44.01 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.3 -40.3 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.73 -45.11 93.16 Favored 'General case' 0 N--CA 1.525 3.31 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.53 -34.05 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.703 0 O-C-N 121.633 -0.667 . . . . 0.0 109.788 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -63.06 -44.32 96.15 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 21.3 m -69.05 -37.88 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 CA-C-O 121.159 0.505 . . . . 0.0 109.841 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 76.3 m -65.54 -33.82 76.81 Favored 'General case' 0 N--CA 1.521 3.08 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.083 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -74.15 -39.75 63.06 Favored 'General case' 0 N--CA 1.537 3.898 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 58.6 m -63.75 -30.11 71.24 Favored 'General case' 0 N--CA 1.52 3.054 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.063 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.77 -21.62 66.51 Favored 'General case' 0 N--CA 1.526 3.364 0 C-N-CA 123.013 0.525 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -98.49 -15.81 19.44 Favored 'General case' 1 N--CA 1.548 4.459 0 C-N-CA 124.017 0.927 . . . . 0.0 110.472 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -68.12 3.53 1.59 Allowed 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.356 0.662 . . . . 0.0 111.624 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -166.02 -28.03 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 122.847 0.459 . . . . 0.0 110.941 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt 63.24 138.81 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 124.275 1.03 . . . . 0.0 110.531 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 56.1 t -134.92 136.96 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.553 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 3.8 tt -133.16 99.83 14.57 Favored Pre-proline 0 N--CA 1.534 3.751 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 1 N--CA 1.536 4.012 0 C-N-CA 122.529 2.153 . . . . 0.0 111.114 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 59.2 tpp . . . . . 0 CA--C 1.577 2.009 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -79.6 -33.35 1.3 Allowed 'Trans proline' 0 N--CA 1.536 3.995 0 C-N-CA 122.454 2.103 . . . . 0.0 110.497 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.37 43.0 95.71 Favored Glycine 1 N--CA 1.519 4.217 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.247 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.0 m -74.63 40.39 0.14 Allowed 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 123.911 0.884 . . . . 0.0 110.571 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.0 -37.48 87.8 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 124.474 1.11 . . . . 0.0 109.978 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 45.2 t -68.61 -26.5 65.39 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.333 0.653 . . . . 0.0 110.702 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.66 -46.59 60.85 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 117.579 1.792 . . . . 0.0 117.579 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.8 -35.66 61.25 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.694 0 CA-C-N 119.612 1.706 . . . . 0.0 113.57 -175.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.54 -38.11 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.543 0 C-N-CA 123.55 0.74 . . . . 0.0 111.997 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 15.2 tt -71.41 -32.86 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.78 -28.87 48.41 Favored Glycine 1 N--CA 1.516 4.003 0 C-N-CA 124.057 0.837 . . . . 0.0 113.243 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.8 m -68.0 -37.27 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 CA-C-N 117.721 0.76 . . . . 0.0 110.407 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.8 p -60.56 -46.08 91.53 Favored 'General case' 0 N--CA 1.527 3.42 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.723 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.24 -31.85 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 C-N-CA 122.73 0.412 . . . . 0.0 110.493 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.44 -34.12 77.05 Favored 'General case' 0 N--CA 1.525 3.297 0 C-N-CA 123.091 0.556 . . . . 0.0 111.456 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.84 -50.24 44.67 Favored 'General case' 0 N--CA 1.519 2.995 0 C-N-CA 122.96 0.504 . . . . 0.0 111.914 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.96 -44.28 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 C-N-CA 123.365 0.666 . . . . 0.0 112.562 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.53 -32.66 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.603 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.24 -42.14 76.03 Favored 'General case' 0 N--CA 1.533 3.689 0 CA-C-N 118.613 0.642 . . . . 0.0 110.34 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.3 mt -54.8 -35.95 35.32 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 O-C-N 122.055 -0.403 . . . . 0.0 110.455 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.46 -37.17 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 O-C-N 121.763 -0.586 . . . . 0.0 110.374 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.87 -33.0 68.24 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.49 -34.54 53.42 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.188 0 CA-C-N 119.145 0.884 . . . . 0.0 110.611 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.96 -44.16 97.34 Favored 'General case' 0 N--CA 1.53 3.551 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.0 -37.6 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.693 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 71.6 m -64.27 -27.85 69.32 Favored 'General case' 0 N--CA 1.527 3.4 0 C-N-CA 123.151 0.58 . . . . 0.0 111.149 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -62.74 -22.88 66.87 Favored 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 122.992 0.517 . . . . 0.0 110.903 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 45.5 t -66.67 -46.2 76.43 Favored 'General case' 0 N--CA 1.525 3.29 0 CA-C-O 121.582 0.706 . . . . 0.0 110.565 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.98 -12.93 13.01 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 125.375 1.47 . . . . 0.0 112.471 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 54.9 tp -85.93 -28.36 24.36 Favored 'General case' 1 N--CA 1.547 4.403 0 C-N-CA 123.25 0.62 . . . . 0.0 111.303 -175.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 -121.26 63.17 0.89 Allowed 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -138.09 21.04 2.81 Favored 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.245 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -158.75 -11.34 0.07 Allowed 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.974 0.909 . . . . 0.0 109.685 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.54 133.22 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.557 0 C-N-CA 125.279 1.432 . . . . 0.0 107.297 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 51.9 tp -107.69 99.33 28.86 Favored Pre-proline 0 N--CA 1.531 3.593 0 C-N-CA 125.023 1.329 . . . . 0.0 108.31 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo . . . . . 1 N--CA 1.548 4.692 0 C-N-CA 122.273 1.982 . . . . 0.0 114.169 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 48.7 ttm . . . . . 0 CA--C 1.574 1.896 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -80.08 -167.11 0.46 Allowed 'Trans proline' 0 N--CA 1.534 3.891 0 C-N-CA 122.556 2.17 . . . . 0.0 110.32 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.34 57.89 4.5 Favored Glycine 1 N--CA 1.516 4.006 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 97.7 p -167.22 -15.26 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.249 0 C-N-CA 124.036 0.934 . . . . 0.0 109.9 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.88 -26.77 68.46 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.976 0.911 . . . . 0.0 109.581 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 90.5 p -68.55 -26.19 65.29 Favored 'General case' 0 N--CA 1.522 3.143 0 C-N-CA 123.44 0.696 . . . . 0.0 110.43 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.36 -44.05 76.02 Favored Glycine 0 N--CA 1.516 3.975 0 C-N-CA 123.737 0.684 . . . . 0.0 114.08 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.87 -36.0 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.791 0 O-C-N 121.67 -0.9 . . . . 0.0 112.14 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 13.9 pt -67.55 -37.17 78.31 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.398 0 CA-C-N 119.001 0.818 . . . . 0.0 111.84 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 46.3 pt -72.26 -33.07 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.11 -45.31 82.51 Favored Glycine 0 N--CA 1.513 3.775 0 C-N-CA 124.419 1.009 . . . . 0.0 114.992 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.58 -37.2 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.734 0 CA-C-N 117.76 0.78 . . . . 0.0 111.163 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.0 p -65.28 -46.11 81.74 Favored 'General case' 0 N--CA 1.533 3.679 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.81 -30.63 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.485 0 C-N-CA 123.158 0.583 . . . . 0.0 111.174 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.81 -35.44 63.9 Favored 'General case' 0 N--CA 1.525 3.3 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -50.32 39.63 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 24.9 m -66.11 -38.24 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.8 -31.98 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.462 0.573 . . . . 0.0 111.859 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.59 -34.74 72.5 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 118.236 0.471 . . . . 0.0 110.746 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.1 -49.37 84.34 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.067 0 CA-C-N 118.065 0.393 . . . . 0.0 111.668 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.6 -37.28 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 O-C-N 121.721 -0.612 . . . . 0.0 109.957 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.48 79.97 Favored 'General case' 0 N--CA 1.524 3.26 0 C-N-CA 123.593 0.757 . . . . 0.0 112.811 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.63 -34.37 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 O-C-N 121.86 -0.525 . . . . 0.0 110.291 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -64.41 -44.21 91.97 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 122.964 0.506 . . . . 0.0 112.332 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.8 -37.91 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.826 0 CA-C-N 118.201 0.455 . . . . 0.0 109.781 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 75.2 m -65.64 -27.69 68.56 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 123.341 0.656 . . . . 0.0 111.211 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -63.82 -29.96 71.1 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 123.134 0.574 . . . . 0.0 110.725 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 54.8 m -64.16 -40.01 95.22 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.252 0.621 . . . . 0.0 110.517 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.88 -21.46 64.25 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.691 0.796 . . . . 0.0 110.251 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.5 tp -87.53 -28.32 22.06 Favored 'General case' 0 N--CA 1.534 3.727 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -77.79 52.7 1.05 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -64.66 -11.49 36.08 Favored 'General case' 0 N--CA 1.525 3.278 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.246 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -68.19 142.35 55.71 Favored 'General case' 0 N--CA 1.524 3.239 0 C-N-CA 123.797 0.839 . . . . 0.0 109.631 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 59.3 t -134.32 138.14 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.557 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 8.7 mp -94.69 106.87 26.85 Favored Pre-proline 0 N--CA 1.527 3.384 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo . . . . . 1 N--CA 1.536 4.012 0 CA-C-N 122.819 2.042 . . . . 0.0 110.858 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.577 1.991 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -77.14 78.93 3.28 Favored 'Trans proline' 1 N--CA 1.537 4.034 0 C-N-CA 122.444 2.096 . . . . 0.0 110.362 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.58 63.59 3.81 Favored Glycine 1 N--CA 1.518 4.153 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 97.0 p -86.02 47.71 1.5 Allowed 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 124.145 0.978 . . . . 0.0 109.605 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -54.36 -26.56 30.74 Favored 'General case' 0 N--CA 1.532 3.646 0 C-N-CA 123.785 0.834 . . . . 0.0 112.224 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 98.3 p -63.6 -36.45 83.86 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.825 0.85 . . . . 0.0 110.312 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.0 -35.75 79.55 Favored Glycine 0 N--CA 1.515 3.965 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.074 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 39.2 mm -70.31 -46.44 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 C-N-CA 124.164 0.986 . . . . 0.0 112.77 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 tt -64.53 -37.5 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.965 0 CA-C-N 118.207 0.458 . . . . 0.0 111.857 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.76 -32.22 39.75 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.13 -28.75 42.67 Favored Glycine 0 N--CA 1.512 3.714 0 C-N-CA 124.41 1.005 . . . . 0.0 113.198 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.34 -37.12 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 CA-C-N 117.383 0.592 . . . . 0.0 110.576 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 46.0 p -62.15 -45.14 94.75 Favored 'General case' 0 N--CA 1.529 3.509 0 CA-C-O 121.743 0.783 . . . . 0.0 110.319 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.86 -31.44 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 124.971 1.308 . . . . 0.0 111.447 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.07 75.69 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.361 0.664 . . . . 0.0 111.869 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.7 -46.78 62.49 Favored 'General case' 0 N--CA 1.521 3.087 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.01 -38.18 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 18.3 m -56.54 -31.33 33.8 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 CA-C-N 118.711 0.687 . . . . 0.0 110.712 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 39.7 tp -52.86 -48.14 67.29 Favored 'General case' 1 N--CA 1.543 4.176 0 CA-C-O 122.138 0.971 . . . . 0.0 109.865 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.78 -38.03 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.49 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.79 -37.64 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.437 0 C-N-CA 123.492 0.717 . . . . 0.0 109.489 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -32.71 68.1 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.216 0.606 . . . . 0.0 111.947 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.34 -43.47 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.12 0.568 . . . . 0.0 111.235 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -62.31 -42.92 99.78 Favored 'General case' 1 N--CA 1.539 4.022 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.03 -37.42 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.724 -0.61 . . . . 0.0 109.929 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 96.7 m -64.89 -27.98 69.23 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 122.657 0.383 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -65.8 -25.93 67.46 Favored 'General case' 0 N--CA 1.532 3.625 0 C-N-CA 123.224 0.609 . . . . 0.0 110.999 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 51.2 m -69.43 -34.08 73.92 Favored 'General case' 0 N--CA 1.525 3.311 0 C-N-CA 123.114 0.566 . . . . 0.0 110.444 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.19 -16.93 60.97 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.584 0.754 . . . . 0.0 110.214 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 57.0 tp -87.62 -20.81 25.84 Favored 'General case' 0 N--CA 1.536 3.864 0 C-N-CA 123.719 0.807 . . . . 0.0 110.218 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.76 -79.7 0.04 OUTLIER 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.808 0.843 . . . . 0.0 110.74 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 58.03 7.66 0.65 Allowed 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 124.206 1.002 . . . . 0.0 112.555 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? 59.82 120.67 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 124.352 1.061 . . . . 0.0 111.335 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.91 137.97 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.579 0 C-N-CA 124.932 1.293 . . . . 0.0 108.116 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.64 146.9 32.28 Favored Pre-proline 0 N--CA 1.53 3.549 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 1 N--CA 1.542 4.337 0 C-N-CA 122.068 1.845 . . . . 0.0 110.888 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.579 2.06 0 CA-C-O 117.541 -1.219 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -90.06 30.8 0.38 Allowed 'Trans proline' 0 N--CA 1.536 3.994 0 C-N-CA 122.703 2.269 . . . . 0.0 110.994 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 69.3 49.79 36.97 Favored Glycine 1 N--CA 1.519 4.224 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 40.5 t -76.34 22.32 0.17 Allowed 'General case' 0 N--CA 1.52 3.041 0 C-N-CA 124.129 0.972 . . . . 0.0 111.501 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 49.7 mt -54.85 -26.71 37.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.015 0.926 . . . . 0.0 111.306 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -59.16 -32.38 69.83 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 123.174 0.59 . . . . 0.0 110.745 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.88 -38.84 89.52 Favored Glycine 1 N--CA 1.516 4.033 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.811 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 214' ' ' ILE . . . . . 0.412 ' N ' HD12 ' D' ' 214' ' ' ILE . 1.5 mp -70.71 -41.1 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.471 0 C-N-CA 124.275 1.03 . . . . 0.0 108.969 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.92 -41.43 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.739 0 C-N-CA 124.326 1.051 . . . . 0.0 111.775 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 6.3 tp -72.73 -32.73 41.88 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.191 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.76 -46.7 91.98 Favored Glycine 1 N--CA 1.518 4.129 0 C-N-CA 123.551 0.596 . . . . 0.0 113.968 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 11.4 m -60.09 -36.46 67.8 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.211 0 CA-C-N 118.325 1.062 . . . . 0.0 111.472 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 22.0 p -55.7 -38.73 70.08 Favored 'General case' 0 N--CA 1.532 3.643 0 C-N-CA 122.988 0.515 . . . . 0.0 111.674 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.73 -37.81 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 C-N-CA 123.247 0.619 . . . . 0.0 110.813 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.87 -36.08 58.59 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 123.561 0.745 . . . . 0.0 112.745 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.53 -50.17 40.47 Favored 'General case' 0 N--CA 1.515 2.804 0 C-N-CA 123.318 0.647 . . . . 0.0 111.07 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.4 -46.03 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.53 0 C-N-CA 123.522 0.729 . . . . 0.0 112.336 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.43 -32.01 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.523 0 C-N-CA 122.537 0.335 . . . . 0.0 111.273 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.09 -41.59 61.44 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 122.435 0.294 . . . . 0.0 110.931 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.34 -42.33 93.23 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.022 0 C-N-CA 122.806 0.442 . . . . 0.0 111.681 -177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.0 -36.83 78.09 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 CA-C-N 118.336 0.517 . . . . 0.0 110.094 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.61 -34.15 72.39 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.858 0.463 . . . . 0.0 111.346 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.93 -39.45 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -62.4 -43.49 98.69 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.527 0.731 . . . . 0.0 112.54 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 14.4 m -68.24 -37.78 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 CA-C-N 118.407 0.549 . . . . 0.0 109.806 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 88.3 m -59.02 -27.73 65.73 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 122.886 0.474 . . . . 0.0 111.082 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -64.56 -30.92 71.95 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 122.836 0.455 . . . . 0.0 110.243 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 24.1 t -64.92 -44.59 89.03 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 123.041 0.536 . . . . 0.0 110.398 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.96 -20.49 65.91 Favored 'General case' 0 N--CA 1.532 3.647 0 C-N-CA 123.477 0.711 . . . . 0.0 110.98 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 36.6 tp -87.75 -3.01 58.98 Favored 'General case' 0 N--CA 1.537 3.889 0 C-N-CA 123.394 0.678 . . . . 0.0 110.944 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -152.37 105.09 2.99 Favored 'General case' 0 N--CA 1.533 3.706 0 C-N-CA 123.037 0.535 . . . . 0.0 111.036 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -151.15 -53.84 0.14 Allowed 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -66.37 150.82 48.3 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 124.053 0.941 . . . . 0.0 109.732 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.2 138.26 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 125.069 1.348 . . . . 0.0 108.149 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.4 98.82 14.93 Favored Pre-proline 0 N--CA 1.533 3.71 0 C-N-CA 124.799 1.24 . . . . 0.0 108.893 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 1 N--CA 1.547 4.658 0 C-N-CA 122.275 1.984 . . . . 0.0 113.866 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 44.3 ttm . . . . . 0 CA--C 1.582 2.191 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -87.16 21.17 1.09 Allowed 'Trans proline' 0 N--CA 1.536 3.971 0 C-N-CA 122.507 2.138 . . . . 0.0 111.294 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.89 -34.83 1.24 Allowed Glycine 1 N--CA 1.519 4.186 0 C-N-CA 123.922 0.772 . . . . 0.0 111.786 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 50.4 m 57.55 67.57 0.95 Allowed 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 124.082 0.953 . . . . 0.0 111.286 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 mt -62.46 -26.35 68.47 Favored 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 124.32 1.048 . . . . 0.0 110.848 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.0 p -64.62 -26.34 68.35 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.143 0.577 . . . . 0.0 110.144 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.81 -46.9 89.5 Favored Glycine 1 N--CA 1.52 4.272 0 CA-C-O 119.523 -0.598 . . . . 0.0 114.095 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 18.8 tt -70.61 -35.61 61.98 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.204 0 CA-C-N 118.549 1.175 . . . . 0.0 109.688 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 46.8 mm -64.63 -42.71 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.753 0 C-N-CA 123.876 0.87 . . . . 0.0 108.834 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 23.0 mm -72.84 -33.39 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.767 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.33 -29.83 57.36 Favored Glycine 0 N--CA 1.513 3.817 0 C-N-CA 124.115 0.864 . . . . 0.0 114.573 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.63 -37.42 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.971 0 CA-C-N 118.113 0.957 . . . . 0.0 111.216 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 67.4 p -61.88 -47.52 84.62 Favored 'General case' 0 N--CA 1.528 3.46 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 10.1 p -70.99 -31.77 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.351 0 C-N-CA 123.02 0.528 . . . . 0.0 111.524 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.36 78.26 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.07 -34.46 77.63 Favored 'General case' 0 N--CA 1.515 2.823 0 C-N-CA 123.276 0.63 . . . . 0.0 111.721 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.22 -53.43 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 122.916 0.486 . . . . 0.0 111.177 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.62 -33.6 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.413 0 O-C-N 121.785 -0.572 . . . . 0.0 111.455 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 40.0 tp -77.2 -38.39 51.6 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 122.908 0.483 . . . . 0.0 112.285 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 16.3 tt -69.35 -38.17 76.87 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.114 0 CA-C-N 118.906 0.775 . . . . 0.0 110.586 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.77 -38.0 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.87 -51.1 71.01 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.281 0.632 . . . . 0.0 112.644 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.85 -34.23 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 C-N-CA 122.533 0.333 . . . . 0.0 110.701 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -70.39 -38.62 74.71 Favored 'General case' 0 N--CA 1.527 3.386 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.1 -37.59 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.625 0 C-N-CA 124.174 0.99 . . . . 0.0 109.464 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -58.72 -34.79 71.73 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 122.655 0.382 . . . . 0.0 110.207 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -74.58 -48.43 26.77 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.863 0.465 . . . . 0.0 110.124 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.5 m -63.68 -25.96 68.45 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 123.419 0.688 . . . . 0.0 111.231 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.43 -14.73 20.73 Favored 'General case' 0 N--CA 1.524 3.257 0 C-N-CA 123.611 0.764 . . . . 0.0 111.193 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 8.6 mp -87.41 -28.38 22.18 Favored 'General case' 0 N--CA 1.538 3.969 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 89.4 m95 53.74 57.7 5.82 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.75 0.82 . . . . 0.0 111.43 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -63.99 107.12 1.17 Allowed 'General case' 0 N--CA 1.524 3.259 0 C-N-CA 123.729 0.812 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -163.63 77.36 0.4 Allowed 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 57.1 t -133.8 138.13 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 57.9 mt -94.51 146.69 31.94 Favored Pre-proline 0 N--CA 1.525 3.308 0 CA-C-O 117.373 -1.298 . . . . 0.0 108.255 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 1 N--CA 1.54 4.216 0 C-N-CA 121.997 1.798 . . . . 0.0 110.82 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 17.0 ptm . . . . . 0 CA--C 1.573 1.846 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -67.98 -43.88 4.52 Favored 'Trans proline' 1 N--CA 1.541 4.306 0 C-N-CA 122.106 1.871 . . . . 0.0 110.634 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.26 -38.38 13.02 Favored Glycine 1 N--CA 1.516 4.003 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 59.5 p 56.02 65.56 1.41 Allowed 'General case' 0 N--CA 1.524 3.229 0 C-N-CA 124.111 0.964 . . . . 0.0 111.261 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.74 -26.8 68.81 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 124.087 0.955 . . . . 0.0 110.121 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 66.0 m -66.23 -32.29 73.62 Favored 'General case' 0 N--CA 1.519 2.985 0 C-N-CA 123.587 0.755 . . . . 0.0 111.061 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.11 -47.53 52.85 Favored Glycine 1 N--CA 1.517 4.056 0 CA-C-N 116.099 -0.5 . . . . 0.0 114.261 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 20.4 tt -71.6 -41.66 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.94 -44.25 82.1 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.272 0 C-N-CA 123.059 0.544 . . . . 0.0 111.737 -176.078 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.1 tt -72.29 -33.16 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.854 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.93 -29.47 51.24 Favored Glycine 0 N--CA 1.512 3.736 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.434 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.69 -37.71 72.27 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 117.495 0.648 . . . . 0.0 110.991 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 72.7 p -62.39 -45.49 92.88 Favored 'General case' 0 N--CA 1.53 3.563 0 CA-C-O 121.648 0.737 . . . . 0.0 110.474 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.21 -31.65 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.094 0 C-N-CA 124.702 1.201 . . . . 0.0 110.814 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.99 -34.72 75.22 Favored 'General case' 0 N--CA 1.531 3.588 0 O-C-N 121.824 -0.547 . . . . 0.0 111.596 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.32 -50.35 70.38 Favored 'General case' 0 N--CA 1.516 2.841 0 C-N-CA 123.51 0.724 . . . . 0.0 112.772 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.03 -38.27 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 CA-C-N 118.373 0.533 . . . . 0.0 111.629 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.22 -34.59 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.827 0 C-N-CA 122.646 0.378 . . . . 0.0 110.664 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 41.3 tp -68.51 -34.46 75.92 Favored 'General case' 0 N--CA 1.533 3.713 0 CA-C-N 118.156 0.434 . . . . 0.0 110.622 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.9 mt -61.82 -35.4 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 C-N-CA 123.683 0.793 . . . . 0.0 109.893 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.34 -35.41 49.0 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.194 0 C-N-CA 123.341 0.657 . . . . 0.0 110.472 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.1 -31.46 63.29 Favored 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 123.468 0.707 . . . . 0.0 112.763 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 4.4 m -57.28 -34.83 46.91 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.123 0 CA-C-N 118.992 0.815 . . . . 0.0 112.682 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -65.2 -43.94 89.97 Favored 'General case' 1 N--CA 1.541 4.094 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.81 -37.14 77.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.019 0 CA-C-N 119.007 0.821 . . . . 0.0 108.982 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 75.5 m -58.37 -27.59 64.36 Favored 'General case' 0 N--CA 1.528 3.429 0 C-N-CA 122.821 0.448 . . . . 0.0 110.909 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.54 -26.14 67.75 Favored 'General case' 0 N--CA 1.53 3.544 0 C-N-CA 122.973 0.509 . . . . 0.0 110.573 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 60.4 p -63.63 -16.89 62.16 Favored 'General case' 0 N--CA 1.534 3.765 0 C-N-CA 123.689 0.796 . . . . 0.0 111.546 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 46.6 tp -59.82 -14.57 15.53 Favored 'General case' 0 N--CA 1.527 3.377 0 C-N-CA 124.284 1.033 . . . . 0.0 112.775 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 pp -86.88 9.01 20.56 Favored 'General case' 1 N--CA 1.545 4.306 0 CA-C-N 118.843 0.747 . . . . 0.0 110.247 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 56.4 m95 58.96 134.64 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.1 0 C-N-CA 124.856 1.262 . . . . 0.0 113.029 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -144.76 63.13 1.31 Allowed 'General case' 0 N--CA 1.525 3.307 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -63.36 -177.1 0.18 Allowed 'General case' 0 N--CA 1.523 3.179 0 C-N-CA 124.335 1.054 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.49 138.07 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.521 0 C-N-CA 124.662 1.185 . . . . 0.0 109.136 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 77.2 mt -102.64 146.92 33.25 Favored Pre-proline 0 N--CA 1.529 3.511 0 C-N-CA 125.097 1.359 . . . . 0.0 108.275 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 1 N--CA 1.541 4.283 0 C-N-CA 121.997 1.798 . . . . 0.0 110.774 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 67.2 mtp . . . . . 0 CA--C 1.574 1.904 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -67.45 -19.24 49.29 Favored 'Trans proline' 1 N--CA 1.543 4.405 0 C-N-CA 122.236 1.957 . . . . 0.0 111.053 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.96 -168.26 6.65 Favored Glycine 1 N--CA 1.519 4.193 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.9 m -162.38 104.73 1.11 Allowed 'General case' 0 N--CA 1.521 3.108 0 C-N-CA 123.708 0.803 . . . . 0.0 108.986 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.27 -26.73 68.56 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.12 0.968 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.8 m -57.64 -26.19 61.26 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.667 0.787 . . . . 0.0 110.921 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.99 -35.62 91.67 Favored Glycine 0 N--CA 1.508 3.466 0 C-N-CA 124.232 0.92 . . . . 0.0 115.205 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.4 tt -68.47 -35.07 68.99 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.286 0 CA-C-N 118.247 1.023 . . . . 0.0 113.55 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.19 -40.61 66.12 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 17.7 tt -73.06 -36.12 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.798 0 O-C-N 121.399 -0.813 . . . . 0.0 109.439 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.94 -43.43 94.9 Favored Glycine 1 N--CA 1.519 4.191 0 C-N-CA 123.37 0.509 . . . . 0.0 114.363 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.83 -36.76 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 CA-C-N 117.907 0.853 . . . . 0.0 110.586 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.2 p -58.38 -44.58 88.97 Favored 'General case' 1 N--CA 1.539 4.008 0 CA-C-N 118.42 0.555 . . . . 0.0 111.118 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.75 -37.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 123.426 0.69 . . . . 0.0 111.405 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.25 -37.03 66.7 Favored 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.2 -50.56 71.33 Favored 'General case' 0 N--CA 1.513 2.682 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.9 m -61.93 -37.8 79.11 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.147 0 CA-C-N 118.529 0.604 . . . . 0.0 111.649 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 56.6 t -59.23 -32.68 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.976 0 O-C-N 121.482 -0.761 . . . . 0.0 110.189 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 73.0 mt -72.82 -34.43 66.83 Favored 'General case' 0 N--CA 1.532 3.639 0 C-N-CA 122.385 0.274 . . . . 0.0 110.294 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.2 -47.8 91.42 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.287 0 C-N-CA 123.039 0.535 . . . . 0.0 111.415 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.51 -36.92 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 O-C-N 121.885 -0.509 . . . . 0.0 110.102 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.99 -49.0 78.33 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.245 0.618 . . . . 0.0 112.304 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.11 -34.28 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.542 0 O-C-N 122.022 -0.424 . . . . 0.0 110.94 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -70.21 -43.1 71.36 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.078 0.551 . . . . 0.0 112.16 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.95 -37.64 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.71 0 O-C-N 122.067 -0.396 . . . . 0.0 111.305 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 20.1 p -67.34 -28.02 67.62 Favored 'General case' 0 N--CA 1.532 3.67 0 CA-C-N 117.886 0.312 . . . . 0.0 110.939 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -67.57 -30.55 70.2 Favored 'General case' 0 N--CA 1.529 3.478 0 C-N-CA 123.217 0.607 . . . . 0.0 110.53 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.7 m -67.4 -27.56 67.18 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 123.356 0.662 . . . . 0.0 110.498 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 235' ' ' LEU . 0.8 OUTLIER -64.4 -14.52 57.02 Favored 'General case' 0 N--CA 1.533 3.702 0 C-N-CA 124.474 1.11 . . . . 0.0 109.908 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 30.2 mt -87.24 2.0 51.41 Favored 'General case' 0 N--CA 1.533 3.714 0 C-N-CA 123.749 0.82 . . . . 0.0 110.578 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -66.48 -2.29 4.49 Favored 'General case' 0 N--CA 1.529 3.525 0 C-N-CA 123.854 0.862 . . . . 0.0 111.001 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -62.22 177.44 0.48 Allowed 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.868 0.867 . . . . 0.0 110.941 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -64.87 153.71 39.41 Favored 'General case' 0 N--CA 1.526 3.335 0 C-N-CA 124.149 0.98 . . . . 0.0 110.097 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.36 138.13 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 C-N-CA 124.927 1.291 . . . . 0.0 108.113 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.66 99.49 38.07 Favored Pre-proline 0 N--CA 1.531 3.581 0 C-N-CA 125.073 1.349 . . . . 0.0 108.191 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo . . . . . 0 N--CA 1.535 3.923 0 C-N-CA 122.591 2.194 . . . . 0.0 110.946 -179.898 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.576 1.949 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.54 -176.22 0.02 OUTLIER 'Trans proline' 1 N--CA 1.547 4.623 0 C-N-CA 122.508 2.138 . . . . 0.0 113.935 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 103.24 67.35 0.75 Allowed Glycine 1 N--CA 1.525 4.629 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 46.5 t -67.06 159.68 28.23 Favored 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.833 0.853 . . . . 0.0 110.788 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.24 -26.98 68.34 Favored 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 124.084 0.954 . . . . 0.0 109.923 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 94.6 p -58.26 -26.37 62.85 Favored 'General case' 0 N--CA 1.529 3.486 0 C-N-CA 123.333 0.653 . . . . 0.0 110.769 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.75 -35.61 75.32 Favored Glycine 0 N--CA 1.508 3.479 0 C-N-CA 124.772 1.177 . . . . 0.0 115.475 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 pt -59.47 -34.65 55.27 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.475 0 CA-C-N 119.039 1.419 . . . . 0.0 113.647 -176.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 1.6 pp -55.78 -35.18 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.976 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 20.0 pt -65.64 -33.74 65.68 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.264 0 CA-C-N 118.849 0.749 . . . . 0.0 109.238 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.77 -38.84 96.11 Favored Glycine 1 N--CA 1.519 4.201 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.26 -47.31 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 123.796 0.838 . . . . 0.0 109.423 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 88.3 m -66.03 -47.66 73.7 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.665 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 71.7 t -70.56 -33.27 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.376 0 C-N-CA 124.054 0.942 . . . . 0.0 111.486 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.87 79.3 Favored 'General case' 0 N--CA 1.534 3.731 0 CA-C-N 118.376 0.534 . . . . 0.0 112.102 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.55 -50.22 59.57 Favored 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.5 m -63.1 -39.07 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.64 -32.72 58.09 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.035 0 CA-C-N 118.723 0.692 . . . . 0.0 110.322 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -44.64 92.14 Favored 'General case' 0 N--CA 1.532 3.639 0 C-N-CA 123.205 0.602 . . . . 0.0 111.056 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.26 -39.74 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.792 0.437 . . . . 0.0 110.456 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.38 -39.34 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.508 0 C-N-CA 122.96 0.504 . . . . 0.0 109.802 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.4 93.9 Favored 'General case' 0 N--CA 1.528 3.46 0 C-N-CA 123.251 0.62 . . . . 0.0 111.961 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 93.0 t -71.65 -34.63 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.602 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.86 -43.87 94.8 Favored 'General case' 0 N--CA 1.526 3.355 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 11.3 m -68.65 -37.81 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 CA-C-N 118.693 0.679 . . . . 0.0 109.718 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.8 m -60.93 -37.18 81.43 Favored 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.844 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -27.25 66.71 Favored 'General case' 0 N--CA 1.537 3.919 0 C-N-CA 122.576 0.35 . . . . 0.0 110.594 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 23.1 t -63.52 -40.84 98.1 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.005 0.522 . . . . 0.0 110.991 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.41 -22.25 66.77 Favored 'General case' 0 N--CA 1.535 3.806 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.17 -4.45 27.22 Favored 'General case' 1 N--CA 1.543 4.222 0 C-N-CA 124.415 1.086 . . . . 0.0 109.378 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -153.34 96.13 2.01 Favored 'General case' 0 N--CA 1.521 3.096 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -134.56 12.56 3.76 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 125.003 1.321 . . . . 0.0 109.575 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt 57.5 -166.26 0.15 Allowed 'General case' 0 N--CA 1.52 3.074 0 C-N-CA 124.187 0.995 . . . . 0.0 111.639 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.2 138.13 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 C-N-CA 125.039 1.336 . . . . 0.0 108.196 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 tt -102.75 100.22 15.81 Favored Pre-proline 0 N--CA 1.535 3.78 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 1 N--CA 1.536 4.029 0 C-N-CA 122.443 2.095 . . . . 0.0 110.993 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.576 1.976 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -68.57 -17.29 43.28 Favored 'Trans proline' 1 N--CA 1.544 4.46 0 C-N-CA 122.213 1.942 . . . . 0.0 111.283 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.87 -96.88 0.02 OUTLIER Glycine 1 N--CA 1.522 4.367 0 C-N-CA 123.53 0.586 . . . . 0.0 112.003 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 23.3 t 59.42 48.3 10.08 Favored 'General case' 0 N--CA 1.522 3.155 0 C-N-CA 124.059 0.944 . . . . 0.0 111.521 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -58.97 -25.82 63.91 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.601 1.16 . . . . 0.0 112.33 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 87.6 p -57.09 -25.73 59.24 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.436 0.694 . . . . 0.0 110.748 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.74 -35.34 62.53 Favored Glycine 0 N--CA 1.515 3.913 0 C-N-CA 124.52 1.057 . . . . 0.0 115.052 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.73 -34.01 62.55 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.427 0 CA-C-N 118.521 1.161 . . . . 0.0 113.872 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 215' ' ' ILE . . . . . 0.498 ' O ' HG12 ' C' ' 218' ' ' VAL . 1.5 pp -55.28 -32.84 29.51 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.115 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -172.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.7 tt -72.64 -32.4 40.97 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.368 0 CA-C-N 119.041 0.837 . . . . 0.0 109.348 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.08 -29.01 43.12 Favored Glycine 0 N--CA 1.515 3.946 0 C-N-CA 124.215 0.912 . . . . 0.0 113.939 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 218' ' ' VAL . . . . . 0.498 HG12 ' O ' ' C' ' 215' ' ' ILE . 15.0 p -58.91 -38.02 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 CA-C-N 117.435 0.618 . . . . 0.0 111.117 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 64.6 p -64.78 -46.09 83.58 Favored 'General case' 0 N--CA 1.529 3.475 0 CA-C-O 121.155 0.502 . . . . 0.0 110.524 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.08 -37.2 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.049 0 C-N-CA 124.078 0.951 . . . . 0.0 110.625 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.71 -39.93 62.49 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.91 65.76 Favored 'General case' 0 N--CA 1.515 2.783 0 C-N-CA 123.127 0.571 . . . . 0.0 111.434 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 44.6 t -61.8 -47.74 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.328 0 C-N-CA 123.225 0.61 . . . . 0.0 112.171 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.6 -32.59 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 C-N-CA 122.404 0.282 . . . . 0.0 111.377 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 38.5 tp -71.52 -34.74 70.33 Favored 'General case' 0 N--CA 1.522 3.173 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 87.1 mt -68.48 -44.85 82.85 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.372 0 CA-C-N 119.645 1.111 . . . . 0.0 110.16 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.11 -35.97 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.945 0.498 . . . . 0.0 109.973 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.12 -38.55 73.62 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.431 0.693 . . . . 0.0 111.904 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.07 -41.13 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 CA-C-O 120.742 0.305 . . . . 0.0 110.282 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -61.5 -43.93 97.99 Favored 'General case' 0 N--CA 1.529 3.498 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.23 -37.42 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.632 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 95.5 m -64.37 -33.52 76.03 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -74.04 -38.0 64.14 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.177 0.591 . . . . 0.0 110.321 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 82.2 p -63.92 -17.04 62.83 Favored 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 123.383 0.673 . . . . 0.0 111.321 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.98 -37.74 88.36 Favored 'General case' 0 N--CA 1.531 3.587 0 C-N-CA 123.963 0.905 . . . . 0.0 111.29 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.19 -2.29 57.53 Favored 'General case' 1 N--CA 1.544 4.231 0 C-N-CA 123.323 0.649 . . . . 0.0 112.2 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -70.98 92.3 0.92 Allowed 'General case' 0 N--CA 1.529 3.516 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.95 142.56 1.88 Allowed 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 124.045 0.938 . . . . 0.0 108.547 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -168.9 103.1 0.39 Allowed 'General case' 0 N--CA 1.52 3.046 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.92 124.5 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 124.884 1.274 . . . . 0.0 107.676 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 56.9 mt -94.54 146.81 32.15 Favored Pre-proline 0 N--CA 1.524 3.258 0 CA-C-O 117.409 -1.281 . . . . 0.0 108.269 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 1 N--CA 1.541 4.309 0 C-N-CA 122.008 1.805 . . . . 0.0 110.587 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 79.2 mtp . . . . . 0 CA--C 1.571 1.771 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.53 160.41 44.37 Favored 'Trans proline' 1 N--CA 1.538 4.106 0 C-N-CA 122.187 1.925 . . . . 0.0 110.259 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.12 -165.61 7.95 Favored Glycine 1 N--CA 1.517 4.072 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 46.7 t -165.35 -25.83 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.153 0 C-N-CA 123.486 0.715 . . . . 0.0 110.339 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 49.3 mt -57.62 -26.77 62.05 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 123.949 0.899 . . . . 0.0 110.866 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 55.4 m -64.14 -35.34 80.45 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.818 0.847 . . . . 0.0 110.787 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.04 -35.02 77.5 Favored Glycine 0 N--CA 1.514 3.863 0 C-N-CA 124.354 0.978 . . . . 0.0 113.056 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 37.0 mm -68.1 -43.61 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.445 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.07 -36.31 50.73 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.213 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 15.8 tt -72.39 -33.16 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.864 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.89 -42.26 99.71 Favored Glycine 1 N--CA 1.518 4.142 0 C-N-CA 123.076 0.37 . . . . 0.0 113.838 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 18.7 m -68.72 -37.17 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.866 0 CA-C-N 118.184 0.992 . . . . 0.0 111.342 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 47.4 p -63.89 -45.78 87.85 Favored 'General case' 0 N--CA 1.53 3.54 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.36 -31.93 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 CA-C-N 118.882 0.765 . . . . 0.0 111.075 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.0 -46.76 82.06 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 122.629 0.371 . . . . 0.0 111.687 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.08 -42.23 85.15 Favored 'General case' 0 N--CA 1.519 2.998 0 C-N-CA 123.485 0.714 . . . . 0.0 111.92 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.58 -44.95 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.462 0 C-N-CA 123.102 0.561 . . . . 0.0 111.209 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.48 -40.38 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 C-N-CA 122.38 0.272 . . . . 0.0 110.626 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.66 -46.55 78.71 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 122.846 0.458 . . . . 0.0 111.603 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 85.7 mt -62.26 -36.99 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 O-C-N 122.029 -0.42 . . . . 0.0 110.585 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.12 -37.55 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.887 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.76 98.57 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.852 0.461 . . . . 0.0 111.202 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.75 -34.66 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.426 0 C-N-CA 123.165 0.586 . . . . 0.0 109.702 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -63.08 -44.1 96.71 Favored 'General case' 0 N--CA 1.53 3.571 0 C-N-CA 123.099 0.56 . . . . 0.0 112.366 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.12 -37.64 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.724 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 85.8 m -61.03 -27.31 68.24 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 123.151 0.58 . . . . 0.0 111.251 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -57.8 -27.19 62.89 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 122.811 0.444 . . . . 0.0 111.251 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 66.1 m -65.97 -41.18 91.51 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 123.78 0.832 . . . . 0.0 111.355 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -60.84 -13.42 15.39 Favored 'General case' 0 N--CA 1.532 3.653 0 C-N-CA 124.338 1.055 . . . . 0.0 111.28 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.45 -23.42 26.03 Favored 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.83 109.82 15.75 Favored 'General case' 0 N--CA 1.527 3.408 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -168.63 166.95 11.68 Favored 'General case' 0 N--CA 1.521 3.102 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.59 172.42 6.26 Favored 'General case' 0 N--CA 1.522 3.142 0 C-N-CA 124.05 0.94 . . . . 0.0 110.866 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.48 138.65 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.284 0 C-N-CA 125.14 1.376 . . . . 0.0 107.728 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 47.9 mt -94.24 122.3 61.77 Favored Pre-proline 0 N--CA 1.524 3.245 0 CA-C-O 116.416 -1.754 . . . . 0.0 108.382 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 1 N--CA 1.549 4.768 0 C-N-CA 122.798 2.332 . . . . 0.0 114.904 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 CA--C 1.574 1.892 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.84 -38.14 67.34 Favored 'Trans proline' 1 N--CA 1.544 4.473 0 C-N-CA 122.382 2.055 . . . . 0.0 113.643 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.93 -176.57 25.34 Favored Glycine 1 N--CA 1.521 4.339 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 45.0 t -165.83 23.87 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 123.178 0.591 . . . . 0.0 110.713 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -61.82 -27.03 68.48 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 123.3 0.64 . . . . 0.0 111.143 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 55.7 m -69.13 -26.1 64.72 Favored 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.984 0.914 . . . . 0.0 109.976 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.34 -46.01 88.32 Favored Glycine 0 N--CA 1.513 3.78 0 CA-C-N 115.394 -0.821 . . . . 0.0 114.256 -177.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 46.6 pt -70.47 -35.63 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 8.6 pt -61.8 -44.45 98.81 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.55 0 CA-C-N 119.249 0.931 . . . . 0.0 111.582 -176.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.33 -32.22 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.871 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.96 -29.4 43.1 Favored Glycine 0 N--CA 1.506 3.302 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.584 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.45 -37.25 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 CA-C-N 117.708 0.754 . . . . 0.0 111.179 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 35.9 p -64.66 -47.61 77.82 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 10.5 p -70.84 -31.24 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.327 0.651 . . . . 0.0 110.987 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.22 65.07 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.07 0.548 . . . . 0.0 112.324 -177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.77 -34.76 69.92 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 123.129 0.571 . . . . 0.0 111.83 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.95 -40.47 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 123.03 0.532 . . . . 0.0 110.307 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.15 -42.08 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.508 0.723 . . . . 0.0 110.746 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 66.6 mt -64.2 -34.58 78.42 Favored 'General case' 0 N--CA 1.528 3.449 0 C-N-CA 122.684 0.394 . . . . 0.0 110.749 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.64 -43.95 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 C-N-CA 122.852 0.461 . . . . 0.0 109.952 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 80.7 t -66.86 -39.2 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.59 -48.03 82.31 Favored 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 123.681 0.792 . . . . 0.0 112.953 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 35.2 m -71.58 -34.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 O-C-N 121.955 -0.465 . . . . 0.0 110.803 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.24 -44.25 92.42 Favored 'General case' 0 N--CA 1.528 3.471 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.96 -37.81 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 83.7 m -66.19 -32.63 74.18 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 122.875 0.47 . . . . 0.0 110.554 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -67.53 -32.2 72.84 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.422 0.689 . . . . 0.0 111.047 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -63.89 -26.8 68.76 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.312 0.645 . . . . 0.0 111.301 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 53.5 mt -70.93 -30.89 67.33 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.379 0.671 . . . . 0.0 110.274 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 9.6 mp -87.96 5.6 39.89 Favored 'General case' 0 N--CA 1.535 3.798 0 C-N-CA 124.175 0.99 . . . . 0.0 110.396 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -73.39 57.68 0.53 Allowed 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.299 0.64 . . . . 0.0 109.452 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -74.8 -175.11 2.38 Favored 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.017 0.927 . . . . 0.0 109.6 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -68.01 149.03 50.22 Favored 'General case' 0 N--CA 1.524 3.239 0 C-N-CA 123.836 0.854 . . . . 0.0 109.499 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.03 138.25 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.568 0 C-N-CA 124.847 1.259 . . . . 0.0 108.361 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 pp -103.09 146.47 32.5 Favored Pre-proline 0 N--CA 1.53 3.567 0 C-N-CA 125.12 1.368 . . . . 0.0 108.623 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo . . . . . 1 N--CA 1.539 4.168 0 C-N-CA 122.053 1.835 . . . . 0.0 110.443 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 23.6 ptt? . . . . . 0 CA--C 1.574 1.869 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -67.13 166.95 21.38 Favored 'Trans proline' 1 N--CA 1.542 4.374 0 C-N-CA 122.182 1.921 . . . . 0.0 110.729 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.76 96.66 0.16 Allowed Glycine 1 N--CA 1.517 4.072 0 C-N-CA 123.703 0.668 . . . . 0.0 112.061 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 69.4 m -67.85 162.02 25.02 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.862 0.865 . . . . 0.0 110.309 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.23 -26.22 68.41 Favored 'General case' 0 N--CA 1.525 3.3 0 C-N-CA 124.014 0.926 . . . . 0.0 111.748 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 40.1 t -66.04 -33.09 75.01 Favored 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 123.609 0.764 . . . . 0.0 111.302 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.74 -45.98 62.99 Favored Glycine 1 N--CA 1.519 4.18 0 N-CA-C 115.047 0.779 . . . . 0.0 115.047 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 8.4 tp -70.85 -40.49 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.888 0 O-C-N 121.653 -0.91 . . . . 0.0 112.319 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 215' ' ' ILE . . . . . 0.479 HD13 ' O ' ' F' ' 215' ' ' ILE . 0.0 OUTLIER -66.01 -36.73 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 C-N-CA 123.207 0.603 . . . . 0.0 111.946 -177.084 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' F' F ' 216' ' ' ILE . . . . . 0.563 HD12 ' N ' ' F' ' 217' ' ' GLY . 1.9 pp -70.92 -31.73 46.34 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.421 0 CA-C-N 119.424 1.011 . . . . 0.0 109.232 177.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' F' F ' 217' ' ' GLY . . . . . 0.563 ' N ' HD12 ' F' ' 216' ' ' ILE . . . -54.49 -29.46 47.6 Favored Glycine 0 N--CA 1.516 3.987 0 C-N-CA 123.845 0.736 . . . . 0.0 113.801 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 218' ' ' VAL . . . . . 0.44 HG12 ' O ' ' F' ' 215' ' ' ILE . 8.2 p -59.74 -39.78 80.68 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.055 0 CA-C-N 117.525 0.663 . . . . 0.0 111.509 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 82.5 p -66.18 -45.91 79.19 Favored 'General case' 0 N--CA 1.53 3.564 0 CA-C-O 121.247 0.546 . . . . 0.0 110.794 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.23 -32.54 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.038 0 C-N-CA 124.24 1.016 . . . . 0.0 110.864 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.65 -45.2 66.6 Favored 'General case' 0 N--CA 1.529 3.498 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.53 -33.46 75.97 Favored 'General case' 0 N--CA 1.523 3.191 0 C-N-CA 123.449 0.7 . . . . 0.0 111.626 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 25.9 t -65.42 -38.62 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.652 0.781 . . . . 0.0 110.934 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.17 -32.52 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 C-N-CA 123.123 0.569 . . . . 0.0 111.185 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 43.2 tp -68.22 -39.26 82.4 Favored 'General case' 0 N--CA 1.526 3.356 0 CA-C-O 120.764 0.316 . . . . 0.0 110.191 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 41.5 mm -54.7 -50.15 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.865 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.742 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 18.7 m -67.04 -37.28 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.896 -0.502 . . . . 0.0 110.214 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.25 93.13 Favored 'General case' 0 N--CA 1.525 3.277 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 15.9 m -71.27 -33.99 52.55 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 CA-C-N 119.223 0.92 . . . . 0.0 110.102 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -64.12 -43.94 93.76 Favored 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 14.3 m -68.74 -37.65 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 CA-C-O 121.007 0.432 . . . . 0.0 109.901 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 91.0 m -58.67 -27.43 64.79 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 123.447 0.699 . . . . 0.0 111.104 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.05 -34.36 78.23 Favored 'General case' 0 N--CA 1.525 3.324 0 C-N-CA 122.335 0.254 . . . . 0.0 110.672 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 79.5 p -68.34 -36.41 79.21 Favored 'General case' 0 N--CA 1.532 3.647 0 C-N-CA 123.181 0.592 . . . . 0.0 110.685 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.85 -13.49 15.89 Favored 'General case' 0 N--CA 1.537 3.902 0 C-N-CA 123.555 0.742 . . . . 0.0 110.964 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 18.2 mt -86.68 0.38 54.72 Favored 'General case' 0 N--CA 1.535 3.811 0 C-N-CA 122.929 0.492 . . . . 0.0 111.383 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -163.92 108.53 1.01 Allowed 'General case' 0 N--CA 1.53 3.552 0 CA-C-N 118.073 0.397 . . . . 0.0 111.248 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -149.51 157.56 43.39 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -172.55 151.85 2.49 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.57 130.01 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.345 0 C-N-CA 124.938 1.295 . . . . 0.0 107.719 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.95 144.79 28.4 Favored Pre-proline 0 N--CA 1.53 3.556 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 1 N--CA 1.538 4.103 0 CA-C-N 122.181 1.815 . . . . 0.0 110.416 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 CA--C 1.575 1.911 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.46 -179.14 0.03 OUTLIER 'Trans proline' 1 N--CA 1.546 4.593 0 C-N-CA 122.426 2.084 . . . . 0.0 113.614 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -167.31 98.8 0.15 Allowed Glycine 1 N--CA 1.519 4.223 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.9 p -166.05 -20.09 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 124.153 0.981 . . . . 0.0 109.387 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.11 -26.41 68.19 Favored 'General case' 0 N--CA 1.528 3.474 0 C-N-CA 124.2 1.0 . . . . 0.0 109.164 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 95.1 p -65.95 -26.96 67.82 Favored 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.547 0.739 . . . . 0.0 110.49 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.12 -46.61 57.67 Favored Glycine 1 N--CA 1.52 4.254 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 8.4 tp -71.17 -41.1 75.41 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.174 0 CA-C-N 118.186 0.993 . . . . 0.0 112.967 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.3 tt -60.87 -35.25 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 123.672 0.789 . . . . 0.0 112.873 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 5.7 tp -73.16 -33.28 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.991 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.43 96.14 Favored Glycine 1 N--CA 1.521 4.311 0 C-N-CA 123.401 0.525 . . . . 0.0 114.219 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.6 p -59.71 -36.84 68.11 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 117.972 0.886 . . . . 0.0 110.787 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.9 p -55.95 -42.15 75.77 Favored 'General case' 0 N--CA 1.535 3.821 0 CA-C-O 120.919 0.39 . . . . 0.0 111.432 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.5 -40.4 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 123.85 0.86 . . . . 0.0 111.601 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.38 -39.91 61.42 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -176.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.54 -46.35 63.74 Favored 'General case' 0 N--CA 1.52 3.054 0 C-N-CA 122.997 0.519 . . . . 0.0 111.185 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.78 -46.62 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 C-N-CA 123.321 0.648 . . . . 0.0 112.385 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.8 p -66.18 -32.28 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.665 0 C-N-CA 122.512 0.325 . . . . 0.0 111.122 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.61 -41.32 96.28 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.584 0.354 . . . . 0.0 110.859 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 88.0 mt -58.62 -36.66 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.916 0 C-N-CA 122.658 0.383 . . . . 0.0 110.287 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.34 -37.69 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 C-N-CA 123.02 0.528 . . . . 0.0 110.324 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.62 -33.25 75.49 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.038 0.535 . . . . 0.0 110.877 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.07 -36.9 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 C-N-CA 123.308 0.643 . . . . 0.0 109.762 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -64.36 -43.45 94.5 Favored 'General case' 0 N--CA 1.528 3.466 0 C-N-CA 123.633 0.773 . . . . 0.0 112.544 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 19.2 m -67.7 -37.23 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 76.8 m -60.24 -38.35 83.19 Favored 'General case' 0 N--CA 1.527 3.392 0 C-N-CA 122.96 0.504 . . . . 0.0 111.26 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -74.27 -40.63 62.2 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 122.64 0.376 . . . . 0.0 110.074 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 83.5 p -63.91 -32.73 74.35 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.15 -23.18 57.77 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.063 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.4 tp -87.11 -22.67 25.24 Favored 'General case' 0 N--CA 1.537 3.919 0 C-N-CA 122.942 0.497 . . . . 0.0 110.16 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -71.45 65.61 0.45 Allowed 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.648 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -143.44 157.9 44.08 Favored 'General case' 0 N--CA 1.526 3.369 0 C-N-CA 124.822 1.249 . . . . 0.0 107.843 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.69 155.93 37.2 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 123.731 0.812 . . . . 0.0 109.216 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.58 137.19 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 124.706 1.203 . . . . 0.0 108.329 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.74 146.58 31.67 Favored Pre-proline 0 N--CA 1.528 3.458 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 1 N--CA 1.54 4.256 0 C-N-CA 121.935 1.756 . . . . 0.0 110.645 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 58.9 mtt . . . . . 0 CA--C 1.585 2.29 0 CA-C-O 117.623 -1.179 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -89.84 -4.38 5.4 Favored 'Trans proline' 1 N--CA 1.536 4.004 0 C-N-CA 122.736 2.291 . . . . 0.0 111.893 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 179.86 93.09 0.09 OUTLIER Glycine 1 N--CA 1.518 4.146 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 47.4 t -64.18 158.0 24.19 Favored 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 123.717 0.807 . . . . 0.0 111.052 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.2 -28.72 69.58 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 124.061 0.944 . . . . 0.0 110.137 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 56.0 m -65.05 -26.88 68.44 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.04 0.536 . . . . 0.0 110.302 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.28 -35.79 91.98 Favored Glycine 1 N--CA 1.524 4.524 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 36.1 mm -68.71 -40.48 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.302 0 C-N-CA 124.583 1.153 . . . . 0.0 109.149 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 48.2 mm -66.46 -40.13 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 C-N-CA 124.538 1.135 . . . . 0.0 108.905 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 14.6 mm -71.38 -31.96 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.97 -29.17 42.58 Favored Glycine 0 N--CA 1.516 3.976 0 C-N-CA 123.708 0.67 . . . . 0.0 113.176 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.59 -37.59 71.31 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.095 0 CA-C-N 117.84 0.82 . . . . 0.0 110.769 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 46.9 p -57.48 -44.79 85.17 Favored 'General case' 0 N--CA 1.528 3.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.824 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.6 t -67.02 -31.79 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 C-N-CA 124.095 0.958 . . . . 0.0 110.875 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.87 79.35 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 122.482 0.313 . . . . 0.0 110.967 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.98 -50.11 74.51 Favored 'General case' 0 N--CA 1.521 3.117 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.37 -38.35 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 CA-C-N 118.224 0.465 . . . . 0.0 111.625 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.2 -38.38 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 118.23 0.468 . . . . 0.0 110.651 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.99 -38.72 92.11 Favored 'General case' 1 N--CA 1.539 4.021 0 C-N-CA 122.55 0.34 . . . . 0.0 110.543 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.78 -42.8 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.818 0 O-C-N 122.005 -0.434 . . . . 0.0 110.221 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 64.6 t -65.52 -37.71 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 C-N-CA 122.964 0.506 . . . . 0.0 110.082 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.56 80.3 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.432 0.693 . . . . 0.0 111.277 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 84.1 t -71.94 -34.88 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.26 0 C-N-CA 122.909 0.484 . . . . 0.0 110.443 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -62.66 -44.46 96.21 Favored 'General case' 0 N--CA 1.534 3.739 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.02 -39.34 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.721 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 73.6 m -67.18 -30.39 70.33 Favored 'General case' 0 N--CA 1.524 3.26 0 C-N-CA 123.115 0.566 . . . . 0.0 110.727 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -73.32 -35.33 66.04 Favored 'General case' 0 N--CA 1.526 3.339 0 C-N-CA 123.249 0.62 . . . . 0.0 110.343 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 62.8 m -63.67 -23.87 67.55 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.554 0.742 . . . . 0.0 111.689 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.95 -24.98 66.13 Favored 'General case' 0 N--CA 1.53 3.557 0 C-N-CA 123.688 0.795 . . . . 0.0 110.285 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.24 -27.2 23.09 Favored 'General case' 0 N--CA 1.535 3.782 0 C-N-CA 123.632 0.773 . . . . 0.0 109.453 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -114.66 102.88 10.44 Favored 'General case' 0 N--CA 1.536 3.835 0 C-N-CA 124.489 1.116 . . . . 0.0 109.35 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -168.37 170.62 9.76 Favored 'General case' 0 N--CA 1.522 3.135 0 C-N-CA 124.003 0.921 . . . . 0.0 109.135 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -166.49 156.01 11.42 Favored 'General case' 0 N--CA 1.524 3.258 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.62 138.09 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.563 0 C-N-CA 125.011 1.324 . . . . 0.0 107.694 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.44 146.78 32.14 Favored Pre-proline 0 N--CA 1.528 3.441 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo . . . . . 1 N--CA 1.539 4.186 0 C-N-CA 122.132 1.888 . . . . 0.0 110.772 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 23.2 ptt? . . . . . 0 CA--C 1.575 1.909 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.77 125.52 12.23 Favored 'Trans proline' 1 N--CA 1.541 4.323 0 C-N-CA 122.155 1.903 . . . . 0.0 110.139 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 177.6 36.17 0.06 OUTLIER Glycine 1 N--CA 1.519 4.167 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 44.6 t -165.7 45.68 0.08 Allowed 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.771 0.828 . . . . 0.0 109.323 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 7.8 mp -65.23 -26.92 68.33 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.932 0.893 . . . . 0.0 109.537 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 41.4 t -58.2 -25.94 62.2 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.579 0.751 . . . . 0.0 110.931 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.65 -34.4 60.51 Favored Glycine 0 N--CA 1.513 3.77 0 C-N-CA 125.123 1.344 . . . . 0.0 114.981 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.0 pt -57.95 -34.11 47.84 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.271 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -175.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 9.8 pt -55.74 -32.43 31.63 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.133 0 C-N-CA 123.128 0.571 . . . . 0.0 111.972 -176.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.96 -33.44 52.84 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.112 0 C-N-CA 123.613 0.765 . . . . 0.0 110.017 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.74 -29.9 50.72 Favored Glycine 0 N--CA 1.513 3.814 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.039 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.1 m -62.26 -37.82 79.55 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 117.937 0.868 . . . . 0.0 111.329 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 68.2 p -62.15 -45.77 91.96 Favored 'General case' 0 N--CA 1.532 3.633 0 CA-C-O 121.364 0.602 . . . . 0.0 110.669 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.18 -32.49 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 C-N-CA 124.197 0.999 . . . . 0.0 110.207 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.3 -34.61 78.74 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.534 0.733 . . . . 0.0 111.776 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.03 -49.87 46.98 Favored 'General case' 0 N--CA 1.516 2.844 0 C-N-CA 123.14 0.576 . . . . 0.0 112.503 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 29.3 m -63.92 -40.11 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.815 0 CA-C-N 118.523 0.602 . . . . 0.0 112.577 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 13.7 p -67.44 -32.01 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 CA-C-N 118.182 0.446 . . . . 0.0 110.558 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.49 -43.96 79.68 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 122.911 0.485 . . . . 0.0 110.333 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.52 -36.54 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 C-N-CA 123.48 0.712 . . . . 0.0 112.028 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.71 -36.68 67.14 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.683 0 CA-C-N 119.447 1.022 . . . . 0.0 110.517 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.28 -32.51 66.7 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.386 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.72 -41.25 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.394 0 C-N-CA 123.261 0.624 . . . . 0.0 110.086 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -61.42 -43.52 98.73 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.607 0.763 . . . . 0.0 112.915 -177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.26 -37.54 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 82.6 m -61.6 -27.82 68.91 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 122.619 0.368 . . . . 0.0 111.07 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -68.21 -27.38 66.33 Favored 'General case' 0 N--CA 1.531 3.576 0 C-N-CA 123.057 0.543 . . . . 0.0 110.738 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.9 m -69.07 -26.77 65.11 Favored 'General case' 0 N--CA 1.531 3.595 0 CA-C-O 121.225 0.536 . . . . 0.0 110.103 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -14.52 47.21 Favored 'General case' 0 N--CA 1.533 3.682 0 C-N-CA 124.807 1.243 . . . . 0.0 110.499 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 32.2 mt -86.59 -27.27 23.98 Favored 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 123.373 0.669 . . . . 0.0 110.387 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -71.56 84.98 0.86 Allowed 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.532 0.733 . . . . 0.0 109.234 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.64 117.09 15.71 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 124.988 1.315 . . . . 0.0 107.766 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? -164.53 134.02 3.78 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 28.9 m -117.78 138.23 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 C-N-CA 125.145 1.378 . . . . 0.0 108.685 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.553 ' H ' HD23 ' C' ' 241' ' ' LEU . 1.6 pt? -133.65 146.5 60.64 Favored Pre-proline 0 N--CA 1.533 3.696 0 C-N-CA 125.154 1.382 . . . . 0.0 109.069 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 1 N--CA 1.541 4.269 0 CA-C-N 122.295 1.855 . . . . 0.0 110.766 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -82.32 26.66 0.62 Allowed 'Trans proline' 0 N--CA 1.536 3.998 0 C-N-CA 122.626 2.217 . . . . 0.0 111.112 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.18 -177.51 9.58 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 123.684 0.659 . . . . 0.0 111.521 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 95.7 p -166.23 80.64 0.27 Allowed 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 123.824 0.85 . . . . 0.0 108.744 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -25.79 68.09 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.887 0.875 . . . . 0.0 111.659 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 212' ' ' SER . . . . . 0.435 ' O ' HD12 ' D' ' 215' ' ' ILE . 99.6 p -68.17 -26.92 65.99 Favored 'General case' 0 N--CA 1.527 3.395 0 C-N-CA 123.331 0.652 . . . . 0.0 110.054 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.06 -34.02 71.35 Favored Glycine 0 N--CA 1.505 3.255 0 C-N-CA 125.589 1.566 . . . . 0.0 115.597 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 13.7 pt -58.24 -33.79 48.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 215' ' ' ILE . . . . . 0.534 HD13 ' H ' ' D' ' 216' ' ' ILE . 0.1 OUTLIER -55.06 -43.39 69.58 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.388 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.302 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' D' D ' 216' ' ' ILE . . . . . 0.534 ' H ' HD13 ' D' ' 215' ' ' ILE . 18.4 tt -73.19 -34.47 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.984 0 CA-C-N 118.252 0.478 . . . . 0.0 110.375 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.11 -44.6 93.89 Favored Glycine 1 N--CA 1.519 4.184 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -60.11 -37.07 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.987 0 CA-C-N 117.629 0.714 . . . . 0.0 111.067 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 61.6 p -59.26 -39.0 81.48 Favored 'General case' 0 N--CA 1.532 3.637 0 CA-C-N 117.963 0.347 . . . . 0.0 111.41 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.48 -38.34 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 C-N-CA 123.41 0.684 . . . . 0.0 111.52 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.16 68.19 Favored 'General case' 0 N--CA 1.531 3.623 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.12 90.06 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 123.5 0.72 . . . . 0.0 111.71 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.23 -42.91 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.289 0.636 . . . . 0.0 112.129 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.81 -32.56 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.58 -47.33 22.82 Favored 'General case' 0 N--CA 1.539 3.997 0 CA-C-N 118.248 0.476 . . . . 0.0 111.352 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 20.2 pt -62.05 -36.31 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.721 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.07 -36.01 76.43 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.199 0 CA-C-N 119.425 1.011 . . . . 0.0 110.321 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.42 -32.16 66.59 Favored 'General case' 0 N--CA 1.523 3.187 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.77 -34.91 67.21 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.296 0 CA-C-N 119.709 1.14 . . . . 0.0 112.269 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -63.21 -43.53 97.86 Favored 'General case' 1 N--CA 1.539 4.019 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.37 -37.32 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 76.4 m -58.7 -31.3 68.12 Favored 'General case' 0 N--CA 1.531 3.619 0 C-N-CA 122.529 0.331 . . . . 0.0 111.257 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.11 -15.32 63.54 Favored 'General case' 0 N--CA 1.534 3.726 0 C-N-CA 123.103 0.561 . . . . 0.0 110.858 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 78.4 p -63.41 -28.78 70.22 Favored 'General case' 0 N--CA 1.529 3.51 0 CA-C-O 121.146 0.498 . . . . 0.0 109.87 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 57.6 mt -91.35 -18.65 23.95 Favored 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 124.507 1.123 . . . . 0.0 112.301 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 53.9 mt -87.53 3.0 49.14 Favored 'General case' 1 N--CA 1.544 4.264 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -70.2 -7.82 45.03 Favored 'General case' 1 N--CA 1.543 4.216 0 CA-C-N 119.65 1.114 . . . . 0.0 109.504 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -67.71 131.78 46.23 Favored 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 124.027 0.931 . . . . 0.0 109.844 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 239' ' ' LYS . . . . . 0.432 ' H ' ' H ' ' D' ' 240' ' ' VAL . 21.9 pttp -168.7 3.52 0.02 OUTLIER 'General case' 0 N--CA 1.526 3.349 0 C-N-CA 123.708 0.803 . . . . 0.0 110.497 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 240' ' ' VAL . . . . . 0.432 ' H ' ' H ' ' D' ' 239' ' ' LYS . 8.6 m -135.53 138.37 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.752 0 C-N-CA 125.229 1.412 . . . . 0.0 107.758 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 70.1 mt -125.85 146.78 56.49 Favored Pre-proline 0 N--CA 1.531 3.599 0 C-N-CA 125.389 1.475 . . . . 0.0 107.629 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 1 N--CA 1.54 4.227 0 C-N-CA 121.999 1.799 . . . . 0.0 110.897 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 CA--C 1.576 1.964 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.52 -22.32 44.98 Favored 'Trans proline' 1 N--CA 1.543 4.429 0 C-N-CA 122.223 1.949 . . . . 0.0 111.264 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 177.91 -171.37 43.9 Favored Glycine 1 N--CA 1.521 4.328 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p -167.16 -65.17 0.03 OUTLIER 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.16 -27.21 68.55 Favored 'General case' 0 N--CA 1.536 3.865 0 C-N-CA 123.641 0.777 . . . . 0.0 109.091 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -66.7 -28.26 68.29 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.421 0.689 . . . . 0.0 110.421 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.77 -35.56 80.3 Favored Glycine 1 N--CA 1.516 4.009 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 38.5 mm -69.81 -43.56 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.153 0 C-N-CA 124.528 1.131 . . . . 0.0 112.841 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 9.4 pt -59.49 -40.87 82.97 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.526 0 CA-C-N 118.852 0.751 . . . . 0.0 112.153 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.0 -32.94 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.98 -50.14 70.86 Favored Glycine 1 N--CA 1.52 4.276 0 C-N-CA 123.603 0.62 . . . . 0.0 113.364 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -61.76 -36.78 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-N 117.458 0.629 . . . . 0.0 109.747 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 86.1 m -63.6 -47.05 83.0 Favored 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 122.693 0.397 . . . . 0.0 111.604 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.7 -34.39 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 C-N-CA 123.491 0.716 . . . . 0.0 110.512 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.7 -46.57 67.39 Favored 'General case' 0 N--CA 1.527 3.382 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.43 91.09 Favored 'General case' 0 N--CA 1.519 2.99 0 C-N-CA 123.033 0.533 . . . . 0.0 111.687 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 43.2 t -68.16 -51.6 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.101 0 C-N-CA 123.134 0.574 . . . . 0.0 111.96 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 31.7 m -67.41 -32.72 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 O-C-N 121.892 -0.505 . . . . 0.0 111.813 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.03 -44.51 72.55 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 122.539 0.335 . . . . 0.0 111.33 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 24.7 pt -69.23 -36.48 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 CA-C-N 118.747 0.703 . . . . 0.0 111.149 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.07 -37.64 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.871 0 O-C-N 121.848 -0.533 . . . . 0.0 109.739 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.78 83.66 Favored 'General case' 0 N--CA 1.532 3.637 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.65 -34.16 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.554 0 O-C-N 122.079 -0.388 . . . . 0.0 110.937 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -68.75 -43.71 75.28 Favored 'General case' 0 N--CA 1.526 3.357 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 13.2 p -68.38 -37.83 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 CA-C-N 118.019 0.372 . . . . 0.0 111.175 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 16.3 p -66.31 -27.88 68.26 Favored 'General case' 0 N--CA 1.533 3.679 0 CA-C-N 117.855 0.298 . . . . 0.0 111.172 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -65.61 -30.98 71.78 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 123.214 0.606 . . . . 0.0 111.109 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 53.0 m -64.47 -32.37 73.96 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.391 0.676 . . . . 0.0 111.277 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 53.8 mt -63.08 -16.41 59.84 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.594 0.758 . . . . 0.0 111.928 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.85 -0.54 57.09 Favored 'General case' 0 N--CA 1.538 3.969 0 C-N-CA 123.356 0.663 . . . . 0.0 109.701 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -70.16 -29.86 66.86 Favored 'General case' 0 N--CA 1.523 3.225 0 C-N-CA 123.743 0.817 . . . . 0.0 110.515 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -61.19 -45.19 95.62 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 123.605 0.762 . . . . 0.0 111.904 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -82.55 166.4 19.29 Favored 'General case' 0 N--CA 1.524 3.271 0 C-N-CA 123.678 0.791 . . . . 0.0 109.772 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.34 138.23 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 C-N-CA 124.894 1.278 . . . . 0.0 108.284 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 8.6 mp -94.55 107.5 30.5 Favored Pre-proline 0 N--CA 1.528 3.431 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo . . . . . 1 N--CA 1.538 4.089 0 CA-C-N 122.725 2.009 . . . . 0.0 110.836 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 CA--C 1.585 2.309 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -87.26 -24.55 1.23 Allowed 'Trans proline' 1 N--CA 1.536 4.028 0 C-N-CA 122.471 2.114 . . . . 0.0 111.104 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 178.36 -16.74 0.03 OUTLIER Glycine 1 N--CA 1.521 4.301 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 51.1 m 57.8 172.68 0.05 Allowed 'General case' 0 N--CA 1.521 3.102 0 C-N-CA 124.482 1.113 . . . . 0.0 112.267 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.08 -35.61 81.69 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 124.312 1.045 . . . . 0.0 110.285 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 42.2 t -57.77 -26.95 62.6 Favored 'General case' 0 N--CA 1.528 3.451 0 C-N-CA 122.886 0.475 . . . . 0.0 111.593 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.38 -35.85 83.01 Favored Glycine 1 N--CA 1.527 4.741 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.29 -40.7 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 C-N-CA 124.428 1.091 . . . . 0.0 108.959 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.23 -42.67 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 C-N-CA 124.524 1.13 . . . . 0.0 108.771 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 30.8 mm -72.38 -33.06 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.627 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.42 -29.71 60.83 Favored Glycine 0 N--CA 1.514 3.88 0 C-N-CA 123.766 0.698 . . . . 0.0 113.362 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 2.5 m -60.43 -37.38 74.39 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 CA-C-N 117.825 0.812 . . . . 0.0 110.653 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 44.5 p -55.92 -46.1 78.55 Favored 'General case' 0 N--CA 1.529 3.517 0 CA-C-O 121.375 0.607 . . . . 0.0 111.403 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.62 -31.92 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.034 0 C-N-CA 124.387 1.075 . . . . 0.0 111.238 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.86 78.99 Favored 'General case' 0 N--CA 1.531 3.588 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.19 -50.28 70.94 Favored 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 28.1 m -63.09 -37.94 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.404 0.547 . . . . 0.0 111.883 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 93.9 t -60.5 -32.71 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 121.77 -0.581 . . . . 0.0 110.232 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.5 -38.08 77.47 Favored 'General case' 0 N--CA 1.532 3.669 0 CA-C-N 118.455 0.571 . . . . 0.0 109.958 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 11.6 mm -54.36 -36.85 35.21 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.026 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.44 -38.09 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 C-N-CA 123.468 0.707 . . . . 0.0 109.829 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.47 -32.21 72.21 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.431 0.692 . . . . 0.0 111.309 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.02 -34.51 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 C-N-CA 122.813 0.445 . . . . 0.0 109.855 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.02 -43.37 83.0 Favored 'General case' 0 N--CA 1.53 3.553 0 C-N-CA 123.07 0.548 . . . . 0.0 112.152 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 4.9 m -67.47 -36.1 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 CA-C-N 118.195 0.452 . . . . 0.0 109.937 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 96.6 m -57.61 -27.13 62.48 Favored 'General case' 0 N--CA 1.526 3.348 0 C-N-CA 123.004 0.521 . . . . 0.0 110.547 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -58.51 -15.71 12.3 Favored 'General case' 0 N--CA 1.531 3.6 0 C-N-CA 122.367 0.267 . . . . 0.0 110.867 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 50.8 m -75.04 -42.07 57.91 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.99 -14.22 21.51 Favored 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.474 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 43.2 tp -87.06 2.3 50.12 Favored 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 46.9 m95 66.92 164.29 0.2 Allowed 'General case' 0 N--CA 1.515 2.799 0 C-N-CA 125.148 1.379 . . . . 0.0 111.214 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -133.86 -148.98 0.34 Allowed 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 125.358 1.463 . . . . 0.0 107.07 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -159.69 63.59 0.37 Allowed 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.53 138.19 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 C-N-CA 125.037 1.335 . . . . 0.0 107.959 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 57.8 tp -103.39 99.78 16.18 Favored Pre-proline 0 N--CA 1.531 3.605 0 C-N-CA 124.842 1.257 . . . . 0.0 108.438 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 N--CA 1.536 3.998 0 C-N-CA 122.426 2.084 . . . . 0.0 110.963 -179.607 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 43.9 ttm . . . . . 0 CA--C 1.583 2.229 0 CA-C-O 117.593 -1.194 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -88.84 -157.08 0.06 OUTLIER 'Trans proline' 1 N--CA 1.536 4.01 0 C-N-CA 122.705 2.27 . . . . 0.0 110.511 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -160.42 -33.41 0.02 OUTLIER Glycine 1 N--CA 1.521 4.301 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 82.8 p 52.34 46.36 26.8 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 124.055 0.942 . . . . 0.0 112.199 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 43.4 mt -61.91 -26.85 68.41 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.774 0.83 . . . . 0.0 110.607 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 45.2 t -68.43 -26.36 65.48 Favored 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.675 0.79 . . . . 0.0 110.596 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.35 -43.79 77.2 Favored Glycine 0 N--CA 1.512 3.714 0 C-N-CA 123.599 0.619 . . . . 0.0 114.103 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.7 pt -70.68 -35.82 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 10.1 pt -58.56 -41.69 82.63 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.66 0 CA-C-N 119.433 1.015 . . . . 0.0 112.542 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.7 -33.18 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.06 -41.0 96.27 Favored Glycine 1 N--CA 1.516 4.002 0 CA-C-O 119.502 -0.61 . . . . 0.0 114.088 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.9 m -63.73 -36.62 77.17 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.349 0 CA-C-N 118.624 1.212 . . . . 0.0 111.134 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.8 p -55.74 -42.56 75.57 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.828 0.451 . . . . 0.0 111.092 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.93 -34.13 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 C-N-CA 124.059 0.944 . . . . 0.0 111.896 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.93 -42.42 65.4 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.75 -34.08 71.47 Favored 'General case' 0 N--CA 1.519 2.992 0 C-N-CA 123.232 0.613 . . . . 0.0 111.314 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.85 -49.23 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 123.647 0.779 . . . . 0.0 111.345 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.68 -32.71 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 C-N-CA 122.633 0.373 . . . . 0.0 110.674 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.28 -36.86 74.67 Favored 'General case' 0 N--CA 1.539 3.985 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.18 -37.11 34.66 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.352 0 C-N-CA 123.168 0.587 . . . . 0.0 109.975 178.587 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.1 t -66.93 -38.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 C-N-CA 123.187 0.595 . . . . 0.0 110.143 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -45.53 86.54 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.387 0.675 . . . . 0.0 112.681 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.7 -34.17 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.613 0 O-C-N 121.898 -0.501 . . . . 0.0 110.228 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.15 -44.1 93.15 Favored 'General case' 0 N--CA 1.532 3.629 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.53 -37.29 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 99.5 m -59.14 -27.95 66.11 Favored 'General case' 0 N--CA 1.531 3.6 0 C-N-CA 122.74 0.416 . . . . 0.0 110.859 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -73.29 -35.05 66.07 Favored 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 63.0 m -72.66 -30.86 64.62 Favored 'General case' 0 N--CA 1.525 3.321 0 C-N-CA 123.108 0.563 . . . . 0.0 109.852 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.78 -14.65 62.5 Favored 'General case' 0 N--CA 1.526 3.339 0 C-N-CA 124.513 1.125 . . . . 0.0 110.926 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 38.3 tp -87.33 10.21 18.0 Favored 'General case' 0 N--CA 1.537 3.917 0 C-N-CA 123.763 0.825 . . . . 0.0 110.663 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -66.05 9.31 0.15 Allowed 'General case' 1 N--CA 1.54 4.065 0 C-N-CA 123.217 0.607 . . . . 0.0 112.444 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -50.6 -47.34 58.16 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 124.099 0.96 . . . . 0.0 111.785 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt 61.18 153.72 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 124.384 1.074 . . . . 0.0 111.348 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.1 m -112.52 138.32 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.508 0 C-N-CA 125.216 1.406 . . . . 0.0 108.513 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -95.76 106.59 28.48 Favored Pre-proline 0 N--CA 1.529 3.523 0 CA-C-O 117.075 -1.441 . . . . 0.0 107.892 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo . . . . . 1 N--CA 1.549 4.742 0 C-N-CA 122.682 2.255 . . . . 0.0 114.965 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 CA--C 1.574 1.892 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.95 -46.18 32.15 Favored 'Trans proline' 1 N--CA 1.543 4.419 0 C-N-CA 122.402 2.068 . . . . 0.0 113.623 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 175.64 155.69 13.34 Favored Glycine 1 N--CA 1.519 4.169 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 42.2 t -87.24 5.75 36.67 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 124.053 0.941 . . . . 0.0 111.234 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -61.89 -26.5 68.2 Favored 'General case' 0 N--CA 1.529 3.48 0 C-N-CA 124.147 0.979 . . . . 0.0 110.162 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 95.7 p -68.15 -32.15 72.21 Favored 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.556 0.742 . . . . 0.0 110.391 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.86 -46.89 58.41 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.924 0.773 . . . . 0.0 115.0 -178.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.9 -41.16 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 tp -60.67 -40.42 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 C-N-CA 122.905 0.482 . . . . 0.0 112.276 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 7.0 tp -73.27 -33.79 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.711 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.13 -47.84 87.07 Favored Glycine 0 N--CA 1.515 3.914 0 C-N-CA 123.799 0.714 . . . . 0.0 114.167 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.16 -37.17 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 CA-C-N 117.566 0.683 . . . . 0.0 111.137 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 61.2 p -66.06 -46.3 78.26 Favored 'General case' 0 N--CA 1.534 3.727 0 CA-C-N 118.136 0.425 . . . . 0.0 110.721 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 84.7 t -70.03 -31.96 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 C-N-CA 123.741 0.817 . . . . 0.0 111.057 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.87 -43.79 66.35 Favored 'General case' 0 N--CA 1.533 3.707 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.06 73.2 Favored 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 123.185 0.594 . . . . 0.0 111.179 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.71 -46.79 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 123.395 0.678 . . . . 0.0 112.292 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.29 -31.58 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 C-N-CA 122.533 0.333 . . . . 0.0 111.39 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.72 -39.64 64.16 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 122.411 -0.181 . . . . 0.0 111.046 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 93.8 mt -59.96 -44.19 94.01 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.097 0 CA-C-N 118.357 0.526 . . . . 0.0 111.653 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 30.0 m -64.07 -36.7 77.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 CA-C-N 118.619 0.645 . . . . 0.0 110.429 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.9 -32.5 71.96 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.238 0.615 . . . . 0.0 111.871 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 86.2 t -71.31 -34.56 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.698 0.399 . . . . 0.0 109.939 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -61.34 -44.02 97.9 Favored 'General case' 0 N--CA 1.53 3.542 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.94 -40.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.858 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 80.7 m -58.67 -27.65 65.0 Favored 'General case' 0 N--CA 1.522 3.17 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.117 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -71.62 -15.85 62.26 Favored 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 122.528 0.331 . . . . 0.0 111.15 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 26.8 t -78.39 -46.55 19.62 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.551 ' H ' HD13 ' B' ' 235' ' ' LEU . 0.0 OUTLIER -83.88 -13.01 54.63 Favored 'General case' 1 N--CA 1.554 4.733 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -175.242 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.69 3.69 43.7 Favored 'General case' 1 N--CA 1.566 5.33 0 CA-C-N 121.915 2.143 . . . . 0.0 112.438 -176.716 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -122.53 -36.61 2.9 Favored 'General case' 1 N--CA 1.543 4.207 0 C-N-CA 124.814 1.246 . . . . 0.0 107.644 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp 62.19 5.36 1.48 Allowed 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 124.598 1.159 . . . . 0.0 112.284 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -73.52 105.19 4.76 Favored 'General case' 0 N--CA 1.533 3.676 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.41 138.33 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.468 0 C-N-CA 124.847 1.259 . . . . 0.0 108.564 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.71 147.53 40.06 Favored Pre-proline 0 N--CA 1.538 3.93 0 C-N-CA 125.435 1.494 . . . . 0.0 108.668 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 1 N--CA 1.542 4.34 0 C-N-CA 121.933 1.755 . . . . 0.0 110.704 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 CA--C 1.575 1.94 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -82.63 179.76 5.13 Favored 'Trans proline' 0 N--CA 1.535 3.915 0 C-N-CA 122.632 2.221 . . . . 0.0 110.732 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.89 -37.98 93.82 Favored Glycine 1 N--CA 1.52 4.26 0 C-N-CA 123.672 0.653 . . . . 0.0 111.486 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 59.9 p 55.98 111.1 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 124.545 1.138 . . . . 0.0 112.225 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.65 -26.66 68.75 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 123.955 0.902 . . . . 0.0 109.646 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 38.7 t -67.95 -26.85 66.15 Favored 'General case' 0 N--CA 1.519 2.993 0 C-N-CA 123.645 0.778 . . . . 0.0 110.611 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.14 -46.78 56.87 Favored Glycine 0 N--CA 1.512 3.704 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.321 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 43.2 pt -70.98 -37.97 70.15 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.121 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 7.5 tp -59.05 -31.8 46.49 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.092 0 C-N-CA 123.288 0.635 . . . . 0.0 112.659 -177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.4 pp -71.3 -32.17 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.7 -43.68 79.75 Favored Glycine 0 N--CA 1.512 3.743 0 C-N-CA 124.463 1.03 . . . . 0.0 114.949 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 11.3 p -68.2 -37.13 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 CA-C-N 118.133 0.967 . . . . 0.0 111.011 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.6 p -65.59 -46.49 79.18 Favored 'General case' 0 N--CA 1.531 3.582 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 10.8 p -69.71 -30.68 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.467 0 C-N-CA 123.451 0.7 . . . . 0.0 111.226 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.07 -43.19 63.71 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.59 -37.36 73.89 Favored 'General case' 0 N--CA 1.521 3.099 0 C-N-CA 123.335 0.654 . . . . 0.0 110.863 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.99 -52.13 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.313 0 C-N-CA 123.668 0.787 . . . . 0.0 111.27 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.4 -31.93 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.925 0 CA-C-O 120.91 0.386 . . . . 0.0 110.235 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -46.24 89.61 Favored 'General case' 0 N--CA 1.531 3.59 0 CA-C-O 121.57 0.7 . . . . 0.0 109.583 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.14 -39.51 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 C-N-CA 123.221 0.608 . . . . 0.0 109.814 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.91 -37.78 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.704 0 C-N-CA 123.144 0.578 . . . . 0.0 109.914 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.66 -46.52 88.78 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.386 0.674 . . . . 0.0 112.602 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.71 -34.26 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 O-C-N 121.825 -0.547 . . . . 0.0 109.871 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.68 -43.91 97.59 Favored 'General case' 0 N--CA 1.529 3.515 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.0 -37.69 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.12 -28.59 69.88 Favored 'General case' 0 N--CA 1.525 3.324 0 C-N-CA 123.23 0.612 . . . . 0.0 111.586 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -62.35 -37.27 85.02 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 122.924 0.49 . . . . 0.0 110.664 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 52.7 m -63.78 -26.84 68.82 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.614 0.766 . . . . 0.0 111.102 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 55.6 mt -90.12 -13.44 35.74 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 124.953 1.301 . . . . 0.0 111.281 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 41.7 tp -86.58 -11.3 51.91 Favored 'General case' 1 N--CA 1.54 4.054 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -175.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -60.55 -67.34 0.41 Allowed 'General case' 1 N--CA 1.541 4.114 0 CA-C-N 119.142 0.883 . . . . 0.0 110.007 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 56.55 -144.66 0.65 Allowed 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.77 0.828 . . . . 0.0 110.751 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp 62.14 170.69 0.13 Allowed 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 124.29 1.036 . . . . 0.0 111.304 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.05 138.64 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.351 0 C-N-CA 125.249 1.419 . . . . 0.0 107.978 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 60.5 tp -94.7 105.33 17.96 Favored Pre-proline 0 N--CA 1.529 3.513 0 CA-C-O 117.311 -1.328 . . . . 0.0 108.352 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 1 N--CA 1.537 4.034 0 C-N-CA 122.359 2.039 . . . . 0.0 110.968 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 CA--C 1.577 1.995 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.77 -170.81 0.73 Allowed 'Trans proline' 1 N--CA 1.538 4.101 0 C-N-CA 122.254 1.969 . . . . 0.0 110.015 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.72 86.86 0.26 Allowed Glycine 1 N--CA 1.518 4.167 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t -165.62 23.29 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.142 0 C-N-CA 123.946 0.899 . . . . 0.0 109.895 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.2 -26.73 68.27 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 124.167 0.987 . . . . 0.0 109.82 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 45.1 t -68.65 -26.45 65.34 Favored 'General case' 0 N--CA 1.52 3.072 0 C-N-CA 123.358 0.663 . . . . 0.0 110.835 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.05 71.48 Favored Glycine 0 N--CA 1.511 3.642 0 C-N-CA 123.693 0.663 . . . . 0.0 114.08 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 6.4 tp -68.9 -35.97 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.911 0 CA-C-N 117.921 0.861 . . . . 0.0 111.908 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 8.3 pt -65.5 -32.37 57.93 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.461 0 CA-C-N 118.961 0.801 . . . . 0.0 110.16 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.62 -33.69 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 124.301 1.04 . . . . 0.0 108.861 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.24 -29.73 60.33 Favored Glycine 1 N--CA 1.518 4.118 0 C-N-CA 123.523 0.582 . . . . 0.0 113.159 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 m -60.07 -37.35 72.46 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 CA-C-N 117.349 0.574 . . . . 0.0 111.042 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 56.8 p -55.6 -39.74 71.16 Favored 'General case' 0 N--CA 1.524 3.235 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.325 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.7 t -61.88 -46.11 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.277 0 C-N-CA 123.703 0.801 . . . . 0.0 110.668 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.51 -35.09 60.27 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.262 0.625 . . . . 0.0 112.538 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.95 -37.32 81.45 Favored 'General case' 0 N--CA 1.519 2.991 0 C-N-CA 123.482 0.713 . . . . 0.0 111.083 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 28.3 t -56.37 -38.89 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 C-N-CA 123.288 0.635 . . . . 0.0 110.573 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.02 -32.11 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.387 0 C-N-CA 123.554 0.741 . . . . 0.0 110.028 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -44.07 70.45 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.433 0.693 . . . . 0.0 109.555 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.15 -49.19 63.72 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 C-N-CA 123.246 0.618 . . . . 0.0 111.772 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 22.2 m -66.19 -36.28 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 C-N-CA 122.594 0.358 . . . . 0.0 110.327 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.28 66.74 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 123.279 0.632 . . . . 0.0 112.338 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.4 -43.91 94.63 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.005 0 CA-C-N 118.237 0.471 . . . . 0.0 112.09 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -61.16 -43.62 98.6 Favored 'General case' 0 N--CA 1.538 3.951 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.56 -37.55 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 O-C-N 121.771 -0.581 . . . . 0.0 109.609 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 85.3 m -64.25 -27.63 69.18 Favored 'General case' 0 N--CA 1.527 3.385 0 C-N-CA 122.973 0.509 . . . . 0.0 111.105 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -64.36 -27.96 69.37 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.039 0.536 . . . . 0.0 111.423 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 50.5 m -63.73 -37.68 88.28 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 123.629 0.771 . . . . 0.0 111.767 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -60.84 -13.79 17.76 Favored 'General case' 0 N--CA 1.531 3.589 0 C-N-CA 124.625 1.17 . . . . 0.0 112.293 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -86.93 -28.15 22.93 Favored 'General case' 1 N--CA 1.542 4.175 0 CA-C-N 118.423 0.556 . . . . 0.0 110.539 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -73.42 68.25 1.09 Allowed 'General case' 0 N--CA 1.533 3.684 0 CA-C-O 121.387 0.613 . . . . 0.0 109.739 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -109.83 -37.61 5.59 Favored 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 125.096 1.358 . . . . 0.0 108.627 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 60.1 tttp 62.24 148.74 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 124.651 1.181 . . . . 0.0 111.214 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.46 138.29 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 C-N-CA 125.003 1.321 . . . . 0.0 108.601 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.58 146.6 31.76 Favored Pre-proline 0 N--CA 1.529 3.512 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 1 N--CA 1.541 4.305 0 C-N-CA 122.04 1.827 . . . . 0.0 110.718 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 CA--C 1.582 2.203 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.35 -10.3 1.28 Allowed 'Trans proline' 1 N--CA 1.55 4.84 0 C-N-CA 122.055 1.837 . . . . 0.0 114.075 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 76.53 -177.51 51.23 Favored Glycine 1 N--CA 1.518 4.165 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 67.1 m -161.27 15.23 0.1 Allowed 'General case' 0 N--CA 1.524 3.241 0 C-N-CA 123.601 0.761 . . . . 0.0 110.35 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.5 -26.86 68.76 Favored 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 123.665 0.786 . . . . 0.0 111.473 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 66.0 m -68.28 -25.86 65.36 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.631 0.772 . . . . 0.0 109.563 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.38 -34.65 59.72 Favored Glycine 0 N--CA 1.512 3.747 0 C-N-CA 124.603 1.097 . . . . 0.0 113.952 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 11.1 tp -59.33 -43.16 89.46 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 CA-C-N 117.67 0.735 . . . . 0.0 112.827 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 5.5 pt -68.85 -34.16 63.07 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.411 0 CA-C-O 121.827 0.822 . . . . 0.0 109.399 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 81.9 mt -73.08 -38.98 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.185 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.56 -46.63 91.83 Favored Glycine 1 N--CA 1.516 4.016 0 CA-C-N 115.606 -0.725 . . . . 0.0 114.374 -177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.13 -37.55 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 CA-C-N 117.506 0.653 . . . . 0.0 110.854 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 70.1 p -66.22 -45.55 80.32 Favored 'General case' 0 N--CA 1.535 3.782 0 CA-C-N 118.354 0.525 . . . . 0.0 110.575 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.24 -31.24 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 C-N-CA 123.964 0.905 . . . . 0.0 110.891 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.32 -47.24 75.93 Favored 'General case' 0 N--CA 1.532 3.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.19 -25.64 67.81 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.571 0.748 . . . . 0.0 112.224 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.53 -37.09 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 C-N-CA 123.526 0.73 . . . . 0.0 109.464 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 46.1 t -55.78 -32.31 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.137 0.575 . . . . 0.0 110.306 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.96 -40.89 91.68 Favored 'General case' 0 N--CA 1.532 3.661 0 C-N-CA 123.017 0.527 . . . . 0.0 109.823 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 34.3 mm -60.62 -44.56 97.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.711 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.84 -39.72 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.258 0 C-N-CA 123.636 0.775 . . . . 0.0 109.855 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.84 87.81 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.676 0.79 . . . . 0.0 112.409 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.82 -34.36 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 O-C-N 121.846 -0.534 . . . . 0.0 110.334 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -63.63 -44.35 94.14 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.15 -37.99 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.9 m -67.26 -30.38 70.25 Favored 'General case' 0 N--CA 1.525 3.286 0 C-N-CA 123.115 0.566 . . . . 0.0 110.911 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -66.67 -35.21 79.61 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.347 0.659 . . . . 0.0 111.237 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 91.8 p -64.83 -33.63 76.46 Favored 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 123.121 0.568 . . . . 0.0 110.94 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 50.7 mt -78.75 -14.86 59.05 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 124.022 0.929 . . . . 0.0 111.166 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 50.6 tp -87.46 -16.1 35.76 Favored 'General case' 0 N--CA 1.536 3.845 0 C-N-CA 123.516 0.727 . . . . 0.0 110.554 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -61.82 -8.26 4.66 Favored 'General case' 0 N--CA 1.53 3.563 0 C-N-CA 123.393 0.677 . . . . 0.0 111.583 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -64.94 144.68 57.12 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 123.782 0.833 . . . . 0.0 110.387 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -69.69 136.03 50.56 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.655 0.782 . . . . 0.0 109.622 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 30.7 m -135.27 138.28 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.413 0 C-N-CA 124.994 1.318 . . . . 0.0 108.192 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 58.2 mt -94.72 129.95 34.69 Favored Pre-proline 0 N--CA 1.527 3.404 0 CA-C-O 116.732 -1.604 . . . . 0.0 108.052 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 1 N--CA 1.538 4.122 0 CA-C-N 123.125 2.152 . . . . 0.0 110.679 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.582 2.199 0 CA-C-O 117.326 -1.321 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -87.91 -177.5 1.95 Allowed 'Trans proline' 0 N--CA 1.535 3.949 0 C-N-CA 122.473 2.115 . . . . 0.0 110.623 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -175.61 -105.75 0.19 Allowed Glycine 1 N--CA 1.518 4.13 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 74.4 p 54.19 44.51 29.02 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-O 122.042 0.925 . . . . 0.0 111.413 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 42.2 mt -60.91 -26.61 67.58 Favored 'General case' 0 N--CA 1.524 3.235 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.952 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 61.9 m -62.99 -26.38 68.82 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.049 0.539 . . . . 0.0 110.069 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.96 -46.51 93.57 Favored Glycine 1 N--CA 1.519 4.23 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.565 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 48.7 pt -70.5 -35.33 61.29 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.141 0 CA-C-N 118.468 1.134 . . . . 0.0 109.85 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 215' ' ' ILE . . . . . 0.432 ' O ' HG12 ' F' ' 218' ' ' VAL . 49.4 mm -62.38 -44.68 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 29.8 mm -72.88 -33.31 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.89 -29.08 49.93 Favored Glycine 0 N--CA 1.512 3.733 0 C-N-CA 124.666 1.126 . . . . 0.0 113.175 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 218' ' ' VAL . . . . . 0.432 HG12 ' O ' ' F' ' 215' ' ' ILE . 9.8 p -59.28 -39.25 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 C-N-CA 122.781 0.433 . . . . 0.0 111.199 -177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 72.9 p -65.91 -45.2 82.84 Favored 'General case' 0 N--CA 1.53 3.547 0 CA-C-O 121.657 0.741 . . . . 0.0 109.987 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 43.3 t -68.56 -31.69 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.976 0 C-N-CA 124.588 1.155 . . . . 0.0 111.676 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.65 77.83 Favored 'General case' 0 N--CA 1.533 3.713 0 O-C-N 121.706 -0.621 . . . . 0.0 112.608 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.39 -50.22 74.48 Favored 'General case' 0 N--CA 1.523 3.189 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.36 -38.11 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 CA-C-N 118.321 0.51 . . . . 0.0 111.402 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 84.2 t -56.75 -35.96 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 O-C-N 122.03 -0.419 . . . . 0.0 111.102 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 52.0 tp -66.32 -44.57 83.01 Favored 'General case' 1 N--CA 1.539 4.01 0 CA-C-N 118.809 0.732 . . . . 0.0 109.685 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.47 -42.45 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.465 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.201 -178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.31 -37.98 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 C-N-CA 123.036 0.534 . . . . 0.0 109.58 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.2 88.65 Favored 'General case' 0 N--CA 1.53 3.574 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 17.4 m -71.42 -34.35 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 O-C-N 121.843 -0.536 . . . . 0.0 110.811 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -64.51 -44.17 91.77 Favored 'General case' 0 N--CA 1.531 3.599 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.74 -37.64 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.1 -27.25 68.79 Favored 'General case' 0 N--CA 1.526 3.363 0 C-N-CA 123.437 0.695 . . . . 0.0 111.182 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -63.17 -34.39 77.52 Favored 'General case' 0 N--CA 1.53 3.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.774 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.8 t -66.1 -36.06 82.17 Favored 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.529 0.732 . . . . 0.0 111.432 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 4.4 tt -61.25 -13.97 22.63 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 124.231 1.012 . . . . 0.0 111.613 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 25.6 mt -86.03 -27.99 24.43 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.166 0.586 . . . . 0.0 109.594 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -102.6 98.1 8.2 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 124.543 1.137 . . . . 0.0 108.193 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -126.38 71.22 1.27 Allowed 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 124.911 1.285 . . . . 0.0 108.659 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -166.1 82.55 0.29 Allowed 'General case' 0 N--CA 1.522 3.174 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.45 132.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.51 146.76 32.07 Favored Pre-proline 0 N--CA 1.528 3.433 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo . . . . . 1 N--CA 1.54 4.225 0 C-N-CA 122.022 1.814 . . . . 0.0 110.72 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 76.5 mtp . . . . . 0 CA--C 1.572 1.81 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.46 3.09 4.46 Favored 'Trans proline' 1 N--CA 1.54 4.248 0 C-N-CA 122.057 1.838 . . . . 0.0 111.184 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.6 -177.92 25.18 Favored Glycine 1 N--CA 1.519 4.211 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.1 p -165.99 62.57 0.11 Allowed 'General case' 0 N--CA 1.523 3.18 0 CA-C-O 121.826 0.822 . . . . 0.0 108.923 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.02 -26.97 68.81 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 123.907 0.883 . . . . 0.0 110.19 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 69.2 m -68.37 -26.74 65.73 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 123.408 0.683 . . . . 0.0 109.993 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.7 -46.96 92.6 Favored Glycine 1 N--CA 1.519 4.228 0 C-N-CA 123.719 0.676 . . . . 0.0 113.562 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.7 tp -70.9 -35.1 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 CA-C-N 117.795 0.797 . . . . 0.0 109.869 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.83 -43.91 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 123.67 0.788 . . . . 0.0 111.512 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 18.6 tt -73.17 -33.48 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 119.263 0.938 . . . . 0.0 109.838 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.55 97.76 Favored Glycine 1 N--CA 1.521 4.352 0 C-N-CA 123.354 0.502 . . . . 0.0 114.091 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 p -59.93 -36.67 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.913 0 CA-C-N 117.677 0.739 . . . . 0.0 110.258 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.9 p -55.98 -44.86 78.94 Favored 'General case' 0 N--CA 1.536 3.843 0 CA-C-O 121.318 0.58 . . . . 0.0 111.388 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.88 -39.99 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 C-N-CA 124.073 0.949 . . . . 0.0 111.748 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.77 -46.78 74.42 Favored 'General case' 0 N--CA 1.528 3.434 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.36 -50.46 71.5 Favored 'General case' 0 N--CA 1.517 2.894 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.54 -38.48 81.53 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.094 0 CA-C-N 119.079 0.854 . . . . 0.0 112.614 -177.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.14 -32.12 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 CA-C-N 118.354 0.525 . . . . 0.0 110.227 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.38 -44.49 36.07 Favored 'General case' 0 N--CA 1.526 3.326 0 C-N-CA 122.653 0.381 . . . . 0.0 110.471 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.34 -44.8 89.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.034 0 C-N-CA 122.945 0.498 . . . . 0.0 111.869 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 30.6 m -61.29 -36.43 72.82 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.22 0 CA-C-N 118.94 0.791 . . . . 0.0 110.834 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.57 -31.87 66.58 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.234 0.614 . . . . 0.0 111.443 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.29 -41.87 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 123.027 0.531 . . . . 0.0 111.507 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -60.7 -43.95 97.15 Favored 'General case' 1 N--CA 1.541 4.091 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.68 -37.73 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 80.1 m -67.27 -32.65 73.81 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 122.733 0.413 . . . . 0.0 110.004 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -72.18 -29.44 64.0 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 123.715 0.806 . . . . 0.0 110.562 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -66.4 -21.35 66.22 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 123.145 0.578 . . . . 0.0 111.061 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 58.6 mt -91.55 -14.26 30.62 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 124.509 1.124 . . . . 0.0 111.189 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.1 tp -87.35 -28.3 22.3 Favored 'General case' 1 N--CA 1.541 4.111 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -174.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 48.8 p-90 -66.32 -64.21 0.91 Allowed 'General case' 1 N--CA 1.544 4.271 0 CA-C-N 120.272 1.396 . . . . 0.0 111.157 -177.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 54.72 176.41 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.852 0.861 . . . . 0.0 112.316 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -97.19 169.73 9.6 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 124.541 1.136 . . . . 0.0 108.918 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 50.3 t -132.34 136.17 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.58 98.75 25.45 Favored Pre-proline 0 N--CA 1.536 3.834 0 C-N-CA 124.939 1.296 . . . . 0.0 109.352 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo . . . . . 1 N--CA 1.547 4.648 0 C-N-CA 122.349 2.033 . . . . 0.0 114.16 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 CA--C 1.572 1.793 0 CA-C-O 116.923 -1.513 . . . . 0.0 107.003 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.66 143.93 30.92 Favored 'Trans proline' 1 N--CA 1.539 4.197 0 CA-C-N 122.656 1.984 . . . . 0.0 109.974 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.03 175.1 48.42 Favored Glycine 1 N--CA 1.516 4.014 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 70.4 m -101.89 27.77 6.25 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 124.741 1.216 . . . . 0.0 109.437 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.8 -26.79 68.32 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 124.232 1.013 . . . . 0.0 111.064 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 91.4 p -68.19 -30.81 70.0 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.535 0.734 . . . . 0.0 110.609 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.0 -46.9 57.58 Favored Glycine 0 N--CA 1.516 3.988 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.737 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 8.2 tp -71.29 -41.74 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 215' ' ' ILE . . . . . 0.411 ' O ' HG12 ' B' ' 218' ' ' VAL . 19.4 tt -60.57 -38.71 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.882 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.78 -32.78 41.86 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.101 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.55 -29.41 47.96 Favored Glycine 0 N--CA 1.512 3.717 0 C-N-CA 124.183 0.897 . . . . 0.0 113.923 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 218' ' ' VAL . . . . . 0.411 HG12 ' O ' ' B' ' 215' ' ' ILE . 8.6 p -59.76 -38.55 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 CA-C-N 117.661 0.73 . . . . 0.0 110.998 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 67.1 p -65.17 -45.53 84.52 Favored 'General case' 0 N--CA 1.528 3.441 0 CA-C-O 121.456 0.646 . . . . 0.0 110.389 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.38 -32.0 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 C-N-CA 124.307 1.043 . . . . 0.0 110.602 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.21 -45.9 82.89 Favored 'General case' 0 N--CA 1.524 3.273 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.95 -41.81 97.49 Favored 'General case' 0 N--CA 1.519 3.0 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.27 -44.14 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.99 -32.75 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 O-C-N 121.293 -0.88 . . . . 0.0 111.457 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 5.4 tt -67.34 -47.54 70.17 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 122.959 0.503 . . . . 0.0 111.446 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 22.8 pt -69.14 -36.29 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 O-C-N 121.671 -0.643 . . . . 0.0 110.884 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.69 -37.36 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.49 -47.47 81.82 Favored 'General case' 0 N--CA 1.532 3.626 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 30.9 m -71.81 -34.53 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 O-C-N 121.939 -0.476 . . . . 0.0 110.605 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -65.61 -43.71 88.78 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.05 -37.0 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.744 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.73 -33.93 70.79 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.308 0.243 . . . . 0.0 110.986 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -74.29 -15.7 60.96 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 122.894 0.478 . . . . 0.0 111.291 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 20.7 t -63.68 -29.13 70.4 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-O 121.467 0.651 . . . . 0.0 109.743 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 57.2 tp -72.18 -31.48 65.96 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.945 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.28 -24.41 24.35 Favored 'General case' 0 N--CA 1.538 3.935 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 61.0 t-105 -69.46 -3.04 12.83 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.639 0.776 . . . . 0.0 110.926 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 168.3 1.07 Allowed 'General case' 0 N--CA 1.527 3.425 0 C-N-CA 123.693 0.797 . . . . 0.0 112.1 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -175.57 171.38 2.79 Favored 'General case' 0 N--CA 1.528 3.445 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 8.0 p -135.39 137.22 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.537 0 C-N-CA 124.537 1.135 . . . . 0.0 108.724 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 60.7 mt -98.36 146.74 32.07 Favored Pre-proline 0 N--CA 1.528 3.427 0 CA-C-O 117.275 -1.345 . . . . 0.0 108.273 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 1 N--CA 1.54 4.25 0 CA-C-N 122.086 1.781 . . . . 0.0 110.679 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 CA--C 1.586 2.354 0 CA-C-O 117.456 -1.259 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -88.79 150.76 6.04 Favored 'Trans proline' 0 N--CA 1.535 3.95 0 C-N-CA 122.534 2.156 . . . . 0.0 111.018 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.81 73.11 1.49 Allowed Glycine 1 N--CA 1.517 4.083 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 98.3 p -66.63 124.17 22.11 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.711 0.804 . . . . 0.0 110.48 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.29 -26.9 68.28 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.926 0.89 . . . . 0.0 109.719 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 46.7 t -68.42 -26.17 65.4 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 123.524 0.73 . . . . 0.0 110.808 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.1 -46.34 66.07 Favored Glycine 0 N--CA 1.514 3.852 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.875 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.4 tt -70.72 -38.17 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.867 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 15.4 pt -57.04 -43.15 80.61 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.685 0 CA-C-N 119.584 1.084 . . . . 0.0 111.946 -176.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 6.1 tp -73.01 -32.97 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.17 -45.57 95.06 Favored Glycine 1 N--CA 1.518 4.121 0 C-N-CA 123.869 0.747 . . . . 0.0 113.292 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.65 -36.68 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 O-C-N 121.954 -0.733 . . . . 0.0 109.776 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 37.6 m -60.54 -47.08 87.75 Favored 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.74 -31.39 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 123.621 0.769 . . . . 0.0 111.23 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.13 -34.3 56.14 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.483 0.713 . . . . 0.0 112.801 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.8 -50.79 39.51 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.17 -38.44 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.665 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.48 -32.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 CA-C-N 118.255 0.479 . . . . 0.0 110.99 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.96 -42.47 99.16 Favored 'General case' 0 N--CA 1.532 3.641 0 O-C-N 122.198 -0.314 . . . . 0.0 110.428 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -57.22 -36.63 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.629 0 C-N-CA 123.317 0.647 . . . . 0.0 110.636 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.52 -37.81 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 123.444 0.697 . . . . 0.0 109.847 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.97 76.76 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.107 0.563 . . . . 0.0 111.219 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.61 -34.76 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.35 0.66 . . . . 0.0 110.15 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -63.81 -43.8 95.18 Favored 'General case' 0 N--CA 1.531 3.596 0 C-N-CA 123.132 0.573 . . . . 0.0 112.243 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 6.8 p -68.87 -37.46 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.675 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 82.2 m -58.84 -27.77 65.43 Favored 'General case' 0 N--CA 1.531 3.575 0 C-N-CA 122.624 0.37 . . . . 0.0 110.833 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -70.87 -22.05 62.34 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.102 0.561 . . . . 0.0 110.942 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 68.6 p -63.81 -26.49 68.65 Favored 'General case' 0 N--CA 1.534 3.742 0 C-N-CA 123.283 0.633 . . . . 0.0 111.552 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.78 -14.46 21.68 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 124.12 0.968 . . . . 0.0 111.43 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.29 8.04 26.0 Favored 'General case' 0 N--CA 1.538 3.971 0 C-N-CA 123.456 0.702 . . . . 0.0 109.243 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -83.57 26.25 0.69 Allowed 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 124.158 0.983 . . . . 0.0 109.493 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -62.41 -46.26 89.41 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 123.838 0.855 . . . . 0.0 110.863 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -69.13 145.62 53.2 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 123.572 0.749 . . . . 0.0 110.325 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 24.4 m -135.25 138.42 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 124.929 1.292 . . . . 0.0 108.205 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.66 146.53 31.6 Favored Pre-proline 0 N--CA 1.529 3.487 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo . . . . . 1 N--CA 1.54 4.264 0 C-N-CA 122.021 1.814 . . . . 0.0 110.686 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.578 2.026 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -77.68 -176.61 3.31 Favored 'Trans proline' 0 N--CA 1.534 3.91 0 C-N-CA 122.127 1.885 . . . . 0.0 110.387 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 69.55 71.11 1.04 Allowed Glycine 1 N--CA 1.517 4.091 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 43.0 t -63.9 149.74 46.48 Favored 'General case' 0 N--CA 1.519 2.98 0 C-N-CA 123.802 0.841 . . . . 0.0 111.587 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -24.91 67.61 Favored 'General case' 0 N--CA 1.527 3.385 0 C-N-CA 124.765 1.226 . . . . 0.0 110.968 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 90.3 p -57.19 -25.53 59.15 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 124.133 0.973 . . . . 0.0 111.96 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.63 83.15 Favored Glycine 0 N--CA 1.514 3.858 0 N-CA-C 115.381 0.912 . . . . 0.0 115.381 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 13.0 tt -59.38 -35.07 56.45 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.512 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 16.8 tt -55.69 -31.19 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.874 0 C-N-CA 123.862 0.865 . . . . 0.0 112.918 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.08 -33.57 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.13 -45.22 96.5 Favored Glycine 1 N--CA 1.522 4.419 0 C-N-CA 123.661 0.648 . . . . 0.0 114.298 -177.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -59.72 -36.08 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.962 0 CA-C-N 117.636 0.718 . . . . 0.0 110.231 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 24.5 p -55.9 -45.05 78.76 Favored 'General case' 0 N--CA 1.536 3.847 0 CA-C-O 120.988 0.423 . . . . 0.0 111.408 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.9 t -58.11 -40.64 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 124.15 0.98 . . . . 0.0 112.289 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.51 -45.93 66.46 Favored 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.57 -42.12 71.49 Favored 'General case' 0 N--CA 1.52 3.026 0 C-N-CA 122.691 0.396 . . . . 0.0 111.489 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.01 -43.6 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.156 0 C-N-CA 123.221 0.609 . . . . 0.0 112.42 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.76 -32.85 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.786 0 CA-C-N 118.51 0.596 . . . . 0.0 111.845 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 51.6 tp -66.0 -41.88 90.46 Favored 'General case' 0 N--CA 1.53 3.546 0 CA-C-N 118.034 0.379 . . . . 0.0 110.609 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 93.1 mt -57.48 -37.43 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 C-N-CA 122.782 0.433 . . . . 0.0 110.527 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.92 -44.12 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 122.847 0.459 . . . . 0.0 110.056 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -45.03 87.33 Favored 'General case' 0 N--CA 1.527 3.417 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.72 -33.89 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.685 0 O-C-N 121.583 -0.698 . . . . 0.0 109.684 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -63.81 -43.39 96.4 Favored 'General case' 0 N--CA 1.529 3.502 0 C-N-CA 123.255 0.622 . . . . 0.0 112.489 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.56 -36.82 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 CA-C-N 118.704 0.684 . . . . 0.0 109.645 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 73.6 m -57.9 -27.33 63.22 Favored 'General case' 0 N--CA 1.528 3.451 0 C-N-CA 122.8 0.44 . . . . 0.0 111.017 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -63.76 -27.67 69.35 Favored 'General case' 0 N--CA 1.532 3.657 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 53.2 p -64.19 -34.43 78.07 Favored 'General case' 0 N--CA 1.527 3.405 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -27.55 67.72 Favored 'General case' 0 N--CA 1.526 3.353 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.591 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 38.9 mt -86.82 -28.11 23.12 Favored 'General case' 0 N--CA 1.533 3.724 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -77.9 101.74 6.96 Favored 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.4 159.85 10.79 Favored 'General case' 0 N--CA 1.519 3.006 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -70.06 121.35 17.29 Favored 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 123.949 0.9 . . . . 0.0 110.085 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.3 138.21 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.403 0 C-N-CA 124.976 1.31 . . . . 0.0 107.767 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.58 146.61 31.77 Favored Pre-proline 0 N--CA 1.529 3.489 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo . . . . . 1 N--CA 1.54 4.261 0 C-N-CA 122.182 1.921 . . . . 0.0 110.657 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 CA--C 1.582 2.197 0 CA-C-O 117.542 -1.218 . . . . 0.0 111.636 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.39 -1.99 6.82 Favored 'Trans proline' 1 N--CA 1.538 4.136 0 C-N-CA 122.615 2.21 . . . . 0.0 111.803 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -79.44 31.16 2.15 Favored Glycine 1 N--CA 1.52 4.258 0 C-N-CA 123.825 0.726 . . . . 0.0 111.525 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 45.3 t -65.58 159.9 23.66 Favored 'General case' 0 N--CA 1.52 3.044 0 C-N-CA 123.651 0.78 . . . . 0.0 111.332 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.1 -26.61 68.29 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 124.318 1.047 . . . . 0.0 110.403 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 93.1 p -63.08 -25.73 68.5 Favored 'General case' 0 N--CA 1.522 3.155 0 C-N-CA 123.668 0.787 . . . . 0.0 111.134 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.53 -46.72 67.16 Favored Glycine 0 N--CA 1.516 3.973 0 CA-C-N 116.061 -0.518 . . . . 0.0 114.28 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.46 -40.2 72.04 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.07 0 CA-C-N 118.179 0.989 . . . . 0.0 113.659 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 18.0 pt -58.94 -40.53 80.62 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.453 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -175.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.2 tt -72.08 -32.33 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.811 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.2 -28.87 43.61 Favored Glycine 0 N--CA 1.515 3.954 0 C-N-CA 123.94 0.781 . . . . 0.0 113.206 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.34 -37.13 67.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.043 0 CA-C-N 117.501 0.651 . . . . 0.0 110.83 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 62.0 p -59.28 -45.19 91.92 Favored 'General case' 0 N--CA 1.527 3.421 0 C-N-CA 123.338 0.655 . . . . 0.0 111.801 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.69 -35.22 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.341 0 C-N-CA 123.607 0.763 . . . . 0.0 109.915 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.3 -34.23 77.66 Favored 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 123.497 0.719 . . . . 0.0 110.883 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.53 91.26 Favored 'General case' 0 N--CA 1.519 3.021 0 C-N-CA 123.135 0.574 . . . . 0.0 111.614 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.72 -52.8 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.612 0 C-N-CA 123.087 0.555 . . . . 0.0 111.851 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.96 -32.09 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 C-N-CA 122.717 0.407 . . . . 0.0 111.026 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.71 -35.28 79.24 Favored 'General case' 1 N--CA 1.541 4.101 0 C-N-CA 122.815 0.446 . . . . 0.0 110.617 -179.278 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 81.3 mt -69.28 -35.68 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.16 -36.21 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 C-N-CA 123.257 0.623 . . . . 0.0 109.692 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.35 -42.38 81.88 Favored 'General case' 0 N--CA 1.526 3.367 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 6.3 m -71.73 -34.49 52.09 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.047 0 CA-C-N 119.063 0.847 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -62.53 -43.76 98.03 Favored 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 123.334 0.654 . . . . 0.0 112.383 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 6.9 p -68.72 -37.43 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.58 -27.75 69.17 Favored 'General case' 0 N--CA 1.528 3.475 0 C-N-CA 123.02 0.528 . . . . 0.0 110.627 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -74.26 -18.4 60.73 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.467 0.707 . . . . 0.0 110.593 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 26.7 t -63.5 -46.37 86.43 Favored 'General case' 0 N--CA 1.529 3.494 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.22 -13.58 58.64 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 123.506 0.722 . . . . 0.0 112.584 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 53.0 tp -87.14 -8.77 56.62 Favored 'General case' 0 N--CA 1.538 3.925 0 C-N-CA 123.566 0.747 . . . . 0.0 110.287 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -58.79 -1.28 0.14 Allowed 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 123.966 0.906 . . . . 0.0 112.792 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -59.59 167.3 2.07 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.32 0.648 . . . . 0.0 110.081 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -165.8 113.85 0.95 Allowed 'General case' 0 N--CA 1.523 3.22 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.46 138.51 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 124.903 1.281 . . . . 0.0 108.436 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.568 ' H ' HD23 ' E' ' 241' ' ' LEU . 1.6 pt? -94.14 147.12 32.85 Favored Pre-proline 0 N--CA 1.532 3.656 0 CA-C-O 116.88 -1.533 . . . . 0.0 109.87 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo . . . . . 1 N--CA 1.551 4.911 0 C-N-CA 122.882 2.388 . . . . 0.0 114.876 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 17.2 ptm . . . . . 0 CA--C 1.574 1.877 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -67.79 -171.57 0.34 Allowed 'Trans proline' 1 N--CA 1.543 4.401 0 C-N-CA 122.337 2.025 . . . . 0.0 110.836 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 76.02 162.07 12.02 Favored Glycine 0 N--CA 1.516 3.999 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 41.3 t -170.89 113.47 0.41 Allowed 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 124.001 0.92 . . . . 0.0 108.969 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.1 -28.69 69.62 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.894 0.878 . . . . 0.0 109.617 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 96.2 p -68.39 -35.52 77.8 Favored 'General case' 0 N--CA 1.521 3.12 0 C-N-CA 123.415 0.686 . . . . 0.0 109.988 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.27 -47.05 54.61 Favored Glycine 0 N--CA 1.512 3.736 0 CA-C-N 115.03 -0.986 . . . . 0.0 114.646 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.0 -41.85 68.28 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.201 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 20.2 tt -56.87 -32.45 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -31.86 43.96 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.666 0 CA-C-N 120.291 1.405 . . . . 0.0 109.038 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.94 -36.18 60.03 Favored Glycine 0 N--CA 1.51 3.617 0 C-N-CA 124.172 0.892 . . . . 0.0 114.646 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.92 -38.24 75.6 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.17 0 CA-C-N 118.508 1.154 . . . . 0.0 111.015 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 29.9 p -66.41 -45.99 78.07 Favored 'General case' 0 N--CA 1.528 3.468 0 CA-C-O 121.617 0.722 . . . . 0.0 110.334 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 58.0 t -69.48 -33.9 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.006 0 C-N-CA 124.714 1.205 . . . . 0.0 110.535 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.16 68.97 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.51 91.92 Favored 'General case' 0 N--CA 1.518 2.928 0 C-N-CA 123.3 0.64 . . . . 0.0 111.275 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 43.4 t -66.75 -48.91 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.314 0 C-N-CA 123.599 0.76 . . . . 0.0 110.556 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.51 -33.83 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.552 0 C-N-CA 123.278 0.631 . . . . 0.0 110.094 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 33.7 tp -67.21 -34.16 76.9 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.247 0.619 . . . . 0.0 110.339 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 39.4 mt -64.66 -41.1 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.893 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.56 -37.89 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 C-N-CA 122.975 0.51 . . . . 0.0 109.825 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.43 71.01 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.695 0.798 . . . . 0.0 112.278 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.38 -33.97 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 C-N-CA 122.814 0.446 . . . . 0.0 110.244 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -65.98 -44.21 85.58 Favored 'General case' 0 N--CA 1.531 3.588 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.87 -37.73 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 O-C-N 122.232 -0.292 . . . . 0.0 110.55 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 8.3 p -58.74 -27.38 64.88 Favored 'General case' 0 N--CA 1.536 3.845 0 O-C-N 122.218 -0.301 . . . . 0.0 111.248 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -59.88 -18.68 46.36 Favored 'General case' 0 N--CA 1.531 3.62 0 C-N-CA 123.279 0.632 . . . . 0.0 111.203 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 51.5 m -70.34 -30.57 67.57 Favored 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.544 0.738 . . . . 0.0 110.362 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 64.4 mt -60.49 -13.12 11.93 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.398 1.079 . . . . 0.0 111.752 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.57 10.5 13.0 Favored 'General case' 0 N--CA 1.532 3.635 0 C-N-CA 123.196 0.598 . . . . 0.0 110.067 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 59.64 116.24 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 124.601 1.161 . . . . 0.0 112.257 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -139.94 105.57 5.12 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 125.099 1.36 . . . . 0.0 107.868 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -132.33 -173.67 3.23 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 124.839 1.256 . . . . 0.0 108.463 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.26 138.11 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 C-N-CA 124.678 1.191 . . . . 0.0 108.566 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.55 146.53 32.19 Favored Pre-proline 0 N--CA 1.529 3.497 0 CA-C-O 117.247 -1.359 . . . . 0.0 108.421 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo . . . . . 1 N--CA 1.54 4.209 0 CA-C-N 122.23 1.832 . . . . 0.0 110.042 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 64.2 mtp . . . . . 0 CA--C 1.585 2.305 0 CA-C-O 117.509 -1.234 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -87.88 -169.99 0.51 Allowed 'Trans proline' 0 N--CA 1.536 3.995 0 C-N-CA 122.649 2.233 . . . . 0.0 110.819 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -169.94 153.29 21.24 Favored Glycine 1 N--CA 1.519 4.181 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.3 p -97.83 41.92 1.11 Allowed 'General case' 0 N--CA 1.526 3.354 0 C-N-CA 124.685 1.194 . . . . 0.0 109.38 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 54.2 tp -59.98 -26.41 66.02 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 124.264 1.026 . . . . 0.0 110.978 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 71.2 m -57.43 -26.15 60.73 Favored 'General case' 0 N--CA 1.526 3.327 0 C-N-CA 123.735 0.814 . . . . 0.0 111.62 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.35 92.66 Favored Glycine 0 N--CA 1.509 3.566 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.91 -46.22 94.2 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.483 0 CA-C-N 118.772 1.286 . . . . 0.0 112.967 -175.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -67.66 -32.13 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.384 0.674 . . . . 0.0 110.323 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 90.4 mt -66.06 -34.06 67.72 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.013 0 C-N-CA 123.054 0.542 . . . . 0.0 109.848 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.69 -29.81 64.79 Favored Glycine 1 N--CA 1.517 4.055 0 CA-C-O 119.831 -0.427 . . . . 0.0 113.675 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.5 m -61.77 -37.11 77.3 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.29 0 CA-C-N 117.764 0.782 . . . . 0.0 110.907 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.6 p -55.51 -43.39 75.62 Favored 'General case' 0 N--CA 1.524 3.234 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.159 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.96 -45.99 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.073 0 C-N-CA 123.824 0.85 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.46 -45.13 65.95 Favored 'General case' 0 N--CA 1.527 3.403 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.32 90.22 Favored 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 122.953 0.501 . . . . 0.0 111.769 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.2 t -66.66 -39.78 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 122.91 0.484 . . . . 0.0 110.693 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.92 -39.78 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.585 0 C-N-CA 122.863 0.465 . . . . 0.0 110.837 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.26 -37.22 84.63 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 117.897 0.317 . . . . 0.0 111.519 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 99.3 mt -64.27 -42.59 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 C-N-CA 123.308 0.643 . . . . 0.0 110.028 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.76 -41.74 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.25 -45.5 87.68 Favored 'General case' 0 N--CA 1.525 3.309 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.73 -34.31 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 O-C-N 121.723 -0.611 . . . . 0.0 110.08 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.42 -44.24 95.96 Favored 'General case' 0 N--CA 1.529 3.516 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.7 m -68.65 -37.42 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 CA-C-O 121.212 0.53 . . . . 0.0 109.683 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 70.9 m -63.39 -46.08 88.1 Favored 'General case' 0 N--CA 1.523 3.178 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.26 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.67 -19.02 35.74 Favored 'General case' 0 N--CA 1.536 3.857 0 C-N-CA 122.744 0.418 . . . . 0.0 112.007 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 52.0 m -74.59 -40.17 61.76 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 51.0 mt -68.71 -29.16 67.54 Favored 'General case' 0 N--CA 1.524 3.264 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.511 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.04 10.58 16.1 Favored 'General case' 1 N--CA 1.545 4.324 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 54.6 t90 -139.81 70.78 1.37 Allowed 'General case' 0 N--CA 1.53 3.557 0 C-N-CA 124.176 0.99 . . . . 0.0 108.875 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -133.74 -18.56 2.13 Favored 'General case' 0 N--CA 1.534 3.765 0 C-N-CA 125.108 1.363 . . . . 0.0 109.139 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -163.68 86.81 0.51 Allowed 'General case' 0 N--CA 1.525 3.283 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.56 130.51 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 60.7 tp -133.36 99.42 14.56 Favored Pre-proline 0 N--CA 1.531 3.581 0 C-N-CA 124.843 1.257 . . . . 0.0 108.478 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo . . . . . 1 N--CA 1.547 4.624 0 C-N-CA 122.331 2.021 . . . . 0.0 114.199 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 CA--C 1.577 2.005 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -47.46 -67.63 0.11 Allowed 'Trans proline' 1 N--CA 1.545 4.545 0 C-N-CA 122.694 2.263 . . . . 0.0 114.12 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 63.19 122.64 0.01 OUTLIER Glycine 1 N--CA 1.523 4.442 0 C-N-CA 123.912 0.768 . . . . 0.0 111.636 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 68.1 m -162.8 89.46 0.66 Allowed 'General case' 0 N--CA 1.524 3.228 0 CA-C-N 117.7 0.75 . . . . 0.0 109.646 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 50.2 mt -65.15 -26.64 68.26 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 124.262 1.025 . . . . 0.0 110.098 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.1 m -59.43 -37.1 77.21 Favored 'General case' 0 N--CA 1.525 3.325 0 C-N-CA 123.14 0.576 . . . . 0.0 110.662 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.33 -36.22 92.76 Favored Glycine 1 N--CA 1.522 4.422 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.07 -40.96 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 C-N-CA 124.27 1.028 . . . . 0.0 109.088 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 91.2 mt -67.71 -39.44 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 C-N-CA 124.674 1.189 . . . . 0.0 109.046 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 87.8 mt -71.15 -32.07 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.77 -29.27 41.13 Favored Glycine 0 N--CA 1.515 3.946 0 C-N-CA 123.74 0.686 . . . . 0.0 113.218 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 4.0 m -59.85 -37.36 71.4 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 117.79 0.795 . . . . 0.0 110.475 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.9 p -62.27 -45.57 92.68 Favored 'General case' 0 N--CA 1.528 3.428 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.382 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.13 -35.48 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.194 0 C-N-CA 124.149 0.98 . . . . 0.0 110.485 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.01 -34.55 68.29 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.358 0.663 . . . . 0.0 111.851 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.2 -42.08 72.82 Favored 'General case' 0 N--CA 1.516 2.864 0 C-N-CA 123.205 0.602 . . . . 0.0 111.403 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.2 t -58.99 -47.0 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 C-N-CA 123.565 0.746 . . . . 0.0 112.19 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.9 m -67.1 -32.28 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.468 0 C-N-CA 122.959 0.504 . . . . 0.0 111.635 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.82 -45.08 45.76 Favored 'General case' 0 N--CA 1.524 3.257 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.7 pt -68.86 -36.75 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.904 0 CA-C-N 118.432 0.56 . . . . 0.0 112.468 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.21 -36.96 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 O-C-N 121.532 -0.73 . . . . 0.0 110.151 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.62 -44.98 85.93 Favored 'General case' 0 N--CA 1.526 3.366 0 C-N-CA 123.56 0.744 . . . . 0.0 112.977 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 13.7 m -71.19 -34.19 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 O-C-N 121.737 -0.602 . . . . 0.0 110.543 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -63.07 -44.49 95.65 Favored 'General case' 0 N--CA 1.531 3.612 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.06 -37.54 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.615 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.94 -29.22 66.96 Favored 'General case' 0 N--CA 1.527 3.411 0 C-N-CA 122.714 0.406 . . . . 0.0 111.424 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -64.19 -15.93 60.91 Favored 'General case' 1 N--CA 1.539 4.009 0 CA-C-N 118.048 0.386 . . . . 0.0 111.075 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 41.5 m -64.64 -34.34 78.06 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 51.1 tp -70.08 -28.19 65.22 Favored 'General case' 0 N--CA 1.526 3.335 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.139 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.95 11.05 14.43 Favored 'General case' 0 N--CA 1.538 3.934 0 C-N-CA 123.884 0.874 . . . . 0.0 109.582 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -155.79 107.47 2.56 Favored 'General case' 0 N--CA 1.526 3.333 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -166.07 10.3 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 123.702 0.801 . . . . 0.0 110.266 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.97 141.29 57.65 Favored 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 124.07 0.948 . . . . 0.0 110.099 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 52.2 t -122.19 137.13 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 C-N-CA 125.036 1.335 . . . . 0.0 107.404 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 7.9 mp -94.2 146.77 32.18 Favored Pre-proline 0 N--CA 1.53 3.543 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 1 N--CA 1.54 4.223 0 C-N-CA 122.139 1.892 . . . . 0.0 110.545 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.573 1.85 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -76.97 48.89 2.62 Favored 'Trans proline' 1 N--CA 1.538 4.13 0 C-N-CA 122.138 1.892 . . . . 0.0 110.056 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.95 81.1 0.21 Allowed Glycine 1 N--CA 1.518 4.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.392 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 69.1 m -64.37 151.56 43.69 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 123.8 0.84 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -64.58 -26.82 68.57 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 124.078 0.951 . . . . 0.0 109.77 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 42.7 t -61.29 -38.66 87.59 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.931 0.892 . . . . 0.0 110.951 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.33 -41.96 76.48 Favored Glycine 0 N--CA 1.513 3.806 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.428 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 61.7 mt -70.62 -45.81 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 C-N-CA 124.498 1.119 . . . . 0.0 113.255 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -56.63 -31.96 36.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.161 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.5 pp -66.98 -31.9 55.57 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.196 0 CA-C-N 119.336 0.971 . . . . 0.0 109.497 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.84 -36.15 59.5 Favored Glycine 0 N--CA 1.51 3.615 0 CA-C-N 115.614 -0.721 . . . . 0.0 114.788 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.46 -45.45 92.83 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 CA-C-N 118.279 1.04 . . . . 0.0 113.104 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 1.3 t -65.03 -45.25 86.25 Favored 'General case' 0 N--CA 1.538 3.945 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.7 -31.14 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.295 0 C-N-CA 122.987 0.515 . . . . 0.0 111.262 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.64 93.43 Favored 'General case' 0 N--CA 1.528 3.471 0 O-C-N 121.803 -0.56 . . . . 0.0 111.987 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.95 -48.03 81.14 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.81 -38.4 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.744 0 CA-C-N 118.196 0.453 . . . . 0.0 111.103 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.26 -40.94 86.01 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.009 0 CA-C-N 118.403 0.547 . . . . 0.0 110.356 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -34.34 77.69 Favored 'General case' 1 N--CA 1.54 4.055 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 tp -54.8 -36.94 38.89 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.401 0 C-N-CA 123.401 0.681 . . . . 0.0 110.483 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.65 -40.96 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 C-N-CA 123.416 0.687 . . . . 0.0 110.545 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.83 -35.61 71.13 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.42 0.688 . . . . 0.0 111.576 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -71.77 -36.61 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.298 0 C-N-CA 123.492 0.717 . . . . 0.0 111.728 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.93 -43.86 64.57 Favored 'General case' 0 N--CA 1.531 3.613 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.42 -37.57 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.087 0.555 . . . . 0.0 110.983 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 15.0 p -62.21 -27.63 69.12 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 122.353 0.261 . . . . 0.0 111.394 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.72 -40.38 84.25 Favored 'General case' 0 N--CA 1.53 3.528 0 CA-C-O 121.007 0.432 . . . . 0.0 110.436 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.7 t -64.03 -22.45 66.94 Favored 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 123.791 0.836 . . . . 0.0 112.467 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.4 tp -67.41 -17.44 64.72 Favored 'General case' 0 N--CA 1.529 3.508 0 C-N-CA 123.345 0.658 . . . . 0.0 110.819 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.35 -28.49 22.18 Favored 'General case' 0 N--CA 1.531 3.584 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -95.72 96.13 8.79 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 124.447 1.099 . . . . 0.0 108.993 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -169.82 9.77 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.382 0 C-N-CA 123.606 0.763 . . . . 0.0 110.511 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.18 137.57 54.95 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.382 0.673 . . . . 0.0 110.093 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.9 p -118.89 138.27 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.565 0 C-N-CA 125.176 1.39 . . . . 0.0 108.96 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 48.6 tp -95.13 104.92 16.63 Favored Pre-proline 0 N--CA 1.528 3.447 0 CA-C-O 117.3 -1.334 . . . . 0.0 107.808 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo . . . . . 1 N--CA 1.537 4.052 0 CA-C-N 122.713 2.005 . . . . 0.0 111.089 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 68.2 mtp . . . . . 0 CA--C 1.574 1.883 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.5 -28.25 8.53 Favored 'Trans proline' 0 N--CA 1.535 3.959 0 C-N-CA 122.293 1.995 . . . . 0.0 110.593 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.7 90.84 0.04 OUTLIER Glycine 1 N--CA 1.519 4.208 0 C-N-CA 123.657 0.646 . . . . 0.0 111.496 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 98.9 p -163.36 7.62 0.05 OUTLIER 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 123.783 0.833 . . . . 0.0 110.422 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.18 -26.83 68.32 Favored 'General case' 0 N--CA 1.528 3.475 0 C-N-CA 123.962 0.905 . . . . 0.0 109.099 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 69.4 m -57.73 -26.15 61.39 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 124.105 0.962 . . . . 0.0 110.907 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.41 -35.28 84.51 Favored Glycine 1 N--CA 1.517 4.072 0 C-N-CA 123.657 0.646 . . . . 0.0 113.102 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -46.98 94.94 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 CA-C-N 117.084 0.442 . . . . 0.0 111.89 -177.256 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.8 -31.76 55.15 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.556 0 C-N-CA 124.038 0.935 . . . . 0.0 109.811 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.29 -33.55 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.29 -33.02 85.6 Favored Glycine 1 N--CA 1.52 4.289 0 C-N-CA 123.69 0.662 . . . . 0.0 112.159 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.23 -43.52 93.5 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.052 0 C-N-CA 124.194 0.997 . . . . 0.0 109.657 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 27.3 p -56.85 -45.31 82.52 Favored 'General case' 0 N--CA 1.525 3.313 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.373 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 49.9 t -67.75 -41.27 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.211 0 C-N-CA 124.251 1.021 . . . . 0.0 111.312 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.3 -44.74 65.2 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.58 81.13 Favored 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 123.254 0.621 . . . . 0.0 111.616 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 t -53.72 -39.49 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.927 0 C-N-CA 123.25 0.62 . . . . 0.0 111.857 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.45 -38.48 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 C-N-CA 122.768 0.427 . . . . 0.0 110.121 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 73.2 mt -70.94 -34.57 71.62 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 122.958 0.503 . . . . 0.0 110.223 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 20.0 mm -60.41 -50.52 80.01 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 C-N-CA 123.532 0.733 . . . . 0.0 110.951 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 31.6 m -66.62 -36.99 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 O-C-N 121.816 -0.553 . . . . 0.0 110.239 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.38 85.92 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.636 0.775 . . . . 0.0 112.594 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 34.4 m -71.98 -34.53 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.696 0 O-C-N 121.823 -0.548 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.58 -43.85 95.77 Favored 'General case' 0 N--CA 1.53 3.525 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.37 -37.22 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 74.3 m -58.76 -27.07 64.61 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.076 0.551 . . . . 0.0 111.845 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.54 -33.21 73.44 Favored 'General case' 0 N--CA 1.537 3.887 0 CA-C-N 118.343 0.519 . . . . 0.0 110.79 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 35.5 t -67.07 -27.86 67.72 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.155 0.582 . . . . 0.0 110.217 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 51.4 tp -89.77 -13.9 35.72 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 124.947 1.299 . . . . 0.0 110.378 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 39.7 tp -85.67 -1.69 57.42 Favored 'General case' 1 N--CA 1.545 4.287 0 CA-C-O 121.046 0.45 . . . . 0.0 109.999 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -139.8 -159.56 0.97 Allowed 'General case' 0 N--CA 1.522 3.125 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 64.27 161.83 0.12 Allowed 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 123.762 0.825 . . . . 0.0 110.283 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? 59.02 17.59 5.58 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 124.218 1.007 . . . . 0.0 110.915 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 16.3 m -117.27 138.29 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 C-N-CA 124.93 1.292 . . . . 0.0 108.152 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 75.5 mt -121.92 146.44 46.15 Favored Pre-proline 0 N--CA 1.53 3.566 0 CA-C-O 116.493 -1.718 . . . . 0.0 107.445 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo . . . . . 1 N--CA 1.548 4.733 0 CA-C-N 123.074 2.134 . . . . 0.0 114.526 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.574 1.867 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -48.02 103.23 0.05 OUTLIER 'Trans proline' 1 N--CA 1.543 4.428 0 C-N-CA 122.707 2.271 . . . . 0.0 114.142 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 63.16 167.82 0.9 Allowed Glycine 1 N--CA 1.519 4.209 0 C-N-CA 123.748 0.69 . . . . 0.0 112.331 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 41.2 t -172.5 -54.4 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.978 0 C-N-CA 124.26 1.024 . . . . 0.0 108.577 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 58.3 tp -64.24 -27.04 68.78 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 124.152 0.981 . . . . 0.0 110.216 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 53.8 m -62.02 -25.91 67.93 Favored 'General case' 0 N--CA 1.518 2.955 0 C-N-CA 124.413 1.085 . . . . 0.0 110.681 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.85 -46.72 71.74 Favored Glycine 0 N--CA 1.51 3.62 0 CA-C-N 115.22 -0.9 . . . . 0.0 114.684 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 29.6 pt -71.04 -38.81 73.36 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 CA-C-N 118.826 1.313 . . . . 0.0 113.961 -177.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.7 tp -62.88 -32.52 56.22 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 C-N-CA 123.239 0.616 . . . . 0.0 112.497 -176.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.8 -34.03 45.64 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.791 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.18 -45.15 83.48 Favored Glycine 0 N--CA 1.515 3.921 0 C-N-CA 124.8 1.191 . . . . 0.0 115.155 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.34 -37.41 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 CA-C-N 117.381 0.591 . . . . 0.0 110.779 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 35.6 p -66.35 -47.27 73.96 Favored 'General case' 0 N--CA 1.532 3.644 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.63 -31.88 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 C-N-CA 123.301 0.64 . . . . 0.0 112.269 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.77 -47.26 70.89 Favored 'General case' 0 N--CA 1.532 3.633 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.59 97.47 Favored 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 123.475 0.71 . . . . 0.0 111.679 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.47 -49.03 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.651 0.78 . . . . 0.0 111.989 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.84 -32.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 C-N-CA 123.321 0.648 . . . . 0.0 110.539 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.33 -39.93 94.88 Favored 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 123.124 0.57 . . . . 0.0 110.143 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.34 -37.7 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 C-N-CA 122.927 0.491 . . . . 0.0 110.426 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.15 -37.85 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 C-N-CA 123.09 0.556 . . . . 0.0 110.28 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.41 -32.27 68.49 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.339 0.655 . . . . 0.0 111.611 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.57 -43.75 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.458 0 C-N-CA 123.299 0.64 . . . . 0.0 111.659 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -62.19 -43.49 98.72 Favored 'General case' 1 N--CA 1.54 4.055 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.14 -38.38 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 95.4 m -67.68 -40.1 84.42 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 122.831 0.452 . . . . 0.0 110.449 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -72.72 -31.16 64.77 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 123.473 0.709 . . . . 0.0 110.454 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 46.2 t -64.44 -34.28 77.82 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.451 0.7 . . . . 0.0 110.765 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.75 -34.54 67.09 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 124.358 1.063 . . . . 0.0 109.747 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 4.6 tt -87.24 -9.0 56.2 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 124.389 1.075 . . . . 0.0 111.633 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -52.27 -38.26 57.77 Favored 'General case' 0 N--CA 1.528 3.47 0 C-N-CA 123.789 0.835 . . . . 0.0 112.129 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -64.92 134.35 53.78 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 123.377 0.671 . . . . 0.0 110.545 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt 61.61 145.14 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 124.637 1.175 . . . . 0.0 111.196 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 47.8 t -135.12 129.27 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 C-N-CA 124.691 1.196 . . . . 0.0 107.834 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.64 146.66 31.85 Favored Pre-proline 0 N--CA 1.529 3.51 0 CA-C-O 116.558 -1.686 . . . . 0.0 107.039 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo . . . . . 1 N--CA 1.55 4.844 0 C-N-CA 122.928 2.419 . . . . 0.0 115.112 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 52.3 tpp . . . . . 0 CA--C 1.573 1.844 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -81.12 133.78 8.97 Favored 'Trans proline' 0 N--CA 1.533 3.805 0 C-N-CA 122.52 2.147 . . . . 0.0 109.945 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.53 -15.51 66.25 Favored Glycine 1 N--CA 1.519 4.189 0 C-N-CA 123.596 0.617 . . . . 0.0 112.206 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 50.7 m 58.77 90.04 0.05 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 124.301 1.04 . . . . 0.0 111.24 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 44.7 mt -54.78 -25.79 30.31 Favored 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 124.885 1.274 . . . . 0.0 111.437 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 54.1 m -57.69 -36.42 71.94 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.583 0.753 . . . . 0.0 111.31 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.72 -39.52 86.03 Favored Glycine 1 N--CA 1.52 4.259 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.533 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.54 -46.27 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.895 0 C-N-CA 124.181 0.992 . . . . 0.0 110.993 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 215' ' ' ILE . . . . . 0.459 HD13 ' O ' ' F' ' 215' ' ' ILE . 0.0 OUTLIER -68.63 -32.17 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.983 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 85.1 mt -73.3 -40.36 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.93 95.51 Favored Glycine 0 N--CA 1.512 3.748 0 CA-C-N 115.227 -0.897 . . . . 0.0 114.8 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.5 -37.08 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 CA-C-N 117.923 0.862 . . . . 0.0 111.448 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 68.5 p -65.93 -46.5 77.99 Favored 'General case' 0 N--CA 1.533 3.695 0 CA-C-O 120.931 0.396 . . . . 0.0 110.715 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.76 -35.45 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.22 0 C-N-CA 124.051 0.94 . . . . 0.0 110.508 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.12 67.41 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.5 -34.53 69.18 Favored 'General case' 0 N--CA 1.521 3.077 0 C-N-CA 123.142 0.577 . . . . 0.0 112.017 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.42 -39.06 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.316 0 C-N-CA 123.048 0.539 . . . . 0.0 110.653 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.72 -41.32 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 123.427 0.691 . . . . 0.0 111.485 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.22 -35.69 77.9 Favored 'General case' 1 N--CA 1.54 4.026 0 C-N-CA 122.594 0.358 . . . . 0.0 110.743 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 68.7 mt -69.26 -40.9 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 98.4 t -66.74 -37.97 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.465 0 C-N-CA 123.335 0.654 . . . . 0.0 109.442 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.08 -47.66 82.53 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.727 0.811 . . . . 0.0 112.696 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 25.6 m -71.9 -34.51 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 O-C-N 121.993 -0.442 . . . . 0.0 110.195 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -63.86 -44.13 94.02 Favored 'General case' 0 N--CA 1.527 3.382 0 C-N-CA 123.053 0.541 . . . . 0.0 112.334 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.45 -37.7 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 86.4 m -62.77 -27.95 69.64 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 122.92 0.488 . . . . 0.0 110.129 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -69.57 -16.86 63.49 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.173 0.589 . . . . 0.0 110.62 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 19.5 m -68.8 -28.69 66.99 Favored 'General case' 0 N--CA 1.53 3.565 0 C-N-CA 123.062 0.545 . . . . 0.0 110.232 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.22 -23.51 66.44 Favored 'General case' 0 N--CA 1.525 3.289 0 C-N-CA 123.727 0.811 . . . . 0.0 110.715 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 8.2 mp -87.47 -26.16 23.37 Favored 'General case' 0 N--CA 1.534 3.732 0 C-N-CA 123.685 0.794 . . . . 0.0 109.215 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -73.64 92.52 1.97 Allowed 'General case' 0 N--CA 1.526 3.359 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -168.57 148.33 4.47 Favored 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 239' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' F' ' 240' ' ' VAL . 4.3 ttmp? -163.96 -19.66 0.03 OUTLIER 'General case' 0 N--CA 1.532 3.662 0 C-N-CA 123.618 0.767 . . . . 0.0 109.738 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 240' ' ' VAL . . . . . 0.409 ' H ' ' H ' ' F' ' 239' ' ' LYS . 7.7 p -112.46 138.2 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.518 0 C-N-CA 125.411 1.485 . . . . 0.0 108.966 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 241' ' ' LEU . . . . . 0.676 ' H ' HD23 ' F' ' 241' ' ' LEU . 1.5 pt? -110.89 146.52 34.62 Favored Pre-proline 0 N--CA 1.536 3.837 0 C-N-CA 125.39 1.476 . . . . 0.0 109.49 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 1 N--CA 1.541 4.303 0 CA-C-N 122.227 1.831 . . . . 0.0 110.392 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.073 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 27.4 t 57.26 55.1 6.13 Favored 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.021 0.928 . . . . 0.0 111.942 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.84 -26.87 68.52 Favored 'General case' 0 N--CA 1.525 3.283 0 C-N-CA 123.989 0.915 . . . . 0.0 110.547 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.4 m -61.71 -26.44 68.04 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 123.498 0.719 . . . . 0.0 110.237 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.9 -35.43 63.55 Favored Glycine 0 N--CA 1.502 3.035 0 C-N-CA 125.108 1.337 . . . . 0.0 115.354 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 16.9 pt -58.0 -33.73 47.03 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.34 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 216' ' ' ILE . 1.3 pp -55.71 -36.41 42.69 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.002 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -174.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 215' ' ' ILE . 5.2 tp -73.49 -38.43 52.69 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.696 0 CA-C-N 119.472 1.033 . . . . 0.0 109.039 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.31 -45.36 88.76 Favored Glycine 1 N--CA 1.522 4.389 0 N-CA-C 114.891 0.716 . . . . 0.0 114.891 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.93 -36.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.971 0 CA-C-N 117.503 0.651 . . . . 0.0 110.724 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.7 p -58.92 -40.61 85.08 Favored 'General case' 0 N--CA 1.535 3.785 0 CA-C-O 121.082 0.467 . . . . 0.0 111.799 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.74 -39.31 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 123.753 0.821 . . . . 0.0 111.877 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.08 79.6 Favored 'General case' 0 N--CA 1.529 3.477 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.38 -50.02 56.0 Favored 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 m -63.75 -38.58 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.87 -32.86 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 CA-C-N 118.848 0.749 . . . . 0.0 110.723 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 5.9 tt -65.08 -37.88 88.95 Favored 'General case' 0 N--CA 1.536 3.829 0 CA-C-N 117.878 0.308 . . . . 0.0 110.708 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.8 mt -61.98 -36.67 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.84 0 C-N-CA 123.079 0.552 . . . . 0.0 110.351 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.21 -40.35 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.68 0 C-N-CA 122.968 0.507 . . . . 0.0 110.07 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.8 -32.59 67.71 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.191 0.596 . . . . 0.0 111.528 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.9 t -68.19 -37.96 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 C-N-CA 123.141 0.577 . . . . 0.0 109.87 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -70.1 -34.78 73.57 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.403 0.681 . . . . 0.0 110.086 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.02 -38.13 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 C-N-CA 123.968 0.907 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 79.8 m -60.07 -38.53 83.13 Favored 'General case' 0 N--CA 1.527 3.379 0 CA-C-O 121.195 0.522 . . . . 0.0 109.748 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -74.39 -37.8 63.32 Favored 'General case' 0 N--CA 1.519 2.998 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.208 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.0 p -63.76 -46.31 85.84 Favored 'General case' 0 N--CA 1.531 3.615 0 CA-C-O 121.434 0.635 . . . . 0.0 109.595 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.49 -19.35 62.94 Favored 'General case' 0 N--CA 1.53 3.561 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.563 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.7 tp -87.09 -28.21 22.66 Favored 'General case' 1 N--CA 1.541 4.115 0 CA-C-N 119.17 0.895 . . . . 0.0 109.11 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.8 m0 -78.68 107.74 11.59 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -168.0 88.99 0.27 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 11.6 tptp 71.92 -164.21 0.13 Allowed 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 124.052 0.941 . . . . 0.0 109.135 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.531 3.61 0 C-N-CA 124.935 1.294 . . . . 0.0 107.69 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.523 3.213 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.09 -36.44 84.32 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 124.299 1.04 . . . . 0.0 109.741 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.6 t -57.38 -25.64 59.81 Favored 'General case' 0 N--CA 1.525 3.316 0 C-N-CA 123.612 0.765 . . . . 0.0 110.907 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.44 -34.48 59.79 Favored Glycine 0 N--CA 1.512 3.752 0 C-N-CA 124.948 1.261 . . . . 0.0 114.544 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 17.3 pt -59.39 -34.8 55.43 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -176.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.21 -47.37 80.96 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.333 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.6 tt -72.48 -32.95 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.55 -29.32 47.68 Favored Glycine 0 N--CA 1.515 3.906 0 C-N-CA 123.444 0.545 . . . . 0.0 113.181 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 m -60.0 -37.38 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 CA-C-N 117.551 0.676 . . . . 0.0 111.8 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 1.3 t -61.05 -39.06 88.41 Favored 'General case' 1 N--CA 1.54 4.063 0 CA-C-O 120.825 0.345 . . . . 0.0 111.539 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 47.4 t -60.99 -31.5 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 123.76 0.824 . . . . 0.0 110.517 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.19 77.83 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 123.06 0.544 . . . . 0.0 111.316 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.69 -50.2 58.84 Favored 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.22 -38.56 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.726 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 27.0 m -65.36 -32.01 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 CA-C-N 118.584 0.629 . . . . 0.0 111.394 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 54.1 mt -66.73 -34.57 78.13 Favored 'General case' 0 N--CA 1.533 3.701 0 O-C-N 122.026 -0.421 . . . . 0.0 111.091 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 59.7 mt -61.35 -49.65 83.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.049 0 CA-C-N 118.066 0.394 . . . . 0.0 111.595 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.65 -37.01 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.71 0 O-C-N 121.902 -0.499 . . . . 0.0 110.099 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.55 -47.15 86.66 Favored 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 123.667 0.787 . . . . 0.0 112.603 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.69 -34.38 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.615 0 O-C-N 121.842 -0.536 . . . . 0.0 110.527 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -63.34 -44.36 95.11 Favored 'General case' 0 N--CA 1.528 3.441 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.92 -37.76 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.3 m -67.02 -32.85 74.34 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 122.988 0.515 . . . . 0.0 110.478 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -66.96 -32.26 73.38 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 123.498 0.719 . . . . 0.0 111.054 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 50.6 m -63.82 -29.34 70.55 Favored 'General case' 0 N--CA 1.528 3.454 0 C-N-CA 123.299 0.639 . . . . 0.0 111.244 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.27 -27.35 68.98 Favored 'General case' 0 N--CA 1.528 3.448 0 C-N-CA 123.45 0.7 . . . . 0.0 110.952 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 N--CA 1.538 3.944 0 C-N-CA 123.79 0.836 . . . . 0.0 109.893 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.52 3.074 0 CA-C-O 121.54 0.686 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 pp -62.9 -26.43 68.79 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 123.882 0.873 . . . . 0.0 111.053 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 34.8 t -62.34 -25.88 68.14 Favored 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 123.476 0.71 . . . . 0.0 110.999 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.48 -38.09 86.27 Favored Glycine 0 N--CA 1.514 3.851 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.91 -35.35 59.38 Favored 'Isoleucine or valine' 1 N--CA 1.555 4.803 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.01 -32.67 33.95 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.41 -31.78 55.34 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.194 0 CA-C-N 119.134 0.879 . . . . 0.0 108.781 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.77 -42.65 79.24 Favored Glycine 0 N--CA 1.516 3.987 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.746 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.48 -37.16 77.38 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 CA-C-N 117.989 0.895 . . . . 0.0 110.384 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 26.4 m -62.51 -47.6 83.25 Favored 'General case' 0 N--CA 1.519 3.002 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.502 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 9.4 p -71.21 -31.47 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.359 0 C-N-CA 123.649 0.78 . . . . 0.0 111.171 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.83 60.63 Favored 'General case' 0 N--CA 1.529 3.505 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.99 -50.34 64.63 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.11 -41.5 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.54 -32.65 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.617 0 O-C-N 121.826 -0.546 . . . . 0.0 112.166 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -75.52 -39.95 57.72 Favored 'General case' 0 N--CA 1.528 3.429 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 19.3 pt -69.49 -38.84 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 CA-C-N 118.562 0.619 . . . . 0.0 111.762 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.67 -37.29 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 O-C-N 121.592 -0.692 . . . . 0.0 109.967 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.99 83.8 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 123.737 0.815 . . . . 0.0 113.045 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.53 -34.26 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 O-C-N 121.811 -0.556 . . . . 0.0 110.223 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -64.08 -44.26 92.92 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.96 -37.59 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 87.8 m -64.66 -27.83 69.19 Favored 'General case' 0 N--CA 1.525 3.325 0 C-N-CA 123.038 0.535 . . . . 0.0 110.878 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -70.93 -35.75 72.36 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 122.901 0.48 . . . . 0.0 110.295 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.4 t -63.92 -23.24 67.27 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.499 0.72 . . . . 0.0 112.18 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.69 -21.57 65.32 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 123.336 0.655 . . . . 0.0 110.749 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.68 0.74 55.27 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 123.66 0.784 . . . . 0.0 109.925 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.26 -76.49 0.07 Allowed 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.503 0.721 . . . . 0.0 110.13 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 55.8 -135.61 1.29 Allowed 'General case' 0 N--CA 1.522 3.162 0 C-N-CA 123.891 0.877 . . . . 0.0 111.0 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 57.21 78.56 0.22 Allowed 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 124.199 1.0 . . . . 0.0 111.753 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.527 3.402 0 C-N-CA 124.968 1.307 . . . . 0.0 107.918 179.28 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.522 3.153 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.04 -28.69 69.66 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 123.812 0.845 . . . . 0.0 109.579 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 39.9 t -68.7 -32.35 72.09 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 123.498 0.719 . . . . 0.0 110.493 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.57 -40.27 86.21 Favored Glycine 0 N--CA 1.515 3.944 0 CA-C-N 114.947 -1.024 . . . . 0.0 115.103 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.05 -46.07 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.677 1.238 . . . . 0.0 112.018 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -32.79 50.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.063 0 C-N-CA 124.353 1.061 . . . . 0.0 113.198 -177.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 37.6 pt -71.84 -33.18 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 119.247 0.931 . . . . 0.0 108.527 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.45 -29.88 76.33 Favored Glycine 1 N--CA 1.521 4.316 0 C-N-CA 123.539 0.59 . . . . 0.0 111.878 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.67 -37.95 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.72 0 C-N-CA 124.102 0.961 . . . . 0.0 109.947 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 30.3 p -62.14 -45.08 95.03 Favored 'General case' 0 N--CA 1.531 3.592 0 CA-C-O 121.598 0.713 . . . . 0.0 110.414 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.06 -34.87 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.051 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.102 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.21 -36.54 84.49 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 123.117 0.567 . . . . 0.0 112.46 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.09 -49.97 45.58 Favored 'General case' 0 N--CA 1.512 2.654 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 33.2 m -63.16 -38.8 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.06 -35.96 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.847 0 CA-C-N 118.633 0.651 . . . . 0.0 111.094 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.29 -34.89 78.67 Favored 'General case' 0 N--CA 1.537 3.921 0 C-N-CA 122.543 0.337 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 78.7 mt -64.0 -36.32 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.767 0 C-N-CA 123.113 0.565 . . . . 0.0 110.051 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.29 -38.07 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 122.959 0.504 . . . . 0.0 110.064 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.08 95.09 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.83 -34.31 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 O-C-N 121.762 -0.586 . . . . 0.0 109.61 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -62.29 -43.57 98.52 Favored 'General case' 0 N--CA 1.529 3.483 0 C-N-CA 123.3 0.64 . . . . 0.0 112.531 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.08 -37.3 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 81.7 m -59.36 -32.21 69.9 Favored 'General case' 0 N--CA 1.529 3.517 0 C-N-CA 122.819 0.448 . . . . 0.0 110.897 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.99 -41.4 61.97 Favored 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 66.8 m -63.92 -31.43 72.61 Favored 'General case' 0 N--CA 1.526 3.347 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -36.19 68.12 Favored 'General case' 0 N--CA 1.524 3.275 0 C-N-CA 124.246 1.018 . . . . 0.0 108.495 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 53.8 tp -87.22 -16.72 34.44 Favored 'General case' 0 N--CA 1.538 3.957 0 C-N-CA 123.286 0.634 . . . . 0.0 110.816 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -61.59 -7.15 2.99 Favored 'General case' 0 N--CA 1.532 3.651 0 C-N-CA 123.447 0.699 . . . . 0.0 111.853 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.43 -31.99 72.77 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.602 0.761 . . . . 0.0 110.629 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 64.1 tttt . . . . . 0 N--CA 1.531 3.593 0 C-N-CA 123.515 0.726 . . . . 0.0 109.977 179.397 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.523 3.188 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 55.9 tp -65.12 -26.93 68.41 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 123.92 0.888 . . . . 0.0 110.177 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.3 p -68.57 -30.76 69.6 Favored 'General case' 0 N--CA 1.52 3.059 0 C-N-CA 123.642 0.777 . . . . 0.0 110.071 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.63 -46.49 61.58 Favored Glycine 0 N--CA 1.515 3.948 0 C-N-CA 124.147 0.879 . . . . 0.0 114.826 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.5 tt -70.73 -41.09 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 122.015 -0.697 . . . . 0.0 112.868 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.0 tt -64.49 -42.21 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 C-N-CA 122.729 0.412 . . . . 0.0 111.577 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . 0.498 HD13 ' O ' ' E' ' 216' ' ' ILE . 0.1 OUTLIER -73.86 -34.39 39.9 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.009 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.553 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.15 -45.29 95.55 Favored Glycine 0 N--CA 1.513 3.801 0 CA-C-N 114.762 -1.108 . . . . 0.0 114.754 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.72 -36.81 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 CA-C-N 117.95 0.875 . . . . 0.0 110.943 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -63.16 -47.8 81.14 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-N 118.339 0.518 . . . . 0.0 112.32 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.43 -35.33 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 123.785 0.834 . . . . 0.0 112.118 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.83 -47.37 70.99 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.2 77.84 Favored 'General case' 0 N--CA 1.517 2.896 0 C-N-CA 123.416 0.686 . . . . 0.0 111.754 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 t -66.68 -49.42 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 C-N-CA 123.224 0.61 . . . . 0.0 110.861 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.26 -32.79 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.498 0 C-N-CA 123.442 0.697 . . . . 0.0 110.917 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.3 tt -64.8 -39.51 93.72 Favored 'General case' 0 N--CA 1.535 3.812 0 C-N-CA 122.991 0.516 . . . . 0.0 110.425 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 88.7 mt -65.35 -36.67 78.26 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 O-C-N 121.508 -0.745 . . . . 0.0 110.283 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.8 -37.44 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 C-N-CA 123.332 0.653 . . . . 0.0 109.807 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.73 -32.09 67.08 Favored 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.398 0.679 . . . . 0.0 111.649 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 46.7 t -68.97 -44.54 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.215 0.606 . . . . 0.0 111.575 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -61.3 -43.12 99.4 Favored 'General case' 1 N--CA 1.54 4.042 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.81 -37.46 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 CA-C-N 118.312 0.505 . . . . 0.0 109.701 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 92.9 m -59.1 -30.48 68.13 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 122.282 -0.261 . . . . 0.0 110.899 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -74.09 -15.47 61.05 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 123.006 0.522 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 67.9 p -63.44 -30.56 71.67 Favored 'General case' 0 N--CA 1.533 3.696 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 57.5 tp . . . . . 0 N--CA 1.517 2.909 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.031 178.429 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.519 3.006 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 55.8 tp -53.64 -26.76 23.67 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 124.655 1.182 . . . . 0.0 111.44 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 52.9 m -60.88 -40.11 91.79 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.857 0.863 . . . . 0.0 111.462 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.97 -35.6 79.35 Favored Glycine 1 N--CA 1.52 4.239 0 C-N-CA 124.0 0.809 . . . . 0.0 112.823 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 38.6 mm -64.57 -42.7 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 17.2 tt -56.62 -44.38 80.91 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.385 0 CA-C-N 119.466 1.03 . . . . 0.0 112.28 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 16.6 tt -73.73 -33.93 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.73 -42.99 99.6 Favored Glycine 0 N--CA 1.512 3.743 0 CA-C-N 114.884 -1.053 . . . . 0.0 114.609 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.91 -37.13 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 CA-C-N 117.729 0.764 . . . . 0.0 111.038 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 59.3 p -66.01 -46.71 76.98 Favored 'General case' 0 N--CA 1.532 3.641 0 CA-C-N 118.379 0.536 . . . . 0.0 112.064 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 11.4 p -69.94 -31.64 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.51 0 C-N-CA 122.778 0.431 . . . . 0.0 111.099 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.16 -41.13 71.46 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.174 0.59 . . . . 0.0 112.396 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.99 93.1 Favored 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 123.238 0.615 . . . . 0.0 111.074 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.82 -50.0 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.323 0 C-N-CA 123.412 0.685 . . . . 0.0 110.384 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.4 -32.54 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 123.626 0.77 . . . . 0.0 110.35 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.5 -34.99 79.0 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 122.891 0.476 . . . . 0.0 110.78 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.53 -37.36 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.47 -37.86 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 C-N-CA 123.233 0.613 . . . . 0.0 109.637 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.85 78.61 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.631 0.772 . . . . 0.0 112.671 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.79 -34.42 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.616 0 O-C-N 121.901 -0.5 . . . . 0.0 110.336 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -65.67 -43.66 88.62 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.107 0.563 . . . . 0.0 112.446 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.4 -37.55 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 79.5 m -61.21 -27.99 68.83 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 122.962 0.505 . . . . 0.0 111.158 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -72.49 -28.71 63.06 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.378 0.671 . . . . 0.0 110.708 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 28.1 t -65.5 -27.81 68.74 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.138 0.575 . . . . 0.0 111.823 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.83 -14.07 60.73 Favored 'General case' 0 N--CA 1.531 3.609 0 C-N-CA 123.916 0.886 . . . . 0.0 111.009 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 20.3 mt -86.87 1.9 50.96 Favored 'General case' 0 N--CA 1.535 3.81 0 C-N-CA 122.775 0.43 . . . . 0.0 110.606 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -76.82 -50.13 14.17 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.552 0.741 . . . . 0.0 109.274 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 50.1 pttt . . . . . 0 N--CA 1.527 3.425 0 C-N-CA 123.76 0.824 . . . . 0.0 111.959 -178.645 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.083 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 49.9 m 57.02 48.92 14.75 Favored 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 124.239 1.016 . . . . 0.0 112.503 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.14 -30.7 71.65 Favored 'General case' 0 N--CA 1.534 3.758 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 97.1 p -68.6 -26.71 65.51 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 123.701 0.8 . . . . 0.0 109.789 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.99 -45.04 64.29 Favored Glycine 1 N--CA 1.517 4.075 0 C-N-CA 124.26 0.933 . . . . 0.0 114.979 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 44.2 pt -70.61 -35.86 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.427 HD13 ' O ' ' A' ' 215' ' ' ILE . 0.1 OUTLIER -66.9 -41.38 87.53 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.319 0 CA-C-N 118.524 0.602 . . . . 0.0 110.834 -177.416 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.523 ' O ' HD13 ' A' ' 216' ' ' ILE . 0.0 OUTLIER -72.22 -33.59 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.93 -42.6 96.8 Favored Glycine 1 N--CA 1.518 4.104 0 N-CA-C 114.79 0.676 . . . . 0.0 114.79 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.0 -41.67 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.633 1.216 . . . . 0.0 111.817 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.1 t -66.72 -40.85 88.57 Favored 'General case' 0 N--CA 1.536 3.848 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.16 -30.92 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.725 0 CA-C-N 118.508 0.595 . . . . 0.0 110.279 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.26 -34.7 78.97 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 122.983 0.513 . . . . 0.0 111.696 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.57 -50.41 51.99 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.1 -38.88 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.57 -32.26 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 CA-C-N 118.112 0.414 . . . . 0.0 110.567 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 tt -74.54 -46.45 38.95 Favored 'General case' 0 N--CA 1.531 3.581 0 C-N-CA 123.102 0.561 . . . . 0.0 110.161 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.5 -44.49 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 O-C-N 121.826 -0.546 . . . . 0.0 111.996 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.3 -36.87 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 CA-C-N 118.665 0.666 . . . . 0.0 110.195 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.78 75.58 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.17 0.588 . . . . 0.0 111.847 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.85 -41.41 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 C-N-CA 122.617 0.367 . . . . 0.0 110.283 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.13 -43.86 98.23 Favored 'General case' 0 N--CA 1.529 3.478 0 C-N-CA 123.503 0.721 . . . . 0.0 112.782 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.62 -37.71 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 99.4 m -63.6 -28.09 69.69 Favored 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 122.855 0.462 . . . . 0.0 111.247 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.86 -28.27 67.4 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 123.227 0.611 . . . . 0.0 110.945 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.7 t -64.05 -36.33 83.63 Favored 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 123.337 0.655 . . . . 0.0 111.874 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.97 -14.4 22.47 Favored 'General case' 0 N--CA 1.533 3.699 0 C-N-CA 123.936 0.894 . . . . 0.0 111.104 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 23.5 mt -87.31 -28.32 22.34 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.271 0.629 . . . . 0.0 109.927 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -78.39 -141.42 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 60.6 15.24 5.54 Favored 'General case' 0 N--CA 1.52 3.028 0 C-N-CA 124.32 1.048 . . . . 0.0 112.102 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -160.12 118.86 2.71 Favored 'General case' 0 N--CA 1.53 3.544 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 N--CA 1.531 3.588 0 C-N-CA 125.175 1.39 . . . . 0.0 107.709 -179.5 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.521 3.112 0 CA-C-O 120.752 0.311 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.93 -26.62 68.67 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 124.253 1.021 . . . . 0.0 110.613 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 60.9 m -67.95 -26.03 65.74 Favored 'General case' 0 N--CA 1.522 3.171 0 C-N-CA 123.425 0.69 . . . . 0.0 110.614 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.14 -46.24 66.42 Favored Glycine 0 N--CA 1.514 3.896 0 C-N-CA 123.699 0.666 . . . . 0.0 113.953 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tp -70.67 -35.53 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.955 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 12.1 pt -56.82 -43.61 80.29 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.766 0 CA-C-N 119.83 1.195 . . . . 0.0 112.22 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -73.56 -33.66 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.616 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.65 -45.94 93.32 Favored Glycine 0 N--CA 1.515 3.942 0 CA-C-N 115.494 -0.776 . . . . 0.0 114.069 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.94 -36.78 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.803 0 CA-C-N 117.873 0.836 . . . . 0.0 111.055 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 50.8 p -62.44 -46.22 89.51 Favored 'General case' 0 N--CA 1.534 3.744 0 CA-C-N 118.252 0.478 . . . . 0.0 111.115 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.97 -34.83 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.414 0 C-N-CA 123.87 0.868 . . . . 0.0 110.676 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.93 -36.32 59.56 Favored 'General case' 0 N--CA 1.527 3.381 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -46.1 64.53 Favored 'General case' 0 N--CA 1.517 2.908 0 C-N-CA 123.136 0.575 . . . . 0.0 111.44 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -58.53 -44.79 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.677 0 C-N-CA 123.768 0.827 . . . . 0.0 112.204 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -66.65 -31.5 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.658 0 CA-C-O 121.125 0.488 . . . . 0.0 110.12 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -42.12 97.41 Favored 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.576 0.75 . . . . 0.0 111.906 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.05 -44.61 97.78 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.005 0 C-N-CA 122.892 0.477 . . . . 0.0 111.809 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 18.2 m -66.48 -36.55 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.792 0 O-C-N 121.801 -0.562 . . . . 0.0 109.928 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.3 86.09 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.73 -34.27 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.964 0 O-C-N 121.606 -0.684 . . . . 0.0 109.963 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.73 -44.03 97.16 Favored 'General case' 0 N--CA 1.53 3.542 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.78 -39.06 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 CA-C-O 121.569 0.7 . . . . 0.0 109.415 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.9 m -65.25 -29.48 70.27 Favored 'General case' 0 N--CA 1.521 3.101 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.311 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.36 -37.77 63.4 Favored 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 123.121 0.568 . . . . 0.0 109.477 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 50.5 m -64.15 -29.78 70.88 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.527 0.731 . . . . 0.0 111.245 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.76 -14.56 22.1 Favored 'General case' 0 N--CA 1.534 3.737 0 C-N-CA 123.61 0.764 . . . . 0.0 111.488 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 1 N--CA 1.54 4.034 0 C-N-CA 123.227 0.611 . . . . 0.0 109.409 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.522 3.13 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.95 -27.17 68.66 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 123.944 0.898 . . . . 0.0 110.16 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 99.3 p -68.13 -30.09 69.15 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.655 0.782 . . . . 0.0 110.625 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.22 -47.07 54.95 Favored Glycine 0 N--CA 1.514 3.842 0 CA-C-N 115.956 -0.565 . . . . 0.0 114.444 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.21 -39.35 73.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.088 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -176.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.44 -32.29 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.781 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.17 -32.77 44.44 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.119 0 CA-C-N 119.129 0.877 . . . . 0.0 109.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.21 -29.17 72.19 Favored Glycine 0 N--CA 1.511 3.67 0 C-N-CA 123.776 0.703 . . . . 0.0 113.648 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 5.4 p -59.27 -48.21 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.946 0 CA-C-N 117.558 0.679 . . . . 0.0 112.817 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 8.9 t -66.7 -39.64 88.16 Favored 'General case' 0 N--CA 1.536 3.841 0 CA-C-N 118.056 0.389 . . . . 0.0 110.95 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.38 -33.28 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.269 0 C-N-CA 123.475 0.71 . . . . 0.0 110.26 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.45 -43.08 97.24 Favored 'General case' 0 N--CA 1.526 3.353 0 O-C-N 122.214 -0.304 . . . . 0.0 111.705 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.43 73.3 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.4 -38.31 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 CA-C-N 118.042 0.383 . . . . 0.0 111.374 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.98 -32.76 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 C-N-CA 122.715 0.406 . . . . 0.0 110.086 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -37.82 85.5 Favored 'General case' 1 N--CA 1.544 4.265 0 CA-C-O 120.999 0.428 . . . . 0.0 110.013 -178.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 71.8 mt -64.09 -40.72 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.096 0.558 . . . . 0.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.63 -37.29 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 123.789 0.835 . . . . 0.0 109.935 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.67 -32.47 67.35 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.314 0.646 . . . . 0.0 112.071 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.47 -44.14 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.663 0 C-N-CA 122.636 0.375 . . . . 0.0 112.001 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -61.54 -43.67 98.45 Favored 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.5 -37.87 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.698 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 86.4 m -67.36 -34.17 76.75 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 122.93 0.492 . . . . 0.0 110.126 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -69.54 -34.53 74.35 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 123.466 0.706 . . . . 0.0 110.388 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 39.3 t -67.18 -37.51 83.82 Favored 'General case' 0 N--CA 1.522 3.169 0 CA-C-O 121.447 0.642 . . . . 0.0 110.198 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.7 -21.77 62.53 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 124.294 1.037 . . . . 0.0 110.512 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 56.0 tp -87.67 -28.08 22.04 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.72 0.808 . . . . 0.0 109.551 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -71.42 -124.82 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.346 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 54.67 111.39 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 124.311 1.045 . . . . 0.0 112.01 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -164.79 152.79 11.88 Favored 'General case' 0 N--CA 1.522 3.168 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 N--CA 1.527 3.41 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.708 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.521 3.095 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.18 -26.75 68.29 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 124.242 1.017 . . . . 0.0 110.651 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 46.9 t -65.8 -26.7 67.81 Favored 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 122.959 0.503 . . . . 0.0 110.528 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.22 -46.34 92.94 Favored Glycine 0 N--CA 1.509 3.545 0 C-N-CA 123.439 0.542 . . . . 0.0 114.192 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.38 -35.39 62.13 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.065 0 CA-C-N 118.446 1.123 . . . . 0.0 109.46 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 83.1 mt -64.56 -35.54 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 11.6 mm -72.5 -33.74 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.825 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.52 -47.16 92.53 Favored Glycine 0 N--CA 1.515 3.917 0 C-N-CA 123.983 0.802 . . . . 0.0 113.49 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 14.6 m -68.92 -36.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 O-C-N 121.781 -0.835 . . . . 0.0 109.981 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 32.9 m -60.44 -45.69 92.76 Favored 'General case' 0 N--CA 1.525 3.281 0 C-N-CA 123.577 0.751 . . . . 0.0 112.539 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.63 -30.83 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 C-N-CA 122.94 0.496 . . . . 0.0 110.049 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.72 -45.19 91.07 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 122.685 0.394 . . . . 0.0 111.868 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.99 -25.56 61.21 Favored 'General case' 0 N--CA 1.535 3.801 0 C-N-CA 123.422 0.689 . . . . 0.0 112.286 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.05 -37.04 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 C-N-CA 123.76 0.824 . . . . 0.0 110.326 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 2.6 p -55.97 -34.84 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.784 0 C-N-CA 123.457 0.703 . . . . 0.0 111.63 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 59.9 tp -69.63 -45.27 68.86 Favored 'General case' 0 N--CA 1.521 3.125 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.867 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.53 -49.76 63.83 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.232 0 C-N-CA 122.858 0.463 . . . . 0.0 111.188 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 26.5 m -66.4 -36.86 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 C-N-CA 122.437 0.295 . . . . 0.0 110.465 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.93 -32.91 68.23 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 123.179 0.592 . . . . 0.0 112.389 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.72 -34.78 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.73 0 O-C-N 122.021 -0.424 . . . . 0.0 110.283 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -68.46 -43.7 76.44 Favored 'General case' 0 N--CA 1.527 3.402 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 11.5 m -68.49 -37.93 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 O-C-N 122.198 -0.314 . . . . 0.0 111.324 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 15.5 p -65.33 -27.74 68.81 Favored 'General case' 0 N--CA 1.529 3.503 0 C-N-CA 122.217 0.207 . . . . 0.0 111.165 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -63.11 -42.51 99.57 Favored 'General case' 0 N--CA 1.526 3.333 0 CA-C-O 121.276 0.56 . . . . 0.0 109.922 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 69.4 m -65.74 -36.89 84.87 Favored 'General case' 0 N--CA 1.521 3.104 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.873 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . 0.552 HD13 ' O ' ' D' ' 235' ' ' LEU . 1.7 tm? -71.87 -25.88 62.13 Favored 'General case' 0 N--CA 1.528 3.475 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.507 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 49.9 tp -87.4 -12.72 45.42 Favored 'General case' 0 N--CA 1.537 3.886 0 C-N-CA 123.85 0.86 . . . . 0.0 110.883 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -55.66 -15.11 2.64 Favored 'General case' 0 N--CA 1.534 3.74 0 C-N-CA 123.684 0.794 . . . . 0.0 112.103 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.65 -25.4 63.89 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.729 0.812 . . . . 0.0 111.224 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 60.4 mttp . . . . . 0 N--CA 1.525 3.303 0 C-N-CA 123.927 0.891 . . . . 0.0 110.169 -178.462 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.522 3.166 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 42.8 mt -64.26 -27.5 69.09 Favored 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 124.114 0.966 . . . . 0.0 110.842 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 66.8 m -61.17 -26.62 67.83 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.669 0.788 . . . . 0.0 110.973 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.54 -34.33 88.81 Favored Glycine 0 N--CA 1.513 3.802 0 C-N-CA 125.062 1.315 . . . . 0.0 114.005 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -34.1 49.55 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.249 0 C-N-CA 124.615 1.166 . . . . 0.0 113.876 -174.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 16.3 pt -54.97 -32.36 26.67 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.257 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -174.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 13.0 pt -64.65 -33.36 62.7 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-O 121.256 0.55 . . . . 0.0 109.734 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.7 -50.14 70.93 Favored Glycine 1 N--CA 1.518 4.166 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.726 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.62 -36.81 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 CA-C-N 117.571 0.685 . . . . 0.0 110.384 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 85.9 m -61.77 -46.05 91.23 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 123.479 0.712 . . . . 0.0 112.043 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 70.1 t -69.19 -31.32 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 C-N-CA 123.712 0.805 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.9 -34.91 57.11 Favored 'General case' 0 N--CA 1.536 3.827 0 CA-C-O 121.041 0.448 . . . . 0.0 112.205 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.78 -43.58 65.48 Favored 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 123.37 0.668 . . . . 0.0 110.949 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.56 -43.11 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.38 0 C-N-CA 124.428 1.091 . . . . 0.0 112.62 -176.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 24.7 m -60.7 -31.29 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 O-C-N 121.992 -0.443 . . . . 0.0 111.628 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 46.9 tp -67.69 -36.23 80.28 Favored 'General case' 0 N--CA 1.536 3.855 0 O-C-N 121.474 -0.766 . . . . 0.0 109.875 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 41.1 mm -55.01 -51.98 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 C-N-CA 122.873 0.469 . . . . 0.0 112.157 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 17.2 m -60.57 -36.71 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 C-N-CA 122.356 0.262 . . . . 0.0 110.856 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.55 -31.84 66.51 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.067 0.547 . . . . 0.0 111.153 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.81 -38.21 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 O-C-N 121.99 -0.444 . . . . 0.0 110.353 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -73.04 -32.21 64.93 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 123.203 0.601 . . . . 0.0 110.076 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.56 -37.59 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.246 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.0 m -58.7 -46.79 86.52 Favored 'General case' 0 N--CA 1.524 3.268 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -74.65 -41.57 60.1 Favored 'General case' 0 N--CA 1.532 3.63 0 CA-C-O 121.111 0.481 . . . . 0.0 111.102 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.3 m -64.52 -46.86 81.09 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 123.565 0.746 . . . . 0.0 112.303 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 1 N--CA 1.54 4.066 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.52 3.056 0 CA-C-O 121.677 0.751 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.43 -27.15 69.1 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 124.044 0.938 . . . . 0.0 110.749 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 99.8 p -68.58 -32.63 72.67 Favored 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 123.581 0.752 . . . . 0.0 110.406 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.76 -46.61 60.14 Favored Glycine 1 N--CA 1.516 4.004 0 CA-C-N 115.362 -0.835 . . . . 0.0 114.979 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -70.91 -42.03 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.907 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -60.05 -42.13 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 C-N-CA 122.999 0.52 . . . . 0.0 112.395 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.71 -33.29 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.858 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.26 58.33 Favored Glycine 0 N--CA 1.51 3.617 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.524 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.0 m -59.47 -37.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.913 0 CA-C-N 117.634 0.717 . . . . 0.0 110.928 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 80.5 p -56.39 -46.61 80.03 Favored 'General case' 0 N--CA 1.531 3.584 0 CA-C-O 121.038 0.447 . . . . 0.0 111.214 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.83 -41.96 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 124.456 1.102 . . . . 0.0 110.88 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.55 -47.12 66.98 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.41 0.684 . . . . 0.0 112.633 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.65 -37.05 72.71 Favored 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 123.385 0.674 . . . . 0.0 111.674 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 36.2 t -67.98 -48.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 CA-C-O 121.315 0.578 . . . . 0.0 110.071 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.53 -32.65 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.111 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.388 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 16.1 mt -73.55 -46.7 45.96 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 122.67 0.388 . . . . 0.0 110.95 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 92.1 mt -60.14 -44.77 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 O-C-N 121.531 -0.731 . . . . 0.0 111.437 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.03 -37.8 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.87 0 CA-C-N 118.843 0.747 . . . . 0.0 110.631 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.81 91.09 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.553 0.741 . . . . 0.0 111.828 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 88.5 t -71.57 -34.47 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.348 0 C-N-CA 123.139 0.576 . . . . 0.0 109.777 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.01 -44.21 89.97 Favored 'General case' 0 N--CA 1.53 3.525 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.68 -37.41 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.781 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 88.0 m -61.19 -33.7 73.88 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 122.913 0.485 . . . . 0.0 110.855 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -74.28 -28.47 61.22 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 122.633 0.373 . . . . 0.0 110.461 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 57.5 m -75.27 -17.74 60.23 Favored 'General case' 0 N--CA 1.524 3.227 0 C-N-CA 123.104 0.562 . . . . 0.0 110.855 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.76 -38.43 86.57 Favored 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 123.499 0.72 . . . . 0.0 112.319 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -110.46 10.16 23.27 Favored 'General case' 1 N--CA 1.556 4.844 0 C-N-CA 123.414 0.686 . . . . 0.0 112.342 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -75.65 5.47 6.07 Favored 'General case' 0 N--CA 1.527 3.396 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 58.2 pttt . . . . . 0 N--CA 1.516 2.85 0 C-N-CA 124.242 1.017 . . . . 0.0 108.958 -179.226 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.144 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 99.3 p -162.61 27.65 0.1 Allowed 'General case' 0 N--CA 1.522 3.125 0 C-N-CA 124.108 0.963 . . . . 0.0 109.2 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 47.5 mt -64.14 -26.55 68.58 Favored 'General case' 0 N--CA 1.522 3.141 0 C-N-CA 124.566 1.147 . . . . 0.0 110.81 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.1 t -57.57 -26.41 61.4 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.606 0.762 . . . . 0.0 111.883 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.65 -34.23 77.92 Favored Glycine 0 N--CA 1.513 3.801 0 C-N-CA 124.724 1.154 . . . . 0.0 114.12 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -46.47 90.79 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.378 0 CA-C-N 117.821 0.81 . . . . 0.0 112.458 -174.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.7 tt -64.84 -31.54 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 C-N-CA 123.116 0.566 . . . . 0.0 110.779 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 51.1 mm -68.22 -33.51 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.37 -50.15 67.48 Favored Glycine 1 N--CA 1.517 4.074 0 C-N-CA 123.119 0.39 . . . . 0.0 113.127 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.0 m -61.85 -35.75 69.75 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 CA-C-N 117.861 0.83 . . . . 0.0 110.655 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.5 m -55.18 -42.28 72.99 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.045 0.538 . . . . 0.0 111.0 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.42 -36.99 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.47 0 C-N-CA 123.483 0.713 . . . . 0.0 110.576 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.47 68.41 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.42 -50.43 65.46 Favored 'General case' 0 N--CA 1.515 2.795 0 C-N-CA 123.315 0.646 . . . . 0.0 112.673 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.02 -38.34 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.784 0 CA-C-N 118.303 0.501 . . . . 0.0 111.311 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.5 t -62.41 -34.65 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 CA-C-N 117.954 0.343 . . . . 0.0 110.391 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.98 -34.53 78.32 Favored 'General case' 0 N--CA 1.529 3.507 0 CA-C-N 117.808 0.276 . . . . 0.0 111.468 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.48 -36.8 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.865 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.74 -37.71 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.692 0 C-N-CA 123.34 0.656 . . . . 0.0 110.212 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.91 -32.52 71.99 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.387 0.675 . . . . 0.0 111.342 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.57 -37.46 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 123.052 0.541 . . . . 0.0 109.899 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.43 -43.78 96.46 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.377 0.671 . . . . 0.0 112.434 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.9 m -68.24 -37.38 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.725 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 93.0 m -62.93 -31.4 72.48 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.989 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -74.43 -38.83 62.91 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 55.9 m -67.37 -28.04 67.61 Favored 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 123.384 0.674 . . . . 0.0 110.576 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.54 -34.54 78.13 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.463 0.705 . . . . 0.0 111.896 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.32 8.1 37.71 Favored 'General case' 1 N--CA 1.544 4.248 0 C-N-CA 123.092 0.557 . . . . 0.0 111.691 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -71.24 2.53 4.58 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 123.479 0.711 . . . . 0.0 110.471 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -52.37 173.57 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 124.52 1.128 . . . . 0.0 112.25 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -63.17 146.36 53.52 Favored 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 124.056 0.942 . . . . 0.0 111.281 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.527 3.402 0 C-N-CA 125.081 1.352 . . . . 0.0 108.128 179.451 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.517 2.925 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.09 -31.96 73.42 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 123.945 0.898 . . . . 0.0 110.162 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.9 t -68.36 -27.95 66.7 Favored 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 123.592 0.757 . . . . 0.0 110.631 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.04 -46.58 58.39 Favored Glycine 0 N--CA 1.514 3.872 0 C-N-CA 124.078 0.847 . . . . 0.0 114.723 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.8 pt -70.71 -37.35 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -64.29 -41.39 92.23 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.054 0 CA-C-N 118.376 0.534 . . . . 0.0 111.609 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.88 -33.28 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.31 -50.11 64.35 Favored Glycine 0 N--CA 1.513 3.807 0 C-N-CA 124.331 0.967 . . . . 0.0 113.906 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.32 -37.13 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 O-C-N 122.22 -0.577 . . . . 0.0 109.887 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 82.0 m -65.31 -47.22 77.34 Favored 'General case' 0 N--CA 1.523 3.204 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.3 p -70.74 -31.54 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 CA-C-N 118.117 0.417 . . . . 0.0 111.611 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.7 67.59 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.44 -36.41 83.83 Favored 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 123.121 0.568 . . . . 0.0 111.506 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 48.0 t -68.13 -52.11 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 C-N-CA 123.525 0.73 . . . . 0.0 111.779 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.08 -35.18 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.457 0 O-C-N 121.413 -0.804 . . . . 0.0 111.944 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 tt -75.01 -43.71 52.2 Favored 'General case' 0 N--CA 1.528 3.444 0 C-N-CA 122.58 0.352 . . . . 0.0 111.204 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 14.8 tt -65.73 -39.75 85.79 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 O-C-N 121.211 -0.931 . . . . 0.0 111.197 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.26 -37.42 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 C-N-CA 123.099 0.56 . . . . 0.0 109.939 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.85 -32.77 67.96 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.25 -38.63 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.594 0 CA-C-N 118.049 0.386 . . . . 0.0 111.386 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -64.39 -44.25 91.9 Favored 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.95 -39.89 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.467 0 C-N-CA 122.841 0.457 . . . . 0.0 110.109 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 99.0 m -67.55 -28.25 67.63 Favored 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 123.242 0.617 . . . . 0.0 111.226 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.3 -45.97 44.13 Favored 'General case' 0 N--CA 1.528 3.436 0 CA-C-O 121.123 0.487 . . . . 0.0 110.499 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.7 t -63.78 -19.05 64.69 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 123.629 0.772 . . . . 0.0 112.203 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 49.7 tp -69.24 -15.64 63.42 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.616 0.766 . . . . 0.0 110.614 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 N--CA 1.534 3.76 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.777 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.523 3.214 0 CA-C-O 121.459 0.647 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.34 -26.97 68.71 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 123.906 0.883 . . . . 0.0 110.294 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.2 m -68.41 -29.82 68.58 Favored 'General case' 0 N--CA 1.52 3.03 0 C-N-CA 123.636 0.775 . . . . 0.0 110.297 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.03 -46.67 58.13 Favored Glycine 1 N--CA 1.516 4.024 0 C-N-CA 123.96 0.79 . . . . 0.0 114.935 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 8.1 tp -70.97 -41.56 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.07 -41.07 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 C-N-CA 123.082 0.553 . . . . 0.0 112.335 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.94 -33.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.18 -28.21 41.46 Favored Glycine 1 N--CA 1.516 4.022 0 C-N-CA 124.54 1.066 . . . . 0.0 113.754 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 5.3 m -58.58 -37.04 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.789 0 CA-C-N 117.482 0.641 . . . . 0.0 111.587 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 7.7 t -55.78 -44.3 77.61 Favored 'General case' 0 N--CA 1.538 3.968 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.27 -31.72 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 C-N-CA 123.355 0.662 . . . . 0.0 110.85 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.76 -46.68 77.83 Favored 'General case' 0 N--CA 1.535 3.785 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.04 74.26 Favored 'General case' 0 N--CA 1.514 2.763 0 C-N-CA 123.529 0.732 . . . . 0.0 111.526 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 38.0 t -64.49 -47.77 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.682 0 C-N-CA 123.49 0.716 . . . . 0.0 110.663 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.48 -32.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 123.586 0.755 . . . . 0.0 109.995 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 36.1 tp -76.81 -33.87 57.96 Favored 'General case' 0 N--CA 1.516 2.865 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 tp -54.84 -43.83 69.48 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 C-N-CA 123.455 0.702 . . . . 0.0 112.267 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 12.6 m -64.73 -37.47 80.23 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.152 0 O-C-N 121.957 -0.464 . . . . 0.0 110.542 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.04 -32.27 67.83 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 122.949 0.5 . . . . 0.0 111.127 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.2 -35.0 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.789 0 C-N-CA 122.739 0.416 . . . . 0.0 110.256 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -72.11 -38.91 69.22 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 123.281 0.632 . . . . 0.0 109.672 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.11 -37.37 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 C-N-CA 124.136 0.974 . . . . 0.0 109.634 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.68 -38.39 78.11 Favored 'General case' 0 N--CA 1.523 3.19 0 C-N-CA 122.781 0.432 . . . . 0.0 110.081 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -74.2 -37.33 63.93 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 122.978 0.511 . . . . 0.0 110.114 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 32.1 t -64.23 -41.48 96.99 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.9 tp -65.19 -16.26 63.33 Favored 'General case' 0 N--CA 1.522 3.129 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.767 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.29 -23.55 14.38 Favored 'General case' 1 N--CA 1.557 4.92 0 C-N-CA 124.262 1.025 . . . . 0.0 108.655 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -108.19 94.58 5.15 Favored 'General case' 0 N--CA 1.53 3.561 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 26.07 0.09 Allowed 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.599 0.76 . . . . 0.0 110.841 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -54.57 154.41 4.88 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 124.143 0.977 . . . . 0.0 112.302 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.527 3.382 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -179.714 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.522 3.145 0 CA-C-O 121.511 0.672 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.03 -26.69 68.68 Favored 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 123.982 0.913 . . . . 0.0 109.735 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 64.0 m -60.45 -26.66 66.91 Favored 'General case' 0 N--CA 1.522 3.157 0 C-N-CA 123.542 0.737 . . . . 0.0 110.924 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.53 -42.17 82.04 Favored Glycine 0 N--CA 1.513 3.775 0 C-N-CA 124.262 0.934 . . . . 0.0 115.385 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -46.38 69.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.239 0 CA-C-N 118.192 0.996 . . . . 0.0 111.546 -176.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 19.7 tt -61.05 -35.55 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.14 -33.15 45.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.063 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.25 -47.41 90.98 Favored Glycine 0 N--CA 1.513 3.791 0 C-N-CA 123.831 0.729 . . . . 0.0 113.29 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 15.1 m -68.83 -37.1 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 CA-C-N 118.119 0.96 . . . . 0.0 110.141 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 37.9 m -62.04 -46.29 89.83 Favored 'General case' 0 N--CA 1.516 2.875 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.469 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 11.8 p -69.67 -31.55 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.546 0 CA-C-N 117.973 0.351 . . . . 0.0 110.572 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.9 70.82 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 122.635 0.374 . . . . 0.0 111.45 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.22 -37.74 86.26 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 123.558 0.743 . . . . 0.0 110.911 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.66 -42.8 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.376 0 C-N-CA 123.597 0.759 . . . . 0.0 110.563 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.08 -44.49 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.285 0.634 . . . . 0.0 111.361 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.2 -35.22 63.91 Favored 'General case' 0 N--CA 1.523 3.203 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 17.9 tt -69.63 -40.3 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 CA-C-N 118.627 0.649 . . . . 0.0 111.162 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.59 -36.97 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 O-C-N 121.942 -0.473 . . . . 0.0 109.948 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.45 82.22 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.945 0.898 . . . . 0.0 112.798 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.68 -34.18 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 O-C-N 121.915 -0.49 . . . . 0.0 110.084 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -64.38 -43.85 93.18 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.015 0.526 . . . . 0.0 112.316 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.59 -37.38 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.832 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 98.5 m -60.05 -28.84 68.11 Favored 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 122.768 0.427 . . . . 0.0 110.945 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -72.83 -32.46 65.51 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.988 0.515 . . . . 0.0 110.564 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 32.1 t -63.75 -17.76 63.36 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 123.159 0.584 . . . . 0.0 112.33 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.62 -20.79 65.12 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 123.503 0.721 . . . . 0.0 112.72 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.44 -5.22 58.92 Favored 'General case' 1 N--CA 1.544 4.262 0 CA-C-N 118.723 0.692 . . . . 0.0 111.116 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -64.89 -16.16 62.88 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.5 0.72 . . . . 0.0 110.622 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.44 161.2 14.72 Favored 'General case' 0 N--CA 1.523 3.199 0 C-N-CA 123.937 0.895 . . . . 0.0 110.651 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 N--CA 1.521 3.081 0 C-N-CA 123.901 0.88 . . . . 0.0 110.057 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.522 3.16 0 CA-C-O 120.36 0.124 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.19 -26.8 68.31 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 124.33 1.052 . . . . 0.0 110.714 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 65.6 m -57.89 -38.47 75.86 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 123.735 0.814 . . . . 0.0 111.254 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.87 -35.72 80.17 Favored Glycine 1 N--CA 1.518 4.147 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.212 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.31 -46.61 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.323 0 C-N-CA 124.072 0.949 . . . . 0.0 112.773 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.3 tt -66.45 -35.22 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.82 -32.95 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.9 -36.49 60.33 Favored Glycine 0 N--CA 1.514 3.854 0 C-N-CA 123.738 0.685 . . . . 0.0 114.683 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.47 -37.56 79.88 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.159 0 CA-C-N 118.214 1.007 . . . . 0.0 110.94 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 26.5 p -63.86 -45.82 87.75 Favored 'General case' 0 N--CA 1.527 3.402 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.931 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 50.9 t -66.92 -31.56 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.163 0 C-N-CA 124.426 1.09 . . . . 0.0 111.328 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.91 -43.07 65.94 Favored 'General case' 0 N--CA 1.532 3.647 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.47 -45.58 65.44 Favored 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 123.188 0.595 . . . . 0.0 110.364 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.97 -47.55 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 124.307 1.043 . . . . 0.0 112.969 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.55 -32.21 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.922 0 CA-C-N 118.093 0.406 . . . . 0.0 110.954 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 83.9 mt -68.67 -33.95 74.86 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 122.579 0.352 . . . . 0.0 110.383 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 46.6 mm -55.01 -39.79 51.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.232 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.01 -41.61 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.127 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.1 94.52 Favored 'General case' 0 N--CA 1.528 3.461 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.96 -34.12 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 O-C-N 121.718 -0.614 . . . . 0.0 109.476 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -63.03 -43.67 98.05 Favored 'General case' 0 N--CA 1.53 3.548 0 C-N-CA 123.103 0.561 . . . . 0.0 112.327 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.4 -37.57 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.7 m -61.51 -31.08 71.07 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.002 0.521 . . . . 0.0 110.358 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -73.86 -41.29 62.43 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 66.7 m -64.69 -32.62 74.37 Favored 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 123.482 0.713 . . . . 0.0 109.843 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.524 3.27 0 C-N-CA 123.862 0.865 . . . . 0.0 109.287 179.033 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.525 3.28 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 40.6 mt -64.98 -26.93 68.5 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.727 0.811 . . . . 0.0 110.54 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 69.6 m -68.5 -30.82 69.74 Favored 'General case' 0 N--CA 1.518 2.968 0 C-N-CA 123.753 0.821 . . . . 0.0 110.396 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.57 -46.33 62.78 Favored Glycine 0 N--CA 1.515 3.955 0 C-N-CA 124.3 0.952 . . . . 0.0 114.912 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 19.3 tt -71.01 -40.48 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.22 -40.28 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 C-N-CA 122.9 0.48 . . . . 0.0 112.075 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.1 tt -72.79 -32.8 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.47 -28.4 44.33 Favored Glycine 0 N--CA 1.51 3.572 0 C-N-CA 124.689 1.138 . . . . 0.0 113.442 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.6 m -58.87 -37.21 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.801 0 CA-C-N 117.339 0.569 . . . . 0.0 111.128 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 65.1 p -61.19 -46.39 90.68 Favored 'General case' 0 N--CA 1.533 3.72 0 CA-C-O 121.258 0.551 . . . . 0.0 110.926 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.75 -31.82 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 C-N-CA 124.545 1.138 . . . . 0.0 110.873 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.92 -42.02 71.7 Favored 'General case' 0 N--CA 1.531 3.623 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.67 90.92 Favored 'General case' 0 N--CA 1.517 2.906 0 C-N-CA 123.56 0.744 . . . . 0.0 111.169 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 26.5 t -58.63 -51.7 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.559 0.744 . . . . 0.0 111.63 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -67.06 -31.97 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 C-N-CA 123.078 0.551 . . . . 0.0 110.567 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.12 -35.46 61.7 Favored 'General case' 0 N--CA 1.533 3.718 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.68 -48.21 72.24 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.578 0 O-C-N 121.593 -0.692 . . . . 0.0 110.976 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 12.4 m -65.77 -36.35 77.35 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.042 0 O-C-N 121.902 -0.499 . . . . 0.0 110.378 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.01 68.14 Favored 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 122.865 0.466 . . . . 0.0 111.434 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.3 -34.82 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 C-N-CA 122.882 0.473 . . . . 0.0 110.41 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -72.66 -43.26 63.4 Favored 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.183 0.593 . . . . 0.0 112.399 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.83 -37.21 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 O-C-N 122.165 -0.335 . . . . 0.0 111.383 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 28.1 p -66.98 -27.71 67.66 Favored 'General case' 0 N--CA 1.53 3.548 0 O-C-N 122.311 -0.243 . . . . 0.0 110.971 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -68.53 -30.51 69.32 Favored 'General case' 0 N--CA 1.531 3.604 0 C-N-CA 123.029 0.532 . . . . 0.0 110.055 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 39.6 t -67.53 -39.62 85.06 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-O 121.437 0.637 . . . . 0.0 110.166 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -13.69 13.4 Favored 'General case' 0 N--CA 1.535 3.805 0 C-N-CA 125.567 1.547 . . . . 0.0 111.339 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 54.3 tp -86.77 -16.85 35.05 Favored 'General case' 1 N--CA 1.544 4.262 0 C-N-CA 123.656 0.782 . . . . 0.0 110.178 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -143.1 78.93 1.63 Allowed 'General case' 0 N--CA 1.52 3.043 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? . . . . . 0 N--CA 1.527 3.406 0 C-N-CA 124.482 1.113 . . . . 0.0 110.183 -175.499 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.154 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 47.8 t -168.38 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 CA-C-N 117.692 0.746 . . . . 0.0 110.305 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 tt -54.67 -28.47 47.68 Favored 'General case' 0 N--CA 1.53 3.558 0 C-N-CA 123.647 0.779 . . . . 0.0 111.234 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 46.5 t -66.52 -42.22 87.63 Favored 'General case' 0 N--CA 1.52 3.026 0 C-N-CA 123.734 0.813 . . . . 0.0 110.522 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.38 69.18 Favored Glycine 1 N--CA 1.517 4.099 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.65 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.96 -46.29 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.306 0 C-N-CA 124.003 0.921 . . . . 0.0 111.556 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 215' ' ' ILE . 0.2 OUTLIER -67.59 -32.79 58.5 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.016 0 CA-C-O 121.268 0.556 . . . . 0.0 109.704 -178.435 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 6.3 mm -71.94 -37.0 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 C-N-CA 123.863 0.865 . . . . 0.0 109.314 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.7 -29.87 71.07 Favored Glycine 1 N--CA 1.517 4.08 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.685 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.1 m -62.56 -36.19 73.83 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.285 0 CA-C-N 117.881 0.841 . . . . 0.0 110.564 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.3 p -55.02 -44.18 74.36 Favored 'General case' 0 N--CA 1.528 3.427 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.24 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.16 -36.1 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.414 0 C-N-CA 123.771 0.828 . . . . 0.0 111.061 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.84 -44.43 66.72 Favored 'General case' 0 N--CA 1.533 3.675 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.95 -37.04 78.59 Favored 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 123.08 0.552 . . . . 0.0 111.541 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.3 t -67.15 -47.17 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 C-N-CA 123.106 0.563 . . . . 0.0 111.974 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.37 -35.85 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 CA-C-N 118.058 0.39 . . . . 0.0 111.006 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.8 mt -60.98 -34.44 74.78 Favored 'General case' 0 N--CA 1.539 3.978 0 CA-C-N 117.91 0.323 . . . . 0.0 110.949 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.26 -36.28 77.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 O-C-N 121.829 -0.544 . . . . 0.0 109.779 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.66 -37.68 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.701 0 C-N-CA 122.955 0.502 . . . . 0.0 110.182 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.41 79.98 Favored 'General case' 0 N--CA 1.53 3.556 0 C-N-CA 123.621 0.768 . . . . 0.0 112.582 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 26.3 m -71.76 -34.1 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.601 0 O-C-N 121.938 -0.476 . . . . 0.0 110.176 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.25 -44.01 97.53 Favored 'General case' 0 N--CA 1.53 3.564 0 C-N-CA 123.057 0.543 . . . . 0.0 112.416 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.73 -37.62 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.739 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -63.41 -27.87 69.59 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 123.066 0.546 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -63.35 -23.59 67.48 Favored 'General case' 0 N--CA 1.533 3.705 0 C-N-CA 123.103 0.561 . . . . 0.0 110.829 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 41.5 m -66.68 -40.27 88.49 Favored 'General case' 0 N--CA 1.526 3.358 0 CA-C-O 121.402 0.62 . . . . 0.0 109.847 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 44.5 mt -63.15 -23.98 67.68 Favored 'General case' 0 N--CA 1.524 3.239 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.289 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 46.4 tp -87.86 9.12 23.04 Favored 'General case' 0 N--CA 1.536 3.846 0 C-N-CA 124.057 0.943 . . . . 0.0 109.455 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -139.66 69.16 1.36 Allowed 'General case' 0 N--CA 1.532 3.626 0 C-N-CA 124.5 1.12 . . . . 0.0 109.816 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -84.83 -63.48 1.33 Allowed 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -168.82 168.11 10.67 Favored 'General case' 0 N--CA 1.521 3.117 0 C-N-CA 124.154 0.982 . . . . 0.0 108.821 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.531 3.603 0 C-N-CA 124.573 1.149 . . . . 0.0 108.761 179.656 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.523 3.182 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.28 -26.64 68.51 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 124.322 1.049 . . . . 0.0 110.268 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 90.9 p -64.93 -27.95 69.19 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 123.432 0.693 . . . . 0.0 110.82 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . 0.53 ' O ' HD12 ' B' ' 216' ' ' ILE . . . -69.69 -47.41 49.0 Favored Glycine 0 N--CA 1.515 3.904 0 N-CA-C 114.822 0.689 . . . . 0.0 114.822 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 39.3 pt -71.42 -34.63 54.09 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.406 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.6 tt -55.06 -31.83 26.24 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.148 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.69 HD13 ' N ' ' B' ' 217' ' ' GLY . 0.0 OUTLIER -59.83 -32.2 49.16 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.496 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.949 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . 0.69 ' N ' HD13 ' B' ' 216' ' ' ILE . . . -54.17 -29.38 44.78 Favored Glycine 0 N--CA 1.51 3.617 0 CA-C-N 115.067 -0.969 . . . . 0.0 114.088 -178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 6.0 m -59.55 -37.49 70.6 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.021 0 CA-C-N 118.429 1.115 . . . . 0.0 110.551 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 48.3 p -66.13 -45.92 79.33 Favored 'General case' 0 N--CA 1.528 3.433 0 CA-C-O 121.13 0.491 . . . . 0.0 110.497 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 49.5 t -69.42 -32.96 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.178 0 C-N-CA 124.322 1.049 . . . . 0.0 110.415 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.13 76.79 Favored 'General case' 0 N--CA 1.523 3.225 0 C-N-CA 123.363 0.665 . . . . 0.0 111.801 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.92 -30.6 68.05 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.086 0.554 . . . . 0.0 111.005 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 38.8 t -64.01 -50.76 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 C-N-CA 123.302 0.641 . . . . 0.0 111.167 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.35 -32.12 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 C-N-CA 122.738 0.415 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.61 -47.36 26.86 Favored 'General case' 0 N--CA 1.528 3.425 0 C-N-CA 123.515 0.726 . . . . 0.0 111.561 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.6 tt -64.24 -39.02 84.04 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.058 0 O-C-N 121.593 -0.692 . . . . 0.0 112.779 -176.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.8 -36.92 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.738 0 O-C-N 122.087 -0.383 . . . . 0.0 110.375 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.66 74.9 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.282 0.633 . . . . 0.0 112.165 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 48.0 t -71.88 -38.96 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 C-N-CA 122.99 0.516 . . . . 0.0 111.159 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -69.23 -43.46 73.97 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.39 -37.73 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 C-N-CA 122.57 0.348 . . . . 0.0 111.232 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 18.7 p -67.03 -28.78 68.51 Favored 'General case' 0 N--CA 1.529 3.51 0 CA-C-N 117.85 0.295 . . . . 0.0 111.203 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -63.52 -29.47 70.73 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 123.301 0.64 . . . . 0.0 111.139 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.4 t -65.28 -33.33 75.72 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.384 0.674 . . . . 0.0 111.215 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 51.0 mt -65.72 -18.39 65.3 Favored 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 123.724 0.81 . . . . 0.0 111.931 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 N--CA 1.539 3.995 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.793 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 N--CA 1.522 3.126 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . 0.406 HD22 ' N ' ' C' ' 211' ' ' LEU . 2.0 mm? -65.29 -26.28 68.0 Favored 'General case' 0 N--CA 1.522 3.158 0 C-N-CA 124.261 1.024 . . . . 0.0 109.896 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 57.7 m -58.39 -27.22 64.05 Favored 'General case' 0 N--CA 1.521 3.077 0 C-N-CA 123.403 0.681 . . . . 0.0 111.293 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.67 -48.15 44.64 Favored Glycine 0 N--CA 1.513 3.83 0 CA-C-N 116.137 -0.483 . . . . 0.0 114.218 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 38.5 pt -72.74 -36.9 54.07 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 N-CA-C 115.618 1.711 . . . . 0.0 115.618 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . 0.471 ' O ' HG12 ' C' ' 218' ' ' VAL . 8.4 tp -56.52 -31.56 34.29 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 14.8 tt -58.98 -32.14 46.98 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.317 0 CA-C-N 119.078 0.854 . . . . 0.0 110.204 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.99 -27.39 37.39 Favored Glycine 1 N--CA 1.518 4.145 0 C-N-CA 123.674 0.654 . . . . 0.0 112.497 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . 0.471 HG12 ' O ' ' C' ' 215' ' ' ILE . 8.6 p -58.4 -44.83 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.77 0 C-N-CA 123.505 0.722 . . . . 0.0 112.888 -176.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 9.7 t -66.24 -40.73 90.42 Favored 'General case' 0 N--CA 1.536 3.871 0 CA-C-N 118.51 0.595 . . . . 0.0 110.752 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 41.8 t -69.68 -32.28 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 C-N-CA 123.883 0.873 . . . . 0.0 110.764 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.4 -41.7 73.05 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.26 -34.56 74.97 Favored 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 123.202 0.601 . . . . 0.0 111.049 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.29 -52.35 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.088 0.555 . . . . 0.0 111.462 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.58 -31.97 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 122.956 0.502 . . . . 0.0 110.683 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.61 -46.1 91.53 Favored 'General case' 0 N--CA 1.534 3.728 0 C-N-CA 123.407 0.683 . . . . 0.0 110.807 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.49 -36.4 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 O-C-N 121.769 -0.582 . . . . 0.0 110.389 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.86 -38.0 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 122.948 0.499 . . . . 0.0 110.168 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.57 81.17 Favored 'General case' 0 N--CA 1.531 3.615 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.34 -34.3 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.854 0 O-C-N 122.088 -0.383 . . . . 0.0 110.017 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.85 -39.4 93.5 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 123.172 0.589 . . . . 0.0 109.545 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 9.4 t -68.17 -40.08 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 124.298 1.039 . . . . 0.0 109.199 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.44 -34.2 77.24 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 122.92 0.488 . . . . 0.0 109.895 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -73.51 -41.65 62.79 Favored 'General case' 0 N--CA 1.522 3.162 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.156 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.2 t -68.47 -45.9 71.18 Favored 'General case' 0 N--CA 1.528 3.473 0 CA-C-O 122.164 0.983 . . . . 0.0 109.389 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 39.7 tp -61.2 -12.94 14.74 Favored 'General case' 0 N--CA 1.521 3.108 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.872 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 40.8 tp -85.15 8.09 19.42 Favored 'General case' 1 N--CA 1.546 4.329 0 CA-C-N 118.369 0.531 . . . . 0.0 110.755 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -158.26 132.59 8.1 Favored 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . 0.423 ' H ' ' H ' ' C' ' 239' ' ' LYS . 58.1 mtmt -152.59 -18.78 0.16 Allowed 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 125.109 1.364 . . . . 0.0 108.235 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . 0.423 ' H ' ' H ' ' C' ' 238' ' ' LYS . 52.8 mtmt -65.99 -167.8 0.04 OUTLIER 'General case' 0 N--CA 1.52 3.053 0 C-N-CA 124.629 1.172 . . . . 0.0 110.187 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 70.1 t . . . . . 0 N--CA 1.529 3.49 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.845 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.523 3.214 0 CA-C-O 121.51 0.672 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.16 -26.36 68.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.121 0.969 . . . . 0.0 109.553 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 41.3 t -57.42 -25.88 60.27 Favored 'General case' 0 N--CA 1.522 3.164 0 C-N-CA 123.976 0.911 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.68 -34.33 83.12 Favored Glycine 0 N--CA 1.515 3.929 0 C-N-CA 124.293 0.949 . . . . 0.0 114.145 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -46.42 90.81 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.3 0 CA-C-N 117.851 0.825 . . . . 0.0 112.183 -175.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -66.73 -31.87 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.732 0 C-N-CA 123.023 0.529 . . . . 0.0 110.542 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 47.9 mm -68.3 -33.81 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.851 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.59 -45.64 92.41 Favored Glycine 1 N--CA 1.519 4.184 0 C-N-CA 123.226 0.441 . . . . 0.0 113.479 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 11.8 m -69.2 -36.85 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 0 O-C-N 121.549 -0.971 . . . . 0.0 109.914 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 95.4 m -58.64 -46.43 87.15 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 30.4 m -67.6 -30.8 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 123.278 0.631 . . . . 0.0 111.203 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.62 74.01 Favored 'General case' 0 N--CA 1.532 3.669 0 O-C-N 121.683 -0.635 . . . . 0.0 111.572 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.38 -50.04 73.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.71 0.804 . . . . 0.0 112.943 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 15.6 m -58.36 -37.61 64.57 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 CA-C-N 119.155 0.888 . . . . 0.0 110.491 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.48 -32.08 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 122.611 0.365 . . . . 0.0 110.873 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.2 -41.13 70.68 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 40.3 mm -55.31 -51.01 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 C-N-CA 123.349 0.66 . . . . 0.0 112.069 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 31.5 m -61.79 -35.75 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.965 0 C-N-CA 122.988 0.515 . . . . 0.0 110.673 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.88 -31.6 65.0 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.1 0.56 . . . . 0.0 111.414 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.03 -34.63 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 C-N-CA 122.758 0.423 . . . . 0.0 111.374 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -66.34 -43.96 84.64 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 122.951 0.5 . . . . 0.0 111.954 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 6.3 p -68.76 -36.74 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 118.76 0.709 . . . . 0.0 109.149 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 80.3 m -58.45 -27.6 64.52 Favored 'General case' 0 N--CA 1.531 3.615 0 C-N-CA 122.708 0.403 . . . . 0.0 110.969 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -62.98 -19.02 63.92 Favored 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 123.173 0.589 . . . . 0.0 110.739 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 37.2 m -64.14 -37.94 89.28 Favored 'General case' 0 N--CA 1.527 3.394 0 C-N-CA 123.564 0.745 . . . . 0.0 110.568 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.91 -28.81 69.21 Favored 'General case' 0 N--CA 1.534 3.747 0 C-N-CA 123.913 0.885 . . . . 0.0 109.841 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.35 -5.93 58.69 Favored 'General case' 0 N--CA 1.537 3.905 0 C-N-CA 124.466 1.106 . . . . 0.0 110.932 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -53.15 -12.72 0.4 Allowed 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 123.964 0.906 . . . . 0.0 112.872 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.37 137.65 52.33 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.392 0.677 . . . . 0.0 110.981 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp . . . . . 0 N--CA 1.521 3.106 0 C-N-CA 123.975 0.91 . . . . 0.0 109.131 -179.268 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.519 3.007 0 CA-C-O 121.948 0.88 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.85 -26.54 68.37 Favored 'General case' 0 N--CA 1.525 3.286 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.589 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 69.8 m -64.71 -30.93 71.96 Favored 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 123.57 0.748 . . . . 0.0 110.933 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.77 -46.97 58.54 Favored Glycine 1 N--CA 1.517 4.047 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.47 -41.52 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 8.1 tp -62.23 -39.19 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.844 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.2 tt -72.03 -33.2 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.818 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.76 -29.8 55.32 Favored Glycine 0 N--CA 1.512 3.747 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.536 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 2.0 m -63.77 -37.56 80.02 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.062 0 CA-C-N 117.768 0.784 . . . . 0.0 110.425 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 31.2 p -60.97 -46.61 90.03 Favored 'General case' 0 N--CA 1.528 3.449 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.37 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.26 -40.17 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.202 0 C-N-CA 124.033 0.933 . . . . 0.0 110.831 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.01 66.83 Favored 'General case' 0 N--CA 1.524 3.255 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.44 -41.51 76.18 Favored 'General case' 0 N--CA 1.514 2.738 0 C-N-CA 122.921 0.488 . . . . 0.0 111.58 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.75 -46.91 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.504 0 O-C-N 122.089 -0.382 . . . . 0.0 111.834 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.42 -32.44 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.626 0 CA-C-N 117.9 0.318 . . . . 0.0 111.697 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 32.9 tp -74.72 -39.25 61.99 Favored 'General case' 0 N--CA 1.521 3.083 0 CA-C-O 119.209 -0.424 . . . . 0.0 112.014 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 81.8 mt -64.87 -43.8 96.3 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.244 0 CA-C-N 118.945 0.793 . . . . 0.0 111.026 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.3 -36.7 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 117.969 0.349 . . . . 0.0 110.318 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.29 65.79 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.362 0.665 . . . . 0.0 111.941 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.6 -40.76 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.905 0 CA-C-N 117.929 0.331 . . . . 0.0 110.219 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -69.44 -36.18 76.4 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.274 0.63 . . . . 0.0 110.436 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.5 -37.5 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.27 0 C-N-CA 123.744 0.818 . . . . 0.0 109.635 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 72.7 m -58.06 -32.04 67.64 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 122.511 0.325 . . . . 0.0 110.146 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.3 -41.63 60.84 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 60.2 p -68.24 -32.87 73.37 Favored 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 123.257 0.623 . . . . 0.0 110.206 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 N--CA 1.535 3.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.624 -179.042 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.522 3.158 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.01 -25.99 68.09 Favored 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 124.437 1.095 . . . . 0.0 111.628 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 39.7 t -67.36 -33.31 74.97 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 123.469 0.708 . . . . 0.0 111.145 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.73 -44.63 69.34 Favored Glycine 1 N--CA 1.519 4.225 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . 0.417 HD13 ' O ' ' F' ' 214' ' ' ILE . 0.0 OUTLIER -70.67 -44.63 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.997 0 O-C-N 121.759 -0.847 . . . . 0.0 111.776 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 18.8 tt -60.68 -36.42 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 45.3 pt -72.48 -33.44 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 CA-C-N 118.699 0.681 . . . . 0.0 109.32 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.23 -48.65 84.5 Favored Glycine 1 N--CA 1.519 4.195 0 C-N-CA 123.835 0.731 . . . . 0.0 113.855 -177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.35 -36.79 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 C-N-CA 122.973 0.509 . . . . 0.0 109.803 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 90.3 m -64.1 -47.16 81.12 Favored 'General case' 0 N--CA 1.519 3.02 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -70.64 -31.48 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 CA-C-N 118.1 0.409 . . . . 0.0 111.191 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.45 -34.91 50.99 Favored 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.79 -38.62 85.95 Favored 'General case' 0 N--CA 1.523 3.194 0 C-N-CA 123.318 0.647 . . . . 0.0 111.0 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.66 -38.53 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.32 0 C-N-CA 123.697 0.799 . . . . 0.0 110.314 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.8 -37.53 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 123.469 0.708 . . . . 0.0 111.312 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 57.6 mt -72.87 -35.13 67.11 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 122.33 0.252 . . . . 0.0 111.208 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.47 -46.52 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.69 0 C-N-CA 123.08 0.552 . . . . 0.0 110.717 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 33.2 m -67.48 -37.27 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 O-C-N 121.687 -0.633 . . . . 0.0 110.225 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.93 95.25 Favored 'General case' 0 N--CA 1.524 3.23 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 18.3 m -71.32 -34.08 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 O-C-N 121.574 -0.704 . . . . 0.0 110.069 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -63.42 -44.32 94.95 Favored 'General case' 0 N--CA 1.528 3.431 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 13.0 m -68.67 -37.97 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 CA-C-N 118.643 0.656 . . . . 0.0 109.919 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 92.9 m -62.88 -27.54 69.42 Favored 'General case' 0 N--CA 1.522 3.14 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.99 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.79 -38.33 88.71 Favored 'General case' 0 N--CA 1.528 3.469 0 CA-C-O 120.939 0.4 . . . . 0.0 110.297 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 47.1 t -66.38 -36.73 83.59 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.632 0.773 . . . . 0.0 110.678 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.82 -13.67 16.88 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.847 0.859 . . . . 0.0 111.675 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 20.2 mt -86.6 -2.67 58.69 Favored 'General case' 0 N--CA 1.537 3.898 0 C-N-CA 123.059 0.543 . . . . 0.0 110.659 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -165.89 120.3 1.2 Allowed 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 123.441 0.696 . . . . 0.0 109.264 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.524 3.243 0 C-N-CA 124.211 1.005 . . . . 0.0 109.141 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.52 4.26 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.4 p -68.98 161.4 28.99 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.786 0.834 . . . . 0.0 110.936 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 211' ' ' LEU . 2.0 mm? -65.44 -26.19 67.85 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 124.73 1.212 . . . . 0.0 109.466 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 40.9 t -57.57 -39.17 76.14 Favored 'General case' 0 N--CA 1.518 2.928 0 C-N-CA 123.934 0.894 . . . . 0.0 112.273 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.36 -38.57 87.3 Favored Glycine 1 N--CA 1.522 4.419 0 C-N-CA 123.208 0.432 . . . . 0.0 112.115 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.18 -46.43 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 C-N-CA 124.107 0.963 . . . . 0.0 111.766 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.97 -31.85 53.76 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.066 0 C-N-CA 123.228 0.611 . . . . 0.0 109.872 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 30.9 mm -72.62 -33.38 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.9 -46.92 79.11 Favored Glycine 1 N--CA 1.518 4.119 0 N-CA-C 114.298 0.479 . . . . 0.0 114.298 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.12 -37.52 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.888 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.3 t -61.12 -38.04 84.94 Favored 'General case' 0 N--CA 1.539 3.989 0 CA-C-N 119.31 0.959 . . . . 0.0 111.464 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 59.6 t -56.67 -36.69 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 C-N-CA 123.067 0.547 . . . . 0.0 110.475 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.5 76.06 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.0 -49.72 71.34 Favored 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.73 -38.45 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.538 0 CA-C-O 119.003 -0.522 . . . . 0.0 112.26 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.25 -33.94 58.57 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.031 0 CA-C-N 119.323 0.965 . . . . 0.0 110.924 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.22 -47.14 71.74 Favored 'General case' 0 N--CA 1.538 3.934 0 CA-C-O 121.745 0.783 . . . . 0.0 109.566 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.2 mt -54.5 -36.77 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 123.305 0.642 . . . . 0.0 111.383 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.84 -39.21 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.919 0 C-N-CA 122.765 0.426 . . . . 0.0 109.886 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.87 97.98 Favored 'General case' 0 N--CA 1.529 3.5 0 C-N-CA 122.853 0.461 . . . . 0.0 111.146 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 50.8 t -71.82 -35.28 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.284 0 C-N-CA 123.221 0.608 . . . . 0.0 110.065 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -64.01 -44.45 92.58 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.96 -38.06 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 81.9 m -67.16 -32.6 73.8 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 123.344 0.658 . . . . 0.0 110.462 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -70.92 -39.72 72.53 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.319 0.648 . . . . 0.0 109.635 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 75.1 m -65.51 -34.91 79.38 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.773 0.829 . . . . 0.0 109.462 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.8 tp -68.99 -14.11 62.85 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 124.444 1.098 . . . . 0.0 109.904 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.3 -22.55 26.7 Favored 'General case' 0 N--CA 1.535 3.8 0 C-N-CA 124.23 1.012 . . . . 0.0 109.592 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -80.88 -8.84 59.83 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.515 0.726 . . . . 0.0 110.142 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -84.84 -65.44 1.01 Allowed 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 124.108 0.963 . . . . 0.0 110.563 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -70.36 65.31 0.28 Allowed 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.934 0.893 . . . . 0.0 111.178 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.537 3.904 0 C-N-CA 124.37 1.068 . . . . 0.0 108.607 178.585 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.517 2.88 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 47.8 mt -64.63 -28.21 69.46 Favored 'General case' 0 N--CA 1.521 3.098 0 C-N-CA 124.134 0.974 . . . . 0.0 111.286 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 46.5 t -59.02 -44.73 91.76 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.695 0.798 . . . . 0.0 112.371 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.52 -36.92 84.67 Favored Glycine 1 N--CA 1.521 4.353 0 C-N-CA 123.311 0.482 . . . . 0.0 112.248 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.92 -46.08 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 C-N-CA 123.514 0.726 . . . . 0.0 111.45 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.1 tp -68.58 -33.37 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 CA-C-N 118.55 0.614 . . . . 0.0 109.835 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 74.3 mt -68.85 -33.81 61.25 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.128 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.05 -29.71 76.07 Favored Glycine 0 N--CA 1.514 3.897 0 C-N-CA 123.626 0.631 . . . . 0.0 113.208 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -37.18 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 C-N-CA 123.144 0.578 . . . . 0.0 110.157 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 64.5 p -65.09 -47.78 76.04 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.09 -32.95 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 C-N-CA 123.145 0.578 . . . . 0.0 112.427 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.98 -47.1 81.59 Favored 'General case' 0 N--CA 1.526 3.372 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.13 86.54 Favored 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 123.152 0.581 . . . . 0.0 112.018 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -68.41 -53.13 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.291 0 C-N-CA 122.743 0.417 . . . . 0.0 111.939 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.96 -32.54 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -176.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 5.3 tt -69.7 -38.23 76.87 Favored 'General case' 0 N--CA 1.522 3.172 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 85.7 mt -66.38 -36.98 78.67 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.004 0 CA-C-N 118.856 0.753 . . . . 0.0 110.184 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -66.39 -37.8 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.8 86.13 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 123.48 0.712 . . . . 0.0 111.867 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 62.9 t -71.86 -35.09 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.058 0.543 . . . . 0.0 110.145 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -64.33 -44.14 92.44 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.9 -37.54 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.19 -27.14 68.76 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.33 0.652 . . . . 0.0 111.125 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -70.93 -25.97 62.99 Favored 'General case' 0 N--CA 1.529 3.52 0 C-N-CA 122.827 0.451 . . . . 0.0 111.165 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 48.0 m -65.96 -46.32 78.54 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 123.156 0.582 . . . . 0.0 112.152 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.7 pp -68.81 -12.97 62.1 Favored 'General case' 0 N--CA 1.53 3.553 0 C-N-CA 123.897 0.879 . . . . 0.0 112.045 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.8 tp . . . . . 0 N--CA 1.536 3.857 0 C-N-CA 123.227 0.611 . . . . 0.0 109.582 -178.349 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.521 3.099 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.85 -26.9 68.53 Favored 'General case' 0 N--CA 1.536 3.835 0 C-N-CA 124.267 1.027 . . . . 0.0 109.328 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 92.1 p -67.86 -25.86 65.75 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.552 0.741 . . . . 0.0 110.37 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.92 -46.22 68.25 Favored Glycine 0 N--CA 1.515 3.961 0 C-N-CA 123.729 0.68 . . . . 0.0 114.665 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.9 tt -70.59 -35.74 62.62 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.029 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.55 -44.29 80.39 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.409 0 CA-C-N 118.874 0.761 . . . . 0.0 112.873 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.3 tt -72.41 -32.77 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.88 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.62 -28.84 46.95 Favored Glycine 1 N--CA 1.517 4.082 0 C-N-CA 124.296 0.951 . . . . 0.0 113.158 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.5 m -59.42 -36.7 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.979 0 CA-C-O 121.08 0.467 . . . . 0.0 111.03 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 66.2 p -55.37 -44.6 76.2 Favored 'General case' 0 N--CA 1.527 3.421 0 C-N-CA 123.139 0.576 . . . . 0.0 111.86 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.28 -33.3 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 123.385 0.674 . . . . 0.0 110.529 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.39 83.91 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 122.658 0.383 . . . . 0.0 110.813 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.66 -50.44 73.86 Favored 'General case' 0 N--CA 1.518 2.964 0 C-N-CA 123.393 0.677 . . . . 0.0 112.826 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 34.5 m -68.04 -38.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 CA-C-N 118.288 0.495 . . . . 0.0 111.004 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.33 -38.91 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.798 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 39.3 tp -62.01 -34.9 77.05 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 122.804 0.441 . . . . 0.0 111.416 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.09 -46.21 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.869 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.39 -37.6 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 123.029 0.532 . . . . 0.0 109.943 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.4 -49.86 75.89 Favored 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 123.586 0.754 . . . . 0.0 112.507 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 11.9 p -71.89 -34.38 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 O-C-N 122.05 -0.406 . . . . 0.0 110.882 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -62.91 -44.34 96.36 Favored 'General case' 0 N--CA 1.529 3.488 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.28 -39.69 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.31 -28.38 67.95 Favored 'General case' 0 N--CA 1.522 3.166 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.08 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.64 -31.03 72.07 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 123.179 0.592 . . . . 0.0 111.092 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 39.2 t -63.96 -36.99 85.78 Favored 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 123.631 0.772 . . . . 0.0 111.639 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 50.3 tp -60.66 -24.34 65.51 Favored 'General case' 0 N--CA 1.528 3.436 0 C-N-CA 123.641 0.776 . . . . 0.0 111.848 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.97 8.26 27.19 Favored 'General case' 0 N--CA 1.538 3.95 0 C-N-CA 123.289 0.636 . . . . 0.0 110.036 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -164.43 71.21 0.2 Allowed 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 122.729 0.412 . . . . 0.0 110.171 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -75.42 163.43 27.43 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -74.43 137.13 42.44 Favored 'General case' 0 N--CA 1.522 3.166 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.53 3.575 0 C-N-CA 124.573 1.149 . . . . 0.0 109.189 -179.19 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.518 2.963 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.2 -26.51 68.17 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 124.311 1.044 . . . . 0.0 109.678 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 43.7 t -67.13 -33.08 74.67 Favored 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 123.767 0.827 . . . . 0.0 111.338 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.87 -46.93 58.22 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 114.251 0.461 . . . . 0.0 114.251 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 tt -69.58 -35.28 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.88 0 CA-C-N 117.544 0.672 . . . . 0.0 112.345 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . 0.461 ' O ' HG12 ' D' ' 218' ' ' VAL . 0.4 OUTLIER -56.51 -32.22 36.04 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 C-N-CA 123.447 0.699 . . . . 0.0 111.403 -177.395 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.86 -32.99 60.61 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.319 0 C-N-CA 122.934 0.494 . . . . 0.0 109.702 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.54 -29.33 47.67 Favored Glycine 1 N--CA 1.518 4.118 0 C-N-CA 123.802 0.715 . . . . 0.0 113.227 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . 0.461 HG12 ' O ' ' D' ' 215' ' ' ILE . 9.5 p -59.41 -37.49 69.92 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.102 0 C-N-CA 123.134 0.573 . . . . 0.0 110.633 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -59.34 -38.99 81.74 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 123.357 0.663 . . . . 0.0 111.252 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.93 -36.89 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.153 0 C-N-CA 123.783 0.833 . . . . 0.0 111.384 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.15 80.67 Favored 'General case' 0 N--CA 1.527 3.376 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.6 -49.95 42.27 Favored 'General case' 0 N--CA 1.518 2.94 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.4 -38.73 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.836 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.29 -32.25 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -36.09 74.34 Favored 'General case' 0 N--CA 1.534 3.754 0 C-N-CA 123.644 0.778 . . . . 0.0 109.833 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 37.2 mm -61.29 -36.98 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.894 0 C-N-CA 123.35 0.66 . . . . 0.0 110.553 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 40.5 t -66.13 -37.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 123.5 0.72 . . . . 0.0 109.892 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.08 77.85 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.51 0.724 . . . . 0.0 112.446 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.71 -34.32 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 O-C-N 122.125 -0.36 . . . . 0.0 110.646 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.99 -44.25 93.24 Favored 'General case' 0 N--CA 1.528 3.435 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.7 -37.75 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.717 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.15 -27.96 69.43 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.006 0.522 . . . . 0.0 111.227 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.69 -33.41 73.91 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 123.112 0.565 . . . . 0.0 110.762 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 49.8 m -63.79 -31.37 72.52 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.49 0.716 . . . . 0.0 112.173 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.34 -14.89 39.52 Favored 'General case' 0 N--CA 1.536 3.837 0 C-N-CA 123.725 0.81 . . . . 0.0 109.898 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -87.58 -11.65 48.03 Favored 'General case' 0 N--CA 1.533 3.716 0 C-N-CA 123.762 0.825 . . . . 0.0 110.962 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -0.55 0.29 Allowed 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.33 167.49 1.35 Allowed 'General case' 0 N--CA 1.531 3.576 0 C-N-CA 123.423 0.689 . . . . 0.0 111.417 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm . . . . . 0 N--CA 1.521 3.115 0 C-N-CA 124.115 0.966 . . . . 0.0 110.025 -179.667 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 95.4 p . . . . . 0 N--CA 1.525 3.279 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.72 -30.05 71.05 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 124.137 0.975 . . . . 0.0 109.9 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 60.4 m -58.37 -26.29 63.0 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 123.207 0.603 . . . . 0.0 110.803 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.29 -34.63 63.32 Favored Glycine 1 N--CA 1.517 4.057 0 C-N-CA 124.121 0.867 . . . . 0.0 113.571 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 13.2 tt -59.59 -44.99 94.48 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.049 0 CA-C-N 117.795 0.797 . . . . 0.0 112.911 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.4 pt -65.68 -34.92 73.6 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.437 0 CA-C-O 121.564 0.697 . . . . 0.0 110.038 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 49.3 mm -71.4 -33.57 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 124.183 0.993 . . . . 0.0 108.758 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.62 -31.02 78.48 Favored Glycine 1 N--CA 1.518 4.109 0 C-N-CA 123.389 0.519 . . . . 0.0 113.6 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 1.3 m -67.06 -37.35 79.13 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.103 0 CA-C-N 117.697 0.748 . . . . 0.0 110.397 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 37.4 p -60.81 -45.28 95.03 Favored 'General case' 0 N--CA 1.526 3.365 0 C-N-CA 123.168 0.587 . . . . 0.0 111.315 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.1 -36.53 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.254 0 C-N-CA 124.038 0.935 . . . . 0.0 111.325 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.91 -47.06 78.16 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 122.835 0.454 . . . . 0.0 112.027 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.72 90.85 Favored 'General case' 0 N--CA 1.52 3.073 0 C-N-CA 123.687 0.795 . . . . 0.0 111.655 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.46 -49.37 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 122.83 0.452 . . . . 0.0 110.699 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.15 -32.61 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.075 0.55 . . . . 0.0 110.312 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.08 -47.2 83.92 Favored 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 123.028 0.531 . . . . 0.0 111.048 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 80.1 mt -62.97 -38.86 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 C-N-CA 122.662 0.385 . . . . 0.0 110.477 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.19 -37.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 C-N-CA 123.288 0.635 . . . . 0.0 109.852 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.42 97.33 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.039 0.536 . . . . 0.0 111.334 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 62.8 t -71.74 -34.62 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.199 0.6 . . . . 0.0 109.749 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -63.46 -44.42 94.52 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.92 -37.7 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 77.5 m -67.12 -35.48 79.83 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.123 0.569 . . . . 0.0 110.295 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.67 -38.75 90.16 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 123.476 0.71 . . . . 0.0 111.282 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 86.7 p -65.1 -21.33 66.79 Favored 'General case' 0 N--CA 1.529 3.5 0 C-N-CA 123.082 0.553 . . . . 0.0 110.971 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.533 3.683 0 C-N-CA 123.958 0.903 . . . . 0.0 110.037 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.522 3.129 0 CA-C-O 121.4 0.619 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.19 -26.56 68.2 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 124.166 0.986 . . . . 0.0 109.445 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 65.5 m -57.66 -25.38 60.14 Favored 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.183 0.993 . . . . 0.0 111.415 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.0 -35.31 83.86 Favored Glycine 0 N--CA 1.515 3.923 0 C-N-CA 124.167 0.889 . . . . 0.0 115.267 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 12.2 tt -59.08 -35.09 55.35 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.593 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 9.3 tp -55.84 -31.85 30.97 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.31 -32.53 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.944 0 CA-C-N 118.383 0.538 . . . . 0.0 110.023 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.79 -29.54 54.91 Favored Glycine 0 N--CA 1.514 3.87 0 CA-C-O 119.555 -0.58 . . . . 0.0 113.873 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.6 m -59.92 -48.26 88.45 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 CA-C-N 118.075 0.938 . . . . 0.0 112.468 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 11.3 t -66.43 -38.76 88.14 Favored 'General case' 0 N--CA 1.536 3.847 0 O-C-N 121.955 -0.466 . . . . 0.0 110.98 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.87 -39.05 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.297 0 C-N-CA 123.46 0.704 . . . . 0.0 109.333 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.18 98.63 Favored 'General case' 0 N--CA 1.522 3.146 0 C-N-CA 123.137 0.575 . . . . 0.0 110.907 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.73 79.29 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 123.264 0.625 . . . . 0.0 111.781 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.37 -51.01 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.545 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.69 -33.25 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 123.632 0.773 . . . . 0.0 111.109 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 38.6 tp -66.07 -35.49 80.67 Favored 'General case' 0 N--CA 1.531 3.593 0 C-N-CA 122.513 0.325 . . . . 0.0 111.218 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 92.2 mt -69.2 -41.15 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.89 -37.96 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 123.413 0.685 . . . . 0.0 109.594 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.22 81.38 Favored 'General case' 0 N--CA 1.526 3.347 0 C-N-CA 123.81 0.844 . . . . 0.0 112.666 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.46 -34.0 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 O-C-N 121.872 -0.517 . . . . 0.0 109.98 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.73 -44.27 94.06 Favored 'General case' 0 N--CA 1.529 3.493 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.95 -37.53 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 98.0 m -59.42 -27.43 66.03 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.336 0.654 . . . . 0.0 111.316 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.34 -40.89 85.91 Favored 'General case' 0 N--CA 1.529 3.501 0 CA-C-O 121.078 0.466 . . . . 0.0 110.426 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 47.6 t -64.77 -17.58 64.3 Favored 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 124.129 0.972 . . . . 0.0 112.45 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.6 -15.08 63.14 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 122.977 0.511 . . . . 0.0 110.627 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.37 -28.7 22.04 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.115 0.566 . . . . 0.0 109.58 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -158.83 144.45 16.47 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.705 0.802 . . . . 0.0 108.98 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 N--CA 1.529 3.524 0 C-N-CA 124.725 1.21 . . . . 0.0 108.149 178.477 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.162 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 43.1 m 60.24 47.63 9.0 Favored 'General case' 0 N--CA 1.519 3.024 0 C-N-CA 124.317 1.047 . . . . 0.0 111.847 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.6 mp -65.14 -26.63 68.27 Favored 'General case' 0 N--CA 1.534 3.735 0 C-N-CA 123.829 0.852 . . . . 0.0 109.251 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 98.0 p -68.41 -27.43 66.2 Favored 'General case' 0 N--CA 1.521 3.076 0 C-N-CA 123.263 0.625 . . . . 0.0 110.049 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.46 -46.9 53.81 Favored Glycine 0 N--CA 1.513 3.779 0 N-CA-C 116.688 1.435 . . . . 0.0 116.688 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.5 pt -59.69 -35.24 58.61 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.467 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 -174.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.2 tt -56.75 -32.06 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 15.5 tt -70.78 -33.79 53.91 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 CA-C-N 120.131 1.332 . . . . 0.0 111.064 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.81 -43.63 80.92 Favored Glycine 1 N--CA 1.52 4.246 0 C-N-CA 123.053 0.359 . . . . 0.0 113.802 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.06 -37.29 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.977 0 O-C-N 121.639 -0.918 . . . . 0.0 110.922 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 61.3 p -64.84 -45.65 85.24 Favored 'General case' 0 N--CA 1.538 3.928 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.49 -30.87 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 C-N-CA 123.093 0.557 . . . . 0.0 111.766 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.43 -47.0 88.01 Favored 'General case' 0 N--CA 1.534 3.732 0 O-C-N 121.496 -0.753 . . . . 0.0 112.614 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.63 -44.24 96.79 Favored 'General case' 0 N--CA 1.521 3.124 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.65 -39.73 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.752 0 CA-C-N 118.773 0.715 . . . . 0.0 112.068 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.32 -34.15 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.339 0.518 . . . . 0.0 110.134 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.7 -48.06 78.65 Favored 'General case' 0 N--CA 1.524 3.24 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.6 pt -70.01 -36.74 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 O-C-N 122.065 -0.397 . . . . 0.0 111.339 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.3 -37.46 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.03 -41.13 82.57 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 122.968 0.507 . . . . 0.0 111.806 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.77 -37.12 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.192 0.597 . . . . 0.0 110.15 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -63.08 -44.16 96.52 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 123.211 0.604 . . . . 0.0 112.377 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.88 -37.62 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 93.2 m -64.68 -28.43 69.59 Favored 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 122.846 0.458 . . . . 0.0 110.727 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -72.93 -23.37 60.68 Favored 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 123.23 0.612 . . . . 0.0 110.924 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.1 m -66.19 -31.36 72.14 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 122.949 0.499 . . . . 0.0 111.432 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.68 -37.53 87.89 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.644 0.777 . . . . 0.0 112.377 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 pp -95.19 -16.26 22.68 Favored 'General case' 1 N--CA 1.547 4.392 0 C-N-CA 123.223 0.609 . . . . 0.0 111.531 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -67.1 -10.39 49.55 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 123.505 0.722 . . . . 0.0 111.193 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.1 116.2 4.01 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 123.625 0.77 . . . . 0.0 111.508 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.62 -162.99 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.648 0 C-N-CA 126.126 1.77 . . . . 0.0 114.538 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.528 3.474 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -179.846 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 71.9 p . . . . . 0 N--CA 1.522 3.128 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 48.4 mt -57.28 -25.82 59.85 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 124.873 1.269 . . . . 0.0 111.613 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.3 t -57.01 -37.69 72.06 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.581 0.752 . . . . 0.0 112.065 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.28 -46.32 57.65 Favored Glycine 1 N--CA 1.518 4.164 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.475 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.403 ' N ' HD12 ' B' ' 214' ' ' ILE . 1.5 mp -70.89 -46.38 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 124.53 1.132 . . . . 0.0 112.79 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . 0.477 ' O ' HG12 ' B' ' 218' ' ' VAL . 18.6 tt -57.07 -38.23 59.42 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -175.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 17.0 tt -72.83 -32.93 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.884 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.6 -29.14 47.69 Favored Glycine 0 N--CA 1.513 3.821 0 C-N-CA 124.19 0.9 . . . . 0.0 113.581 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . 0.477 HG12 ' O ' ' B' ' 215' ' ' ILE . 8.3 p -59.5 -37.74 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.875 0 CA-C-N 117.27 0.535 . . . . 0.0 111.157 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 69.0 p -63.87 -45.93 87.22 Favored 'General case' 0 N--CA 1.529 3.489 0 CA-C-O 121.224 0.535 . . . . 0.0 110.804 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.52 -34.69 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.059 0 C-N-CA 124.101 0.961 . . . . 0.0 110.962 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.61 -46.96 67.22 Favored 'General case' 0 N--CA 1.529 3.52 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.8 74.53 Favored 'General case' 0 N--CA 1.522 3.143 0 C-N-CA 123.285 0.634 . . . . 0.0 111.807 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -67.13 -41.38 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.438 0 C-N-CA 122.913 0.485 . . . . 0.0 110.451 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.94 -38.52 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 0 C-N-CA 122.899 0.48 . . . . 0.0 111.495 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 56.9 tp -66.77 -43.13 84.82 Favored 'General case' 0 N--CA 1.532 3.631 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.19 -39.15 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.809 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.77 -37.07 78.74 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 CA-C-N 118.717 0.69 . . . . 0.0 109.82 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.55 -32.08 66.75 Favored 'General case' 0 N--CA 1.525 3.305 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.24 -34.89 72.13 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.175 0 CA-C-N 119.286 0.948 . . . . 0.0 112.355 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.73 -43.98 91.67 Favored 'General case' 0 N--CA 1.536 3.871 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.92 -37.73 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.803 0 O-C-N 121.832 -0.543 . . . . 0.0 109.574 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.08 -27.92 67.77 Favored 'General case' 0 N--CA 1.527 3.391 0 C-N-CA 123.259 0.623 . . . . 0.0 111.148 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.16 -30.19 71.26 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.054 0.542 . . . . 0.0 110.507 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 34.9 t -63.82 -39.03 93.27 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.368 0.667 . . . . 0.0 110.774 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.12 -15.94 63.04 Favored 'General case' 0 N--CA 1.527 3.418 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.746 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 49.6 tp . . . . . 0 N--CA 1.537 3.901 0 C-N-CA 124.184 0.993 . . . . 0.0 109.523 179.871 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 100.0 p . . . . . 0 N--CA 1.522 3.134 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.66 -39.43 88.36 Favored 'General case' 0 N--CA 1.535 3.782 0 C-N-CA 124.129 0.972 . . . . 0.0 109.25 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 42.0 t -68.19 -32.24 72.33 Favored 'General case' 0 N--CA 1.517 2.92 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.487 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.41 -46.34 63.9 Favored Glycine 0 N--CA 1.514 3.896 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.443 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 41.8 pt -66.3 -38.49 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 CA-C-N 118.062 0.931 . . . . 0.0 112.344 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.98 -32.59 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.37 -32.8 43.66 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.23 -29.09 44.51 Favored Glycine 0 N--CA 1.513 3.819 0 C-N-CA 124.172 0.891 . . . . 0.0 113.529 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.46 -37.57 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 117.505 0.653 . . . . 0.0 110.739 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 61.4 p -63.08 -46.21 88.47 Favored 'General case' 0 N--CA 1.528 3.432 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.959 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.77 -38.08 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 124.226 1.011 . . . . 0.0 110.184 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.06 63.98 Favored 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 123.663 0.785 . . . . 0.0 112.659 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.67 75.0 Favored 'General case' 0 N--CA 1.519 3.009 0 C-N-CA 123.345 0.658 . . . . 0.0 111.664 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.8 -48.25 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.367 0 C-N-CA 123.165 0.586 . . . . 0.0 111.425 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.4 -32.45 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 C-N-CA 122.615 0.366 . . . . 0.0 110.537 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.44 -42.24 98.44 Favored 'General case' 0 N--CA 1.53 3.546 0 C-N-CA 123.361 0.664 . . . . 0.0 110.313 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 94.8 mt -65.72 -44.17 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 123.33 0.652 . . . . 0.0 109.753 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.45 -37.55 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.484 0 C-N-CA 123.32 0.648 . . . . 0.0 109.708 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.95 81.55 Favored 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.284 0.634 . . . . 0.0 112.322 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 17.6 m -71.9 -34.44 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 O-C-N 121.96 -0.463 . . . . 0.0 110.647 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.69 -44.44 93.69 Favored 'General case' 0 N--CA 1.53 3.536 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.89 -37.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.759 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 70.7 m -67.47 -39.15 85.27 Favored 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 122.966 0.507 . . . . 0.0 110.479 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.15 -32.77 63.27 Favored 'General case' 0 N--CA 1.524 3.271 0 C-N-CA 123.554 0.742 . . . . 0.0 111.008 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 86.3 p -63.76 -24.75 67.89 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.175 0.59 . . . . 0.0 111.505 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.59 -30.9 69.75 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.804 0.842 . . . . 0.0 110.355 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.24 1.9 56.0 Favored 'General case' 0 N--CA 1.535 3.82 0 C-N-CA 124.25 1.02 . . . . 0.0 110.128 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -59.65 -15.95 22.85 Favored 'General case' 0 N--CA 1.533 3.682 0 C-N-CA 123.239 0.616 . . . . 0.0 110.978 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -67.49 157.57 33.95 Favored 'General case' 0 N--CA 1.518 2.962 0 C-N-CA 124.176 0.99 . . . . 0.0 110.011 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -165.36 -22.09 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.429 0 C-N-CA 123.856 0.862 . . . . 0.0 109.624 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.529 3.505 0 C-N-CA 125.2 1.4 . . . . 0.0 108.406 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 89.9 p . . . . . 0 N--CA 1.522 3.136 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.13 -39.04 92.5 Favored 'General case' 0 N--CA 1.527 3.391 0 C-N-CA 124.055 0.942 . . . . 0.0 109.817 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 92.4 p -68.23 -27.71 66.6 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.082 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.65 -47.25 50.31 Favored Glycine 0 N--CA 1.504 3.21 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.543 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.48 -37.98 66.44 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.322 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -176.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 10.2 tp -56.87 -31.86 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.622 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 pt -59.74 -39.65 80.3 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.318 0 CA-C-N 119.325 0.966 . . . . 0.0 111.562 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.53 -28.87 46.32 Favored Glycine 0 N--CA 1.516 3.992 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.257 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 2.9 p -59.36 -46.66 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 C-N-CA 123.697 0.799 . . . . 0.0 112.753 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 3.2 t -66.08 -38.71 88.95 Favored 'General case' 0 N--CA 1.534 3.752 0 CA-C-O 121.217 0.532 . . . . 0.0 110.667 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.4 -34.81 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.033 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.484 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.78 79.07 Favored 'General case' 0 N--CA 1.527 3.377 0 C-N-CA 123.03 0.532 . . . . 0.0 111.533 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -49.93 44.9 Favored 'General case' 0 N--CA 1.511 2.58 0 C-N-CA 123.38 0.672 . . . . 0.0 112.588 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 21.8 m -61.04 -42.27 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.82 -32.09 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.68 0 C-N-CA 122.845 0.458 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.15 -40.24 53.12 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mp -54.98 -44.41 73.69 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 C-N-CA 124.128 0.971 . . . . 0.0 112.187 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 22.5 m -66.19 -36.88 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 O-C-N 121.762 -0.586 . . . . 0.0 111.129 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.49 85.97 Favored 'General case' 0 N--CA 1.529 3.481 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 11.3 m -71.68 -34.32 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 O-C-N 121.873 -0.517 . . . . 0.0 110.326 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -63.67 -43.96 95.13 Favored 'General case' 0 N--CA 1.531 3.615 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.5 -37.18 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.62 -28.64 65.83 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 122.704 0.402 . . . . 0.0 111.566 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -58.01 -16.56 13.05 Favored 'General case' 1 N--CA 1.54 4.073 0 CA-C-N 118.308 0.503 . . . . 0.0 111.56 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 45.8 t -68.14 -43.98 77.08 Favored 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.79 -27.48 68.31 Favored 'General case' 0 N--CA 1.528 3.435 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.396 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.19 10.45 16.86 Favored 'General case' 1 N--CA 1.542 4.127 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -159.89 98.98 1.37 Allowed 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 123.176 0.59 . . . . 0.0 109.839 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -137.72 144.12 41.56 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 125.087 1.355 . . . . 0.0 107.441 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.518 2.962 0 C-N-CA 123.786 0.834 . . . . 0.0 108.843 179.102 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.524 3.232 0 CA-C-O 119.947 -0.073 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 47.3 mt -63.55 -26.79 68.86 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.014 0.926 . . . . 0.0 110.54 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 94.3 p -62.07 -39.73 93.38 Favored 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 123.844 0.858 . . . . 0.0 110.741 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.06 -39.98 83.89 Favored Glycine 1 N--CA 1.517 4.061 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.656 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.65 -46.36 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.405 0 C-N-CA 124.026 0.93 . . . . 0.0 112.669 -176.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.4 tt -61.94 -37.53 78.49 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.024 0 O-C-N 121.915 -0.49 . . . . 0.0 112.294 -176.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.1 tp -73.18 -33.65 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.684 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.8 -46.86 91.83 Favored Glycine 1 N--CA 1.516 4.009 0 CA-C-N 115.781 -0.645 . . . . 0.0 114.487 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.94 -37.42 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.844 0 CA-C-N 117.806 0.803 . . . . 0.0 110.899 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 54.5 p -66.36 -45.75 79.08 Favored 'General case' 0 N--CA 1.531 3.592 0 CA-C-O 120.914 0.388 . . . . 0.0 111.113 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.67 -31.37 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.417 0 C-N-CA 123.918 0.887 . . . . 0.0 111.212 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.71 72.48 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.03 -49.26 53.06 Favored 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.54 -39.81 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 31.9 m -68.02 -35.41 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 CA-C-N 118.519 0.6 . . . . 0.0 112.017 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 26.3 tp -69.87 -42.72 73.12 Favored 'General case' 0 N--CA 1.524 3.261 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 33.2 pt -66.67 -35.83 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.838 0.745 . . . . 0.0 111.153 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 92.9 t -65.05 -37.67 80.81 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.036 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.46 -35.81 74.79 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 123.17 0.588 . . . . 0.0 111.665 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 71.0 t -71.9 -36.33 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.27 0 C-N-CA 123.45 0.7 . . . . 0.0 110.762 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.07 -43.96 81.33 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.52 -38.01 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.519 0 C-N-CA 122.555 0.342 . . . . 0.0 110.893 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 14.4 p -67.11 -27.8 67.63 Favored 'General case' 0 N--CA 1.534 3.765 0 CA-C-N 117.876 0.307 . . . . 0.0 111.297 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -60.43 -30.04 69.38 Favored 'General case' 0 N--CA 1.529 3.489 0 C-N-CA 123.153 0.581 . . . . 0.0 110.965 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 45.6 t -64.94 -41.77 95.23 Favored 'General case' 0 N--CA 1.525 3.322 0 CA-C-O 121.695 0.759 . . . . 0.0 110.572 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 45.6 mt . . . . . 0 N--CA 1.518 2.938 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.053 -179.284 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.521 3.123 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.13 -26.91 68.39 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.785 0.834 . . . . 0.0 110.451 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 67.1 m -68.61 -35.18 76.98 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 123.544 0.737 . . . . 0.0 110.308 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.68 -43.2 76.99 Favored Glycine 1 N--CA 1.517 4.044 0 CA-C-N 115.228 -0.896 . . . . 0.0 115.17 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . 0.409 HD13 ' O ' ' F' ' 214' ' ' ILE . 0.0 OUTLIER -70.72 -45.85 71.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 CA-C-N 118.026 0.913 . . . . 0.0 111.406 -176.863 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 19.8 tt -60.83 -34.35 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 44.9 pt -72.57 -32.81 42.85 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.195 0 CA-C-N 119.556 1.071 . . . . 0.0 108.929 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.88 -29.77 51.6 Favored Glycine 0 N--CA 1.514 3.872 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.979 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.0 -37.53 72.88 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.021 0 CA-C-N 117.588 0.694 . . . . 0.0 110.963 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 43.1 p -62.99 -46.21 88.73 Favored 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.048 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.95 -36.06 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.151 0 C-N-CA 124.212 1.005 . . . . 0.0 110.749 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.42 -43.13 64.64 Favored 'General case' 0 N--CA 1.525 3.313 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.73 -43.11 85.1 Favored 'General case' 0 N--CA 1.519 3.012 0 C-N-CA 123.261 0.624 . . . . 0.0 111.972 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 36.9 t -66.72 -45.56 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 C-N-CA 122.943 0.497 . . . . 0.0 111.022 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.16 -38.83 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 123.263 0.625 . . . . 0.0 111.153 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.81 -34.63 78.6 Favored 'General case' 0 N--CA 1.532 3.64 0 CA-C-N 117.828 0.285 . . . . 0.0 110.803 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.67 -44.26 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.886 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.04 -37.77 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.625 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.65 -48.22 81.77 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.731 0.813 . . . . 0.0 112.807 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.58 -34.22 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 O-C-N 121.948 -0.47 . . . . 0.0 110.084 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -64.01 -44.13 93.53 Favored 'General case' 0 N--CA 1.527 3.401 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.71 -37.74 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 98.9 m -61.66 -27.92 69.02 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.039 0.536 . . . . 0.0 111.212 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -67.62 -30.62 70.24 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 122.947 0.499 . . . . 0.0 111.49 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 49.4 m -64.04 -31.99 73.38 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 123.324 0.649 . . . . 0.0 112.407 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.78 -33.0 72.31 Favored 'General case' 0 N--CA 1.534 3.754 0 C-N-CA 123.793 0.837 . . . . 0.0 112.379 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . 0.544 HD13 ' H ' ' F' ' 236' ' ' LEU . 0.0 OUTLIER -110.33 10.97 23.47 Favored 'General case' 1 N--CA 1.547 4.399 0 C-N-CA 124.019 0.928 . . . . 0.0 111.466 -179.773 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 31.7 t90 -139.25 79.24 1.71 Allowed 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 124.374 1.07 . . . . 0.0 108.648 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.525 3.277 0 C-N-CA 124.159 0.984 . . . . 0.0 109.963 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.1 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.8 m -161.22 44.25 0.17 Allowed 'General case' 0 N--CA 1.52 3.067 0 C-N-CA 123.684 0.794 . . . . 0.0 109.185 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 48.2 mt -64.72 -41.18 96.16 Favored 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 123.972 0.909 . . . . 0.0 110.123 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 95.3 p -57.95 -26.96 62.95 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 123.271 0.629 . . . . 0.0 110.678 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.21 -41.52 86.08 Favored Glycine 1 N--CA 1.52 4.266 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 62.3 mt -65.62 -37.1 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 C-N-CA 124.348 1.059 . . . . 0.0 109.083 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 45.6 mm -67.48 -40.81 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 C-N-CA 124.151 0.981 . . . . 0.0 108.384 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 87.7 mt -72.33 -33.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.04 -29.72 75.24 Favored Glycine 1 N--CA 1.518 4.111 0 C-N-CA 123.336 0.493 . . . . 0.0 112.458 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -37.23 72.81 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.18 0 C-N-CA 123.394 0.678 . . . . 0.0 109.916 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -57.46 -45.24 84.98 Favored 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.342 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 51.2 t -56.57 -42.07 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 C-N-CA 124.323 1.049 . . . . 0.0 111.454 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.62 -40.74 63.04 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.96 -37.25 75.76 Favored 'General case' 0 N--CA 1.523 3.179 0 C-N-CA 123.114 0.566 . . . . 0.0 111.726 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.09 -48.52 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.502 0 C-N-CA 123.492 0.717 . . . . 0.0 111.359 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.14 -32.62 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 O-C-N 121.926 -0.484 . . . . 0.0 111.847 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.15 -40.65 37.29 Favored 'General case' 0 N--CA 1.534 3.748 0 C-N-CA 122.61 0.364 . . . . 0.0 111.705 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.42 -38.78 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.355 0.525 . . . . 0.0 111.711 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 35.4 m -67.89 -37.59 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.564 0 CA-C-O 121.047 0.451 . . . . 0.0 110.406 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.05 97.17 Favored 'General case' 0 N--CA 1.523 3.21 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.03 -33.95 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 O-C-N 121.726 -0.609 . . . . 0.0 110.149 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -60.03 -44.27 94.73 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.95 -42.08 82.12 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 CA-C-O 121.681 0.753 . . . . 0.0 109.468 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 83.0 m -61.57 -27.56 68.71 Favored 'General case' 0 N--CA 1.518 2.955 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.293 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.21 -30.9 71.84 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 122.635 0.374 . . . . 0.0 110.373 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 34.0 t -64.01 -35.17 79.82 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.243 0.617 . . . . 0.0 111.152 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.91 -18.42 56.54 Favored 'General case' 0 N--CA 1.532 3.636 0 C-N-CA 122.968 0.507 . . . . 0.0 111.592 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.54 -2.01 58.32 Favored 'General case' 1 N--CA 1.541 4.119 0 C-N-CA 123.054 0.542 . . . . 0.0 109.86 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -66.62 -68.47 0.37 Allowed 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.172 0.589 . . . . 0.0 110.005 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 56.96 176.98 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.227 0 C-N-CA 124.26 1.024 . . . . 0.0 112.024 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -69.97 -178.22 1.53 Allowed 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 124.0 0.92 . . . . 0.0 110.359 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.529 3.498 0 C-N-CA 125.203 1.401 . . . . 0.0 108.228 179.8 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.52 3.068 0 CA-C-O 121.387 0.613 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 53.9 mt -65.1 -26.83 68.38 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.6 0.76 . . . . 0.0 109.996 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -65.82 -29.23 69.67 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.34 0.656 . . . . 0.0 110.519 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.52 -35.68 81.9 Favored Glycine 1 N--CA 1.523 4.451 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.21 -45.97 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 C-N-CA 124.037 0.935 . . . . 0.0 111.555 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.7 pt -65.22 -33.21 62.12 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.492 0 CA-C-O 121.844 0.83 . . . . 0.0 110.019 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 40.0 mm -73.06 -33.67 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.285 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.45 -48.26 77.32 Favored Glycine 1 N--CA 1.52 4.249 0 C-N-CA 123.435 0.541 . . . . 0.0 114.29 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.96 -37.71 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.77 0 CA-C-N 117.434 0.617 . . . . 0.0 110.861 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 72.7 p -66.64 -45.92 77.46 Favored 'General case' 0 N--CA 1.533 3.722 0 CA-C-N 118.141 0.428 . . . . 0.0 111.354 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.48 -31.53 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.25 0 C-N-CA 123.797 0.839 . . . . 0.0 111.301 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.49 -37.23 75.12 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.21 -50.08 43.67 Favored 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.13 -38.46 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.32 -32.5 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 36.2 tp -77.84 -39.4 43.64 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.0 pt -69.51 -37.01 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 CA-C-N 119.053 0.842 . . . . 0.0 112.171 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.0 -37.09 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 121.838 -0.539 . . . . 0.0 110.15 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.19 79.87 Favored 'General case' 0 N--CA 1.525 3.3 0 C-N-CA 123.78 0.832 . . . . 0.0 112.888 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.64 -34.43 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 O-C-N 121.926 -0.484 . . . . 0.0 110.394 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -64.38 -44.08 92.45 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 123.091 0.556 . . . . 0.0 112.307 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.85 -37.57 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.704 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 83.4 m -64.35 -27.84 69.29 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.066 0.546 . . . . 0.0 111.018 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -69.3 -30.52 68.62 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.089 0.556 . . . . 0.0 111.05 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 82.4 p -64.73 -31.22 72.35 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.198 0.599 . . . . 0.0 111.706 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.3 -17.32 62.41 Favored 'General case' 0 N--CA 1.536 3.825 0 C-N-CA 123.462 0.705 . . . . 0.0 111.085 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.537 3.892 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.519 3.025 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 45.8 mt -61.07 -26.2 67.48 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.49 1.116 . . . . 0.0 111.279 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 63.5 m -57.75 -43.49 85.43 Favored 'General case' 0 N--CA 1.522 3.174 0 C-N-CA 123.677 0.791 . . . . 0.0 112.097 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.62 81.28 Favored Glycine 1 N--CA 1.523 4.443 0 C-N-CA 123.559 0.599 . . . . 0.0 112.707 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 41.6 mm -59.98 -46.54 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.627 0 C-N-CA 123.979 0.912 . . . . 0.0 112.898 -176.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . 0.452 HD13 ' O ' ' C' ' 215' ' ' ILE . 0.1 OUTLIER -69.01 -35.77 70.63 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.683 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.5 mm -72.25 -33.36 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.04 -29.72 56.15 Favored Glycine 0 N--CA 1.513 3.798 0 C-N-CA 124.018 0.818 . . . . 0.0 113.415 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 m -59.98 -37.63 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 CA-C-N 117.349 0.574 . . . . 0.0 110.89 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 43.7 p -61.09 -46.72 89.5 Favored 'General case' 0 N--CA 1.526 3.34 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.213 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.96 -39.87 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.037 0 C-N-CA 124.277 1.031 . . . . 0.0 110.453 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.41 -38.42 58.99 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.11 -43.38 82.59 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 122.952 0.501 . . . . 0.0 110.562 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.08 -43.31 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.368 0 C-N-CA 123.773 0.829 . . . . 0.0 110.811 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.6 -32.31 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.56 0 C-N-CA 123.468 0.707 . . . . 0.0 109.969 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -45.71 91.04 Favored 'General case' 0 N--CA 1.537 3.925 0 CA-C-O 121.293 0.568 . . . . 0.0 109.939 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 80.9 mt -54.94 -35.89 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.821 0 C-N-CA 123.615 0.766 . . . . 0.0 111.028 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.42 -36.1 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 C-N-CA 123.117 0.567 . . . . 0.0 110.487 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.2 64.63 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 3.1 m -64.41 -34.87 72.17 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.426 0 CA-C-N 119.582 1.083 . . . . 0.0 110.619 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -72.94 -31.93 64.93 Favored 'General case' 0 N--CA 1.529 3.496 0 C-N-CA 123.093 0.557 . . . . 0.0 110.04 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.44 -37.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.579 0 C-N-CA 123.41 0.684 . . . . 0.0 109.29 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.58 -36.58 74.19 Favored 'General case' 0 N--CA 1.525 3.324 0 CA-C-O 121.073 0.463 . . . . 0.0 110.06 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.33 -38.2 63.35 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.201 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.8 m -63.91 -46.7 83.63 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 123.066 0.546 . . . . 0.0 110.846 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 85.1 mt -67.05 -18.01 65.16 Favored 'General case' 0 N--CA 1.53 3.53 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.706 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 41.7 tp -92.4 -11.66 34.31 Favored 'General case' 1 N--CA 1.539 4.008 0 C-N-CA 123.907 0.883 . . . . 0.0 110.141 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -51.41 -26.31 7.72 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.993 0.917 . . . . 0.0 112.308 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -65.43 143.15 57.89 Favored 'General case' 0 N--CA 1.526 3.375 0 C-N-CA 123.375 0.67 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.66 8.42 Favored 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 124.119 0.968 . . . . 0.0 108.81 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.529 3.515 0 C-N-CA 124.832 1.253 . . . . 0.0 108.523 179.944 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.523 3.187 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.09 -43.18 92.98 Favored 'General case' 0 N--CA 1.534 3.746 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 89.4 p -58.94 -26.3 64.27 Favored 'General case' 0 N--CA 1.526 3.374 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.823 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.47 -34.43 79.3 Favored Glycine 0 N--CA 1.506 3.363 0 C-N-CA 124.64 1.114 . . . . 0.0 113.68 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -35.26 52.63 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.297 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -174.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 16.8 tt -55.96 -32.42 33.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.81 -32.31 48.53 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.258 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.65 -40.59 96.66 Favored Glycine 1 N--CA 1.519 4.167 0 CA-C-O 119.653 -0.526 . . . . 0.0 113.653 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.45 -37.07 78.22 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 CA-C-N 118.458 1.129 . . . . 0.0 109.924 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 89.1 m -56.0 -45.1 79.16 Favored 'General case' 0 N--CA 1.522 3.163 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.54 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.53 -41.66 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 123.385 0.674 . . . . 0.0 110.7 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.82 -35.59 64.07 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.63 -50.36 37.82 Favored 'General case' 0 N--CA 1.521 3.094 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 12.9 p -68.02 -38.59 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.567 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.34 -31.99 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 CA-C-N 118.161 0.437 . . . . 0.0 110.237 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.97 -34.86 63.7 Favored 'General case' 1 N--CA 1.54 4.062 0 CA-C-O 121.485 0.66 . . . . 0.0 110.607 -178.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 67.4 mt -61.14 -36.04 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 124.002 0.921 . . . . 0.0 110.76 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.68 -37.64 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 123.272 0.629 . . . . 0.0 110.226 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -47.59 84.71 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.401 0.681 . . . . 0.0 112.571 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.56 -34.06 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.624 0 O-C-N 121.866 -0.521 . . . . 0.0 110.168 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.97 -44.2 97.24 Favored 'General case' 0 N--CA 1.529 3.503 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.86 -37.84 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 70.8 m -62.06 -27.57 68.99 Favored 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.081 0.552 . . . . 0.0 111.11 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -59.76 -18.66 44.88 Favored 'General case' 0 N--CA 1.533 3.706 0 C-N-CA 122.946 0.498 . . . . 0.0 111.244 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 97.3 p -73.81 -40.08 63.63 Favored 'General case' 0 N--CA 1.524 3.275 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.15 -14.88 63.32 Favored 'General case' 0 N--CA 1.537 3.895 0 C-N-CA 123.411 0.684 . . . . 0.0 110.481 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 57.2 tp -89.62 -28.9 19.21 Favored 'General case' 1 N--CA 1.54 4.045 0 C-N-CA 124.252 1.021 . . . . 0.0 109.826 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -79.88 -71.36 0.46 Allowed 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 43.6 tptt 44.62 17.31 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? . . . . . 0 N--CA 1.529 3.523 0 C-N-CA 123.921 0.888 . . . . 0.0 109.094 179.648 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.523 3.181 0 N-CA-C 111.203 0.075 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 mp -64.22 -26.93 68.73 Favored 'General case' 1 N--CA 1.54 4.041 0 C-N-CA 123.498 0.719 . . . . 0.0 109.116 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 39.2 t -63.68 -35.85 81.91 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 123.805 0.842 . . . . 0.0 111.21 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.27 -35.69 83.22 Favored Glycine 1 N--CA 1.519 4.2 0 C-N-CA 123.846 0.736 . . . . 0.0 112.549 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.17 -47.04 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 C-N-CA 123.857 0.863 . . . . 0.0 112.292 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.83 -32.51 52.19 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 CA-C-N 118.564 0.62 . . . . 0.0 109.684 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.66 -32.24 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.76 -29.49 41.63 Favored Glycine 0 N--CA 1.511 3.698 0 C-N-CA 123.843 0.735 . . . . 0.0 113.402 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 m -60.32 -37.59 74.56 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.108 0 CA-C-N 117.918 0.859 . . . . 0.0 110.381 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 37.8 p -60.02 -45.8 91.61 Favored 'General case' 0 N--CA 1.528 3.47 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.235 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 47.6 t -69.49 -37.83 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 C-N-CA 124.229 1.012 . . . . 0.0 111.091 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.61 -42.96 65.06 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.85 -31.85 72.73 Favored 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 123.067 0.547 . . . . 0.0 111.748 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.05 -39.51 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.529 0 C-N-CA 123.089 0.556 . . . . 0.0 110.384 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.89 -33.01 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 C-N-CA 123.389 0.676 . . . . 0.0 110.558 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.59 -45.93 84.89 Favored 'General case' 0 N--CA 1.532 3.631 0 C-N-CA 122.715 0.406 . . . . 0.0 109.923 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 73.2 mt -54.78 -36.53 37.27 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 C-N-CA 122.851 0.46 . . . . 0.0 110.891 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.62 -37.88 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 C-N-CA 123.029 0.532 . . . . 0.0 109.889 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.95 -32.36 69.54 Favored 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.43 0.692 . . . . 0.0 111.387 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.17 -34.72 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.23 0 C-N-CA 123.638 0.775 . . . . 0.0 111.16 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -69.13 -43.98 73.3 Favored 'General case' 0 N--CA 1.531 3.586 0 O-C-N 122.059 -0.401 . . . . 0.0 112.015 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.69 -37.62 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 122.688 0.395 . . . . 0.0 110.661 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 12.3 p -59.98 -27.54 66.93 Favored 'General case' 0 N--CA 1.535 3.8 0 CA-C-N 118.089 0.404 . . . . 0.0 111.078 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -59.99 -27.01 66.5 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 123.393 0.677 . . . . 0.0 111.134 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 48.7 m -63.96 -33.99 76.96 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.401 0.68 . . . . 0.0 110.889 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 N--CA 1.525 3.292 0 C-N-CA 124.483 1.113 . . . . 0.0 111.973 -179.538 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 N--CA 1.521 3.098 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.14 -27.01 68.43 Favored 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 124.246 1.018 . . . . 0.0 110.369 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 50.3 m -57.79 -26.19 61.58 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.1 0.56 . . . . 0.0 111.074 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.38 -34.58 63.61 Favored Glycine 1 N--CA 1.516 4.011 0 C-N-CA 124.362 0.982 . . . . 0.0 113.612 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 10.9 tp -59.32 -43.68 90.6 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 5.8 pt -66.73 -35.99 76.14 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.389 0 CA-C-O 121.906 0.86 . . . . 0.0 109.437 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 87.8 mt -72.68 -40.05 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.254 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.507 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.58 -48.76 84.46 Favored Glycine 1 N--CA 1.518 4.126 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.874 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.31 -36.55 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 123.036 0.535 . . . . 0.0 109.869 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 90.5 m -64.33 -47.5 79.17 Favored 'General case' 0 N--CA 1.523 3.202 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.69 -31.62 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.64 0 C-N-CA 122.76 0.424 . . . . 0.0 111.257 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.05 -47.18 68.63 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.223 0.609 . . . . 0.0 112.614 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.41 69.96 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.346 0.658 . . . . 0.0 112.548 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 45.3 t -68.09 -53.16 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.462 0 O-C-N 122.109 -0.37 . . . . 0.0 111.113 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.39 -32.14 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.361 0 C-N-CA 123.144 0.578 . . . . 0.0 112.411 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -39.03 55.97 Favored 'General case' 1 N--CA 1.541 4.085 0 C-N-CA 122.698 0.399 . . . . 0.0 111.467 -177.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 95.3 mt -69.1 -40.78 81.07 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 O-C-N 121.193 -0.942 . . . . 0.0 111.172 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.76 -36.51 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 O-C-N 121.476 -0.765 . . . . 0.0 109.894 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.21 -45.56 83.72 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.455 0.702 . . . . 0.0 112.621 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 16.8 m -71.86 -34.54 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 O-C-N 121.785 -0.572 . . . . 0.0 110.3 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.19 -44.2 92.74 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.67 -37.53 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 90.2 m -65.22 -29.76 70.59 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.063 0.545 . . . . 0.0 110.739 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -69.5 -39.49 77.55 Favored 'General case' 0 N--CA 1.529 3.499 0 C-N-CA 122.846 0.458 . . . . 0.0 109.927 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.8 t -64.06 -17.93 63.87 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 123.569 0.748 . . . . 0.0 111.386 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.57 -24.48 64.61 Favored 'General case' 0 N--CA 1.532 3.628 0 C-N-CA 124.096 0.958 . . . . 0.0 109.352 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -87.41 -26.56 23.24 Favored 'General case' 0 N--CA 1.539 3.982 0 C-N-CA 123.587 0.755 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -63.95 -69.79 0.26 Allowed 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.261 0.624 . . . . 0.0 110.74 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 61.5 pttt . . . . . 0 N--CA 1.526 3.371 0 C-N-CA 123.615 0.766 . . . . 0.0 110.81 -179.803 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.223 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.3 p -69.77 139.5 53.27 Favored 'General case' 0 N--CA 1.522 3.144 0 C-N-CA 123.647 0.779 . . . . 0.0 110.326 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.4 mp -65.35 -26.4 68.01 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 124.072 0.949 . . . . 0.0 109.536 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 38.8 t -67.72 -27.52 66.87 Favored 'General case' 0 N--CA 1.519 3.009 0 C-N-CA 123.4 0.68 . . . . 0.0 110.527 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.92 -47.16 56.59 Favored Glycine 0 N--CA 1.504 3.217 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -70.55 -41.69 78.02 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.223 0 CA-C-N 118.085 0.943 . . . . 0.0 113.499 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 tt -59.23 -31.03 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 C-N-CA 123.614 0.766 . . . . 0.0 111.734 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -33.4 50.23 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.352 0 O-C-N 121.8 -0.562 . . . . 0.0 109.664 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.02 -38.5 65.85 Favored Glycine 1 N--CA 1.518 4.137 0 N-CA-C 115.282 0.873 . . . . 0.0 115.282 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.49 -37.53 77.91 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.285 0 CA-C-N 118.355 1.078 . . . . 0.0 111.199 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.7 p -63.46 -46.02 88.15 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.48 -31.42 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.553 0 C-N-CA 123.424 0.69 . . . . 0.0 110.981 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.3 -47.02 72.87 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.22 -34.94 74.35 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.484 0.714 . . . . 0.0 112.376 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.61 -40.44 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.292 0 C-N-CA 123.482 0.713 . . . . 0.0 111.178 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.18 -45.19 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 C-N-CA 122.722 0.409 . . . . 0.0 110.985 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.55 -34.79 78.58 Favored 'General case' 0 N--CA 1.535 3.793 0 C-N-CA 122.418 0.287 . . . . 0.0 110.424 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 74.7 mt -64.35 -44.94 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.705 0 C-N-CA 122.581 0.352 . . . . 0.0 110.531 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.11 -41.05 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.684 0 O-C-N 121.829 -0.544 . . . . 0.0 109.842 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.38 94.58 Favored 'General case' 0 N--CA 1.524 3.252 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.0 m -71.51 -34.05 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 O-C-N 121.603 -0.686 . . . . 0.0 110.194 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -61.13 -44.11 97.84 Favored 'General case' 0 N--CA 1.526 3.341 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 10.1 m -68.84 -41.39 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.83 0 CA-C-N 118.596 0.635 . . . . 0.0 109.576 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 74.5 m -60.52 -27.75 67.86 Favored 'General case' 0 N--CA 1.523 3.215 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.326 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -66.65 -35.06 79.27 Favored 'General case' 0 N--CA 1.523 3.186 0 C-N-CA 122.675 0.39 . . . . 0.0 110.362 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 31.8 t -64.28 -38.48 91.19 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.424 0.69 . . . . 0.0 111.234 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.75 -13.99 18.47 Favored 'General case' 0 N--CA 1.536 3.852 0 C-N-CA 123.265 0.626 . . . . 0.0 110.998 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.06 -17.95 31.71 Favored 'General case' 0 N--CA 1.534 3.735 0 C-N-CA 123.02 0.528 . . . . 0.0 110.281 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -88.9 3.09 52.55 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 124.146 0.978 . . . . 0.0 111.13 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -64.28 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 123.107 0.563 . . . . 0.0 110.171 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -71.2 148.36 47.37 Favored 'General case' 0 N--CA 1.522 3.142 0 C-N-CA 123.698 0.799 . . . . 0.0 110.03 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.531 3.599 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.396 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.521 3.09 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.21 -26.22 68.03 Favored 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 124.703 1.201 . . . . 0.0 110.517 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 43.7 t -57.05 -24.99 57.84 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.539 0.736 . . . . 0.0 111.092 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.91 -47.01 82.29 Favored Glycine 1 N--CA 1.518 4.136 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.455 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 29.3 pt -71.6 -35.7 57.08 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.163 0 CA-C-N 118.204 1.002 . . . . 0.0 111.095 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 45.3 mm -57.23 -44.44 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.84 0 C-N-CA 124.474 1.11 . . . . 0.0 111.972 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.1 tp -72.41 -33.09 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.82 -44.68 97.73 Favored Glycine 1 N--CA 1.517 4.071 0 C-N-CA 123.919 0.771 . . . . 0.0 114.158 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.7 -37.21 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.726 0 CA-C-N 117.727 0.763 . . . . 0.0 110.905 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 67.4 p -65.44 -46.14 81.08 Favored 'General case' 0 N--CA 1.534 3.729 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.56 -31.03 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 C-N-CA 122.621 0.368 . . . . 0.0 111.262 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.22 -42.69 63.76 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.8 88.53 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.092 0.557 . . . . 0.0 111.249 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 24.3 t -64.66 -40.27 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 123.779 0.832 . . . . 0.0 111.234 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.57 -32.45 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 C-N-CA 123.247 0.619 . . . . 0.0 110.943 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 tp -76.54 -42.96 41.2 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.5 -44.05 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 C-N-CA 122.976 0.511 . . . . 0.0 111.841 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.27 -37.04 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.892 0 CA-C-N 118.575 0.625 . . . . 0.0 110.365 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.33 79.46 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.098 0.559 . . . . 0.0 111.812 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 90.3 t -71.66 -35.01 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 122.748 0.419 . . . . 0.0 109.995 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.29 -44.54 96.29 Favored 'General case' 0 N--CA 1.532 3.655 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.04 -38.25 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 73.4 m -67.2 -30.46 70.41 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 122.987 0.515 . . . . 0.0 110.711 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -67.34 -25.3 65.93 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.453 0.701 . . . . 0.0 111.097 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -63.91 -40.28 96.13 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.206 0.602 . . . . 0.0 111.292 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.95 -23.1 65.05 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.636 0.774 . . . . 0.0 110.734 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 N--CA 1.537 3.912 0 C-N-CA 124.129 0.971 . . . . 0.0 109.524 -179.564 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 N--CA 1.52 3.075 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.46 -40.98 96.73 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 123.636 0.774 . . . . 0.0 110.626 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 40.4 t -69.6 -26.59 64.52 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 123.144 0.577 . . . . 0.0 110.719 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.58 -46.03 64.11 Favored Glycine 1 N--CA 1.517 4.061 0 N-CA-C 116.508 1.363 . . . . 0.0 116.508 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -35.01 60.59 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 CA-C-N 119.806 1.803 . . . . 0.0 112.274 -176.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 2.7 pt -58.92 -45.0 92.1 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.491 0 CA-C-N 118.694 0.679 . . . . 0.0 111.812 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.0 pt -68.99 -32.99 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 C-N-CA 122.986 0.514 . . . . 0.0 109.75 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.7 -29.94 68.1 Favored Glycine 0 N--CA 1.513 3.783 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.425 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 2.7 m -60.38 -37.65 75.06 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.006 0 CA-C-N 117.847 0.823 . . . . 0.0 111.142 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 56.2 p -63.14 -46.67 86.15 Favored 'General case' 0 N--CA 1.526 3.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.444 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 47.2 t -70.1 -33.57 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.086 0 C-N-CA 124.158 0.983 . . . . 0.0 110.5 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.91 90.04 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.538 0.735 . . . . 0.0 112.523 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.97 -48.55 70.9 Favored 'General case' 0 N--CA 1.516 2.841 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.4 m -67.9 -39.96 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.55 -34.16 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 CA-C-N 119.354 0.979 . . . . 0.0 111.759 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 45.1 tp -67.83 -47.59 68.57 Favored 'General case' 0 N--CA 1.528 3.425 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 27.7 pt -68.95 -36.3 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-N 118.231 0.469 . . . . 0.0 111.002 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.48 -37.42 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.962 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.25 72.47 Favored 'General case' 0 N--CA 1.533 3.683 0 C-N-CA 122.931 0.492 . . . . 0.0 112.086 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.77 -37.05 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.066 0.546 . . . . 0.0 110.304 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -63.31 -44.08 96.01 Favored 'General case' 0 N--CA 1.532 3.64 0 C-N-CA 123.135 0.574 . . . . 0.0 112.443 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.62 -37.46 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.63 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 98.0 m -62.2 -29.72 70.58 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 122.879 0.472 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -69.58 -27.67 65.32 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.214 0.606 . . . . 0.0 111.07 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 30.3 t -64.07 -32.72 74.38 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 123.204 0.602 . . . . 0.0 112.094 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.39 -21.48 66.31 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.648 0.779 . . . . 0.0 110.885 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 7.9 mp -87.51 -28.28 22.12 Favored 'General case' 0 N--CA 1.532 3.672 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -83.39 86.82 7.01 Favored 'General case' 0 N--CA 1.52 3.048 0 C-N-CA 123.978 0.911 . . . . 0.0 108.734 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.19 -17.88 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.294 0 C-N-CA 123.675 0.79 . . . . 0.0 110.204 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 59.0 -171.41 0.12 Allowed 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.932 0.893 . . . . 0.0 110.673 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.532 3.642 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.522 3.14 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.07 -32.71 74.56 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 123.88 0.872 . . . . 0.0 109.243 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 52.2 m -68.46 -25.48 65.01 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 123.682 0.793 . . . . 0.0 109.155 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.74 -46.88 89.01 Favored Glycine 0 N--CA 1.508 3.487 0 C-N-CA 123.848 0.737 . . . . 0.0 114.512 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 tt -70.84 -35.55 60.58 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.412 0 CA-C-N 118.688 1.244 . . . . 0.0 111.324 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 49.9 mm -56.28 -32.46 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 124.807 1.243 . . . . 0.0 112.124 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 1.7 pp -68.32 -33.96 63.39 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.091 0 CA-C-N 119.493 1.042 . . . . 0.0 109.569 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.09 -34.46 89.81 Favored Glycine 1 N--CA 1.521 4.32 0 C-N-CA 123.483 0.564 . . . . 0.0 111.799 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.07 -39.83 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 124.213 1.005 . . . . 0.0 110.031 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 30.1 p -61.01 -38.92 87.8 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 123.162 0.585 . . . . 0.0 110.938 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 41.2 t -67.12 -41.46 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.081 0 C-N-CA 123.79 0.836 . . . . 0.0 110.36 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.88 -47.18 85.86 Favored 'General case' 0 N--CA 1.523 3.187 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.51 -47.95 68.5 Favored 'General case' 0 N--CA 1.513 2.701 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.57 -41.94 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.471 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.08 -33.4 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 O-C-N 122.228 -0.295 . . . . 0.0 111.282 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.22 -35.6 81.34 Favored 'General case' 0 N--CA 1.529 3.499 0 C-N-CA 122.736 0.414 . . . . 0.0 110.675 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.43 -36.86 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.702 0 C-N-CA 123.191 0.597 . . . . 0.0 110.119 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.66 -43.31 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 C-N-CA 122.973 0.509 . . . . 0.0 110.093 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.14 87.72 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 20.9 m -71.58 -33.89 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 O-C-N 121.806 -0.559 . . . . 0.0 110.071 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.41 -43.49 97.36 Favored 'General case' 0 N--CA 1.526 3.359 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 10.0 m -68.38 -40.16 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 CA-C-N 118.684 0.675 . . . . 0.0 110.884 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 14.5 p -66.35 -28.5 68.7 Favored 'General case' 0 N--CA 1.533 3.711 0 O-C-N 122.197 -0.315 . . . . 0.0 110.38 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -73.77 -32.55 63.85 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 123.446 0.698 . . . . 0.0 109.845 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 47.8 m -64.18 -31.17 72.26 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.182 0.593 . . . . 0.0 110.751 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 60.0 mt -60.79 -23.66 65.2 Favored 'General case' 0 N--CA 1.531 3.594 0 C-N-CA 122.586 0.354 . . . . 0.0 111.206 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.68 -7.36 52.83 Favored 'General case' 1 N--CA 1.539 4.017 0 C-N-CA 123.946 0.898 . . . . 0.0 110.33 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -69.19 3.51 2.13 Favored 'General case' 0 N--CA 1.534 3.764 0 C-N-CA 123.013 0.525 . . . . 0.0 111.31 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -53.2 149.32 7.19 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 123.937 0.895 . . . . 0.0 111.332 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.52 3.034 0 C-N-CA 123.935 0.894 . . . . 0.0 110.79 -178.846 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 99.6 p . . . . . 0 N--CA 1.525 3.295 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 41.9 mt -64.28 -34.3 77.8 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.695 0.798 . . . . 0.0 110.056 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 61.2 m -68.69 -26.57 65.36 Favored 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 123.575 0.75 . . . . 0.0 110.104 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.84 -46.18 61.35 Favored Glycine 0 N--CA 1.514 3.887 0 C-N-CA 124.071 0.844 . . . . 0.0 114.705 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 45.9 pt -70.76 -35.77 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -175.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . 0.411 HD13 ' H ' ' E' ' 216' ' ' ILE 0.253 0.1 OUTLIER -57.77 -41.3 79.31 Favored 'Isoleucine or valine' 1 N--CA 1.558 4.95 0 CA-C-N 119.984 1.265 . . . . 0.0 112.945 -175.033 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . 0.411 ' H ' HD13 ' E' ' 215' ' ' ILE . 17.0 tt -72.38 -32.16 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 C-N-CA 124.297 1.039 . . . . 0.0 108.863 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.01 -29.37 43.39 Favored Glycine 0 N--CA 1.512 3.704 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.395 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.16 -37.8 79.39 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 CA-C-N 118.089 0.944 . . . . 0.0 110.7 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 36.1 p -65.98 -40.51 91.29 Favored 'General case' 0 N--CA 1.529 3.477 0 C-N-CA 123.344 0.657 . . . . 0.0 110.366 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.59 -32.08 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.06 0 C-N-CA 124.046 0.939 . . . . 0.0 110.49 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.54 91.48 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-O 121.062 0.458 . . . . 0.0 110.761 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.28 -47.97 80.09 Favored 'General case' 0 N--CA 1.519 3.017 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.91 -38.57 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.48 -32.8 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 40.6 tp -78.18 -42.64 30.94 Favored 'General case' 0 N--CA 1.535 3.79 0 CA-C-N 118.755 0.707 . . . . 0.0 112.311 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.12 -35.56 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.476 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 28.6 m -65.51 -35.21 74.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.354 0 CA-C-N 119.241 0.928 . . . . 0.0 109.978 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.07 -31.24 63.02 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.467 0.707 . . . . 0.0 112.144 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 3.2 m -56.96 -34.17 43.91 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 O-C-N 121.635 -0.666 . . . . 0.0 110.848 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.96 -44.65 96.3 Favored 'General case' 0 N--CA 1.53 3.527 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.59 -37.3 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.974 0 CA-C-N 119.067 0.849 . . . . 0.0 108.875 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 63.4 m -58.54 -27.56 64.66 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 122.854 0.461 . . . . 0.0 110.901 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -60.78 -18.12 53.2 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 122.916 0.487 . . . . 0.0 110.695 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 33.5 t -66.2 -25.53 66.97 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.616 0.766 . . . . 0.0 111.244 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 N--CA 1.532 3.641 0 C-N-CA 123.848 0.859 . . . . 0.0 111.4 -179.382 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 N--CA 1.524 3.262 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.54 -26.52 68.45 Favored 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.451 1.101 . . . . 0.0 110.871 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 55.1 m -65.46 -26.25 67.86 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.246 0.619 . . . . 0.0 111.002 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.15 -46.57 64.35 Favored Glycine 0 N--CA 1.516 3.974 0 C-N-CA 123.406 0.527 . . . . 0.0 114.233 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -70.85 -35.55 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 11.6 pt -56.64 -45.11 82.43 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.587 0 CA-C-N 119.529 1.059 . . . . 0.0 112.607 -175.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.99 -33.76 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 C-N-CA 123.358 0.663 . . . . 0.0 109.823 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.91 -30.08 76.69 Favored Glycine 0 N--CA 1.509 3.525 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.684 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.04 -37.65 73.55 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 CA-C-N 118.106 0.953 . . . . 0.0 111.589 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 29.2 p -65.82 -47.31 75.46 Favored 'General case' 0 N--CA 1.529 3.518 0 CA-C-O 121.319 0.58 . . . . 0.0 110.518 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.66 -42.38 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 C-N-CA 124.264 1.026 . . . . 0.0 111.176 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.04 -43.0 73.38 Favored 'General case' 0 N--CA 1.528 3.468 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.13 -50.49 68.01 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 p -68.39 -38.66 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 CA-C-N 118.499 0.59 . . . . 0.0 111.883 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.34 -33.69 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.456 0.571 . . . . 0.0 110.79 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 25.0 tp -69.71 -34.47 73.94 Favored 'General case' 0 N--CA 1.531 3.618 0 CA-C-N 118.689 0.677 . . . . 0.0 111.016 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 79.2 mt -65.72 -41.46 90.44 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.134 0 O-C-N 121.728 -0.608 . . . . 0.0 109.436 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.11 -37.41 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 C-N-CA 123.54 0.736 . . . . 0.0 109.807 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.09 68.35 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.21 0.604 . . . . 0.0 111.863 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 69.6 t -71.68 -38.04 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 122.812 0.445 . . . . 0.0 110.391 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -62.12 -44.07 97.45 Favored 'General case' 0 N--CA 1.532 3.644 0 C-N-CA 123.186 0.594 . . . . 0.0 112.579 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.69 -37.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.685 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 93.3 m -64.77 -29.68 70.66 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 122.924 0.489 . . . . 0.0 110.463 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -74.32 -40.03 62.47 Favored 'General case' 0 N--CA 1.525 3.321 0 C-N-CA 123.059 0.543 . . . . 0.0 109.585 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.3 t -63.82 -18.91 64.6 Favored 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 123.946 0.899 . . . . 0.0 112.376 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 50.5 tp -70.56 -14.82 62.66 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.673 0.789 . . . . 0.0 110.95 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 mp -87.21 -0.91 57.44 Favored 'General case' 0 N--CA 1.534 3.754 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.619 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -163.23 82.48 0.48 Allowed 'General case' 0 N--CA 1.538 3.949 0 CA-C-N 119.042 0.837 . . . . 0.0 112.3 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt . . . . . 0 N--CA 1.538 3.927 0 C-N-CA 125.038 1.335 . . . . 0.0 108.595 177.843 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.981 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.9 p -168.49 -53.17 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.88 -26.38 68.3 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 123.726 0.81 . . . . 0.0 109.099 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 37.4 t -57.79 -41.32 81.85 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 123.815 0.846 . . . . 0.0 112.248 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -35.48 79.71 Favored Glycine 1 N--CA 1.521 4.348 0 C-N-CA 123.883 0.754 . . . . 0.0 112.978 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.25 -46.29 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 C-N-CA 123.97 0.908 . . . . 0.0 112.845 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.11 -32.18 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 121.986 -0.446 . . . . 0.0 110.786 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.8 -33.75 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 C-N-CA 123.437 0.695 . . . . 0.0 110.185 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.32 84.8 Favored Glycine 1 N--CA 1.521 4.301 0 CA-C-O 119.941 -0.366 . . . . 0.0 113.851 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.7 m -60.0 -36.75 69.1 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.343 0 CA-C-N 117.762 0.781 . . . . 0.0 110.784 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -55.47 -45.28 76.97 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.502 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 42.6 t -65.73 -37.96 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 C-N-CA 124.151 0.98 . . . . 0.0 111.46 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.95 -42.44 65.48 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.34 83.4 Favored 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 123.126 0.57 . . . . 0.0 111.184 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.4 t -64.29 -42.93 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.442 0.697 . . . . 0.0 110.934 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.2 -40.93 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 C-N-CA 123.144 0.578 . . . . 0.0 110.291 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.39 -38.5 91.39 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.928 0.491 . . . . 0.0 110.466 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.4 mt -56.97 -36.41 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.772 0 C-N-CA 123.441 0.696 . . . . 0.0 110.692 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 50.4 t -61.91 -37.94 79.44 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 C-N-CA 122.737 0.415 . . . . 0.0 110.469 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -31.85 68.71 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.563 0.745 . . . . 0.0 111.754 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.63 -34.73 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 C-N-CA 122.948 0.499 . . . . 0.0 111.393 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -67.59 -44.1 78.94 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.8 -37.43 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.954 0 CA-C-N 118.713 0.688 . . . . 0.0 109.903 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 76.4 m -66.12 -33.1 75.02 Favored 'General case' 0 N--CA 1.522 3.154 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.085 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -70.01 -41.24 74.6 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 123.276 0.631 . . . . 0.0 110.219 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 95.9 p -66.34 -30.21 70.57 Favored 'General case' 0 N--CA 1.53 3.539 0 C-N-CA 123.284 0.633 . . . . 0.0 109.766 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -14.32 45.25 Favored 'General case' 0 N--CA 1.531 3.618 0 C-N-CA 124.543 1.137 . . . . 0.0 110.255 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 32.5 mt -86.66 5.05 37.9 Favored 'General case' 0 N--CA 1.537 3.877 0 C-N-CA 123.241 0.617 . . . . 0.0 110.826 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -168.33 122.31 0.9 Allowed 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.558 0.743 . . . . 0.0 109.085 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -139.24 -0.64 1.8 Allowed 'General case' 0 N--CA 1.531 3.613 0 C-N-CA 124.81 1.244 . . . . 0.0 109.546 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -167.02 155.29 9.74 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.531 3.595 0 C-N-CA 124.886 1.275 . . . . 0.0 108.963 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 98.7 p . . . . . 0 N--CA 1.521 3.125 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.7 -26.81 68.27 Favored 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 124.31 1.044 . . . . 0.0 111.038 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 68.5 m -60.39 -26.53 66.73 Favored 'General case' 0 N--CA 1.528 3.463 0 C-N-CA 123.427 0.691 . . . . 0.0 110.647 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.09 -34.96 81.83 Favored Glycine 0 N--CA 1.512 3.767 0 C-N-CA 124.944 1.259 . . . . 0.0 115.015 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 14.4 tt -59.75 -35.76 61.93 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -175.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 1.9 pp -56.81 -47.76 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.0 tt -73.26 -33.5 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.32 -46.55 93.67 Favored Glycine 0 N--CA 1.513 3.782 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.979 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.59 -37.39 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 CA-C-N 117.615 0.707 . . . . 0.0 110.847 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 28.3 p -66.11 -46.1 78.77 Favored 'General case' 0 N--CA 1.526 3.371 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -69.93 -31.68 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.94 68.96 Favored 'General case' 0 N--CA 1.528 3.46 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.0 -49.97 58.36 Favored 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 22.0 m -66.95 -38.26 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 CA-C-N 118.534 0.606 . . . . 0.0 111.902 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.07 -32.74 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 122.504 0.322 . . . . 0.0 110.136 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.28 -41.43 94.18 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 122.602 0.361 . . . . 0.0 110.589 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 73.7 mt -56.85 -36.41 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 C-N-CA 122.889 0.476 . . . . 0.0 110.579 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.95 -37.28 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 C-N-CA 122.985 0.514 . . . . 0.0 110.517 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -31.88 66.96 Favored 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.53 0.732 . . . . 0.0 112.224 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.9 -34.92 73.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 O-C-N 121.587 -0.696 . . . . 0.0 110.469 -178.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -64.24 -44.58 91.41 Favored 'General case' 0 N--CA 1.527 3.409 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 16.0 m -69.07 -37.6 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-O 121.29 0.567 . . . . 0.0 109.742 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -66.46 -30.42 70.76 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -74.32 -40.12 62.43 Favored 'General case' 0 N--CA 1.525 3.285 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 70.9 m -65.07 -35.55 81.51 Favored 'General case' 0 N--CA 1.523 3.196 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.204 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.21 -14.23 24.09 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 124.082 0.953 . . . . 0.0 111.194 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 N--CA 1.522 3.168 0 C-N-CA 123.263 0.625 . . . . 0.0 109.412 179.534 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.521 3.085 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 tp -64.98 -35.74 82.17 Favored 'General case' 0 N--CA 1.527 3.424 0 C-N-CA 123.881 0.872 . . . . 0.0 109.971 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.0 m -67.2 -30.39 70.31 Favored 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 123.778 0.831 . . . . 0.0 110.446 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -47.0 57.97 Favored Glycine 0 N--CA 1.513 3.829 0 CA-C-N 115.526 -0.761 . . . . 0.0 114.334 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 34.6 pt -71.35 -39.7 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -176.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.2 tt -62.79 -39.77 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.62 -33.08 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.9 -29.12 50.13 Favored Glycine 0 N--CA 1.515 3.96 0 C-N-CA 123.609 0.623 . . . . 0.0 113.363 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.3 m -59.53 -46.28 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 5.3 t -66.11 -38.79 89.06 Favored 'General case' 0 N--CA 1.536 3.832 0 CA-C-O 121.045 0.45 . . . . 0.0 111.067 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.1 -39.61 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.183 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.66 72.68 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 123.461 0.704 . . . . 0.0 111.05 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.82 87.67 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 123.499 0.719 . . . . 0.0 111.224 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.33 -48.42 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 C-N-CA 123.269 0.627 . . . . 0.0 110.089 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.73 -36.77 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.561 0 C-N-CA 123.766 0.826 . . . . 0.0 110.9 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 22.4 mt -65.04 -34.35 78.21 Favored 'General case' 0 N--CA 1.534 3.727 0 C-N-CA 122.898 0.479 . . . . 0.0 110.591 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.98 -39.64 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.74 -37.87 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.514 0 C-N-CA 123.262 0.625 . . . . 0.0 109.601 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.28 83.29 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.748 0.819 . . . . 0.0 112.623 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.83 -34.35 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.594 0 O-C-N 121.897 -0.502 . . . . 0.0 110.215 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -63.8 -43.92 94.86 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 123.141 0.577 . . . . 0.0 112.517 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.39 -37.25 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 77.4 m -60.03 -28.42 67.73 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 122.658 0.383 . . . . 0.0 111.367 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -74.09 -28.65 61.48 Favored 'General case' 0 N--CA 1.531 3.602 0 C-N-CA 122.653 0.381 . . . . 0.0 110.817 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 57.9 m -67.41 -17.69 64.82 Favored 'General case' 0 N--CA 1.53 3.569 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.78 -38.54 67.25 Favored 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 124.126 0.97 . . . . 0.0 110.459 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 pp -87.93 -4.14 58.85 Favored 'General case' 1 N--CA 1.553 4.687 0 CA-C-N 118.767 0.712 . . . . 0.0 111.923 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -69.68 -11.84 61.16 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.518 0.727 . . . . 0.0 110.717 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -64.91 -26.09 68.17 Favored 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 124.009 0.924 . . . . 0.0 111.39 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -74.83 72.03 2.03 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.59 0.756 . . . . 0.0 109.852 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.533 3.718 0 C-N-CA 124.591 1.157 . . . . 0.0 108.178 179.351 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.518 2.956 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.04 -35.07 79.99 Favored 'General case' 0 N--CA 1.527 3.4 0 C-N-CA 124.533 1.133 . . . . 0.0 109.741 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 70.7 m -57.14 -26.04 59.88 Favored 'General case' 0 N--CA 1.525 3.318 0 C-N-CA 123.725 0.81 . . . . 0.0 110.523 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.46 -34.45 59.82 Favored Glycine 0 N--CA 1.509 3.504 0 C-N-CA 124.929 1.252 . . . . 0.0 114.979 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 16.2 pt -59.15 -34.67 54.2 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.12 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -175.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 8.9 pt -56.15 -45.57 80.84 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.265 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 5.8 tp -72.37 -33.87 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.26 -48.27 84.48 Favored Glycine 1 N--CA 1.517 4.039 0 C-N-CA 123.89 0.757 . . . . 0.0 113.706 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.29 -37.32 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.771 0 O-C-N 121.763 -0.845 . . . . 0.0 109.628 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 25.3 m -66.26 -45.75 79.47 Favored 'General case' 0 N--CA 1.519 2.978 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 12.8 p -63.59 -31.12 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 CA-C-N 118.203 0.456 . . . . 0.0 110.436 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.1 -47.2 81.64 Favored 'General case' 0 N--CA 1.528 3.453 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.94 73.93 Favored 'General case' 0 N--CA 1.523 3.194 0 C-N-CA 123.556 0.742 . . . . 0.0 112.036 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.83 -38.61 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 C-N-CA 123.366 0.666 . . . . 0.0 110.602 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.32 -44.79 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 C-N-CA 123.154 0.582 . . . . 0.0 110.135 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.73 -34.54 73.07 Favored 'General case' 1 N--CA 1.54 4.028 0 C-N-CA 123.12 0.568 . . . . 0.0 110.752 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.85 -40.1 87.5 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.22 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.65 -41.94 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 122.989 0.516 . . . . 0.0 109.814 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -41.06 82.09 Favored 'General case' 0 N--CA 1.527 3.406 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 19.0 m -71.17 -33.74 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 O-C-N 121.709 -0.619 . . . . 0.0 110.062 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -66.26 -43.92 85.14 Favored 'General case' 0 N--CA 1.528 3.463 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.76 -37.89 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 CA-C-N 118.327 0.512 . . . . 0.0 111.082 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 10.1 p -58.68 -27.51 64.88 Favored 'General case' 0 N--CA 1.531 3.616 0 C-N-CA 122.367 0.267 . . . . 0.0 111.499 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -61.27 -31.16 70.98 Favored 'General case' 0 N--CA 1.521 3.113 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.05 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 71.2 p -66.0 -38.06 87.52 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.459 0.704 . . . . 0.0 110.607 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 61.0 mt -60.77 -13.34 14.55 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 123.638 0.775 . . . . 0.0 111.901 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 26.8 mt -86.04 -7.65 58.48 Favored 'General case' 0 N--CA 1.534 3.727 0 C-N-CA 123.054 0.542 . . . . 0.0 110.366 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -70.67 -106.65 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.235 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 53.18 23.08 2.9 Favored 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 123.845 0.858 . . . . 0.0 111.94 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 24.7 tptm . . . . . 0 N--CA 1.526 3.341 0 C-N-CA 124.731 1.213 . . . . 0.0 110.537 -179.303 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.521 3.081 0 CA-C-O 120.579 0.228 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.24 -26.25 68.03 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 124.495 1.118 . . . . 0.0 109.945 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.4 p -57.32 -25.96 60.17 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.404 0.682 . . . . 0.0 110.975 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.11 -35.24 68.83 Favored Glycine 0 N--CA 1.516 3.998 0 C-N-CA 123.837 0.732 . . . . 0.0 113.755 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 7.6 pt -60.28 -44.04 94.81 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.203 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . 0.514 ' O ' HG12 ' E' ' 218' ' ' VAL . 6.1 pt -67.68 -32.47 56.93 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.284 0 C-N-CA 122.934 0.493 . . . . 0.0 110.26 -178.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 47.7 mm -72.08 -32.7 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.601 0 C-N-CA 124.674 1.189 . . . . 0.0 108.79 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.93 -29.13 64.47 Favored Glycine 1 N--CA 1.518 4.13 0 C-N-CA 123.529 0.585 . . . . 0.0 113.26 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . 0.514 HG12 ' O ' ' E' ' 215' ' ' ILE . 9.8 p -59.71 -47.55 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 9.0 t -66.36 -38.96 88.79 Favored 'General case' 0 N--CA 1.537 3.899 0 O-C-N 121.827 -0.546 . . . . 0.0 111.196 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.17 -31.82 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 C-N-CA 123.511 0.724 . . . . 0.0 110.431 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.89 76.88 Favored 'General case' 0 N--CA 1.529 3.504 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.68 74.74 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 122.86 0.464 . . . . 0.0 111.459 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.7 -45.52 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 123.291 0.636 . . . . 0.0 112.296 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.24 -32.55 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 C-N-CA 122.352 0.261 . . . . 0.0 111.652 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.5 -34.85 78.83 Favored 'General case' 1 N--CA 1.541 4.117 0 O-C-N 122.098 -0.376 . . . . 0.0 110.255 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.39 -37.94 80.86 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.08 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.06 -37.86 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.5 0 C-N-CA 123.248 0.619 . . . . 0.0 109.975 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.24 96.6 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 17.2 m -71.66 -33.96 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.741 0 O-C-N 121.613 -0.679 . . . . 0.0 109.703 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -63.47 -43.75 96.4 Favored 'General case' 0 N--CA 1.529 3.483 0 C-N-CA 123.062 0.545 . . . . 0.0 112.309 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.41 -37.41 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.351 0.523 . . . . 0.0 109.631 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 79.1 m -60.21 -27.93 67.57 Favored 'General case' 0 N--CA 1.525 3.283 0 C-N-CA 123.143 0.577 . . . . 0.0 111.018 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.71 -35.02 79.55 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 122.796 0.438 . . . . 0.0 110.243 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 68.0 m -73.72 -36.27 65.19 Favored 'General case' 0 N--CA 1.523 3.185 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.529 3.501 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.827 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 64.8 m . . . . . 0 N--CA 1.52 3.034 0 CA-C-O 120.662 0.268 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.17 -26.38 68.14 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.915 0.886 . . . . 0.0 110.245 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 57.0 m -61.65 -26.78 68.22 Favored 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 123.653 0.781 . . . . 0.0 111.062 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.9 -47.5 54.49 Favored Glycine 1 N--CA 1.518 4.128 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.902 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 45.3 pt -72.33 -40.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -44.92 95.35 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.276 0 C-N-CA 123.194 0.597 . . . . 0.0 111.876 -175.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 6.4 tp -63.21 -32.62 57.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 C-N-CA 123.278 0.631 . . . . 0.0 109.382 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.31 -29.99 63.9 Favored Glycine 0 N--CA 1.513 3.802 0 CA-C-O 119.346 -0.697 . . . . 0.0 113.855 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.0 m -62.2 -47.21 94.16 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 CA-C-N 118.528 1.164 . . . . 0.0 112.045 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -38.82 89.24 Favored 'General case' 0 N--CA 1.536 3.872 0 C-N-CA 122.202 0.201 . . . . 0.0 110.766 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.78 -39.94 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.55 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.6 83.01 Favored 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 123.198 0.599 . . . . 0.0 111.136 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.66 85.64 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.173 0.589 . . . . 0.0 112.175 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.85 -41.15 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 122.909 0.483 . . . . 0.0 110.962 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.05 -41.89 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 C-N-CA 123.143 0.577 . . . . 0.0 110.852 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.7 -37.33 86.07 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 122.606 0.362 . . . . 0.0 111.667 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.76 -44.01 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.3 -40.3 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.73 -45.11 93.16 Favored 'General case' 0 N--CA 1.525 3.31 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.53 -34.05 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.703 0 O-C-N 121.633 -0.667 . . . . 0.0 109.788 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -63.06 -44.32 96.15 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 21.3 m -69.05 -37.88 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 CA-C-O 121.159 0.505 . . . . 0.0 109.841 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 76.3 m -65.54 -33.82 76.81 Favored 'General case' 0 N--CA 1.521 3.08 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.083 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -74.15 -39.75 63.06 Favored 'General case' 0 N--CA 1.537 3.898 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 58.6 m -63.75 -30.11 71.24 Favored 'General case' 0 N--CA 1.52 3.054 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.063 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.77 -21.62 66.51 Favored 'General case' 0 N--CA 1.526 3.364 0 C-N-CA 123.013 0.525 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -98.49 -15.81 19.44 Favored 'General case' 1 N--CA 1.548 4.459 0 C-N-CA 124.017 0.927 . . . . 0.0 110.472 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -68.12 3.53 1.59 Allowed 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.356 0.662 . . . . 0.0 111.624 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt . . . . . 0 N--CA 1.528 3.435 0 C-N-CA 122.847 0.459 . . . . 0.0 110.941 -179.534 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.217 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.0 m -74.63 40.39 0.14 Allowed 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 123.911 0.884 . . . . 0.0 110.571 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.0 -37.48 87.8 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 124.474 1.11 . . . . 0.0 109.978 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 45.2 t -68.61 -26.5 65.39 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.333 0.653 . . . . 0.0 110.702 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.66 -46.59 60.85 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 117.579 1.792 . . . . 0.0 117.579 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.8 -35.66 61.25 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.694 0 CA-C-N 119.612 1.706 . . . . 0.0 113.57 -175.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.54 -38.11 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.543 0 C-N-CA 123.55 0.74 . . . . 0.0 111.997 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 15.2 tt -71.41 -32.86 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.78 -28.87 48.41 Favored Glycine 1 N--CA 1.516 4.003 0 C-N-CA 124.057 0.837 . . . . 0.0 113.243 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.8 m -68.0 -37.27 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 CA-C-N 117.721 0.76 . . . . 0.0 110.407 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.8 p -60.56 -46.08 91.53 Favored 'General case' 0 N--CA 1.527 3.42 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.723 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.24 -31.85 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 C-N-CA 122.73 0.412 . . . . 0.0 110.493 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.44 -34.12 77.05 Favored 'General case' 0 N--CA 1.525 3.297 0 C-N-CA 123.091 0.556 . . . . 0.0 111.456 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.84 -50.24 44.67 Favored 'General case' 0 N--CA 1.519 2.995 0 C-N-CA 122.96 0.504 . . . . 0.0 111.914 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.96 -44.28 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 C-N-CA 123.365 0.666 . . . . 0.0 112.562 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.53 -32.66 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.603 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.24 -42.14 76.03 Favored 'General case' 0 N--CA 1.533 3.689 0 CA-C-N 118.613 0.642 . . . . 0.0 110.34 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.3 mt -54.8 -35.95 35.32 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 O-C-N 122.055 -0.403 . . . . 0.0 110.455 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.46 -37.17 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 O-C-N 121.763 -0.586 . . . . 0.0 110.374 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.87 -33.0 68.24 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.49 -34.54 53.42 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.188 0 CA-C-N 119.145 0.884 . . . . 0.0 110.611 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.96 -44.16 97.34 Favored 'General case' 0 N--CA 1.53 3.551 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.0 -37.6 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.693 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 71.6 m -64.27 -27.85 69.32 Favored 'General case' 0 N--CA 1.527 3.4 0 C-N-CA 123.151 0.58 . . . . 0.0 111.149 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -62.74 -22.88 66.87 Favored 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 122.992 0.517 . . . . 0.0 110.903 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 45.5 t -66.67 -46.2 76.43 Favored 'General case' 0 N--CA 1.525 3.29 0 CA-C-O 121.582 0.706 . . . . 0.0 110.565 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.98 -12.93 13.01 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 125.375 1.47 . . . . 0.0 112.471 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 54.9 tp -85.93 -28.36 24.36 Favored 'General case' 1 N--CA 1.547 4.403 0 C-N-CA 123.25 0.62 . . . . 0.0 111.303 -175.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 -121.26 63.17 0.89 Allowed 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -138.09 21.04 2.81 Favored 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.245 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -158.75 -11.34 0.07 Allowed 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.974 0.909 . . . . 0.0 109.685 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 N--CA 1.53 3.557 0 C-N-CA 125.279 1.432 . . . . 0.0 107.297 179.152 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 97.7 p . . . . . 0 N--CA 1.524 3.249 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.88 -26.77 68.46 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.976 0.911 . . . . 0.0 109.581 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 90.5 p -68.55 -26.19 65.29 Favored 'General case' 0 N--CA 1.522 3.143 0 C-N-CA 123.44 0.696 . . . . 0.0 110.43 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.36 -44.05 76.02 Favored Glycine 0 N--CA 1.516 3.975 0 C-N-CA 123.737 0.684 . . . . 0.0 114.08 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.87 -36.0 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.791 0 O-C-N 121.67 -0.9 . . . . 0.0 112.14 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 13.9 pt -67.55 -37.17 78.31 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.398 0 CA-C-N 119.001 0.818 . . . . 0.0 111.84 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 46.3 pt -72.26 -33.07 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.11 -45.31 82.51 Favored Glycine 0 N--CA 1.513 3.775 0 C-N-CA 124.419 1.009 . . . . 0.0 114.992 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.58 -37.2 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.734 0 CA-C-N 117.76 0.78 . . . . 0.0 111.163 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.0 p -65.28 -46.11 81.74 Favored 'General case' 0 N--CA 1.533 3.679 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.81 -30.63 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.485 0 C-N-CA 123.158 0.583 . . . . 0.0 111.174 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.81 -35.44 63.9 Favored 'General case' 0 N--CA 1.525 3.3 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -50.32 39.63 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 24.9 m -66.11 -38.24 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.8 -31.98 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.462 0.573 . . . . 0.0 111.859 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.59 -34.74 72.5 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 118.236 0.471 . . . . 0.0 110.746 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.1 -49.37 84.34 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.067 0 CA-C-N 118.065 0.393 . . . . 0.0 111.668 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.6 -37.28 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 O-C-N 121.721 -0.612 . . . . 0.0 109.957 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.48 79.97 Favored 'General case' 0 N--CA 1.524 3.26 0 C-N-CA 123.593 0.757 . . . . 0.0 112.811 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.63 -34.37 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 O-C-N 121.86 -0.525 . . . . 0.0 110.291 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -64.41 -44.21 91.97 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 122.964 0.506 . . . . 0.0 112.332 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.8 -37.91 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.826 0 CA-C-N 118.201 0.455 . . . . 0.0 109.781 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 75.2 m -65.64 -27.69 68.56 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 123.341 0.656 . . . . 0.0 111.211 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -63.82 -29.96 71.1 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 123.134 0.574 . . . . 0.0 110.725 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 54.8 m -64.16 -40.01 95.22 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.252 0.621 . . . . 0.0 110.517 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.88 -21.46 64.25 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.691 0.796 . . . . 0.0 110.251 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.5 tp . . . . . 0 N--CA 1.534 3.727 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.599 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 97.0 p . . . . . 0 N--CA 1.524 3.232 0 CA-C-O 121.375 0.607 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -54.36 -26.56 30.74 Favored 'General case' 0 N--CA 1.532 3.646 0 C-N-CA 123.785 0.834 . . . . 0.0 112.224 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 98.3 p -63.6 -36.45 83.86 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.825 0.85 . . . . 0.0 110.312 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.0 -35.75 79.55 Favored Glycine 0 N--CA 1.515 3.965 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.074 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 39.2 mm -70.31 -46.44 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 C-N-CA 124.164 0.986 . . . . 0.0 112.77 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 tt -64.53 -37.5 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.965 0 CA-C-N 118.207 0.458 . . . . 0.0 111.857 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.76 -32.22 39.75 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.13 -28.75 42.67 Favored Glycine 0 N--CA 1.512 3.714 0 C-N-CA 124.41 1.005 . . . . 0.0 113.198 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.34 -37.12 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 CA-C-N 117.383 0.592 . . . . 0.0 110.576 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 46.0 p -62.15 -45.14 94.75 Favored 'General case' 0 N--CA 1.529 3.509 0 CA-C-O 121.743 0.783 . . . . 0.0 110.319 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.86 -31.44 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 124.971 1.308 . . . . 0.0 111.447 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.07 75.69 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.361 0.664 . . . . 0.0 111.869 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.7 -46.78 62.49 Favored 'General case' 0 N--CA 1.521 3.087 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.01 -38.18 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 18.3 m -56.54 -31.33 33.8 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 CA-C-N 118.711 0.687 . . . . 0.0 110.712 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 39.7 tp -52.86 -48.14 67.29 Favored 'General case' 1 N--CA 1.543 4.176 0 CA-C-O 122.138 0.971 . . . . 0.0 109.865 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.78 -38.03 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.49 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.79 -37.64 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.437 0 C-N-CA 123.492 0.717 . . . . 0.0 109.489 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -32.71 68.1 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.216 0.606 . . . . 0.0 111.947 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.34 -43.47 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.12 0.568 . . . . 0.0 111.235 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -62.31 -42.92 99.78 Favored 'General case' 1 N--CA 1.539 4.022 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.03 -37.42 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.724 -0.61 . . . . 0.0 109.929 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 96.7 m -64.89 -27.98 69.23 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 122.657 0.383 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -65.8 -25.93 67.46 Favored 'General case' 0 N--CA 1.532 3.625 0 C-N-CA 123.224 0.609 . . . . 0.0 110.999 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 51.2 m -69.43 -34.08 73.92 Favored 'General case' 0 N--CA 1.525 3.311 0 C-N-CA 123.114 0.566 . . . . 0.0 110.444 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.19 -16.93 60.97 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.584 0.754 . . . . 0.0 110.214 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 57.0 tp -87.62 -20.81 25.84 Favored 'General case' 0 N--CA 1.536 3.864 0 C-N-CA 123.719 0.807 . . . . 0.0 110.218 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.76 -79.7 0.04 OUTLIER 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.808 0.843 . . . . 0.0 110.74 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 58.03 7.66 0.65 Allowed 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 124.206 1.002 . . . . 0.0 112.555 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? 59.82 120.67 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 124.352 1.061 . . . . 0.0 111.335 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.531 3.579 0 C-N-CA 124.932 1.293 . . . . 0.0 108.116 179.192 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.52 3.041 0 N-CA-C 111.501 0.186 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 49.7 mt -54.85 -26.71 37.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.015 0.926 . . . . 0.0 111.306 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -59.16 -32.38 69.83 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 123.174 0.59 . . . . 0.0 110.745 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.88 -38.84 89.52 Favored Glycine 1 N--CA 1.516 4.033 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.811 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . 0.412 ' N ' HD12 ' D' ' 214' ' ' ILE . 1.5 mp -70.71 -41.1 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.471 0 C-N-CA 124.275 1.03 . . . . 0.0 108.969 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.92 -41.43 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.739 0 C-N-CA 124.326 1.051 . . . . 0.0 111.775 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 6.3 tp -72.73 -32.73 41.88 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.191 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.76 -46.7 91.98 Favored Glycine 1 N--CA 1.518 4.129 0 C-N-CA 123.551 0.596 . . . . 0.0 113.968 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 11.4 m -60.09 -36.46 67.8 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.211 0 CA-C-N 118.325 1.062 . . . . 0.0 111.472 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 22.0 p -55.7 -38.73 70.08 Favored 'General case' 0 N--CA 1.532 3.643 0 C-N-CA 122.988 0.515 . . . . 0.0 111.674 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.73 -37.81 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 C-N-CA 123.247 0.619 . . . . 0.0 110.813 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.87 -36.08 58.59 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 123.561 0.745 . . . . 0.0 112.745 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.53 -50.17 40.47 Favored 'General case' 0 N--CA 1.515 2.804 0 C-N-CA 123.318 0.647 . . . . 0.0 111.07 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.4 -46.03 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.53 0 C-N-CA 123.522 0.729 . . . . 0.0 112.336 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.43 -32.01 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.523 0 C-N-CA 122.537 0.335 . . . . 0.0 111.273 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.09 -41.59 61.44 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 122.435 0.294 . . . . 0.0 110.931 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.34 -42.33 93.23 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.022 0 C-N-CA 122.806 0.442 . . . . 0.0 111.681 -177.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.0 -36.83 78.09 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 CA-C-N 118.336 0.517 . . . . 0.0 110.094 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.61 -34.15 72.39 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.858 0.463 . . . . 0.0 111.346 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.93 -39.45 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -62.4 -43.49 98.69 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.527 0.731 . . . . 0.0 112.54 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 14.4 m -68.24 -37.78 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 CA-C-N 118.407 0.549 . . . . 0.0 109.806 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 88.3 m -59.02 -27.73 65.73 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 122.886 0.474 . . . . 0.0 111.082 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -64.56 -30.92 71.95 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 122.836 0.455 . . . . 0.0 110.243 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 24.1 t -64.92 -44.59 89.03 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 123.041 0.536 . . . . 0.0 110.398 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.96 -20.49 65.91 Favored 'General case' 0 N--CA 1.532 3.647 0 C-N-CA 123.477 0.711 . . . . 0.0 110.98 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 36.6 tp -87.75 -3.01 58.98 Favored 'General case' 0 N--CA 1.537 3.889 0 C-N-CA 123.394 0.678 . . . . 0.0 110.944 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -152.37 105.09 2.99 Favored 'General case' 0 N--CA 1.533 3.706 0 C-N-CA 123.037 0.535 . . . . 0.0 111.036 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -151.15 -53.84 0.14 Allowed 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? . . . . . 0 N--CA 1.525 3.31 0 C-N-CA 124.053 0.941 . . . . 0.0 109.732 -179.673 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.521 3.11 0 CA-C-O 121.413 0.625 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 mt -62.46 -26.35 68.47 Favored 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 124.32 1.048 . . . . 0.0 110.848 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.0 p -64.62 -26.34 68.35 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.143 0.577 . . . . 0.0 110.144 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.81 -46.9 89.5 Favored Glycine 1 N--CA 1.52 4.272 0 CA-C-O 119.523 -0.598 . . . . 0.0 114.095 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 18.8 tt -70.61 -35.61 61.98 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.204 0 CA-C-N 118.549 1.175 . . . . 0.0 109.688 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 46.8 mm -64.63 -42.71 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.753 0 C-N-CA 123.876 0.87 . . . . 0.0 108.834 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 23.0 mm -72.84 -33.39 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.767 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.33 -29.83 57.36 Favored Glycine 0 N--CA 1.513 3.817 0 C-N-CA 124.115 0.864 . . . . 0.0 114.573 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.63 -37.42 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.971 0 CA-C-N 118.113 0.957 . . . . 0.0 111.216 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 67.4 p -61.88 -47.52 84.62 Favored 'General case' 0 N--CA 1.528 3.46 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 10.1 p -70.99 -31.77 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.351 0 C-N-CA 123.02 0.528 . . . . 0.0 111.524 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.36 78.26 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.07 -34.46 77.63 Favored 'General case' 0 N--CA 1.515 2.823 0 C-N-CA 123.276 0.63 . . . . 0.0 111.721 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.22 -53.43 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 122.916 0.486 . . . . 0.0 111.177 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.62 -33.6 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.413 0 O-C-N 121.785 -0.572 . . . . 0.0 111.455 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 40.0 tp -77.2 -38.39 51.6 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 122.908 0.483 . . . . 0.0 112.285 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 16.3 tt -69.35 -38.17 76.87 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.114 0 CA-C-N 118.906 0.775 . . . . 0.0 110.586 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.77 -38.0 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.87 -51.1 71.01 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.281 0.632 . . . . 0.0 112.644 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.85 -34.23 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 C-N-CA 122.533 0.333 . . . . 0.0 110.701 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -70.39 -38.62 74.71 Favored 'General case' 0 N--CA 1.527 3.386 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.1 -37.59 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.625 0 C-N-CA 124.174 0.99 . . . . 0.0 109.464 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -58.72 -34.79 71.73 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 122.655 0.382 . . . . 0.0 110.207 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -74.58 -48.43 26.77 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.863 0.465 . . . . 0.0 110.124 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.5 m -63.68 -25.96 68.45 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 123.419 0.688 . . . . 0.0 111.231 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 4.8 tt . . . . . 0 N--CA 1.524 3.257 0 C-N-CA 123.611 0.764 . . . . 0.0 111.193 179.84 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.524 3.229 0 CA-C-O 121.544 0.687 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.74 -26.8 68.81 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 124.087 0.955 . . . . 0.0 110.121 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 66.0 m -66.23 -32.29 73.62 Favored 'General case' 0 N--CA 1.519 2.985 0 C-N-CA 123.587 0.755 . . . . 0.0 111.061 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.11 -47.53 52.85 Favored Glycine 1 N--CA 1.517 4.056 0 CA-C-N 116.099 -0.5 . . . . 0.0 114.261 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 20.4 tt -71.6 -41.66 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.94 -44.25 82.1 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.272 0 C-N-CA 123.059 0.544 . . . . 0.0 111.737 -176.078 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.1 tt -72.29 -33.16 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.854 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.93 -29.47 51.24 Favored Glycine 0 N--CA 1.512 3.736 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.434 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.69 -37.71 72.27 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 117.495 0.648 . . . . 0.0 110.991 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 72.7 p -62.39 -45.49 92.88 Favored 'General case' 0 N--CA 1.53 3.563 0 CA-C-O 121.648 0.737 . . . . 0.0 110.474 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.21 -31.65 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.094 0 C-N-CA 124.702 1.201 . . . . 0.0 110.814 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.99 -34.72 75.22 Favored 'General case' 0 N--CA 1.531 3.588 0 O-C-N 121.824 -0.547 . . . . 0.0 111.596 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.32 -50.35 70.38 Favored 'General case' 0 N--CA 1.516 2.841 0 C-N-CA 123.51 0.724 . . . . 0.0 112.772 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.03 -38.27 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 CA-C-N 118.373 0.533 . . . . 0.0 111.629 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.22 -34.59 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.827 0 C-N-CA 122.646 0.378 . . . . 0.0 110.664 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 41.3 tp -68.51 -34.46 75.92 Favored 'General case' 0 N--CA 1.533 3.713 0 CA-C-N 118.156 0.434 . . . . 0.0 110.622 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.9 mt -61.82 -35.4 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 C-N-CA 123.683 0.793 . . . . 0.0 109.893 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.34 -35.41 49.0 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.194 0 C-N-CA 123.341 0.657 . . . . 0.0 110.472 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.1 -31.46 63.29 Favored 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 123.468 0.707 . . . . 0.0 112.763 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 4.4 m -57.28 -34.83 46.91 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.123 0 CA-C-N 118.992 0.815 . . . . 0.0 112.682 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -65.2 -43.94 89.97 Favored 'General case' 1 N--CA 1.541 4.094 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.81 -37.14 77.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.019 0 CA-C-N 119.007 0.821 . . . . 0.0 108.982 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 75.5 m -58.37 -27.59 64.36 Favored 'General case' 0 N--CA 1.528 3.429 0 C-N-CA 122.821 0.448 . . . . 0.0 110.909 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.54 -26.14 67.75 Favored 'General case' 0 N--CA 1.53 3.544 0 C-N-CA 122.973 0.509 . . . . 0.0 110.573 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 60.4 p -63.63 -16.89 62.16 Favored 'General case' 0 N--CA 1.534 3.765 0 C-N-CA 123.689 0.796 . . . . 0.0 111.546 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 46.6 tp -59.82 -14.57 15.53 Favored 'General case' 0 N--CA 1.527 3.377 0 C-N-CA 124.284 1.033 . . . . 0.0 112.775 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 pp -86.88 9.01 20.56 Favored 'General case' 1 N--CA 1.545 4.306 0 CA-C-N 118.843 0.747 . . . . 0.0 110.247 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 56.4 m95 58.96 134.64 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.1 0 C-N-CA 124.856 1.262 . . . . 0.0 113.029 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp . . . . . 0 N--CA 1.525 3.307 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.202 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.193 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.9 m -162.38 104.73 1.11 Allowed 'General case' 0 N--CA 1.521 3.108 0 C-N-CA 123.708 0.803 . . . . 0.0 108.986 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.27 -26.73 68.56 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.12 0.968 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.8 m -57.64 -26.19 61.26 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.667 0.787 . . . . 0.0 110.921 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.99 -35.62 91.67 Favored Glycine 0 N--CA 1.508 3.466 0 C-N-CA 124.232 0.92 . . . . 0.0 115.205 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.4 tt -68.47 -35.07 68.99 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.286 0 CA-C-N 118.247 1.023 . . . . 0.0 113.55 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.19 -40.61 66.12 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 17.7 tt -73.06 -36.12 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.798 0 O-C-N 121.399 -0.813 . . . . 0.0 109.439 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.94 -43.43 94.9 Favored Glycine 1 N--CA 1.519 4.191 0 C-N-CA 123.37 0.509 . . . . 0.0 114.363 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.83 -36.76 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 CA-C-N 117.907 0.853 . . . . 0.0 110.586 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.2 p -58.38 -44.58 88.97 Favored 'General case' 1 N--CA 1.539 4.008 0 CA-C-N 118.42 0.555 . . . . 0.0 111.118 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.75 -37.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 123.426 0.69 . . . . 0.0 111.405 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.25 -37.03 66.7 Favored 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.2 -50.56 71.33 Favored 'General case' 0 N--CA 1.513 2.682 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.9 m -61.93 -37.8 79.11 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.147 0 CA-C-N 118.529 0.604 . . . . 0.0 111.649 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 56.6 t -59.23 -32.68 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.976 0 O-C-N 121.482 -0.761 . . . . 0.0 110.189 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 73.0 mt -72.82 -34.43 66.83 Favored 'General case' 0 N--CA 1.532 3.639 0 C-N-CA 122.385 0.274 . . . . 0.0 110.294 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.2 -47.8 91.42 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.287 0 C-N-CA 123.039 0.535 . . . . 0.0 111.415 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.51 -36.92 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 O-C-N 121.885 -0.509 . . . . 0.0 110.102 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.99 -49.0 78.33 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.245 0.618 . . . . 0.0 112.304 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.11 -34.28 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.542 0 O-C-N 122.022 -0.424 . . . . 0.0 110.94 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -70.21 -43.1 71.36 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.078 0.551 . . . . 0.0 112.16 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.95 -37.64 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.71 0 O-C-N 122.067 -0.396 . . . . 0.0 111.305 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 20.1 p -67.34 -28.02 67.62 Favored 'General case' 0 N--CA 1.532 3.67 0 CA-C-N 117.886 0.312 . . . . 0.0 110.939 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -67.57 -30.55 70.2 Favored 'General case' 0 N--CA 1.529 3.478 0 C-N-CA 123.217 0.607 . . . . 0.0 110.53 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.7 m -67.4 -27.56 67.18 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 123.356 0.662 . . . . 0.0 110.498 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 235' ' ' LEU . 0.8 OUTLIER -64.4 -14.52 57.02 Favored 'General case' 0 N--CA 1.533 3.702 0 C-N-CA 124.474 1.11 . . . . 0.0 109.908 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 30.2 mt -87.24 2.0 51.41 Favored 'General case' 0 N--CA 1.533 3.714 0 C-N-CA 123.749 0.82 . . . . 0.0 110.578 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -66.48 -2.29 4.49 Favored 'General case' 0 N--CA 1.529 3.525 0 C-N-CA 123.854 0.862 . . . . 0.0 111.001 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -62.22 177.44 0.48 Allowed 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.868 0.867 . . . . 0.0 110.941 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -64.87 153.71 39.41 Favored 'General case' 0 N--CA 1.526 3.335 0 C-N-CA 124.149 0.98 . . . . 0.0 110.097 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.528 3.432 0 C-N-CA 124.927 1.291 . . . . 0.0 108.113 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.521 3.081 0 N-CA-C 110.788 -0.079 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.24 -26.98 68.34 Favored 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 124.084 0.954 . . . . 0.0 109.923 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 94.6 p -58.26 -26.37 62.85 Favored 'General case' 0 N--CA 1.529 3.486 0 C-N-CA 123.333 0.653 . . . . 0.0 110.769 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.75 -35.61 75.32 Favored Glycine 0 N--CA 1.508 3.479 0 C-N-CA 124.772 1.177 . . . . 0.0 115.475 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 pt -59.47 -34.65 55.27 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.475 0 CA-C-N 119.039 1.419 . . . . 0.0 113.647 -176.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 1.6 pp -55.78 -35.18 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.976 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 20.0 pt -65.64 -33.74 65.68 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.264 0 CA-C-N 118.849 0.749 . . . . 0.0 109.238 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.77 -38.84 96.11 Favored Glycine 1 N--CA 1.519 4.201 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.26 -47.31 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 123.796 0.838 . . . . 0.0 109.423 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 88.3 m -66.03 -47.66 73.7 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.665 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 71.7 t -70.56 -33.27 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.376 0 C-N-CA 124.054 0.942 . . . . 0.0 111.486 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.87 79.3 Favored 'General case' 0 N--CA 1.534 3.731 0 CA-C-N 118.376 0.534 . . . . 0.0 112.102 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.55 -50.22 59.57 Favored 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.5 m -63.1 -39.07 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.64 -32.72 58.09 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.035 0 CA-C-N 118.723 0.692 . . . . 0.0 110.322 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -44.64 92.14 Favored 'General case' 0 N--CA 1.532 3.639 0 C-N-CA 123.205 0.602 . . . . 0.0 111.056 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.26 -39.74 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.792 0.437 . . . . 0.0 110.456 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.38 -39.34 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.508 0 C-N-CA 122.96 0.504 . . . . 0.0 109.802 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.4 93.9 Favored 'General case' 0 N--CA 1.528 3.46 0 C-N-CA 123.251 0.62 . . . . 0.0 111.961 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 93.0 t -71.65 -34.63 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.602 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.86 -43.87 94.8 Favored 'General case' 0 N--CA 1.526 3.355 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 11.3 m -68.65 -37.81 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 CA-C-N 118.693 0.679 . . . . 0.0 109.718 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.8 m -60.93 -37.18 81.43 Favored 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.844 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -27.25 66.71 Favored 'General case' 0 N--CA 1.537 3.919 0 C-N-CA 122.576 0.35 . . . . 0.0 110.594 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 23.1 t -63.52 -40.84 98.1 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.005 0.522 . . . . 0.0 110.991 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.41 -22.25 66.77 Favored 'General case' 0 N--CA 1.535 3.806 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 1 N--CA 1.543 4.222 0 C-N-CA 124.415 1.086 . . . . 0.0 109.378 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.522 3.155 0 CA-C-O 121.894 0.854 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -58.97 -25.82 63.91 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.601 1.16 . . . . 0.0 112.33 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 87.6 p -57.09 -25.73 59.24 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.436 0.694 . . . . 0.0 110.748 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.74 -35.34 62.53 Favored Glycine 0 N--CA 1.515 3.913 0 C-N-CA 124.52 1.057 . . . . 0.0 115.052 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.73 -34.01 62.55 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.427 0 CA-C-N 118.521 1.161 . . . . 0.0 113.872 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . 0.498 ' O ' HG12 ' C' ' 218' ' ' VAL . 1.5 pp -55.28 -32.84 29.51 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.115 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -172.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.7 tt -72.64 -32.4 40.97 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.368 0 CA-C-N 119.041 0.837 . . . . 0.0 109.348 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.08 -29.01 43.12 Favored Glycine 0 N--CA 1.515 3.946 0 C-N-CA 124.215 0.912 . . . . 0.0 113.939 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . 0.498 HG12 ' O ' ' C' ' 215' ' ' ILE . 15.0 p -58.91 -38.02 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 CA-C-N 117.435 0.618 . . . . 0.0 111.117 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 64.6 p -64.78 -46.09 83.58 Favored 'General case' 0 N--CA 1.529 3.475 0 CA-C-O 121.155 0.502 . . . . 0.0 110.524 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.08 -37.2 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.049 0 C-N-CA 124.078 0.951 . . . . 0.0 110.625 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.71 -39.93 62.49 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.91 65.76 Favored 'General case' 0 N--CA 1.515 2.783 0 C-N-CA 123.127 0.571 . . . . 0.0 111.434 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 44.6 t -61.8 -47.74 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.328 0 C-N-CA 123.225 0.61 . . . . 0.0 112.171 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.6 -32.59 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 C-N-CA 122.404 0.282 . . . . 0.0 111.377 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 38.5 tp -71.52 -34.74 70.33 Favored 'General case' 0 N--CA 1.522 3.173 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 87.1 mt -68.48 -44.85 82.85 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.372 0 CA-C-N 119.645 1.111 . . . . 0.0 110.16 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.11 -35.97 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.945 0.498 . . . . 0.0 109.973 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.12 -38.55 73.62 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.431 0.693 . . . . 0.0 111.904 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.07 -41.13 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 CA-C-O 120.742 0.305 . . . . 0.0 110.282 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -61.5 -43.93 97.99 Favored 'General case' 0 N--CA 1.529 3.498 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.23 -37.42 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.632 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 95.5 m -64.37 -33.52 76.03 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -74.04 -38.0 64.14 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.177 0.591 . . . . 0.0 110.321 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 82.2 p -63.92 -17.04 62.83 Favored 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 123.383 0.673 . . . . 0.0 111.321 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.98 -37.74 88.36 Favored 'General case' 0 N--CA 1.531 3.587 0 C-N-CA 123.963 0.905 . . . . 0.0 111.29 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.19 -2.29 57.53 Favored 'General case' 1 N--CA 1.544 4.231 0 C-N-CA 123.323 0.649 . . . . 0.0 112.2 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -70.98 92.3 0.92 Allowed 'General case' 0 N--CA 1.529 3.516 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.95 142.56 1.88 Allowed 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 124.045 0.938 . . . . 0.0 108.547 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -168.9 103.1 0.39 Allowed 'General case' 0 N--CA 1.52 3.046 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.531 3.577 0 C-N-CA 124.884 1.274 . . . . 0.0 107.676 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.522 3.153 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 49.3 mt -57.62 -26.77 62.05 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 123.949 0.899 . . . . 0.0 110.866 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 55.4 m -64.14 -35.34 80.45 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.818 0.847 . . . . 0.0 110.787 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.04 -35.02 77.5 Favored Glycine 0 N--CA 1.514 3.863 0 C-N-CA 124.354 0.978 . . . . 0.0 113.056 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 37.0 mm -68.1 -43.61 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.445 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.07 -36.31 50.73 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.213 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 15.8 tt -72.39 -33.16 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.864 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.89 -42.26 99.71 Favored Glycine 1 N--CA 1.518 4.142 0 C-N-CA 123.076 0.37 . . . . 0.0 113.838 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 18.7 m -68.72 -37.17 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.866 0 CA-C-N 118.184 0.992 . . . . 0.0 111.342 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 47.4 p -63.89 -45.78 87.85 Favored 'General case' 0 N--CA 1.53 3.54 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.36 -31.93 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 CA-C-N 118.882 0.765 . . . . 0.0 111.075 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.0 -46.76 82.06 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 122.629 0.371 . . . . 0.0 111.687 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.08 -42.23 85.15 Favored 'General case' 0 N--CA 1.519 2.998 0 C-N-CA 123.485 0.714 . . . . 0.0 111.92 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.58 -44.95 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.462 0 C-N-CA 123.102 0.561 . . . . 0.0 111.209 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.48 -40.38 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 C-N-CA 122.38 0.272 . . . . 0.0 110.626 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.66 -46.55 78.71 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 122.846 0.458 . . . . 0.0 111.603 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 85.7 mt -62.26 -36.99 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 O-C-N 122.029 -0.42 . . . . 0.0 110.585 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.12 -37.55 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.887 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.76 98.57 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.852 0.461 . . . . 0.0 111.202 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.75 -34.66 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.426 0 C-N-CA 123.165 0.586 . . . . 0.0 109.702 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -63.08 -44.1 96.71 Favored 'General case' 0 N--CA 1.53 3.571 0 C-N-CA 123.099 0.56 . . . . 0.0 112.366 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.12 -37.64 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.724 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 85.8 m -61.03 -27.31 68.24 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 123.151 0.58 . . . . 0.0 111.251 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -57.8 -27.19 62.89 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 122.811 0.444 . . . . 0.0 111.251 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 66.1 m -65.97 -41.18 91.51 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 123.78 0.832 . . . . 0.0 111.355 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -60.84 -13.42 15.39 Favored 'General case' 0 N--CA 1.532 3.653 0 C-N-CA 124.338 1.055 . . . . 0.0 111.28 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.45 -23.42 26.03 Favored 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.83 109.82 15.75 Favored 'General case' 0 N--CA 1.527 3.408 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -168.63 166.95 11.68 Favored 'General case' 0 N--CA 1.521 3.102 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 22.7 pttp . . . . . 0 N--CA 1.522 3.142 0 C-N-CA 124.05 0.94 . . . . 0.0 110.866 -179.388 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.525 3.299 0 CA-C-O 120.61 0.243 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -61.82 -27.03 68.48 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 123.3 0.64 . . . . 0.0 111.143 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 55.7 m -69.13 -26.1 64.72 Favored 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.984 0.914 . . . . 0.0 109.976 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.34 -46.01 88.32 Favored Glycine 0 N--CA 1.513 3.78 0 CA-C-N 115.394 -0.821 . . . . 0.0 114.256 -177.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 46.6 pt -70.47 -35.63 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 8.6 pt -61.8 -44.45 98.81 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.55 0 CA-C-N 119.249 0.931 . . . . 0.0 111.582 -176.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.33 -32.22 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.871 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.96 -29.4 43.1 Favored Glycine 0 N--CA 1.506 3.302 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.584 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.45 -37.25 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 CA-C-N 117.708 0.754 . . . . 0.0 111.179 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 35.9 p -64.66 -47.61 77.82 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 10.5 p -70.84 -31.24 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.327 0.651 . . . . 0.0 110.987 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.22 65.07 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.07 0.548 . . . . 0.0 112.324 -177.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.77 -34.76 69.92 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 123.129 0.571 . . . . 0.0 111.83 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.95 -40.47 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 123.03 0.532 . . . . 0.0 110.307 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.15 -42.08 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.508 0.723 . . . . 0.0 110.746 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 66.6 mt -64.2 -34.58 78.42 Favored 'General case' 0 N--CA 1.528 3.449 0 C-N-CA 122.684 0.394 . . . . 0.0 110.749 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.64 -43.95 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 C-N-CA 122.852 0.461 . . . . 0.0 109.952 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 80.7 t -66.86 -39.2 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.59 -48.03 82.31 Favored 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 123.681 0.792 . . . . 0.0 112.953 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 35.2 m -71.58 -34.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 O-C-N 121.955 -0.465 . . . . 0.0 110.803 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.24 -44.25 92.42 Favored 'General case' 0 N--CA 1.528 3.471 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.96 -37.81 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 83.7 m -66.19 -32.63 74.18 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 122.875 0.47 . . . . 0.0 110.554 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -67.53 -32.2 72.84 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.422 0.689 . . . . 0.0 111.047 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -63.89 -26.8 68.76 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.312 0.645 . . . . 0.0 111.301 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 53.5 mt . . . . . 0 N--CA 1.525 3.282 0 C-N-CA 123.379 0.671 . . . . 0.0 110.274 179.82 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.521 3.103 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.23 -26.22 68.41 Favored 'General case' 0 N--CA 1.525 3.3 0 C-N-CA 124.014 0.926 . . . . 0.0 111.748 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 40.1 t -66.04 -33.09 75.01 Favored 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 123.609 0.764 . . . . 0.0 111.302 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.74 -45.98 62.99 Favored Glycine 1 N--CA 1.519 4.18 0 N-CA-C 115.047 0.779 . . . . 0.0 115.047 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 8.4 tp -70.85 -40.49 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.888 0 O-C-N 121.653 -0.91 . . . . 0.0 112.319 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . 0.479 HD13 ' O ' ' F' ' 215' ' ' ILE . 0.0 OUTLIER -66.01 -36.73 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 C-N-CA 123.207 0.603 . . . . 0.0 111.946 -177.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . 0.563 HD12 ' N ' ' F' ' 217' ' ' GLY . 1.9 pp -70.92 -31.73 46.34 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.421 0 CA-C-N 119.424 1.011 . . . . 0.0 109.232 177.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . 0.563 ' N ' HD12 ' F' ' 216' ' ' ILE . . . -54.49 -29.46 47.6 Favored Glycine 0 N--CA 1.516 3.987 0 C-N-CA 123.845 0.736 . . . . 0.0 113.801 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . 0.44 HG12 ' O ' ' F' ' 215' ' ' ILE . 8.2 p -59.74 -39.78 80.68 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.055 0 CA-C-N 117.525 0.663 . . . . 0.0 111.509 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 82.5 p -66.18 -45.91 79.19 Favored 'General case' 0 N--CA 1.53 3.564 0 CA-C-O 121.247 0.546 . . . . 0.0 110.794 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.23 -32.54 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.038 0 C-N-CA 124.24 1.016 . . . . 0.0 110.864 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.65 -45.2 66.6 Favored 'General case' 0 N--CA 1.529 3.498 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.53 -33.46 75.97 Favored 'General case' 0 N--CA 1.523 3.191 0 C-N-CA 123.449 0.7 . . . . 0.0 111.626 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 25.9 t -65.42 -38.62 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.652 0.781 . . . . 0.0 110.934 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.17 -32.52 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 C-N-CA 123.123 0.569 . . . . 0.0 111.185 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 43.2 tp -68.22 -39.26 82.4 Favored 'General case' 0 N--CA 1.526 3.356 0 CA-C-O 120.764 0.316 . . . . 0.0 110.191 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 41.5 mm -54.7 -50.15 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.865 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.742 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 18.7 m -67.04 -37.28 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.896 -0.502 . . . . 0.0 110.214 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.25 93.13 Favored 'General case' 0 N--CA 1.525 3.277 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 15.9 m -71.27 -33.99 52.55 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 CA-C-N 119.223 0.92 . . . . 0.0 110.102 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -64.12 -43.94 93.76 Favored 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 14.3 m -68.74 -37.65 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 CA-C-O 121.007 0.432 . . . . 0.0 109.901 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 91.0 m -58.67 -27.43 64.79 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 123.447 0.699 . . . . 0.0 111.104 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.05 -34.36 78.23 Favored 'General case' 0 N--CA 1.525 3.324 0 C-N-CA 122.335 0.254 . . . . 0.0 110.672 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 79.5 p -68.34 -36.41 79.21 Favored 'General case' 0 N--CA 1.532 3.647 0 C-N-CA 123.181 0.592 . . . . 0.0 110.685 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.85 -13.49 15.89 Favored 'General case' 0 N--CA 1.537 3.902 0 C-N-CA 123.555 0.742 . . . . 0.0 110.964 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 18.2 mt -86.68 0.38 54.72 Favored 'General case' 0 N--CA 1.535 3.811 0 C-N-CA 122.929 0.492 . . . . 0.0 111.383 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -163.92 108.53 1.01 Allowed 'General case' 0 N--CA 1.53 3.552 0 CA-C-N 118.073 0.397 . . . . 0.0 111.248 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 54.9 mttp . . . . . 0 N--CA 1.526 3.362 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.269 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.223 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.9 p -166.05 -20.09 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 124.153 0.981 . . . . 0.0 109.387 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.11 -26.41 68.19 Favored 'General case' 0 N--CA 1.528 3.474 0 C-N-CA 124.2 1.0 . . . . 0.0 109.164 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 95.1 p -65.95 -26.96 67.82 Favored 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.547 0.739 . . . . 0.0 110.49 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.12 -46.61 57.67 Favored Glycine 1 N--CA 1.52 4.254 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 8.4 tp -71.17 -41.1 75.41 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.174 0 CA-C-N 118.186 0.993 . . . . 0.0 112.967 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.3 tt -60.87 -35.25 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 123.672 0.789 . . . . 0.0 112.873 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 5.7 tp -73.16 -33.28 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.991 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.43 96.14 Favored Glycine 1 N--CA 1.521 4.311 0 C-N-CA 123.401 0.525 . . . . 0.0 114.219 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.6 p -59.71 -36.84 68.11 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 117.972 0.886 . . . . 0.0 110.787 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.9 p -55.95 -42.15 75.77 Favored 'General case' 0 N--CA 1.535 3.821 0 CA-C-O 120.919 0.39 . . . . 0.0 111.432 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.5 -40.4 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 123.85 0.86 . . . . 0.0 111.601 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.38 -39.91 61.42 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -176.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.54 -46.35 63.74 Favored 'General case' 0 N--CA 1.52 3.054 0 C-N-CA 122.997 0.519 . . . . 0.0 111.185 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.78 -46.62 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 C-N-CA 123.321 0.648 . . . . 0.0 112.385 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.8 p -66.18 -32.28 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.665 0 C-N-CA 122.512 0.325 . . . . 0.0 111.122 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.61 -41.32 96.28 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.584 0.354 . . . . 0.0 110.859 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 88.0 mt -58.62 -36.66 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.916 0 C-N-CA 122.658 0.383 . . . . 0.0 110.287 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.34 -37.69 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 C-N-CA 123.02 0.528 . . . . 0.0 110.324 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.62 -33.25 75.49 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.038 0.535 . . . . 0.0 110.877 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.07 -36.9 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 C-N-CA 123.308 0.643 . . . . 0.0 109.762 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -64.36 -43.45 94.5 Favored 'General case' 0 N--CA 1.528 3.466 0 C-N-CA 123.633 0.773 . . . . 0.0 112.544 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 19.2 m -67.7 -37.23 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 76.8 m -60.24 -38.35 83.19 Favored 'General case' 0 N--CA 1.527 3.392 0 C-N-CA 122.96 0.504 . . . . 0.0 111.26 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -74.27 -40.63 62.2 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 122.64 0.376 . . . . 0.0 110.074 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 83.5 p -63.91 -32.73 74.35 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.15 -23.18 57.77 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.063 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.4 tp -87.11 -22.67 25.24 Favored 'General case' 0 N--CA 1.537 3.919 0 C-N-CA 122.942 0.497 . . . . 0.0 110.16 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -71.45 65.61 0.45 Allowed 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.648 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -143.44 157.9 44.08 Favored 'General case' 0 N--CA 1.526 3.369 0 C-N-CA 124.822 1.249 . . . . 0.0 107.843 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.69 155.93 37.2 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 123.731 0.812 . . . . 0.0 109.216 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.529 3.488 0 C-N-CA 124.706 1.203 . . . . 0.0 108.329 179.579 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.522 3.168 0 CA-C-O 120.167 0.032 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.2 -28.72 69.58 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 124.061 0.944 . . . . 0.0 110.137 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 56.0 m -65.05 -26.88 68.44 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.04 0.536 . . . . 0.0 110.302 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.28 -35.79 91.98 Favored Glycine 1 N--CA 1.524 4.524 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 36.1 mm -68.71 -40.48 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.302 0 C-N-CA 124.583 1.153 . . . . 0.0 109.149 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 48.2 mm -66.46 -40.13 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 C-N-CA 124.538 1.135 . . . . 0.0 108.905 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 14.6 mm -71.38 -31.96 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.97 -29.17 42.58 Favored Glycine 0 N--CA 1.516 3.976 0 C-N-CA 123.708 0.67 . . . . 0.0 113.176 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.59 -37.59 71.31 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.095 0 CA-C-N 117.84 0.82 . . . . 0.0 110.769 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 46.9 p -57.48 -44.79 85.17 Favored 'General case' 0 N--CA 1.528 3.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.824 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.6 t -67.02 -31.79 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 C-N-CA 124.095 0.958 . . . . 0.0 110.875 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.87 79.35 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 122.482 0.313 . . . . 0.0 110.967 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.98 -50.11 74.51 Favored 'General case' 0 N--CA 1.521 3.117 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.37 -38.35 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 CA-C-N 118.224 0.465 . . . . 0.0 111.625 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.2 -38.38 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 118.23 0.468 . . . . 0.0 110.651 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.99 -38.72 92.11 Favored 'General case' 1 N--CA 1.539 4.021 0 C-N-CA 122.55 0.34 . . . . 0.0 110.543 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.78 -42.8 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.818 0 O-C-N 122.005 -0.434 . . . . 0.0 110.221 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 64.6 t -65.52 -37.71 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 C-N-CA 122.964 0.506 . . . . 0.0 110.082 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.56 80.3 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.432 0.693 . . . . 0.0 111.277 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 84.1 t -71.94 -34.88 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.26 0 C-N-CA 122.909 0.484 . . . . 0.0 110.443 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -62.66 -44.46 96.21 Favored 'General case' 0 N--CA 1.534 3.739 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.02 -39.34 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.721 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 73.6 m -67.18 -30.39 70.33 Favored 'General case' 0 N--CA 1.524 3.26 0 C-N-CA 123.115 0.566 . . . . 0.0 110.727 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -73.32 -35.33 66.04 Favored 'General case' 0 N--CA 1.526 3.339 0 C-N-CA 123.249 0.62 . . . . 0.0 110.343 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 62.8 m -63.67 -23.87 67.55 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.554 0.742 . . . . 0.0 111.689 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.95 -24.98 66.13 Favored 'General case' 0 N--CA 1.53 3.557 0 C-N-CA 123.688 0.795 . . . . 0.0 110.285 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.535 3.782 0 C-N-CA 123.632 0.773 . . . . 0.0 109.453 179.909 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.521 3.093 0 CA-C-O 121.819 0.819 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 7.8 mp -65.23 -26.92 68.33 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.932 0.893 . . . . 0.0 109.537 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 41.4 t -58.2 -25.94 62.2 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.579 0.751 . . . . 0.0 110.931 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.65 -34.4 60.51 Favored Glycine 0 N--CA 1.513 3.77 0 C-N-CA 125.123 1.344 . . . . 0.0 114.981 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.0 pt -57.95 -34.11 47.84 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.271 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -175.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 9.8 pt -55.74 -32.43 31.63 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.133 0 C-N-CA 123.128 0.571 . . . . 0.0 111.972 -176.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.96 -33.44 52.84 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.112 0 C-N-CA 123.613 0.765 . . . . 0.0 110.017 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.74 -29.9 50.72 Favored Glycine 0 N--CA 1.513 3.814 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.039 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.1 m -62.26 -37.82 79.55 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 117.937 0.868 . . . . 0.0 111.329 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 68.2 p -62.15 -45.77 91.96 Favored 'General case' 0 N--CA 1.532 3.633 0 CA-C-O 121.364 0.602 . . . . 0.0 110.669 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.18 -32.49 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 C-N-CA 124.197 0.999 . . . . 0.0 110.207 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.3 -34.61 78.74 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.534 0.733 . . . . 0.0 111.776 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.03 -49.87 46.98 Favored 'General case' 0 N--CA 1.516 2.844 0 C-N-CA 123.14 0.576 . . . . 0.0 112.503 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 29.3 m -63.92 -40.11 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.815 0 CA-C-N 118.523 0.602 . . . . 0.0 112.577 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 13.7 p -67.44 -32.01 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 CA-C-N 118.182 0.446 . . . . 0.0 110.558 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.49 -43.96 79.68 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 122.911 0.485 . . . . 0.0 110.333 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.52 -36.54 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 C-N-CA 123.48 0.712 . . . . 0.0 112.028 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.71 -36.68 67.14 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.683 0 CA-C-N 119.447 1.022 . . . . 0.0 110.517 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.28 -32.51 66.7 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.386 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.72 -41.25 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.394 0 C-N-CA 123.261 0.624 . . . . 0.0 110.086 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -61.42 -43.52 98.73 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.607 0.763 . . . . 0.0 112.915 -177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.26 -37.54 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 82.6 m -61.6 -27.82 68.91 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 122.619 0.368 . . . . 0.0 111.07 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -68.21 -27.38 66.33 Favored 'General case' 0 N--CA 1.531 3.576 0 C-N-CA 123.057 0.543 . . . . 0.0 110.738 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.9 m -69.07 -26.77 65.11 Favored 'General case' 0 N--CA 1.531 3.595 0 CA-C-O 121.225 0.536 . . . . 0.0 110.103 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -14.52 47.21 Favored 'General case' 0 N--CA 1.533 3.682 0 C-N-CA 124.807 1.243 . . . . 0.0 110.499 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 32.2 mt -86.59 -27.27 23.98 Favored 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 123.373 0.669 . . . . 0.0 110.387 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -71.56 84.98 0.86 Allowed 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.532 0.733 . . . . 0.0 109.234 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.64 117.09 15.71 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 124.988 1.315 . . . . 0.0 107.766 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? -164.53 134.02 3.78 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.531 3.578 0 C-N-CA 125.145 1.378 . . . . 0.0 108.685 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 N--CA 1.522 3.134 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -25.79 68.09 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.887 0.875 . . . . 0.0 111.659 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . 0.435 ' O ' HD12 ' D' ' 215' ' ' ILE . 99.6 p -68.17 -26.92 65.99 Favored 'General case' 0 N--CA 1.527 3.395 0 C-N-CA 123.331 0.652 . . . . 0.0 110.054 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.06 -34.02 71.35 Favored Glycine 0 N--CA 1.505 3.255 0 C-N-CA 125.589 1.566 . . . . 0.0 115.597 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 13.7 pt -58.24 -33.79 48.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . 0.534 HD13 ' H ' ' D' ' 216' ' ' ILE . 0.1 OUTLIER -55.06 -43.39 69.58 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.388 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.302 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . 0.534 ' H ' HD13 ' D' ' 215' ' ' ILE . 18.4 tt -73.19 -34.47 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.984 0 CA-C-N 118.252 0.478 . . . . 0.0 110.375 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.11 -44.6 93.89 Favored Glycine 1 N--CA 1.519 4.184 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -60.11 -37.07 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.987 0 CA-C-N 117.629 0.714 . . . . 0.0 111.067 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 61.6 p -59.26 -39.0 81.48 Favored 'General case' 0 N--CA 1.532 3.637 0 CA-C-N 117.963 0.347 . . . . 0.0 111.41 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.48 -38.34 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 C-N-CA 123.41 0.684 . . . . 0.0 111.52 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.16 68.19 Favored 'General case' 0 N--CA 1.531 3.623 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.12 90.06 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 123.5 0.72 . . . . 0.0 111.71 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.23 -42.91 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.289 0.636 . . . . 0.0 112.129 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.81 -32.56 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.58 -47.33 22.82 Favored 'General case' 0 N--CA 1.539 3.997 0 CA-C-N 118.248 0.476 . . . . 0.0 111.352 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 20.2 pt -62.05 -36.31 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.721 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.07 -36.01 76.43 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.199 0 CA-C-N 119.425 1.011 . . . . 0.0 110.321 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.42 -32.16 66.59 Favored 'General case' 0 N--CA 1.523 3.187 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.77 -34.91 67.21 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.296 0 CA-C-N 119.709 1.14 . . . . 0.0 112.269 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -63.21 -43.53 97.86 Favored 'General case' 1 N--CA 1.539 4.019 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.37 -37.32 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 76.4 m -58.7 -31.3 68.12 Favored 'General case' 0 N--CA 1.531 3.619 0 C-N-CA 122.529 0.331 . . . . 0.0 111.257 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.11 -15.32 63.54 Favored 'General case' 0 N--CA 1.534 3.726 0 C-N-CA 123.103 0.561 . . . . 0.0 110.858 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 78.4 p -63.41 -28.78 70.22 Favored 'General case' 0 N--CA 1.529 3.51 0 CA-C-O 121.146 0.498 . . . . 0.0 109.87 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 57.6 mt -91.35 -18.65 23.95 Favored 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 124.507 1.123 . . . . 0.0 112.301 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 53.9 mt -87.53 3.0 49.14 Favored 'General case' 1 N--CA 1.544 4.264 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -70.2 -7.82 45.03 Favored 'General case' 1 N--CA 1.543 4.216 0 CA-C-N 119.65 1.114 . . . . 0.0 109.504 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -67.71 131.78 46.23 Favored 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 124.027 0.931 . . . . 0.0 109.844 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 N--CA 1.526 3.349 0 C-N-CA 123.708 0.803 . . . . 0.0 110.497 179.585 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p . . . . . 0 N--CA 1.519 3.018 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.16 -27.21 68.55 Favored 'General case' 0 N--CA 1.536 3.865 0 C-N-CA 123.641 0.777 . . . . 0.0 109.091 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -66.7 -28.26 68.29 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.421 0.689 . . . . 0.0 110.421 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.77 -35.56 80.3 Favored Glycine 1 N--CA 1.516 4.009 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 38.5 mm -69.81 -43.56 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.153 0 C-N-CA 124.528 1.131 . . . . 0.0 112.841 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 9.4 pt -59.49 -40.87 82.97 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.526 0 CA-C-N 118.852 0.751 . . . . 0.0 112.153 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.0 -32.94 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.98 -50.14 70.86 Favored Glycine 1 N--CA 1.52 4.276 0 C-N-CA 123.603 0.62 . . . . 0.0 113.364 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -61.76 -36.78 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-N 117.458 0.629 . . . . 0.0 109.747 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 86.1 m -63.6 -47.05 83.0 Favored 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 122.693 0.397 . . . . 0.0 111.604 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.7 -34.39 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 C-N-CA 123.491 0.716 . . . . 0.0 110.512 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.7 -46.57 67.39 Favored 'General case' 0 N--CA 1.527 3.382 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.43 91.09 Favored 'General case' 0 N--CA 1.519 2.99 0 C-N-CA 123.033 0.533 . . . . 0.0 111.687 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 43.2 t -68.16 -51.6 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.101 0 C-N-CA 123.134 0.574 . . . . 0.0 111.96 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 31.7 m -67.41 -32.72 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 O-C-N 121.892 -0.505 . . . . 0.0 111.813 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.03 -44.51 72.55 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 122.539 0.335 . . . . 0.0 111.33 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 24.7 pt -69.23 -36.48 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 CA-C-N 118.747 0.703 . . . . 0.0 111.149 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.07 -37.64 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.871 0 O-C-N 121.848 -0.533 . . . . 0.0 109.739 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.78 83.66 Favored 'General case' 0 N--CA 1.532 3.637 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.65 -34.16 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.554 0 O-C-N 122.079 -0.388 . . . . 0.0 110.937 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -68.75 -43.71 75.28 Favored 'General case' 0 N--CA 1.526 3.357 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 13.2 p -68.38 -37.83 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 CA-C-N 118.019 0.372 . . . . 0.0 111.175 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 16.3 p -66.31 -27.88 68.26 Favored 'General case' 0 N--CA 1.533 3.679 0 CA-C-N 117.855 0.298 . . . . 0.0 111.172 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -65.61 -30.98 71.78 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 123.214 0.606 . . . . 0.0 111.109 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 53.0 m -64.47 -32.37 73.96 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.391 0.676 . . . . 0.0 111.277 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 53.8 mt . . . . . 0 N--CA 1.527 3.379 0 C-N-CA 123.594 0.758 . . . . 0.0 111.928 -178.932 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.521 3.102 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.08 -35.61 81.69 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 124.312 1.045 . . . . 0.0 110.285 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 42.2 t -57.77 -26.95 62.6 Favored 'General case' 0 N--CA 1.528 3.451 0 C-N-CA 122.886 0.475 . . . . 0.0 111.593 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.38 -35.85 83.01 Favored Glycine 1 N--CA 1.527 4.741 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.29 -40.7 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 C-N-CA 124.428 1.091 . . . . 0.0 108.959 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.23 -42.67 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 C-N-CA 124.524 1.13 . . . . 0.0 108.771 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 30.8 mm -72.38 -33.06 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.627 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.42 -29.71 60.83 Favored Glycine 0 N--CA 1.514 3.88 0 C-N-CA 123.766 0.698 . . . . 0.0 113.362 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 2.5 m -60.43 -37.38 74.39 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 CA-C-N 117.825 0.812 . . . . 0.0 110.653 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 44.5 p -55.92 -46.1 78.55 Favored 'General case' 0 N--CA 1.529 3.517 0 CA-C-O 121.375 0.607 . . . . 0.0 111.403 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.62 -31.92 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.034 0 C-N-CA 124.387 1.075 . . . . 0.0 111.238 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.86 78.99 Favored 'General case' 0 N--CA 1.531 3.588 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.19 -50.28 70.94 Favored 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 28.1 m -63.09 -37.94 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.404 0.547 . . . . 0.0 111.883 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 93.9 t -60.5 -32.71 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 121.77 -0.581 . . . . 0.0 110.232 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.5 -38.08 77.47 Favored 'General case' 0 N--CA 1.532 3.669 0 CA-C-N 118.455 0.571 . . . . 0.0 109.958 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 11.6 mm -54.36 -36.85 35.21 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.026 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.44 -38.09 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 C-N-CA 123.468 0.707 . . . . 0.0 109.829 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.47 -32.21 72.21 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.431 0.692 . . . . 0.0 111.309 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.02 -34.51 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 C-N-CA 122.813 0.445 . . . . 0.0 109.855 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.02 -43.37 83.0 Favored 'General case' 0 N--CA 1.53 3.553 0 C-N-CA 123.07 0.548 . . . . 0.0 112.152 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 4.9 m -67.47 -36.1 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 CA-C-N 118.195 0.452 . . . . 0.0 109.937 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 96.6 m -57.61 -27.13 62.48 Favored 'General case' 0 N--CA 1.526 3.348 0 C-N-CA 123.004 0.521 . . . . 0.0 110.547 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -58.51 -15.71 12.3 Favored 'General case' 0 N--CA 1.531 3.6 0 C-N-CA 122.367 0.267 . . . . 0.0 110.867 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 50.8 m -75.04 -42.07 57.91 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.99 -14.22 21.51 Favored 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.474 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 43.2 tp -87.06 2.3 50.12 Favored 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 46.9 m95 66.92 164.29 0.2 Allowed 'General case' 0 N--CA 1.515 2.799 0 C-N-CA 125.148 1.379 . . . . 0.0 111.214 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.522 3.134 0 C-N-CA 125.358 1.463 . . . . 0.0 107.07 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.521 4.301 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 82.8 p 52.34 46.36 26.8 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 124.055 0.942 . . . . 0.0 112.199 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 43.4 mt -61.91 -26.85 68.41 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.774 0.83 . . . . 0.0 110.607 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 45.2 t -68.43 -26.36 65.48 Favored 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.675 0.79 . . . . 0.0 110.596 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.35 -43.79 77.2 Favored Glycine 0 N--CA 1.512 3.714 0 C-N-CA 123.599 0.619 . . . . 0.0 114.103 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.7 pt -70.68 -35.82 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 10.1 pt -58.56 -41.69 82.63 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.66 0 CA-C-N 119.433 1.015 . . . . 0.0 112.542 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.7 -33.18 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.06 -41.0 96.27 Favored Glycine 1 N--CA 1.516 4.002 0 CA-C-O 119.502 -0.61 . . . . 0.0 114.088 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.9 m -63.73 -36.62 77.17 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.349 0 CA-C-N 118.624 1.212 . . . . 0.0 111.134 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.8 p -55.74 -42.56 75.57 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.828 0.451 . . . . 0.0 111.092 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.93 -34.13 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 C-N-CA 124.059 0.944 . . . . 0.0 111.896 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.93 -42.42 65.4 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.75 -34.08 71.47 Favored 'General case' 0 N--CA 1.519 2.992 0 C-N-CA 123.232 0.613 . . . . 0.0 111.314 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.85 -49.23 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 123.647 0.779 . . . . 0.0 111.345 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.68 -32.71 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 C-N-CA 122.633 0.373 . . . . 0.0 110.674 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.28 -36.86 74.67 Favored 'General case' 0 N--CA 1.539 3.985 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.18 -37.11 34.66 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.352 0 C-N-CA 123.168 0.587 . . . . 0.0 109.975 178.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.1 t -66.93 -38.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 C-N-CA 123.187 0.595 . . . . 0.0 110.143 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -45.53 86.54 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.387 0.675 . . . . 0.0 112.681 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.7 -34.17 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.613 0 O-C-N 121.898 -0.501 . . . . 0.0 110.228 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.15 -44.1 93.15 Favored 'General case' 0 N--CA 1.532 3.629 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.53 -37.29 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 99.5 m -59.14 -27.95 66.11 Favored 'General case' 0 N--CA 1.531 3.6 0 C-N-CA 122.74 0.416 . . . . 0.0 110.859 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -73.29 -35.05 66.07 Favored 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 63.0 m -72.66 -30.86 64.62 Favored 'General case' 0 N--CA 1.525 3.321 0 C-N-CA 123.108 0.563 . . . . 0.0 109.852 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.78 -14.65 62.5 Favored 'General case' 0 N--CA 1.526 3.339 0 C-N-CA 124.513 1.125 . . . . 0.0 110.926 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 38.3 tp -87.33 10.21 18.0 Favored 'General case' 0 N--CA 1.537 3.917 0 C-N-CA 123.763 0.825 . . . . 0.0 110.663 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -66.05 9.31 0.15 Allowed 'General case' 1 N--CA 1.54 4.065 0 C-N-CA 123.217 0.607 . . . . 0.0 112.444 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -50.6 -47.34 58.16 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 124.099 0.96 . . . . 0.0 111.785 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt 61.18 153.72 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 124.384 1.074 . . . . 0.0 111.348 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.529 3.508 0 C-N-CA 125.216 1.406 . . . . 0.0 108.513 -179.898 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.524 3.247 0 N-CA-C 111.234 0.087 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -61.89 -26.5 68.2 Favored 'General case' 0 N--CA 1.529 3.48 0 C-N-CA 124.147 0.979 . . . . 0.0 110.162 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 95.7 p -68.15 -32.15 72.21 Favored 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.556 0.742 . . . . 0.0 110.391 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.86 -46.89 58.41 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.924 0.773 . . . . 0.0 115.0 -178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.9 -41.16 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 tp -60.67 -40.42 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 C-N-CA 122.905 0.482 . . . . 0.0 112.276 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 7.0 tp -73.27 -33.79 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.711 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.13 -47.84 87.07 Favored Glycine 0 N--CA 1.515 3.914 0 C-N-CA 123.799 0.714 . . . . 0.0 114.167 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.16 -37.17 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 CA-C-N 117.566 0.683 . . . . 0.0 111.137 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 61.2 p -66.06 -46.3 78.26 Favored 'General case' 0 N--CA 1.534 3.727 0 CA-C-N 118.136 0.425 . . . . 0.0 110.721 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 84.7 t -70.03 -31.96 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 C-N-CA 123.741 0.817 . . . . 0.0 111.057 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.87 -43.79 66.35 Favored 'General case' 0 N--CA 1.533 3.707 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.06 73.2 Favored 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 123.185 0.594 . . . . 0.0 111.179 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.71 -46.79 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 123.395 0.678 . . . . 0.0 112.292 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.29 -31.58 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 C-N-CA 122.533 0.333 . . . . 0.0 111.39 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.72 -39.64 64.16 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 122.411 -0.181 . . . . 0.0 111.046 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 93.8 mt -59.96 -44.19 94.01 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.097 0 CA-C-N 118.357 0.526 . . . . 0.0 111.653 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 30.0 m -64.07 -36.7 77.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 CA-C-N 118.619 0.645 . . . . 0.0 110.429 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.9 -32.5 71.96 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.238 0.615 . . . . 0.0 111.871 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 86.2 t -71.31 -34.56 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.698 0.399 . . . . 0.0 109.939 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -61.34 -44.02 97.9 Favored 'General case' 0 N--CA 1.53 3.542 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.94 -40.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.858 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 80.7 m -58.67 -27.65 65.0 Favored 'General case' 0 N--CA 1.522 3.17 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.117 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -71.62 -15.85 62.26 Favored 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 122.528 0.331 . . . . 0.0 111.15 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 26.8 t -78.39 -46.55 19.62 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.551 HD13 ' H ' ' B' ' 235' ' ' LEU . 0.0 OUTLIER -83.88 -13.01 54.63 Favored 'General case' 1 N--CA 1.554 4.733 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -175.242 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 1 N--CA 1.566 5.33 0 CA-C-N 121.915 2.143 . . . . 0.0 112.438 -176.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 59.9 p . . . . . 0 N--CA 1.525 3.279 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.65 -26.66 68.75 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 123.955 0.902 . . . . 0.0 109.646 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 38.7 t -67.95 -26.85 66.15 Favored 'General case' 0 N--CA 1.519 2.993 0 C-N-CA 123.645 0.778 . . . . 0.0 110.611 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.14 -46.78 56.87 Favored Glycine 0 N--CA 1.512 3.704 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.321 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 43.2 pt -70.98 -37.97 70.15 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.121 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 7.5 tp -59.05 -31.8 46.49 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.092 0 C-N-CA 123.288 0.635 . . . . 0.0 112.659 -177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.4 pp -71.3 -32.17 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.7 -43.68 79.75 Favored Glycine 0 N--CA 1.512 3.743 0 C-N-CA 124.463 1.03 . . . . 0.0 114.949 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 11.3 p -68.2 -37.13 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 CA-C-N 118.133 0.967 . . . . 0.0 111.011 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.6 p -65.59 -46.49 79.18 Favored 'General case' 0 N--CA 1.531 3.582 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 10.8 p -69.71 -30.68 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.467 0 C-N-CA 123.451 0.7 . . . . 0.0 111.226 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.07 -43.19 63.71 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.59 -37.36 73.89 Favored 'General case' 0 N--CA 1.521 3.099 0 C-N-CA 123.335 0.654 . . . . 0.0 110.863 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.99 -52.13 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.313 0 C-N-CA 123.668 0.787 . . . . 0.0 111.27 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.4 -31.93 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.925 0 CA-C-O 120.91 0.386 . . . . 0.0 110.235 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -46.24 89.61 Favored 'General case' 0 N--CA 1.531 3.59 0 CA-C-O 121.57 0.7 . . . . 0.0 109.583 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.14 -39.51 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 C-N-CA 123.221 0.608 . . . . 0.0 109.814 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.91 -37.78 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.704 0 C-N-CA 123.144 0.578 . . . . 0.0 109.914 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.66 -46.52 88.78 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.386 0.674 . . . . 0.0 112.602 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.71 -34.26 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 O-C-N 121.825 -0.547 . . . . 0.0 109.871 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.68 -43.91 97.59 Favored 'General case' 0 N--CA 1.529 3.515 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.0 -37.69 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.12 -28.59 69.88 Favored 'General case' 0 N--CA 1.525 3.324 0 C-N-CA 123.23 0.612 . . . . 0.0 111.586 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -62.35 -37.27 85.02 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 122.924 0.49 . . . . 0.0 110.664 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 52.7 m -63.78 -26.84 68.82 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.614 0.766 . . . . 0.0 111.102 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 55.6 mt -90.12 -13.44 35.74 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 124.953 1.301 . . . . 0.0 111.281 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 41.7 tp -86.58 -11.3 51.91 Favored 'General case' 1 N--CA 1.54 4.054 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -175.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -60.55 -67.34 0.41 Allowed 'General case' 1 N--CA 1.541 4.114 0 CA-C-N 119.142 0.883 . . . . 0.0 110.007 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 56.55 -144.66 0.65 Allowed 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.77 0.828 . . . . 0.0 110.751 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp 62.14 170.69 0.13 Allowed 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 124.29 1.036 . . . . 0.0 111.304 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.526 3.351 0 C-N-CA 125.249 1.419 . . . . 0.0 107.978 -179.832 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.522 3.142 0 CA-C-O 121.061 0.458 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.2 -26.73 68.27 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 124.167 0.987 . . . . 0.0 109.82 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 45.1 t -68.65 -26.45 65.34 Favored 'General case' 0 N--CA 1.52 3.072 0 C-N-CA 123.358 0.663 . . . . 0.0 110.835 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.05 71.48 Favored Glycine 0 N--CA 1.511 3.642 0 C-N-CA 123.693 0.663 . . . . 0.0 114.08 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 6.4 tp -68.9 -35.97 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.911 0 CA-C-N 117.921 0.861 . . . . 0.0 111.908 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 8.3 pt -65.5 -32.37 57.93 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.461 0 CA-C-N 118.961 0.801 . . . . 0.0 110.16 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.62 -33.69 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 124.301 1.04 . . . . 0.0 108.861 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.24 -29.73 60.33 Favored Glycine 1 N--CA 1.518 4.118 0 C-N-CA 123.523 0.582 . . . . 0.0 113.159 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 m -60.07 -37.35 72.46 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 CA-C-N 117.349 0.574 . . . . 0.0 111.042 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 56.8 p -55.6 -39.74 71.16 Favored 'General case' 0 N--CA 1.524 3.235 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.325 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.7 t -61.88 -46.11 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.277 0 C-N-CA 123.703 0.801 . . . . 0.0 110.668 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.51 -35.09 60.27 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.262 0.625 . . . . 0.0 112.538 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.95 -37.32 81.45 Favored 'General case' 0 N--CA 1.519 2.991 0 C-N-CA 123.482 0.713 . . . . 0.0 111.083 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 28.3 t -56.37 -38.89 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 C-N-CA 123.288 0.635 . . . . 0.0 110.573 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.02 -32.11 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.387 0 C-N-CA 123.554 0.741 . . . . 0.0 110.028 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -44.07 70.45 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.433 0.693 . . . . 0.0 109.555 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.15 -49.19 63.72 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 C-N-CA 123.246 0.618 . . . . 0.0 111.772 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 22.2 m -66.19 -36.28 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 C-N-CA 122.594 0.358 . . . . 0.0 110.327 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.28 66.74 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 123.279 0.632 . . . . 0.0 112.338 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.4 -43.91 94.63 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.005 0 CA-C-N 118.237 0.471 . . . . 0.0 112.09 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -61.16 -43.62 98.6 Favored 'General case' 0 N--CA 1.538 3.951 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.56 -37.55 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 O-C-N 121.771 -0.581 . . . . 0.0 109.609 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 85.3 m -64.25 -27.63 69.18 Favored 'General case' 0 N--CA 1.527 3.385 0 C-N-CA 122.973 0.509 . . . . 0.0 111.105 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -64.36 -27.96 69.37 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.039 0.536 . . . . 0.0 111.423 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 50.5 m -63.73 -37.68 88.28 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 123.629 0.771 . . . . 0.0 111.767 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -60.84 -13.79 17.76 Favored 'General case' 0 N--CA 1.531 3.589 0 C-N-CA 124.625 1.17 . . . . 0.0 112.293 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -86.93 -28.15 22.93 Favored 'General case' 1 N--CA 1.542 4.175 0 CA-C-N 118.423 0.556 . . . . 0.0 110.539 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -73.42 68.25 1.09 Allowed 'General case' 0 N--CA 1.533 3.684 0 CA-C-O 121.387 0.613 . . . . 0.0 109.739 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -109.83 -37.61 5.59 Favored 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 125.096 1.358 . . . . 0.0 108.627 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 60.1 tttp . . . . . 0 N--CA 1.524 3.248 0 C-N-CA 124.651 1.181 . . . . 0.0 111.214 -179.657 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.524 3.241 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.5 -26.86 68.76 Favored 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 123.665 0.786 . . . . 0.0 111.473 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 66.0 m -68.28 -25.86 65.36 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.631 0.772 . . . . 0.0 109.563 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.38 -34.65 59.72 Favored Glycine 0 N--CA 1.512 3.747 0 C-N-CA 124.603 1.097 . . . . 0.0 113.952 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 11.1 tp -59.33 -43.16 89.46 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 CA-C-N 117.67 0.735 . . . . 0.0 112.827 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 5.5 pt -68.85 -34.16 63.07 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.411 0 CA-C-O 121.827 0.822 . . . . 0.0 109.399 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 81.9 mt -73.08 -38.98 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.185 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.56 -46.63 91.83 Favored Glycine 1 N--CA 1.516 4.016 0 CA-C-N 115.606 -0.725 . . . . 0.0 114.374 -177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.13 -37.55 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 CA-C-N 117.506 0.653 . . . . 0.0 110.854 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 70.1 p -66.22 -45.55 80.32 Favored 'General case' 0 N--CA 1.535 3.782 0 CA-C-N 118.354 0.525 . . . . 0.0 110.575 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.24 -31.24 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 C-N-CA 123.964 0.905 . . . . 0.0 110.891 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.32 -47.24 75.93 Favored 'General case' 0 N--CA 1.532 3.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.19 -25.64 67.81 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.571 0.748 . . . . 0.0 112.224 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.53 -37.09 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 C-N-CA 123.526 0.73 . . . . 0.0 109.464 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 46.1 t -55.78 -32.31 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.137 0.575 . . . . 0.0 110.306 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.96 -40.89 91.68 Favored 'General case' 0 N--CA 1.532 3.661 0 C-N-CA 123.017 0.527 . . . . 0.0 109.823 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 34.3 mm -60.62 -44.56 97.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.711 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.84 -39.72 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.258 0 C-N-CA 123.636 0.775 . . . . 0.0 109.855 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.84 87.81 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.676 0.79 . . . . 0.0 112.409 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.82 -34.36 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 O-C-N 121.846 -0.534 . . . . 0.0 110.334 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -63.63 -44.35 94.14 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.15 -37.99 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.9 m -67.26 -30.38 70.25 Favored 'General case' 0 N--CA 1.525 3.286 0 C-N-CA 123.115 0.566 . . . . 0.0 110.911 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -66.67 -35.21 79.61 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.347 0.659 . . . . 0.0 111.237 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 91.8 p -64.83 -33.63 76.46 Favored 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 123.121 0.568 . . . . 0.0 110.94 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 50.7 mt . . . . . 0 N--CA 1.523 3.176 0 C-N-CA 124.022 0.929 . . . . 0.0 111.166 -178.911 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 74.4 p . . . . . 0 N--CA 1.523 3.198 0 CA-C-O 122.042 0.925 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 42.2 mt -60.91 -26.61 67.58 Favored 'General case' 0 N--CA 1.524 3.235 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.952 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 61.9 m -62.99 -26.38 68.82 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.049 0.539 . . . . 0.0 110.069 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.96 -46.51 93.57 Favored Glycine 1 N--CA 1.519 4.23 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.565 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 48.7 pt -70.5 -35.33 61.29 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.141 0 CA-C-N 118.468 1.134 . . . . 0.0 109.85 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . 0.432 ' O ' HG12 ' F' ' 218' ' ' VAL . 49.4 mm -62.38 -44.68 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 29.8 mm -72.88 -33.31 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.89 -29.08 49.93 Favored Glycine 0 N--CA 1.512 3.733 0 C-N-CA 124.666 1.126 . . . . 0.0 113.175 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . 0.432 HG12 ' O ' ' F' ' 215' ' ' ILE . 9.8 p -59.28 -39.25 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 C-N-CA 122.781 0.433 . . . . 0.0 111.199 -177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 72.9 p -65.91 -45.2 82.84 Favored 'General case' 0 N--CA 1.53 3.547 0 CA-C-O 121.657 0.741 . . . . 0.0 109.987 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 43.3 t -68.56 -31.69 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.976 0 C-N-CA 124.588 1.155 . . . . 0.0 111.676 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.65 77.83 Favored 'General case' 0 N--CA 1.533 3.713 0 O-C-N 121.706 -0.621 . . . . 0.0 112.608 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.39 -50.22 74.48 Favored 'General case' 0 N--CA 1.523 3.189 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.36 -38.11 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 CA-C-N 118.321 0.51 . . . . 0.0 111.402 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 84.2 t -56.75 -35.96 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 O-C-N 122.03 -0.419 . . . . 0.0 111.102 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 52.0 tp -66.32 -44.57 83.01 Favored 'General case' 1 N--CA 1.539 4.01 0 CA-C-N 118.809 0.732 . . . . 0.0 109.685 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.47 -42.45 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.465 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.201 -178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.31 -37.98 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 C-N-CA 123.036 0.534 . . . . 0.0 109.58 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.2 88.65 Favored 'General case' 0 N--CA 1.53 3.574 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 17.4 m -71.42 -34.35 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 O-C-N 121.843 -0.536 . . . . 0.0 110.811 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -64.51 -44.17 91.77 Favored 'General case' 0 N--CA 1.531 3.599 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.74 -37.64 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.1 -27.25 68.79 Favored 'General case' 0 N--CA 1.526 3.363 0 C-N-CA 123.437 0.695 . . . . 0.0 111.182 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -63.17 -34.39 77.52 Favored 'General case' 0 N--CA 1.53 3.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.774 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.8 t -66.1 -36.06 82.17 Favored 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.529 0.732 . . . . 0.0 111.432 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 4.4 tt -61.25 -13.97 22.63 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 124.231 1.012 . . . . 0.0 111.613 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 25.6 mt -86.03 -27.99 24.43 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.166 0.586 . . . . 0.0 109.594 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -102.6 98.1 8.2 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 124.543 1.137 . . . . 0.0 108.193 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? . . . . . 0 N--CA 1.527 3.398 0 C-N-CA 124.911 1.285 . . . . 0.0 108.659 -179.505 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.211 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.1 p -165.99 62.57 0.11 Allowed 'General case' 0 N--CA 1.523 3.18 0 CA-C-O 121.826 0.822 . . . . 0.0 108.923 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.02 -26.97 68.81 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 123.907 0.883 . . . . 0.0 110.19 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 69.2 m -68.37 -26.74 65.73 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 123.408 0.683 . . . . 0.0 109.993 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.7 -46.96 92.6 Favored Glycine 1 N--CA 1.519 4.228 0 C-N-CA 123.719 0.676 . . . . 0.0 113.562 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.7 tp -70.9 -35.1 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 CA-C-N 117.795 0.797 . . . . 0.0 109.869 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.83 -43.91 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 123.67 0.788 . . . . 0.0 111.512 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 18.6 tt -73.17 -33.48 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 119.263 0.938 . . . . 0.0 109.838 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.55 97.76 Favored Glycine 1 N--CA 1.521 4.352 0 C-N-CA 123.354 0.502 . . . . 0.0 114.091 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 p -59.93 -36.67 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.913 0 CA-C-N 117.677 0.739 . . . . 0.0 110.258 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.9 p -55.98 -44.86 78.94 Favored 'General case' 0 N--CA 1.536 3.843 0 CA-C-O 121.318 0.58 . . . . 0.0 111.388 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.88 -39.99 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 C-N-CA 124.073 0.949 . . . . 0.0 111.748 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.77 -46.78 74.42 Favored 'General case' 0 N--CA 1.528 3.434 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.36 -50.46 71.5 Favored 'General case' 0 N--CA 1.517 2.894 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.54 -38.48 81.53 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.094 0 CA-C-N 119.079 0.854 . . . . 0.0 112.614 -177.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.14 -32.12 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 CA-C-N 118.354 0.525 . . . . 0.0 110.227 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.38 -44.49 36.07 Favored 'General case' 0 N--CA 1.526 3.326 0 C-N-CA 122.653 0.381 . . . . 0.0 110.471 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.34 -44.8 89.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.034 0 C-N-CA 122.945 0.498 . . . . 0.0 111.869 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 30.6 m -61.29 -36.43 72.82 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.22 0 CA-C-N 118.94 0.791 . . . . 0.0 110.834 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.57 -31.87 66.58 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.234 0.614 . . . . 0.0 111.443 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.29 -41.87 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 123.027 0.531 . . . . 0.0 111.507 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -60.7 -43.95 97.15 Favored 'General case' 1 N--CA 1.541 4.091 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.68 -37.73 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 80.1 m -67.27 -32.65 73.81 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 122.733 0.413 . . . . 0.0 110.004 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -72.18 -29.44 64.0 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 123.715 0.806 . . . . 0.0 110.562 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -66.4 -21.35 66.22 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 123.145 0.578 . . . . 0.0 111.061 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 58.6 mt -91.55 -14.26 30.62 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 124.509 1.124 . . . . 0.0 111.189 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.1 tp -87.35 -28.3 22.3 Favored 'General case' 1 N--CA 1.541 4.111 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -174.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 48.8 p-90 -66.32 -64.21 0.91 Allowed 'General case' 1 N--CA 1.544 4.271 0 CA-C-N 120.272 1.396 . . . . 0.0 111.157 -177.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 54.72 176.41 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.852 0.861 . . . . 0.0 112.316 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -97.19 169.73 9.6 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 124.541 1.136 . . . . 0.0 108.918 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 50.3 t . . . . . 0 N--CA 1.531 3.604 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.811 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 N--CA 1.529 3.479 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.8 -26.79 68.32 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 124.232 1.013 . . . . 0.0 111.064 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 91.4 p -68.19 -30.81 70.0 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.535 0.734 . . . . 0.0 110.609 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.0 -46.9 57.58 Favored Glycine 0 N--CA 1.516 3.988 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.737 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 8.2 tp -71.29 -41.74 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . 0.411 ' O ' HG12 ' B' ' 218' ' ' VAL . 19.4 tt -60.57 -38.71 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.882 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.78 -32.78 41.86 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.101 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.55 -29.41 47.96 Favored Glycine 0 N--CA 1.512 3.717 0 C-N-CA 124.183 0.897 . . . . 0.0 113.923 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . 0.411 HG12 ' O ' ' B' ' 215' ' ' ILE . 8.6 p -59.76 -38.55 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 CA-C-N 117.661 0.73 . . . . 0.0 110.998 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 67.1 p -65.17 -45.53 84.52 Favored 'General case' 0 N--CA 1.528 3.441 0 CA-C-O 121.456 0.646 . . . . 0.0 110.389 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.38 -32.0 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 C-N-CA 124.307 1.043 . . . . 0.0 110.602 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.21 -45.9 82.89 Favored 'General case' 0 N--CA 1.524 3.273 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.95 -41.81 97.49 Favored 'General case' 0 N--CA 1.519 3.0 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.27 -44.14 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.99 -32.75 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 O-C-N 121.293 -0.88 . . . . 0.0 111.457 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 5.4 tt -67.34 -47.54 70.17 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 122.959 0.503 . . . . 0.0 111.446 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 22.8 pt -69.14 -36.29 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 O-C-N 121.671 -0.643 . . . . 0.0 110.884 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.69 -37.36 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.49 -47.47 81.82 Favored 'General case' 0 N--CA 1.532 3.626 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 30.9 m -71.81 -34.53 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 O-C-N 121.939 -0.476 . . . . 0.0 110.605 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -65.61 -43.71 88.78 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.05 -37.0 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.744 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.73 -33.93 70.79 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.308 0.243 . . . . 0.0 110.986 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -74.29 -15.7 60.96 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 122.894 0.478 . . . . 0.0 111.291 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 20.7 t -63.68 -29.13 70.4 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-O 121.467 0.651 . . . . 0.0 109.743 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 57.2 tp -72.18 -31.48 65.96 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.945 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.538 3.935 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.029 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 98.3 p . . . . . 0 N--CA 1.525 3.288 0 CA-C-O 119.65 -0.214 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.29 -26.9 68.28 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.926 0.89 . . . . 0.0 109.719 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 46.7 t -68.42 -26.17 65.4 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 123.524 0.73 . . . . 0.0 110.808 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.1 -46.34 66.07 Favored Glycine 0 N--CA 1.514 3.852 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.875 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.4 tt -70.72 -38.17 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.867 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 15.4 pt -57.04 -43.15 80.61 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.685 0 CA-C-N 119.584 1.084 . . . . 0.0 111.946 -176.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 6.1 tp -73.01 -32.97 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.17 -45.57 95.06 Favored Glycine 1 N--CA 1.518 4.121 0 C-N-CA 123.869 0.747 . . . . 0.0 113.292 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.65 -36.68 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 O-C-N 121.954 -0.733 . . . . 0.0 109.776 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 37.6 m -60.54 -47.08 87.75 Favored 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.74 -31.39 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 123.621 0.769 . . . . 0.0 111.23 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.13 -34.3 56.14 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.483 0.713 . . . . 0.0 112.801 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.8 -50.79 39.51 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.17 -38.44 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.665 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.48 -32.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 CA-C-N 118.255 0.479 . . . . 0.0 110.99 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.96 -42.47 99.16 Favored 'General case' 0 N--CA 1.532 3.641 0 O-C-N 122.198 -0.314 . . . . 0.0 110.428 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -57.22 -36.63 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.629 0 C-N-CA 123.317 0.647 . . . . 0.0 110.636 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.52 -37.81 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 123.444 0.697 . . . . 0.0 109.847 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.97 76.76 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.107 0.563 . . . . 0.0 111.219 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.61 -34.76 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.35 0.66 . . . . 0.0 110.15 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -63.81 -43.8 95.18 Favored 'General case' 0 N--CA 1.531 3.596 0 C-N-CA 123.132 0.573 . . . . 0.0 112.243 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 6.8 p -68.87 -37.46 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.675 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 82.2 m -58.84 -27.77 65.43 Favored 'General case' 0 N--CA 1.531 3.575 0 C-N-CA 122.624 0.37 . . . . 0.0 110.833 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -70.87 -22.05 62.34 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.102 0.561 . . . . 0.0 110.942 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 68.6 p -63.81 -26.49 68.65 Favored 'General case' 0 N--CA 1.534 3.742 0 C-N-CA 123.283 0.633 . . . . 0.0 111.552 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.78 -14.46 21.68 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 124.12 0.968 . . . . 0.0 111.43 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.29 8.04 26.0 Favored 'General case' 0 N--CA 1.538 3.971 0 C-N-CA 123.456 0.702 . . . . 0.0 109.243 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -83.57 26.25 0.69 Allowed 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 124.158 0.983 . . . . 0.0 109.493 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -62.41 -46.26 89.41 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 123.838 0.855 . . . . 0.0 110.863 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -69.13 145.62 53.2 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 123.572 0.749 . . . . 0.0 110.325 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.528 3.448 0 C-N-CA 124.929 1.292 . . . . 0.0 108.205 179.888 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.519 2.98 0 N-CA-C 111.587 0.218 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -24.91 67.61 Favored 'General case' 0 N--CA 1.527 3.385 0 C-N-CA 124.765 1.226 . . . . 0.0 110.968 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 90.3 p -57.19 -25.53 59.15 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 124.133 0.973 . . . . 0.0 111.96 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.63 83.15 Favored Glycine 0 N--CA 1.514 3.858 0 N-CA-C 115.381 0.912 . . . . 0.0 115.381 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 13.0 tt -59.38 -35.07 56.45 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.512 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 16.8 tt -55.69 -31.19 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.874 0 C-N-CA 123.862 0.865 . . . . 0.0 112.918 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.08 -33.57 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.13 -45.22 96.5 Favored Glycine 1 N--CA 1.522 4.419 0 C-N-CA 123.661 0.648 . . . . 0.0 114.298 -177.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -59.72 -36.08 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.962 0 CA-C-N 117.636 0.718 . . . . 0.0 110.231 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 24.5 p -55.9 -45.05 78.76 Favored 'General case' 0 N--CA 1.536 3.847 0 CA-C-O 120.988 0.423 . . . . 0.0 111.408 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.9 t -58.11 -40.64 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 124.15 0.98 . . . . 0.0 112.289 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.51 -45.93 66.46 Favored 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.57 -42.12 71.49 Favored 'General case' 0 N--CA 1.52 3.026 0 C-N-CA 122.691 0.396 . . . . 0.0 111.489 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.01 -43.6 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.156 0 C-N-CA 123.221 0.609 . . . . 0.0 112.42 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.76 -32.85 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.786 0 CA-C-N 118.51 0.596 . . . . 0.0 111.845 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 51.6 tp -66.0 -41.88 90.46 Favored 'General case' 0 N--CA 1.53 3.546 0 CA-C-N 118.034 0.379 . . . . 0.0 110.609 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 93.1 mt -57.48 -37.43 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 C-N-CA 122.782 0.433 . . . . 0.0 110.527 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.92 -44.12 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 122.847 0.459 . . . . 0.0 110.056 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -45.03 87.33 Favored 'General case' 0 N--CA 1.527 3.417 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.72 -33.89 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.685 0 O-C-N 121.583 -0.698 . . . . 0.0 109.684 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -63.81 -43.39 96.4 Favored 'General case' 0 N--CA 1.529 3.502 0 C-N-CA 123.255 0.622 . . . . 0.0 112.489 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.56 -36.82 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 CA-C-N 118.704 0.684 . . . . 0.0 109.645 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 73.6 m -57.9 -27.33 63.22 Favored 'General case' 0 N--CA 1.528 3.451 0 C-N-CA 122.8 0.44 . . . . 0.0 111.017 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -63.76 -27.67 69.35 Favored 'General case' 0 N--CA 1.532 3.657 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 53.2 p -64.19 -34.43 78.07 Favored 'General case' 0 N--CA 1.527 3.405 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -27.55 67.72 Favored 'General case' 0 N--CA 1.526 3.353 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.591 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 38.9 mt -86.82 -28.11 23.12 Favored 'General case' 0 N--CA 1.533 3.724 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -77.9 101.74 6.96 Favored 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.4 159.85 10.79 Favored 'General case' 0 N--CA 1.519 3.006 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 63.4 tttp . . . . . 0 N--CA 1.522 3.147 0 C-N-CA 123.949 0.9 . . . . 0.0 110.085 -179.459 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.52 3.044 0 N-CA-C 111.332 0.123 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.1 -26.61 68.29 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 124.318 1.047 . . . . 0.0 110.403 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 93.1 p -63.08 -25.73 68.5 Favored 'General case' 0 N--CA 1.522 3.155 0 C-N-CA 123.668 0.787 . . . . 0.0 111.134 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.53 -46.72 67.16 Favored Glycine 0 N--CA 1.516 3.973 0 CA-C-N 116.061 -0.518 . . . . 0.0 114.28 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.46 -40.2 72.04 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.07 0 CA-C-N 118.179 0.989 . . . . 0.0 113.659 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 18.0 pt -58.94 -40.53 80.62 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.453 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -175.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.2 tt -72.08 -32.33 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.811 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.2 -28.87 43.61 Favored Glycine 0 N--CA 1.515 3.954 0 C-N-CA 123.94 0.781 . . . . 0.0 113.206 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.34 -37.13 67.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.043 0 CA-C-N 117.501 0.651 . . . . 0.0 110.83 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 62.0 p -59.28 -45.19 91.92 Favored 'General case' 0 N--CA 1.527 3.421 0 C-N-CA 123.338 0.655 . . . . 0.0 111.801 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.69 -35.22 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.341 0 C-N-CA 123.607 0.763 . . . . 0.0 109.915 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.3 -34.23 77.66 Favored 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 123.497 0.719 . . . . 0.0 110.883 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.53 91.26 Favored 'General case' 0 N--CA 1.519 3.021 0 C-N-CA 123.135 0.574 . . . . 0.0 111.614 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.72 -52.8 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.612 0 C-N-CA 123.087 0.555 . . . . 0.0 111.851 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.96 -32.09 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 C-N-CA 122.717 0.407 . . . . 0.0 111.026 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.71 -35.28 79.24 Favored 'General case' 1 N--CA 1.541 4.101 0 C-N-CA 122.815 0.446 . . . . 0.0 110.617 -179.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 81.3 mt -69.28 -35.68 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.16 -36.21 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 C-N-CA 123.257 0.623 . . . . 0.0 109.692 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.35 -42.38 81.88 Favored 'General case' 0 N--CA 1.526 3.367 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 6.3 m -71.73 -34.49 52.09 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.047 0 CA-C-N 119.063 0.847 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -62.53 -43.76 98.03 Favored 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 123.334 0.654 . . . . 0.0 112.383 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 6.9 p -68.72 -37.43 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.58 -27.75 69.17 Favored 'General case' 0 N--CA 1.528 3.475 0 C-N-CA 123.02 0.528 . . . . 0.0 110.627 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -74.26 -18.4 60.73 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.467 0.707 . . . . 0.0 110.593 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 26.7 t -63.5 -46.37 86.43 Favored 'General case' 0 N--CA 1.529 3.494 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.53 3.568 0 C-N-CA 123.506 0.722 . . . . 0.0 112.584 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.52 3.049 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.1 -28.69 69.62 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.894 0.878 . . . . 0.0 109.617 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 96.2 p -68.39 -35.52 77.8 Favored 'General case' 0 N--CA 1.521 3.12 0 C-N-CA 123.415 0.686 . . . . 0.0 109.988 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.27 -47.05 54.61 Favored Glycine 0 N--CA 1.512 3.736 0 CA-C-N 115.03 -0.986 . . . . 0.0 114.646 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.0 -41.85 68.28 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.201 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 20.2 tt -56.87 -32.45 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -31.86 43.96 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.666 0 CA-C-N 120.291 1.405 . . . . 0.0 109.038 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.94 -36.18 60.03 Favored Glycine 0 N--CA 1.51 3.617 0 C-N-CA 124.172 0.892 . . . . 0.0 114.646 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.92 -38.24 75.6 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.17 0 CA-C-N 118.508 1.154 . . . . 0.0 111.015 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 29.9 p -66.41 -45.99 78.07 Favored 'General case' 0 N--CA 1.528 3.468 0 CA-C-O 121.617 0.722 . . . . 0.0 110.334 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 58.0 t -69.48 -33.9 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.006 0 C-N-CA 124.714 1.205 . . . . 0.0 110.535 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.16 68.97 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.51 91.92 Favored 'General case' 0 N--CA 1.518 2.928 0 C-N-CA 123.3 0.64 . . . . 0.0 111.275 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 43.4 t -66.75 -48.91 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.314 0 C-N-CA 123.599 0.76 . . . . 0.0 110.556 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.51 -33.83 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.552 0 C-N-CA 123.278 0.631 . . . . 0.0 110.094 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 33.7 tp -67.21 -34.16 76.9 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.247 0.619 . . . . 0.0 110.339 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 39.4 mt -64.66 -41.1 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.893 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.56 -37.89 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 C-N-CA 122.975 0.51 . . . . 0.0 109.825 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.43 71.01 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.695 0.798 . . . . 0.0 112.278 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.38 -33.97 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 C-N-CA 122.814 0.446 . . . . 0.0 110.244 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -65.98 -44.21 85.58 Favored 'General case' 0 N--CA 1.531 3.588 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.87 -37.73 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 O-C-N 122.232 -0.292 . . . . 0.0 110.55 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 8.3 p -58.74 -27.38 64.88 Favored 'General case' 0 N--CA 1.536 3.845 0 O-C-N 122.218 -0.301 . . . . 0.0 111.248 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -59.88 -18.68 46.36 Favored 'General case' 0 N--CA 1.531 3.62 0 C-N-CA 123.279 0.632 . . . . 0.0 111.203 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 51.5 m -70.34 -30.57 67.57 Favored 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.544 0.738 . . . . 0.0 110.362 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 64.4 mt -60.49 -13.12 11.93 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.398 1.079 . . . . 0.0 111.752 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.57 10.5 13.0 Favored 'General case' 0 N--CA 1.532 3.635 0 C-N-CA 123.196 0.598 . . . . 0.0 110.067 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 59.64 116.24 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 124.601 1.161 . . . . 0.0 112.257 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 mttp . . . . . 0 N--CA 1.526 3.334 0 C-N-CA 125.099 1.36 . . . . 0.0 107.868 179.156 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.519 4.181 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.3 p -97.83 41.92 1.11 Allowed 'General case' 0 N--CA 1.526 3.354 0 C-N-CA 124.685 1.194 . . . . 0.0 109.38 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 54.2 tp -59.98 -26.41 66.02 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 124.264 1.026 . . . . 0.0 110.978 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 71.2 m -57.43 -26.15 60.73 Favored 'General case' 0 N--CA 1.526 3.327 0 C-N-CA 123.735 0.814 . . . . 0.0 111.62 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.35 92.66 Favored Glycine 0 N--CA 1.509 3.566 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.91 -46.22 94.2 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.483 0 CA-C-N 118.772 1.286 . . . . 0.0 112.967 -175.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -67.66 -32.13 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.384 0.674 . . . . 0.0 110.323 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 90.4 mt -66.06 -34.06 67.72 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.013 0 C-N-CA 123.054 0.542 . . . . 0.0 109.848 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.69 -29.81 64.79 Favored Glycine 1 N--CA 1.517 4.055 0 CA-C-O 119.831 -0.427 . . . . 0.0 113.675 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.5 m -61.77 -37.11 77.3 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.29 0 CA-C-N 117.764 0.782 . . . . 0.0 110.907 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.6 p -55.51 -43.39 75.62 Favored 'General case' 0 N--CA 1.524 3.234 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.159 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.96 -45.99 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.073 0 C-N-CA 123.824 0.85 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.46 -45.13 65.95 Favored 'General case' 0 N--CA 1.527 3.403 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.32 90.22 Favored 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 122.953 0.501 . . . . 0.0 111.769 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.2 t -66.66 -39.78 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 122.91 0.484 . . . . 0.0 110.693 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.92 -39.78 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.585 0 C-N-CA 122.863 0.465 . . . . 0.0 110.837 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.26 -37.22 84.63 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 117.897 0.317 . . . . 0.0 111.519 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 99.3 mt -64.27 -42.59 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 C-N-CA 123.308 0.643 . . . . 0.0 110.028 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.76 -41.74 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.25 -45.5 87.68 Favored 'General case' 0 N--CA 1.525 3.309 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.73 -34.31 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 O-C-N 121.723 -0.611 . . . . 0.0 110.08 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.42 -44.24 95.96 Favored 'General case' 0 N--CA 1.529 3.516 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.7 m -68.65 -37.42 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 CA-C-O 121.212 0.53 . . . . 0.0 109.683 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 70.9 m -63.39 -46.08 88.1 Favored 'General case' 0 N--CA 1.523 3.178 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.26 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.67 -19.02 35.74 Favored 'General case' 0 N--CA 1.536 3.857 0 C-N-CA 122.744 0.418 . . . . 0.0 112.007 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 52.0 m -74.59 -40.17 61.76 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 51.0 mt -68.71 -29.16 67.54 Favored 'General case' 0 N--CA 1.524 3.264 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.511 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.04 10.58 16.1 Favored 'General case' 1 N--CA 1.545 4.324 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 54.6 t90 -139.81 70.78 1.37 Allowed 'General case' 0 N--CA 1.53 3.557 0 C-N-CA 124.176 0.99 . . . . 0.0 108.875 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -133.74 -18.56 2.13 Favored 'General case' 0 N--CA 1.534 3.765 0 C-N-CA 125.108 1.363 . . . . 0.0 109.139 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -163.68 86.81 0.51 Allowed 'General case' 0 N--CA 1.525 3.283 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.528 3.459 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.57 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.524 3.228 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 50.2 mt -65.15 -26.64 68.26 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 124.262 1.025 . . . . 0.0 110.098 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.1 m -59.43 -37.1 77.21 Favored 'General case' 0 N--CA 1.525 3.325 0 C-N-CA 123.14 0.576 . . . . 0.0 110.662 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.33 -36.22 92.76 Favored Glycine 1 N--CA 1.522 4.422 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.07 -40.96 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 C-N-CA 124.27 1.028 . . . . 0.0 109.088 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 91.2 mt -67.71 -39.44 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 C-N-CA 124.674 1.189 . . . . 0.0 109.046 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 87.8 mt -71.15 -32.07 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.77 -29.27 41.13 Favored Glycine 0 N--CA 1.515 3.946 0 C-N-CA 123.74 0.686 . . . . 0.0 113.218 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 4.0 m -59.85 -37.36 71.4 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 117.79 0.795 . . . . 0.0 110.475 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.9 p -62.27 -45.57 92.68 Favored 'General case' 0 N--CA 1.528 3.428 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.382 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.13 -35.48 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.194 0 C-N-CA 124.149 0.98 . . . . 0.0 110.485 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.01 -34.55 68.29 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.358 0.663 . . . . 0.0 111.851 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.2 -42.08 72.82 Favored 'General case' 0 N--CA 1.516 2.864 0 C-N-CA 123.205 0.602 . . . . 0.0 111.403 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.2 t -58.99 -47.0 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 C-N-CA 123.565 0.746 . . . . 0.0 112.19 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.9 m -67.1 -32.28 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.468 0 C-N-CA 122.959 0.504 . . . . 0.0 111.635 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.82 -45.08 45.76 Favored 'General case' 0 N--CA 1.524 3.257 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.7 pt -68.86 -36.75 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.904 0 CA-C-N 118.432 0.56 . . . . 0.0 112.468 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.21 -36.96 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 O-C-N 121.532 -0.73 . . . . 0.0 110.151 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.62 -44.98 85.93 Favored 'General case' 0 N--CA 1.526 3.366 0 C-N-CA 123.56 0.744 . . . . 0.0 112.977 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 13.7 m -71.19 -34.19 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 O-C-N 121.737 -0.602 . . . . 0.0 110.543 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -63.07 -44.49 95.65 Favored 'General case' 0 N--CA 1.531 3.612 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.06 -37.54 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.615 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.94 -29.22 66.96 Favored 'General case' 0 N--CA 1.527 3.411 0 C-N-CA 122.714 0.406 . . . . 0.0 111.424 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -64.19 -15.93 60.91 Favored 'General case' 1 N--CA 1.539 4.009 0 CA-C-N 118.048 0.386 . . . . 0.0 111.075 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 41.5 m -64.64 -34.34 78.06 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 51.1 tp -70.08 -28.19 65.22 Favored 'General case' 0 N--CA 1.526 3.335 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.139 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.538 3.934 0 C-N-CA 123.884 0.874 . . . . 0.0 109.582 -179.314 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 N--CA 1.521 3.111 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -64.58 -26.82 68.57 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 124.078 0.951 . . . . 0.0 109.77 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 42.7 t -61.29 -38.66 87.59 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.931 0.892 . . . . 0.0 110.951 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.33 -41.96 76.48 Favored Glycine 0 N--CA 1.513 3.806 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.428 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 61.7 mt -70.62 -45.81 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 C-N-CA 124.498 1.119 . . . . 0.0 113.255 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -56.63 -31.96 36.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.161 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.5 pp -66.98 -31.9 55.57 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.196 0 CA-C-N 119.336 0.971 . . . . 0.0 109.497 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.84 -36.15 59.5 Favored Glycine 0 N--CA 1.51 3.615 0 CA-C-N 115.614 -0.721 . . . . 0.0 114.788 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.46 -45.45 92.83 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 CA-C-N 118.279 1.04 . . . . 0.0 113.104 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 1.3 t -65.03 -45.25 86.25 Favored 'General case' 0 N--CA 1.538 3.945 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.7 -31.14 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.295 0 C-N-CA 122.987 0.515 . . . . 0.0 111.262 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.64 93.43 Favored 'General case' 0 N--CA 1.528 3.471 0 O-C-N 121.803 -0.56 . . . . 0.0 111.987 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.95 -48.03 81.14 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.81 -38.4 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.744 0 CA-C-N 118.196 0.453 . . . . 0.0 111.103 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.26 -40.94 86.01 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.009 0 CA-C-N 118.403 0.547 . . . . 0.0 110.356 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -34.34 77.69 Favored 'General case' 1 N--CA 1.54 4.055 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 tp -54.8 -36.94 38.89 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.401 0 C-N-CA 123.401 0.681 . . . . 0.0 110.483 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.65 -40.96 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 C-N-CA 123.416 0.687 . . . . 0.0 110.545 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.83 -35.61 71.13 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.42 0.688 . . . . 0.0 111.576 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -71.77 -36.61 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.298 0 C-N-CA 123.492 0.717 . . . . 0.0 111.728 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.93 -43.86 64.57 Favored 'General case' 0 N--CA 1.531 3.613 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.42 -37.57 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.087 0.555 . . . . 0.0 110.983 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 15.0 p -62.21 -27.63 69.12 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 122.353 0.261 . . . . 0.0 111.394 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.72 -40.38 84.25 Favored 'General case' 0 N--CA 1.53 3.528 0 CA-C-O 121.007 0.432 . . . . 0.0 110.436 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.7 t -64.03 -22.45 66.94 Favored 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 123.791 0.836 . . . . 0.0 112.467 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.4 tp -67.41 -17.44 64.72 Favored 'General case' 0 N--CA 1.529 3.508 0 C-N-CA 123.345 0.658 . . . . 0.0 110.819 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.35 -28.49 22.18 Favored 'General case' 0 N--CA 1.531 3.584 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -95.72 96.13 8.79 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 124.447 1.099 . . . . 0.0 108.993 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -169.82 9.77 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.382 0 C-N-CA 123.606 0.763 . . . . 0.0 110.511 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.18 137.57 54.95 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.382 0.673 . . . . 0.0 110.093 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.53 3.565 0 C-N-CA 125.176 1.39 . . . . 0.0 108.96 -179.359 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 98.9 p . . . . . 0 N--CA 1.523 3.222 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.18 -26.83 68.32 Favored 'General case' 0 N--CA 1.528 3.475 0 C-N-CA 123.962 0.905 . . . . 0.0 109.099 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 69.4 m -57.73 -26.15 61.39 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 124.105 0.962 . . . . 0.0 110.907 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.41 -35.28 84.51 Favored Glycine 1 N--CA 1.517 4.072 0 C-N-CA 123.657 0.646 . . . . 0.0 113.102 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -46.98 94.94 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 CA-C-N 117.084 0.442 . . . . 0.0 111.89 -177.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.8 -31.76 55.15 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.556 0 C-N-CA 124.038 0.935 . . . . 0.0 109.811 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.29 -33.55 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.29 -33.02 85.6 Favored Glycine 1 N--CA 1.52 4.289 0 C-N-CA 123.69 0.662 . . . . 0.0 112.159 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.23 -43.52 93.5 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.052 0 C-N-CA 124.194 0.997 . . . . 0.0 109.657 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 27.3 p -56.85 -45.31 82.52 Favored 'General case' 0 N--CA 1.525 3.313 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.373 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 49.9 t -67.75 -41.27 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.211 0 C-N-CA 124.251 1.021 . . . . 0.0 111.312 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.3 -44.74 65.2 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.58 81.13 Favored 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 123.254 0.621 . . . . 0.0 111.616 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 t -53.72 -39.49 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.927 0 C-N-CA 123.25 0.62 . . . . 0.0 111.857 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.45 -38.48 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 C-N-CA 122.768 0.427 . . . . 0.0 110.121 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 73.2 mt -70.94 -34.57 71.62 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 122.958 0.503 . . . . 0.0 110.223 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 20.0 mm -60.41 -50.52 80.01 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 C-N-CA 123.532 0.733 . . . . 0.0 110.951 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 31.6 m -66.62 -36.99 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 O-C-N 121.816 -0.553 . . . . 0.0 110.239 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.38 85.92 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.636 0.775 . . . . 0.0 112.594 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 34.4 m -71.98 -34.53 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.696 0 O-C-N 121.823 -0.548 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.58 -43.85 95.77 Favored 'General case' 0 N--CA 1.53 3.525 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.37 -37.22 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 74.3 m -58.76 -27.07 64.61 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.076 0.551 . . . . 0.0 111.845 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.54 -33.21 73.44 Favored 'General case' 0 N--CA 1.537 3.887 0 CA-C-N 118.343 0.519 . . . . 0.0 110.79 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 35.5 t -67.07 -27.86 67.72 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.155 0.582 . . . . 0.0 110.217 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 51.4 tp -89.77 -13.9 35.72 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 124.947 1.299 . . . . 0.0 110.378 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 39.7 tp -85.67 -1.69 57.42 Favored 'General case' 1 N--CA 1.545 4.287 0 CA-C-O 121.046 0.45 . . . . 0.0 109.999 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -139.8 -159.56 0.97 Allowed 'General case' 0 N--CA 1.522 3.125 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 64.27 161.83 0.12 Allowed 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 123.762 0.825 . . . . 0.0 110.283 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? . . . . . 0 N--CA 1.528 3.427 0 C-N-CA 124.218 1.007 . . . . 0.0 110.915 -179.87 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.519 2.978 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 58.3 tp -64.24 -27.04 68.78 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 124.152 0.981 . . . . 0.0 110.216 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 53.8 m -62.02 -25.91 67.93 Favored 'General case' 0 N--CA 1.518 2.955 0 C-N-CA 124.413 1.085 . . . . 0.0 110.681 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.85 -46.72 71.74 Favored Glycine 0 N--CA 1.51 3.62 0 CA-C-N 115.22 -0.9 . . . . 0.0 114.684 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 29.6 pt -71.04 -38.81 73.36 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 CA-C-N 118.826 1.313 . . . . 0.0 113.961 -177.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.7 tp -62.88 -32.52 56.22 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 C-N-CA 123.239 0.616 . . . . 0.0 112.497 -176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.8 -34.03 45.64 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.18 -45.15 83.48 Favored Glycine 0 N--CA 1.515 3.921 0 C-N-CA 124.8 1.191 . . . . 0.0 115.155 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.34 -37.41 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 CA-C-N 117.381 0.591 . . . . 0.0 110.779 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 35.6 p -66.35 -47.27 73.96 Favored 'General case' 0 N--CA 1.532 3.644 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.63 -31.88 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 C-N-CA 123.301 0.64 . . . . 0.0 112.269 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.77 -47.26 70.89 Favored 'General case' 0 N--CA 1.532 3.633 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.59 97.47 Favored 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 123.475 0.71 . . . . 0.0 111.679 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.47 -49.03 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.651 0.78 . . . . 0.0 111.989 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.84 -32.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 C-N-CA 123.321 0.648 . . . . 0.0 110.539 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.33 -39.93 94.88 Favored 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 123.124 0.57 . . . . 0.0 110.143 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.34 -37.7 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 C-N-CA 122.927 0.491 . . . . 0.0 110.426 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.15 -37.85 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 C-N-CA 123.09 0.556 . . . . 0.0 110.28 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.41 -32.27 68.49 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.339 0.655 . . . . 0.0 111.611 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.57 -43.75 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.458 0 C-N-CA 123.299 0.64 . . . . 0.0 111.659 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -62.19 -43.49 98.72 Favored 'General case' 1 N--CA 1.54 4.055 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.14 -38.38 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 95.4 m -67.68 -40.1 84.42 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 122.831 0.452 . . . . 0.0 110.449 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -72.72 -31.16 64.77 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 123.473 0.709 . . . . 0.0 110.454 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 46.2 t -64.44 -34.28 77.82 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.451 0.7 . . . . 0.0 110.765 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.522 3.151 0 C-N-CA 124.358 1.063 . . . . 0.0 109.747 -179.933 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.521 3.124 0 CA-C-O 120.546 0.212 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 44.7 mt -54.78 -25.79 30.31 Favored 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 124.885 1.274 . . . . 0.0 111.437 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 54.1 m -57.69 -36.42 71.94 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.583 0.753 . . . . 0.0 111.31 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.72 -39.52 86.03 Favored Glycine 1 N--CA 1.52 4.259 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.533 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.54 -46.27 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.895 0 C-N-CA 124.181 0.992 . . . . 0.0 110.993 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 215' ' ' ILE . . . . . 0.459 HD13 ' O ' ' F' ' 215' ' ' ILE . 0.0 OUTLIER -68.63 -32.17 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.983 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 85.1 mt -73.3 -40.36 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.93 95.51 Favored Glycine 0 N--CA 1.512 3.748 0 CA-C-N 115.227 -0.897 . . . . 0.0 114.8 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.5 -37.08 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 CA-C-N 117.923 0.862 . . . . 0.0 111.448 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 68.5 p -65.93 -46.5 77.99 Favored 'General case' 0 N--CA 1.533 3.695 0 CA-C-O 120.931 0.396 . . . . 0.0 110.715 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.76 -35.45 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.22 0 C-N-CA 124.051 0.94 . . . . 0.0 110.508 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.12 67.41 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.5 -34.53 69.18 Favored 'General case' 0 N--CA 1.521 3.077 0 C-N-CA 123.142 0.577 . . . . 0.0 112.017 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.42 -39.06 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.316 0 C-N-CA 123.048 0.539 . . . . 0.0 110.653 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.72 -41.32 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 123.427 0.691 . . . . 0.0 111.485 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.22 -35.69 77.9 Favored 'General case' 1 N--CA 1.54 4.026 0 C-N-CA 122.594 0.358 . . . . 0.0 110.743 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 68.7 mt -69.26 -40.9 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 98.4 t -66.74 -37.97 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.465 0 C-N-CA 123.335 0.654 . . . . 0.0 109.442 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.08 -47.66 82.53 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.727 0.811 . . . . 0.0 112.696 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 25.6 m -71.9 -34.51 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 O-C-N 121.993 -0.442 . . . . 0.0 110.195 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -63.86 -44.13 94.02 Favored 'General case' 0 N--CA 1.527 3.382 0 C-N-CA 123.053 0.541 . . . . 0.0 112.334 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.45 -37.7 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 86.4 m -62.77 -27.95 69.64 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 122.92 0.488 . . . . 0.0 110.129 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -69.57 -16.86 63.49 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.173 0.589 . . . . 0.0 110.62 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 19.5 m -68.8 -28.69 66.99 Favored 'General case' 0 N--CA 1.53 3.565 0 C-N-CA 123.062 0.545 . . . . 0.0 110.232 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.22 -23.51 66.44 Favored 'General case' 0 N--CA 1.525 3.289 0 C-N-CA 123.727 0.811 . . . . 0.0 110.715 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 8.2 mp -87.47 -26.16 23.37 Favored 'General case' 0 N--CA 1.534 3.732 0 C-N-CA 123.685 0.794 . . . . 0.0 109.215 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -73.64 92.52 1.97 Allowed 'General case' 0 N--CA 1.526 3.359 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 21.8 pttp . . . . . 0 N--CA 1.518 2.929 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.771 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 CA--C 1.574 1.888 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -78.65 145.66 20.68 Favored 'Trans proline' 0 N--CA 1.534 3.879 0 C-N-CA 122.359 2.04 . . . . 0.0 110.091 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 171.32 -39.93 0.18 Allowed Glycine 1 N--CA 1.517 4.073 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 27.4 t 57.26 55.1 6.13 Favored 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.021 0.928 . . . . 0.0 111.942 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.84 -26.87 68.52 Favored 'General case' 0 N--CA 1.525 3.283 0 C-N-CA 123.989 0.915 . . . . 0.0 110.547 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.4 m -61.71 -26.44 68.04 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 123.498 0.719 . . . . 0.0 110.237 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.9 -35.43 63.55 Favored Glycine 0 N--CA 1.502 3.035 0 C-N-CA 125.108 1.337 . . . . 0.0 115.354 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 16.9 pt -58.0 -33.73 47.03 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.34 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 216' ' ' ILE . 1.3 pp -55.71 -36.41 42.69 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.002 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -174.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 215' ' ' ILE . 5.2 tp -73.49 -38.43 52.69 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.696 0 CA-C-N 119.472 1.033 . . . . 0.0 109.039 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.31 -45.36 88.76 Favored Glycine 1 N--CA 1.522 4.389 0 N-CA-C 114.891 0.716 . . . . 0.0 114.891 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.93 -36.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.971 0 CA-C-N 117.503 0.651 . . . . 0.0 110.724 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.7 p -58.92 -40.61 85.08 Favored 'General case' 0 N--CA 1.535 3.785 0 CA-C-O 121.082 0.467 . . . . 0.0 111.799 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 47.9 t -56.74 -39.31 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 123.753 0.821 . . . . 0.0 111.877 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.08 79.6 Favored 'General case' 0 N--CA 1.529 3.477 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.38 -50.02 56.0 Favored 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 m -63.75 -38.58 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.87 -32.86 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 CA-C-N 118.848 0.749 . . . . 0.0 110.723 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 5.9 tt -65.08 -37.88 88.95 Favored 'General case' 0 N--CA 1.536 3.829 0 CA-C-N 117.878 0.308 . . . . 0.0 110.708 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.8 mt -61.98 -36.67 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.84 0 C-N-CA 123.079 0.552 . . . . 0.0 110.351 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.21 -40.35 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.68 0 C-N-CA 122.968 0.507 . . . . 0.0 110.07 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.8 -32.59 67.71 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.191 0.596 . . . . 0.0 111.528 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.9 t -68.19 -37.96 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 C-N-CA 123.141 0.577 . . . . 0.0 109.87 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -70.1 -34.78 73.57 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.403 0.681 . . . . 0.0 110.086 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.02 -38.13 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 C-N-CA 123.968 0.907 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 79.8 m -60.07 -38.53 83.13 Favored 'General case' 0 N--CA 1.527 3.379 0 CA-C-O 121.195 0.522 . . . . 0.0 109.748 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -74.39 -37.8 63.32 Favored 'General case' 0 N--CA 1.519 2.998 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.208 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 80.0 p -63.76 -46.31 85.84 Favored 'General case' 0 N--CA 1.531 3.615 0 CA-C-O 121.434 0.635 . . . . 0.0 109.595 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.49 -19.35 62.94 Favored 'General case' 0 N--CA 1.53 3.561 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.563 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.7 tp -87.09 -28.21 22.66 Favored 'General case' 1 N--CA 1.541 4.115 0 CA-C-N 119.17 0.895 . . . . 0.0 109.11 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.8 m0 -78.68 107.74 11.59 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -168.0 88.99 0.27 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 11.6 tptp 71.92 -164.21 0.13 Allowed 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 124.052 0.941 . . . . 0.0 109.135 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.51 138.03 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 C-N-CA 124.935 1.294 . . . . 0.0 107.69 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -100.29 102.0 16.75 Favored Pre-proline 0 N--CA 1.53 3.568 0 C-N-CA 125.017 1.327 . . . . 0.0 107.459 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo . . . . . 1 N--CA 1.536 4.014 0 C-N-CA 122.432 2.088 . . . . 0.0 110.788 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 CA--C 1.572 1.816 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.16 -17.1 15.28 Favored 'Trans proline' 1 N--CA 1.536 4.029 0 C-N-CA 122.434 2.089 . . . . 0.0 110.911 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 63.96 -169.54 21.52 Favored Glycine 1 N--CA 1.519 4.21 0 C-N-CA 123.701 0.667 . . . . 0.0 112.211 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 41.9 t -167.53 5.92 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.955 0.902 . . . . 0.0 110.45 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.09 -36.44 84.32 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 124.299 1.04 . . . . 0.0 109.741 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.6 t -57.38 -25.64 59.81 Favored 'General case' 0 N--CA 1.525 3.316 0 C-N-CA 123.612 0.765 . . . . 0.0 110.907 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.44 -34.48 59.79 Favored Glycine 0 N--CA 1.512 3.752 0 C-N-CA 124.948 1.261 . . . . 0.0 114.544 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 17.3 pt -59.39 -34.8 55.43 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -176.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.21 -47.37 80.96 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.333 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.6 tt -72.48 -32.95 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.55 -29.32 47.68 Favored Glycine 0 N--CA 1.515 3.906 0 C-N-CA 123.444 0.545 . . . . 0.0 113.181 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 m -60.0 -37.38 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 CA-C-N 117.551 0.676 . . . . 0.0 111.8 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 1.3 t -61.05 -39.06 88.41 Favored 'General case' 1 N--CA 1.54 4.063 0 CA-C-O 120.825 0.345 . . . . 0.0 111.539 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 47.4 t -60.99 -31.5 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 123.76 0.824 . . . . 0.0 110.517 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.19 77.83 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 123.06 0.544 . . . . 0.0 111.316 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.69 -50.2 58.84 Favored 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.22 -38.56 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.726 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 27.0 m -65.36 -32.01 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 CA-C-N 118.584 0.629 . . . . 0.0 111.394 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 54.1 mt -66.73 -34.57 78.13 Favored 'General case' 0 N--CA 1.533 3.701 0 O-C-N 122.026 -0.421 . . . . 0.0 111.091 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 59.7 mt -61.35 -49.65 83.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.049 0 CA-C-N 118.066 0.394 . . . . 0.0 111.595 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.65 -37.01 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.71 0 O-C-N 121.902 -0.499 . . . . 0.0 110.099 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.55 -47.15 86.66 Favored 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 123.667 0.787 . . . . 0.0 112.603 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.69 -34.38 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.615 0 O-C-N 121.842 -0.536 . . . . 0.0 110.527 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -63.34 -44.36 95.11 Favored 'General case' 0 N--CA 1.528 3.441 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.92 -37.76 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.3 m -67.02 -32.85 74.34 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 122.988 0.515 . . . . 0.0 110.478 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -66.96 -32.26 73.38 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 123.498 0.719 . . . . 0.0 111.054 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 50.6 m -63.82 -29.34 70.55 Favored 'General case' 0 N--CA 1.528 3.454 0 C-N-CA 123.299 0.639 . . . . 0.0 111.244 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.27 -27.35 68.98 Favored 'General case' 0 N--CA 1.528 3.448 0 C-N-CA 123.45 0.7 . . . . 0.0 110.952 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -87.81 -3.4 58.94 Favored 'General case' 0 N--CA 1.538 3.944 0 C-N-CA 123.79 0.836 . . . . 0.0 109.893 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -155.36 67.56 0.65 Allowed 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.858 0.863 . . . . 0.0 108.934 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.31 87.41 2.0 Allowed 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -70.66 67.66 0.37 Allowed 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 123.821 0.848 . . . . 0.0 111.276 -177.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.08 133.05 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 8.5 mp -94.63 145.07 28.97 Favored Pre-proline 0 N--CA 1.532 3.641 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 1 N--CA 1.538 4.108 0 C-N-CA 122.028 1.819 . . . . 0.0 110.627 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 55.8 mtt . . . . . 0 CA--C 1.581 2.162 0 CA-C-O 117.776 -1.106 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.81 -23.32 20.3 Favored 'Trans proline' 1 N--CA 1.548 4.701 0 CA-C-N 122.26 1.843 . . . . 0.0 113.211 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 179.49 -78.31 0.06 OUTLIER Glycine 1 N--CA 1.52 4.297 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 49.8 m 56.22 48.48 17.22 Favored 'General case' 0 N--CA 1.52 3.074 0 C-N-CA 124.123 0.969 . . . . 0.0 111.854 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 pp -62.9 -26.43 68.79 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 123.882 0.873 . . . . 0.0 111.053 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 34.8 t -62.34 -25.88 68.14 Favored 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 123.476 0.71 . . . . 0.0 110.999 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.48 -38.09 86.27 Favored Glycine 0 N--CA 1.514 3.851 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.91 -35.35 59.38 Favored 'Isoleucine or valine' 1 N--CA 1.555 4.803 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.01 -32.67 33.95 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.41 -31.78 55.34 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.194 0 CA-C-N 119.134 0.879 . . . . 0.0 108.781 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.77 -42.65 79.24 Favored Glycine 0 N--CA 1.516 3.987 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.746 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.48 -37.16 77.38 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 CA-C-N 117.989 0.895 . . . . 0.0 110.384 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 26.4 m -62.51 -47.6 83.25 Favored 'General case' 0 N--CA 1.519 3.002 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.502 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 9.4 p -71.21 -31.47 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.359 0 C-N-CA 123.649 0.78 . . . . 0.0 111.171 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.83 60.63 Favored 'General case' 0 N--CA 1.529 3.505 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.99 -50.34 64.63 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.11 -41.5 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.54 -32.65 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.617 0 O-C-N 121.826 -0.546 . . . . 0.0 112.166 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -75.52 -39.95 57.72 Favored 'General case' 0 N--CA 1.528 3.429 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 19.3 pt -69.49 -38.84 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 CA-C-N 118.562 0.619 . . . . 0.0 111.762 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.67 -37.29 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 O-C-N 121.592 -0.692 . . . . 0.0 109.967 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.99 83.8 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 123.737 0.815 . . . . 0.0 113.045 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.53 -34.26 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 O-C-N 121.811 -0.556 . . . . 0.0 110.223 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -64.08 -44.26 92.92 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.96 -37.59 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 87.8 m -64.66 -27.83 69.19 Favored 'General case' 0 N--CA 1.525 3.325 0 C-N-CA 123.038 0.535 . . . . 0.0 110.878 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -70.93 -35.75 72.36 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 122.901 0.48 . . . . 0.0 110.295 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.4 t -63.92 -23.24 67.27 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.499 0.72 . . . . 0.0 112.18 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.69 -21.57 65.32 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 123.336 0.655 . . . . 0.0 110.749 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.68 0.74 55.27 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 123.66 0.784 . . . . 0.0 109.925 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.26 -76.49 0.07 Allowed 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.503 0.721 . . . . 0.0 110.13 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 55.8 -135.61 1.29 Allowed 'General case' 0 N--CA 1.522 3.162 0 C-N-CA 123.891 0.877 . . . . 0.0 111.0 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 57.21 78.56 0.22 Allowed 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 124.199 1.0 . . . . 0.0 111.753 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.2 135.15 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.402 0 C-N-CA 124.968 1.307 . . . . 0.0 107.918 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.56 146.71 31.95 Favored Pre-proline 0 N--CA 1.53 3.549 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 1 N--CA 1.54 4.251 0 C-N-CA 122.101 1.867 . . . . 0.0 110.652 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 CA--C 1.575 1.932 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.76 -57.49 2.23 Favored 'Trans proline' 1 N--CA 1.544 4.464 0 C-N-CA 122.416 2.077 . . . . 0.0 113.746 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 168.69 38.11 0.02 OUTLIER Glycine 1 N--CA 1.518 4.149 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 35.2 t -61.39 -12.51 14.53 Favored 'General case' 0 N--CA 1.522 3.153 0 C-N-CA 123.865 0.866 . . . . 0.0 112.216 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.04 -28.69 69.66 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 123.812 0.845 . . . . 0.0 109.579 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 39.9 t -68.7 -32.35 72.09 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 123.498 0.719 . . . . 0.0 110.493 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.57 -40.27 86.21 Favored Glycine 0 N--CA 1.515 3.944 0 CA-C-N 114.947 -1.024 . . . . 0.0 115.103 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.05 -46.07 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.677 1.238 . . . . 0.0 112.018 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -32.79 50.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.063 0 C-N-CA 124.353 1.061 . . . . 0.0 113.198 -177.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 37.6 pt -71.84 -33.18 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 119.247 0.931 . . . . 0.0 108.527 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.45 -29.88 76.33 Favored Glycine 1 N--CA 1.521 4.316 0 C-N-CA 123.539 0.59 . . . . 0.0 111.878 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.67 -37.95 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.72 0 C-N-CA 124.102 0.961 . . . . 0.0 109.947 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 30.3 p -62.14 -45.08 95.03 Favored 'General case' 0 N--CA 1.531 3.592 0 CA-C-O 121.598 0.713 . . . . 0.0 110.414 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.06 -34.87 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.051 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.102 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.21 -36.54 84.49 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 123.117 0.567 . . . . 0.0 112.46 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.09 -49.97 45.58 Favored 'General case' 0 N--CA 1.512 2.654 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 33.2 m -63.16 -38.8 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.06 -35.96 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.847 0 CA-C-N 118.633 0.651 . . . . 0.0 111.094 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.29 -34.89 78.67 Favored 'General case' 0 N--CA 1.537 3.921 0 C-N-CA 122.543 0.337 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 78.7 mt -64.0 -36.32 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.767 0 C-N-CA 123.113 0.565 . . . . 0.0 110.051 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.29 -38.07 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 122.959 0.504 . . . . 0.0 110.064 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.08 95.09 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.83 -34.31 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 O-C-N 121.762 -0.586 . . . . 0.0 109.61 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -62.29 -43.57 98.52 Favored 'General case' 0 N--CA 1.529 3.483 0 C-N-CA 123.3 0.64 . . . . 0.0 112.531 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.08 -37.3 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 81.7 m -59.36 -32.21 69.9 Favored 'General case' 0 N--CA 1.529 3.517 0 C-N-CA 122.819 0.448 . . . . 0.0 110.897 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.99 -41.4 61.97 Favored 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 66.8 m -63.92 -31.43 72.61 Favored 'General case' 0 N--CA 1.526 3.347 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -36.19 68.12 Favored 'General case' 0 N--CA 1.524 3.275 0 C-N-CA 124.246 1.018 . . . . 0.0 108.495 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 53.8 tp -87.22 -16.72 34.44 Favored 'General case' 0 N--CA 1.538 3.957 0 C-N-CA 123.286 0.634 . . . . 0.0 110.816 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -61.59 -7.15 2.99 Favored 'General case' 0 N--CA 1.532 3.651 0 C-N-CA 123.447 0.699 . . . . 0.0 111.853 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.43 -31.99 72.77 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.602 0.761 . . . . 0.0 110.629 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 64.1 tttt 64.1 177.25 0.17 Allowed 'General case' 0 N--CA 1.531 3.593 0 C-N-CA 123.515 0.726 . . . . 0.0 109.977 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.28 130.01 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 58.7 tp -98.3 103.05 16.05 Favored Pre-proline 0 N--CA 1.528 3.463 0 CA-C-O 117.328 -1.32 . . . . 0.0 108.66 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo . . . . . 1 N--CA 1.537 4.074 0 CA-C-N 122.674 1.991 . . . . 0.0 110.852 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 23.2 ptp . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.746 -1.121 . . . . 0.0 108.053 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.9 130.49 16.85 Favored 'Trans proline' 1 N--CA 1.54 4.225 0 C-N-CA 122.039 1.826 . . . . 0.0 110.286 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.68 -168.67 7.87 Favored Glycine 1 N--CA 1.517 4.083 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 69.8 m -161.18 17.26 0.11 Allowed 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 123.756 0.823 . . . . 0.0 110.044 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 55.9 tp -65.12 -26.93 68.41 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 123.92 0.888 . . . . 0.0 110.177 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.3 p -68.57 -30.76 69.6 Favored 'General case' 0 N--CA 1.52 3.059 0 C-N-CA 123.642 0.777 . . . . 0.0 110.071 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.63 -46.49 61.58 Favored Glycine 0 N--CA 1.515 3.948 0 C-N-CA 124.147 0.879 . . . . 0.0 114.826 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.5 tt -70.73 -41.09 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 122.015 -0.697 . . . . 0.0 112.868 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.0 tt -64.49 -42.21 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 C-N-CA 122.729 0.412 . . . . 0.0 111.577 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . 0.498 HD13 ' O ' ' E' ' 216' ' ' ILE . 0.1 OUTLIER -73.86 -34.39 39.9 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.009 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.553 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.15 -45.29 95.55 Favored Glycine 0 N--CA 1.513 3.801 0 CA-C-N 114.762 -1.108 . . . . 0.0 114.754 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.72 -36.81 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 CA-C-N 117.95 0.875 . . . . 0.0 110.943 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -63.16 -47.8 81.14 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-N 118.339 0.518 . . . . 0.0 112.32 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.43 -35.33 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 123.785 0.834 . . . . 0.0 112.118 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.83 -47.37 70.99 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.2 77.84 Favored 'General case' 0 N--CA 1.517 2.896 0 C-N-CA 123.416 0.686 . . . . 0.0 111.754 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 t -66.68 -49.42 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 C-N-CA 123.224 0.61 . . . . 0.0 110.861 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.26 -32.79 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.498 0 C-N-CA 123.442 0.697 . . . . 0.0 110.917 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.3 tt -64.8 -39.51 93.72 Favored 'General case' 0 N--CA 1.535 3.812 0 C-N-CA 122.991 0.516 . . . . 0.0 110.425 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 88.7 mt -65.35 -36.67 78.26 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 O-C-N 121.508 -0.745 . . . . 0.0 110.283 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.8 -37.44 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 C-N-CA 123.332 0.653 . . . . 0.0 109.807 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.73 -32.09 67.08 Favored 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.398 0.679 . . . . 0.0 111.649 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 46.7 t -68.97 -44.54 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.215 0.606 . . . . 0.0 111.575 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -61.3 -43.12 99.4 Favored 'General case' 1 N--CA 1.54 4.042 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.81 -37.46 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 CA-C-N 118.312 0.505 . . . . 0.0 109.701 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 92.9 m -59.1 -30.48 68.13 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 122.282 -0.261 . . . . 0.0 110.899 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -74.09 -15.47 61.05 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 123.006 0.522 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 67.9 p -63.44 -30.56 71.67 Favored 'General case' 0 N--CA 1.533 3.696 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 57.5 tp -76.36 -30.97 57.79 Favored 'General case' 0 N--CA 1.517 2.909 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.031 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 32.3 mt -87.52 10.16 18.64 Favored 'General case' 0 N--CA 1.533 3.702 0 C-N-CA 123.349 0.659 . . . . 0.0 110.775 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -77.7 25.79 0.19 Allowed 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.855 0.862 . . . . 0.0 110.317 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -66.57 142.51 57.47 Favored 'General case' 0 N--CA 1.525 3.286 0 C-N-CA 123.843 0.857 . . . . 0.0 109.827 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.49 168.76 19.09 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.1 138.38 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 C-N-CA 124.908 1.283 . . . . 0.0 108.373 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 71.6 mt -114.89 99.29 51.86 Favored Pre-proline 0 N--CA 1.526 3.353 0 C-N-CA 124.963 1.305 . . . . 0.0 108.574 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo . . . . . 1 N--CA 1.546 4.562 0 C-N-CA 122.314 2.009 . . . . 0.0 113.756 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.582 2.19 0 CA-C-O 117.474 -1.25 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -89.76 12.14 2.66 Favored 'Trans proline' 0 N--CA 1.535 3.968 0 C-N-CA 122.657 2.238 . . . . 0.0 111.589 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -179.19 -177.41 47.64 Favored Glycine 1 N--CA 1.519 4.185 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 45.8 t -167.91 88.66 0.26 Allowed 'General case' 0 N--CA 1.519 3.006 0 C-N-CA 123.913 0.885 . . . . 0.0 108.977 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 55.8 tp -53.64 -26.76 23.67 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 124.655 1.182 . . . . 0.0 111.44 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 52.9 m -60.88 -40.11 91.79 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.857 0.863 . . . . 0.0 111.462 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.97 -35.6 79.35 Favored Glycine 1 N--CA 1.52 4.239 0 C-N-CA 124.0 0.809 . . . . 0.0 112.823 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 38.6 mm -64.57 -42.7 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 17.2 tt -56.62 -44.38 80.91 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.385 0 CA-C-N 119.466 1.03 . . . . 0.0 112.28 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 16.6 tt -73.73 -33.93 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.73 -42.99 99.6 Favored Glycine 0 N--CA 1.512 3.743 0 CA-C-N 114.884 -1.053 . . . . 0.0 114.609 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.91 -37.13 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 CA-C-N 117.729 0.764 . . . . 0.0 111.038 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 59.3 p -66.01 -46.71 76.98 Favored 'General case' 0 N--CA 1.532 3.641 0 CA-C-N 118.379 0.536 . . . . 0.0 112.064 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 11.4 p -69.94 -31.64 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.51 0 C-N-CA 122.778 0.431 . . . . 0.0 111.099 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.16 -41.13 71.46 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.174 0.59 . . . . 0.0 112.396 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.99 93.1 Favored 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 123.238 0.615 . . . . 0.0 111.074 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.82 -50.0 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.323 0 C-N-CA 123.412 0.685 . . . . 0.0 110.384 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.4 -32.54 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 123.626 0.77 . . . . 0.0 110.35 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.5 -34.99 79.0 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 122.891 0.476 . . . . 0.0 110.78 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.53 -37.36 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.47 -37.86 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 C-N-CA 123.233 0.613 . . . . 0.0 109.637 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.85 78.61 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.631 0.772 . . . . 0.0 112.671 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.79 -34.42 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.616 0 O-C-N 121.901 -0.5 . . . . 0.0 110.336 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -65.67 -43.66 88.62 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.107 0.563 . . . . 0.0 112.446 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.4 -37.55 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 79.5 m -61.21 -27.99 68.83 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 122.962 0.505 . . . . 0.0 111.158 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -72.49 -28.71 63.06 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.378 0.671 . . . . 0.0 110.708 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 28.1 t -65.5 -27.81 68.74 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.138 0.575 . . . . 0.0 111.823 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.83 -14.07 60.73 Favored 'General case' 0 N--CA 1.531 3.609 0 C-N-CA 123.916 0.886 . . . . 0.0 111.009 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 20.3 mt -86.87 1.9 50.96 Favored 'General case' 0 N--CA 1.535 3.81 0 C-N-CA 122.775 0.43 . . . . 0.0 110.606 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -76.82 -50.13 14.17 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.552 0.741 . . . . 0.0 109.274 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -62.94 82.69 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.425 0 C-N-CA 123.76 0.824 . . . . 0.0 111.959 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -136.5 8.09 3.09 Favored 'General case' 0 N--CA 1.534 3.761 0 C-N-CA 124.831 1.252 . . . . 0.0 109.331 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.54 136.22 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 125.149 1.38 . . . . 0.0 107.9 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -94.63 146.33 31.25 Favored Pre-proline 0 N--CA 1.529 3.516 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 1 N--CA 1.539 4.151 0 C-N-CA 122.015 1.81 . . . . 0.0 110.641 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 CA--C 1.573 1.846 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.81 156.44 9.26 Favored 'Trans proline' 1 N--CA 1.544 4.461 0 C-N-CA 122.329 2.019 . . . . 0.0 113.126 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 175.13 -48.01 0.13 Allowed Glycine 1 N--CA 1.517 4.083 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 49.9 m 57.02 48.92 14.75 Favored 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 124.239 1.016 . . . . 0.0 112.503 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.14 -30.7 71.65 Favored 'General case' 0 N--CA 1.534 3.758 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 97.1 p -68.6 -26.71 65.51 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 123.701 0.8 . . . . 0.0 109.789 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.99 -45.04 64.29 Favored Glycine 1 N--CA 1.517 4.075 0 C-N-CA 124.26 0.933 . . . . 0.0 114.979 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 44.2 pt -70.61 -35.86 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.427 HD13 ' O ' ' A' ' 215' ' ' ILE . 0.1 OUTLIER -66.9 -41.38 87.53 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.319 0 CA-C-N 118.524 0.602 . . . . 0.0 110.834 -177.416 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.523 ' O ' HD13 ' A' ' 216' ' ' ILE . 0.0 OUTLIER -72.22 -33.59 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.93 -42.6 96.8 Favored Glycine 1 N--CA 1.518 4.104 0 N-CA-C 114.79 0.676 . . . . 0.0 114.79 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.0 -41.67 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.633 1.216 . . . . 0.0 111.817 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.1 t -66.72 -40.85 88.57 Favored 'General case' 0 N--CA 1.536 3.848 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.16 -30.92 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.725 0 CA-C-N 118.508 0.595 . . . . 0.0 110.279 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.26 -34.7 78.97 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 122.983 0.513 . . . . 0.0 111.696 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.57 -50.41 51.99 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.1 -38.88 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.57 -32.26 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 CA-C-N 118.112 0.414 . . . . 0.0 110.567 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 tt -74.54 -46.45 38.95 Favored 'General case' 0 N--CA 1.531 3.581 0 C-N-CA 123.102 0.561 . . . . 0.0 110.161 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.5 -44.49 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 O-C-N 121.826 -0.546 . . . . 0.0 111.996 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.3 -36.87 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 CA-C-N 118.665 0.666 . . . . 0.0 110.195 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.78 75.58 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.17 0.588 . . . . 0.0 111.847 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.85 -41.41 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 C-N-CA 122.617 0.367 . . . . 0.0 110.283 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.13 -43.86 98.23 Favored 'General case' 0 N--CA 1.529 3.478 0 C-N-CA 123.503 0.721 . . . . 0.0 112.782 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.62 -37.71 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 99.4 m -63.6 -28.09 69.69 Favored 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 122.855 0.462 . . . . 0.0 111.247 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.86 -28.27 67.4 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 123.227 0.611 . . . . 0.0 110.945 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.7 t -64.05 -36.33 83.63 Favored 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 123.337 0.655 . . . . 0.0 111.874 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.97 -14.4 22.47 Favored 'General case' 0 N--CA 1.533 3.699 0 C-N-CA 123.936 0.894 . . . . 0.0 111.104 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 23.5 mt -87.31 -28.32 22.34 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.271 0.629 . . . . 0.0 109.927 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -78.39 -141.42 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 60.6 15.24 5.54 Favored 'General case' 0 N--CA 1.52 3.028 0 C-N-CA 124.32 1.048 . . . . 0.0 112.102 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -160.12 118.86 2.71 Favored 'General case' 0 N--CA 1.53 3.544 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.3 t -112.77 138.41 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.588 0 C-N-CA 125.175 1.39 . . . . 0.0 107.709 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.25 146.74 32.12 Favored Pre-proline 0 N--CA 1.527 3.406 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 1 N--CA 1.541 4.287 0 C-N-CA 122.085 1.857 . . . . 0.0 110.664 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 CA--C 1.576 1.957 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -80.54 -110.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.534 3.864 0 C-N-CA 122.66 2.24 . . . . 0.0 110.099 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 61.27 12.19 30.33 Favored Glycine 1 N--CA 1.52 4.27 0 C-N-CA 123.689 0.661 . . . . 0.0 112.617 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 68.0 m -66.84 178.07 1.46 Allowed 'General case' 0 N--CA 1.521 3.112 0 C-N-CA 123.949 0.9 . . . . 0.0 110.95 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.93 -26.62 68.67 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 124.253 1.021 . . . . 0.0 110.613 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 60.9 m -67.95 -26.03 65.74 Favored 'General case' 0 N--CA 1.522 3.171 0 C-N-CA 123.425 0.69 . . . . 0.0 110.614 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.14 -46.24 66.42 Favored Glycine 0 N--CA 1.514 3.896 0 C-N-CA 123.699 0.666 . . . . 0.0 113.953 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.0 tp -70.67 -35.53 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.955 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 12.1 pt -56.82 -43.61 80.29 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.766 0 CA-C-N 119.83 1.195 . . . . 0.0 112.22 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -73.56 -33.66 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.616 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.65 -45.94 93.32 Favored Glycine 0 N--CA 1.515 3.942 0 CA-C-N 115.494 -0.776 . . . . 0.0 114.069 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.94 -36.78 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.803 0 CA-C-N 117.873 0.836 . . . . 0.0 111.055 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 50.8 p -62.44 -46.22 89.51 Favored 'General case' 0 N--CA 1.534 3.744 0 CA-C-N 118.252 0.478 . . . . 0.0 111.115 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.97 -34.83 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.414 0 C-N-CA 123.87 0.868 . . . . 0.0 110.676 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.93 -36.32 59.56 Favored 'General case' 0 N--CA 1.527 3.381 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -46.1 64.53 Favored 'General case' 0 N--CA 1.517 2.908 0 C-N-CA 123.136 0.575 . . . . 0.0 111.44 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -58.53 -44.79 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.677 0 C-N-CA 123.768 0.827 . . . . 0.0 112.204 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -66.65 -31.5 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.658 0 CA-C-O 121.125 0.488 . . . . 0.0 110.12 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -42.12 97.41 Favored 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.576 0.75 . . . . 0.0 111.906 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.05 -44.61 97.78 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.005 0 C-N-CA 122.892 0.477 . . . . 0.0 111.809 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 18.2 m -66.48 -36.55 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.792 0 O-C-N 121.801 -0.562 . . . . 0.0 109.928 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.3 86.09 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.73 -34.27 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.964 0 O-C-N 121.606 -0.684 . . . . 0.0 109.963 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.73 -44.03 97.16 Favored 'General case' 0 N--CA 1.53 3.542 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.78 -39.06 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 CA-C-O 121.569 0.7 . . . . 0.0 109.415 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.9 m -65.25 -29.48 70.27 Favored 'General case' 0 N--CA 1.521 3.101 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.311 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.36 -37.77 63.4 Favored 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 123.121 0.568 . . . . 0.0 109.477 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 50.5 m -64.15 -29.78 70.88 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.527 0.731 . . . . 0.0 111.245 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.76 -14.56 22.1 Favored 'General case' 0 N--CA 1.534 3.737 0 C-N-CA 123.61 0.764 . . . . 0.0 111.488 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.95 10.34 16.6 Favored 'General case' 1 N--CA 1.54 4.034 0 C-N-CA 123.227 0.611 . . . . 0.0 109.409 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . 0.406 ' H ' ' H ' ' B' ' 238' ' ' LYS . 19.3 t-105 -157.42 -18.35 0.09 Allowed 'General case' 0 N--CA 1.53 3.529 0 C-N-CA 123.561 0.745 . . . . 0.0 109.508 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . 0.406 ' H ' ' H ' ' B' ' 237' ' ' TRP . 90.4 mttt 66.62 -40.17 0.36 Allowed 'General case' 0 N--CA 1.519 2.997 0 C-N-CA 125.443 1.497 . . . . 0.0 113.35 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt 59.33 60.95 2.17 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 123.515 0.726 . . . . 0.0 111.085 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.13 136.72 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 49.8 mt -94.7 146.66 31.82 Favored Pre-proline 0 N--CA 1.527 3.388 0 CA-C-O 117.222 -1.37 . . . . 0.0 108.192 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo . . . . . 1 N--CA 1.54 4.25 0 C-N-CA 122.002 1.801 . . . . 0.0 110.688 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 52.3 tpp . . . . . 0 CA--C 1.572 1.817 0 CA-C-O 116.78 -1.581 . . . . 0.0 107.054 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -76.33 -32.24 4.09 Favored 'Trans proline' 1 N--CA 1.537 4.05 0 CA-C-N 122.9 2.072 . . . . 0.0 110.144 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.04 169.01 49.68 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 70.7 m -165.6 -57.1 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.13 0 C-N-CA 123.873 0.869 . . . . 0.0 108.722 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.95 -27.17 68.66 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 123.944 0.898 . . . . 0.0 110.16 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 99.3 p -68.13 -30.09 69.15 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.655 0.782 . . . . 0.0 110.625 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.22 -47.07 54.95 Favored Glycine 0 N--CA 1.514 3.842 0 CA-C-N 115.956 -0.565 . . . . 0.0 114.444 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.21 -39.35 73.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.088 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -176.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.44 -32.29 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.781 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.17 -32.77 44.44 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.119 0 CA-C-N 119.129 0.877 . . . . 0.0 109.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.21 -29.17 72.19 Favored Glycine 0 N--CA 1.511 3.67 0 C-N-CA 123.776 0.703 . . . . 0.0 113.648 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 5.4 p -59.27 -48.21 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.946 0 CA-C-N 117.558 0.679 . . . . 0.0 112.817 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 8.9 t -66.7 -39.64 88.16 Favored 'General case' 0 N--CA 1.536 3.841 0 CA-C-N 118.056 0.389 . . . . 0.0 110.95 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.38 -33.28 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.269 0 C-N-CA 123.475 0.71 . . . . 0.0 110.26 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.45 -43.08 97.24 Favored 'General case' 0 N--CA 1.526 3.353 0 O-C-N 122.214 -0.304 . . . . 0.0 111.705 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.43 73.3 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 14.6 p -68.4 -38.31 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 CA-C-N 118.042 0.383 . . . . 0.0 111.374 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.98 -32.76 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 C-N-CA 122.715 0.406 . . . . 0.0 110.086 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -37.82 85.5 Favored 'General case' 1 N--CA 1.544 4.265 0 CA-C-O 120.999 0.428 . . . . 0.0 110.013 -178.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 71.8 mt -64.09 -40.72 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.096 0.558 . . . . 0.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.63 -37.29 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 123.789 0.835 . . . . 0.0 109.935 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.67 -32.47 67.35 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.314 0.646 . . . . 0.0 112.071 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.47 -44.14 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.663 0 C-N-CA 122.636 0.375 . . . . 0.0 112.001 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -61.54 -43.67 98.45 Favored 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.5 -37.87 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.698 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 86.4 m -67.36 -34.17 76.75 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 122.93 0.492 . . . . 0.0 110.126 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -69.54 -34.53 74.35 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 123.466 0.706 . . . . 0.0 110.388 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 39.3 t -67.18 -37.51 83.82 Favored 'General case' 0 N--CA 1.522 3.169 0 CA-C-O 121.447 0.642 . . . . 0.0 110.198 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.7 -21.77 62.53 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 124.294 1.037 . . . . 0.0 110.512 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 56.0 tp -87.67 -28.08 22.04 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.72 0.808 . . . . 0.0 109.551 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -71.42 -124.82 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.346 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 54.67 111.39 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 124.311 1.045 . . . . 0.0 112.01 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -164.79 152.79 11.88 Favored 'General case' 0 N--CA 1.522 3.168 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 78.5 t -113.12 128.75 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.65 99.3 33.09 Favored Pre-proline 0 N--CA 1.53 3.546 0 C-N-CA 124.87 1.268 . . . . 0.0 108.237 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo . . . . . 1 N--CA 1.546 4.616 0 C-N-CA 122.254 1.969 . . . . 0.0 113.603 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.574 1.882 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.38 -33.69 10.72 Favored 'Trans proline' 1 N--CA 1.54 4.225 0 C-N-CA 122.234 1.956 . . . . 0.0 110.28 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 176.51 178.08 46.0 Favored Glycine 1 N--CA 1.518 4.133 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 45.3 t -69.38 143.34 53.72 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.633 0.773 . . . . 0.0 110.495 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.18 -26.75 68.29 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 124.242 1.017 . . . . 0.0 110.651 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 46.9 t -65.8 -26.7 67.81 Favored 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 122.959 0.503 . . . . 0.0 110.528 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.22 -46.34 92.94 Favored Glycine 0 N--CA 1.509 3.545 0 C-N-CA 123.439 0.542 . . . . 0.0 114.192 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.38 -35.39 62.13 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.065 0 CA-C-N 118.446 1.123 . . . . 0.0 109.46 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 83.1 mt -64.56 -35.54 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 11.6 mm -72.5 -33.74 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.825 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.52 -47.16 92.53 Favored Glycine 0 N--CA 1.515 3.917 0 C-N-CA 123.983 0.802 . . . . 0.0 113.49 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 14.6 m -68.92 -36.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 O-C-N 121.781 -0.835 . . . . 0.0 109.981 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 32.9 m -60.44 -45.69 92.76 Favored 'General case' 0 N--CA 1.525 3.281 0 C-N-CA 123.577 0.751 . . . . 0.0 112.539 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.63 -30.83 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 C-N-CA 122.94 0.496 . . . . 0.0 110.049 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.72 -45.19 91.07 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 122.685 0.394 . . . . 0.0 111.868 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.99 -25.56 61.21 Favored 'General case' 0 N--CA 1.535 3.801 0 C-N-CA 123.422 0.689 . . . . 0.0 112.286 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.05 -37.04 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 C-N-CA 123.76 0.824 . . . . 0.0 110.326 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 2.6 p -55.97 -34.84 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.784 0 C-N-CA 123.457 0.703 . . . . 0.0 111.63 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 59.9 tp -69.63 -45.27 68.86 Favored 'General case' 0 N--CA 1.521 3.125 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.867 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.53 -49.76 63.83 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.232 0 C-N-CA 122.858 0.463 . . . . 0.0 111.188 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 26.5 m -66.4 -36.86 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 C-N-CA 122.437 0.295 . . . . 0.0 110.465 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.93 -32.91 68.23 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 123.179 0.592 . . . . 0.0 112.389 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 77.5 t -71.72 -34.78 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.73 0 O-C-N 122.021 -0.424 . . . . 0.0 110.283 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -68.46 -43.7 76.44 Favored 'General case' 0 N--CA 1.527 3.402 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 11.5 m -68.49 -37.93 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 O-C-N 122.198 -0.314 . . . . 0.0 111.324 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 15.5 p -65.33 -27.74 68.81 Favored 'General case' 0 N--CA 1.529 3.503 0 C-N-CA 122.217 0.207 . . . . 0.0 111.165 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -63.11 -42.51 99.57 Favored 'General case' 0 N--CA 1.526 3.333 0 CA-C-O 121.276 0.56 . . . . 0.0 109.922 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 69.4 m -65.74 -36.89 84.87 Favored 'General case' 0 N--CA 1.521 3.104 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.873 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . 0.552 HD13 ' O ' ' D' ' 235' ' ' LEU . 1.7 tm? -71.87 -25.88 62.13 Favored 'General case' 0 N--CA 1.528 3.475 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.507 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 49.9 tp -87.4 -12.72 45.42 Favored 'General case' 0 N--CA 1.537 3.886 0 C-N-CA 123.85 0.86 . . . . 0.0 110.883 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -55.66 -15.11 2.64 Favored 'General case' 0 N--CA 1.534 3.74 0 C-N-CA 123.684 0.794 . . . . 0.0 112.103 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.65 -25.4 63.89 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.729 0.812 . . . . 0.0 111.224 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 59.71 -157.65 0.33 Allowed 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.927 0.891 . . . . 0.0 110.169 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.68 137.9 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.578 ' H ' HD23 ' D' ' 241' ' ' LEU . 1.7 pt? -94.38 146.54 31.71 Favored Pre-proline 0 N--CA 1.532 3.661 0 C-N-CA 124.813 1.245 . . . . 0.0 109.808 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo . . . . . 1 N--CA 1.541 4.286 0 C-N-CA 121.964 1.776 . . . . 0.0 110.751 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 CA--C 1.576 1.967 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.58 -53.5 6.94 Favored 'Trans proline' 1 N--CA 1.549 4.756 0 C-N-CA 121.894 1.73 . . . . 0.0 113.95 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.06 159.01 53.46 Favored Glycine 1 N--CA 1.52 4.241 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 89.8 p -165.95 -111.04 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 123.698 0.799 . . . . 0.0 109.133 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 42.8 mt -64.26 -27.5 69.09 Favored 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 124.114 0.966 . . . . 0.0 110.842 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 66.8 m -61.17 -26.62 67.83 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.669 0.788 . . . . 0.0 110.973 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.54 -34.33 88.81 Favored Glycine 0 N--CA 1.513 3.802 0 C-N-CA 125.062 1.315 . . . . 0.0 114.005 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -34.1 49.55 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.249 0 C-N-CA 124.615 1.166 . . . . 0.0 113.876 -174.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 16.3 pt -54.97 -32.36 26.67 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.257 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -174.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 13.0 pt -64.65 -33.36 62.7 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-O 121.256 0.55 . . . . 0.0 109.734 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.7 -50.14 70.93 Favored Glycine 1 N--CA 1.518 4.166 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.726 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.62 -36.81 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 CA-C-N 117.571 0.685 . . . . 0.0 110.384 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 85.9 m -61.77 -46.05 91.23 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 123.479 0.712 . . . . 0.0 112.043 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 70.1 t -69.19 -31.32 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 C-N-CA 123.712 0.805 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.9 -34.91 57.11 Favored 'General case' 0 N--CA 1.536 3.827 0 CA-C-O 121.041 0.448 . . . . 0.0 112.205 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.78 -43.58 65.48 Favored 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 123.37 0.668 . . . . 0.0 110.949 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.56 -43.11 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.38 0 C-N-CA 124.428 1.091 . . . . 0.0 112.62 -176.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 24.7 m -60.7 -31.29 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 O-C-N 121.992 -0.443 . . . . 0.0 111.628 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 46.9 tp -67.69 -36.23 80.28 Favored 'General case' 0 N--CA 1.536 3.855 0 O-C-N 121.474 -0.766 . . . . 0.0 109.875 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 41.1 mm -55.01 -51.98 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 C-N-CA 122.873 0.469 . . . . 0.0 112.157 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 17.2 m -60.57 -36.71 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 C-N-CA 122.356 0.262 . . . . 0.0 110.856 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.55 -31.84 66.51 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.067 0.547 . . . . 0.0 111.153 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.81 -38.21 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 O-C-N 121.99 -0.444 . . . . 0.0 110.353 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -73.04 -32.21 64.93 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 123.203 0.601 . . . . 0.0 110.076 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.56 -37.59 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.246 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.0 m -58.7 -46.79 86.52 Favored 'General case' 0 N--CA 1.524 3.268 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -74.65 -41.57 60.1 Favored 'General case' 0 N--CA 1.532 3.63 0 CA-C-O 121.111 0.481 . . . . 0.0 111.102 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.3 m -64.52 -46.86 81.09 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 123.565 0.746 . . . . 0.0 112.303 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -22.48 63.89 Favored 'General case' 1 N--CA 1.54 4.066 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 43.6 tp -87.65 -9.59 53.78 Favored 'General case' 0 N--CA 1.539 3.984 0 C-N-CA 123.472 0.709 . . . . 0.0 110.613 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -53.87 -14.79 1.07 Allowed 'General case' 0 N--CA 1.531 3.616 0 C-N-CA 123.871 0.868 . . . . 0.0 112.369 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -59.14 154.75 15.31 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.746 0.818 . . . . 0.0 110.459 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -68.55 93.17 0.49 Allowed 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 123.806 0.842 . . . . 0.0 109.993 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.97 121.36 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 57.4 mt -94.58 146.96 32.4 Favored Pre-proline 0 N--CA 1.525 3.296 0 CA-C-O 117.453 -1.26 . . . . 0.0 108.254 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo . . . . . 1 N--CA 1.542 4.369 0 C-N-CA 122.115 1.877 . . . . 0.0 110.814 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 CA--C 1.576 1.958 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.91 -57.18 2.41 Favored 'Trans proline' 1 N--CA 1.544 4.453 0 C-N-CA 122.413 2.075 . . . . 0.0 113.543 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 169.23 -12.6 0.05 OUTLIER Glycine 1 N--CA 1.522 4.405 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 48.5 m 58.39 57.66 3.77 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 124.112 0.965 . . . . 0.0 111.286 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.43 -27.15 69.1 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 124.044 0.938 . . . . 0.0 110.749 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 99.8 p -68.58 -32.63 72.67 Favored 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 123.581 0.752 . . . . 0.0 110.406 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.76 -46.61 60.14 Favored Glycine 1 N--CA 1.516 4.004 0 CA-C-N 115.362 -0.835 . . . . 0.0 114.979 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -70.91 -42.03 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.907 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -60.05 -42.13 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 C-N-CA 122.999 0.52 . . . . 0.0 112.395 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.71 -33.29 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.858 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.26 58.33 Favored Glycine 0 N--CA 1.51 3.617 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.524 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.0 m -59.47 -37.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.913 0 CA-C-N 117.634 0.717 . . . . 0.0 110.928 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 80.5 p -56.39 -46.61 80.03 Favored 'General case' 0 N--CA 1.531 3.584 0 CA-C-O 121.038 0.447 . . . . 0.0 111.214 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.83 -41.96 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 124.456 1.102 . . . . 0.0 110.88 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.55 -47.12 66.98 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.41 0.684 . . . . 0.0 112.633 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.65 -37.05 72.71 Favored 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 123.385 0.674 . . . . 0.0 111.674 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 36.2 t -67.98 -48.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 CA-C-O 121.315 0.578 . . . . 0.0 110.071 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.53 -32.65 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.111 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.388 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 16.1 mt -73.55 -46.7 45.96 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 122.67 0.388 . . . . 0.0 110.95 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 92.1 mt -60.14 -44.77 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 O-C-N 121.531 -0.731 . . . . 0.0 111.437 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.03 -37.8 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.87 0 CA-C-N 118.843 0.747 . . . . 0.0 110.631 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.81 91.09 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.553 0.741 . . . . 0.0 111.828 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 88.5 t -71.57 -34.47 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.348 0 C-N-CA 123.139 0.576 . . . . 0.0 109.777 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.01 -44.21 89.97 Favored 'General case' 0 N--CA 1.53 3.525 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.68 -37.41 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.781 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 88.0 m -61.19 -33.7 73.88 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 122.913 0.485 . . . . 0.0 110.855 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -74.28 -28.47 61.22 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 122.633 0.373 . . . . 0.0 110.461 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 57.5 m -75.27 -17.74 60.23 Favored 'General case' 0 N--CA 1.524 3.227 0 C-N-CA 123.104 0.562 . . . . 0.0 110.855 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.76 -38.43 86.57 Favored 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 123.499 0.72 . . . . 0.0 112.319 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -110.46 10.16 23.27 Favored 'General case' 1 N--CA 1.556 4.844 0 C-N-CA 123.414 0.686 . . . . 0.0 112.342 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -75.65 5.47 6.07 Favored 'General case' 0 N--CA 1.527 3.396 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -163.84 172.53 13.93 Favored 'General case' 0 N--CA 1.516 2.85 0 C-N-CA 124.242 1.017 . . . . 0.0 108.958 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.11 -175.63 3.75 Favored 'General case' 0 N--CA 1.531 3.594 0 C-N-CA 124.565 1.146 . . . . 0.0 109.757 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.12 138.73 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 C-N-CA 125.09 1.356 . . . . 0.0 108.889 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.48 108.25 35.4 Favored Pre-proline 0 N--CA 1.526 3.336 0 CA-C-O 116.882 -1.533 . . . . 0.0 107.237 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo . . . . . 1 N--CA 1.549 4.736 0 C-N-CA 122.753 2.302 . . . . 0.0 114.727 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 85.4 mmm . . . . . 0 CA--C 1.576 1.96 0 CA-C-O 117.641 -1.171 . . . . 0.0 107.883 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.11 -36.62 55.75 Favored 'Trans proline' 1 N--CA 1.548 4.705 0 C-N-CA 121.95 1.766 . . . . 0.0 113.431 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.56 -154.88 0.49 Allowed Glycine 1 N--CA 1.518 4.144 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.761 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 99.3 p -162.61 27.65 0.1 Allowed 'General case' 0 N--CA 1.522 3.125 0 C-N-CA 124.108 0.963 . . . . 0.0 109.2 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 47.5 mt -64.14 -26.55 68.58 Favored 'General case' 0 N--CA 1.522 3.141 0 C-N-CA 124.566 1.147 . . . . 0.0 110.81 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.1 t -57.57 -26.41 61.4 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.606 0.762 . . . . 0.0 111.883 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.65 -34.23 77.92 Favored Glycine 0 N--CA 1.513 3.801 0 C-N-CA 124.724 1.154 . . . . 0.0 114.12 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -46.47 90.79 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.378 0 CA-C-N 117.821 0.81 . . . . 0.0 112.458 -174.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.7 tt -64.84 -31.54 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 C-N-CA 123.116 0.566 . . . . 0.0 110.779 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 51.1 mm -68.22 -33.51 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.37 -50.15 67.48 Favored Glycine 1 N--CA 1.517 4.074 0 C-N-CA 123.119 0.39 . . . . 0.0 113.127 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.0 m -61.85 -35.75 69.75 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 CA-C-N 117.861 0.83 . . . . 0.0 110.655 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.5 m -55.18 -42.28 72.99 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.045 0.538 . . . . 0.0 111.0 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.42 -36.99 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.47 0 C-N-CA 123.483 0.713 . . . . 0.0 110.576 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.47 68.41 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.42 -50.43 65.46 Favored 'General case' 0 N--CA 1.515 2.795 0 C-N-CA 123.315 0.646 . . . . 0.0 112.673 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.02 -38.34 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.784 0 CA-C-N 118.303 0.501 . . . . 0.0 111.311 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.5 t -62.41 -34.65 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 CA-C-N 117.954 0.343 . . . . 0.0 110.391 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.98 -34.53 78.32 Favored 'General case' 0 N--CA 1.529 3.507 0 CA-C-N 117.808 0.276 . . . . 0.0 111.468 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.48 -36.8 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.865 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.74 -37.71 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.692 0 C-N-CA 123.34 0.656 . . . . 0.0 110.212 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.91 -32.52 71.99 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.387 0.675 . . . . 0.0 111.342 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.57 -37.46 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 123.052 0.541 . . . . 0.0 109.899 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.43 -43.78 96.46 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.377 0.671 . . . . 0.0 112.434 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.9 m -68.24 -37.38 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.725 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 93.0 m -62.93 -31.4 72.48 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.989 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -74.43 -38.83 62.91 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 55.9 m -67.37 -28.04 67.61 Favored 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 123.384 0.674 . . . . 0.0 110.576 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.54 -34.54 78.13 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.463 0.705 . . . . 0.0 111.896 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.32 8.1 37.71 Favored 'General case' 1 N--CA 1.544 4.248 0 C-N-CA 123.092 0.557 . . . . 0.0 111.691 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -71.24 2.53 4.58 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 123.479 0.711 . . . . 0.0 110.471 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -52.37 173.57 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 124.52 1.128 . . . . 0.0 112.25 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -63.17 146.36 53.52 Favored 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 124.056 0.942 . . . . 0.0 111.281 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.51 138.29 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.402 0 C-N-CA 125.081 1.352 . . . . 0.0 108.128 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 66.4 mt -113.6 99.27 49.36 Favored Pre-proline 0 N--CA 1.525 3.319 0 C-N-CA 124.814 1.246 . . . . 0.0 108.629 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo . . . . . 1 N--CA 1.547 4.641 0 C-N-CA 122.345 2.03 . . . . 0.0 114.132 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.573 1.854 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.74 -40.06 4.11 Favored 'Trans proline' 1 N--CA 1.54 4.225 0 C-N-CA 122.02 1.813 . . . . 0.0 110.755 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 171.89 -163.42 35.86 Favored Glycine 1 N--CA 1.518 4.156 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 48.1 t -165.67 -57.59 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.925 0 C-N-CA 123.794 0.837 . . . . 0.0 109.11 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.09 -31.96 73.42 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 123.945 0.898 . . . . 0.0 110.162 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.9 t -68.36 -27.95 66.7 Favored 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 123.592 0.757 . . . . 0.0 110.631 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.04 -46.58 58.39 Favored Glycine 0 N--CA 1.514 3.872 0 C-N-CA 124.078 0.847 . . . . 0.0 114.723 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.8 pt -70.71 -37.35 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -64.29 -41.39 92.23 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.054 0 CA-C-N 118.376 0.534 . . . . 0.0 111.609 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.88 -33.28 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.31 -50.11 64.35 Favored Glycine 0 N--CA 1.513 3.807 0 C-N-CA 124.331 0.967 . . . . 0.0 113.906 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.32 -37.13 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 O-C-N 122.22 -0.577 . . . . 0.0 109.887 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 82.0 m -65.31 -47.22 77.34 Favored 'General case' 0 N--CA 1.523 3.204 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.3 p -70.74 -31.54 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 CA-C-N 118.117 0.417 . . . . 0.0 111.611 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.7 67.59 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.44 -36.41 83.83 Favored 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 123.121 0.568 . . . . 0.0 111.506 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 48.0 t -68.13 -52.11 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 C-N-CA 123.525 0.73 . . . . 0.0 111.779 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.08 -35.18 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.457 0 O-C-N 121.413 -0.804 . . . . 0.0 111.944 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 tt -75.01 -43.71 52.2 Favored 'General case' 0 N--CA 1.528 3.444 0 C-N-CA 122.58 0.352 . . . . 0.0 111.204 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 14.8 tt -65.73 -39.75 85.79 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 O-C-N 121.211 -0.931 . . . . 0.0 111.197 -177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.26 -37.42 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 C-N-CA 123.099 0.56 . . . . 0.0 109.939 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.85 -32.77 67.96 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.25 -38.63 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.594 0 CA-C-N 118.049 0.386 . . . . 0.0 111.386 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -64.39 -44.25 91.9 Favored 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.95 -39.89 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.467 0 C-N-CA 122.841 0.457 . . . . 0.0 110.109 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 99.0 m -67.55 -28.25 67.63 Favored 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 123.242 0.617 . . . . 0.0 111.226 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.3 -45.97 44.13 Favored 'General case' 0 N--CA 1.528 3.436 0 CA-C-O 121.123 0.487 . . . . 0.0 110.499 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.7 t -63.78 -19.05 64.69 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 123.629 0.772 . . . . 0.0 112.203 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 49.7 tp -69.24 -15.64 63.42 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.616 0.766 . . . . 0.0 110.614 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.52 -4.03 58.99 Favored 'General case' 0 N--CA 1.534 3.76 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 72.7 m95 61.5 160.8 0.06 Allowed 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 124.521 1.128 . . . . 0.0 110.668 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -129.49 -121.82 0.22 Allowed 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 124.615 1.166 . . . . 0.0 108.281 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -66.0 130.62 43.89 Favored 'General case' 0 N--CA 1.523 3.215 0 C-N-CA 123.501 0.72 . . . . 0.0 109.815 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 24.1 m -135.04 138.71 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 125.167 1.387 . . . . 0.0 108.338 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.25 146.64 31.94 Favored Pre-proline 0 N--CA 1.53 3.574 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 1 N--CA 1.54 4.25 0 C-N-CA 122.142 1.895 . . . . 0.0 110.843 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 66.4 mtp . . . . . 0 CA--C 1.584 2.262 0 CA-C-O 117.563 -1.208 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.82 172.4 15.92 Favored 'Trans proline' 1 N--CA 1.543 4.406 0 CA-C-N 122.914 2.076 . . . . 0.0 110.276 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.26 -43.11 93.64 Favored Glycine 1 N--CA 1.519 4.195 0 C-N-CA 123.683 0.659 . . . . 0.0 111.985 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 50.5 m 57.85 61.27 2.45 Favored 'General case' 0 N--CA 1.523 3.214 0 C-N-CA 124.032 0.933 . . . . 0.0 111.625 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.34 -26.97 68.71 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 123.906 0.883 . . . . 0.0 110.294 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.2 m -68.41 -29.82 68.58 Favored 'General case' 0 N--CA 1.52 3.03 0 C-N-CA 123.636 0.775 . . . . 0.0 110.297 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.03 -46.67 58.13 Favored Glycine 1 N--CA 1.516 4.024 0 C-N-CA 123.96 0.79 . . . . 0.0 114.935 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 8.1 tp -70.97 -41.56 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.07 -41.07 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 C-N-CA 123.082 0.553 . . . . 0.0 112.335 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.94 -33.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.18 -28.21 41.46 Favored Glycine 1 N--CA 1.516 4.022 0 C-N-CA 124.54 1.066 . . . . 0.0 113.754 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 5.3 m -58.58 -37.04 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.789 0 CA-C-N 117.482 0.641 . . . . 0.0 111.587 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 7.7 t -55.78 -44.3 77.61 Favored 'General case' 0 N--CA 1.538 3.968 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.27 -31.72 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 C-N-CA 123.355 0.662 . . . . 0.0 110.85 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.76 -46.68 77.83 Favored 'General case' 0 N--CA 1.535 3.785 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.04 74.26 Favored 'General case' 0 N--CA 1.514 2.763 0 C-N-CA 123.529 0.732 . . . . 0.0 111.526 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 38.0 t -64.49 -47.77 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.682 0 C-N-CA 123.49 0.716 . . . . 0.0 110.663 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.48 -32.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 123.586 0.755 . . . . 0.0 109.995 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 36.1 tp -76.81 -33.87 57.96 Favored 'General case' 0 N--CA 1.516 2.865 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 tp -54.84 -43.83 69.48 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 C-N-CA 123.455 0.702 . . . . 0.0 112.267 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 12.6 m -64.73 -37.47 80.23 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.152 0 O-C-N 121.957 -0.464 . . . . 0.0 110.542 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.04 -32.27 67.83 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 122.949 0.5 . . . . 0.0 111.127 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.2 -35.0 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.789 0 C-N-CA 122.739 0.416 . . . . 0.0 110.256 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -72.11 -38.91 69.22 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 123.281 0.632 . . . . 0.0 109.672 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.11 -37.37 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 C-N-CA 124.136 0.974 . . . . 0.0 109.634 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.68 -38.39 78.11 Favored 'General case' 0 N--CA 1.523 3.19 0 C-N-CA 122.781 0.432 . . . . 0.0 110.081 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -74.2 -37.33 63.93 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 122.978 0.511 . . . . 0.0 110.114 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 32.1 t -64.23 -41.48 96.99 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.9 tp -65.19 -16.26 63.33 Favored 'General case' 0 N--CA 1.522 3.129 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.767 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.29 -23.55 14.38 Favored 'General case' 1 N--CA 1.557 4.92 0 C-N-CA 124.262 1.025 . . . . 0.0 108.655 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -108.19 94.58 5.15 Favored 'General case' 0 N--CA 1.53 3.561 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 26.07 0.09 Allowed 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.599 0.76 . . . . 0.0 110.841 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -54.57 154.41 4.88 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 124.143 0.977 . . . . 0.0 112.302 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.47 138.49 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 49.3 mt -94.34 146.53 31.71 Favored Pre-proline 0 N--CA 1.529 3.488 0 CA-C-O 117.399 -1.286 . . . . 0.0 108.554 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 1 N--CA 1.54 4.246 0 C-N-CA 122.101 1.867 . . . . 0.0 110.734 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.14 173.29 13.18 Favored 'Trans proline' 1 N--CA 1.539 4.159 0 C-N-CA 122.074 1.85 . . . . 0.0 110.392 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -175.29 36.64 0.1 Allowed Glycine 1 N--CA 1.519 4.172 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 60.0 p 56.44 67.44 1.0 Allowed 'General case' 0 N--CA 1.522 3.145 0 C-N-CA 124.317 1.047 . . . . 0.0 111.711 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.03 -26.69 68.68 Favored 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 123.982 0.913 . . . . 0.0 109.735 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 64.0 m -60.45 -26.66 66.91 Favored 'General case' 0 N--CA 1.522 3.157 0 C-N-CA 123.542 0.737 . . . . 0.0 110.924 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.53 -42.17 82.04 Favored Glycine 0 N--CA 1.513 3.775 0 C-N-CA 124.262 0.934 . . . . 0.0 115.385 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -46.38 69.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.239 0 CA-C-N 118.192 0.996 . . . . 0.0 111.546 -176.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 19.7 tt -61.05 -35.55 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.14 -33.15 45.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.063 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.25 -47.41 90.98 Favored Glycine 0 N--CA 1.513 3.791 0 C-N-CA 123.831 0.729 . . . . 0.0 113.29 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 15.1 m -68.83 -37.1 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 CA-C-N 118.119 0.96 . . . . 0.0 110.141 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 37.9 m -62.04 -46.29 89.83 Favored 'General case' 0 N--CA 1.516 2.875 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.469 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 11.8 p -69.67 -31.55 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.546 0 CA-C-N 117.973 0.351 . . . . 0.0 110.572 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.9 70.82 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 122.635 0.374 . . . . 0.0 111.45 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.22 -37.74 86.26 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 123.558 0.743 . . . . 0.0 110.911 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.66 -42.8 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.376 0 C-N-CA 123.597 0.759 . . . . 0.0 110.563 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.08 -44.49 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.285 0.634 . . . . 0.0 111.361 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.2 -35.22 63.91 Favored 'General case' 0 N--CA 1.523 3.203 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 17.9 tt -69.63 -40.3 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 CA-C-N 118.627 0.649 . . . . 0.0 111.162 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.59 -36.97 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 O-C-N 121.942 -0.473 . . . . 0.0 109.948 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.45 82.22 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.945 0.898 . . . . 0.0 112.798 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.68 -34.18 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 O-C-N 121.915 -0.49 . . . . 0.0 110.084 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -64.38 -43.85 93.18 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.015 0.526 . . . . 0.0 112.316 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.59 -37.38 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.832 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 98.5 m -60.05 -28.84 68.11 Favored 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 122.768 0.427 . . . . 0.0 110.945 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -72.83 -32.46 65.51 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.988 0.515 . . . . 0.0 110.564 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 32.1 t -63.75 -17.76 63.36 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 123.159 0.584 . . . . 0.0 112.33 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.62 -20.79 65.12 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 123.503 0.721 . . . . 0.0 112.72 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.44 -5.22 58.92 Favored 'General case' 1 N--CA 1.544 4.262 0 CA-C-N 118.723 0.692 . . . . 0.0 111.116 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -64.89 -16.16 62.88 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.5 0.72 . . . . 0.0 110.622 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.44 161.2 14.72 Favored 'General case' 0 N--CA 1.523 3.199 0 C-N-CA 123.937 0.895 . . . . 0.0 110.651 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.9 168.28 15.58 Favored 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.901 0.88 . . . . 0.0 110.057 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.2 138.48 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.407 0 C-N-CA 124.859 1.264 . . . . 0.0 108.202 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.36 146.51 31.66 Favored Pre-proline 0 N--CA 1.529 3.513 0 CA-C-O 116.579 -1.677 . . . . 0.0 107.095 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 1 N--CA 1.549 4.773 0 C-N-CA 123.015 2.477 . . . . 0.0 114.905 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 CA--C 1.573 1.836 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.62 154.44 12.12 Favored 'Trans proline' 1 N--CA 1.542 4.38 0 C-N-CA 122.356 2.037 . . . . 0.0 113.086 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.7 67.52 2.05 Favored Glycine 1 N--CA 1.517 4.091 0 C-N-CA 123.678 0.656 . . . . 0.0 112.025 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 87.8 p -64.26 -78.2 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.757 0.823 . . . . 0.0 110.991 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.19 -26.8 68.31 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 124.33 1.052 . . . . 0.0 110.714 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 65.6 m -57.89 -38.47 75.86 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 123.735 0.814 . . . . 0.0 111.254 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.87 -35.72 80.17 Favored Glycine 1 N--CA 1.518 4.147 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.212 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.31 -46.61 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.323 0 C-N-CA 124.072 0.949 . . . . 0.0 112.773 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.3 tt -66.45 -35.22 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.82 -32.95 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.9 -36.49 60.33 Favored Glycine 0 N--CA 1.514 3.854 0 C-N-CA 123.738 0.685 . . . . 0.0 114.683 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.47 -37.56 79.88 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.159 0 CA-C-N 118.214 1.007 . . . . 0.0 110.94 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 26.5 p -63.86 -45.82 87.75 Favored 'General case' 0 N--CA 1.527 3.402 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.931 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 50.9 t -66.92 -31.56 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.163 0 C-N-CA 124.426 1.09 . . . . 0.0 111.328 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.91 -43.07 65.94 Favored 'General case' 0 N--CA 1.532 3.647 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.47 -45.58 65.44 Favored 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 123.188 0.595 . . . . 0.0 110.364 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.97 -47.55 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 124.307 1.043 . . . . 0.0 112.969 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.55 -32.21 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.922 0 CA-C-N 118.093 0.406 . . . . 0.0 110.954 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 83.9 mt -68.67 -33.95 74.86 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 122.579 0.352 . . . . 0.0 110.383 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 46.6 mm -55.01 -39.79 51.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.232 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.01 -41.61 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.127 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.1 94.52 Favored 'General case' 0 N--CA 1.528 3.461 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.96 -34.12 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 O-C-N 121.718 -0.614 . . . . 0.0 109.476 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -63.03 -43.67 98.05 Favored 'General case' 0 N--CA 1.53 3.548 0 C-N-CA 123.103 0.561 . . . . 0.0 112.327 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.4 -37.57 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.7 m -61.51 -31.08 71.07 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.002 0.521 . . . . 0.0 110.358 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -73.86 -41.29 62.43 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 66.7 m -64.69 -32.62 74.37 Favored 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 123.482 0.713 . . . . 0.0 109.843 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -72.29 -29.45 63.88 Favored 'General case' 0 N--CA 1.524 3.27 0 C-N-CA 123.862 0.865 . . . . 0.0 109.287 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 56.3 tp -87.11 -21.35 26.06 Favored 'General case' 0 N--CA 1.533 3.694 0 C-N-CA 123.848 0.859 . . . . 0.0 110.533 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -62.55 -13.08 26.93 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.48 0.712 . . . . 0.0 110.819 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -59.62 -101.61 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 124.165 0.986 . . . . 0.0 110.546 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -72.5 162.49 29.41 Favored 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 123.662 0.785 . . . . 0.0 109.575 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.19 138.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 C-N-CA 124.786 1.234 . . . . 0.0 108.169 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 58.5 tp -95.28 104.91 16.89 Favored Pre-proline 0 N--CA 1.529 3.514 0 CA-C-O 117.223 -1.37 . . . . 0.0 108.253 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo . . . . . 1 N--CA 1.537 4.059 0 CA-C-N 122.766 2.024 . . . . 0.0 111.063 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.37 -178.48 0.03 OUTLIER 'Trans proline' 1 N--CA 1.546 4.561 0 C-N-CA 122.462 2.108 . . . . 0.0 113.903 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 71.6 166.74 8.0 Favored Glycine 1 N--CA 1.516 4.024 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.067 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 72.4 m -163.63 -1.13 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 123.934 0.894 . . . . 0.0 110.244 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 40.6 mt -64.98 -26.93 68.5 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.727 0.811 . . . . 0.0 110.54 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 69.6 m -68.5 -30.82 69.74 Favored 'General case' 0 N--CA 1.518 2.968 0 C-N-CA 123.753 0.821 . . . . 0.0 110.396 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.57 -46.33 62.78 Favored Glycine 0 N--CA 1.515 3.955 0 C-N-CA 124.3 0.952 . . . . 0.0 114.912 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 19.3 tt -71.01 -40.48 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.22 -40.28 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 C-N-CA 122.9 0.48 . . . . 0.0 112.075 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.1 tt -72.79 -32.8 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.47 -28.4 44.33 Favored Glycine 0 N--CA 1.51 3.572 0 C-N-CA 124.689 1.138 . . . . 0.0 113.442 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.6 m -58.87 -37.21 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.801 0 CA-C-N 117.339 0.569 . . . . 0.0 111.128 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 65.1 p -61.19 -46.39 90.68 Favored 'General case' 0 N--CA 1.533 3.72 0 CA-C-O 121.258 0.551 . . . . 0.0 110.926 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.75 -31.82 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 C-N-CA 124.545 1.138 . . . . 0.0 110.873 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.92 -42.02 71.7 Favored 'General case' 0 N--CA 1.531 3.623 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.67 90.92 Favored 'General case' 0 N--CA 1.517 2.906 0 C-N-CA 123.56 0.744 . . . . 0.0 111.169 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 26.5 t -58.63 -51.7 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.559 0.744 . . . . 0.0 111.63 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -67.06 -31.97 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 C-N-CA 123.078 0.551 . . . . 0.0 110.567 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.12 -35.46 61.7 Favored 'General case' 0 N--CA 1.533 3.718 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.68 -48.21 72.24 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.578 0 O-C-N 121.593 -0.692 . . . . 0.0 110.976 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 12.4 m -65.77 -36.35 77.35 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.042 0 O-C-N 121.902 -0.499 . . . . 0.0 110.378 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.01 68.14 Favored 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 122.865 0.466 . . . . 0.0 111.434 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.3 -34.82 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 C-N-CA 122.882 0.473 . . . . 0.0 110.41 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -72.66 -43.26 63.4 Favored 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.183 0.593 . . . . 0.0 112.399 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.83 -37.21 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 O-C-N 122.165 -0.335 . . . . 0.0 111.383 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 28.1 p -66.98 -27.71 67.66 Favored 'General case' 0 N--CA 1.53 3.548 0 O-C-N 122.311 -0.243 . . . . 0.0 110.971 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -68.53 -30.51 69.32 Favored 'General case' 0 N--CA 1.531 3.604 0 C-N-CA 123.029 0.532 . . . . 0.0 110.055 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 39.6 t -67.53 -39.62 85.06 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-O 121.437 0.637 . . . . 0.0 110.166 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -13.69 13.4 Favored 'General case' 0 N--CA 1.535 3.805 0 C-N-CA 125.567 1.547 . . . . 0.0 111.339 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 54.3 tp -86.77 -16.85 35.05 Favored 'General case' 1 N--CA 1.544 4.262 0 C-N-CA 123.656 0.782 . . . . 0.0 110.178 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -143.1 78.93 1.63 Allowed 'General case' 0 N--CA 1.52 3.043 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -147.13 -21.66 0.4 Allowed 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 124.482 1.113 . . . . 0.0 110.183 -175.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -70.13 100.59 1.67 Allowed 'General case' 0 N--CA 1.524 3.259 0 C-N-CA 123.835 0.854 . . . . 0.0 109.284 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 8.1 p -135.49 138.2 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 124.704 1.201 . . . . 0.0 108.739 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 75.6 mt -102.25 99.93 14.06 Favored Pre-proline 0 N--CA 1.527 3.376 0 C-N-CA 124.849 1.259 . . . . 0.0 108.606 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 N--CA 1.535 3.942 0 C-N-CA 122.433 2.089 . . . . 0.0 110.869 -179.262 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.181 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.55 125.84 10.99 Favored 'Trans proline' 1 N--CA 1.538 4.14 0 C-N-CA 121.931 1.754 . . . . 0.0 110.47 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.38 141.63 15.98 Favored Glycine 1 N--CA 1.518 4.154 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 47.8 t -168.38 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 CA-C-N 117.692 0.746 . . . . 0.0 110.305 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 tt -54.67 -28.47 47.68 Favored 'General case' 0 N--CA 1.53 3.558 0 C-N-CA 123.647 0.779 . . . . 0.0 111.234 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 46.5 t -66.52 -42.22 87.63 Favored 'General case' 0 N--CA 1.52 3.026 0 C-N-CA 123.734 0.813 . . . . 0.0 110.522 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.38 69.18 Favored Glycine 1 N--CA 1.517 4.099 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.65 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.96 -46.29 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.306 0 C-N-CA 124.003 0.921 . . . . 0.0 111.556 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 215' ' ' ILE . 0.2 OUTLIER -67.59 -32.79 58.5 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.016 0 CA-C-O 121.268 0.556 . . . . 0.0 109.704 -178.435 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 6.3 mm -71.94 -37.0 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 C-N-CA 123.863 0.865 . . . . 0.0 109.314 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.7 -29.87 71.07 Favored Glycine 1 N--CA 1.517 4.08 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.685 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.1 m -62.56 -36.19 73.83 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.285 0 CA-C-N 117.881 0.841 . . . . 0.0 110.564 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.3 p -55.02 -44.18 74.36 Favored 'General case' 0 N--CA 1.528 3.427 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.24 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.16 -36.1 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.414 0 C-N-CA 123.771 0.828 . . . . 0.0 111.061 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.84 -44.43 66.72 Favored 'General case' 0 N--CA 1.533 3.675 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.95 -37.04 78.59 Favored 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 123.08 0.552 . . . . 0.0 111.541 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.3 t -67.15 -47.17 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 C-N-CA 123.106 0.563 . . . . 0.0 111.974 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.37 -35.85 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 CA-C-N 118.058 0.39 . . . . 0.0 111.006 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.8 mt -60.98 -34.44 74.78 Favored 'General case' 0 N--CA 1.539 3.978 0 CA-C-N 117.91 0.323 . . . . 0.0 110.949 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.26 -36.28 77.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 O-C-N 121.829 -0.544 . . . . 0.0 109.779 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.66 -37.68 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.701 0 C-N-CA 122.955 0.502 . . . . 0.0 110.182 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.41 79.98 Favored 'General case' 0 N--CA 1.53 3.556 0 C-N-CA 123.621 0.768 . . . . 0.0 112.582 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 26.3 m -71.76 -34.1 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.601 0 O-C-N 121.938 -0.476 . . . . 0.0 110.176 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.25 -44.01 97.53 Favored 'General case' 0 N--CA 1.53 3.564 0 C-N-CA 123.057 0.543 . . . . 0.0 112.416 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.73 -37.62 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.739 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -63.41 -27.87 69.59 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 123.066 0.546 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -63.35 -23.59 67.48 Favored 'General case' 0 N--CA 1.533 3.705 0 C-N-CA 123.103 0.561 . . . . 0.0 110.829 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 41.5 m -66.68 -40.27 88.49 Favored 'General case' 0 N--CA 1.526 3.358 0 CA-C-O 121.402 0.62 . . . . 0.0 109.847 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 44.5 mt -63.15 -23.98 67.68 Favored 'General case' 0 N--CA 1.524 3.239 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.289 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 46.4 tp -87.86 9.12 23.04 Favored 'General case' 0 N--CA 1.536 3.846 0 C-N-CA 124.057 0.943 . . . . 0.0 109.455 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -139.66 69.16 1.36 Allowed 'General case' 0 N--CA 1.532 3.626 0 C-N-CA 124.5 1.12 . . . . 0.0 109.816 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -84.83 -63.48 1.33 Allowed 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -168.82 168.11 10.67 Favored 'General case' 0 N--CA 1.521 3.117 0 C-N-CA 124.154 0.982 . . . . 0.0 108.821 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.13 138.29 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.603 0 C-N-CA 124.573 1.149 . . . . 0.0 108.761 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.579 ' H ' HD23 ' A' ' 241' ' ' LEU . 1.6 pt? -94.61 146.44 31.45 Favored Pre-proline 0 N--CA 1.533 3.701 0 C-N-CA 124.798 1.239 . . . . 0.0 109.498 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 1 N--CA 1.541 4.295 0 CA-C-N 122.223 1.829 . . . . 0.0 110.65 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 CA--C 1.574 1.872 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.96 112.33 3.38 Favored 'Trans proline' 1 N--CA 1.538 4.12 0 C-N-CA 122.173 1.915 . . . . 0.0 110.627 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.15 147.16 0.07 OUTLIER Glycine 1 N--CA 1.517 4.054 0 C-N-CA 123.882 0.753 . . . . 0.0 111.59 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 69.7 m -167.22 -25.54 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 C-N-CA 124.405 1.082 . . . . 0.0 108.982 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.28 -26.64 68.51 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 124.322 1.049 . . . . 0.0 110.268 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 90.9 p -64.93 -27.95 69.19 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 123.432 0.693 . . . . 0.0 110.82 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.53 ' O ' HD12 ' B' ' 216' ' ' ILE . . . -69.69 -47.41 49.0 Favored Glycine 0 N--CA 1.515 3.904 0 N-CA-C 114.822 0.689 . . . . 0.0 114.822 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 39.3 pt -71.42 -34.63 54.09 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.406 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.6 tt -55.06 -31.83 26.24 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.148 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.69 HD13 ' N ' ' B' ' 217' ' ' GLY . 0.0 OUTLIER -59.83 -32.2 49.16 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.496 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.949 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . 0.69 ' N ' HD13 ' B' ' 216' ' ' ILE . . . -54.17 -29.38 44.78 Favored Glycine 0 N--CA 1.51 3.617 0 CA-C-N 115.067 -0.969 . . . . 0.0 114.088 -178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 6.0 m -59.55 -37.49 70.6 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.021 0 CA-C-N 118.429 1.115 . . . . 0.0 110.551 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 48.3 p -66.13 -45.92 79.33 Favored 'General case' 0 N--CA 1.528 3.433 0 CA-C-O 121.13 0.491 . . . . 0.0 110.497 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 49.5 t -69.42 -32.96 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.178 0 C-N-CA 124.322 1.049 . . . . 0.0 110.415 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.13 76.79 Favored 'General case' 0 N--CA 1.523 3.225 0 C-N-CA 123.363 0.665 . . . . 0.0 111.801 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.92 -30.6 68.05 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.086 0.554 . . . . 0.0 111.005 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 38.8 t -64.01 -50.76 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 C-N-CA 123.302 0.641 . . . . 0.0 111.167 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.35 -32.12 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 C-N-CA 122.738 0.415 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.61 -47.36 26.86 Favored 'General case' 0 N--CA 1.528 3.425 0 C-N-CA 123.515 0.726 . . . . 0.0 111.561 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.6 tt -64.24 -39.02 84.04 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.058 0 O-C-N 121.593 -0.692 . . . . 0.0 112.779 -176.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.8 -36.92 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.738 0 O-C-N 122.087 -0.383 . . . . 0.0 110.375 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.66 74.9 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.282 0.633 . . . . 0.0 112.165 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 48.0 t -71.88 -38.96 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 C-N-CA 122.99 0.516 . . . . 0.0 111.159 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -69.23 -43.46 73.97 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.39 -37.73 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 C-N-CA 122.57 0.348 . . . . 0.0 111.232 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 18.7 p -67.03 -28.78 68.51 Favored 'General case' 0 N--CA 1.529 3.51 0 CA-C-N 117.85 0.295 . . . . 0.0 111.203 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -63.52 -29.47 70.73 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 123.301 0.64 . . . . 0.0 111.139 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.4 t -65.28 -33.33 75.72 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.384 0.674 . . . . 0.0 111.215 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 51.0 mt -65.72 -18.39 65.3 Favored 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 123.724 0.81 . . . . 0.0 111.931 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.2 mp -87.39 -28.35 22.23 Favored 'General case' 0 N--CA 1.539 3.995 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 51.7 t90 -87.17 58.8 5.23 Favored 'General case' 0 N--CA 1.526 3.349 0 C-N-CA 124.004 0.921 . . . . 0.0 108.88 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -67.21 -102.78 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 123.757 0.823 . . . . 0.0 110.318 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 58.28 108.37 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 124.437 1.095 . . . . 0.0 111.185 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.15 138.63 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 125.142 1.377 . . . . 0.0 108.393 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.525 HD13 ' H ' ' B' ' 241' ' ' LEU . 0.0 OUTLIER -133.25 147.41 64.96 Favored Pre-proline 0 N--CA 1.534 3.768 0 CA-C-O 116.81 -1.567 . . . . 0.0 109.161 -179.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo . . . . . 1 N--CA 1.55 4.851 0 C-N-CA 123.13 2.553 . . . . 0.0 115.37 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 CA--C 1.575 1.91 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -82.34 16.29 1.82 Allowed 'Trans proline' 1 N--CA 1.537 4.05 0 C-N-CA 122.553 2.169 . . . . 0.0 111.089 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.79 39.39 1.11 Allowed Glycine 1 N--CA 1.518 4.103 0 C-N-CA 123.97 0.795 . . . . 0.0 111.994 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 74.8 m -163.56 170.13 17.68 Favored 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 123.841 0.857 . . . . 0.0 109.276 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . 0.406 HD22 ' N ' ' C' ' 211' ' ' LEU . 2.0 mm? -65.29 -26.28 68.0 Favored 'General case' 0 N--CA 1.522 3.158 0 C-N-CA 124.261 1.024 . . . . 0.0 109.896 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 57.7 m -58.39 -27.22 64.05 Favored 'General case' 0 N--CA 1.521 3.077 0 C-N-CA 123.403 0.681 . . . . 0.0 111.293 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.67 -48.15 44.64 Favored Glycine 0 N--CA 1.513 3.83 0 CA-C-N 116.137 -0.483 . . . . 0.0 114.218 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 38.5 pt -72.74 -36.9 54.07 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 N-CA-C 115.618 1.711 . . . . 0.0 115.618 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . 0.471 ' O ' HG12 ' C' ' 218' ' ' VAL . 8.4 tp -56.52 -31.56 34.29 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 14.8 tt -58.98 -32.14 46.98 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.317 0 CA-C-N 119.078 0.854 . . . . 0.0 110.204 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.99 -27.39 37.39 Favored Glycine 1 N--CA 1.518 4.145 0 C-N-CA 123.674 0.654 . . . . 0.0 112.497 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . 0.471 HG12 ' O ' ' C' ' 215' ' ' ILE . 8.6 p -58.4 -44.83 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.77 0 C-N-CA 123.505 0.722 . . . . 0.0 112.888 -176.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 9.7 t -66.24 -40.73 90.42 Favored 'General case' 0 N--CA 1.536 3.871 0 CA-C-N 118.51 0.595 . . . . 0.0 110.752 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 41.8 t -69.68 -32.28 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 C-N-CA 123.883 0.873 . . . . 0.0 110.764 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.4 -41.7 73.05 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.26 -34.56 74.97 Favored 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 123.202 0.601 . . . . 0.0 111.049 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.29 -52.35 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.088 0.555 . . . . 0.0 111.462 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.58 -31.97 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 122.956 0.502 . . . . 0.0 110.683 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.61 -46.1 91.53 Favored 'General case' 0 N--CA 1.534 3.728 0 C-N-CA 123.407 0.683 . . . . 0.0 110.807 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.49 -36.4 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 O-C-N 121.769 -0.582 . . . . 0.0 110.389 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.86 -38.0 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 122.948 0.499 . . . . 0.0 110.168 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.57 81.17 Favored 'General case' 0 N--CA 1.531 3.615 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.34 -34.3 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.854 0 O-C-N 122.088 -0.383 . . . . 0.0 110.017 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.85 -39.4 93.5 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 123.172 0.589 . . . . 0.0 109.545 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 9.4 t -68.17 -40.08 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 124.298 1.039 . . . . 0.0 109.199 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.44 -34.2 77.24 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 122.92 0.488 . . . . 0.0 109.895 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -73.51 -41.65 62.79 Favored 'General case' 0 N--CA 1.522 3.162 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.156 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.2 t -68.47 -45.9 71.18 Favored 'General case' 0 N--CA 1.528 3.473 0 CA-C-O 122.164 0.983 . . . . 0.0 109.389 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 39.7 tp -61.2 -12.94 14.74 Favored 'General case' 0 N--CA 1.521 3.108 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.872 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 40.8 tp -85.15 8.09 19.42 Favored 'General case' 1 N--CA 1.546 4.329 0 CA-C-N 118.369 0.531 . . . . 0.0 110.755 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -158.26 132.59 8.1 Favored 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . 0.423 ' H ' ' H ' ' C' ' 239' ' ' LYS . 58.1 mtmt -152.59 -18.78 0.16 Allowed 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 125.109 1.364 . . . . 0.0 108.235 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . 0.423 ' H ' ' H ' ' C' ' 238' ' ' LYS . 52.8 mtmt -65.99 -167.8 0.04 OUTLIER 'General case' 0 N--CA 1.52 3.053 0 C-N-CA 124.629 1.172 . . . . 0.0 110.187 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 70.1 t -112.63 130.32 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 52.2 mt -94.64 146.66 31.84 Favored Pre-proline 0 N--CA 1.526 3.331 0 CA-C-O 117.434 -1.27 . . . . 0.0 108.501 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 1 N--CA 1.542 4.356 0 C-N-CA 122.015 1.81 . . . . 0.0 110.779 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 18.0 ptt? . . . . . 0 CA--C 1.578 2.038 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.12 168.94 0.11 Allowed 'Trans proline' 1 N--CA 1.546 4.596 0 C-N-CA 122.689 2.259 . . . . 0.0 113.84 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -173.35 45.43 0.16 Allowed Glycine 1 N--CA 1.52 4.278 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 77.2 p 55.16 66.99 1.08 Allowed 'General case' 0 N--CA 1.523 3.214 0 C-N-CA 124.357 1.063 . . . . 0.0 112.326 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.16 -26.36 68.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.121 0.969 . . . . 0.0 109.553 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 41.3 t -57.42 -25.88 60.27 Favored 'General case' 0 N--CA 1.522 3.164 0 C-N-CA 123.976 0.911 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.68 -34.33 83.12 Favored Glycine 0 N--CA 1.515 3.929 0 C-N-CA 124.293 0.949 . . . . 0.0 114.145 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -46.42 90.81 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.3 0 CA-C-N 117.851 0.825 . . . . 0.0 112.183 -175.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -66.73 -31.87 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.732 0 C-N-CA 123.023 0.529 . . . . 0.0 110.542 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 47.9 mm -68.3 -33.81 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.851 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.59 -45.64 92.41 Favored Glycine 1 N--CA 1.519 4.184 0 C-N-CA 123.226 0.441 . . . . 0.0 113.479 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 11.8 m -69.2 -36.85 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 0 O-C-N 121.549 -0.971 . . . . 0.0 109.914 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 95.4 m -58.64 -46.43 87.15 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 30.4 m -67.6 -30.8 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 123.278 0.631 . . . . 0.0 111.203 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.62 74.01 Favored 'General case' 0 N--CA 1.532 3.669 0 O-C-N 121.683 -0.635 . . . . 0.0 111.572 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.38 -50.04 73.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.71 0.804 . . . . 0.0 112.943 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 15.6 m -58.36 -37.61 64.57 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 CA-C-N 119.155 0.888 . . . . 0.0 110.491 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.48 -32.08 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 122.611 0.365 . . . . 0.0 110.873 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.2 -41.13 70.68 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 40.3 mm -55.31 -51.01 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 C-N-CA 123.349 0.66 . . . . 0.0 112.069 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 31.5 m -61.79 -35.75 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.965 0 C-N-CA 122.988 0.515 . . . . 0.0 110.673 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.88 -31.6 65.0 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.1 0.56 . . . . 0.0 111.414 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.03 -34.63 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 C-N-CA 122.758 0.423 . . . . 0.0 111.374 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -66.34 -43.96 84.64 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 122.951 0.5 . . . . 0.0 111.954 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 6.3 p -68.76 -36.74 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 118.76 0.709 . . . . 0.0 109.149 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 80.3 m -58.45 -27.6 64.52 Favored 'General case' 0 N--CA 1.531 3.615 0 C-N-CA 122.708 0.403 . . . . 0.0 110.969 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -62.98 -19.02 63.92 Favored 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 123.173 0.589 . . . . 0.0 110.739 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 37.2 m -64.14 -37.94 89.28 Favored 'General case' 0 N--CA 1.527 3.394 0 C-N-CA 123.564 0.745 . . . . 0.0 110.568 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.91 -28.81 69.21 Favored 'General case' 0 N--CA 1.534 3.747 0 C-N-CA 123.913 0.885 . . . . 0.0 109.841 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.35 -5.93 58.69 Favored 'General case' 0 N--CA 1.537 3.905 0 C-N-CA 124.466 1.106 . . . . 0.0 110.932 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -53.15 -12.72 0.4 Allowed 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 123.964 0.906 . . . . 0.0 112.872 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.37 137.65 52.33 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.392 0.677 . . . . 0.0 110.981 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -83.94 121.88 27.97 Favored 'General case' 0 N--CA 1.521 3.106 0 C-N-CA 123.975 0.91 . . . . 0.0 109.131 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.08 138.2 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 124.882 1.273 . . . . 0.0 108.141 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 65.8 mt -124.86 146.78 54.31 Favored Pre-proline 0 N--CA 1.532 3.651 0 C-N-CA 125.137 1.375 . . . . 0.0 107.961 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 1 N--CA 1.54 4.218 0 C-N-CA 122.038 1.826 . . . . 0.0 110.672 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.578 2.053 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -81.29 171.65 13.56 Favored 'Trans proline' 0 N--CA 1.535 3.97 0 C-N-CA 122.568 2.178 . . . . 0.0 110.647 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.5 -166.23 3.94 Favored Glycine 1 N--CA 1.519 4.197 0 C-N-CA 123.855 0.74 . . . . 0.0 111.502 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 47.2 t -163.26 54.6 0.18 Allowed 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 121.948 0.88 . . . . 0.0 109.582 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.85 -26.54 68.37 Favored 'General case' 0 N--CA 1.525 3.286 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.589 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 69.8 m -64.71 -30.93 71.96 Favored 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 123.57 0.748 . . . . 0.0 110.933 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.77 -46.97 58.54 Favored Glycine 1 N--CA 1.517 4.047 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.47 -41.52 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 8.1 tp -62.23 -39.19 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.844 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.2 tt -72.03 -33.2 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.818 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.76 -29.8 55.32 Favored Glycine 0 N--CA 1.512 3.747 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.536 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 2.0 m -63.77 -37.56 80.02 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.062 0 CA-C-N 117.768 0.784 . . . . 0.0 110.425 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 31.2 p -60.97 -46.61 90.03 Favored 'General case' 0 N--CA 1.528 3.449 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.37 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.26 -40.17 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.202 0 C-N-CA 124.033 0.933 . . . . 0.0 110.831 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.01 66.83 Favored 'General case' 0 N--CA 1.524 3.255 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.44 -41.51 76.18 Favored 'General case' 0 N--CA 1.514 2.738 0 C-N-CA 122.921 0.488 . . . . 0.0 111.58 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.75 -46.91 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.504 0 O-C-N 122.089 -0.382 . . . . 0.0 111.834 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.42 -32.44 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.626 0 CA-C-N 117.9 0.318 . . . . 0.0 111.697 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 32.9 tp -74.72 -39.25 61.99 Favored 'General case' 0 N--CA 1.521 3.083 0 CA-C-O 119.209 -0.424 . . . . 0.0 112.014 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 81.8 mt -64.87 -43.8 96.3 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.244 0 CA-C-N 118.945 0.793 . . . . 0.0 111.026 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.3 -36.7 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 117.969 0.349 . . . . 0.0 110.318 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.29 65.79 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.362 0.665 . . . . 0.0 111.941 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.6 -40.76 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.905 0 CA-C-N 117.929 0.331 . . . . 0.0 110.219 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -69.44 -36.18 76.4 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.274 0.63 . . . . 0.0 110.436 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.5 -37.5 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.27 0 C-N-CA 123.744 0.818 . . . . 0.0 109.635 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 72.7 m -58.06 -32.04 67.64 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 122.511 0.325 . . . . 0.0 110.146 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.3 -41.63 60.84 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 60.2 p -68.24 -32.87 73.37 Favored 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 123.257 0.623 . . . . 0.0 110.206 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.54 -37.54 81.57 Favored 'General case' 0 N--CA 1.535 3.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.624 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 3.2 pp -91.28 -28.13 17.97 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.686 0.794 . . . . 0.0 109.733 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 51.27 8.87 0.05 Allowed 'General case' 0 N--CA 1.529 3.497 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -65.31 164.31 13.77 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-N 118.798 0.726 . . . . 0.0 110.742 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -138.52 157.84 45.4 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 125.045 1.338 . . . . 0.0 107.488 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.33 138.13 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.56 0 C-N-CA 124.533 1.133 . . . . 0.0 109.216 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 46.1 tp -112.82 99.85 49.25 Favored Pre-proline 0 N--CA 1.531 3.587 0 C-N-CA 125.314 1.446 . . . . 0.0 107.433 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo . . . . . 0 N--CA 1.534 3.905 0 C-N-CA 122.274 1.983 . . . . 0.0 110.857 -179.106 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 CA--C 1.574 1.885 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.42 38.29 0.6 Allowed 'Trans proline' 1 N--CA 1.543 4.413 0 C-N-CA 122.27 1.98 . . . . 0.0 110.936 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 171.65 160.39 20.07 Favored Glycine 1 N--CA 1.519 4.193 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 89.8 p -168.59 161.24 11.38 Favored 'General case' 0 N--CA 1.522 3.158 0 C-N-CA 123.692 0.797 . . . . 0.0 109.237 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.01 -25.99 68.09 Favored 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 124.437 1.095 . . . . 0.0 111.628 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 39.7 t -67.36 -33.31 74.97 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 123.469 0.708 . . . . 0.0 111.145 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.73 -44.63 69.34 Favored Glycine 1 N--CA 1.519 4.225 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . 0.417 HD13 ' O ' ' F' ' 214' ' ' ILE . 0.0 OUTLIER -70.67 -44.63 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.997 0 O-C-N 121.759 -0.847 . . . . 0.0 111.776 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 18.8 tt -60.68 -36.42 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 45.3 pt -72.48 -33.44 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 CA-C-N 118.699 0.681 . . . . 0.0 109.32 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.23 -48.65 84.5 Favored Glycine 1 N--CA 1.519 4.195 0 C-N-CA 123.835 0.731 . . . . 0.0 113.855 -177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.35 -36.79 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 C-N-CA 122.973 0.509 . . . . 0.0 109.803 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 90.3 m -64.1 -47.16 81.12 Favored 'General case' 0 N--CA 1.519 3.02 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -70.64 -31.48 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 CA-C-N 118.1 0.409 . . . . 0.0 111.191 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.45 -34.91 50.99 Favored 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.79 -38.62 85.95 Favored 'General case' 0 N--CA 1.523 3.194 0 C-N-CA 123.318 0.647 . . . . 0.0 111.0 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.66 -38.53 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.32 0 C-N-CA 123.697 0.799 . . . . 0.0 110.314 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.8 -37.53 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 C-N-CA 123.469 0.708 . . . . 0.0 111.312 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 57.6 mt -72.87 -35.13 67.11 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 122.33 0.252 . . . . 0.0 111.208 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.47 -46.52 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.69 0 C-N-CA 123.08 0.552 . . . . 0.0 110.717 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 33.2 m -67.48 -37.27 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 O-C-N 121.687 -0.633 . . . . 0.0 110.225 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.93 95.25 Favored 'General case' 0 N--CA 1.524 3.23 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 18.3 m -71.32 -34.08 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 O-C-N 121.574 -0.704 . . . . 0.0 110.069 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -63.42 -44.32 94.95 Favored 'General case' 0 N--CA 1.528 3.431 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 13.0 m -68.67 -37.97 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 CA-C-N 118.643 0.656 . . . . 0.0 109.919 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 92.9 m -62.88 -27.54 69.42 Favored 'General case' 0 N--CA 1.522 3.14 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.99 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.79 -38.33 88.71 Favored 'General case' 0 N--CA 1.528 3.469 0 CA-C-O 120.939 0.4 . . . . 0.0 110.297 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 47.1 t -66.38 -36.73 83.59 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.632 0.773 . . . . 0.0 110.678 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.82 -13.67 16.88 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.847 0.859 . . . . 0.0 111.675 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 20.2 mt -86.6 -2.67 58.69 Favored 'General case' 0 N--CA 1.537 3.898 0 C-N-CA 123.059 0.543 . . . . 0.0 110.659 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -165.89 120.3 1.2 Allowed 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 123.441 0.696 . . . . 0.0 109.264 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.34 23.59 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.211 1.005 . . . . 0.0 109.141 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -167.83 141.17 3.32 Favored 'General case' 0 N--CA 1.521 3.099 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.41 138.5 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 C-N-CA 124.876 1.27 . . . . 0.0 108.457 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 60.2 tp -105.68 99.7 23.13 Favored Pre-proline 0 N--CA 1.531 3.591 0 C-N-CA 125.082 1.353 . . . . 0.0 108.381 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo . . . . . 1 N--CA 1.549 4.741 0 C-N-CA 122.307 2.005 . . . . 0.0 114.01 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 CA--C 1.575 1.938 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.74 166.6 29.33 Favored 'Trans proline' 1 N--CA 1.539 4.161 0 C-N-CA 122.387 2.058 . . . . 0.0 110.475 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.44 24.35 65.71 Favored Glycine 1 N--CA 1.52 4.26 0 C-N-CA 123.686 0.66 . . . . 0.0 112.318 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.4 p -68.98 161.4 28.99 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.786 0.834 . . . . 0.0 110.936 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 211' ' ' LEU . 2.0 mm? -65.44 -26.19 67.85 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 124.73 1.212 . . . . 0.0 109.466 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 40.9 t -57.57 -39.17 76.14 Favored 'General case' 0 N--CA 1.518 2.928 0 C-N-CA 123.934 0.894 . . . . 0.0 112.273 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.36 -38.57 87.3 Favored Glycine 1 N--CA 1.522 4.419 0 C-N-CA 123.208 0.432 . . . . 0.0 112.115 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.18 -46.43 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 C-N-CA 124.107 0.963 . . . . 0.0 111.766 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.97 -31.85 53.76 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.066 0 C-N-CA 123.228 0.611 . . . . 0.0 109.872 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 30.9 mm -72.62 -33.38 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.9 -46.92 79.11 Favored Glycine 1 N--CA 1.518 4.119 0 N-CA-C 114.298 0.479 . . . . 0.0 114.298 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.12 -37.52 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.888 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.3 t -61.12 -38.04 84.94 Favored 'General case' 0 N--CA 1.539 3.989 0 CA-C-N 119.31 0.959 . . . . 0.0 111.464 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 59.6 t -56.67 -36.69 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 C-N-CA 123.067 0.547 . . . . 0.0 110.475 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.5 76.06 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.0 -49.72 71.34 Favored 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.73 -38.45 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.538 0 CA-C-O 119.003 -0.522 . . . . 0.0 112.26 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.25 -33.94 58.57 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.031 0 CA-C-N 119.323 0.965 . . . . 0.0 110.924 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.22 -47.14 71.74 Favored 'General case' 0 N--CA 1.538 3.934 0 CA-C-O 121.745 0.783 . . . . 0.0 109.566 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.2 mt -54.5 -36.77 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 123.305 0.642 . . . . 0.0 111.383 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.84 -39.21 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.919 0 C-N-CA 122.765 0.426 . . . . 0.0 109.886 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.87 97.98 Favored 'General case' 0 N--CA 1.529 3.5 0 C-N-CA 122.853 0.461 . . . . 0.0 111.146 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 50.8 t -71.82 -35.28 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.284 0 C-N-CA 123.221 0.608 . . . . 0.0 110.065 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -64.01 -44.45 92.58 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.96 -38.06 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 81.9 m -67.16 -32.6 73.8 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 123.344 0.658 . . . . 0.0 110.462 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -70.92 -39.72 72.53 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.319 0.648 . . . . 0.0 109.635 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 75.1 m -65.51 -34.91 79.38 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.773 0.829 . . . . 0.0 109.462 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.8 tp -68.99 -14.11 62.85 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 124.444 1.098 . . . . 0.0 109.904 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.3 -22.55 26.7 Favored 'General case' 0 N--CA 1.535 3.8 0 C-N-CA 124.23 1.012 . . . . 0.0 109.592 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -80.88 -8.84 59.83 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.515 0.726 . . . . 0.0 110.142 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -84.84 -65.44 1.01 Allowed 'General case' 0 N--CA 1.523 3.193 0 C-N-CA 124.108 0.963 . . . . 0.0 110.563 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -70.36 65.31 0.28 Allowed 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.934 0.893 . . . . 0.0 111.178 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 m -135.53 137.59 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.904 0 C-N-CA 124.37 1.068 . . . . 0.0 108.607 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 9.1 mp -97.34 106.35 31.6 Favored Pre-proline 0 N--CA 1.528 3.433 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo . . . . . 1 N--CA 1.549 4.76 0 C-N-CA 122.461 2.107 . . . . 0.0 114.455 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.583 2.225 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -85.68 78.54 2.34 Favored 'Trans proline' 0 N--CA 1.534 3.88 0 CA-C-N 122.688 1.996 . . . . 0.0 110.669 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.38 -43.66 98.75 Favored Glycine 1 N--CA 1.518 4.105 0 C-N-CA 123.752 0.692 . . . . 0.0 111.539 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 39.5 t 55.68 -97.05 0.07 Allowed 'General case' 0 N--CA 1.517 2.88 0 C-N-CA 124.102 0.961 . . . . 0.0 112.445 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 47.8 mt -64.63 -28.21 69.46 Favored 'General case' 0 N--CA 1.521 3.098 0 C-N-CA 124.134 0.974 . . . . 0.0 111.286 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 46.5 t -59.02 -44.73 91.76 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.695 0.798 . . . . 0.0 112.371 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.52 -36.92 84.67 Favored Glycine 1 N--CA 1.521 4.353 0 C-N-CA 123.311 0.482 . . . . 0.0 112.248 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.92 -46.08 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 C-N-CA 123.514 0.726 . . . . 0.0 111.45 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.1 tp -68.58 -33.37 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 CA-C-N 118.55 0.614 . . . . 0.0 109.835 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 74.3 mt -68.85 -33.81 61.25 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.128 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.05 -29.71 76.07 Favored Glycine 0 N--CA 1.514 3.897 0 C-N-CA 123.626 0.631 . . . . 0.0 113.208 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -37.18 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 C-N-CA 123.144 0.578 . . . . 0.0 110.157 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 64.5 p -65.09 -47.78 76.04 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.09 -32.95 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 C-N-CA 123.145 0.578 . . . . 0.0 112.427 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.98 -47.1 81.59 Favored 'General case' 0 N--CA 1.526 3.372 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.13 86.54 Favored 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 123.152 0.581 . . . . 0.0 112.018 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.8 t -68.41 -53.13 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.291 0 C-N-CA 122.743 0.417 . . . . 0.0 111.939 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.96 -32.54 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -176.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 5.3 tt -69.7 -38.23 76.87 Favored 'General case' 0 N--CA 1.522 3.172 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 85.7 mt -66.38 -36.98 78.67 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.004 0 CA-C-N 118.856 0.753 . . . . 0.0 110.184 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -66.39 -37.8 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.8 86.13 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 123.48 0.712 . . . . 0.0 111.867 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 62.9 t -71.86 -35.09 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.058 0.543 . . . . 0.0 110.145 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -64.33 -44.14 92.44 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.9 -37.54 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.19 -27.14 68.76 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.33 0.652 . . . . 0.0 111.125 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -70.93 -25.97 62.99 Favored 'General case' 0 N--CA 1.529 3.52 0 C-N-CA 122.827 0.451 . . . . 0.0 111.165 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 48.0 m -65.96 -46.32 78.54 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 123.156 0.582 . . . . 0.0 112.152 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.7 pp -68.81 -12.97 62.1 Favored 'General case' 0 N--CA 1.53 3.553 0 C-N-CA 123.897 0.879 . . . . 0.0 112.045 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.8 tp -86.2 -19.32 30.2 Favored 'General case' 0 N--CA 1.536 3.857 0 C-N-CA 123.227 0.611 . . . . 0.0 109.582 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -101.86 61.31 0.88 Allowed 'General case' 0 N--CA 1.528 3.475 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -63.26 72.56 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.264 1.026 . . . . 0.0 111.801 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -72.89 151.06 42.1 Favored 'General case' 0 N--CA 1.525 3.294 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.95 122.27 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.636 0 C-N-CA 124.65 1.18 . . . . 0.0 108.431 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -95.25 105.56 20.57 Favored Pre-proline 0 N--CA 1.529 3.495 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo . . . . . 1 N--CA 1.54 4.258 0 CA-C-N 122.851 2.054 . . . . 0.0 111.288 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.583 2.223 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.93 -162.99 0.02 OUTLIER 'Trans proline' 1 N--CA 1.549 4.772 0 C-N-CA 122.326 2.017 . . . . 0.0 112.817 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.01 -95.57 0.01 OUTLIER Glycine 1 N--CA 1.522 4.391 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 25.1 t 56.85 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.099 0 C-N-CA 124.408 1.083 . . . . 0.0 112.663 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.85 -26.9 68.53 Favored 'General case' 0 N--CA 1.536 3.835 0 C-N-CA 124.267 1.027 . . . . 0.0 109.328 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 92.1 p -67.86 -25.86 65.75 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.552 0.741 . . . . 0.0 110.37 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.92 -46.22 68.25 Favored Glycine 0 N--CA 1.515 3.961 0 C-N-CA 123.729 0.68 . . . . 0.0 114.665 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.9 tt -70.59 -35.74 62.62 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.029 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.55 -44.29 80.39 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.409 0 CA-C-N 118.874 0.761 . . . . 0.0 112.873 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.3 tt -72.41 -32.77 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.88 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.62 -28.84 46.95 Favored Glycine 1 N--CA 1.517 4.082 0 C-N-CA 124.296 0.951 . . . . 0.0 113.158 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.5 m -59.42 -36.7 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.979 0 CA-C-O 121.08 0.467 . . . . 0.0 111.03 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 66.2 p -55.37 -44.6 76.2 Favored 'General case' 0 N--CA 1.527 3.421 0 C-N-CA 123.139 0.576 . . . . 0.0 111.86 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.28 -33.3 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 123.385 0.674 . . . . 0.0 110.529 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.39 83.91 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 122.658 0.383 . . . . 0.0 110.813 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.66 -50.44 73.86 Favored 'General case' 0 N--CA 1.518 2.964 0 C-N-CA 123.393 0.677 . . . . 0.0 112.826 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 34.5 m -68.04 -38.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 CA-C-N 118.288 0.495 . . . . 0.0 111.004 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.33 -38.91 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.798 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 39.3 tp -62.01 -34.9 77.05 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 122.804 0.441 . . . . 0.0 111.416 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.09 -46.21 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.869 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.39 -37.6 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 123.029 0.532 . . . . 0.0 109.943 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.4 -49.86 75.89 Favored 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 123.586 0.754 . . . . 0.0 112.507 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 11.9 p -71.89 -34.38 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 O-C-N 122.05 -0.406 . . . . 0.0 110.882 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -62.91 -44.34 96.36 Favored 'General case' 0 N--CA 1.529 3.488 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.28 -39.69 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.31 -28.38 67.95 Favored 'General case' 0 N--CA 1.522 3.166 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.08 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.64 -31.03 72.07 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 123.179 0.592 . . . . 0.0 111.092 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 39.2 t -63.96 -36.99 85.78 Favored 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 123.631 0.772 . . . . 0.0 111.639 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 50.3 tp -60.66 -24.34 65.51 Favored 'General case' 0 N--CA 1.528 3.436 0 C-N-CA 123.641 0.776 . . . . 0.0 111.848 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.97 8.26 27.19 Favored 'General case' 0 N--CA 1.538 3.95 0 C-N-CA 123.289 0.636 . . . . 0.0 110.036 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -164.43 71.21 0.2 Allowed 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 122.729 0.412 . . . . 0.0 110.171 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -75.42 163.43 27.43 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -74.43 137.13 42.44 Favored 'General case' 0 N--CA 1.522 3.166 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.39 138.4 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.575 0 C-N-CA 124.573 1.149 . . . . 0.0 109.189 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.0 mp -94.37 146.61 31.85 Favored Pre-proline 0 N--CA 1.53 3.559 0 CA-C-O 116.668 -1.634 . . . . 0.0 106.707 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo . . . . . 1 N--CA 1.549 4.772 0 C-N-CA 122.782 2.322 . . . . 0.0 114.807 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.575 1.941 0 CA-C-O 117.725 -1.131 . . . . 0.0 108.117 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.16 -31.55 36.52 Favored 'Trans proline' 1 N--CA 1.547 4.669 0 C-N-CA 121.905 1.737 . . . . 0.0 113.661 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.58 -19.68 67.19 Favored Glycine 1 N--CA 1.523 4.474 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.753 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 40.6 m 60.84 136.07 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.963 0 C-N-CA 124.948 1.299 . . . . 0.0 112.002 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.2 -26.51 68.17 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 124.311 1.044 . . . . 0.0 109.678 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 43.7 t -67.13 -33.08 74.67 Favored 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 123.767 0.827 . . . . 0.0 111.338 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.87 -46.93 58.22 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 114.251 0.461 . . . . 0.0 114.251 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 tt -69.58 -35.28 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.88 0 CA-C-N 117.544 0.672 . . . . 0.0 112.345 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . 0.461 ' O ' HG12 ' D' ' 218' ' ' VAL . 0.4 OUTLIER -56.51 -32.22 36.04 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 C-N-CA 123.447 0.699 . . . . 0.0 111.403 -177.395 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.86 -32.99 60.61 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.319 0 C-N-CA 122.934 0.494 . . . . 0.0 109.702 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.54 -29.33 47.67 Favored Glycine 1 N--CA 1.518 4.118 0 C-N-CA 123.802 0.715 . . . . 0.0 113.227 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . 0.461 HG12 ' O ' ' D' ' 215' ' ' ILE . 9.5 p -59.41 -37.49 69.92 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.102 0 C-N-CA 123.134 0.573 . . . . 0.0 110.633 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -59.34 -38.99 81.74 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 123.357 0.663 . . . . 0.0 111.252 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.93 -36.89 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.153 0 C-N-CA 123.783 0.833 . . . . 0.0 111.384 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.15 80.67 Favored 'General case' 0 N--CA 1.527 3.376 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.6 -49.95 42.27 Favored 'General case' 0 N--CA 1.518 2.94 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.4 -38.73 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.836 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.29 -32.25 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -36.09 74.34 Favored 'General case' 0 N--CA 1.534 3.754 0 C-N-CA 123.644 0.778 . . . . 0.0 109.833 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 37.2 mm -61.29 -36.98 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.894 0 C-N-CA 123.35 0.66 . . . . 0.0 110.553 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 40.5 t -66.13 -37.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 123.5 0.72 . . . . 0.0 109.892 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.08 77.85 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.51 0.724 . . . . 0.0 112.446 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.71 -34.32 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 O-C-N 122.125 -0.36 . . . . 0.0 110.646 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.99 -44.25 93.24 Favored 'General case' 0 N--CA 1.528 3.435 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.7 -37.75 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.717 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.15 -27.96 69.43 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.006 0.522 . . . . 0.0 111.227 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.69 -33.41 73.91 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 123.112 0.565 . . . . 0.0 110.762 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 49.8 m -63.79 -31.37 72.52 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.49 0.716 . . . . 0.0 112.173 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.34 -14.89 39.52 Favored 'General case' 0 N--CA 1.536 3.837 0 C-N-CA 123.725 0.81 . . . . 0.0 109.898 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -87.58 -11.65 48.03 Favored 'General case' 0 N--CA 1.533 3.716 0 C-N-CA 123.762 0.825 . . . . 0.0 110.962 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -0.55 0.29 Allowed 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.33 167.49 1.35 Allowed 'General case' 0 N--CA 1.531 3.576 0 C-N-CA 123.423 0.689 . . . . 0.0 111.417 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -69.82 166.68 18.87 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.115 0.966 . . . . 0.0 110.025 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.75 136.29 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 59.6 mt -94.85 146.72 31.88 Favored Pre-proline 0 N--CA 1.529 3.483 0 CA-C-O 117.486 -1.245 . . . . 0.0 108.434 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 1 N--CA 1.54 4.207 0 C-N-CA 122.001 1.801 . . . . 0.0 110.715 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 57.4 mtm . . . . . 0 CA--C 1.583 2.242 0 CA-C-O 117.5 -1.238 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -87.77 -18.0 2.54 Favored 'Trans proline' 1 N--CA 1.536 4.003 0 C-N-CA 122.533 2.155 . . . . 0.0 110.968 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -179.86 164.94 33.12 Favored Glycine 1 N--CA 1.516 4.013 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . 0.419 ' H ' ' H ' ' E' ' 211' ' ' LEU . 95.4 p -168.76 -19.57 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 124.052 0.941 . . . . 0.0 109.56 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . 0.419 ' H ' ' H ' ' E' ' 210' ' ' SER . 8.7 mp -64.72 -30.05 71.05 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 124.137 0.975 . . . . 0.0 109.9 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 60.4 m -58.37 -26.29 63.0 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 123.207 0.603 . . . . 0.0 110.803 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.29 -34.63 63.32 Favored Glycine 1 N--CA 1.517 4.057 0 C-N-CA 124.121 0.867 . . . . 0.0 113.571 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 13.2 tt -59.59 -44.99 94.48 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.049 0 CA-C-N 117.795 0.797 . . . . 0.0 112.911 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.4 pt -65.68 -34.92 73.6 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.437 0 CA-C-O 121.564 0.697 . . . . 0.0 110.038 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 49.3 mm -71.4 -33.57 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 124.183 0.993 . . . . 0.0 108.758 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.62 -31.02 78.48 Favored Glycine 1 N--CA 1.518 4.109 0 C-N-CA 123.389 0.519 . . . . 0.0 113.6 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 1.3 m -67.06 -37.35 79.13 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.103 0 CA-C-N 117.697 0.748 . . . . 0.0 110.397 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 37.4 p -60.81 -45.28 95.03 Favored 'General case' 0 N--CA 1.526 3.365 0 C-N-CA 123.168 0.587 . . . . 0.0 111.315 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.1 -36.53 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.254 0 C-N-CA 124.038 0.935 . . . . 0.0 111.325 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.91 -47.06 78.16 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 122.835 0.454 . . . . 0.0 112.027 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.72 90.85 Favored 'General case' 0 N--CA 1.52 3.073 0 C-N-CA 123.687 0.795 . . . . 0.0 111.655 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.46 -49.37 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 122.83 0.452 . . . . 0.0 110.699 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.15 -32.61 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 123.075 0.55 . . . . 0.0 110.312 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.08 -47.2 83.92 Favored 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 123.028 0.531 . . . . 0.0 111.048 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 80.1 mt -62.97 -38.86 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 C-N-CA 122.662 0.385 . . . . 0.0 110.477 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.19 -37.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 C-N-CA 123.288 0.635 . . . . 0.0 109.852 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.42 97.33 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.039 0.536 . . . . 0.0 111.334 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 62.8 t -71.74 -34.62 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.199 0.6 . . . . 0.0 109.749 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -63.46 -44.42 94.52 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.92 -37.7 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 77.5 m -67.12 -35.48 79.83 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.123 0.569 . . . . 0.0 110.295 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.67 -38.75 90.16 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 123.476 0.71 . . . . 0.0 111.282 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 86.7 p -65.1 -21.33 66.79 Favored 'General case' 0 N--CA 1.529 3.5 0 C-N-CA 123.082 0.553 . . . . 0.0 110.971 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.73 -21.58 64.37 Favored 'General case' 0 N--CA 1.533 3.683 0 C-N-CA 123.958 0.903 . . . . 0.0 110.037 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.6 -8.45 56.24 Favored 'General case' 1 N--CA 1.541 4.089 0 C-N-CA 123.592 0.757 . . . . 0.0 110.248 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 30.5 t90 -65.07 -106.43 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.541 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? 55.89 36.27 27.0 Favored 'General case' 0 N--CA 1.52 3.038 0 C-N-CA 123.952 0.901 . . . . 0.0 111.539 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 62.0 tttm 62.57 150.55 0.03 OUTLIER 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 124.463 1.105 . . . . 0.0 110.918 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 50.2 t -132.89 127.03 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 C-N-CA 124.743 1.217 . . . . 0.0 107.843 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.544 ' H ' HD13 ' E' ' 241' ' ' LEU . 0.0 OUTLIER -94.73 147.46 33.2 Favored Pre-proline 0 N--CA 1.533 3.685 0 CA-C-O 116.701 -1.619 . . . . 0.0 109.201 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo . . . . . 1 N--CA 1.551 4.865 0 C-N-CA 122.974 2.449 . . . . 0.0 115.098 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.99 -161.51 0.03 OUTLIER 'Trans proline' 1 N--CA 1.55 4.796 0 C-N-CA 121.896 1.73 . . . . 0.0 112.547 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -167.71 -98.81 0.13 Allowed Glycine 1 N--CA 1.519 4.204 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 48.1 t -166.58 76.34 0.19 Allowed 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.493 0.717 . . . . 0.0 109.802 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.19 -26.56 68.2 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 124.166 0.986 . . . . 0.0 109.445 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 65.5 m -57.66 -25.38 60.14 Favored 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.183 0.993 . . . . 0.0 111.415 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.0 -35.31 83.86 Favored Glycine 0 N--CA 1.515 3.923 0 C-N-CA 124.167 0.889 . . . . 0.0 115.267 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 12.2 tt -59.08 -35.09 55.35 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.593 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 9.3 tp -55.84 -31.85 30.97 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.31 -32.53 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.944 0 CA-C-N 118.383 0.538 . . . . 0.0 110.023 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.79 -29.54 54.91 Favored Glycine 0 N--CA 1.514 3.87 0 CA-C-O 119.555 -0.58 . . . . 0.0 113.873 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.6 m -59.92 -48.26 88.45 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 CA-C-N 118.075 0.938 . . . . 0.0 112.468 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 11.3 t -66.43 -38.76 88.14 Favored 'General case' 0 N--CA 1.536 3.847 0 O-C-N 121.955 -0.466 . . . . 0.0 110.98 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.87 -39.05 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.297 0 C-N-CA 123.46 0.704 . . . . 0.0 109.333 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.18 98.63 Favored 'General case' 0 N--CA 1.522 3.146 0 C-N-CA 123.137 0.575 . . . . 0.0 110.907 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.73 79.29 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 123.264 0.625 . . . . 0.0 111.781 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.37 -51.01 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.545 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.69 -33.25 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 123.632 0.773 . . . . 0.0 111.109 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 38.6 tp -66.07 -35.49 80.67 Favored 'General case' 0 N--CA 1.531 3.593 0 C-N-CA 122.513 0.325 . . . . 0.0 111.218 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 92.2 mt -69.2 -41.15 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.89 -37.96 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 123.413 0.685 . . . . 0.0 109.594 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.22 81.38 Favored 'General case' 0 N--CA 1.526 3.347 0 C-N-CA 123.81 0.844 . . . . 0.0 112.666 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.46 -34.0 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 O-C-N 121.872 -0.517 . . . . 0.0 109.98 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.73 -44.27 94.06 Favored 'General case' 0 N--CA 1.529 3.493 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.95 -37.53 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 98.0 m -59.42 -27.43 66.03 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.336 0.654 . . . . 0.0 111.316 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.34 -40.89 85.91 Favored 'General case' 0 N--CA 1.529 3.501 0 CA-C-O 121.078 0.466 . . . . 0.0 110.426 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 47.6 t -64.77 -17.58 64.3 Favored 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 124.129 0.972 . . . . 0.0 112.45 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.6 -15.08 63.14 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 122.977 0.511 . . . . 0.0 110.627 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.37 -28.7 22.04 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.115 0.566 . . . . 0.0 109.58 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -158.83 144.45 16.47 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.705 0.802 . . . . 0.0 108.98 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -140.19 160.4 40.03 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 124.725 1.21 . . . . 0.0 108.149 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -76.42 44.04 0.33 Allowed 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.152 0.981 . . . . 0.0 110.012 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.16 133.43 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.529 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.95 99.76 24.37 Favored Pre-proline 0 N--CA 1.532 3.657 0 C-N-CA 125.05 1.34 . . . . 0.0 107.502 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo . . . . . 1 N--CA 1.549 4.754 0 C-N-CA 122.476 2.118 . . . . 0.0 114.47 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 88.0 mmm . . . . . 0 CA--C 1.586 2.35 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.21 66.56 3.31 Favored 'Trans proline' 0 N--CA 1.535 3.926 0 C-N-CA 122.617 2.212 . . . . 0.0 110.627 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -178.42 -169.92 39.84 Favored Glycine 1 N--CA 1.518 4.162 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 43.1 m 60.24 47.63 9.0 Favored 'General case' 0 N--CA 1.519 3.024 0 C-N-CA 124.317 1.047 . . . . 0.0 111.847 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.6 mp -65.14 -26.63 68.27 Favored 'General case' 0 N--CA 1.534 3.735 0 C-N-CA 123.829 0.852 . . . . 0.0 109.251 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 98.0 p -68.41 -27.43 66.2 Favored 'General case' 0 N--CA 1.521 3.076 0 C-N-CA 123.263 0.625 . . . . 0.0 110.049 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.46 -46.9 53.81 Favored Glycine 0 N--CA 1.513 3.779 0 N-CA-C 116.688 1.435 . . . . 0.0 116.688 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.5 pt -59.69 -35.24 58.61 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.467 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 -174.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.2 tt -56.75 -32.06 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 15.5 tt -70.78 -33.79 53.91 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 CA-C-N 120.131 1.332 . . . . 0.0 111.064 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.81 -43.63 80.92 Favored Glycine 1 N--CA 1.52 4.246 0 C-N-CA 123.053 0.359 . . . . 0.0 113.802 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.06 -37.29 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.977 0 O-C-N 121.639 -0.918 . . . . 0.0 110.922 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 61.3 p -64.84 -45.65 85.24 Favored 'General case' 0 N--CA 1.538 3.928 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.49 -30.87 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 C-N-CA 123.093 0.557 . . . . 0.0 111.766 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.43 -47.0 88.01 Favored 'General case' 0 N--CA 1.534 3.732 0 O-C-N 121.496 -0.753 . . . . 0.0 112.614 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.63 -44.24 96.79 Favored 'General case' 0 N--CA 1.521 3.124 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.65 -39.73 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.752 0 CA-C-N 118.773 0.715 . . . . 0.0 112.068 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.32 -34.15 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.339 0.518 . . . . 0.0 110.134 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.7 -48.06 78.65 Favored 'General case' 0 N--CA 1.524 3.24 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.6 pt -70.01 -36.74 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 O-C-N 122.065 -0.397 . . . . 0.0 111.339 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.3 -37.46 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.03 -41.13 82.57 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 122.968 0.507 . . . . 0.0 111.806 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.77 -37.12 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.192 0.597 . . . . 0.0 110.15 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -63.08 -44.16 96.52 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 123.211 0.604 . . . . 0.0 112.377 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.88 -37.62 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 93.2 m -64.68 -28.43 69.59 Favored 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 122.846 0.458 . . . . 0.0 110.727 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -72.93 -23.37 60.68 Favored 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 123.23 0.612 . . . . 0.0 110.924 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.1 m -66.19 -31.36 72.14 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 122.949 0.499 . . . . 0.0 111.432 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.68 -37.53 87.89 Favored 'General case' 0 N--CA 1.529 3.481 0 C-N-CA 123.644 0.777 . . . . 0.0 112.377 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 pp -95.19 -16.26 22.68 Favored 'General case' 1 N--CA 1.547 4.392 0 C-N-CA 123.223 0.609 . . . . 0.0 111.531 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -67.1 -10.39 49.55 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 123.505 0.722 . . . . 0.0 111.193 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.1 116.2 4.01 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 123.625 0.77 . . . . 0.0 111.508 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.62 -162.99 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.648 0 C-N-CA 126.126 1.77 . . . . 0.0 114.538 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.15 136.15 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 56.0 tp -133.42 99.57 14.39 Favored Pre-proline 0 N--CA 1.531 3.595 0 C-N-CA 124.86 1.264 . . . . 0.0 108.06 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 1 N--CA 1.536 4.007 0 C-N-CA 122.417 2.078 . . . . 0.0 111.097 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 49.1 tpp . . . . . 0 CA--C 1.58 2.101 0 CA-C-O 117.657 -1.164 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.03 141.96 55.47 Favored 'Trans proline' 1 N--CA 1.548 4.707 0 CA-C-N 122.41 1.897 . . . . 0.0 113.082 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 170.78 -137.7 4.56 Favored Glycine 1 N--CA 1.519 4.21 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 71.9 p 56.51 176.43 0.04 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 124.557 1.143 . . . . 0.0 112.519 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 48.4 mt -57.28 -25.82 59.85 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 124.873 1.269 . . . . 0.0 111.613 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 38.3 t -57.01 -37.69 72.06 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.581 0.752 . . . . 0.0 112.065 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.28 -46.32 57.65 Favored Glycine 1 N--CA 1.518 4.164 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.475 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.403 ' N ' HD12 ' B' ' 214' ' ' ILE . 1.5 mp -70.89 -46.38 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 124.53 1.132 . . . . 0.0 112.79 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . 0.477 ' O ' HG12 ' B' ' 218' ' ' VAL . 18.6 tt -57.07 -38.23 59.42 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -175.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 17.0 tt -72.83 -32.93 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.884 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.6 -29.14 47.69 Favored Glycine 0 N--CA 1.513 3.821 0 C-N-CA 124.19 0.9 . . . . 0.0 113.581 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . 0.477 HG12 ' O ' ' B' ' 215' ' ' ILE . 8.3 p -59.5 -37.74 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.875 0 CA-C-N 117.27 0.535 . . . . 0.0 111.157 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 69.0 p -63.87 -45.93 87.22 Favored 'General case' 0 N--CA 1.529 3.489 0 CA-C-O 121.224 0.535 . . . . 0.0 110.804 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.52 -34.69 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.059 0 C-N-CA 124.101 0.961 . . . . 0.0 110.962 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.61 -46.96 67.22 Favored 'General case' 0 N--CA 1.529 3.52 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.8 74.53 Favored 'General case' 0 N--CA 1.522 3.143 0 C-N-CA 123.285 0.634 . . . . 0.0 111.807 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -67.13 -41.38 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.438 0 C-N-CA 122.913 0.485 . . . . 0.0 110.451 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.94 -38.52 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 0 C-N-CA 122.899 0.48 . . . . 0.0 111.495 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 56.9 tp -66.77 -43.13 84.82 Favored 'General case' 0 N--CA 1.532 3.631 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.19 -39.15 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.809 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.77 -37.07 78.74 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 CA-C-N 118.717 0.69 . . . . 0.0 109.82 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.55 -32.08 66.75 Favored 'General case' 0 N--CA 1.525 3.305 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.24 -34.89 72.13 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.175 0 CA-C-N 119.286 0.948 . . . . 0.0 112.355 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.73 -43.98 91.67 Favored 'General case' 0 N--CA 1.536 3.871 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.92 -37.73 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.803 0 O-C-N 121.832 -0.543 . . . . 0.0 109.574 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.08 -27.92 67.77 Favored 'General case' 0 N--CA 1.527 3.391 0 C-N-CA 123.259 0.623 . . . . 0.0 111.148 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.16 -30.19 71.26 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.054 0.542 . . . . 0.0 110.507 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 34.9 t -63.82 -39.03 93.27 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.368 0.667 . . . . 0.0 110.774 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.12 -15.94 63.04 Favored 'General case' 0 N--CA 1.527 3.418 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.746 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 49.6 tp -101.99 -17.37 16.13 Favored 'General case' 0 N--CA 1.537 3.901 0 C-N-CA 124.184 0.993 . . . . 0.0 109.523 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -74.99 15.77 0.37 Allowed 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 124.056 0.942 . . . . 0.0 111.155 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.46 -175.6 0.13 Allowed 'General case' 0 N--CA 1.532 3.656 0 C-N-CA 123.234 0.614 . . . . 0.0 110.116 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 66.39 156.82 0.1 Allowed 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 124.523 1.129 . . . . 0.0 110.094 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.04 137.97 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.645 0 C-N-CA 124.839 1.256 . . . . 0.0 107.776 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.86 105.93 21.88 Favored Pre-proline 0 N--CA 1.529 3.502 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo . . . . . 1 N--CA 1.537 4.07 0 CA-C-N 122.743 2.015 . . . . 0.0 110.792 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 CA--C 1.581 2.164 0 CA-C-O 117.53 -1.224 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -89.5 68.48 2.2 Favored 'Trans proline' 0 N--CA 1.533 3.852 0 C-N-CA 122.723 2.282 . . . . 0.0 110.97 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.48 -171.58 36.8 Favored Glycine 1 N--CA 1.519 4.211 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.56 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 100.0 p -163.97 -165.32 0.99 Allowed 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 123.739 0.816 . . . . 0.0 109.093 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.66 -39.43 88.36 Favored 'General case' 0 N--CA 1.535 3.782 0 C-N-CA 124.129 0.972 . . . . 0.0 109.25 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 42.0 t -68.19 -32.24 72.33 Favored 'General case' 0 N--CA 1.517 2.92 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.487 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.41 -46.34 63.9 Favored Glycine 0 N--CA 1.514 3.896 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.443 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 41.8 pt -66.3 -38.49 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 CA-C-N 118.062 0.931 . . . . 0.0 112.344 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.98 -32.59 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.37 -32.8 43.66 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.23 -29.09 44.51 Favored Glycine 0 N--CA 1.513 3.819 0 C-N-CA 124.172 0.891 . . . . 0.0 113.529 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.46 -37.57 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 117.505 0.653 . . . . 0.0 110.739 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 61.4 p -63.08 -46.21 88.47 Favored 'General case' 0 N--CA 1.528 3.432 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.959 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.77 -38.08 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 124.226 1.011 . . . . 0.0 110.184 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.06 63.98 Favored 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 123.663 0.785 . . . . 0.0 112.659 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.67 75.0 Favored 'General case' 0 N--CA 1.519 3.009 0 C-N-CA 123.345 0.658 . . . . 0.0 111.664 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.8 -48.25 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.367 0 C-N-CA 123.165 0.586 . . . . 0.0 111.425 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.4 -32.45 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 C-N-CA 122.615 0.366 . . . . 0.0 110.537 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.44 -42.24 98.44 Favored 'General case' 0 N--CA 1.53 3.546 0 C-N-CA 123.361 0.664 . . . . 0.0 110.313 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 94.8 mt -65.72 -44.17 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 123.33 0.652 . . . . 0.0 109.753 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.45 -37.55 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.484 0 C-N-CA 123.32 0.648 . . . . 0.0 109.708 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.95 81.55 Favored 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.284 0.634 . . . . 0.0 112.322 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 17.6 m -71.9 -34.44 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 O-C-N 121.96 -0.463 . . . . 0.0 110.647 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.69 -44.44 93.69 Favored 'General case' 0 N--CA 1.53 3.536 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.89 -37.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.759 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 70.7 m -67.47 -39.15 85.27 Favored 'General case' 0 N--CA 1.523 3.188 0 C-N-CA 122.966 0.507 . . . . 0.0 110.479 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.15 -32.77 63.27 Favored 'General case' 0 N--CA 1.524 3.271 0 C-N-CA 123.554 0.742 . . . . 0.0 111.008 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 86.3 p -63.76 -24.75 67.89 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.175 0.59 . . . . 0.0 111.505 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.59 -30.9 69.75 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.804 0.842 . . . . 0.0 110.355 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.24 1.9 56.0 Favored 'General case' 0 N--CA 1.535 3.82 0 C-N-CA 124.25 1.02 . . . . 0.0 110.128 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -59.65 -15.95 22.85 Favored 'General case' 0 N--CA 1.533 3.682 0 C-N-CA 123.239 0.616 . . . . 0.0 110.978 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -67.49 157.57 33.95 Favored 'General case' 0 N--CA 1.518 2.962 0 C-N-CA 124.176 0.99 . . . . 0.0 110.011 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -165.36 -22.09 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.429 0 C-N-CA 123.856 0.862 . . . . 0.0 109.624 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.14 138.45 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 125.2 1.4 . . . . 0.0 108.406 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 53.0 tp -133.21 99.62 14.63 Favored Pre-proline 0 N--CA 1.53 3.57 0 C-N-CA 124.988 1.315 . . . . 0.0 107.765 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 N--CA 1.536 3.978 0 C-N-CA 122.528 2.152 . . . . 0.0 110.966 -179.509 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.576 1.957 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.01 -10.78 23.15 Favored 'Trans proline' 1 N--CA 1.538 4.121 0 C-N-CA 122.277 1.985 . . . . 0.0 111.076 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.59 -95.7 0.33 Allowed Glycine 1 N--CA 1.518 4.128 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 89.9 p -167.76 96.86 0.46 Allowed 'General case' 0 N--CA 1.522 3.136 0 C-N-CA 123.841 0.856 . . . . 0.0 108.81 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.13 -39.04 92.5 Favored 'General case' 0 N--CA 1.527 3.391 0 C-N-CA 124.055 0.942 . . . . 0.0 109.817 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 92.4 p -68.23 -27.71 66.6 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.082 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.65 -47.25 50.31 Favored Glycine 0 N--CA 1.504 3.21 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.543 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.48 -37.98 66.44 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.322 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -176.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 10.2 tp -56.87 -31.86 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.622 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 7.3 pt -59.74 -39.65 80.3 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.318 0 CA-C-N 119.325 0.966 . . . . 0.0 111.562 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.53 -28.87 46.32 Favored Glycine 0 N--CA 1.516 3.992 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.257 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 2.9 p -59.36 -46.66 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 C-N-CA 123.697 0.799 . . . . 0.0 112.753 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 3.2 t -66.08 -38.71 88.95 Favored 'General case' 0 N--CA 1.534 3.752 0 CA-C-O 121.217 0.532 . . . . 0.0 110.667 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.4 -34.81 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.033 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.484 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.78 79.07 Favored 'General case' 0 N--CA 1.527 3.377 0 C-N-CA 123.03 0.532 . . . . 0.0 111.533 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -49.93 44.9 Favored 'General case' 0 N--CA 1.511 2.58 0 C-N-CA 123.38 0.672 . . . . 0.0 112.588 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 21.8 m -61.04 -42.27 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.82 -32.09 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.68 0 C-N-CA 122.845 0.458 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.15 -40.24 53.12 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mp -54.98 -44.41 73.69 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 C-N-CA 124.128 0.971 . . . . 0.0 112.187 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 22.5 m -66.19 -36.88 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 O-C-N 121.762 -0.586 . . . . 0.0 111.129 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.71 -44.49 85.97 Favored 'General case' 0 N--CA 1.529 3.481 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 11.3 m -71.68 -34.32 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 O-C-N 121.873 -0.517 . . . . 0.0 110.326 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -63.67 -43.96 95.13 Favored 'General case' 0 N--CA 1.531 3.615 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.5 -37.18 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.62 -28.64 65.83 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 122.704 0.402 . . . . 0.0 111.566 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -58.01 -16.56 13.05 Favored 'General case' 1 N--CA 1.54 4.073 0 CA-C-N 118.308 0.503 . . . . 0.0 111.56 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 45.8 t -68.14 -43.98 77.08 Favored 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.79 -27.48 68.31 Favored 'General case' 0 N--CA 1.528 3.435 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.396 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.19 10.45 16.86 Favored 'General case' 1 N--CA 1.542 4.127 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -159.89 98.98 1.37 Allowed 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 123.176 0.59 . . . . 0.0 109.839 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -137.72 144.12 41.56 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 125.087 1.355 . . . . 0.0 107.441 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -74.94 105.91 6.2 Favored 'General case' 0 N--CA 1.518 2.962 0 C-N-CA 123.786 0.834 . . . . 0.0 108.843 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 30.3 m -134.9 138.18 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 124.728 1.211 . . . . 0.0 108.568 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.492 ' N ' HD13 ' D' ' 241' ' ' LEU . 0.0 OUTLIER -133.48 98.88 14.77 Favored Pre-proline 0 N--CA 1.528 3.469 0 C-N-CA 124.823 1.249 . . . . 0.0 107.966 179.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo . . . . . 1 N--CA 1.548 4.716 0 C-N-CA 122.365 2.044 . . . . 0.0 114.155 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.575 1.94 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.35 160.66 3.28 Favored 'Trans proline' 1 N--CA 1.548 4.696 0 CA-C-N 121.962 1.737 . . . . 0.0 113.154 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 62.94 97.56 0.01 OUTLIER Glycine 1 N--CA 1.52 4.277 0 C-N-CA 123.622 0.629 . . . . 0.0 111.772 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t -166.87 5.06 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.675 0.79 . . . . 0.0 110.816 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 47.3 mt -63.55 -26.79 68.86 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.014 0.926 . . . . 0.0 110.54 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 94.3 p -62.07 -39.73 93.38 Favored 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 123.844 0.858 . . . . 0.0 110.741 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.06 -39.98 83.89 Favored Glycine 1 N--CA 1.517 4.061 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.656 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 66.3 mt -70.65 -46.36 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.405 0 C-N-CA 124.026 0.93 . . . . 0.0 112.669 -176.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 19.4 tt -61.94 -37.53 78.49 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.024 0 O-C-N 121.915 -0.49 . . . . 0.0 112.294 -176.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.1 tp -73.18 -33.65 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.684 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.8 -46.86 91.83 Favored Glycine 1 N--CA 1.516 4.009 0 CA-C-N 115.781 -0.645 . . . . 0.0 114.487 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.94 -37.42 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.844 0 CA-C-N 117.806 0.803 . . . . 0.0 110.899 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 54.5 p -66.36 -45.75 79.08 Favored 'General case' 0 N--CA 1.531 3.592 0 CA-C-O 120.914 0.388 . . . . 0.0 111.113 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.67 -31.37 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.417 0 C-N-CA 123.918 0.887 . . . . 0.0 111.212 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.71 72.48 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.03 -49.26 53.06 Favored 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.54 -39.81 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 31.9 m -68.02 -35.41 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 CA-C-N 118.519 0.6 . . . . 0.0 112.017 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 26.3 tp -69.87 -42.72 73.12 Favored 'General case' 0 N--CA 1.524 3.261 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 33.2 pt -66.67 -35.83 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.838 0.745 . . . . 0.0 111.153 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 92.9 t -65.05 -37.67 80.81 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.036 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.46 -35.81 74.79 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 123.17 0.588 . . . . 0.0 111.665 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 71.0 t -71.9 -36.33 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.27 0 C-N-CA 123.45 0.7 . . . . 0.0 110.762 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.07 -43.96 81.33 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.52 -38.01 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.519 0 C-N-CA 122.555 0.342 . . . . 0.0 110.893 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 14.4 p -67.11 -27.8 67.63 Favored 'General case' 0 N--CA 1.534 3.765 0 CA-C-N 117.876 0.307 . . . . 0.0 111.297 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -60.43 -30.04 69.38 Favored 'General case' 0 N--CA 1.529 3.489 0 C-N-CA 123.153 0.581 . . . . 0.0 110.965 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 45.6 t -64.94 -41.77 95.23 Favored 'General case' 0 N--CA 1.525 3.322 0 CA-C-O 121.695 0.759 . . . . 0.0 110.572 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 45.6 mt -69.29 -13.73 62.55 Favored 'General case' 0 N--CA 1.518 2.938 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.053 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 55.6 tp -86.61 -28.5 23.21 Favored 'General case' 0 N--CA 1.538 3.972 0 C-N-CA 122.908 0.483 . . . . 0.0 110.124 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -82.51 -149.23 0.08 Allowed 'General case' 0 N--CA 1.527 3.4 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 55.3 mttm 62.02 53.82 2.91 Favored 'General case' 0 N--CA 1.519 3.024 0 C-N-CA 123.875 0.87 . . . . 0.0 111.119 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -164.3 -16.12 0.03 OUTLIER 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 123.808 0.843 . . . . 0.0 110.01 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 31.4 m -112.76 138.23 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.626 0 C-N-CA 125.18 1.392 . . . . 0.0 109.295 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -133.41 99.49 14.46 Favored Pre-proline 0 N--CA 1.53 3.537 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo . . . . . 1 N--CA 1.538 4.105 0 C-N-CA 122.438 2.092 . . . . 0.0 111.279 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 83.3 mmm . . . . . 0 CA--C 1.586 2.334 0 CA-C-O 117.491 -1.242 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -88.17 157.62 6.98 Favored 'Trans proline' 0 N--CA 1.535 3.939 0 C-N-CA 122.51 2.14 . . . . 0.0 110.569 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.43 135.7 24.02 Favored Glycine 1 N--CA 1.516 4.011 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 69.5 m -70.52 162.17 29.29 Favored 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 123.76 0.824 . . . . 0.0 109.917 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.13 -26.91 68.39 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.785 0.834 . . . . 0.0 110.451 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 67.1 m -68.61 -35.18 76.98 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 123.544 0.737 . . . . 0.0 110.308 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.68 -43.2 76.99 Favored Glycine 1 N--CA 1.517 4.044 0 CA-C-N 115.228 -0.896 . . . . 0.0 115.17 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . 0.409 HD13 ' O ' ' F' ' 214' ' ' ILE . 0.0 OUTLIER -70.72 -45.85 71.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 CA-C-N 118.026 0.913 . . . . 0.0 111.406 -176.863 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 19.8 tt -60.83 -34.35 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 44.9 pt -72.57 -32.81 42.85 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.195 0 CA-C-N 119.556 1.071 . . . . 0.0 108.929 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.88 -29.77 51.6 Favored Glycine 0 N--CA 1.514 3.872 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.979 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.0 -37.53 72.88 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.021 0 CA-C-N 117.588 0.694 . . . . 0.0 110.963 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 43.1 p -62.99 -46.21 88.73 Favored 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.048 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.95 -36.06 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.151 0 C-N-CA 124.212 1.005 . . . . 0.0 110.749 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.42 -43.13 64.64 Favored 'General case' 0 N--CA 1.525 3.313 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.73 -43.11 85.1 Favored 'General case' 0 N--CA 1.519 3.012 0 C-N-CA 123.261 0.624 . . . . 0.0 111.972 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 36.9 t -66.72 -45.56 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 C-N-CA 122.943 0.497 . . . . 0.0 111.022 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.16 -38.83 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 123.263 0.625 . . . . 0.0 111.153 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.81 -34.63 78.6 Favored 'General case' 0 N--CA 1.532 3.64 0 CA-C-N 117.828 0.285 . . . . 0.0 110.803 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.67 -44.26 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.886 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.04 -37.77 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.625 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.65 -48.22 81.77 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.731 0.813 . . . . 0.0 112.807 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.58 -34.22 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.57 0 O-C-N 121.948 -0.47 . . . . 0.0 110.084 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -64.01 -44.13 93.53 Favored 'General case' 0 N--CA 1.527 3.401 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.71 -37.74 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 98.9 m -61.66 -27.92 69.02 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.039 0.536 . . . . 0.0 111.212 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -67.62 -30.62 70.24 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 122.947 0.499 . . . . 0.0 111.49 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 49.4 m -64.04 -31.99 73.38 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 123.324 0.649 . . . . 0.0 112.407 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.78 -33.0 72.31 Favored 'General case' 0 N--CA 1.534 3.754 0 C-N-CA 123.793 0.837 . . . . 0.0 112.379 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . 0.544 HD13 ' H ' ' F' ' 236' ' ' LEU . 0.0 OUTLIER -110.33 10.97 23.47 Favored 'General case' 1 N--CA 1.547 4.399 0 C-N-CA 124.019 0.928 . . . . 0.0 111.466 -179.773 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 31.7 t90 -139.25 79.24 1.71 Allowed 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 124.374 1.07 . . . . 0.0 108.648 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.33 11.46 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 124.159 0.984 . . . . 0.0 109.963 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -67.38 108.55 2.82 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 123.83 0.852 . . . . 0.0 110.046 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.16 138.25 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.389 0 C-N-CA 124.976 1.31 . . . . 0.0 108.244 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.48 113.11 60.15 Favored Pre-proline 0 N--CA 1.526 3.363 0 CA-C-O 116.859 -1.543 . . . . 0.0 107.314 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo . . . . . 1 N--CA 1.536 4.013 0 CA-C-N 123.052 2.126 . . . . 0.0 110.698 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.576 1.946 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.85 -169.47 0.34 Allowed 'Trans proline' 1 N--CA 1.543 4.409 0 C-N-CA 122.36 2.04 . . . . 0.0 110.214 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -163.36 -153.07 7.11 Favored Glycine 1 N--CA 1.517 4.1 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.8 m -161.22 44.25 0.17 Allowed 'General case' 0 N--CA 1.52 3.067 0 C-N-CA 123.684 0.794 . . . . 0.0 109.185 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 48.2 mt -64.72 -41.18 96.16 Favored 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 123.972 0.909 . . . . 0.0 110.123 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 95.3 p -57.95 -26.96 62.95 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 123.271 0.629 . . . . 0.0 110.678 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.21 -41.52 86.08 Favored Glycine 1 N--CA 1.52 4.266 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 62.3 mt -65.62 -37.1 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 C-N-CA 124.348 1.059 . . . . 0.0 109.083 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 45.6 mm -67.48 -40.81 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 C-N-CA 124.151 0.981 . . . . 0.0 108.384 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 87.7 mt -72.33 -33.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.04 -29.72 75.24 Favored Glycine 1 N--CA 1.518 4.111 0 C-N-CA 123.336 0.493 . . . . 0.0 112.458 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -37.23 72.81 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.18 0 C-N-CA 123.394 0.678 . . . . 0.0 109.916 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -57.46 -45.24 84.98 Favored 'General case' 0 N--CA 1.526 3.368 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.342 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 51.2 t -56.57 -42.07 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 C-N-CA 124.323 1.049 . . . . 0.0 111.454 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.62 -40.74 63.04 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.96 -37.25 75.76 Favored 'General case' 0 N--CA 1.523 3.179 0 C-N-CA 123.114 0.566 . . . . 0.0 111.726 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 45.9 t -65.09 -48.52 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.502 0 C-N-CA 123.492 0.717 . . . . 0.0 111.359 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.14 -32.62 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 O-C-N 121.926 -0.484 . . . . 0.0 111.847 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.15 -40.65 37.29 Favored 'General case' 0 N--CA 1.534 3.748 0 C-N-CA 122.61 0.364 . . . . 0.0 111.705 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.42 -38.78 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.355 0.525 . . . . 0.0 111.711 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 35.4 m -67.89 -37.59 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.564 0 CA-C-O 121.047 0.451 . . . . 0.0 110.406 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.05 97.17 Favored 'General case' 0 N--CA 1.523 3.21 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.03 -33.95 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 O-C-N 121.726 -0.609 . . . . 0.0 110.149 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -60.03 -44.27 94.73 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.95 -42.08 82.12 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 CA-C-O 121.681 0.753 . . . . 0.0 109.468 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 83.0 m -61.57 -27.56 68.71 Favored 'General case' 0 N--CA 1.518 2.955 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.293 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.21 -30.9 71.84 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 122.635 0.374 . . . . 0.0 110.373 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 34.0 t -64.01 -35.17 79.82 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.243 0.617 . . . . 0.0 111.152 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.91 -18.42 56.54 Favored 'General case' 0 N--CA 1.532 3.636 0 C-N-CA 122.968 0.507 . . . . 0.0 111.592 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.54 -2.01 58.32 Favored 'General case' 1 N--CA 1.541 4.119 0 C-N-CA 123.054 0.542 . . . . 0.0 109.86 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -66.62 -68.47 0.37 Allowed 'General case' 0 N--CA 1.527 3.406 0 C-N-CA 123.172 0.589 . . . . 0.0 110.005 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 56.96 176.98 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.227 0 C-N-CA 124.26 1.024 . . . . 0.0 112.024 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -69.97 -178.22 1.53 Allowed 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 124.0 0.92 . . . . 0.0 110.359 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.95 138.31 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.498 0 C-N-CA 125.203 1.401 . . . . 0.0 108.228 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -108.16 99.21 30.39 Favored Pre-proline 0 N--CA 1.532 3.665 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo . . . . . 1 N--CA 1.547 4.67 0 C-N-CA 122.451 2.101 . . . . 0.0 114.55 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 CA--C 1.574 1.885 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.76 -97.59 0.01 OUTLIER 'Trans proline' 1 N--CA 1.542 4.368 0 C-N-CA 122.214 1.943 . . . . 0.0 110.72 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -168.91 -175.95 38.68 Favored Glycine 1 N--CA 1.52 4.249 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 99.5 p -78.9 72.94 5.45 Favored 'General case' 0 N--CA 1.52 3.068 0 C-N-CA 123.798 0.839 . . . . 0.0 110.035 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 53.9 mt -65.1 -26.83 68.38 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.6 0.76 . . . . 0.0 109.996 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -65.82 -29.23 69.67 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.34 0.656 . . . . 0.0 110.519 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.52 -35.68 81.9 Favored Glycine 1 N--CA 1.523 4.451 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.21 -45.97 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 C-N-CA 124.037 0.935 . . . . 0.0 111.555 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.7 pt -65.22 -33.21 62.12 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.492 0 CA-C-O 121.844 0.83 . . . . 0.0 110.019 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 40.0 mm -73.06 -33.67 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.285 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.45 -48.26 77.32 Favored Glycine 1 N--CA 1.52 4.249 0 C-N-CA 123.435 0.541 . . . . 0.0 114.29 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.96 -37.71 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.77 0 CA-C-N 117.434 0.617 . . . . 0.0 110.861 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 72.7 p -66.64 -45.92 77.46 Favored 'General case' 0 N--CA 1.533 3.722 0 CA-C-N 118.141 0.428 . . . . 0.0 111.354 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.48 -31.53 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.25 0 C-N-CA 123.797 0.839 . . . . 0.0 111.301 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.49 -37.23 75.12 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.21 -50.08 43.67 Favored 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.13 -38.46 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.32 -32.5 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 36.2 tp -77.84 -39.4 43.64 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.0 pt -69.51 -37.01 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 CA-C-N 119.053 0.842 . . . . 0.0 112.171 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.0 -37.09 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 121.838 -0.539 . . . . 0.0 110.15 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.19 79.87 Favored 'General case' 0 N--CA 1.525 3.3 0 C-N-CA 123.78 0.832 . . . . 0.0 112.888 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.64 -34.43 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 O-C-N 121.926 -0.484 . . . . 0.0 110.394 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -64.38 -44.08 92.45 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 123.091 0.556 . . . . 0.0 112.307 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.85 -37.57 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.704 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 83.4 m -64.35 -27.84 69.29 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.066 0.546 . . . . 0.0 111.018 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -69.3 -30.52 68.62 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 123.089 0.556 . . . . 0.0 111.05 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 82.4 p -64.73 -31.22 72.35 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.198 0.599 . . . . 0.0 111.706 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.3 -17.32 62.41 Favored 'General case' 0 N--CA 1.536 3.825 0 C-N-CA 123.462 0.705 . . . . 0.0 111.085 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -87.57 -28.54 21.88 Favored 'General case' 0 N--CA 1.537 3.892 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -79.15 -150.44 0.05 Allowed 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm 60.88 109.7 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.251 0 C-N-CA 123.929 0.892 . . . . 0.0 110.997 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -165.8 151.06 8.77 Favored 'General case' 0 N--CA 1.522 3.172 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.3 138.43 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.458 0 C-N-CA 124.857 1.263 . . . . 0.0 108.405 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 54.7 mt -94.56 146.67 31.89 Favored Pre-proline 0 N--CA 1.526 3.351 0 CA-C-O 117.295 -1.336 . . . . 0.0 108.179 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo . . . . . 1 N--CA 1.54 4.256 0 C-N-CA 122.044 1.829 . . . . 0.0 110.737 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 16.8 ptm . . . . . 0 CA--C 1.574 1.896 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.67 -29.69 19.16 Favored 'Trans proline' 1 N--CA 1.542 4.346 0 C-N-CA 122.268 1.979 . . . . 0.0 110.468 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.2 92.47 0.21 Allowed Glycine 1 N--CA 1.519 4.205 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.633 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 75.3 m -164.43 -41.16 0.03 OUTLIER 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 124.122 0.969 . . . . 0.0 108.598 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 45.8 mt -61.07 -26.2 67.48 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.49 1.116 . . . . 0.0 111.279 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 63.5 m -57.75 -43.49 85.43 Favored 'General case' 0 N--CA 1.522 3.174 0 C-N-CA 123.677 0.791 . . . . 0.0 112.097 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.62 81.28 Favored Glycine 1 N--CA 1.523 4.443 0 C-N-CA 123.559 0.599 . . . . 0.0 112.707 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 41.6 mm -59.98 -46.54 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.627 0 C-N-CA 123.979 0.912 . . . . 0.0 112.898 -176.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . 0.452 HD13 ' O ' ' C' ' 215' ' ' ILE . 0.1 OUTLIER -69.01 -35.77 70.63 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.683 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.5 mm -72.25 -33.36 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.04 -29.72 56.15 Favored Glycine 0 N--CA 1.513 3.798 0 C-N-CA 124.018 0.818 . . . . 0.0 113.415 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 m -59.98 -37.63 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 CA-C-N 117.349 0.574 . . . . 0.0 110.89 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 43.7 p -61.09 -46.72 89.5 Favored 'General case' 0 N--CA 1.526 3.34 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.213 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.96 -39.87 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.037 0 C-N-CA 124.277 1.031 . . . . 0.0 110.453 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.41 -38.42 58.99 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.11 -43.38 82.59 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 122.952 0.501 . . . . 0.0 110.562 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.08 -43.31 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.368 0 C-N-CA 123.773 0.829 . . . . 0.0 110.811 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.6 -32.31 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.56 0 C-N-CA 123.468 0.707 . . . . 0.0 109.969 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -45.71 91.04 Favored 'General case' 0 N--CA 1.537 3.925 0 CA-C-O 121.293 0.568 . . . . 0.0 109.939 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 80.9 mt -54.94 -35.89 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.821 0 C-N-CA 123.615 0.766 . . . . 0.0 111.028 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.42 -36.1 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 C-N-CA 123.117 0.567 . . . . 0.0 110.487 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.2 64.63 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 3.1 m -64.41 -34.87 72.17 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.426 0 CA-C-N 119.582 1.083 . . . . 0.0 110.619 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -72.94 -31.93 64.93 Favored 'General case' 0 N--CA 1.529 3.496 0 C-N-CA 123.093 0.557 . . . . 0.0 110.04 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.44 -37.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.579 0 C-N-CA 123.41 0.684 . . . . 0.0 109.29 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.58 -36.58 74.19 Favored 'General case' 0 N--CA 1.525 3.324 0 CA-C-O 121.073 0.463 . . . . 0.0 110.06 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.33 -38.2 63.35 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.201 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.8 m -63.91 -46.7 83.63 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 123.066 0.546 . . . . 0.0 110.846 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 85.1 mt -67.05 -18.01 65.16 Favored 'General case' 0 N--CA 1.53 3.53 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.706 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 41.7 tp -92.4 -11.66 34.31 Favored 'General case' 1 N--CA 1.539 4.008 0 C-N-CA 123.907 0.883 . . . . 0.0 110.141 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -51.41 -26.31 7.72 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.993 0.917 . . . . 0.0 112.308 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -65.43 143.15 57.89 Favored 'General case' 0 N--CA 1.526 3.375 0 C-N-CA 123.375 0.67 . . . . 0.0 110.289 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.66 8.42 Favored 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 124.119 0.968 . . . . 0.0 108.81 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 m -135.33 138.53 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 C-N-CA 124.832 1.253 . . . . 0.0 108.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.47 147.28 64.12 Favored Pre-proline 0 N--CA 1.535 3.814 0 C-N-CA 125.183 1.393 . . . . 0.0 108.652 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo . . . . . 1 N--CA 1.541 4.307 0 C-N-CA 122.0 1.8 . . . . 0.0 110.7 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 CA--C 1.576 1.95 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.67 -175.95 1.82 Allowed 'Trans proline' 1 N--CA 1.539 4.197 0 C-N-CA 122.332 2.021 . . . . 0.0 110.572 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -175.68 -169.53 37.45 Favored Glycine 1 N--CA 1.519 4.169 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 68.2 m -160.26 27.17 0.17 Allowed 'General case' 0 N--CA 1.523 3.187 0 C-N-CA 123.63 0.772 . . . . 0.0 109.825 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.09 -43.18 92.98 Favored 'General case' 0 N--CA 1.534 3.746 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 89.4 p -58.94 -26.3 64.27 Favored 'General case' 0 N--CA 1.526 3.374 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.823 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.47 -34.43 79.3 Favored Glycine 0 N--CA 1.506 3.363 0 C-N-CA 124.64 1.114 . . . . 0.0 113.68 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -35.26 52.63 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.297 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -174.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 16.8 tt -55.96 -32.42 33.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.81 -32.31 48.53 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.258 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.65 -40.59 96.66 Favored Glycine 1 N--CA 1.519 4.167 0 CA-C-O 119.653 -0.526 . . . . 0.0 113.653 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.45 -37.07 78.22 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 CA-C-N 118.458 1.129 . . . . 0.0 109.924 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 89.1 m -56.0 -45.1 79.16 Favored 'General case' 0 N--CA 1.522 3.163 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.54 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.53 -41.66 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 123.385 0.674 . . . . 0.0 110.7 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.82 -35.59 64.07 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.63 -50.36 37.82 Favored 'General case' 0 N--CA 1.521 3.094 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 12.9 p -68.02 -38.59 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.567 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.34 -31.99 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 CA-C-N 118.161 0.437 . . . . 0.0 110.237 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.97 -34.86 63.7 Favored 'General case' 1 N--CA 1.54 4.062 0 CA-C-O 121.485 0.66 . . . . 0.0 110.607 -178.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 67.4 mt -61.14 -36.04 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 124.002 0.921 . . . . 0.0 110.76 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.68 -37.64 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 123.272 0.629 . . . . 0.0 110.226 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -47.59 84.71 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.401 0.681 . . . . 0.0 112.571 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.56 -34.06 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.624 0 O-C-N 121.866 -0.521 . . . . 0.0 110.168 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.97 -44.2 97.24 Favored 'General case' 0 N--CA 1.529 3.503 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.86 -37.84 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 70.8 m -62.06 -27.57 68.99 Favored 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.081 0.552 . . . . 0.0 111.11 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -59.76 -18.66 44.88 Favored 'General case' 0 N--CA 1.533 3.706 0 C-N-CA 122.946 0.498 . . . . 0.0 111.244 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 97.3 p -73.81 -40.08 63.63 Favored 'General case' 0 N--CA 1.524 3.275 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.15 -14.88 63.32 Favored 'General case' 0 N--CA 1.537 3.895 0 C-N-CA 123.411 0.684 . . . . 0.0 110.481 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 57.2 tp -89.62 -28.9 19.21 Favored 'General case' 1 N--CA 1.54 4.045 0 C-N-CA 124.252 1.021 . . . . 0.0 109.826 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -79.88 -71.36 0.46 Allowed 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 43.6 tptt 44.62 17.31 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? 64.83 115.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.523 0 C-N-CA 123.921 0.888 . . . . 0.0 109.094 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.71 138.12 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.632 0 C-N-CA 124.834 1.253 . . . . 0.0 109.146 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 58.3 mt -97.91 146.88 32.22 Favored Pre-proline 0 N--CA 1.526 3.373 0 CA-C-O 117.249 -1.358 . . . . 0.0 108.211 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 1 N--CA 1.541 4.286 0 C-N-CA 122.013 1.809 . . . . 0.0 110.625 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.578 2.025 0 CA-C-O 117.6 -1.19 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.83 -1.59 6.46 Favored 'Trans proline' 1 N--CA 1.537 4.058 0 C-N-CA 122.52 2.146 . . . . 0.0 111.688 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -179.78 -132.18 1.76 Allowed Glycine 1 N--CA 1.518 4.139 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 19.9 p 81.23 -29.19 0.12 Allowed 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 125.416 1.487 . . . . 0.0 111.203 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 mp -64.22 -26.93 68.73 Favored 'General case' 1 N--CA 1.54 4.041 0 C-N-CA 123.498 0.719 . . . . 0.0 109.116 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 39.2 t -63.68 -35.85 81.91 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 123.805 0.842 . . . . 0.0 111.21 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.27 -35.69 83.22 Favored Glycine 1 N--CA 1.519 4.2 0 C-N-CA 123.846 0.736 . . . . 0.0 112.549 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.17 -47.04 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 C-N-CA 123.857 0.863 . . . . 0.0 112.292 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.83 -32.51 52.19 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 CA-C-N 118.564 0.62 . . . . 0.0 109.684 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.66 -32.24 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.76 -29.49 41.63 Favored Glycine 0 N--CA 1.511 3.698 0 C-N-CA 123.843 0.735 . . . . 0.0 113.402 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 m -60.32 -37.59 74.56 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.108 0 CA-C-N 117.918 0.859 . . . . 0.0 110.381 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 37.8 p -60.02 -45.8 91.61 Favored 'General case' 0 N--CA 1.528 3.47 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.235 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 47.6 t -69.49 -37.83 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 C-N-CA 124.229 1.012 . . . . 0.0 111.091 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.61 -42.96 65.06 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.85 -31.85 72.73 Favored 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 123.067 0.547 . . . . 0.0 111.748 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.05 -39.51 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.529 0 C-N-CA 123.089 0.556 . . . . 0.0 110.384 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.89 -33.01 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 C-N-CA 123.389 0.676 . . . . 0.0 110.558 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.59 -45.93 84.89 Favored 'General case' 0 N--CA 1.532 3.631 0 C-N-CA 122.715 0.406 . . . . 0.0 109.923 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 73.2 mt -54.78 -36.53 37.27 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 C-N-CA 122.851 0.46 . . . . 0.0 110.891 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.62 -37.88 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 C-N-CA 123.029 0.532 . . . . 0.0 109.889 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.95 -32.36 69.54 Favored 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.43 0.692 . . . . 0.0 111.387 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.17 -34.72 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.23 0 C-N-CA 123.638 0.775 . . . . 0.0 111.16 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -69.13 -43.98 73.3 Favored 'General case' 0 N--CA 1.531 3.586 0 O-C-N 122.059 -0.401 . . . . 0.0 112.015 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.69 -37.62 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 122.688 0.395 . . . . 0.0 110.661 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 12.3 p -59.98 -27.54 66.93 Favored 'General case' 0 N--CA 1.535 3.8 0 CA-C-N 118.089 0.404 . . . . 0.0 111.078 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -59.99 -27.01 66.5 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 123.393 0.677 . . . . 0.0 111.134 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 48.7 m -63.96 -33.99 76.96 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.401 0.68 . . . . 0.0 110.889 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 46.3 mt -61.05 -13.85 19.61 Favored 'General case' 0 N--CA 1.525 3.292 0 C-N-CA 124.483 1.113 . . . . 0.0 111.973 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 31.7 mt -86.57 -21.45 26.85 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.352 0.661 . . . . 0.0 110.233 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -76.94 95.2 4.07 Favored 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -166.63 -173.04 2.32 Favored 'General case' 0 N--CA 1.52 3.042 0 C-N-CA 123.849 0.859 . . . . 0.0 109.131 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -60.45 141.46 56.39 Favored 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 123.991 0.916 . . . . 0.0 111.088 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.63 138.22 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 124.834 1.254 . . . . 0.0 108.226 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 51.2 tp -109.24 99.64 37.22 Favored Pre-proline 0 N--CA 1.531 3.591 0 C-N-CA 124.871 1.269 . . . . 0.0 108.017 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo . . . . . 0 N--CA 1.535 3.968 0 C-N-CA 122.449 2.099 . . . . 0.0 111.11 -179.674 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 73.7 mtp . . . . . 0 CA--C 1.576 1.947 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.17 82.79 1.53 Allowed 'Trans proline' 1 N--CA 1.538 4.113 0 C-N-CA 122.318 2.012 . . . . 0.0 110.148 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.24 -131.58 30.14 Favored Glycine 1 N--CA 1.519 4.228 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 98.5 p -163.91 158.42 19.78 Favored 'General case' 0 N--CA 1.521 3.098 0 C-N-CA 123.581 0.753 . . . . 0.0 109.081 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.14 -27.01 68.43 Favored 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 124.246 1.018 . . . . 0.0 110.369 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 50.3 m -57.79 -26.19 61.58 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.1 0.56 . . . . 0.0 111.074 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.38 -34.58 63.61 Favored Glycine 1 N--CA 1.516 4.011 0 C-N-CA 124.362 0.982 . . . . 0.0 113.612 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 10.9 tp -59.32 -43.68 90.6 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 5.8 pt -66.73 -35.99 76.14 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.389 0 CA-C-O 121.906 0.86 . . . . 0.0 109.437 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 87.8 mt -72.68 -40.05 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.254 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.507 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.58 -48.76 84.46 Favored Glycine 1 N--CA 1.518 4.126 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.874 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.31 -36.55 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 123.036 0.535 . . . . 0.0 109.869 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 90.5 m -64.33 -47.5 79.17 Favored 'General case' 0 N--CA 1.523 3.202 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.69 -31.62 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.64 0 C-N-CA 122.76 0.424 . . . . 0.0 111.257 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.05 -47.18 68.63 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.223 0.609 . . . . 0.0 112.614 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.41 69.96 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.346 0.658 . . . . 0.0 112.548 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 45.3 t -68.09 -53.16 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.462 0 O-C-N 122.109 -0.37 . . . . 0.0 111.113 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.39 -32.14 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.361 0 C-N-CA 123.144 0.578 . . . . 0.0 112.411 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -39.03 55.97 Favored 'General case' 1 N--CA 1.541 4.085 0 C-N-CA 122.698 0.399 . . . . 0.0 111.467 -177.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 95.3 mt -69.1 -40.78 81.07 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 O-C-N 121.193 -0.942 . . . . 0.0 111.172 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.76 -36.51 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 O-C-N 121.476 -0.765 . . . . 0.0 109.894 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.21 -45.56 83.72 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.455 0.702 . . . . 0.0 112.621 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 16.8 m -71.86 -34.54 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 O-C-N 121.785 -0.572 . . . . 0.0 110.3 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.19 -44.2 92.74 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.67 -37.53 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 90.2 m -65.22 -29.76 70.59 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.063 0.545 . . . . 0.0 110.739 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -69.5 -39.49 77.55 Favored 'General case' 0 N--CA 1.529 3.499 0 C-N-CA 122.846 0.458 . . . . 0.0 109.927 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.8 t -64.06 -17.93 63.87 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 123.569 0.748 . . . . 0.0 111.386 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.57 -24.48 64.61 Favored 'General case' 0 N--CA 1.532 3.628 0 C-N-CA 124.096 0.958 . . . . 0.0 109.352 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -87.41 -26.56 23.24 Favored 'General case' 0 N--CA 1.539 3.982 0 C-N-CA 123.587 0.755 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 70.7 t-105 -63.95 -69.79 0.26 Allowed 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.261 0.624 . . . . 0.0 110.74 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -66.28 -179.46 0.79 Allowed 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 123.615 0.766 . . . . 0.0 110.81 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -167.81 173.3 8.42 Favored 'General case' 0 N--CA 1.521 3.121 0 C-N-CA 123.889 0.876 . . . . 0.0 109.305 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 26.1 m -135.13 138.24 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 C-N-CA 124.837 1.255 . . . . 0.0 108.245 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 53.1 tp -98.4 103.44 18.3 Favored Pre-proline 0 N--CA 1.529 3.498 0 CA-C-O 117.27 -1.348 . . . . 0.0 108.329 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo . . . . . 1 N--CA 1.536 4.003 0 C-N-CA 122.276 1.984 . . . . 0.0 110.974 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 CA--C 1.58 2.103 0 CA-C-O 117.714 -1.136 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.53 -31.99 51.42 Favored 'Trans proline' 1 N--CA 1.548 4.734 0 CA-C-N 122.302 1.858 . . . . 0.0 113.227 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 179.2 163.11 29.62 Favored Glycine 1 N--CA 1.519 4.223 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.3 p -69.77 139.5 53.27 Favored 'General case' 0 N--CA 1.522 3.144 0 C-N-CA 123.647 0.779 . . . . 0.0 110.326 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.4 mp -65.35 -26.4 68.01 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 124.072 0.949 . . . . 0.0 109.536 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 38.8 t -67.72 -27.52 66.87 Favored 'General case' 0 N--CA 1.519 3.009 0 C-N-CA 123.4 0.68 . . . . 0.0 110.527 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.92 -47.16 56.59 Favored Glycine 0 N--CA 1.504 3.217 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -70.55 -41.69 78.02 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.223 0 CA-C-N 118.085 0.943 . . . . 0.0 113.499 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 tt -59.23 -31.03 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 C-N-CA 123.614 0.766 . . . . 0.0 111.734 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -33.4 50.23 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.352 0 O-C-N 121.8 -0.562 . . . . 0.0 109.664 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.02 -38.5 65.85 Favored Glycine 1 N--CA 1.518 4.137 0 N-CA-C 115.282 0.873 . . . . 0.0 115.282 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.49 -37.53 77.91 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.285 0 CA-C-N 118.355 1.078 . . . . 0.0 111.199 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.7 p -63.46 -46.02 88.15 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.48 -31.42 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.553 0 C-N-CA 123.424 0.69 . . . . 0.0 110.981 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.3 -47.02 72.87 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.22 -34.94 74.35 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.484 0.714 . . . . 0.0 112.376 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.61 -40.44 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.292 0 C-N-CA 123.482 0.713 . . . . 0.0 111.178 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.18 -45.19 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 C-N-CA 122.722 0.409 . . . . 0.0 110.985 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.55 -34.79 78.58 Favored 'General case' 0 N--CA 1.535 3.793 0 C-N-CA 122.418 0.287 . . . . 0.0 110.424 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 74.7 mt -64.35 -44.94 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.705 0 C-N-CA 122.581 0.352 . . . . 0.0 110.531 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.11 -41.05 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.684 0 O-C-N 121.829 -0.544 . . . . 0.0 109.842 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.38 94.58 Favored 'General case' 0 N--CA 1.524 3.252 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.0 m -71.51 -34.05 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 O-C-N 121.603 -0.686 . . . . 0.0 110.194 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -61.13 -44.11 97.84 Favored 'General case' 0 N--CA 1.526 3.341 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 10.1 m -68.84 -41.39 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.83 0 CA-C-N 118.596 0.635 . . . . 0.0 109.576 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 74.5 m -60.52 -27.75 67.86 Favored 'General case' 0 N--CA 1.523 3.215 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.326 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -66.65 -35.06 79.27 Favored 'General case' 0 N--CA 1.523 3.186 0 C-N-CA 122.675 0.39 . . . . 0.0 110.362 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 31.8 t -64.28 -38.48 91.19 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.424 0.69 . . . . 0.0 111.234 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.75 -13.99 18.47 Favored 'General case' 0 N--CA 1.536 3.852 0 C-N-CA 123.265 0.626 . . . . 0.0 110.998 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.06 -17.95 31.71 Favored 'General case' 0 N--CA 1.534 3.735 0 C-N-CA 123.02 0.528 . . . . 0.0 110.281 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -88.9 3.09 52.55 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 124.146 0.978 . . . . 0.0 111.13 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -64.28 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 123.107 0.563 . . . . 0.0 110.171 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -71.2 148.36 47.37 Favored 'General case' 0 N--CA 1.522 3.142 0 C-N-CA 123.698 0.799 . . . . 0.0 110.03 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.96 128.86 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -103.53 99.84 16.83 Favored Pre-proline 0 N--CA 1.532 3.651 0 C-N-CA 124.873 1.269 . . . . 0.0 107.652 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 1 N--CA 1.536 4.01 0 C-N-CA 122.434 2.089 . . . . 0.0 110.564 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 44.1 ttm . . . . . 0 CA--C 1.58 2.115 0 CA-C-O 117.73 -1.129 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.5 172.88 0.11 Allowed 'Trans proline' 1 N--CA 1.548 4.701 0 CA-C-N 122.241 1.836 . . . . 0.0 113.782 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -178.5 -129.89 1.35 Allowed Glycine 1 N--CA 1.517 4.062 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 41.2 t -167.23 156.45 10.34 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-N 117.686 0.743 . . . . 0.0 110.004 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.21 -26.22 68.03 Favored 'General case' 0 N--CA 1.524 3.256 0 C-N-CA 124.703 1.201 . . . . 0.0 110.517 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 43.7 t -57.05 -24.99 57.84 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.539 0.736 . . . . 0.0 111.092 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.91 -47.01 82.29 Favored Glycine 1 N--CA 1.518 4.136 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.455 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 29.3 pt -71.6 -35.7 57.08 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.163 0 CA-C-N 118.204 1.002 . . . . 0.0 111.095 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 45.3 mm -57.23 -44.44 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.84 0 C-N-CA 124.474 1.11 . . . . 0.0 111.972 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.1 tp -72.41 -33.09 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.889 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.82 -44.68 97.73 Favored Glycine 1 N--CA 1.517 4.071 0 C-N-CA 123.919 0.771 . . . . 0.0 114.158 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.7 -37.21 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.726 0 CA-C-N 117.727 0.763 . . . . 0.0 110.905 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 67.4 p -65.44 -46.14 81.08 Favored 'General case' 0 N--CA 1.534 3.729 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.56 -31.03 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 C-N-CA 122.621 0.368 . . . . 0.0 111.262 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.22 -42.69 63.76 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.8 88.53 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.092 0.557 . . . . 0.0 111.249 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 24.3 t -64.66 -40.27 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 123.779 0.832 . . . . 0.0 111.234 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.57 -32.45 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 C-N-CA 123.247 0.619 . . . . 0.0 110.943 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 tp -76.54 -42.96 41.2 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.5 -44.05 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 C-N-CA 122.976 0.511 . . . . 0.0 111.841 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.27 -37.04 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.892 0 CA-C-N 118.575 0.625 . . . . 0.0 110.365 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.33 79.46 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.098 0.559 . . . . 0.0 111.812 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 90.3 t -71.66 -35.01 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 122.748 0.419 . . . . 0.0 109.995 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.29 -44.54 96.29 Favored 'General case' 0 N--CA 1.532 3.655 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.04 -38.25 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 73.4 m -67.2 -30.46 70.41 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 122.987 0.515 . . . . 0.0 110.711 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -67.34 -25.3 65.93 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.453 0.701 . . . . 0.0 111.097 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -63.91 -40.28 96.13 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.206 0.602 . . . . 0.0 111.292 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.95 -23.1 65.05 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.636 0.774 . . . . 0.0 110.734 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.7 mp -91.89 -19.82 22.09 Favored 'General case' 0 N--CA 1.537 3.912 0 C-N-CA 124.129 0.971 . . . . 0.0 109.524 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -146.69 57.18 1.16 Allowed 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.754 0.822 . . . . 0.0 109.187 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -79.05 -27.83 43.14 Favored 'General case' 0 N--CA 1.524 3.253 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.06 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 62.5 tttm 61.87 150.73 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 124.709 1.204 . . . . 0.0 111.367 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 66.1 t -113.06 135.35 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 125.031 1.332 . . . . 0.0 107.566 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.98 107.06 29.06 Favored Pre-proline 0 N--CA 1.526 3.348 0 CA-C-O 116.928 -1.511 . . . . 0.0 107.492 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo . . . . . 1 N--CA 1.548 4.721 0 CA-C-N 122.95 2.089 . . . . 0.0 114.27 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 CA--C 1.582 2.182 0 CA-C-O 117.892 -1.051 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -53.56 -10.24 1.43 Allowed 'Trans proline' 1 N--CA 1.548 4.733 0 C-N-CA 122.155 1.903 . . . . 0.0 114.132 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.68 87.79 0.28 Allowed Glycine 1 N--CA 1.518 4.153 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 96.2 p -58.33 -62.31 1.93 Allowed 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.929 0.891 . . . . 0.0 111.96 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.46 -40.98 96.73 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 123.636 0.774 . . . . 0.0 110.626 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 40.4 t -69.6 -26.59 64.52 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 123.144 0.577 . . . . 0.0 110.719 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.58 -46.03 64.11 Favored Glycine 1 N--CA 1.517 4.061 0 N-CA-C 116.508 1.363 . . . . 0.0 116.508 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -35.01 60.59 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.462 0 CA-C-N 119.806 1.803 . . . . 0.0 112.274 -176.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 2.7 pt -58.92 -45.0 92.1 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.491 0 CA-C-N 118.694 0.679 . . . . 0.0 111.812 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.0 pt -68.99 -32.99 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 C-N-CA 122.986 0.514 . . . . 0.0 109.75 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.7 -29.94 68.1 Favored Glycine 0 N--CA 1.513 3.783 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.425 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 2.7 m -60.38 -37.65 75.06 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.006 0 CA-C-N 117.847 0.823 . . . . 0.0 111.142 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 56.2 p -63.14 -46.67 86.15 Favored 'General case' 0 N--CA 1.526 3.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.444 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 47.2 t -70.1 -33.57 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.086 0 C-N-CA 124.158 0.983 . . . . 0.0 110.5 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.91 90.04 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.538 0.735 . . . . 0.0 112.523 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.97 -48.55 70.9 Favored 'General case' 0 N--CA 1.516 2.841 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.4 m -67.9 -39.96 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.55 -34.16 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 CA-C-N 119.354 0.979 . . . . 0.0 111.759 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 45.1 tp -67.83 -47.59 68.57 Favored 'General case' 0 N--CA 1.528 3.425 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 27.7 pt -68.95 -36.3 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-N 118.231 0.469 . . . . 0.0 111.002 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.48 -37.42 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.962 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.25 72.47 Favored 'General case' 0 N--CA 1.533 3.683 0 C-N-CA 122.931 0.492 . . . . 0.0 112.086 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.77 -37.05 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.066 0.546 . . . . 0.0 110.304 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -63.31 -44.08 96.01 Favored 'General case' 0 N--CA 1.532 3.64 0 C-N-CA 123.135 0.574 . . . . 0.0 112.443 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.62 -37.46 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.63 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 98.0 m -62.2 -29.72 70.58 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 122.879 0.472 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -69.58 -27.67 65.32 Favored 'General case' 0 N--CA 1.529 3.513 0 C-N-CA 123.214 0.606 . . . . 0.0 111.07 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 30.3 t -64.07 -32.72 74.38 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 123.204 0.602 . . . . 0.0 112.094 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 8.3 mp -63.39 -21.48 66.31 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.648 0.779 . . . . 0.0 110.885 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 7.9 mp -87.51 -28.28 22.12 Favored 'General case' 0 N--CA 1.532 3.672 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -83.39 86.82 7.01 Favored 'General case' 0 N--CA 1.52 3.048 0 C-N-CA 123.978 0.911 . . . . 0.0 108.734 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.19 -17.88 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.294 0 C-N-CA 123.675 0.79 . . . . 0.0 110.204 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 59.0 -171.41 0.12 Allowed 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.932 0.893 . . . . 0.0 110.673 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.64 117.96 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.52 146.73 32.01 Favored Pre-proline 0 N--CA 1.528 3.431 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo . . . . . 1 N--CA 1.54 4.233 0 C-N-CA 122.089 1.859 . . . . 0.0 110.619 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 CA--C 1.575 1.928 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -50.83 143.36 30.19 Favored 'Trans proline' 1 N--CA 1.544 4.448 0 C-N-CA 122.441 2.094 . . . . 0.0 113.671 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.55 -169.03 9.98 Favored Glycine 0 N--CA 1.515 3.957 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 99.5 p -165.96 67.83 0.12 Allowed 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 123.735 0.814 . . . . 0.0 108.841 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.07 -32.71 74.56 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 123.88 0.872 . . . . 0.0 109.243 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 52.2 m -68.46 -25.48 65.01 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 123.682 0.793 . . . . 0.0 109.155 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.74 -46.88 89.01 Favored Glycine 0 N--CA 1.508 3.487 0 C-N-CA 123.848 0.737 . . . . 0.0 114.512 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 tt -70.84 -35.55 60.58 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.412 0 CA-C-N 118.688 1.244 . . . . 0.0 111.324 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 49.9 mm -56.28 -32.46 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 124.807 1.243 . . . . 0.0 112.124 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 1.7 pp -68.32 -33.96 63.39 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.091 0 CA-C-N 119.493 1.042 . . . . 0.0 109.569 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.09 -34.46 89.81 Favored Glycine 1 N--CA 1.521 4.32 0 C-N-CA 123.483 0.564 . . . . 0.0 111.799 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.07 -39.83 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.396 0 C-N-CA 124.213 1.005 . . . . 0.0 110.031 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 30.1 p -61.01 -38.92 87.8 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 123.162 0.585 . . . . 0.0 110.938 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 41.2 t -67.12 -41.46 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.081 0 C-N-CA 123.79 0.836 . . . . 0.0 110.36 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.88 -47.18 85.86 Favored 'General case' 0 N--CA 1.523 3.187 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.51 -47.95 68.5 Favored 'General case' 0 N--CA 1.513 2.701 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.57 -41.94 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.471 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.08 -33.4 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 O-C-N 122.228 -0.295 . . . . 0.0 111.282 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.22 -35.6 81.34 Favored 'General case' 0 N--CA 1.529 3.499 0 C-N-CA 122.736 0.414 . . . . 0.0 110.675 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.43 -36.86 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.702 0 C-N-CA 123.191 0.597 . . . . 0.0 110.119 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.66 -43.31 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 C-N-CA 122.973 0.509 . . . . 0.0 110.093 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.25 -43.14 87.72 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 20.9 m -71.58 -33.89 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 O-C-N 121.806 -0.559 . . . . 0.0 110.071 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.41 -43.49 97.36 Favored 'General case' 0 N--CA 1.526 3.359 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 10.0 m -68.38 -40.16 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 CA-C-N 118.684 0.675 . . . . 0.0 110.884 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 14.5 p -66.35 -28.5 68.7 Favored 'General case' 0 N--CA 1.533 3.711 0 O-C-N 122.197 -0.315 . . . . 0.0 110.38 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -73.77 -32.55 63.85 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 123.446 0.698 . . . . 0.0 109.845 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 47.8 m -64.18 -31.17 72.26 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.182 0.593 . . . . 0.0 110.751 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 60.0 mt -60.79 -23.66 65.2 Favored 'General case' 0 N--CA 1.531 3.594 0 C-N-CA 122.586 0.354 . . . . 0.0 111.206 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.68 -7.36 52.83 Favored 'General case' 1 N--CA 1.539 4.017 0 C-N-CA 123.946 0.898 . . . . 0.0 110.33 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -69.19 3.51 2.13 Favored 'General case' 0 N--CA 1.534 3.764 0 C-N-CA 123.013 0.525 . . . . 0.0 111.31 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -53.2 149.32 7.19 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 123.937 0.895 . . . . 0.0 111.332 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -67.29 126.16 28.38 Favored 'General case' 0 N--CA 1.52 3.034 0 C-N-CA 123.935 0.894 . . . . 0.0 110.79 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 22.2 m -135.3 138.26 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.457 0 C-N-CA 124.952 1.301 . . . . 0.0 108.059 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.561 ' H ' HD23 ' D' ' 241' ' ' LEU . 1.7 pt? -94.53 146.38 31.37 Favored Pre-proline 0 N--CA 1.534 3.746 0 C-N-CA 124.634 1.174 . . . . 0.0 109.629 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 1 N--CA 1.54 4.26 0 CA-C-N 122.166 1.809 . . . . 0.0 110.796 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.573 1.844 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.09 -42.31 3.17 Favored 'Trans proline' 1 N--CA 1.54 4.249 0 C-N-CA 122.02 1.813 . . . . 0.0 110.485 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -75.31 138.02 22.77 Favored Glycine 1 N--CA 1.518 4.102 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 99.6 p -167.3 -21.84 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.612 0.765 . . . . 0.0 109.99 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 41.9 mt -64.28 -34.3 77.8 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.695 0.798 . . . . 0.0 110.056 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 61.2 m -68.69 -26.57 65.36 Favored 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 123.575 0.75 . . . . 0.0 110.104 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.84 -46.18 61.35 Favored Glycine 0 N--CA 1.514 3.887 0 C-N-CA 124.071 0.844 . . . . 0.0 114.705 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 45.9 pt -70.76 -35.77 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -175.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . 0.411 HD13 ' H ' ' E' ' 216' ' ' ILE 0.253 0.1 OUTLIER -57.77 -41.3 79.31 Favored 'Isoleucine or valine' 1 N--CA 1.558 4.95 0 CA-C-N 119.984 1.265 . . . . 0.0 112.945 -175.033 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . 0.411 ' H ' HD13 ' E' ' 215' ' ' ILE . 17.0 tt -72.38 -32.16 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 C-N-CA 124.297 1.039 . . . . 0.0 108.863 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.01 -29.37 43.39 Favored Glycine 0 N--CA 1.512 3.704 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.395 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.16 -37.8 79.39 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 CA-C-N 118.089 0.944 . . . . 0.0 110.7 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 36.1 p -65.98 -40.51 91.29 Favored 'General case' 0 N--CA 1.529 3.477 0 C-N-CA 123.344 0.657 . . . . 0.0 110.366 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.59 -32.08 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.06 0 C-N-CA 124.046 0.939 . . . . 0.0 110.49 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.54 91.48 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-O 121.062 0.458 . . . . 0.0 110.761 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.28 -47.97 80.09 Favored 'General case' 0 N--CA 1.519 3.017 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.91 -38.57 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.48 -32.8 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 40.6 tp -78.18 -42.64 30.94 Favored 'General case' 0 N--CA 1.535 3.79 0 CA-C-N 118.755 0.707 . . . . 0.0 112.311 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.12 -35.56 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.476 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 28.6 m -65.51 -35.21 74.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.354 0 CA-C-N 119.241 0.928 . . . . 0.0 109.978 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.07 -31.24 63.02 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.467 0.707 . . . . 0.0 112.144 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 3.2 m -56.96 -34.17 43.91 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 O-C-N 121.635 -0.666 . . . . 0.0 110.848 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.96 -44.65 96.3 Favored 'General case' 0 N--CA 1.53 3.527 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.59 -37.3 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.974 0 CA-C-N 119.067 0.849 . . . . 0.0 108.875 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 63.4 m -58.54 -27.56 64.66 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 122.854 0.461 . . . . 0.0 110.901 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -60.78 -18.12 53.2 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 122.916 0.487 . . . . 0.0 110.695 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 33.5 t -66.2 -25.53 66.97 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.616 0.766 . . . . 0.0 111.244 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 46.0 tp -60.38 -14.42 18.72 Favored 'General case' 0 N--CA 1.532 3.641 0 C-N-CA 123.848 0.859 . . . . 0.0 111.4 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.16 3.1 47.74 Favored 'General case' 0 N--CA 1.534 3.773 0 C-N-CA 123.682 0.793 . . . . 0.0 111.142 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -73.04 68.18 0.92 Allowed 'General case' 1 N--CA 1.542 4.166 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -92.25 -167.98 1.88 Allowed 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 124.907 1.283 . . . . 0.0 109.063 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -168.28 153.22 6.45 Favored 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 124.099 0.96 . . . . 0.0 108.458 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 23.8 m -135.21 138.23 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 124.851 1.26 . . . . 0.0 108.477 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.596 ' H ' HD23 ' E' ' 241' ' ' LEU . 1.7 pt? -94.81 146.91 32.23 Favored Pre-proline 0 N--CA 1.534 3.734 0 CA-C-O 116.657 -1.64 . . . . 0.0 109.602 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo . . . . . 1 N--CA 1.55 4.838 0 C-N-CA 122.654 2.236 . . . . 0.0 114.818 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 CA--C 1.575 1.921 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -75.33 48.52 2.1 Favored 'Trans proline' 1 N--CA 1.54 4.236 0 C-N-CA 122.53 2.153 . . . . 0.0 110.446 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -176.05 142.4 6.02 Favored Glycine 1 N--CA 1.519 4.226 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . 0.424 ' H ' ' H ' ' F' ' 211' ' ' LEU . 93.3 p -170.17 7.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 124.476 1.11 . . . . 0.0 109.524 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . 0.424 ' H ' ' H ' ' F' ' 210' ' ' SER . 56.9 tp -64.54 -26.52 68.45 Favored 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.451 1.101 . . . . 0.0 110.871 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 55.1 m -65.46 -26.25 67.86 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.246 0.619 . . . . 0.0 111.002 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.15 -46.57 64.35 Favored Glycine 0 N--CA 1.516 3.974 0 C-N-CA 123.406 0.527 . . . . 0.0 114.233 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -70.85 -35.55 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 11.6 pt -56.64 -45.11 82.43 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.587 0 CA-C-N 119.529 1.059 . . . . 0.0 112.607 -175.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.99 -33.76 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 C-N-CA 123.358 0.663 . . . . 0.0 109.823 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.91 -30.08 76.69 Favored Glycine 0 N--CA 1.509 3.525 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.684 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.04 -37.65 73.55 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 CA-C-N 118.106 0.953 . . . . 0.0 111.589 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 29.2 p -65.82 -47.31 75.46 Favored 'General case' 0 N--CA 1.529 3.518 0 CA-C-O 121.319 0.58 . . . . 0.0 110.518 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.66 -42.38 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 C-N-CA 124.264 1.026 . . . . 0.0 111.176 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.04 -43.0 73.38 Favored 'General case' 0 N--CA 1.528 3.468 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.13 -50.49 68.01 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 p -68.39 -38.66 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 CA-C-N 118.499 0.59 . . . . 0.0 111.883 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.34 -33.69 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.456 0.571 . . . . 0.0 110.79 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 25.0 tp -69.71 -34.47 73.94 Favored 'General case' 0 N--CA 1.531 3.618 0 CA-C-N 118.689 0.677 . . . . 0.0 111.016 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 79.2 mt -65.72 -41.46 90.44 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.134 0 O-C-N 121.728 -0.608 . . . . 0.0 109.436 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.11 -37.41 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 C-N-CA 123.54 0.736 . . . . 0.0 109.807 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.09 68.35 Favored 'General case' 0 N--CA 1.527 3.405 0 C-N-CA 123.21 0.604 . . . . 0.0 111.863 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 69.6 t -71.68 -38.04 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 122.812 0.445 . . . . 0.0 110.391 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -62.12 -44.07 97.45 Favored 'General case' 0 N--CA 1.532 3.644 0 C-N-CA 123.186 0.594 . . . . 0.0 112.579 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.69 -37.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.685 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 93.3 m -64.77 -29.68 70.66 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 122.924 0.489 . . . . 0.0 110.463 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -74.32 -40.03 62.47 Favored 'General case' 0 N--CA 1.525 3.321 0 C-N-CA 123.059 0.543 . . . . 0.0 109.585 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.3 t -63.82 -18.91 64.6 Favored 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 123.946 0.899 . . . . 0.0 112.376 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 50.5 tp -70.56 -14.82 62.66 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.673 0.789 . . . . 0.0 110.95 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 mp -87.21 -0.91 57.44 Favored 'General case' 0 N--CA 1.534 3.754 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.619 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -163.23 82.48 0.48 Allowed 'General case' 0 N--CA 1.538 3.949 0 CA-C-N 119.042 0.837 . . . . 0.0 112.3 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -145.61 -8.37 0.57 Allowed 'General case' 0 N--CA 1.538 3.927 0 C-N-CA 125.038 1.335 . . . . 0.0 108.595 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -70.43 149.96 46.72 Favored 'General case' 0 N--CA 1.527 3.402 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.32 138.38 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 124.82 1.248 . . . . 0.0 108.368 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.9 pp -94.67 146.51 31.56 Favored Pre-proline 0 N--CA 1.528 3.462 0 CA-C-O 117.316 -1.326 . . . . 0.0 108.444 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 1 N--CA 1.539 4.195 0 C-N-CA 122.011 1.807 . . . . 0.0 110.104 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 3.5 ppp? . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 117.746 -1.121 . . . . 0.0 108.172 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.22 153.82 56.65 Favored 'Trans proline' 1 N--CA 1.539 4.151 0 C-N-CA 122.026 1.817 . . . . 0.0 110.157 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -73.6 178.72 41.82 Favored Glycine 0 N--CA 1.516 3.981 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.9 p -168.49 -53.17 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.88 -26.38 68.3 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 123.726 0.81 . . . . 0.0 109.099 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 37.4 t -57.79 -41.32 81.85 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 123.815 0.846 . . . . 0.0 112.248 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -35.48 79.71 Favored Glycine 1 N--CA 1.521 4.348 0 C-N-CA 123.883 0.754 . . . . 0.0 112.978 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.25 -46.29 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 C-N-CA 123.97 0.908 . . . . 0.0 112.845 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.11 -32.18 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 O-C-N 121.986 -0.446 . . . . 0.0 110.786 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.8 -33.75 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 C-N-CA 123.437 0.695 . . . . 0.0 110.185 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.32 84.8 Favored Glycine 1 N--CA 1.521 4.301 0 CA-C-O 119.941 -0.366 . . . . 0.0 113.851 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.7 m -60.0 -36.75 69.1 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.343 0 CA-C-N 117.762 0.781 . . . . 0.0 110.784 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -55.47 -45.28 76.97 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.502 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 42.6 t -65.73 -37.96 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 C-N-CA 124.151 0.98 . . . . 0.0 111.46 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.95 -42.44 65.48 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.34 83.4 Favored 'General case' 0 N--CA 1.521 3.079 0 C-N-CA 123.126 0.57 . . . . 0.0 111.184 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.4 t -64.29 -42.93 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.442 0.697 . . . . 0.0 110.934 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.2 -40.93 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 C-N-CA 123.144 0.578 . . . . 0.0 110.291 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.39 -38.5 91.39 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.928 0.491 . . . . 0.0 110.466 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.4 mt -56.97 -36.41 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.772 0 C-N-CA 123.441 0.696 . . . . 0.0 110.692 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 50.4 t -61.91 -37.94 79.44 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 C-N-CA 122.737 0.415 . . . . 0.0 110.469 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -31.85 68.71 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.563 0.745 . . . . 0.0 111.754 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.0 t -61.63 -34.73 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 C-N-CA 122.948 0.499 . . . . 0.0 111.393 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -67.59 -44.1 78.94 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.8 -37.43 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.954 0 CA-C-N 118.713 0.688 . . . . 0.0 109.903 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 76.4 m -66.12 -33.1 75.02 Favored 'General case' 0 N--CA 1.522 3.154 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.085 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -70.01 -41.24 74.6 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 123.276 0.631 . . . . 0.0 110.219 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 95.9 p -66.34 -30.21 70.57 Favored 'General case' 0 N--CA 1.53 3.539 0 C-N-CA 123.284 0.633 . . . . 0.0 109.766 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -14.32 45.25 Favored 'General case' 0 N--CA 1.531 3.618 0 C-N-CA 124.543 1.137 . . . . 0.0 110.255 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 32.5 mt -86.66 5.05 37.9 Favored 'General case' 0 N--CA 1.537 3.877 0 C-N-CA 123.241 0.617 . . . . 0.0 110.826 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -168.33 122.31 0.9 Allowed 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.558 0.743 . . . . 0.0 109.085 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -139.24 -0.64 1.8 Allowed 'General case' 0 N--CA 1.531 3.613 0 C-N-CA 124.81 1.244 . . . . 0.0 109.546 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -167.02 155.29 9.74 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.61 138.27 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 C-N-CA 124.886 1.275 . . . . 0.0 108.963 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.85 147.28 33.22 Favored Pre-proline 0 N--CA 1.526 3.346 0 C-N-CA 125.312 1.445 . . . . 0.0 108.329 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 1 N--CA 1.541 4.307 0 C-N-CA 121.991 1.794 . . . . 0.0 110.758 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.574 1.883 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -69.63 165.19 31.65 Favored 'Trans proline' 1 N--CA 1.54 4.259 0 C-N-CA 122.281 1.987 . . . . 0.0 110.378 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.07 178.65 15.93 Favored Glycine 1 N--CA 1.517 4.038 0 C-N-CA 123.723 0.677 . . . . 0.0 112.036 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 98.7 p -167.19 39.15 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.125 0 C-N-CA 124.222 1.009 . . . . 0.0 108.395 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 49.8 mt -61.7 -26.81 68.27 Favored 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 124.31 1.044 . . . . 0.0 111.038 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 68.5 m -60.39 -26.53 66.73 Favored 'General case' 0 N--CA 1.528 3.463 0 C-N-CA 123.427 0.691 . . . . 0.0 110.647 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.09 -34.96 81.83 Favored Glycine 0 N--CA 1.512 3.767 0 C-N-CA 124.944 1.259 . . . . 0.0 115.015 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 14.4 tt -59.75 -35.76 61.93 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -175.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 1.9 pp -56.81 -47.76 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.0 tt -73.26 -33.5 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.32 -46.55 93.67 Favored Glycine 0 N--CA 1.513 3.782 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.979 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.59 -37.39 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 CA-C-N 117.615 0.707 . . . . 0.0 110.847 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 28.3 p -66.11 -46.1 78.77 Favored 'General case' 0 N--CA 1.526 3.371 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -69.93 -31.68 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.94 68.96 Favored 'General case' 0 N--CA 1.528 3.46 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.0 -49.97 58.36 Favored 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 22.0 m -66.95 -38.26 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 CA-C-N 118.534 0.606 . . . . 0.0 111.902 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.07 -32.74 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 122.504 0.322 . . . . 0.0 110.136 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.28 -41.43 94.18 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 122.602 0.361 . . . . 0.0 110.589 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 73.7 mt -56.85 -36.41 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 C-N-CA 122.889 0.476 . . . . 0.0 110.579 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.95 -37.28 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 C-N-CA 122.985 0.514 . . . . 0.0 110.517 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -31.88 66.96 Favored 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.53 0.732 . . . . 0.0 112.224 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.9 -34.92 73.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 O-C-N 121.587 -0.696 . . . . 0.0 110.469 -178.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -64.24 -44.58 91.41 Favored 'General case' 0 N--CA 1.527 3.409 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 16.0 m -69.07 -37.6 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-O 121.29 0.567 . . . . 0.0 109.742 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -66.46 -30.42 70.76 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -74.32 -40.12 62.43 Favored 'General case' 0 N--CA 1.525 3.285 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 70.9 m -65.07 -35.55 81.51 Favored 'General case' 0 N--CA 1.523 3.196 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.204 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.21 -14.23 24.09 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 124.082 0.953 . . . . 0.0 111.194 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 21.9 mt -87.56 10.15 18.78 Favored 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 123.263 0.625 . . . . 0.0 109.412 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -25.33 134.91 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.068 0 C-N-CA 125.629 1.572 . . . . 0.0 113.427 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -132.43 166.84 21.09 Favored 'General case' 0 N--CA 1.526 3.36 0 C-N-CA 124.191 0.996 . . . . 0.0 109.698 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -67.63 -171.71 0.21 Allowed 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 124.14 0.976 . . . . 0.0 110.452 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.88 130.06 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 52.3 tp -133.43 99.83 14.22 Favored Pre-proline 0 N--CA 1.531 3.605 0 C-N-CA 124.981 1.312 . . . . 0.0 107.975 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 1 N--CA 1.536 4.022 0 C-N-CA 122.351 2.034 . . . . 0.0 110.926 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.577 1.982 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -85.25 28.07 0.58 Allowed 'Trans proline' 0 N--CA 1.535 3.949 0 C-N-CA 122.89 2.393 . . . . 0.0 110.769 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.13 14.1 65.58 Favored Glycine 1 N--CA 1.519 4.228 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.19 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 50.0 m 55.08 88.04 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 124.126 0.97 . . . . 0.0 111.829 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 tp -64.98 -35.74 82.17 Favored 'General case' 0 N--CA 1.527 3.424 0 C-N-CA 123.881 0.872 . . . . 0.0 109.971 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.0 m -67.2 -30.39 70.31 Favored 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 123.778 0.831 . . . . 0.0 110.446 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -47.0 57.97 Favored Glycine 0 N--CA 1.513 3.829 0 CA-C-N 115.526 -0.761 . . . . 0.0 114.334 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 34.6 pt -71.35 -39.7 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -176.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.2 tt -62.79 -39.77 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.62 -33.08 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.942 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.9 -29.12 50.13 Favored Glycine 0 N--CA 1.515 3.96 0 C-N-CA 123.609 0.623 . . . . 0.0 113.363 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.3 m -59.53 -46.28 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 5.3 t -66.11 -38.79 89.06 Favored 'General case' 0 N--CA 1.536 3.832 0 CA-C-O 121.045 0.45 . . . . 0.0 111.067 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.1 -39.61 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.183 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.66 72.68 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 123.461 0.704 . . . . 0.0 111.05 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.82 87.67 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 123.499 0.719 . . . . 0.0 111.224 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.33 -48.42 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 C-N-CA 123.269 0.627 . . . . 0.0 110.089 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.73 -36.77 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.561 0 C-N-CA 123.766 0.826 . . . . 0.0 110.9 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 22.4 mt -65.04 -34.35 78.21 Favored 'General case' 0 N--CA 1.534 3.727 0 C-N-CA 122.898 0.479 . . . . 0.0 110.591 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.98 -39.64 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.74 -37.87 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.514 0 C-N-CA 123.262 0.625 . . . . 0.0 109.601 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.28 83.29 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.748 0.819 . . . . 0.0 112.623 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.83 -34.35 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.594 0 O-C-N 121.897 -0.502 . . . . 0.0 110.215 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -63.8 -43.92 94.86 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 123.141 0.577 . . . . 0.0 112.517 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.39 -37.25 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 77.4 m -60.03 -28.42 67.73 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 122.658 0.383 . . . . 0.0 111.367 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -74.09 -28.65 61.48 Favored 'General case' 0 N--CA 1.531 3.602 0 C-N-CA 122.653 0.381 . . . . 0.0 110.817 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 57.9 m -67.41 -17.69 64.82 Favored 'General case' 0 N--CA 1.53 3.569 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.78 -38.54 67.25 Favored 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 124.126 0.97 . . . . 0.0 110.459 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 pp -87.93 -4.14 58.85 Favored 'General case' 1 N--CA 1.553 4.687 0 CA-C-N 118.767 0.712 . . . . 0.0 111.923 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -69.68 -11.84 61.16 Favored 'General case' 0 N--CA 1.528 3.428 0 C-N-CA 123.518 0.727 . . . . 0.0 110.717 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -64.91 -26.09 68.17 Favored 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 124.009 0.924 . . . . 0.0 111.39 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -74.83 72.03 2.03 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.59 0.756 . . . . 0.0 109.852 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.48 135.82 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 124.591 1.157 . . . . 0.0 108.178 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.9 mp -94.88 116.48 66.42 Favored Pre-proline 0 N--CA 1.527 3.417 0 CA-C-O 116.568 -1.682 . . . . 0.0 106.917 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 1 N--CA 1.538 4.093 0 CA-C-N 123.325 2.223 . . . . 0.0 110.66 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 CA--C 1.579 2.084 0 CA-C-O 117.753 -1.117 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.77 -18.64 9.31 Favored 'Trans proline' 1 N--CA 1.548 4.684 0 CA-C-N 122.283 1.851 . . . . 0.0 113.331 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.48 -170.84 50.23 Favored Glycine 1 N--CA 1.518 4.12 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 70.2 m -159.7 40.61 0.2 Allowed 'General case' 0 N--CA 1.518 2.956 0 C-N-CA 124.084 0.954 . . . . 0.0 108.736 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.04 -35.07 79.99 Favored 'General case' 0 N--CA 1.527 3.4 0 C-N-CA 124.533 1.133 . . . . 0.0 109.741 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 70.7 m -57.14 -26.04 59.88 Favored 'General case' 0 N--CA 1.525 3.318 0 C-N-CA 123.725 0.81 . . . . 0.0 110.523 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.46 -34.45 59.82 Favored Glycine 0 N--CA 1.509 3.504 0 C-N-CA 124.929 1.252 . . . . 0.0 114.979 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 16.2 pt -59.15 -34.67 54.2 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.12 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -175.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 8.9 pt -56.15 -45.57 80.84 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.265 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 5.8 tp -72.37 -33.87 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.26 -48.27 84.48 Favored Glycine 1 N--CA 1.517 4.039 0 C-N-CA 123.89 0.757 . . . . 0.0 113.706 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.29 -37.32 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.771 0 O-C-N 121.763 -0.845 . . . . 0.0 109.628 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 25.3 m -66.26 -45.75 79.47 Favored 'General case' 0 N--CA 1.519 2.978 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 12.8 p -63.59 -31.12 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 CA-C-N 118.203 0.456 . . . . 0.0 110.436 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.1 -47.2 81.64 Favored 'General case' 0 N--CA 1.528 3.453 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.94 73.93 Favored 'General case' 0 N--CA 1.523 3.194 0 C-N-CA 123.556 0.742 . . . . 0.0 112.036 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.83 -38.61 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 C-N-CA 123.366 0.666 . . . . 0.0 110.602 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.32 -44.79 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 C-N-CA 123.154 0.582 . . . . 0.0 110.135 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.73 -34.54 73.07 Favored 'General case' 1 N--CA 1.54 4.028 0 C-N-CA 123.12 0.568 . . . . 0.0 110.752 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.85 -40.1 87.5 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.22 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.65 -41.94 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 C-N-CA 122.989 0.516 . . . . 0.0 109.814 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -41.06 82.09 Favored 'General case' 0 N--CA 1.527 3.406 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 19.0 m -71.17 -33.74 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 O-C-N 121.709 -0.619 . . . . 0.0 110.062 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -66.26 -43.92 85.14 Favored 'General case' 0 N--CA 1.528 3.463 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.76 -37.89 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 CA-C-N 118.327 0.512 . . . . 0.0 111.082 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 10.1 p -58.68 -27.51 64.88 Favored 'General case' 0 N--CA 1.531 3.616 0 C-N-CA 122.367 0.267 . . . . 0.0 111.499 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -61.27 -31.16 70.98 Favored 'General case' 0 N--CA 1.521 3.113 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.05 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 71.2 p -66.0 -38.06 87.52 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.459 0.704 . . . . 0.0 110.607 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 61.0 mt -60.77 -13.34 14.55 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 123.638 0.775 . . . . 0.0 111.901 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 26.8 mt -86.04 -7.65 58.48 Favored 'General case' 0 N--CA 1.534 3.727 0 C-N-CA 123.054 0.542 . . . . 0.0 110.366 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -70.67 -106.65 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.235 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 53.18 23.08 2.9 Favored 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 123.845 0.858 . . . . 0.0 111.94 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 24.7 tptm 61.01 121.65 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.341 0 C-N-CA 124.731 1.213 . . . . 0.0 110.537 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.81 138.06 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.613 0 C-N-CA 124.928 1.291 . . . . 0.0 108.985 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.669 ' H ' HD23 ' D' ' 241' ' ' LEU . 1.6 pt? -106.03 146.5 33.03 Favored Pre-proline 0 N--CA 1.535 3.793 0 C-N-CA 125.29 1.436 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo . . . . . 1 N--CA 1.542 4.327 0 CA-C-N 122.267 1.845 . . . . 0.0 110.597 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.573 1.83 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.83 -179.66 4.44 Favored 'Trans proline' 1 N--CA 1.539 4.192 0 C-N-CA 122.139 1.893 . . . . 0.0 110.46 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.65 88.99 0.14 Allowed Glycine 1 N--CA 1.519 4.189 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 66.5 m -63.55 165.14 8.4 Favored 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.918 0.887 . . . . 0.0 111.347 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.24 -26.25 68.03 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 124.495 1.118 . . . . 0.0 109.945 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.4 p -57.32 -25.96 60.17 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.404 0.682 . . . . 0.0 110.975 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.11 -35.24 68.83 Favored Glycine 0 N--CA 1.516 3.998 0 C-N-CA 123.837 0.732 . . . . 0.0 113.755 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 7.6 pt -60.28 -44.04 94.81 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.203 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . 0.514 ' O ' HG12 ' E' ' 218' ' ' VAL . 6.1 pt -67.68 -32.47 56.93 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.284 0 C-N-CA 122.934 0.493 . . . . 0.0 110.26 -178.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 47.7 mm -72.08 -32.7 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.601 0 C-N-CA 124.674 1.189 . . . . 0.0 108.79 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.93 -29.13 64.47 Favored Glycine 1 N--CA 1.518 4.13 0 C-N-CA 123.529 0.585 . . . . 0.0 113.26 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . 0.514 HG12 ' O ' ' E' ' 215' ' ' ILE . 9.8 p -59.71 -47.55 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 9.0 t -66.36 -38.96 88.79 Favored 'General case' 0 N--CA 1.537 3.899 0 O-C-N 121.827 -0.546 . . . . 0.0 111.196 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.17 -31.82 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 C-N-CA 123.511 0.724 . . . . 0.0 110.431 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.89 76.88 Favored 'General case' 0 N--CA 1.529 3.504 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.68 74.74 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 122.86 0.464 . . . . 0.0 111.459 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.7 -45.52 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 123.291 0.636 . . . . 0.0 112.296 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.24 -32.55 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 C-N-CA 122.352 0.261 . . . . 0.0 111.652 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.5 -34.85 78.83 Favored 'General case' 1 N--CA 1.541 4.117 0 O-C-N 122.098 -0.376 . . . . 0.0 110.255 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.39 -37.94 80.86 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.08 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.06 -37.86 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.5 0 C-N-CA 123.248 0.619 . . . . 0.0 109.975 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.24 96.6 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 17.2 m -71.66 -33.96 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.741 0 O-C-N 121.613 -0.679 . . . . 0.0 109.703 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -63.47 -43.75 96.4 Favored 'General case' 0 N--CA 1.529 3.483 0 C-N-CA 123.062 0.545 . . . . 0.0 112.309 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.41 -37.41 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.351 0.523 . . . . 0.0 109.631 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 79.1 m -60.21 -27.93 67.57 Favored 'General case' 0 N--CA 1.525 3.283 0 C-N-CA 123.143 0.577 . . . . 0.0 111.018 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.71 -35.02 79.55 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 122.796 0.438 . . . . 0.0 110.243 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 68.0 m -73.72 -36.27 65.19 Favored 'General case' 0 N--CA 1.523 3.185 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -17.75 63.65 Favored 'General case' 0 N--CA 1.529 3.501 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.827 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.11 -26.67 23.54 Favored 'General case' 0 N--CA 1.536 3.842 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -78.89 66.36 4.34 Favored 'General case' 0 N--CA 1.52 3.059 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.1 170.17 3.85 Favored 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 123.913 0.885 . . . . 0.0 110.759 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.75 -14.84 62.11 Favored 'General case' 0 N--CA 1.526 3.36 0 C-N-CA 123.996 0.918 . . . . 0.0 111.156 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.57 138.28 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 C-N-CA 125.316 1.446 . . . . 0.0 108.874 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.44 146.56 31.73 Favored Pre-proline 0 N--CA 1.53 3.56 0 CA-C-O 116.579 -1.677 . . . . 0.0 106.989 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 1 N--CA 1.55 4.8 0 C-N-CA 123.05 2.5 . . . . 0.0 114.933 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 CA--C 1.569 1.704 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.68 168.13 25.3 Favored 'Trans proline' 1 N--CA 1.539 4.192 0 C-N-CA 122.063 1.842 . . . . 0.0 110.168 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 173.97 -12.74 0.04 OUTLIER Glycine 1 N--CA 1.522 4.408 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 64.8 m -68.56 89.79 0.37 Allowed 'General case' 0 N--CA 1.52 3.034 0 C-N-CA 123.762 0.825 . . . . 0.0 110.962 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.17 -26.38 68.14 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.915 0.886 . . . . 0.0 110.245 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 57.0 m -61.65 -26.78 68.22 Favored 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 123.653 0.781 . . . . 0.0 111.062 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.9 -47.5 54.49 Favored Glycine 1 N--CA 1.518 4.128 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.902 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 45.3 pt -72.33 -40.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -44.92 95.35 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.276 0 C-N-CA 123.194 0.597 . . . . 0.0 111.876 -175.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 6.4 tp -63.21 -32.62 57.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 C-N-CA 123.278 0.631 . . . . 0.0 109.382 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.31 -29.99 63.9 Favored Glycine 0 N--CA 1.513 3.802 0 CA-C-O 119.346 -0.697 . . . . 0.0 113.855 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.0 m -62.2 -47.21 94.16 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 CA-C-N 118.528 1.164 . . . . 0.0 112.045 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -38.82 89.24 Favored 'General case' 0 N--CA 1.536 3.872 0 C-N-CA 122.202 0.201 . . . . 0.0 110.766 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.78 -39.94 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.55 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.6 83.01 Favored 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 123.198 0.599 . . . . 0.0 111.136 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.77 -45.66 85.64 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.173 0.589 . . . . 0.0 112.175 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.85 -41.15 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 122.909 0.483 . . . . 0.0 110.962 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.05 -41.89 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 C-N-CA 123.143 0.577 . . . . 0.0 110.852 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.7 -37.33 86.07 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 122.606 0.362 . . . . 0.0 111.667 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.76 -44.01 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.3 -40.3 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.73 -45.11 93.16 Favored 'General case' 0 N--CA 1.525 3.31 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.53 -34.05 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.703 0 O-C-N 121.633 -0.667 . . . . 0.0 109.788 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -63.06 -44.32 96.15 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 21.3 m -69.05 -37.88 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 CA-C-O 121.159 0.505 . . . . 0.0 109.841 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 76.3 m -65.54 -33.82 76.81 Favored 'General case' 0 N--CA 1.521 3.08 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.083 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -74.15 -39.75 63.06 Favored 'General case' 0 N--CA 1.537 3.898 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 58.6 m -63.75 -30.11 71.24 Favored 'General case' 0 N--CA 1.52 3.054 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.063 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.77 -21.62 66.51 Favored 'General case' 0 N--CA 1.526 3.364 0 C-N-CA 123.013 0.525 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -98.49 -15.81 19.44 Favored 'General case' 1 N--CA 1.548 4.459 0 C-N-CA 124.017 0.927 . . . . 0.0 110.472 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -68.12 3.53 1.59 Allowed 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.356 0.662 . . . . 0.0 111.624 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -166.02 -28.03 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 122.847 0.459 . . . . 0.0 110.941 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt 63.24 138.81 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 124.275 1.03 . . . . 0.0 110.531 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 56.1 t -134.92 136.96 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.553 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 3.8 tt -133.16 99.83 14.57 Favored Pre-proline 0 N--CA 1.534 3.751 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 1 N--CA 1.536 4.012 0 C-N-CA 122.529 2.153 . . . . 0.0 111.114 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 59.2 tpp . . . . . 0 CA--C 1.577 2.009 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -79.6 -33.35 1.3 Allowed 'Trans proline' 0 N--CA 1.536 3.995 0 C-N-CA 122.454 2.103 . . . . 0.0 110.497 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.37 43.0 95.71 Favored Glycine 1 N--CA 1.519 4.217 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.247 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.0 m -74.63 40.39 0.14 Allowed 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 123.911 0.884 . . . . 0.0 110.571 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.0 -37.48 87.8 Favored 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 124.474 1.11 . . . . 0.0 109.978 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 45.2 t -68.61 -26.5 65.39 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.333 0.653 . . . . 0.0 110.702 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.66 -46.59 60.85 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 117.579 1.792 . . . . 0.0 117.579 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.8 -35.66 61.25 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.694 0 CA-C-N 119.612 1.706 . . . . 0.0 113.57 -175.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.54 -38.11 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.543 0 C-N-CA 123.55 0.74 . . . . 0.0 111.997 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 15.2 tt -71.41 -32.86 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.78 -28.87 48.41 Favored Glycine 1 N--CA 1.516 4.003 0 C-N-CA 124.057 0.837 . . . . 0.0 113.243 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.8 m -68.0 -37.27 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 CA-C-N 117.721 0.76 . . . . 0.0 110.407 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.8 p -60.56 -46.08 91.53 Favored 'General case' 0 N--CA 1.527 3.42 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.723 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.24 -31.85 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 C-N-CA 122.73 0.412 . . . . 0.0 110.493 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.44 -34.12 77.05 Favored 'General case' 0 N--CA 1.525 3.297 0 C-N-CA 123.091 0.556 . . . . 0.0 111.456 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.84 -50.24 44.67 Favored 'General case' 0 N--CA 1.519 2.995 0 C-N-CA 122.96 0.504 . . . . 0.0 111.914 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.96 -44.28 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 C-N-CA 123.365 0.666 . . . . 0.0 112.562 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.53 -32.66 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.603 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.24 -42.14 76.03 Favored 'General case' 0 N--CA 1.533 3.689 0 CA-C-N 118.613 0.642 . . . . 0.0 110.34 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.3 mt -54.8 -35.95 35.32 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 O-C-N 122.055 -0.403 . . . . 0.0 110.455 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.46 -37.17 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 O-C-N 121.763 -0.586 . . . . 0.0 110.374 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.87 -33.0 68.24 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.49 -34.54 53.42 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.188 0 CA-C-N 119.145 0.884 . . . . 0.0 110.611 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.96 -44.16 97.34 Favored 'General case' 0 N--CA 1.53 3.551 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.0 -37.6 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.693 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 71.6 m -64.27 -27.85 69.32 Favored 'General case' 0 N--CA 1.527 3.4 0 C-N-CA 123.151 0.58 . . . . 0.0 111.149 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -62.74 -22.88 66.87 Favored 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 122.992 0.517 . . . . 0.0 110.903 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 45.5 t -66.67 -46.2 76.43 Favored 'General case' 0 N--CA 1.525 3.29 0 CA-C-O 121.582 0.706 . . . . 0.0 110.565 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.98 -12.93 13.01 Favored 'General case' 0 N--CA 1.528 3.44 0 C-N-CA 125.375 1.47 . . . . 0.0 112.471 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 54.9 tp -85.93 -28.36 24.36 Favored 'General case' 1 N--CA 1.547 4.403 0 C-N-CA 123.25 0.62 . . . . 0.0 111.303 -175.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 -121.26 63.17 0.89 Allowed 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -138.09 21.04 2.81 Favored 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.245 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -158.75 -11.34 0.07 Allowed 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.974 0.909 . . . . 0.0 109.685 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.54 133.22 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.557 0 C-N-CA 125.279 1.432 . . . . 0.0 107.297 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 51.9 tp -107.69 99.33 28.86 Favored Pre-proline 0 N--CA 1.531 3.593 0 C-N-CA 125.023 1.329 . . . . 0.0 108.31 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo . . . . . 1 N--CA 1.548 4.692 0 C-N-CA 122.273 1.982 . . . . 0.0 114.169 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 48.7 ttm . . . . . 0 CA--C 1.574 1.896 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -80.08 -167.11 0.46 Allowed 'Trans proline' 0 N--CA 1.534 3.891 0 C-N-CA 122.556 2.17 . . . . 0.0 110.32 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.34 57.89 4.5 Favored Glycine 1 N--CA 1.516 4.006 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 97.7 p -167.22 -15.26 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.249 0 C-N-CA 124.036 0.934 . . . . 0.0 109.9 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.88 -26.77 68.46 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.976 0.911 . . . . 0.0 109.581 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 90.5 p -68.55 -26.19 65.29 Favored 'General case' 0 N--CA 1.522 3.143 0 C-N-CA 123.44 0.696 . . . . 0.0 110.43 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.36 -44.05 76.02 Favored Glycine 0 N--CA 1.516 3.975 0 C-N-CA 123.737 0.684 . . . . 0.0 114.08 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.87 -36.0 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.791 0 O-C-N 121.67 -0.9 . . . . 0.0 112.14 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 13.9 pt -67.55 -37.17 78.31 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.398 0 CA-C-N 119.001 0.818 . . . . 0.0 111.84 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 46.3 pt -72.26 -33.07 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.11 -45.31 82.51 Favored Glycine 0 N--CA 1.513 3.775 0 C-N-CA 124.419 1.009 . . . . 0.0 114.992 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.58 -37.2 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.734 0 CA-C-N 117.76 0.78 . . . . 0.0 111.163 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.0 p -65.28 -46.11 81.74 Favored 'General case' 0 N--CA 1.533 3.679 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.81 -30.63 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.485 0 C-N-CA 123.158 0.583 . . . . 0.0 111.174 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.81 -35.44 63.9 Favored 'General case' 0 N--CA 1.525 3.3 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -50.32 39.63 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 24.9 m -66.11 -38.24 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.8 -31.98 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 CA-C-N 118.462 0.573 . . . . 0.0 111.859 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.59 -34.74 72.5 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 118.236 0.471 . . . . 0.0 110.746 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.1 -49.37 84.34 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.067 0 CA-C-N 118.065 0.393 . . . . 0.0 111.668 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.6 -37.28 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 O-C-N 121.721 -0.612 . . . . 0.0 109.957 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.48 79.97 Favored 'General case' 0 N--CA 1.524 3.26 0 C-N-CA 123.593 0.757 . . . . 0.0 112.811 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.63 -34.37 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 O-C-N 121.86 -0.525 . . . . 0.0 110.291 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -64.41 -44.21 91.97 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 122.964 0.506 . . . . 0.0 112.332 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.8 -37.91 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.826 0 CA-C-N 118.201 0.455 . . . . 0.0 109.781 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 75.2 m -65.64 -27.69 68.56 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 123.341 0.656 . . . . 0.0 111.211 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -63.82 -29.96 71.1 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 123.134 0.574 . . . . 0.0 110.725 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 54.8 m -64.16 -40.01 95.22 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.252 0.621 . . . . 0.0 110.517 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.88 -21.46 64.25 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.691 0.796 . . . . 0.0 110.251 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.5 tp -87.53 -28.32 22.06 Favored 'General case' 0 N--CA 1.534 3.727 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -77.79 52.7 1.05 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -64.66 -11.49 36.08 Favored 'General case' 0 N--CA 1.525 3.278 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.246 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -68.19 142.35 55.71 Favored 'General case' 0 N--CA 1.524 3.239 0 C-N-CA 123.797 0.839 . . . . 0.0 109.631 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 59.3 t -134.32 138.14 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.557 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 8.7 mp -94.69 106.87 26.85 Favored Pre-proline 0 N--CA 1.527 3.384 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo . . . . . 1 N--CA 1.536 4.012 0 CA-C-N 122.819 2.042 . . . . 0.0 110.858 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.577 1.991 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -77.14 78.93 3.28 Favored 'Trans proline' 1 N--CA 1.537 4.034 0 C-N-CA 122.444 2.096 . . . . 0.0 110.362 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.58 63.59 3.81 Favored Glycine 1 N--CA 1.518 4.153 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 97.0 p -86.02 47.71 1.5 Allowed 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 124.145 0.978 . . . . 0.0 109.605 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -54.36 -26.56 30.74 Favored 'General case' 0 N--CA 1.532 3.646 0 C-N-CA 123.785 0.834 . . . . 0.0 112.224 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 98.3 p -63.6 -36.45 83.86 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.825 0.85 . . . . 0.0 110.312 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.0 -35.75 79.55 Favored Glycine 0 N--CA 1.515 3.965 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.074 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 39.2 mm -70.31 -46.44 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 C-N-CA 124.164 0.986 . . . . 0.0 112.77 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 18.9 tt -64.53 -37.5 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.965 0 CA-C-N 118.207 0.458 . . . . 0.0 111.857 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.76 -32.22 39.75 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.13 -28.75 42.67 Favored Glycine 0 N--CA 1.512 3.714 0 C-N-CA 124.41 1.005 . . . . 0.0 113.198 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.34 -37.12 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.9 0 CA-C-N 117.383 0.592 . . . . 0.0 110.576 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 46.0 p -62.15 -45.14 94.75 Favored 'General case' 0 N--CA 1.529 3.509 0 CA-C-O 121.743 0.783 . . . . 0.0 110.319 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.86 -31.44 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 124.971 1.308 . . . . 0.0 111.447 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.07 75.69 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.361 0.664 . . . . 0.0 111.869 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.7 -46.78 62.49 Favored 'General case' 0 N--CA 1.521 3.087 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 26.7 m -68.01 -38.18 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 18.3 m -56.54 -31.33 33.8 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 CA-C-N 118.711 0.687 . . . . 0.0 110.712 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 39.7 tp -52.86 -48.14 67.29 Favored 'General case' 1 N--CA 1.543 4.176 0 CA-C-O 122.138 0.971 . . . . 0.0 109.865 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.78 -38.03 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.49 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.79 -37.64 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.437 0 C-N-CA 123.492 0.717 . . . . 0.0 109.489 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -32.71 68.1 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.216 0.606 . . . . 0.0 111.947 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.34 -43.47 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.12 0.568 . . . . 0.0 111.235 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -62.31 -42.92 99.78 Favored 'General case' 1 N--CA 1.539 4.022 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.03 -37.42 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.724 -0.61 . . . . 0.0 109.929 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 96.7 m -64.89 -27.98 69.23 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 122.657 0.383 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -65.8 -25.93 67.46 Favored 'General case' 0 N--CA 1.532 3.625 0 C-N-CA 123.224 0.609 . . . . 0.0 110.999 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 51.2 m -69.43 -34.08 73.92 Favored 'General case' 0 N--CA 1.525 3.311 0 C-N-CA 123.114 0.566 . . . . 0.0 110.444 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.19 -16.93 60.97 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.584 0.754 . . . . 0.0 110.214 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 57.0 tp -87.62 -20.81 25.84 Favored 'General case' 0 N--CA 1.536 3.864 0 C-N-CA 123.719 0.807 . . . . 0.0 110.218 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.76 -79.7 0.04 OUTLIER 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.808 0.843 . . . . 0.0 110.74 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 58.03 7.66 0.65 Allowed 'General case' 0 N--CA 1.526 3.361 0 C-N-CA 124.206 1.002 . . . . 0.0 112.555 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? 59.82 120.67 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 124.352 1.061 . . . . 0.0 111.335 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.91 137.97 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.579 0 C-N-CA 124.932 1.293 . . . . 0.0 108.116 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.64 146.9 32.28 Favored Pre-proline 0 N--CA 1.53 3.549 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 1 N--CA 1.542 4.337 0 C-N-CA 122.068 1.845 . . . . 0.0 110.888 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.579 2.06 0 CA-C-O 117.541 -1.219 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -90.06 30.8 0.38 Allowed 'Trans proline' 0 N--CA 1.536 3.994 0 C-N-CA 122.703 2.269 . . . . 0.0 110.994 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 69.3 49.79 36.97 Favored Glycine 1 N--CA 1.519 4.224 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 40.5 t -76.34 22.32 0.17 Allowed 'General case' 0 N--CA 1.52 3.041 0 C-N-CA 124.129 0.972 . . . . 0.0 111.501 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 49.7 mt -54.85 -26.71 37.13 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.015 0.926 . . . . 0.0 111.306 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -59.16 -32.38 69.83 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 123.174 0.59 . . . . 0.0 110.745 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.88 -38.84 89.52 Favored Glycine 1 N--CA 1.516 4.033 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.811 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . 0.412 ' N ' HD12 ' D' ' 214' ' ' ILE . 1.5 mp -70.71 -41.1 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.471 0 C-N-CA 124.275 1.03 . . . . 0.0 108.969 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.92 -41.43 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.739 0 C-N-CA 124.326 1.051 . . . . 0.0 111.775 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 6.3 tp -72.73 -32.73 41.88 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.191 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.76 -46.7 91.98 Favored Glycine 1 N--CA 1.518 4.129 0 C-N-CA 123.551 0.596 . . . . 0.0 113.968 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 11.4 m -60.09 -36.46 67.8 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.211 0 CA-C-N 118.325 1.062 . . . . 0.0 111.472 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 22.0 p -55.7 -38.73 70.08 Favored 'General case' 0 N--CA 1.532 3.643 0 C-N-CA 122.988 0.515 . . . . 0.0 111.674 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.73 -37.81 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 C-N-CA 123.247 0.619 . . . . 0.0 110.813 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.87 -36.08 58.59 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 123.561 0.745 . . . . 0.0 112.745 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.53 -50.17 40.47 Favored 'General case' 0 N--CA 1.515 2.804 0 C-N-CA 123.318 0.647 . . . . 0.0 111.07 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.4 -46.03 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.53 0 C-N-CA 123.522 0.729 . . . . 0.0 112.336 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.43 -32.01 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.523 0 C-N-CA 122.537 0.335 . . . . 0.0 111.273 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.09 -41.59 61.44 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 122.435 0.294 . . . . 0.0 110.931 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.34 -42.33 93.23 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.022 0 C-N-CA 122.806 0.442 . . . . 0.0 111.681 -177.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.0 -36.83 78.09 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 CA-C-N 118.336 0.517 . . . . 0.0 110.094 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.61 -34.15 72.39 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.858 0.463 . . . . 0.0 111.346 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.93 -39.45 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -62.4 -43.49 98.69 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.527 0.731 . . . . 0.0 112.54 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 14.4 m -68.24 -37.78 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 CA-C-N 118.407 0.549 . . . . 0.0 109.806 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 88.3 m -59.02 -27.73 65.73 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 122.886 0.474 . . . . 0.0 111.082 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -64.56 -30.92 71.95 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 122.836 0.455 . . . . 0.0 110.243 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 24.1 t -64.92 -44.59 89.03 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 123.041 0.536 . . . . 0.0 110.398 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.96 -20.49 65.91 Favored 'General case' 0 N--CA 1.532 3.647 0 C-N-CA 123.477 0.711 . . . . 0.0 110.98 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 36.6 tp -87.75 -3.01 58.98 Favored 'General case' 0 N--CA 1.537 3.889 0 C-N-CA 123.394 0.678 . . . . 0.0 110.944 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -152.37 105.09 2.99 Favored 'General case' 0 N--CA 1.533 3.706 0 C-N-CA 123.037 0.535 . . . . 0.0 111.036 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -151.15 -53.84 0.14 Allowed 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -66.37 150.82 48.3 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 124.053 0.941 . . . . 0.0 109.732 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.2 138.26 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 125.069 1.348 . . . . 0.0 108.149 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.4 98.82 14.93 Favored Pre-proline 0 N--CA 1.533 3.71 0 C-N-CA 124.799 1.24 . . . . 0.0 108.893 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 1 N--CA 1.547 4.658 0 C-N-CA 122.275 1.984 . . . . 0.0 113.866 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 44.3 ttm . . . . . 0 CA--C 1.582 2.191 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -87.16 21.17 1.09 Allowed 'Trans proline' 0 N--CA 1.536 3.971 0 C-N-CA 122.507 2.138 . . . . 0.0 111.294 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.89 -34.83 1.24 Allowed Glycine 1 N--CA 1.519 4.186 0 C-N-CA 123.922 0.772 . . . . 0.0 111.786 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 50.4 m 57.55 67.57 0.95 Allowed 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 124.082 0.953 . . . . 0.0 111.286 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 46.7 mt -62.46 -26.35 68.47 Favored 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 124.32 1.048 . . . . 0.0 110.848 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 97.0 p -64.62 -26.34 68.35 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.143 0.577 . . . . 0.0 110.144 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.81 -46.9 89.5 Favored Glycine 1 N--CA 1.52 4.272 0 CA-C-O 119.523 -0.598 . . . . 0.0 114.095 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 18.8 tt -70.61 -35.61 61.98 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.204 0 CA-C-N 118.549 1.175 . . . . 0.0 109.688 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 46.8 mm -64.63 -42.71 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.753 0 C-N-CA 123.876 0.87 . . . . 0.0 108.834 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 23.0 mm -72.84 -33.39 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.767 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.33 -29.83 57.36 Favored Glycine 0 N--CA 1.513 3.817 0 C-N-CA 124.115 0.864 . . . . 0.0 114.573 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.63 -37.42 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.971 0 CA-C-N 118.113 0.957 . . . . 0.0 111.216 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 67.4 p -61.88 -47.52 84.62 Favored 'General case' 0 N--CA 1.528 3.46 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 10.1 p -70.99 -31.77 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.351 0 C-N-CA 123.02 0.528 . . . . 0.0 111.524 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.36 78.26 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.07 -34.46 77.63 Favored 'General case' 0 N--CA 1.515 2.823 0 C-N-CA 123.276 0.63 . . . . 0.0 111.721 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.22 -53.43 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 122.916 0.486 . . . . 0.0 111.177 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.62 -33.6 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.413 0 O-C-N 121.785 -0.572 . . . . 0.0 111.455 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 40.0 tp -77.2 -38.39 51.6 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 122.908 0.483 . . . . 0.0 112.285 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 16.3 tt -69.35 -38.17 76.87 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.114 0 CA-C-N 118.906 0.775 . . . . 0.0 110.586 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.77 -38.0 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.87 -51.1 71.01 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.281 0.632 . . . . 0.0 112.644 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.85 -34.23 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 C-N-CA 122.533 0.333 . . . . 0.0 110.701 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -70.39 -38.62 74.71 Favored 'General case' 0 N--CA 1.527 3.386 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.1 -37.59 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.625 0 C-N-CA 124.174 0.99 . . . . 0.0 109.464 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 71.5 m -58.72 -34.79 71.73 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 122.655 0.382 . . . . 0.0 110.207 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -74.58 -48.43 26.77 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.863 0.465 . . . . 0.0 110.124 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.5 m -63.68 -25.96 68.45 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 123.419 0.688 . . . . 0.0 111.231 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.43 -14.73 20.73 Favored 'General case' 0 N--CA 1.524 3.257 0 C-N-CA 123.611 0.764 . . . . 0.0 111.193 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 8.6 mp -87.41 -28.38 22.18 Favored 'General case' 0 N--CA 1.538 3.969 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 89.4 m95 53.74 57.7 5.82 Favored 'General case' 0 N--CA 1.524 3.269 0 C-N-CA 123.75 0.82 . . . . 0.0 111.43 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -63.99 107.12 1.17 Allowed 'General case' 0 N--CA 1.524 3.259 0 C-N-CA 123.729 0.812 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -163.63 77.36 0.4 Allowed 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 57.1 t -133.8 138.13 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 57.9 mt -94.51 146.69 31.94 Favored Pre-proline 0 N--CA 1.525 3.308 0 CA-C-O 117.373 -1.298 . . . . 0.0 108.255 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 1 N--CA 1.54 4.216 0 C-N-CA 121.997 1.798 . . . . 0.0 110.82 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 17.0 ptm . . . . . 0 CA--C 1.573 1.846 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -67.98 -43.88 4.52 Favored 'Trans proline' 1 N--CA 1.541 4.306 0 C-N-CA 122.106 1.871 . . . . 0.0 110.634 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.26 -38.38 13.02 Favored Glycine 1 N--CA 1.516 4.003 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 59.5 p 56.02 65.56 1.41 Allowed 'General case' 0 N--CA 1.524 3.229 0 C-N-CA 124.111 0.964 . . . . 0.0 111.261 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -63.74 -26.8 68.81 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 124.087 0.955 . . . . 0.0 110.121 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 66.0 m -66.23 -32.29 73.62 Favored 'General case' 0 N--CA 1.519 2.985 0 C-N-CA 123.587 0.755 . . . . 0.0 111.061 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.11 -47.53 52.85 Favored Glycine 1 N--CA 1.517 4.056 0 CA-C-N 116.099 -0.5 . . . . 0.0 114.261 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 20.4 tt -71.6 -41.66 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.94 -44.25 82.1 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.272 0 C-N-CA 123.059 0.544 . . . . 0.0 111.737 -176.078 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 18.1 tt -72.29 -33.16 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.854 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.93 -29.47 51.24 Favored Glycine 0 N--CA 1.512 3.736 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.434 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.69 -37.71 72.27 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 117.495 0.648 . . . . 0.0 110.991 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 72.7 p -62.39 -45.49 92.88 Favored 'General case' 0 N--CA 1.53 3.563 0 CA-C-O 121.648 0.737 . . . . 0.0 110.474 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.21 -31.65 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.094 0 C-N-CA 124.702 1.201 . . . . 0.0 110.814 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.99 -34.72 75.22 Favored 'General case' 0 N--CA 1.531 3.588 0 O-C-N 121.824 -0.547 . . . . 0.0 111.596 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.32 -50.35 70.38 Favored 'General case' 0 N--CA 1.516 2.841 0 C-N-CA 123.51 0.724 . . . . 0.0 112.772 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.03 -38.27 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 CA-C-N 118.373 0.533 . . . . 0.0 111.629 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.22 -34.59 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.827 0 C-N-CA 122.646 0.378 . . . . 0.0 110.664 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 41.3 tp -68.51 -34.46 75.92 Favored 'General case' 0 N--CA 1.533 3.713 0 CA-C-N 118.156 0.434 . . . . 0.0 110.622 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 97.9 mt -61.82 -35.4 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 C-N-CA 123.683 0.793 . . . . 0.0 109.893 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.34 -35.41 49.0 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.194 0 C-N-CA 123.341 0.657 . . . . 0.0 110.472 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.1 -31.46 63.29 Favored 'General case' 0 N--CA 1.524 3.246 0 C-N-CA 123.468 0.707 . . . . 0.0 112.763 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 4.4 m -57.28 -34.83 46.91 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.123 0 CA-C-N 118.992 0.815 . . . . 0.0 112.682 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -65.2 -43.94 89.97 Favored 'General case' 1 N--CA 1.541 4.094 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.81 -37.14 77.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.019 0 CA-C-N 119.007 0.821 . . . . 0.0 108.982 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 75.5 m -58.37 -27.59 64.36 Favored 'General case' 0 N--CA 1.528 3.429 0 C-N-CA 122.821 0.448 . . . . 0.0 110.909 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.54 -26.14 67.75 Favored 'General case' 0 N--CA 1.53 3.544 0 C-N-CA 122.973 0.509 . . . . 0.0 110.573 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 60.4 p -63.63 -16.89 62.16 Favored 'General case' 0 N--CA 1.534 3.765 0 C-N-CA 123.689 0.796 . . . . 0.0 111.546 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 46.6 tp -59.82 -14.57 15.53 Favored 'General case' 0 N--CA 1.527 3.377 0 C-N-CA 124.284 1.033 . . . . 0.0 112.775 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 pp -86.88 9.01 20.56 Favored 'General case' 1 N--CA 1.545 4.306 0 CA-C-N 118.843 0.747 . . . . 0.0 110.247 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 56.4 m95 58.96 134.64 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.1 0 C-N-CA 124.856 1.262 . . . . 0.0 113.029 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -144.76 63.13 1.31 Allowed 'General case' 0 N--CA 1.525 3.307 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -63.36 -177.1 0.18 Allowed 'General case' 0 N--CA 1.523 3.179 0 C-N-CA 124.335 1.054 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.49 138.07 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.521 0 C-N-CA 124.662 1.185 . . . . 0.0 109.136 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 77.2 mt -102.64 146.92 33.25 Favored Pre-proline 0 N--CA 1.529 3.511 0 C-N-CA 125.097 1.359 . . . . 0.0 108.275 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 1 N--CA 1.541 4.283 0 C-N-CA 121.997 1.798 . . . . 0.0 110.774 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 67.2 mtp . . . . . 0 CA--C 1.574 1.904 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -67.45 -19.24 49.29 Favored 'Trans proline' 1 N--CA 1.543 4.405 0 C-N-CA 122.236 1.957 . . . . 0.0 111.053 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.96 -168.26 6.65 Favored Glycine 1 N--CA 1.519 4.193 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.9 m -162.38 104.73 1.11 Allowed 'General case' 0 N--CA 1.521 3.108 0 C-N-CA 123.708 0.803 . . . . 0.0 108.986 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.27 -26.73 68.56 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.12 0.968 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.8 m -57.64 -26.19 61.26 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.667 0.787 . . . . 0.0 110.921 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.99 -35.62 91.67 Favored Glycine 0 N--CA 1.508 3.466 0 C-N-CA 124.232 0.92 . . . . 0.0 115.205 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.4 tt -68.47 -35.07 68.99 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.286 0 CA-C-N 118.247 1.023 . . . . 0.0 113.55 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.19 -40.61 66.12 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 17.7 tt -73.06 -36.12 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.798 0 O-C-N 121.399 -0.813 . . . . 0.0 109.439 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.94 -43.43 94.9 Favored Glycine 1 N--CA 1.519 4.191 0 C-N-CA 123.37 0.509 . . . . 0.0 114.363 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.83 -36.76 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 CA-C-N 117.907 0.853 . . . . 0.0 110.586 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.2 p -58.38 -44.58 88.97 Favored 'General case' 1 N--CA 1.539 4.008 0 CA-C-N 118.42 0.555 . . . . 0.0 111.118 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.75 -37.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 123.426 0.69 . . . . 0.0 111.405 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.25 -37.03 66.7 Favored 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.2 -50.56 71.33 Favored 'General case' 0 N--CA 1.513 2.682 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.9 m -61.93 -37.8 79.11 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.147 0 CA-C-N 118.529 0.604 . . . . 0.0 111.649 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 56.6 t -59.23 -32.68 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.976 0 O-C-N 121.482 -0.761 . . . . 0.0 110.189 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 73.0 mt -72.82 -34.43 66.83 Favored 'General case' 0 N--CA 1.532 3.639 0 C-N-CA 122.385 0.274 . . . . 0.0 110.294 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.2 -47.8 91.42 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.287 0 C-N-CA 123.039 0.535 . . . . 0.0 111.415 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.51 -36.92 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.749 0 O-C-N 121.885 -0.509 . . . . 0.0 110.102 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.99 -49.0 78.33 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.245 0.618 . . . . 0.0 112.304 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.11 -34.28 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.542 0 O-C-N 122.022 -0.424 . . . . 0.0 110.94 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -70.21 -43.1 71.36 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.078 0.551 . . . . 0.0 112.16 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.95 -37.64 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.71 0 O-C-N 122.067 -0.396 . . . . 0.0 111.305 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 20.1 p -67.34 -28.02 67.62 Favored 'General case' 0 N--CA 1.532 3.67 0 CA-C-N 117.886 0.312 . . . . 0.0 110.939 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -67.57 -30.55 70.2 Favored 'General case' 0 N--CA 1.529 3.478 0 C-N-CA 123.217 0.607 . . . . 0.0 110.53 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.7 m -67.4 -27.56 67.18 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 123.356 0.662 . . . . 0.0 110.498 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 235' ' ' LEU . 0.8 OUTLIER -64.4 -14.52 57.02 Favored 'General case' 0 N--CA 1.533 3.702 0 C-N-CA 124.474 1.11 . . . . 0.0 109.908 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 30.2 mt -87.24 2.0 51.41 Favored 'General case' 0 N--CA 1.533 3.714 0 C-N-CA 123.749 0.82 . . . . 0.0 110.578 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -66.48 -2.29 4.49 Favored 'General case' 0 N--CA 1.529 3.525 0 C-N-CA 123.854 0.862 . . . . 0.0 111.001 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -62.22 177.44 0.48 Allowed 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.868 0.867 . . . . 0.0 110.941 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -64.87 153.71 39.41 Favored 'General case' 0 N--CA 1.526 3.335 0 C-N-CA 124.149 0.98 . . . . 0.0 110.097 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.36 138.13 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 C-N-CA 124.927 1.291 . . . . 0.0 108.113 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.66 99.49 38.07 Favored Pre-proline 0 N--CA 1.531 3.581 0 C-N-CA 125.073 1.349 . . . . 0.0 108.191 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo . . . . . 0 N--CA 1.535 3.923 0 C-N-CA 122.591 2.194 . . . . 0.0 110.946 -179.898 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.576 1.949 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.54 -176.22 0.02 OUTLIER 'Trans proline' 1 N--CA 1.547 4.623 0 C-N-CA 122.508 2.138 . . . . 0.0 113.935 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 103.24 67.35 0.75 Allowed Glycine 1 N--CA 1.525 4.629 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 46.5 t -67.06 159.68 28.23 Favored 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.833 0.853 . . . . 0.0 110.788 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.24 -26.98 68.34 Favored 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 124.084 0.954 . . . . 0.0 109.923 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 94.6 p -58.26 -26.37 62.85 Favored 'General case' 0 N--CA 1.529 3.486 0 C-N-CA 123.333 0.653 . . . . 0.0 110.769 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.75 -35.61 75.32 Favored Glycine 0 N--CA 1.508 3.479 0 C-N-CA 124.772 1.177 . . . . 0.0 115.475 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 18.9 pt -59.47 -34.65 55.27 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.475 0 CA-C-N 119.039 1.419 . . . . 0.0 113.647 -176.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 1.6 pp -55.78 -35.18 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.976 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 20.0 pt -65.64 -33.74 65.68 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.264 0 CA-C-N 118.849 0.749 . . . . 0.0 109.238 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -64.77 -38.84 96.11 Favored Glycine 1 N--CA 1.519 4.201 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.26 -47.31 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.507 0 C-N-CA 123.796 0.838 . . . . 0.0 109.423 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 88.3 m -66.03 -47.66 73.7 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.665 -177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 71.7 t -70.56 -33.27 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.376 0 C-N-CA 124.054 0.942 . . . . 0.0 111.486 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.87 79.3 Favored 'General case' 0 N--CA 1.534 3.731 0 CA-C-N 118.376 0.534 . . . . 0.0 112.102 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.55 -50.22 59.57 Favored 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.5 m -63.1 -39.07 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.64 -32.72 58.09 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.035 0 CA-C-N 118.723 0.692 . . . . 0.0 110.322 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -44.64 92.14 Favored 'General case' 0 N--CA 1.532 3.639 0 C-N-CA 123.205 0.602 . . . . 0.0 111.056 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.26 -39.74 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.792 0.437 . . . . 0.0 110.456 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.38 -39.34 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.508 0 C-N-CA 122.96 0.504 . . . . 0.0 109.802 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.4 93.9 Favored 'General case' 0 N--CA 1.528 3.46 0 C-N-CA 123.251 0.62 . . . . 0.0 111.961 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 93.0 t -71.65 -34.63 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.602 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -63.86 -43.87 94.8 Favored 'General case' 0 N--CA 1.526 3.355 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 11.3 m -68.65 -37.81 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.839 0 CA-C-N 118.693 0.679 . . . . 0.0 109.718 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.8 m -60.93 -37.18 81.43 Favored 'General case' 0 N--CA 1.523 3.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.844 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -27.25 66.71 Favored 'General case' 0 N--CA 1.537 3.919 0 C-N-CA 122.576 0.35 . . . . 0.0 110.594 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 23.1 t -63.52 -40.84 98.1 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.005 0.522 . . . . 0.0 110.991 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.41 -22.25 66.77 Favored 'General case' 0 N--CA 1.535 3.806 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.17 -4.45 27.22 Favored 'General case' 1 N--CA 1.543 4.222 0 C-N-CA 124.415 1.086 . . . . 0.0 109.378 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -153.34 96.13 2.01 Favored 'General case' 0 N--CA 1.521 3.096 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -134.56 12.56 3.76 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 125.003 1.321 . . . . 0.0 109.575 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt 57.5 -166.26 0.15 Allowed 'General case' 0 N--CA 1.52 3.074 0 C-N-CA 124.187 0.995 . . . . 0.0 111.639 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.2 138.13 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 C-N-CA 125.039 1.336 . . . . 0.0 108.196 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 tt -102.75 100.22 15.81 Favored Pre-proline 0 N--CA 1.535 3.78 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 1 N--CA 1.536 4.029 0 C-N-CA 122.443 2.095 . . . . 0.0 110.993 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.576 1.976 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -68.57 -17.29 43.28 Favored 'Trans proline' 1 N--CA 1.544 4.46 0 C-N-CA 122.213 1.942 . . . . 0.0 111.283 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.87 -96.88 0.02 OUTLIER Glycine 1 N--CA 1.522 4.367 0 C-N-CA 123.53 0.586 . . . . 0.0 112.003 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 23.3 t 59.42 48.3 10.08 Favored 'General case' 0 N--CA 1.522 3.155 0 C-N-CA 124.059 0.944 . . . . 0.0 111.521 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -58.97 -25.82 63.91 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.601 1.16 . . . . 0.0 112.33 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 87.6 p -57.09 -25.73 59.24 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.436 0.694 . . . . 0.0 110.748 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.74 -35.34 62.53 Favored Glycine 0 N--CA 1.515 3.913 0 C-N-CA 124.52 1.057 . . . . 0.0 115.052 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.73 -34.01 62.55 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.427 0 CA-C-N 118.521 1.161 . . . . 0.0 113.872 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . 0.498 ' O ' HG12 ' C' ' 218' ' ' VAL . 1.5 pp -55.28 -32.84 29.51 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.115 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -172.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.7 tt -72.64 -32.4 40.97 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.368 0 CA-C-N 119.041 0.837 . . . . 0.0 109.348 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.08 -29.01 43.12 Favored Glycine 0 N--CA 1.515 3.946 0 C-N-CA 124.215 0.912 . . . . 0.0 113.939 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . 0.498 HG12 ' O ' ' C' ' 215' ' ' ILE . 15.0 p -58.91 -38.02 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 CA-C-N 117.435 0.618 . . . . 0.0 111.117 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 64.6 p -64.78 -46.09 83.58 Favored 'General case' 0 N--CA 1.529 3.475 0 CA-C-O 121.155 0.502 . . . . 0.0 110.524 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.08 -37.2 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.049 0 C-N-CA 124.078 0.951 . . . . 0.0 110.625 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.71 -39.93 62.49 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.91 65.76 Favored 'General case' 0 N--CA 1.515 2.783 0 C-N-CA 123.127 0.571 . . . . 0.0 111.434 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 44.6 t -61.8 -47.74 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.328 0 C-N-CA 123.225 0.61 . . . . 0.0 112.171 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.6 -32.59 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 C-N-CA 122.404 0.282 . . . . 0.0 111.377 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 38.5 tp -71.52 -34.74 70.33 Favored 'General case' 0 N--CA 1.522 3.173 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 87.1 mt -68.48 -44.85 82.85 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.372 0 CA-C-N 119.645 1.111 . . . . 0.0 110.16 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 20.8 m -66.11 -35.97 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.945 0.498 . . . . 0.0 109.973 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.12 -38.55 73.62 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.431 0.693 . . . . 0.0 111.904 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.07 -41.13 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.635 0 CA-C-O 120.742 0.305 . . . . 0.0 110.282 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -61.5 -43.93 97.99 Favored 'General case' 0 N--CA 1.529 3.498 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.23 -37.42 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.632 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 95.5 m -64.37 -33.52 76.03 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -74.04 -38.0 64.14 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.177 0.591 . . . . 0.0 110.321 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 82.2 p -63.92 -17.04 62.83 Favored 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 123.383 0.673 . . . . 0.0 111.321 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.98 -37.74 88.36 Favored 'General case' 0 N--CA 1.531 3.587 0 C-N-CA 123.963 0.905 . . . . 0.0 111.29 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.19 -2.29 57.53 Favored 'General case' 1 N--CA 1.544 4.231 0 C-N-CA 123.323 0.649 . . . . 0.0 112.2 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -70.98 92.3 0.92 Allowed 'General case' 0 N--CA 1.529 3.516 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.95 142.56 1.88 Allowed 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 124.045 0.938 . . . . 0.0 108.547 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -168.9 103.1 0.39 Allowed 'General case' 0 N--CA 1.52 3.046 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.92 124.5 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 C-N-CA 124.884 1.274 . . . . 0.0 107.676 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 56.9 mt -94.54 146.81 32.15 Favored Pre-proline 0 N--CA 1.524 3.258 0 CA-C-O 117.409 -1.281 . . . . 0.0 108.269 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 1 N--CA 1.541 4.309 0 C-N-CA 122.008 1.805 . . . . 0.0 110.587 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 79.2 mtp . . . . . 0 CA--C 1.571 1.771 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.53 160.41 44.37 Favored 'Trans proline' 1 N--CA 1.538 4.106 0 C-N-CA 122.187 1.925 . . . . 0.0 110.259 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.12 -165.61 7.95 Favored Glycine 1 N--CA 1.517 4.072 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 46.7 t -165.35 -25.83 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.153 0 C-N-CA 123.486 0.715 . . . . 0.0 110.339 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 49.3 mt -57.62 -26.77 62.05 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 123.949 0.899 . . . . 0.0 110.866 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 55.4 m -64.14 -35.34 80.45 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.818 0.847 . . . . 0.0 110.787 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.04 -35.02 77.5 Favored Glycine 0 N--CA 1.514 3.863 0 C-N-CA 124.354 0.978 . . . . 0.0 113.056 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 37.0 mm -68.1 -43.61 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.445 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.07 -36.31 50.73 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.213 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 15.8 tt -72.39 -33.16 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.864 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.89 -42.26 99.71 Favored Glycine 1 N--CA 1.518 4.142 0 C-N-CA 123.076 0.37 . . . . 0.0 113.838 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 18.7 m -68.72 -37.17 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.866 0 CA-C-N 118.184 0.992 . . . . 0.0 111.342 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 47.4 p -63.89 -45.78 87.85 Favored 'General case' 0 N--CA 1.53 3.54 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.36 -31.93 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 CA-C-N 118.882 0.765 . . . . 0.0 111.075 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.0 -46.76 82.06 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 122.629 0.371 . . . . 0.0 111.687 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -58.08 -42.23 85.15 Favored 'General case' 0 N--CA 1.519 2.998 0 C-N-CA 123.485 0.714 . . . . 0.0 111.92 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.58 -44.95 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.462 0 C-N-CA 123.102 0.561 . . . . 0.0 111.209 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.48 -40.38 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 C-N-CA 122.38 0.272 . . . . 0.0 110.626 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.66 -46.55 78.71 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 122.846 0.458 . . . . 0.0 111.603 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 85.7 mt -62.26 -36.99 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 O-C-N 122.029 -0.42 . . . . 0.0 110.585 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.12 -37.55 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.887 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.76 98.57 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.852 0.461 . . . . 0.0 111.202 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.75 -34.66 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.426 0 C-N-CA 123.165 0.586 . . . . 0.0 109.702 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -63.08 -44.1 96.71 Favored 'General case' 0 N--CA 1.53 3.571 0 C-N-CA 123.099 0.56 . . . . 0.0 112.366 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.12 -37.64 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.724 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 85.8 m -61.03 -27.31 68.24 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 123.151 0.58 . . . . 0.0 111.251 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -57.8 -27.19 62.89 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 122.811 0.444 . . . . 0.0 111.251 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 66.1 m -65.97 -41.18 91.51 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 123.78 0.832 . . . . 0.0 111.355 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -60.84 -13.42 15.39 Favored 'General case' 0 N--CA 1.532 3.653 0 C-N-CA 124.338 1.055 . . . . 0.0 111.28 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.45 -23.42 26.03 Favored 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.83 109.82 15.75 Favored 'General case' 0 N--CA 1.527 3.408 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -168.63 166.95 11.68 Favored 'General case' 0 N--CA 1.521 3.102 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.59 172.42 6.26 Favored 'General case' 0 N--CA 1.522 3.142 0 C-N-CA 124.05 0.94 . . . . 0.0 110.866 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.48 138.65 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.284 0 C-N-CA 125.14 1.376 . . . . 0.0 107.728 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 47.9 mt -94.24 122.3 61.77 Favored Pre-proline 0 N--CA 1.524 3.245 0 CA-C-O 116.416 -1.754 . . . . 0.0 108.382 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 1 N--CA 1.549 4.768 0 C-N-CA 122.798 2.332 . . . . 0.0 114.904 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 CA--C 1.574 1.892 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.84 -38.14 67.34 Favored 'Trans proline' 1 N--CA 1.544 4.473 0 C-N-CA 122.382 2.055 . . . . 0.0 113.643 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.93 -176.57 25.34 Favored Glycine 1 N--CA 1.521 4.339 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 45.0 t -165.83 23.87 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 123.178 0.591 . . . . 0.0 110.713 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -61.82 -27.03 68.48 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 123.3 0.64 . . . . 0.0 111.143 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 55.7 m -69.13 -26.1 64.72 Favored 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.984 0.914 . . . . 0.0 109.976 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.34 -46.01 88.32 Favored Glycine 0 N--CA 1.513 3.78 0 CA-C-N 115.394 -0.821 . . . . 0.0 114.256 -177.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 46.6 pt -70.47 -35.63 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 8.6 pt -61.8 -44.45 98.81 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.55 0 CA-C-N 119.249 0.931 . . . . 0.0 111.582 -176.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.33 -32.22 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.871 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.96 -29.4 43.1 Favored Glycine 0 N--CA 1.506 3.302 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.584 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.45 -37.25 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 CA-C-N 117.708 0.754 . . . . 0.0 111.179 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 35.9 p -64.66 -47.61 77.82 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 10.5 p -70.84 -31.24 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.327 0.651 . . . . 0.0 110.987 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.22 65.07 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.07 0.548 . . . . 0.0 112.324 -177.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.77 -34.76 69.92 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 123.129 0.571 . . . . 0.0 111.83 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.95 -40.47 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 123.03 0.532 . . . . 0.0 110.307 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.15 -42.08 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.508 0.723 . . . . 0.0 110.746 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 66.6 mt -64.2 -34.58 78.42 Favored 'General case' 0 N--CA 1.528 3.449 0 C-N-CA 122.684 0.394 . . . . 0.0 110.749 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.64 -43.95 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 C-N-CA 122.852 0.461 . . . . 0.0 109.952 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 80.7 t -66.86 -39.2 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.59 -48.03 82.31 Favored 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 123.681 0.792 . . . . 0.0 112.953 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 35.2 m -71.58 -34.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 O-C-N 121.955 -0.465 . . . . 0.0 110.803 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.24 -44.25 92.42 Favored 'General case' 0 N--CA 1.528 3.471 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.96 -37.81 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 83.7 m -66.19 -32.63 74.18 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 122.875 0.47 . . . . 0.0 110.554 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -67.53 -32.2 72.84 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.422 0.689 . . . . 0.0 111.047 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -63.89 -26.8 68.76 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.312 0.645 . . . . 0.0 111.301 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 53.5 mt -70.93 -30.89 67.33 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.379 0.671 . . . . 0.0 110.274 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 9.6 mp -87.96 5.6 39.89 Favored 'General case' 0 N--CA 1.535 3.798 0 C-N-CA 124.175 0.99 . . . . 0.0 110.396 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -73.39 57.68 0.53 Allowed 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.299 0.64 . . . . 0.0 109.452 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -74.8 -175.11 2.38 Favored 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.017 0.927 . . . . 0.0 109.6 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -68.01 149.03 50.22 Favored 'General case' 0 N--CA 1.524 3.239 0 C-N-CA 123.836 0.854 . . . . 0.0 109.499 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.03 138.25 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.568 0 C-N-CA 124.847 1.259 . . . . 0.0 108.361 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 pp -103.09 146.47 32.5 Favored Pre-proline 0 N--CA 1.53 3.567 0 C-N-CA 125.12 1.368 . . . . 0.0 108.623 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo . . . . . 1 N--CA 1.539 4.168 0 C-N-CA 122.053 1.835 . . . . 0.0 110.443 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 23.6 ptt? . . . . . 0 CA--C 1.574 1.869 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -67.13 166.95 21.38 Favored 'Trans proline' 1 N--CA 1.542 4.374 0 C-N-CA 122.182 1.921 . . . . 0.0 110.729 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.76 96.66 0.16 Allowed Glycine 1 N--CA 1.517 4.072 0 C-N-CA 123.703 0.668 . . . . 0.0 112.061 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 69.4 m -67.85 162.02 25.02 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.862 0.865 . . . . 0.0 110.309 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.23 -26.22 68.41 Favored 'General case' 0 N--CA 1.525 3.3 0 C-N-CA 124.014 0.926 . . . . 0.0 111.748 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 40.1 t -66.04 -33.09 75.01 Favored 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 123.609 0.764 . . . . 0.0 111.302 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.74 -45.98 62.99 Favored Glycine 1 N--CA 1.519 4.18 0 N-CA-C 115.047 0.779 . . . . 0.0 115.047 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 8.4 tp -70.85 -40.49 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.888 0 O-C-N 121.653 -0.91 . . . . 0.0 112.319 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . 0.479 HD13 ' O ' ' F' ' 215' ' ' ILE . 0.0 OUTLIER -66.01 -36.73 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.861 0 C-N-CA 123.207 0.603 . . . . 0.0 111.946 -177.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . 0.563 HD12 ' N ' ' F' ' 217' ' ' GLY . 1.9 pp -70.92 -31.73 46.34 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.421 0 CA-C-N 119.424 1.011 . . . . 0.0 109.232 177.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . 0.563 ' N ' HD12 ' F' ' 216' ' ' ILE . . . -54.49 -29.46 47.6 Favored Glycine 0 N--CA 1.516 3.987 0 C-N-CA 123.845 0.736 . . . . 0.0 113.801 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . 0.44 HG12 ' O ' ' F' ' 215' ' ' ILE . 8.2 p -59.74 -39.78 80.68 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.055 0 CA-C-N 117.525 0.663 . . . . 0.0 111.509 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 82.5 p -66.18 -45.91 79.19 Favored 'General case' 0 N--CA 1.53 3.564 0 CA-C-O 121.247 0.546 . . . . 0.0 110.794 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.23 -32.54 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.038 0 C-N-CA 124.24 1.016 . . . . 0.0 110.864 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.65 -45.2 66.6 Favored 'General case' 0 N--CA 1.529 3.498 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.53 -33.46 75.97 Favored 'General case' 0 N--CA 1.523 3.191 0 C-N-CA 123.449 0.7 . . . . 0.0 111.626 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 25.9 t -65.42 -38.62 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.652 0.781 . . . . 0.0 110.934 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.17 -32.52 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 C-N-CA 123.123 0.569 . . . . 0.0 111.185 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 43.2 tp -68.22 -39.26 82.4 Favored 'General case' 0 N--CA 1.526 3.356 0 CA-C-O 120.764 0.316 . . . . 0.0 110.191 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 41.5 mm -54.7 -50.15 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.865 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.742 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 18.7 m -67.04 -37.28 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.896 -0.502 . . . . 0.0 110.214 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.25 93.13 Favored 'General case' 0 N--CA 1.525 3.277 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 15.9 m -71.27 -33.99 52.55 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 CA-C-N 119.223 0.92 . . . . 0.0 110.102 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -64.12 -43.94 93.76 Favored 'General case' 0 N--CA 1.528 3.466 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 14.3 m -68.74 -37.65 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 CA-C-O 121.007 0.432 . . . . 0.0 109.901 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 91.0 m -58.67 -27.43 64.79 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 123.447 0.699 . . . . 0.0 111.104 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.05 -34.36 78.23 Favored 'General case' 0 N--CA 1.525 3.324 0 C-N-CA 122.335 0.254 . . . . 0.0 110.672 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 79.5 p -68.34 -36.41 79.21 Favored 'General case' 0 N--CA 1.532 3.647 0 C-N-CA 123.181 0.592 . . . . 0.0 110.685 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.85 -13.49 15.89 Favored 'General case' 0 N--CA 1.537 3.902 0 C-N-CA 123.555 0.742 . . . . 0.0 110.964 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 18.2 mt -86.68 0.38 54.72 Favored 'General case' 0 N--CA 1.535 3.811 0 C-N-CA 122.929 0.492 . . . . 0.0 111.383 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -163.92 108.53 1.01 Allowed 'General case' 0 N--CA 1.53 3.552 0 CA-C-N 118.073 0.397 . . . . 0.0 111.248 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -149.51 157.56 43.39 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -172.55 151.85 2.49 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.57 130.01 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.345 0 C-N-CA 124.938 1.295 . . . . 0.0 107.719 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.95 144.79 28.4 Favored Pre-proline 0 N--CA 1.53 3.556 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 1 N--CA 1.538 4.103 0 CA-C-N 122.181 1.815 . . . . 0.0 110.416 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 CA--C 1.575 1.911 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.46 -179.14 0.03 OUTLIER 'Trans proline' 1 N--CA 1.546 4.593 0 C-N-CA 122.426 2.084 . . . . 0.0 113.614 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -167.31 98.8 0.15 Allowed Glycine 1 N--CA 1.519 4.223 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.9 p -166.05 -20.09 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 124.153 0.981 . . . . 0.0 109.387 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.11 -26.41 68.19 Favored 'General case' 0 N--CA 1.528 3.474 0 C-N-CA 124.2 1.0 . . . . 0.0 109.164 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 95.1 p -65.95 -26.96 67.82 Favored 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.547 0.739 . . . . 0.0 110.49 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.12 -46.61 57.67 Favored Glycine 1 N--CA 1.52 4.254 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 8.4 tp -71.17 -41.1 75.41 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.174 0 CA-C-N 118.186 0.993 . . . . 0.0 112.967 -176.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 18.3 tt -60.87 -35.25 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 123.672 0.789 . . . . 0.0 112.873 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 5.7 tp -73.16 -33.28 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.991 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.43 96.14 Favored Glycine 1 N--CA 1.521 4.311 0 C-N-CA 123.401 0.525 . . . . 0.0 114.219 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.6 p -59.71 -36.84 68.11 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 117.972 0.886 . . . . 0.0 110.787 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.9 p -55.95 -42.15 75.77 Favored 'General case' 0 N--CA 1.535 3.821 0 CA-C-O 120.919 0.39 . . . . 0.0 111.432 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.5 -40.4 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 123.85 0.86 . . . . 0.0 111.601 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.38 -39.91 61.42 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -176.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.54 -46.35 63.74 Favored 'General case' 0 N--CA 1.52 3.054 0 C-N-CA 122.997 0.519 . . . . 0.0 111.185 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.78 -46.62 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 C-N-CA 123.321 0.648 . . . . 0.0 112.385 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.8 p -66.18 -32.28 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.665 0 C-N-CA 122.512 0.325 . . . . 0.0 111.122 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.61 -41.32 96.28 Favored 'General case' 0 N--CA 1.526 3.35 0 C-N-CA 122.584 0.354 . . . . 0.0 110.859 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 88.0 mt -58.62 -36.66 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.916 0 C-N-CA 122.658 0.383 . . . . 0.0 110.287 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.34 -37.69 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 C-N-CA 123.02 0.528 . . . . 0.0 110.324 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.62 -33.25 75.49 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.038 0.535 . . . . 0.0 110.877 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.07 -36.9 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 C-N-CA 123.308 0.643 . . . . 0.0 109.762 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -64.36 -43.45 94.5 Favored 'General case' 0 N--CA 1.528 3.466 0 C-N-CA 123.633 0.773 . . . . 0.0 112.544 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 19.2 m -67.7 -37.23 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 76.8 m -60.24 -38.35 83.19 Favored 'General case' 0 N--CA 1.527 3.392 0 C-N-CA 122.96 0.504 . . . . 0.0 111.26 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -74.27 -40.63 62.2 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 122.64 0.376 . . . . 0.0 110.074 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 83.5 p -63.91 -32.73 74.35 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.15 -23.18 57.77 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.063 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.4 tp -87.11 -22.67 25.24 Favored 'General case' 0 N--CA 1.537 3.919 0 C-N-CA 122.942 0.497 . . . . 0.0 110.16 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -71.45 65.61 0.45 Allowed 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.648 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -143.44 157.9 44.08 Favored 'General case' 0 N--CA 1.526 3.369 0 C-N-CA 124.822 1.249 . . . . 0.0 107.843 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.69 155.93 37.2 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 123.731 0.812 . . . . 0.0 109.216 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.58 137.19 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.488 0 C-N-CA 124.706 1.203 . . . . 0.0 108.329 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.74 146.58 31.67 Favored Pre-proline 0 N--CA 1.528 3.458 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 1 N--CA 1.54 4.256 0 C-N-CA 121.935 1.756 . . . . 0.0 110.645 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 58.9 mtt . . . . . 0 CA--C 1.585 2.29 0 CA-C-O 117.623 -1.179 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -89.84 -4.38 5.4 Favored 'Trans proline' 1 N--CA 1.536 4.004 0 C-N-CA 122.736 2.291 . . . . 0.0 111.893 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 179.86 93.09 0.09 OUTLIER Glycine 1 N--CA 1.518 4.146 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 47.4 t -64.18 158.0 24.19 Favored 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 123.717 0.807 . . . . 0.0 111.052 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.2 -28.72 69.58 Favored 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 124.061 0.944 . . . . 0.0 110.137 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 56.0 m -65.05 -26.88 68.44 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.04 0.536 . . . . 0.0 110.302 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.28 -35.79 91.98 Favored Glycine 1 N--CA 1.524 4.524 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 36.1 mm -68.71 -40.48 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.302 0 C-N-CA 124.583 1.153 . . . . 0.0 109.149 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 48.2 mm -66.46 -40.13 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 C-N-CA 124.538 1.135 . . . . 0.0 108.905 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 14.6 mm -71.38 -31.96 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.97 -29.17 42.58 Favored Glycine 0 N--CA 1.516 3.976 0 C-N-CA 123.708 0.67 . . . . 0.0 113.176 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.59 -37.59 71.31 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.095 0 CA-C-N 117.84 0.82 . . . . 0.0 110.769 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 46.9 p -57.48 -44.79 85.17 Favored 'General case' 0 N--CA 1.528 3.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.824 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.6 t -67.02 -31.79 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 C-N-CA 124.095 0.958 . . . . 0.0 110.875 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.87 79.35 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 122.482 0.313 . . . . 0.0 110.967 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.98 -50.11 74.51 Favored 'General case' 0 N--CA 1.521 3.117 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.37 -38.35 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 CA-C-N 118.224 0.465 . . . . 0.0 111.625 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.2 -38.38 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 CA-C-N 118.23 0.468 . . . . 0.0 110.651 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.99 -38.72 92.11 Favored 'General case' 1 N--CA 1.539 4.021 0 C-N-CA 122.55 0.34 . . . . 0.0 110.543 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.78 -42.8 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.818 0 O-C-N 122.005 -0.434 . . . . 0.0 110.221 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 64.6 t -65.52 -37.71 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 C-N-CA 122.964 0.506 . . . . 0.0 110.082 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.56 80.3 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.432 0.693 . . . . 0.0 111.277 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 84.1 t -71.94 -34.88 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.26 0 C-N-CA 122.909 0.484 . . . . 0.0 110.443 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -62.66 -44.46 96.21 Favored 'General case' 0 N--CA 1.534 3.739 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.02 -39.34 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.721 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 73.6 m -67.18 -30.39 70.33 Favored 'General case' 0 N--CA 1.524 3.26 0 C-N-CA 123.115 0.566 . . . . 0.0 110.727 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -73.32 -35.33 66.04 Favored 'General case' 0 N--CA 1.526 3.339 0 C-N-CA 123.249 0.62 . . . . 0.0 110.343 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 62.8 m -63.67 -23.87 67.55 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.554 0.742 . . . . 0.0 111.689 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.95 -24.98 66.13 Favored 'General case' 0 N--CA 1.53 3.557 0 C-N-CA 123.688 0.795 . . . . 0.0 110.285 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.24 -27.2 23.09 Favored 'General case' 0 N--CA 1.535 3.782 0 C-N-CA 123.632 0.773 . . . . 0.0 109.453 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -114.66 102.88 10.44 Favored 'General case' 0 N--CA 1.536 3.835 0 C-N-CA 124.489 1.116 . . . . 0.0 109.35 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -168.37 170.62 9.76 Favored 'General case' 0 N--CA 1.522 3.135 0 C-N-CA 124.003 0.921 . . . . 0.0 109.135 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -166.49 156.01 11.42 Favored 'General case' 0 N--CA 1.524 3.258 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.62 138.09 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.563 0 C-N-CA 125.011 1.324 . . . . 0.0 107.694 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.44 146.78 32.14 Favored Pre-proline 0 N--CA 1.528 3.441 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo . . . . . 1 N--CA 1.539 4.186 0 C-N-CA 122.132 1.888 . . . . 0.0 110.772 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 23.2 ptt? . . . . . 0 CA--C 1.575 1.909 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.77 125.52 12.23 Favored 'Trans proline' 1 N--CA 1.541 4.323 0 C-N-CA 122.155 1.903 . . . . 0.0 110.139 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 177.6 36.17 0.06 OUTLIER Glycine 1 N--CA 1.519 4.167 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 44.6 t -165.7 45.68 0.08 Allowed 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.771 0.828 . . . . 0.0 109.323 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 7.8 mp -65.23 -26.92 68.33 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.932 0.893 . . . . 0.0 109.537 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 41.4 t -58.2 -25.94 62.2 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.579 0.751 . . . . 0.0 110.931 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.65 -34.4 60.51 Favored Glycine 0 N--CA 1.513 3.77 0 C-N-CA 125.123 1.344 . . . . 0.0 114.981 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.0 pt -57.95 -34.11 47.84 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.271 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -175.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 9.8 pt -55.74 -32.43 31.63 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.133 0 C-N-CA 123.128 0.571 . . . . 0.0 111.972 -176.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.96 -33.44 52.84 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.112 0 C-N-CA 123.613 0.765 . . . . 0.0 110.017 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.74 -29.9 50.72 Favored Glycine 0 N--CA 1.513 3.814 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.039 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 4.1 m -62.26 -37.82 79.55 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 117.937 0.868 . . . . 0.0 111.329 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 68.2 p -62.15 -45.77 91.96 Favored 'General case' 0 N--CA 1.532 3.633 0 CA-C-O 121.364 0.602 . . . . 0.0 110.669 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.18 -32.49 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 C-N-CA 124.197 0.999 . . . . 0.0 110.207 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.3 -34.61 78.74 Favored 'General case' 0 N--CA 1.525 3.282 0 C-N-CA 123.534 0.733 . . . . 0.0 111.776 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.03 -49.87 46.98 Favored 'General case' 0 N--CA 1.516 2.844 0 C-N-CA 123.14 0.576 . . . . 0.0 112.503 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 29.3 m -63.92 -40.11 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.815 0 CA-C-N 118.523 0.602 . . . . 0.0 112.577 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 13.7 p -67.44 -32.01 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 CA-C-N 118.182 0.446 . . . . 0.0 110.558 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.49 -43.96 79.68 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 122.911 0.485 . . . . 0.0 110.333 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.52 -36.54 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 C-N-CA 123.48 0.712 . . . . 0.0 112.028 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.71 -36.68 67.14 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.683 0 CA-C-N 119.447 1.022 . . . . 0.0 110.517 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.28 -32.51 66.7 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.386 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.72 -41.25 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.394 0 C-N-CA 123.261 0.624 . . . . 0.0 110.086 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -61.42 -43.52 98.73 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.607 0.763 . . . . 0.0 112.915 -177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.26 -37.54 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 82.6 m -61.6 -27.82 68.91 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 122.619 0.368 . . . . 0.0 111.07 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -68.21 -27.38 66.33 Favored 'General case' 0 N--CA 1.531 3.576 0 C-N-CA 123.057 0.543 . . . . 0.0 110.738 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.9 m -69.07 -26.77 65.11 Favored 'General case' 0 N--CA 1.531 3.595 0 CA-C-O 121.225 0.536 . . . . 0.0 110.103 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -14.52 47.21 Favored 'General case' 0 N--CA 1.533 3.682 0 C-N-CA 124.807 1.243 . . . . 0.0 110.499 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 32.2 mt -86.59 -27.27 23.98 Favored 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 123.373 0.669 . . . . 0.0 110.387 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -71.56 84.98 0.86 Allowed 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.532 0.733 . . . . 0.0 109.234 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.64 117.09 15.71 Favored 'General case' 0 N--CA 1.527 3.419 0 C-N-CA 124.988 1.315 . . . . 0.0 107.766 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? -164.53 134.02 3.78 Favored 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 28.9 m -117.78 138.23 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 C-N-CA 125.145 1.378 . . . . 0.0 108.685 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.553 ' H ' HD23 ' C' ' 241' ' ' LEU . 1.6 pt? -133.65 146.5 60.64 Favored Pre-proline 0 N--CA 1.533 3.696 0 C-N-CA 125.154 1.382 . . . . 0.0 109.069 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 1 N--CA 1.541 4.269 0 CA-C-N 122.295 1.855 . . . . 0.0 110.766 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -82.32 26.66 0.62 Allowed 'Trans proline' 0 N--CA 1.536 3.998 0 C-N-CA 122.626 2.217 . . . . 0.0 111.112 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.18 -177.51 9.58 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 123.684 0.659 . . . . 0.0 111.521 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 95.7 p -166.23 80.64 0.27 Allowed 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 123.824 0.85 . . . . 0.0 108.744 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -25.79 68.09 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.887 0.875 . . . . 0.0 111.659 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . 0.435 ' O ' HD12 ' D' ' 215' ' ' ILE . 99.6 p -68.17 -26.92 65.99 Favored 'General case' 0 N--CA 1.527 3.395 0 C-N-CA 123.331 0.652 . . . . 0.0 110.054 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.06 -34.02 71.35 Favored Glycine 0 N--CA 1.505 3.255 0 C-N-CA 125.589 1.566 . . . . 0.0 115.597 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 13.7 pt -58.24 -33.79 48.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . 0.534 HD13 ' H ' ' D' ' 216' ' ' ILE . 0.1 OUTLIER -55.06 -43.39 69.58 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.388 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.302 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . 0.534 ' H ' HD13 ' D' ' 215' ' ' ILE . 18.4 tt -73.19 -34.47 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.984 0 CA-C-N 118.252 0.478 . . . . 0.0 110.375 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.11 -44.6 93.89 Favored Glycine 1 N--CA 1.519 4.184 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -60.11 -37.07 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.987 0 CA-C-N 117.629 0.714 . . . . 0.0 111.067 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 61.6 p -59.26 -39.0 81.48 Favored 'General case' 0 N--CA 1.532 3.637 0 CA-C-N 117.963 0.347 . . . . 0.0 111.41 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.48 -38.34 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 C-N-CA 123.41 0.684 . . . . 0.0 111.52 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.16 68.19 Favored 'General case' 0 N--CA 1.531 3.623 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.12 90.06 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 123.5 0.72 . . . . 0.0 111.71 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.23 -42.91 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.289 0.636 . . . . 0.0 112.129 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.81 -32.56 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.58 -47.33 22.82 Favored 'General case' 0 N--CA 1.539 3.997 0 CA-C-N 118.248 0.476 . . . . 0.0 111.352 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 20.2 pt -62.05 -36.31 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.721 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.07 -36.01 76.43 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.199 0 CA-C-N 119.425 1.011 . . . . 0.0 110.321 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.42 -32.16 66.59 Favored 'General case' 0 N--CA 1.523 3.187 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.77 -34.91 67.21 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.296 0 CA-C-N 119.709 1.14 . . . . 0.0 112.269 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -63.21 -43.53 97.86 Favored 'General case' 1 N--CA 1.539 4.019 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.37 -37.32 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 76.4 m -58.7 -31.3 68.12 Favored 'General case' 0 N--CA 1.531 3.619 0 C-N-CA 122.529 0.331 . . . . 0.0 111.257 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.11 -15.32 63.54 Favored 'General case' 0 N--CA 1.534 3.726 0 C-N-CA 123.103 0.561 . . . . 0.0 110.858 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 78.4 p -63.41 -28.78 70.22 Favored 'General case' 0 N--CA 1.529 3.51 0 CA-C-O 121.146 0.498 . . . . 0.0 109.87 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 57.6 mt -91.35 -18.65 23.95 Favored 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 124.507 1.123 . . . . 0.0 112.301 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 53.9 mt -87.53 3.0 49.14 Favored 'General case' 1 N--CA 1.544 4.264 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -70.2 -7.82 45.03 Favored 'General case' 1 N--CA 1.543 4.216 0 CA-C-N 119.65 1.114 . . . . 0.0 109.504 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -67.71 131.78 46.23 Favored 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 124.027 0.931 . . . . 0.0 109.844 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . 0.432 ' H ' ' H ' ' D' ' 240' ' ' VAL . 21.9 pttp -168.7 3.52 0.02 OUTLIER 'General case' 0 N--CA 1.526 3.349 0 C-N-CA 123.708 0.803 . . . . 0.0 110.497 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . 0.432 ' H ' ' H ' ' D' ' 239' ' ' LYS . 8.6 m -135.53 138.37 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.752 0 C-N-CA 125.229 1.412 . . . . 0.0 107.758 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 70.1 mt -125.85 146.78 56.49 Favored Pre-proline 0 N--CA 1.531 3.599 0 C-N-CA 125.389 1.475 . . . . 0.0 107.629 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 1 N--CA 1.54 4.227 0 C-N-CA 121.999 1.799 . . . . 0.0 110.897 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 CA--C 1.576 1.964 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.52 -22.32 44.98 Favored 'Trans proline' 1 N--CA 1.543 4.429 0 C-N-CA 122.223 1.949 . . . . 0.0 111.264 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 177.91 -171.37 43.9 Favored Glycine 1 N--CA 1.521 4.328 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p -167.16 -65.17 0.03 OUTLIER 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.16 -27.21 68.55 Favored 'General case' 0 N--CA 1.536 3.865 0 C-N-CA 123.641 0.777 . . . . 0.0 109.091 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 50.2 m -66.7 -28.26 68.29 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.421 0.689 . . . . 0.0 110.421 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.77 -35.56 80.3 Favored Glycine 1 N--CA 1.516 4.009 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 38.5 mm -69.81 -43.56 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.153 0 C-N-CA 124.528 1.131 . . . . 0.0 112.841 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 9.4 pt -59.49 -40.87 82.97 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.526 0 CA-C-N 118.852 0.751 . . . . 0.0 112.153 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.0 -32.94 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.98 -50.14 70.86 Favored Glycine 1 N--CA 1.52 4.276 0 C-N-CA 123.603 0.62 . . . . 0.0 113.364 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 5.0 p -61.76 -36.78 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-N 117.458 0.629 . . . . 0.0 109.747 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 86.1 m -63.6 -47.05 83.0 Favored 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 122.693 0.397 . . . . 0.0 111.604 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.7 -34.39 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 C-N-CA 123.491 0.716 . . . . 0.0 110.512 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.7 -46.57 67.39 Favored 'General case' 0 N--CA 1.527 3.382 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.43 91.09 Favored 'General case' 0 N--CA 1.519 2.99 0 C-N-CA 123.033 0.533 . . . . 0.0 111.687 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 43.2 t -68.16 -51.6 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.101 0 C-N-CA 123.134 0.574 . . . . 0.0 111.96 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 31.7 m -67.41 -32.72 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 O-C-N 121.892 -0.505 . . . . 0.0 111.813 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.03 -44.51 72.55 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 122.539 0.335 . . . . 0.0 111.33 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 24.7 pt -69.23 -36.48 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 CA-C-N 118.747 0.703 . . . . 0.0 111.149 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.07 -37.64 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.871 0 O-C-N 121.848 -0.533 . . . . 0.0 109.739 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.78 83.66 Favored 'General case' 0 N--CA 1.532 3.637 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.65 -34.16 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.554 0 O-C-N 122.079 -0.388 . . . . 0.0 110.937 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -68.75 -43.71 75.28 Favored 'General case' 0 N--CA 1.526 3.357 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 13.2 p -68.38 -37.83 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 CA-C-N 118.019 0.372 . . . . 0.0 111.175 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 16.3 p -66.31 -27.88 68.26 Favored 'General case' 0 N--CA 1.533 3.679 0 CA-C-N 117.855 0.298 . . . . 0.0 111.172 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -65.61 -30.98 71.78 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 123.214 0.606 . . . . 0.0 111.109 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 53.0 m -64.47 -32.37 73.96 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.391 0.676 . . . . 0.0 111.277 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 53.8 mt -63.08 -16.41 59.84 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.594 0.758 . . . . 0.0 111.928 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.85 -0.54 57.09 Favored 'General case' 0 N--CA 1.538 3.969 0 C-N-CA 123.356 0.663 . . . . 0.0 109.701 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -70.16 -29.86 66.86 Favored 'General case' 0 N--CA 1.523 3.225 0 C-N-CA 123.743 0.817 . . . . 0.0 110.515 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -61.19 -45.19 95.62 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 123.605 0.762 . . . . 0.0 111.904 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -82.55 166.4 19.29 Favored 'General case' 0 N--CA 1.524 3.271 0 C-N-CA 123.678 0.791 . . . . 0.0 109.772 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.34 138.23 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 C-N-CA 124.894 1.278 . . . . 0.0 108.284 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 8.6 mp -94.55 107.5 30.5 Favored Pre-proline 0 N--CA 1.528 3.431 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo . . . . . 1 N--CA 1.538 4.089 0 CA-C-N 122.725 2.009 . . . . 0.0 110.836 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 CA--C 1.585 2.309 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -87.26 -24.55 1.23 Allowed 'Trans proline' 1 N--CA 1.536 4.028 0 C-N-CA 122.471 2.114 . . . . 0.0 111.104 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 178.36 -16.74 0.03 OUTLIER Glycine 1 N--CA 1.521 4.301 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 51.1 m 57.8 172.68 0.05 Allowed 'General case' 0 N--CA 1.521 3.102 0 C-N-CA 124.482 1.113 . . . . 0.0 112.267 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.08 -35.61 81.69 Favored 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 124.312 1.045 . . . . 0.0 110.285 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 42.2 t -57.77 -26.95 62.6 Favored 'General case' 0 N--CA 1.528 3.451 0 C-N-CA 122.886 0.475 . . . . 0.0 111.593 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.38 -35.85 83.01 Favored Glycine 1 N--CA 1.527 4.741 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.29 -40.7 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 C-N-CA 124.428 1.091 . . . . 0.0 108.959 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.23 -42.67 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 C-N-CA 124.524 1.13 . . . . 0.0 108.771 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 30.8 mm -72.38 -33.06 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.627 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.42 -29.71 60.83 Favored Glycine 0 N--CA 1.514 3.88 0 C-N-CA 123.766 0.698 . . . . 0.0 113.362 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 2.5 m -60.43 -37.38 74.39 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 CA-C-N 117.825 0.812 . . . . 0.0 110.653 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 44.5 p -55.92 -46.1 78.55 Favored 'General case' 0 N--CA 1.529 3.517 0 CA-C-O 121.375 0.607 . . . . 0.0 111.403 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.62 -31.92 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.034 0 C-N-CA 124.387 1.075 . . . . 0.0 111.238 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.86 78.99 Favored 'General case' 0 N--CA 1.531 3.588 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.19 -50.28 70.94 Favored 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 28.1 m -63.09 -37.94 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.404 0.547 . . . . 0.0 111.883 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 93.9 t -60.5 -32.71 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 121.77 -0.581 . . . . 0.0 110.232 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.5 -38.08 77.47 Favored 'General case' 0 N--CA 1.532 3.669 0 CA-C-N 118.455 0.571 . . . . 0.0 109.958 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 11.6 mm -54.36 -36.85 35.21 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.026 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.44 -38.09 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 C-N-CA 123.468 0.707 . . . . 0.0 109.829 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.47 -32.21 72.21 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 123.431 0.692 . . . . 0.0 111.309 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.02 -34.51 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.494 0 C-N-CA 122.813 0.445 . . . . 0.0 109.855 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.02 -43.37 83.0 Favored 'General case' 0 N--CA 1.53 3.553 0 C-N-CA 123.07 0.548 . . . . 0.0 112.152 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 4.9 m -67.47 -36.1 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 CA-C-N 118.195 0.452 . . . . 0.0 109.937 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 96.6 m -57.61 -27.13 62.48 Favored 'General case' 0 N--CA 1.526 3.348 0 C-N-CA 123.004 0.521 . . . . 0.0 110.547 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -58.51 -15.71 12.3 Favored 'General case' 0 N--CA 1.531 3.6 0 C-N-CA 122.367 0.267 . . . . 0.0 110.867 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 50.8 m -75.04 -42.07 57.91 Favored 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.99 -14.22 21.51 Favored 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.474 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 43.2 tp -87.06 2.3 50.12 Favored 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 46.9 m95 66.92 164.29 0.2 Allowed 'General case' 0 N--CA 1.515 2.799 0 C-N-CA 125.148 1.379 . . . . 0.0 111.214 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -133.86 -148.98 0.34 Allowed 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 125.358 1.463 . . . . 0.0 107.07 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -159.69 63.59 0.37 Allowed 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.53 138.19 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 C-N-CA 125.037 1.335 . . . . 0.0 107.959 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 57.8 tp -103.39 99.78 16.18 Favored Pre-proline 0 N--CA 1.531 3.605 0 C-N-CA 124.842 1.257 . . . . 0.0 108.438 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 N--CA 1.536 3.998 0 C-N-CA 122.426 2.084 . . . . 0.0 110.963 -179.607 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 43.9 ttm . . . . . 0 CA--C 1.583 2.229 0 CA-C-O 117.593 -1.194 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -88.84 -157.08 0.06 OUTLIER 'Trans proline' 1 N--CA 1.536 4.01 0 C-N-CA 122.705 2.27 . . . . 0.0 110.511 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -160.42 -33.41 0.02 OUTLIER Glycine 1 N--CA 1.521 4.301 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 82.8 p 52.34 46.36 26.8 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 124.055 0.942 . . . . 0.0 112.199 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 43.4 mt -61.91 -26.85 68.41 Favored 'General case' 0 N--CA 1.527 3.414 0 C-N-CA 123.774 0.83 . . . . 0.0 110.607 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 45.2 t -68.43 -26.36 65.48 Favored 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.675 0.79 . . . . 0.0 110.596 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.35 -43.79 77.2 Favored Glycine 0 N--CA 1.512 3.714 0 C-N-CA 123.599 0.619 . . . . 0.0 114.103 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.7 pt -70.68 -35.82 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 10.1 pt -58.56 -41.69 82.63 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.66 0 CA-C-N 119.433 1.015 . . . . 0.0 112.542 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.7 -33.18 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.06 -41.0 96.27 Favored Glycine 1 N--CA 1.516 4.002 0 CA-C-O 119.502 -0.61 . . . . 0.0 114.088 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.9 m -63.73 -36.62 77.17 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.349 0 CA-C-N 118.624 1.212 . . . . 0.0 111.134 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.8 p -55.74 -42.56 75.57 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.828 0.451 . . . . 0.0 111.092 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 39.5 t -56.93 -34.13 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 C-N-CA 124.059 0.944 . . . . 0.0 111.896 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.93 -42.42 65.4 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.75 -34.08 71.47 Favored 'General case' 0 N--CA 1.519 2.992 0 C-N-CA 123.232 0.613 . . . . 0.0 111.314 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.85 -49.23 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 C-N-CA 123.647 0.779 . . . . 0.0 111.345 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.68 -32.71 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 C-N-CA 122.633 0.373 . . . . 0.0 110.674 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.28 -36.86 74.67 Favored 'General case' 0 N--CA 1.539 3.985 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.18 -37.11 34.66 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.352 0 C-N-CA 123.168 0.587 . . . . 0.0 109.975 178.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 57.1 t -66.93 -38.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 C-N-CA 123.187 0.595 . . . . 0.0 110.143 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -45.53 86.54 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.387 0.675 . . . . 0.0 112.681 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.7 -34.17 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.613 0 O-C-N 121.898 -0.501 . . . . 0.0 110.228 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.15 -44.1 93.15 Favored 'General case' 0 N--CA 1.532 3.629 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.53 -37.29 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 99.5 m -59.14 -27.95 66.11 Favored 'General case' 0 N--CA 1.531 3.6 0 C-N-CA 122.74 0.416 . . . . 0.0 110.859 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -73.29 -35.05 66.07 Favored 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 63.0 m -72.66 -30.86 64.62 Favored 'General case' 0 N--CA 1.525 3.321 0 C-N-CA 123.108 0.563 . . . . 0.0 109.852 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.78 -14.65 62.5 Favored 'General case' 0 N--CA 1.526 3.339 0 C-N-CA 124.513 1.125 . . . . 0.0 110.926 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 38.3 tp -87.33 10.21 18.0 Favored 'General case' 0 N--CA 1.537 3.917 0 C-N-CA 123.763 0.825 . . . . 0.0 110.663 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -66.05 9.31 0.15 Allowed 'General case' 1 N--CA 1.54 4.065 0 C-N-CA 123.217 0.607 . . . . 0.0 112.444 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -50.6 -47.34 58.16 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 124.099 0.96 . . . . 0.0 111.785 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt 61.18 153.72 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 124.384 1.074 . . . . 0.0 111.348 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.1 m -112.52 138.32 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.508 0 C-N-CA 125.216 1.406 . . . . 0.0 108.513 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -95.76 106.59 28.48 Favored Pre-proline 0 N--CA 1.529 3.523 0 CA-C-O 117.075 -1.441 . . . . 0.0 107.892 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo . . . . . 1 N--CA 1.549 4.742 0 C-N-CA 122.682 2.255 . . . . 0.0 114.965 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 CA--C 1.574 1.892 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.95 -46.18 32.15 Favored 'Trans proline' 1 N--CA 1.543 4.419 0 C-N-CA 122.402 2.068 . . . . 0.0 113.623 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 175.64 155.69 13.34 Favored Glycine 1 N--CA 1.519 4.169 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 42.2 t -87.24 5.75 36.67 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 124.053 0.941 . . . . 0.0 111.234 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -61.89 -26.5 68.2 Favored 'General case' 0 N--CA 1.529 3.48 0 C-N-CA 124.147 0.979 . . . . 0.0 110.162 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 95.7 p -68.15 -32.15 72.21 Favored 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.556 0.742 . . . . 0.0 110.391 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.86 -46.89 58.41 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.924 0.773 . . . . 0.0 115.0 -178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.9 -41.16 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 7.6 tp -60.67 -40.42 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 C-N-CA 122.905 0.482 . . . . 0.0 112.276 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 7.0 tp -73.27 -33.79 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.711 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.13 -47.84 87.07 Favored Glycine 0 N--CA 1.515 3.914 0 C-N-CA 123.799 0.714 . . . . 0.0 114.167 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.16 -37.17 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 CA-C-N 117.566 0.683 . . . . 0.0 111.137 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 61.2 p -66.06 -46.3 78.26 Favored 'General case' 0 N--CA 1.534 3.727 0 CA-C-N 118.136 0.425 . . . . 0.0 110.721 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 84.7 t -70.03 -31.96 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 C-N-CA 123.741 0.817 . . . . 0.0 111.057 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.87 -43.79 66.35 Favored 'General case' 0 N--CA 1.533 3.707 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.06 73.2 Favored 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 123.185 0.594 . . . . 0.0 111.179 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.71 -46.79 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 123.395 0.678 . . . . 0.0 112.292 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.29 -31.58 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.687 0 C-N-CA 122.533 0.333 . . . . 0.0 111.39 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.72 -39.64 64.16 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 122.411 -0.181 . . . . 0.0 111.046 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 93.8 mt -59.96 -44.19 94.01 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.097 0 CA-C-N 118.357 0.526 . . . . 0.0 111.653 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 30.0 m -64.07 -36.7 77.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 CA-C-N 118.619 0.645 . . . . 0.0 110.429 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.9 -32.5 71.96 Favored 'General case' 0 N--CA 1.529 3.51 0 C-N-CA 123.238 0.615 . . . . 0.0 111.871 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 86.2 t -71.31 -34.56 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 122.698 0.399 . . . . 0.0 109.939 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -61.34 -44.02 97.9 Favored 'General case' 0 N--CA 1.53 3.542 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.94 -40.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.858 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 80.7 m -58.67 -27.65 65.0 Favored 'General case' 0 N--CA 1.522 3.17 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.117 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -71.62 -15.85 62.26 Favored 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 122.528 0.331 . . . . 0.0 111.15 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 26.8 t -78.39 -46.55 19.62 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.551 HD13 ' H ' ' B' ' 235' ' ' LEU . 0.0 OUTLIER -83.88 -13.01 54.63 Favored 'General case' 1 N--CA 1.554 4.733 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -175.242 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.69 3.69 43.7 Favored 'General case' 1 N--CA 1.566 5.33 0 CA-C-N 121.915 2.143 . . . . 0.0 112.438 -176.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -122.53 -36.61 2.9 Favored 'General case' 1 N--CA 1.543 4.207 0 C-N-CA 124.814 1.246 . . . . 0.0 107.644 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp 62.19 5.36 1.48 Allowed 'General case' 0 N--CA 1.522 3.17 0 C-N-CA 124.598 1.159 . . . . 0.0 112.284 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -73.52 105.19 4.76 Favored 'General case' 0 N--CA 1.533 3.676 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.41 138.33 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.468 0 C-N-CA 124.847 1.259 . . . . 0.0 108.564 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.71 147.53 40.06 Favored Pre-proline 0 N--CA 1.538 3.93 0 C-N-CA 125.435 1.494 . . . . 0.0 108.668 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 1 N--CA 1.542 4.34 0 C-N-CA 121.933 1.755 . . . . 0.0 110.704 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 CA--C 1.575 1.94 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -82.63 179.76 5.13 Favored 'Trans proline' 0 N--CA 1.535 3.915 0 C-N-CA 122.632 2.221 . . . . 0.0 110.732 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.89 -37.98 93.82 Favored Glycine 1 N--CA 1.52 4.26 0 C-N-CA 123.672 0.653 . . . . 0.0 111.486 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 59.9 p 55.98 111.1 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 124.545 1.138 . . . . 0.0 112.225 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.65 -26.66 68.75 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 123.955 0.902 . . . . 0.0 109.646 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 38.7 t -67.95 -26.85 66.15 Favored 'General case' 0 N--CA 1.519 2.993 0 C-N-CA 123.645 0.778 . . . . 0.0 110.611 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.14 -46.78 56.87 Favored Glycine 0 N--CA 1.512 3.704 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.321 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 43.2 pt -70.98 -37.97 70.15 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.121 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 7.5 tp -59.05 -31.8 46.49 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.092 0 C-N-CA 123.288 0.635 . . . . 0.0 112.659 -177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.4 pp -71.3 -32.17 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.7 -43.68 79.75 Favored Glycine 0 N--CA 1.512 3.743 0 C-N-CA 124.463 1.03 . . . . 0.0 114.949 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 11.3 p -68.2 -37.13 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 CA-C-N 118.133 0.967 . . . . 0.0 111.011 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.6 p -65.59 -46.49 79.18 Favored 'General case' 0 N--CA 1.531 3.582 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 10.8 p -69.71 -30.68 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.467 0 C-N-CA 123.451 0.7 . . . . 0.0 111.226 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.07 -43.19 63.71 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.59 -37.36 73.89 Favored 'General case' 0 N--CA 1.521 3.099 0 C-N-CA 123.335 0.654 . . . . 0.0 110.863 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.99 -52.13 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.313 0 C-N-CA 123.668 0.787 . . . . 0.0 111.27 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.4 -31.93 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.925 0 CA-C-O 120.91 0.386 . . . . 0.0 110.235 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -46.24 89.61 Favored 'General case' 0 N--CA 1.531 3.59 0 CA-C-O 121.57 0.7 . . . . 0.0 109.583 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.14 -39.51 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 C-N-CA 123.221 0.608 . . . . 0.0 109.814 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.91 -37.78 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.704 0 C-N-CA 123.144 0.578 . . . . 0.0 109.914 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.66 -46.52 88.78 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.386 0.674 . . . . 0.0 112.602 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.71 -34.26 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 O-C-N 121.825 -0.547 . . . . 0.0 109.871 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.68 -43.91 97.59 Favored 'General case' 0 N--CA 1.529 3.515 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.0 -37.69 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.12 -28.59 69.88 Favored 'General case' 0 N--CA 1.525 3.324 0 C-N-CA 123.23 0.612 . . . . 0.0 111.586 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -62.35 -37.27 85.02 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 122.924 0.49 . . . . 0.0 110.664 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 52.7 m -63.78 -26.84 68.82 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.614 0.766 . . . . 0.0 111.102 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 55.6 mt -90.12 -13.44 35.74 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 124.953 1.301 . . . . 0.0 111.281 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 41.7 tp -86.58 -11.3 51.91 Favored 'General case' 1 N--CA 1.54 4.054 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -175.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -60.55 -67.34 0.41 Allowed 'General case' 1 N--CA 1.541 4.114 0 CA-C-N 119.142 0.883 . . . . 0.0 110.007 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 56.55 -144.66 0.65 Allowed 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.77 0.828 . . . . 0.0 110.751 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp 62.14 170.69 0.13 Allowed 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 124.29 1.036 . . . . 0.0 111.304 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.05 138.64 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.351 0 C-N-CA 125.249 1.419 . . . . 0.0 107.978 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 60.5 tp -94.7 105.33 17.96 Favored Pre-proline 0 N--CA 1.529 3.513 0 CA-C-O 117.311 -1.328 . . . . 0.0 108.352 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 1 N--CA 1.537 4.034 0 C-N-CA 122.359 2.039 . . . . 0.0 110.968 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 CA--C 1.577 1.995 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.77 -170.81 0.73 Allowed 'Trans proline' 1 N--CA 1.538 4.101 0 C-N-CA 122.254 1.969 . . . . 0.0 110.015 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.72 86.86 0.26 Allowed Glycine 1 N--CA 1.518 4.167 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 46.8 t -165.62 23.29 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.142 0 C-N-CA 123.946 0.899 . . . . 0.0 109.895 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.2 -26.73 68.27 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 124.167 0.987 . . . . 0.0 109.82 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 45.1 t -68.65 -26.45 65.34 Favored 'General case' 0 N--CA 1.52 3.072 0 C-N-CA 123.358 0.663 . . . . 0.0 110.835 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.05 71.48 Favored Glycine 0 N--CA 1.511 3.642 0 C-N-CA 123.693 0.663 . . . . 0.0 114.08 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 6.4 tp -68.9 -35.97 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.911 0 CA-C-N 117.921 0.861 . . . . 0.0 111.908 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 8.3 pt -65.5 -32.37 57.93 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.461 0 CA-C-N 118.961 0.801 . . . . 0.0 110.16 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.62 -33.69 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 124.301 1.04 . . . . 0.0 108.861 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.24 -29.73 60.33 Favored Glycine 1 N--CA 1.518 4.118 0 C-N-CA 123.523 0.582 . . . . 0.0 113.159 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 m -60.07 -37.35 72.46 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 CA-C-N 117.349 0.574 . . . . 0.0 111.042 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 56.8 p -55.6 -39.74 71.16 Favored 'General case' 0 N--CA 1.524 3.235 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.325 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.7 t -61.88 -46.11 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.277 0 C-N-CA 123.703 0.801 . . . . 0.0 110.668 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.51 -35.09 60.27 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.262 0.625 . . . . 0.0 112.538 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.95 -37.32 81.45 Favored 'General case' 0 N--CA 1.519 2.991 0 C-N-CA 123.482 0.713 . . . . 0.0 111.083 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 28.3 t -56.37 -38.89 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 C-N-CA 123.288 0.635 . . . . 0.0 110.573 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.02 -32.11 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.387 0 C-N-CA 123.554 0.741 . . . . 0.0 110.028 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -44.07 70.45 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.433 0.693 . . . . 0.0 109.555 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.15 -49.19 63.72 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.157 0 C-N-CA 123.246 0.618 . . . . 0.0 111.772 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 22.2 m -66.19 -36.28 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 C-N-CA 122.594 0.358 . . . . 0.0 110.327 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.28 66.74 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 123.279 0.632 . . . . 0.0 112.338 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.4 -43.91 94.63 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.005 0 CA-C-N 118.237 0.471 . . . . 0.0 112.09 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -61.16 -43.62 98.6 Favored 'General case' 0 N--CA 1.538 3.951 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.56 -37.55 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.783 0 O-C-N 121.771 -0.581 . . . . 0.0 109.609 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 85.3 m -64.25 -27.63 69.18 Favored 'General case' 0 N--CA 1.527 3.385 0 C-N-CA 122.973 0.509 . . . . 0.0 111.105 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -64.36 -27.96 69.37 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.039 0.536 . . . . 0.0 111.423 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 50.5 m -63.73 -37.68 88.28 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 123.629 0.771 . . . . 0.0 111.767 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -60.84 -13.79 17.76 Favored 'General case' 0 N--CA 1.531 3.589 0 C-N-CA 124.625 1.17 . . . . 0.0 112.293 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -86.93 -28.15 22.93 Favored 'General case' 1 N--CA 1.542 4.175 0 CA-C-N 118.423 0.556 . . . . 0.0 110.539 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -73.42 68.25 1.09 Allowed 'General case' 0 N--CA 1.533 3.684 0 CA-C-O 121.387 0.613 . . . . 0.0 109.739 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -109.83 -37.61 5.59 Favored 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 125.096 1.358 . . . . 0.0 108.627 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 60.1 tttp 62.24 148.74 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 124.651 1.181 . . . . 0.0 111.214 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.46 138.29 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 C-N-CA 125.003 1.321 . . . . 0.0 108.601 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.58 146.6 31.76 Favored Pre-proline 0 N--CA 1.529 3.512 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 1 N--CA 1.541 4.305 0 C-N-CA 122.04 1.827 . . . . 0.0 110.718 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 CA--C 1.582 2.203 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.35 -10.3 1.28 Allowed 'Trans proline' 1 N--CA 1.55 4.84 0 C-N-CA 122.055 1.837 . . . . 0.0 114.075 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 76.53 -177.51 51.23 Favored Glycine 1 N--CA 1.518 4.165 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 67.1 m -161.27 15.23 0.1 Allowed 'General case' 0 N--CA 1.524 3.241 0 C-N-CA 123.601 0.761 . . . . 0.0 110.35 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.5 -26.86 68.76 Favored 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 123.665 0.786 . . . . 0.0 111.473 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 66.0 m -68.28 -25.86 65.36 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.631 0.772 . . . . 0.0 109.563 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.38 -34.65 59.72 Favored Glycine 0 N--CA 1.512 3.747 0 C-N-CA 124.603 1.097 . . . . 0.0 113.952 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 11.1 tp -59.33 -43.16 89.46 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.023 0 CA-C-N 117.67 0.735 . . . . 0.0 112.827 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 5.5 pt -68.85 -34.16 63.07 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.411 0 CA-C-O 121.827 0.822 . . . . 0.0 109.399 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 81.9 mt -73.08 -38.98 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.185 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.56 -46.63 91.83 Favored Glycine 1 N--CA 1.516 4.016 0 CA-C-N 115.606 -0.725 . . . . 0.0 114.374 -177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.13 -37.55 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 CA-C-N 117.506 0.653 . . . . 0.0 110.854 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 70.1 p -66.22 -45.55 80.32 Favored 'General case' 0 N--CA 1.535 3.782 0 CA-C-N 118.354 0.525 . . . . 0.0 110.575 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.24 -31.24 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 C-N-CA 123.964 0.905 . . . . 0.0 110.891 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.32 -47.24 75.93 Favored 'General case' 0 N--CA 1.532 3.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.19 -25.64 67.81 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 123.571 0.748 . . . . 0.0 112.224 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.53 -37.09 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 C-N-CA 123.526 0.73 . . . . 0.0 109.464 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 46.1 t -55.78 -32.31 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.137 0.575 . . . . 0.0 110.306 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.96 -40.89 91.68 Favored 'General case' 0 N--CA 1.532 3.661 0 C-N-CA 123.017 0.527 . . . . 0.0 109.823 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 34.3 mm -60.62 -44.56 97.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.711 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.84 -39.72 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.258 0 C-N-CA 123.636 0.775 . . . . 0.0 109.855 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.84 87.81 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 123.676 0.79 . . . . 0.0 112.409 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.82 -34.36 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 O-C-N 121.846 -0.534 . . . . 0.0 110.334 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -63.63 -44.35 94.14 Favored 'General case' 0 N--CA 1.526 3.374 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.15 -37.99 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 70.9 m -67.26 -30.38 70.25 Favored 'General case' 0 N--CA 1.525 3.286 0 C-N-CA 123.115 0.566 . . . . 0.0 110.911 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -66.67 -35.21 79.61 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.347 0.659 . . . . 0.0 111.237 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 91.8 p -64.83 -33.63 76.46 Favored 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 123.121 0.568 . . . . 0.0 110.94 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 50.7 mt -78.75 -14.86 59.05 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 124.022 0.929 . . . . 0.0 111.166 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 50.6 tp -87.46 -16.1 35.76 Favored 'General case' 0 N--CA 1.536 3.845 0 C-N-CA 123.516 0.727 . . . . 0.0 110.554 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -61.82 -8.26 4.66 Favored 'General case' 0 N--CA 1.53 3.563 0 C-N-CA 123.393 0.677 . . . . 0.0 111.583 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -64.94 144.68 57.12 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 123.782 0.833 . . . . 0.0 110.387 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -69.69 136.03 50.56 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.655 0.782 . . . . 0.0 109.622 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 30.7 m -135.27 138.28 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.413 0 C-N-CA 124.994 1.318 . . . . 0.0 108.192 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 58.2 mt -94.72 129.95 34.69 Favored Pre-proline 0 N--CA 1.527 3.404 0 CA-C-O 116.732 -1.604 . . . . 0.0 108.052 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 1 N--CA 1.538 4.122 0 CA-C-N 123.125 2.152 . . . . 0.0 110.679 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.582 2.199 0 CA-C-O 117.326 -1.321 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -87.91 -177.5 1.95 Allowed 'Trans proline' 0 N--CA 1.535 3.949 0 C-N-CA 122.473 2.115 . . . . 0.0 110.623 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -175.61 -105.75 0.19 Allowed Glycine 1 N--CA 1.518 4.13 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 74.4 p 54.19 44.51 29.02 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-O 122.042 0.925 . . . . 0.0 111.413 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 42.2 mt -60.91 -26.61 67.58 Favored 'General case' 0 N--CA 1.524 3.235 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.952 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 61.9 m -62.99 -26.38 68.82 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.049 0.539 . . . . 0.0 110.069 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.96 -46.51 93.57 Favored Glycine 1 N--CA 1.519 4.23 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.565 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 48.7 pt -70.5 -35.33 61.29 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.141 0 CA-C-N 118.468 1.134 . . . . 0.0 109.85 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . 0.432 ' O ' HG12 ' F' ' 218' ' ' VAL . 49.4 mm -62.38 -44.68 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 29.8 mm -72.88 -33.31 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.89 -29.08 49.93 Favored Glycine 0 N--CA 1.512 3.733 0 C-N-CA 124.666 1.126 . . . . 0.0 113.175 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . 0.432 HG12 ' O ' ' F' ' 215' ' ' ILE . 9.8 p -59.28 -39.25 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.845 0 C-N-CA 122.781 0.433 . . . . 0.0 111.199 -177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 72.9 p -65.91 -45.2 82.84 Favored 'General case' 0 N--CA 1.53 3.547 0 CA-C-O 121.657 0.741 . . . . 0.0 109.987 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 43.3 t -68.56 -31.69 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.976 0 C-N-CA 124.588 1.155 . . . . 0.0 111.676 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.65 77.83 Favored 'General case' 0 N--CA 1.533 3.713 0 O-C-N 121.706 -0.621 . . . . 0.0 112.608 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.39 -50.22 74.48 Favored 'General case' 0 N--CA 1.523 3.189 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.36 -38.11 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 CA-C-N 118.321 0.51 . . . . 0.0 111.402 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 84.2 t -56.75 -35.96 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 O-C-N 122.03 -0.419 . . . . 0.0 111.102 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 52.0 tp -66.32 -44.57 83.01 Favored 'General case' 1 N--CA 1.539 4.01 0 CA-C-N 118.809 0.732 . . . . 0.0 109.685 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.47 -42.45 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.465 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.201 -178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.31 -37.98 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 C-N-CA 123.036 0.534 . . . . 0.0 109.58 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.2 88.65 Favored 'General case' 0 N--CA 1.53 3.574 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 17.4 m -71.42 -34.35 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 O-C-N 121.843 -0.536 . . . . 0.0 110.811 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -64.51 -44.17 91.77 Favored 'General case' 0 N--CA 1.531 3.599 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.74 -37.64 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.1 -27.25 68.79 Favored 'General case' 0 N--CA 1.526 3.363 0 C-N-CA 123.437 0.695 . . . . 0.0 111.182 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -63.17 -34.39 77.52 Favored 'General case' 0 N--CA 1.53 3.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.774 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 38.8 t -66.1 -36.06 82.17 Favored 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.529 0.732 . . . . 0.0 111.432 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 4.4 tt -61.25 -13.97 22.63 Favored 'General case' 0 N--CA 1.528 3.465 0 C-N-CA 124.231 1.012 . . . . 0.0 111.613 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 25.6 mt -86.03 -27.99 24.43 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.166 0.586 . . . . 0.0 109.594 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -102.6 98.1 8.2 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 124.543 1.137 . . . . 0.0 108.193 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -126.38 71.22 1.27 Allowed 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 124.911 1.285 . . . . 0.0 108.659 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -166.1 82.55 0.29 Allowed 'General case' 0 N--CA 1.522 3.174 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.45 132.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.51 146.76 32.07 Favored Pre-proline 0 N--CA 1.528 3.433 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo . . . . . 1 N--CA 1.54 4.225 0 C-N-CA 122.022 1.814 . . . . 0.0 110.72 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 76.5 mtp . . . . . 0 CA--C 1.572 1.81 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.46 3.09 4.46 Favored 'Trans proline' 1 N--CA 1.54 4.248 0 C-N-CA 122.057 1.838 . . . . 0.0 111.184 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.6 -177.92 25.18 Favored Glycine 1 N--CA 1.519 4.211 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.1 p -165.99 62.57 0.11 Allowed 'General case' 0 N--CA 1.523 3.18 0 CA-C-O 121.826 0.822 . . . . 0.0 108.923 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.02 -26.97 68.81 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 123.907 0.883 . . . . 0.0 110.19 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 69.2 m -68.37 -26.74 65.73 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 123.408 0.683 . . . . 0.0 109.993 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.7 -46.96 92.6 Favored Glycine 1 N--CA 1.519 4.228 0 C-N-CA 123.719 0.676 . . . . 0.0 113.562 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.7 tp -70.9 -35.1 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 CA-C-N 117.795 0.797 . . . . 0.0 109.869 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.83 -43.91 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 123.67 0.788 . . . . 0.0 111.512 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 18.6 tt -73.17 -33.48 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 119.263 0.938 . . . . 0.0 109.838 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.55 97.76 Favored Glycine 1 N--CA 1.521 4.352 0 C-N-CA 123.354 0.502 . . . . 0.0 114.091 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 p -59.93 -36.67 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.913 0 CA-C-N 117.677 0.739 . . . . 0.0 110.258 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.9 p -55.98 -44.86 78.94 Favored 'General case' 0 N--CA 1.536 3.843 0 CA-C-O 121.318 0.58 . . . . 0.0 111.388 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.88 -39.99 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 C-N-CA 124.073 0.949 . . . . 0.0 111.748 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.77 -46.78 74.42 Favored 'General case' 0 N--CA 1.528 3.434 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.36 -50.46 71.5 Favored 'General case' 0 N--CA 1.517 2.894 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.54 -38.48 81.53 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.094 0 CA-C-N 119.079 0.854 . . . . 0.0 112.614 -177.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.14 -32.12 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.96 0 CA-C-N 118.354 0.525 . . . . 0.0 110.227 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.38 -44.49 36.07 Favored 'General case' 0 N--CA 1.526 3.326 0 C-N-CA 122.653 0.381 . . . . 0.0 110.471 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.34 -44.8 89.15 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.034 0 C-N-CA 122.945 0.498 . . . . 0.0 111.869 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 30.6 m -61.29 -36.43 72.82 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.22 0 CA-C-N 118.94 0.791 . . . . 0.0 110.834 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.57 -31.87 66.58 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.234 0.614 . . . . 0.0 111.443 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.29 -41.87 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 C-N-CA 123.027 0.531 . . . . 0.0 111.507 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -60.7 -43.95 97.15 Favored 'General case' 1 N--CA 1.541 4.091 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.68 -37.73 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 80.1 m -67.27 -32.65 73.81 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 122.733 0.413 . . . . 0.0 110.004 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -72.18 -29.44 64.0 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 123.715 0.806 . . . . 0.0 110.562 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -66.4 -21.35 66.22 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 123.145 0.578 . . . . 0.0 111.061 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 58.6 mt -91.55 -14.26 30.62 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 124.509 1.124 . . . . 0.0 111.189 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.1 tp -87.35 -28.3 22.3 Favored 'General case' 1 N--CA 1.541 4.111 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -174.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 48.8 p-90 -66.32 -64.21 0.91 Allowed 'General case' 1 N--CA 1.544 4.271 0 CA-C-N 120.272 1.396 . . . . 0.0 111.157 -177.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 54.72 176.41 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.852 0.861 . . . . 0.0 112.316 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -97.19 169.73 9.6 Favored 'General case' 0 N--CA 1.527 3.404 0 C-N-CA 124.541 1.136 . . . . 0.0 108.918 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 50.3 t -132.34 136.17 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.58 98.75 25.45 Favored Pre-proline 0 N--CA 1.536 3.834 0 C-N-CA 124.939 1.296 . . . . 0.0 109.352 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo . . . . . 1 N--CA 1.547 4.648 0 C-N-CA 122.349 2.033 . . . . 0.0 114.16 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 CA--C 1.572 1.793 0 CA-C-O 116.923 -1.513 . . . . 0.0 107.003 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.66 143.93 30.92 Favored 'Trans proline' 1 N--CA 1.539 4.197 0 CA-C-N 122.656 1.984 . . . . 0.0 109.974 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.03 175.1 48.42 Favored Glycine 1 N--CA 1.516 4.014 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 70.4 m -101.89 27.77 6.25 Favored 'General case' 0 N--CA 1.529 3.479 0 C-N-CA 124.741 1.216 . . . . 0.0 109.437 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.8 -26.79 68.32 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 124.232 1.013 . . . . 0.0 111.064 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 91.4 p -68.19 -30.81 70.0 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.535 0.734 . . . . 0.0 110.609 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.0 -46.9 57.58 Favored Glycine 0 N--CA 1.516 3.988 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.737 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 8.2 tp -71.29 -41.74 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . 0.411 ' O ' HG12 ' B' ' 218' ' ' VAL . 19.4 tt -60.57 -38.71 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.882 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 6.6 tp -72.78 -32.78 41.86 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.101 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.55 -29.41 47.96 Favored Glycine 0 N--CA 1.512 3.717 0 C-N-CA 124.183 0.897 . . . . 0.0 113.923 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . 0.411 HG12 ' O ' ' B' ' 215' ' ' ILE . 8.6 p -59.76 -38.55 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.97 0 CA-C-N 117.661 0.73 . . . . 0.0 110.998 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 67.1 p -65.17 -45.53 84.52 Favored 'General case' 0 N--CA 1.528 3.441 0 CA-C-O 121.456 0.646 . . . . 0.0 110.389 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.38 -32.0 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 C-N-CA 124.307 1.043 . . . . 0.0 110.602 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.21 -45.9 82.89 Favored 'General case' 0 N--CA 1.524 3.273 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.95 -41.81 97.49 Favored 'General case' 0 N--CA 1.519 3.0 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.27 -44.14 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.599 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.99 -32.75 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 O-C-N 121.293 -0.88 . . . . 0.0 111.457 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 5.4 tt -67.34 -47.54 70.17 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 122.959 0.503 . . . . 0.0 111.446 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 22.8 pt -69.14 -36.29 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 O-C-N 121.671 -0.643 . . . . 0.0 110.884 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.69 -37.36 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.793 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.49 -47.47 81.82 Favored 'General case' 0 N--CA 1.532 3.626 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 30.9 m -71.81 -34.53 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.577 0 O-C-N 121.939 -0.476 . . . . 0.0 110.605 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -65.61 -43.71 88.78 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.05 -37.0 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.744 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.73 -33.93 70.79 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.308 0.243 . . . . 0.0 110.986 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -74.29 -15.7 60.96 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 122.894 0.478 . . . . 0.0 111.291 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 20.7 t -63.68 -29.13 70.4 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-O 121.467 0.651 . . . . 0.0 109.743 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 57.2 tp -72.18 -31.48 65.96 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.945 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.28 -24.41 24.35 Favored 'General case' 0 N--CA 1.538 3.935 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 61.0 t-105 -69.46 -3.04 12.83 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.639 0.776 . . . . 0.0 110.926 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 168.3 1.07 Allowed 'General case' 0 N--CA 1.527 3.425 0 C-N-CA 123.693 0.797 . . . . 0.0 112.1 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -175.57 171.38 2.79 Favored 'General case' 0 N--CA 1.528 3.445 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 8.0 p -135.39 137.22 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.537 0 C-N-CA 124.537 1.135 . . . . 0.0 108.724 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 60.7 mt -98.36 146.74 32.07 Favored Pre-proline 0 N--CA 1.528 3.427 0 CA-C-O 117.275 -1.345 . . . . 0.0 108.273 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 1 N--CA 1.54 4.25 0 CA-C-N 122.086 1.781 . . . . 0.0 110.679 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 CA--C 1.586 2.354 0 CA-C-O 117.456 -1.259 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -88.79 150.76 6.04 Favored 'Trans proline' 0 N--CA 1.535 3.95 0 C-N-CA 122.534 2.156 . . . . 0.0 111.018 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.81 73.11 1.49 Allowed Glycine 1 N--CA 1.517 4.083 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 98.3 p -66.63 124.17 22.11 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.711 0.804 . . . . 0.0 110.48 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.29 -26.9 68.28 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.926 0.89 . . . . 0.0 109.719 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 46.7 t -68.42 -26.17 65.4 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 123.524 0.73 . . . . 0.0 110.808 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.1 -46.34 66.07 Favored Glycine 0 N--CA 1.514 3.852 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.875 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.4 tt -70.72 -38.17 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.867 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 15.4 pt -57.04 -43.15 80.61 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.685 0 CA-C-N 119.584 1.084 . . . . 0.0 111.946 -176.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 6.1 tp -73.01 -32.97 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -63.17 -45.57 95.06 Favored Glycine 1 N--CA 1.518 4.121 0 C-N-CA 123.869 0.747 . . . . 0.0 113.292 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.65 -36.68 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 O-C-N 121.954 -0.733 . . . . 0.0 109.776 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 37.6 m -60.54 -47.08 87.75 Favored 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.74 -31.39 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 123.621 0.769 . . . . 0.0 111.23 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.13 -34.3 56.14 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.483 0.713 . . . . 0.0 112.801 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.8 -50.79 39.51 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.17 -38.44 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.665 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.48 -32.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 0 CA-C-N 118.255 0.479 . . . . 0.0 110.99 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.96 -42.47 99.16 Favored 'General case' 0 N--CA 1.532 3.641 0 O-C-N 122.198 -0.314 . . . . 0.0 110.428 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -57.22 -36.63 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.629 0 C-N-CA 123.317 0.647 . . . . 0.0 110.636 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.52 -37.81 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 123.444 0.697 . . . . 0.0 109.847 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.97 76.76 Favored 'General case' 0 N--CA 1.529 3.487 0 C-N-CA 123.107 0.563 . . . . 0.0 111.219 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.61 -34.76 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.35 0.66 . . . . 0.0 110.15 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -63.81 -43.8 95.18 Favored 'General case' 0 N--CA 1.531 3.596 0 C-N-CA 123.132 0.573 . . . . 0.0 112.243 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 6.8 p -68.87 -37.46 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.675 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 82.2 m -58.84 -27.77 65.43 Favored 'General case' 0 N--CA 1.531 3.575 0 C-N-CA 122.624 0.37 . . . . 0.0 110.833 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -70.87 -22.05 62.34 Favored 'General case' 0 N--CA 1.528 3.459 0 C-N-CA 123.102 0.561 . . . . 0.0 110.942 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 68.6 p -63.81 -26.49 68.65 Favored 'General case' 0 N--CA 1.534 3.742 0 C-N-CA 123.283 0.633 . . . . 0.0 111.552 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.78 -14.46 21.68 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 124.12 0.968 . . . . 0.0 111.43 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.29 8.04 26.0 Favored 'General case' 0 N--CA 1.538 3.971 0 C-N-CA 123.456 0.702 . . . . 0.0 109.243 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -83.57 26.25 0.69 Allowed 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 124.158 0.983 . . . . 0.0 109.493 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -62.41 -46.26 89.41 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 123.838 0.855 . . . . 0.0 110.863 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -69.13 145.62 53.2 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 123.572 0.749 . . . . 0.0 110.325 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 24.4 m -135.25 138.42 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 C-N-CA 124.929 1.292 . . . . 0.0 108.205 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.66 146.53 31.6 Favored Pre-proline 0 N--CA 1.529 3.487 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo . . . . . 1 N--CA 1.54 4.264 0 C-N-CA 122.021 1.814 . . . . 0.0 110.686 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.578 2.026 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -77.68 -176.61 3.31 Favored 'Trans proline' 0 N--CA 1.534 3.91 0 C-N-CA 122.127 1.885 . . . . 0.0 110.387 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 69.55 71.11 1.04 Allowed Glycine 1 N--CA 1.517 4.091 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 43.0 t -63.9 149.74 46.48 Favored 'General case' 0 N--CA 1.519 2.98 0 C-N-CA 123.802 0.841 . . . . 0.0 111.587 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -24.91 67.61 Favored 'General case' 0 N--CA 1.527 3.385 0 C-N-CA 124.765 1.226 . . . . 0.0 110.968 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 90.3 p -57.19 -25.53 59.15 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 124.133 0.973 . . . . 0.0 111.96 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.26 -35.63 83.15 Favored Glycine 0 N--CA 1.514 3.858 0 N-CA-C 115.381 0.912 . . . . 0.0 115.381 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 13.0 tt -59.38 -35.07 56.45 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.512 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 16.8 tt -55.69 -31.19 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.874 0 C-N-CA 123.862 0.865 . . . . 0.0 112.918 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.08 -33.57 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.13 -45.22 96.5 Favored Glycine 1 N--CA 1.522 4.419 0 C-N-CA 123.661 0.648 . . . . 0.0 114.298 -177.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -59.72 -36.08 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.962 0 CA-C-N 117.636 0.718 . . . . 0.0 110.231 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 24.5 p -55.9 -45.05 78.76 Favored 'General case' 0 N--CA 1.536 3.847 0 CA-C-O 120.988 0.423 . . . . 0.0 111.408 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.9 t -58.11 -40.64 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 124.15 0.98 . . . . 0.0 112.289 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.51 -45.93 66.46 Favored 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.57 -42.12 71.49 Favored 'General case' 0 N--CA 1.52 3.026 0 C-N-CA 122.691 0.396 . . . . 0.0 111.489 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.01 -43.6 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.156 0 C-N-CA 123.221 0.609 . . . . 0.0 112.42 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.76 -32.85 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.786 0 CA-C-N 118.51 0.596 . . . . 0.0 111.845 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 51.6 tp -66.0 -41.88 90.46 Favored 'General case' 0 N--CA 1.53 3.546 0 CA-C-N 118.034 0.379 . . . . 0.0 110.609 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 93.1 mt -57.48 -37.43 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 C-N-CA 122.782 0.433 . . . . 0.0 110.527 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.92 -44.12 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 122.847 0.459 . . . . 0.0 110.056 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.96 -45.03 87.33 Favored 'General case' 0 N--CA 1.527 3.417 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.72 -33.89 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.685 0 O-C-N 121.583 -0.698 . . . . 0.0 109.684 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -63.81 -43.39 96.4 Favored 'General case' 0 N--CA 1.529 3.502 0 C-N-CA 123.255 0.622 . . . . 0.0 112.489 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.56 -36.82 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 CA-C-N 118.704 0.684 . . . . 0.0 109.645 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 73.6 m -57.9 -27.33 63.22 Favored 'General case' 0 N--CA 1.528 3.451 0 C-N-CA 122.8 0.44 . . . . 0.0 111.017 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -63.76 -27.67 69.35 Favored 'General case' 0 N--CA 1.532 3.657 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 53.2 p -64.19 -34.43 78.07 Favored 'General case' 0 N--CA 1.527 3.405 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -27.55 67.72 Favored 'General case' 0 N--CA 1.526 3.353 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.591 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 38.9 mt -86.82 -28.11 23.12 Favored 'General case' 0 N--CA 1.533 3.724 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -77.9 101.74 6.96 Favored 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.4 159.85 10.79 Favored 'General case' 0 N--CA 1.519 3.006 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -70.06 121.35 17.29 Favored 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 123.949 0.9 . . . . 0.0 110.085 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.3 138.21 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.403 0 C-N-CA 124.976 1.31 . . . . 0.0 107.767 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.58 146.61 31.77 Favored Pre-proline 0 N--CA 1.529 3.489 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo . . . . . 1 N--CA 1.54 4.261 0 C-N-CA 122.182 1.921 . . . . 0.0 110.657 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 CA--C 1.582 2.197 0 CA-C-O 117.542 -1.218 . . . . 0.0 111.636 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.39 -1.99 6.82 Favored 'Trans proline' 1 N--CA 1.538 4.136 0 C-N-CA 122.615 2.21 . . . . 0.0 111.803 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . -79.44 31.16 2.15 Favored Glycine 1 N--CA 1.52 4.258 0 C-N-CA 123.825 0.726 . . . . 0.0 111.525 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 45.3 t -65.58 159.9 23.66 Favored 'General case' 0 N--CA 1.52 3.044 0 C-N-CA 123.651 0.78 . . . . 0.0 111.332 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.1 -26.61 68.29 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 124.318 1.047 . . . . 0.0 110.403 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 93.1 p -63.08 -25.73 68.5 Favored 'General case' 0 N--CA 1.522 3.155 0 C-N-CA 123.668 0.787 . . . . 0.0 111.134 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -67.53 -46.72 67.16 Favored Glycine 0 N--CA 1.516 3.973 0 CA-C-N 116.061 -0.518 . . . . 0.0 114.28 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.46 -40.2 72.04 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.07 0 CA-C-N 118.179 0.989 . . . . 0.0 113.659 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 18.0 pt -58.94 -40.53 80.62 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.453 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -175.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 17.2 tt -72.08 -32.33 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.811 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.2 -28.87 43.61 Favored Glycine 0 N--CA 1.515 3.954 0 C-N-CA 123.94 0.781 . . . . 0.0 113.206 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 4.4 m -59.34 -37.13 67.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.043 0 CA-C-N 117.501 0.651 . . . . 0.0 110.83 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 62.0 p -59.28 -45.19 91.92 Favored 'General case' 0 N--CA 1.527 3.421 0 C-N-CA 123.338 0.655 . . . . 0.0 111.801 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.69 -35.22 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.341 0 C-N-CA 123.607 0.763 . . . . 0.0 109.915 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.3 -34.23 77.66 Favored 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 123.497 0.719 . . . . 0.0 110.883 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.53 91.26 Favored 'General case' 0 N--CA 1.519 3.021 0 C-N-CA 123.135 0.574 . . . . 0.0 111.614 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 45.9 t -61.72 -52.8 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.612 0 C-N-CA 123.087 0.555 . . . . 0.0 111.851 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.96 -32.09 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 C-N-CA 122.717 0.407 . . . . 0.0 111.026 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.71 -35.28 79.24 Favored 'General case' 1 N--CA 1.541 4.101 0 C-N-CA 122.815 0.446 . . . . 0.0 110.617 -179.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 81.3 mt -69.28 -35.68 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.16 -36.21 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 C-N-CA 123.257 0.623 . . . . 0.0 109.692 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.35 -42.38 81.88 Favored 'General case' 0 N--CA 1.526 3.367 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 6.3 m -71.73 -34.49 52.09 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.047 0 CA-C-N 119.063 0.847 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -62.53 -43.76 98.03 Favored 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 123.334 0.654 . . . . 0.0 112.383 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 6.9 p -68.72 -37.43 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.58 -27.75 69.17 Favored 'General case' 0 N--CA 1.528 3.475 0 C-N-CA 123.02 0.528 . . . . 0.0 110.627 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -74.26 -18.4 60.73 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.467 0.707 . . . . 0.0 110.593 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 26.7 t -63.5 -46.37 86.43 Favored 'General case' 0 N--CA 1.529 3.494 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.22 -13.58 58.64 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 123.506 0.722 . . . . 0.0 112.584 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 53.0 tp -87.14 -8.77 56.62 Favored 'General case' 0 N--CA 1.538 3.925 0 C-N-CA 123.566 0.747 . . . . 0.0 110.287 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -58.79 -1.28 0.14 Allowed 'General case' 0 N--CA 1.531 3.601 0 C-N-CA 123.966 0.906 . . . . 0.0 112.792 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -59.59 167.3 2.07 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.32 0.648 . . . . 0.0 110.081 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -165.8 113.85 0.95 Allowed 'General case' 0 N--CA 1.523 3.22 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.46 138.51 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 124.903 1.281 . . . . 0.0 108.436 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.568 ' H ' HD23 ' E' ' 241' ' ' LEU . 1.6 pt? -94.14 147.12 32.85 Favored Pre-proline 0 N--CA 1.532 3.656 0 CA-C-O 116.88 -1.533 . . . . 0.0 109.87 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo . . . . . 1 N--CA 1.551 4.911 0 C-N-CA 122.882 2.388 . . . . 0.0 114.876 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 17.2 ptm . . . . . 0 CA--C 1.574 1.877 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -67.79 -171.57 0.34 Allowed 'Trans proline' 1 N--CA 1.543 4.401 0 C-N-CA 122.337 2.025 . . . . 0.0 110.836 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . 76.02 162.07 12.02 Favored Glycine 0 N--CA 1.516 3.999 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 41.3 t -170.89 113.47 0.41 Allowed 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 124.001 0.92 . . . . 0.0 108.969 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.1 -28.69 69.62 Favored 'General case' 0 N--CA 1.528 3.443 0 C-N-CA 123.894 0.878 . . . . 0.0 109.617 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 96.2 p -68.39 -35.52 77.8 Favored 'General case' 0 N--CA 1.521 3.12 0 C-N-CA 123.415 0.686 . . . . 0.0 109.988 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.27 -47.05 54.61 Favored Glycine 0 N--CA 1.512 3.736 0 CA-C-N 115.03 -0.986 . . . . 0.0 114.646 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.0 -41.85 68.28 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.201 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . . . . . . . . . 20.2 tt -56.87 -32.45 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -31.86 43.96 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.666 0 CA-C-N 120.291 1.405 . . . . 0.0 109.038 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.94 -36.18 60.03 Favored Glycine 0 N--CA 1.51 3.617 0 C-N-CA 124.172 0.892 . . . . 0.0 114.646 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.92 -38.24 75.6 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.17 0 CA-C-N 118.508 1.154 . . . . 0.0 111.015 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 29.9 p -66.41 -45.99 78.07 Favored 'General case' 0 N--CA 1.528 3.468 0 CA-C-O 121.617 0.722 . . . . 0.0 110.334 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 58.0 t -69.48 -33.9 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.006 0 C-N-CA 124.714 1.205 . . . . 0.0 110.535 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.16 68.97 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.51 91.92 Favored 'General case' 0 N--CA 1.518 2.928 0 C-N-CA 123.3 0.64 . . . . 0.0 111.275 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 43.4 t -66.75 -48.91 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.314 0 C-N-CA 123.599 0.76 . . . . 0.0 110.556 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.51 -33.83 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.552 0 C-N-CA 123.278 0.631 . . . . 0.0 110.094 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 33.7 tp -67.21 -34.16 76.9 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 123.247 0.619 . . . . 0.0 110.339 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 39.4 mt -64.66 -41.1 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.893 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.56 -37.89 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 C-N-CA 122.975 0.51 . . . . 0.0 109.825 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.43 71.01 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.695 0.798 . . . . 0.0 112.278 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.38 -33.97 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.945 0 C-N-CA 122.814 0.446 . . . . 0.0 110.244 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -65.98 -44.21 85.58 Favored 'General case' 0 N--CA 1.531 3.588 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.87 -37.73 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 O-C-N 122.232 -0.292 . . . . 0.0 110.55 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 8.3 p -58.74 -27.38 64.88 Favored 'General case' 0 N--CA 1.536 3.845 0 O-C-N 122.218 -0.301 . . . . 0.0 111.248 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -59.88 -18.68 46.36 Favored 'General case' 0 N--CA 1.531 3.62 0 C-N-CA 123.279 0.632 . . . . 0.0 111.203 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 51.5 m -70.34 -30.57 67.57 Favored 'General case' 0 N--CA 1.53 3.538 0 C-N-CA 123.544 0.738 . . . . 0.0 110.362 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 64.4 mt -60.49 -13.12 11.93 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 124.398 1.079 . . . . 0.0 111.752 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.57 10.5 13.0 Favored 'General case' 0 N--CA 1.532 3.635 0 C-N-CA 123.196 0.598 . . . . 0.0 110.067 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 59.64 116.24 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.314 0 C-N-CA 124.601 1.161 . . . . 0.0 112.257 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -139.94 105.57 5.12 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 125.099 1.36 . . . . 0.0 107.868 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -132.33 -173.67 3.23 Favored 'General case' 0 N--CA 1.531 3.584 0 C-N-CA 124.839 1.256 . . . . 0.0 108.463 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.26 138.11 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 C-N-CA 124.678 1.191 . . . . 0.0 108.566 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.55 146.53 32.19 Favored Pre-proline 0 N--CA 1.529 3.497 0 CA-C-O 117.247 -1.359 . . . . 0.0 108.421 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo . . . . . 1 N--CA 1.54 4.209 0 CA-C-N 122.23 1.832 . . . . 0.0 110.042 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 64.2 mtp . . . . . 0 CA--C 1.585 2.305 0 CA-C-O 117.509 -1.234 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -87.88 -169.99 0.51 Allowed 'Trans proline' 0 N--CA 1.536 3.995 0 C-N-CA 122.649 2.233 . . . . 0.0 110.819 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -169.94 153.29 21.24 Favored Glycine 1 N--CA 1.519 4.181 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.3 p -97.83 41.92 1.11 Allowed 'General case' 0 N--CA 1.526 3.354 0 C-N-CA 124.685 1.194 . . . . 0.0 109.38 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 54.2 tp -59.98 -26.41 66.02 Favored 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 124.264 1.026 . . . . 0.0 110.978 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 71.2 m -57.43 -26.15 60.73 Favored 'General case' 0 N--CA 1.526 3.327 0 C-N-CA 123.735 0.814 . . . . 0.0 111.62 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.35 92.66 Favored Glycine 0 N--CA 1.509 3.566 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.91 -46.22 94.2 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.483 0 CA-C-N 118.772 1.286 . . . . 0.0 112.967 -175.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -67.66 -32.13 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.384 0.674 . . . . 0.0 110.323 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 90.4 mt -66.06 -34.06 67.72 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.013 0 C-N-CA 123.054 0.542 . . . . 0.0 109.848 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.69 -29.81 64.79 Favored Glycine 1 N--CA 1.517 4.055 0 CA-C-O 119.831 -0.427 . . . . 0.0 113.675 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.5 m -61.77 -37.11 77.3 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.29 0 CA-C-N 117.764 0.782 . . . . 0.0 110.907 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.6 p -55.51 -43.39 75.62 Favored 'General case' 0 N--CA 1.524 3.234 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.159 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.96 -45.99 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.073 0 C-N-CA 123.824 0.85 . . . . 0.0 110.843 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.46 -45.13 65.95 Favored 'General case' 0 N--CA 1.527 3.403 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.32 90.22 Favored 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 122.953 0.501 . . . . 0.0 111.769 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.2 t -66.66 -39.78 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 122.91 0.484 . . . . 0.0 110.693 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.92 -39.78 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.585 0 C-N-CA 122.863 0.465 . . . . 0.0 110.837 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.26 -37.22 84.63 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 117.897 0.317 . . . . 0.0 111.519 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 99.3 mt -64.27 -42.59 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.621 0 C-N-CA 123.308 0.643 . . . . 0.0 110.028 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.76 -41.74 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.25 -45.5 87.68 Favored 'General case' 0 N--CA 1.525 3.309 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.73 -34.31 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 O-C-N 121.723 -0.611 . . . . 0.0 110.08 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.42 -44.24 95.96 Favored 'General case' 0 N--CA 1.529 3.516 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.7 m -68.65 -37.42 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 CA-C-O 121.212 0.53 . . . . 0.0 109.683 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 70.9 m -63.39 -46.08 88.1 Favored 'General case' 0 N--CA 1.523 3.178 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.26 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.67 -19.02 35.74 Favored 'General case' 0 N--CA 1.536 3.857 0 C-N-CA 122.744 0.418 . . . . 0.0 112.007 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 52.0 m -74.59 -40.17 61.76 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 51.0 mt -68.71 -29.16 67.54 Favored 'General case' 0 N--CA 1.524 3.264 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.511 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.04 10.58 16.1 Favored 'General case' 1 N--CA 1.545 4.324 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 54.6 t90 -139.81 70.78 1.37 Allowed 'General case' 0 N--CA 1.53 3.557 0 C-N-CA 124.176 0.99 . . . . 0.0 108.875 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -133.74 -18.56 2.13 Favored 'General case' 0 N--CA 1.534 3.765 0 C-N-CA 125.108 1.363 . . . . 0.0 109.139 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -163.68 86.81 0.51 Allowed 'General case' 0 N--CA 1.525 3.283 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.56 130.51 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.459 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 60.7 tp -133.36 99.42 14.56 Favored Pre-proline 0 N--CA 1.531 3.581 0 C-N-CA 124.843 1.257 . . . . 0.0 108.478 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo . . . . . 1 N--CA 1.547 4.624 0 C-N-CA 122.331 2.021 . . . . 0.0 114.199 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 CA--C 1.577 2.005 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -47.46 -67.63 0.11 Allowed 'Trans proline' 1 N--CA 1.545 4.545 0 C-N-CA 122.694 2.263 . . . . 0.0 114.12 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 63.19 122.64 0.01 OUTLIER Glycine 1 N--CA 1.523 4.442 0 C-N-CA 123.912 0.768 . . . . 0.0 111.636 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 68.1 m -162.8 89.46 0.66 Allowed 'General case' 0 N--CA 1.524 3.228 0 CA-C-N 117.7 0.75 . . . . 0.0 109.646 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 50.2 mt -65.15 -26.64 68.26 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 124.262 1.025 . . . . 0.0 110.098 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.1 m -59.43 -37.1 77.21 Favored 'General case' 0 N--CA 1.525 3.325 0 C-N-CA 123.14 0.576 . . . . 0.0 110.662 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.33 -36.22 92.76 Favored Glycine 1 N--CA 1.522 4.422 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.07 -40.96 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 C-N-CA 124.27 1.028 . . . . 0.0 109.088 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 91.2 mt -67.71 -39.44 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 C-N-CA 124.674 1.189 . . . . 0.0 109.046 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 87.8 mt -71.15 -32.07 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.77 -29.27 41.13 Favored Glycine 0 N--CA 1.515 3.946 0 C-N-CA 123.74 0.686 . . . . 0.0 113.218 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 4.0 m -59.85 -37.36 71.4 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 117.79 0.795 . . . . 0.0 110.475 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.9 p -62.27 -45.57 92.68 Favored 'General case' 0 N--CA 1.528 3.428 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.382 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.13 -35.48 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.194 0 C-N-CA 124.149 0.98 . . . . 0.0 110.485 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.01 -34.55 68.29 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.358 0.663 . . . . 0.0 111.851 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.2 -42.08 72.82 Favored 'General case' 0 N--CA 1.516 2.864 0 C-N-CA 123.205 0.602 . . . . 0.0 111.403 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.2 t -58.99 -47.0 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.649 0 C-N-CA 123.565 0.746 . . . . 0.0 112.19 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.9 m -67.1 -32.28 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.468 0 C-N-CA 122.959 0.504 . . . . 0.0 111.635 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.82 -45.08 45.76 Favored 'General case' 0 N--CA 1.524 3.257 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.7 pt -68.86 -36.75 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.904 0 CA-C-N 118.432 0.56 . . . . 0.0 112.468 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.21 -36.96 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 O-C-N 121.532 -0.73 . . . . 0.0 110.151 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.62 -44.98 85.93 Favored 'General case' 0 N--CA 1.526 3.366 0 C-N-CA 123.56 0.744 . . . . 0.0 112.977 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 13.7 m -71.19 -34.19 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 O-C-N 121.737 -0.602 . . . . 0.0 110.543 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -63.07 -44.49 95.65 Favored 'General case' 0 N--CA 1.531 3.612 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.06 -37.54 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.615 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.94 -29.22 66.96 Favored 'General case' 0 N--CA 1.527 3.411 0 C-N-CA 122.714 0.406 . . . . 0.0 111.424 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -64.19 -15.93 60.91 Favored 'General case' 1 N--CA 1.539 4.009 0 CA-C-N 118.048 0.386 . . . . 0.0 111.075 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 41.5 m -64.64 -34.34 78.06 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 51.1 tp -70.08 -28.19 65.22 Favored 'General case' 0 N--CA 1.526 3.335 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.139 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.95 11.05 14.43 Favored 'General case' 0 N--CA 1.538 3.934 0 C-N-CA 123.884 0.874 . . . . 0.0 109.582 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -155.79 107.47 2.56 Favored 'General case' 0 N--CA 1.526 3.333 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -166.07 10.3 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 123.702 0.801 . . . . 0.0 110.266 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.97 141.29 57.65 Favored 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 124.07 0.948 . . . . 0.0 110.099 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 52.2 t -122.19 137.13 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 C-N-CA 125.036 1.335 . . . . 0.0 107.404 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 7.9 mp -94.2 146.77 32.18 Favored Pre-proline 0 N--CA 1.53 3.543 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 1 N--CA 1.54 4.223 0 C-N-CA 122.139 1.892 . . . . 0.0 110.545 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.573 1.85 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -76.97 48.89 2.62 Favored 'Trans proline' 1 N--CA 1.538 4.13 0 C-N-CA 122.138 1.892 . . . . 0.0 110.056 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.95 81.1 0.21 Allowed Glycine 1 N--CA 1.518 4.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.392 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 69.1 m -64.37 151.56 43.69 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 123.8 0.84 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -64.58 -26.82 68.57 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 124.078 0.951 . . . . 0.0 109.77 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 42.7 t -61.29 -38.66 87.59 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.931 0.892 . . . . 0.0 110.951 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.33 -41.96 76.48 Favored Glycine 0 N--CA 1.513 3.806 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.428 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 61.7 mt -70.62 -45.81 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 C-N-CA 124.498 1.119 . . . . 0.0 113.255 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 7.4 tp -56.63 -31.96 36.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.161 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.5 pp -66.98 -31.9 55.57 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.196 0 CA-C-N 119.336 0.971 . . . . 0.0 109.497 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.84 -36.15 59.5 Favored Glycine 0 N--CA 1.51 3.615 0 CA-C-N 115.614 -0.721 . . . . 0.0 114.788 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.46 -45.45 92.83 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 CA-C-N 118.279 1.04 . . . . 0.0 113.104 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 1.3 t -65.03 -45.25 86.25 Favored 'General case' 0 N--CA 1.538 3.945 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.7 -31.14 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.295 0 C-N-CA 122.987 0.515 . . . . 0.0 111.262 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.64 93.43 Favored 'General case' 0 N--CA 1.528 3.471 0 O-C-N 121.803 -0.56 . . . . 0.0 111.987 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.95 -48.03 81.14 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.81 -38.4 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.744 0 CA-C-N 118.196 0.453 . . . . 0.0 111.103 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.26 -40.94 86.01 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.009 0 CA-C-N 118.403 0.547 . . . . 0.0 110.356 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -34.34 77.69 Favored 'General case' 1 N--CA 1.54 4.055 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 tp -54.8 -36.94 38.89 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.401 0 C-N-CA 123.401 0.681 . . . . 0.0 110.483 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.65 -40.96 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 C-N-CA 123.416 0.687 . . . . 0.0 110.545 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.83 -35.61 71.13 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.42 0.688 . . . . 0.0 111.576 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -71.77 -36.61 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.298 0 C-N-CA 123.492 0.717 . . . . 0.0 111.728 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.93 -43.86 64.57 Favored 'General case' 0 N--CA 1.531 3.613 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.42 -37.57 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.087 0.555 . . . . 0.0 110.983 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 15.0 p -62.21 -27.63 69.12 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 122.353 0.261 . . . . 0.0 111.394 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.72 -40.38 84.25 Favored 'General case' 0 N--CA 1.53 3.528 0 CA-C-O 121.007 0.432 . . . . 0.0 110.436 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.7 t -64.03 -22.45 66.94 Favored 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 123.791 0.836 . . . . 0.0 112.467 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.4 tp -67.41 -17.44 64.72 Favored 'General case' 0 N--CA 1.529 3.508 0 C-N-CA 123.345 0.658 . . . . 0.0 110.819 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.35 -28.49 22.18 Favored 'General case' 0 N--CA 1.531 3.584 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -95.72 96.13 8.79 Favored 'General case' 0 N--CA 1.529 3.485 0 C-N-CA 124.447 1.099 . . . . 0.0 108.993 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -169.82 9.77 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.382 0 C-N-CA 123.606 0.763 . . . . 0.0 110.511 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.18 137.57 54.95 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 123.382 0.673 . . . . 0.0 110.093 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.9 p -118.89 138.27 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.565 0 C-N-CA 125.176 1.39 . . . . 0.0 108.96 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 48.6 tp -95.13 104.92 16.63 Favored Pre-proline 0 N--CA 1.528 3.447 0 CA-C-O 117.3 -1.334 . . . . 0.0 107.808 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo . . . . . 1 N--CA 1.537 4.052 0 CA-C-N 122.713 2.005 . . . . 0.0 111.089 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 207' ' ' MET . . . . . . . . . . . . . 68.2 mtp . . . . . 0 CA--C 1.574 1.883 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 208' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.5 -28.25 8.53 Favored 'Trans proline' 0 N--CA 1.535 3.959 0 C-N-CA 122.293 1.995 . . . . 0.0 110.593 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.7 90.84 0.04 OUTLIER Glycine 1 N--CA 1.519 4.208 0 C-N-CA 123.657 0.646 . . . . 0.0 111.496 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 210' ' ' SER . . . . . . . . . . . . . 98.9 p -163.36 7.62 0.05 OUTLIER 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 123.783 0.833 . . . . 0.0 110.422 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.18 -26.83 68.32 Favored 'General case' 0 N--CA 1.528 3.475 0 C-N-CA 123.962 0.905 . . . . 0.0 109.099 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 212' ' ' SER . . . . . . . . . . . . . 69.4 m -57.73 -26.15 61.39 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 124.105 0.962 . . . . 0.0 110.907 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.41 -35.28 84.51 Favored Glycine 1 N--CA 1.517 4.072 0 C-N-CA 123.657 0.646 . . . . 0.0 113.102 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -46.98 94.94 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 CA-C-N 117.084 0.442 . . . . 0.0 111.89 -177.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 215' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.8 -31.76 55.15 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.556 0 C-N-CA 124.038 0.935 . . . . 0.0 109.811 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 216' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.29 -33.55 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 217' ' ' GLY . . . . . . . . . . . . . . . -65.29 -33.02 85.6 Favored Glycine 1 N--CA 1.52 4.289 0 C-N-CA 123.69 0.662 . . . . 0.0 112.159 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 218' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.23 -43.52 93.5 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.052 0 C-N-CA 124.194 0.997 . . . . 0.0 109.657 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 219' ' ' THR . . . . . . . . . . . . . 27.3 p -56.85 -45.31 82.52 Favored 'General case' 0 N--CA 1.525 3.313 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.373 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 49.9 t -67.75 -41.27 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.211 0 C-N-CA 124.251 1.021 . . . . 0.0 111.312 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.3 -44.74 65.2 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.58 81.13 Favored 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 123.254 0.621 . . . . 0.0 111.616 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 t -53.72 -39.49 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.927 0 C-N-CA 123.25 0.62 . . . . 0.0 111.857 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.45 -38.48 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.618 0 C-N-CA 122.768 0.427 . . . . 0.0 110.121 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 225' ' ' LEU . . . . . . . . . . . . . 73.2 mt -70.94 -34.57 71.62 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 122.958 0.503 . . . . 0.0 110.223 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 20.0 mm -60.41 -50.52 80.01 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 C-N-CA 123.532 0.733 . . . . 0.0 110.951 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 227' ' ' VAL . . . . . . . . . . . . . 31.6 m -66.62 -36.99 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 O-C-N 121.816 -0.553 . . . . 0.0 110.239 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.38 85.92 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.636 0.775 . . . . 0.0 112.594 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 34.4 m -71.98 -34.53 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.696 0 O-C-N 121.823 -0.548 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 230' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.58 -43.85 95.77 Favored 'General case' 0 N--CA 1.53 3.525 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 231' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.37 -37.22 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 232' ' ' CYS . . . . . . . . . . . . . 74.3 m -58.76 -27.07 64.61 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.076 0.551 . . . . 0.0 111.845 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 233' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.54 -33.21 73.44 Favored 'General case' 0 N--CA 1.537 3.887 0 CA-C-N 118.343 0.519 . . . . 0.0 110.79 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 234' ' ' SER . . . . . . . . . . . . . 35.5 t -67.07 -27.86 67.72 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.155 0.582 . . . . 0.0 110.217 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 235' ' ' LEU . . . . . . . . . . . . . 51.4 tp -89.77 -13.9 35.72 Favored 'General case' 0 N--CA 1.524 3.254 0 C-N-CA 124.947 1.299 . . . . 0.0 110.378 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 236' ' ' LEU . . . . . . . . . . . . . 39.7 tp -85.67 -1.69 57.42 Favored 'General case' 1 N--CA 1.545 4.287 0 CA-C-O 121.046 0.45 . . . . 0.0 109.999 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 237' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -139.8 -159.56 0.97 Allowed 'General case' 0 N--CA 1.522 3.125 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 64.27 161.83 0.12 Allowed 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 123.762 0.825 . . . . 0.0 110.283 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 239' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? 59.02 17.59 5.58 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 124.218 1.007 . . . . 0.0 110.915 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . . . . . . . . . 16.3 m -117.27 138.29 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 C-N-CA 124.93 1.292 . . . . 0.0 108.152 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 75.5 mt -121.92 146.44 46.15 Favored Pre-proline 0 N--CA 1.53 3.566 0 CA-C-O 116.493 -1.718 . . . . 0.0 107.445 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 242' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo . . . . . 1 N--CA 1.548 4.733 0 CA-C-N 123.074 2.134 . . . . 0.0 114.526 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 207' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.574 1.867 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 208' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -48.02 103.23 0.05 OUTLIER 'Trans proline' 1 N--CA 1.543 4.428 0 C-N-CA 122.707 2.271 . . . . 0.0 114.142 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 209' ' ' GLY . . . . . . . . . . . . . . . 63.16 167.82 0.9 Allowed Glycine 1 N--CA 1.519 4.209 0 C-N-CA 123.748 0.69 . . . . 0.0 112.331 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 210' ' ' SER . . . . . . . . . . . . . 41.2 t -172.5 -54.4 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.978 0 C-N-CA 124.26 1.024 . . . . 0.0 108.577 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 211' ' ' LEU . . . . . . . . . . . . . 58.3 tp -64.24 -27.04 68.78 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 124.152 0.981 . . . . 0.0 110.216 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 212' ' ' SER . . . . . . . . . . . . . 53.8 m -62.02 -25.91 67.93 Favored 'General case' 0 N--CA 1.518 2.955 0 C-N-CA 124.413 1.085 . . . . 0.0 110.681 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.85 -46.72 71.74 Favored Glycine 0 N--CA 1.51 3.62 0 CA-C-N 115.22 -0.9 . . . . 0.0 114.684 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 214' ' ' ILE . . . . . . . . . . . . . 29.6 pt -71.04 -38.81 73.36 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 CA-C-N 118.826 1.313 . . . . 0.0 113.961 -177.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 215' ' ' ILE . . . . . . . . . . . . . 6.7 tp -62.88 -32.52 56.22 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 C-N-CA 123.239 0.616 . . . . 0.0 112.497 -176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 216' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.8 -34.03 45.64 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.18 -45.15 83.48 Favored Glycine 0 N--CA 1.515 3.921 0 C-N-CA 124.8 1.191 . . . . 0.0 115.155 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 218' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.34 -37.41 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 CA-C-N 117.381 0.591 . . . . 0.0 110.779 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 219' ' ' THR . . . . . . . . . . . . . 35.6 p -66.35 -47.27 73.96 Favored 'General case' 0 N--CA 1.532 3.644 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 220' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.63 -31.88 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 C-N-CA 123.301 0.64 . . . . 0.0 112.269 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.77 -47.26 70.89 Favored 'General case' 0 N--CA 1.532 3.633 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.59 97.47 Favored 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 123.475 0.71 . . . . 0.0 111.679 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.47 -49.03 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 C-N-CA 123.651 0.78 . . . . 0.0 111.989 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 224' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.84 -32.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 C-N-CA 123.321 0.648 . . . . 0.0 110.539 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 225' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.33 -39.93 94.88 Favored 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 123.124 0.57 . . . . 0.0 110.143 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.34 -37.7 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 C-N-CA 122.927 0.491 . . . . 0.0 110.426 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.15 -37.85 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.897 0 C-N-CA 123.09 0.556 . . . . 0.0 110.28 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.41 -32.27 68.49 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.339 0.655 . . . . 0.0 111.611 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 229' ' ' VAL . . . . . . . . . . . . . 44.5 t -70.57 -43.75 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.458 0 C-N-CA 123.299 0.64 . . . . 0.0 111.659 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 230' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -62.19 -43.49 98.72 Favored 'General case' 1 N--CA 1.54 4.055 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 231' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.14 -38.38 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.608 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 232' ' ' CYS . . . . . . . . . . . . . 95.4 m -67.68 -40.1 84.42 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 122.831 0.452 . . . . 0.0 110.449 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 233' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -72.72 -31.16 64.77 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 123.473 0.709 . . . . 0.0 110.454 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 234' ' ' SER . . . . . . . . . . . . . 46.2 t -64.44 -34.28 77.82 Favored 'General case' 0 N--CA 1.526 3.328 0 C-N-CA 123.451 0.7 . . . . 0.0 110.765 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 235' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.75 -34.54 67.09 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 124.358 1.063 . . . . 0.0 109.747 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 236' ' ' LEU . . . . . . . . . . . . . 4.6 tt -87.24 -9.0 56.2 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 124.389 1.075 . . . . 0.0 111.633 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 237' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -52.27 -38.26 57.77 Favored 'General case' 0 N--CA 1.528 3.47 0 C-N-CA 123.789 0.835 . . . . 0.0 112.129 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 238' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -64.92 134.35 53.78 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 123.377 0.671 . . . . 0.0 110.545 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 239' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt 61.61 145.14 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 124.637 1.175 . . . . 0.0 111.196 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 240' ' ' VAL . . . . . . . . . . . . . 47.8 t -135.12 129.27 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 C-N-CA 124.691 1.196 . . . . 0.0 107.834 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.64 146.66 31.85 Favored Pre-proline 0 N--CA 1.529 3.51 0 CA-C-O 116.558 -1.686 . . . . 0.0 107.039 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 242' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo . . . . . 1 N--CA 1.55 4.844 0 C-N-CA 122.928 2.419 . . . . 0.0 115.112 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 207' ' ' MET . . . . . . . . . . . . . 52.3 tpp . . . . . 0 CA--C 1.573 1.844 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' 208' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -81.12 133.78 8.97 Favored 'Trans proline' 0 N--CA 1.533 3.805 0 C-N-CA 122.52 2.147 . . . . 0.0 109.945 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.53 -15.51 66.25 Favored Glycine 1 N--CA 1.519 4.189 0 C-N-CA 123.596 0.617 . . . . 0.0 112.206 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 210' ' ' SER . . . . . . . . . . . . . 50.7 m 58.77 90.04 0.05 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 124.301 1.04 . . . . 0.0 111.24 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 211' ' ' LEU . . . . . . . . . . . . . 44.7 mt -54.78 -25.79 30.31 Favored 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 124.885 1.274 . . . . 0.0 111.437 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 212' ' ' SER . . . . . . . . . . . . . 54.1 m -57.69 -36.42 71.94 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.583 0.753 . . . . 0.0 111.31 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.72 -39.52 86.03 Favored Glycine 1 N--CA 1.52 4.259 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.533 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 214' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.54 -46.27 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.895 0 C-N-CA 124.181 0.992 . . . . 0.0 110.993 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 215' ' ' ILE . . . . . 0.459 HD13 ' O ' ' F' ' 215' ' ' ILE . 0.0 OUTLIER -68.63 -32.17 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.983 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' F' F ' 216' ' ' ILE . . . . . . . . . . . . . 85.1 mt -73.3 -40.36 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.93 95.51 Favored Glycine 0 N--CA 1.512 3.748 0 CA-C-N 115.227 -0.897 . . . . 0.0 114.8 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 218' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.5 -37.08 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 CA-C-N 117.923 0.862 . . . . 0.0 111.448 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 219' ' ' THR . . . . . . . . . . . . . 68.5 p -65.93 -46.5 77.99 Favored 'General case' 0 N--CA 1.533 3.695 0 CA-C-O 120.931 0.396 . . . . 0.0 110.715 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 220' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.76 -35.45 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.22 0 C-N-CA 124.051 0.94 . . . . 0.0 110.508 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.12 67.41 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 222' ' ' ALA . . . . . . . . . . . . . . . -57.5 -34.53 69.18 Favored 'General case' 0 N--CA 1.521 3.077 0 C-N-CA 123.142 0.577 . . . . 0.0 112.017 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 223' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.42 -39.06 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.316 0 C-N-CA 123.048 0.539 . . . . 0.0 110.653 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 224' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.72 -41.32 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 123.427 0.691 . . . . 0.0 111.485 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 225' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.22 -35.69 77.9 Favored 'General case' 1 N--CA 1.54 4.026 0 C-N-CA 122.594 0.358 . . . . 0.0 110.743 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 68.7 mt -69.26 -40.9 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 227' ' ' VAL . . . . . . . . . . . . . 98.4 t -66.74 -37.97 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.465 0 C-N-CA 123.335 0.654 . . . . 0.0 109.442 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.08 -47.66 82.53 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.727 0.811 . . . . 0.0 112.696 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 229' ' ' VAL . . . . . . . . . . . . . 25.6 m -71.9 -34.51 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.651 0 O-C-N 121.993 -0.442 . . . . 0.0 110.195 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 230' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -63.86 -44.13 94.02 Favored 'General case' 0 N--CA 1.527 3.382 0 C-N-CA 123.053 0.541 . . . . 0.0 112.334 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 231' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.45 -37.7 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 232' ' ' CYS . . . . . . . . . . . . . 86.4 m -62.77 -27.95 69.64 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 122.92 0.488 . . . . 0.0 110.129 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 233' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -69.57 -16.86 63.49 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 123.173 0.589 . . . . 0.0 110.62 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 234' ' ' SER . . . . . . . . . . . . . 19.5 m -68.8 -28.69 66.99 Favored 'General case' 0 N--CA 1.53 3.565 0 C-N-CA 123.062 0.545 . . . . 0.0 110.232 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 235' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.22 -23.51 66.44 Favored 'General case' 0 N--CA 1.525 3.289 0 C-N-CA 123.727 0.811 . . . . 0.0 110.715 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 236' ' ' LEU . . . . . . . . . . . . . 8.2 mp -87.47 -26.16 23.37 Favored 'General case' 0 N--CA 1.534 3.732 0 C-N-CA 123.685 0.794 . . . . 0.0 109.215 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 237' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -73.64 92.52 1.97 Allowed 'General case' 0 N--CA 1.526 3.359 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 238' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -168.57 148.33 4.47 Favored 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 239' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' F' ' 240' ' ' VAL . 4.3 ttmp? -163.96 -19.66 0.03 OUTLIER 'General case' 0 N--CA 1.532 3.662 0 C-N-CA 123.618 0.767 . . . . 0.0 109.738 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 240' ' ' VAL . . . . . 0.409 ' H ' ' H ' ' F' ' 239' ' ' LYS . 7.7 p -112.46 138.2 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.518 0 C-N-CA 125.411 1.485 . . . . 0.0 108.966 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 241' ' ' LEU . . . . . 0.676 ' H ' HD23 ' F' ' 241' ' ' LEU . 1.5 pt? -110.89 146.52 34.62 Favored Pre-proline 0 N--CA 1.536 3.837 0 C-N-CA 125.39 1.476 . . . . 0.0 109.49 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 242' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 1 N--CA 1.541 4.303 0 CA-C-N 122.227 1.831 . . . . 0.0 110.392 -179.558 . . . . . . . . 1 1 . 1 stop_ save_